PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Marin-Royo, G; Rodriguez, C; Le Pape, A; Jurado-Lopez, R; Luaces, M; Antequera, A; Martinez-Gonzalez, J; Souza-Neto, FV; Nieto, ML; Martinez-Martinez, E; Cachofeiro, V				Marin-Royo, Gema; Rodriguez, Cristina; Le Pape, Aliaume; Jurado-Lopez, Raquel; Luaces, Maria; Antequera, Alfonso; Martinez-Gonzalez, Jose; Souza-Neto, Francisco V.; Luisa Nieto, Maria; Martinez-Martinez, Ernesto; Cachofeiro, Victoria			The role of mitochondrial oxidative stress in the metabolic alterations in diet-induced obesity in rats	FASEB JOURNAL			English	Article						insulin resistance; mitochondrial function; adipose tissue	ADIPOSE-TISSUE; INSULIN-RESISTANCE; LINKING OBESITY; WEIGHT-GAIN; PROFILE; GAMMA; INFLAMMATION; ANTIOXIDANT; DYSFUNCTION; BIOGENESIS	The impact of the mitochondria-targeted antioxidant MitoQ was evaluated in the metabolic alterations and the adipose tissue remodeling associated with obesity. Male Wistar rats were fed either a high-fat diet (HFD; 35% fat) or a standard diet (3.5% fat) for 7 wk and treated with MitoQ (200 mu M). A proteomic analysis of visceral adipose tissue from patients with obesity and patients without obesity was performed. MitoQ partially prevented the increase in body weight, adiposity, homeostasis model assessment index, and adipose tissue remodeling in HFD rats. It also ameliorated protein level changes of factors involved in insulin signaling observed in adipose tissue of obese rats: reductions in adiponectin and glucose transporter 4 (GLUT 4) and increases in dipeptidylpeptidase 4, suppressor of cytokine signaling 3 (SOCS3), and insulin receptor substrate 1 phosphorylation. MitoQ prevented down-regulation of adiponectin and GLUT 4 and increases in SOCS3 levels in a TNF-alpha-induced insulin-resistant 3T3-L1 adipocyte model. MitoQ also ameliorated alterations in mitochondrial proteins observed in obese rats: increases in cyclophylin F and camitine palmitoyl transferase 1A and reductions in mitofusinl, peroxiredoxin 4, and fumarate hydratase. The proteomic analysis of the visceral adipose tissue from patients with obesity show alterations in mitochondrial proteins similar to those observed in obese rats. Therefore, the data show the beneficial effect of MitoQ in the metabolic dysfunction induced by obesity.	[Marin-Royo, Gema; Le Pape, Aliaume; Jurado-Lopez, Raquel; Souza-Neto, Francisco V.; Martinez-Martinez, Ernesto; Cachofeiro, Victoria] Univ Complutense Madrid, IiSGM, Fac Med, Dept Fisiol, Madrid, Spain; [Rodriguez, Cristina] Hosp Santa Creu & Sant Pau, Inst Recerca, Inst Invest Biomed IIB St Pau, Barcelona, Spain; [Rodriguez, Cristina; Martinez-Gonzalez, Jose; Luisa Nieto, Maria; Martinez-Martinez, Ernesto; Cachofeiro, Victoria] Inst Salud Carlos III, Ciber Enfermedades Cardiovasc CIBERCV, Madrid, Spain; [Luaces, Maria] Hosp Clin San Carlos, Inst Cardiovasc, Serv Cardiol, Madrid, Spain; [Antequera, Alfonso] St Bernards Hosp, Surg Dept, Gibraltar Gi, Gibraltar; [Martinez-Gonzalez, Jose] CSIC, IIB St Pau, IIBB, Barcelona, Spain; [Luisa Nieto, Maria] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain	Complutense University of Madrid; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; Hospital Clinico San Carlos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Martinez-Martinez, E; Cachofeiro, V (corresponding author), Univ Complutense, Fac Med, Dept Fisiol, Ave Complutense S-N, E-28040 Madrid, Spain.	ernmarti@ucm.es; vcara@ucm.es	Rodriguez, Cristina/D-3099-2011; Martinez-Martinez, Ernesto/M-1376-2017; Antequera, Alfonso/ABB-1579-2021; Nieto, Marisa/G-7492-2015	Rodriguez, Cristina/0000-0002-6472-5647; Martinez-Martinez, Ernesto/0000-0002-3011-2041; Jurado Lopez, Raquel/0000-0002-9149-1073; Luaces, Maria/0000-0001-9529-9655; Nieto, Marisa/0000-0001-6842-799X; Vasconcelos de Souza Neto, Francisco das Chagas/0000-0003-3704-494X	Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [PI15/01060, PI18/00257, PI18/0919]; Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [Ciber de Enfermedades Cardiovasculares (CIBERCV)]; Way to Build Europe, Ministerio de Economia y Competitividad [SAF2016-81063]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Program of Support to Research Groups) [2017-SGR-00333]; Complementary and Alternative Medicine (Comunidad Aut'onoma de Madrid) (Atraccion de Talento);  [PT13/0001]	Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [Ciber de Enfermedades Cardiovasculares (CIBERCV)]; Way to Build Europe, Ministerio de Economia y Competitividad; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Program of Support to Research Groups); Complementary and Alternative Medicine (Comunidad Aut'onoma de Madrid) (Atraccion de Talento); 	The authors thank Avelina Hidalgo, Blanca Martinez, Virginia Peinado, and Roberto Canadas (Departamento de Fisiologia, Facultad de Medicina, Universidad Complutense de Madrid) for technical help; Isabel Ruppen, Javier Munoz, and Pilar Ximenez-Embun [Proteomics Unit of the Centro Nacional de Investigaciones Oncologicas (CNIO), ProteoRed, PRB2-ISCIII], supported by Grant PT13/0001; and Anthony DeMarco for help in editing. MitoQ was provided by M. P. Murphy (Medical Research Council Mitochondrial Biology Unit, Cambridge BioMedical Campus, Cambridge, United Kingdom). This work was supported by Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [PI15/01060, PI18/00257, PI18/0919, and Ciber de Enfermedades Cardiovasculares (CIBERCV)], a Way to Build Europe, Ministerio de Economia y Competitividad (SAF2016-81063), and Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Program of Support to Research Groups, 2017-SGR-00333). E.M.-M. was supported by a contract from Complementary and Alternative Medicine (Comunidad Aut ' onoma de Madrid) (Atraccion de Talento). The authors declare no conflicts of interest.	Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Bond ST, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00543; Coudray C, 2016, BRIT J NUTR, V115, P1155, DOI 10.1017/S0007114515005528; Cydylo MA, 2017, OBESITY, V25, P290, DOI 10.1002/oby.21720; Elrayess MA, 2017, FREE RADICAL BIO MED, V104, P129, DOI 10.1016/j.freeradbiomed.2017.01.015; Feillet-Coudray C, 2014, FREE RADICAL RES, V48, P1232, DOI 10.3109/10715762.2014.945079; Feng DR, 2011, DIABETES, V60, P2134, DOI 10.2337/db10-1411; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fink BD, 2014, J PHARMACOL EXP THER, V351, P699, DOI 10.1124/jpet.114.219329; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Fruhbeck G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06997-0; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haczeyni F, 2018, OBES REV, V19, P406, DOI 10.1111/obr.12646; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Ibarrola J, 2018, INT J CARDIOL, V258, P217, DOI 10.1016/j.ijcard.2017.12.103; Imai Y, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.393; Jeong EM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003046; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kline KG, 2008, J PROTEOME RES, V7, P5055, DOI 10.1021/pr800239e; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lopez-Lluch G, 2017, MECH AGEING DEV, V162, P108, DOI 10.1016/j.mad.2016.12.005; Ly LD, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.157; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Miana M, 2015, DIS MODEL MECH, V8, P543, DOI 10.1242/dmm.020107; Monzo-Beltran L, 2017, REDOX BIOL, V12, P389, DOI 10.1016/j.redox.2017.02.003; Palanivel R, 2012, DIABETOLOGIA, V55, P3083, DOI 10.1007/s00125-012-2665-3; Rivera-Barahona A, 2017, MOL GENET METAB, V122, P43, DOI 10.1016/j.ymgme.2017.07.009; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Tian ZM, 2009, HYPERTENSION, V54, P255, DOI 10.1161/HYPERTENSIONAHA.109.129528; Tol MJ, 2016, DIABETES, V65, P2591, DOI 10.2337/db16-0243; Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yin X, 2014, J CLIN ENDOCR METAB, V99, pE209, DOI 10.1210/jc.2013-3042; Zamora-Mendoza R, 2018, INT J OBESITY, V42, P618, DOI 10.1038/ijo.2017.274	41	23	23	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12060	12072		10.1096/fj.201900347RR	http://dx.doi.org/10.1096/fj.201900347RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370681	Green Published			2022-12-26	WOS:000507461600036
J	Kamikubo, K; Kato, H; Kioka, H; Yamazaki, S; Tsukamoto, O; Nishida, Y; Asano, Y; Imamura, H; Kawahara, H; Shintani, Y; Takashima, S				Kamikubo, Kenta; Kato, Hisakazu; Kioka, Hidetaka; Yamazaki, Satoru; Tsukamoto, Osamu; Nishida, Yuya; Asano, Yoshihiro; Imamura, Hiromi; Kawahara, Hiroyuki; Shintani, Yasunori; Takashima, Seiji			A molecular triage process mediated by RING finger protein 126 and BCL2-associated athanogene 6 regulates degradation of G(0)/G(1) switch gene 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small interfering RNA (siRNA); ubiquitin ligase; hypoxia; mitochondria; ATP; protein degradation; BCL2-associated athanogene 6; ischemic heart disease; RING finger protein 126 (RNF126)	POSITIVE REGULATOR; QUALITY-CONTROL; ATP LEVELS; RNF126; HYPOXIA; DEHYDROGENASE; ELIMINATION; ADAPTATION; KINASE	Oxidative phosphorylation generates most of the ATP in respiring cells. ATP is an essential energy source, especially in cardiomyocytes because of their continuous contraction and relaxation. Previously, we reported that G(0)/G(1) switch gene 2 (G0S2) positively regulates mitochondrial ATP production by interacting with FOF1-ATP synthase. G0S2 overexpression mitigates ATP decline in cardiomyocytes and strongly increases their hypoxic tolerance during ischemia. Here, we show that G0S2 protein undergoes proteasomal degradation via a cytosolic molecular triage system and that inhibiting this process increases mitochondrial ATP production in hypoxia. First, we performed screening with a library of siRNAs targeting ubiquitin-related genes and identified RING finger protein 126 (RNF126) as an E3 ligase involved in G0S2 degradation. RNF126-deficient cells exhibited prolonged G0S2 protein turnover and reduced G0S2 ubiquitination. BCL2-associated athanogene 6 (BAG6), involved in the molecular triage of nascent membrane proteins, enhanced RNF126-mediated G0S2 ubiquitination both in vitro and in vivo. Next, we found that Glu-44 in the hydrophobic region of G0S2 acts as a degron necessary for G0S2 polyubiquitination and proteasomal degradation. Because this degron was required for an interaction of G0S2 with BAG6, an alanine-replaced G0S2 mutant (E44A) escaped degradation. In primary cultured cardiomyocytes, both overexpression of the G0S2 E44A mutant and RNF126 knockdown effectively attenuated ATP decline under hypoxic conditions. We conclude that the RNF126/BAG6 complex contributes to G0S2 degradation and that interventions to prevent G0S2 degradation may offer a therapeutic strategy for managing ischemic diseases.	[Kamikubo, Kenta; Kato, Hisakazu; Tsukamoto, Osamu; Nishida, Yuya; Shintani, Yasunori; Takashima, Seiji] Osaka Univ, Dept Med Biochem, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Kioka, Hidetaka; Asano, Yoshihiro] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yamazaki, Satoru] Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Suita, Osaka 5658565, Japan; [Nishida, Yuya; Takashima, Seiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto 6068501, Japan; [Kawahara, Hiroyuki] Tokyo Metropolitan Univ, Dept Biol Sci, Lab Cell Biol & Biochem, Tokyo 1920397, Japan	Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan; Japan Science & Technology Agency (JST); Kyoto University; Tokyo Metropolitan University	Kato, H; Takashima, S (corresponding author), Osaka Univ, Dept Med Biochem, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan.; Takashima, S (corresponding author), Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan.	katohisa@medbio.med.osaka-u.ac.jp; takasima@cardiology.med.osaka-u.ac.jp	Imamura, Hiromi/AAD-5109-2019	Imamura, Hiromi/0000-0002-1896-0443; Kato, Hisakazu/0000-0003-4619-3680; Tsukamoto, Osamu/0000-0002-9504-8001; Shintani, Yasunori/0000-0001-9579-0727; nishida, yuya/0000-0002-1994-0807	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15H04820, JP26670402, JP15K19378, JP17K09577]; JSPS through the Funding Program for Next Generation World-Leading Researchers, NEXT Program, CSTP; JSPS [LS079]; Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency (CREST, JST) [JPMJCR14M2]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS through the Funding Program for Next Generation World-Leading Researchers, NEXT Program, CSTP; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency (CREST, JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP15H04820 and JP26670402 (to S. T.) and JP15K19378 and JP17K09577 (to H. Kato). This work was also supported by the JSPS through the Funding Program for Next Generation World-Leading Researchers, NEXT Program, CSTP, and JSPS Grant LS079 (to S. T.) and Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency Grant JPMJCR14M2 (CREST, JST) (to S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benini M, 2017, CELL REP, V18, P2007, DOI 10.1016/j.celrep.2017.01.079; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Guna A, 2018, CURR BIOL, V28, pR498, DOI 10.1016/j.cub.2018.02.004; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Heckmann BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156742; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Ishida N, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00347-16; Juszkiewicz S, 2018, MOL CELL, V71, P443, DOI 10.1016/j.molcel.2018.07.001; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shao SC, 2017, SCIENCE, V355, P298, DOI 10.1126/science.aah6130; Smith CJ, 2013, J CELL SCI, V126, P1366, DOI 10.1242/jcs.116129; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Wang LN, 2016, CANCER MED-US, V5, P2043, DOI 10.1002/cam4.771; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wertz IE, 2019, CELL CHEM BIOL, V26, P156, DOI 10.1016/j.chembiol.2018.10.022; Yamamoto K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14975-9; Yoshino S, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.19; Zhi X, 2013, CANCER RES, V73, P385, DOI 10.1158/0008-5472.CAN-12-0562	29	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14562	14573		10.1074/jbc.RA119.008544	http://dx.doi.org/10.1074/jbc.RA119.008544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31371451	Green Published, hybrid			2022-12-26	WOS:000497955000006
J	Rajamaki, ML; Lemmetty, A; Laamanen, J; Roininen, E; Vishwakarma, A; Streng, J; Latvala, S; Valkonen, JPT				Rajamaki, Minna-Liisa; Lemmetty, Anne; Laamanen, Jaana; Roininen, Elina; Vishwakarma, Archana; Streng, Janne; Latvala, Satu; Valkonen, Jari P. T.			Small-RNA analysis of pre-basic mother plants and conserved accessions of plant genetic resources for the presence of viruses	PLOS ONE			English	Article							YELLOW-NET-VIRUS; BUSHY-DWARF-VIRUS; BLACK-CURRANT; RT-PCR; MOTTLE-VIRUS; RUBUS-IDAEUS; HOST-RANGE; 1ST REPORT; RASPBERRY; SEQUENCE	Pathogen-free stocks of vegetatively propagated plants are crucial in certified plant production. They require regular monitoring of the plant germplasm for pathogens, especially of the stocks maintained in the field. Here we tested pre-basic mother plants of Fragaria, Rubus and Ribes spp., and conserved accessions of the plant genetic resources of Rubus spp. maintained at research stations in Finland, for the presence of viruses using small interfering RNA (siRNA) -based diagnostics (VirusDetect). The advance of the method is that unrelated viruses can be detected simultaneously without resumptions of the viruses present. While no virus was detected in pre-basic mother plants of Fragaria and Ribes species, rubus yellow net virus (RYNV) was detected in pre-basic mother plants of Rubus. Raspberry bushy dwarf virus (RBDV), black raspberry necrosis virus (BRNV), raspberry vein chlorosis virus (RVCV) and RYNV were detected in the Rubus genetic resource collection. The L polymerase encoding sequence characterized from seven RVCV isolates showed considerable genetic variation. The data provide the first molecular biological evidence for the presence of RYNV in Finland. RYNV was not revealed in virus indexing by indicator plants, which suggests that it may be endogenously present in some raspberry cultivars. In addition, a putative new RYNV-like badnavirus was detected in Rubus spp. Blackcurrant reversion virus (BRV) and gooseberry vein banding associated virus (GVBaV) were detected in symptomatic Ribes plants grown in the field. Results were consistent with those obtained using PCR or reverse transcription PCR and suggest that the current virus indexing methods of prebasic mother plants work as expected. Furthermore, many new viruses were identified in the collections of plant genetic resources not previously tested for viruses. In the future, siRNA-based diagnostics could be a useful supplement for the currently used virus detection methods in certified plant production and thus rationalize and simplify the current testing system.	[Rajamaki, Minna-Liisa; Roininen, Elina; Vishwakarma, Archana; Streng, Janne; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Lemmetty, Anne; Latvala, Satu] Nat Resources Inst Finland Luke, Jokioinen, Finland; [Laamanen, Jaana] Nat Resources Inst Finland Luke, Jyvaskyla, Finland	University of Helsinki; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke)	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.; Laamanen, J (corresponding author), Nat Resources Inst Finland Luke, Jyvaskyla, Finland.	jaana.laamanen@luke.fi; jari.valkonen@helsinki.fi	Rajamäki, Minna-Liisa/AAY-5758-2020	Rajamäki, Minna-Liisa/0000-0002-7952-0433; Valkonen, Jari/0000-0002-3704-9911; Vishwakarma, Archana/0000-0002-4820-6468	Ministry of Agriculture and Forestry, Finland [1872/312/2012, 2221/03.01.02/2015]	Ministry of Agriculture and Forestry, Finland	This study was supported by Ministry of Agriculture and Forestry, Finland (grants 1872/312/2012 and 2221/03.01.02/2015 to JPTV); https://mmm.fi/en/about-the-site.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011; Anonymous, 2008, Bulletin OEPP, V38, P430, DOI 10.1111/j.1365-2338.2008.01259.x; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; BHAT AI, 2016, VIRUSES-BASEL, V8, DOI DOI 10.1111/J.1364-3703.2004.00217.X; Chang S., 1993, FRONT MICROBIOL, V11, P113, DOI 10.1007/BF02670468; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Diaz-Lara A, 2015, VIRUS GENES, V50, P104, DOI 10.1007/s11262-014-1149-6; DIAZLARA A, 2016, APS ANNUAL MEETING, V30, P3; Halgren A, 2007, PHYTOPATHOLOGY, V97, P44, DOI 10.1094/PHYTO-97-0044; HOHN T, 2008, SPRINGER, P54, DOI DOI 10.1016/J.VIROL.2015.02.011; HTTPS, DA; Isogai M, 2012, J GEN PLANT PATHOL, V78, P360, DOI 10.1007/s10327-012-0392-8; Jaakola L, 2010, PLANT CELL ENVIRON, V33, P1239, DOI 10.1111/j.1365-3040.2010.02154.x; Jones AT, 2000, EUR J PLANT PATHOL, V106, P623, DOI 10.1023/A:1008765819284; JONES AT, 1986, ANN APPL BIOL, V109, P323, DOI 10.1111/j.1744-7348.1986.tb05324.x; Jones AT, 2002, ANN APPL BIOL, V141, P1, DOI 10.1111/j.1744-7348.2002.tb00189.x; JONES AT, 1991, ANN APPL BIOL, V118, P331, DOI 10.1111/j.1744-7348.1991.tb05633.x; Kalischuk ML, 2008, PLANT DIS, V92, P974, DOI 10.1094/PDIS-92-6-0974A; Kalischuka ML, 2013, VIRUS RES, V178, P306, DOI 10.1016/j.virusres.2013.09.026; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kokko H, 1996, EUR J PLANT PATHOL, V102, P713, DOI 10.1007/BF01877253; Kokko HI, 1996, BIOTECHNIQUES, V20, P842; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LANGMEAD B, GENOME BIOL, P10, DOI DOI 10.1016/J.VIROL.2016.10.017; Latvala S, 1997, ANN APPL BIOL, V131, P283, DOI 10.1111/j.1744-7348.1997.tb05157.x; Lemmetty A, 2004, ACTA HORTIC, P115, DOI 10.17660/ActaHortic.2004.656.17; Lemmetty A, 1997, PHYTOPATHOLOGY, V87, P404, DOI 10.1094/PHYTO.1997.87.4.404; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Manduric S., 2017, NJF REPORT, V493; Maree HJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01082; Martin RR, 2013, PLANT DIS, V97, P168, DOI 10.1094/PDIS-04-12-0362-FE; Martin RR, 2004, ISHS ACTA HORT, V656, P199; McGavin WJ, 2011, PLANT PATHOL, V60, P462, DOI 10.1111/j.1365-3059.2010.02387.x; McGavin WJ, 2010, ARCH VIROL, V155, P1897, DOI 10.1007/s00705-010-0807-9; McMenemy LS, 2009, AGR FOREST ENTOMOL, V11, P61, DOI 10.1111/j.1461-9563.2008.00409.x; Nukari A, 2009, AGR FOOD SCI, V18, P117, DOI 10.2137/145960609789267506; OEPP/EPPO, 2009, B OEPP EPPO B, V39, P271; OEPP/EPPO, 2008, BULLETIN, V38, P14; Official Statistics of Finland (OSF), 2018, HORTICULTURAL STATIS; Olmos A., 2018, Bulletin OEPP, V48, P219, DOI 10.1111/epp.12472; Quito-Avila DF, 2012, J VIROL METHODS, V179, P38, DOI 10.1016/j.jviromet.2011.09.016; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith GR, 2017, AUSTRALAS PLANT PATH, V46, P277, DOI 10.1007/s13313-017-0489-9; SUSI H, 2018, ANN APPL BIOL; Susi P, 2004, MOL PLANT PATHOL, V5, P167, DOI 10.1111/J.1364-3703.2004.00217.X; TAPIO E, 1961, PUBLICATIONS OF THE, V184, P1, DOI DOI 10.1094/PDIS-92-6-0974A; Tapio E, 1961, THESIS, V184, P1; UOSUKAINEN M, 1988, ANN AGR FENN, V27, P209; Valasevich N, 2011, ARCH VIROL, V156, P369, DOI 10.1007/s00705-010-0912-9; Vappula N., 1962, ANN AGR FENN, V1, P124; Wang QC, 2005, PLANT CELL REP, V24, P280, DOI 10.1007/s00299-005-0936-x; Wang QC, 2008, MOL PLANT PATHOL, V9, P237, DOI [10.1111/j.1364-3703.2007.00456.x, 10.1111/J.1364-3703.2007.00456.X]; Xu DL, 2011, VIRUS GENES, V43, P130, DOI 10.1007/s11262-011-0614-8; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng Yanyan, VIROLOGY, V342, P150, DOI [10.1016/j.virol.2005.07.030, DOI 10.1016/J.VIROL.2005.07.030, DOI 10.1016/J.VIROL.2009.03.024]; Zheng Y, 2017, VIROLOGY, V500, P130, DOI 10.1016/j.virol.2016.10.017; ZIEGLER A, 1992, J GEN VIROL, V73, P3213, DOI 10.1099/0022-1317-73-12-3213	60	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220621	10.1371/journal.pone.0220621	http://dx.doi.org/10.1371/journal.pone.0220621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390343	Green Published, gold, Green Submitted			2022-12-26	WOS:000484999400022
J	Takacs, L; Smolik, F; Putnam, S				Takacs, Lea; Smolik, Filip; Putnam, Samuel			Assessing longitudinal pathways between maternal depressive symptoms, parenting self-esteem and infant temperament	PLOS ONE			English	Article							PERINATAL DEPRESSION; SOCIAL SUPPORT; POSTNATAL DEPRESSION; CHILDRENS BEHAVIOR; PERSONALITY-TRAITS; ANTENATAL ANXIETY; MOTHERS; EFFICACY; STRESS; POSTPARTUM	Background Previous studies of relations between parenting self-concepts, parental adjustment and child temperament have been ambiguous regarding the direction of influence; and have rarely followed families from pregnancy through the first year of life. The current study examines change and stability in maternal depressive symptoms, parenting competences and child temperament through the perinatal period until nine months postpartum. Methods Czech mothers (N = 282) participated at three time points: the third trimester of pregnancy (Time 1), six weeks (Time 2) and nine months postpartum (Time 3). Questionnaire data concerned depressive symptoms (T1, T2, T3), maternal parenting self-esteem (T1, T2) and sense of competence (T3), and child temperament (T2, T3). A path model was used to examine concurrent and longitudinal relations between these variables. Results The analyses indicated longitudinal stability of all constructs, as well as concurrent relations between them. Longitudinal relations supported child-to-parent, rather than parent-to-child, effects: child difficult temperament predicted decreases in perceived maternal parenting competences, but maternal variables did not predict change in infant temperament. In addition, we observed weak mutual relations between maternal depression levels and parenting competences, such that maternal depression diminished perceived parenting competences that in turn contributed to higher levels of depression. Conclusion Mothers' confidence in their ability to parent is influenced by their experience with a difficult infant and by their depressive symptoms during the child's first year of life. Depressive symptoms are, in turn, aggravated by mothers' low perceived competences in the parenting role.	[Takacs, Lea] Charles Univ Prague, Fac Arts, Dept Psychol, Prague, Czech Republic; [Smolik, Filip] Czech Acad Sci, Inst Psychol, Prague, Czech Republic; [Putnam, Samuel] Bowdoin Coll, Dept Psychol, Brunswick, ME 04011 USA	Charles University Prague; Czech Academy of Sciences; Institute of Psychology of the Czech Academy of Sciences; Bowdoin College	Takacs, L (corresponding author), Charles Univ Prague, Fac Arts, Dept Psychol, Prague, Czech Republic.	lea.takacs@ff.cuni.cz	Smolík, Filip/B-6342-2013; Takács, Lea/AAL-4968-2020	Smolík, Filip/0000-0003-4160-6124; Takács, Lea/0000-0002-8137-026X	Czech Science Foundation [17-10464S]; European Regional Development Fund-Project "Creativity and Adaptability as Conditions of the Success of Europe in an Interrelated World" [CZ.02.1.01/0.0/0.0/16_019/0000734]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund-Project "Creativity and Adaptability as Conditions of the Success of Europe in an Interrelated World"	This study was supported by the Czech Science Foundation (project GA CR No. 17-10464S, Perinatal risk factors, maternal competences and child development - A prospective study from prenatal period to preschool age), the grant was awarded to LT. LT was funded by the European Regional Development Fund-Project "Creativity and Adaptability as Conditions of the Success of Europe in an Interrelated World" (No. CZ.02.1.01/0.0/0.0/16_019/0000734). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann AES, 2016, J ABNORM CHILD PSYCH, V44, P421, DOI 10.1007/s10802-015-0058-z; Austin MP, 2005, EARLY HUM DEV, V81, P183, DOI 10.1016/j.earlhumdev.2004.07.001; Bagner DM, 2010, J AM ACAD CHILD PSY, V49, P699, DOI 10.1016/j.jaac.2010.03.012; BATES JE, 1979, CHILD DEV, V50, P794, DOI 10.1111/j.1467-8624.1979.tb02428.x; Bauer A, 2015, PSYCHOL MED, V45, P51, DOI 10.1017/S0033291714001044; Beck CT, 1996, NURS RES, V45, P225, DOI 10.1097/00006199-199607000-00006; BELL RQ, 1968, PSYCHOL REV, V75, P81, DOI 10.1037/h0025583; Bhat A, 2015, INFANT BEHAV DEV, V39, P35, DOI 10.1016/j.infbeh.2014.12.002; Braithwaite EC, 2013, J AM ACAD CHILD PSY, V52, P519, DOI 10.1016/j.jaac.2013.02.010; Breedlove G, 2011, J MIDWIFERY WOM HEAL, V56, P18, DOI 10.1111/j.1542-2011.2010.00002.x; Bridgett DJ, 2009, INFANT BEHAV DEV, V32, P103, DOI 10.1016/j.infbeh.2008.10.007; Britton JR, 2011, WOMEN HEALTH, V51, P55, DOI 10.1080/03630242.2011.540741; Chong SC, 2016, INFANT MENT HEALTH J, V37, P584, DOI 10.1002/imhj.21582; Coleman PK, 2003, INF MENTAL HLTH J, V24, P126, DOI 10.1002/imhj.10048; Cornish AM, 2006, J REPROD INFANT PSYC, V24, P121, DOI 10.1080/02646830600644021; Cornish AM, 2005, INFANT BEHAV DEV, V28, P407, DOI 10.1016/j.infbeh.2005.03.004; Cox J., 2003, PERINATAL MENTAL HLT; CUTRONA CE, 1986, CHILD DEV, V57, P1507, DOI 10.1111/j.1467-8624.1986.tb00475.x; Davis EP, 2007, J AM ACAD CHILD PSY, V46, P737, DOI 10.1097/chi.0b013e318047b775; Dennis C.-L, 2013, PSYCHOSOCIAL PSYCHOL; Eastwood JG, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-148; Edhborg M, 2000, J REPROD INFANT PSYC, V18, P225, DOI 10.1080/713683036; Erickson NL, 2017, JOGNN-J OBST GYN NEO, V46, P588, DOI 10.1016/j.jogn.2017.03.008; Farrow C, 2007, INFANT MENT HEALTH J, V28, P517, DOI 10.1002/imhj.20151; Feldman R, 2009, J AM ACAD CHILD PSY, V48, P919, DOI 10.1097/CHI.0b013e3181b21651; Fiala A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1261-y; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Forbes EE, 2008, J ABNORM CHILD PSYCH, V36, P207, DOI 10.1007/s10802-007-9171-y; Fox NA, 2001, CHILD DEV, V72, P1, DOI 10.1111/1467-8624.00262; Gao LL, 2014, MIDWIFERY, V30, P532, DOI 10.1016/j.midw.2013.06.007; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Gartstein MA, 2009, J APPL DEV PSYCHOL, V30, P149, DOI 10.1016/j.appdev.2008.12.001; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; Gray PH, 2013, EARLY HUM DEV, V89, P625, DOI 10.1016/j.earlhumdev.2013.04.005; GROSS D, 1994, RES NURS HEALTH, V17, P207, DOI 10.1002/nur.4770170308; Hanington L, 2010, INFANT BEHAV DEV, V33, P88, DOI 10.1016/j.infbeh.2009.11.004; Hummel AC, 2015, CHILD PSYCHIAT HUM D, V46, P21, DOI 10.1007/s10578-014-0448-4; Jover M, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.87; Keller H, 2009, J CROSS CULT PSYCHOL, V40, P996, DOI 10.1177/0022022109348576; Kerstis B, 2013, SCAND J PUBLIC HEALT, V41, P233, DOI 10.1177/1403494812472006; Koutra K, 2017, J AFFECT DISORDERS, V217, P89, DOI 10.1016/j.jad.2017.04.002; Leahy-Warren P, 2012, J CLIN NURS, V21, P388, DOI 10.1111/j.1365-2702.2011.03701.x; Letourneau NL, 2017, DEPRESS ANXIETY, V34, P928, DOI 10.1002/da.22687; Lin YF, 2017, J AFFECT DISORDERS, V207, P9, DOI 10.1016/j.jad.2016.09.010; Lusby CM, 2014, DEV PSYCHOBIOL, V56, P459, DOI 10.1002/dev.21112; McMahon C, 2001, AUST NZ J PSYCHIAT, V35, P581, DOI 10.1046/j.1440-1614.2001.00942.x; Melchior M, 2012, J AFFECT DISORDERS, V137, P165, DOI 10.1016/j.jad.2011.09.018; Misri S, 2006, AM J ORTHOPSYCHIAT, V76, P115, DOI 10.1037/0002-9432.76.1.115; Norcross PL, 2017, INFANT BEHAV DEV, V49, P238, DOI 10.1016/j.infbeh.2017.09.009; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; Ohan JL, 2000, CAN J BEHAV SCI, V32, P251, DOI 10.1037/h0087122; Pauli-Pott U, 2004, DEV PSYCHOPATHOL, V16, P19, DOI 10.1017/S0954579404040398; Porter CL, 2003, J FAM PSYCHOL, V17, P54, DOI 10.1037/0893-3200.17.1.54; Putnam SP, 2017, J RES PERS, V67, P157, DOI 10.1016/j.jrp.2016.07.009; Razurel C, 2017, WOMEN HEALTH, V57, P154, DOI 10.1080/03630242.2016.1157125; Rode JL, 2016, ARCH WOMEN MENT HLTH, V19, P133, DOI 10.1007/s00737-015-0540-1; Rosseel Y, 2012, LAVAAN; Rothbart M.K., 1998, HDB CHILD PSYCHOL, P105, DOI DOI 10.1002/9780470147658.CHPSY0303; ROTHBART MK, 1981, CHILD DEV, V52, P569, DOI 10.1111/j.1467-8624.1981.tb03082.x; Rouse MH, 2014, INFANT BEHAV DEV, V37, P739, DOI 10.1016/j.infbeh.2014.09.001; Shea E., 1988, THEORY RES BEHAVIORA, V4, P101; Skipstein A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1120; SUPER CM, 1986, INT J BEHAV DEV, V9, P545, DOI 10.1177/016502548600900409; Thomason E, 2014, INFANT BEHAV DEV, V37, P406, DOI 10.1016/j.infbeh.2014.05.009; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; van der Waerden J, 2015, J PEDIATR-US, V166, P1440, DOI 10.1016/j.jpeds.2015.03.002; Verhage ML, 2013, J FAM PSYCHOL, V27, P844, DOI 10.1037/a0034263; Woolhouse H, 2016, ARCH WOMEN MENT HLTH, V19, P141, DOI 10.1007/s00737-015-0562-8	68	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220633	10.1371/journal.pone.0220633	http://dx.doi.org/10.1371/journal.pone.0220633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381596	Green Submitted, Green Published, gold			2022-12-26	WOS:000484993600025
J	Choi, BKA; D'Onofrio, PM; Shabanzadeh, AP; Koeberle, PD				Choi, Brian K. A.; D'Onofrio, Philippe M.; Shabanzadeh, Alireza P.; Koeberle, Paulo D.			Stabilization of primary cilia reduces abortive cell cycle re-entry to protect injured adult CNS neurons from apoptosis	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ALZHEIMERS-DISEASE; PROVIDES NEUROPROTECTION; SCAR FORMATION; OPTIC-NERVE; INHIBITION; EXPRESSION; AURORA; PROGRESSION; ACTIVATION	Abortive cell cycle (ACC) re-entry of apoptotic neurons is a recently characterized phenomenon that occurs after central nervous system (CNS) injury or over the course of CNS disease. Consequently, inhibiting cell cycle progression is neuroprotective in numerous CNS pathology models. Primary cilia are ubiquitous, centriole-based cellular organelles that prevent cell cycling, but their ability to modulate abortive cell cycle has not been described. Here, we show that neuronal cilia are ablated in-vitro and in-vivo following injury by hypoxia or optic nerve transection (ONT), respectively. Furthermore, forced cilia resorption sensitized neurons to these injuries and enhanced cell death. In contrast, pharmacological inhibition or shRNA knockdown of the proteins that disassemble the cilia increased neuron survival and decreased the phosphorylation of retinoblastoma (Rb), a master switch for cell cycle re-entry. Our findings show that the stabilization of neuronal primary cilia inhibits, at least transiently, apoptotic cell cycling, which has implications for future therapeutic strategies that halt or slow the progression of neurodegenerative diseases and acute CNS injuries.	[Choi, Brian K. A.; D'Onofrio, Philippe M.; Shabanzadeh, Alireza P.; Koeberle, Paulo D.] Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada; [Choi, Brian K. A.; D'Onofrio, Philippe M.; Koeberle, Paulo D.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Shabanzadeh, Alireza P.] Univ Toronto, Krembil Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; Krembil Research Institute; University of Toronto	Koeberle, PD (corresponding author), Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada.; Koeberle, PD (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada.	paulo.koeberle@utoronto.ca		Choi, Kyung An Brian/0000-0002-4607-3833	Canadian Institutes of Health Research [MOP 119309]; University of Toronto Division of Anatomy, Department of Surgery	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Division of Anatomy, Department of Surgery	This research was supported by the Canadian Institutes of Health Research Operating Grant (MOP 119309 to PDK) and the University of Toronto Division of Anatomy, Department of Surgery Bridge funding awarded to PDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2013, J NEUROSCI, V33, P14645, DOI 10.1523/JNEUROSCI.1327-13.2013; Aliagas-Martin I, 2009, J MED CHEM, V52, P3300, DOI 10.1021/jm9000314; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Cao Muqing, 2015, Cilia, V5, P4, DOI 10.1186/s13630-016-0027-3; Carlen B, 2005, ULTRASTRUCT PATHOL, V29, P217, DOI 10.1080/01913120590951220; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dai Yun, 2004, Curr Oncol Rep, V6, P123, DOI 10.1007/s11912-004-0024-3; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Folch J, 2012, NEUROTOX RES, V22, P195, DOI 10.1007/s12640-011-9277-4; Galan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101349; Gendron TF, 2001, J NEUROCHEM, V78, P316, DOI 10.1046/j.1471-4159.2001.00423.x; Goto H, 2013, CELL MOL LIFE SCI, V70, P3893, DOI 10.1007/s00018-013-1302-8; Gradilone SA, 2013, CANCER RES, V73, P2259, DOI 10.1158/0008-5472.CAN-12-2938; Hassounah NB, 2012, CLIN CANCER RES, V18, P2429, DOI 10.1158/1078-0432.CCR-11-0755; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Hu W, 2014, CANC RES S, V65, P1350; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Imai H, 2002, EUR J NEUROSCI, V15, P1929, DOI 10.1046/j.1460-9568.2002.02025.x; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; Izawa Ichiro, 2015, Cilia, V4, P12, DOI 10.1186/s13630-015-0021-1; Jordan-Sciutto KL, 2003, J NEUROPATH EXP NEUR, V62, P68, DOI 10.1093/jnen/62.1.68; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kasper M, 2017, EUR J CANCER, V42, P437; Kim S, 2011, CELL CYCLE, V10, P2683, DOI 10.4161/cc.10.16.17009; Kim S, 2011, NAT CELL BIOL, V13, P351, DOI 10.1038/ncb2183; Kinzel D, 2010, DEV CELL, V19, P66, DOI 10.1016/j.devcel.2010.06.005; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; Magharious Mark M, 2011, J Vis Exp, DOI 10.3791/2241; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Miyamoto T, 2015, CELL REP, V10, P664, DOI 10.1016/j.celrep.2015.01.003; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pazour GJ, 2000, J CELL BIOL, V151; Pelegri C, 2008, INT J DEV NEUROSCI, V26, P665, DOI 10.1016/j.ijdevneu.2008.07.016; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Ran J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12917; Ranganathan S, 2003, AM J PATHOL, V162, P823, DOI 10.1016/S0002-9440(10)63879-5; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rosenbaum T, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-4; Saito M, 2017, EMBO REP, V18, P1460, DOI 10.15252/embr.201744204; Sasaki H, 1999, DEVELOPMENT, V126, P3915; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; SMITH TW, 1995, J NEUROPATH EXP NEUR, V54, P297, DOI 10.1097/00005072-199505000-00002; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Tian H, 2017, HUM MOL GENET, V26, P860, DOI 10.1093/hmg/ddx002; Varvel NH, 2008, J NEUROSCI, V28, P10786, DOI 10.1523/JNEUROSCI.2441-08.2008; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Yi ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38574; Yu Y, 2012, NEUROCHEM RES, V37, P503, DOI 10.1007/s11064-011-0636-6; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZHANG WH, 2011, NAT CELL BIOL, P1013; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	70	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220056	10.1371/journal.pone.0220056	http://dx.doi.org/10.1371/journal.pone.0220056			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369591	gold, Green Published, Green Submitted			2022-12-26	WOS:000484987900022
J	Mizuno, H; Yuasa, N; Takeuchi, E; Miyake, H; Nagai, H; Yoshioka, Y; Miyata, K				Mizuno, Hironori; Yuasa, Norihiro; Takeuchi, Eiji; Miyake, Hideo; Nagai, Hidemasa; Yoshioka, Yuichiro; Miyata, Kanji			Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer	PLOS ONE			English	Article							MEAN CORPUSCULAR VOLUME; TO-LYMPHOCYTE RATIO; PROGNOSTIC SCORE GPS; MONOCYTE RATIO; PREOPERATIVE LYMPHOCYTE; ENDOTHELIAL DYSFUNCTION; PLATELET COUNT; NEUTROPHIL; COLON; SURVIVAL	Objectives To identify blood cell markers that predict the long-term outcomes of patients with colorectal cancer. Methods Data from 892 stage II and III colorectal cancer patients who underwent R0 resection were included. We analyzed the correlations of the preoperative blood data, previously reported prognostic indices, and clinicopathologic factors with the long-term outcomes, such as relapse-free survival and overall survival, using univariate and multivariate analyses. Results Multivariate analysis showed that tumor location, stage, mean corpuscular volume, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio were significantly correlated with relapse-free survival. A mean corpuscular volume >= 80.5 fL, neutrophil-to-lymphocyte ratio >= 5.5, and lymphocyte-to-monocyte ratio <3.4 had hazard ratios for disease relapse between 1.39 and 1.93. The cumulative scores of these three factors were aggregated into a laboratory prognostic score, with a maximum score at 6. The relapse-free survival and overall survival were well stratified by a laboratory prognostic score between 0-3 and 4-6, respectively, independent of the stage. Conclusion The mean corpuscular volume, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio can serve as blood cell markers to predict the long-term outcomes of patients who underwent R0 resection for stage II/III colorectal cancer.	[Mizuno, Hironori; Yuasa, Norihiro; Takeuchi, Eiji; Miyake, Hideo; Nagai, Hidemasa; Yoshioka, Yuichiro; Miyata, Kanji] Japanese Red Cross Nagoya First Hosp, Dept Gastrointestinal Surg, Nakamura Ku, Michishita Cho, Nagoya, Aichi, Japan	Red Cross Nagoya Daiichi Hospital	Mizuno, H (corresponding author), Japanese Red Cross Nagoya First Hosp, Dept Gastrointestinal Surg, Nakamura Ku, Michishita Cho, Nagoya, Aichi, Japan.	hironori.miz@gmail.com			Japanese Red Cross Nagoya First Hospital Research Grant [NFRCH 18-0016]	Japanese Red Cross Nagoya First Hospital Research Grant	This work was supported by the Japanese Red Cross Nagoya First Hospital Research Grant (NFRCH 18-0016) to HM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balde AI, 2017, J SURG RES, V219, P244, DOI 10.1016/j.jss.2017.05.109; Chan JCY, 2017, ANN SURG, V265, P539, DOI 10.1097/SLA.0000000000001743; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Evani SJ, 2013, FASEB J, V27, P3017, DOI 10.1096/fj.12-224824; Feliciano EMC, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2319; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo YH, 2017, ONCOTARGET, V8, P20011, DOI 10.18632/oncotarget.15311; Han FY, 2018, ONCOL LETT, V15, P3339, DOI 10.3892/ol.2017.7697; Haram A, 2017, J SURG ONCOL, V115, P470, DOI 10.1002/jso.24523; He WZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0439-x; Huang XZ, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/1053125; Iseki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132488; Ishizuka M, 2013, BRIT J CANCER, V109, P401, DOI 10.1038/bjc.2013.350; Li M, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/132642; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Mahmoud MY, 1996, AGE AGEING, V25, P310, DOI 10.1093/ageing/25.4.310; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; Mohri Y, 2013, WORLD J SURG, V37, P2688, DOI 10.1007/s00268-013-2156-9; Monreal M, 1998, THROMB HAEMOSTASIS, V79, P916; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Moritani K, 2014, SURG TODAY, V44, P1685, DOI 10.1007/s00595-013-0748-5; Nagai H, 2018, SURG TODAY, V48, P186, DOI 10.1007/s00595-017-1575-x; Nozoe T, 2014, INT SURG, V99, P512, DOI 10.9738/INTSURG-D-13-00118.1; Pectasides D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1406-7; Pine JK, 2015, BRIT J CANCER, V113, P204, DOI 10.1038/bjc.2015.87; PORATHFUREDI A, 1983, CYTOMETRY, V4, P263, DOI 10.1002/cyto.990040312; SATOMI A, 1995, ACTA ONCOL, V34, P69, DOI 10.3109/02841869509093641; Schneider C, 2018, EUR J CANCER PREV, V27, P530, DOI 10.1097/CEJ.0000000000000397; Shibutani M, 2017, ONCOL LETT, V13, P1000, DOI 10.3892/ol.2016.5487; Skjelbakken T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001109; Sobin LH., 2010, TNM CLASSIFICATION M; Solak Y, 2013, NEPHROLOGY, V18, P728, DOI 10.1111/nep.12130; Son HJ, 2013, ANN SURG ONCOL, V20, P2908, DOI 10.1245/s10434-013-2968-8; Song W, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005540; Song YX, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3752-0; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; Ueda T, 2013, CIRC J, V77, P2766, DOI 10.1253/circj.CJ-13-0718; Vayrynen JP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19572-y; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Warschkow R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2412-0; Watanabe T, 2018, INT J CLIN ONCOL, V23, P1, DOI 10.1007/s10147-017-1101-6; Wu QB, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007051; Yoon HJ, 2016, CLIN CHEM LAB MED, V54, P1247, DOI 10.1515/cclm-2015-0786; Yoshida N, 2018, ANN SURG; Zheng YZ, 2013, WORLD J GASTROENTERO, V19, P2811, DOI 10.3748/wjg.v19.i18.2811	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220579	10.1371/journal.pone.0220579	http://dx.doi.org/10.1371/journal.pone.0220579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369651	Green Submitted, gold, Green Published			2022-12-26	WOS:000484987900066
J	Wong, RJ; Tran, T; Kaufman, H; Niles, J; Gish, R				Wong, Robert J.; Tran, Tram; Kaufman, Harvey; Niles, Justin; Gish, Robert			Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; LONG-TERM OUTCOMES; NATIONAL-HEALTH; UNITED-STATES; PREVALENCE; TRANSPLANTATION; MORTALITY; DIAGNOSIS; CIRRHOSIS; SEVERITY	Hepatic fibrosis and advanced fibrosis in particular is the strongest predictor of liver-related outcomes and mortality among nonalcoholic steatohepatitis (NASH) patients. Understanding prevalence and predictors of NASH with advanced fibrosis is critical for healthcare resource planning. Using a large U.S. clinical laboratory database from 10/1/2017-9/30/2018, adults negative for hepatitis B and hepatitis C and after excluding for alcoholic liver disease and pregnancy were evaluated for prevalence of F3 and F4 fibrosis using a systematic algorithm of five fibrosis-4 (FIB-4) criteria: Criteria 1 (>= F3: > 2.67), Criteria 2 (2.67 < F3 <= 4.12 and F4 > 4.12), Criteria 3 (2.67 < F3 <= 3.15, F4 > 3.15), Criteria 4 (3.25 < F3 <= 3.5,F4 > 3.5),Criteria 5 (3.25 < F3 <= 4.12, F4 > 4.12). Metabolic co-morbidities evaluated included decreased high density lipoprotein (< 40 mg/dL men, < 50 mg/dL women), high triglycerides (>= 150 mg/dL), elevated hemoglobin A1C (>= 6.5%). Parallel analyses of patients with specific NAFLD/NASH ICD-9/10 codes from 10/1/2013-9/30/2018 were performed. Multivariate logistic regression models evaluated for predictors of >= F3 fibrosis. Among patients with NAFLD/NASH ICD-9/10 codes, >= F3 prevalence ranged from 4.35%-6.90%, and F4 prevalence ranged from 2.52%-3.67%. Increasing metabolic co-morbidities was associated with higher risk of. F3 fibrosis. Compared to NASH patients without metabolic co-morbidities, NASH with four concurrent metabolic co-morbidities had higher risk of >= F3 (OR 1.56, 95% CI 1.40-1.73, p < 0.001). In summary, prevalence of NASH with advanced fibrosis among U.S. adults was as high as 6.90% and prevalence of NASH with cirrhosis was as high as 3.67%, representing 5.18 million and 2.75 million, respectively, when using an estimate of 75 million U.S. adults with NAFLD. Co-morbid metabolic abnormalities were associated with higher risk of advanced fibrosis among NASH patients.	[Wong, Robert J.] Alameda Hlth Syst Highland Hosp, Div Gastroenterol & Hepatol, Oakland, CA 94602 USA; [Tran, Tram] Gilead Sci, Foster City, CA USA; [Kaufman, Harvey; Niles, Justin] Quest Diagnost, Secaucus, NJ USA; [Gish, Robert] Stanford Hlth Care, Div Gastroenterol & Hepatol, Palo Alto, CA USA	Gilead Sciences; Stanford University	Wong, RJ (corresponding author), Alameda Hlth Syst Highland Hosp, Div Gastroenterol & Hepatol, Oakland, CA 94602 USA.	Rowong@alamedahealthsystem.org	Gish, Robert/B-3605-2018	Gish, Robert/0000-0001-6306-3189; Wong, Robert/0000-0002-8923-2806	Gilead Sciences	Gilead Sciences(Gilead Sciences)	This study was supported by a research grant from Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fujii H, 2019, J GASTROEN HEPATOL, V34, P1390, DOI 10.1111/jgh.14595; Goldberg D, 2017, GASTROENTEROLOGY, V152, P1090, DOI 10.1053/j.gastro.2017.01.003; Gordon SC, 2018, HEPATOLOGY, V68, p617A; Holmberg SD, 2013, CLIN INFECT DIS, V57, P240, DOI 10.1093/cid/cit245; Kabbany MN, 2017, AM J GASTROENTEROL, V112, P581, DOI 10.1038/ajg.2017.5; Le MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173499; McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453; Nakahara T, 2014, J GASTROENTEROL, V49, P1477, DOI 10.1007/s00535-013-0911-1; Patel PJ, 2018, INTERN MED J, V48, P144, DOI 10.1111/imj.13667; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Petta S, 2017, LIVER INT, V37, P1389, DOI 10.1111/liv.13397; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Sanyal AJ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1149-9; Stepanova M, 2010, GUT, V59, P1410, DOI 10.1136/gut.2010.213553; Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034; Wong RJ, 2017, ALIMENT PHARM THER, V46, P974, DOI 10.1111/apt.14327; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2013, METABOLISM, V62, P352, DOI 10.1016/j.metabol.2012.08.005	27	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220612	10.1371/journal.pone.0220612	http://dx.doi.org/10.1371/journal.pone.0220612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369606	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900067
J	Engberink, RHGO; de Vos, J; van Weert, A; Zhang, YH; van Vlies, N; van den Born, BJH; Titze, JM; van Bavel, E; Vogt, L				Engberink, Rik H. G. Olde; de Vos, Judith; van Weert, Angela; Zhang, Yahua; van Vlies, Naomi; van den Born, Bert-Jan H.; Titze, Jens M.; van Bavel, Ed; Vogt, Liffert			Abnormal sodium and water homeostasis in mice with defective heparan sulfate polymerization	PLOS ONE			English	Article							HYPERTONIC SALINE INFUSION; ENDOTHELIAL GLYCOCALYX; STORAGE CAPACITY; TISSUE SODIUM; SULODEXIDE; EXPRESSION; MICROALBUMINURIA; HYPERTENSION; DYSFUNCTION; THERAPY	Glycosaminoglycans in the skin interstitium and endothelial surface layer have been shown to be involved in local sodium accumulation without commensurate water retention. Dysfunction of heparan sulfate glycosaminoglycans may therefore disrupt sodium and water homeostasis. In this study, we investigated the effects of combined heterozygous loss of heparan sulfate polymerization genes (exostosin glycosyltransferase 1 and 2; Ext1(+/-)Ext2(+/-)) on sodium and water homeostasis. Sodium storage capacity was decreased in Ext1(+/-)Ext2(+/-) mice as reflected by a 77% reduction in endothelial surface layer thickness and a lower skin sodium-to-glycosaminoglycan ratio. Also, these mice were characterized by a higher heart rate, increased fluid intake, increased plasma osmolality and a decreased skin water and sodium content, suggesting volume depletion. Upon chronic high sodium intake, the initial volume depletion was restored but no blood pressure increase was observed. Acute hypertonic saline infusion resulted in a distinct blood pressure response: we observed a significant 15% decrease in control mice whereas blood pressure did not change in Ext1(+/-)Ext2(+/-) mice. This differential blood pressure response may be explained by the reduced capacity for sodium storage and/or the impaired vasodilation response, as measured by wire myography, which was observed in Ext1(+/-)Ext2(+/-) mice. Together, these data demonstrate that defective heparan sulfate glycosaminoglycan synthesis leads to abnormal sodium and water homeostasis and an abnormal response to sodium loading, most likely caused by inadequate capacity for local sodium storage.	[Engberink, Rik H. G. Olde; Vogt, Liffert] Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Dept Internal Med,Sect Nephrol, Amsterdam, Netherlands; [de Vos, Judith; van Weert, Angela; van Bavel, Ed] Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Zhang, Yahua; Titze, Jens M.] Vanderbilt Univ, Dept Clin Pharmacol, 221 Kirkland Hall, Nashville, TN 37235 USA; [van Vlies, Naomi] Univ Amsterdam, Med Ctr, Amsterdam Cardiovasc Sci, Lab Genet Metab Dis,Amsterdam UMC, Amsterdam, Netherlands; [van den Born, Bert-Jan H.] Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Dept Internal Med,Sect Vasc Med, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Vanderbilt University; University of Amsterdam; University of Amsterdam	Engberink, RHGO (corresponding author), Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Dept Internal Med,Sect Nephrol, Amsterdam, Netherlands.	r.h.oldeengberink@amsterdamumc.nl	Vogt, Liffert/C-3168-2018; Engberink, Rik Olde/AAC-3216-2020; Titze, Jens/GXV-1636-2022	Vogt, Liffert/0000-0002-4585-7505; Engberink, Rik Olde/0000-0002-3177-2279; Titze, Jens/0000-0001-8463-8404; de Vos, Judith/0000-0003-0736-7449; van den Born, Bert-Jan H. (BJH)/0000-0003-0943-4393; van Bavel, Ed/0000-0001-8654-986X	Dutch Kidney Foundation [KJPB 11.22]	Dutch Kidney Foundation	L.V. was supported by Kolff Grant KJPB 11.22 from the Dutch Kidney Foundation (www.nierstichting.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Jurgen van Teeffelen and Hanneke Cobelens (Maastricht University, Maastricht) for providing training in cremaster surgery, Beatrice Bedussi (AMC, Amsterdam) for her contributions to the carotid artery surgery and Tom Wagemans (AMC, Amsterdam) for his help with the HPLC MS/MS measurements. L.V. was supported by Kolff Grant KJPB 11.22 from the Dutch Kidney Foundation.	Abe C, 2013, J PHYSIOL SCI, V63, P55, DOI 10.1007/s12576-012-0235-6; Andriessen MP, 1997, J PATHOL, V183, P264; Constantinescu AA, 2011, THROMB HAEMOSTASIS, V105, P790, DOI 10.1160/TH10-08-0560; Dahlmann A, 2015, KIDNEY INT, V87, P434, DOI 10.1038/ki.2014.269; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; de Ru MH, 2013, J INHERIT METAB DIS, V36, P247, DOI 10.1007/s10545-012-9538-2; DuPont JJ, 2013, J HYPERTENS, V31, P530, DOI 10.1097/HJH.0b013e32835c6ca8; Engberink RHGO, 2017, KIDNEY INT, V91, P738, DOI 10.1016/j.kint.2016.12.004; Engberink RHGO, 2016, BRIT J CLIN PHARMACO, V82, P1351, DOI 10.1111/bcp.13062; Engberink RHGO, 2015, BRIT J CLIN PHARMACO, V80, P1245, DOI 10.1111/bcp.12722; Engberink RHGO, 2015, J AM SOC NEPHROL, V26, P777, DOI 10.1681/ASN.2014050430; FARBER SJ, 1957, J CLIN INVEST, V36, P1715, DOI 10.1172/JCI103573; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; Fischereder M, 2017, AM J PHYSIOL-RENAL, V313, pF319, DOI 10.1152/ajprenal.00703.2016; Fraser TB, 2001, CLIN EXP PHARMACOL P, V28, P831, DOI 10.1046/j.1440-1681.2001.03531.x; FREY L, 1994, ANESTH ANALG, V79, P517; Hammon M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141336; Hijmans RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178940; Hofmeister L, 2015, PFLUG ARCH EUR J PHY, V467, P551, DOI 10.1007/s00424-014-1685-x; IVANOVA L N, 1978, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V64, P358; Jablonski KL, 2013, J AM COLL CARDIOL, V61, P335, DOI 10.1016/j.jacc.2012.09.010; KIEN ND, 1991, ANESTH ANALG, V73, P597; Kingma SDK, 2014, J INHERIT METAB DIS, V37, P813, DOI 10.1007/s10545-014-9703-x; Kopp C, 2013, HYPERTENSION, V61, P635, DOI 10.1161/HYPERTENSIONAHA.111.00566; Kopp C, 2012, HYPERTENSION, V59, P167, DOI 10.1161/HYPERTENSIONAHA.111.183517; Laffer CL, 2016, HYPERTENSION, V68, P195, DOI 10.1161/HYPERTENSIONAHA.116.07289; Li P, 2012, ACTA PHARMACOL SIN, V33, P644, DOI 10.1038/aps.2012.2; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machnik A, 2010, HYPERTENSION, V55, P755, DOI 10.1161/HYPERTENSIONAHA.109.143339; Mooij HL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001274; NADER HB, 1983, COMP BIOCHEM PHYS B, V76, P433, DOI 10.1016/0305-0491(83)90271-7; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nikpey E, 2017, HYPERTENSION, V69, P660, DOI 10.1161/HYPERTENSIONAHA.116.08539; Padberg JS, 2014, ATHEROSCLEROSIS, V234, P335, DOI 10.1016/j.atherosclerosis.2014.03.016; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; READ RC, 1960, CIRC RES, V8, P538, DOI 10.1161/01.RES.8.3.538; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Siegel G, 1996, BIOSENS BIOELECTRON, V11, P281, DOI 10.1016/0956-5663(96)88415-6; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029222; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Talsma DT, 2017, NEPHROL DIAL TRANSPL, V32, P611, DOI 10.1093/ndt/gfw371; Titze J, 2004, AM J PHYSIOL-HEART C, V287, pH203, DOI 10.1152/ajpheart.01237.2003; Titze J, 2002, AM J KIDNEY DIS, V40, P508, DOI 10.1053/ajkd.2002.34908; Titze J, 2002, AM J PHYSIOL-RENAL, V283, pF134, DOI 10.1152/ajprenal.00323.2001; Filho IT, 2013, MICROVASC RES, V85, P128, DOI 10.1016/j.mvr.2012.11.005; WARNER RR, 1988, J INVEST DERMATOL, V90, P78, DOI 10.1111/1523-1747.ep12462576; Wenstedt EFE, 2018, HYPERTENSION, V71, P990, DOI 10.1161/HYPERTENSIONAHA.118.10211; Wouda RD, 2019, AM J KIDNEY DIS, V74, P320, DOI 10.1053/j.ajkd.2019.02.021	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220333	10.1371/journal.pone.0220333	http://dx.doi.org/10.1371/journal.pone.0220333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365577	Green Published, Green Submitted, gold			2022-12-26	WOS:000484983600039
J	Hollander, M; de Miranda, E; Vandenbussche, F; van Dillen, J; Holten, L				Hollander, Martine; de Miranda, Esteriek; Vandenbussche, Frank; van Dillen, Jeroen; Holten, Lianne			Addressing a need. Holistic midwifery in the Netherlands: A qualitative analysis	PLOS ONE			English	Article							PLANNED HOME BIRTH; MATERNITY CARE; MIDWIVES; CONTINUITY; WOMEN; EXPERIENCES; CHILDBIRTH; OBSTETRICIANS; EXPLORATION; ATTITUDES	The Netherlands has a maternity care system with integrated midwifery care, including the option of home birth for low risk women. A small group of Dutch (holistic) midwives is willing to assist women in high risk pregnancies during a home birth against medical advice. We examined holistic midwives' motivations and way of practice, in order to provide other maternity care professionals with insight into the way they work and to improve professional relationships between all care providers in the field. An exploratory qualitative research design with a constructivist approach and a grounded theory method were used. We performed in-depth interviews with twenty-four holistic midwives on their motivations for working outside their professional boundaries. Open, axial and selective coding of the interview data was done in order to generate themes. We held a focus group for a member check of the findings. Four main themes were found: 1) The regular system is failing women, 2) The relationship as basis for empowerment, 3) Delivering client centered care in the current system is demanding, and 4) Future directions. One core theme emerged that covered all other themes: Addressing a need. Holistic midwives explained that many of their clients had no other choice than to choose a home birth in a high risk pregnancy because they felt let down by the regular system of maternity care. Holistic midwives appear to deliver an important service. They provide continuity of care and succeed in establishing a relationship with their clients built on trust and mutual respect, truly putting their clients' needs first. Some women feel let down by the regular system, and holistic midwives may be the last resort before those women choose to deliver unattended by any medical professional. Maternity care providers should consider working with holistic midwives in the interest of good patient care.	[Hollander, Martine; Vandenbussche, Frank; van Dillen, Jeroen] Radboud Univ Nijmegen, Med Ctr, Amalia Childrens Hosp, Dept Obstet, Nijmegen, Netherlands; [de Miranda, Esteriek] Amsterdam UMC, Acad Med Ctr, Dept Obstet, Amsterdam, Netherlands; [Holten, Lianne] AVAG Sch Midwifery, Amsterdam, Netherlands; [Holten, Lianne] Amsterdam UMC, VU EMGO Res Inst, Amsterdam, Netherlands	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Hollander, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Amalia Childrens Hosp, Dept Obstet, Nijmegen, Netherlands.	martine.hollander@radboudumc.nl						Amelink-Verburg MP, 2010, J MIDWIFERY WOM HEAL, V55, P216, DOI 10.1016/j.jmwh.2010.01.001; [Anonymous], 2013, J PERINAT EDUC, V22, P14, DOI [10.1891/1058-1243.22.1.14, 10.1111/j.1542-2011.2012.00218.x]; [Anonymous], 2014, STATE NEWSPAPER; Bastian H, 1998, BRIT MED J, V317, P384; Boenigk Monika, 2007, Pract Midwife, V10, P18; Charmaz K., PRACTICAL GUIDE QUAL, V2; Chervenak FA, 2013, AM J OBSTET GYNECOL, V208, P31, DOI 10.1016/j.ajog.2012.10.002; Christiaens W, 2013, MIDWIFERY, V29, pE1, DOI 10.1016/j.midw.2012.08.010; Crowther S, 2018, WOMEN BIRTH, V31, pE59, DOI 10.1016/j.wombi.2017.06.019; Crowther S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1164-9; Dahlberg U, 2013, MIDWIFERY, V29, P407, DOI 10.1016/j.midw.2012.09.006; Danerek M, 2011, BIRTH-ISS PERINAT C, V38, P71, DOI 10.1111/j.1523-536X.2010.00440.x; Davison C, 2015, MIDWIFERY, V31, P772, DOI 10.1016/j.midw.2015.04.012; de Jonge A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-103; De Vries RG, 2012, J PERINAT EDUC, V21, P9, DOI 10.1891/1058-1243.21.1.9; Feeley C, 2019, MIDWIFERY, V72, P50, DOI 10.1016/j.midw.2019.02.009; Forster DA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0798-y; Green JM, 2000, MIDWIFERY, V16, P186, DOI 10.1054/midw.1999.0208; Harris G, 2000, Aust Coll Midwives Inc J, V13, P10, DOI 10.1016/S1031-170X(00)80048-3; Healy S, 2017, WOMEN BIRTH, V30, P367, DOI 10.1016/j.wombi.2017.02.005; Hollander M, 2016, J PREG CHILD HLTH, V3, P2; Hollander M, 2018, WOMEN BIRTH; Hollander MH, 2017, ARCH WOMEN MENT HLTH, V20, P515, DOI 10.1007/s00737-017-0729-6; Hollander M, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1621-0; Holten L, 2018, QUAL HEALTH RES, V28, P1883, DOI 10.1177/1049732318791535; Holten L, 2016, MIDWIFERY, V38, P55, DOI 10.1016/j.midw.2016.03.010; Jefford E, 2015, INT J CHILDBIRTH, V5, P116, DOI 10.1891/2156-5287.5.3.116; Jenkinson B, 2017, MIDWIFERY, V52, P1, DOI 10.1016/j.midw.2017.05.006; Kensington M, 2018, NURSE EDUC PRACT, V31, P143, DOI 10.1016/j.nepr.2018.06.001; Lynch B, 2002, MIDWIFERY, V18, P178, DOI 10.1054/midw.2002.0319; MacDorman MF, 2013, J MIDWIFERY WOM HEAL, V58, P494, DOI 10.1111/jmwh.12092; Mills J., 2006, INT J QUAL METHODS, V5, P25, DOI [DOI 10.1177/160940690600500103, 10.1177/160940690600500103]; Mitchell ED, 2002, RCM MIDWIVES S4  DEC; Offerhaus PM, 2013, BIRTH-ISS PERINAT C, V40, P192, DOI 10.1111/birt.12055; Perdok H, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-017-1615-y; Perry C, 2002, HASTINGS CENT REP, V32, P12, DOI 10.2307/3528517; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Sandall J, 1995, MIDWIFERY, V11, P201, DOI 10.1016/0266-6138(95)90005-5; Sandall J., 1997, BR J MIDWIFERY, V5, P106, DOI [10.12968/bjom.1997.5.2.106, DOI 10.12968/BJOM.1997.5.2.106]; Sandall J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub4; Scamell M, 2012, HEALTH RISK SOC, V14, P207, DOI 10.1080/13698575.2012.661041; Shorten A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2210; Symon A, 2010, BIRTH-ISS PERINAT C, V37, P280, DOI 10.1111/j.1523-536X.2010.00422.x; Thompson A., BRIT J MIDWIFERY, V21, P564; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Stenus CMV, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1369-6; Young C. J., 2011, THESIS	47	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220489	10.1371/journal.pone.0220489	http://dx.doi.org/10.1371/journal.pone.0220489			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WU	31361787	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300032
J	Jung, D; Han, KD; Cho, YS; Rhee, CS; Lee, KY				Jung, Da Jung; Han, Kyung Do; Cho, Yang-Sun; Rhee, Chae Seo; Lee, Kyu-Yup			Association of metabolic syndrome with the incidence of hearing loss: A national population-based study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; NITRIC-OXIDE; DYSFUNCTION	Background & aims Sensorineural hearing loss (HL) is one of the most common public health problems, and its prevalence increases with increasing life expectancy. An association between HL and metabolic syndrome (MetS) is suspected. Although previous epidemiological studies have investigated the association between the two variables, there have been conflicting conclusions. Therefore, we aimed to evaluate the association between the presence of MetS-and individual components of MetS-and HL, using a longitudinal design and a large-scale population. Methods A total of 17,513,555 individuals who underwent national health screening between January 2009 and December 2010 were identified. Subject data from the Korean Health Insurance Review and Assessment Service were reviewed. A total of 11,457,931 subjects were ultimately included in the analysis. Baseline comorbidities were defined according to the ICD-10 code from the Korean Health Insurance Review and Assessment Service data. If the participants had an ICD-10 code for HL during the follow-up, they were defined as having incident HL. Criteria for MetS adhered to the revised National Cholesterol Education Program Adult Treatment Panel III. Results There were 7,574,432 subjects without MetS and 3,883,499 with MetS. The incidence of HL in subjects without MetS and with MetS was 1.3% and 1.8% at 1 year, 4.1% and 5.2% at 3 years, and 6.8% and 8.6% at 5 years, respectively (P < 0.001). However, multivariate analyses revealed a negative association. Analyses according to the components of MetS demonstrated a positive association for those associated with dyslipidemia; however, the others exhibited an inverse association with HL. We also performed analyses using 4 groups according to the presence of MetS and the components of dyslipidemia. Univariate analysis revealed a positive association between the presence of MetS and HL; however, multivariate analysis revealed a positive association between the presence of dyslipidemia components and HL, regardless of the presence of MetS. Conclusion Among the components of MetS, the association between low HDL or high TG levels and HL was most apparent. It is useful to evaluate each MetS component in isolation, such as the presence of low HDL or high TG levels, rather than the presence of MetS as a cluster of components.	[Jung, Da Jung; Lee, Kyu-Yup] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea; [Han, Kyung Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Cho, Yang-Sun] Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea; [Rhee, Chae Seo] Seoul Natl Univ, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea	Kyungpook National University; Kyungpook National University Hospital; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU)	Lee, KY (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea.	kylee@knu.ac.kr			Korean Society of Otorhinolaryngology-Head and Neck Surgery; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI18C1892]	Korean Society of Otorhinolaryngology-Head and Neck Surgery; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by grants from the Korean Society of Otorhinolaryngology-Head and Neck Surgery, 2017 and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI18C1892) to KL.	Aghazadeh-Attari J, 2017, DIABET METAB SYND OB, V10, P459, DOI 10.2147/DMSO.S150893; BRECHTELSBAUER PB, 1994, HEARING RES, V77, P38, DOI 10.1016/0378-5955(94)90251-8; CULLEN JR, 1993, J LARYNGOL OTOL, V107, P179, DOI 10.1017/S0022215100122571; Engdahl B, 2015, INT J AUDIOL, V54, P958, DOI 10.3109/14992027.2015.1090631; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Han X, 2018, ANN MED, V9, P1; HARNER SG, 1981, OTOLARYNG HEAD NECK, V89, P322, DOI 10.1177/019459988108900235; Heinrich UR, 2012, NITRIC OXIDE-BIOL CH, V27, P106, DOI 10.1016/j.niox.2012.05.005; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; HODGSON MJ, 1987, J OCCUP ENVIRON MED, V29, P576; Im GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28279-z; ISHII EK, 1992, SCI TOTAL ENVIRON, V127, P155, DOI 10.1016/0048-9697(92)90474-7; Kang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120372; Kim TS, 2017, METAB SYNDR RELAT D, V15, P240, DOI 10.1089/met.2016.0153; Lee HY, 2016, J NUTR HEALTH AGING, V20, P816, DOI 10.1007/s12603-015-0647-0; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Oron Y, 2014, AUDIOL NEURO-OTOL, V19, P256, DOI 10.1159/000363215; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; SAITO T, 1986, ARCH OTO-RHINO-LARYN, V243, P242, DOI 10.1007/BF00464438; Satar B, 2001, OTOL NEUROTOL, V22, P786, DOI 10.1097/00129492-200111000-00012; Sun YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134388; Suzuki K, 2000, LARYNGOSCOPE, V110, P1736, DOI 10.1097/00005537-200010000-00033; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; World Health Organization, 2013, DEAFNESS PREVENTION	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220370	10.1371/journal.pone.0220370	http://dx.doi.org/10.1371/journal.pone.0220370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348810	Green Published, gold, Green Submitted			2022-12-26	WOS:000484979500031
J	Mochizuki, H; Takeda, K; Sato, Y; Nagashima, I; Harada, Y; Shimoda, N				Mochizuki, Hideki; Takeda, Kotaro; Sato, Yutaka; Nagashima, Izumi; Harada, Yusuke; Shimoda, Nobuaki			Response time differences between men and women during hand mental rotation	PLOS ONE			English	Article							RIGHT-LEFT DISCRIMINATION; IMPLICIT MOTOR IMAGERY; SEX-DIFFERENCES; GENDER-DIFFERENCES; SPATIAL ABILITIES; YOUNG; TASK; AGE; REPRESENTATIONS; LATERALIZATION	This study explored gender differences in correct response rates and response times on a task involving left or right arrow selection and another involving the transformation of mental rotation of the hand. We recruited 15 healthy, right-handed men (age 24.5 +/- 6.4) and 15 healthy, right-handed women (age 21.3 +/- 4.9). For the tasks, we used pictures of left and right arrows and 32 hand pictures (left and right, palm and back) placed in cons (each at 45 degrees from 0 degrees to 315 degrees). Hand and arrow pictures alternated and were shown at random. Participants decided as quickly as possible whether each picture was left or right. To compare the time taken for the transformation of mental rotation of the hand, we subtracted the average arrow response time from that for the left and right hand pictures for each participant. Correct response rates did not differ significantly between men and women or left and right for either arrow or hand pictures. Regardless of gender, the response time was longer for the left arrow picture than right arrow picture. The response time for the hand picture was longest for both men and women for pictures at rotation angles that were most difficult to align with participants' hands. While there was no difference between men's responses for left and right hand pictures, the responses of women were longer for left than right hand pictures and also than those of men. These findings suggest that both men and women mainly perform the hand mental rotation task with implicit motor imagery. On the other hand, the gender difference in performance might be explained by the difference in balance with other strategies, such as visual imagery, and by cognitive, neurophysiological, and morphological differences.	[Mochizuki, Hideki; Nagashima, Izumi; Harada, Yusuke] Kyorin Univ, Fac Hlth Sci, Dept Occupat Therapy, Tokyo, Japan; [Takeda, Kotaro] Fujita Hlth Univ, Fac Rehabil, Sch Healthcare, Tsu, Mie, Japan; [Sato, Yutaka] Tokushima Univ, Grad Sch Technol Ind & Social Sci, Tokushima, Japan; [Shimoda, Nobuaki] Tokyo Kasei Univ, Fac Hlth Sci, Dept Rehabil, Tokyo, Japan	Kyorin University; Fujita Health University; Tokushima University	Takeda, K (corresponding author), Fujita Hlth Univ, Fac Rehabil, Sch Healthcare, Tsu, Mie, Japan.; Shimoda, N (corresponding author), Tokyo Kasei Univ, Fac Hlth Sci, Dept Rehabil, Tokyo, Japan.	ktakeda@fujita-hu.ac.jp; shimoda-n@tokyo-kasei.ac.jp	Takeda, Kotaro/F-8948-2019	Takeda, Kotaro/0000-0002-0446-4043	JSPS KAKENHI [JP 15K01432, 18K10790, 19H03990]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by JSPS KAKENHI Grant Numbers JP 15K01432, 18K10790, and 19H03990. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.T	Ariel R, 2018, AGING NEUROPSYCHOL C, V25, P351, DOI 10.1080/13825585.2017.1305086; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; Butson ML, 2014, HUM MOVEMENT SCI, V35, P50, DOI 10.1016/j.humov.2014.03.013; Chen J, 2013, PSYCHIAT RES, V209, P32, DOI 10.1016/j.psychres.2012.10.003; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Debarnot U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060296; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; DEUTSCH G, 1988, NEUROPSYCHOLOGIA, V26, P445, DOI 10.1016/0028-3932(88)90097-8; Dykiert D, 2012, DEV PSYCHOL, V48, P1262, DOI 10.1037/a0027550; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; GEARY DC, 1992, J GENET PSYCHOL, V153, P115; Gentilucci M, 1998, COGNITIVE BRAIN RES, V6, P185, DOI 10.1016/S0926-6410(97)00034-7; Guillot A, 2007, ADV HEALTH SCI EDUC, V12, P491, DOI 10.1007/s10459-006-9021-7; Hahn N, 2010, COGN NEUROSCI-UK, V1, P261, DOI 10.1080/17588928.2010.485248; Harada Y., 2016, J ERGON TECHNOL, V16, P15; Hattemer K, 2011, J NEUROIMAGING, V21, P16, DOI 10.1111/j.1552-6569.2009.00402.x; Heil M, 2008, Q J EXP PSYCHOL, V61, P683, DOI 10.1080/17470210701822967; Ietswaart M, 2011, BRAIN, V134, P1373, DOI 10.1093/brain/awr077; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Karadi K, 1999, PERCEPT MOTOR SKILL, V89, P969, DOI 10.2466/PMS.89.7.969-972; Koscik T, 2009, BRAIN COGNITION, V69, P451, DOI 10.1016/j.bandc.2008.09.004; LAHTELA K, 1985, SCAND J PSYCHOL, V26, P357, DOI 10.1111/j.1467-9450.1985.tb01175.x; LANDAUER AA, 1980, BRIT J PSYCHOL, V71, P551, DOI 10.1111/j.2044-8295.1980.tb01766.x; Lebon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037850; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P379, DOI 10.1016/S0028-3932(98)00064-5; Moseley GL, 2004, PAIN, V108, P192, DOI 10.1016/j.pain.2004.01.006; Nico D, 2004, BRAIN, V127, P120, DOI 10.1093/brain/awh006; Ofte SH, 2002, J CLIN EXP NEUROPSYC, V24, P82, DOI 10.1076/jcen.24.1.82.966; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Pintzka CWS, 2016, BEHAV BRAIN RES, V298, P78, DOI 10.1016/j.bbr.2015.10.056; RABBITT P, 1978, Q J EXP PSYCHOL, V30, P407, DOI 10.1080/00335557843000016; Rilea SL, 2008, BRAIN COGNITION, V67, P168, DOI 10.1016/j.bandc.2008.01.001; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; Seurinck R, 2004, NEUROIMAGE, V23, P1440, DOI 10.1016/j.neuroimage.2004.08.010; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shibui M., 2016, THE J, V16, P24; Takeda K, 2010, LATERALITY, V15, P415, DOI 10.1080/13576500902938105; TENG EL, 1982, PERCEPT MOTOR SKILL, V55, P299, DOI 10.2466/pms.1982.55.1.299; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Tomasino Barbara, 2015, Front Hum Neurosci, V9, P693, DOI 10.3389/fnhum.2015.00693; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; VOYER D, 1990, BRAIN COGNITION, V13, P18, DOI 10.1016/0278-2626(90)90037-O; Voyer SD, 2015, J CLIN EXP NEUROPSYC, V37, P27, DOI 10.1080/13803395.2014.985191; Wei W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00580; Zapparoli L, 2016, BEHAV BRAIN RES, V303, P137, DOI 10.1016/j.bbr.2016.01.058	57	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220414	10.1371/journal.pone.0220414	http://dx.doi.org/10.1371/journal.pone.0220414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WC	31348807	Green Published, gold, Green Submitted			2022-12-26	WOS:000484979500035
J	van der Veen, DJ; Dopp, CME; Siemonsma, PC; Nijhuis-van der Sanden, MWG; de Swart, BJM; Steultjens, EM				van der Veen, Dinja J.; Dopp, Carola M. E.; Siemonsma, Petra C.; Nijhuis-van der Sanden, Maria W. G.; de Swart, Bert J. M.; Steultjens, Esther M.			Factors influencing the implementation of Home-Based Stroke Rehabilitation: Professionals' perspective	PLOS ONE			English	Article							SUPPORTED DISCHARGE; HEALTH-CARE; DISORDERS; CAREGIVERS; THERAPY; IMPACT; BRAIN	Background Stroke has a major impact on survivors and their social environment. Care delivery is advocated to become more client-centered and home-based because of their positive impact on client outcomes. The objective of this study was to explore professionals' perspectives on the provision of Home-Based Stroke Rehabilitation (HBSR) in the Netherlands and on the barriers and facilitators influencing the implementation of HBSR in daily practice. Methods Semi-structured focus groups were conducted to explore the perspectives of health and social care professionals involved in stroke rehabilitation. Directed content analysis was performed to analyze the transcripts of recorded conversations. Results Fourteen professionals participated in focus groups (n = 12) or, if unable to attend, an interview (n = 2). Participants varied in professional backgrounds and roles in treating Dutch clients post stroke. Barriers and facilitators influencing the implementation of HBSR in daily practice were identified in relation to: the innovation, the user, the organization and the socio-political context. Participants reported that HBSR can be efficient and effective to most clients because it facilitates client-and caregiver-centered rehabilitation within the clients' own environment. However, barriers in implementing HBSR were perceived in a lack of (structured) inter-professional collaboration and the transparency of expertise of primary care professionals. Also, the current financial structures for HBSR in the Netherlands are viewed as inappropriate. Discussion In line with previous studies, we found that HBSR is recognized by professionals as a promising alternative to institution-based rehabilitation for clients with sufficient capabilities (e.g. their own health and informal support). Conclusion Multiple factors influencing the implementation of HBSR were identified. Our study suggests that, in order to implement HBSR in daily practice, region specific implementation strategies need to be developed. We recommend developing strategies concerning: organized and coordinated inter-professional collaboration, transparency of the expertise of primary care professionals, and the financial structures of HBSR.	[van der Veen, Dinja J.; de Swart, Bert J. M.; Steultjens, Esther M.] Univ Appl Sci HAN, Inst Hlth Studies, Nijmegen, Netherlands; [Dopp, Carola M. E.; Siemonsma, Petra C.] TNO Leiden, Hlth Living, Leiden, Netherlands; [Siemonsma, Petra C.] Univ Appl Sci THIM, Nieuwegein, Netherlands; [Siemonsma, Petra C.] Univ Appl Sci Leiden, Fac Hlth, Leiden, Netherlands; [Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Res Inst Hlth Sci, IQ Healthcare, Med Ctr, Nijmegen, Netherlands; [de Swart, Bert J. M.] Radboud Univ Nijmegen, Dept Neurorehabil, Med Ctr, Nijmegen, Netherlands	Netherlands Organization Applied Science Research; Radboud University Nijmegen; Radboud University Nijmegen	van der Veen, DJ (corresponding author), Univ Appl Sci HAN, Inst Hlth Studies, Nijmegen, Netherlands.	Dinja.vanderveen@radboudumc.nl	der Sanden, Maria WG Nijhuis-van/B-3463-2012	der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; van der Veen, Dinja/0000-0001-5891-5914				Allen LJ, 2015, COST EFFECTIVENESS S; Arya KN, 2012, TOP STROKE REHABIL, V19, P193, DOI 10.1310/tsr1903-193; Australian Commission on Safety and Quality in Health Care, 2011, PAT CAR IMPR QUAL SA; Beaulieu MD, 2013, CAN MED ASSOC J, V185, pE590, DOI 10.1503/cmaj.121802; Camak DJ, 2015, J CLIN NURS, V24, P2376, DOI 10.1111/jocn.12884; Chandra RV, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00060; Combs SA, 2010, DISABIL REHABIL, V32, P669, DOI 10.3109/09638280903242716; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; DePoy E, 2013, INTRO RES UNDERSTAND; Doig E, 2010, DISABIL REHABIL, V32, P2061, DOI 10.3109/09638281003797356; Dopp CME, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-131; Ellis-Hill C, 2009, DISABIL REHABIL, V31, P61, DOI 10.1080/09638280701775289; Epstein RM, 2010, HEALTH AFFAIR, V29, P1489, DOI 10.1377/hlthaff.2009.0888; Fearon P., 2012, COCHRANE DATABASE SY, V12; Freeman T, 2006, J ADV NURS, V56, P491, DOI 10.1111/j.1365-2648.2006.04043.x; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gilbertson L, 2000, BRIT MED J, V320, P603, DOI 10.1136/bmj.320.7235.603; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Holmqvist LW, 2000, SCAND J REHABIL MED, V32, P173, DOI 10.1080/003655000750060922; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jaracz K, 2014, NEUROL NEUROCHIR POL, V48, P280, DOI 10.1016/j.pjnns.2014.07.004; Jellema S, 2016, ARCH PHYS MED REHAB, V97, P991, DOI 10.1016/j.apmr.2016.01.015; Kent TA, 2001, STROKE, V32, P2318, DOI 10.1161/hs1001.096588; Klomp J., 2019, NAH EXPERTISE TEAM I; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P59; Lamontagne ME, 2019, TOP STROKE REHABIL, V26, P39, DOI 10.1080/10749357.2018.1534453; Langhorne P, 2007, J REHABIL MED, V39, P103, DOI 10.2340/16501977-0042; Larsen T, 2006, INT J TECHNOL ASSESS, V22, P313, DOI 10.1017/S0266462306051208; Liamputtong Pranee, 2011, FOCUS GROUP METHODOL; Lincoln NB, 2004, CLIN REHABIL, V18, P40, DOI 10.1191/0269215504cr700oa; Minkman M M N, 2005, Int J Integr Care, V5, pe14; Mulvale G, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0492-1; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Pantoni L, 2014, CEREBRAL SMALL VESSE, VFirst; Peters M, 2000, J NURS EDUC, V39, P166; Revalidatie CG, 2013, LEIDRAAD GERIATRISCH; Rogers EM., 2010, INTEGRATED APPROACH; Satink T, 2015, DISABIL REHABIL, V37, P1745, DOI 10.3109/09638288.2014.976717; Siemonsma P, 2014, DISABILITY REHABILIT, V13, P13; Sit JWH, 2004, J CLIN NURS, V13, P816, DOI 10.1111/j.1365-2702.2004.00943.x; Soydan Haluk, 2009, J Evid Based Med, V2, P143, DOI 10.1111/j.1756-5391.2009.01031.x; Stiekema AW I., 2018, HERVINDEN BALANS LEV; Stolee P, 2012, CLIN REHABIL, V26, P387, DOI 10.1177/0269215511423279; Supper I, 2014, J PUBLIC HLTH OXFORD; Takeuchi N, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/128641; TURNERSTOKES L, 2015, COCHRANE DATABASE SY; Vaartjes I, 2014, NEEMT AANTAL MENSEN; Vat LE, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2444; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; Walker MF, 2013, STROKE, V44, P293, DOI 10.1161/STROKEAHA.111.639914; Weert S., 2016, GEZONDHEIDSKRANT SJG, V3, P5; Wottrich AW, 2007, PHYS THER, V87, P778, DOI 10.2522/ptj.20060152	53	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220226	10.1371/journal.pone.0220226	http://dx.doi.org/10.1371/journal.pone.0220226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344103	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900071
J	Gottlieb, CD; Thompson, ACS; Ordureau, A; Harper, JW; Kopito, RR				Gottlieb, Colin D.; Thompson, Airlia C. S.; Ordureau, Alban; Harper, J. Wade; Kopito, Ron R.			Acute unfolding of a single protein immediately stimulates recruitment of ubiquitin protein ligase E3C (UBE3C) to 26S proteasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein misfolding; protein aggregation; proteasome; ubiquitin; E3 ubiquitin ligase; ADRM1; RPN13; UBE3C	DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; PROTEOSTASIS; DEGRADATION; SUBUNIT; BINDING; RPN13; UCH37; POLY(ADP-RIBOSE); PHOSPHORYLATION	The intracellular accumulation of aggregated misfolded proteins is a cytopathological hallmark of neurodegenerative diseases. However, the functional relationship between protein misfolding or aggregation and the cellular proteostasis network that monitors and maintains proteome health is poorly understood. Previous studies have associated translational suppression and transcriptional remodeling with the appearance of protein aggregates, but whether these responses are induced by aggregates or their misfolded monomeric or oligomeric precursors remains unclear. Because aggregation in cells is rapid, nonlinear, and asynchronous, it has not been possible to deconvolve these kinetically linked processes to determine the earliest cellular responses to misfolded proteins. Upon removal of the synthetic, biologically inert ligand shield-1 (S1), AgDD, an engineered variant FK506-binding protein (FKBP1A), rapidly (t(?) ?5 min) unfolds and self-associates, forming detergent-insoluble, microscopic cytoplasmic aggregates. Using global diglycine-capture (K-GG) proteomics, we found here that this solubility transition is associated with immediate increases in ubiquitylation of AgDD itself, along with that of endogenous proteins that are components of the ribosome and the 26S proteasome. We also found that the earliest cellular responses to acute S1 removal include recruitment of ubiquitin protein ligase E3C (UBE3C) to the 26S proteasome and ubiquitylation of two key proteasomal ubiquitin receptors, 26S proteasome regulatory subunit RPN10 (RPN10) and Rpn13 homolog (RPN13 or ADRM1). We conclude that these proteasomal responses are due to AgDD protein misfolding and not to the presence of detergent-insoluble aggregates.	[Gottlieb, Colin D.; Thompson, Airlia C. S.; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Ordureau, Alban; Harper, J. Wade] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Harvard University; Harvard Medical School	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	kopito@stanford.edu	Ordureau, Alban/C-7558-2012	Ordureau, Alban/0000-0002-4924-8520	National Institutes of Health [2R01NS042842, R37NS083524, RO1AG011085]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842, R37NS083524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants 2R01NS042842 (to R. R. K.) and R37NS083524 and RO1AG011085 (to J. W. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aillet F, 2012, METHODS MOL BIOL, V832, P173, DOI 10.1007/978-1-61779-474-2_12; Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bersuker K, 2016, J CELL BIOL, V213, P229, DOI 10.1083/jcb.201511024; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Chu BW, 2013, J BIOL CHEM, V288, P34575, DOI 10.1074/jbc.M113.499350; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grandjean JMD, 2019, ACS CHEM BIOL, V14, P784, DOI 10.1021/acschembio.9b00134; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Klaips CL, 2018, J CELL BIOL, V217, P51, DOI 10.1083/jcb.201709072; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kristariyanto YA, 2015, MOL CELL, V58, P83, DOI 10.1016/j.molcel.2015.01.041; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuo CL, 2017, P NATL ACAD SCI USA, V114, pE3404, DOI 10.1073/pnas.1701734114; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lu XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15540; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Miyazaki Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11689; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ordureau A, 2018, MOL CELL, V70, P211, DOI 10.1016/j.molcel.2018.03.012; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rose CM, 2016, CELL SYST, V3, P395, DOI 10.1016/j.cels.2016.08.009; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Thibaudeau TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03509-0; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Tyler RE, 2012, MOL BIOL CELL, V23, P4668, DOI 10.1091/mbc.E12-06-0428; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2017, MOL CELL PROTEOMICS, V16, P840, DOI 10.1074/mcp.M116.065326; Wilson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046398; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	58	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16511	16524		10.1074/jbc.RA119.009654	http://dx.doi.org/10.1074/jbc.RA119.009654			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31375563	Green Published, hybrid			2022-12-26	WOS:000501801900004
J	Preising, MN; Gorg, B; Friedburg, C; Qvartskhava, N; Budde, BS; Bonus, M; Toliat, MR; Pfleger, C; Altmuller, J; Herebian, D; Beyer, M; Zollner, HJ; Wittsack, HJ; Schaper, J; Klee, D; Zechner, U; Nurnberg, P; Schipper, J; Schnitzler, A; Gohlke, H; Lorenz, B; Haussinger, D; Bolz, HJ				Preising, Markus N.; Goerg, Boris; Friedburg, Christoph; Qvartskhava, Natalia; Budde, Birgit S.; Bonus, Michele; Toliat, Mohammad R.; Pfleger, Christopher; Altmueller, Janine; Herebian, Diran; Beyer, Mila; Zoellner, Helge J.; Wittsack, Hans-Joerg; Schaper, Joerg; Klee, Dirk; Zechner, Ulrich; Nuernberg, Peter; Schipper, Joerg; Schnitzler, Alfons; Gohlke, Holger; Lorenz, Birgit; Haeussinger, Dieter; Bolz, Hanno J.			Biallelic mutation of human SLC6A6 encoding the taurine transporter TAUT is linked to early retinal degeneration	FASEB JOURNAL			English	Article						exome sequencing; homozygosity mapping; consanguinity	MOLECULAR-DYNAMICS SIMULATIONS; RIGIDITY THEORY; ISCEV STANDARD; SOFTWARE; KNOCKOUT; MOUSE; ACCURACY; SODIUM; MODEL; FLEXIBILITY	We previously reported that inactivation of the transmembrane taurine transporter (TauT or solute carrier 6a6) causes early retinal degeneration in mice. Compatible with taurine's indispensability for cell volume homeostasis, protein stabilization, cytoprotection, antioxidation, and immuno- and neuromodulation, mice develop multisystemic dysfunctions (hearing loss; liver fibrosis; and behavioral, heart, and skeletal muscle abnormalities) later on. Here, by genetic, cell biologic, in vivo H-1-magnetic resonance spectroscopy and molecular dynamics simulation studies, we conducted in-depth characterization of a novel disorder: human TAUT deficiency. Loss of TAUT function due to a homozygous missense mutation caused panretinal degeneration in 2 brothers. TAUT(p.A78E) still localized in the plasma membrane but is predicted to impact structural stabilization. H-3-taurine uptake by peripheral blood mononuclear cells was reduced by 95%, and taurine levels were severely reduced in plasma, skeletal muscle, and brain. Extraocular dysfunctions were not yet detected, but significantly increased urinary excretion of 8-oxo-7,8-dihydroguanosine indicated generally enhanced (yet clinically unapparent) oxidative stress and RNA oxidation, warranting continuous broad surveillance.-Preising, M. N., Gorg, B., Friedburg, C., Qvartskhava, N., Budde, B. S., Bonus, M., Toliat, M. R., Pfleger, C., Altmuller, J., Herebian, D., Beyer, M., Zollner, H. J., Wittsack, H.-J., Schaper, J., Klee, D., Zechner, U., Nurnberg, P., Schipper, J., Schnitzler, A., Gohlke, H., Lorenz, B., Haussinger, D., Bolz, H. J. Biallelic mutation of human SLC6A6 encoding the taurine transporter TAUT is linked to early retinal degeneration.	[Preising, Markus N.; Friedburg, Christoph; Lorenz, Birgit] Justus Liebig Univ Giessen, Dept Ophthalmol, Giessen, Germany; [Goerg, Boris; Qvartskhava, Natalia; Beyer, Mila; Haeussinger, Dieter] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Herebian, Diran] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Gen Pediat Neonatol & Pediat Cardiol, Med Fac, Dusseldorf, Germany; [Zoellner, Helge J.; Schnitzler, Alfons] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Wittsack, Hans-Joerg; Schaper, Joerg; Klee, Dirk] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Schipper, Joerg] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Klin Hals Nasen Ohren Heilkunde, Dusseldorf, Germany; [Budde, Birgit S.; Toliat, Mohammad R.; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Bolz, Hanno J.] Univ Cologne, Inst Human Genet, Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Bonus, Michele; Pfleger, Christopher; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Zechner, Ulrich; Bolz, Hanno J.] Senckenberg Ctr Human Genet, Weismullerstr 50, D-60314 Frankfurt, Germany; [Zechner, Ulrich] Mainz Univ, Med Ctr, Inst Human Genet, Mainz, Germany; [Gohlke, Holger] John von Neumann Inst Comp NIC, Res Ctr Julich, Julich Supercomp Ctr JSC Struct Biochem, Inst Complex Syst ICS 6, Julich, Germany	Justus Liebig University Giessen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; Johannes Gutenberg University of Mainz; Helmholtz Association; Research Center Julich	Bolz, HJ (corresponding author), Senckenberg Ctr Human Genet, Weismullerstr 50, D-60314 Frankfurt, Germany.; Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de; h.bolz@senckenberg-humangenetik.de	Schnitzler, Alfons/AAT-1054-2021; Preising, Markus/GQA-9591-2022; Wittsack, Hans-Joerg/AAM-3179-2020; Lorenz, Birgit/AAJ-1351-2020; Zöllner, Helge/ABE-2726-2020; Bonus, Michele/P-4170-2018; Schnitzler, Alfons/Q-5520-2019	Wittsack, Hans-Joerg/0000-0002-5830-423X; Lorenz, Birgit/0000-0002-9737-8127; Bonus, Michele/0000-0003-4411-7342; Schnitzler, Alfons/0000-0002-6414-7939; Altmuller, Janine/0000-0003-4372-1521; Budde, Birgit/0000-0001-9385-4168; Dr. Herebian, Diran/0000-0002-8528-0122; Gorg, Boris/0000-0002-4630-9420	PRO RETINA Deutschland, Stiftung Auge (Deutsche Ophthalmologische Gesellschaft); Dr. Senckenbergische Stiftung; Deutsche Forschungsgemeinschaft (DFG) [190586431-SFB, 9741367/2-1]	PRO RETINA Deutschland, Stiftung Auge (Deutsche Ophthalmologische Gesellschaft); Dr. Senckenbergische Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Mrs. Ursula Wiggen (University Hospital Dusseldorf-Heinrich Heine University Dusseldorf) for the patient handling during the magnetic resonance spectroscopy measurement, Dr. Ute Albrecht for coordinating clinical examinations and Ina Park for SLC6A6 mutation analyses. The authors are grateful for computational support and infrastructure provided by the Zentrum fur Informations und Medientechnologie (ZIM) at Heinrich Heine University Dusseldorf, and the computing time provided by the John von Neumann Institute for Computing (NIC) to H.G. on the supercomputer Julich Wizard for European Leadership Science (JUWELS) at the Julich Supercomputing Centre (JSC) (ID: HKF7). This study was supported by grants from PRO RETINA Deutschland, Stiftung Auge (Deutsche Ophthalmologische Gesellschaft), Dr. Senckenbergische Stiftung; the Deutsche Forschungsgemeinschaft (DFG; Projektnummer 190586431-SFB 974) Communication and Systems Relevance in Liver Injury and Regeneration (Dusseldorf, Germany), and Research Group FOR 2518 DynIon (Project P7, GO 1367/2-1 to H.G.). M.N.P. and B.G. are joint first authors. D.H. and H.J.B. share senior authorship. The authors declare no conflicts of interest.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Alagramam KN, 2016, NAT CHEM BIOL, V12, P444, DOI [10.1038/nchembio.2069, 10.1038/NCHEMBIO.2069]; AMENT ME, 1986, J AM COLL NUTR, V5, P127; Beck BB, 2014, HUM MUTAT, V35, P1153, DOI 10.1002/humu.22618; Behnen P, 2018, ISCIENCE, V4, P1, DOI 10.1016/j.isci.2018.05.001; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Case D. A., 2018, AMBER 2019; Chavent M, 2016, CURR OPIN STRUC BIOL, V40, P8, DOI 10.1016/j.sbi.2016.06.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Ehnes A, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.1.1; Elsayed SM, 2015, HUM MOL GENET, V24, P2594, DOI 10.1093/hmg/ddv022; Farrar GJ, 2017, HUM MOL GENET, V26, pR2, DOI 10.1093/hmg/ddx185; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Froger N, 2013, ADV EXP MED BIOL, V775, P69, DOI 10.1007/978-1-4614-6130-2_6; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Gan W, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00034; Garcia-Ayuso D, 2018, INVEST OPHTH VIS SCI, V59, P1396, DOI 10.1167/iovs.17-23258; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; GEGGEL HS, 1985, NEW ENGL J MED, V312, P142, DOI 10.1056/NEJM198501173120302; Gorg B, 2015, GLIA, V63, P37, DOI 10.1002/glia.22731; HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Hermans SMA, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1311; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Huxtable RJ, 2000, ADV EXP MED BIOL, V483, P1; Imaki H, 1996, ADV EXP MED BIOL, V403, P351; IMAKI H, 1993, J NEUROSCI RES, V36, P290, DOI 10.1002/jnr.490360307; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kawalia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126321; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Moukarzel C, 1999, PHYS REV E, V59, P2614, DOI 10.1103/PhysRevE.59.2614; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Otte M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33050-5; Pagani G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23778-5; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Pfleger C, 2017, J CHEM THEORY COMPUT, V13, P6343, DOI 10.1021/acs.jctc.7b00529; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pierce EA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017285; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Radestock S, 2008, ENG LIFE SCI, V8, P507, DOI 10.1002/elsc.200800043; Rascher K, 2004, VISION RES, V44, P2091, DOI 10.1016/j.visres.2004.03.027; Rathi PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130289; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scholl HPN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2838; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Skolnick J, 1997, PROTEIN SCI, V6, P676; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Venable RM, 2015, CHEM PHYS LIPIDS, V192, P60, DOI 10.1016/j.chemphyslip.2015.07.014; Vinnakota S, 1997, J NEUROCHEM, V69, P2238; Wakeling M. N., 2018, GENET MED, V21, P21; Wakeling MN, 2019, GENET MED, V21, P982, DOI 10.1038/s41436-018-0281-4; Wakeling MN, 2019, GENET MED, V21, P766, DOI 10.1038/s41436-018-0357-1; Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje; Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	79	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11507	11527		10.1096/fj.201900914RR	http://dx.doi.org/10.1096/fj.201900914RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31345061				2022-12-26	WOS:000489166300075
J	Zhao, WC; Bohleber, S; Schmidt, H; Seeher, S; Howard, MT; Braun, D; Arndt, S; Reuter, U; Wende, H; Birchmeier, C; Fradejas-Villar, N; Schweizer, U				Zhao, Wenchao; Bohleber, Simon; Schmidt, Henrik; Seeher, Sandra; Howard, Michael T.; Braun, Doreen; Arndt, Simone; Reuter, Uschi; Wende, Hagen; Birchmeier, Carmen; Fradejas-Villar, Noelia; Schweizer, Ulrich			Ribosome profiling of selenoproteins in vivo reveals consequences of pathogenic Secisbp2 missense mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						selenium; selenocysteine insertion sequence (SECIS); selenoprotein; neurobiology; neuroinflammation; translation; thyroid hormone; Sbp2; selenocysteine; thermal instability; brain; liver; deiodinase; SECIS-binding protein 2 (SECISBP2)	INSERTION-SEQUENCE-BINDING; RNA-BINDING; ELONGATION-FACTOR; PROTEIN; SELENOCYSTEINE; EXPRESSION; SBP2; TRANSLATION; AFFINITY; DOMAIN	Recoding of UGA codons as selenocysteine (Sec) codons in selenoproteins depends on a selenocysteine insertion sequence (SECIS) in the 3?-UTR of mRNAs of eukaryotic selenoproteins. SECIS-binding protein 2 (SECISBP2) increases the efficiency of this process. Pathogenic mutations in SECISBP2 reduce selenoprotein expression and lead to phenotypes associated with the reduction of deiodinase activities and selenoprotein N expression in humans. Two functions have been ascribed to SECISBP2: binding of SECIS elements in selenoprotein mRNAs and facilitation of co-translational Sec insertion. To separately probe both functions, we established here two mouse models carrying two pathogenic missense mutations in Secisbp2 previously identified in patients. We found that the C696R substitution in the RNA-binding domain abrogates SECIS binding and does not support selenoprotein translation above the level of a complete Secisbp2 null mutation. The R543Q missense substitution located in the selenocysteine insertion domain resulted in residual activity and caused reduced selenoprotein translation, as demonstrated by ribosomal profiling to determine the impact on UGA recoding in individual selenoproteins. We found, however, that the R543Q variant is thermally unstable in vitro and completely degraded in the mouse liver in vivo, while being partially functional in the brain. The moderate impairment of selenoprotein expression in neurons led to astrogliosis and transcriptional induction of genes associated with immune responses. We conclude that differential SECISBP2 protein stability in individual cell types may dictate clinical phenotypes to a much greater extent than molecular interactions involving a mutated amino acid in SECISBP2.	[Zhao, Wenchao; Bohleber, Simon; Schmidt, Henrik; Seeher, Sandra; Braun, Doreen; Arndt, Simone; Reuter, Uschi; Fradejas-Villar, Noelia; Schweizer, Ulrich] Rheinische Friedrich Wilhelms Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany; [Howard, Michael T.] Univ Utah, Dept Genet, Salt Lake City, UT 84112 USA; [Wende, Hagen; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	University of Bonn; Utah System of Higher Education; University of Utah; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Schweizer, U (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	Ulrich.schweizer@uni-bonn.de		Fradejas-Villar, Noelia/0000-0003-3418-0743; Schweizer, Ulrich/0000-0003-1380-4780; Birchmeier, Carmen/0000-0002-2041-8872; Bohleber, Simon/0000-0002-1551-9839; Wende, Hagen/0000-0002-9168-8095; Reuter, Uwe/0000-0002-8527-0725	Deutsche Forschungsgemeinschaft [Schw914/2, Schw914/5]; Universitatsklinikum Bonn; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114291] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Universitatsklinikum Bonn; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grants Schw914/2 and Schw914/5 and Universitatsklinikum Bonn. The authors declare that they have no conflicts of interest with the contents of this article.	Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Azevedo MF, 2010, J CLIN ENDOCR METAB, V95, P4066, DOI 10.1210/jc.2009-2611; Bubenik JL, 2007, J BIOL CHEM, V282, P34653, DOI 10.1074/jbc.M707059200; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304; Catli G, 2018, THYROID, V28, P1221, DOI 10.1089/thy.2018.0015; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Di Cosmo C, 2009, J CLIN ENDOCR METAB, V94, P4003, DOI 10.1210/jc.2009-0686; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Dumitrescu AM, 2010, ANTIOXID REDOX SIGN, V12, P905, DOI 10.1089/ars.2009.2892; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fradejas-Villar N, 2017, NUCLEIC ACIDS RES, V45, P4094, DOI 10.1093/nar/gkw1255; Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155; Hamajima T, 2012, EUR J ENDOCRINOL, V166, P957, DOI 10.1530/EJE-11-0812e; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jo S, 2019, J CLIN INVEST, V129, P230, DOI 10.1172/JCI123176; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Kirchner S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000779; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Krueger F., 2014, TRIM GALORE WRAPPER; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Olieric V, 2009, BIOCHIMIE, V91, P1003, DOI 10.1016/j.biochi.2009.05.004; Pitts MW, 2012, NEUROSCIENCE, V208, P58, DOI 10.1016/j.neuroscience.2012.02.017; R Core Team, 2018, R LANG ENV STAT COMP; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schweizer U, 2016, FASEB J, V30, P3669, DOI 10.1096/fj.201600424; Seeher S, 2014, ANTIOXID REDOX SIGN, V21, P835, DOI 10.1089/ars.2013.5358; Seeher S, 2014, BIOCHEM J, V462, P67, DOI 10.1042/BJ20140423; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Smith AC, 2014, J MED GENET, V51, P470, DOI 10.1136/jmedgenet-2013-102218; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Takeuchi A, 2009, NUCLEIC ACIDS RES, V37, P2126, DOI 10.1093/nar/gkp078; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200	56	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14185	14200		10.1074/jbc.RA119.009369	http://dx.doi.org/10.1074/jbc.RA119.009369			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31350336	hybrid, Green Published			2022-12-26	WOS:000499248200003
J	Staus, DP; Wingler, LM; Pichugin, D; Prosser, RS; Lefkowitz, RJ				Staus, Dean P.; Wingler, Laura M.; Pichugin, Dmitry; Prosser, Robert Scott; Lefkowitz, Robert J.			Detergent- and phospholipid-based reconstitution systems have differential effects on constitutive activity of G-protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled receptor (GPCR); G protein; nuclear magnetic resonance (NMR); cell signaling; allosteric regulation; beta 2-adrenergic receptor; constitutive activity; detergent; phospholipid bilayer; receptor reconstitution	BETA(2)-ADRENERGIC RECEPTOR; LIGAND EFFICACY; UP-REGULATION; ACTIVATION; MECHANISMS	A hallmark of G-protein-coupled receptors (GPCRs) is the conversion of external stimuli into specific cellular responses. In this tightly-regulated process, extracellular ligand binding by GPCRs promotes specific conformational changes within the seven transmembrane helices, leading to the coupling and activation of intracellular "transducer" proteins, such as heterotrimeric G proteins. Much of our understanding of the molecular mechanisms that govern GPCR activation is derived from experiments with purified receptors reconstituted in detergent micelles. To elucidate the influence of the phospholipid bilayer on GPCR activation, here we interrogated the functional, pharmacological, and biophysical properties of a GPCR, the beta(2)-adrenergic receptor (beta(2)AR), in high-density lipoprotein (HDL) particles. Compared with detergent-reconstituted beta(2)AR, the beta(2)AR in HDL particles had greatly enhanced levels of basal (constitutive) activity and displayed increased sensitivity to agonist activation, as assessed by activation of heterotrimeric G protein and allosteric coupling between the ligand-binding and transducer-binding pockets. Using F-19 NMR spectroscopy, we directly linked these functional differences in detergent- and HDL-reconstituted beta(2)AR to a change in the equilibrium between inactive and active receptor states. The contrast between the low levels of beta(2)AR constitutive activity in cells and the high constitutive activity observed in an isolated phospholipid bilayer indicates that beta(2)AR basal activity depends on the reconstitution system and further suggests that various cellular mechanisms suppress beta(2)AR basal activity physiologically. Our findings provide critical additional insights into GPCR activation and reveal how dramatically reconstitution systems can impact membrane protein function.	[Staus, Dean P.; Wingler, Laura M.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Pichugin, Dmitry; Prosser, Robert Scott] Univ Toronto, UTM, Dept Chem, 3359 Mississauga Rd North, Mississauga, ON L5L 1C6, Canada; [Staus, Dean P.; Wingler, Laura M.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; University of Toronto; University Toronto Mississauga; Duke University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Prosser, RS (corresponding author), Univ Toronto, UTM, Dept Chem, 3359 Mississauga Rd North, Mississauga, ON L5L 1C6, Canada.; Lefkowitz, RJ (corresponding author), Howard Hughes Med Inst, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, 467 CARL Bldg,Box 3821,Res Dr, Durham, NC 27710 USA.	scott.prosser@utoronto.ca; lefko001@receptor-biol.duke.edu	Wingler, Laura/ABA-4466-2020; Lefkowitz, Robert/AAW-2649-2021	Wingler, Laura/0000-0002-3688-5088; Pichugin, Dmitry/0000-0003-3730-0931; Prosser, Robert Scott/0000-0001-9351-178X	National Institutes of Health [HL16037]; Natural Sciences and Engineering Research Council of Canada [418679]; Canadian Institutes of Health Research (CIHR) [MOP-43998]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL16037 (to R. J. L.), Natural Sciences and Engineering Research Council of Canada Discovery Grant 418679 (to R. S. P.), and Canadian Institutes of Health Research (CIHR) Operating Grant MOP-43998 (to R. S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Chung KY, 2012, J BIOL CHEM, V287, P36305, DOI 10.1074/jbc.M112.406371; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Gregorio GG, 2017, NATURE, V547, P68, DOI 10.1038/nature22354; Grinkova YV, 2010, PROTEIN ENG DES SEL, V23, P843, DOI 10.1093/protein/gzq060; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kofuku Y, 2014, ANGEW CHEM INT EDIT, V53, P13376, DOI 10.1002/anie.201406603; Lamichhane R, 2015, P NATL ACAD SCI USA, V112, P14254, DOI 10.1073/pnas.1519626112; Lee TW, 1997, BIOCHEM J, V325, P733, DOI 10.1042/bj3250733; MacEwan DJ, 1996, MOL PHARMACOL, V50, P1479; Manglik A, 2017, BIOCHEMISTRY-US, V56, P5628, DOI 10.1021/acs.biochem.7b00747; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Staus DP, 2018, P NATL ACAD SCI USA, V115, P3834, DOI 10.1073/pnas.1722336115; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; van der Westhuizen ET, 2015, J PHARMACOL EXP THER, V353, P246, DOI 10.1124/jpet.114.221606; Van Eps N, 2017, P NATL ACAD SCI USA, V114, pE3268, DOI 10.1073/pnas.1620405114; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668	23	21	22	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13218	13223		10.1074/jbc.AC119.009848	http://dx.doi.org/10.1074/jbc.AC119.009848			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31362983	Green Published, hybrid			2022-12-26	WOS:000486417200002
J	Golestanirad, L; Kazemivalipour, E; Keil, B; Downs, S; Kirsch, J; Elahi, B; Pilitsis, J; Wald, LL				Golestanirad, Laleh; Kazemivalipour, Ehsan; Keil, Boris; Downs, Sean; Kirsch, John; Elahi, Behzad; Pilitsis, Julie; Wald, Lawrence L.			Reconfigurable MRI coil technology can substantially reduce RF heating of deep brain stimulation implants: First in-vitro study of RF heating reduction in bilateral DBS leads at 1.5 T	PLOS ONE			English	Article							CARDIAC-PACEMAKERS; SAFETY; WIRES; TESLA; SAR	Patients with deep brain stimulation (DBS) implants can significantly benefit from magnetic resonance imaging (MRI), however access to MRI is restricted in these patients because of safety concerns due to RF heating of the leads. Recently we introduced a patient-adjustable reconfigurable transmit coil for low-SAR imaging of DBS at 1.5T. A previous simulation study demonstrated a substantial reduction in the local SAR around single DBS leads in 9 unilateral lead models. This work reports the first experimental results of temperature measurement at the tips of bilateral DBS leads with realistic trajectories extracted from postoperative CT images of 10 patients (20 leads in total). A total of 200 measurements were performed to record temperature rise at the tips of the leads during 2 minutes of scanning with the coil rotated to cover all accessible rotation angles. In all patients, we were able to find an optimum coil rotation angle and reduced the heating of both left and right leads to a level below the heating produced by the body coil. An average heat reduction of 65% was achieved for bilateral leads. When considering each lead alone, an average heat reduction of 80% was achieved. Our results suggest that reconfigurable coil technology introduces a promising approach for imaging of patients with DBS implants.	[Golestanirad, Laleh] Northwestern Univ, Dept Biomed Engn, McCormick Sch Engn, Evanston, IL 60208 USA; [Golestanirad, Laleh] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Kazemivalipour, Ehsan] Bilkent Univ, Dept Elect & Elect Engn, Ankara, Turkey; [Keil, Boris] Inst Med Phys & Radiat Protect, Dept Life Sci Engn, Giessen, Germany; [Downs, Sean; Kirsch, John; Wald, Lawrence L.] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Elahi, Behzad] Bryan Hlth, Dept Neurol, Lincoln, NE USA; [Pilitsis, Julie] Albany Med Ctr, Dept Neurosurg, Albany, NY USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Ihsan Dogramaci Bilkent University; Harvard University; Massachusetts General Hospital; Albany Medical College	Golestanirad, L (corresponding author), Northwestern Univ, Dept Biomed Engn, McCormick Sch Engn, Evanston, IL 60208 USA.; Golestanirad, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA.	Laleh.rad1@northwestern.edu	Wald, Lawrence L/D-4151-2009; Keil, Boris/AAX-9557-2020; Golestanirad, Laleh/P-7096-2018	Wald, Lawrence L/0000-0001-8278-6307; Golestani Rad, Laleh/0000-0003-3869-6114; Keil, Boris/0000-0003-0805-8330; Kazemivalipour, Ehsan/0000-0003-4221-2397; Elahi, Behzad/0000-0002-4397-4935	National Institute of Health (NIH) [R03EB024705, R00EB021320]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB024705, R00EB021320] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	LG has received awards R03EB024705 and R00EB021320 from National Institute of Health (NIH).	Ackermans L, 2008, NEUROTHERAPEUTICS, V5, P339, DOI 10.1016/j.nurt.2008.01.009; Baker KB, 2005, NEUROSURGERY, V57, P392, DOI 10.1227/01.NEU.0000176877.26994.0C; Calcagnini G, 2008, J MAGN RESON IMAGING, V28, P879, DOI 10.1002/jmri.21536; Corripio I, 2016, BIOL PSYCHIAT, V80, pE69, DOI 10.1016/j.biopsych.2016.03.1049; Elwassif MM, 2006, J NEURAL ENG, V3, P306, DOI 10.1088/1741-2560/3/4/008; Eryaman Y., 2012, MAGNETIC RESONANCE M; Eryaman Y, 2019, NEUROIMAGE, V184, P658, DOI 10.1016/j.neuroimage.2018.09.072; Eryaman Y, 2015, MAGN RESON MED, V73, P1896, DOI 10.1002/mrm.25324; Eryaman Y, 2011, MAGN RESON MED, V65, P1305, DOI 10.1002/mrm.22724; Finelli DA, 2002, AM J NEURORADIOL, V23, P1795; Golestanirad L, 2018, MAGNETIC RESONANCE M; Golestanirad L, 2017, 25 ANN M INT SOSC MA; Golestanirad L, 2019, IEEE T MICROW THEORY, V67, P1265, DOI 10.1109/TMTT.2018.2885517; Golestanirad L, 2019, NEUROIMAGE, V184, P566, DOI 10.1016/j.neuroimage.2018.09.034; Golestanirad L, 2017, MAGN RESON MED, V78, P1558, DOI 10.1002/mrm.26535; Golestanirad L, 2017, MAGN RESON MED, V77, P1701, DOI 10.1002/mrm.26220; Golestanirad L, 2017, NEUROIMAGE, V147, P577, DOI 10.1016/j.neuroimage.2016.12.056; Golestanirad L, 2016, CAN J NEUROL SCI, V43, P120, DOI 10.1017/cjn.2015.318; Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Mattei E, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-11; McElcheran CE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38099-w; McElcheran Clare, 2014, JOINT ANN M INT SOC; McElcheran CE, 2017, MAGN RESON MED, V78, P2406, DOI 10.1002/mrm.26622; McElcheran CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134379; Moeschler SM, 2015, NEUROMODULATION, V18, P285, DOI 10.1111/ner.12254; Nitz WR, 2001, J MAGN RESON IMAGING, V13, P105, DOI 10.1002/1522-2586(200101)13:1<105::AID-JMRI1016>3.0.CO;2-0; Nordbeck P, 2011, MAGN RESON MED, V65, P44, DOI 10.1002/mrm.22592; Ondo W, 2001, ARCH NEUROL-CHICAGO, V58, P218, DOI 10.1001/archneur.58.2.218; Park SM, 2007, J MAGN RESON IMAGING, V26, P1278, DOI 10.1002/jmri.21159; Rezai AR, 2004, INVEST RADIOL, V39, P300, DOI 10.1097/01.rli.0000124940.02340.ab; Rezai AR, 2002, J MAGN RESON IMAGING, V15, P241, DOI 10.1002/jmri.10069; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schrock LE, 2015, MOVEMENT DISORD, V30, P448, DOI 10.1002/mds.26094; Shellock FG, 2007, J CARDIOVASC MAGN R, V9, P21, DOI 10.1080/10976640600897237; Sommer T, 2006, CIRCULATION, V114, P1285, DOI 10.1161/CIRCULATIONAHA.105.597013; Taba HA, 2010, J NEUROSURG, V113, P1224, DOI 10.3171/2010.8.JNS10312; Tagliati M, 2009, NEUROIMAGE, V47, pT53, DOI 10.1016/j.neuroimage.2009.04.044; US Food and Drug Administration, 2017, FDA EX SUMM MEDTR AC; US Food and Drug Administration (FDA), 2018, MEDTR DBS SYST EP; US Food and Drug Administration (FDA), 2009, MEDTR ACTIVA DEEP BR; Yeung CJ, 2002, MAGNET RESON MED, V48, P1096, DOI 10.1002/mrm.10310	43	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220043	10.1371/journal.pone.0220043	http://dx.doi.org/10.1371/journal.pone.0220043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390346	Green Submitted, Green Published, gold			2022-12-26	WOS:000484999400010
J	Hatano, M; Tokuda, K; Kobayashi, Y; Yamashiro, C; Uchi, SH; Kobayashi, M; Kimura, K				Hatano, Makoto; Tokuda, Kazuhiro; Kobayashi, Yuka; Yamashiro, Chiemi; Uchi, Sho-Hei; Kobayashi, Masaaki; Kimura, Kazuhiro			Inhibitory effect of nintedanib on VEGF secretion in retinal pigment epithelial cells induced by exposure to a necrotic cell lysate	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCED CHOROIDAL NEOVASCULARIZATION; TRIPLE ANGIOKINASE INHIBITOR; MACULAR DEGENERATION; INFLAMMATION; KINASE; PROGRESSION; ACTIVATION; PI3K/AKT; THERAPY	Necrosis is a form of cell death that results in rupture of the plasma membrane and the release of cellular contents, and it can give rise to sterile inflammation in the retina and other tissues. The secretion of vascular endothelial growth factor (VEGF) by retinal pigment epithelial (RPE) cells contributes to retinal homeostasis as well as to pathological angiogenesis. We have now examined the effect of a necrotic cell lysate prepared from human RPE cells (NLR) on the release of VEGF by healthy RPE cells. We found that NLR markedly increased the release of VEGF from RPE cells and that this effect was attenuated by nintedanib, a multiple receptor tyrosine kinase inhibitor, whereas it was unaffected by inhibitors of NF-kappa B signaling or of caspase-1. NLR also induced the phosphorylation of extracellular signal-regulated kinase (Erk) and signal transducer and activator of transcription 3 (Stat3) in a manner sensitive to inhibition by nintedanib, although inhibitors of Erk and Stat3 signaling pathways did not affect NLR-induced VEGF secretion. In addition, nintedanib attenuated the development of choroidal neovascularization in mice. Our results have thus shown that a necrotic lysate of RPE cells induced VEGF secretion from healthy RPE cells and that this effect was mediated by receptor tyrosine kinase signaling. They therefore suggest that VEGF secretion by healthy RPE cells is a potential therapeutic target for retinal diseases associated with sterile inflammation and pathological angiogenesis.	[Hatano, Makoto; Tokuda, Kazuhiro; Kobayashi, Yuka; Yamashiro, Chiemi; Uchi, Sho-Hei; Kobayashi, Masaaki; Kimura, Kazuhiro] Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube, Yamaguchi, Japan	Yamaguchi University	Kimura, K (corresponding author), Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube, Yamaguchi, Japan.	kimura@yamaguchi-u.ac.jp						Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Chan-Ling T, 2006, AM J PATHOL, V168, P1031, DOI 10.2353/ajpath.2006.050697; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Feenstra Derrick J, 2013, J Clin Exp Ophthalmol, V4, P298; Fleshner M, 2017, NEUROPSYCHOPHARMACOL, V42, P36, DOI 10.1038/npp.2016.125; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; GJNRI, 2010, STERILE INFLAMMATION, V10, P826; Hanus J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.478; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Kang S, 2013, CURR EYE RES, V38, P119, DOI 10.3109/02713683.2012.727520; Kent D, 2003, MOL VIS, V9, P747; Kimura K, 2015, J MOL MED, V93, P749, DOI 10.1007/s00109-015-1289-8; Kobayashi M, 2019, INVEST OPHTH VIS SCI, V60, P528, DOI 10.1167/iovs.18-25678; Kobayashi Y, 2016, LAB INVEST, V96, P1178, DOI 10.1038/labinvest.2016.99; Krause TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094313; Krysko O, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.156; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kutikhin AG, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00343; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Ledermann JA, 2011, J CLIN ONCOL, V29, P3798, DOI 10.1200/JCO.2010.33.5208; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125001; Murakami Y, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.58; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Pandolfi F, 2016, CLIN THER, V38, P1017, DOI 10.1016/j.clinthera.2016.02.028; Park GB, 2018, MOL MED REP, V17, P3563, DOI 10.3892/mmr.2017.8355; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Qin SF, 2011, EXP EYE RES, V93, P889, DOI 10.1016/j.exer.2011.10.002; Qiu YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep14362; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Salvi V, 2016, ONCOTARGET, V7, P39256, DOI 10.18632/oncotarget.9684; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Seo MS, 1999, AM J PATHOL, V154, P1743, DOI 10.1016/S0002-9440(10)65430-2; Simo R, 2010, RETINAL PIGMENT EPIT, V2010; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Szade A, 2015, IUBMB LIFE, V67, P145, DOI 10.1002/iub.1358; Yan YJ, 2017, BIOL PHARM BULL, V40, P2088, DOI 10.1248/bpb.b17-00319; Yi XJ, 1997, GRAEF ARCH CLIN EXP, V235, P313, DOI 10.1007/BF01739641; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393; Zhou QB, 2014, MOL THER, V22, P378, DOI 10.1038/mt.2013.243; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034; Zhuang Z, 2015, MOL VIS, V21, P1173	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0218632	10.1371/journal.pone.0218632	http://dx.doi.org/10.1371/journal.pone.0218632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386668	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100004
J	Blanco-Rayon, E; Ivanina, AV; Sokolova, IM; Marigomez, I; Izagirre, U				Blanco-Rayon, Esther; Ivanina, Anna, V; Sokolova, Inna M.; Marigomez, Ionan; Izagirre, Urtzi			Food-type may jeopardize biomarker interpretation in mussels used in aquatic toxicological experimentation	PLOS ONE			English	Article							WATER-ACCOMMODATED FRACTION; MYTILUS-GALLOPROVINCIALIS; DIGESTIVE GLAND; MARINE MUSSEL; LYSOSOMAL RESPONSES; HEAVY-METALS; DNA-DAMAGE; TRANSCRIPTIONAL RESPONSES; QUANTITATIVE ALTERATIONS; MEDITERRANEAN MUSSEL	To assess the influence of food type on biomarkers, mussels (Mytilus galloprovincialis) were maintained under laboratory conditions and fed using 4 different microalgae diets ad libitum for 1 week: (a) Isochrysis galbana; (b) Tetraselmis chuii; (c) a mixture of I. galbana and T. chuii; and (d) a commercial food (Microalgae Composed Diet, Acuinuga). Different microalgae were shown to present different distribution and fate in the midgut. I. galbana (approximate to 4 mu m empty set) readily reached digestive cells to be intracellularly digested. T. chuii (approximate to 10 mu m empty set and hardly digestible) was retained in stomach and digestive ducts for long times and extracellularly digested. Based on these findings, it appeared likely that the presence of large amounts of microalgal enzymes and metabolites might interfere with biochemical determinations of mussel's biomarkers and/or that the diet-induced alterations of mussels' digestion could modulate lysosomal and tissue-level biomarkers. To test these hypotheses, a battery of common biochemical, cytological and tissue-level biomarkers were determined in the gills (including activities of pyruvate kinase, phosphoenolpyruvate carboxykinase and cytochrome c oxidase) and the digestive gland of the mussels (including protein, lipid, free glucose and glycogen total content, lysosomal structural changes and membrane stability, intracellular accumulation of neutral lipids and lipofuscins, changes in cell type composition and epithelial thinning, as well as altered tissue integrity). The type of food was concluded to be a major factor influencing biomarkers in short-term experiments though not all the microalgae affected biomarkers and their responsiveness in the same way. T. chuii seemed to alter the nutritional status, oxidative stress and digestion processes, thus interfering with a variety of biomarkers. On the other hand, the massive presence of I. galbana within digestive cells hampered the measurement of cytochemical biomarkers and rendered less reliable the results of biochemical biomarkers (as these could be attributed to both the mussel and the microalgae). Research to optimize dietary food type, composition, regime and rations for toxicological experimentation is urgently needed. Meanwhile, a detailed description of the food type and feeding conditions should be always provided when reporting aquatic toxicological experiments with mussels, as a necessary prerequisite to compare and interpret the biological responses elicited by pollutants.	[Blanco-Rayon, Esther; Marigomez, Ionan; Izagirre, Urtzi] Univ Basque Country, UPV EHU, Dept Zool & Anim Cell Biol, CBET Res Grp, Leioa, Basque Country, Spain; [Blanco-Rayon, Esther; Marigomez, Ionan; Izagirre, Urtzi] Univ Basque Country, PiE UPV EHU, Plentzia Marine Stn, Res Ctr Expt Marine Biol & Biotechnol, Plentzia, Basque Country, Spain; [Ivanina, Anna, V; Sokolova, Inna M.] Univ N Carolina, Dept Biol Sci, Charlotte, NC USA; [Sokolova, Inna M.] Univ Rostock, Interdisciplinary Fac, Dept Marine Biol, Inst Biosci, Rostock, Germany; [Sokolova, Inna M.] Univ Rostock, Interdisciplinary Fac, Dept Maritime Syst, Rostock, Germany	University of Basque Country; University of Basque Country; University of North Carolina; University of North Carolina Charlotte; University of Rostock; University of Rostock	Marigomez, I (corresponding author), Univ Basque Country, UPV EHU, Dept Zool & Anim Cell Biol, CBET Res Grp, Leioa, Basque Country, Spain.; Marigomez, I (corresponding author), Univ Basque Country, PiE UPV EHU, Plentzia Marine Stn, Res Ctr Expt Marine Biol & Biotechnol, Plentzia, Basque Country, Spain.	ionan.marigomez@ehu.eus	Sokolova, Inna M./B-4955-2009; MARIGOMEZ, Ionan/C-3909-2017; Sokolova, Inna/AAE-4150-2019; Izagirre, Urtzi/C-3848-2017	Sokolova, Inna M./0000-0002-2068-4302; MARIGOMEZ, Ionan/0000-0001-6274-541X; Sokolova, Inna/0000-0002-2068-4302; Izagirre, Urtzi/0000-0002-3477-4974	Spanish Ministry of Economy and Finance [BMW-CTM2012-40203-C02-01]; University of the Basque Country UPV/EHU [UFI 11/37]; Basque Government [IT810-B]; Department of Education of the Basque Government [PRE2013 1 640]	Spanish Ministry of Economy and Finance(Spanish Government); University of the Basque Country UPV/EHU; Basque Government(Basque Government); Department of Education of the Basque Government	This work was funded by the Spanish Ministry of Economy and Finance (BMW-CTM2012-40203-C02-01), the University of the Basque Country UPV/EHU (UFI 11/37) and the Basque Government (Consolidated Research Groups Grant IT810-B). EB-R was recipient of a doctoral fellowship (PRE2013 1 640) financed by the Department of Education of the Basque Government (Eusko Jaurlaritza).	Albentosa M, 1997, AQUACULTURE, V154, P305, DOI 10.1016/S0044-8486(97)00057-4; ARANDA DA, 1994, AQUACULTURE, V126, P151, DOI 10.1016/0044-8486(94)90256-9; Attig H, 2010, ECOTOX ENVIRON SAFE, V73, P1712, DOI 10.1016/j.ecoenv.2010.08.007; Banni M, 2010, ECOTOX ENVIRON SAFE, V73, P842, DOI 10.1016/j.ecoenv.2009.12.032; Barmo C, 2012, COMP BIOCHEM PHYS A, V163, pS11, DOI 10.1016/j.cbpa.2012.05.037; Barmo C, 2011, CHEMOSPHERE, V83, P1087, DOI 10.1016/j.chemosphere.2011.01.037; Baussant T, 2011, MAR POLLUT BULL, V62, P1437, DOI 10.1016/j.marpolbul.2011.04.029; Bebianno MJ, 1998, SCI TOTAL ENVIRON, V214, P123, DOI 10.1016/S0048-9697(98)00059-X; Becker B, 1998, J PHYCOL, V34, P779, DOI 10.1046/j.1529-8817.1998.340779.x; Bergmeyer H., 1985, METHODS ENZYMATIC AN, VVI; Bergmeyer H.U., 1985, METHODS ENZYMATIC AN, VVIII; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Blanco-Rayon E, 2019, J INVERTEBR PATHOL, V161, P29, DOI 10.1016/j.jip.2019.01.001; Blanco-Rayon E, 2019, AQUAT TOXICOL, V206, P164, DOI 10.1016/j.aquatox.2018.11.016; Brate ILN, 2018, SCI TOTAL ENVIRON, V626, P1310, DOI 10.1016/j.scitotenv.2018.01.141; BRICELJ VM, 1984, MAR ECOL PROG SER, V17, P57, DOI 10.3354/meps017057; Brooks SPJ, 1997, COMP BIOCHEM PHYS A, V118, P1103, DOI 10.1016/S0300-9629(97)00237-5; Brooks S, 2011, MAR POLLUT BULL, V62, P327, DOI 10.1016/j.marpolbul.2010.10.007; Brooks SJ, 2015, AQUAT TOXICOL, V160, P1, DOI 10.1016/j.aquatox.2014.12.018; CAJARAVILLE MP, 1991, ARCH ENVIRON CON TOX, V21, P395, DOI 10.1007/BF01060362; CAJARAVILLE MP, 1995, ENVIRON TOXIC WATER, V10, P1, DOI 10.1002/tox.2530100102; Cajaraville MP, 1997, COMP BIOCHEM PHYS C, V117, P233, DOI 10.1016/S0742-8413(97)00057-1; CAJARAVILLE MP, 1990, DIS AQUAT ORGAN, V9, P221, DOI 10.3354/dao009221; CAJARAVILLE MP, 1992, COMP BIOCHEM PHYS C, V102, P113; CAJARAVILLE MP, 1992, COMP BIOCHEM PHYS C, V102, P103, DOI 10.1016/0742-8413(92)90051-8; Cancio I, 1999, COMP BIOCHEM PHYS C, V123, P135, DOI 10.1016/S0742-8413(99)00019-5; Cancio I, 1998, TOXICOL APPL PHARM, V149, P64, DOI 10.1006/taap.1997.8358; Canesi L, 1998, COMP BIOCHEM PHYS C, V120, P261, DOI 10.1016/S0742-8413(98)10004-X; Canesi L, 1999, AQUAT TOXICOL, V46, P67, DOI 10.1016/S0166-445X(98)00116-7; Cappello T, 2017, ECOTOX ENVIRON SAFE, V143, P166, DOI 10.1016/j.ecoenv.2017.05.031; Cavaletto M, 2002, COMP BIOCHEM PHYS C, V131, P447, DOI 10.1016/S1532-0456(02)00030-3; Chandurvelan R, 2013, COMP BIOCHEM PHYS A, V164, P84, DOI 10.1016/j.cbpa.2012.10.011; Chandurvelan R, 2012, AQUAT TOXICOL, V124, P114, DOI 10.1016/j.aquatox.2012.07.013; Chaparro OR, 2001, MAR ECOL PROG SER, V222, P119, DOI 10.3354/meps222119; COUCH JA, 1984, MAR ENVIRON RES, V14, P525, DOI 10.1016/0141-1136(84)90145-4; CROSBY ND, 1971, CAN J ZOOLOG, V49, P617, DOI 10.1139/z71-099; Culling CFA, 1974, HDB HISTOPATHOLOGICA, V3rd; Dallas LJ, 2018, CHEMOSPHERE, V196, P531, DOI 10.1016/j.chemosphere.2017.12.144; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Davies IM, 2012, ICES COOPERATIVE RES; Dimitriadis VK, 2012, MAR ENVIRON RES, V73, P70, DOI 10.1016/j.marenvres.2011.11.004; Domouhtsidou GP, 2000, ARCH ENVIRON CON TOX, V38, P472, DOI 10.1007/s002449910062; Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040; Faria M, 2018, SCI TOTAL ENVIRON, V625, P1467, DOI 10.1016/j.scitotenv.2017.12.274; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontes MK, 2018, WATER RES, V132, P361, DOI 10.1016/j.watres.2017.12.077; Franzellitti S, 2012, AQUAT TOXICOL, V124, P125, DOI 10.1016/j.aquatox.2012.07.011; Garmendia L, 2011, J ENVIRON MONITOR, V13, P915, DOI 10.1039/c0em00410c; Giuliani ME, 2013, AQUAT TOXICOL, V134, P120, DOI 10.1016/j.aquatox.2013.03.012; Gonzalez-Fernandez C, 2016, AQUAT TOXICOL, V177, P211, DOI 10.1016/j.aquatox.2016.05.027; Gonzalez-Fernandez C, 2015, AQUAT TOXICOL, V167, P90, DOI 10.1016/j.aquatox.2015.07.007; Gonzalez-Rey M, 2012, ENVIRON TOXICOL PHAR, V33, P361, DOI 10.1016/j.etap.2011.12.017; Gueguen M, 2008, AQUAT LIVING RESOUR, V21, P21, DOI 10.1051/alr:2008018; Guerra-Rivas G, 2002, COMP BIOCHEM PHYS C, V132, P171, DOI 10.1016/S1532-0456(02)00061-3; HARRISON FL, 1982, MAR BIOL, V68, P109, DOI 10.1007/BF00397598; HAWKINS AJS, 1984, MAR BIOL, V82, P233, DOI 10.1007/BF00392404; HOLWERDA DA, 1981, MOL PHYSIOL, V1, P165; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Ibarrola I, 2017, AQUACULTURE, V479, P544, DOI 10.1016/j.aquaculture.2017.06.031; Ivanina AV, 2016, J EXP BIOL, V219, P1659, DOI 10.1242/jeb.134700; Ivanina AV, 2010, AQUAT TOXICOL, V99, P330, DOI 10.1016/j.aquatox.2010.05.013; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Izagirre U., 2007, THESIS; Izagirre U, 2014, AQUAT TOXICOL, V149, P145, DOI 10.1016/j.aquatox.2014.01.013; Izagirre U, 2008, MAR ECOL PROG SER, V372, P105, DOI 10.3354/meps07656; Izagirre U, 2009, COMP BIOCHEM PHYS C, V149, P587, DOI 10.1016/j.cbpc.2009.01.004; Jimeno-Romero A, 2016, NANOTOXICOLOGY, V10, P1168, DOI 10.1080/17435390.2016.1196250; Fernandez-Reiriz MJ, 2015, AQUACULTURE, V446, P42, DOI 10.1016/j.aquaculture.2015.04.025; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; KRISHNAKUMAR PK, 1994, MAR ECOL PROG SER, V106, P249, DOI 10.3354/meps106249; Lacroix C, 2015, AQUAT TOXICOL, V162, P126, DOI 10.1016/j.aquatox.2015.03.008; Lima I, 2008, MAR POLLUT BULL, V56, P633, DOI 10.1016/j.marpolbul.2008.01.018; Lucassen M, 2003, AM J PHYSIOL-REG I, V285, pR1410, DOI 10.1152/ajpregu.00111.2003; Maria VL, 2011, COMP BIOCHEM PHYS C, V154, P56, DOI 10.1016/j.cbpc.2011.02.004; Marigomez I, 2005, COMP BIOCHEM PHYS C, V141, P188, DOI 10.1016/j.cca.2005.06.005; Marigomez I, 2003, AQUAT TOXICOL, V64, P235, DOI 10.1016/S0166-445X(03)00056-0; Marigomez I, 2006, MAR POLLUT BULL, V53, P287, DOI 10.1016/j.marpolbul.2005.09.026; Martinez-Fernandeza E, 2004, AQUACULTURE, V230, P417, DOI 10.1016/S0044-8486(03)00416-2; Mezzelani M, 2016, AQUAT TOXICOL, V180, P306, DOI 10.1016/j.aquatox.2016.10.006; Milan M, 2018, ENVIRON POLLUT, V237, P442, DOI 10.1016/j.envpol.2018.02.049; Moore MN, 2007, AQUAT TOXICOL, V84, P80, DOI 10.1016/j.aquatox.2007.06.007; Moore MN, 2004, MAR ENVIRON RES, V58, P603, DOI 10.1016/j.marenvres.2004.03.049; Moore MN, 2004, 36 ICES TIMES, P31; Morley SA, 2009, COMP BIOCHEM PHYS A, V152, P423, DOI 10.1016/j.cbpa.2008.11.015; Mugica M, 2015, AQUAT TOXICOL, V164, P99, DOI 10.1016/j.aquatox.2015.04.020; Mugica M, 2015, MAR ENVIRON RES, V103, P1, DOI 10.1016/j.marenvres.2014.10.005; Nardi A, 2017, CHEMOSPHERE, V169, P493, DOI 10.1016/j.chemosphere.2016.11.093; Okay OS, 2006, ENVIRON INT, V32, P538, DOI 10.1016/j.envint.2005.12.005; Oliveira P, 2017, WATER RES, V117, P102, DOI 10.1016/j.watres.2017.03.052; Ortiz-Zarragoitia M, 2006, ARCH ENVIRON CON TOX, V50, P361, DOI 10.1007/s00244-005-1082-8; Ortiz-Zarragoitia M, 2011, J ENVIRON MONITOR, V13, P84, DOI 10.1039/c0em00102c; Patetsini E, 2012, COMP BIOCHEM PHYS A, V163, pS26, DOI 10.1016/j.cbpa.2012.05.082; Paul-Pont I, 2016, ENVIRON POLLUT, V216, P724, DOI 10.1016/j.envpol.2016.06.039; Pearse A. G. E., 1972, HISTOCHEMISTRY THEOR, V2, P761; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; PIPE RK, 1985, MAR BIOL, V87, P157, DOI 10.1007/BF00539423; REGOLI F, 1992, MAR ECOL PROG SER, V84, P63, DOI 10.3354/meps084063; Ricciardi F, 2008, MAR POLLUT BULL, V57, P365, DOI 10.1016/j.marpolbul.2008.02.023; Rocha TL, 2016, AQUAT TOXICOL, V177, P306, DOI 10.1016/j.aquatox.2016.06.003; Rouillon G, 2003, ACTA OECOL, V24, pS299, DOI 10.1016/S1146-609X(03)00029-8; Ruiz P, 2015, MAR ENVIRON RES, V111, P107, DOI 10.1016/j.marenvres.2015.07.018; Satoh A, 2005, ENVIRON INT, V31, P713, DOI 10.1016/j.envint.2005.01.001; Serafim MA, 2002, MAR ENVIRON RES, V54, P361, DOI 10.1016/S0141-1136(02)00121-6; Shaw JP, 2011, MAR ENVIRON RES, V72, P13, DOI 10.1016/j.marenvres.2011.05.003; SIDELL BD, 1987, PHYSIOL ZOOL, V60, P221, DOI 10.1086/physzool.60.2.30158646; SIMON LM, 1971, INT J BIOCHEM, V2, P569, DOI 10.1016/0020-711X(71)90026-7; Sokolova IM, 2000, J COMP PHYSIOL B, V170, P91, DOI 10.1007/s003600050264; Sokolova IM, 2001, MAR ECOL PROG SER, V224, P171, DOI 10.3354/meps224171; Sokolova I, 2018, INTEGR COMP BIOL, V58, P519, DOI 10.1093/icb/icy017; Sole M, 2007, SCI MAR, V71, P373, DOI 10.3989/scimar.2007.71n2373; Sole M, 2010, ANAL BIOANAL CHEM, V396, P649, DOI 10.1007/s00216-009-3182-1; Soto M, 1996, TISSUE CELL, V28, P557, DOI 10.1016/S0040-8166(96)80058-9; Southgate PC, 2017, AQUACULTURE, V473, P443, DOI 10.1016/j.aquaculture.2017.02.032; Speciale A, 2018, ECOTOX ENVIRON SAFE, V150, P96, DOI 10.1016/j.ecoenv.2017.12.038; STOREY KB, 1995, J EXP MAR BIOL ECOL, V188, P99, DOI 10.1016/0022-0981(94)00191-F; Taban IC, 2004, MAR ENVIRON RES, V58, P701, DOI 10.1016/j.marenvres.2004.03.018; Tizon RU, 2013, ISR J AQUAC, V890, P1; Torre A, 2013, TOXICOL IN VITRO, V27, P1260, DOI 10.1016/j.tiv.2013.02.017; UNEP/RAMOGE, 1999, MAN BIOM REC MED POL; VEGA MM, 1989, MAR BIOL, V103, P547, DOI 10.1007/BF00399587; VIARENGO A, 1991, COMP BIOCHEM PHYS C, V100, P187, DOI 10.1016/0742-8413(91)90151-I; Vidal-Linan L, 2016, ENVIRON POLLUT, V214, P885, DOI 10.1016/j.envpol.2016.04.083; Vidal-Linan L, 2013, SCI TOTAL ENVIRON, V461, P56, DOI 10.1016/j.scitotenv.2013.04.079; WIDDOWS J, 1982, MAR BIOL, V67, P15, DOI 10.1007/BF00397090; Woo S, 2011, COMP BIOCHEM PHYS D, V6, P348, DOI 10.1016/j.cbd.2011.07.003; You LP, 2013, FISH SHELLFISH IMMUN, V35, P343, DOI 10.1016/j.fsi.2013.04.021; Zaldibar B, 2007, AQUAT TOXICOL, V81, P183, DOI 10.1016/j.aquatox.2006.12.007	127	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220661	10.1371/journal.pone.0220661	http://dx.doi.org/10.1371/journal.pone.0220661			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381612	Green Submitted, Green Published, gold			2022-12-26	WOS:000484993600027
J	Ah, YM; Han, E; Jun, K; Yu, YM; Lee, JY				Ah, Young-Mi; Han, Euna; Jun, Kwanghee; Yu, Yun Mi; Lee, Ju-Yeun			Change in sedative burden after dementia onset using difference-in-difference estimations	PLOS ONE			English	Article							MEDICATION USE; OLDER-PEOPLE; DRUG-USE; LOAD; MORTALITY; RISK; CARE; POPULATION; PREVALENCE; RESIDENTS	Background Sedative agents are avoided in older adults because of potential risks including cognitive impairment, fall, frailty, and mortality. However, no studies addressing both prediagnostic and postdiagnostic period of dementia have evaluated sedative agent usage over an extended period. Objectives To describe a longitudinal change in sedative medication use before and after the diagnosis with dementia over 10 years compared to patients without dementia. Methods We conducted a retrospective cohort study using longitudinal claims data for senior national health insurance beneficiaries. After 1:4 propensity score matching, 54,165 older patients (>= 60 years) were included. Difference-in-difference (DID) of sedative burden and use of sedative agents pre- and post-dementia diagnosis were estimated, and compared to those of patients without dementia. The yearly average daily sedative load (adSL) for each individual was calculated after applying duration, dose, and sedative score of medications from the sedative load model. The medication use for each sedative category was calculated using the defined daily dose (DDD) per 1000 patient-days. Results The adSL in patients with dementia was consistently high before and after diagnosis and significantly increased after diagnosis, compared to those of patients without dementia (DID 0.123 unit/day, 95% confidence interval 0.117-0.129). DID of medication use was the highest for antidepressants (64.764 DDD/1000 patient-days) followed by Z-drugs and antipsychotics. Atypical antipsychotic and antidepressant usage steeply increased after dementia diagnosis. Conclusion Sedative burden in patients with dementia before and after dementia diagnosis was higher than that in patients without dementia, and was further increased after dementia diagnosis.	[Ah, Young-Mi] Yeungnam Univ, Coll Pharm, Gyeongsangbuk Do, South Korea; [Han, Euna; Yu, Yun Mi] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Res, Incheon, South Korea; [Jun, Kwanghee; Lee, Ju-Yeun] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Jun, Kwanghee; Lee, Ju-Yeun] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea	Yeungnam University; Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Lee, JY (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.; Lee, JY (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea.	jypham@snu.ac.kr		Yu, Yun Mi/0000-0002-8267-9453; Han, Euna/0000-0003-2656-7059; Lee, Ju-Yeun/0000-0002-2261-7330	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03029528]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03029528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; de Mauleon A, 2014, J AM MED DIR ASSOC, V15, P812, DOI 10.1016/j.jamda.2014.06.015; Gadzhanova Svetla, 2015, Drugs Real World Outcomes, V2, P53; Gnjidic D, 2014, FUND CLIN PHARMACOL, V28, P10, DOI 10.1111/j.1472-8206.2012.01063.x; Herrmann N, 2007, ALZHEIMERS DEMENT, V3, P385, DOI 10.1016/j.jalz.2007.07.007; Hilmer SN, 2007, ARCH INTERN MED, V167, P781, DOI 10.1001/archinte.167.8.781; Hwang SH, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1467-z; Islam MM, 2016, NEUROEPIDEMIOLOGY, V47, P181, DOI 10.1159/000454881; Jean-Bart E, 2017, INT J CLIN PHARM-NET, V39, P1237, DOI 10.1007/s11096-017-0533-4; Ko SJ, 2016, THE SOCIAL BURDEN AN; Kripke DF, 1998, BIOL PSYCHIAT, V43, P687, DOI 10.1016/S0006-3223(97)00292-8; Lapeyre-Mestre M, 2016, DRUG AGING, V33, P865, DOI 10.1007/s40266-016-0414-x; Linjakumpu T, 2003, INT J GERIATR PSYCH, V18, P542, DOI 10.1002/gps.846; Linjakumpu T, 2002, INT J GERIATR PSYCH, V17, P874, DOI 10.1002/gps.712; Linjakumpu TA, 2004, ANN PHARMACOTHER, V38, P2017, DOI 10.1345/aph.1E067; Nair NP, 2016, CLIN INTERV AGING, V11, P497, DOI 10.2147/CIA.S99097; Ni Chroinin D, 2016, AUSTRALAS J AGEING, V35, P262, DOI 10.1111/ajag.12312; Norgaard A, 2017, J ALZHEIMERS DIS, V56, P707, DOI 10.3233/JAD-160828; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Parsons C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-56; Peklar J, 2015, J AM MED DIR ASSOC, V16, P282, DOI 10.1016/j.jamda.2014.10.010; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Reus VI, 2016, AM J PSYCHIAT, V173, P543, DOI 10.1176/appi.ajp.2015.173501; Schwertner E, 2019, J AM MED DIR ASSOC, V20, P323, DOI 10.1016/j.jamda.2018.12.019; Taipale HT, 2010, AM J GERIATR PHARMAC, V8, P460, DOI 10.1016/j.amjopharm.2010.10.004; Taipale HT, 2009, DRUG AGING, V26, P871, DOI 10.2165/11317080-000000000-00000; Wilson NM, 2010, AGE AGEING, V39, P503, DOI 10.1093/ageing/afq053; Wimo A, 2017, ALZHEIMERS DEMENT, V13, P1, DOI 10.1016/j.jalz.2016.07.150; Wright RM, 2009, J AM GERIATR SOC, V57, P243, DOI 10.1111/j.1532-5415.2008.02127.x; Yu NW, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0530-4; Zerah L, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.02.001	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220582	10.1371/journal.pone.0220582	http://dx.doi.org/10.1371/journal.pone.0220582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374112	Green Submitted, Green Published, gold			2022-12-26	WOS:000484991500022
J	Chiazzari, B; Magalon, H; Gelin, P; Macdonald, A				Chiazzari, Brent; Magalon, Helene; Gelin, Pauline; Macdonald, Angus			Living on the edge: Assessing the diversity of South African Pocillopora on the margins of the Southwestern Indian Ocean	PLOS ONE			English	Article							CORAL GENUS POCILLOPORA; SPECIES DELIMITATION; SODWANA BAY; REEF CORAL; CONNECTIVITY; PATTERNS; SCLERACTINIA; POLYMORPHISM; INDIVIDUALS; POPULATIONS	Scleractinia of the Maputaland reef complex (MRC) in South Africa exist at the margins of the Western Indian Ocean (WIO) coral distribution and are the only substantial hermatypic coral communities in South Africa. Pocillopora species occupy a conspicuous component of the MRC, and previous investigations identified three species of Pocillopora utilizing conventional taxonomy. Thus, our aims were four-fold: to elucidate Pocillopora species diversity using genetic techniques, primarily using species delimitation methods based on the ORF gene; to test for the presence of hybridisation within the Pocillopora community on the South-West margin of distribution in the Indian Ocean using two nuclear and two mitochondrial markers; to test the presence of cryptic species, using 13 microsatellite markers, finally, to elucidate the degree of genetic diversity within each Pocillopora species found and compare this to communities in lower latitudes. We illustrate taxonomic inconsistencies between these inventories and our phylogenetic data. The MRC harbours unique populations of Pocillopora, consisting of three species hypothetically co-occurring throughout the south WIO, namely: P. meandrina/P. eydouxi, commonly misidentified as P. verrucosa, P. verrucosa, sometimes correctly identified, but also commonly misidentified as P. damicornis sensu lato, and P. villosa, almost always misidentified as P. eydouxi. The hypothesis that hybrid swarms of Pocillopora occur in marginal environments such as the MRC was not supported, with low levels of introgressive hybridization reported instead. Analyses illustrate low genetic diversity at the species and population resolutions, suggesting a small founder population for each species. Nevertheless, these populations are demographically unique, exhibiting high levels of ITS2 haplotype endemism compared to higher latitude populations and the rest of the WIO. Pocillopora diversity on the MRC represents a unique assemblage and warrants further protection.	[Chiazzari, Brent; Macdonald, Angus] Univ KwaZulu Natal, Sch Life Sci, Westville, Kwazulu Natal, South Africa; [Magalon, Helene; Gelin, Pauline] Univ La Reunion, Fac Sci & Technol, CNRS, IRD,Lab Excellence CORAIL,UMR ENTROPIE, St Denis, Reunion, France	University of Kwazulu Natal; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of La Reunion	Chiazzari, B (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Westville, Kwazulu Natal, South Africa.	brent.chiazzari@gmail.com	Magalon, Helene/ABH-1252-2020	Magalon, Helene/0000-0002-7061-955X	National Research Foundation of South Africa; SANBI as part of the SeaKeys project (FBI Marine grant); SANBI	National Research Foundation of South Africa(National Research Foundation - South Africa); SANBI as part of the SeaKeys project (FBI Marine grant); SANBI	This work was supported by a personal grant to BC from the National Research Foundation of South Africa, and a portion of the laboratory work was funded by SANBI as part of the SeaKeys project (FBI Marine grant). HM funded the microsatellite laboratory work through personal university stipend. AM funded the bulk of laboratory work and field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to members of the Marine Evolution Lab (MAREVOL) that assisted in sampling: Kerry Etsebeth, Carolina Barausse, Kirsty Wiggill, and Jessica Chiazzari. We are also thankful to David Obura, and Louis Celliers who aided in identifying species in the field, and Louis Celliers for aiding in confirming previous information on species identification. Thanks go to Kerry Sink, Mari-Lise Franken and Prideel Madjiet and SANBI for logistical and funding support. We acknowledge the Plateforme Gentyane of the Institut National de la Recherche Agronomique (INRA, Clermont-Ferrand, France) for genotyping and technical support. Lastly, thanks to the three anonymous reviewers, their advice and comments have greatly improved the overall quality of this manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baums IB, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00059; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Celliers L, 2008, BIODIVERS CONSERV, V17, P3097, DOI 10.1007/s10531-007-9271-6; Chiazzari B, 2013, AFR J MAR SCI, V35, P233, DOI 10.2989/1814232X.2013.795915; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Combosch DJ, 2015, MOL PHYLOGENET EVOL, V88, P154, DOI 10.1016/j.ympev.2015.03.022; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; FLOT JF, 2006, P 10 INT COR REEF S, V1, P24, DOI DOI 10.1016/J.AUTREV.2006.09.014; FLOT JF, 2010, BMC EVOL BIOL, V10; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gelin P, 2017, MOL PHYLOGENET EVOL, V109, P430, DOI 10.1016/j.ympev.2017.01.018; Gelin P, 2018, ECOL EVOL, V8, P1411, DOI 10.1002/ece3.3747; Glassom D, 2006, CORAL REEFS, V25, P485, DOI 10.1007/s00338-006-0117-6; Gorospe KD, 2013, MOL ECOL, V22, P3721, DOI 10.1111/mec.12335; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hsu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107366; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnston EC, 2018, PEERJ, V6, DOI 10.7717/peerj.4355; Johnston EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06085-3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitahara MV, 2016, CNIDARIA PRESENT FUT, P41; Lamarck JB, 1816, IRE PARTIE, V1, P1; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lutjeharms JRE, 2007, OCEAN SCI, V3, P129, DOI 10.5194/os-3-129-2007; Macdonald AHH, 2011, MAR BIOL, V158, P613, DOI 10.1007/s00227-010-1585-3; Magalon H, 2004, MOL ECOL NOTES, V4, P206, DOI 10.1111/j.1471-8286.2004.00618.x; Marti-Puig P, 2014, B MAR SCI, V90, P211, DOI 10.5343/bms.2012.1080; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Nylander J.A.A, 2004, MRMODELTEST V2; Pante E, 2015, MOL ECOL, V24, P525, DOI 10.1111/mec.13048; Paz DA, 2015, MORPHOLOGICAL VARIAT, DOI [10.1007/s00442-014-3199-9, DOI 10.1007/S00442-014-3199-9]; Pinzon JH, 2013, J BIOGEOGR, V40, P1595, DOI 10.1111/jbi.12110; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porter SN, 2017, CORAL REEFS, V36, P369, DOI 10.1007/s00338-016-1531-z; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2011, MOL ECOL; Rambaut A., 2014, TRACER V1 6; Rambaut A, 2013, TREEANNOTATOR V1 7 0; Ridgway T, 2008, MAR ECOL PROG SER, V354, P161, DOI 10.3354/meps07245; RIEGL B, 1995, B MAR SCI, V56, P676; Riegl Bernard, 1996, Pacific Science, V50, P404; Schleyer M.H., 2003, Zoologische Verhandelingen (Leiden), V345, P387; Schleyer Michael H., 2000, P83; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Schmidt-Roach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050847; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schweigger AF., 1820, HDB NATURGESCHICHTE; Smit K, 2017, HELGOLAND MAR RES, V71, DOI 10.1186/s10152-017-0482-2; Soto D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202586; Souter P, 2010, MAR BIOL, V157, P875, DOI 10.1007/s00227-009-1370-3; Starger CJ, 2008, MOL ECOL RESOUR, V8, P619, DOI 10.1111/j.1471-8286.2007.02017.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Teske PR, 2015, MAR ECOL PROG SER, V539, P153, DOI 10.3354/meps11516; Torda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058447; Torres AF, 2018, CORAL REEFS, V37, P1209, DOI 10.1007/s00338-018-1729-3; Veron JEN, 1978, J MAR BIOL ASSOC UK, V58, P544, DOI [10.1017/S0025315400028289, DOI 10.1017/S0025315400028289]; Veron JEN, 2000, CORALS WORLD, DOI [10.1126/Science.1061936, DOI 10.1126/SCIENCE.1061936]; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	73	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220477	10.1371/journal.pone.0220477	http://dx.doi.org/10.1371/journal.pone.0220477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374077	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500014
J	Sati, HF; Bruinsma, N; Galas, M; Hsieh, J; Sanhueza, A; Pardo, PR; Espinal, MA				Sati, Hatim F.; Bruinsma, Nienke; Galas, Marcelo; Hsieh, Jenny; Sanhueza, Antonio; Pardo, Pilar Ramon; Espinal, Marcos A.			Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000-2015	PLOS ONE			English	Article							EUROPE-AMERICA; ASIA-AFRICA; RESISTANCE; COUNTRIES; STRAINS; ENTEROBACTERIACEAE; BANGLADESH	Background Shigellosis is the second leading cause of diarrheal death globally. The global burden has been complicated by the emergence of Shigella strains resistant to first line antibiotic treatments such as ciprofloxacin. This study aims to describe the epidemiologic distribution of the most common Shigella species, and their antimicrobial susceptibility patterns to ciprofloxacin and nalidixic acid (NA) in Latin America. Methods Laboratory data from 19 countries were obtained through the Latin American Network for Antimicrobial Resistance Surveillance (ReLAVRA) from 2000-2015. The Clinical Laboratory Standards Institute reduced susceptibility breakpoints for Enterobacteriaceae was used to interpret the disc diffusion tests for Shigella susceptibility to ciprofloxacin and NA. Negative binominal regression was used to analyze longitudinal trends of Shigella isolates antimicrobial susceptibility. Results 79,548 Shigella isolates were tested and reported between 2000-2015. The most common isolated species were S. flexneri (49%), and S. sonnei (28%). There was a steady increase in the proportion of S. sonnei isolates within the region(p<0.001). The average annual percentage increase (AAPI) in nonsusceptibility was 18.4% (p<0.001) for ciprofloxacin (baseline = 0.3); and 13.2%(p<0.001) for NA (baseline = 3). AAPI nonsusceptibility to ciprofloxacin was 13.3% for S. flexneri (p<0.04); and 39.9% for S. sonnei (p<0.001). Honduras, Dominican Republic, Venezuela, and Chile reported the highest increase in nonsusceptibility to ciprofloxacin among all Shigella isolates. Conclusion There is an increasing trend in Shigella nonsusceptibility to ciprofloxacin and NA, including among the most common shigella species, in Latin America. This rise of nonsusceptibility among Shigella species to commonly used treatments such as ciprofloxacin is alarming and threatens the control and management of this currently treatable infection. Improved data quality, collection and reporting is needed in Latin America to respond effectively to the rising trends observed. This includes the need for quality isolate level epidemiological data; molecular data, and data on antibiotic consumption and use.	[Sati, Hatim F.; Bruinsma, Nienke; Galas, Marcelo; Hsieh, Jenny; Pardo, Pilar Ramon; Espinal, Marcos A.] Pan Amer Hlth Org, Communicable Dis & Environm Determinants Hlth, Antimicrobial Resistance Special Program, Washington, DC 20037 USA; [Sanhueza, Antonio] Pan Amer Hlth Org, Evidence & Intelligence Act Hlth EIH, Hlth Anal Metr & Evidence EIH HA, Washington, DC USA	Pan American Health Organization; Pan American Health Organization	Sati, HF (corresponding author), Pan Amer Hlth Org, Communicable Dis & Environm Determinants Hlth, Antimicrobial Resistance Special Program, Washington, DC 20037 USA.	satihat@paho.org		Sati, Hatim/0000-0003-2358-0522				Ahmed AM, 2006, J MED MICROBIOL, V55, P1685, DOI 10.1099/jmm.0.46725-0; Anderson M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00045; Arcilla MS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-410; Avdic E, 2014, INFECT DIS CLIN N AM, V28, P215, DOI 10.1016/j.idc.2014.01.002; BENNISH ML, 1992, CLIN INFECT DIS, V14, P1055, DOI 10.1093/clinids/14.5.1055; Byarugaba DK, 2004, INT J ANTIMICROB AG, V24, P105, DOI 10.1016/j.ijantimicag.2004.02.015; CDCP enters for Disease Control and Prevention, 2017, CDCHAN 0040; CLSI, 2019, 15 INF SUPPL CLIN LA, V29th; Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4; Gu B, 2015, EPIDEMIOL INFECT, V143, P2687, DOI 10.1017/S0950268814003446; Gu B, 2012, INT J ANTIMICROB AG, V40, P9, DOI 10.1016/j.ijantimicag.2012.02.005; Hakanen A, 1999, J CLIN MICROBIOL, V37, P3572, DOI 10.1128/JCM.37.11.3572-3577.1999; The HC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002055; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; HOOPER DC, 1985, ANTIMICROB AGENTS CH, V28, P716, DOI 10.1128/AAC.28.5.716; Jacoby GA, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.PLAS-0006-2013, 10.1128/microbiolspec.PLAS-0006.2013]; Kahsay Atsebaha Gebrekidan, 2016, BMC Res Notes, V9, P422, DOI 10.1186/s13104-016-2236-7; Ke X, 2011, ARCH MICROBIOL, V193, P767, DOI 10.1007/s00203-011-0744-3; Kerneis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004494; Khalil IA, 2018, LANCET INFECT DIS, V18, P1229, DOI [10.1016/S1473-3099(18)30475-4, 10.1016/s1473-3099(18)30475-4]; Kotloff KL, 2018, LANCET, V391, P801, DOI 10.1016/S0140-6736(17)33296-8; Kuo CY, 2008, J MICROBIOL IMMUNOL, V41, P107; Lawless J, 1987, CANADIAN J STAT, V15; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Lluque A, 2015, INT J MED MICROBIOL, V305, P480, DOI 10.1016/j.ijmm.2015.04.005; O'Hara CM, 2005, CLIN MICROBIOL REV, V18, P147, DOI 10.1128/CMR.18.1.147-162.2005; Octavia SLR, 2015, SHIGELLA SHIGELLOSIS; Puzari M, 2018, J INFECT PUBLIC HEAL, V11, P451, DOI 10.1016/j.jiph.2017.09.025; Rahman M, 2007, J HEALTH POPUL NUTR, V25, P158; Ram PK, 2008, EPIDEMIOL INFECT, V136, P577, DOI 10.1017/S0950268807009351; Rossotti R, 2012, EUR J CLIN MICROBIOL, V31, P1517, DOI 10.1007/s10096-011-1472-y; SACK DA, 1994, LANCET, V343, P1413, DOI 10.1016/S0140-6736(94)92531-3; Sader HS, 2007, DIAGN MICR INFEC DIS, V58, P27, DOI 10.1016/j.diagmicrobio.2006.12.006; Strockbine NA BC, 2015, ESCHERICHIA SHIGELLA; Taylor DN, 2017, J TRAVEL MED, V24, pS17, DOI 10.1093/jtm/taw097; Thompson CN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003708; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; WHO, 2015, GLOB ANT RES SURV SY; Williams PCM, 2018, PAEDIATR INT CHILD H, V38, pS50, DOI 10.1080/20469047.2017.1409454; World Health Organization, 2005, GUIDELINES CONTROL S; World Health Organization, 2014, ANT RES GLOB REP SUR	43	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220445	10.1371/journal.pone.0220445	http://dx.doi.org/10.1371/journal.pone.0220445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374081	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500012
J	Ayub, M; Ghazanfar, MA; Mehmood, Z; Saba, T; Alharbey, R; Munshi, AM; Alrige, MA				Ayub, Mubbashir; Ghazanfar, Mustansar Ali; Mehmood, Zahid; Saba, Tanzila; Alharbey, Riad; Munshi, Asmaa Mandi; Alrige, Mayda Abdullateef			Modeling user rating preference behavior to improve the performance of the collaborative filtering based recommender systems	PLOS ONE			English	Article							SIMILARITY MEASURE; IMAGE RETRIEVAL; TRUST; ALLEVIATE	One of the main concerns for online shopping websites is to provide efficient and customized recommendations to a very large number of users based on their preferences. Collaborative filtering (CF) is the most famous type of recommender system method to provide personalized recommendations to users. CF generates recommendations by identifying clusters of similar users or items from the user-item rating matrix. This cluster of similar users or items is generally identified by using some similarity measurement method. Among numerous proposed similarity measure methods by researchers, the Pearson correlation coefficient (PCC) is a commonly used similarity measure method for CF-based recommender systems. The standard PCC suffers some inherent limitations and ignores user rating preference behavior (RPB). Typically, users have different RPB, where some users may give the same rating to various items without liking the items and some users may tend to give average rating albeit liking the items. Traditional similarity measure methods (including PCC) do not consider this rating pattern of users. In this article, we present a novel similarity measure method to consider user RPB while calculating similarity among users. The proposed similarity measure method state user RPB as a function of user average rating value, and variance or standard deviation. The user RPB is then combined with an improved model of standard PCC to form an improved similarity measure method for CF-based recommender systems. The proposed similarity measure is named as improved PCC weighted with RPB (IPWR). The qualitative and quantitative analysis of the IPWR similarity measure method is performed using five state-of-the-art datasets (i.e. Epinions, MovieLens-100K, MovieLens-1M, CiaoDVD, and MovieTweetings). The IPWR similarity measure method performs better than state-of-the-art similarity measure methods in terms of mean absolute error (MAE), root mean square error (RMSE), precision, recall, and F-measure.	[Ayub, Mubbashir; Ghazanfar, Mustansar Ali] Univ Engn & Technol, Dept Software Engn, Taxila, Pakistan; [Mehmood, Zahid] Univ Engn & Technol, Dept Comp Engn, Taxila, Pakistan; [Saba, Tanzila] Prince Sultan Univ, Coll Comp & Informat Sci, Riyadh, Saudi Arabia; [Alharbey, Riad; Munshi, Asmaa Mandi] Univ Jeddah, Coll Comp Sci & Engn, Jeddah, Saudi Arabia; [Alrige, Mayda Abdullateef] King Abdulaziz Univ, Fac Comp & Informat Technol, Informat Syst Dept, Jeddah, Saudi Arabia	University of Engineering & Technology Taxila; University of Engineering & Technology Taxila; Prince Sultan University; University of Jeddah; King Abdulaziz University	Mehmood, Z (corresponding author), Univ Engn & Technol, Dept Comp Engn, Taxila, Pakistan.	zahid.mehmood@uettaxila.edu.pk	Ayub, Mubbashir/AAK-8982-2020; Ghazanfar, Mustansar/ABA-3929-2020; Mehmood, Dr. Zahid/S-1709-2018; Saba, Tanzila/D-4593-2018; Alrige, Mayada/AAS-5593-2021	Ghazanfar, Mustansar/0000-0003-1967-6273; Mehmood, Dr. Zahid/0000-0003-4888-2594; Saba, Tanzila/0000-0003-3138-3801; Alrige, Mayada/0000-0002-1315-7053				Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Ahn HJ, 2008, INFORM SCIENCES, V178, P37, DOI 10.1016/j.ins.2007.07.024; Al-Oufi S, 2012, EXPERT SYST APPL, V39, P13173, DOI 10.1016/j.eswa.2012.05.084; Alahmadi DH, 2015, 2015 IEEE 27 INT C T; Ayub M, 2018, 32 INT C INF NETW IC; Ayub M, 2018, 2018 INT C INF NETW; Baluja S., 2008, P 17 INT C WORLD WID, P895; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; Bobadilla J, 2012, KNOWL-BASED SYST, V26, P225, DOI 10.1016/j.knosys.2011.07.021; Bobadilla J, 2012, INFORM SCIENCES, V185, P1, DOI 10.1016/j.ins.2011.09.014; Bobadilla J, 2012, INFORM PROCESS MANAG, V48, P204, DOI 10.1016/j.ipm.2011.03.007; Boratto L, 2017, INFORM SCIENCES, V378, P424, DOI 10.1016/j.ins.2016.07.060; Ghazanfar M.A., 2010, 2010 3 INT C KNOWL D; Ghazanfar MA, 2013, PROC SPIE, V9067, DOI 10.1117/12.2051416; Ghazanfar MA, 2010, THIRD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING: WKDD 2010, PROCEEDINGS, P94, DOI 10.1109/WKDD.2010.117; Golbeck J., 2006, P IEEE CONS COMM NET; Gong S, 2009, 2009 2 INT WORKSH KN; Guo G., 2013, P 7 ACM C RECOMMENDE, P451; Guo G., 2014, P 2014 IEEE ACM INT; Guo GB, 2014, KNOWL-BASED SYST, V57, P57, DOI 10.1016/j.knosys.2013.12.007; Harper FM, 2016, ACM T INTERACT INTEL, V5, DOI 10.1145/2827872; Jabeen S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194526; Jamali M., 2009, P 3 ACM C REC SYST; Janasiewicz T., 2011, INT C COMP COLL INT; Lee WP, 2016, KNOWL-BASED SYST, V106, P125, DOI 10.1016/j.knosys.2016.05.037; Li YM, 2013, DECIS SUPPORT SYST, V55, P740, DOI 10.1016/j.dss.2013.02.009; Liu B.Y.Y.L.D., P 23 INT JOINT C ART; Liu HF, 2014, KNOWL-BASED SYST, V56, P156, DOI 10.1016/j.knosys.2013.11.006; Ma H, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961201; Mehmood A, 2018, 2018 14TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P1, DOI 10.1109/CIS2018.2018.00009; Mehmood Z, 2018, ARAB J SCI ENG, V43, P7265, DOI 10.1007/s13369-018-3062-0; Mehmood Z, 2018, KUWAIT J SCI, V45, P54; Mehmood Z, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/8217250; Patra BK, 2015, KNOWL-BASED SYST, V82, P163, DOI 10.1016/j.knosys.2015.03.001; Polatidis N, 2016, EXPERT SYST APPL, V48, P100, DOI 10.1016/j.eswa.2015.11.023; Qazi KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194151; Ricci F., 2011, INTRO RECOMMENDER SY; Safoury Laila, 2013, Lecture Notes on Software Engineering, V1, P303, DOI 10.7763/LNSE.2013.V1.66; Saranya KG, 2017, APPL MATH INFORM SCI, V11, P317, DOI [DOI 10.18576/AMIS/110137, 10.18576/amis/110137]; Sarwar A, 2019, J INF SCI, V45, P117, DOI 10.1177/0165551518782825; Sun S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002527; Tan ZH, 2017, IEEE ACCESS, V5, P27211, DOI 10.1109/ACCESS.2017.2778424; XIONG L, 2010, P 2010 SIAM INT C DA; Zahra S, 2015, INFORM SCIENCES, V320, P156, DOI 10.1016/j.ins.2015.03.062	44	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220129	10.1371/journal.pone.0220129	http://dx.doi.org/10.1371/journal.pone.0220129			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369585	Green Published, gold			2022-12-26	WOS:000484987900027
J	Ehling, R; Bsteh, G; Muehlbacher, A; Hermann, K; Brenneis, C				Ehling, Rainer; Bsteh, Gabriel; Muehlbacher, Andreas; Hermann, Kay; Brenneis, Christian			Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis	PLOS ONE			English	Article							TIMED 25-FOOT WALK; LOWER PHYSICAL-ACTIVITY; CLINICALLY MEANINGFUL; ACTIVITY MONITORS; 6-MINUTE WALK; DISABILITY; ACCELEROMETRY; RELIABILITY; PERFORMANCE; IMPACT	Background Walking capacity tests are commonly used to evaluate interventions aiming at reducing walking impairment in people with multiple sclerosis (pwMS). However, their ecological validity has recently been questioned. The aim of the present study was to investigate the ecological validity of the 2- and 6-minutes walking tests (2MWT and 6MWT) and the timed 25-foot walk (T25FW) after 28 days of multidisciplinary inpatient rehabilitation (MIR) in pwMS using accelerometry. Methods PwMS wore an accelerometer on 7 consecutive days within a 14-day period prior to MIR, performed 2/6MWT and T25FW at the beginning and at the end of MIR, followed by another 7 consecutive days of accelerometry. Results Significant improvements in 2/6MWT and T25FW after MIR in a cohort of 76 pwMS (mean age = 47.9, SD 8.3 years) were overall correlated to a significant gain in everyday life mobility (total steps/day). However, the correlation was strongly dependent on pre-existing walking disability defined by EDSS and only pwMS with "mild" walking impairment (EDSS 2-3.5) were able to transfer benefits measurable by walking capacity tests into improved everyday life mobility, while pwMS with "moderate to severe" walking disability (EDSS 4-6.5) were not. Conclusion Ecological validity of changes in walking capacity tests following MIR is strongly dependent on pre-existing walking impairment.	[Ehling, Rainer; Muehlbacher, Andreas; Hermann, Kay; Brenneis, Christian] Clin Rehabil Munster, Dept Neurol, Munster, Austria; [Ehling, Rainer; Brenneis, Christian] Karl Landsteiner Inst Interdisziplinare Forsch, Reha Zentrum Munster, Munster, Austria; [Bsteh, Gabriel] Med Univ Innsbruck, Clin Dept Neurol, Innsbruck, Austria	Medical University of Innsbruck	Ehling, R (corresponding author), Clin Rehabil Munster, Dept Neurol, Munster, Austria.; Ehling, R (corresponding author), Karl Landsteiner Inst Interdisziplinare Forsch, Reha Zentrum Munster, Munster, Austria.	rainer.ehling@reha-muenster.at			Austrian Multiple Sclerosis Research Foundation	Austrian Multiple Sclerosis Research Foundation	This work was supported by a research grant of the Austrian Multiple Sclerosis Research Foundation (no grant number). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Auty A, 1998, CAN J NEUROL SCI, V25, P31; Baert I, 2014, NEUROREHAB NEURAL RE, V28, P621, DOI 10.1177/1545968314521010; Bradshaw MJ, 2017, NEUROL-CLIN PRACT, V7, P354, DOI 10.1212/CPJ.0000000000000382; Engelhard MM, 2018, GAIT POSTURE, V59, P211, DOI 10.1016/j.gaitpost.2017.10.015; Feys P, 2013, NEUROREHABILITATION, V33, P439, DOI 10.3233/NRE-130975; Gijbels D, 2011, MULT SCLER J, V17, P1269, DOI 10.1177/1352458511408475; Gijbels D, 2010, MULT SCLER J, V16, P618, DOI 10.1177/1352458510361357; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Goldman MD, 2013, NEUROLOGY, V81, P1856, DOI 10.1212/01.wnl.0000436065.97642.d2; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; GOODKIN DE, 1991, NEUROLOGY, V41, P332, DOI 10.1212/WNL.41.2_Part_1.332; Hobart J, 2000, BRAIN, V123, P1027, DOI 10.1093/brain/123.5.1027; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Hobart J, 2013, NEUROLOGY, V80, P1509, DOI 10.1212/WNL.0b013e31828cf7f3; Kieseier BC, 2012, MULT SCLER J, V18, P914, DOI 10.1177/1352458512444498; Kragt JJ, 2006, MULT SCLER J, V12, P594, DOI 10.1177/1352458506070768; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LaRocca NG, 2011, PATIENT, V4, P189, DOI 10.2165/11591150-000000000-00000; Learmonth YC, 2013, MULT SCLER J, V19, P1784, DOI 10.1177/1352458513483890; Motl RW, 2008, MULT SCLER J, V14, P140, DOI 10.1177/1352458507079126; Motl RW, 2013, ACTA NEUROL SCAND, V127, P384, DOI 10.1111/ane.12036; Motl RW, 2007, ADAPT PHYS ACT Q, V24, P245, DOI 10.1123/apaq.24.3.245; Motl RW, 2017, MULT SCLER J, V23, P704, DOI 10.1177/1352458517690823; Motl RW, 2014, BEHAV MED, V40, P29, DOI 10.1080/08964289.2013.821966; Motl RW, 2012, EXPERT REV NEUROTHER, V12, P1079, DOI [10.1586/ern.12.74, 10.1586/ERN.12.74]; Motl RW, 2011, BEHAV MED, V37, P125, DOI 10.1080/08964289.2011.636769; Neven A, 2016, NEUROL SCI, V37, P1483, DOI 10.1007/s10072-016-2609-7; Ng AV, 1997, MED SCI SPORT EXER, V29, P517, DOI 10.1097/00005768-199704000-00014; Paltamaa J, 2008, PHYS THER, V88, P176, DOI 10.2522/ptj.20070064; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Riemenschneider M, 2018, MULT SCLER J, V24, P886, DOI 10.1177/1352458518777377; Sandroff BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093511; Sandroff BM, 2013, DISABIL REHABIL, V35, P725, DOI 10.3109/09638288.2012.707745; Sasaki JE, 2017, EXPERT REV MED DEVIC, V14, P891, DOI 10.1080/17434440.2017.1386550; Stellmann JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123822; Weikert M, 2010, J NEUROL SCI, V290, P6, DOI 10.1016/j.jns.2009.12.021; Wens I, 2013, MULT SCLER J, V19, P1556, DOI 10.1177/1352458513504252; WHO, 2001, WHO INT CLASS FUNCT	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220613	10.1371/journal.pone.0220613	http://dx.doi.org/10.1371/journal.pone.0220613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369622	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900068
J	Howe, C; Moparthi, VK; Ho, FM; Persson, K; Stensjo, K				Howe, Christoph; Moparthi, Vamsi K.; Ho, Felix M.; Persson, Karina; Stensjo, Karin			The Dps4 from Nostoc punctiforme ATCC 29133 is a member of His-type FOC containing Dps protein class that can be broadly found among cyanobacteria	PLOS ONE			English	Article							DNA-BINDING PROTEIN; MYCOBACTERIUM-SMEGMATIS DPS; FERROXIDASE CENTER; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; IRON-BINDING; THERMOSYNECHOCOCCUS-ELONGATUS; ESCHERICHIA-COLI; FERRITIN HOMOLOG; RESISTANCE	Dps proteins (DNA-binding proteins from starved cells) have been found to detoxify H2O2. At their catalytic centers, the ferroxidase center (FOC), Dps proteins utilize Fe2+ to reduce H2O2 and therefore play an essential role in the protection against oxidative stress and maintaining iron homeostasis. Whereas most bacteria accommodate one or two Dps, there are five different Dps proteins in Nostoc punctiforme, a phototrophic and filamentous cyanobacterium. This uncommonly high number of Dps proteins implies a sophisticated machinery for maintaining complex iron homeostasis and for protection against oxidative stress. Functional analyses and structural information on cyanobacterial Dps proteins are rare, but essential for understanding the function of each of the NpDps proteins. In this study, we present the crystal structure of NpDps4 in its metal-free, iron-and zinc-bound forms. The FOC coordinates either two iron atoms or one zinc atom. Spectroscopic analyses revealed that NpDps4 could oxidize Fe2+ utilizing O-2, but no evidence for its use of the oxidant H2O2 could be found. We identified Zn2+ to be an effective inhibitor of the O-2-mediated Fe2+ oxidation in NpDps4. NpDps4 exhibits a FOC that is very different from canonical Dps, but structurally similar to the atypical one from DpsA of Thermosynechococcus elongatus. Sequence comparisons among Dps protein homologs to NpDps4 within the cyanobacterial phylum led us to classify a novel FOC class: the His-type FOC. The features of this special FOC have not been identified in Dps proteins from other bacterial phyla and it might be unique to cyanobacterial Dps proteins.	[Howe, Christoph; Moparthi, Vamsi K.; Ho, Felix M.; Stensjo, Karin] Uppsala Univ, Angstrom Lab, Dept Chem, Uppsala, Sweden; [Persson, Karina] Umea Univ, Dept Chem, Umea, Sweden; [Moparthi, Vamsi K.] Linkoping Univ, Dept Phys Chem & Biol, Div Chem, Linkoping, Sweden	Uppsala University; Umea University; Linkoping University	Howe, C; Stensjo, K (corresponding author), Uppsala Univ, Angstrom Lab, Dept Chem, Uppsala, Sweden.; Persson, K (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	karina.persson@umu.se; karin.stensjo@kemi.uu.se	Stensjo, Karin/E-3801-2017	Stensjo, Karin/0000-0001-6993-8476; Ho, Felix/0000-0001-7731-3396	NordForsk [82845]; NCoE program "NordAqua"; Swedish Energy Agency [11674-5]; Sven and Lilly Lawski foundation; Stiftelsen Lars Hiertas Minne	NordForsk; NCoE program "NordAqua"; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Sven and Lilly Lawski foundation; Stiftelsen Lars Hiertas Minne	This work was supported by KS: NordForsk (project 82845) (https://www.nordforsk.org/en), the NCoE program "NordAqua", KS: Swedish Energy Agency (https://www.energimyndigheten.se/en/), (project 11674-5); VKM: Post Doc scholarship, Sven and Lilly Lawski foundation, CH: Stiftelsen Lars Hiertas Minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alaleona F, 2010, FEBS J, V277, P903, DOI 10.1111/j.1742-4658.2009.07532.x; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; Ardini M, 2013, BBA-GEN SUBJECTS, V1830, P3745, DOI 10.1016/j.bbagen.2013.02.003; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Ceci P, 2011, J BIOL INORG CHEM, V16, P869, DOI 10.1007/s00775-011-0784-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Ebrahimi KH, 2015, CHEM REV, V115, P295, DOI 10.1021/cr5004908; Ebrahimi KH, 2010, J BIOL INORG CHEM, V15, P1243, DOI 10.1007/s00775-010-0682-6; Ekman M, 2014, ENVIRON MICROBIOL, V16, P829, DOI 10.1111/1462-2920.12233; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franceschini S, 2006, FEBS J, V273, P4913, DOI 10.1111/j.1742-4658.2006.05490.x; Fujisawa T, 2017, NUCLEIC ACIDS RES, V45, pD551, DOI 10.1093/nar/gkw1131; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Grove A, 2005, J MOL BIOL, V347, P495, DOI 10.1016/j.jmb.2005.01.055; Haikarainen T, 2010, BIOCHEM BIOPH RES CO, V398, P361, DOI 10.1016/j.bbrc.2010.06.071; Haikarainen T, 2010, J BIOL INORG CHEM, V15, P183, DOI 10.1007/s00775-009-0582-9; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Havukainen H, 2008, PROTEIN SCI, V17, P1513, DOI 10.1110/ps.036236.108; Howe C, 2018, J BIOL CHEM, V293, P16635, DOI 10.1074/jbc.RA118.002425; Hudek L, 2012, BIOMETALS, V25, P893, DOI 10.1007/s10534-012-9556-4; Hudek L, 2013, FEMS MICROBIOL ECOL, V86, P149, DOI 10.1111/1574-6941.12153; Huergo LF, 2013, J BACTERIOL, V195, P1970, DOI 10.1128/JB.00059-13; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kauko A, 2004, J MOL BIOL, V338, P547, DOI 10.1016/j.jmb.2004.03.009; Kauko A, 2006, J MOL BIOL, V364, P97, DOI 10.1016/j.jmb.2006.08.061; Kim SG, 2006, J MOL BIOL, V361, P105, DOI 10.1016/j.jmb.2006.06.010; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Li X, 2007, MOL MICROBIOL, V63, P694, DOI 10.1111/j.1365-2958.2006.05550.x; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; Miyamoto T, 2011, ACTA CRYSTALLOGR F, V67, P17, DOI 10.1107/S1744309110043113; Moparthi VK, 2016, BBA-BIOENERGETICS, V1857, P1766, DOI 10.1016/j.bbabio.2016.08.003; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Ow SY, 2009, J PROTEOME RES, V8, P187, DOI 10.1021/pr800285v; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Pospisil P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01950; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; PRICE D, 1982, P NATL ACAD SCI-BIOL, V79, P3116, DOI 10.1073/pnas.79.10.3116; Ren B, 2003, J MOL BIOL, V329, P467, DOI 10.1016/S0022-2836(03)00466-2; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Santos SP, 2015, FEBS J, V282, P4307, DOI 10.1111/febs.13420; Stefanini S, 1999, BIOCHEM J, V338, P71, DOI 10.1042/0264-6021:3380071; Stillman TJ, 2005, MOL MICROBIOL, V57, P1101, DOI 10.1111/j.1365-2958.2005.04757.x; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Uyeda JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162539; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; Williams SM, 2017, STRUCTURE, V25, P1449, DOI 10.1016/j.str.2017.07.006; Williams SM, 2014, J BIOL CHEM, V289, P11042, DOI 10.1074/jbc.M113.524421; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Zanotti G, 2002, J MOL BIOL, V323, P125, DOI 10.1016/S0022-2836(02)00879-3; Zeth K, 2004, P NATL ACAD SCI USA, V101, P13780, DOI 10.1073/pnas.0401821101; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	72	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218300	10.1371/journal.pone.0218300	http://dx.doi.org/10.1371/journal.pone.0218300			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369577	gold, Green Published, Green Submitted			2022-12-26	WOS:000484987900009
J	Parundekar, A; Kalantre, G; Khadpekar, A; Viswanathan, GA				Parundekar, Akshay; Kalantre, Girija; Khadpekar, Akshada; Viswanathan, Ganesh A.			Operating regimes in a single enzymatic cascade at ensemble-level	PLOS ONE			English	Article							COVALENT MODIFICATION; FLOW-CYTOMETRY; PROTEIN-KINASE; ZERO-ORDER; ULTRASENSITIVITY; FLUCTUATIONS; CANCER; CELLS	Single enzymatic cascade, ubiquitously found in cellular signaling networks, is a phosphorylation-dephosphorylation reaction cycle causing a transition between inactive and active states of a protein catalysed by kinase and phosphatase, respectively. Steady-state information processing ability of such a cycle (e.g., MAPK cascade) has been classified into four qualitatively different operating regimes, viz., hyperbolic (H), signal-transducing (ST), threshold-hyperbolic (TH) and ultrasensitive (U). These four regimes represent qualitatively different dose-response curves, that is, relationship between concentrations of input kinase (e.g., pMEK) and response activated protein (e.g., pERK). Regimes were identified using a deterministic model accounting for population-averaged behavior only. Operating regimes can be strongly influenced by the inherently present cell-to-cell variability in an ensemble of cells which is captured in the form of pMEK and pERK distributions using reporter-based single-cell experimentation. In this study, we show that such experimentally acquired snapshot pMEK and pERK distribution data of a single MAPK cascade can be directly used to infer the underlying operating regime even in the absence of a dose-response curve. This deduction is possible primarily due to the presence of a monotonic relationship between experimental observables RIQR, ratio of the inter-quartile range of the pERK and pMEK distribution pairs and RM, ratio of the medians of the distribution pair. We demonstrate this relationship by systematic analysis of a quasi-steady state approximated model superimposed with an input gamma distribution constrained by the stimulus strength specific pMEK distribution measured on Jurkat-T cells stimulated with PMA. As a first, we show that introduction of cell-to-cell variability only in the upstream kinase achieved by superimposition of an appropriate input pMEK distribution on the dose-response curve can predict bimodal response pERK distribution in ST regime. Implementation of the proposed method on the input-response distribution pair obtained in stimulated Jurkat-T cells revealed that while low-dosage PMA stimulation preserves the H regime observed in resting cells, high-dosage causes H to ST regime transition.	[Parundekar, Akshay; Kalantre, Girija; Khadpekar, Akshada; Viswanathan, Ganesh A.] Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Viswanathan, GA (corresponding author), Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India.	ganeshav@iitb.ac.in		Viswanathan, Ganesh A/0000-0001-6424-0765	Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India [SB/S3/CE/048/2014]; University Grants Commission, Government of India	Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India; University Grants Commission, Government of India(University Grants Commission, India)	This research was funded by the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, SB/S3/CE/048/2014 to GAV; and University Grants Commission, Government of India to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Dhananjaneyulu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035958; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dobrzynski M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0383; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasenauer J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-125; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Knijnenburg TA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.64; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Krutzik PO, 2011, FLUORESCENT CELL BAR, V6, P31, DOI DOI 10.1002/0471142956.CY0631S55; Levine J, 2007, BIOPHYS J, V92, P4473, DOI 10.1529/biophysj.106.088856; Lipshtat A, 2010, P NATL ACAD SCI USA, V107, P1247, DOI 10.1073/pnas.0908647107; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Manohar S, 2019, CYTOM PART A, V95A, P192, DOI 10.1002/cyto.a.23602; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Qian H, 2009, PHYS CHEM CHEM PHYS, V11, P4861, DOI 10.1039/b900335p; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Ruf F, 2006, J BIOL CHEM, V281, P30967, DOI 10.1074/jbc.M606486200; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Straube R, 2017, J THEOR BIOL, V431, P39, DOI 10.1016/j.jtbi.2017.08.006; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220243	10.1371/journal.pone.0220243	http://dx.doi.org/10.1371/journal.pone.0220243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369598	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900038
J	van Horn, N; Faizy, TD; Schoenfeld, MH; Kohlmann, P; Broocks, G; Haag, P; Fiehler, J; Habermann, CR; Karul, M				van Horn, Noel; Faizy, Tobias Djamsched; Schoenfeld, Michael Hinrich; Kohlmann, Patrick; Broocks, Gabriel; Haag, Pascal; Fiehler, Jens; Habermann, Christian Richard; Karul, Murat			Computed tomography findings in patients with primarily unknown causes of severe or recurrent epistaxis	PLOS ONE			English	Article							EMERGENCY-DEPARTMENTS; EMBOLIZATION; MANAGEMENT; DIAGNOSIS	Objective In addition to rhinoscopy, computed tomography of paranasal sinuses (CT) may be performed on patients with primary unknown cause of severe epistaxis (SE) or recurrent epistaxis (RE) to further assess the potential cause of bleeding. The aim of this study was to evaluate CT findings during the work-up of intractable epistaxis patients. Methods 6937 patients were treated in our emergency department with acute epistaxis between 2009-2018. 304/6937 patients underwent CT and rhinoscopy due to intractable SE or RE. 33 patients presented with head trauma prior to epistaxis and were excluded from the final analysis. In 271 cases the primary causes of SE (n = 252) or RE (n = 19) remained unknown. Two observers retrospectively evaluated CT scans for potential sources of epistaxis. Disagreement was settled by consensus. CT and rhinoscopy findings were compared. Results In 247/271 (91.1%) SE patients no related pathology was found on CT. A possible cause for epistaxis was found in all RE patients, but only in 5/252 (1.9%) patients with SE. Most tumours (10/11) and inflammatory conditions (9/10) were found in patients with RE. In three SE cases, a tumour was suspected on CT, from which two suspicions were refuted during rhinoscopy. CT revealed 10 cases of inflammatory conditions of the sinus and anatomical variant as potential cause of bleeding. Conclusion For patients with unknown causes of epistaxis, supplementary CT imaging may be a useful diagnostic add-on to rhinoscopy in the event of RE, tumour suspicion or inflammation of the paranasal sinuses. However, in most cases of first-time SE, CT does not necessarily add to the diagnosis. In these cases, the marginal benefit of CT needs to be weighed carefully against its risks.	[van Horn, Noel; Faizy, Tobias Djamsched; Haag, Pascal; Habermann, Christian Richard; Karul, Murat] Marien Hosp, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Faizy, Tobias Djamsched; Schoenfeld, Michael Hinrich; Broocks, Gabriel; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Kohlmann, Patrick] Marien Hosp, Dept Otolaryngol, Hamburg, Germany	St. Marien Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; St. Marien Hospital	Faizy, TD (corresponding author), Marien Hosp, Dept Diagnost & Intervent Radiol, Hamburg, Germany.; Faizy, TD (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	T.Faizy@uke.de	van Horn, Noel/AAW-5274-2020	van Horn, Noel/0000-0001-5764-1982; Schonfeld, Michael/0000-0003-2096-3448; Haag, Pascal/0000-0001-8764-0665				Andersen PJ, 2005, ACTA OTO-LARYNGOL, V125, P293, DOI 10.1080/00016480410023029; [Anonymous], 2018, CLINICAL PRACTICE GU; Beck R, 2018, DTSCH ARZTEBL INT, V115, P12, DOI 10.3238/arztebl.2018.0012; Chiu TW, 2007, OTOLARYNG HEAD NECK, V137, P390, DOI 10.1016/j.otohns.2006.10.035; DENHOLM SW, 1993, J LARYNGOL OTOL, V107, P195, DOI 10.1017/S0022215100122613; Eggesbo HB, 2012, CANCER IMAGING, V12, P136, DOI 10.1102/1470-7330.2012.0015; Folz BJ, 2008, HNO, V56, P1157, DOI 10.1007/s00106-008-1838-3; Fuchs FD, 2003, BLOOD PRESSURE, V12, P145, DOI 10.1080/08037050310001750; Gurney TA, 2004, AM J RHINOL, V18, P335, DOI 10.1177/194589240401800513; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kawaguchi M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6120116; Krajina A, 2014, CARDIOVASC INTER RAD, V37, P26, DOI 10.1007/s00270-013-0776-y; Likness MM, 2014, OTOLARYNG HEAD NECK, V150, P305, DOI 10.1177/0194599813513881; Myga-Porosilo J, 2011, POL J RADIOL, V76, P41; Nikupaavo U, 2015, AM J ROENTGENOL, V204, P117, DOI 10.2214/AJR.14.12763; Nouraei SAR, 2007, LARYNGOSCOPE, V117, P1452, DOI 10.1097/MLG.0b013e318065b86f; Pallin DJ, 2005, ANN EMERG MED, V46, P77, DOI 10.1016/j.annemergmed.2004.12.014; Pantanowitz L, 1999, J AM GERIATR SOC, V47, P631, DOI 10.1111/j.1532-5415.1999.tb02585.x; PETRUSON B, 1975, Rhinology (Utrecht), V13, P129; ROWE LD, 1981, LARYNGOSCOPE, V91, P745; Simmen D, 1998, LARYNGO RHINO OTOL, V77, P100, DOI 10.1055/s-2007-996941; Small M, 1982, Health Bull (Edinb), V40, P20; Soyka MB, 2011, RHINOLOGY, V49, P474, DOI 10.4193/Rhino10.313; Soyka MB, 2010, LARYNGOSCOPE, V120, P200, DOI 10.1002/lary.20695; Stewart F. A., 2012, Annals of the ICRP, V41, P37, DOI 10.1016/j.icrp.2012.02.001; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stokes SM, 2010, HEAD NECK PATHOL, V4, P210, DOI 10.1007/s12105-010-0181-7; Szymanska Anna, 2005, Otolaryngol Pol, V59, P85; Tay HL, 1998, ANN OTO RHINOL LARYN, V107, P671, DOI 10.1177/000348949810700808; Traboulsi Henri, 2015, Int J Otolaryngol, V2015, P263987, DOI 10.1155/2015/263987; Tseng EY, 1998, LARYNGOSCOPE, V108, P615, DOI 10.1097/00005537-199804000-00028; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Viehweg TL, 2006, J ORAL MAXIL SURG, V64, P511, DOI 10.1016/j.joms.2005.11.031; Vosler PS, 2016, OTOLARYNG HEAD NECK, V155, P879, DOI 10.1177/0194599816657045; Wani AA, 2009, INDIAN J OTOLARYNGOL, V61, P163, DOI 10.1007/s12070-009-0059-8; Weigel K, 2016, LARYNGO RHINO OTOL, V95, P837, DOI 10.1055/s-0042-111013; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Willems PWA, 2009, AM J NEURORADIOL, V30, P1637, DOI 10.3174/ajnr.A1607	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220380	10.1371/journal.pone.0220380	http://dx.doi.org/10.1371/journal.pone.0220380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369603	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900045
J	Hendrix, P; Ramscar, M; Baayen, H				Hendrix, Peter; Ramscar, Michael; Baayen, Harald			NDRA: A single route model of response times in the reading aloud task based on discriminative learning	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; SPELLING-SOUND CONSISTENCY; LEXICAL ACCESS; COMPUTATIONAL MODELS; CASCADED MODEL; LETTER STRINGS; NEURAL BASIS; ITEM-LEVEL; FREQUENCY; NEIGHBORHOOD	We present the Naive Discriminative Reading Aloud (NDRA) model. The NDRA differs from existing models of response times in the reading aloud task in two ways. First, a single lexical architecture is responsible for both word and non-word naming. As such, the model differs from dual-route models, which consist of both a lexical route and a sub-lexical route that directly maps orthographic units onto phonological units. Second, the linguistic core of the NDRA exclusively operates on the basis of the equilibrium equations for the well-established general human learning algorithm provided by the Rescorla-Wagner model. The model therefore does not posit language-specific processing mechanisms and avoids the problems of psychological and neurobiological implausibility associated with alternative computational implementations. We demonstrate that the single-route discriminative learning architecture of the NDRA captures a wide range of effects documented in the experimental reading aloud literature and that the overall fit of the model is at least as good as that of state-of-the-art dual-route models.	[Hendrix, Peter; Ramscar, Michael; Baayen, Harald] Eberhard Karls Univ Tubingen, Seminar Sprachwissensch, Tubingen, Germany	Eberhard Karls University of Tubingen	Hendrix, P (corresponding author), Eberhard Karls Univ Tubingen, Seminar Sprachwissensch, Tubingen, Germany.	peter.hendrix@gmail.com		Baayen, Harald/0000-0003-3178-3944	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [387774888]; European Research Council [742545]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This research was partially funded by grant number 387774888 from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), which was awarded to the first author of this paper. Furthermore, it was partially funded by grant number 742545 from the European Research Council, which was awarded to the third author of this paper. No additional external funding was received for this study.	Adelman JS, 2008, J MEM LANG, V59, P524, DOI 10.1016/j.jml.2007.11.008; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDREWS S, 1989, J EXP PSYCHOL LEARN, V15, P802, DOI 10.1037/0278-7393.15.5.802; ANDREWS S, 1992, J EXP PSYCHOL LEARN, V18, P234, DOI 10.1037/0278-7393.18.2.234; Andrews S, 1997, PSYCHON B REV, V4, P439, DOI 10.3758/BF03214334; Andrews S, 1998, J EXP PSYCHOL HUMAN, V24, P1052, DOI 10.1037/0096-1523.24.4.1052; Andrews S, 1996, J MEM LANG, V35, P775, DOI 10.1006/jmla.1996.0040; Aronoff Mark, 1994, MORPHOLOGY ITSELF ST; Baayen R., 2006, J MEM LANG, V53, P496; Baayen R. H, 1995, CELEX LEXICAL DATABA; Baayen RH, 2013, LANG SPEECH, V56, P329, DOI 10.1177/0023830913484896; Baayen RH, 2011, PSYCHOL REV, V118, P438, DOI 10.1037/a0023851; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; BALOTA DA, 1985, J MEM LANG, V24, P89, DOI 10.1016/0749-596X(85)90017-8; Balota DA, 1998, PSYCHOL SCI, V9, P238, DOI 10.1111/1467-9280.00047; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Binder JR, 2003, J COGNITIVE NEUROSCI, V15, P372, DOI 10.1162/089892903321593108; Borowsky R, 2002, MEM COGNITION, V30, P969, DOI 10.3758/BF03195781; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brants T., 2006, WEB 1T 5 GRAM VERSIO; Browman C., 1989, PHONOLOGY, V6, P201, DOI [10.1017/S0952675700001019, DOI 10.1017/S0952675700001019]; Browman Catherine, 1986, PHONOLOGY YB, V3, P219, DOI [DOI 10.1017/S0952675700000658, 10.1017/S0952675700000658]; BROWMAN CP, 1990, J PHONETICS, V18, P299, DOI 10.1016/S0095-4470(19)30376-6; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; BROWN GDA, 1987, J MEM LANG, V26, P1, DOI 10.1016/0749-596X(87)90059-3; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Chater N, 2006, TRENDS COGN SCI, V10, P287, DOI 10.1016/j.tics.2006.05.007; Church JA, 2011, J COGNITIVE NEUROSCI, V23, P1475, DOI 10.1162/jocn.2010.21515; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Coltheart M, 1994, J EXPT PSYCHOL HUMAN, V20; COLTHEART V, 1988, BRIT J PSYCHOL, V79, P1, DOI 10.1111/j.2044-8295.1988.tb02270.x; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; CRICK F, 1989, NATURE, V337, P129, DOI 10.1038/337129a0; Danks D, 2003, J MATH PSYCHOL, V47, P109, DOI 10.1016/S0022-2496(02)00016-0; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Derousne J., 1985, SURFACE DYSLEXIA NEU, P399; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; FORSTER KI, 1973, J VERB LEARN VERB BE, V12, P627, DOI 10.1016/S0022-5371(73)80042-8; FREDERIKSEN JR, 1976, J EXP PSYCHOL HUMAN, V2, P361, DOI 10.1037/0096-1523.2.3.361; Friedman L, 2005, AM STAT, V59, P127, DOI 10.1198/000313005X41337; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; GLUSHKO RJ, 1979, J EXP PSYCHOL HUMAN, V5, P674, DOI 10.1037/0096-1523.5.4.674; GRAINGER J, 1990, J MEM LANG, V29, P228, DOI 10.1016/0749-596X(90)90074-A; Grindrod CM, 2008, BRAIN RES, V1229, P167, DOI 10.1016/j.brainres.2008.07.017; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; Han J, 2000, MORGAN KAUFMAN SERIE; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; Hastie T., 1986, STAT SCI, V1, P297; Henderson L., 1982, ORTHOGRAPHY WORD REC; Hendriks AW, 1997, COGNITIVE NEUROPSYCH, V14, P321; Hendrix P., 2019, NDRA NAIVE DISCRIMIN; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; Houghton G, 2003, COGN NEUROPSYCHOL, V20, P115, DOI 10.1080/02643290242000871; Hsu AS, 2011, COGNITION, V120, P380, DOI 10.1016/j.cognition.2011.02.013; Indefrey P, 1997, NEUROIMAGE, V5, P78, DOI 10.1006/nimg.1996.0232; JACOBS AM, 1994, J EXP PSYCHOL HUMAN, V20, P1311, DOI 10.1037/0096-1523.20.6.1311; JARED D, 1990, J MEM LANG, V29, P687, DOI 10.1016/0749-596X(90)90044-Z; Jared D, 2002, J MEM LANG, V46, P723, DOI 10.1006/jmla.2001.2827; Jared D, 1997, J MEM LANG, V36, P505, DOI 10.1006/jmla.1997.2496; JARED D, 1990, J EXP PSYCHOL HUMAN, V16, P92, DOI 10.1037/0096-1523.16.1.92; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Juphard A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00101; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kessler B, 2002, J MEM LANG, V47, P145, DOI 10.1006/jmla.2001.2835; KLATT DH, 1979, J PHONETICS, V7, P279, DOI 10.1016/S0095-4470(19)31059-9; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Marmurek HHC, 1996, Q J EXP PSYCHOL-A, V49, P696, DOI 10.1080/713755634; MCCANN RS, 1987, J EXP PSYCHOL HUMAN, V13, P14, DOI 10.1037/0096-1523.13.1.14; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; Miller G., 1990, INT J LEXICOGR, V3, P235, DOI DOI 10.1093/IJL/3.4.235; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; Moscoso del Prado Martin F, 2003, MPI SERIES PSYCHOLIN; Mulatti C, 2006, J EXP PSYCHOL HUMAN, V32, P799, DOI 10.1037/0096-1523.32.4.799; MURRE JMJ, 1992, NEURAL NETWORKS, V5, P55, DOI 10.1016/S0893-6080(05)80007-3; Novick JM, 2010, LANG LINGUIST COMPAS, V4, P906, DOI 10.1111/j.1749-818x.2010.00244.x; O'Reilly RC, 1998, TRENDS COGN SCI, V2, P455, DOI 10.1016/S1364-6613(98)01241-8; O'Reilly RC, 2001, NEURAL COMPUT, V13, P1199, DOI 10.1162/08997660152002834; PAAP KR, 1991, PSYCHOL RES-PSYCH FO, V53, P13, DOI 10.1007/BF00867328; PAAP KR, 1987, ATTENTION PERFORM, P221; Patterson K, 1997, J EXP PSYCHOL HUMAN, V23, P1217, DOI 10.1037/0096-1523.23.4.1217; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Perry C, 2007, PSYCHOL REV, V114, P273, DOI 10.1037/0033-295X.114.2.273; Perry C, 2010, COGNITIVE PSYCHOL, V61, P106, DOI 10.1016/j.cogpsych.2010.04.001; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Pritchard SC, 2018, COGNITIVE SCI, V42, P722, DOI 10.1111/cogs.12571; Pritchard SC, 2016, SCI STUD READ, V20, P49, DOI 10.1080/10888438.2015.1085384; Pritchard SC, 2012, J EXP PSYCHOL HUMAN, V38, P1268, DOI 10.1037/a0026703; Ramscar M, 2013, CHILD DEV, V84, P1308, DOI 10.1111/cdev.12044; Ramscar M, 2010, COGNITIVE SCI, V34, P909, DOI 10.1111/j.1551-6709.2009.01092.x; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Rastle K, 1999, J EXP PSYCHOL HUMAN, V25, P482, DOI 10.1037/0096-1523.25.2.482; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reynolds M, 2005, PSYCHON B REV, V12, P622, DOI 10.3758/BF03196752; RICHARDSON JTE, 1976, BRIT J PSYCHOL, V67, P315, DOI 10.1111/j.2044-8295.1976.tb01518.x; Roberts MA, 2003, PSYCHON B REV, V10, P405, DOI 10.3758/BF03196499; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; RUMELHART DE, 1974, PSYCHOL REV, V81, P99, DOI 10.1037/h0036117; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Schreuder R, 1997, J MEM LANG, V37, P118, DOI 10.1006/jmla.1997.2510; Seidenberg M. S., 2006, OXFORD HDB PSYCHOLIN, P235; Seidenberg MS, 2006, FROM INKMARKS TO IDEAS: CURRENT ISSUES IN LEXICAL PROCESSING, P25; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Seidenberg MS, 1996, J EXP PSYCHOL LEARN, V22, P48, DOI 10.1037/0278-7393.22.1.48; SEIDENBERG MS, 1994, J EXP PSYCHOL HUMAN, V20, P1177, DOI 10.1037/0096-1523.20.6.1177; Seidenberg MS, 1998, PSYCHOL SCI, V9, P234, DOI 10.1111/1467-9280.00046; SEIDENBERG MS, 1989, B PSYCHONOMIC SOC, V27, P489; SEIDENBERG MS, 1990, PSYCHOL REV, V97, P447, DOI 10.1037/0033-295X.97.3.447; Seidenberg MS, 2000, TRENDS COGN SCI, V4, P353, DOI 10.1016/S1364-6613(00)01515-1; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Siegel S, 1996, PSYCHON B REV, V3, P314, DOI 10.3758/BF03210755; Snyder HR, 2007, J COGNITIVE NEUROSCI, V19, P761, DOI 10.1162/jocn.2007.19.5.761; Spieler DH, 1997, PSYCHOL SCI, V8, P411, DOI 10.1111/j.1467-9280.1997.tb00453.x; TAFT M, 1992, Q J EXP PSYCHOL-A, V45, P51, DOI 10.1080/14640749208401315; TARABAN R, 1987, J MEM LANG, V26, P608, DOI 10.1016/0749-596X(87)90105-7; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Taylor JSH, 2013, PSYCHOL BULL, V139, P766, DOI 10.1037/a0030266; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; TREIMAN R, 1995, J EXP PSYCHOL GEN, V124, P107, DOI 10.1037/0096-3445.124.2.107; van Turennout M, 2003, CEREB CORTEX, V13, P381, DOI 10.1093/cercor/13.4.381; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Weekes BS, 1997, Q J EXP PSYCHOL-A, V50, P439, DOI 10.1080/027249897392170; WICKELGR.WA, 1969, PSYCHOL REV, V76, P1, DOI 10.1037/h0026823; Widrow B, 1960, IRE WESCON, DOI DOI 10.21236/AD0241531; Williams E.J., 1959, REGRESSION ANAL; Wilson T, 2005, EXP BRAIN RES, V162, P1, DOI 10.1007/s00221-004-2099-3; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wydell TN, 2003, J COGNITIVE NEUROSCI, V15, P1052, DOI 10.1162/089892903770007434; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Zevin JD, 2006, J MEM LANG, V54, P145, DOI 10.1016/j.jml.2005.08.002; Ziegler JC, 1998, COGNITION, V68, pB53; Ziegler JC, 2001, PSYCHOL SCI, V12, P379, DOI 10.1111/1467-9280.00370; Zorzi M, 1998, J EXP PSYCHOL HUMAN, V24, P1131, DOI 10.1037/0096-1523.24.4.1131; Zorzi M, 1998, LANG COGNITIVE PROC, V13, P337, DOI 10.1080/016909698386555; Zorzi M, 1999, THESIS	142	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0218802	10.1371/journal.pone.0218802	http://dx.doi.org/10.1371/journal.pone.0218802			63	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365531	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600005
J	Loras, H; Aune, TK; Ingvaldsen, R; Pedersen, AV				Loras, Havard; Aune, Tore Kristian; Ingvaldsen, Rolf; Pedersen, Arve Vorland			Interpersonal and intrapersonal entrainment of self-paced tapping rate	PLOS ONE			English	Article							INTERLIMB COORDINATION; JOINT ACTION; SENSORIMOTOR SYNCHRONIZATION; DYNAMICS; MOVEMENT; MECHANISM; PATTERN; SYSTEMS	Entrainment is a ubiquitous property not only of interacting non-linear dynamical systems but also of human movements. In the study reported here, two premises of entrainment theory were investigated in a tapping task conducted in both interpersonal (i.e. between individuals) and intrapersonal (i. e. between effectors) conditions. Hypothesis 1 was that interacting oscillatory systems should demonstrate synchronisation, which was predicted to emerge as in-phase tapping behaviour in both inter-and intrapersonal conditions. Support for Hypothesis 1 was observed in the in-phase synchronisation of tapping in both individual bimanual trials and uni-manual and bimanual tapping in dyads. By contrast, Hypothesis 2 was that the oscillatory system with the faster initial rate would decelerate, whereas the one with the slower initial rate would accelerate, as manifest in increased self-paced tapping rates amongst participants with initially slower rates and decreased rates amongst ones who initially tapped at faster rates. However, that pattern predicted in Hypothesis 2 was not observed; on the contrary, all participants increased their tapping rates in interpersonal conditions, which occurred significantly amongst participants with the lowest preferred tapping rates. Such an outcome indicates a novel aspect of synchronised movement in humans that warrants further investigation.	[Loras, Havard; Aune, Tore Kristian; Ingvaldsen, Rolf] Nord Univ, Fac Teaching Art & Culture, Dept Sport Sci & Phys Educ, Levanger, Norway; [Pedersen, Arve Vorland] NTNU Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neurosci & Human Movement Sci, Trondheim, Norway	Nord University; Norwegian University of Science & Technology (NTNU)	Loras, H (corresponding author), Nord Univ, Fac Teaching Art & Culture, Dept Sport Sci & Phys Educ, Levanger, Norway.	havard.w.loras@nord.no						[Anonymous], PHYSL MENSCHEN TIERE, V240, P44; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BOND CF, 1983, PSYCHOL BULL, V94, P265, DOI 10.1037/0033-2909.94.2.265; Clausius R, PHILOS MAG, V2, P1; Cuijpers LS, 2019, HUM MOVEMENT SCI, V64, P38, DOI 10.1016/j.humov.2018.12.008; Fine JM, 2011, EXP BRAIN RES, V211, P459, DOI 10.1007/s00221-011-2707-y; Fontaine RJ, 1997, CAN J EXP PSYCHOL, V51, P1, DOI 10.1037/1196-1961.51.1.1; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gooijers J, 2014, NEUROSCI BIOBEHAV R, V43, P1, DOI 10.1016/j.neubiorev.2014.03.008; Gurtubay-Antolin A, 2015, J NEUROPHYSIOL, V113, P3069, DOI 10.1152/jn.00836.2014; Haken H., 1977, Physics Bulletin, V28, P412; Haken H., 2013, PRINCIPLES BRAIN FUN, V67; Haken H., 2008, SCHOLARPEDIA, V3, P1401, DOI [DOI 10.4249/SCH0LARPEDIA.1401, 10.4249/scholarpedia.1401]; Hansen EA, 2008, EXP BRAIN RES, V186, P365, DOI 10.1007/s00221-007-1240-5; Hansen EA, 2015, J MOTOR BEHAV, V47, P490, DOI 10.1080/00222895.2015.1015675; KELSO JAS, 1988, HUM MOVEMENT SCI, V7, P27, DOI 10.1016/0167-9457(88)90003-6; KELSO JAS, 1981, J MOTOR BEHAV, V13, P226; Kelso JAS., 2009, ENCY COMPLEXITY SYST, P1, DOI [10.1007/978-3-642-27737-5_101-3, DOI 10.1007/978-3-642-27737-5_101-3]; Kelso S., 1995, DYNAMIC PATTERNS SEL; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Kovacs AJ, 2011, ACTA PSYCHOL, V136, P311, DOI 10.1016/j.actpsy.2010.12.004; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakshmanan M., 1996, CHAOS NONLINEAR OSCI, DOI [10.1142/2637, DOI 10.1142/2637]; Landa PS, 2013, NONLINEAR OSCILLATIO, V360; Loras H, 2012, EXP BRAIN RES, V220, P335, DOI 10.1007/s00221-012-3142-4; Madison G, 2001, J EXP PSYCHOL HUMAN, V27, P411, DOI 10.1037/0096-1523.27.2.411; Mann RP, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0466; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Molinari M, 2003, ANN NY ACAD SCI, V999, P313, DOI 10.1196/annals.1284.042; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Nessler JA, 2015, HUM MOVEMENT SCI, V41, P32, DOI 10.1016/j.humov.2015.02.005; Nessler JA, 2011, MOTOR CONTROL, V15, P390, DOI 10.1123/mcj.15.3.390; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; Okano M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43987; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oscilatorium Horoloqium, 1673, THE PENDULUM CLOCK; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pantaleone J, 2002, AM J PHYS, V70, P992, DOI 10.1119/1.1501118; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; Pikovsky A., 2003, SYNCHRONIZATION UNIV, V12; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Richardson MJ, 2008, NEUROSCI LETT, V438, P340, DOI 10.1016/j.neulet.2008.04.083; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Ridderinkhof KR, 2014, NEUROSCI BIOBEHAV R, V46, P3, DOI 10.1016/j.neubiorev.2014.05.008; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Romero V, 2015, J EXP PSYCHOL HUMAN, V41, P1223, DOI 10.1037/xhp0000083; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Studenka BE, 2004, J SPORT EXERCISE PSY, V26, pS182; Thaut MH, 2015, PROG BRAIN RES, V217, P253, DOI 10.1016/bs.pbr.2014.11.030; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Varlet M, 2018, PSYCHOL RES, P1; Varlet M, 2018, EXP BRAIN RES, V236, P3341, DOI 10.1007/s00221-018-5382-4; von Holst E., 1939, ERGEBNISSE PHYSL, V42, P228, DOI [10.1007/BF02322567, DOI 10.1007/BF02322567]; Von Holst E, 1973, COLLECTED PAPERS E V; WALLER I, 1984, PHYS REV A, V30, P2047, DOI 10.1103/PhysRevA.30.2047; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; WILLEMS JC, 1972, ARCH RATION MECH AN, V45, P321, DOI 10.1007/BF00276493; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; Wing AM, 2002, BRAIN COGNITION, V48, P7, DOI 10.1006/brcg.2001.1301; Zehr EP, 2005, EXERC SPORT SCI REV, V33, P54	72	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220505	10.1371/journal.pone.0220505	http://dx.doi.org/10.1371/journal.pone.0220505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WU	31361779	gold, Green Published, Green Submitted			2022-12-26	WOS:000484981300035
J	Souza, JD; Difante, GD; Neto, JVE; Lana, AMQ; Roberto, FFD; Ribeiro, PHC				Souza, Joelma da Silva; Difante, Gelson do Santos; Emerenciano Neto, Joao Virginio; Quintao Lana, Angela Maria; da Silva Roberto, Francisca Fernanda; Cavalcante Ribeiro, Pedro Henrique			Biometric measurements of Santa Ines meat sheep reared on Brachiaria brizantha pastures in Northeast Brazil	PLOS ONE			English	Article							SWARD CHARACTERISTICS; ANIMAL PERFORMANCE; GRASS PASTURES; LAMBS; TRAITS; BIRTH; WEIGHT; GROWTH	This study was undertaken to examine biometric measurements during the growth phase of male and female Santa Ines sheep reared in Brachiaria brizantha pastures in northeastern Brazil. The experiment involved 24 castrated males and 24 females at an initial age of 90 days, with an average body weight of 19.04 +/- 0.96 kg. Treatments consisted of the effect of four cultivars (Marandu, Xarae's, Piata and Paiagua's) and two sexes. Six animals were used per treatment, in a randomized-block experimental design. The following characteristics were evaluated: abdominal circumference (AC), body condition score (BCS), body length (BL), body weight (BW), body capacity 1 (BC1), body capacity 2 (BC2), chest width (CW), heart girth (HG), leg circumference (LC), leg length (LL), rump height (RH), rump width (RW) and withers height (WH). Data were subjected to descriptive analysis, Pearson's correlation, ANOVA and Tukey's, Kruskal Wallis and Mann-Whitney tests. Univariate and multiple regressions were applied to estimate BW with a maximum error level of 5%. Significant differences were observed for the biometric measurements between sexes and cultivars (p< 0.05). Body weight was highly correlated (> 70%) with AC, WH, CG, RW, BC1 and BC2. The male sheep grazed on cultivars Piata showed the best values for BW (40.43 kg), HG, RW, WH, LL, LC (102.46; 20.8; 65.23; 60.44; 42.54 cm respectively) and BC1 (4.25 kg/cm). Females grazed on cultivar Marandu had higher values for RW, CW, LL (17.26; 20.1; 75.98 cm respectively), BC1 (6.03 kg/cm) and BC2 (0.422 kg/cm). The equations that best estimated live weight were BC1 and HG. In male and female Santa Ines sheep, biometric parameters grow differently depending on the cultivar where they are grazed during the growth phase. Cultivars Marandu and Piata are the most recommended for sheep production, as they provided the best performance and body development in those animals.	[Souza, Joelma da Silva; Quintao Lana, Angela Maria] Univ Fed Minas Gerais, Dept Anim Sci, Belo Horizonte, MG, Brazil; [Difante, Gelson do Santos] Univ Fed Mato Grosso do Sul, Dept Anim Sci, Campo Grande, MS, Brazil; [Emerenciano Neto, Joao Virginio] Fed Univ Vale Sao Francisco, Petrolina, Dept Anim Sci, Pernambuco, Brazil; [da Silva Roberto, Francisca Fernanda] Univ Fed Paraiba, Dept Anim Sci, Areia, Paraiba, Brazil; [Cavalcante Ribeiro, Pedro Henrique] Univ Fed Rio Grande do Norte, Dept Anim Sci, Natal, RN, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Mato Grosso do Sul; Universidade Federal da Paraiba; Universidade Federal do Rio Grande do Norte	Souza, JD (corresponding author), Univ Fed Minas Gerais, Dept Anim Sci, Belo Horizonte, MG, Brazil.	joelm_sousa@hotmail.com	Neto, João Virgínio Emerenciano/A-8996-2017; Difante, Gelson Santos/J-1280-2016; Lana, Angela Maria/ABH-6903-2020; Difante, Gelson/AAM-7243-2020	Neto, João Virgínio Emerenciano/0000-0003-3060-9696; Difante, Gelson Santos/0000-0001-6610-8952; Difante, Gelson/0000-0001-6610-8952; Ribeiro, Pedro/0000-0002-9268-0693; Lana, Angela/0000-0003-0066-6198; da Silva Roberto, Francisca Fernanda/0000-0001-6081-9542; Souza, Joelma daSILVA/0000-0001-5579-8943	National Council for Scientific and Technological Development (CNPq) [12/2017, 307331/ 2017-2]; Federal University of Rio Grande do Norte; Coordination for the Improvement of Higher Education Personnel (CAPES)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Rio Grande do Norte; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research project was developed with the financial support of the National Council for Scientific and Technological Development (CNPq) No. 12/2017 - Research Productivity Scholarships - PQ - Process Number: 307331/ 2017-2 - to Gelson do Santos Difante. For the Productivity Exchange - Angela Maria Quintao Lana. Support of the physical structure and PhD grant of the author Joelma da Silva Souza was provided by the Federal University of Rio Grande do Norte. This project was also supported by a fellowship grant from the Coordination for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy Y, 2016, ITAL J FOOD SCI, V28, P131, DOI 10.14674/1120-1770%2Fijfs.v465; Alcalde Aldea M J, 1993, ARCH ZOOTEC, V42, P161; Alves JM, 2006, REV BRAS ZOOTECN, V35, P958, DOI 10.1590/S1516-35982006000400004; Alves L G C, 2014, ENCICLOPEDIA BIOSFER, V10, P2400; Araujo R P, 2015, REV CIENTIFICA PRODU, V17, P1, DOI DOI 10.15528/3812; Euclides VPB, 2016, REV BRAS ZOOTECN, V45, P85, DOI 10.1590/S1806-92902016000300001; de Castro FAB, 2012, SEMIN-CIENC AGRAR, V33, P3379, DOI 10.5433/1679-0359.2012v33Supl2p3379; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa GD, 2006, REV BRAS ZOOTECN, V35, P2260, DOI 10.1590/S1516-35982006000800009; Osorio JCDS, 2012, AGRARIAN, V5, P433; Trindade TFD, 2018, BIOSCI J, V34, P172; Gizaw S, 2008, LIVEST SCI, V118, P92, DOI 10.1016/j.livsci.2008.01.006; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2017, SIST REC AUT BANC DA; Koritiaki Natália Albieri, 2012, Rev. bras. saúde prod. anim., V13, P258; Mcmanus C, 2010, ESCORE CORPORAL; MELO Jnahtan Chaves, 2016, Rev. bras. saúde prod. anim., V17, P385, DOI 10.1590/S1519-99402016000300006; Moreira A L, 2014, REV ELETRONICA NUTRI, V11, P3607; Nantes NN, 2013, PESQUI AGROPECU BRAS, V48, P114, DOI 10.1590/S0100-204X2013000100015; NRC, 2007, NUTR REQ SMALL RUM S, P362; Oliveira N M, 2014, REV AGRARIAN, V7, P300; PACHECO A, 2008, PUBVET LONDRINA, V2, P1982, DOI DOI 10.31533/PUBVET; Sarmento JLR, 2006, REV BRAS ZOOTECN, V35, P435, DOI 10.1590/S1516-35982006000200014; Sidney S, 1956, NONPARAMETRIC STAT B, P241; Silva D. L. S. da, 2015, Acta Veterinaria Brasilica, V9, P306; SILVA Nelson Vieira da, 2016, Rev. bras. saúde prod. anim., V17, P101, DOI 10.1590/S1519-99402016000100010; Soares BC, 2012, ARQ BRAS MED VET ZOO, V64, P1747, DOI 10.1590/S0102-09352012000600046; Souza Rafael Araujo, 2010, Acta Scientiarum Animal Sciences, V32, P323, DOI 10.4025/actascianimsci.v32i3.8320; Souza S., 2009, Archivos Latinoamericanos de Produccion Animal, V17, P61; Souza W.H., 2011, TECNOLOGIA CIENCIA A, V5, P47; TEIXEIRA NETO Milton Rezende, 2016, Rev. bras. saúde prod. anim., V17, P26, DOI 10.1590/S1519-99402016000100003; Neto MRT, 2012, REV BRAS ZOOTECN, V41, P58, DOI 10.1590/S1516-35982012000100009; Yanez EA, 2004, REV BRAS ZOOTECN, V33, P1564, DOI 10.1590/S1516-35982004000600024; Yildirim A, 2014, S AFRICAN J ANIMAL S, V1, P44; Yildirim A, 2017, SAINS MALAYS, V46, P429, DOI 10.17576/jsm-2017-4603-10; Yildirim A, 2013, ITAL J ANIM SCI, V12, DOI 10.4081/ijas.2013.e89	35	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0219343	10.1371/journal.pone.0219343	http://dx.doi.org/10.1371/journal.pone.0219343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361775	Green Submitted, Green Published, gold			2022-12-26	WOS:000484981300010
J	Yoon, SY; Dieterich, LC; Karaman, S; Proulx, ST; Bachmann, SB; Sciaroni, C; Detmar, M				Yoon, Sun-Young; Dieterich, Lothar C.; Karaman, Sinem; Proulx, Steven T.; Bachmann, Samia B.; Sciaroni, Carol; Detmar, Michael			An important role of cutaneous lymphatic vessels in coordinating and promoting anagen hair follicle growth	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; TUMOR LYMPHANGIOGENESIS; ALOPECIA-AREATA; T-LYMPHOCYTES; SKIN; METASTASIS; CANCER; ACTIVATION; MICE; PROLIFERATION	The lymphatic vascular system plays important roles in the control of tissue fluid homeostasis and immune responses. While VEGF-A-induced angiogenesis promotes hair follicle (HF) growth, the potential role of lymphatic vessels (LVs) in HF cycling has remained unknown. In this study, we found that LVs are localized in close proximity to the HF bulge area throughout the postnatal and depilation-induced hair cycle in mice and that a network of LVs directly connects the individual HFs. Increased LV density in the skin of K14-VEGF-C transgenic mice was associated with prolongation of anagen HF growth. Conversely, HF entry into the catagen phase was accelerated in K14-sVEGFR3 transgenic mice that lack cutaneous LVs. Importantly, repeated intradermal injections of VEGF-C promoted hair growth in mice. Conditioned media from lymphatic endothelial cells promoted human dermal papilla cell (DPC) growth and expression of IGF-1 and alkaline phosphatase, both activators of DPCs. Our results reveal an unexpected role of LVs in coordinating and promoting HF growth and identify potential new therapeutic strategies for hair loss-associated conditions.	[Yoon, Sun-Young; Dieterich, Lothar C.; Karaman, Sinem; Proulx, Steven T.; Bachmann, Samia B.; Sciaroni, Carol; Detmar, Michael] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Yoon, Sun-Young] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea	Swiss Federal Institutes of Technology Domain; ETH Zurich; Sungkyunkwan University (SKKU)	Detmar, M (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Karaman, Sinem/C-4428-2017	Karaman, Sinem/0000-0002-0719-1773	Swiss National Science Foundation [31003A-130627, 310030B-185392]; Advanced European Research Council grant LYVICAM; Leducq Transatlantic Network of Excellence on Lymph Vessels in Obesity and Cardiovascular Disease [11CVD03]; Mutant Mouse Regional Resource Centers (MMRRC), a NCRR-NIH [036531-UCD]; NINDS	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced European Research Council grant LYVICAM; Leducq Transatlantic Network of Excellence on Lymph Vessels in Obesity and Cardiovascular Disease; Mutant Mouse Regional Resource Centers (MMRRC), a NCRR-NIH; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Swiss National Science Foundation grants 31003A-130627 and 310030B-185392, Advanced European Research Council grant LYVICAM and Leducq Transatlantic Network of Excellence on Lymph Vessels in Obesity and Cardiovascular Disease (11CVD03).; The authors thank Vivianne Otto for helpful discussions, Marko Sesartic, Roberta Bianchi and Alexandra Ochsenbein for assistance with animal studies, Catharina Commerford and Steffi Lehmann for acquisition of whole-mount staining images, Jeannette Scholl and Carlos Ochoa for technical assistance, Marion Hermerschmidt and Sven Nowok for help with maintaining the mouse lines, and Kari Alitalo for providing the transgenic mouse lines. The mouse strain used for this research project, STOCK Tg (Prox1-tdTomato) TA76Gsat/Mmucd, identification number 036531-UCD, was obtained from the Mutant Mouse Regional Resource Centers (MMRRC), a NCRR-NIH funded strain repository, and was donated to the MMRRC by the NINDS funded GENSAT BAC transgenic project. This work was supported by Swiss National Science Foundation grants 31003A-130627 and 310030B-185392, Advanced European Research Council grant LYVICAM and Leducq Transatlantic Network of Excellence on Lymph Vessels in Obesity and Cardiovascular Disease (11CVD03).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bassino E, 2015, EXP DERMATOL, V24, P388, DOI 10.1111/exd.12670; Card CM, 2014, J CLIN INVEST, V124, P943, DOI 10.1172/JCI73316; Castellana D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002002; Christiansen AJ, 2016, ONCOTARGET, V7, P39421, DOI 10.18632/oncotarget.9820; Cotsarelis G, 2001, TRENDS MOL MED, V7, P293, DOI 10.1016/S1471-4914(01)02027-5; D'Alessio S, 2014, J CLIN INVEST, V124, P3863, DOI 10.1172/JCI72189; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Dieterich LC, 2014, ANGIOGENESIS, V17, P359, DOI 10.1007/s10456-013-9406-1; Dietrich T, 2010, J IMMUNOL, V184, P535, DOI 10.4049/jimmunol.0903180; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gilhar A, 1999, J INVEST DERM SYMP P, V4, P207, DOI 10.1038/sj.jidsp.5640212; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hirakawa S, 2014, ADV DRUG DELIVER REV, V74, P12, DOI 10.1016/j.addr.2014.01.011; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Huggenberger R, 2011, J INVEST DERM SYMP P, V15, P24, DOI 10.1038/jidsymp.2011.5; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Kholova I, 2011, EUR J CLIN INVEST, V41, P487, DOI 10.1111/j.1365-2362.2010.02431.x; Kubota Yoshiaki, 2012, Keio Journal of Medicine, V61, P47; Kwon OS, 2007, J KOREAN MED SCI, V22, P283, DOI 10.3346/jkms.2007.22.2.283; Li J, 2014, GROWTH HORM IGF RES, V24, P89, DOI 10.1016/j.ghir.2014.03.004; Li W, 2012, EXP CELL RES, V318, P1633, DOI 10.1016/j.yexcr.2012.05.003; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Martin JM, 2005, J AM ACAD DERMATOL, V52, P152, DOI 10.1016/j.jaad.2004.05.016; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Messenger AG, 2004, BRIT J DERMATOL, V150, P186, DOI 10.1111/j.1365-2133.2004.05785.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Odorisio T, 2006, J DERMATOL SCI, V41, P11, DOI 10.1016/j.jdermsci.2005.08.008; Paik SH, 2013, EXP DERMATOL, V22, P496, DOI 10.1111/exd.12182; PAUS R, 1989, LAB INVEST, V60, P365; Philpott M P, 1994, J Dermatol Sci, V7 Suppl, pS55, DOI 10.1016/0923-1811(94)90036-1; Proulx ST, 2013, J CONTROL RELEASE, V172, P550, DOI 10.1016/j.jconrel.2013.04.027; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Skobe M, 2000, J INVEST DERM SYMP P, V5, P14, DOI 10.1046/j.1087-0024.2000.00001.x; Sundberg JP, 2016, EXP MOL PATHOL, V100, P332, DOI 10.1016/j.yexmp.2016.03.001; Tacconi C, 2015, GASTROENTEROLOGY, V148, P1438, DOI 10.1053/j.gastro.2015.03.005; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Yamauchi K, 2009, ARCH DERMATOL RES, V301, P357, DOI 10.1007/s00403-009-0929-7; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yano K, 2003, J INVEST DERMATOL, V120, P14, DOI 10.1046/j.1523-1747.2003.12045.x; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Yoon SY, 2014, J DERMATOL SCI, V74, P125, DOI 10.1016/j.jdermsci.2014.01.011	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220341	10.1371/journal.pone.0220341	http://dx.doi.org/10.1371/journal.pone.0220341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344105	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900087
J	Yu, J; Canalis, E				Yu, Jungeun; Canalis, Ernesto			The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor ?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; inflammation; Notch receptor; osteoclast; tumor necrosis factor (TNF); Hajdu Cheney syndrome; osteolysis	NF-KAPPA-B; BONE-RESORPTION; NUCLEAR-FACTOR; NOTCH2 CAUSE; DIFFERENTIATION; ALPHA; TNF; OSTEOCLASTOGENESIS; ACROOSTEOLYSIS; LIGAND	Hajdu Cheney syndrome (HCS) is characterized by craniofacial developmental abnormalities, acro-osteolysis, and osteoporosis and is associated with gain?of?NOTCH2 function mutations. A mouse model of HCS termed Notch2(tm1.1Ecan) harboring a mutation in exon 34 of Notch2 replicating the one found in HCS was used to determine whether the HCS mutation sensitizes the skeleton to the osteolytic effects of tumor necrosis factor ? (TNF?). TNF? injected over the calvarial vault caused a greater increase in osteoclast number, osteoclast surface, and eroded surface in Notch2(tm1.1Ecan) mice compared with littermate WT controls. Accordingly, the effect of TNF? on osteoclastogenesis was greatly enhanced in cultures of bone marrow?derived macrophages (BMMs) from Notch2(tm1.1Ecan) mice when compared with the activity of TNF? in control cultures. TNF? induced the expression of Notch2 and Notch2 mutant mRNA by ?2-fold, possibly amplifying the NOTCH2-dependent induction of osteoclastogenesis. The effect of TNF? on osteoclastogenesis in Notch2(tm1.1Ecan) mutants depended on NOTCH2 activation because it was reversed by anti-NOTCH2 negative regulatory region and anti-jagged 1 antibodies. The inactivation of Hes1 prevented the TNF? effect on osteoclastogenesis in the context of the Notch2(tm1.1Ecan) mutation. In addition, the induction of Il1b, but not of Tnfa and Il6, mRNA by TNF? was greater in Notch2(tm1.1Ecan) BMMs than in control cells, possibly contributing to the actions of TNF? and NOTCH2 on osteoclastogenesis. In conclusion, the HCS mutation enhances TNF?-induced osteoclastogenesis and the inflammatory bone-resorptive response possibly explaining the acro-osteolysis observed in affected individuals.	[Yu, Jungeun; Canalis, Ernesto] UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Canalis, Ernesto] UConn Hlth, Dept Med, Farmington, CT 06030 USA; [Yu, Jungeun; Canalis, Ernesto] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA		Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, Dept Med, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA.	canalis@uchc.edu			National Institutes of Health from NIAMS [AR068160]; National Institutes of Health from NIDDK [DK045227]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant AR068160 from NIAMS and Grant DK045227 from NIDDK. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Axmann R, 2009, ARTHRITIS RHEUM-US, V60, P2747, DOI 10.1002/art.24781; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Blumenauer BT, 2002, CLIN EXP RHEUMATOL, V20, P574; BROWN DM, 1976, J PEDIATR-US, V88, P573, DOI 10.1016/S0022-3476(76)80009-1; Canalis E, 2018, OSTEOPOROSIS INT, V29, P2611, DOI 10.1007/s00198-018-4694-3; Canalis E, 2018, J BIOL CHEM, V293, P14165, DOI 10.1074/jbc.RA118.004242; Canalis E, 2017, ENDOCRINOLOGY, V158, P730, DOI 10.1210/en.2016-1787; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0200-y; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Cenciarelli C, 2017, ONCOTARGET, V8, P17873, DOI 10.18632/oncotarget.15013; CHENEY WD, 1965, AMER J ROENTGENOL RA, V94, P595; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Fukushima H, 2017, MOL CELL, V68, P645, DOI 10.1016/j.molcel.2017.10.018; Gray MJ, 2012, EUR J HUM GENET, V20, P122, DOI 10.1038/ejhg.2011.125; Gu QL, 2017, J ORTHOP TRANSL, V10, P86, DOI 10.1016/j.jot.2017.05.002; HAJDU N, 1948, BRIT J RADIOL, V21, P42, DOI 10.1259/0007-1285-21-241-42; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kim JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189702; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Komine M, 2001, BONE, V28, P474, DOI 10.1016/S8756-3282(01)00420-3; Kotake S, 1996, J BONE MINER RES, V11, P88; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lafkas D, 2015, NATURE, V528, P127, DOI 10.1038/nature15715; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048; Ottaviani S, 2010, ANN RHEUM DIS, V69, P1488, DOI 10.1136/ard.2009.120816; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Park HJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030495; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Sakka S, 2017, J CLIN ENDOCR METAB, V102, P4163, DOI 10.1210/jc.2017-01102; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Shang YL, 2016, PROTEIN CELL, V7, P159, DOI 10.1007/s13238-016-0250-0; Shiratori T, 2018, J IMMUNOL, V200, P218, DOI 10.4049/jimmunol.1602035; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Sisto M, 2014, IMMUNOLOGY, V143, P42, DOI 10.1111/imm.12288; Tanaka S, 2017, J BONE MINER RES, V32, P431, DOI 10.1002/jbmr.3092; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; UDELL J, 1986, ARTHRITIS RHEUM, V29, P1032, DOI 10.1002/art.1780290815; Vollersen N, 2018, J BONE MINER RES, V33, P70, DOI 10.1002/jbmr.3283; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Won HY, 2016, ARTHRITIS RHEUMATOL, V68, P1301, DOI 10.1002/art.39538; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Yu JG, 2018, AM J PATHOL, V188, P149, DOI 10.1016/j.ajpath.2017.09.010; Zanotti S, 2018, BONE, V114, P198, DOI 10.1016/j.bone.2018.06.020; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zanotti S, 2013, J BIOL CHEM, V288, P624, DOI 10.1074/jbc.M112.340455; Zanotti S, 2011, J BIOL CHEM, V286, P2648, DOI 10.1074/jbc.M110.183038; Zhao BH, 2017, CURR OSTEOPOROS REP, V15, P126, DOI 10.1007/s11914-017-0358-z; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao W, 2013, OSTEOPOROSIS INT, V24, P2275, DOI 10.1007/s00198-013-2298-5	66	9	9	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14203	14214		10.1074/jbc.RA119.009824	http://dx.doi.org/10.1074/jbc.RA119.009824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31371452	Green Published, hybrid			2022-12-26	WOS:000499248200005
J	Chik, JK; Moiseeva, V; Goel, PK; Meinen, B; Koldewey, P; An, S; Mellone, BG; Subramanian, L; Cho, US				Chik, Jennifer K.; Moiseeva, Vera; Goel, Pavitra K.; Meinen, Ben A.; Koldewey, Philipp; An, Sojin; Mellone, Barbara G.; Subramanian, Lakxmi; Cho, Uhn-Soo			Structures of CENP-C cupin domains at regional centromeres reveal unique patterns of dimerization and recruitment functions for the inner pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centromere; kinetochore; X-ray crystallography; analytical ultracentrifugation; meiosis; CENP-C; cupin domain; fission yeast; Moa1	CRYSTAL-STRUCTURE; YEAST CENTROMERE; KINETOCHORE; PROTEIN; COMPLEX; DNA; ORGANIZATION; RECOGNITION; NUCLEOSOME; IMAGE	The successful assembly and regulation of the kinetochore are critical for the equal and accurate segregation of genetic material during the cell cycle. CENP-C (centromere protein C), a conserved inner kinetochore component, has been broadly characterized as a scaffolding protein and is required for the recruitment of multiple kinetochore proteins to the centromere. At its C terminus, CENP-C harbors a conserved cupin domain that has an established role in protein dimerization. Although the crystal structure of the Saccharomyces cerevisiae Mif2(CENP-C) cupin domain has been determined, centromeric organization and kinetochore composition vary greatly between S. cerevisiae (point centromere) and other eukaryotes (regional centromere). Therefore, whether the structural and functional role of the cupin domain is conserved throughout evolution requires investigation. Here, we report the crystal structures of the Schizosaccharomyces pombe and Drosophila melanogaster CENP-C cupin domains at 2.52 and 1.81 angstrom resolutions, respectively. Although the central jelly roll architecture is conserved among the three determined CENP-C cupin domain structures, the cupin domains from organisms with regional centromeres contain additional structural features that aid in dimerization. Moreover, we found that the S. pombe Cnp3(CENP-C) jelly roll fold harbors an inner binding pocket that is used to recruit the meiosis-specific protein Moa1. In summary, our results unveil the evolutionarily conserved and unique features of the CENP-C cupin domain and uncover the mechanism by which it functions as a recruitment factor.	[Chik, Jennifer K.; An, Sojin; Cho, Uhn-Soo] Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Chik, Jennifer K.] Univ Michigan, Med Sch, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Moiseeva, Vera; Goel, Pavitra K.; Subramanian, Lakxmi] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Meinen, Ben A.; Koldewey, Philipp] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Mellone, Barbara G.] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of London; Queen Mary University London; University of Michigan System; University of Michigan; University of Connecticut	Cho, US (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA.; Subramanian, L (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	l.subramanian@qmul.ac.uk; uhnsoo@med.umich.edu	Meinen, Ben Alexander/ADS-1907-2022	Meinen, Ben Alexander/0000-0002-6180-8594; cho, uhn-soo/0000-0002-6992-2455	National Institutes of Health [R01GM-108829, DK111465]; March of Dimes Foundation [N019154-00]; Queen Mary University of London; Biotechnology and Biological Sciences Research Council [BB/R00868X/1]; National Institutes of Health Cellular and Molecular Biology Training Grant [T-32-GM007315]; Rackham Graduate Student Precandidate and Candidate Research Grants; BBSRC [BB/R00868X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, R01GM108829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Queen Mary University of London; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health Cellular and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rackham Graduate Student Precandidate and Candidate Research Grants; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant DK111465, March of Dimes Foundation Grant N019154-00 (to U.-S. C.), and a Queen Mary University of London start-up grant and Biotechnology and Biological Sciences Research Council Grant BB/R00868X/1 (to L. S.). This work was also supported in part by National Institutes of Health Grant R01GM-108829 (to B. G. M.), National Institutes of Health Cellular and Molecular Biology Training Grant T-32-GM007315 (to J. K. C.), and Rackham Graduate Student Precandidate and Candidate Research Grants (to J. K. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; COTTAREL G, 1989, MOL CELL BIOL, V9, P3342, DOI 10.1128/MCB.9.8.3342; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Drinnenberg IA, 2016, TRENDS CELL BIOL, V26, P498, DOI 10.1016/j.tcb.2016.01.005; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hinshaw SM, 2013, CELL REP, V5, P29, DOI 10.1016/j.celrep.2013.08.036; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Kim J, 2015, NATURE, V517, P466, DOI 10.1038/nature14097; Klare K, 2015, J CELL BIOL, V210, P11, DOI 10.1083/jcb.201412028; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Marshall OJ, 2008, J CELL BIOL, V183, P1193, DOI 10.1083/jcb.200804078; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Miyazaki S, 2017, GENES CELLS, V22, P552, DOI 10.1111/gtc.12496; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Nagpal H, 2015, MOL BIOL CELL, V26, P3768, DOI 10.1091/mbc.E15-07-0531; Pang H, 2004, J BIOL CHEM, V279, P1491, DOI 10.1074/jbc.M310022200; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Rajavel M, 2009, J BIOL CHEM, V284, P31882, DOI 10.1074/jbc.M109.014522; Salas-Pino S, 2017, J CELL BIOL, V216, P3591, DOI 10.1083/jcb.201612194; Schittenhelm RB, 2010, J CELL SCI, V123, P3768, DOI 10.1242/jcs.067934; Schmid-Burgk JL, 2014, METHODS MOL BIOL, V1116, P49, DOI 10.1007/978-1-62703-764-8_4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Soisson SM, 1997, SCIENCE, V276, P421, DOI 10.1126/science.276.5311.421; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subramanian L, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140043; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	60	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14119	14134		10.1074/jbc.RA119.008464	http://dx.doi.org/10.1074/jbc.RA119.008464			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366733	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000490729800024
J	Lu, ZJ; Hu, XB; Reilly, J; Jia, DN; Liu, F; Yu, SS; Liu, XL; Xie, SL; Qu, Z; Qin, YY; Huang, YW; Lv, YX; Li, JZ; Gao, P; Wong, F; Shu, XH; Tang, Z; Liu, MG				Lu, Zhaojing; Hu, Xuebin; Reilly, James; Jia, Danna; Liu, Fei; Yu, Shanshan; Liu, Xiliang; Xie, Shanglun; Qu, Zhen; Qin, Yayun; Huang, Yuwen; Lv, Yuexia; Li, Jingzhen; Gao, Pan; Wong, Fulton; Shu, Xinhua; Tang, Zhaohui; Liu, Mugen			Deletion of the transmembrane protein Prom1b in zebrafish disrupts outer-segment morphogenesis and causes photoreceptor degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retinal degeneration; photoreceptor; zebrafish; morphogenesis; development; Danio rerio; eye disease; peripherin 2 (PRPH2); prominin 1 (PROM1)	CONE-ROD DYSTROPHY; XENOPUS-LAEVIS ROD; RETINITIS-PIGMENTOSA; FRAMESHIFT MUTATION; RDS; PROMININ-1; EXPRESSION; OLIGOMERIZATION; IDENTIFICATION; LOCALIZATION	Mutations in human prominin 1 (PROM1), encoding a transmembrane glycoprotein localized mainly to plasma membrane protrusions, have been reported to cause retinitis pigmentosa, macular degeneration, and cone-rod dystrophy. Although the structural role of PROM1 in outer-segment (OS) morphogenesis has been demonstrated in Prom1-knockout mouse, the mechanisms underlying these complex disease phenotypes remain unclear. Here, we utilized a zebrafish model to further investigate PROM1's role in the retina. The Prom1 orthologs in zebrafish include prom1a and prom1b, and our results showed that prom1b, rather than prom1a, plays an important role in zebrafish photoreceptors. Loss of prom1b disrupted OS morphogenesis, with rods and cones exhibiting differences in impairment: cones degenerated at an early age, whereas rods remained viable but with an abnormal OS, even at 9 months postfertilization. Immunofluorescence experiments with WT zebrafish revealed that Prph2, an ortholog of the human transmembrane protein peripherin 2 and also associated with OS formation, is localized to the edge of OS and is more highly expressed in the cone OS than in the rod OS. Moreover, we found that Prom1b deletion causes mislocalization of Prph2 and disrupts its oligomerization. We conclude that the variation in Prph2 levels between cones and rods was one of the reasons for the different PROM1 mutation-induced phenotypes of these retinal structures. These findings expand our understanding of the phenotypes caused by PROM1 mutations and provide critical insights into its function.	[Lu, Zhaojing; Hu, Xuebin; Jia, Danna; Liu, Fei; Yu, Shanshan; Liu, Xiliang; Xie, Shanglun; Qu, Zhen; Qin, Yayun; Huang, Yuwen; Lv, Yuexia; Li, Jingzhen; Gao, Pan; Tang, Zhaohui; Liu, Mugen] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China; [Hu, Xuebin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Reilly, James; Shu, Xinhua] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Wong, Fulton] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA	Huazhong University of Science & Technology; Sun Yat Sen University; Glasgow Caledonian University; Duke University	Tang, Z; Liu, MG (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	zh_tang@mail.hust.edu.cn; lium@hust.edu.cn	Liu, Fei/AAR-6464-2021	Liu, Fei/0000-0002-0310-1072; shanglun, xie/0000-0002-8947-1399	National Natural Science Foundation of China [81800870, 31571303, 31801041, 81670890, 31871260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81800870, 31571303, 31801041, 81670890, and 31871260. The authors declare that they have no conflicts of interest with the contents of this article.	Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Beryozkin A, 2014, INVEST OPHTH VIS SCI, V55, P1149, DOI 10.1167/iovs.13-13625; Bhattacharya S, 2017, INVEST OPHTH VIS SCI, V58, P2366, DOI 10.1167/iovs.16-21162; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Boulanger-Scemama E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0300-3; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Conley SM, 2014, FASEB J, V28, P3468, DOI 10.1096/fj.14-251397; Crespo C, 2018, BIOL OPEN, V7, DOI 10.1242/bio.036632; Damek-Poprawa M, 2005, J BIOL CHEM, V280, P9217, DOI 10.1074/jbc.M407166200; Eidinger O, 2015, MOL VIS, V21, P1295; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Fargeas CA, 2004, J CELL SCI, V117, P4301, DOI 10.1242/jcs.01315; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Hu XB, 2019, AUTOPHAGY, V15, P453, DOI 10.1080/15548627.2018.1520548; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; Jaszai J, 2007, EXP EYE RES, V85, P585, DOI 10.1016/j.exer.2006.03.022; Jinda W, 2014, INVEST OPHTH VIS SCI, V55, P2259, DOI 10.1167/iovs.13-13567; Khan AO, 2015, OPHTHALMIC GENET, V36, P349, DOI 10.3109/13816810.2014.886266; KLJAVIN IJ, 1987, J COMP NEUROL, V260, P461, DOI 10.1002/cne.902600311; Lin-Jones J, 2004, J CELL SCI, V117, P5825, DOI 10.1242/jcs.01512; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Liu F, 2017, J BIOL CHEM, V292, P6225, DOI 10.1074/jbc.M116.760314; Lu ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46098; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Mayer AK, 2016, EUR J HUM GENET, V24, P459, DOI 10.1038/ejhg.2015.144; McGrail M, 2010, DEV DYNAM, V239, P1849, DOI 10.1002/dvdy.22307; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; NAGLE BW, 1986, INVEST OPHTH VIS SCI, V27, P689; Permanyer J, 2010, INVEST OPHTH VIS SCI, V51, P2656, DOI 10.1167/iovs.09-4857; Pras E, 2009, MOL VIS, V15, P1709; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Salles MV, 2017, OPHTHALMIC GENET, V38, P39, DOI 10.1080/13816810.2016.1275022; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Stuck MW, 2016, PROG RETIN EYE RES, V52, P47, DOI 10.1016/j.preteyeres.2015.12.002; Stuck MW, 2015, J BIOL CHEM, V290, P27901, DOI 10.1074/jbc.M115.683698; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yu SS, 2017, HUM MOL GENET, V26, P2335, DOI 10.1093/hmg/ddx137; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/s00439-007-0395-2; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095528; Zhao L, 2015, HUM GENET, V134, P217, DOI 10.1007/s00439-014-1512-7; Zhou ZQ, 2015, AUTOPHAGY, V11, P1821, DOI 10.1080/15548627.2015.1084456; Zulliger R, 2018, HUM MOL GENET, V27, P3507, DOI 10.1093/hmg/ddy240	50	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13953	13963		10.1074/jbc.RA119.008618	http://dx.doi.org/10.1074/jbc.RA119.008618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31362982	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000490729800010
J	Mack, EA; Xiao, YP; Allred, DR				Mack, Erin A.; Xiao, Yu-Ping; Allred, David R.			Knockout of Babesia bovis rad51 ortholog and its complementation by expression from the BbACc3 artificial chromosome platform	PLOS ONE			English	Article							BABESIA-BOVIS OCCURS; SINGLE-STRAND BREAKS; VES MULTIGENE FAMILY; ANTIGENIC VARIATION; HOMOLOGOUS RECOMBINATION; PLASMODIUM-FALCIPARUM; STRUCTURE PREDICTION; GENE-EXPRESSION; DNA-DAMAGE; PSI-BLAST	Babesia bovis establishes persistent infections of long duration in cattle, despite the development of effective anti-disease immunity. One mechanism used by the parasite to achieve persistence is rapid antigenic variation of the VESA1 cytoadhesion ligand through segmental gene conversion (SGC), a phenomenon thought to be a form of homologous recombination (HR). To begin investigation of the enzymatic basis for SGC we initially identified and knocked out the Bbrad51 gene encoding the B. bovis Rad51 ortholog. BbRad51 was found to be non-essential for in vitro growth of asexual-stage parasites. However, its loss resulted in hypersensitivity to methylmethane sulfonate (MMS) and an apparent defect in HR. This defect rendered attempts to complement the knockout phenotype by reinsertion of the Bbrad51 gene into the genome unsuccessful. To circumvent this difficulty, we constructed an artificial chromosome, BbACc3, into which the complete Bbrad51 locus was inserted, for expression of BbRad51 under regulation by autologous elements. Maintenance of BbACc3 makes use of centromeric sequences from chromosome 3 and telomeric ends from chromosome 1 of the B. bovis C9.1 line. A selection cassette employing human dihydrofolate reductase enables recovery of transformants by selection with pyrimethamine. We demonstrate that the BbACc3 platform is stably maintained once established, assembles nucleosomes to form native chromatin, and expands in telomere length over time. Significantly, the MMS-sensitivity phenotype observed in the absence of Bbrad51 was successfully complemented at essentially normal levels. We provide cautionary evidence, however, that in HR-competent parasites BbACc3 can recombine with native chromosomes, potentially resulting in crossover. We propose that, under certain circumstances this platform can provide a useful alternative for the genetic manipulation of this group of parasites, particularly when regulated gene expression under the control of autologous elements may be important.	[Mack, Erin A.; Xiao, Yu-Ping; Allred, David R.] Univ Florida, Coll Vet Med, Dept Infect Dis & Immunol, Gainesville, FL 32611 USA; [Allred, David R.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Allred, David R.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Mack, Erin A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Idaho; University of Idaho	Allred, DR (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Immunol, Gainesville, FL 32611 USA.; Allred, DR (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.; Allred, DR (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	allredd@ufl.edu	Allred, David/M-1299-2019	Allred, David/0000-0001-9347-5918	National Institutes of Health [R01 AI0055864, T32 AI0007110]; U. F. College of Veterinary Medicine Faculty Competitive Research Awards; USDA Animal Health project [FLA-VME-005011]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. F. College of Veterinary Medicine Faculty Competitive Research Awards; USDA Animal Health project	This work was supported by funds from National Institutes of Health grants R01 AI0055864 (DRA; https://www.niaid.nih.gov/) and T32 AI0007110 (University of Florida; https://www.niaid.nih.gov/), USDA Animal Health project FLA-VME-005011 (DRA; https://nifa.usda.gov/), and U. F. College of Veterinary Medicine Faculty Competitive Research Awards (DRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khedery B, 2006, MOL MICROBIOL, V59, P402, DOI 10.1111/j.1365-2958.2005.04993.x; Allred DR, 2006, VET PARASITOL, V138, P50, DOI 10.1016/j.vetpar.2006.01.039; Allred DR, 2004, MOL BIOCHEM PARASIT, V134, P27, DOI 10.1016/j.molbiopara.2003.09.012; ALLRED DR, 1993, MOL BIOCHEM PARASIT, V60, P121, DOI 10.1016/0166-6851(93)90035-V; Allred DR, 2000, MOL CELL, V5, P153, DOI 10.1016/S1097-2765(00)80411-6; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMBROSIO RE, 1986, ONDERSTEPOORT J VET, V53, P179; Asada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125993; Asada M, 2012, MOL BIOCHEM PARASIT, V181, P162, DOI 10.1016/j.molbiopara.2011.11.001; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; BOYCE RP, 1968, VIROLOGY, V35, P601, DOI 10.1016/0042-6822(68)90289-4; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Cable RG, 2003, CURR OPIN HEMATOL, V10, P405, DOI 10.1097/00062752-200311000-00002; Chen J, 2010, NUCLEIC ACIDS RES, V38, P4889, DOI 10.1093/nar/gkq209; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; de Vries E, 2006, VET PARASITOL, V138, P61, DOI 10.1016/j.vetpar.2006.01.040; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gonzalez-Prieto R, 2013, EMBO J, V32, P1307, DOI 10.1038/emboj.2013.73; Hakimi H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1439-z; Huang YL, 2013, INT J PARASITOL, V43, P163, DOI 10.1016/j.ijpara.2012.10.018; Iwanaga S, 2012, GENOME RES, V22, P985, DOI 10.1101/gr.124164.111; Iwanaga S, 2010, CELL HOST MICROBE, V7, P245, DOI 10.1016/j.chom.2010.02.010; Jackson AP, 2014, NUCLEIC ACIDS RES, V42, P7113, DOI 10.1093/nar/gku322; KAMPER SM, 1992, MOL BIOCHEM PARASIT, V53, P33, DOI 10.1016/0166-6851(92)90004-4; Keroack CD, 2019, INT J PARASITOL, V49, P153, DOI 10.1016/j.ijpara.2018.09.005; Kim DE, 2014, PROTEINS, V82, P208, DOI 10.1002/prot.24374; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Lau AOT, 2007, EXP PARASITOL, V117, P93, DOI 10.1016/j.exppara.2007.03.004; Leiby DA, 2005, TRANSFUSION, V45, P1804, DOI 10.1111/j.1537-2995.2005.00609.x; LEVY MG, 1980, SCIENCE, V207, P1218, DOI 10.1126/science.7355284; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Mack E, 2014, THESIS; Mack EA, 2019, BIORXIV, DOI [10.1101/606590, DOI 10.1101/606590]; Mamoun CB, 2018, ELS, DOI [10.1002/9780470015902.a0001945.pub2, DOI 10.1002/9780470015902.A0001945.PUB2]; Maniatis T, 1982, MOLECULAR CLONING A; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MARTIN WJ, 1971, NATURE-NEW BIOL, V233, P260, DOI 10.1038/newbio233260a0; McCulloch R, 1999, GENE DEV, V13, P2875, DOI 10.1101/gad.13.21.2875; O'Connor RM, 2000, J IMMUNOL, V164, P2037, DOI 10.4049/jimmunol.164.4.2037; OConnor RM, 1997, MOL BIOCHEM PARASIT, V89, P259, DOI 10.1016/S0166-6851(97)00125-4; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Pascucci B, 2005, NUCLEIC ACIDS RES, V33, P280, DOI 10.1093/nar/gki168; Patnaik PK, 1996, NUCLEIC ACIDS RES, V24, P668, DOI 10.1093/nar/24.4.668; Pelle KG, 2015, CELL MICROBIOL, V17, P1618, DOI 10.1111/cmi.12460; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PONTKINGDON G, 1994, BIOTECHNIQUES, V16, P1010; Proudfoot C, 2005, NUCLEIC ACIDS RES, V33, P6906, DOI 10.1093/nar/gki996; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Rossi MJ, 2011, P NATL ACAD SCI USA, V108, P6432, DOI 10.1073/pnas.1016072108; ROTH C, 1989, P NATL ACAD SCI USA, V86, P9375, DOI 10.1073/pnas.86.23.9375; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Suarez CE, 2006, INT J PARASITOL, V36, P965, DOI 10.1016/j.ijpara.2006.02.022; Suarez CE, 2015, MOL BIOCHEM PARASIT, V202, P23, DOI 10.1016/j.molbiopara.2015.09.003; Suarez CE, 2012, MOL BIOCHEM PARASIT, V185, P52, DOI 10.1016/j.molbiopara.2012.05.003; Suarez CE, 2009, INT J PARASITOL, V39, P289, DOI 10.1016/j.ijpara.2008.08.006; Suarez CE, 2004, INT J PARASITOL, V34, P1177, DOI 10.1016/j.ijpara.2004.07.001; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; TRIPP CA, 1989, EXP PARASITOL, V69, P211, DOI 10.1016/0014-4894(89)90068-4; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wang X, 2010, THESIS; Wang XY, 2012, EUKARYOT CELL, V11, P260, DOI 10.1128/EC.05318-11; Zintl A, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-19	77	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0215882	10.1371/journal.pone.0215882	http://dx.doi.org/10.1371/journal.pone.0215882			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386669	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100002
J	Simsa, R; Vila, XM; Salzer, E; Teuschl, A; Jenndahl, L; Bergh, N; Fogelstrand, P				Simsa, Robin; Vila, Xavier Monforte; Salzer, Elias; Teuschl, Andreas; Jenndahl, Lachmi; Bergh, Niklas; Fogelstrand, Per			Effect of fluid dynamics on decellularization efficacy and mechanical properties of blood vessels	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; VASCULAR GRAFT; ARTERIAL-WALL; TISSUE; SCAFFOLD; ENDOTHELIALIZATION; FIBRONECTIN; STIFFNESS; IMPACT; CELLS	Decellularization of blood vessels is a promising approach to generate native biomaterials for replacement of diseased vessels. The decellularization process affects the mechanical properties of the vascular graft and thus can have a negative impact for in vivo functionality. The aim of this study was to determine how detergents under different fluid dynamics affects decellularization efficacy and mechanical properties of the vascular graft. We applied a protocol utilizing 1% TritonX, 1% Tributyl phosphate (TnBP) and DNase on porcine vena cava. The detergents were applied to the vessels under different conditions; static, agitation and perfusion with 3 different perfusion rates (25, 100 and 400 mL/min). The decellularized grafts were analyzed with histological, immunohistochemical and mechanical tests. We found that decellularization efficacy was equal in all groups, however the luminal ultrastructure of the static group showed remnant cell debris and the 400 mL/min perfusion group showed local damage and tearing of the luminal surface. The mechanical stiffness and maximum tensile strength were not influenced by the detergent application method. In conclusion, our results indicate that agitation or low-velocity perfusion with detergents are preferable methods for blood vessel decellularization.	[Simsa, Robin; Jenndahl, Lachmi] VERIGRAFT AB, Gothenburg, Sweden; [Simsa, Robin; Bergh, Niklas; Fogelstrand, Per] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Vila, Xavier Monforte; Salzer, Elias; Teuschl, Andreas] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Vila, Xavier Monforte; Salzer, Elias; Teuschl, Andreas] Univ Appl Sci Technikum Wien, Dept Life Sci Engn, Vienna, Austria	University of Gothenburg	Simsa, R (corresponding author), VERIGRAFT AB, Gothenburg, Sweden.; Simsa, R (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden.	robin.simsa@verigraft.com		Teuschl-Woller, Andreas/0000-0002-3817-1572; Simsa, Robin/0000-0003-2889-1442	European Union [722779]	European Union(European Commission)	This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 722779 and was conducted within the "Training 4 Cell Regenerative Medicine" (T4CRM) network.	Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Bharadwaj M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14348; Bourgine PE, 2013, BIOMATERIALS, V34, P6099, DOI 10.1016/j.biomaterials.2013.04.058; Breuls Roel G M, 2008, Open Orthop J, V2, P103, DOI 10.2174/1874325000802010103; Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003; BUDD JS, 1990, J VASC SURG, V12, P126, DOI 10.1067/mva.1990.21400; Consolo F, 2016, J TISSUE ENG REGEN M, V10, pE101, DOI 10.1002/term.1767; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016; Dixit P, 2001, J BIOMED MATER RES, V56, P545, DOI 10.1002/1097-4636(20010915)56:4<545::AID-JBM1126>3.0.CO;2-V; Dong CJ, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8020042; FARQUHARSON C, 1989, HISTOCHEM J, V21, P172, DOI 10.1007/BF01007492; Garreta E, 2017, MATER TODAY, V20, P166, DOI 10.1016/j.mattod.2016.12.005; Green EM, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0058; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-9; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; Kuna VK, 2018, JOVE-J VIS EXP, DOI 10.3791/57803; Kuna VK, 2015, J VASC SURG-VENOUS L, V3, P421, DOI 10.1016/j.jvsv.2014.12.002; Leonel LCPC, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20176382, 10.1590/1414-431x20176382]; Madhavan K, 2013, J BIOMED MATER RES B, V101B, P506, DOI 10.1002/jbm.b.32851; Mallis P, 2018, BIOMED MAT ENG, P1, DOI [10.3233/BME-171708, DOI 10.3233/BME-171708]; Mattson JM, 2017, BIOMECH MODEL MECHAN, V16, P213, DOI 10.1007/s10237-016-0811-4; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Nerem RM, 2000, YONSEI MED J, V41, P735, DOI 10.3349/ymj.2000.41.6.735; Pashneh-Tala S, 2016, TISSUE ENG PART B-RE, V22, P68, DOI 10.1089/ten.teb.2015.0100; Pellegata AF, 2014, CELLS TISSUES ORGANS, V200, P363, DOI 10.1159/000439082; Pellegata AF, 2012, INT J ARTIF ORGANS, V35, P191, DOI 10.5301/ijao.5000079; Rambol MH, 2018, EBIOMEDICINE, V32, P215, DOI 10.1016/j.ebiom.2018.05.012; Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77; Sack KD, 2016, J CELL PHYSIOL, V231, P2026, DOI 10.1002/jcp.25312; Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033; Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002; Schneider KH, 2016, ACTA BIOMATER, V29, P125, DOI 10.1016/j.actbio.2015.09.038; Simsa R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209269; Thottappillil N, 2015, VASC HEALTH RISK MAN, V11, P79, DOI 10.2147/VHRM.S50536; Wang YJ, 2018, J MECH BEHAV BIOMED, V77, P634, DOI 10.1016/j.jmbbm.2017.10.023; Williams C, 2009, ACTA BIOMATER, V5, P993, DOI 10.1016/j.actbio.2008.11.028; Wingate K, 2014, TISSUE ENG PT A, V20, P2503, DOI [10.1089/ten.tea.2013.0249, 10.1089/ten.TEA.2013.0249]; Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088	39	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220743	10.1371/journal.pone.0220743	http://dx.doi.org/10.1371/journal.pone.0220743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381614	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600035
J	Oduor, FO; Boedecker, J; Kennedy, G; Termote, C				Oduor, Francis Odhiambo; Boedecker, Julia; Kennedy, Gina; Termote, Celine			Exploring agrobiodiversity for nutrition: Household on-farm agrobiodiversity is associated with improved quality of diet of young children in Vihiga, Kenya	PLOS ONE			English	Article							DIVERSITY; BIODIVERSITY; INDICATOR	Due to their limited access to the external productive inputs and the dependency on rain-fed agricultural production, small scale farmers in sub-Saharan Africa have continued to face undernutrition despite the significant advancements in agriculture. They however often live in areas endowed with high agrobiodiversity which could contribute, if explored, to improved diets and nutrition. Few studies have linked the contribution of agrobiodiversity to the micronutrient adequacy of the diets of young children among smallholder farmers. The study explored this relationship and contributes to the growing body of literature linking agrobiodiversity to nutrition of young children. Two cross-sectional surveys were conducted as part of baseline assessment for an intervention study, one in the lean and a second in the plenty season in Vihiga county, Kenya. Household level interviews were administered to 634 households with children 12-23 months. Agrobiodiversity was defined as the number of crop species cultivated or harvested from the wild and the number of livestock maintained by the household across two agricultural seasons. Dietary data were collected using two-non-consecutive quantitative 24-hour recalls and analyzed using Lucille software. Diet quality was assessed using dietary diversity score based on seven food groups and mean probability of micronutrient adequacy computed for eleven micronutrients. A total of 80 species were maintained or harvested from the wild by the households. Mean household species richness was 9.9 +/- 4.3. One in every four children did not meet the minimum dietary diversity score. The average mean probability of micronutrient adequacy was 68.11 +/- 16.08 in plenty season compared to 56.37 +/- 19.5% in the lean season. Iron, zinc and calcium were most limiting micronutrients in the diet, with less than 30% average probability of adequacy in both seasons. Household agrobiodiversity was positively associated with both dietary diversity score (r = 0.09, p = 0.029) and micronutrient adequacy (r = 0.15, p<0.000) in the pooled sample. One unit increase in species diversity was associated with 12.7% improvement in micronutrient adequacy. Despite the rich agrobiodiversity in the study area the diets were low in diversity and there is an unrealized opportunity to improve micronutrient intake through greater promotion and consumption of locally available agrobiodiversity.	[Oduor, Francis Odhiambo; Boedecker, Julia; Termote, Celine] Biovers Int, Hlth Diets Sustainable Food Syst Initiat, Nairobi, Kenya; [Kennedy, Gina] Biovers Int, Hlth Diets Sustainable Food Syst Initiat, Rome, Italy	Alliance; Bioversity International; Alliance; Bioversity International	Oduor, FO (corresponding author), Biovers Int, Hlth Diets Sustainable Food Syst Initiat, Nairobi, Kenya.	francodhis@gmail.com		Oduor, Francis/0000-0001-8082-6387; Termote, Celine/0000-0003-3217-0226	HumidTropics CGIAR Research Program; Agriculture for Nutrition and Health (A4NH) CGIAR Research Program; Biovision Foundation Switzerland	HumidTropics CGIAR Research Program(CGIAR); Agriculture for Nutrition and Health (A4NH) CGIAR Research Program(CGIAR); Biovision Foundation Switzerland	The research was supported by funding from the HumidTropics CGIAR Research Program, the Agriculture for Nutrition and Health (A4NH) CGIAR Research Program, and the Biovision Foundation Switzerland. The funds were awarded to Bioversity International. The funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2015, AFSUN FOOD SECURITY; [Anonymous], LUC SOFTW PROC YOUR; Bahadur KCK, 2016, REG ENVIRON CHANGE, V16, P1239, DOI 10.1007/s10113-015-0851-9; Bridson D, 1998, HERBARIUM HDB; Daelmans B, 2013, MATERN CHILD NUTR, V9, P116, DOI 10.1111/mcn.12083; Daniels MC, 2009, EUR J CLIN NUTR, V63, P199, DOI 10.1038/sj.ejcn.1602927; Dioula B. M., ENHANCING ROLE SMALL; Ekesa B. N., 2008, African Journal of Food, Agriculture, Nutrition and Development, V8, P390; Ferguson E, 2015, MATERN CHILD NUTR, V11, P6, DOI 10.1111/mcn.12243; Food and Agriculture Organization; Platform for Agrobiodiversity Research, 2011, BIODIVERSITY FOR FOO; Frei M, 2004, BIODIVERS CONSERV, V13, P1591, DOI 10.1023/B:BIOC.0000021330.81998.bb; Gewa CA, 2014, PUBLIC HEALTH NUTR, V17, P2667, DOI 10.1017/S1368980014000469; Gibson RS, 2008, INTERACTIVE 24 HOUR; Hillocks R. J, 2011, AFR J FOOD AGR NUTR, V11; Hirvonen K, 2017, AGR ECON-BLACKWELL, V48, P469, DOI 10.1111/agec.12348; Institute of Medicine (US) Subcommittee on Interpretation and Uses of Dietary Reference Intakes; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2000, DRI DIET REF INT APP; Jones AD, 2018, J NUTR, V148, P1625, DOI 10.1093/jn/nxy166; Jones AD, 2014, FOOD POLICY, V46, P1, DOI 10.1016/j.foodpol.2014.02.001; Kahane R, 2013, AGRON SUSTAIN DEV, V33, P671, DOI 10.1007/s13593-013-0147-8; Keding G. B., 2013, LINKING NUTR AGROBIO; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Kenya National Bureau of Statistics, 2013, COUNT STAT; Kenya National Bureau of Statistics, EXPL KEN IN PULL AP; Kenya National Bureau of Statistics (KNBS); Division of Nutrition Ministry of Public Health and Sanitation (MOPHS); Kenya Medical Research Institute (KEMRI), 2011, KEN NAT MICR SURV 20; [Kenya National Bureau of Statistics; Ministry of Health/ Kenya; National AIDS Control Council/ Kenya Kenya Medical Research Institute; National Council for Population and Development/ Kenya; ICF International], 2015, KEN DEM HLHT SURV 20; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kindt R, 2006, BIODIVERS CONSERV, V15, P3235, DOI 10.1007/s10531-005-0311-9; Lukmanji Z., 2008, TANZANIA FOOD COMPOS; Magnani R., 1999, SAMPLING GUIDE; Mburu SW., 2016, AGR FOOD SECUR, V5, P1, DOI [10.1186/s40066-016-0068-2, DOI 10.1186/S40066-016-0068-2]; Mirmiran P, 2006, J AM COLL NUTR, V25, P354, DOI 10.1080/07315724.2006.10719546; Mosites EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136686; Ng'endo M, 2018, FOOD NUTR BULL, V39, P86, DOI 10.1177/0379572117723135; Ng'endo M, 2015, AGROECOL SUST FOOD, V39, P1071, DOI 10.1080/21683565.2015.1073206; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Rathnayake Kumari Malkanthi, 2012, BMC Res Notes, V5, P469, DOI 10.1186/1756-0500-5-469; Sehmi J.K., 1993, NATL FOOD COMPOSITIO; Stadlmayr B, 2012, INT NETW FOOD DAT SY; Thompson B., 2014, IMPROVING DIETS NUTR; U.S. Department of Agriculture Agriculture Research Service, 2014, USDA NAT NUTR DAT ST; USDA, 2007, NUTR DAT LAB 2007 US; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walingo M. K., 2013, Pakistan Journal of Nutrition, V12, P854; Waswa L.B, 2016, NUTR BASELINE SURVEY; WHO/UNICEF, 2010, INDICATORS FOR ASSES	47	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0219680	10.1371/journal.pone.0219680	http://dx.doi.org/10.1371/journal.pone.0219680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374090	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500002
J	Choi, WR; Yang, JH; Jeong, SY; Lee, JK				Choi, Won Rak; Yang, Jae-Hyuk; Jeong, Soo-Young; Lee, Jin Kyu			MRI comparison of injury mechanism and anatomical factors between sexes in non-contact anterior cruciate ligament injuries	PLOS ONE			English	Article							VIDEO ANALYSIS; TIBIAL SLOPE; NEUROMUSCULAR CONTROL; KNEE ABDUCTION; RISK; ACL; ASSOCIATION; BASKETBALL; KINEMATICS; TRUNK	Non-contact anterior cruciate ligament (ACL) rupture is mostly caused by a pivot shift mechanism including valgus collapse and internal tibial rotation. In female athletes, the incidence of ACL rupture has been reported to be significantly higher than in their male counterparts. However, to date, there have been limited reports and controversy regarding sex differences underlying injury mechanisms of ACL and severity of injury. In this study, we hypothesized that 1) in patients with non-contact ACL rupture, the incidence and severity of pivot shift injury, which are determined by injury pattern on MRI, would be significantly higher in females, and 2) anatomical factors associated with pivot shift injury would be significantly associated with female sex. A total of 148 primary ACL ruptures (145 patients) caused by non-contact injury mechanisms were included in this study. Among them, 41 knees (41 patients) were female and 107 knees (104 patients) were male. The status of the osseous lesions, lateral and medial tibial slope, depth of the medial tibial plateau, collateral ligaments, and menisci were assessed by MRI and compared between sexes. The severity of osseous lesions at the lateral tibial plateau, lateral femoral condyle, medial tibial plateau, and medial femoral condyle were comparable between sexes. There were no significant differences between sexes in the location of tibial contusions (p = 0.21), femoral contusions (p = 0.23), or meniscus tears (p = 0.189). Lateral tibial slope was found to be significantly larger in females (8.95 degrees vs. 6.82 degrees; p<0.0001; odds ratio = 1.464), and medial tibial depth was significantly shallower in females (1.80mm vs. 2.41mm; p<0.0001; odds ratio = 0.145). In conclusion, females showed greater lateral tibial slope and shallower medial tibial depth compared to males, however it did not affect the sex differences in injury pattern.	[Choi, Won Rak; Jeong, Soo-Young; Lee, Jin Kyu] Hanyang Univ, Dept Orthopaed Surg, Seoul Hosp, Seoul, South Korea; [Yang, Jae-Hyuk] Hanyang Univ, Dept Orthopaed Surg, Guri Hosp, Guri, Gyeonggi Do, South Korea	Hanyang University; Hanyang University	Lee, JK (corresponding author), Hanyang Univ, Dept Orthopaed Surg, Seoul Hosp, Seoul, South Korea.	jklee77@hanyang.ac.kr		Lee, Jin Kyu/0000-0001-8547-4616; Jeong, Soo-Young/0000-0002-4513-0461; Choi, Won Rak/0000-0002-0854-7567; Yang, Jae-Hyuk/0000-0001-8853-1997	Hanyang University [HY2018]	Hanyang University	The study was supported by the research fund of Hanyang University (grant number HY2018).	Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Barber-Westin SD, 1999, AM J SPORT MED, V27, P402, DOI 10.1177/03635465990270040201; Beynnon BD, 2014, AM J SPORT MED, V42, P1806, DOI 10.1177/0363546514540862; Boden BP, 2009, AM J SPORT MED, V37, P252, DOI 10.1177/0363546508328107; Brandon ML, 2006, ARTHROSCOPY, V22, P894, DOI 10.1016/j.arthro.2006.04.098; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008; Chappell JD, 2002, AM J SPORT MED, V30, P261, DOI 10.1177/03635465020300021901; De Smet AA, 2012, AM J ROENTGENOL, V199, P481, DOI 10.2214/AJR.12.8663; DeMorat G, 2004, AM J SPORT MED, V32, P477, DOI 10.1177/0363546503258928; Fayad LM, 2003, SKELETAL RADIOL, V32, P639, DOI 10.1007/s00256-003-0694-1; Ford KR, 2010, MED SCI SPORT EXER, V42, P1923, DOI 10.1249/MSS.0b013e3181dc99b1; Griffin LY, 2006, AM J SPORT MED, V34, P1512, DOI 10.1177/0363546506286866; Hashemi J, 2010, AM J SPORT MED, V38, P54, DOI 10.1177/0363546509349055; Hewett TE, 2009, BRIT J SPORT MED, V43, P417, DOI 10.1136/bjsm.2009.059162; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hohmann E, 2011, KNEE SURG SPORT TR A, V19, pS109, DOI 10.1007/s00167-011-1547-4; Hudek R, 2009, CLIN ORTHOP RELAT R, V467, P2066, DOI 10.1007/s11999-009-0711-3; Ireland ML, 2002, ORTHOP CLIN N AM, V33, P637, DOI 10.1016/S0030-5898(02)00028-7; Kim SY, 2015, AM J SPORT MED, V43, P2515, DOI 10.1177/0363546515594446; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Lipps DB, 2012, AM J SPORT MED, V40, P2731, DOI 10.1177/0363546512461749; NOYES FR, 1989, CLIN ORTHOP RELAT R, P238; Oh YK, 2012, AM J SPORT MED, V40, P574, DOI 10.1177/0363546511432544; Owusu-Akyaw KA, 2018, AM J SPORT MED, V46, P1559, DOI 10.1177/0363546518764681; Prodromos CC, 2007, ARTHROSCOPY, V23, P1174, DOI 10.1016/j.arthro.2007.06.018; Quatman CE, 2009, BRIT J SPORT MED, V43, P328, DOI 10.1136/bjsm.2009.059139; Quatman CE, 2010, SPORTS MED, V40, P729, DOI 10.2165/11534950-000000000-00000; Schneider A, 2018, KNEE SURG SPORT TR A, V26, P1375, DOI 10.1007/s00167-017-4756-7; SCHWEITZER ME, 1995, RADIOLOGY, V194, P825, DOI 10.1148/radiology.194.3.7862987; Shimokochi Y, 2008, J ATHL TRAINING, V43, P396, DOI 10.4085/1062-6050-43.4.396; Stijak L, 2008, KNEE SURG SPORT TR A, V16, P112, DOI 10.1007/s00167-007-0438-1; Wittstein J, 2014, AM J SPORT MED, V42, P1401, DOI 10.1177/0363546514527415; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	35	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219586	10.1371/journal.pone.0219586	http://dx.doi.org/10.1371/journal.pone.0219586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369583	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900014
J	Fagerli, K; Routh, J; Hancock, WT; Hoots, B; Gunda, A; Deng, L; Barr, BT; Kamb, M; Quick, R				Fagerli, Kirsten; Routh, Janell; Hancock, W. Thane; Hoots, Brooke; Gunda, Andrews; Deng, Li; Barr, Beth Tippett; Kamb, Mary; Quick, Robert			Impact of program transfer from a non-governmental organization to a district health office: Evaluation of a program integrating water treatment and hygiene kits into reproductive health and HIV services, Machinga District, Malawi, 2010-2012	PLOS ONE			English	Article							OPTION B PLUS	Background In September 2009, the Machinga Integrated Antenatal Water Hygiene Kit Program began addressing problems of unsafe water, high infant mortality, and low antenatal care (ANC) attendance in Machinga District, Malawi. In March 2011, the supporting international nongovernmental organization transitioned management of the program to the Machinga District Health Office (DHO). We evaluated maternal and HIV service use before and after program transition to the DHO. Methods We compared pre-and post-transition periods by examining data recorded in ANC and maternal registries in 15 healthcare facilities (HCFs) by proportion z-tests. We classified HCFs by size, using the median monthly patient volumes as the split for large or small facilities. We used logistic regression to evaluate changes in the use of ANC, maternal, and HIV services and their interactions with HCF size. Results The percentage of women attending their first ANC visit during the first trimester was similar in the pre-and post-transition periods (9.3% vs 10.2%). Although the percentage of women with. 4 ANC visits was similar from pre-to post-transition (26.0% vs 24.8%), the odds increased among women in small facilities (OR: 1.37, 95% CI: 1.24-1.51), and decreased among women in large facilities (OR: 0.80, 95% CI: 0.75-0.85). Although a similar percentages of pregnant women were diagnosed with HIV in all HCFs in the pre-and post-transitions periods (6.4% vs 4.8%), a substantially larger proportion of women were not tested for HIV in large HCFs (OR: 6.34, 95% CI: 5.88-6.84). A larger proportion of women gave birth at both small (OR: 1.30, 95% CI: 1.16-1.45) and large HCFs (OR: 1.55, 95% CI: 1.43-1.67) in the post-transition vs. the pre-transition period. Conclusions The evaluation results suggest that many positive aspects of this donor-supported program continued following transition of program management from a non-governmental organization to a DHO.	[Fagerli, Kirsten; Routh, Janell; Hancock, W. Thane; Deng, Li; Quick, Robert] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Zoonot & Emerging Infect Dis, Atlanta, GA 30333 USA; [Hoots, Brooke; Kamb, Mary] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Gunda, Andrews] Clinton Hlth Access Initiat, Lilongwe, Malawi; [Barr, Beth Tippett] Ctr Dis Control & Prevent, Div Global HIV & TB, Ctr Global Hlth, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fagerli, K (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Zoonot & Emerging Infect Dis, Atlanta, GA 30333 USA.	kfagerli@cdc.gov	Tippett Barr, Beth A./GLU-1101-2022	Deng, Li/0000-0003-3174-8989; Fagerli, Kirsten/0000-0001-7471-6317	United States Agency for International Development; Procter Gamble Fund	United States Agency for International Development(United States Agency for International Development (USAID)); Procter Gamble Fund(Procter & Gamble)	Funding for this evaluation was provided by the United States Agency for International Development and Procter & Gamble Fund. No grant number was assigned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkenbrack S., 2005, LESSONS LEARNED PHAS; Bennett S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136177; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; de Villiers A, 2005, PUBLIC HEALTH NUTR, V8, P520, DOI 10.1079/PHN2005787; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Fawcus S, 1996, STUD FAMILY PLANN, V27, P319, DOI 10.2307/2138027; Gathigah M., 2013, KENYAS MOTHERS SHUN, P3; Gruen RL, 2008, LANCET, V372, P1579, DOI 10.1016/S0140-6736(08)61659-1; Hollander D, 1997, INT FAM PLAN PERSPEC, V23, P94, DOI 10.2307/2950832; Joint United Nations Programme on HIV/AIDS, 2012, TOG WE WILL END AIDS; Kalembo FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066517; Kieffer MP, 2014, JAIDS-J ACQ IMM DEF, V67, pS188, DOI 10.1097/QAI.0000000000000372; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Kumbani L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-9; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; National Statistical Office (NSO) [Malawi] and ICF, 2017, MALAWI DEMOGRAPHIC H; Njuguna J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2376-z; NSO ICF, 2005, MAL DEM HLTH SURV 20; Obare F, 2013, HEALTH POLICY PLANN, V28, P165, DOI 10.1093/heapol/czs033; Routh JA, 2018, AM J TROP MED HYG, V98, P1234, DOI 10.4269/ajtmh.17-0328; Stirman SW, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-17; UNAIDS, AIDINFO COUNTR FACT; United Nations, MILL DEV GOALS IND; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219984	10.1371/journal.pone.0219984	http://dx.doi.org/10.1371/journal.pone.0219984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365562	Green Submitted, gold, Green Published			2022-12-26	WOS:000484983600024
J	Moodley, R; Suleman, F				Moodley, Rajatheran; Suleman, Fatima			The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014	PLOS ONE			English	Article							COUNTRIES; SUBSTITUTION	Background Regulating pharmaceutical markets have become a key strategy by most governments in ensuring the availability and accessibility of quality medicines to its citizens. The South African government, when faced with high medicine prices, implemented the Single Exit Price (SEP) in 2004. This study assessed the impact of the of the Single Exit Price (SEP) regulation introduced in South Africa in 2004 on a basket of generic. Method Private sector price data of a basket of medicines (December 1999 to December 2014) was obtained from various price files (Pharmacy Software Vendors and Community Pharmacy). The price of the medicine was expressed in a single unit dose. The medicines investigated used the WHO/HAI methodology. The Interrupted Time-Series (ITS) model was used to estimate the change in slope and level of medicines investigated (50 originator and its available generics) before and after the policy change. Results Majority of the medicines analysed reflect a substantial decrease in medicine prices immediately after implementation of the pricing regulations as reflected in both the change in level and the change in slope using the interrupted time series analysis. Discussion This study indicates that the SEP regulation had an impact on medicine pricing in South Africa in both the short (immediately on the introduction) and long term (over the study period). Most medicines investigated showed a smaller yearly increase in price compared to before regulations. Conclusion This study provides evidence of the impact of medicine pricing intervention from a middleincome country, and useful lessons can be drawn by other developing countries looking at introducing medicine price controls.	[Moodley, Rajatheran; Suleman, Fatima] Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa; [Suleman, Fatima] Univ Utrecht, Fac Sci, Utrecht, Netherlands	University of Kwazulu Natal; Utrecht University	Suleman, F (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa.; Suleman, F (corresponding author), Univ Utrecht, Fac Sci, Utrecht, Netherlands.	sulemanf@ukzn.ac.za	Suleman, Fatima/GQP-0955-2022; Moodley, Rajatheran/AAR-9988-2020	Suleman, Fatima/0000-0002-8559-9168; Moodley, Rajatheran/0000-0003-0399-0460				Aitken M., 2016, PPL, V18, P55, DOI [10.3233/PPL-160432, DOI 10.3233/PPL-160432]; [Anonymous], 2017, WORLD J PHARM RES, V6; Antonanzas F, 2017, PHARMACOECONOMICS, V35, P777, DOI 10.1007/s40273-017-0514-4; Auta A, 2014, MED PRIN PRACT, V23, P53, DOI 10.1159/000355473; Bangalee V, TRANSPARENT PRICING; Bangalee V, 2016, HEALTH SA GESONDHEID, V21, DOI 10.1016/j.hsag.2015.10.004; Barron P, 2014, AFRICAN PRIVATE PHAR; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Cambourieu C, 2013, GENERIC DRUG PRICING; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2010, COST SAVINGS SWITCHI, P11; Cameron A, 2012, VALUE HEALTH, V15, P664, DOI 10.1016/j.jval.2012.04.004; Carone G, 2012, EC PAPERS, DOI [DOI 10.2765/27111, 10.2139/ssrn.2161803]; Council for Medical Schemes, 1995, CMS ANN REP 1995; Danzon PM, 2000, J LAW ECON, V43, P311, DOI 10.1086/467458; De La Maisonneuve C., 2013, OECD EC POLICY PAPER, V6, P1; Deroukakis M, 2007, SAMJ S AFR MED J, V97, P63; Dias V, 2012, MANAG SCI HLTH; Gray A, 2015, PHARM PRICES 21 CENT; Hassali MA, 2014, SAUDI PHARM J, V22, P491, DOI 10.1016/j.jsps.2013.12.017; Hollis A., 2008, GENERIC DRUG PRICING, V2; Hollis Aidan, 2015, Healthc Policy, V11, P10; IFPMA, 2021, PHARM IND GLOB HLTH; Kaplan W, 2016, HLTH ACTION INT, P1; Mediscor, 2013, MED MED REV 2013; Moreno-Torres I, 2011, EUR J HEALTH ECON, V12, P563, DOI 10.1007/s10198-010-0271-1; National Department of Health South Africa, 1996, NAT DRUG POL S AFR T; National Department of Health South Africa, 2004, REG REL TRANSP PRIC; Seeley E, 2008, PHARM POLICY COST CO, P18; South Africa N. National Department of Health, S AFR MED PRIC REG; StataCorp, 2013, STAT REL 13, V161; Vernon JA, 2005, S EC J, V73, P233; Vogler S, 2017, EXPERT REV PHARM OUT, V17, P221, DOI 10.1080/14737167.2016.1223543; Vogler S, 2012, GABI J, V1, P93, DOI 10.5639/gabij.2012.0102.020; Vogler Sabine, 2011, South Med Rev, V4, P69, DOI 10.5655/smr.v4i2.1004; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; World Health Organization, 2015, WHO GUID COUNTR PHAR, P134; Xiphu L, 2004, MED PRICES SURVEY GA	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219690	10.1371/journal.pone.0219690	http://dx.doi.org/10.1371/journal.pone.0219690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365534	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600015
J	Abouelkhair, MA; Bemis, DA; Giannone, RJ; Frank, LA; Kania, SA				Abouelkhair, Mohamed A.; Bemis, David A.; Giannone, Richard J.; Frank, Linda A.; Kania, Stephen A.			Identification, cloning and characterization of SpEX exotoxin produced by Staphylococcus pseudintermedius	PLOS ONE			English	Article							SUPERANTIGEN-LIKE PROTEIN; AUREUS; SEQUENCE; COMPLEX; VACCINE; BINDING	Staphylococci have evolved numerous strategies to evade their hosts' immune systems. Some staphylococcal toxins target essential components of host innate immunity, one of the two main branches of the immune system. Analysis of the Staphylococcus pseudintermedius secretome using liquid chromatography mass spectrometry guided by genomic data, was used to identify an S. pseudintermedius exotoxin provisionally named SpEX. This exoprotein has low overall amino acid identity with the Staphylococcus aureus group of proteins named staphylococcal superantigen like proteins (SSLs) and staphylococcal enterotoxin- like toxin X (SEIX), but predictive modeling showed that it shares similar folds and domain architecture to these important virulence factors. In this study, we found SpEX binds to complement component C5, prevents complement mediated lysis of sensitized bovine red blood cells, kills polymorphonuclear leukocytes and monocytes and inhibits neutrophil migration at sub-lethal concentrations. A mutant version of SpEX, produced through amino acid substitution at selected positions, had diminished cytotoxicity. Anti-SpEX produced in dogs reduced the inhibitory effect of native SpEX on canine neutrophil migration and protected immune cells from the toxic effects of the native recombinant protein. These results suggest that SpEX likely plays an important role in S. pseudintermedius virulence and that attenuated SpEX may be an important candidate for inclusion in a vaccine against S. pseudintermedius infections.	[Abouelkhair, Mohamed A.; Bemis, David A.; Kania, Stephen A.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Abouelkhair, Mohamed A.] Univ Sadat City, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Menoufia, Egypt; [Giannone, Richard J.] Oak Ridge Natl Lab, Biol Mass Spectrometry, Chem Sci Div, Oak Ridge, TN USA; [Frank, Linda A.] Univ Tennessee, Coll Vet Med, Dept Small Anim Clin Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Egyptian Knowledge Bank (EKB); University of Sadat City; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Kania, SA (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	skania@utk.edu	Kania, Stephen/ABF-6920-2021; Giannone, Richard/ABC-8247-2020; Abouelkhair, Mohamed/AAA-4665-2020	Giannone, Richard/0000-0001-8551-0138; Abouelkhair, Mohamed/0000-0003-0109-6000; Kania, Stephen/0000-0002-4490-7347	University of Tennessee, Center of Excellence in Livestock Diseases and Human Health; Egyptian Cultural and Educational Bureau, Washington D. C.	University of Tennessee, Center of Excellence in Livestock Diseases and Human Health; Egyptian Cultural and Educational Bureau, Washington D. C.(Egyptian Cultural & Educational Bureau)	This research was supported by the University of Tennessee, Center of Excellence in Livestock Diseases and Human Health. The Egyptian Cultural and Educational Bureau, Washington D. C. provided support for MA.	Abouelkhair MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204450; Abouelkhair MA, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01651-16, 10.1128/genomea.01651-16]; Abouelkhair MA, 2018, VIRULENCE, V9, P1050, DOI 10.1080/21505594.2018.1489199; Abouelkhair MA, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.01599-17; Arcus VL, 2002, J BIOL CHEM, V277, P32274, DOI 10.1074/jbc.M203914200; Bagnoli F, 2012, STAPHYLOCOCCI STAPHY, P7; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Baker HM, 2007, J MOL BIOL, V374, P1298, DOI 10.1016/j.jmb.2007.09.091; Balachandran M, 2018, VIRULENCE, V9, P390, DOI 10.1080/21505594.2017.1403710; Begier E, 2017, VACCINE, V35, P1132, DOI 10.1016/j.vaccine.2017.01.024; Ben Zakour NL, 2011, J BACTERIOL, V193, P2363, DOI 10.1128/JB.00137-11; Cheung GYC, 2012, EXPERT OPIN THER TAR, V16, P601, DOI 10.1517/14728222.2012.682573; Chung MC, 2007, MOL MICROBIOL, V66, P1342, DOI 10.1111/j.1365-2958.2007.05989.x; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Devriese LA, 2005, INT J SYST EVOL MICR, V55, P1569, DOI 10.1099/ijs.0.63413-0; Fitzgerald JR, 2009, VET DERMATOL, V20, P490, DOI 10.1111/j.1365-3164.2009.00828.x; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Giersing BK, 2016, VACCINE, V34, P2962, DOI 10.1016/j.vaccine.2016.03.110; Hermans SJ, 2012, INFECT IMMUN, V80, P4004, DOI 10.1128/IAI.00764-12; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kobayashi SD, 2018, J INNATE IMMUN, V10, P432, DOI 10.1159/000487756; Koop G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40660; Koymans KJ, 2015, P NATL ACAD SCI USA, V112, P11018, DOI 10.1073/pnas.1502026112; Kusek ME, 2014, JOVE-J VIS EXP, DOI 10.3791/50823; Langereis JD, 2013, CELL ADHES MIGR, V7, P476, DOI 10.4161/cam.27293; Langley RJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006549; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Moodley A, 2014, VET MICROBIOL, V171, P337, DOI 10.1016/j.vetmic.2014.02.008; ODONNELL RT, 1982, INFECT IMMUN, V38, P351, DOI 10.1128/IAI.38.1.351-359.1982; Pantrangi M, 2015, CLIN MED RES, V13, DOI 10.3121/cmr.2014.1226; Paul P, 2016, J PROTEOMICS, V131, P48, DOI 10.1016/j.jprot.2015.10.009; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Riley MC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01194-16; Sewid AH, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00027-18; Solyman SM, 2013, J CLIN MICROBIOL, V51, P306, DOI 10.1128/JCM.02421-12; Tuffs SW, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020053; Tuffs SW, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006461; van Duijkeren E, 2011, J ANTIMICROB CHEMOTH, V66, P2705, DOI 10.1093/jac/dkr367; Videla R, 2018, MICROB DRUG RESIST, V24, P83, DOI 10.1089/mdr.2016.0250; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039	42	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220301	10.1371/journal.pone.0220301	http://dx.doi.org/10.1371/journal.pone.0220301			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356636	Green Submitted, gold, Green Published			2022-12-26	WOS:000484047000024
J	Beaudreuil, S; Zhang, XM; Herr, F; Harper, F; Candelier, JJ; Fan, Y; Yeter, H; Dudreuilh, C; Lecru, L; Vazquez, A; Charpentier, B; Lorenzo, HK; Durrbach, A				Beaudreuil, Severine; Zhang, Xiaomeng; Herr, Florence; Harper, Francis; Candelier, Jean Jacques; Fan, Ye; Yeter, Hilal; Dudreuilh, Caroline; Lecru, Lola; Vazquez, Aime; Charpentier, Bernard; Lorenzo, Hans K.; Durrbach, Antoine			Circulating CASK is associated with recurrent focal segmental glomerulosclerosis after transplantation	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; NEPHROTIC SYNDROME; PERMEABILITY FACTORS; PROTEIN EXCRETION; UROKINASE; SERUM; CD98; FSGS; PATHOGENESIS; RECIPIENTS	Introduction Focal and Segmental GlomeruloSclerosis (FSGS) can cause nephrotic syndrome with a risk of progression to end-stage renal disease. The idiopathic form has a high rate of recurrence after transplantation, suggesting the presence of a systemic circulating factor that causes glomerular permeability and can be removed by plasmapheresis or protein-A immunoadsorption. Results To identify this circulating factor, the eluate proteins bound on therapeutic immunoadsorption with protein-A columns were analyzed by comparative electrophoresis and mass spectrometry. A soluble form of calcium/calmodulin-dependent serine protein kinase (CASK) was identified. CASK was immunoprecipitated only in the sera of patients with recurrent FSGS after transplantation and not in control patients. Recombinant-CASK (rCASK) induced the reorganization of the actin cytoskeleton in immortalized podocytes, a redistribution of synaptopodin, ZO-1, vinculin and ENA. rCASK also induced alterations in the permeability of a monolayer of podocytes and increased the motility of pdodocytes in vitro. The extracellular domain of CD98, a transmembrane receptor expressed on renal epithelial cells, has been found to coimmunoprecipitated with rCASK. The invalidation of CD98 with siRNA avoided the structural changes of rCask treated cells suggesting its involvement in physiopathology of the disease. In mice, recombinant CASK induced proteinuria and foot process effacement in podocytes. Conclusion Our results suggest that CASK can induce the recurrence of FSGS after renal transplantation.	[Beaudreuil, Severine; Dudreuilh, Caroline; Charpentier, Bernard; Lorenzo, Hans K.; Durrbach, Antoine] Univ Paris Sud, IFRNT, Dept Nephrol, Bicetre Hosp, Le Kremlin Bicetre, France; [Beaudreuil, Severine; Zhang, Xiaomeng; Herr, Florence; Candelier, Jean Jacques; Fan, Ye; Yeter, Hilal; Dudreuilh, Caroline; Lecru, Lola; Vazquez, Aime; Charpentier, Bernard; Lorenzo, Hans K.; Durrbach, Antoine] INSERM, U1197, Villejuif, France; [Harper, Francis] Inst Gustave Roussy, CNRS, UMR 8122, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Lorenzo, HK; Durrbach, A (corresponding author), Univ Paris Sud, IFRNT, Dept Nephrol, Bicetre Hosp, Le Kremlin Bicetre, France.; Lorenzo, HK; Durrbach, A (corresponding author), INSERM, U1197, Villejuif, France.	hlorenzo@gmail.com; a.durrbach@gmail.com	Lorenzo, Hans-Kristian/GLR-5785-2022	dudreuilh, caroline/0000-0003-4975-6872; Lorenzo, Hans Kristian/0000-0002-7921-177X	"Association des Malades d'un Syndrome Nephrotique" (France); "Fondation pour la Recherche Medicale", "Fondation du Rein" (France); "Fondation Serge Dassault" (France); "Agence de la Biomedicine" (France); INSERM-transfert (France)	"Association des Malades d'un Syndrome Nephrotique" (France); "Fondation pour la Recherche Medicale", "Fondation du Rein" (France); "Fondation Serge Dassault" (France); "Agence de la Biomedicine" (France); INSERM-transfert (France)	HKL and AD were supported by "Association des Malades d'un Syndrome Nephrotique" (France), the "Fondation pour la Recherche Medicale", "Fondation du Rein" (France), the "Fondation Serge Dassault" (France) the "Agence de la Biomedicine" (France) and INSERM-transfert (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6; Beaudreuil S, 2014, NEPHROL DIAL TRANSPL, V29, P458, DOI 10.1093/ndt/gft453; Boulter E, 2013, J EXP MED, V210, P173, DOI 10.1084/jem.20121651; Cai S, 2005, J CELL SCI, V118, P889, DOI 10.1242/jcs.01674; Canaud G, 2009, AM J TRANSPLANT, V9, P1081, DOI 10.1111/j.1600-6143.2009.02580.x; Canaud G, 2010, NEPHROL DIAL TRANSPL, V25, P1321, DOI 10.1093/ndt/gfp500; Caruana G, 2002, INT J DEV BIOL, V46, P511; Cho JY, 2003, EXP CELL RES, V286, P1, DOI 10.1016/S0014-4827(03)00106-X; Coppo R, 2013, CONTRIB NEPHROL, V181, P84, DOI 10.1159/000348637; D'Agati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96; DANTAL J, 1994, NEW ENGL J MED, V330, P7, DOI 10.1056/NEJM199401063300102; Delville M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008538; Feld SM, 1998, AM J KIDNEY DIS, V32, P230, DOI 10.1053/ajkd.1998.v32.pm9708606; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; Fogo AB, 2003, SEMIN NEPHROL, V23, P161, DOI 10.1053/snep.2003.50015; Gigante M, 2009, NEPHROL DIAL TRANSPL, V24, P1858, DOI 10.1093/ndt/gfn712; Haas M, 1998, NEPHROL DIAL TRANSPL, V13, P2013, DOI 10.1093/ndt/13.8.2013; Hayashi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181791; Kaltenis P, 2004, PEDIATR NEPHROL, V19, P353, DOI 10.1007/s00467-003-1372-1; LaConte L, 2013, BIOCHEM SOC T, V41, P1017, DOI 10.1042/BST20130061; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Maezawa Y, 2014, J AM SOC NEPHROL, V25, P2459, DOI 10.1681/ASN.2013121307; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Michaud JLR, 2006, KIDNEY INT, V70, P1054, DOI 10.1038/sj.ki.5001665; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Savin VJ, 2003, SEMIN NEPHROL, V23, P147, DOI 10.1053/snep.2003.50024; Schell C, 2012, NEPHROL DIAL TRANSPL, V27, P3406, DOI 10.1093/ndt/gfs273; Schlondorff D, 2014, KIDNEY INT, V85, P498, DOI 10.1038/ki.2013.549; Shevchenko A, 2000, METH MOL B, V146, P1, DOI 10.1385/1-59259-045-4:1; Sidenius N, 2000, BLOOD, V96, P4091; Sier CFM, 1998, CANCER RES, V58, P1843; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Vinai M, 2010, PEDIATR TRANSPLANT, V14, P314, DOI 10.1111/j.1399-3046.2009.01261.x; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Yan Y, 2007, J MEMBRANE BIOL, V215, P15, DOI 10.1007/s00232-007-9001-8; Yan Y, 2007, AM J PHYSIOL-GASTR L, V292, pG535, DOI 10.1152/ajpgi.00385.2006; Zenker M, 2009, J MOL MED, V87, P849, DOI 10.1007/s00109-009-0505-9; ZIMMERMAN SW, 1984, CLIN NEPHROL, V22, P32	45	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0219353	10.1371/journal.pone.0219353	http://dx.doi.org/10.1371/journal.pone.0219353			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356645	Green Submitted, Green Published, gold			2022-12-26	WOS:000484047000006
J	Cosme, JRA; Bryant, HE; Claeyssens, F				Cosme, Jose R. Aguilar; Bryant, Helen E.; Claeyssens, Frederik			Carbon dot-protoporphyrin IX conjugates for improved drug delivery and bioimaging	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; QUANTUM DOTS; CANCER-CELLS; 5-AMINOLEVULINIC ACID; SURFACE PASSIVATION; IN-VITRO; NANOPARTICLES; FUNCTIONALIZATION; LUMINESCENCE; PERFORMANCE	Photodynamic therapy (PDT) uses photosensitisers such as protoporphyrin IX (PpIX) to target tumours via the release of toxic singlet oxygen when irradiated. The effectivity of the treatment is limited by the innate properties of the photosensitizers; they typically exhibit inefficient accumulation in target tissue and high dark toxicity. Carbon dots (CDs) are biocompatible fluorescent nanoparticles which can improve PpIX cellular uptake and solubility. In this work, we present conjugates synthesised by host-guest encapsulation (PpIX@CD) and amide cross-linking (PpIX-CD). Characterization demonstrated conjugates have a loading efficiency of 34-48% and similar singlet oxygen production to PpIX. PpIX-containing CDs showed a 2.2 to 3.7-fold decrease in dark toxicity. PpIX-CD and PpIX@CD showed equivalent light-induced toxicity to PpIX in concentrations >1 mu g/ml, leading to a 3.2 to 4.1-fold increase in photo-toxicity index (PI). The less soluble fraction of cross-linked conjugates (PpIX-CD)p did not show significant difference from PpIX. Confocal light scanning microscopy demonstrated rapid intracellular uptake and accumulation of conjugates. Our results demonstrate the variations between cross-linking strategies in CD-based conjugates, highlighting their potential as carriers in drug delivery and bioimaging applications.	[Cosme, Jose R. Aguilar; Claeyssens, Frederik] Univ Sheffield, Kroto Res Inst, Dept Mat Sci & Engn, Sheffield, S Yorkshire, England; [Bryant, Helen E.] Univ Sheffield, Med Sch, Dept Oncol & Metab, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Claeyssens, F (corresponding author), Univ Sheffield, Kroto Res Inst, Dept Mat Sci & Engn, Sheffield, S Yorkshire, England.	f.claeyssens@sheffield.ac.uk	Aguilar Cosme, Jose Ricardo/ABD-2412-2021; bryant, helen/AHB-1139-2022	bryant, helen/0000-0003-2720-7020; Aguilar Cosme, Jose Ricardo/0000-0001-7933-3905	Mexican Federal Government through the National Council of Science and Technology; Nuevo Leon Institute of Innovation and Technology Transfer [426851 CVU-610782]; EPSRC [EP/K002503/1]	Mexican Federal Government through the National Council of Science and Technology; Nuevo Leon Institute of Innovation and Technology Transfer; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a grant awarded to JRAC from the Mexican Federal Government through the National Council of Science and Technology and the Nuevo Leon Institute of Innovation and Technology Transfer (Grant No. 426851 CVU-610782). FC also acknowledges EPSRC for funding under Grant No. EP/K002503/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiades-Armenakas M, 2006, CLIN DERMATOL, V24, P16, DOI 10.1016/j.clindermatol.2005.10.027; Allison RR, 2010, FUTURE ONCOL, V6, P929, DOI 10.2217/FON.10.51; Atkin P, 2016, J MATER CHEM A, V4, P13563, DOI 10.1039/c6ta06415a; Bader MJ, 2013, UROL ONCOL-SEMIN ORI, V31, P1178, DOI 10.1016/j.urolonc.2012.02.007; Beack S, 2015, ACTA BIOMATER, V26, P295, DOI 10.1016/j.actbio.2015.08.027; Bechet D, 2008, TRENDS BIOTECHNOL, V26, P612, DOI 10.1016/j.tibtech.2008.07.007; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Cao L, 2007, J AM CHEM SOC, V129, P11318, DOI 10.1021/ja073527l; Chen XF, 2014, CARBON, V79, P165, DOI 10.1016/j.carbon.2014.07.056; Chung J, 2012, CURR OPIN HEMATOL, V19, P156, DOI 10.1097/MOH.0b013e328351c48b; DAS S, 2015, AM CHEM SOC, V7, P1953, DOI DOI 10.1021/ACSAMI.5B05232; Ding H, 2016, ACS NANO, V10, P484, DOI 10.1021/acsnano.5b05406; Ding HY, 2011, J CONTROL RELEASE, V151, P271, DOI 10.1016/j.jconrel.2011.01.004; Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3; Fowley C, 2013, CHEM COMMUN, V49, P8934, DOI 10.1039/c3cc45181j; Fu M, 2015, NANO LETT, V15, P6030, DOI 10.1021/acs.nanolett.5b02215; GUNTER EW, 1989, CLIN CHEM, V35, P1601; Havrdova M, 2016, CARBON, V99, P238, DOI 10.1016/j.carbon.2015.12.027; Hilf R, 2007, J BIOENERG BIOMEMBR, V39, P85, DOI 10.1007/s10863-006-9064-8; Homayoni H, 2015, PHOTODIAGN PHOTODYN, V12, P258, DOI 10.1016/j.pdpdt.2015.01.003; Hu XH, 2005, PHOTOCHEM PHOTOBIOL, V81, P1460, DOI 10.1562/2005-05-04-RA-513; Hua XW, 2018, ACS APPL MATER INTER, V10, P10664, DOI 10.1021/acsami.7b19549; Hua XW, 2017, NANOSCALE, V9, P10948, DOI 10.1039/c7nr03658b; Kang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11835; KENNEDY JC, 1990, J PHOTOCH PHOTOBIO B, V6, P143, DOI 10.1016/1011-1344(90)85083-9; Konan-Kouakou YN, 2005, J CONTROL RELEASE, V103, P83, DOI 10.1016/j.jconrel.2004.11.023; Lee WH, 2013, CHEM-BIOL INTERACT, V204, P49, DOI 10.1016/j.cbi.2013.04.006; Li LB, 2018, J MATER CHEM C, V6, P7944, DOI 10.1039/c7tc05878k; Li Y, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201600924; Loewen GM, 2006, LASER SURG MED, V38, P364, DOI 10.1002/lsm.20354; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Mandani S, 2016, RSC ADV, V6, P84599, DOI 10.1039/c6ra17306c; McKenzie LK, 2017, CHEM-EUR J, V23, P234, DOI 10.1002/chem.201604792; Meiling TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28557; Nakayama T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36478; Peng ZL, 2017, COORDIN CHEM REV, V343, P256, DOI 10.1016/j.ccr.2017.06.001; Robertson CA, 2009, J PHOTOCH PHOTOBIO B, V96, P1, DOI 10.1016/j.jphotobiol.2009.04.001; Sazgarnia A, 2013, ULTRASONICS, V53, P29, DOI 10.1016/j.ultras.2012.03.009; Singh V, 2018, J MATER CHEM B, V6, P3366, DOI 10.1039/c8tb00503f; Sun YP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12354; Thakur M, 2014, J DRUG DELIV, V2014, DOI 10.1155/2014/282193; Tostado-Plascencia MM, 2016, DIAM RELAT MATER, V70, P65, DOI 10.1016/j.diamond.2016.09.030; Tsay JM, 2007, J AM CHEM SOC, V129, P6865, DOI 10.1021/ja070713i; Uehlinger P, 2000, J PHOTOCH PHOTOBIO B, V54, P72, DOI 10.1016/S1011-1344(99)00159-1; Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016; Wang HB, 2018, NANOSCALE, V10, P21492, DOI 10.1039/c8nr07385f; Wang JL, 2016, J MATER SCI, V51, P4728, DOI 10.1007/s10853-016-9797-7; Wang P, 2017, J MATER CHEM C, V5, P6328, DOI 10.1039/c7tc01574g; Wang Q, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0058-0; Wang YF, 2014, J MATER CHEM C, V2, P6921, DOI 10.1039/c4tc00988f; Wu LN, 2013, THERANOSTICS, V3, P677, DOI 10.7150/thno.6535; Wu XX, 2017, BIOSENS BIOELECTRON, V90, P501, DOI 10.1016/j.bios.2016.10.060; Wu ZL, 2017, J MATER CHEM B, V5, P3794, DOI 10.1039/c7tb00363c; Yildiz I, 2010, LANGMUIR, V26, P11503, DOI 10.1021/la1010488; Zawacka-Pankau J, 2007, J BIOL CHEM, V282, P2466, DOI 10.1074/jbc.M608906200; Zeng QH, 2016, J MATER CHEM B, V4, P5119, DOI 10.1039/c6tb01259k; Zhai XY, 2012, CHEM COMMUN, V48, P7955, DOI 10.1039/c2cc33869f; Zhang J, 2016, MATER TODAY, V19, P382, DOI 10.1016/j.mattod.2015.11.008; Zheng DW, 2016, ACS NANO, V10, P8715, DOI 10.1021/acsnano.6b04156; Zhou D, 2017, CHEM MATER, V29, P1779, DOI 10.1021/acs.chemmater.6b05375; Zhou N, 2014, RSC ADV, V4, P62086, DOI 10.1039/c4ra09525a	61	16	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220210	10.1371/journal.pone.0220210	http://dx.doi.org/10.1371/journal.pone.0220210			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344086	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000484977900069
J	Huang, HY; Huang, CC; Guo, LM; Zeng, CS; Ye, HH				Huang, Huiyang; Huang, Chencui; Guo, Limei; Zeng, Chaoshu; Ye, Haihui			Profiles of calreticulin and Ca2+ concentration under low temperature and salinity stress in the mud crab, Scylla paramamosain	PLOS ONE			English	Article							MOLECULAR-CLONING; EXPRESSION ANALYSIS; SIGNALING PATHWAYS; CALCIUM; GENE; SHRIMP; IDENTIFICATION; SPECIFICITY; CHALLENGE; INDUCTION	Calreticulin (CRT) is an important molecular chaperon crucial to survival of organisms under adverse conditions. In this study, the potential roles of CRT in the mud crab, Scylla paramamosain, were investigated. Firstly, SpCRT gene expression was detected in various tissues of S. paramamosain with the highest expression found in the hepatopancreas. To evaluate potential role of SpCRT in cold adaption, sub-adult crabs were subjected to temperatures of 10, 15, 20 and 25 degrees C and the profiles of SpCRT gene were determined in the hepatopancreas, chela muscle and gills. The results showed that the expressions of SpCRT mRNA in these tissues were significantly higher for those crabs exposed to low temperatures of 10 and 15 degrees C as compared to those exposed to the higher temperatures, indicating SpCRT was involved in cold adaptation-probably through facilitating protein folding. When low temperature 10 degrees C or 15 degrees C was further combined with high and low salinity stress, the expression of SpCRT mRNA at low salinity (10 ppt) was in most cases significantly higher than that at high salinity (35 ppt), suggesting that under low temperatures, low salinity may represents a more stressful condition to the crab than high salinity. It was also shown that when crabs challenged by 10 degrees C, Ca2+ concentration increased rapidly in the hepatopancreas and an in vitro experiment further showed that the expression of SpCRT mRNA increased concurrently with added Ca2+ concentration; these results together imply that Ca2+ probably plays a major role in low temperature signaling, which induces expression of genes related to cold adaption, such as CRT.	[Huang, Huiyang; Huang, Chencui; Guo, Limei; Ye, Haihui] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian, Peoples R China; [Zeng, Chaoshu] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia	Xiamen University; James Cook University	Ye, HH (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian, Peoples R China.; Zeng, CS (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	chaoshu.zeng@jcu.edu.au; haihuiye@xmu.edu.cn		Zeng, Chaoshu/0000-0001-9022-6588	Important Science & Technology Specific Project of Zhejiang Province for Selective Breeding [2016C02055-8]; Fujian Provincial Project of Science and Technology [2017N0030, 2019S0049]	Important Science & Technology Specific Project of Zhejiang Province for Selective Breeding; Fujian Provincial Project of Science and Technology	This work was supported by the Important Science & Technology Specific Project of Zhejiang Province for Selective Breeding (No. 2016C02055-8); the Fujian Provincial Project of Science and Technology (Nos. 2017N0030, 2019S0049).; This study was supported by the Important Science & Technology Specific Project of Zhejiang Province for Selective Breeding (No. 2016C02055-8) and the Fujian Provincial Project of Science and Technology (Nos. 2017N0030; 2019S0049).	[Anonymous], MUD CRAB AQUACULTURE; Bai ZY, 2012, ANIMAL, V6, P887, DOI 10.1017/S1751731111002199; Barman HK, 2012, SCI WORLD J, DOI 10.1100/2012/149361; Carafoli E, 1999, CALCIUM CELLULAR REG; Coppolino MG, 1998, INT J BIOCHEM CELL B, V30, P553, DOI 10.1016/S1357-2725(97)00153-2; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Duan YF, 2014, FISH SHELLFISH IMMUN, V36, P164, DOI 10.1016/j.fsi.2013.10.024; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Gao WH, 2016, AQUACULTURE, V454, P265, DOI 10.1016/j.aquaculture.2016.01.005; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Hamasaki Katsuyuki, 2002, Suisan Zoshoku, V50, P301; Heal R, 1998, BIOCHEM J, V329, P389, DOI 10.1042/bj3290389; Ihara Y, 2005, BIOCHEM BIOPH RES CO, V329, P1343, DOI 10.1016/j.bbrc.2005.02.112; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kales S, 2004, IMMUNOGENETICS, V55, P717, DOI 10.1007/s00251-003-0631-4; Kawabe S, 2010, MAR GENOM, V3, P19, DOI 10.1016/j.margen.2010.01.002; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Kong XH, 2012, AQUACULTURE, V370, P144, DOI 10.1016/j.aquaculture.2012.10.012; Le Vay L, 2008, REV FISH SCI, V16, P72, DOI 10.1080/10641260701727285; Lima FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055668; Liu H, 2011, DEV COMP IMMUNOL, V35, P267, DOI 10.1016/j.dci.2010.11.009; Llewellyn DH, 1996, BIOCHEM J, V318, P555, DOI 10.1042/bj3180555; Luana W, 2007, COMP BIOCHEM PHYS B, V147, P482, DOI 10.1016/j.cbpb.2007.03.001; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Lv JJ, 2015, CELL STRESS CHAPERON, V20, P811, DOI 10.1007/s12192-015-0602-3; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 1998, BIOCHEM CELL BIOL, V76, P779, DOI 10.1139/bcb-76-5-779; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nguyen TQ, 1996, MOL IMMUNOL, V33, P379, DOI 10.1016/0161-5890(95)00149-2; Paital B, 2012, COMP BIOCHEM PHYS C, V155, P228, DOI 10.1016/j.cbpc.2011.08.009; Pfeifer S, 2005, J EXP MAR BIOL ECOL, V320, P93, DOI 10.1016/j.jembe.2004.12.020; Romano N, 2014, MAR BIOL RES, V10, P460, DOI 10.1080/17451000.2013.819981; Shekhar MS, 2013, FISH SHELLFISH IMMUN, V35, P1957, DOI 10.1016/j.fsi.2013.09.038; Shu MiaoAn, 2013, Acta Hydrobiologica Sinica, V37, P999; Visudtiphole V, 2010, AQUACULTURE, V308, pS100, DOI 10.1016/j.aquaculture.2010.06.040; Watthanasurorot A, 2013, J MOL CELL BIOL, V5, P120, DOI 10.1093/jmcb/mjt005; Wilder MN, 2009, AQUACULTURE, V292, P104, DOI 10.1016/j.aquaculture.2009.03.034; Xu BP, 2016, AQUAC RES, V47, P3276, DOI 10.1111/are.12781; Yamamoto S, 1996, J EXP ZOOL, V275, P431; Yang YN, 2013, FISH SHELLFISH IMMUN, V35, P1185, DOI 10.1016/j.fsi.2013.07.029; Ye HH, 2011, AQUACULT INT, V19, P313, DOI 10.1007/s10499-010-9399-3; Yu K, 2015, CELL STRESS CHAPERON, V20, P853, DOI 10.1007/s12192-015-0612-1	44	5	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220405	10.1371/journal.pone.0220405	http://dx.doi.org/10.1371/journal.pone.0220405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344118	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000484977900099
J	Shaskolskiy, B; Dementieva, E; Kandinov, I; Filippova, M; Petrova, N; Plakhova, X; Chestkov, A; Kubanov, A; Deryabin, D; Gryadunov, D				Shaskolskiy, Boris; Dementieva, Ekaterina; Kandinov, Ilya; Filippova, Marina; Petrova, Natalia; Plakhova, Xenia; Chestkov, Alexander; Kubanov, Alexey; Deryabin, Dmitry; Gryadunov, Dmitry			Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015-2017	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-2; ANTIMICROBIAL RESISTANCE; REDUCED SUSCEPTIBILITY; MULTIDRUG-RESISTANT; SEQUENCE-ANALYSIS; DRUG-RESISTANT; AMINO-ACID; PLASMIDS; CEFIXIME; GENETICS	The goal of this work was to study the phenotypic susceptibility and resistance determinants of N. gonorrhoeae isolates to beta-lactam antimicrobials (benzylpenicillin and ceftriaxone). A total of 522 clinical isolates collected in Russia in 2015-2017 were analysed for susceptibility using the agar dilution method. DNA loci involved in antimicrobial resistance were identified using DNA microarray analysis and sequencing. Resistance to benzylpenicillin remained high, with 7.7% of isolates resistant (MICpen > 1 mg/L) and 47.5% of isolates showing intermediate susceptibility (MICpen = 0.12-1 mg/L). The most frequent resistance determinant (72.4% isolates) was the Asp345 insertion in penA, both as a single mutation and in combination with other mutations, particularly with the substitution Leu421Pro in ponA (39.0%). Mutations affecting the influx and efflux of drugs were also found, including amino acid substitutions in PorB (26.8% isolates) and delA in the promoter region of mtrR (22.8%). The accumulation of mutations in chromosomal genes (penA, pon, porA, and mtrR) led to a stepwise increase in MICpen to values characteristic of intermediate resistance. The presence of blaTEM plasmids was found in 25 isolates (4.8%), resulting in a strong increase in resistance to penicillin (MICpen > 16 mg/L) compared with the chromosomal mutations; 23 plasmids were of the African type with TEM-1 beta-lactamase, and two plasmids were of the Toronto/Rio type with TEM-135 beta-lactamase. Only three isolates were found with reduced susceptibility to ceftriaxone, with MICcef = 0.12-0.25 mg/L. Sequencing of penA did not reveal mutations associated with resistance to third-generation cephalosporins, and the gene structure was non-mosaic. The majority of isolates (21 of 25) carrying the bla(TEM) plasmid also contained the conjugative plasmid with tetM (resistance to tetracyclines), consistent with previously reported data that the presence of the conjugative plasmid facilitates the transfer of other plasmids associated with antimicrobial resistance.	[Shaskolskiy, Boris; Dementieva, Ekaterina; Kandinov, Ilya; Filippova, Marina; Gryadunov, Dmitry] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Petrova, Natalia; Plakhova, Xenia; Chestkov, Alexander; Kubanov, Alexey; Deryabin, Dmitry] Russian Minist Hlth, State Res Ctr Dermatovenerol & Cosmetol, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Ministry of Health of the Russian Federation	Shaskolskiy, B (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	b.shaskolskiy@biochip.ru	Gryadunov, Dmitry A/F-5251-2014; Shaskolskiy, Boris/H-4260-2014; Filippova, Marina/G-9006-2017; Shaskolskiy, Boris Leonidovich/M-6168-2019; Kandinov, Ilya/AAA-8506-2020; Plakhova, Xenia/I-8108-2014; Kubanov, Alexey/L-3008-2014	Gryadunov, Dmitry A/0000-0003-3183-318X; Shaskolskiy, Boris/0000-0002-0316-2262; Shaskolskiy, Boris Leonidovich/0000-0002-0316-2262; Kandinov, Ilya/0000-0001-9416-875X; Deryabin, Dmitry/0000-0002-9578-7947; Filippova, Marina/0000-0002-9454-5938; Plakhova, Xenia/0000-0003-4169-4128; Kubanov, Alexey/0000-0002-7625-0503	Russian Science Foundation [17-75-20039]; Ministry of Health of the Russian Federation [056-00015-18-00]	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Health of the Russian Federation	This work was supported by the Russian Science Foundation Grant No. 17-75-20039 (Boris Shaskolskiy, Ekaterina Dementieva, Ilya Kandinov, Marina Filippova, Dmitry Gryadunov) and the Ministry of Health of the Russian Federation, Project No. 056-00015-18-00 (Alexey Kubanov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AJ, 2017, SEX TRANSM DIS, V44, P492, DOI 10.1097/OLQ.0000000000000645; Arlet G, 1999, ANTIMICROB AGENTS CH, V43, P969, DOI 10.1128/AAC.43.4.969; ASHFORD WA, 1976, LANCET, V2, P657; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; BRANNIGAN JA, 1990, MOL MICROBIOL, V4, P913, DOI 10.1111/j.1365-2958.1990.tb00664.x; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; Chisholm SA, 2013, EUROSURVEILLANCE, V18, P14; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Demczuk W, 2017, J CLIN MICROBIOL, V55, P1454, DOI [10.1128/jcm.00100-17, 10.1128/JCM.00100-17]; DOWSON CG, 1989, MOL MICROBIOL, V3, P35, DOI 10.1111/j.1365-2958.1989.tb00101.x; European Centre for Disease Prevention and Control, 2018, GON ANT SUSC SURV EU; Folster JP, 2009, J BACTERIOL, V191, P287, DOI 10.1128/JB.01165-08; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Kubanov A, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.02024-18, 10.1128/jcm.02024-18]; Kubanov A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1688-7; Kubanova A, 2010, EUROSURVEILLANCE, V15, P10; Kubanova A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-342; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leinsoo AT, 2017, B EXP BIOL MED+, V164, P54, DOI 10.1007/s10517-017-3925-5; Lindberg R, 2007, ANTIMICROB AGENTS CH, V51, P2117, DOI 10.1128/AAC.01604-06; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; Martin I, 2012, SEX TRANSM DIS, V39, P316, DOI 10.1097/OLQ.0b013e3182401b69; Mlynarczyk-Bonikowska B, 2016, FOLIA MICROBIOL, V61, P269, DOI 10.1007/s12223-015-0434-7; Muller EE, 2011, J ANTIMICROB CHEMOTH, V66, P1514, DOI 10.1093/jac/dkr162; Muhammad I, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-454; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Olesky M, 2006, J BACTERIOL, V188, P2300, DOI 10.1128/JB.188.7.2300-2308.2006; Osaka Kazuyoshi, 2008, Journal of Infection and Chemotherapy, V14, P195, DOI 10.1007/s10156-008-0610-7; Pachulec E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009962; Pagotto F, 2000, PLASMID, V43, P24, DOI 10.1006/plas.1999.1431; Palmer HM, 2000, J ANTIMICROB CHEMOTH, V45, P777, DOI 10.1093/jac/45.6.777; ROBERTS MC, 1989, CLIN MICROBIOL REV, V2, pS18, DOI 10.1128/CMR.2.Suppl.S18-S23.1989; ROBERTS MC, 1988, ANTIMICROB AGENTS CH, V32, P1430, DOI 10.1128/AAC.32.9.1430; Ropp PA, 2002, ANTIMICROB AGENTS CH, V46, P769, DOI 10.1128/AAC.46.3.769-777.2002; Rotman E, 2014, ANNU REV GENET, V48, P405, DOI 10.1146/annurev-genet-120213-092007; Shaskolskiy B, 2018, INFECT GENET EVOL, V63, P236, DOI 10.1016/j.meegid.2018.06.003; Shaskolskiy B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00747; Shimuta K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1110-x; Suay-Garcia B, 2017, EUR J CLIN MICROBIOL, V36, P1065, DOI 10.1007/s10096-017-2931-x; The European Committee on Antimicrobial Susceptibility Testing, 2019, BREAKP TABL INT MICS, P55; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Whiley DM, 2007, ANTIMICROB AGENTS CH, V51, P3111, DOI 10.1128/AAC.00306-07; Whiley DM, 2010, J ANTIMICROB CHEMOTH, V65, P1615, DOI 10.1093/jac/dkq187; World Health Organization, 2014, ANT RES GLOB REP SUR; Zapun A, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5040035; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhao SQ, 2009, ANTIMICROB AGENTS CH, V53, P3744, DOI 10.1128/AAC.00304-09	50	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220339	10.1371/journal.pone.0220339	http://dx.doi.org/10.1371/journal.pone.0220339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344102	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900086
J	Kim, EH; Jo, Y; Sai, S; Park, MJ; Kim, JY; Kim, JS; Lee, YJ; Cho, JM; Kwak, SY; Baek, JH; Jeong, YK; Song, JY; Yoon, M; Hwang, SG				Kim, Eun Ho; Jo, Yunhui; Sai, Sei; Park, Mung-Jin; Kim, Jeong-Yub; Kim, Jin Su; Lee, Yeon-Joo; Cho, Jae-Min; Kwak, Seo-Young; Baek, Jeong-Hwa; Jeong, Youn Kyoung; Song, Jie-Young; Yoon, Myonggeun; Hwang, Sang-Gu			Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells	ONCOGENE			English	Article							CANCER; PROLIFERATION; EXPRESSION; SURVIVAL; PATHWAY	Tumor-treating fields (TTFs) - a type of electromagnetic field-based therapy using low-intensity electrical fields - has recently been characterized as a potential anticancer therapy for glioblastoma multiforme (GBM). However, the molecular mechanisms involved remain poorly understood. Our results show that the activation of autophagy contributes to the TTF-induced anti-GBM activity in vitro or in vivo and GBM patient stem cells or primary in vivo culture systems. TTF-treatment upregulated several autophagy-related genes (similar to 2-fold) and induced cytomorphological changes. TTF-induced autophagy in GBM was associated with decreased Akt2 expression, not Akt1 or Akt3, via the mTOR/p70S6K pathway. An Affymetrix GeneChip miRNA 4.0 Array analysis revealed that TTFs altered the expression of many microRNAs (miRNAs). TTF-induced autophagy upregulated miR-29b, which subsequently suppressed the Akt signaling pathway. A luciferase reporter assay confirmed that TTFs induced miR-29b to target Akt2, negatively affecting Akt2 expression thereby triggering autophagy. TTF-induced autophagy suppressed tumor growth in GBM mouse models subjected to TTFs as determined by positron emission tomography and computed tomography (PET-CT). GBM patient stem cells and a primary in vivo culture system with high Akt2 levels also showed TTF-induced inhibition. Taken together, our results identified autophagy as a critical cell death pathway triggered by TTFs in GBM and indicate that TTF is a potential treatment option for GBM.	[Kim, Eun Ho; Jo, Yunhui; Park, Mung-Jin; Kim, Jeong-Yub; Lee, Yeon-Joo; Cho, Jae-Min; Baek, Jeong-Hwa; Song, Jie-Young; Hwang, Sang-Gu] Korea Inst Radiol & Med Sci, Div Radiat Biomed Res, Seoul 01812, South Korea; [Jo, Yunhui; Yoon, Myonggeun] Korea Univ, Dept Bioconvergence Engn, Seoul 02842, South Korea; [Sai, Sei] Natl Inst Radiol Sci, Dept Basic Med Sci Radiat Damages, Chiba, Japan; [Kim, Jin Su] Korea Inst Radiol & Med Sci, Div RI Convergence Res, Seoul 01812, South Korea; [Kwak, Seo-Young] Korea Inst Sci & Technol, Ctr Theragnosis, Biomed Res Inst, Seoul 02792, South Korea; [Jeong, Youn Kyoung] Korea Inst Radiol & Med Sci, Radiat Nonclin Ctr, Div Radiat Res Infrastruct Operat, Seoul 01812, South Korea	Korea Institute of Radiological & Medical Sciences; Korea University; National Institutes for Quantum Science & Technology; Korea Institute of Radiological & Medical Sciences; Korea Institute of Science & Technology (KIST); Korea Institute of Radiological & Medical Sciences	Hwang, SG (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Biomed Res, Seoul 01812, South Korea.; Yoon, M (corresponding author), Korea Univ, Dept Bioconvergence Engn, Seoul 02842, South Korea.	radioyoon@korea.ac.kr; sgh63@kcch.re.kr	KIM, JIN SU/U-2112-2019; Song, Jie-Young/AAG-6684-2019; Song, Jie-Young/AAH-1254-2019	KIM, JIN SU/0000-0001-8965-9538; Song, Jie-Young/0000-0002-5769-3886; baeg, jeonghwa/0000-0001-5364-0026; Lee, Yeon-Joo/0000-0002-6605-8761	National Research Foundation of Korea (NRF) [NRF-2017R1D1A1B03028923]; Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science, ICT (MSIP) Republic of Korea [50531-2018, 50538-2019]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science, ICT (MSIP) Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant (no. NRF-2017R1D1A1B03028923) and a grant from the Korea Institute of Radiological and Medical Sciences (KIRAMS), which was funded by the Ministry of Science, ICT (MSIP) Republic of Korea (50531-2018, 50538-2019).	[Anonymous], 2011, NOVOTTF 100A SYST PR; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; Davies AM, 2013, ANN NY ACAD SCI, V1291, P86, DOI 10.1111/nyas.12112; Fohlin H, 2013, EUR J CANCER, V49, P1196, DOI 10.1016/j.ejca.2012.12.006; Ganapathy B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155456; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Giladi M, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0941-6; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Jeong H, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902112; Jo Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113684; Johnson DR, 2012, CANCER-AM CANCER SOC, V118, P5608, DOI 10.1002/cncr.27590; Kessler AF, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0079-9; Kim EH, 2016, ONCOTARGET, V7, P65125, DOI 10.18632/oncotarget.11372; Kim EH, 2016, ONCOTARGET, V7, P62267, DOI 10.18632/oncotarget.11407; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Li Y, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0093-9; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Plastaras JP, 2008, CANCER BIOL THER, V7, P2047, DOI 10.4161/cbt.7.12.7570; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Rivas S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010029; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Stupp R., 2015, JCO, V33, P2000; Stupp R, 2017, JAMA-J AM MED ASSOC, V318, P2306, DOI 10.1001/jama.2017.18718; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Toms SA, 2019, J NEURO-ONCOL, V141, P467, DOI 10.1007/s11060-018-03057-z; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Yin J, 2017, CANCER RES, V77, P4973, DOI 10.1158/0008-5472.CAN-17-0388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	39	30	31	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2019	38	39					6630	6646		10.1038/s41388-019-0882-7	http://dx.doi.org/10.1038/s41388-019-0882-7			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JA5AQ	31375748				2022-12-26	WOS:000487856000005
J	Ou, WB; Ni, N; Zuo, R; Zhuang, WH; Zhu, MJ; Kyriazoglou, A; Wu, DL; Eilers, G; Demetri, GD; Qiu, HB; Li, B; Marino-Enriquez, A; Fletcher, JA				Ou, Wen-Bin; Ni, Nan; Zuo, Rui; Zhuang, Weihao; Zhu, Meijun; Kyriazoglou, Anastasios; Wu, Duolin; Eilers, Grant; Demetri, George D.; Qiu, Haibo; Li, Bin; Marino-Enriquez, Adrian; Fletcher, Jonathan A.			Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence	ONCOGENE			English	Article							KINASE-C-THETA; CANCER-CELL-GROWTH; IMATINIB MESYLATE; ADIPOCYTIC DIFFERENTIATION; PKC-THETA; EXPRESSION; PROLIFERATION; RESISTANCE; MUTATIONS; OVEREXPRESSION	Oncogenic KIT or PDGFRA tyrosine kinase mutations are compelling therapeutic targets in most gastrointestinal stromal tumors (GISTs), and the KIT inhibitor, imatinib, is therefore standard of care for patients with metastatic GIST. However, some GISTs lose expression of KIT oncoproteins, and therefore become KIT-independent and are consequently resistant to KIT-inhibitor drugs. We identified distinctive biologic features in KIT-independent, imatinib-resistant GISTs as a step towards identifying drug targets in these poorly understood tumors. We developed isogenic GIST lines in which the parental forms were KIT oncoprotein-dependent, whereas sublines had loss of KIT oncoprotein expression, accompanied by markedly downregulated expression of the GIST biomarker, protein kinase C-theta (PRKCQ). Biologic mechanisms unique to KIT-independent GISTs were identified by transcriptome sequencing, qRT-PCR, immunoblotting, protein interaction studies, knockdown and expression assays, and dual-luciferase assays. Transcriptome sequencing showed that cyclin D1 expression was extremely low in two of three parental KIT-dependent GIST lines, whereas cyclin D1 expression was high in each of the KIT-independent GIST sublines. Cyclin D1 inhibition in KIT-independent GISTs had anti-proliferative and pro-apoptotic effects, associated with Rb activation and p27 upregulation. PRKCQ, but not KIT, was a negative regulator of cyclin D1 expression, whereas JUN and Hippo pathway effectors YAP and TAZ were positive regulators of cyclin D1 expression. PRKCQ, JUN, and the Hippo pathway coordinately regulate GIST cyclin D1 expression. These findings highlight the roles of PRKCQ, JUN, Hippo, and cyclin D1 as oncogenic mediators in GISTs that have converted, during TKI-therapy, to a KIT-independent state. Inhibitors of these pathways could be effective therapeutically for these now untreatable tumors.	[Ou, Wen-Bin; Ni, Nan; Zuo, Rui; Zhuang, Weihao; Wu, Duolin] Zhejiang Sci Tech Univ, Coll Life Sci & Med, Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou, Zhejiang, Peoples R China; [Ou, Wen-Bin; Zhu, Meijun; Kyriazoglou, Anastasios; Eilers, Grant; Qiu, Haibo; Li, Bin; Marino-Enriquez, Adrian; Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ou, Wen-Bin; Zhu, Meijun; Kyriazoglou, Anastasios; Eilers, Grant; Demetri, George D.; Marino-Enriquez, Adrian; Fletcher, Jonathan A.] Harvard Med Sch, Boston, MA 02115 USA; [Demetri, George D.] Dana Farber Harvard Canc Ctr, Ludwig Ctr Dana Farber, Boston, MA 02115 USA; [Demetri, George D.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Qiu, Haibo] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Li, Bin] Cent S Univ, Xiangya Hosp, Div Oncol, Changsha, Hunan, Peoples R China	Zhejiang Sci-Tech University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; State Key Lab Oncology South China; Sun Yat Sen University; Central South University	Ou, WB (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci & Med, Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou, Zhejiang, Peoples R China.; Ou, WB; Fletcher, JA (corresponding author), Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.; Ou, WB; Fletcher, JA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ouwenbin@tsinghua.org.cn; jfletcher@partners.org		, Wenbin/0000-0002-6311-9442; Marino-Enriquez, Adrian/0000-0002-7680-9901	NIH [1P50CA127003, 1P50CA168512]; GIST Cancer Research Fund; David Foundation; National Natural Science Foundation of China [81728012, 81602061]; Natural Science Foundation of Zhejiang Province [LY18H160065]; Zhejiang medical and health science and technology plan project [2018KY651]; Zhejiang Xinmiao Talents Program [2017R406050]; National Undergraduate Training Program for Innovation and Entrepreneurship, Science Foundation of Zhejiang Sci-Tech University [14042107-Y]; Graduate research and innovation projects of Zhejiang Sci-Tech University, China; SARC; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GIST Cancer Research Fund; David Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang medical and health science and technology plan project; Zhejiang Xinmiao Talents Program; National Undergraduate Training Program for Innovation and Entrepreneurship, Science Foundation of Zhejiang Sci-Tech University; Graduate research and innovation projects of Zhejiang Sci-Tech University, China; SARC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants 1P50CA127003 and 1P50CA168512, and by the GIST Cancer Research Fund, SARC and David Foundation. This research was also supported by National Natural Science Foundation of China (81728012, 81602061), the Natural Science Foundation of Zhejiang Province (LY18H160065), Zhejiang medical and health science and technology plan project (2018KY651), Zhejiang Xinmiao Talents Program (2017R406050), National Undergraduate Training Program for Innovation and Entrepreneurship, Science Foundation of Zhejiang Sci-Tech University (14042107-Y), Graduate research and innovation projects of Zhejiang Sci-Tech University, China. We thank Adalis Maisonet, Terry Haley, and Edward Fox for technical and biostatistical support in the whole transcriptome sequencing.	Barbash O, 2008, CELL CYCLE, V7, P2983, DOI 10.4161/cc.7.19.6775; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Blay JY, 2005, ANN ONCOL, V16, P566, DOI 10.1093/annonc/mdi127; Blay P, 2004, CLIN CANCER RES, V10, P4089, DOI 10.1158/1078-0432.CCR-04-0630; Casimiro MC, 2017, CANCER RES, V77, P3391, DOI 10.1158/0008-5472.CAN-16-0425; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Demetri GD, 2009, CLIN CANCER RES, V15, P5902, DOI 10.1158/1078-0432.CCR-09-0482; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Draper N, 2008, HUM PATHOL, V39, P1784, DOI 10.1016/j.humpath.2008.05.007; Duensing A, 2004, CANCER RES, V64, P5127, DOI 10.1158/0008-5472.CAN-04-0559; Essat M, 2011, INT J CANCER, V128, P2202, DOI 10.1002/ijc.25827; Fernando R, 2007, J BIOL CHEM, V282, P28864, DOI 10.1074/jbc.M700785200; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Fletcher J.A., 2003, P AM SOC CLIN ONCOL, V22, P815; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Huang SF, 1996, AM J PATHOL, V149, P1565; Husson H, 2002, BLOOD, V99, P282, DOI 10.1182/blood.V99.1.282; Jean S, 2001, BBA-GENE STRUCT EXPR, V1522, P89, DOI 10.1016/S0167-4781(01)00326-8; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Li HY, 2006, CANCER RES, V66, P11399, DOI 10.1158/0008-5472.CAN-06-2386; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Motegi A, 2005, PATHOL INT, V55, P106, DOI 10.1111/j.1440-1827.2005.01806.x; Ou WB, 2008, ONCOGENE, V27, P5624, DOI 10.1038/onc.2008.177; Page K, 2002, AM J RESP CELL MOL, V27, P204, DOI 10.1165/ajrcmb.27.2.20010016oc; Pruneri G, 2003, MODERN PATHOL, V16, P886, DOI 10.1097/01.MP.0000085026.38856.B9; Rubin BP, 2001, CANCER RES, V61, P8118; Serrano C, 2015, J CLIN ONCOL, V33, pE93, DOI 10.1200/JCO.2013.48.7488; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Siegmund K, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0100-3; Snyder EL, 2009, J PATHOL, V218, P292, DOI 10.1002/path.2564; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Thomazy VA, 2002, J MOL DIAGN, V4, P201, DOI 10.1016/S1525-1578(10)60704-0; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Yang PP, 2016, ONCOTARGET, V7, P32652, DOI 10.18632/oncotarget.8999; Zhu MJ, 2007, ONCOGENE, V26, P6386, DOI 10.1038/sj.onc.1210464	54	18	20	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2019	38	39					6615	6629		10.1038/s41388-019-0894-3	http://dx.doi.org/10.1038/s41388-019-0894-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JA5AQ	31371779				2022-12-26	WOS:000487856000004
J	He, GJ; Zhang, ZL; Sathanantham, P; Zhang, X; Wu, ZJ; Xie, LH; Wang, XF				He, Guijuan; Zhang, Zhenlu; Sathanantham, Preethi; Zhang, Xin; Wu, Zujian; Xie, Lianhui; Wang, Xiaofeng			An engineered mutant of a host phospholipid synthesis gene inhibits viral replication without compromising host fitness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plus-stranded RNA virus; phosphatidylcholine; metabolic engineering; protein targeting; viral replication; phosphatidylethanolamine methyltransferase; viral replication complex; virus control	VIRUS-RNA REPLICATION; 4-KINASE III ALPHA; RECESSIVE RESISTANCE; CRUCIAL ROLES; PLANT-VIRUSES; PROTEIN; PHOSPHATIDYLCHOLINE; 1A; METABOLISM; YEAST	Viral infections universally rely on numerous hijacked host factors to be successful. It is therefore possible to control viral infections by manipulating host factors that are critical for viral replication. Given that host genes may play essential roles in certain cellular processes, any successful manipulations for virus control should cause no or mild effects on host fitness. We previously showed that a group of positive-strand RNA viruses enrich phosphatidylcholine (PC) at the sites of viral replication. Specifically, brome mosaic virus (BMV) replication protein 1a interacts with and recruits a PC synthesis enzyme, phosphatidylethanolamine methyltransferase, Cho2p, to the viral replication sites that are assembled on the perinuclear endoplasmic reticulum (ER) membrane. Deletion of the CHO2 gene inhibited BMV replication by 5-fold; however, it slowed down host cell growth as well. Here, we show that an engineered Cho2p mutant supports general PC synthesis and normal cell growth but blocks BMV replication. This mutant interacts and colocalizes with BMV 1a but prevents BMV 1a from localizing to the perinuclear ER membrane. The mislocalized BMV 1a fails to induce the formation of viral replication complexes. Our study demonstrates an effective antiviral strategy in which a host lipid synthesis gene is engineered to control viral replication without comprising host growth.	[He, Guijuan; Zhang, Zhenlu; Wu, Zujian; Xie, Lianhui] Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Prov Key Lab Plant Virol, Fuzhou 350002, Fujian, Peoples R China; [He, Guijuan; Zhang, Zhenlu; Sathanantham, Preethi; Zhang, Xin; Wang, Xiaofeng] Virginia Tech, Sch Plant & Environm Sci, Blacksburg, VA 24061 USA; [Zhang, Zhenlu] Shandong Agr Univ, Coll Hort Sci & Engn, Natl Res Ctr Apple Engn & Technol, Natl Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China	Fujian Agriculture & Forestry University; Virginia Polytechnic Institute & State University; Shandong Agricultural University	Xie, LH (corresponding author), Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Prov Key Lab Plant Virol, Fuzhou 350002, Fujian, Peoples R China.; Wang, XF (corresponding author), Virginia Tech, Sch Plant & Environm Sci, Blacksburg, VA 24061 USA.	fjxlh@126.com; reachxw@vt.edu	; Wang, Xiaofeng/E-9940-2016	Sathanantham, Preethi/0000-0002-1826-1538; Wang, Xiaofeng/0000-0002-3850-3274	National Science Foundation [IOS-1645740]; United States-Israel Binational Agricultural and Research Development Fund [US-5019-17]	National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Agricultural and Research Development Fund	This work was partially supported by National Science Foundation Grant IOS-1645740 and United States-Israel Binational Agricultural and Research Development Fund Grant US-5019-17. The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007086; Barajas D, 2014, VIROLOGY, V471, P72, DOI 10.1016/j.virol.2014.10.005; Belov GA, 2016, CURR OPIN VIROL, V19, P1, DOI 10.1016/j.coviro.2016.05.003; Belov GA, 2014, CURR OPIN VIROL, V9, P19, DOI 10.1016/j.coviro.2014.08.007; Belov GA, 2012, CURR OPIN VIROL, V2, P740, DOI 10.1016/j.coviro.2012.09.006; Berger KL, 2011, J VIROL, V85, P8870, DOI 10.1128/JVI.00059-11; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Castorena Kathryn M, 2010, BMC Genomics, V11, P183, DOI 10.1186/1471-2164-11-183; Castro-Perez JM, 2010, J PROTEOME RES, V9, P2377, DOI 10.1021/pr901094j; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; den Boon JA, 2001, J VIROL, V75, P12370, DOI 10.1128/JVI.75.24.12370-12381.2001; Diaz A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004742; Diaz A, 2014, CURR OPIN VIROL, V9, P104, DOI 10.1016/j.coviro.2014.09.018; Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107; Du ZY, 2016, PROG LIPID RES, V63, P165, DOI 10.1016/j.plipres.2016.06.002; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Galvez LC, 2014, PLANT SCI, V228, P11, DOI 10.1016/j.plantsci.2014.07.006; GARCIARUIZ H, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10090484; Guo ZX, 2017, P NATL ACAD SCI USA, V114, P1377, DOI 10.1073/pnas.1614204114; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hashimoto M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01695; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Hyodo K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004909; Ilnytska O, 2013, CELL HOST MICROBE, V14, P281, DOI 10.1016/j.chom.2013.08.002; Ishikawa M, 1997, J VIROL, V71, P7781, DOI 10.1128/JVI.71.10.7781-7790.1997; Jiang J, 2015, J VIROL, V89, P6695, DOI 10.1128/JVI.00503-15; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kong F, 1999, VIROLOGY, V259, P200, DOI 10.1006/viro.1999.9763; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Lee WM, 2003, J VIROL, V77, P12819, DOI 10.1128/JVI.77.23.12819-12828.2003; Lee WM, 2001, J VIROL, V75, P2097, DOI 10.1128/JVI.75.5.2097-2106.2001; Li FF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03658-2; Li JH, 2016, J CELL SCI, V129, P3597, DOI 10.1242/jcs.190082; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Liu L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000351; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Maule AJ, 2007, MOL PLANT PATHOL, V8, P223, DOI 10.1111/J.1364-3703.2007.00386.X; Nagy PD, 2016, ANNU REV VIROL, V3, P491, DOI 10.1146/annurev-virology-110615-042312; Neess D, 2015, PROG LIPID RES, V59, P1, DOI 10.1016/j.plipres.2015.04.001; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Pimentel David, 2005, Environment Development and Sustainability, V7, P229, DOI 10.1007/s10668-005-7314-2; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Renne MF, 2018, FEBS LETT, V592, P1330, DOI 10.1002/1873-3468.12944; Restrepo-Hartwig M, 1999, J VIROL, V73, P10303, DOI 10.1128/JVI.73.12.10303-10309.1999; Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Roulin PS, 2014, CELL HOST MICROBE, V16, P677, DOI 10.1016/j.chom.2014.10.003; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; Sharma M, 2011, VIROLOGY, V415, P141, DOI 10.1016/j.virol.2011.04.008; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; Stapleford KA, 2010, VIRUSES-BASEL, V2, P1055, DOI 10.3390/v2051055; Strating JRPM, 2017, CURR OPIN CELL BIOL, V47, P24, DOI 10.1016/j.ceb.2017.02.005; SUMMERS EF, 1988, GENETICS, V120, P909; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; VANCE DE, 1980, J BIOL CHEM, V255, P1064; Wang AM, 2015, ANNU REV PHYTOPATHOL, V53, P45, DOI 10.1146/annurev-phyto-080614-120001; Wang AM, 2012, MOL PLANT PATHOL, V13, P795, DOI 10.1111/j.1364-3703.2012.00791.x; Wang X., 2008, ENCY VIROLOGY, P381; Wang XF, 2005, J VIROL, V79, P13747, DOI 10.1128/JVI.79.21.13747-13758.2005; Xu K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000128; Xu K, 2015, P NATL ACAD SCI USA, V112, pE1782, DOI 10.1073/pnas.1418971112; Zhang JT, 2016, P NATL ACAD SCI USA, V113, pE1064, DOI 10.1073/pnas.1519730113; Zhang JT, 2012, J VIROL, V86, P5110, DOI 10.1128/JVI.06701-11; Zhang ZL, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006988; Zhou ZG, 2011, LIPIDS, V46, P879, DOI 10.1007/s11745-011-3575-8	77	3	3	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13973	13982		10.1074/jbc.RA118.007051	http://dx.doi.org/10.1074/jbc.RA118.007051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31362985	Green Published, hybrid			2022-12-26	WOS:000490729800012
J	Tripathi, V; Kaur, E; Kharat, SS; Hussain, M; Damodaran, AP; Kulshrestha, S; Sengupta, S				Tripathi, Vivek; Kaur, Ekjot; Kharat, Suhas Sampat; Hussain, Mansoor; Damodaran, Arun Prasath; Kulshrestha, Swati; Sengupta, Sagar			Abrogation of FBW7 alpha-dependent p53 degradation enhances p53's function as a tumor suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin ligase; p53; E3 ubiquitin ligase; tumor suppressor gene; ubiquitylation (ubiquitination); DNA damage; Fbw7; p53; SCFFbw7 complex	UBIQUITIN-INDEPENDENT DEGRADATION; HOT-SPOT MUTANTS; HUMAN-CELLS; CYCLIN-E; LIGASE; FBW7; PHOSPHORYLATION; RESTORATION; INACTIVATION; CROSSROADS	The gene encoding the tumor suppressor p53 is mutated in most cancers. p53 expression is known to be tightly controlled by several E3 ligases. Here, we show that F-box and WD repeat domain-containing 7 alpha (FBW7 alpha), the substrate-recognition component of the SCFFBW7 multiprotein E3 ligase complex, targets both WT and tumor-derived mutants of p53 for proteasomal degradation in multiple human cancer cell lines (HCT116 and U2OS). We found that lack of FBW7 alpha stabilizes p53 levels, thereby increasing its half-life. p53 ubiquitylation and subsequent degradation require the F-box and the C-terminal WD40 repeats in FBW7 alpha. The polyubiquitylation of p53 occurred via Lys-48 linkage and involved phosphorylation on p53 at Ser-33 and Ser-37 by glycogen synthase kinase 3 beta (GSK3 beta) and DNA-dependent protein kinase (DNA-PK), respectively. These phosphorylation events created a phosphodegron that enhanced p53 binding to FBW7 alpha, allowing for the attachment of polyubiquitin moieties at Lys-132 in p53. FBW7 alpha-dependent p53 polyubiquitylation apparently occurred during and immediately after DNA double-strand breaks induced by either doxorubicin or ionizing radiation. Accordingly, in cells lacking FBW7 alpha, p53 induction was enhanced after DNA damage. Phosphodegron-mediated polyubiquitylation of p53 on Lys-132 had functional consequences, with cells in which FBW7 alpha-mediated p53 degradation was abrogated exhibiting enhancement of their tumorigenic potential. We conclude that p53, which previously has been reported to transactivate FBW7, is also targeted by the same E3 ligase for degradation, suggesting the presence of a regulatory feedback loop that controls p53 levels and functions during DNA damage.	[Tripathi, Vivek; Kaur, Ekjot; Kharat, Suhas Sampat; Hussain, Mansoor; Damodaran, Arun Prasath; Kulshrestha, Swati; Sengupta, Sagar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sengupta, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sagar@nii.ac.in	Hussain, Mansoor/GQI-2915-2022; Kharat, Suhas/V-2129-2019; Sengupta, Sagar/AGR-1063-2022	Kharat, Suhas/0000-0003-2283-7429; Sengupta, Sagar/0000-0002-6365-1770; Hussain, Mansoor/0000-0003-4260-2256; Kaur, Ekjot/0000-0002-7937-6646	National Institute of Immunology core funds; Department of Biotechnology India (DBT) [BT/MED/30/SP11263/2015, BT/PR23545/BRB/10/1593/2017]; Council of Scientific and Industrial Research (CSIR) India [37(1699)/17/EMR-11]; Science and Engineering Research Board (SERB) India [EMR/2017/000541]; J. C. Bose Fellowship by Science and Engineering Research Board (SERB) India [JCB/2018/000013]; Department of Science and Technology [DST/INSPIRE/04/2017/000088]	National Institute of Immunology core funds; Department of Biotechnology India (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India); Science and Engineering Research Board (SERB) India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); J. C. Bose Fellowship by Science and Engineering Research Board (SERB) India; Department of Science and Technology(Department of Science & Technology (India))	This work was supported by National Institute of Immunology core funds; Department of Biotechnology India (DBT) Grants BT/MED/30/SP11263/2015 and BT/PR23545/BRB/10/1593/2017; Council of Scientific and Industrial Research (CSIR) India Grants 37(1699)/17/EMR-11; Science and Engineering Research Board (SERB) India Grant EMR/2017/000541; and J. C. Bose Fellowship by Science and Engineering Research Board (SERB) India Grant JCB/2018/000013 (to S. S.) and Department of Science and Technology Grant DST/INSPIRE/04/2017/000088 for the INSPIRE Faculty Award (to E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali A, 2017, BIOCHEM J, V474, P1653, DOI 10.1042/BCJ20160304; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bunz F, 2002, CANCER RES, V62, P1129; Calcagno DQ, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-141; Cao J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002496; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dai XP, 2014, ONCOTARGET, V5, P3307, DOI 10.18632/oncotarget.1939; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Galanis E, 2005, GENE THER, V12, P437, DOI 10.1038/sj.gt.3302436; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Grim JE, 2012, MOL CELL BIOL, V32, P2160, DOI 10.1128/MCB.00305-12; Gupta S, 2014, CARCINOGENESIS, V35, P34, DOI 10.1093/carcin/bgt315; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jain AK, 2014, MOL CELL BIOL, V34, P2695, DOI 10.1128/MCB.01705-12; Kharat SS, 2016, ONCOGENE, V35, P1025, DOI 10.1038/onc.2015.157; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li Z, 2015, MOL CANCER RES, V13, P584, DOI 10.1158/1541-7786.MCR-14-0277-T; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Minella AC, 2007, ONCOGENE, V26, P6948, DOI 10.1038/sj.onc.1210518; Monke G, 2017, SCI REP-UK, V7, DOI 10.1038/srep46571; Nemunaitis J, 2007, CANCER GENE THER, V14, P885, DOI 10.1038/sj.cgt.7701080; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Perez-Losada J, 2005, CANCER RES, V65, P6488, DOI 10.1158/0008-5472.CAN-05-1294; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sengupta S, 2005, ONCOGENE, V24, P1738, DOI 10.1038/sj.onc.1208380; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Spruck CH, 2002, CANCER RES, V62, P4535; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan MJ, 2011, DEV CELL, V21, P1062, DOI 10.1016/j.devcel.2011.09.014; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200; Yeh CH, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0857-2; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846	53	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13224	13232		10.1074/jbc.AC119.008483	http://dx.doi.org/10.1074/jbc.AC119.008483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31346036	hybrid, Green Published			2022-12-26	WOS:000486417200003
J	Pang, K; Zhu, ZK; Zhu, SB; Han, LQ				Pang, Kun; Zhu, Zhongke; Zhu, Songbo; Han, Liqiang			A high dose of conjugated linoleic acid increases fatty liver and insulin resistance in lactating mice	PLOS ONE			English	Article							MILK-FAT; LIPID-METABOLISM; BODY-COMPOSITION; ADIPOSE-TISSUE; LITTER GROWTH; TRANS-10; RATS; ISOMERS; SUPPLEMENTATION; ENZYMES	This study aimed to evaluate the effects of a high dose of conjugated linoleic acid (CLA) on lactating mice. In one experiment, Kunming mice were separated into four groups (n = 6 per group); the control (CON) group received 3.0% linoleic acid (LA) oil, the L-CLA group received a mixture of 2.0% LA and 1.0% CLA, the M-CLA group received a mixture of 1.0% LA and a 2.0% CLA, and the H-CLA group received 3.0% CLA. Feeding proceeded from day 4 to day 10 of lactation. In a second experiment, a CON group received 3.0% LA, and an H-CLA group received 3.0% CLA. Plasma parameters were analyzed for all groups, and insulin tolerance tests (ITTs) were conducted. CLA treatment did not affect dam weight but significantly decreased the food intake of dams during lactation. Furthermore, CLA decreased the weight of pups on day 10 of lactation; this effect was attributed to lower milk fat of dams in the CLA group than in those of the other groups. Relative to mice in the CON group, the mice in the H-CLA group displayed increased liver weight and liver triglyceride (TG) content as well as higher TG content and gamma-glutamyl transferase (gamma-GT) activity in the plasma. Moreover, high-dose CLA resulted in insulin resistance, possibly affecting the red blood cell (RBC) and hemoglobin (HCB) levels in the plasma. In conclusion, lactating mice receiving a high dose of CLA exhibited fatty liver, insulin resistance, and impaired lactation performance.	[Pang, Kun; Zhu, Zhongke] Xinyang Agr & Forestry Univ, Coll Anim Sci & Vet Med, Xinyang, Peoples R China; [Zhu, Songbo] Zhengzhou Acad Agr & Forestry Sci, Zhengzhou, Henan, Peoples R China; [Han, Liqiang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Xinyang Agriculture & Forestry University; Henan Agricultural University	Han, LQ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China.	qlhan2001@126.com						Assumpcao RP, 2004, NUTRITION, V20, P806, DOI 10.1016/j.nut.2004.05.004; Belury MA, 2002, ANNU REV NUTR, V22, P505, DOI 10.1146/annurev.nutr.22.021302.121842; Bezan PN, 2018, EXP CLIN ENDOCR DIAB, V126, P379, DOI 10.1055/s-0043-118348; Bhattacharya A, 2006, J NUTR BIOCHEM, V17, P789, DOI 10.1016/j.jnutbio.2006.02.009; BURNOL AF, 1983, AM J PHYSIOL, V245, pE351, DOI 10.1152/ajpendo.1983.245.4.E351; Chapman C, 2000, J NUTR, V130, P146, DOI 10.1093/jn/130.2.146; CHIN SF, 1994, J NUTR, V124, P2344, DOI 10.1093/jn/124.12.2344; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Cocciardi RA, 2002, MILCHWISSENSCHAFT, V57, P90; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; FOLCH J, 1957, J BIOL CHEM, V226, P497; Harvatine KJ, 2014, J NUTR, V144, P1928, DOI 10.3945/jn.114.198911; Hayashi AA, 2007, J DAIRY RES, V74, P160, DOI 10.1017/S002202990600224X; HILLER A, 1948, J BIOL CHEM, V176, P1421; Jiang YZ, 2014, J GASTROEN HEPATOL, V29, P1508, DOI 10.1111/jgh.12580; Kadegowda AKG, 2010, J NUTR, V140, P919, DOI 10.3945/jn.109.110890; Lee KW, 2005, CRIT REV FOOD SCI, V45, P135, DOI 10.1080/10408690490911800; Lock AL, 2008, J DAIRY SCI, V91, P3291, DOI 10.3168/jds.2008-1071; Lock AL, 2006, J DAIRY SCI, V89, P1525, DOI 10.3168/jds.S0022-0302(06)72220-2; Loor JJ, 2003, BRIT J NUTR, V90, P1039, DOI 10.1079/BJN20031002; Masters N, 2002, LIPIDS, V37, P133, DOI 10.1007/s11745-002-0872-8; Perfield JW, 2007, J DAIRY SCI, V90, P2211, DOI 10.3168/jds.2006-745; Ringseis R, 2004, J NUTR, V134, P3327, DOI 10.1093/jn/134.12.3327; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Sandri EC, 2018, ANIMAL, V12, P1405, DOI [10.1017/S1751731117002956, 10.1017/s1751731117002956]; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Urrutia NL, 2018, BRIT J NUTR, V120, P259, DOI 10.1017/S0007114518001551; Scalerandi MV, 2014, NUTR HOSP, V29, P591, DOI [10.3305/NH.2014.29.3.7180, 10.3305/nh.2014.29.3.7180]; Vyas D, 2014, LIPIDS, V49, P641, DOI 10.1007/s11745-014-3906-7; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; West DB, 1998, AM J PHYSIOL-REG I, V275, pR667; Yang L, 2002, BRIT J NUTR, V87, P253, DOI 10.1079/BJN2001516; Zabala A, 2006, LIPIDS, V41, P993, DOI 10.1007/s11745-006-5050-5	33	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0214903	10.1371/journal.pone.0214903	http://dx.doi.org/10.1371/journal.pone.0214903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390361	Green Submitted, Green Published, gold			2022-12-26	WOS:000484999400002
J	Kostner, N; Jurgens, K; Labrenz, M; Herndl, GJ; Winter, C				Koestner, Nicole; Juergens, Klaus; Labrenz, Matthias; Herndl, Gerhard J.; Winter, Christian			Uneven host cell growth causes lysogenic virus induction in the Baltic Sea	PLOS ONE			English	Article							WATER COLUMN; PROPHAGE INDUCTION; ESCHERICHIA-COLI; MARINE-BACTERIA; MITOMYCIN-C; ANTIBIOTICS; MORTALITY; BACTERIOPLANKTON; SUSCEPTIBILITY; COMMUNITIES	In the Baltic Sea redoxcline, lysogenic viruses infecting prokaryotes have rarely been detected using the commonly used inducing agent mitomycin C. However, it is well known that not all viruses are induceable by mitomycin C and growing evidence suggests that changes in trophic conditions may trigger the induction of lysogenic viruses. We hypothesized that using antibiotics to simulate a strong change in trophic conditions for antibioticaresistant cells due to reduced competition for resources might lead to the induction of lysogenic viruses into the lytic cycle within these cells. This hypothesis was tested by incubating prokaryotes obtained throughout the Baltic Sea redoxcline in seawater with substantially reduced numbers of viruses. We used a mixture of the protein synthesis-inhibiting antibiotics streptomycin and erythromycin to induce the desired changes in trophic conditions for resistant cells and at the same time ensuring that no progeny viruses were formed in sensitive cells. No inducible lysogenic viruses could be detected in incubations amended with mitomycin C. Yet, the presence of streptomycin and erythromycin increased virus-induced mortality of prokaryotes by 56-930% compared to controls, resulting in the induction of lysogenic viruses equivalent to 2-14% of in situ prokaryotic abundance. The results indicate the existence of a previously unrecognized induction mechanism for lysogenic viruses in the Baltic Sea redoxcline, as the mode of action distinctly differs between the used antibiotics (no virus production within affected cells) and mitomycin C (lysogenic viruses are produced within affected cells). Obtaining accurate experimental data on levels of lysogeny in prokaryotic host cells remains challenging, as relying on mitomycin C alone may severely underestimate lysogeny.	[Koestner, Nicole; Herndl, Gerhard J.; Winter, Christian] Univ Vienna, Ctr Funct Ecol, Dept Limnol & Biooceanog, Vienna, Austria; [Juergens, Klaus; Labrenz, Matthias] Leibniz Inst Baltic Sea Res IOW, Dept Biol Oceanog, Rostock, Germany; [Herndl, Gerhard J.] Univ Utrecht, Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, NIOZ, Ab Den Burg, Netherlands	University of Vienna; Leibniz Institut fur Ostseeforschung Warnemunde; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Winter, C (corresponding author), Univ Vienna, Ctr Funct Ecol, Dept Limnol & Biooceanog, Vienna, Austria.	christian.winter@univie.ac.at	Herndl, Gerhard J./S-3011-2019	Herndl, Gerhard J./0000-0002-2223-2852; Jurgens, Klaus/0000-0002-7999-9368; Winter, Christian/0000-0001-6327-0209	Austrian Science Fund (FWF) [P28781-B21, P24413-B21]; European Research Council Advanced Grant (MEDEA) [268595]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council Advanced Grant (MEDEA)	This study was financially supported by the Austrian Science Fund (FWF) project P24413-B21 to CW. Additional financial support came from a European Research Council Advanced Grant (MEDEA, grant number 268595) and the Austrian Science Fund (FWF) project P28781-B21, both to GJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2012, MAR ECOL PROG SER, V467, P1, DOI 10.3354/meps10001; Berg C, 2015, ISME J, V9, P1319, DOI 10.1038/ismej.2014.218; Bettarel Y, 2011, MICROB ECOL, V62, P143, DOI 10.1007/s00248-011-9835-6; Binder B, 1999, AQUAT MICROB ECOL, V18, P207, DOI 10.3354/ame018207; BIZANEK R, 1992, BIOCHEMISTRY-US, V31, P3084, DOI 10.1021/bi00127a008; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; BUSSE HJ, 1992, J GEN MICROBIOL, V138, P551, DOI 10.1099/00221287-138-3-551; Chen F, 2006, APPL ENVIRON MICROB, V72, P4995, DOI 10.1128/AEM.00056-06; Cissoko M, 2008, FRESHWATER BIOL, V53, P1154, DOI 10.1111/j.1365-2427.2007.01930.x; De Paepe M, 2006, PLOS BIOL, V4, P1248, DOI 10.1371/journal.pbio.0040193; Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; Elmgren R., 2001, TheScientificWorldJOURNAL, V1, P371, DOI 10.1100/tsw.2001.291; Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049; Frank AH, 2016, AQUAT MICROB ECOL, V77, P99, DOI 10.3354/ame01792; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Grenni P, 2018, MICROCHEM J, V136, P25, DOI 10.1016/j.microc.2017.02.006; HELDAL M, 1991, MAR ECOL PROG SER, V72, P205, DOI 10.3354/meps072205; Hwang CY, 2002, AQUAT MICROB ECOL, V27, P211, DOI 10.3354/ame027211; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; Jost G, 2010, FEMS MICROBIOL ECOL, V71, P226, DOI 10.1111/j.1574-6941.2009.00798.x; Jurgens K, 2018, MICROBIAL ECOLOGY OC, P231; Khelaifia S, 2012, CLIN MICROBIOL INFEC, V18, P841, DOI 10.1111/j.1469-0691.2012.03913.x; Knowles B, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.64; Kostner N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178467; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Korneeva VA, 2015, MICROBIOLOGY+, V84, P268, DOI 10.1134/S002626171502006X; Labrenz M, 2007, AQUAT MICROB ECOL, V46, P177, DOI 10.3354/ame046177; Labrenz M, 2010, ISME J, V4, P1496, DOI 10.1038/ismej.2010.78; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Meyer KM, 2008, ANNU REV EARTH PL SC, V36, P251, DOI 10.1146/annurev.earth.36.031207.124256; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Moskot M, 2012, INT MICROBIOL, V15, P131, DOI 10.2436/20.1501.01.166; Mudryk ZJ, 2015, BALTIC COASTAL ZONE, V19; Parvathi A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110588; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rogge A, 2017, ENVIRON MICROBIOL, V19, P2495, DOI 10.1111/1462-2920.13783; Rozanov DV, 1998, J BACTERIOL, V180, P6306; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Weber F, 2014, AQUAT MICROB ECOL, V73, P1, DOI 10.3354/ame01702; Weinbauer MG, 1999, AQUAT MICROB ECOL, V18, P217, DOI 10.3354/ame018217; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Weng MW, 2010, NUCLEIC ACIDS RES, V38, P6976, DOI 10.1093/nar/gkq576; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Williamson SJ, 2006, MICROB ECOL, V52, P217, DOI 10.1007/s00248-006-9113-1; Williamson SJ, 2004, AQUAT MICROB ECOL, V36, P9, DOI 10.3354/ame036009; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Winter C, 2018, ECOLOGY, V99, P700, DOI 10.1002/ecy.2135	54	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220716	10.1371/journal.pone.0220716	http://dx.doi.org/10.1371/journal.pone.0220716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386696	Green Submitted, Green Published, gold			2022-12-26	WOS:000484997100033
J	Worbes, M; Schongart, J				Worbes, Martin; Schongart, Jochen			Measures for sustainable forest management in the tropics - A tree-ring based case study on tree growth and forest dynamics in a Central Amazonian lowland moist forest	PLOS ONE			English	Article							MAHOGANY SWIETENIA-MACROPHYLLA; WOOD DENSITY; AGE; PATTERNS; INCREMENT; RAINFALL; CEDRELA; BIOMASS; STAND; RADIOCARBON	The conservation of tropical forests is recognized as one of the most important challenges for forestry, ecology and politics. Besides strict protection, the sustainable management of natural forests should be enhanced as a key part of the foundation for the maintenance of tropical rain forest ecosystems. Due to methodological reasons it has been complicated to attain reliable growth data to plan sustainable felling cycles and rotation periods. Tree ring analyses enable the estimation of growth rates over the entire life span of trees and their age as well as giving hints from forest dynamics in previous centuries. For tree ring analysis, stem disk samples were taken from three important commercial tree species (Cariniana micrantha, Caryocar villosum and Manilkara huberi) in the upland (terra firme) forests of the Precious Woods Amazon logging company near Itacoatiara, Brazil. Based on radiocarbon estimates of individual growth zones, the annual nature of tree rings was proven for the three species. Tree rings were measured and the results used together with height estimates to model diameter, height and volume growth. The age of the eldest tree, a C. micrantha, was 585 yrs with 165 cm in diameter. The species' diameter increments range from 0.20 +/- 0.12 cm yr(-1) to 0.29 +/- 0.08 cm yr(-1). At first sight, this is considerably lower than increments reported from other Amazonian or African timber species. Considering the respective wood density there is no significant difference in growth performance of dominant timber species across continents. The interpretation of lifetime tree ring curves indicate differences in shadow tolerance among species, the persistence of individuals in the understory for up to 150 years and natural stand dynamics without major disturbances. Management criteria should be adapted for the measured growth rates as they differed considerably from the Brazilian standards fixed by laws (felling cycle of 25-35 years and a common minimum logging diameter of 50 cm). Felling cycles should be increased to 32-51 years and minimum logging diameters to 63-123 cm depending on the species.	[Worbes, Martin] Georg August Univ, Dept Crop Sci, Grisebachstr, Gottingen, Germany; [Schongart, Jochen] INPA, Manaus, Amazonas, Brazil	University of Gottingen; Institute Nacional de Pesquisas da Amazonia	Worbes, M (corresponding author), Georg August Univ, Dept Crop Sci, Grisebachstr, Gottingen, Germany.	mworbes@gwdg.de			Stiftung zur Forderung der nachhaltigen Forstwirtschaft in den Tropen, Zurich, Switzerland; Brazilian Council for Scientific and Technological Development [309199/2014-0]	Stiftung zur Forderung der nachhaltigen Forstwirtschaft in den Tropen, Zurich, Switzerland; Brazilian Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MWwas supported by Stiftung zur Forderung der nachhaltigen Forstwirtschaft in den Tropen, Zurich, Switzerland. JS was supported by Grant number: 309199/2014-0, Brazilian Council for Scientific and Technological Development.	Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Aubreville A., 1938, ANN ACAD SCI COLONIA, V9, P1, DOI DOI 10.2307/1787233; Baker PJ, 2005, ECOL MONOGR, V75, P317, DOI 10.1890/04-0488; Berlage H.P., 1931, TECTONA, V24, P939; BOOT RGA, 1995, ECOL APPL, V5, P896, DOI 10.2307/2269340; Brienen RJW, 2006, FOREST ECOL MANAG, V226, P256, DOI 10.1016/j.foreco.2006.01.038; Brienen RJW, 2006, J ECOL, V94, P481, DOI 10.1111/j.1365-2745.2005.01080.x; Brienen RJW, 2005, OECOLOGIA, V146, P1, DOI 10.1007/s00442-005-0160-y; Brienen RJW, 2016, TREE PHYSIOL-NETH, V6, P439, DOI 10.1007/978-3-319-27422-5_20; CANNELL MGR, 1984, FOREST ECOL MANAG, V8, P299, DOI 10.1016/0378-1127(84)90062-8; Castro TD, 2014, CIENC FLOREST, V24, P161, DOI 10.5902/1980509813333; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Clement C.R., 1993, SELECTED SPECIES STR; Coster C., 1928, ANN JARD BOT BUITENZ, V37, P49; da Cunha TA, 2016, FOREST ECOL MANAG, V365, P174, DOI 10.1016/j.foreco.2015.12.031; da Fonseca SF, 2009, TREES-STRUCT FUNCT, V23, P127, DOI 10.1007/s00468-008-0261-4; da Silva RP, 2002, FOREST ECOL MANAG, V166, P295, DOI 10.1016/S0378-1127(01)00678-8; De Ridder M, 2013, FOREST ECOL MANAG, V304, P417, DOI 10.1016/j.foreco.2013.05.007; DEGRAAF NR, 1990, ALTERNATIVES TO DEFORESTATION : STEPS TOWARD SUSTAINABLE USE TO THE AMAZON RAIN FOREST, P116; Dunisch O, 2003, TREES-STRUCT FUNCT, V17, P244, DOI 10.1007/s00468-002-0230-2; Edwards DP, 2014, TRENDS ECOL EVOL, V29, P511, DOI 10.1016/j.tree.2014.07.003; Fearnside P., 2017, OXFORD RES ENCY ENV, DOI [10.1093/acrefore/9780199389414.013.102, DOI 10.1093/ACREFORE/9780199389414.013.102]; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Free CM, 2017, FOREST ECOL MANAG, V386, P81, DOI 10.1016/j.foreco.2016.09.031; Free CM, 2014, FOREST ECOL MANAG, V330, P46, DOI 10.1016/j.foreco.2014.05.057; FSC, 2015, FSCSTD01001V52 EN; Groenendijk P, 2014, FOREST ECOL MANAG, V323, P65, DOI 10.1016/j.foreco.2014.03.037; Grogan J, 2014, J APPL ECOL, V51, P664, DOI 10.1111/1365-2664.12210; Henry M, 2010, FOREST ECOL MANAG, V260, P1375, DOI 10.1016/j.foreco.2010.07.040; Hua Q, 2013, RADIOCARBON, V55, P2059, DOI 10.2458/azu_js_rc.v55i2.16177; Kurokawa H, 2003, J TROP ECOL, V19, P1, DOI 10.1017/S0266467403003018; Lamprecht H., 1989, SILVICULTURE TROPICS; Laurance WF, 2004, FOREST ECOL MANAG, V190, P131, DOI 10.1016/j.foreco.2003.09.011; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorenzi, 2002, RVORES BRASILEIRAS M; Loureiro A, 1968, CATALOGO MADEIRAS AM; Loureiro AA, 1968, CATALOGO MADEIRAS AM, P411; Malhi Y, 2010, CURR OPIN ENV SUST, V2, P237, DOI 10.1016/j.cosust.2010.08.002; Nebel G, 2001, FOREST ECOL MANAG, V150, P115, DOI 10.1016/S0378-1127(00)00685-X; Newbery DM, 2013, ECOL MONOGR, V83, P339, DOI 10.1890/12-1699.1; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; NYDAL R, 1970, J GEOPHYS RES, V75, P2271, DOI 10.1029/JC075i012p02271; Oldeman R.A.A., 1983, TROPICAL RAIN FOREST, P139; Pires JM, 1984, AMAZON LIMNOLOGY LAN, P581, DOI DOI 10.1007/978-94-009-6542-3; PRANCE GT, 1990, 4 NEOTROPICAL RAINFO, P112; Precious Woods, ANN REP 2017; Procopio LC, 2010, ACTA BOT BRAS, V24, P883, DOI 10.1590/S0102-33062010000400002; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; Rosa SA, 2017, TREES-STRUCT FUNCT, V31, P729, DOI 10.1007/s00468-016-1503-5; Rozendaal DMA, 2010, FOREST ECOL MANAG, V259, P2292, DOI 10.1016/j.foreco.2010.02.030; Santini NS, 2012, TREES-STRUCT FUNCT, V26, P1555, DOI 10.1007/s00468-012-0729-0; Schongart J, 2011, BIOGEOSCIENCES, V8, P3407, DOI 10.5194/bg-8-3407-2011; Schongart J, 2008, FOREST ECOL MANAG, V256, P46, DOI 10.1016/j.foreco.2008.03.037; Schongart J, 2007, ANN FOREST SCI, V64, P657, DOI 10.1051/forest:2007044; Schongart J, 2006, GLOBAL CHANGE BIOL, V12, P1139, DOI 10.1111/j.1365-2486.2006.01154.x; Schongart J, 2015, BIOTROPICA, V47, P550, DOI 10.1111/btp.12243; Schongart J., 2010, AMAZONIAN FLOODPLAIN, P437, DOI DOI 10.1007/978-90-481-8725-6_21; Schongart J, 2017, ECOL STUD-ANAL SYNTH, V231, P35, DOI 10.1007/978-3-319-61669-8_3; SFB/IMAZON, 2010, AT MAD AM BRAS PROD; Souza D. V., 2014, FLORESTA, V44, P485, DOI [10.5380/rf.v44i3.29423, DOI 10.5380/RF.V44I3.29423]; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; van Gardingen PR, 2006, FOREST ECOL MANAG, V231, P184, DOI 10.1016/j.foreco.2006.05.047; van Rheenen HMPJB, 2004, FOREST ECOL MANAG, V200, P39, DOI 10.1016/j.foreco.2004.06.024; VETTER RE, 1989, IAWA BULL, V10, P133, DOI 10.1163/22941932-90000481; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Vlam M, 2014, OECOLOGIA, V174, P1449, DOI 10.1007/s00442-013-2846-x; Wagner FH, 2016, BIOGEOSCIENCES, V13, P2537, DOI 10.5194/bg-13-2537-2016; Whitmore T.C, 1990, INTRO TROPICAL RAIN; Worbes M, 1999, J ECOL, V87, P391, DOI 10.1046/j.1365-2745.1999.00361.x; WORBES M, 1989, IAWA BULL, V10, P109, DOI 10.1163/22941932-90000479; Worbes M, 2003, FOREST ECOL MANAG, V173, P105, DOI 10.1016/S0378-1127(01)00814-3; Worbes M, 1999, IAWA J, V20, P255, DOI 10.1163/22941932-90000689; WORBES M, 1989, ECOLOGY, V70, P503, DOI 10.2307/1937554; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]	77	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219770	10.1371/journal.pone.0219770	http://dx.doi.org/10.1371/journal.pone.0219770			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386676	gold, Green Published, Green Submitted			2022-12-26	WOS:000484997100010
J	Huang, WM; Sung, SH; Yu, WC; Cheng, HM; Huang, CJ; Guo, CY; Lu, DY; Lee, CW; Chen, CH				Huang, Wei-Ming; Sung, Shih-Hsien; Yu, Wen-Chung; Cheng, Hao-Min; Huang, Chi-Jung; Guo, Chao-Yu; Lu, Dai-Yin; Lee, Ching-Wei; Chen, Chen-Huan			Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction	PLOS ONE			English	Article							ARTERIAL STIFFNESS; VENTRICULAR STRUCTURE; WAVE REFLECTIONS; CHINESE PATIENTS; MORTALITY; SURVIVAL; HOSPITALIZATION; DETERMINANTS; DYSFUNCTION; MORBIDITY	Background Heart failure with mid-range ejection fraction (HFmrEF) has been proposed as a new phenotype of heart failure. We therefore investigated the pulsatile hemodynamic characteristics and outcomes in patients with HFmrEF, in comparison with those with reduced (HFrEF) or preserved (HFpEF) ejection fraction. Methods The study was composed of two cohorts of patients hospitalized due to acute heart failure. Pulsatile hemodynamic measures, including carotid-femoral pulse wave velocity (cf-PWV), carotid pulse pressure (cPP), amplitude of the backward pressure wave (Pb) and carotid augmentation index (cAIx), were recorded on admission and before discharge in Cohort A (n = 230, mean age 69.9 +/- 15.4 years), and long-term follow-up was performed in Cohort B (n = 2677, mean age 76.3 +/- 33.4 years). Results In Cohort A, patients with HFmrEF had persistently greater cf-PWV, cPP, Pb, and cAI than those with HFrEF, both on admission and before discharge. In contrast, patients with HFmrEF and HFpEF had similar pulsatile hemodynamic characteristics. In cohort B, patients with HFmrEF and HFrEF had similar three-year mortality rates and both were significantly higher than that in patients with HFpEF (both P values < 0.05). Conclusions Patients with HFmrEF were characterized by a worse left ventricular systolic function than patients with HFpEF and excessive wave reflections than patients with HFrEF. Future studies are required to confirm that the unfavorable ventriculo-arterial coupling in HFmrEF might play a role in the pathogenesis of high long-term mortality in these patients.	[Huang, Wei-Ming; Sung, Shih-Hsien; Yu, Wen-Chung; Lu, Dai-Yin; Lee, Ching-Wei; Chen, Chen-Huan] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Huang, Wei-Ming; Sung, Shih-Hsien; Yu, Wen-Chung; Cheng, Hao-Min; Huang, Chi-Jung; Lu, Dai-Yin; Lee, Ching-Wei; Chen, Chen-Huan] Natl Yang Ming Univ, Dept Med, Taipei, Taiwan; [Huang, Wei-Ming; Sung, Shih-Hsien; Guo, Chao-Yu; Chen, Chen-Huan] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Cheng, Hao-Min; Huang, Chi-Jung] Taipei Vet Gen Hosp, Dept Med Educ, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Sung, SH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Sung, SH (corresponding author), Natl Yang Ming Univ, Dept Med, Taipei, Taiwan.; Sung, SH (corresponding author), Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan.	mr.sungsh@gmail.com	Chen, Chen-Huan/AAE-4036-2022	Sung, Shih-Hsien/0000-0001-9441-1836; Guo, Chao-Yu/0000-0002-9066-9933	Ministry of Health and Welfare, Taiwan [MOHW-104-TDU-B-211-113003, MOHW-105-TDU-B-211-133017, MOHW106-TDU-B-211-113001, MOHW107-TDU-B-211-123001]; Taipei Veterans General Hospital [V100C-145, V101C-092, V102C-119, V103B-017, V104C-172]	Ministry of Health and Welfare, Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work received support from: Ministry of Health and Welfare, Taiwan with grant - MOHW-104-TDU-B-211-113003, MOHW-105-TDU-B-211-133017, MOHW106-TDU-B-211-113001, MOHW107-TDU-B-211-123001 (Dr. Shih-Hsien Sung); Taipei Veterans General Hospital - (V100C-145, V101C-092, V102C-119, V103B-017, and V104C-172) (Dr. Shih-Hsien Sung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Cheng HM, 2008, EUR J HEART FAIL, V10, P1192, DOI 10.1016/j.ejheart.2008.09.003; Cheng YL, 2016, AM J CARDIOL, V117, P399, DOI 10.1016/j.amjcard.2015.11.011; Chow B, 2015, HEART FAIL REV, V20, P291, DOI 10.1007/s10741-015-9471-1; Cotter G, 2003, EUR J HEART FAIL, V5, P443, DOI 10.1016/S1388-9842(03)00100-4; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Gladden JD, 2014, PFLUG ARCH EUR J PHY, V466, P1037, DOI 10.1007/s00424-014-1480-8; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; Halabi CM, 2015, AM J PHYSIOL-HEART C, V309, pH1008, DOI 10.1152/ajpheart.00288.2015; He KL, 2009, AM J CARDIOL, V103, P845, DOI 10.1016/j.amjcard.2008.11.050; Huang WM, 2016, CIRC J, V80, P404, DOI 10.1253/circj.CJ-15-0964; Lam CSP, 2014, EUR J HEART FAIL, V16, P1049, DOI 10.1002/ejhf.159; Lekavich CL, 2015, HEART FAIL REV, V20, P643, DOI 10.1007/s10741-015-9506-7; Lu DY, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002668; Lund LH, 2016, J CARD FAIL, V22, P769, DOI 10.1016/j.cardfail.2016.07.439; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Milo-Cotter O, 2007, EUR J HEART FAIL, V9, P178, DOI 10.1016/j.ejheart.2006.06.004; Mottram PM, 2005, HEART, V91, P1551, DOI 10.1136/hrt.2004.046805; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Parragh S, 2015, INT J CARDIOL, V190, P308, DOI 10.1016/j.ijcard.2015.04.183; Penicka M, 2010, J AM COLL CARDIOL, V55, P1700, DOI 10.1016/j.jacc.2009.11.076; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Redfield MM, 2016, NEW ENGL J MED, V375, P1868, DOI 10.1056/NEJMcp1511175; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; SCHILLER NB, 1979, CIRCULATION, V60, P547, DOI 10.1161/01.CIR.60.3.547; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Sung SH, 2014, PULSE, V2, P18, DOI 10.1159/000367645; Sung SH, 2013, HYPERTENSION, V61, P1346, DOI 10.1161/HYPERTENSIONAHA.111.00569; Sung SH, 2012, EUR J HEART FAIL, V14, P1348, DOI 10.1093/eurjhf/hfs124; Sung SH, 2011, AM J HYPERTENS, V24, P775, DOI 10.1038/ajh.2011.26; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tsao CW, 2015, J AM HEART ASSOC, V4, P11; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220183	10.1371/journal.pone.0220183	http://dx.doi.org/10.1371/journal.pone.0220183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381586	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600012
J	Li, ZY; Konisky, DM; Zirogiannis, N				Li, Zhengyan; Konisky, David M.; Zirogiannis, Nikolaos			Racial, ethnic, and income disparities in air pollution: A study of excess emissions in Texas	PLOS ONE			English	Article							ENVIRONMENTAL JUSTICE; HAZARDOUS-WASTE; OZONE FORMATION; HUMAN HEALTH; EVENTS; HOUSTON; RISK; ENFORCEMENT; INEQUITIES; INEQUALITY	Objective Excess emissions are pollutant releases that occur during periods of startups, shutdowns or malfunctions and are considered violations of the U.S. Clean Air Act. They are an important, but understudied and under-regulated, category of pollution releases given their frequency and magnitude. In this paper, we examine the demographic correlates of excess emissions, using data from industrial sources in Texas. Methods We conduct two complementary sets of analyses: one at the census tract level and one at the facility level. At the census tract level, we use a multinomial logit model to examine the relationships between racial, ethnic, and income characteristics and the incidence of excess emissions. At the facility level, we first estimate a logit model to examine whether these characteristics are associated with facilities that emit excess emissions, and then, conditional on the presence of excess emissions, we use ordinary least square regression to estimate their correlation with the magnitude of releases. Results Across our analyses, we find that the percentage of Black population and median household income are positively associated with excess emissions; percentage of college graduate, population density, median housing value, and percentage of owner-occupied housing unit are negatively associated with excess emissions. We, however, have not found a clear and significant relationship between the percentage of Hispanic population and excess emissions.	[Li, Zhengyan; Konisky, David M.; Zirogiannis, Nikolaos] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Li, ZY (corresponding author), Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.	zl31@indiana.edu	Li, Zhengyan/GSD-3935-2022; Zirogiannis, Nikolaos/GWC-7057-2022	Zirogiannis, Nikolaos/0000-0003-4903-8897; Konisky, David/0000-0002-1146-3938; Li, Zhengyan/0000-0003-2006-2922				Adar SD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001430; Arora S, 1999, SOUTHERN ECON J, V65, P691, DOI 10.2307/1061271; Ash M, 2004, SOC SCI QUART, V85, P441, DOI 10.1111/j.0038-4941.2004.08502011.x; Banzhaf S, 2019, J ECON PERSPECT, V33, P185, DOI 10.1257/jep.33.1.185; Been V, 1997, ECOL LAW QUART, V24, P1; Been V., 1995, J LAND USE ENV LAW, V11, P36; Bento A, 2015, REV ECON STAT, V97, P610, DOI 10.1162/REST_a_00493; Boer JT, 1997, SOC SCI QUART, V78, P793; Brulle RJ, 2006, ANNU REV PUBL HEALTH, V27, P103, DOI 10.1146/annurev.publhealth.27.021405.102124; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Choi YJ, 2006, ATMOS ENVIRON, V40, P5181, DOI 10.1016/j.atmosenv.2006.04.025; Clark LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094431; Cole Luke, 2001, GROUND ENV RACISM RI; Cushing L, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002604; Daniels G, 1999, SOC SCI QUART, V80, P244; Environmental Integrity Project, 2004, GAM SYST OFF THE BOO; Environmental Protection Agency U.S, 2019, EPAR04OAR20190303; Gray WB, 2004, J ENVIRON ECON MANAG, V47, P510, DOI 10.1016/j.jeem.2003.01.001; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Hird JA, 1998, SOC SCI QUART, V79, P693; Hollingsworth AJ, 2019, HLTH CONSEQUENCES WE, DOI [10.2139/ssrn.3382541, DOI 10.2139/SSRN.3382541]; Jones MR, 2014, AM J PUBLIC HEALTH, V104, P2130, DOI 10.2105/AJPH.2014.302135; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Konisky DM, 2018, POLICY STUD J, V46, P7, DOI 10.1111/psj.12203; Konisky DM, 2013, J POLIT, V75, P506, DOI 10.1017/S0022381613000170; Konisky DM, 2009, POLICY STUD J, V37, P475, DOI 10.1111/j.1541-0072.2009.00324.x; Konisky DM, 2009, J POLICY ANAL MANAG, V28, P102, DOI 10.1002/pam.20404; Konisky DM, 2015, AM COMP ENVIRON POLI, P1, DOI 10.7551/mitpress/9780262028837.001.0001; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Kulkarni P, 2007, ENV SCI TECHNOLOGY, V41; Mccoy BJ, 2010, ATMOS ENVIRON, V44, P4230, DOI 10.1016/j.atmosenv.2010.07.008; Mohai P, 2007, SOC PROBL, V54, P343, DOI 10.1525/sp.2007.54.3.343; Mohai P, 2006, DEMOGRAPHY, V43, P383, DOI 10.1353/dem.2006.0017; Mohai P, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125011; Mohai Paul, 2009, Am J Public Health, V99 Suppl 3, pS649, DOI 10.2105/AJPH.2007.131383; Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI 10.1146/annurev.environ.082508-094348; Morello-Frosch R, 2001, URBAN AFF REV, V36, P551, DOI 10.1177/10780870122184993; Muller NZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192461; Murphy CF, 2005, ATMOS ENVIRON, V39, P3785, DOI 10.1016/j.atmosenv.2005.02.051; Nam J, 2006, ATMOS ENVIRON, V40, P5329, DOI 10.1016/j.atmosenv.2006.05.002; Ozymy J, 2011, REV POLICY RES, V28, P365, DOI 10.1111/j.1541-1338.2011.00502.x; Pastor M, 2001, J URBAN AFF, V23, P1, DOI 10.1111/0735-2166.00072; PERLIN SA, 1995, ENVIRON SCI TECHNOL, V29, P69, DOI 10.1021/es00001a008; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Ringquist EJ, 2005, J POLICY ANAL MANAG, V24, P223, DOI 10.1002/pam.20088; Ringquist EJ, 1997, SOC SCI QUART, V78, P811; Schwarz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122051; Shadbegian R.J., 2012, POLITICAL EC ENV JUS, P225, DOI [10.11126/stanford/9780804780612.001.0001, DOI 10.11126/STANFORD/9780804780612.001.0001]; Taylor DE, 2000, AM BEHAV SCI, V43, P508, DOI 10.1177/0002764200043004003; Texas Commission on Environmental Quality, 2016, TEX ADM COD GEN AIR; U.S. Environmental Protection Agency, DESCR TRI DAT TERMS; U.S. Environmental Protection Agency, 2018, SUMM NON AR POP EXP; U.S. Environmental Protection Agency, 2015, STAT IMPL PLANS RESP; U.S. Environmental Protection Agency, 2019, EPAR06OAR20180770; Viscusi WK, 1999, AM ECON REV, V89, P1010, DOI 10.1257/aer.89.4.1010; Vizuete W, 2008, ATMOS ENVIRON, V42, P7641, DOI 10.1016/j.atmosenv.2008.05.063; Wolverton Ann, 2012, POLITICAL EC ENV JUS, P119; Zirogiannis N, 2018, ENVIRON SCI TECHNOL, V52, P2482, DOI 10.1021/acs.est.7b04887	58	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220696	10.1371/journal.pone.0220696	http://dx.doi.org/10.1371/journal.pone.0220696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374099	Green Submitted, gold, Green Published			2022-12-26	WOS:000484991500026
J	Meurisse, GM; Bastien, GJ; Schepens, B				Meurisse, Guillaume M.; Bastien, Guillaume J.; Schepens, Benedicte			The step-to-step transition mode: A potential indicator of first-fall risk in elderly adults?	PLOS ONE			English	Article							POSTURAL STABILITY; BALANCE DISORDERS; TINETTI TEST; LEVEL GAIT; FALL-RISK; WALKING; PEOPLE; CONSEQUENCES; MECHANICS; FORCES		[Meurisse, Guillaume M.; Bastien, Guillaume J.; Schepens, Benedicte] Catholic Univ Louvain, Inst Neurosci IoNS, Lab Physiol & Biomech Locomot, Louvain La Neuve, Belgium	Universite Catholique Louvain	Schepens, B (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, Lab Physiol & Biomech Locomot, Louvain La Neuve, Belgium.	benedicte.schepens@uclouvain.be		Schepens, Benedicte/0000-0002-8352-1244	Universite catholique de Louvain	Universite catholique de Louvain	This work was supported by the Universite catholique de Louvain (BE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk PG, 2009, J EXP BIOL, V212, P2668, DOI 10.1242/jeb.027581; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Boyer KA, 2017, EXP GERONTOL, V95, P63, DOI 10.1016/j.exger.2017.05.005; Breniere Y, 1998, EXP BRAIN RES, V121, P255, DOI 10.1007/s002210050458; Browne MG, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171673; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; Chastan N, 2010, NEUROSCI LETT, V469, P400, DOI 10.1016/j.neulet.2009.12.038; Chastan N, 2009, BRAIN, V132, P172, DOI 10.1093/brain/awn294; Chastan N, 2008, MOVEMENT DISORD, V23, P366, DOI 10.1002/mds.21840; Chastan N, 2009, MOVEMENT DISORD, V24, P188, DOI 10.1002/mds.22269; Chong RKY, 2009, NEUROSCI LETT, V458, P23, DOI 10.1016/j.neulet.2009.04.022; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Demain A, 2014, J NEUROL, V261, P196, DOI 10.1007/s00415-013-7174-x; Edginton Bigelow K., 2010, THE JOURNALS OF GERO, V66, P228; Franz JR, 2016, EXERC SPORT SCI REV, V44, P129, DOI 10.1249/JES.0000000000000086; Franz JR, 2013, J BIOMECH, V46, P535, DOI 10.1016/j.jbiomech.2012.09.032; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Gerdhem P, 2005, J CLIN EPIDEMIOL, V58, P226, DOI 10.1016/j.jclinepi.2004.06.013; Honeine JL, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.229; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; Konig N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0353; Koepke S, 2006, Z GERONTOL GERIATR, V39, P288, DOI 10.1007/s00391-006-0398-y; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Meurisse GM, 2019, J BIOMECH, V83, P253, DOI 10.1016/j.jbiomech.2018.12.001; Meurisse GM, 2016, GAIT POSTURE, V43, P245, DOI 10.1016/j.gaitpost.2015.10.005; Miodonska Z, 2018, BIOMED SIGNAL PROCES, V44, P38, DOI 10.1016/j.bspc.2018.03.012; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; Panella L, 2002, FUNCT NEUROL, V17, P25; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Schloemer SA, 2017, ANN BIOMED ENG, V45, P695, DOI 10.1007/s10439-016-1713-4; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Welter ML, 2007, GAIT POSTURE, V26, P393, DOI 10.1016/j.gaitpost.2006.10.005; Yardley L, 2002, GERONTOLOGIST, V42, P17, DOI 10.1093/geront/42.1.17	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220791	10.1371/journal.pone.0220791	http://dx.doi.org/10.1371/journal.pone.0220791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374108	Green Published, gold, Green Submitted			2022-12-26	WOS:000484991500034
J	Cheng, C; Liu, XB; Bi, SJ; Lu, QH; Zhang, J				Cheng, Chao; Liu, Xiao-Bo; Bi, Shao-Jie; Lu, Qing-Hua; Zhang, Juan			Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; DIABETES-MELLITUS; PREDICTORS; EVENTS; RISK; ASSOCIATION; MECHANISMS; IMPACT; DEATH; GFR	Background/Aim No-reflow is a serious and frequent event during primary percutaneous coronary intervention (PPCI) for acute ST segment elevation myocardial infarction (STEMI). The aim of this study was to identify possible predictors for no-reflow. Patients and methods We investigated 218 patients with acute anterior STEMI who underwent PPCI from December 2016 to December 2018. No-reflow was defined as a coronary TIMI flow grade of <= 2. TIMI flow grade 3 was defined as normal reflow. Results In our study, the no-reflow phenomenon was observed in 39 patients (18%) during angiography. The patients of no-reflow group were found to be more older, diabetics, longer pain-toballoon time, lower blood pressure, higher platelet counts and higher levels of D-Dimer and Cystatin C (Cys-C). In multivariate logistic regression analysis, only diabetes (OR = 0.371, 95% CI: 0.157-0.872, P = 0.023), longer pain-to-balloon time (OR = 1.147, 95% CI: 1.015-1.297, P = 0.028) and higher Cys-C level (OR = 10.07, 95% CI: 2.340-43.377, P = 0.002) were predictors for no-reflow. Conclusion Cys-C might be a useful predictor for the no-reflow phenomenon after PPCI in STEMI patients. It might help to screen STEMI patients with high risk of no-reflow on admission.	[Cheng, Chao; Bi, Shao-Jie; Lu, Qing-Hua; Zhang, Juan] Shandong Univ, Dept Cardiol, Hosp 2, Jinan, Shandong, Peoples R China; [Liu, Xiao-Bo] Shandong Blood Ctr, Jinan, Shandong, Peoples R China	Shandong University	Zhang, J (corresponding author), Shandong Univ, Dept Cardiol, Hosp 2, Jinan, Shandong, Peoples R China.	awwa69040@sina.com	zhang, juan/AAO-8519-2020	zhang, juan/0000-0001-6241-7176	National Natural Science Foundation of China (Youth Foundation) [81600284]	National Natural Science Foundation of China (Youth Foundation)	This work was supported by the National Natural Science Foundation of China (Youth Foundation), Grant Number: 81600284, Recipient: Juan Zhang, URL: http://www.nsfc.gov.cn/.	Abdi Seifollah, 2015, Res Cardiovasc Med, V4, pe25414, DOI 10.5812/cardiovascmed.4(2)2015.25414; Alidoosti Mohammad, 2018, J Tehran Heart Cent, V13, P108; Aronson D, 1996, J AM COLL CARDIOL, V27, P528, DOI 10.1016/0735-1097(95)00496-3; Arpegard J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001467; Bonderman D, 2002, BLOOD, V99, P2794, DOI 10.1182/blood.V99.8.2794; Brosh D, 2007, AM J CARDIOL, V99, P442, DOI 10.1016/j.amjcard.2006.08.054; Choo EH, 2014, CORONARY ARTERY DIS, V25, P392, DOI 10.1097/MCA.0000000000000108; Correa S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009077; Eeckhout E, 2001, EUR HEART J, V22, P729, DOI 10.1053/euhj.2000.2172; Gao RH, 2018, MED SCI MONITOR, V24, P3549, DOI 10.12659/MSM.908980; Gibson CM, 2004, CIRCULATION, V109, P3096, DOI 10.1161/01.CIR.0000134278.50359.CB; Harrison RW, 2013, AM J CARDIOL, V111, P178, DOI 10.1016/j.amjcard.2012.09.015; Jinnouchi H, 2014, HEART VESSELS, V29, P429, DOI 10.1007/s00380-013-0379-1; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keller T, 2009, EUR HEART J, V30, P314, DOI 10.1093/eurheartj/ehn598; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Kubisz P, 2010, ACTA DIABETOL, V47, P119, DOI 10.1007/s00592-009-0127-2; Kurtul A, 2015, ANGIOLOGY, V66, P644, DOI 10.1177/0003319714546738; Li DB, 2010, CLIN CARDIOL, V33, pE7, DOI 10.1002/clc.20634; Macdonald J, 2006, AM J KIDNEY DIS, V48, P712, DOI 10.1053/j.ajkd.2006.07.001; Mazhar J, 2016, IJC HEART VASC, V10, P8, DOI 10.1016/j.ijcha.2015.11.002; Mirbolouk F, 2018, J CARDIOVASC THORAC, V10, P46, DOI 10.15171/jcvtr.2018.08; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Ni L, 2007, STROKE, V38, P3287, DOI 10.1161/STROKEAHA.107.489625; Rezkalla Shereif H, 2005, Curr Treat Options Cardiovasc Med, V7, P75, DOI 10.1007/s11936-005-0008-0; Schwartz BG, 2012, J MOL CELL CARDIOL, V52, P873, DOI 10.1016/j.yjmcc.2011.06.009; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak Michael G, 2005, Am J Med, V118, P1416; Silva D, 2012, AM J CARDIOL, V109, P1431, DOI 10.1016/j.amjcard.2012.01.356; Singh D, 2007, NEPHROL DIAL TRANSPL, V22, P1087, DOI 10.1093/ndt/gfl744; Tang L, 2016, HEART VESSELS, V31, P1456, DOI 10.1007/s00380-015-0764-z; Wagdy S, 2016, CLIN MED INSIGHTS-CA, V10, P19, DOI 10.4137/CMC.S35555; Woitas RP, 2013, ATHEROSCLEROSIS, V229, P541, DOI 10.1016/j.atherosclerosis.2013.04.027; Wong DTL, 2013, INT J CARDIOL, V167, P1798, DOI 10.1016/j.ijcard.2012.12.049; Yetkin E, 2015, ANGIOGENESIS, V18, P201, DOI 10.1007/s10456-015-9460-y; Zhang JJ, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0483-8	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220654	10.1371/journal.pone.0220654	http://dx.doi.org/10.1371/journal.pone.0220654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369621	gold, Green Published, Green Submitted			2022-12-26	WOS:000484987900076
J	Steingass, S; Horning, M; Bishop, AM				Steingass, Sheanna; Horning, Markus; Bishop, Amanda M.			Space use of Pacific harbor seals (Phoca vitulina richardii) from two haulout locations along the Oregon coast	PLOS ONE			English	Article							BAY NATIONAL-PARK; DIVING BEHAVIOR; FEEDING-HABITS; SITE FIDELITY; DIVE BEHAVIOR; CALIFORNIA; MOVEMENTS; ABUNDANCE; PATTERNS; DIET	Background There are approximately 10,000-12,000 Pacific harbor seals (Phoca vitulina richardii) inhabiting the Oregon coast, and unlike other species of pinnipeds in this region, are reliably present year-round. Despite this, and drastic rebounds in population since the enactment of the Marine Mammal Protection Act, limited data is available for the present period regarding their space use at sea, and within estuarine, riverine, or bay areas within the state. Objective To examine site-based differences in space use for 24 adult Pacific harbor seals captured and outfitted with satellite transmitters at two predominant haulout sites on the Oregon Coast, USA. Design We captured 24 adult harbor seals from two haulout sites on the Central Oregon coast between September 2014-16 and fitted them with external Wildlife Computers SPOT5 satellite transmitters to track movement. Using state-space modeled locations derived from satellite telemetry data, we evaluated spatial behavior of these animals using a correlated random walk model via R package crawl. Kernel density estimation was subsequently used to calculate home range and core area for each animal. Percent use of open ocean habitat versus use of estuaries, rivers and bays was quantified, as was an initial examination of presence within five newly-established marine reserves in Oregon. Examination of haulout site-related differences in spatial behavior were examined for seals captured in Netarts and Alsea Bays, Oregon and haul out behavior related to time of day, season, and tidal level was also investigated. Results The average individual home range for seals was 364.47 +/- 382.87 km(2) with seals captured in Alsea bay demonstrating a significantly higher home range area than those captured in Netarts Bay. Alsea bay seals also tended to range farther from shore than Netarts Bay animals. The average calculated core area for seals encompassed on average 29.41 +/- 29.23 km(2) per animal, however the home range of one animal was so small, core area could not be calculated. Use of marine reserves was limited for animals in this study, representing less than 2% of locations with a majority occurring in Cape Perpetua Marine Reserve and North Marine Protected Area. Seals were more likely to haul out during low tides and periods of low light (dusk, night and dawn), and hauling out behavior increased in winter months. Significance These findings demonstrate the first major documentation of space use of harbor seals in the state for nearly three decades, and lends itself to future comparison and formation of mechanistically-based hypotheses for behavior of a common marine mammal in the highly productive northern California Current System.	[Steingass, Sheanna] Oregon State Univ, Dept Fisheries & Wildlife, Oregon Dept Fish & Wildlife, Corvallis, OR 97331 USA; [Horning, Markus; Bishop, Amanda M.] Alaska SeaLife Ctr, Seward, AK USA; [Horning, Markus] Oregon State Univ, Dept Fisheries & Wildlife, Newport, OR USA	Oregon State University; Oregon State University	Steingass, S (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Oregon Dept Fish & Wildlife, Corvallis, OR 97331 USA.	sheanna.m.steingass@state.or.us	Horning, Markus/I-3019-2015	Horning, Markus/0000-0001-6178-4935	Oregon Community Foundation [95507]; Achievement Rewards for Collegiate Scholars Oregon (Reiersgaard Award); Oregon Department of Fisheries and Wildlife Marine Reserves Scholarship; Marine Mammal Endowed Fund at Oregon State University; Holt Marine Education Award of the Oregon State University Hatfield Marine Science Center; Henry Mastin Graduate Student Fund from the Oregon State University Department of Fisheries and Wildlife	Oregon Community Foundation; Achievement Rewards for Collegiate Scholars Oregon (Reiersgaard Award); Oregon Department of Fisheries and Wildlife Marine Reserves Scholarship; Marine Mammal Endowed Fund at Oregon State University; Holt Marine Education Award of the Oregon State University Hatfield Marine Science Center; Henry Mastin Graduate Student Fund from the Oregon State University Department of Fisheries and Wildlife	Funding support for this project was provided by the Oregon Community Foundation Award #95507 (https://www.oregoncf.org/), Achievement Rewards for Collegiate Scholars Oregon (Reiersgaard Award) (https://oregon.arcsfoundation.org/), Oregon Department of Fisheries and Wildlife Marine Reserves Scholarship (http://oregonmarinereserves.com/), The Marine Mammal Endowed Fund at Oregon State University (https://mmi.oregonstate.edu/), and the Holt Marine Education Award of the Oregon State University Hatfield Marine Science Center (http://hmsc.oregonstate.edu/).Publication of this paper was supported, in part, by the Henry Mastin Graduate Student Fund from the Oregon State University Department of Fisheries and Wildlife.	ANDERSON DJ, 1982, ECOLOGY, V63, P103, DOI 10.2307/1937036; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Beach R.J., 1985, 3 WASH DEP WILDL WIL; Beyer HL., 2015, GEOSPATIAL MODELING; Bishop R. H., 1967, THESIS; Bjorge A, 1995, DEV MAR BIO, V4, P211; Blanchet MA, 2014, AQUAT BIOL, V21, P167, DOI 10.3354/ab00580; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bowen WD, 1999, CAN J ZOOL, V77, P978, DOI 10.1139/cjz-77-6-978; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Brown RE, 2005, MAR MAMMAL SCI, V21, P657, DOI 10.1111/j.1748-7692.2005.tb01258.x; BROWN RF, 1983, FISH B-NOAA, V81, P291; Brown RF, 2013, DTIC DOCUMENT; Burt W.V., 1959, RES BRIEFS FISH COMM, V7, P14; Byrne JV, 1962, GEOMORPHOLOGY CONTIN; Carretta JV, 2013, NOAA TECHNICAL MEMOR; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Connolly TP, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005283; Dietz R, 2013, ICES J MAR SCI, V70, P186, DOI 10.1093/icesjms/fss144; Dishman DL, 2011, THESIS; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Germain LR, 2012, MAR MAMMAL SCI, V28, P542, DOI 10.1111/j.1748-7692.2011.00516.x; Goldfinger C, 2002, INTERIM SEAFLOOR LIT, P1; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Graybill MR, 1981, THESIS; Grigg EK, 2009, FISH B-NOAA, V107, P359; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Huber HR, 2001, MAR MAMMAL SCI, V17, P276, DOI 10.1111/j.1748-7692.2001.tb01271.x; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Johnson DS, 2017, CRAWL FIT CONTINUOUS; Laake JL, 2002, FISH B-NOAA, V100, P434; Lamont MM, 1996, MAR MAMMAL SCI, V12, P402, DOI 10.1111/j.1748-7692.1996.tb00592.x; Lance MM, 2012, MAR ECOL PROG SER, V464, P257, DOI 10.3354/meps09880; Lluch-Belda D, 2003, CAL COOP OCEAN FISH, V44, P76; LONDON JM, 2002, OBSERVATIONS HARBOR; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; McHuron EA, THESIS; NEWBY T C, 1973, Murrelet, V54, P4, DOI 10.2307/3535680; Norton JG, 2005, CAL COOP OCEAN FISH, V46, P83; ODFW, 2017, OR DEP FISH WILDL MA, V2017; Orr AJ, 2004, FISH B-NOAA, V102, P108; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pearson J. P, 1970, Murrelet, V51, P1, DOI 10.2307/3534256; Peterson SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039046; PITCHER KW, 1981, CAN FIELD NAT, V95, P292; Pitcher KW, 1979, BIOL HARBOR SEAL PHO; Riemer SD, 1997, PREY PINNIPEDS SELEC; ROFFE TJ, 1984, J WILDLIFE MANAGE, V48, P1262, DOI 10.2307/3801787; Scordino J., 2010, W COAST PINNIPED PRO; Small RJ, 2005, MAR MAMMAL SCI, V21, P671, DOI 10.1111/j.1748-7692.2005.tb01259.x; Steingass Sheanna, 2017, Northwestern Naturalist, V98, P8; Steingass S, 2017, J THEOR BIOL, V416, P190, DOI 10.1016/j.jtbi.2017.01.006; TEMTE JL, 1991, J ZOOL, V224, P617, DOI 10.1111/j.1469-7998.1991.tb03790.x; Thompson PM, 1996, J APPL ECOL, V33, P1572, DOI 10.2307/2404795; THOMPSON PM, 1990, J APPL ECOL, V27, P492, DOI 10.2307/2404296; Thomton Jamie D., 2008, Endangered Species Research, V4, P195, DOI 10.3354/esr00062; Vander Wal E, 2012, ECOL MODEL, V224, P48, DOI 10.1016/j.ecolmodel.2011.10.006; Veit RR, 1996, MAR ECOL PROG SER, V139, P11, DOI 10.3354/meps139011; Womble J.N., 2012, THESIS; Womble JN, 2007, MAR MAMMAL SCI, V23, P203, DOI 10.1111/j.1748-7692.2006.00089.x; Womble JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055386; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wright BE, 2007, ECOL APPL, V17, P338, DOI 10.1890/05-1941; YOCHEM PK, 1987, MAR MAMMAL SCI, V3, P323, DOI 10.1111/j.1748-7692.1987.tb00319.x; Zhao LY, 2004, MAR ECOL PROG SER, V281, P267, DOI 10.3354/meps281267	68	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219484	10.1371/journal.pone.0219484	http://dx.doi.org/10.1371/journal.pone.0219484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365532	Green Submitted, Green Published, gold			2022-12-26	WOS:000484983600010
J	Tijerina-Rodriguez, L; Villarreal-Trevino, L; Baines, SD; Morfin-Otero, R; Camacho-Ortiz, A; Flores-Trevino, S; Maldonado-Garza, H; Rodriguez-Noriega, E; Garza-Gonzalez, E				Tijerina-Rodriguez, Laura; Villarreal-Trevino, Licet; Baines, Simon D.; Morfin-Otero, Rayo; Camacho-Ortiz, Adrian; Flores-Trevino, Samantha; Maldonado-Garza, Hector; Rodriguez-Noriega, Eduardo; Garza-Gonzalez, Elvira			High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates	PLOS ONE			English	Article							RESISTANCE; GENE; TRANSMISSION; METRONIDAZOLE; ANTIBIOTICS; REINFECTION; DISEASE; RELAPSE; TOXIN	Clostridium [Clostridioides] difficile infection (CDI) is one of the leading causes of diarrhea associated with medical care worldwide, and up to 60% of patients with CDI can develop a recurrent infection (R-CDI). A multi-species microbiota biofilm model of C. difficile was designed to evaluate the differences in the production of biofilms, sporulation, susceptibility to drugs, expression of sporulating (sigH, spo0A), quorum sensing (agrD(1), and luxS), and adhesion-associated (slpA and cwp84) pathway genes between selected C. difficile isolates from R-CDI and non-recurrent patients (NR-CDI). We obtained 102 C. difficile isolates from 254 patients with confirmed CDI (66 from NR-CDI and 36 from R-CDI). Most of the isolates were biofilm producers, and most of the strains were ribotype 027 (81.374%, 83/102). Most C. difficile isolates were producers of biofilm (100/102), and most were strongly adherent. Sporulation was higher in the R-CDI than in the NR-CDI isolates (p = 0.015). The isolates from R-CDI patients more frequently demonstrated reduced susceptibility to vancomycin than isolates of NR-CDI patients (27.78% [10/36] and 9.09% [6/66], respectively, p = 0.013). The minimum inhibitory concentrations for vancomycin and linezolid against biofilms (BMIC) were up to 100 times and 20 times higher, respectively, than the corresponding planktonic MICs. Expression of sigH, spo0A, cwp84, and agrD(1) was higher in R-CDI than in NR-CDI isolates. Most of the C. difficile isolates were producers of biofilms with no correlation with the ribotype. Sporulation was greater in R-CDI than in NR-CDI isolates in the biofilm model of C. difficile. The R-CDI isolates more frequently demonstrated reduced susceptibility to vancomycin and linezolid than the NR-CDI isolates in both planktonic cells and biofilm isolates. A higher expression of sporulating pathway (sigH, spo0A), quorum sensing (agrD(1)), and adhesion-associated (cwp84) genes was found in R-CDI than in NR-CDI isolates. All of these factors can have effect on the recurrence of the infection.	[Tijerina-Rodriguez, Laura; Villarreal-Trevino, Licet] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Dept Microbiol & Inmunol, San Nicolas De Los Garza, Mexico; [Baines, Simon D.] Univ Hertfordshire, Sch Life & Med Sci, Dept Biol & Environm Sci, Hatfield, Herts, England; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo] Univ Guadalajara, Inst Patol Infecciosa & Expt, Ctr Univ Ciencias Salud, Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Camacho-Ortiz, Adrian; Flores-Trevino, Samantha; Maldonado-Garza, Hector; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Mexico	Universidad Autonoma de Nuevo Leon; University of Hertfordshire; Universidad de Guadalajara; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Mexico.	elvira_garza_gzz@yahoo.com	Flores-Treviño, Samantha/AAB-4537-2020; Morfín-Otero, Rayo/AAR-8027-2021	Flores-Treviño, Samantha/0000-0003-1259-7425; Morfín-Otero, Rayo/0000-0001-9576-1950; Tijerina Rodriguez, Laura/0000-0001-5626-8039; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Garza-Gonzalez, Elvira/0000-0001-5831-9661	Mexico's National Council for Science and Technology, CONACYT [284042]	Mexico's National Council for Science and Technology, CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by Mexico's National Council for Science and Technology, CONACYT, grant 284042. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Chakra CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098400; Baines SD, 2008, J ANTIMICROB CHEMOTH, V62, P1046, DOI 10.1093/jac/dkn313; Berger FK, 2018, INT J MED MICROBIOL, V308, P358, DOI 10.1016/j.ijmm.2018.01.004; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Buchler AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0607-z; Camacho-Ortiz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122627; Chang LL, 2004, J ANTIMICROB CHEMOTH, V53, P518, DOI 10.1093/jac/dkh094; Crowther GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088396; Dapa T, 2013, GUT MICROBES, V4, P397, DOI 10.4161/gmic.25862; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Darkoh C, 2016, MBIO, V7, DOI 10.1128/mBio.01237-16; Darkoh C, 2015, MBIO, V6, DOI 10.1128/mBio.02569-14; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Deneve C, 2008, J MED MICROBIOL, V57, P732, DOI 10.1099/jmm.0.47676-0; Donelli G, 2012, FEMS IMMUNOL MED MIC, V65, P318, DOI 10.1111/j.1574-695X.2012.00962.x; Edwards AN, 2014, INFECT IMMUN, V82, P4276, DOI 10.1128/IAI.02323-14; Figueroa I, 2012, CLIN INFECT DIS, V55, pS104, DOI 10.1093/cid/cis357; Freeman J, 2005, J ANTIMICROB CHEMOTH, V56, P988, DOI 10.1093/jac/dki357; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; Gil F, 2015, FUTURE MICROBIOL, V10, P1649, DOI 10.2217/fmb.15.94; Goldstein EJC, 2003, ANTIMICROB AGENTS CH, V47, P337, DOI 10.1128/AAC.47.1.337-341.2003; Hammond EN, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-329; James GA, 2018, J ANTIMICROB CHEMOTH, V73, P102, DOI 10.1093/jac/dkx353; Karlsson S, 2008, MICROBIOL-SGM, V154, P3430, DOI 10.1099/mic.0.2008/019778-0; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Mac Aogain M, 2015, J HOSP INFECT, V90, P108, DOI 10.1016/j.jhin.2015.01.021; Marin M, 2015, ANTIMICROB AGENTS CH, V59, P586, DOI 10.1128/AAC.04082-14; Martin MJ, 2013, J BACTERIOL, V195, P3672, DOI 10.1128/JB.00473-13; Mathur H, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0102-8; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Mora-Uribe P, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.201.00099; O'Connor JR, 2008, ANTIMICROB AGENTS CH, V52, P2813, DOI 10.1128/AAC.00342-08; Pantaleon V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124971; Paredes-Sabja D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043635; Pelaez T, 2005, ANTIMICROB AGENTS CH, V49, P1157, DOI 10.1128/AAC.49.3.1157-1159.2005; Pickering DS, 2018, ANAEROBE, V54, P169, DOI 10.1016/j.anaerobe.2018.10.003; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Semenyuk EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087757; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Yun B, 2014, J DAIRY SCI, V97, P4745, DOI 10.3168/jds.2014-7921	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220671	10.1371/journal.pone.0220671	http://dx.doi.org/10.1371/journal.pone.0220671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365590	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600064
J	Yasobant, S; Saxena, D; Bruchhausen, W; Memon, FZ; Falkenberg, T				Yasobant, Sandul; Saxena, Deepak; Bruchhausen, Walter; Memon, Farjana Zakir; Falkenberg, Timo			Multi-sectoral prioritization of zoonotic diseases: One health perspective from Ahmedabad, India	PLOS ONE			English	Article							OPPORTUNITIES; CHALLENGES; ZOONOSES; CRITERIA	Background Prioritizing zoonotic diseases is one of the emerging tasks for developing multi-sectoral collaboration within One Health. Globally, many efforts have been made to prioritize zoonotic diseases at national levels, especially in low resource settings. Prioritization of zoonoses has been conducted in different countries at different levels (i. e. national, regional and local) for different purposes. India has also initiated prioritization of zoonotic diseases at the national level. However, in a country like India with wide climatic variations, different animalhuman and vector densities, it is important to look at these zoonotic conditions in local settings too. The present study aims to determine which zoonoses should be prioritized for collaboration between stakeholders in the Indian city of Ahmedabad. Methods The present study followed a participatory research method, entailing a stakeholder workshop for prioritizing zoonotic diseases in Ahmedabad. It was carried out through a facilitated consultative process involving 19 experts in zoonoses from the human and animal health systems during a one-day workshop in September 2018. To prioritize the zoonotic diseases, the One Health Zoonotic Disease Prioritization (OHZDP) tool of the U.S. Centers for Disease Control and Prevention was adopted. The Analytical Hierarchical Process (AHP) and decision-tree analysis were used to rank the diseases. Results Out of 38 listed zoonotic diseases, 14 were selected for prioritization. These were scored and weighed against five criteria: severity of disease in humans, potential for epidemic and/or pandemic, availability of prevention and/or control strategies, burden of animal disease existing inter-sectoral collaboration. The top five diseases that have been prioritized for Ahmedabad are Rabies, Brucellosis, Avian Influenza (H5N1), Influenza A (H1N1) and Crimean-Congo Hemorrhagic Fever. Sensitivity analysis did not indicate significant changes in zoonotic disease prioritization based on criteria weights. Conclusion Prioritization of zoonotic diseases at the local level is essential for development of effective One Health strategies. This type of participatory disease prioritization workshop is highly recommended and can be replicated in other Indian cities, as well as in other low and middle-income countries.	[Yasobant, Sandul; Bruchhausen, Walter; Falkenberg, Timo] Univ Bonn, Ctr Dev Res ZEF, Bonn, Germany; [Yasobant, Sandul] Univ Bonn, Fac Med, Bonn, Germany; [Saxena, Deepak; Memon, Farjana Zakir] Indian Inst Publ Hlth Gandhinagar, Gandhinagar, Gujarat, India; [Bruchhausen, Walter] Univ Cologne, Fac Med, Inst Hist & Eth Med, Cologne, Germany; [Bruchhausen, Walter] Univ Hosp Cologne, Cologne, Germany; [Falkenberg, Timo] Univ Bonn, GeoHlth Ctr, Inst Hyg & Publ Hlth, Bonn, Germany	University of Bonn; University of Bonn; University of Cologne; University of Cologne; University of Bonn	Yasobant, S (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Bonn, Germany.; Yasobant, S (corresponding author), Univ Bonn, Fac Med, Bonn, Germany.	yasobant@uni-bonn.de	Yasobant, Dr. Sandul/I-4008-2013; Bruchhausen, Walter/AAA-3430-2020; Falkenberg, Timo/GVS-7787-2022; Saxena, Deepak/AAH-7395-2019	Yasobant, Dr. Sandul/0000-0003-1770-8745; Saxena, Deepak/0000-0003-0563-4259; Falkenberg, Timo/0000-0001-6778-4178; Bruchhausen, Walter/0000-0002-8115-2334	Ministry of Culture and Science of North Rhine-Westphalia, Germany through the Forschungskolleg `One Health and Urban Transformation'	Ministry of Culture and Science of North Rhine-Westphalia, Germany through the Forschungskolleg `One Health and Urban Transformation'	The Ministry of Culture and Science of North Rhine-Westphalia, Germany through the Forschungskolleg `One Health and Urban Transformation' funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00923-8; [Anonymous], 2002, EMERG INFECT DIS; [Anonymous], 2008, INT J SERVICES SCI; [Anonymous], COMMUN DIS REP CDR S; [Anonymous], 2018, TIMES INDIA, P1; Brookes VJ, 2015, EPIDEMIOL INFECT, V143, P2911, DOI [10.1017/S0950268815000801, 10.1017/S0950268]; Centers for Disease Control and Prevention, 2017, ON HLTH ZOON DIS PRI; Centers for Disease Control and Prevention, 2014, ZOON DIS PRIOR, P1; Conrad PA, 2013, COMP IMMUNOL MICROB, V36, P211, DOI 10.1016/j.cimid.2013.03.006; Gebreyes WA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003257; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Integrated Disease Surveillance Program (IDSP), 2017, BIRD FLU SCAR FOR OR; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kadohira M, 2015, EPIDEMIOL INFECT, V143, P1477, DOI 10.1017/S0950268814002246; Kou G, 2016, TECHNOL ECON DEV ECO, V22, P649, DOI 10.3846/20294913.2016.1202353; Kurian A, 2014, INDIAN J ANIM SCI, V84, P357; Mavalankar D, 2007, CHIKUNGUNYA FEVER KI; Mazet JAK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000190; McPherson A, 2018, INT J HEALTH PLAN M, V33, P677, DOI 10.1002/hpm.2521; Minergy, 2017, INT ANN REP, P1; Muhemedi S, 2016, J ZOONOTIC DIS PUBLI, P2; Munyua P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161576; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048519; Okello AL, 2011, VET REC, V169, P281, DOI 10.1136/vr.d5378; One Health Bangladesh Secretariat, 2012, STRAT FRAM ON HLTH A; Patel Atul K, 2011, J Assoc Physicians India, V59, P585; Pieracci EG, 2016, ONE HEALTH, V2, P131, DOI 10.1016/j.onehlt.2016.09.001; R Core Team, 2021, R LANG ENV STAT; Rist CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109986; Rubin C, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.OH-0016-2012; Schelling E, 2005, BMJ-BRIT MED J, V331, P1264, DOI 10.1136/bmj.331.7527.1264; Sekamatte M, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.019679, 10.1371/journal.pone.0196799]; Sekar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017120; Stebler N, 2015, PREV VET MED, V121, P165, DOI 10.1016/j.prevetmed.2015.05.006; Stephen C, 2016, ONE HEALTH, V2, P161, DOI 10.1016/j.onehlt.2016.10.002; Tangcharoensathien V, 2017, INT J HEALTH POLICY, V6, P359, DOI 10.15171/ijhpm.2017.61; World Health Organization, 2017, WHO EM PREP RESP; Yasobant S, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0398-6; Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003	40	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220152	10.1371/journal.pone.0220152	http://dx.doi.org/10.1371/journal.pone.0220152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361782	gold, Green Submitted, Green Published			2022-12-26	WOS:000484981300023
J	Bhatnagar, T; Ralte, M; Ralte, L; Chawnglungmuana; Sundaramoorthy, L; Chhakchhuak, L				Bhatnagar, Tarun; Ralte, Malsawmtluangi; Ralte, Lalhriatzuali; Chawnglungmuana; Sundaramoorthy, L.; Chhakchhuak, Lily			Intensified tuberculosis and HIV surveillance in a prison in Northeast India: Implementation research	PLOS ONE			English	Article							ROUTINE; INCARCERATION; PREVALENCE	Structural and individual level factors in prisons create challenges towards detection and management of HIV/tuberculosis. WHO and India's HIV/tuberculosis control programs recommend intensified case finding in prisons. Low HIV and tuberculosis detection rates suggest poor implementation of existing surveillance strategies within the prison healthcare system in Mizoram's capital city of Aizawl. We explored the operational feasibility of implementing the intensified case finding strategy in Aizawl central prison. We implemented the intensified screening through entry screening of new inmates, mass screening of resident inmates and exit screening at release. We set up digital chest radiography, sputum smear microscopy and HIV testing facilities within the prison and referral to external facility for Cartridge Based Nucleic Acid Amplification Test (CBNAAT). We screened 738 inmates (Male: 626; Female: 112). Of 53% inmates having presumptive tuberculosis symptoms, 37% underwent sputum microscopy. We detected 14 new tuberculosis cases; overall tuberculosis positivity 1.9%. We tested 65% of 657 inmates for HIV, of which 41 new cases were detected; overall HIV positivity 16.5%. Three male inmates had HIV-tuberculosis co-infection. It is feasible to implement intensified case detection for tuberculosis/HIV in the prison with inter-departmental coordination, albeit with certain challenges.	[Bhatnagar, Tarun; Sundaramoorthy, L.] ICMR Natl Inst Epidemiol, ICMR Sch Publ Hlth, Chennai, Tamil Nadu, India; [Ralte, Malsawmtluangi] Minist Hlth & Family Welf, Mizoram State AIDS Control Soc, Aizawl, India; [Ralte, Lalhriatzuali; Chhakchhuak, Lily] Dept Hlth & Family Welf, Mizoram, Aizawl, India; [Chawnglungmuana] SHALOM NGO, Aizawl, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE)	Bhatnagar, T (corresponding author), ICMR Natl Inst Epidemiol, ICMR Sch Publ Hlth, Chennai, Tamil Nadu, India.	tarunbhatnagar@nie.gov.in		Bhatnagar, Tarun/0000-0002-5603-1418	ICMR-National Institute for Research in Tuberculosis [GF/001/IR_OR-004/2016-DSBR]	ICMR-National Institute for Research in Tuberculosis(Indian Council of Medical Research (ICMR))	This work was supported by the ICMR-National Institute for Research in Tuberculosis, Grant number: GF/001/IR_OR-004/2016-DSBR (www.nirt.res.in) to MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, HIV EST 2017 TECHN R; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Bureau of Police Research and Development, 2003, MOD PRIS MAN SUP MAN; Central TB Division Directorate General of Health Services M of H and FW, 2016, REV NAT TB CONTR PRO; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Coninx R, 2000, BRIT MED J, V320, P440, DOI 10.1136/bmj.320.7232.440; Dara M, 2013, INT J TUBERC LUNG D, V17, P4, DOI 10.5588/ijtld.12.0909; Dara M, 2014, PRISON HLTH; Dara M, 2009, GUIDELINES CONTROL T; Dara M, 2015, INT J INFECT DIS, V32, P111, DOI 10.1016/j.ijid.2014.12.029; Dolan K, 2010, INDIAN J MED RES, V132, P696; DROBNIEWSKI F, 1995, LANCET, V346, P948, DOI 10.1016/S0140-6736(95)91562-1; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Guin Sayantani, 2009, J Correct Health Care, V15, P179, DOI 10.1177/1078345809333409; Henostroza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067338; Iroh PA, 2015, AM J PUBLIC HEALTH, V105, pE5, DOI 10.2105/AJPH.2015.302635; Kumar Sunil D, 2013, Indian J Psychol Med, V35, P373, DOI 10.4103/0253-7176.122230; Lucas KD, 2016, MMWR-MORBID MORTAL W, V65, P178, DOI 10.15585/mmwr.mm6507a3; Meundi AD, 2016, BRIT J MED MED RES, V11, P1; National AIDS Control Organisation, 2015, NAT GUID HIV TEST; Nelwan EJ, 2016, INT J PRISON HEALTH, V12, P17, DOI 10.1108/IJPH-04-2015-0012; Reyes H, 1997, BRIT MED J, V315, P1447, DOI 10.1136/bmj.315.7120.1447; Reyes H, 2010, WORLD MED J, V56, P6; Rosen DL, 2016, JAIDS-J ACQ IMM DEF, V71, pE85, DOI 10.1097/QAI.0000000000000889; Rosen DL, 2015, AIDS CARE, V27, P545, DOI 10.1080/09540121.2014.989486; Rumble C, 2015, EUR J PUBLIC HEALTH, V25, P1078, DOI 10.1093/eurpub/ckv133; Singh S, 1999, INT J STD AIDS, V10, P475, DOI 10.1258/0956462991914357; Stern V, 2001, ANN NY ACAD SCI, V953, P113, DOI 10.1111/j.1749-6632.2001.tb11367.x; Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105; Union Home Minister approves New Prison Manual, 2016, PRESS INFORM BUREAU; World Health Organization, TB PRIS; World Health Organization, 2015, SYSTEMATIC SCREENING; World Health Organization (WHO), 2001, HUM RIGHTS APPR TUB; World health organizations, GLOB PLAN END TB 201	34	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0219988	10.1371/journal.pone.0219988	http://dx.doi.org/10.1371/journal.pone.0219988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV1OL	31356606	Green Submitted, Green Published, gold			2022-12-26	WOS:000484047000013
J	Wei, GW; Chen, Y; Sun, XS; Chen, YH; Luo, FL; Yu, FH				Wei, Guan-Wen; Chen, Yue; Sun, Xin-Sheng; Chen, Yu-Han; Luo, Fang-Li; Yu, Fei-Hai			Growth responses of eight wetland species to water level fluctuation with different ranges and frequencies	PLOS ONE			English	Article							UNDERWATER PHOTOSYNTHESIS; PHENOTYPIC PLASTICITY; MYRIOPHYLLUM-SPICATUM; FLOODING TOLERANCE; MECHANICAL-STRESS; RIPARIAN PLANT; DE-SUBMERGENCE; UV-B; ELONGATION; NUTRIENT	Fluctuation range and frequency are two important components of water level fluctuation, but their effects on wetland plants have not been evaluated separately. We subjected eight wetland species to a control treatment with static water level and fluctuation treatments with different ranges or frequencies to examine their effects on plant growth. Acorus calamus, Butomus umbellatus and Iris wilsonii showed high survival rates in all treatments with various fluctuation ranges and frequencies. Their survival rates were higher at the medium fluctuation frequency than at the low and high frequencies, suggesting beneficial effects of the medium frequency. In the experiment comparing the fluctuation ranges, A. calamus and I. wilsonii could maintain the capacity for asexual propagation and accumulate higher biomass compared with the control plants, while biomass of the other six species dramatically decreased. In the experiment comparing fluctuation frequency, species with relatively high survival rates (>= 50%) maintained or increased the capacity of asexual propagation, and A. calamus and I. wilsonii allocated relatively more biomass to roots, which may enhance plant growth and survival. In contrast, these species did not show increased biomass allocation to shoots in response to both fluctuation range and frequency, presumably because shoots are prone to mechanical damage caused by streaming floodwater. Taken together, biomass accumulation in roots rather than in shoots and the ability to asexually propagate are important for the survival of these species during water fluctuation.	[Wei, Guan-Wen; Chen, Yue; Sun, Xin-Sheng; Chen, Yu-Han; Luo, Fang-Li; Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Yu, Fei-Hai] Taizhou Univ, Inst Wetland Ecol & Clone Ecol, Zhejiang Prov Key Lab Plant Evolutionary Ecol & C, Taizhou, Zhejiang, Peoples R China	Beijing Forestry University; Taizhou University	Luo, FL (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	ecoluofangli@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745	National Key R&D Program of China [2017YFC0505903]; Fundamental Research Funds for the Central Universities [2015ZCQ-BH-01]; National Science Foundation of China [31670428]	National Key R&D Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key R&D Program of China (2017YFC0505903, FLL), the Fundamental Research Funds for the Central Universities (2015ZCQ-BH-01, FHY) and the National Science Foundation of China (31670428, FLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias ME, 2018, HYDROBIOLOGIA, V814, P5, DOI 10.1007/s10750-016-2664-3; Baastrup-Spohr L, 2016, FRESHWATER BIOL, V61, P301, DOI 10.1111/fwb.12704; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Byun YJ, 2014, PHYSIOL PLANTARUM, V152, P256, DOI 10.1111/ppl.12163; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; Chen D, 2019, SCI TOTAL ENVIRON, V657, P1568, DOI 10.1016/j.scitotenv.2018.12.099; Chen XS, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01970; Chun YJ, 2010, AQUAT BOT, V93, P221, DOI 10.1016/j.aquabot.2010.09.001; Colmer TD, 2013, ENVIRON EXP BOT, V92, P73, DOI 10.1016/j.envexpbot.2012.07.002; de los Santos CB, 2010, MAR ECOL PROG SER, V398, P127, DOI 10.3354/meps08343; Deegan BM, 2012, RIVER RES APPL, V28, P359, DOI 10.1002/rra.1461; Deegan BM, 2007, AQUAT BOT, V86, P309, DOI 10.1016/j.aquabot.2006.11.006; Fleta-Soriano E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00143; Garssen AG, 2015, GLOBAL CHANGE BIOL, V21, P2881, DOI 10.1111/gcb.12921; Gattringer JP, 2018, PLANT ECOL, V219, P973, DOI 10.1007/s11258-018-0850-2; Hu T, 2016, PHYSIOL PLANTARUM, V156, P54, DOI 10.1111/ppl.12342; Hu T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00403; Huber H, 2012, NEW PHYTOL, V194, P572, DOI 10.1111/j.1469-8137.2012.04075.x; IPCC-Intergovernmental Panel on Climate Change, 2014, CLIMATE CHANGE 2014; Iwasaki M, 2014, EMBO J, V33, P1987, DOI 10.15252/embj.201488883; Jian ZJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207689; Leyer I, 2005, J APPL ECOL, V42, P239, DOI 10.1111/j.1365-2664.2005.01009.x; Li YK, 2005, J FRESHWATER ECOL, V20, P59, DOI 10.1080/02705060.2005.9664936; Liu B, 2016, WETLANDS, V36, P979, DOI 10.1007/s13157-016-0805-0; Lopez P, 2016, SCI TOTAL ENVIRON, V540, P158, DOI 10.1016/j.scitotenv.2015.06.033; Lu J, 2018, SCI TOTAL ENVIRON, V622, P29, DOI 10.1016/j.scitotenv.2017.11.199; Luo FL, 2018, ENVIRON EXP BOT, V155, P641, DOI 10.1016/j.envexpbot.2018.08.015; Luo FL, 2016, J PLANT ECOL, V9, P434, DOI 10.1093/jpe/rtv065; Menezes-Silva PE, 2017, J EXP BOT, V68, P4309, DOI 10.1093/jxb/erx211; Pedersen O, 2010, FUNCT PLANT BIOL, V37, P524, DOI 10.1071/FP09298; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Puijalon S, 2006, AM J BOT, V93, P1090, DOI 10.3732/ajb.93.8.1090; Puijalon S, 2008, NEW PHYTOL, V177, P907, DOI 10.1111/j.1469-8137.2007.02314.x; Raulings EJ, 2010, FRESHWATER BIOL, V55, P701, DOI 10.1111/j.1365-2427.2009.02311.x; Roro AG, 2017, J PLANT GROWTH REGUL, V36, P680, DOI 10.1007/s00344-017-9671-0; Sarneel JM, 2014, J APPL ECOL, V51, P1006, DOI 10.1111/1365-2664.12288; Sasayama D, 2016, WEED BIOL MANAG, V16, P147, DOI 10.1111/wbm.12105; Sasidharan R, 2018, PLANT PHYSIOL, V176, P1106, DOI 10.1104/pp.17.01232; Schluter U, 2001, J EXP BOT, V52, P2213, DOI 10.1093/jexbot/52.364.2213; Striker GG, 2017, FUNCT PLANT BIOL, V44, P899, DOI 10.1071/FP17128; Striker GG, 2017, J EXP BOT, V68, P1851, DOI 10.1093/jxb/erw239; van der Valk A, 2016, WETLANDS, V36, pS397, DOI 10.1007/s13157-016-0850-8; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Voesenek LACJ, 2004, ECOLOGY, V85, P16, DOI 10.1890/02-740; Voesenek LACJ, 2016, NEW PHYTOL, V209, P39, DOI 10.1111/nph.13775; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wang P, 2016, FLORA, V223, P83, DOI 10.1016/j.flora.2016.05.005; Warwick NWM, 2003, AQUAT BOT, V77, P153, DOI 10.1016/S0304-3770(03)00102-5; Winkel A, 2016, PLANT CELL ENVIRON, V39, P1537, DOI 10.1111/pce.12717; Wright AJ, 2017, NEW PHYTOL, V213, P645, DOI 10.1111/nph.14185; Wu YS, 2016, RICE, V9, DOI 10.1186/s12284-016-0074-9; Wu Z.Y., 2004, FLORA REPUBLICAE POP; Zhang AY, 2019, CLEAN-SOIL AIR WATER, V47, DOI 10.1002/clen.201700497; Zhang XK, 2013, J PLANT ECOL, V6, P64, DOI 10.1093/jpe/rts009	55	11	13	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220231	10.1371/journal.pone.0220231	http://dx.doi.org/10.1371/journal.pone.0220231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344145	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900072
J	Vantaku, V; Putluri, V; Bader, DA; Maity, S; Ma, J; Arnold, JM; Rajapakshe, K; Donepudi, SR; von Rundstedt, FC; Devarakonda, V; Dubrulle, J; Karanam, B; McGuire, SE; Stossi, F; Jain, AK; Coarfa, C; Cao, Q; Sikora, AG; Villanueva, H; Kavuri, SM; Lotan, Y; Sreekumar, A; Putluri, N				Vantaku, Venkatrao; Putluri, Vasanta; Bader, David A.; Maity, Suman; Ma, Jing; Arnold, James M.; Rajapakshe, Kimal; Donepudi, Sri Ramya; von Rundstedt, Friedrich-Carl; Devarakonda, Vaishnavi; Dubrulle, Julien; Karanam, Balasubramanyam; McGuire, Sean E.; Stossi, Fabio; Jain, Abhinav K.; Coarfa, Cristian; Cao, Qi; Sikora, Andrew G.; Villanueva, Hugo; Kavuri, Shyam M.; Lotan, Yair; Sreekumar, Arun; Putluri, Nagireddy			Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression	ONCOGENE			English	Article							GROUP PROTEIN EZH2; BREAST-CANCER; DNA METHYLATION; CELLULAR FUNCTIONS; METASTASIS; PROSTATE; GENES; HYPERMETHYLATION; IDENTIFICATION; SUPPRESSOR	Advanced Bladder Cancer (BLCA) remains a clinical challenge that lacks effective therapeutic measures. Here, we show that distinct, stage-wise metabolic alterations in BLCA are associated with the loss of function of aldehyde oxidase (AOX1). AOX1 associated metabolites have a high predictive value for advanced BLCA and our findings demonstrate that AOX1 is epigenetically silenced during BLCA progression by the methyltransferase activity of EZH2. Knockdown (KD) of AOX1 in normal bladder epithelial cells re-wires the tryptophan-kynurenine pathway resulting in elevated NADP levels which may increase metabolic flux through the pentose phosphate (PPP) pathway, enabling increased nucleotide synthesis, and promoting cell invasion. Inhibition of NADP synthesis rescues the metabolic effects of AOX1 KD. Ectopic AOX1 expression decreases NADP production, PPP flux and nucleotide synthesis, while decreasing invasion in cell line models and suppressing growth in tumor xenografts. Further gain and loss of AOX1 confirm the EZH2-dependent activation, metabolic deregulation, and tumor growth in BLCA. Our findings highlight the therapeutic potential of AOX1 and provide a basis for the development of prognostic markers for advanced BLCA.	[Vantaku, Venkatrao; Bader, David A.; Rajapakshe, Kimal; Dubrulle, Julien; McGuire, Sean E.; Stossi, Fabio; Coarfa, Cristian; Sreekumar, Arun; Putluri, Nagireddy] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Putluri, Vasanta; Donepudi, Sri Ramya; Dubrulle, Julien; McGuire, Sean E.; Stossi, Fabio; Coarfa, Cristian; Sikora, Andrew G.; Villanueva, Hugo; Sreekumar, Arun; Putluri, Nagireddy] Baylor Coll Med, Dan L Duncan Canc Ctr, Alkek Ctr Mol Discovery, Adv Technol Core, Houston, TX 77030 USA; [Maity, Suman] Univ Texas Houston, Sch Publ Hlth, Dept Biostat, Houston, TX USA; [Ma, Jing] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Arnold, James M.; Sreekumar, Arun] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [von Rundstedt, Friedrich-Carl] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [von Rundstedt, Friedrich-Carl] Friedrich Schiller Univ, Jena Univ Hosp, Dept Urol, Jena, Germany; [Devarakonda, Vaishnavi; Kavuri, Shyam M.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Karanam, Balasubramanyam] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Karanam, Balasubramanyam] Tuskegee Univ, Ctr Canc Res, Tuskegee, AL 36088 USA; [Jain, Abhinav K.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Ctr Canc Epigenet, Houston, TX 77030 USA; [Cao, Qi] Houston Methodist Res Inst, Inst Acad Med, Ctr Inflammat & Epigenet, Houston, TX USA; [Sikora, Andrew G.; Villanueva, Hugo] Baylor Coll Med, Dept Otolaryngol Head Neck Surg, Houston, TX 77030 USA; [Lotan, Yair] Univ Texas SouthWestern, Dept Urol, Dallas, TX USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Fred Hutchinson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Friedrich Schiller University of Jena; Baylor College of Medicine; Tuskegee University; Tuskegee University; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Putluri, N (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Putluri, N (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Alkek Ctr Mol Discovery, Adv Technol Core, Houston, TX 77030 USA.	putluri@bcm.edu	; Cao, Qi/A-5517-2010	Putluri, Nagireddy/0000-0003-4488-7400; Cao, Qi/0000-0002-5140-3681; Ma, Jing/0000-0001-6294-227X; Bader, David/0000-0003-0514-7346; Donepudi, Sri Ramya/0000-0002-2845-1212				Ablain J, 2014, INT J CANCER, V135, P2262, DOI 10.1002/ijc.29081; Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; [Anonymous], 2018, CANCER DISCOV, V8, pOF15, DOI [10.1158/2159-8290.CD-RW2018-067, DOI 10.1158/2159-8290.CD-RW2018-067]; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Baylin SB, 1998, ADV CANCER RES, V72, P141; BEACONSFIELD P, 1964, Dev Med Child Neurol, V6, P469; Bhowmik SK, 2015, ONCOTARGET, V6, P42651, DOI 10.18632/oncotarget.4765; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Chen YG, 2009, INT J COMPUT INT SYS, V2, P1, DOI 10.2991/jnmp.2009.2.1.1; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; D'Amato NC, 2015, CANCER RES, V75, P4651, DOI 10.1158/0008-5472.CAN-15-2011; Davidson B, 2014, HUM PATHOL, V45, P691, DOI 10.1016/j.humpath.2013.11.003; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dudziec E, 2011, EPIGENOMICS-UK, V3, P35, DOI 10.2217/EPI.10.71; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Esteller M, 2000, CANCER RES, V60, P129; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Garattini Enrico, 2009, Human Genomics, V4, P119; Haldrup C, 2013, J CLIN ONCOL, V31, P3250, DOI 10.1200/JCO.2012.47.1847; Hurst CD, 2017, CANCER CELL, V32, P701, DOI 10.1016/j.ccell.2017.08.005; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Jin F, 2017, CANCER PREV RES, V10, P588, DOI [10.1158/1940-6207.CAPR-17-0198, 10.1158/1940-6207.capr-17-0198]; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Kitamura S, 2006, DRUG METAB PHARMACOK, V21, P83, DOI 10.2133/dmpk.21.83; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Li M, 2015, JOVE-J VIS EXP, DOI 10.3791/52411; Ma J, 2016, BIOINFORMATICS, V32, P3165, DOI 10.1093/bioinformatics/btw410; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Oster B, 2011, INT J CANCER, V129, P2855, DOI 10.1002/ijc.25951; Ozturk S, 2016, P NATL ACAD SCI USA, V113, P638, DOI 10.1073/pnas.1514663113; Park JS, 2014, IEEE ENG MED BIO, P3430, DOI 10.1109/EMBC.2014.6944360; Piyarathna DWB, 2018, EUR UROL FOCUS, V4, P907, DOI 10.1016/j.euf.2017.04.005; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Prendergast GC, 2011, NATURE, V478, P192, DOI 10.1038/478192a; Putluri N, 2014, NEOPLASIA, V16, P390, DOI 10.1016/j.neo.2014.05.007; Putluri N, 2011, CANCER RES, V71, P7376, DOI 10.1158/0008-5472.CAN-11-1154; Putluri N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021417; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; SALTER M, 1985, BIOCHEM J, V229, P499, DOI 10.1042/bj2290499; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sievert KD, 2009, WORLD J UROL, V27, P295, DOI 10.1007/s00345-009-0395-z; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Sun SS, 2016, CELL SIGNAL, V28, P481, DOI 10.1016/j.cellsig.2016.02.004; Tan JZ, 2014, ACTA PHARMACOL SIN, V35, P161, DOI 10.1038/aps.2013.161; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Thoma C, 2018, NAT REV UROL, V15, P1, DOI 10.1038/nrurol.2017.207; Vantaku V, 2019, CLIN CANCER RES, V25, P3689, DOI 10.1158/1078-0432.CCR-18-1515; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yan JL, 2013, BLOOD, V121, P4512, DOI 10.1182/blood-2012-08-450494; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang M, 2013, CANCER CELL, V23, P709, DOI 10.1016/j.ccr.2013.05.015; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhai LJ, 2015, CLIN CANCER RES, V21, P5427, DOI 10.1158/1078-0432.CCR-15-0420	69	23	23	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2020	39	40					6265	6285		10.1038/s41388-019-0902-7	http://dx.doi.org/10.1038/s41388-019-0902-7			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NV5JK	31383940	Green Accepted			2022-12-26	WOS:000574357500001
J	Guo, Y; Wei, XB; Yan, H; Qin, Y; Yan, SQ; Liu, J; Zhao, Y; Jiang, F; Lou, HY				Guo, Ying; Wei, Xinbing; Yan, Hua; Qin, Yue; Yan, Shaoqi; Liu, Jia; Zhao, Yong; Jiang, Fan; Lou, Haiyan			TREM2 deficiency aggravates alpha-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models	FASEB JOURNAL			English	Article						microglia; PD; alpha-syn; inflammation	MYELOID CELLS 2; ATTENUATES NEUROINFLAMMATION; MICROGLIAL RESPONSE; UP-REGULATION; ACTIVATION; M1; DIFFERENTIATION; POLARIZATION; VARIANTS; PROTECTS	Variants in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2) are known to increase the risk of developing Alzheimer disease and Parkinson's disease (PD). However, the potential role of TREM2 effect on synucleinopathy has not been characterized. In this study, we investigated whether loss of TREM2 function affects alpha-synucleinopathy both in vitro and in vivo. In vitro, BV2 microglial cells were exposed to alpha-synuclein (alpha-syn) in the presence or absence of TREM2 small interference RNA. For in vivo studies, wild-type controls and TREM2 gene knockout mice were intracranially injected in the substantia nigra with adeno-associated viral vectors expressing human alpha-syn (AAV-SYN) to induce PD. Our results revealed that knockdown of TREM2 aggravated alpha-syn-induced inflammatory responses in BV2 cells and caused greater apoptosis in SH-SY5Y cells treated with BV2-conditioned medium. In mice, TREM2 knockout exacerbated dopaminergic neuron loss in response to AAV-SYN. Moreover, both in vitro and in vivo TREM2 deficiency induced a shift from an anti-inflammatory toward a proinflammatory activation status of microglia. These data suggest that impairing microglial TREM2 signaling aggravates proinflammatory responses to alpha-syn and exacerbates alpha-syn-induced neurodegeneration by modulating microglial activation state.	[Guo, Ying; Wei, Xinbing; Qin, Yue; Yan, Shaoqi; Liu, Jia; Zhao, Yong; Lou, Haiyan] Shandong Univ, Sch Med, Dept Pharmacol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Jiang, Fan] Shandong Univ, Sch Med, Dept Pathophysiol, Jinan, Peoples R China; [Yan, Hua] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Gastroenterol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University of Traditional Chinese Medicine	Lou, HY (corresponding author), Shandong Univ, Sch Med, Dept Pharmacol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	louhaiyan@sdu.edu.cn			Shandong Natural Science Foundation [ZR2018MH043]; Shandong Province Science and Technology Program [2017GSF18187]	Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Province Science and Technology Program	The authors are thankful to Dr. Ruth G. Perez (Texas Tech University Health Science Center, El Paso, TX, USA) for editorial assistance with the manuscript. This work was supported by grants from the Shandong Natural Science Foundation (ZR2018MH043) and the Shandong Province Science and Technology Program (2017GSF18187). The authors declare no conflicts of interest.	Allen Reish HE, 2015, J PARKINSON DIS, V5, P1, DOI DOI 10.3233/JPD-140491; Arcuri C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00191; Belloli S, 2017, NEUROBIOL AGING, V53, P159, DOI 10.1016/j.neurobiolaging.2017.01.010; Benitez BA, 2013, NEW ENGL J MED, V369, P1567, DOI 10.1056/NEJMc1306509; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Dickson DW, 2018, PARKINSONISM RELAT D, V46, pS30, DOI 10.1016/j.parkreldis.2017.07.033; Gawish R, 2015, FASEB J, V29, P1247, DOI 10.1096/fj.14-260067; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Jay TR, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0197-5; Jha MK, 2016, BIOCHEM PHARMACOL, V103, P1, DOI 10.1016/j.bcp.2015.11.003; Jiang T, 2014, NEUROBIOL AGING, V35, P1243, DOI 10.1016/j.neurobiolaging.2013.11.026; Jiang YH, 2018, CELL PHYSIOL BIOCHEM, V46, P1398, DOI 10.1159/000489155; Joers V, 2017, PROG NEUROBIOL, V155, P57, DOI 10.1016/j.pneurobio.2016.04.006; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Lastres-Becker I, 2016, ANTIOXID REDOX SIGN, V25, P61, DOI 10.1089/ars.2015.6549; Le WD, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00089; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Liu GY, 2016, MOL NEUROBIOL, V53, P4931, DOI 10.1007/s12035-015-9416-7; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Moehle MS, 2015, NEUROSCIENCE, V302, P59, DOI 10.1016/j.neuroscience.2014.11.018; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Owens R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00056; Painter MM, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0040-9; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Perry VH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009373; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Ren MR, 2018, EXP NEUROL, V302, P205, DOI 10.1016/j.expneurol.2018.01.016; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Sheldon KE, 2013, J IMMUNOL, V191, P2290, DOI 10.4049/jimmunol.1202102; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Zhai Q, 2017, ANESTHESIOLOGY, V127, P98, DOI 10.1097/ALN.0000000000001628; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang YW, 2018, BIOCHEM BIOPH RES CO, V499, P797, DOI 10.1016/j.bbrc.2018.03.226; Zheng HH, 2017, J NEUROSCI, V37, P1772, DOI 10.1523/JNEUROSCI.2459-16.2017; Zheng HH, 2016, NEUROBIOL AGING, V42, P132, DOI 10.1016/j.neurobiolaging.2016.03.004	47	19	21	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12164	12174		10.1096/fj.201900992R	http://dx.doi.org/10.1096/fj.201900992R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370707	Green Published			2022-12-26	WOS:000507461600044
J	Rider, AT; Henning, GB; Stockman, A				Rider, Andrew T.; Henning, G. Bruce; Stockman, Andrew			Light adaptation controls visual sensitivity by adjusting the speed and gain of the response to light	PLOS ONE			English	Article							TIME-DEPENDENT STIMULI; MODULATION SENSITIVITY; DYNAMIC PROPERTIES; TEMPORAL IMPULSE; GANGLION-CELLS; PRIMATE CONES; FLICKER; ISOCHROME; MODEL; LUMINANCE	The range of c. 10(12) ambient light levels to which we can be exposed massively exceeds the <10(3) response range of neurons in the visual system, but we can see well in dim starlight and bright sunlight. This remarkable ability is achieved largely by a speeding up of the visual response as light levels increase, causing characteristic changes in our sensitivity to different rates of flicker. Here, we account for over 65 years of flicker-sensitivity measurements with an elegantly-simple, physiologically-relevant model built from first-order low-pass filters and subtractive inhibition. There are only two intensity-dependent model parameters: one adjusts the speed of the visual response by shortening the time constants of some of the filters in the direct cascade as well as those in the inhibitory stages; the other parameter adjusts the overall gain at higher light levels. After reviewing the physiological literature, we associate the variable gain and three of the variable-speed filters with biochemical processes in cone photoreceptors, and a further variable-speed filter with processes in ganglion cells. The variable-speed but fixed-strength subtractive inhibition is most likely associated with lateral connections in the retina. Additional fixed-speed filters may be more central. The model can explain the important characteristics of human flicker-sensitivity including the approximate dependences of low-frequency sensitivity on contrast (Weber's law) and of high-frequency sensitivity on amplitude ("high-frequency linearity"), the exponential loss of high-frequency sensitivity with increasing frequency, and the logarithmic increase in temporal acuity with light level (Ferry-Porter law). In the time-domain, the model can account for several characteristics of flash sensitivity including changes in contrast sensitivity with light level (de Vries-Rose and Weber's laws) and changes in temporal summation (Bloch's law). The new model provides fundamental insights into the workings of the visual system and gives a simple account of many visual phenomena.	[Rider, Andrew T.; Henning, G. Bruce; Stockman, Andrew] UCL, UCL Inst Ophthalmol, London, England	University of London; University College London	Stockman, A (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	a.stockman@ucl.ac.uk		Rider, Andy/0000-0001-8251-1100; Stockman, Andrew/0000-0001-9807-6289	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M01858X/1, BB/R019487/1]; BBSRC [BB/M01858X/1, BB/R019487/1]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) grants BB/M01858X/1 and BB/R019487/1 to AS.; This work was supported by BBSRC grants BB/M01858X/1 and BB/R019487/1. We thank Rhea Eskew for comments and an anonymous reviewer who encouraged us to make substantial improvements to the original manuscript.	BARLOW HB, 1976, J PHYSIOL-LONDON, V259, P737, DOI 10.1113/jphysiol.1976.sp011492; Barten PGJ., 1999, CONTRAST SENSITIVITY, DOI 10.1117/3.353254; Baudin J, 2019, ELIFE, V8, DOI 10.7554/eLife.39166; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; Bills MA, 1920, LAG VISUAL SENSATION, Vvi; Bloch M. A. -M., 1885, CR HEBD ACAD SCI, V37, P493; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Cao LH, 2014, P NATL ACAD SCI USA, V111, P2752, DOI 10.1073/pnas.1400268111; CHEN B, 1987, J PHYSIOL-LONDON, V394, P41, DOI 10.1113/jphysiol.1987.sp016859; DELAN.H, 1961, J OPT SOC AM, V51, P415, DOI 10.1364/JOSA.51.000415; DELANGE H, 1952, PHYSICA, V18, P935, DOI 10.1016/S0031-8914(52)80230-7; deLange H., 1957, ATTENUATION CHARACTE; DELANGEDZN H, 1958, J OPT SOC AM, V48, P777, DOI 10.1364/JOSA.48.000777; DONNER K, 1995, VISION RES, V35, P2255, DOI 10.1016/0042-6989(94)00319-H; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Enoch JM, 1972, HDB SENSORY PHYSL, VVII, P537; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P579, DOI 10.1113/jphysiol.1975.sp010948; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; Eskew Jr R.T., 1999, COLOR VISION GENES P, P345, DOI DOI 10.1016/B978-012370880-9.00302-9; FUORTES MGF, 1964, J PHYSIOL-LONDON, V172, P239, DOI 10.1113/jphysiol.1964.sp007415; GEISLER WS, 1978, VISION RES, V18, P279, DOI 10.1016/0042-6989(78)90162-1; GRAHAM N, 1992, VISION RES, V32, P1373, DOI 10.1016/0042-6989(92)90230-G; GRAHAM N, 1992, VISION RES, V32, P779, DOI 10.1016/0042-6989(92)90193-M; HARTMANN EE, 1992, VISION RES, V32, P1163, DOI 10.1016/0042-6989(92)90018-E; Hecht S, 1936, J GEN PHYSIOL, V19, P965, DOI 10.1085/jgp.19.6.965; Hood DC, 1998, ANNU REV PSYCHOL, V49, P503, DOI 10.1146/annurev.psych.49.1.503; Howlett MHC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001210; Ives HE, 1922, J OPT SOC AM REV SCI, V6, P343, DOI 10.1364/JOSA.6.000343; Kamar S, 2019, J VISION, V19, DOI 10.1167/19.5.14; Kaufman L, 1986, HDB PERCEPTION HUMAN, Vfirst, P1; KELLY DH, 1961, J OPT SOC AM, V51, P422, DOI 10.1364/JOSA.51.000422; KELLY DH, 1969, J OPT SOC AM, V59, P1665, DOI 10.1364/JOSA.59.001665; KELLY DH, 1962, J OPT SOC AM, V52, P89, DOI 10.1364/JOSA.52.000089; Kelly DH, 1972, HDB SENSORY PHYSL, VVII, P273; KULIKOWSKI JJ, 1971, VISION RES, V11, P83, DOI 10.1016/0042-6989(71)90206-9; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; MACLEOD DIA, 1978, ANNU REV PSYCHOL, V29, P613, DOI 10.1146/annurev.ps.29.020178.003145; MACLEOD DIA, 1993, NATURE, V361, P256, DOI 10.1038/361256a0; Manahilov V, 1998, VISION RES, V38, P447, DOI 10.1016/S0042-6989(97)00149-1; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MATIN L, 1968, J OPT SOC AM, V58, P404, DOI 10.1364/JOSA.58.000404; Packer OS, 2005, J VISION, V5, P1038, DOI 10.1167/5.11.9; Parinaud H., 1881, CR HEBD ACAD SCI, V93, P286; Petrova D, 2013, J VISION, V13, DOI 10.1167/13.7.15; Petrova D, 2013, J VISION, V13, DOI 10.1167/13.4.2; Porter TC, 1902, P R SOC LONDON, V70, P313, DOI 10.1098/rspl.1902.0032; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P714, DOI 10.1007/BF01564983; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P596, DOI 10.1007/BF01565761; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P569, DOI 10.1007/BF01565573; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P735, DOI 10.1007/BF01566229; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P553, DOI 10.1007/BF01571319; Pulfrich C., 1922, NATURWISSENSCHAFTEN, V10, P51; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; ROGERS BJ, 1972, VISION RES, V12, P909, DOI 10.1016/0042-6989(72)90014-4; ROUFS JAJ, 1981, VISION RES, V21, P1203, DOI 10.1016/0042-6989(81)90225-X; ROUFS JAJ, 1972, VISION RES, V12, P261, DOI 10.1016/0042-6989(72)90117-4; ROUFS JAJ, 1972, VISION RES, V12, P279, DOI 10.1016/0042-6989(72)90118-6; Rovamo J, 1999, VISION RES, V39, P533, DOI 10.1016/S0042-6989(98)00120-5; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schultze M., 1866, ARCH MICROSK ANAT, V2, P175, DOI DOI 10.1007/BF02962033; SEIPLE W, 1992, VISION RES, V32, P2043, DOI 10.1016/0042-6989(92)90065-Q; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; Shapley R, 2009, VISION RES, V49, P907, DOI 10.1016/j.visres.2008.09.026; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Sinha R, 2017, CELL, V168, P413, DOI 10.1016/j.cell.2017.01.005; Smith VC, 2001, J NEUROPHYSIOL, V85, P545, DOI 10.1152/jn.2001.85.2.545; SPERLING G, 1968, J OPT SOC AM, V58, P1133, DOI 10.1364/JOSA.58.001133; Stiles W. S, 1978, MECH COLOUR VISION; Stockman A, 1998, VISION RES, V38, P3703, DOI 10.1016/S0042-6989(98)00049-2; Stockman A., 2010, OSA HDB OPTICS, V3rd Edn, p11.11; Stockman A, 2006, J VISION, V6, P1194, DOI 10.1167/6.11.5; Stockman A, 2017, J VISION, V17, DOI 10.1167/17.9.2; Stockman A, 2014, J VISION, V14, DOI 10.1167/14.3.1; Stockman A, 2010, J VISION, V10, DOI 10.1167/10.2.12; SWANSON WH, 1987, J OPT SOC AM A, V4, P1992, DOI 10.1364/JOSAA.4.001992; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0; TYLER CW, 1985, J OPT SOC AM A, V2, P393, DOI 10.1364/JOSAA.2.000393; VALETON JM, 1983, VISION RES, V23, P1539, DOI 10.1016/0042-6989(83)90167-0; van Hateren H, 2005, J VISION, V5, P331, DOI 10.1167/5.4.5; van Hateren JH, 2007, J VISION, V7, DOI 10.1167/7.4.1; Veringa F., 1961, ENIGE NATUURKUNDIGE; vonKries J., 1894, BERICHT NATURFORSCHU, V9, P61; VonKries J., 1892, AM J SCI, V44, P192; VONWIEGAND TE, 1995, VISION RES, V35, P3037, DOI 10.1016/0042-6989(95)00047-4; Watson A.B., 2015, SID S SID S, V46, P30; Watson A. B., 1986, HDB PERCEPTION HUMAN, P6, DOI DOI 10.1016/0003-6870(87)90144-X	91	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220358	10.1371/journal.pone.0220358	http://dx.doi.org/10.1371/journal.pone.0220358			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390358	Green Submitted, Green Published, gold			2022-12-26	WOS:000484999400016
J	Grosse, C; Soltermann, A; Rechsteiner, M; Grosse, A				Grosse, Claudia; Soltermann, Alex; Rechsteiner, Markus; Grosse, Alexandra			Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome	PLOS ONE			English	Article							EML4-ALK FUSION GENE; KRAS MUTATIONS; CLINICAL CHARACTERISTICS; BRAIN METASTASIS; YOUNG-PATIENTS; CANCER; EGFR; FEATURES; SURVIVAL; PREVALENCE	Purpose Lung cancer in never smokers is recognized as a distinct molecular, clinicopathologic and epidemiologic entity. The aim of the study was to investigate the molecular profile in Swiss never smokers with lung adenocarcinoma and to correlate the mutation status with clinicopathologic and demographic patient characteristics and outcome. Methods One hundred thirty-eight never smokers diagnosed with lung adenocarcinoma at the University Hospital Zurich between 2011-2018 were included in the study. Data from the electronic medical records were reviewed to characterize clinicopathologic and demographic features, molecular profile, treatment and outcome. Results The majority of patients were female (58.7%) with a median age at diagnosis of 64.5 years (range, 27.1-94.2 years). The most common mutations were EGFR (58.7%) followed by ALK (12.3%), TP53 (5.8%), MET (5.8%), KRAS (4.3%), ERBB2 (4.3%), PIK3CA (2.9%), BRAF (2.2%), ROS1 (1.4%), RET (1.4%), CTNNB1 (0.7%), PARP1 (0.7%), TET1 (0.7%) and PIK3CG (0.7%). Median overall survival (mOS) was 51.0 months (mo). Early clinical stage (p = 0.002) and treatment with targeted therapy (HR 2.53, 95% CI 1.35-4.74, p = 0.004) were independently associated with longer mOS. Patients with oncogenic driver mutations had significantly longer mOS (52.2 mo) compared to patients without mutations (16.9 mo) (HR 3.38, 95% CI 1.52-7.55, p = 0.003). Besides, patients with EGFR mutated (57.8 mo) or ALK rearranged (59.9 mo) tumors had significantly longer mOS compared to the EGFR wildtype (35.0 mo), ALK wildtype (46.5 mo) and pan-negative (16.9 mo) cohorts (HR 2.35, 95% CI 1.37-4.04, p = 0.002; HR 7.80, 95% CI 3.28-18.55, p < 0.001; HR 3.96, 95% CI 1.21-12.95, p = 0.023 and HR 34.78, 95% CI 3.48-34.65, p = 0.003). Conclusion Never smokers with lung adenocarcinoma display distinct clinicopathologic and molecular features and are characterized by a high incidence of targetable mutations. Never smokers with targetable mutations have significantly longer survival compared to patients without mutations.	[Grosse, Claudia; Soltermann, Alex; Grosse, Alexandra] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Clin Pathol, Zurich, Switzerland; [Rechsteiner, Markus] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Diagnost Mol Pathol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Grosse, C (corresponding author), Univ Hosp Zurich, Inst Pathol & Mol Pathol, Clin Pathol, Zurich, Switzerland.	claudiagrosse@gmx.at	Soltermann, Alex/GRR-3265-2022; Soltermann, Alex/AAE-3012-2020	Soltermann, Alex/0000-0001-9509-6938				Bauml J, 2013, LUNG CANCER, V81, P347, DOI 10.1016/j.lungcan.2013.05.011; Brierley JD, 2017, TNM CLASSIFICATION M; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Costa DB, 2015, J CLIN ONCOL, V33, P1881, DOI 10.1200/JCO.2014.59.0539; Couraud S, 2015, EUR RESPIR J, V45, P1403, DOI 10.1183/09031936.00097214; Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; Eichler AF, 2010, NEURO-ONCOLOGY, V12, P1193, DOI 10.1093/neuonc/noq076; Fekrazad MH, 2007, J CLIN ONCOL, V25, P5024, DOI 10.1200/JCO.2007.13.3751; Fidler MM, 2017, LANCET ONCOL, V18, P1579, DOI 10.1016/S1470-2045(17)30677-0; Gao B, 2010, J THORAC ONCOL, V5, P1130, DOI 10.1097/JTO.0b013e3181e05016; Gounant V, 2007, LUNG CANCER, V58, P425, DOI 10.1016/j.lungcan.2007.07.010; Grosse A, 2019, DIAGN PATHOL, V14, DOI 10.1186/s13000-019-0789-1; Hsu CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-241; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kim HR, 2012, CANCER-AM CANCER SOC, V118, P729, DOI 10.1002/cncr.26311; Korpanty Grzegorz J, 2018, Oncotarget, V9, P22559, DOI 10.18632/oncotarget.25176; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee CK, 2015, J CLIN ONCOL, V33, DOI [10.1200/JCO.2014.60.4769, DOI 10.1200/JCO.2014.60.4769]; Lee HL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-181; Lee YJ, 2011, LUNG CANCER, V72, P9, DOI 10.1016/j.lungcan.2010.12.013; Lee YJ, 2010, J CLIN ONCOL, V28, P487, DOI 10.1200/JCO.2009.24.5480; Luo WX, 2018, INT J CANCER, V143, P1696, DOI 10.1002/ijc.31542; Midha A, 2015, AM J CANCER RES, V5, P2892; Mounawar M, 2007, CANCER RES, V67, P5667, DOI 10.1158/0008-5472.CAN-06-4229; Nagashima O, 2013, J THORAC DIS, V5, P27, DOI 10.3978/j.issn.2072-1439.2012.12.02; Ng TL, 2019, CANCER-AM CANCER SOC, V125, P1038, DOI 10.1002/cncr.31871; Paik JH, 2012, LUNG CANCER, V76, P403, DOI 10.1016/j.lungcan.2011.11.008; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Lamelas IP, 2014, ARCH BRONCONEUMOL, V50, P62, DOI 10.1016/j.arbres.2013.09.015; Ramlau R, 2015, J THORAC ONCOL, V10, P1370, DOI 10.1097/JTO.0000000000000621; Sacher AG, 2016, JAMA ONCOL, V2, P313, DOI 10.1001/jamaoncol.2015.4482; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; She CH, 2019, THORAC CANCER, V10, P137, DOI 10.1111/1759-7714.12913; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Tanaka K, 2017, CANCER-AM CANCER SOC, V123, P1731, DOI 10.1002/cncr.30539; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Toh CK, 2006, J CLIN ONCOL, V24, P2245, DOI 10.1200/JCO.2005.04.8033; Travis WD., 2014, WHO CLASSIFICATION T, V4 ed; Vallee A, 2013, INT J ONCOL, V43, P1045, DOI 10.3892/ijo.2013.2056; VandenBussche CJ, 2014, HUM PATHOL, V45, P2379, DOI 10.1016/j.humpath.2014.08.005; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Xia N, 2013, EXP LUNG RES, V39, P328, DOI 10.3109/01902148.2013.819535; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Ye T, 2014, J THORAC DIS, V6, P1396, DOI 10.3978/j.issn.2072-1439.2014.08.50; Zhang J, 2010, CANCER-AM CANCER SOC, V116, P3656, DOI 10.1002/cncr.25100; Zhao FZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117333	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220691	10.1371/journal.pone.0220691	http://dx.doi.org/10.1371/journal.pone.0220691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386689	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000484997100031
J	Walteros, DM; Soares, J; Styczynski, AR; Abrams, JY; Galindo-Buitrago, JI; Acosta-Reyes, J; Bravo-Ribero, E; Arteta, ZE; Solano-Sanchez, A; Prieto, FE; Gonzalez-Duarte, M; Navarro-Lechuga, E; Salinas, JL; Belay, ED; Schonberger, LB; Damon, IK; Ospina, ML; Sejvar, JJ				Walteros, Diana M.; Soares, Jesus; Styczynski, Ashley R.; Abrams, Joseph Y.; Galindo-Buitrago, Jose, I; Acosta-Reyes, Jorge; Bravo-Ribero, Elsa; Arteta, Zuleima E.; Solano-Sanchez, Alma; Prieto, Franklyn E.; Gonzalez-Duarte, Maritza; Navarro-Lechuga, Edgar; Salinas, Jorge L.; Belay, Ermias D.; Schonberger, Lawrence B.; Damon, Inger K.; Ospina, Martha L.; Sejvar, James J.			Long-term outcomes of Guillain-Barre syndrome possibly associated with Zika virus infection	PLOS ONE			English	Article							QUALITY-OF-LIFE; MORTALITY; VALIDATION; DISABILITY; DEPRESSION; EXPERIENCE; PROGNOSIS; DIAGNOSIS; COLOMBIA; ADULTS	Background This prospective cohort investigation analyzed the long-term functional and neurologic outcomes of patients with Zika virus-associated Guillain-Barre syndrome (GBS) in Barranquilla, Colombia. Methods Thirty-four Zika virus-associated GBS cases were assessed a median of 17 months following acute GBS illness. We assessed demographics, results of Overall Disability Sum Scores (ODSS), Hughes Disability Score (HDS), Zung Depression Scale (ZDS), and Health Related Quality of Life (HRQL) questionnaires; and compared outcomes indices with a normative sample of neighborhood-selected control subjects in Barranquilla without GBS. Results Median age at time of acute neurologic onset was 49 years (range, 10-80); 17 (50%) were male. No deaths occurred. At long-term follow-up, 25 (73%) patients had a HDS 0-1, indicating complete / near complete recovery. Among the group, HDS (mean 1.4, range 0-4), ODSS (mean 1.9, range 0-9) and ZDS score (mean 34.4, range 20-56) indicated mild / moderate ongoing disability. Adjusting for age and sex, Zika virus-associated GBS cases were similar to a population comparison group (n = 368) in Barranquilla without GBS in terms of prevalence of physical or mental health complaints, though GBS patients were more likely to have an ODSS of >= 1 (OR 8.8, 95% CI 3.2-24.5) and to suffer from moderate / moderate-severe depression (OR 3.89, 95% CI 1.23-11.17) than the comparison group. Conclusions Long-term outcomes of Zika virus-associated GBS are consistent with those associated with other antecedent antigenic stimuli in terms of mortality and ongoing long-term morbidity, as published in the literature. Persons with Zika virus-associated GBS more frequently reported disability and depression after approximately one year compared with those without GBS.	[Walteros, Diana M.; Prieto, Franklyn E.; Gonzalez-Duarte, Maritza; Ospina, Martha L.] Inst Nacl Salud, Bogota, Colombia; [Soares, Jesus; Abrams, Joseph Y.; Belay, Ermias D.; Schonberger, Lawrence B.; Damon, Inger K.; Sejvar, James J.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Styczynski, Ashley R.] Stanford Univ, Dept Infect Dis, Palo Alto, CA 94304 USA; [Galindo-Buitrago, Jose, I] TEPHINET Inst Global Hlth, Decatur, GA USA; [Acosta-Reyes, Jorge; Navarro-Lechuga, Edgar] Univ Norte, Barranquilla, Colombia; [Bravo-Ribero, Elsa; Arteta, Zuleima E.; Solano-Sanchez, Alma] Secretaria Salud Barranquilla, Barranquilla, Colombia; [Salinas, Jorge L.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA	Instituto Nacional de Salud (Colombia); Centers for Disease Control & Prevention - USA; Stanford University; Universidad del Norte; University of Iowa	Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	zea3@cdc.gov	Galindo-Buitrado, Dr. José I/R-1399-2018; Salinas, Jorge/ABC-7735-2021; Lechuga, Edgar Navarro/ABB-2780-2021; Acosta-Reyes, Jorge/D-1906-2011; Soares, Jesus/D-2992-2016	Galindo-Buitrado, Dr. José I/0000-0002-3790-6725; Salinas, Jorge/0000-0002-9193-820X; Acosta-Reyes, Jorge/0000-0003-4303-3243; Navarro-Lechuga, Edgar/0000-0002-3181-2891; Styczynski, Ashley/0000-0002-4682-8087; Abrams, Joseph/0000-0002-2278-2467; PRIETO ALVARADO, FRANKLYN EDWIN/0000-0002-2079-7251; Soares, Jesus/0000-0002-8640-8618; Bravo, Elsa/0000-0003-2985-3843; Belay, Ermias/0000-0002-9837-0960				Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4; Bernsen RAJAM, 2005, ACTA NEUROL SCAND, V112, P51, DOI 10.1111/j.1600-0404.2005.00429.x; Bersano A, 2006, J NEUROL, V253, P214, DOI 10.1007/s00415-005-0958-x; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9; Cheng BC, 2003, J CLIN APHERESIS, V18, P175, DOI 10.1002/jca.10066; Cheng Q, 2000, EUR J NEUROL, V7, P685, DOI 10.1046/j.1468-1331.2000.00128.x; Cornblath DR, 2006, HDB CLIN NEUROPHYSIO, V7, P695; Darweesh SKL, 2014, J PERIPHER NERV SYST, V19, P24, DOI 10.1111/jns5.12051; Dimachkie MM, 2013, CURR TREAT OPTION NE, V15, P338, DOI 10.1007/s11940-013-0231-z; Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058; Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1; Dominguez-Moreno R, 2014, REV NEUROLOGIA, V58, P4, DOI 10.33588/rn.5801.2013370; Farbu E, 2016, CLIN NEUROL NEUROSUR, V141, P33, DOI 10.1016/j.clineuro.2015.12.008; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fletcher DD, 2000, NEUROLOGY, V54, P2311, DOI 10.1212/WNL.54.12.2311; Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285; Gupta A, 2010, DISABIL REHABIL, V32, P1897, DOI 10.3109/09638281003734474; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8; Merkies ISJ, 2006, J NEUROL NEUROSUR PS, V77, P970, DOI 10.1136/jnnp.2005.076174; Merkies ISJ, 2016, EUR NEUROL, V75, P199, DOI 10.1159/000445347; Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511; Rees JH, 1998, J NEUROL NEUROSUR PS, V64, P74, DOI 10.1136/jnnp.64.1.74; Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Soysal A, 2011, ACTA NEUROL SCAND, V123, P181, DOI 10.1111/j.1600-0404.2010.01366.x; Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869; US Centers for Disease Control and Prevention, 2000, MEASURING HEALTHY DA; van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; Walling AD, 2013, AM FAM PHYSICIAN, V87, P191; Wang Y, 2017, ONCOTARGET, V8, P79991, DOI 10.18632/oncotarget.20620; Wei JCC, 2018, INT J RHEUM DIS, V21, P1443, DOI 10.1111/1756-185X.12973; Wong AHY, 2014, J NEUROL SCI, V344, P60, DOI 10.1016/j.jns.2014.06.021; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	40	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220049	10.1371/journal.pone.0220049	http://dx.doi.org/10.1371/journal.pone.0220049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369576	Green Submitted, gold, Green Published			2022-12-26	WOS:000484987900021
J	Loozen, LD; Kruyt, MC; Kragten, AHM; Schoenfeldt, T; Croes, M; Oner, CF; Dhert, WJA; Alblas, J				Loozen, Loek D.; Kruyt, Moyo C.; Kragten, Angela H. M.; Schoenfeldt, Ted; Croes, Michiel; Oner, Cumhur F.; Dhert, Wouter J. A.; Alblas, Jacqueline			BMP-2 gene delivery in cell-loaded and cell-free constructs for bone regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; SAFETY PROFILE; SPINE FUSION; IN-VIVO; THERAPY; OSTEOINDUCTION; OSTEOGENESIS; TECHNOLOGY	To induce osteogenicity in bone graft substitutes, plasmid-based expression of BMP-2 (pBMP-2) has been successfully applied in gene activated matrices based on alginate polymer constructs. Here, we investigated whether cell seeding is necessary for non-viral BMP-2 gene expression in vivo. Furthermore, to gain insight in the role of BMP-producing cells, we compared inclusion of bone progenitor cells with non-osteogenic target cells in gene delivery constructs. Plasmid DNA encoding GFP (pGFP) was used to trace transfection of host tissue cells and seeded cells in a rat model. Transgene expression was followed in both cell-free alginate-ceramic constructs as well as constructs seeded with syngeneic fibroblasts or multipotent mesenchymal stromal cells (MSCs). Titration of pGFP revealed that the highest pGFP dose resulted in frequent presence of positive host cells in the constructs. Both cell-loaded groups were associated with transgene expression, most effectively in the MSC-loaded constructs. Subsequently, we investigated effectiveness of cell-free and cell-loaded alginate-ceramic constructs with pBMP-2 to induce bone formation. Local BMP-2 production was found in all groups containing BMP-2 plasmid DNA, and was most pronounced in the groups with MSCs transfected with high concentration pBMP-2. Bone formation was only apparent in the recombinant protein BMP-2 group. In conclusion, we show that non-viral gene delivery of BMP-2 is a potentially effective way to induce transgene expression in vivo, both in cell-seeded as well as cell-free conditions. However, alginate-based gene delivery of BMP-2 to host cells or seeded cells did not result in protein levels adequate for bone formation in this setting, calling for more reliable scaffold compatible transfection methods.	[Loozen, Loek D.; Kruyt, Moyo C.; Kragten, Angela H. M.; Schoenfeldt, Ted; Croes, Michiel; Oner, Cumhur F.; Dhert, Wouter J. A.; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Alblas, J (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.alblas@umcutrecht.nl		Croes, Michiel/0000-0002-0270-8905; Alblas, Jacqueline/0000-0002-2996-9697	Dutch government [FES0908]; Dutch Arthritis Foundation	Dutch government; Dutch Arthritis Foundation	Wouter Dhert was supported by a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908), http://www.nirmresearch.nl/index.html.Jacqueline Alblas was supported by the Dutch Arthritis Foundation, https://reumanederland.nl/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank dr. Marianna Tryfonidou for her help with the GFP immunohistochemistry. This work was supported by a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908). JA was supported by the Dutch Arthritis Foundation.	Asatrian G, 2015, STEM CELLS CLONING, V8, P39, DOI 10.2147/SCCAA.S48423; Becquart P, 2012, TISSUE ENG PT A, V18, P2084, DOI [10.1089/ten.tea.2011.0690, 10.1089/ten.TEA.2011.0690]; Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8; Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Dawson JI, 2014, STEM CELLS, V32, P35, DOI 10.1002/stem.1559; Dickerman RD, 2007, SPINE J, V7, P508, DOI 10.1016/j.spinee.2007.03.003; Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107; Evans CH, 2012, ADV DRUG DELIVER REV, V64, P1331, DOI 10.1016/j.addr.2012.03.013; Evans CH, 2015, NAT REV RHEUMATOL, V11, P234, DOI 10.1038/nrrheum.2015.28; Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753; Feichtinger GA, 2014, EUR CELLS MATER, V27, P166, DOI 10.22203/eCM.v027a13; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Geuze RE, 2010, TISSUE ENG PT A, V16, P3343, DOI [10.1089/ten.tea.2009.0774, 10.1089/ten.TEA.2009.0774]; Giacca M, 2012, GENE THER, V19, P622, DOI 10.1038/gt.2012.17; Glass GE, 2013, J HAND SURG-EUR VOL, V38E, P447, DOI 10.1177/1753193412474593; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; Gugala Z, 2003, GENE THER, V10, P1289, DOI 10.1038/sj.gt.3302006; Gugala Z, 2007, BIOMATERIALS, V28, P4469, DOI 10.1016/j.biomaterials.2007.07.007; Hsu WK, 2008, J BONE JOINT SURG AM, V90A, P1043, DOI 10.2106/JBJS.G.00292; Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0; Jo JI, 2015, EXPERT OPIN DRUG DEL, V12, P1689, DOI 10.1517/17425247.2015.1048221; Kong HJ, 2008, PHARM RES, V25, P1230, DOI 10.1007/s11095-007-9526-7; Krebs MD, 2010, J BIOMED MATER RES A, V92A, P1131, DOI 10.1002/jbm.a.32441; Kruyt MC, 2004, J ORTHOP RES, V22, P697, DOI 10.1016/j.orthres.2003.10.021; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z; Loozen LD, 2015, TISSUE ENG PT A, V21, P1672, DOI [10.1089/ten.tea.2014.0593, 10.1089/ten.TEA.2014.0593]; Loozen LD, 2013, J MATER CHEM B, V1, P6619, DOI 10.1039/c3tb21093f; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Oddie GW, 2000, BONE, V27, P575, DOI 10.1016/S8756-3282(00)00368-9; Osawa K, 2010, J GENE MED, V12, P937, DOI 10.1002/jgm.1515; Park DJ, 2007, LARYNGOSCOPE, V117, P1267, DOI 10.1097/MLG.0b013e31805f680e; Pensak M, 2015, GENE THER, V22, P467, DOI 10.1038/gt.2015.14; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Sheyn D, 2008, STEM CELLS, V26, P1056, DOI 10.1634/stemcells.2007-0858; Virk MS, 2011, MOL THER, V19, P960, DOI 10.1038/mt.2011.2; Wegman F, 2011, EUR CELLS MATER, V21, P230, DOI 10.22203/eCM.v021a18; Yasuda K, 2009, J IMMUNOL, V183, P3109, DOI 10.4049/jimmunol.0900399	44	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220028	10.1371/journal.pone.0220028	http://dx.doi.org/10.1371/journal.pone.0220028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365542	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600026
J	Zaytseva, AS; Volodin, IA; Ilchenko, OG; Volodina, EV				Zaytseva, Alexandra S.; Volodin, Ilya A.; Ilchenko, Olga G.; Volodina, Elena V.			Ultrasonic vocalization of pup and adult fat-tailed gerbils (Pachyuromys duprasi)	PLOS ONE			English	Article							JAMAICAN FRUIT BATS; MONGOLIAN GERBIL; MERIONES-UNGUICULATUS; POSTNATAL-GROWTH; MOUSE PUPS; DEVELOPMENTAL-CHANGES; INFANTILE VOCALIZATIONS; ONTOGENIC DEVELOPMENT; VOCAL DEVELOPMENT; BODY-TEMPERATURE	Ultrasonic vocalizations (USVs) of laboratory rodents indicate animal emotional arousal and may serve as models of human disorders. We analysed spectrographically USV calls of pup and adult fat-tailed gerbils Pachyuromys duprasi during 420-s tests, including isolation, touch and handling. Based on combination of six different USV syllable contour shapes and six different note compositions, we classified 782 USV syllables of 24 pups aged 5-10 days to 18 types and 232 syllables of 7 adults to 24 types. Pups and adults shared 16 of these 26 USV types. Percentages of USV syllables with certain contour shapes differed between pups and adults. The contour shape and note composition significantly affected most acoustic variables of USV syllables in either pups or adults. The 1-note USV syllables were most common in either pups or adults. Pup USV syllables were overall longer and higher-frequency than adult ones, reminiscent of the USV ontogenetic pathway of bats and distinctive to rats and mice. We discuss that the USV syllable types of fat-tailed gerbils were generally similar in contour shapes and note compositions with USV syllable types of mice and rats, what means that software developed for automated classifying of mice ultrasound might be easily adapted or re-tuned to gerbil USV calls. However, using fat-tailed gerbils as model for biomedical research including control of USV vocalization is only possible since 6th day of pup life, because of the delayed emergence of USV calls in ontogeny of this species.	[Zaytseva, Alexandra S.; Volodin, Ilya A.] Lomonosov Moscow State Univ, Dept Vertebrate Zool, Fac Biol, Moscow, Russia; [Zaytseva, Alexandra S.; Volodin, Ilya A.; Ilchenko, Olga G.; Volodina, Elena V.] Moscow Zoo, Sci Res Dept, Moscow, Russia	Lomonosov Moscow State University	Volodin, IA (corresponding author), Lomonosov Moscow State Univ, Dept Vertebrate Zool, Fac Biol, Moscow, Russia.; Volodin, IA (corresponding author), Moscow Zoo, Sci Res Dept, Moscow, Russia.	volodinsvoc@gmail.com	Volodin, Ilya/Q-7903-2018	Volodin, Ilya/0000-0001-6278-0354; Volodina, Elena/0000-0001-9755-4576	Russian Science Foundation [19-14-00037]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation (http://www.rscf.ru/) funding to IAV and EVV, grant number 19-14-00037. This research received no additional funding from any public, commercial or not-for-profit sectors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIN J T, 1971, Developmental Psychobiology, V4, P149, DOI 10.1002/dev.420040206; Ancillotto L, 2016, MAMM BIOL, V81, P410, DOI 10.1016/j.mambio.2016.05.001; Ancillotto L, 2014, BIOACOUSTICS, V23, P129, DOI 10.1080/09524622.2013.838146; Arriaga G, 2013, BRAIN LANG, V124, P96, DOI 10.1016/j.bandl.2012.10.002; Basken JN, 2012, EXP BRAIN RES, V219, P351, DOI 10.1007/s00221-012-3096-6; BERTORELLI R, 1995, ITAL J NEUROL SCI, V16, P101, DOI 10.1007/BF02229081; Blake BH, 2012, J MAMMAL, V93, P1051, DOI 10.1644/11-MAMM-A-356.2; Boulanger-Bertolus J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13518-6; BRIDELANCE P, 1989, MAMMALIA, V53, P3, DOI 10.1515/mamm.1989.53.1.3; Briefer EF, 2012, ANIM BEHAV, V83, P991, DOI 10.1016/j.anbehav.2012.01.020; BROOKE R K, 1973, Arnoldia (Rhodesia), V6, P1, DOI 10.1016/0003-3472(73)90003-1; BROOM DM, 1977, J ZOOL, V183, P281; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Brudzynski SM, 2015, CURR NEUROPHARMACOL, V13, P180, DOI 10.2174/1570159X13999150210141444; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Brunelli SA, 2006, PHYSIOL BEHAV, V87, P527, DOI 10.1016/j.physbeh.2005.11.020; Campbell P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113628; Carter RT, 2014, J ZOOL, V293, P25, DOI 10.1111/jzo.12097; Carter RT, 2014, ANAT REC, V297, P1270, DOI 10.1002/ar.22934; Caruso A, 2018, HBK BEHAV NEUROSCI, V25, P139, DOI 10.1016/B978-0-12-809600-0.00013-5; Castellucci GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23305; CERON RJ, 1995, AM IND HYG ASSOC J, V56, P558, DOI 10.1202/0002-8894(1995)056<0558:HSTVFW>2.0.CO;2; Choi H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-104; Coffey KR, 2019, NEUROPSYCHOPHARMACOL, V44, P859, DOI 10.1038/s41386-018-0303-6; CONSTANTINI F, 2006, ACTA ZOOL SINICA, V52, P619; DEFANIS E, 1995, J ZOOL, V235, P85; DEGHETT VJ, 1974, DEV PSYCHOBIOL, V7, P267, DOI 10.1002/dev.420070311; Dempster ER, 2018, HBK BEHAV NEUROSCI, V25, P207, DOI 10.1016/B978-0-12-809600-0.00020-2; DEMPSTER ER, 1991, ETHOLOGY, V88, P1; DEMPSTER ER, 1994, MAMMALIA, V58, P93, DOI 10.1515/mamm.1994.58.1.93; Dou XL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196834; Ehret G, 2018, HBK BEHAV NEUROSCI, V25, P187, DOI 10.1016/B978-0-12-809600-0.00018-4; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Engler S, 2017, BEHAVIOUR, V154, P267, DOI 10.1163/1568539X-00003421; Esposito G, 2017, INT J NEUROPSYCHOPH, V20, P498, DOI 10.1093/ijnp/pyx014; Ey E, 2013, BEHAV BRAIN RES, V256, P677, DOI 10.1016/j.bbr.2013.08.031; Felt SA, 2008, LAB ANIMAL, V37, P256, DOI 10.1038/laban0608-256; Ferhat AT, 2016, JOVE-J VIS EXP, DOI 10.3791/53871; Fernandez-Vargas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116789; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Floody OR, 2018, HBK BEHAV NEUROSCI, V25, P197, DOI 10.1016/B978-0-12-809600-0.00019-6; Funakoshi K, 2013, MAMM STUDY, V38, P49, DOI 10.3106/041.038.0106; Furtak SC, 2018, HBK BEHAV NEUROSCI, V25, P95, DOI 10.1016/B978-0-12-809600-0.00009-3; Gaub S, 2016, GENES BRAIN BEHAV, V15, P243, DOI 10.1111/gbb.12274; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Gouaref I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172053; Granon S, 2018, HBK BEHAV NEUROSCI, V25, P423, DOI 10.1016/B978-0-12-809600-0.00040-8; Griffiths S, 2010, BIOACOUSTICS, V19, P143, DOI 10.1080/09524622.2010.9753621; Grimsley JMS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00038; Grimsley Jasmine M S, 2012, Front Behav Neurosci, V6, P89, DOI 10.3389/fnbeh.2012.00089; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Groenink L, 2015, EUR J PHARMACOL, V753, P191, DOI 10.1016/j.ejphar.2014.10.062; Gulia KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084948; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Hahn ME, 2002, BEHAV GENET, V32, P267, DOI 10.1023/A:1019728813891; Hahn ME, 1998, BEHAV GENET, V28, P315, DOI 10.1023/A:1021679615792; Hammerschmidt K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-40; Hanafi HA, 2013, VECTOR-BORNE ZOONOT, V13, P650, DOI 10.1089/vbz.2012.1185; Hashimoto H, 2004, EXP ANIM TOKYO, V53, P409, DOI 10.1538/expanim.53.409; Hashimoto H, 2001, EXP ANIM TOKYO, V50, P313, DOI 10.1538/expanim.50.313; Hashimoto H, 2007, EXP ANIM TOKYO, V56, P315, DOI 10.1538/expanim.56.315; Heckman J, 2016, NEUROSCI BIOBEHAV R, V65, P313, DOI 10.1016/j.neubiorev.2016.03.029; Hiryu S, 2011, J ACOUST SOC AM, V130, pEL147, DOI 10.1121/1.3632044; Hoffmann F, 2012, J ETHOL, V30, P173, DOI 10.1007/s10164-011-0312-y; HOLMAN SD, 1995, PHYSIOL BEHAV, V57, P451, DOI 10.1016/0031-9384(94)00237-Y; HOLMAN SD, 1980, BEHAV NEURAL BIOL, V28, P183, DOI 10.1016/S0163-1047(80)91535-6; HOLMAN SD, 1991, DEV PSYCHOBIOL, V24, P103, DOI 10.1002/dev.420240204; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Inagaki H, 2012, PHYSIOL BEHAV, V106, P224, DOI 10.1016/j.physbeh.2012.01.018; Ito Umeo, 2013, Acta Neurochir Suppl, V118, P17, DOI 10.1007/978-3-7091-1434-6_3; Ivanenko A, 2018, BIORXIV, DOI [10.1101/358143, DOI 10.1101/358143]; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Jin LR, 2011, ACTA THERIOL, V56, P13, DOI 10.1007/s13364-010-0011-z; Jin LR, 2012, MAMM BIOL, V77, P339, DOI 10.1016/j.mambio.2012.05.001; Johnson AM, 2015, CURR NEUROPHARMACOL, V13, P211, DOI 10.2174/1570159X1302150525122416; Johnson SA, 2017, J COMP PSYCHOL, V131, P30, DOI 10.1037/com0000057; JONES G, 1991, J ZOOL, V225, P71, DOI 10.1111/j.1469-7998.1991.tb03802.x; Jouda J, 2019, ANN NY ACAD SCI, V1437, P68, DOI 10.1111/nyas.13931; Kalcounis-Rueppell MC, 2018, HBK BEHAV NEUROSCI, V25, P149, DOI 10.1016/B978-0-12-809600-0.00014-7; Kalcounis-Rueppell MC, 2018, HBK BEHAV NEUROSCI, V25, P227, DOI 10.1016/B978-0-12-809600-0.00022-6; Kanwal JS, 2018, HBK BEHAV NEUROSCI, V25, P493, DOI 10.1016/B978-0-12-809600-0.00046-9; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Kapusta J, 2007, BEHAVIOUR, V144, P283, DOI 10.1163/156853907780425730; Kapusta J, 2009, BEHAVIOUR, V146, P939, DOI 10.1163/156853908X396818; Kelm-Nelson CA, 2018, HBK BEHAV NEUROSCI, V25, P37, DOI 10.1016/B978-0-12-809600-0.00004-4; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Kisko TM, 2020, GENES BRAIN BEHAV, V19, DOI 10.1111/gbb.12552; Kobayasi KI, 2012, J ACOUST SOC AM, V131, P1622, DOI 10.1121/1.3672693; Kolacz J, 2018, HBK BEHAV NEUROSCI, V25, P23, DOI 10.1016/B978-0-12-809600-0.00003-2; Kromkhun Pudcharaporn, 2013, Lab Anim Res, V29, P77, DOI 10.5625/lar.2013.29.2.77; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Lai JKY, 2014, BEHAV BRAIN RES, V259, P119, DOI 10.1016/j.bbr.2013.10.049; LAY DOUGLAS, 1972, J MORPHOL, V138, P41, DOI 10.1002/jmor.1051380103; Lemasson M, 2005, BEHAV PROCESS, V68, P13, DOI 10.1016/j.beproc.2004.09.001; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu Y, 2007, FOLIA ZOOL, V56, P126; Mahrt E, 2016, CURR BIOL, V26, pR880, DOI 10.1016/j.cub.2016.08.032; Mandelli MJ, 2004, J MAMMAL, V85, P282, DOI 10.1644/1545-1542(2004)085<0282:UVOISF>2.0.CO;2; Marchlewska-Koj A, 2018, HBK BEHAV NEUROSCI, V25, P169, DOI 10.1016/B978-0-12-809600-0.00016-0; Mason MJ, 2016, J ANAT, V228, P284, DOI 10.1111/joa.12313; Matrosova VA, 2012, ACTA THERIOL, V57, P65, DOI 10.1007/s13364-011-0046-9; Matsumoto YK, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180378; Mayberry HW, 2015, BIOL OPEN, V4, P22, DOI 10.1242/bio.201410181; McMurray MS, 2018, HBK BEHAV NEUROSCI, V25, P457, DOI 10.1016/B978-0-12-809600-0.00043-3; Mehdizadeh R, 2018, ZOOL STUD, V57, DOI 10.6620/ZS.2018.57-37; Miller JR, 2007, J MAMMAL, V88, P1447, DOI 10.1644/06-MAMM-A-386R.1; Monroy JA, 2011, J COMP PHYSIOL A, V197, P459, DOI 10.1007/s00359-010-0614-5; Moss CF, 1997, ANIM BEHAV, V54, P131, DOI 10.1006/anbe.1996.0410; Motomura N, 2002, EXP ANIM TOKYO, V51, P187, DOI 10.1538/expanim.51.187; MULLER M, 1991, HEARING RES, V56, P191, DOI 10.1016/0378-5955(91)90169-A; Mun HS, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00316; Murrant MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073045; Musolf K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134123; Nakagawa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049233; Nishiyama K, 2011, J ACOUST SOC AM, V130, P4148, DOI 10.1121/1.3651815; NOIROT E, 1968, ANIM BEHAV, V16, P129, DOI 10.1016/0003-3472(68)90123-1; NOIROT E, 1969, ANIM BEHAV, V17, P340, DOI 10.1016/0003-3472(69)90020-7; NOIROT E, 1966, ANIM BEHAV, V14, P459, DOI 10.1016/S0003-3472(66)80045-3; NOVICK A, 1961, J EXP ZOOL, V148, P125, DOI 10.1002/jez.1401480203; OKON EE, 1970, J ZOOL, V162, P71; OKON EE, 1970, J ZOOL, V162, P485; OKON EE, 1971, J ZOOL, V164, P227; Panyutina AA, 2017, INTEGR ZOOL, V12, P172, DOI 10.1111/1749-4877.12249; Pasch B, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1158; Pasch B, 2016, PHYSIOL BEHAV, V157, P265, DOI 10.1016/j.physbeh.2016.02.012; Pellis SM, 2018, HBK BEHAV NEUROSCI, V25, P117, DOI 10.1016/B978-0-12-809600-0.00011-1; Peterson JR, 2013, DEV PSYCHOBIOL, V55, P818, DOI 10.1002/dev.21072; PLASSMANN W, 1991, BRAIN BEHAV EVOLUT, V38, P115, DOI 10.1159/000114382; PONTET A, 1989, BEHAVIOUR, V108, P241, DOI 10.1163/156853989X00321; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Portfors CV, 2018, HBK BEHAV NEUROSCI, V25, P73, DOI 10.1016/B978-0-12-809600-0.00007-X; Pultorak JD, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00125; Quintar AA, 2017, CELL BIOL INT, V41, P1234, DOI 10.1002/cbin.10789; Refinetti R, 1998, COMP BIOCHEM PHYS A, V119, P295, DOI 10.1016/S1095-6433(97)00436-4; Refinetti R, 1999, J THERM BIOL, V24, P477, DOI 10.1016/S0306-4565(99)00077-7; Riede T, 2018, HBK BEHAV NEUROSCI, V25, P45, DOI 10.1016/B978-0-12-809600-0.00005-6; Riede T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170976; Riede T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12350; Riede T, 2013, J EXP ZOOL PART A, V319A, P213, DOI 10.1002/jez.1785; Riede T, 2011, J NEUROPHYSIOL, V106, P2580, DOI 10.1152/jn.00478.2011; Rieger NS, 2018, ANIM BEHAV, V135, P97, DOI 10.1016/j.anbehav.2017.11.008; Roberts PD, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00172; SALES GD, 1978, DEV PSYCHOBIOL, V11, P595, DOI 10.1002/dev.420110609; Scattoni ML, 2018, HBK BEHAV NEUROSCI, V25, P445, DOI 10.1016/B978-0-12-809600-0.00042-1; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schneider N, 2011, MAMM BIOL, V76, P549, DOI 10.1016/j.mambio.2011.03.002; Schneiderova I, 2014, ACTA THERIOL, V59, P149, DOI 10.1007/s13364-013-0141-1; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; Shair HN, 2018, HBK BEHAV NEUROSCI, V25, P157, DOI 10.1016/B978-0-12-809600-0.00015-9; Shair HN, 2018, HBK BEHAV NEUROSCI, V25, P129, DOI 10.1016/B978-0-12-809600-0.00012-3; Simola N, 2018, HBK BEHAV NEUROSCI, V25, P177, DOI 10.1016/B978-0-12-809600-0.00017-2; Simola N, 2019, NEUROPHARMACOLOGY, V159, DOI 10.1016/j.neuropharm.2018.11.008; Soltis J, 2012, J ACOUST SOC AM, V132, P3550, DOI 10.1121/1.4757097; Somova LI, 2000, METHOD FIND EXP CLIN, V22, P203, DOI 10.1358/mf.2000.22.4.584452; Spence HR, 2016, ECOL EVOL, V6, P1922, DOI 10.1002/ece3.1907; Stark RA, 2017, THESIS; Stewart AM, 2015, PHYSIOL BEHAV, V138, P94, DOI 10.1016/j.physbeh.2014.10.011; SUTHERS RA, 1973, AM ZOOL, V13, P1215; Ter-Mikaelian M, 2012, BEHAVIOUR, V149, P461, DOI 10.1163/156853912X639778; Terleph TA, 2011, BEHAVIOUR, V148, P1277, DOI 10.1163/000579511X600727; THIESSEN DD, 1978, J COMP PHYSIOL PSYCH, V92, P1041, DOI 10.1037/h0077512; Titze IR, 1994, PRINCIPLES VOICE PRO; Vieira ML, 2002, BEHAV PROCESS, V59, P147, DOI 10.1016/S0376-6357(02)00089-X; Volodin IA, 1996, GERBILS CAPTIVE MANA; Volodin IA, 2019, BIOACOUSTICS, V28, P575, DOI 10.1080/09524622.2018.1509374; Volodin IA, 2015, ETHOLOGY, V121, P103, DOI 10.1111/eth.12321; Volodin IA, 2014, ANIM COGN, V17, P349, DOI 10.1007/s10071-013-0666-3; Wang L, 2014, ACTA THERIOL, V59, P435, DOI 10.1007/s13364-014-0182-0; WATTS CHS, 1980, J ZOOL, V191, P531, DOI 10.1111/j.1469-7998.1980.tb01484.x; Wiaderkiewicz J, 2013, ACTA NEUROBIOL EXP, V73, P557; Williams WO, 2008, J AM ASSOC LAB ANIM, V47, P8; Wilson DR, 2006, CAN J ZOOL, V84, P1322, DOI 10.1139/Z06-120; Wilson DR, 2004, NATURE, V430, P523, DOI 10.1038/430523a; Wohr M, 2008, BEHAV GENET, V38, P579, DOI 10.1007/s10519-008-9221-4; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y; Yu P, 2011, BEHAV PROCESS, V88, P162, DOI 10.1016/j.beproc.2011.09.001; Zala SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188647; Zala SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181200; Zaytseva AS, 2016, ZOOL ZH, V95, P94, DOI 10.7868/S0044513416010141; Zaytseva AS, 2017, BIOACOUSTICS, V26, P1, DOI 10.1080/09524622.2016.1164076; Zaytseva AS, 2015, BEHAV PROCESS, V118, P130, DOI 10.1016/j.beproc.2015.06.012; Zeskind PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110349; Zhang LB, 2005, ACTA CHIROPTEROL, V7, P91, DOI 10.3161/1733-5329(2005)7[91:DOVITF]2.0.CO;2	186	13	14	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0219749	10.1371/journal.pone.0219749	http://dx.doi.org/10.1371/journal.pone.0219749			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV1OL	31356642	gold, Green Submitted, Green Published			2022-12-26	WOS:000484047000010
J	Borges, MASB; de Araujo, JA; Oliveira, BDS; Moreira, IS; de Paula, VV; de Bastos, AL; Soares, RDA; Turchi, MD				Santa Barbara Borges, Moara Alves; de Araujo Filho, Joao Alves; Silva Oliveira, Bruno de Jesus; Moreira, Isabela Silverio; de Paula, Vanessa Valadares; de Bastos, Angelica Lima; Ascenco Soares, Renata de Bastos; Turchi, Marilia Dalva			Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; LATERAL FLOW ASSAY; ANTIRETROVIRAL THERAPY; MENINGITIS; EPIDEMIOLOGY; PREVALENCE; STATE; SERUM	Background Cryptococcal meningitis has a high morbidity and mortality among AIDS population. Cryptococcal antigen (CrAg) detection is considered an independent predictor for meningitis and death. Since 2011, the World Health Organization recommends CrAg screening for people living with HIV/AIDS (PLHAs) with CD4 counts <100-200 cells/mu l. Its implementation is still limited in low-middle-income countries. We aimed to estimate the prevalence and predictors of CrAg positivity in PLHAs. We also evaluated outcomes among those who were CrAg-positive. Methods Prospective cohort conducted at an infectious diseases hospital, in Brazil. Adults with CD4 <200 cells/mu l, without previous cryptococcal disease and regardless of symptoms, were enrolled from 2015 to 2018. CrAg tests were performed by LFA. Lumbar puncture was done in CrAg+ individuals and pre-emptive therapy was offered for those without meningitis. Results Of 214 individuals recruited, 88% were antiretroviral experienced, of which only 11.6% with viral suppression. Overall, CrAg prevalence was 7.9% (95% CI, 4.7-12.4). In CD4 <= 100 cells/mu l group it was 7.5% (95% CI, 4.1-12.6) and 9.1% (95% CI, 3.4-19.0) in the group with CD4 101 to 199 cells/mu l (p = 0.17). Prevalence in asymptomatic subjects was 5.3% (95% CI, 1.4-13.1). One among 17 CrAg+ participants had documented meningoencephalitis and no subclinical meningitis was detected. Adherence to pre-emptive treatment was 68.7% (11/16). There were no statistically significant differences in sociodemographic, clinical or laboratory characteristics to predict CrAg positivity. No case of cryptococcal disease was diagnosed among CrAg + subjects, followed by a median of 12 months. Conclusions CrAg screening for severely immunosuppressed PLHAs in Brazil yielded a prevalence of 7.9%. No difference was found in the prevalence of CrAg stratified by CD4 values (CD4 <100 versus CD4 101-199 cells/mu l). No clinical nor laboratory factors predicted CrAg positivity, corroborating the need for the implementation of universal CrAg screening for PLHAs with CD4 <200 cells/mu l in similar settings.	[Santa Barbara Borges, Moara Alves; de Araujo Filho, Joao Alves; Turchi, Marilia Dalva] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Santa Barbara Borges, Moara Alves] Univ Fed Goias, Infect Dis Unit, Clin Hosp, Goiania, Go, Brazil; [de Araujo Filho, Joao Alves; Silva Oliveira, Bruno de Jesus; Moreira, Isabela Silverio; de Paula, Vanessa Valadares; Ascenco Soares, Renata de Bastos] Pontifical Catholic Univ Goia, Goiania, Go, Brazil; [de Araujo Filho, Joao Alves; Ascenco Soares, Renata de Bastos; Turchi, Marilia Dalva] Trop Dis State Hosp Dr Anuar Auad, Goiania, Go, Brazil; [de Bastos, Angelica Lima] State Lab Publ Hlth Dr Giovanni Cysneiros, Goiania, Go, Brazil; [Santa Barbara Borges, Moara Alves] Univ Fed Goias, Dept Trop Med & Dermatol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Borges, MASB (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.; Borges, MASB (corresponding author), Univ Fed Goias, Infect Dis Unit, Clin Hosp, Goiania, Go, Brazil.; Borges, MASB (corresponding author), Univ Fed Goias, Dept Trop Med & Dermatol, Goiania, Go, Brazil.	moarasb@gmail.com	Filho, João Alves Araújo/V-5279-2019; DE BASTOS ASCENCO SOARES, RENATA/G-4330-2019	Filho, João Alves Araújo/0000-0002-8810-6998; Lima de Bastos, Angelica/0000-0001-5426-8107; Turchi, Marilia Dalva/0000-0001-5438-1345; DE BASTOS ASCENCO SOARES, RENATA/0000-0003-1029-325X; Borges, Moara/0000-0003-2461-2063	Foundation for Research Support of the State of Goias [17809]	Foundation for Research Support of the State of Goias	JAAF received financial support from the Foundation for Research Support of the State of Goias (www.fapeg.go.gov.br), Digital number 17809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058377; Beyene T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075585; Brasil M. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2018, PREV CONTR INF SEX T; Chipungu Chifundo, 2015, J Int Assoc Provid AIDS Care, V14, P387, DOI 10.1177/2325957415592475; da Costa MM, 2013, CURR HIV RES, V11, P647, DOI 10.2174/1570162X12666140311125420; de Aguiar PADF, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759013, 10.1590/S1678-9946201759013]; Dubbels M, 2017, J CLIN MICROBIOL, V55, P2472, DOI 10.1128/JCM.00751-17; Ferreira G, 2017, PROC IEEE ACM INT C, P100, DOI 10.1109/ICSE-C.2017.156; Firacative C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170554; Ford N, 2018, CLIN INFECT DIS, V66, pS152, DOI 10.1093/cid/cix1143; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Huang HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127117; Jarvis JN, 2016, LANCET INFECT DIS, V16, P756, DOI 10.1016/S1473-3099(16)00128-6; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kaplan JE, 2015, JAIDS-J ACQ IMM DEF, V68, pS331, DOI 10.1097/QAI.0000000000000484; Larson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158986; Lawrence DS, 2019, CURR OPIN INFECT DIS, V32, P16, DOI [10.1097/QCO.0000000000000514, 10.1097/qco.0000000000000514]; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Nunes JD, 2018, REV SOC BRAS MED TRO, V51, P485, DOI 10.1590/0037-8682-0050-2018; Oyella J, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-15; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Rugemalila J, 2013, TROP MED INT HEALTH, V18, P1075, DOI 10.1111/tmi.12157; Scriven JE, 2016, LANCET INFECT DIS, V16, P891, DOI 10.1016/S1473-3099(16)30145-1; Soares EA, 2015, THESIS; Temfack E, 2019, CLIN INFECT DIS, V68, P688, DOI 10.1093/cid/ciy567; Vidal JE, 2016, TROP MED INT HEALTH, V21, P1539, DOI 10.1111/tmi.12790; Vidal JE, 2012, DIAGN MICR INFEC DIS, V73, P68, DOI 10.1016/j.diagmicrobio.2012.01.014; World Health Organization, 2018, GUID DIAGN PREV MAN; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219928	10.1371/journal.pone.0219928	http://dx.doi.org/10.1371/journal.pone.0219928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344140	Green Submitted, gold, Green Published			2022-12-26	WOS:000484977900041
J	Fujita, N; Fujimoto, H; Hamamatsu, K; Murakami, T; Kimura, H; Toyoda, K; Saji, H; Inagaki, N				Fujita, Naotaka; Fujimoto, Hiroyuki; Hamamatsu, Keita; Murakami, Takaaki; Kimura, Hiroyuki; Toyoda, Kentaro; Saji, Hideo; Inagaki, Nobuya			Noninvasive longitudinal quantification of beta-cell mass with [In-111]-labeled exendin-4	FASEB JOURNAL			English	Article						in vivo radioisotope; GLP-1 receptor; SPECT	EXENDIN(9-39) DERIVATIVES; PEPTIDE-1 RECEPTOR; PANCREAS; MICE; PET	Currently, quantifying beta-cell mass (BCM) requires harvesting the pancreas. In this study, we investigated a potential noninvasive method to quantify BCM changes longitudinally using [Lys(12)(In-111-BnDTPA-Ahx)] exendin-4 ([In-111]-Ex4) and single-photon emission computed tomography (SPECT). We used autoradiography and transgenic mice expressing green fluorescent protein under the control of mouse insulin 1 gene promotor to evaluate the specificity of [In-111]-Ex4 toward beta cells. Using nonobese diabetic (NOD) mice, we injected [In-111]-Ex4 (3.0 MBq) intravenously and performed SPECT 30 min later, repeating this at a 2-wk interval. After the second scan, we harvested the pancreas and calculated BCM from immunohistochemically stained pancreatic sections. Specific accumulation of [In-111]-Ex4 in beta cells was confirmed by autoradiography, with a significant correlation (r = 0.94) between the fluorescent and radioactive signal intensities. The radioactive signal from the pancreas in the second SPECT scan significantly correlated (r = 0.89) with BCM calculated from the immunostained pancreatic sections. We developed a regression formula to estimate BCM from the radioactive signals from the pancreas in SPECT scans. BCM can be quantified longitudinally and noninvasively by SPECT imaging with [In-111]-Ex4. This technique successfully demonstrated longitudinal changes in BCM in NOD mice before and after onset of hyperglycemia.	[Fujita, Naotaka; Fujimoto, Hiroyuki; Hamamatsu, Keita; Murakami, Takaaki; Toyoda, Kentaro; Inagaki, Nobuya] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan; [Fujimoto, Hiroyuki] Kyoto Univ, Radioisotope Res Ctr, Agcy Hlth Safety & Environm, Kyoto, Japan; [Saji, Hideo] Kyoto Univ, Dept Pathofunct Bioanal, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Kimura, Hiroyuki] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto Pharmaceutical University	Inagaki, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, Shogoin kawahara Cho 54, Kyoto 6068507, Japan.	inagaki@kuhp.kyoto-u.ac.jp			Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED); Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development (AMED); Center of Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [JP18K08475]	Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Center of Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Asami Mori (Kyoto University) for technical support. This study was funded by the Translational Research Network Program and the Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development (AMED), the Center of Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Japan Science and Technology Agency (JST), and the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI; JP18K08475); however, they played no role in the study design or conduct, data collection, analysis, or interpretation, or the preparation, review, or approval of the manuscript. H.S. received grants from Nihon Medi-Physics Co. Ltd., outside the submitted work. N.I. received grants from Sumitomo Dainippon Pharma Co. Ltd., and personal fees from MSD Co. Ltd., Mitsubishi Tanabe Pharma Corp., AstraZeneca Co. Ltd., Ono Pharmaceutical Co. Ltd., and Daiichi-Sankyo Co. Ltd., outside the submitted work. Moreover, H.K., H.S., and N.I. have a patent, WO2011071083A1, issued to Kyoto University and Arkray, Inc. All remaining authors declare no conflicts of interest.	Alavi A, 2018, DIABETOLOGIA, V61, P2512, DOI 10.1007/s00125-018-4676-1; BOLENDER RP, 1974, J CELL BIOL, V61, P269, DOI 10.1083/jcb.61.2.269; Brom M, 2014, DIABETOLOGIA, V57, P950, DOI 10.1007/s00125-014-3166-3; Brom M, 2010, EUR J NUCL MED MOL I, V37, P1345, DOI 10.1007/s00259-009-1363-y; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cline GW, 2018, DIABETOLOGIA, V61, P2671, DOI 10.1007/s00125-018-4718-8; Cline GW, 2018, DIABETOLOGIA, V61, P2598, DOI 10.1007/s00125-018-4624-0; Eriksson O, 2016, DIABETOLOGIA, V59, P1340, DOI 10.1007/s00125-016-3959-7; Eriksson O, 2010, NUCL MED BIOL, V37, P357, DOI 10.1016/j.nucmedbio.2009.12.004; Freeby MJ, 2016, MOL IMAGING BIOL, V18, P292, DOI 10.1007/s11307-015-0888-7; Gotthardt M, 2018, DIABETOLOGIA, V61, P2516, DOI 10.1007/s00125-018-4745-5; Hamamatsu K, 2018, NUCL MED BIOL, V64-65, P22, DOI 10.1016/j.nucmedbio.2018.06.002; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Jodal A, 2017, EUR J NUCL MED MOL I, V44, P712, DOI 10.1007/s00259-016-3592-1; Kimura H, 2018, BIOORGAN MED CHEM, V26, P463, DOI 10.1016/j.bmc.2017.12.007; Kimura H, 2017, BIOORGAN MED CHEM, V25, P5772, DOI 10.1016/j.bmc.2017.09.005; Kimura H, 2017, BIOORGAN MED CHEM, V25, P1406, DOI 10.1016/j.bmc.2016.12.051; Mathijs I, 2015, MOL IMAGING BIOL, V17, P58, DOI 10.1007/s11307-014-0771-y; Meier JJ, 2009, DIABETES, V58, P1595, DOI 10.2337/db08-1611; Mukai E, 2009, BIOCHEM BIOPH RES CO, V389, P523, DOI 10.1016/j.bbrc.2009.09.014; Normandin MD, 2012, J NUCL MED, V53, P908, DOI 10.2967/jnumed.111.100545; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Selvaraju RK, 2013, J NUCL MED, V54, P1458, DOI 10.2967/jnumed.112.114066; Souza F, 2006, J CLIN INVEST, V116, P1506, DOI 10.1172/JCI27645; TURNER RC, 1995, DIABETES, V44, P1249; van der Kroon I, 2016, MOL PHARMACEUT, V13, P3478, DOI 10.1021/acs.molpharmaceut.6b00495; Vinet L, 2015, DIABETOLOGIA, V58, P304, DOI 10.1007/s00125-014-3442-2; Virostko J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057784; Wild D, 2006, J NUCL MED, V47, P2025; YASUNAMI R, 1988, EUR J IMMUNOL, V18, P481, DOI 10.1002/eji.1830180325; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	34	9	9	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11836	11844		10.1096/fj.201900555RR	http://dx.doi.org/10.1096/fj.201900555RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370679	Green Published			2022-12-26	WOS:000507461600020
J	Ke, YZD; Chan, G; Stefanoska, K; Au, C; Bi, M; Muller, J; Przybyla, M; Feiten, A; Prikas, E; Halliday, GM; Piguet, O; Kiernan, MC; Kassiou, M; Hodges, JR; Loy, CT; Mattick, JS; Ittner, A; Kril, JJ; Sutherland, GT; Ittner, LM				Ke, Yazi D.; Chan, Gabriella; Stefanoska, Kristie; Au, Carol; Bi, Mian; Mueller, Julius; Przybyla, Magdalena; Feiten, Astrid; Prikas, Emmanuel; Halliday, Glenda M.; Piguet, Olivier; Kiernan, Matthew C.; Kassiou, Michael; Hodges, John R.; Loy, Clement T.; Mattick, John S.; Ittner, Arne; Kril, Jillian J.; Sutherland, Greg T.; Ittner, Lars M.			CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); neurodegenerative disease; mouse; gene expression; neurobiology; transgenic mice	AMYLOID-BETA TOXICITY; ALZHEIMERS-DISEASE; MOUSE MODEL; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; PROTEIN-TAU; PHOSPHORYLATION; DATABASE; ASSOCIATION; ISOFORMS	The microtubule-associated protein tau undergoes aberrant modification resulting in insoluble brain deposits in various neurodegenerative diseases, including frontotemporal dementia (FTD), progressive supranuclear palsy, and corticobasal degeneration. Tau aggregates can form in different cell types of the central nervous system (CNS) but are most prevalent in neurons. We have previously recapitulated aspects of human FTD in mouse models by overexpressing mutant human tau in CNS neurons, including a P301S tau variant in TAU58/2 mice, characterized by early-onset and progressive behavioral deficits and FTD-like neuropathology. The molecular mechanisms underlying the functional deficits of TAU58/2 mice remain mostly elusive. Here, we employed functional genomics (i.e. RNAseq) to determine differentially expressed genes in young and aged TAU58/2 mice to identify alterations in cellular processes that may contribute to neuropathy. We identified genes in cortical brain samples differentially regulated between young and old TAU58/2 mice relative to nontransgenic littermates and by comparative analysis with a dataset of CNS cell type-specific genes expressed in nontransgenic mice. Most differentially-regulated genes had known or putative roles in neurons and included presynaptic and excitatory genes. Specifically, we observed changes in presynaptic factors, glutamatergic signaling, and protein scaffolding. Moreover, in the aged mice, expression levels of several genes whose expression was annotated to occur in other brain cell types were altered. Immunoblotting and immunostaining of brain samples from the TAU58/2 mice confirmed altered expression and localization of identified and network-linked proteins. Our results have revealed genes dysregulated by progressive tau accumulation in an FTD mouse model.	[Ke, Yazi D.; Chan, Gabriella; Stefanoska, Kristie; Au, Carol; Bi, Mian; Przybyla, Magdalena; Feiten, Astrid; Prikas, Emmanuel; Ittner, Arne; Ittner, Lars M.] Macquarie Univ, Fac Med & Hlth Sci, Dementia Res Ctr, Sydney, NSW 2109, Australia; [Ke, Yazi D.; Chan, Gabriella; Stefanoska, Kristie; Au, Carol; Bi, Mian; Przybyla, Magdalena; Feiten, Astrid; Prikas, Emmanuel; Ittner, Arne; Ittner, Lars M.] Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW 2109, Australia; [Mueller, Julius] Univ Oxford, Jenner Inst, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England; [Halliday, Glenda M.; Piguet, Olivier; Kiernan, Matthew C.; Hodges, John R.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW 2005, Australia; [Piguet, Olivier] Univ Sydney, Sch Psychol, Sydney, NSW 2005, Australia; [Piguet, Olivier] Univ Sydney, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2005, Australia; [Kassiou, Michael] Univ Sydney, Sch Chem, Sydney, NSW 2005, Australia; [Kiernan, Matthew C.] Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW 2005, Australia; [Loy, Clement T.; Mattick, John S.] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Loy, Clement T.; Mattick, John S.] Univ New South Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Mattick, John S.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Kril, Jillian J.; Sutherland, Greg T.] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW 2005, Australia; [Kril, Jillian J.; Sutherland, Greg T.] Univ Sydney, Fac Med & Hlth, Discipline Pathol, Sydney, NSW 2005, Australia	Macquarie University; Macquarie University; University of Oxford; Jenner Institute; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney	Ittner, LM (corresponding author), Macquarie Univ, Fac Med & Hlth Sci, Dementia Res Ctr, Sydney, NSW 2109, Australia.; Ittner, LM (corresponding author), Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW 2109, Australia.	lars.ittner@mq.edu.au	Halliday, Glenda M/E-8555-2011; Mattick, John/ABH-6130-2020; Ittner, Arne/ABD-3072-2021; Ke, Yazi/ABC-3052-2020; Sutherland, Greg/C-8674-2015; Przybyla, Magdalena/https://orcid.org/0000-0001-6292-5971	Halliday, Glenda M/0000-0003-0422-8398; Mattick, John/0000-0002-7680-7527; Ittner, Arne/0000-0001-5244-6897; Ke, Yazi/0000-0002-1423-0451; Kassiou, Michael/0000-0002-6655-0529; Sutherland, Greg/0000-0003-2493-9736; Bi, Mian/0000-0002-4383-3606; Kiernan, Matthew/0000-0001-9054-026X; Ittner, Lars/0000-0001-6738-3825; Feiten, Astrid Feentje/0000-0002-9134-2852; Prikas, Emmanuel/0000-0001-8833-2728; Chan, Gabriella/0000-0001-7526-4412; Przybyla, Magdalena/0000-0001-6292-5971; Stefanoska, Kristie/0000-0001-9322-9936; Muller, Julius/0000-0002-1046-2968	National Health and Medical Research Council [1081916, 1103258, 1107657, 1132524, 1136241, 1143848, 1143978]; Australian Research Council [DP170100781, DP170100843, CE110001021]; CurePSP Grant [609-2015-07]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); CurePSP Grant	This work was supported by National Health and Medical Research Council Grants 1081916, 1103258, 1107657, 1132524, 1136241, 1143848, and 1143978, Australian Research Council Grants DP170100781, DP170100843, and CE110001021, CurePSP Grant 609-2015-07, and a generous donation by the Crescitelli family. The authors declare that they have no conflicts of interest with the contents of this article.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Burkhard PR, 2001, NEUROLOGY, V56, P1528, DOI 10.1212/WNL.56.11.1528; Burrell JR, 2016, LANCET, V388, P919, DOI 10.1016/S0140-6736(16)00737-6; Camp AJ, 2009, INT J BIOCHEM CELL B, V41, P2118, DOI 10.1016/j.biocel.2009.05.007; David DC, 2006, PROTEOMICS, V6, P6566, DOI 10.1002/pmic.200600634; Decker JM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0193-3; Ferguson GD, 1999, J NEUROCHEM, V72, P1821, DOI 10.1046/j.1471-4159.1999.0721821.x; Forrest SL, 2018, BRAIN, V141, P521, DOI 10.1093/brain/awx328; Garcia-Cabrero AM, 2013, NEUROBIOL DIS, V58, P200, DOI 10.1016/j.nbd.2013.06.005; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hernandez F, 2004, NEUROSCI LETT, V357, P143, DOI 10.1016/j.neulet.2003.12.049; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ittner A, 2018, NEURON, V99, P13, DOI 10.1016/j.neuron.2018.06.003; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner AA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0149-z; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2015, NAT REV NEUROL, V11, P360, DOI 10.1038/nrneurol.2015.65; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Ittner LM, 2005, BIOCHEMISTRY-US, V44, P5749, DOI 10.1021/bi048111o; Joo Y, 2015, FASEB J, V29, P4133, DOI 10.1096/fj.14-265009; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim E, 2016, NUCLEIC ACIDS RES, V44, pD848, DOI 10.1093/nar/gkv1155; KIRSCHNER MA, 1994, GENOMICS, V24, P218, DOI 10.1006/geno.1994.1609; Koller D, 2004, J BIOL CHEM, V279, P20387, DOI 10.1074/jbc.M313058200; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Leitao MJ, 2016, NEUROSCIENCE, V322, P398, DOI 10.1016/j.neuroscience.2016.02.057; Li T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160635; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Liu SJ, 2017, EPILEPSIA, V58, pE136, DOI 10.1111/epi.13847; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; McInnes J, 2018, NEURON, V97, P823, DOI 10.1016/j.neuron.2018.01.022; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Miao LQ, 2013, J CELL SCI, V126, P427, DOI 10.1242/jcs.105817; Ohrfelt A, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0208-8; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Papanikolopoulou K, 2018, HUM MOL GENET, V27, P2244, DOI 10.1093/hmg/ddy129; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Przybyla M, 2016, NEUROSCI LETT, V631, P24, DOI 10.1016/j.neulet.2016.08.007; Qureshi HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084615; Qureshi HY, 2013, BIOCHEMISTRY-US, V52, P6445, DOI 10.1021/bi400442d; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sluchanko NN, 2011, J ALZHEIMERS DIS, V27, P467, DOI 10.3233/JAD-2011-110692; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stefanoska K, 2018, J BIOL CHEM, V293, P3710, DOI 10.1074/jbc.RA118.001784; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Umahara T, 2004, NEUROSCI LETT, V371, P215, DOI 10.1016/j.neulet.2004.08.079; Van der Jeugd A, 2016, NEUROBIOL LEARN MEM, V130, P34, DOI 10.1016/j.nlm.2016.01.007; van Eersel J, 2015, NEUROPATH APPL NEURO, V41, P906, DOI 10.1111/nan.12233; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Warren JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4827; Yin ZR, 2017, J ALZHEIMERS DIS, V60, pS41, DOI 10.3233/JAD-161206; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhou LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15295	62	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14149	14162		10.1074/jbc.RA118.005263	http://dx.doi.org/10.1074/jbc.RA118.005263			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366728	hybrid, Green Published			2022-12-26	WOS:000490729800026
J	Tan, SY; Li, JQ; Cheng, HY; Li, ZF; Lan, Y; Zhang, TT; Yang, ZC; Li, WJ; Qi, T; Qiu, YR; Chen, ZP; Li, L; Liu, SW				Tan, Suiyi; Li, Jin-Qing; Cheng, Hongyan; Li, Zhaofeng; Lan, Yan; Zhang, Ting-Ting; Yang, Zi-Chao; Li, Wenjuan; Qi, Tao; Qiu, Yu-Rong; Chen, Zhipeng; Li, Lin; Liu, Shu-wen			The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); amyloid; antiviral agent; inhibitor; fibril; ADS-J1; semen; semen-derived enhancer of viral infection (SEVI); sexual transmission; suramin	MEDIATED ENHANCEMENT; GENITAL INFLAMMATION; HIGH-THROUGHPUT; VIRUS TYPE-1; BINDING; MICROBICIDE; ACQUISITION; ANTAGONIST; PROTEINS; GP120	Seminal amyloid fibrils are made up of naturally occurring peptide fragments and are key targets for the development of combination microbicides or antiviral drugs. Previously, we reported that the polysulfonic compound ADS-J1 is a potential candidate microbicide that not only inhibits HIV-1 entry, but also seminal fibrils. However, the carcinogenic azo moieties in ADS-J1 preclude its clinical application. Here, we screened several ADS-J1-like analogs and found that the antiparasitic drug suramin most potently inhibited seminal amyloid fibrils. Using various biochemical methods, including Congo red staining, CD analysis, transmission EM, viral infection assays, surface plasmon resonance imaging, and molecular dynamics simulations, we investigated suramin's inhibitory effects and its putative mechanism of action. We found that by forming a multivalent interaction, suramin binds to proteolytic peptides and mature fibrils, thereby inhibiting seminal fibril formation and blocking fibril-mediated enhancement of viral infection. Of note, suramin exhibited potent anti-HIV activities, and combining suramin with several antiretroviral drugs produced synergistic effects against HIV-1 in semen. Suramin also displayed a good safety profile for vaginal application. Moreover, suramin inhibited the semen-derived enhancer of viral infection (SEVI)/semen-mediated enhancement of HIV-1 transcytosis through genital epithelial cells and the subsequent infection of target cells. Collectively, suramin has great potential for further development as a combination microbicide to reduce the spread of the AIDS pandemic by targeting both viral and host factors involved in HIV-1 sexual transmission.	[Tan, Suiyi; Li, Jin-Qing; Cheng, Hongyan; Li, Zhaofeng; Lan, Yan; Zhang, Ting-Ting; Yang, Zi-Chao; Li, Wenjuan; Chen, Zhipeng; Li, Lin; Liu, Shu-wen] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China; [Qi, Tao; Qiu, Yu-Rong] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liu, SW (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China.	liusw@smu.edu.cn	LI, LI/GVS-5344-2022; Li, Wenjuan/GRR-3618-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022	Li, Wenjuan/0000-0002-2231-7338; Liu, Shuwen/0000-0001-6346-5006	Pearl River S&T Nova Program of Guangzhou Grant [201610010132]; Program for Outstanding Young Teacher in Guangdong Province [YQ2015039]; Natural Science Foundation of China [81772194, 81773787]; Natural Science Foundation of Guangdong Province [2017A030313598, 2015A030313241]	Pearl River S&T Nova Program of Guangzhou Grant; Program for Outstanding Young Teacher in Guangdong Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by Pearl River S&T Nova Program of Guangzhou Grant 201610010132, the Program for Outstanding Young Teacher in Guangdong Province Grant YQ2015039, Natural Science Foundation of China Grants 81772194 (to S. T.) and 81773787 (to S. L.), and Natural Science Foundation of Guangdong Province Grants 2017A030313598 and 2015A030313241. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723; Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016; Alexandre KB, 2016, VIROLOGY, V497, P69, DOI 10.1016/j.virol.2016.07.004; Anderson DJ, 2014, J INFECT DIS, V210, pS648, DOI 10.1093/infdis/jiu537; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Capule CC, 2012, J AM CHEM SOC, V134, P905, DOI 10.1021/ja210931b; CHESON BD, 1987, JAMA-J AM MED ASSOC, V258, P1347, DOI 10.1001/jama.258.10.1347; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DECLERCQ E, 1979, CANCER LETT, V8, P9, DOI 10.1016/0304-3835(79)90017-X; Dupre TV, 2016, AM J PHYSIOL-RENAL, V310, pF248, DOI 10.1152/ajprenal.00433.2015; Henss L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0607-2; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098077; Koval A, 2016, BIOCHEM J, V473, P371, DOI 10.1042/BJ20150913; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Li HP, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0196-y; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036194; LoRicco JG, 2016, J BIOL CHEM, V291, P14045, DOI 10.1074/jbc.M116.718684; Lump E, 2015, ELIFE, V4, DOI 10.7554/eLife.05397; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; McKinnon LR, 2018, NAT MED, V24, P491, DOI 10.1038/nm.4506; MITSUYA H, 1984, SCIENCE, V226, P172, DOI 10.1126/science.6091268; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nanga RPR, 2009, J AM CHEM SOC, V131, P17972, DOI 10.1021/ja908170s; Naviaux RK, 2017, ANN CLIN TRANSL NEUR, V4, P491, DOI 10.1002/acn3.424; Olsen JS, 2010, J BIOL CHEM, V285, P35488, DOI 10.1074/jbc.M110.163659; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ren PJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42902; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sahu D, 2017, EUR J PHARM SCI, V101, P125, DOI 10.1016/j.ejps.2017.02.013; SCHOLS D, 1990, VIROLOGY, V175, P556, DOI 10.1016/0042-6822(90)90440-3; Smith-McCune K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129769; Tan SY, 2014, LAB INVEST, V94, P777, DOI 10.1038/labinvest.2014.72; Tan SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059777; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Xu W, 2014, JAIDS-J ACQ IMM DEF, V67, P1, DOI 10.1097/QAI.0000000000000265; Xun TR, 2015, ANTIMICROB AGENTS CH, V59, P5123, DOI 10.1128/AAC.00385-15; YAHI N, 1994, J BIOL CHEM, V269, P24349; Yang J, 2012, AIDS RES HUM RETROV, V28, P1498, DOI [10.1089/AID.2012.0084, 10.1089/aid.2012.0084]; Zhao Q, 2002, AIDS RES HUM RETROV, V18, P989, DOI 10.1089/08892220260235353; Zirafi O, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009634	47	4	6	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13740	13754		10.1074/jbc.RA118.006797	http://dx.doi.org/10.1074/jbc.RA118.006797			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346035	hybrid, Green Published			2022-12-26	WOS:000486418600019
J	Bailey, NW; Freedman, G; Raj, K; Sullivan, CM; Rogasch, NC; Chung, SW; Hoy, KE; Chambers, R; Hassed, C; Van Dam, NT; Koenig, T; Fitzgerald, PB				Bailey, Neil W.; Freedman, Gabrielle; Raj, Kavya; Sullivan, Caley M.; Rogasch, Nigel C.; Chung, Sung W.; Hoy, Kate E.; Chambers, Richard; Hassed, Craig; Van Dam, Nicholas T.; Koenig, Thomas; Fitzgerald, Paul B.			Mindfulness meditators show altered distributions of early and late neural activity markers of attention in a response inhibition task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; COGNITIVE THERAPY; VISUAL-ATTENTION; PARIETAL CORTEX; ERP; MECHANISMS; CONFLICT; ALPHA; EEG; PERFORMANCE	Attention is vital for optimal behavioural performance in every-day life. Mindfulness meditation has been shown to enhance attention. However, the components of attention altered by meditation and the related neural activities are underexplored. In particular, the contributions of inhibitory processes and sustained attention are not well understood. To address these points, 34 meditators were compared to 28 age and gender matched controls during electroencephalography (EEG) recordings of neural activity during a Go/Nogo response inhibition task. This task generates a P3 event related potential, which is related to response inhibition processes in Nogo trials, and attention processes across both trial types. Compared with controls, meditators were more accurate at responding to Go and Nogo trials. Meditators showed a more frontally distributed P3 to both Go and Nogo trials, suggesting more frontal involvement in sustained attention rather than activity specific to response inhibition. Unexpectedly, meditators also showed increased positivity over the right parietal cortex prior to visual information reaching the occipital cortex (during the pre-C1 window). Both results were positively related to increased accuracy across both groups. The results suggest that meditators show altered engagement of neural regions related to attention, including both higher order processes generated by frontal regions, and sensory anticipation processes generated by poster regions. This activity may reflect an increased capacity to modulate a range of neural processes in order to meet task requirements. This increased capacity may underlie the improved attentional function observed in mindfulness meditators.	[Bailey, Neil W.; Freedman, Gabrielle; Raj, Kavya; Sullivan, Caley M.; Chung, Sung W.; Hoy, Kate E.; Fitzgerald, Paul B.] Monash Univ, Monash Alfred Psychiat Res Ctr, Cent Clin Sch, Melbourne, Vic, Australia; [Bailey, Neil W.; Fitzgerald, Paul B.] Epworth Healthcare, Epworth Ctr Innovat Mental Hlth, Epworth Clin, Camberwell, Vic, Australia; [Raj, Kavya; Rogasch, Nigel C.] Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Brain & Mental Hlth Res Hub, Clayton, Vic, Australia; [Raj, Kavya; Rogasch, Nigel C.] Monash Univ, Monash Biomed Imaging, Clayton, Vic, Australia; [Chambers, Richard] Monash Univ, Campus Community Div, Melbourne, Vic, Australia; [Hassed, Craig] Monash Univ, Dept Gen Practice, Melbourne, Vic, Australia; [Van Dam, Nicholas T.] Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia; [Van Dam, Nicholas T.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Koenig, Thomas] Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Bern, Switzerland	Monash University; Monash University; Monash University; Monash University; Monash University; University of Melbourne; Icahn School of Medicine at Mount Sinai; University of Bern; University Hospital of Bern	Bailey, NW (corresponding author), Monash Univ, Monash Alfred Psychiat Res Ctr, Cent Clin Sch, Melbourne, Vic, Australia.; Bailey, NW (corresponding author), Epworth Healthcare, Epworth Ctr Innovat Mental Hlth, Epworth Clin, Camberwell, Vic, Australia.	neil.bailey@monash.edu	Koenig, Thomas/ABD-2278-2020; Van Dam, Nicholas Thomas/G-2799-2010; Bailey, Neil/AAB-2741-2021	Koenig, Thomas/0000-0002-1472-4638; Van Dam, Nicholas Thomas/0000-0002-1131-0739; Hoy, Kate/0000-0003-0694-9674; Bailey, Neil/0000-0002-8483-1068; Rogasch, Nigel/0000-0002-4484-1069; Chung, Sung Wook/0000-0001-8022-8037	Neuronetics; Cervel Neurotech; National Health and Medical Research Council of Australia [6069070, 1082894, 1072057]	Neuronetics; Cervel Neurotech; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	PBF has received equipment for research from MagVenture A/S, Medtronic Ltd, Cervel Neurotech and Brainsway Ltd and funding for research from Neuronetics and Cervel Neurotech. PBF is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship (6069070). KEH is supported by a National Health and Medical Research Council of Australia Career Development Fellowship (1082894). NCR is supported by a National Health and Medical Research Council of Australia Fellowship (1072057). These funders supported the researchers for other projects but no funding contribution was made to this specific project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PBF has received equipment for research from MagVenture A/S, Medtronic Ltd, Cervel Neurotech and Brainsway Ltd and funding for research from Neuronetics and Cervel Neurotech. PBF is on the scientific advisory board for Bionomics Ltd. All other authors have no conflicts to report. PBF is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship (6069070). KEH is supported by a National Health and Medical Research Council of Australia Career Development Fellowship (1082894). NCR is supported by a National Health and Medical Research Council of Australia Fellowship (1072057). This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Andreu CI, 2017, MINDFULNESS, V8, P1603, DOI 10.1007/s12671-017-0732-z; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; BAILEY N, 2018, MINDFULNESS, P1; Bailey NW, 2014, PSYCHIAT RES-NEUROIM, V224, P324, DOI 10.1016/j.pscychresns.2014.09.008; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Benikos N, 2013, INT J PSYCHOPHYSIOL, V87, P262, DOI 10.1016/j.ijpsycho.2012.08.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Chambers R, 2008, COGNITIVE THER RES, V32, P303, DOI 10.1007/s10608-007-9119-0; Cheng KS, 2017, PEERJ, V5, DOI 10.7717/peerj.3857; Cramer AOJ, 2016, PSYCHON B REV, V23, P640, DOI 10.3758/s13423-015-0913-5; Crane RS, 2017, PSYCHOL MED, V47, P990, DOI 10.1017/S0033291716003317; Datta A, 2007, COMPUTATIONAL INTELL, V2007; Davidson RJ, 2015, AM PSYCHOL, V70, P581, DOI 10.1037/a0039512; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Eldar S, 2010, BIOL PSYCHOL, V85, P252, DOI 10.1016/j.biopsycho.2010.07.010; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M, 2006, CLIN NEUROPHYSIOL, V117, P1638, DOI 10.1016/j.clinph.2006.05.002; Fox KCR, 2014, NEUROSCI BIOBEHAV R, V43, P48, DOI 10.1016/j.neubiorev.2014.03.016; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Foxe JJ, 2005, EXP BRAIN RES, V166, P370, DOI 10.1007/s00221-005-2378-7; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Fu SM, 2005, COGNITIVE BRAIN RES, V23, P341, DOI 10.1016/j.cogbrainres.2004.11.014; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Hartmann L, 2016, BRAIN STRUCT FUNCT, V221, P3835, DOI 10.1007/s00429-015-1131-7; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Hong XF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08807-z; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Junior R.D.M., 2014, PSYCHOL NEUROSCI, V7, P503, DOI [10.3922/j.psns.2014.4.09, DOI 10.3922/J.PSNS.2014.4.09]; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; Keil A, 2007, NEUROIMAGE, V36, P472, DOI 10.1016/j.neuroimage.2007.02.048; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Kerr CE, 2011, BRAIN RES BULL, V85, P96, DOI 10.1016/j.brainresbull.2011.03.026; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Koenig T., 2011, COMPUT INTEL NEUROSC, V2011, P4; Koenig T, 2014, BRAIN TOPOGR, V27, P72, DOI 10.1007/s10548-013-0310-1; Krompinger JW, 2009, BIOL PSYCHOL, V81, P153, DOI 10.1016/j.biopsycho.2009.03.007; Lao SA, 2016, CONSCIOUS COGN, V45, P109, DOI 10.1016/j.concog.2016.08.017; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Malinowski P, 2017, MINDFULNESS, V8, P78, DOI 10.1007/s12671-015-0482-8; Malinowski P, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00008; Manna A, 2010, BRAIN RES BULL, V82, P46, DOI 10.1016/j.brainresbull.2010.03.001; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Moore A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00018; Moore A, 2009, CONSCIOUS COGN, V18, P176, DOI 10.1016/j.concog.2008.12.008; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Palmer JA, 2008, AC SPEECH SIGN PROC; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Posner MI, 2015, CURR OPIN BEHAV SCI, V4, P1, DOI 10.1016/j.cobeha.2014.12.008; Quaglia JT, 2016, J PERS, V84, P393, DOI 10.1111/jopy.12167; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; Sandra BK, 2011, EMOTION, V11, P299, DOI 10.1037/a0022764; Sanger KL, 2016, TRENDS NEUROSCI EDUC, V5, P1, DOI 10.1016/j.tine.2016.01.001; Schoenberg PLA, 2015, COGN NEURODYNAMICS, V9, P13, DOI 10.1007/s11571-014-9308-y; Schoenberg PLA, 2014, COGN NEURODYNAMICS, V8, P373, DOI 10.1007/s11571-014-9294-0; Schoenberg PLA, 2014, CLIN NEUROPHYSIOL, V125, P1407, DOI 10.1016/j.clinph.2013.11.031; Schroeder CE, 2001, FRONT BIOSCI-LANDMRK, V6, pD672, DOI 10.2741/Schroed; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Slagter HA, 2009, J COGNITIVE NEUROSCI, V21, P1536, DOI 10.1162/jocn.2009.21125; Steer RA., 1997, BECK ANXIETY INVENTO; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Valentine E.R., 1999, MENTAL HLTH RELIG CU, V2, P59, DOI DOI 10.1080/13674679908406332; Van der Lubbe RHJ, 2005, J COGNITIVE NEUROSCI, V17, P1829, DOI 10.1162/089892905775008634; van Leeuwen S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00133; Vogel EK, 2005, J COGNITIVE NEUROSCI, V17, P1907, DOI 10.1162/089892905775008599; Walach H, 2006, PERS INDIV DIFFER, V40, P1543, DOI 10.1016/j.paid.2005.11.025; Wessel JR, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.12871; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Worden MS, 2000, J NEUROSCI, V20	93	14	14	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0203096	10.1371/journal.pone.0203096	http://dx.doi.org/10.1371/journal.pone.0203096			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386663	gold, Green Published, Green Submitted			2022-12-26	WOS:000484997100001
J	Mehmood, A; Yao, J; Fan, DY; Bongole, K; Liu, JR; Zhang, X				Mehmood, Asif; Yao, Jun; Fan, Dongyan; Bongole, Kelvin; Liu, Junrong; Zhang, Xu			Potential for heat production by retrofitting abandoned gas wells into geothermal wells	PLOS ONE			English	Article							NUMERICAL-SIMULATION; RENEWABLE ENERGY; POWER-GENERATION; OIL; TECHNOLOGY; EXTRACTION; SYSTEMS; FLOW; RESERVOIRS; PAKISTAN	Using abandoned gas wells as geothermal resources for energy production is an effective way to extract geothermal energy from geological formations. These abandoned wells have the potential to significantly contribute in the rising global demand for energy without requiring the land disruption resulting from deep drilling or digging, processes necessary for energy extraction from geological formations via more traditional methods. In this paper, a method to extract geothermal energy from abandoned gas wells is proposed. The method offers an efficient, economical, and environmentally-conscious way to generate electricity. A mathematical model of a thermal and hydraulic coupling process is constructed, and a 3D numerical model is generated to study the process of geothermal energy extraction by retrofitting an abandoned gas reservoir into a geothermal reservoir. Using the model, heat extraction and fluid flow are analyzed over a period of 50 years. The heat production, electricity generation, and thermal recovery over the lifetime of the reservoir indicate that a commercially viable geothermal dual well system can produce geothermal energy effectively. Dual-well systems contain at least one injection well and one production well. They are composed of a two-way flow system in which the fluid flows into the reservoir via an injection well and returns from the production well having absorbed thermal energy from the surrounding rocks. Sensitivity analysis of the main parameters controlling the average outlet temperature of the fluid from the sedimentary geothermal system reveals that abandoned gas wells are a suitable source of geothermal energy. This energy can be harvested via a method whose use of reservoir fluids differs from that of the traditional method of closed-loop circulation via a borehole heat exchanger. Here, it is demonstrated that abandoned oil and gas fields can be repurposed to be geothermal energy sources that provide low-cost electricity and are economically sustainable.	[Mehmood, Asif; Yao, Jun; Fan, Dongyan; Bongole, Kelvin; Liu, Junrong; Zhang, Xu] China Univ Petr East China, Sch Petr Engn, Qingdao, Shandong, Peoples R China	China University of Petroleum	Yao, J (corresponding author), China Univ Petr East China, Sch Petr Engn, Qingdao, Shandong, Peoples R China.	rcogfr_upc@126.com	Yao, Jun/HCI-2731-2022; Bongole, Kelvin/AAH-4939-2021	Bongole, Kelvin/0000-0001-5399-553X	National Natural Science Foundation of China [51674278]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by "The National Natural Science Foundation of China" under Grant 51674278. The National Natural Science Foundation of China (http://www.nsfc.gov.cn) provided support in the form of funding for author Junrong Liu, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2002, GEOTHERMICS, V31, P613, DOI 10.1016/S0375-6505(02)00009-3; [Anonymous], 1983, HYDRAULICS; Augustine C., 2006, P 31 WORKSH GEOTH RE, P5; Barbier E, 2002, RENEW SUST ENERG REV, V6, P3, DOI 10.1016/S1364-0321(02)00002-3; Baria R, 1999, GEOTHERMICS, V28, P533, DOI 10.1016/S0375-6505(99)00045-0; Beerepoot M., 2011, TECHNOLOGY ROADMAP G; Brown D, 1995, P WORLD GEOTHERMAL C, P2607; Bu XB, 2012, RENEW ENERG, V41, P80, DOI 10.1016/j.renene.2011.10.009; Bujok P., 2012, INT J GEOPHYS, V29, P97, DOI DOI 10.1155/2013/916541; Caulk RA, 2017, RENEW ENERG, V112, P388, DOI 10.1016/j.renene.2017.05.042; [陈继良 Chen Jiliang], 2013, [计算物理, Chinese Journal of Computational Physics], V30, P871; Davis AP, 2009, ENERGY, V34, P866, DOI 10.1016/j.energy.2009.03.017; ELSWORTH D, 1990, J VOLCANOL GEOTH RES, V44, P283, DOI 10.1016/0377-0273(90)90022-8; Evans K., 2010, ENHANCED ENG GEOTHER; Fridleifsson IB, 2001, RENEW SUST ENERG REV, V5, P299, DOI 10.1016/S1364-0321(01)00002-8; Gondal IA, 2017, RENEW SUST ENERG REV, V71, P687, DOI 10.1016/j.rser.2016.12.097; Guo T, 2011, INT J ENERG RES, V35, P530, DOI 10.1002/er.1710; Hussain SD, 1995, P FIN RES COORD M AP; Johnson L., 2009, P 34 WORKSH GEOTH RE; Kadri IB., 1995, PETROLEUM GEOLOGY PA; Kazmi A, 1977, 18 ANN SCI C MULT PA, P26; Kohl T, 2002, GEOTHERMICS, V31, P687, DOI 10.1016/S0375-6505(02)00031-7; Kujawa T, 2004, ICHMT DIGITAL LIB ON; Liang B, 2016, J NAT GAS SCI ENG, V28, P711, DOI 10.1016/j.jngse.2015.12.011; Macenic M, 2018, INTERPRETATION-J SUB, V6, pSB1, DOI 10.1190/INT-2017-0079.1; Mehmood A., 2017, J PETROLEUM ENV BIOT, V7, P332, DOI [10.4172/2157-7463.1000332, DOI 10.4172/2157-7463.1000332]; Mehmood A, 2017, OPEN J YANGTZE OIL G, V2, P191, DOI DOI 10.4236/ojogas.2017.24015; Mehmood A., 2019, ADV PETROLEUM ENG PE, P181, DOI [10.1007/978-3-030-01578-7_42, DOI 10.1007/978-3-030-01578-7_42]; Mikael H(o)(o)k, 2010, [石油勘探与开发, Petroleum Exploration and Development], V37, P237; Nian YL, 2018, ENERGY, V142, P592, DOI 10.1016/j.energy.2017.10.062; Pruess K, 2006, GEOTHERMICS, V35, P351, DOI 10.1016/j.geothermics.2006.08.002; Quadri V., 1986, PAKISTAN AM ASS PETR, V70, P730; Sanyal SK, 2005, WORLD GEOTH C ANT AP; Schulz R, 2005, P WORLD GEOTH C; Sliwa T., 2014, RES J ENVIRON SCI, V8, P231, DOI DOI 10.3923/rjes.2014.231.242; Stackhouse P, 2006, P SOL 06 DENV CO AM; Sun ZX, 2017, ENERGY, V120, P20, DOI 10.1016/j.energy.2016.10.046; Sun ZX, 2018, ENERGIES, V11, DOI 10.3390/en11020280; Templeton JD, 2014, ENERGY, V70, P366, DOI 10.1016/j.energy.2014.04.006; Tester J.W, 1994, SCI GLOBAL SECUR, V5, P99; Toth AN, 2018, 43 WORDSH GEOTH RES; Wang K, 2018, GEOTHERMICS, V76, P141, DOI 10.1016/j.geothermics.2018.07.005; Wang K, 2018, J PETROL SCI ENG, V168, P465, DOI 10.1016/j.petrol.2018.05.012; Xu CS, 2015, APPL ENERG, V140, P135, DOI 10.1016/j.apenergy.2014.11.050; Yao J, 2018, GEOTHERMICS, V74, P19, DOI 10.1016/j.geothermics.2017.12.005; Younas U, 2016, RENEW SUST ENERG REV, V63, P398, DOI 10.1016/j.rser.2016.04.038; Zaigham N.A., 2000, Thar rift and its significance for hydrocarbons; Zaigham NA., 2005, P WORLD GEOTH C ANT; Zaigham NA, 2010, RENEW SUST ENERG REV, V14, P1124, DOI 10.1016/j.rser.2009.10.002; Zhang L, 2008, GAS NOW DELIV EXPECT, V1, P495, DOI [10.2118/115055-ms, DOI 10.2118/115055-MS, 10.2118/115055-MS]; Zhang QF, 2017, ADV WATER RESOUR, V107, P180, DOI 10.1016/j.advwatres.2017.06.020; Zhang QF, 2017, J COMPUT APPL MATH, V323, P95, DOI 10.1016/j.cam.2017.04.005; Zhang YJ, 2014, ENERGY, V78, P788, DOI 10.1016/j.energy.2014.10.073; Zhu GP, 2016, J NAT GAS SCI ENG, V28, P305, DOI 10.1016/j.jngse.2015.11.051	54	12	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220128	10.1371/journal.pone.0220128	http://dx.doi.org/10.1371/journal.pone.0220128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386664	gold, Green Published, Green Submitted			2022-12-26	WOS:000484997100016
J	D'Angelo, A; Sobhani, N; Roviello, G; Bagby, S; Bonazza, D; Bottin, C; Giudici, F; Zanconati, F; De Manzini, N; Guglielmi, A; Generali, D				D'Angelo, Alberto; Sobhani, Navid; Roviello, Giandomenico; Bagby, Stefan; Bonazza, Deborah; Bottin, Cristina; Giudici, Fabiola; Zanconati, Fabrizio; De Manzini, Nicolo; Guglielmi, Alessandra; Generali, Daniele			Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma	PLOS ONE			English	Article							FAVORABLE CLINICOPATHOLOGICAL VARIABLES; ISOLATED LIMB PERFUSION; NECROSIS-FACTOR; GASTRIC ADENOCARCINOMA; FOXP3 EXPRESSION; TNF-ALPHA; IMMUNOTHERAPY; CELLS; SURVIVAL; MICROENVIRONMENT	Background We investigated the correlation between pancreatic ductal adenocarcinoma patient prognosis and the presence of tumour infiltrating lymphocytes and expression of 521 immune system genes. Methods Intratumoural CD3+, CD8+, and CD20+ lymphocytes were examined by immunohistochemistry in 12 PDAC patients with different outcomes who underwent pancreaticoduodenectomy. The results were correlated with gene expression profile using the digital multiplexed NanoString nCounter analysis system (NanoString Technologies, Seattle, WA, USA). Results Twenty immune system genes were significantly differentially expressed in patients with a good prognosis relative to patients with a worse prognosis: TLR2 and TLR7 (Toll-like receptor superfamily); CD4, CD37, FOXP3, PTPRC (B cell and T cell signalling); IRF5, IRF8, STAT1, TFE3 (transcription factors); ANP32B, CCND3 (cell cycle); BTK (B cell development); TNF, TNFRF1A (TNF superfamily); HCK (leukocyte function); C1QA (complement system); BAX, PNMA1 (apoptosis); IKBKE (NF kappa B pathway). Differential expression was more than twice log 2 for TLR7, TNF, C1QA, FOXP3, and CD37. Discussion Tumour infiltrating lymphocytes were present at higher levels in samples from patients with better prognosis. Our findings indicate that tumour infiltrating lymphocyte levels and expression level of the immune system genes listed above influence pancreatic ductal adenocarcinoma prognosis. This information could be used to improve selection of best responders to immune inhibitors.	[D'Angelo, Alberto; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [D'Angelo, Alberto; Sobhani, Navid; Roviello, Giandomenico; Guglielmi, Alessandra; Generali, Daniele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Sobhani, Navid; Generali, Daniele] ASST Cremona, Breast Canc Unit, Cremona, Italy; [Bonazza, Deborah; Bottin, Cristina; Giudici, Fabiola; Zanconati, Fabrizio; De Manzini, Nicolo; Generali, Daniele] Univ Trieste, Osped Cattinara, Dept Med Sci, Trieste, Italy	University of Bath; University of Trieste; University of Trieste	D'Angelo, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.; D'Angelo, A (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	A.DAngelo@bath.ac.uk	GIUDICI, FABIOLA/AAJ-4919-2020; Giudici, Fabiola/R-8426-2016; D'Angelo, Alberto/AAC-7434-2021; Roviello, Giandomenico/AAA-5310-2019; Sobhani, Navid/AAB-8484-2020; Sobhani, Navid/AAL-3475-2020	GIUDICI, FABIOLA/0000-0002-4160-3479; Giudici, Fabiola/0000-0002-4160-3479; D'Angelo, Alberto/0000-0001-8417-9172; Sobhani, Navid/0000-0003-1381-0283; GENERALI, DANIELE/0000-0003-2480-3855; Roviello, Giandomenico/0000-0001-5504-8237; BONAZZA, DEBORAH/0000-0002-5605-6711				Alexander HR, 2009, ANN SURG ONCOL, V16, P1852, DOI 10.1245/s10434-009-0482-9; Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245; Azzato EM, 2010, BRIT J CANCER, V102, P1294, DOI 10.1038/sj.bjc.6605625; Beckwith KA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00091; Bourquin C, 2009, J IMMUNOL, V183, P6078, DOI 10.4049/jimmunol.0901594; Bray F, 2018, CA CANC J CLIN; Bulla R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10346; Caragine TA, 2002, CANCER RES, V62, P1110; Cauwels A, 2007, ARCH BIOCHEM BIOPHYS, V462, P132, DOI 10.1016/j.abb.2007.01.021; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Chen DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133562; De Divitiis C, 2014, WORLD J GASTROENTERO, V20, P15049, DOI 10.3748/wjg.v20.i41.15049; Deroose JP, 2011, BRIT J SURG, V98, P1573, DOI 10.1002/bjs.7621; Douglass S, 2012, CANCER METAST REV, V31, P843, DOI 10.1007/s10555-012-9395-3; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Gartlan KH, 2013, EUR J IMMUNOL, V43, P1208, DOI 10.1002/eji.201242730; GLENN J, 1988, J CLIN ONCOL, V6, P462, DOI 10.1200/JCO.1988.6.3.462; Gruenhagen Dirk J., 2009, V179, P257; Guo SC, 2017, WORLD J CLIN ONCOL, V8, P230, DOI 10.5306/wjco.v8.i3.230; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Hotz C, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232219; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Junt T, 2015, NAT REV IMMUNOL, V15, P529, DOI 10.1038/nri3875; Karakhanova S, 2015, BRIT J CANCER, V112, P1027, DOI 10.1038/bjc.2015.72; Koti M, 2015, BRIT J CANCER, V112, P1215, DOI 10.1038/bjc.2015.81; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Li XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0790-8; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Martin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095843; Morrison AH, 2018, TRENDS CANCER, V4, P418, DOI 10.1016/j.trecan.2018.04.001; Nejati R, 2017, PANCREAS, V46, P1180, DOI 10.1097/MPA.0000000000000914; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Peris K, 2005, DERMATOL SURG, V31, P318; Protti MP, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00210; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Schaper F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01185; Schober M, 2014, CANCERS, V6, P2137, DOI 10.3390/cancers6042137; Sergeant G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-527; Sideras K, 2014, CANCER TREAT REV, V40, P513, DOI 10.1016/j.ctrv.2013.11.005; Slotwinski R, 2018, CENT EUR J IMMUNOL, V43, P314, DOI 10.5114/ceji.2018.80051; Spinetti T, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1230578; Steinman RM, 2016, INNATE IMMUN IMMUNOL, V64, P392, DOI [10.1007/3-540-32636-7_2, DOI 10.1007/3-540-32636-7_2]; Stromnes IM, 2017, CANCER IMMUNOL RES, V5, P978, DOI 10.1158/2326-6066.CIR-16-0322; Suh JH, 2015, INT J CLIN EXP PATHO, V8, P14608; Tao H, 2012, LUNG CANCER, V75, P95, DOI 10.1016/j.lungcan.2011.06.002; Tao LY, 2018, CANCER BIOL THER, V19, P296, DOI 10.1080/15384047.2017.1416932; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; Tesfaye AA, 2019, AM J PATHOL, V189, P58, DOI 10.1016/j.ajpath.2018.10.005; Tewari N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-436; Torphy RJ, 2018, ANN GASTROENT SURG, V2, P274, DOI 10.1002/ags3.12176; Van den Broeck A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073968; van Deventer SJ, 2017, BIOCHEM SOC T, V45, P741, DOI 10.1042/BST20160284; Vonderheide RH, 2013, CURR OPIN IMMUNOL, V25, P200, DOI 10.1016/j.coi.2013.01.006; Wang DQ, 2010, MOL CANCER THER, V9, P1788, DOI 10.1158/1535-7163.MCT-09-1198; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; Waters JP, 2013, J PATHOL, V230, P132, DOI 10.1002/path.4187; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Winslow S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0530-2; Won KY, 2017, HUM PATHOL, V68, P112, DOI 10.1016/j.humpath.2017.08.023; Zhang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031507; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	69	15	15	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219566	10.1371/journal.pone.0219566	http://dx.doi.org/10.1371/journal.pone.0219566			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381571	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600005
J	Komal, S; Simon, L; Garu, G; Mateu, A; Villaverde, MD; de la Sierra, A; Almagro, P				Komal, Shakeel; Simon, Lluis; Garu, Gemma; Mateu, Aina; de la Asuncion Villaverde, Maria; de la Sierra, Alex; Almagro, Pere			Utility of FEV1/FEV6 index in patients with multimorbidity hospitalized for decompensation of chronic diseases	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SPIROMETRY TECHNIQUE; COGNITIVE FUNCTION; PERFORMANCE; QUALITY; VALIDATION; COPD; CARE	Spirometry remains essential for the diagnosis of airway obstruction. Nevertheless, its performance in elderly hospitalized patients with multimorbidity can be difficult. The aim of this study is to assess the utility of the COPD-6 portable device in this population. We included all patients hospitalized for exacerbation of chronic diseases in a medical ward specialized in the care of multimorbidity patients, between September 2017 and May 2018. A questionnaire including sociodemographic, cognitive and functional impairment, among other variables, was completed the last day of admission. Subsequently, patients attempted to perform three valid respiratory manoeuvres with the COPD-6 device and then conventional spirometry. A total of 184 patients were included (mean age of 79.61 years, 55% men). Forty-seven (25.54%) patients were able to perform complete spirometric manoeuvres and 99 (53.8%) could perform a valid FEV1/FEV6 determination. The inability to perform a valid spirometry was related with the patient's age, functional physical disability, cognitive impairment or the presence of delirium or dysphagia during admission. Only 9% of patients with a Mini Mental Cognitive Examination (MMEC) lower than 24 points could perform a valid spirometry. Of the patients with an MMEC < 24 points and unable to perform spirometry, 34% were able to complete the FEV1/FEV6 manoeuvres. No differences were found in the Charlson index, multimorbidity scale, number of domiciliary drugs, or length of stay between those patients able and those not able to perform respiratory manoeuvres. The agreement between the values for FEV1 measured with COPD-6 and those observed in the spirometry was good (r:0.71; p<0.0001). Inability to perform a valid spirometry during hospitalization in elderly patients with multimorbidity is frequent and related with functional and cognitive impairment. FEV1/FEV6 determination using the COPD-6 portable device allows an important percentage of the patients with limitations to complete spirometric measurement.	[Komal, Shakeel; Simon, Lluis; Garu, Gemma; Mateu, Aina; de la Asuncion Villaverde, Maria; Almagro, Pere] Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Serv, Multimorbid Unit, Terrassa, Spain; [Komal, Shakeel; Simon, Lluis; Garu, Gemma; Mateu, Aina; de la Asuncion Villaverde, Maria; de la Sierra, Alex; Almagro, Pere] Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Dept, Terrassa, Spain	Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona	Almagro, P (corresponding author), Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Serv, Multimorbid Unit, Terrassa, Spain.; Almagro, P (corresponding author), Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Dept, Terrassa, Spain.	19908pam@comb.cat		Almagro, Pere/0000-0002-8476-4942; Malik Khanam, Komal/0000-0001-9761-8445	Astra-Zeneca Spain grant [PAM-000-2017-01]; Astra-Zeneca Spain	Astra-Zeneca Spain grant; Astra-Zeneca Spain(AstraZeneca)	This study was supported in part by Astra-Zeneca Spain grant PAM-000-2017-01 to PA. The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript.r This study was supported in part by Astra-Zeneca Spain. The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript. The authors thank Tom Yohannan for medical writing services.	Allen SC, 2006, AGE AGEING, V35, P304, DOI 10.1093/ageing/afj090; Allen S, 2008, CLIN RESPIR J, V2, P208, DOI 10.1111/j.1752-699X.2008.00063.x; Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; Almagro P, 2017, LANCET RESP MED, V5, P367, DOI 10.1016/S2213-2600(17)30133-9; [Anonymous], 2018, PLAN ATENCION INTEGR; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bellia V, 2008, THORAX, V63, P60, DOI 10.1136/thx.2007.080572; Bellia V, 2000, AM J RESP CRIT CARE, V161, P1094, DOI 10.1164/ajrccm.161.4.9810093; CARVALHAESNETO N, 1995, AM J RESP CRIT CARE, V152, P1611, DOI 10.1164/ajrccm.152.5.7582303; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clerencia-Sierra M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132909; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; de Queiroz RS, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e374; Diez-Manglano J, 2015, INTERN EMERG MED, V10, P915, DOI 10.1007/s11739-015-1252-2; Eikhof KD, 2017, EUR CLIN RESPIR J, V4, DOI 10.1080/20018525.2017.1292376; Fernandez-Villar A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194983; Goncalves JMF, 2017, MED CLIN-BARCELONA, V149, P483, DOI 10.1016/j.medcli.2017.05.034; Fogg C, 2018, INT J GERIATR PSYCH, V33, P1177, DOI 10.1002/gps.4919; Garcia-Rio F, 2013, ARCH BRONCONEUMOL, V49, P388, DOI 10.1016/j.arbres.2013.04.001; Haynes JM, 2014, RESP CARE, V59, P16, DOI 10.4187/respcare.02331; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jing JY, 2009, CHEST, V135, P991, DOI 10.1378/chest.08-0723; Johnston MC, 2019, EUR J PUBLIC HEALTH, V29, P182, DOI 10.1093/eurpub/cky098; Kjeldgaard P, 2017, INT J CHRONIC OBSTR, V12, P2323, DOI 10.2147/COPD.S136244; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Llordes M, 2017, COPD, V14, P43, DOI 10.1080/15412555.2016.1239703; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; Lorenzo Hernandez Maria Vanesa, 2017, Rev Esp Geriatr Gerontol, V52, P193, DOI 10.1016/j.regg.2016.08.006; Lopez-Campos JL, 2016, RESPIROLOGY, V21, P14, DOI 10.1111/resp.12660; MAHONEY F I, 1965, Md State Med J, V14, P61; Matsuo H, 2017, GERIATR GERONTOL INT, V17, P1610, DOI 10.1111/ggi.12941; Melbye Hasse, 2006, Prim Care Respir J, V15, P294, DOI 10.1016/j.pcrj.2006.07.002; Perez-Padilla R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067960; Pezzoli L, 2003, AGE AGEING, V32, P43, DOI 10.1093/ageing/32.1.43; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Represas-Represas C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145571; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; SHERMAN CB, 1993, AM REV RESPIR DIS, V148, P123, DOI 10.1164/ajrccm/148.1.123; Singh B, 2013, MAYO CLIN PROC, V88, P1222, DOI 10.1016/j.mayocp.2013.08.012; Sorino C, 2011, CLIN PHYSIOL FUNCT I, V31, P101, DOI 10.1111/j.1475-097X.2010.00984.x; Turkeshi E, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.48; Vandevoorde J, 2006, EUR RESPIR J, V27, P378, DOI 10.1183/09031936.06.00036005; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Yarnall AJ, 2017, AGE AGEING, V46, P882, DOI 10.1093/ageing/afx150	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220491	10.1371/journal.pone.0220491	http://dx.doi.org/10.1371/journal.pone.0220491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374087	gold, Green Published, Green Submitted			2022-12-26	WOS:000484991500015
J	Klein-Joebstl, D; Quijada, NM; Dzieciol, M; Feldbacher, B; Wagner, M; Drillich, M; Schmitz-Esser, S; Mann, E				Klein-Joebstl, Daniela; Quijada, Narciso M.; Dzieciol, Monika; Feldbacher, Benjamin; Wagner, Martin; Drillich, Marc; Schmitz-Esser, Stephan; Mann, Evelyne			Microbiota of newborn calves and their mothers reveals possible transfer routes for newborn calves' gastrointestinal microbiota	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOTA; BACTERIA; CHEESE; BIODIVERSITY; COMMUNITIES; DIVERSITY; SEQUENCES; COLOSTRUM; MILK	The intestinal microbiota of newborns plays an important role in the development of immunity and metabolism. In livestock animals, knowledge of the intestinal microbiota is essential not only to prevent diseases but also to optimize weight gain and performance. The aim of our study was to examine faecal samples repeatedly within the first two days of life using 16S rRNA gene High Throughput Sequencing. Additionally, samples from the mouths of the calves and the vaginas, colostrum, and faeces of the dams were included to evaluate possible sources of the calf faecal microbiota. The calf faecal microbiota was highly variable during the first 48 hours post natum (p.n.). Significant changes were found in species diversity and richness, in copy numbers evaluated by qPCR and in predominant bacteria over time. The most pronounced changes occurred between 6 and 24 hours p.n. All calf faecal samples were dominated by Operational Taxonomic Units (OTUs) belonging to the family Enterobacteriaceae. Cow faecal samples showed significantly higher species richness, diversity, number of observed OTUs, and copy numbers compared to all other samples. OTUs belonging to the family Ruminococcaceae were most abundant in cow faecal and vaginal samples. Colostrum was dominated by Enhydrobacter affiliated OTUs. To identify possible inoculation routes for the calf microbiota, we analysed OTU sharing between samples. The calf microbiota during the first two days of life was clearly distinct from the dam's faecal microbiota. Furthermore, colostrum microbiota clearly differed from calf and cow faecal microbiota and thus most likely does not play an important role as inoculation source for calf microbiota during the first two days of life. In contrast, the cow vaginal and the calf faecal microbiota were more similar, suggesting that some of the calf faecal microbiota may derive from inoculation from the birth canal during birth.	[Klein-Joebstl, Daniela; Feldbacher, Benjamin; Drillich, Marc] Univ Vet Med Vienna, Univ Clin Ruminants, Dept Farm Anim & Vet Publ Hlth, Clin Unit Herd Hlth Management, Vienna, Austria; [Quijada, Narciso M.] Inst Tecnol Agr Castilla & Leon, Lab Mol Biol & Microbiol, Valladolid, Spain; [Dzieciol, Monika; Feldbacher, Benjamin; Wagner, Martin; Mann, Evelyne] Univ Vet Med Vienna, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Schmitz-Esser, Stephan] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Iowa State University	Klein-Joebstl, D (corresponding author), Univ Vet Med Vienna, Univ Clin Ruminants, Dept Farm Anim & Vet Publ Hlth, Clin Unit Herd Hlth Management, Vienna, Austria.	Daniela.Klein@vetmeduni.ac.at	Dzieciol, Monika/ABC-7284-2020; Schmitz-Esser, Stephan/AAA-7287-2019; Selberherr, Evelyne/I-3795-2014; Selberherr, Evelyne/AAM-9702-2021; Quijada, Narciso Martin/HII-5674-2022	Dzieciol, Monika/0000-0002-0972-6241; Schmitz-Esser, Stephan/0000-0002-1907-0709; Selberherr, Evelyne/0000-0002-2253-5247; Klein-Jobstl, Daniela/0000-0001-5806-7601; Quijada, Narciso M./0000-0002-1956-7205; Drillich, Marc/0000-0002-2824-8185	University of Veterinary Medicine Vienna; Spanish National Institute for Agriculture and Food Research and Technology (INIA) - European Social Fund [FPI2014-020]; COST action [STSM-FA1202]	University of Veterinary Medicine Vienna; Spanish National Institute for Agriculture and Food Research and Technology (INIA) - European Social Fund; COST action(European Cooperation in Science and Technology (COST))	The authors received funding from: 1. start-up project (Profillinie 2) by the University of Veterinary Medicine Vienna; (no award number available); Recipient Daniela Klein-Jobstl; 2. Ph.D. studentship from the Spanish National Institute for Agriculture and Food Research and Technology (INIA) cofinanced by the European Social Fund; number: FPI2014-020; Recipient Narciso M. Quijada; and 3. COST action; STSM-FA1202; Recipient Narciso M. Quijada.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Aldrete-Tapia A, 2014, FOOD MICROBIOL, V44, P136, DOI 10.1016/j.fm.2014.05.022; Alegria A, 2012, APPL ENVIRON MICROB, V78, P1890, DOI 10.1128/AEM.06081-11; Alipour MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28733-y; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Chase CCL, 2018, VET CLIN N AM-FOOD A, V34, P1, DOI 10.1016/j.cvfa.2017.10.006; Chen PW, 2018, J FOOD DRUG ANAL, V26, P1235, DOI 10.1016/j.jfda.2018.03.004; Clemmons BA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01047; Dill-McFarland KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40864; Dogra S, 2015, GUT MICROBES, V6, P321, DOI 10.1080/19490976.2015.1078051; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Drago L, 2017, ISME J, V11, P875, DOI 10.1038/ismej.2016.183; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edrington TS, 2012, J DAIRY SCI, V95, P4519, DOI 10.3168/jds.2011-5119; Gritz EC, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00017; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jeon SJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0328-9; Karstrup CC, 2017, THERIOGENOLOGY, V99, P41, DOI 10.1016/j.theriogenology.2017.05.013; Kawamura Y, 2012, MICROBIOL IMMUNOL, V56, P21, DOI 10.1111/j.1348-0421.2011.00401.x; Kim M, 2014, J ANIM SCI, V92, P683, DOI 10.2527/jas.2013-6841; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Korpela K, 2018, CURR OPIN MICROBIOL, V44, P70, DOI 10.1016/j.mib.2018.06.003; Korpela K, 2018, GENOME RES, V28, P561, DOI 10.1101/gr.233940.117; Laguardia-Nascimento M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143294; Lim ES, 2016, TRENDS MICROBIOL, V24, P801, DOI 10.1016/j.tim.2016.06.001; Lima SF, 2017, J DAIRY SCI, V100, P3031, DOI 10.3168/jds.2016-11604; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malmuthuge N, 2017, J DAIRY SCI, V100, P5996, DOI 10.3168/jds.2016-12239; Malmuthuge N, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00036; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Martinez KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197439; Mayer M, 2012, VET MICROBIOL, V161, P179, DOI 10.1016/j.vetmic.2012.07.023; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meale SJ, 2017, J DAIRY SCI, V100, P5984, DOI 10.3168/jds.2016-12474; Metzler-Zebeli BU, 2013, ANAEROBE, V20, P65, DOI 10.1016/j.anaerobe.2013.02.005; Mueller NT, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120364; Obermajer T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10244-x; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Ozutsumi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1793, DOI 10.1271/bbb.69.1793; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Prunner I, 2014, THERIOGENOLOGY, V82, P857, DOI 10.1016/j.theriogenology.2014.06.015; Riquelme C, 2015, INT J FOOD MICROBIOL, V192, P86, DOI 10.1016/j.ijfoodmicro.2014.09.031; Sakwinska O, 2017, BENEF MICROBES, V8, P763, DOI 10.3920/BM2017.0064; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Toscano M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02100; Uyeno Y, 2010, LETT APPL MICROBIOL, V51, P570, DOI 10.1111/j.1472-765X.2010.02937.x; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yeoman CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21440-8	57	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220554	10.1371/journal.pone.0220554	http://dx.doi.org/10.1371/journal.pone.0220554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369600	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900064
J	von May, R; Catenazzi, A; Santa-Cruz, R; Gutierrez, AS; Moritz, C; Rabosky, DL				von May, Rudolf; Catenazzi, Alessandro; Santa-Cruz, Roy; Gutierrez, Andrea S.; Moritz, Craig; Rabosky, Daniel L.			Thermal physiological traits in tropical lowland amphibians: Vulnerability to climate warming and cooling	PLOS ONE			English	Article							MANU NATIONAL-PARK; PHYLOGENETIC SIGNAL; DIURNAL ACTIVITY; EASTERN SLOPES; HEAT TOLERANCE; EVOLUTION; FROGS; LATITUDE; TEMPERATURE; DIVERGENCE	Climate change is affecting biodiversity and ecosystem function worldwide, and the lowland tropics are of special concern because organisms living in this region experience temperatures that are close to their upper thermal limits. However, it remains unclear how and whether tropical lowland species will be able to cope with the predicted pace of climate warming. Additionally, there is growing interest in examining how quickly thermal physiological traits have evolved across taxa, and whether thermal physiological traits are evolutionarily conserved or labile. We measured critical thermal maximum (CTmax) and minimum (CTmin) in 56 species of lowland Amazonian frogs to determine the extent of phylogenetic conservatism in tolerance to heat and cold, and to predict species' vulnerability to climate change. The species we studied live in sympatry and represent similar to 65% of the known alpha diversity at our study site. Given that critical thermal limits may have evolved differently in response to different temperature constraints, we tested whether CTmax and CTmin exhibit different rates of evolutionary change. Measuring both critical thermal traits allowed us to estimate species' thermal breadth and infer their potential to respond to abrupt changes in temperature (warming and cooling). Additionally, we assessed the contribution of life history traits and found that both critical thermal traits were correlated with species' body size and microhabitat use. Specifically, small direct-developing frogs in the Strabomantidae family appear to be at highest risk of thermal stress while tree frogs (Hylidae) and narrow mouthed frogs (Microhylidae) tolerate higher temperatures. While CTmax and CTmin had considerable variation within and among families, both critical thermal traits exhibited similar rates of evolutionary change. Our results suggest that 4% of lowland rainforest frogs assessed will experience temperatures exceeding their CTmax, 25% might be moderately affected and 70% are unlikely to experience pronounced heat stress under a hypothetical 3 degrees C temperature increase.	[von May, Rudolf; Rabosky, Daniel L.] Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [von May, Rudolf; Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Catenazzi, Alessandro] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Santa-Cruz, Roy] Univ Nacl San Agustin MUSA, Area Herpetol, Museo Hist Nat, Arequipa, Peru; [Gutierrez, Andrea S.] Univ Nacl Agr La Molina, Fac Ciencias Biol, Lima, Peru; [Moritz, Craig] Australian Natl Univ, Ctr Biodivers Anal & Res Sch Biol, Canberra, ACT, Australia	University of Michigan System; University of Michigan; University of California System; University of California Berkeley; State University System of Florida; Florida International University; Universidad Nacional de San Agustin de Arequipa; University Nacional Agraria La Molina; Australian National University	von May, R (corresponding author), Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.; von May, R (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	rvonmay@gmail.com	Catenazzi, Alessandro/C-8615-2009	Catenazzi, Alessandro/0000-0002-3650-4783; von May, Rudolf/0000-0003-3981-2615; Santa-Cruz, Roy/0000-0002-0448-0270	National Science Foundation [DBI-1103087]; American Philosophical Society; National Geographic Society [9191-12]; Amazon Conservation Association; Swiss National Science Foundation [116305]; Rufford Small Grants Foundation; Chicago Board of Trade Endangered Species Fund; Amphibian Specialist Group; Disney Worldwide Conservation Fund	National Science Foundation(National Science Foundation (NSF)); American Philosophical Society; National Geographic Society(National Geographic Society); Amazon Conservation Association; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Rufford Small Grants Foundation; Chicago Board of Trade Endangered Species Fund; Amphibian Specialist Group; Disney Worldwide Conservation Fund	Research was supported with grants from the National Science Foundation (Postdoctoral Research Fellowship DBI-1103087), the American Philosophical Society, and the National Geographic Society (Grant #9191-12) to RvM; the Amazon Conservation Association to RvM and A. Catenazzi; and the Swiss National Science Foundation (#116305), the Rufford Small Grants Foundation, the Chicago Board of Trade Endangered Species Fund, the Amphibian Specialist Group and the Disney Worldwide Conservation Fund to A. Catenazzi. D. L. Rabosky thanks the David and Lucile Packard Foundation. A. Catenazzi thanks the Amazon Center for Environmental Education and Research for support during field courses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, SYST BIOL, V62, P181, DOI 10.1093/sysbio/sys083; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Ashton KG, 2004, J EVOLUTION BIOL, V17, P1157, DOI 10.1111/j.1420-9101.2004.00764.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bovo RP, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10040118; Brusch GA, 2016, OECOLOGIA, V180, P325, DOI 10.1007/s00442-015-3467-3; Burnham K. P., 1998, MODEL SELECTION INFE; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; Catenazzi A, 2001, MANU OTRAS EXPERIENC, P53; Catenazzi A, 2016, PEERJ, V4, DOI 10.7717/peerj.2072; Catenazzi A, 2014, CONSERV BIOL, V28, P509, DOI 10.1111/cobi.12194; Catenazzi A, 2013, BIOTA NEOTROP, V13, P269, DOI 10.1590/S1676-06032013000400024; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; CHRISTIAN KA, 1988, BIOTROPICA, V20, P236, DOI 10.2307/2388239; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Corl A, 2010, EVOLUTION, V64, P79, DOI 10.1111/j.1558-5646.2009.00791.x; Doan TM, 2004, J HERPETOL, V38, P422, DOI 10.1670/155-03N; Franken O, 2018, OECOLOGIA, V186, P311, DOI 10.1007/s00442-017-4032-z; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey P. H., 1991, COMP METHOD EVOLUTIO; HEATWOLE H, 1968, COMP BIOCHEM PHYSIOL, V27, P807, DOI 10.1016/0010-406X(68)90620-8; Heinicke MP, 2018, MOL PHYLOGENET EVOL, V118, P145, DOI 10.1016/j.ympev.2017.09.021; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Katzenberger M, 2018, J THERM BIOL, V76, P171, DOI 10.1016/j.jtherbio.2018.07.005; Londono GA, 2015, FUNCT ECOL, V29, P338, DOI 10.1111/1365-2435.12348; Marengo J, 1997, MON WEATHER REV, V125, P2759, DOI 10.1175/1520-0493(1997)125<2759:CSITAE>2.0.CO;2; Marengo J, 1984, REV FORESTAL PERU, V12, P55; Marengo JA, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00228; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Munoz MM, 2016, EVOLUTION, V70, P2537, DOI 10.1111/evo.13064; Munoz MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2433; Navas CA, 2007, COMP BIOCHEM PHYS A, V147, P647, DOI 10.1016/j.cbpa.2006.04.035; Nowakowski AJ, 2018, ECOL LETT, V21, P345, DOI 10.1111/ele.12901; Nowakowski AJ, 2017, CONSERV BIOL, V31, P96, DOI 10.1111/cobi.12769; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Rambaut A., 2007, TRACER V1 4; Renton K, 2002, J FIELD ORNITHOL, V73, P15, DOI 10.1648/0273-8570-73.1.15; Revell LJ, 2008, AM NAT, V172, P140, DOI 10.1086/588078; REVELL LJ, 2010, METHODS ECOLOGY EVOL, V3, P217; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rowley Jodi J. L., 2007, Herpetological Review, V38, P308; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Tracy CR, 2013, AUSTRAL ECOL, V38, P476, DOI 10.1111/j.1442-9993.2012.02416.x; von May R, 2018, TROP CONSERV SCI, V11, DOI 10.1177/1940082918797057; von May R, 2018, PEERJ, V6, DOI 10.7717/peerj.4313; von May R, 2017, ECOL EVOL, V7, P3257, DOI 10.1002/ece3.2929; von May R, 2010, J TROP ECOL, V26, P509, DOI 10.1017/S0266467410000301; von May R, 2009, HERPETOL CONSERV BIO, V4, P14; von May R, 2009, AUSTRAL ECOL, V34, P613, DOI 10.1111/j.1442-9993.2009.01965.x; Warren RJ, 2013, GLOBAL CHANGE BIOL, V19, P2082, DOI 10.1111/gcb.12169; Williams Stephen E, 2008, PLoS Biol, V6, P2621, DOI 10.1371/journal.pbio.0060325	65	18	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219759	10.1371/journal.pone.0219759	http://dx.doi.org/10.1371/journal.pone.0219759			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369565	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900017
J	Lauer, FT; Parvez, F; Factor-Litvak, P; Liu, XH; Santella, RM; Islam, T; Eunus, M; Alam, N; Hasan, AKMR; Rahman, M; Ahsan, H; Graziano, J; Burchiel, SW				Lauer, Fredine T.; Parvez, Faruque; Factor-Litvak, Pam; Liu, Xinhua; Santella, Regina M.; Islam, Tariqul; Eunus, Mahbubul; Alam, Nur; Hasan, A. K. M. Rabiul; Rahman, Mizanour; Ahsan, Habibul; Graziano, Joseph; Burchiel, Scott W.			Changes in human peripheral blood mononuclear cell (HPBMC) populations and T-cell subsets associated with arsenic and polycyclic aromatic hydrocarbon exposures in a Bangladesh cohort	PLOS ONE			English	Article							ENVIRONMENTALLY RELEVANT CONCENTRATIONS; DRINKING-WATER; EXPRESSION; CHILDREN; ADDUCTS; CANCER; HEALTH; INTERACTS; PATHWAYS; RISK	Exposures to environmental arsenic (As) and polycyclic aromatic hydrocarbons (PAH) have been shown to independently cause dysregulation of immune function. Little data exists on the associations between combined exposures to As and PAH with immunotoxicity in humans. In this work we examined associations between As and PAH exposures with lymphoid cell populations in human peripheral blood mononuclear cells (PBMC), as well as alterations in differentiation and activation of B and T cells. Two hundred men, participating in the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh, were selected for the present study based on their exposure to As from drinking water and their cigarette smoking status. Blood and urine samples were collected from study participants. We utilized multiparameter flow cytometry in PBMC to identify immune cells (B, T, monocytes, NK) as well as the T-helper (Th) cell subsets (Th1, Th2, Th17, and Tregs) following ex vivo activation. We did not find evidence of interactions between As and PAH exposures. However, individual exposures (As or PAH) were associated with changes to immune cell populations, including Th cell subsets. Arsenic exposure was associated with an increase in the percentage of Th cells, and dose dependent changes in monocytes, NKT cells and a monocyte subset. Within the Th cell subset we found that Arsenic exposure was also associated with a significant increase in the percentage of circulating proinflammatory Th17 cells. PAH exposure was associated with changes in T cells, monocytes and T memory (Tmem) cells and with changes in Th, Th1, Th2 and Th17 subsets all of which were non-monotonic (dose dependent). Alterations of immune cell populations caused by environmental exposures to As and PAH may result in adverse health outcomes, such as changes in systemic inflammation, immune suppression, or autoimmunity.	[Lauer, Fredine T.; Burchiel, Scott W.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Parvez, Faruque; Santella, Regina M.; Graziano, Joseph] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Factor-Litvak, Pam] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Liu, Xinhua] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA; [Islam, Tariqul; Eunus, Mahbubul; Alam, Nur; Hasan, A. K. M. Rabiul; Rahman, Mizanour] Univ Chicago, Field Res Off, Dhaka, Bangladesh; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of New Mexico; Columbia University; Columbia University; Columbia University; University of Chicago	Burchiel, SW (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	sburchiel@salud.unm.edu		ALAM, MD NUR/0000-0002-2885-8936	National Institutes of Environmental Health Sciences (NIEHS) ViCTER Program [R01 ES019968S1]; Columbia NIEHS Superfund Basic Research Program [P42 ES010349, P30 ES009089]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES027792, P42ES010349, R24ES028532, P30ES009089] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences (NIEHS) ViCTER Program; Columbia NIEHS Superfund Basic Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Environmental Health Sciences (NIEHS) ViCTER Program R01 ES019968S1 (SWB) and by the Columbia NIEHS Superfund Basic Research Program P42 ES010349 (JG) and P30 ES009089 (JG).	Ahmed S, 2014, TOXICOL SCI, V141, P166, DOI 10.1093/toxsci/kfu113; Argos M, 2013, INT J CANCER, V133, P2422, DOI 10.1002/ijc.28250; Argos M, 2013, EUR J CLIN INVEST, V43, P579, DOI 10.1111/eci.12085; Attreed Sarah E, 2017, Curr Environ Health Rep, V4, P229, DOI 10.1007/s40572-017-0141-4; Banerjee N, 2009, J CLIN IMMUNOL, V29, P582, DOI 10.1007/s10875-009-9304-x; Burchiel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109192; Burchiel SW, 2009, TOXICOL APPL PHARM, V241, P253, DOI 10.1016/j.taap.2009.09.019; Burchiel SW, 2001, CLIN IMMUNOL, V98, P2, DOI 10.1006/clim.2000.4934; Chen Y, 2013, ENVIRON HEALTH PERSP, V121, P427, DOI 10.1289/ehp.1205197; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Divi RL, 2002, CARCINOGENESIS, V23, P2043, DOI 10.1093/carcin/23.12.2043; Ezeh PC, 2016, TOXICOL SCI, V149, P289, DOI 10.1093/toxsci/kfv233; Ezeh PC, 2015, BIOL TRACE ELEM RES, V166, P82, DOI 10.1007/s12011-015-0279-6; Farzan SF, 2016, ENVIRON HEALTH PERSP, V124, P840, DOI 10.1289/ehp.1409282; Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P677; George CM, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0069-9; Hertz-Picciotto I, 2007, ENVIRON HEALTH PERSP, V115, P1510, DOI 10.1289/ehp.9617; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; Karakaya A, 2004, HUM EXP TOXICOL, V23, P317, DOI 10.1191/0960327104ht455oa; King BS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393504; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1108, DOI 10.1289/ehp.0800199; Kuo CC, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP577; Lauer Fredine T, 2017, Curr Protoc Toxicol, V73, DOI 10.1002/cptx.26; Lauer Fredine T, 2017, Curr Protoc Toxicol, V74, DOI 10.1002/cptx.31; Lemarie A, 2006, J IMMUNOL, V177, P3019, DOI 10.4049/jimmunol.177.5.3019; Li JL, 2017, ENVIRON RES, V159, P381, DOI 10.1016/j.envres.2017.08.036; Li Q, 2010, TOXICOL APPL PHARM, V245, P344, DOI 10.1016/j.taap.2010.03.020; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Lovelace P, 2018, METHODS MOL BIOL, V1678, P151, DOI 10.1007/978-1-4939-7346-0_9; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Maier A, 2002, MUTAT RES-GEN TOX EN, V517, P101, DOI 10.1016/S1383-5718(02)00057-8; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Moon KA, 2017, INT J EPIDEMIOL, V46, P1924, DOI 10.1093/ije/dyx202; Morzadec C, 2012, TOXICOLOGY, V300, P46, DOI 10.1016/j.tox.2012.05.025; Morzadec C, 2012, TOXICOL APPL PHARM, V262, P217, DOI 10.1016/j.taap.2012.05.004; Nadeau KC, 2014, CLIN IMMUNOL, V155, P188, DOI 10.1016/j.clim.2014.09.004; Nargis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141135; NIXON DE, 1991, CLIN CHEM, V37, P1575; Nygaard UC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179606; Oliveira M, 2019, ENVIRON INT, V124, P180, DOI 10.1016/j.envint.2018.12.052; Parvez F, 2008, ENVIRON HEALTH PERSP, V116, P190, DOI 10.1289/ehp.9507; Parvez F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216662; Parvez F, 2013, AM J RESP CRIT CARE, V188, P813, DOI 10.1164/rccm.201212-2282OC; POIRIER MC, 1980, CANCER RES, V40, P412; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Rahman MH, 2003, INT ARCH OCC ENV HEA, V76, P533, DOI 10.1007/s00420-003-0431-z; Raqib R, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/ehp318, 10.1289/EHP318]; Sanchez TR, 2016, ENVIRON RES, V147, P537, DOI 10.1016/j.envres.2016.02.009; Soto-Pena GA, 2006, FASEB J, V20, P779, DOI 10.1096/fj.05-4860fje; Sun X, 2014, TOXICOL APPL PHARM, V274, P313, DOI 10.1016/j.taap.2013.11.010; Wang YH, 2013, J HAZARD MATER, V262, P1139, DOI 10.1016/j.jhazmat.2012.08.056; Winker N, 1997, J APPL TOXICOL, V17, P23, DOI 10.1002/(SICI)1099-1263(199701)17:1<23::AID-JAT387>3.0.CO;2-O; Wu F, 2012, AM J EPIDEMIOL, V175, P1252, DOI 10.1093/aje/kwr464; Xu H, 2016, TOXICOL SCI, V154, P153, DOI 10.1093/toxsci/kfw151; Xu H, 2016, TOXICOL LETT, V247, P62, DOI 10.1016/j.toxlet.2016.02.014; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	59	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220451	10.1371/journal.pone.0220451	http://dx.doi.org/10.1371/journal.pone.0220451			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365547	gold, Green Submitted, Green Published			2022-12-26	WOS:000484983600044
J	Leulseged, TW; Ayele, BT				Leulseged, Tigist W.; Ayele, Birhanu T.			Time to optimal glycaemic control and prognostic factors among type 2 diabetes mellitus patients in public teaching hospitals in Addis Ababa, Ethiopia	PLOS ONE			English	Article								Aim To estimate time to first optimal glycaemic control and identify prognostic factors among type 2 diabetes mellitus (T2DM) patients attending diabetes clinic of public teaching hospitals in Addis Ababa, Ethiopia. Methods A retrospective chart review study was conducted at diabetes clinic of Addis Ababa's public teaching hospitals among a randomly selected sample of 685 charts of patients with T2DMwho were on follow up from January 1, 2013 to June 30, 2017. Data was collected using data abstraction tool. Descriptive statistics, Kaplan Meier plots, median survival time, Log-rank test and Cox proportional hazard survival models were used for analysis. Results Median time to first optimal glycaemic control among the study population was 9.5 months. Factors that affect time to first optimal glycaemic control were age group (HR = 0.635, 95% CI: 0.486-0.831 for 50-59 years, HR = 0.558, 95% CI: 0.403-0.771for 60-69 years and HR = 0.495, 95% CI: 0.310-0.790 for > = 70 years), diabetes neuropathy (HR = 0.502, 95% CI: 0.375-0.672), more than one complication (HR = 0.381, 95% CI: 0.177-0.816), hypertension (HR = 0.611, 95% CI: 0.486-0.769), dyslipidemia (HR = 0.609, 95% CI: 0.450-0.824), cardiovascular disease (HR = 0.670, 95% CI: 0.458-0.979) and hospital patient being treated (HR = 1.273, 95% CI: 1.052-1.541). Conclusions Median time to first optimal glycaemic control among T2DM patients is longer than expected which might imply that patients are being exposed to more risk of complication and death.	[Leulseged, Tigist W.] Millennium Med Coll, Dept Internal Med, St Pauls Hosp, Addis Ababa, Ethiopia; [Ayele, Birhanu T.] Stellenbosch Univ, Fac Med & Hlth Sci, Div Epidemiol & Biostat, Cape Town, South Africa	Stellenbosch University	Leulseged, TW (corresponding author), Millennium Med Coll, Dept Internal Med, St Pauls Hosp, Addis Ababa, Ethiopia.	tigdolly@gmail.com	Ayele, Birhanu/AAG-4155-2019	Ayele, Birhanu/0000-0002-5589-8327; Leulseged, Tigist/0000-0002-5767-1417				Abebe SM, 2015, DIABET METAB SYND OB, V8, P65, DOI 10.2147/DMSO.S75467; ADA, 2017, STAND MED CAR DIAB G; AHMAD R, 2014, KUMAR CLARK CLIN MED, P243, DOI DOI 10.1109/BDCLOUD.2014.88; Berhane F., 2017, J DIABETES METABOLIS, V8, P729; Blonde L, 2017, DIABETES VASC DIS RE, V14, P172, DOI 10.1177/1479164116679775; CARL J, 2002, DIABETES CARE, V25, P1297, DOI [10.2337/diacare.25.8.1297, DOI 10.2337/DIACARE.25.8.1297]; David Hosmer, 2008, APPL SURVIVAL ANAL; Derbachew Asfaw Teni, 2015, Ethiopian e-Journal for Research and Innovation Foresight, V7, P20; Ewenighi Chinwe O, 2013, Indian J Med Sci, V67, P61; Fauci A, 2015, HARRISON PRINCIPLES; Gebregziabher M, 2010, AM J EPIDEMIOL, V171, P1090, DOI 10.1093/aje/kwq070; Kassahun Tefera, 2016, BMC Res Notes, V9, P78, DOI 10.1186/s13104-016-1896-7; Kibirige D, 2017, INT J GEN MED, V10, P33, DOI 10.2147/IJGM.S124548; Mohammed J, 2016, J DIABETES RES, V2108, P14; Ngoyo J, 2016, J ENDOCRINOLOGY DIAB, V3, P1; Senait M, 2015, ETHIOPIAN PHARM J, V31, P131; Su JB, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0693-0; World Health Organization, 2016, GLOB REP DIAB, P16; Xu F, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-139	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220309	10.1371/journal.pone.0220309	http://dx.doi.org/10.1371/journal.pone.0220309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365544	gold, Green Submitted, Green Published			2022-12-26	WOS:000484983600035
J	di Tullio, PO; Giordano, V; Souto, E; Assed, H; Chequer, JP; Belangero, W; Mariolani, JRL; Koch, HA				di Tullio, Paulo Ottoni; Giordano, Vincenzo; Souto, Eder; Assed, Hugo; Chequer, Joao Paulo; Belangero, William; Mariolani, Jose Ricardo L.; Koch, Hilton A.			Biomechanical behavior of three types of fixation in the two-part proximal humerus fracture without medial cortical support	PLOS ONE			English	Article							LOCKING PLATE FIXATION	Background The purpose of this study was to evaluate the role of a non-locking plate applied to the anteromedial surface of the proximal humerus on loads at the implant-bone interface of nonlocking and locking lateral plate fixation of proximal humeral fractures with a medial gap. Methods Twenty synthetic humeri models were used. In fifteen, the proximal portion of the humerus was osteotomized to create a two-part surgical neck fracture, with a 10-mm medial gap and a 5-mm lateral gap; five models were controls. In the osteotomized humeri, five models were stabilized with a locking lateral plate (group L), five with a locking lateral plate and an anteromedial non-locking plate (group L+ T), and five with a non-locking lateral plate and a non-locking anteromedial plate (group T+T). All humeri were tested under axial loading until catastrophic failure, which was characterized as complete closure of the medial gap. Stiffness was calculated using force vs. displacement curves. The data were analyzed via descriptive and inferential studies, at a 5% significance level. Results Statistically significant differences were seen among all the constructions. The combination of a lateral locking plate with an anteromedial non-locking plate (group L+ T) was the stiffest construction, while the combination of a non-locking lateral plate with a non-locking anteromedial plate (group T+T) was the least stiff, even in comparison with a single locking lateral plate (p = 0.01). When the two groups which utilized a lateral locking plate (groups L+ T and L) were compared, the group with additional anteromedial support demonstrated greater stiffness (p = 0.03), and stiffness values for the control group comprised of intact humeri models were even higher (p = 0.01). Conclusion Combining a lateral locking plate with a non-locking anteromedial plate provides a stiffer construction for fixation of unstable two-part proximal humerus fractures with a medial gap. Mechanical benefits of medial support with a second non-locking antero-medial plate seems to be related with better construct stability in terms of strength and fatigue, potentially reducing the risk of varus collapse of the humerus head and fracture healing disturbances.	[di Tullio, Paulo Ottoni; Giordano, Vincenzo; Souto, Eder; Assed, Hugo; Chequer, Joao Paulo] Hosp Municipal Miguel Couto, Serv Ortopedia & Traumatol Prof Nova Monteiro, Rio De Janeiro, RJ, Brazil; [Belangero, William; Mariolani, Jose Ricardo L.] Univ Campinas UNICAMP, Fac Ciencias Med, Lab Biomat Ortopedia, Campinas, SP, Brazil; [Belangero, William] Univ Campinas UNICAMP, Fac Ciencias Med, Dept Ortopedia, Campinas, SP, Brazil; [Koch, Hilton A.] Univ Fed Rio de Janeiro UFRJ, Dept Radiol, Rio De Janeiro, RJ, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal do Rio de Janeiro	Giordano, V (corresponding author), Hosp Municipal Miguel Couto, Serv Ortopedia & Traumatol Prof Nova Monteiro, Rio De Janeiro, RJ, Brazil.	v_giordano@me.com	Giordano, Vincenzo/B-6285-2018	Giordano, Vincenzo/0000-0002-4429-312X				Burke NG, 2014, J ORTHOP SURG-HONG K, V22, P190, DOI 10.1177/230949901402200215; Chen YX, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-39; Choi S, 2014, INJURY, V45, P1280, DOI 10.1016/j.injury.2014.04.029; da Graca E, 2013, ACTA ORTOP BRAS, V21, P34, DOI 10.1590/S1413-78522013000100007; Dunlap JT, 2008, ANN BIOMED ENG, V36, P1922, DOI 10.1007/s10439-008-9568-y; Esenyel CZ, 2018, NIGER J CLIN PRACT, V21, P362, DOI 10.4103/njcp.njcp_400_16; Fuchtmeier B, 2007, ARCH ORTHOP TRAUM SU, V127, P441, DOI 10.1007/s00402-007-0319-6; Gardner MJ, 2008, J ORTHOP TRAUMA, V22, P195, DOI 10.1097/BOT.0b013e31815b3922; Gardner MJ, 2007, J ORTHOP TRAUMA, V21, P185, DOI 10.1097/BOT.0b013e3180333094; Giordano V, 2019, J EXP ORTHOP, V6, DOI 10.1186/s40634-019-0187-3; Giordano Vincenzo, 2018, Eur J Orthop Surg Traumatol, V28, P1359, DOI 10.1007/s00590-018-2207-x; Gradl G, 2013, J ORTHOP TRAUMA, V27, P399, DOI 10.1097/BOT.0b013e318278c595; Grover P, 2011, P I MECH ENG H, V225, P1169, DOI 10.1177/0954411911423346; He Y, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0573-4; He Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001775; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; Jabran A, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0479-3; Jung WB, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-102; Krappinger D, 2011, INJURY, V42, P1283, DOI 10.1016/j.injury.2011.01.017; Lambert SM, 2018, EFORT OPEN REV, V3, P304, DOI 10.1302/2058-5241.3.180005; Lin J, 1998, CLIN ORTHOP RELAT R, P203; Oppeboen S, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0906-y; Ponce BA, 2011, J BONE JT SURG AM, V95, pe113; Theopold J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206349; Wanner GA, 2003, J TRAUMA, V54, P536, DOI 10.1097/01.TA.0000052365.96538.42; Zeng LQ, 2018, CHINESE MED J-PEKING, V131, DOI 10.4103/0366-6999.237396; Zhang L, 2011, INT ORTHOP, V35, P1655, DOI 10.1007/s00264-011-1227-5; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103297; ZIMMERMAN MC, 1994, J ORTHOP TRAUMA, V8, P233, DOI 10.1097/00005131-199406000-00009	29	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220523	10.1371/journal.pone.0220523	http://dx.doi.org/10.1371/journal.pone.0220523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361778	Green Submitted, Green Published, gold			2022-12-26	WOS:000484981300039
J	Sarkar, A; Chanda, A; Regmi, SC; Karve, K; Deng, LL; Jay, GD; Jirik, FR; Schmidt, TA; Bonni, S				Sarkar, Anusi; Chanda, Ayan; Regmi, Suresh C.; Karve, Kunal; Deng, Lili; Jay, Gregory D.; Jirik, Frank R.; Schmidt, Tannin A.; Bonni, Shirin			Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGF beta-Hyaluronan-CD44 signalling pathway	PLOS ONE			English	Article							HUMAN PROTEOGLYCAN 4; TGF-BETA RECEPTOR; LUBRICATING ABILITY; CD44; HYALURONAN; CARTILAGE; GROWTH; PROLIFERATION; LUBRICIN; TRANSCRIPTION	Metastasis is the major cause of cancer-related morbidity and mortality. The ability of cancer cells to become invasive and migratory contribute significantly to metastatic growth, which necessitates the identification of novel anti-migratory and anti-invasive therapeutic approaches. Proteoglycan 4 (PRG4), a mucin-like glycoprotein, contributes to joint synovial homeostasis through its friction-reducing and anti-adhesive properties. Adhesion to surrounding extracellular matrix (ECM) components is critical for cancer cells to invade the ECM and eventually become metastatic, raising the question whether PRG4 has an antiinvasive effect on cancer cells. Here, we report that a full-length recombinant human PRG4 (rhPRG4) suppresses the ability of the secreted protein transforming growth factor beta (TGF beta) to induce phenotypic disruption of three-dimensional human breast cancer cell-derived organoids by reducing ligand-induced cell invasion. In mechanistic studies, we find that rhPRG4 suppresses TGF beta-induced invasiveness of cancer cells by inhibiting the downstream hyaluronan (HA)-cell surface cluster of differentiation 44 (CD44) signalling axis. Furthermore, we find that rhPRG4 represses TGF beta-dependent increase in the protein abundance of CD44 and of the enzyme HAS2, which is involved in HA biosynthesis. It is widely accepted that TGF beta has both tumor suppressing and tumor promoting roles in cancer. The novel finding that rhPRG4 opposes HAS2 and CD44 induction by TGF beta has implications for downregulating the tumor promoting roles, while maintaining the tumor suppressive aspects of TGF beta actions. Finally, these findings point to rhPRG4's potential clinical utility as a therapeutic treatment for invasive and metastatic breast cancer.	[Sarkar, Anusi; Chanda, Ayan; Karve, Kunal; Deng, Lili; Jirik, Frank R.; Bonni, Shirin] Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Calgary, AB, Canada; [Sarkar, Anusi; Chanda, Ayan; Karve, Kunal; Deng, Lili; Jirik, Frank R.; Bonni, Shirin] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Sarkar, Anusi; Regmi, Suresh C.; Schmidt, Tannin A.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Jay, Gregory D.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Jay, Gregory D.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Schmidt, Tannin A.] Univ Connecticut, Hlth Ctr, Biomed Engn Dept, Farmington, CT USA	University of Calgary; University of Calgary; University of Calgary; Brown University; Brown University; University of Connecticut	Bonni, S (corresponding author), Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Calgary, AB, Canada.; Bonni, S (corresponding author), Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Schmidt, TA (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.; Schmidt, TA (corresponding author), Univ Connecticut, Hlth Ctr, Biomed Engn Dept, Farmington, CT USA.	tschmidt@uchc.edu; sbonni@ucalgary.ca	Schmidt, Tannin/AAE-3830-2019	Chanda, Ayan/0000-0002-2692-8558	University of Calgary (UC); William H. Davies Medical Research Scholarship; UC; Canadian Cancer Society; Faculty of Kinesiology; Natural Sciences and Engineering Research Council of Canada (NSERC); Clinical Research Fund Grant	University of Calgary (UC); William H. Davies Medical Research Scholarship; UC; Canadian Cancer Society(Canadian Cancer Society (CCS)); Faculty of Kinesiology; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Clinical Research Fund Grant	This work was funded by 1. University of Calgary (UC) Eyes High Doctoral Recruitment Scholarship (AS), https://www.ucalgary.ca/eyeshigh; 2. William H. Davies Medical Research Scholarship (AC), https://cumming.ucalgary.ca/gse/prospective/awards-and-financial-support; 3. UC Eyes high International Doctoral Scholarship (AC), https://www.ucalgary.ca/eyeshigh; 4. UC Doctoral Scholarship (KK), https://cumming.ucalgary.ca/gse/prospective/awards-and-financialsupport; 5. Canadian Cancer Society grant (SB), Grant number N/A, http://www.cancer.ca/; 6. Faculty of Kinesiology Seed Grant (TS), Grant number N/A, https://www.ucalgary.ca/knes/; 7. Natural Sciences and Engineering Research Council of Canada (NSERC) Tier II Canada Research Chair (TS), http://www.nserc-crsng.gc.ca/; and 8. Clinical Research Fund Grant (SB), Grant number N/A https://cumming.ucalgary.ca/research/services/clinical-research-fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubacker S, 2016, CONNECT TISSUE RES, V57, P113, DOI 10.3109/03008207.2015.1113271; Abubacker S, 2016, ANN BIOMED ENG, V44, P1128, DOI 10.1007/s10439-015-1390-8; Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; Al-Sharif A, 2015, ARTHRITIS RHEUMATOL, V67, P1503, DOI 10.1002/art.39087; Alquraini A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1301-5; Alquraini A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0877-x; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Auvinen P, 2014, BREAST CANCER RES TR, V143, P277, DOI 10.1007/s10549-013-2804-7; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bray F, 2018, CA CANC J CLIN; Chanda A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177639; Chawla K, 2010, ACTA BIOMATER, V6, P3388, DOI 10.1016/j.actbio.2010.03.025; CHEIFETZ S, 1986, J BIOL CHEM, V261, P9972; Dadakhujaev Shorafidinkhuja, 2014, Oncoscience, V1, P229; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Elsaid KA, 2015, OSTEOARTHR CARTILAGE, V23, P114, DOI 10.1016/j.joca.2014.09.006; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iqbal SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep18910; Jay GD, 2014, MATRIX BIOL, V39, P17, DOI 10.1016/j.matbio.2014.08.008; Jitariu AA, 2017, ONCOTARGET, V8, P46652, DOI 10.18632/oncotarget.16938; Kariya Y, 2015, BBA CLIN, V3, P126, DOI 10.1016/j.bbacli.2015.01.003; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lambiase A, 2017, OCUL SURF, V15, P77, DOI 10.1016/j.jtos.2016.08.004; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Li LM, 2015, INT J MOL MED, V36, P113, DOI 10.3892/ijmm.2015.2222; Liu SL, 2017, CANCER RES, V77, P3791, DOI 10.1158/0008-5472.CAN-16-2545; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Masui K, 2013, CARCINOGENESIS, V34, P725, DOI 10.1093/carcin/bgt086; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Nam K, 2015, CELL SIGNAL, V27, P1882, DOI 10.1016/j.cellsig.2015.05.002; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Nikitovic D, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00069; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Connor C. M., 2010, ESSENTIALS CELL BIOL; Peng CK, 2016, INT J CANCER, V138, P2499, DOI 10.1002/ijc.29975; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Qadri M, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1693-x; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Samsom ML, 2014, EXP EYE RES, V127, P14, DOI 10.1016/j.exer.2014.06.015; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Schwertfeger KL, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00236; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Toss A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0560-9; Tripathi V, 2016, MOL CELL, V64, P549, DOI 10.1016/j.molcel.2016.09.013; Twelves C, 2016, CRIT REV ONCOL HEMAT, V100, P74, DOI 10.1016/j.critrevonc.2016.01.021; Urakawa H, 2012, INT J CANCER, V130, P454, DOI 10.1002/ijc.26014; Waller KA, 2017, AM J SPORT MED, V45, P1512, DOI 10.1177/0363546516686965; Wang H, 2017, ONCOL LETT, V14, P5890, DOI 10.3892/ol.2017.6959; Wobus M, 2002, APPL IMMUNOHISTO M M, V10, P34, DOI 10.1097/00022744-200203000-00006; Wu M, 2015, FASEB J, V29, P1290, DOI 10.1096/fj.14-259978; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	58	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0219697	10.1371/journal.pone.0219697	http://dx.doi.org/10.1371/journal.pone.0219697			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361756	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300015
J	Combier, M; Evangelisti, E; Piron, MC; Rengel, D; Legrand, L; Shenhav, L; Bouchez, O; Schornack, S; Mestre, P				Combier, Maud; Evangelisti, Edouard; Piron, Marie-Christine; Rengel, David; Legrand, Ludovic; Shenhav, Liron; Bouchez, Olivier; Schornack, Sebastian; Mestre, Pere			A secreted WY-domain-containing protein present in European isolates of the oomycete Plasmopara viticola induces cell death in grapevine and tobacco species	PLOS ONE			English	Article							CANDIDATE RXLR EFFECTOR; PHYTOPHTHORA-INFESTANS; DISEASE-RESISTANCE; SUBCELLULAR-LOCALIZATION; GENE-EXPRESSION; PLANT IMMUNITY; HOST; PREDICTION; TRANSIENT; AVR3A	Plasmopara viticola is a biotrophic oomycete pathogen causing grapevine downy mildew. We characterized the repertoire of P. viticola effector proteins which may be translocated into plants to support the disease. We found several secreted proteins that contain canonical dEER motifs and conserved WY-domains but lack the characteristic RXLR motif reported previously from oomycete effectors. We cloned four candidates and showed that one of them, Pv33, induces plant cell death in grapevine and Nicotiana species. This activity is dependent on the nuclear localization of the protein. Sequence similar effectors were present in seven European, but in none of the tested American isolates. Together our work contributes a new type of conserved P. viticola effector candidates.	[Combier, Maud; Piron, Marie-Christine; Mestre, Pere] Univ Strasbourg, INRA, SVQV, Colmar, France; [Evangelisti, Edouard; Shenhav, Liron; Schornack, Sebastian] Univ Cambridge, Sainsbury Lab SLCU, Cambridge, England; [Rengel, David; Legrand, Ludovic] Univ Toulouse, INRA, CNRS, LIPM, Castanet Tolosan, France; [Bouchez, Olivier] Genotoul, INRA, US GeT PlaGe 1426, Castanet Tolosan, France	INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Cambridge; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); INRAE	Mestre, P (corresponding author), Univ Strasbourg, INRA, SVQV, Colmar, France.	pere.mestre@inra.fr	Schornack, Sebastian/AAE-4897-2020	Schornack, Sebastian/0000-0002-7836-5881; Mestre, Pere/0000-0003-4488-6563; Legrand, Ludovic/0000-0001-9634-709X; Shenhav, Liron/0000-0003-1961-4187	Agence Nationale de la Recherche (ANR) grant EFFECTOORES [ANR-13-ADAP-0003]; INRA BAP Department; Region Alsace; Gatsby Charitable Foundation	Agence Nationale de la Recherche (ANR) grant EFFECTOORES(French National Research Agency (ANR)); INRA BAP Department; Region Alsace(Region Grand-Est); Gatsby Charitable Foundation	Research was funded by Agence Nationale de la Recherche (ANR) grant EFFECTOORES (ANR-13-ADAP-0003) PM.(https://anr.fr/).MC was funded by a joint fellowship from INRA BAP Department (http://www.bap.inra.fr/) and Region Alsace (https://www.grandest.fr/).EE and SS are funded by the Gatsby Charitable Foundation (https://www.gatsby.org.uk/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Asai S, 2015, CURR OPIN PLANT BIOL, V28, P1, DOI 10.1016/j.pbi.2015.08.008; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bailey K, 2011, MOL PLANT MICROBE IN, V24, P827, DOI 10.1094/MPMI-12-10-0278; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bezier A, 2002, J EXP BOT, V53, P2279, DOI 10.1093/jxb/erf101; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brilli M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19158-8; Caillaud MC, 2012, PLANT J, V69, P252, DOI 10.1111/j.1365-313X.2011.04787.x; Casagrande K, 2011, PLANTA, V234, P1097, DOI 10.1007/s00425-011-1461-5; Chen CL, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02062; Chong J, 2014, J EXP BOT, V65, P6589, DOI 10.1093/jxb/eru375; Cock PJA, 2013, PEERJ, V1, DOI 10.7717/peerj.167; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Derevnina L, 2015, MOL PLANT MICROBE IN, V28, P1198, DOI 10.1094/MPMI-05-15-0112-R; Dussert Y. D., 2018, BIORXIV, DOI [10.1101/350041, DOI 10.1101/350041]; Dussert Y, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00987-16; Evangelisti E, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0379-1; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Henry G, 2012, BIOTECHNOL AGRON SOC, V16, P257; Huang GY, 2019, MOL PLANT PATHOL, V20, P356, DOI 10.1111/mpp.12760; Huang J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02233-5; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Le Fevre R, 2015, ANNU REV CELL DEV BI, V31, P201, DOI 10.1146/annurev-cellbio-102314-112502; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Lin JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076864; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Liu YX, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00286; Lizamore D, 2015, PLANT CELL TISS ORG, V120, P607, DOI 10.1007/s11240-014-0627-9; Mestre P, 2016, PLANT PATHOL, V65, P767, DOI 10.1111/ppa.12469; Mestre P, 2017, MOL PLANT PATHOL, V18, P708, DOI 10.1111/mpp.12431; Mestre P, 2012, FUNGAL BIOL-UK, V116, P825, DOI 10.1016/j.funbio.2012.04.016; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Peart JR, 2002, PLANT J, V29, P569, DOI 10.1046/j.1365-313X.2002.029005569.x; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Pecrix Y, 2019, PLANT J, V97, P730, DOI 10.1111/tpj.14157; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santos-Rosa M, 2008, PLANT CELL REP, V27, P1053, DOI 10.1007/s00299-008-0531-z; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Sharma R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1904-7; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stassen JHM, 2013, MOL PLANT MICROBE IN, V26, P1259, DOI 10.1094/MPMI-05-13-0142-R; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wawra S, 2017, PLANT CELL, V29, P1184, DOI 10.1105/tpc.16.00552; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Wu CH, 2017, P NATL ACAD SCI USA, V114, P8113, DOI 10.1073/pnas.1702041114; Xiang J, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1016-4; Xiang J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00709; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yin L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46553; Yin L, 2015, PHYSIOL MOL PLANT P, V91, P1, DOI 10.1016/j.pmpp.2015.05.002; Yu XL, 2012, NEW PHYTOL, V196, P247, DOI 10.1111/j.1469-8137.2012.04241.x	65	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220184	10.1371/journal.pone.0220184	http://dx.doi.org/10.1371/journal.pone.0220184			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356604	Green Published, Green Submitted, gold			2022-12-26	WOS:000484047000020
J	Bagamasbad, PD; Espina, JEC; Knoedler, JR; Subramani, A; Harden, AJ; Denver, RJ				Bagamasbad, Pia D.; Espina, Jose Ezekiel C.; Knoedler, Joseph R.; Subramani, Arasakumar; Harden, Ariel J.; Denver, Robert J.			Coordinated transcriptional regulation by thyroid hormone and glucocorticoid interaction in adult mouse hippocampus-derived neuronal cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; FACTOR 9 GENE; CYTOCHROME B561; DENTATE GYRUS; LONG-TERM; CHROMATIN ACCESSIBILITY; FUNCTIONAL-ANALYSIS; RECEPTOR-ALPHA; GENOME BROWSER; AMYLOID-BETA	The hippocampus is a well-known target of thyroid hormone (TH; e.g., 3,5,3'-triiodothyronine-T-3) and glucocorticoid (GC; e.g., corticosterone-CORT) action. Despite evidence that TH and GC play critical roles in neural development and function, few studies have identified genes and patterns of gene regulation influenced by the interaction of these hormones at a genome-wide scale. In this study we investigated gene regulation by T-3, CORT, and T-3 + CORT in the mouse hippocampus-derived cell line HT-22. We treated cells with T-3, CORT, or T-3 + CORT for 4 hr before cell harvest and RNA isolation for microarray analysis. We identified 9 genes regulated by T-3, 432 genes by CORT, and 412 genes by T-3 + CORT. Among the 432 CORT-regulated genes, there were 203 genes that exhibited an altered CORT response in the presence of T-3, suggesting that T-3 plays a significant role in modulating CORT-regulated genes. We also found 80 genes synergistically induced, and 73 genes synergistically repressed by T-3 + CORT treatment. We performed in silico analysis using publicly available mouse neuronal chromatin immunoprecipitation-sequencing datasets and identified a considerable number of synergistically regulated genes with TH receptor and GC receptor peaks mapping within 1 kb of chromatin marks indicative of hormone-responsive enhancer regions. Functional annotation clustering of synergistically regulated genes reveal the relevance of proteasomal-dependent degradation, neuroprotective effect of growth hormones, and neuroinflammatory responses as key pathways to how TH and GC may coordinately influence learning and memory. Taken together, our transcriptome data represents a promising exploratory dataset for further study of common molecular mechanisms behind synergistic TH and GC gene regulation, and identify specific genes and their role in processes mediated by cross-talk between the thyroid and stress axes in a mammalian hippocampal model system.	[Bagamasbad, Pia D.; Subramani, Arasakumar; Harden, Ariel J.; Denver, Robert J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Bagamasbad, Pia D.; Espina, Jose Ezekiel C.] Univ Philippines Diliman, Natl Inst Mol Biol & Biotechnol, Quezon City, Philippines; [Knoedler, Joseph R.] Univ Michigan, Ann Arbor, MI 48109 USA; [Knoedler, Joseph R.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of the Philippines System; University of the Philippines Diliman; University of Michigan System; University of Michigan; Stanford University	Bagamasbad, PD (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.; Bagamasbad, PD (corresponding author), Univ Philippines Diliman, Natl Inst Mol Biol & Biotechnol, Quezon City, Philippines.	piab@mbb.upd.edu.ph	Denver, Robert/AAT-7481-2021	Bagamasbad, Pia/0000-0001-9751-7521	NINDS [1 R01 NS046690]; NSF [IOS 0922583]; NIH [1T32HD079342-01]; MCubed grant; Rackham Graduate School; Department of Molecular, Cellular and Developmental Biology, University of Michigan; University of the Philippines [OVPAA-BPhD-2014-02, NIMBB-15-090-160-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD079342] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MCubed grant; Rackham Graduate School; Department of Molecular, Cellular and Developmental Biology, University of Michigan(University of Michigan System); University of the Philippines(Commission on Higher Education (CHED), Philippines); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work presented in this manuscript was supported by grants NINDS 1 R01 NS046690 and NSF IOS 0922583 to RJD. JRK was supported by NIH 1T32HD079342-01 and a MCubed grant. PDB was supported by a Predoctoral Fellowship from the Rackham Graduate School and an Edwin Edwards Scholarship from the Department of Molecular, Cellular and Developmental Biology, University of Michigan, and OVPAA-BPhD-2014-02 grant from the University of the Philippines. JCE was supported by OVPAA-BPhD-2014-02 grant and NIMBB-15-090-160-11 grant from the University of the Philippines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabrera-Reyes EA, 2017, ENDOCRINE, V57, P199, DOI 10.1007/s12020-017-1346-x; Ambrogini P, 2005, NEUROENDOCRINOLOGY, V81, P244, DOI 10.1159/000087648; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Asard H, 2013, ANTIOXID REDOX SIGN, V19, P1026, DOI 10.1089/ars.2012.5065; Astapova I, 2013, BBA-GEN SUBJECTS, V1830, P3876, DOI 10.1016/j.bbagen.2012.07.001; Baumer BE, 2014, J NEUROSCI, V34, P1633, DOI 10.1523/JNEUROSCI.3094-13.2014; Bagamasbad P, 2008, J BIOL CHEM, V283, P2275, DOI 10.1074/jbc.M709306200; Bagamasbad P, 2012, ENDOCRINOLOGY, V153, P5334, DOI 10.1210/en.2012-1303; Bagamasbad PD, 2015, MOL ENDOCRINOL, V29, P856, DOI 10.1210/me.2014-1349; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Baxter PS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16158; Berczi A, 2014, CURR PROTEIN PEPT SC, V15, P745, DOI 10.2174/1389203715666140828100351; Bernal J., 2000, ENDOTEXT; Biddie SC, 2009, STRESS, V12, P193, DOI 10.1080/10253890802506409; Bikbaev A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14527; Bonett RM, 2010, GEN COMP ENDOCR, V168, P209, DOI 10.1016/j.ygcen.2010.03.014; Bonett RM, 2009, ENDOCRINOLOGY, V150, P1757, DOI 10.1210/en.2008-1441; Buchholz DR, 2005, J BIOL CHEM, V280, P41222, DOI 10.1074/jbc.M509593200; Buss Claudia, 2012, Cerebrum, V2012, P4; Calza L, 2015, COMPR PHYSIOL, V5, P1405, DOI 10.1002/cphy.c140035; Carleton JB, 2017, CELL SYST, V5, P333, DOI 10.1016/j.cels.2017.08.011; Carretero J, 2019, CELL TISSUE RES, V375, P193, DOI 10.1007/s00441-018-2858-2; Cayrou C, 2002, ENDOCRINOLOGY, V143, P2242, DOI 10.1210/en.143.6.2242; Challis JRG, 2001, MOL CELL ENDOCRINOL, V185, P135, DOI 10.1016/S0303-7207(01)00624-4; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Chen ZP, 2010, BEST PRACT RES CL EN, V24, P39, DOI 10.1016/j.beem.2009.08.014; Cheng F, 2017, EXP CELL RES, V360, P171, DOI 10.1016/j.yexcr.2017.09.003; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cornelisse S, 2011, PSYCHONEUROENDOCRINO, V36, P569, DOI 10.1016/j.psyneuen.2010.09.002; Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; Cruz R, 2003, REV NEUROLOGIA, V36, P877, DOI 10.33588/rn.3609.2002395; Cullen PK, 2017, LEARN MEMORY, V24, P589, DOI 10.1101/lm.045443.117; Currais A, 2013, ANTIOXID REDOX SIGN, V19, P813, DOI 10.1089/ars.2012.4996; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Datson NA, 2011, ENDOCRINOLOGY, V152, P3749, DOI 10.1210/en.2011-0287; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; Datson NA, 2012, HIPPOCAMPUS, V22, P359, DOI 10.1002/hipo.20905; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; DEESCOBAR GM, 2004, EUR J ENDOCRINOL S3, V151; Denver RJ, 1999, J BIOL CHEM, V274, P23128, DOI 10.1074/jbc.274.33.23128; Denver RJ, 2009, GEN COMP ENDOCR, V164, P20, DOI 10.1016/j.ygcen.2009.04.016; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Dzyubenko E, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5214961; EMANUELE NV, 1992, MOL ENDOCRINOL, V6, P35, DOI 10.1210/me.6.1.35; Farr SA, 2014, FREE RADICAL BIO MED, V67, P387, DOI 10.1016/j.freeradbiomed.2013.11.014; Fitzsimons CP, 2013, MOL PSYCHIATR, V18, P993, DOI 10.1038/mp.2012.123; Fondell JD, 2013, BBA-GEN SUBJECTS, V1830, P3867, DOI 10.1016/j.bbagen.2012.02.012; Gil-Ibanez P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091692; Gilabert-Juan J, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.534; Gilbert ME, 2004, DEV BRAIN RES, V148, P11, DOI 10.1016/j.devbrainres.2003.09.018; Goo MS, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00060; GOULD E, 1991, PSYCHONEUROENDOCRINO, V16, P67, DOI 10.1016/0306-4530(91)90071-Z; Grontved L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8048; Hegde AN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00096; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang RR, 2015, INT J MOL MED, V35, P553, DOI 10.3892/ijmm.2014.2026; Iliadi KG, 2008, P NATL ACAD SCI USA, V105, P19986, DOI 10.1073/pnas.0810698105; Jeronimo C, 2017, TRENDS CELL BIOL, V27, P765, DOI 10.1016/j.tcb.2017.07.001; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jones E., 2001, SCIPY OPEN SOURCE SC; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kallarackal AJ, 2013, J NEUROSCI, V33, P15669, DOI 10.1523/JNEUROSCI.2588-13.2013; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kino T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003333; Knight D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132548; Knoedler JR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3640-7; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kon Kazuhiro, 2017, Brain Nerve, V69, P257, DOI 10.11477/mf.1416200735; Kondo S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-27; Kulkarni SS, 2012, ENDOCRINOLOGY, V153, P5309, DOI 10.1210/en.2012-1432; Bitzer-Quintero OK, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/348642; Labes M, 1998, MOL CELL NEUROSCI, V12, P29, DOI 10.1006/mcne.1998.0692; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Landgraf D, 2015, CHRONOBIOL INT, V32, P416, DOI 10.3109/07420528.2014.986576; Landgraf D, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00143; Lee C, 2014, BIOINFORMATICS, V30, P1923, DOI 10.1093/bioinformatics/btu115; Li YF, 2017, J MAGN RESON IMAGING, V46, P1456, DOI 10.1002/jmri.25667; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; MacDougall MJ, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.35; Maher P, 1996, J NEUROSCI, V16, P6394; Mai W, 2004, P NATL ACAD SCI USA, V101, P10332, DOI 10.1073/pnas.0401843101; Malik AR, 2013, J BIOL CHEM, V288, P8544, DOI 10.1074/jbc.M112.411629; Manchanda S, 2018, MOL CELL BIOCHEM, V449, P63, DOI 10.1007/s11010-018-3343-7; MARTIAL JA, 1977, P NATL ACAD SCI USA, V74, P4293, DOI 10.1073/pnas.74.10.4293; Martin NP, 2014, ENDOCRINOLOGY, V155, P3713, DOI 10.1210/en.2013-2058; MCDONALD MC, 1992, PEDIATR RES, V32, P306, DOI 10.1203/00006450-199209000-00012; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Miranda TB, 2013, CANCER RES, V73, P5130, DOI 10.1158/0008-5472.CAN-13-0742; Moog NK, 2017, NEUROSCIENCE, V342, P68, DOI 10.1016/j.neuroscience.2015.09.070; MORIMOTO BH, 1990, P NATL ACAD SCI USA, V87, P3518, DOI 10.1073/pnas.87.9.3518; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Morte B, 2010, ENDOCRINOLOGY, V151, P810, DOI 10.1210/en.2009-0958; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Navakkode S, 2018, AGEING RES REV, V42, P86, DOI 10.1016/j.arr.2018.01.001; Navarro D, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00009; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oliveira JF, 2013, FRONT NEURAL CIRCUIT, V7, DOI [10.1016/j.psyneuen.2010.09.002, DOI 10.1016/J.PSYNEUEN.2010.09.002]; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; Polman JAE, 2013, ENDOCRINOLOGY, V154, P1832, DOI 10.1210/en.2012-2187; Pooley JR, 2017, ENDOCRINOLOGY, V158, P1486, DOI 10.1210/en.2016-1929; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Porterfield SP, 2000, ENVIRON HEALTH PERSP, V108, P433, DOI 10.2307/3454533; Preuss D, 2009, NEUROBIOL LEARN MEM, V92, P318, DOI 10.1016/j.nlm.2009.03.009; Puzianowska-Kuznicka M, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/601246; Ramadoss P, 2014, J BIOL CHEM, V289, P1313, DOI 10.1074/jbc.M113.521450; Reyes-Mendoza J, 2016, NEUROSCIENCE, V328, P58, DOI 10.1016/j.neuroscience.2016.04.030; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robson H, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000023494.70201.1C; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Sachs LM, 2000, P NATL ACAD SCI USA, V97, P13138, DOI 10.1073/pnas.260141297; Sachs LM, 2002, MOL CELL BIOL, V22, P8527, DOI 10.1128/MCB.22.24.8527-8538.2002; Sagara Y, 1998, FREE RADICAL BIO MED, V24, P1375, DOI 10.1016/S0891-5849(97)00457-7; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Schmidt H, 2016, EUR J NEUROSCI, V44, P2991, DOI 10.1111/ejn.13434; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Shiraki A, 2012, ARCH TOXICOL, V86, P1559, DOI 10.1007/s00204-012-0846-y; Siebler T, 2001, HORM RES, V56, P7, DOI 10.1159/000048127; Smeets T, 2009, PSYCHONEUROENDOCRINO, V34, P1152, DOI 10.1016/j.psyneuen.2009.03.001; SMITH BT, 1983, P NATL ACAD SCI-BIOL, V80, P1951, DOI 10.1073/pnas.80.7.1951; Fustinana MS, 2014, LEARN MEMORY, V21, P478, DOI 10.1101/lm.035998.114; Song I, 2018, BRAIN RES BULL, V136, P101, DOI 10.1016/j.brainresbull.2017.03.003; Soutourina J, 2018, NAT REV MOL CELL BIO, V19, P262, DOI 10.1038/nrm.2017.115; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Sporl F, 2012, P NATL ACAD SCI USA, V109, P10903, DOI 10.1073/pnas.1118641109; Stankiewicz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142195; Stavreva DA, 2015, GENOME RES, V25, P845, DOI 10.1101/gr.184168.114; Sukhareva E V, 2016, Mol Biol (Mosk), V50, P266, DOI 10.7868/S0026898416020257; Sunkaria A, 2017, NEUROSCIENCE, V367, P47, DOI 10.1016/j.neuroscience.2017.10.021; Thakurela S, 2015, GENOME RES, V25, P1309, DOI 10.1101/gr.190926.115; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; van't Spijker HM, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00033; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wang DY, 2017, AUTOPHAGY, V13, P914, DOI 10.1080/15548627.2017.1293766; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang LC, 2016, GLIA, V64, P1021, DOI 10.1002/glia.22980; Wang Y, 2013, TOXICOL APPL PHARM, V271, P257, DOI 10.1016/j.taap.2013.04.034; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Wuwongse S, 2013, BBA-MOL BASIS DIS, V1832, P2245, DOI 10.1016/j.bbadis.2013.07.022; Yao LJ, 2015, CRIT REV BIOCHEM MOL, V50, P550, DOI 10.3109/10409238.2015.1087961; Yao M, 2008, ENDOCRINOLOGY, V149, P2352, DOI 10.1210/en.2007-1551; Yu F, 2014, ENVIRON TOXICOL, V29, P847, DOI 10.1002/tox.21811	157	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220378	10.1371/journal.pone.0220378	http://dx.doi.org/10.1371/journal.pone.0220378			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348800	Green Published, Green Submitted, gold			2022-12-26	WOS:000484979500032
J	Chi, XL; Zheng, Q; Jiang, RH; Chen-Tsai, RY; Kong, LJ				Chi, Xiuling; Zheng, Qi; Jiang, Ruhong; Chen-Tsai, Ruby Yanru; Kong, Ling-Jie			A system for site-specific integration of transgenes in mammalian cells	PLOS ONE			English	Article							CHO-CELLS; KNOCK-IN; GENOME; CRISPR-CAS9; TOOLBOX	Mammalian cell expression systems are the most commonly used platforms for producing biotherapeutic proteins. However, development of recombinant mammalian cell lines is often hindered by the unstable and variable transgene expression associated with random integration. We have developed an efficient strategy for site-specific integration of genes of interest (GOIs). This method enables rapid and precise insertion of a gene expression cassette at defined loci in mammalian cells, resulting in homogeneous transgene expression. We identified the Hipp11 (H11) gene as a "safe harbor" locus for gene knock-in in CHO-S cells. Using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 mediated homologous recombination, we knocked in a DNA cassette (the landing pad) that includes a pair of PhiC31 bacteriophage attP sites and genes facilitating integrase-based GOI integration. A master cell line, with the landing pad inserted correctly in the H11 locus, was established. This master cell line was used for site-specific, irreversible recombination, catalyzed by PhiC31 integrase. Using this system, an integration efficiency of 97.7% was achieved with green fluorescent protein (GFP) after selection. The system was then further validated in HEK293T cells, using an analogous protocol to insert the GFP gene at the ROSA26 locus, resulting in 90.7% GFP-positive cells after selection. In comparison, random insertion yielded 0.68% and 1.32% GFP-positive cells in the CHO-S and HEK293T cells, respectively. Taken together, these findings demonstrated an accurate and effective protocol for generating recombinant cell lines to provide consistent protein production. Its likely broad applicability was illustrated here in two cell lines, CHO-S and HEK293T, using two different genomic loci as integration sites. Thus, the system is potentially valuable for biomanufacturing therapeutic proteins.	[Chi, Xiuling; Zheng, Qi; Jiang, Ruhong; Chen-Tsai, Ruby Yanru; Kong, Ling-Jie] Appl StemCell Inc, Milpitas, CA 95035 USA		Chen-Tsai, RY; Kong, LJ (corresponding author), Appl StemCell Inc, Milpitas, CA 95035 USA.	ruby.tsai@appliedstemcell.com; ling-jie.kong@appliedstemcell.com			Applied StemCell, Inc.	Applied StemCell, Inc.	This work was funded by Applied StemCell, Inc. Two of the cofounders (RJ and RYCT) of the company played roles besides providing the resource for the project. The specific roles they played are listed in the "author contribution" section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Bachu R, 2015, BIOTECHNOL BIOENG, V112, P2154, DOI 10.1002/bit.25629; Bode J, 2000, BIOL CHEM, V381, P801, DOI 10.1515/BC.2000.103; Feichtinger J, 2016, BIOTECHNOL BIOENG, V113, P2241, DOI 10.1002/bit.25990; Ginsburg DS, 2005, ADV GENET, V54, P179, DOI 10.1016/S0065-2660(05)54008-2; Kawabe Y., 2015, INBMC P, V9, P1, DOI [10.1186/1753-6561-9-S9-P5, DOI 10.1186/1753-6561-9-S9-P5]; Keravala Annahita, 2008, V435, P165, DOI 10.1007/978-1-59745-232-8_12; Lee J. S., 2015, SCI REP, V5, P1, DOI DOI 10.1038/SREP12135; Lee JS, 2015, BIOTECHNOL J, V10, P979, DOI 10.1002/biot.201500082; Malphettes L, 2010, BIOTECHNOL BIOENG, V106, P774, DOI 10.1002/bit.22751; Noh SM, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Paix A, 2017, P NATL ACAD SCI USA; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sakuma T, 2015, INT J MOL SCI, V16, P23849, DOI 10.3390/ijms161023849; Simon H, 2010, NEURON, V68, P694; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Turan S, 2013, GENE, V515, P1, DOI 10.1016/j.gene.2012.11.016; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wurm FM, 2017, PROCESSES, V5, DOI 10.3390/pr5020020; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zhou H, 2010, J BIOTECHNOL, V147, P122, DOI 10.1016/j.jbiotec.2010.03.020; Zhu FF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1290	24	11	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219842	10.1371/journal.pone.0219842	http://dx.doi.org/10.1371/journal.pone.0219842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344144	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900032
J	Zhang, TY; Ouyang, H; Mei, XY; Lu, B; Yu, ZY; Chen, KX; Wang, ZT; Ji, LL				Zhang, Tianyu; Ouyang, Hao; Mei, Xiyu; Lu, Bin; Yu, Zengyang; Chen, Kaixian; Wang, Zhengtao; Ji, Lili			Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						BRB breakdown; GLUT1; TNF-alpha; tight junctions; molecular docking analysis	MAJOR RISK-FACTORS; GLOBAL PREVALENCE; ENDOTHELIAL-CELL; ACTIVATION; MODULATION; TRANSPORT; INSIGHTS; BARRIER; HEALTH	Blood-retinal barrier (BRB) breakdown is a typical event in the early stage of diabetic retinopathy (DR). This study aims to elucidate the protection of erianin, a natural compound isolated from Dendrobium chrysotoxum Lindl, against DR development. Erianin alleviated BRB breakdown and rescued the reduced claudinl and occludin expression in retinas from streptozotocin-induced diabetic mice. Erianin reduced microglial activation, ERK1/2 phosphorylation, NF-kappa B transcriptional activation, and the elevated TNF-alpha expression both in vitro and in vivo. ERK1/2 inhibitor U0126 abrogated NF-kappa B activation in D-glucose-treated BV2 cells. Erianin reduced cellular glucose uptake, and molecular docking analysis indicated the potential interaction of erianin with glucose transporter (GLUT)1. GLUT1 inhibitor (STF31) reduced the activation of the ERK1/2-NF-kappa B signaling pathway. Co culture with D-glucose-stimulated microglial BV2 cells and with TNF-alpha stimulation both induced inner BRB and outer BRB damage in human retinal endothelial cells and APRE19 cells, but erianin improved all these damages. In summary, erianin attenuated BRB breakdown during DR development by inhibiting microglia-triggered retinal inflammation via reducing cellular glucose uptake and abrogating the subsequent activation of the downstream ERK1/2-NF-kappa B pathway. Moreover, erianin also alleviated BRB damage induced by TNF-alpha released from the activated microglia.	[Zhang, Tianyu; Ouyang, Hao; Mei, Xiyu; Lu, Bin; Yu, Zengyang; Chen, Kaixian; Wang, Zhengtao; Ji, Lili] Shanghai Univ Tradit Chinese Med, Key Lab New Resources & Qual Evaluat Chinese Med, Shanghai Key Lab Compound Chinese Med,Minist Educ, MOE Key Lab Standardizat Chinese Med,Inst Chinese, 1200 Cailun Rd, Shanghai 201203, Peoples R China	Shanghai University of Traditional Chinese Medicine	Wang, ZT; Ji, LL (corresponding author), Shanghai Univ Tradit Chinese Med, Key Lab New Resources & Qual Evaluat Chinese Med, Shanghai Key Lab Compound Chinese Med,Minist Educ, MOE Key Lab Standardizat Chinese Med,Inst Chinese, 1200 Cailun Rd, Shanghai 201203, Peoples R China.	lichenyue1307@126.com; lichenyue1307@126.com	Mei, Xiyu/GYA-4526-2022	Mei, Xiyu/0000-0003-2206-7647; Hao, Ouyang/0000-0001-6930-2363	Leadership in Science and Technology Innovation of the third batch of the national "Ten Thousand People Plan"; National Natural Science Foundation of China [81322053, 81173517, 81573679]	Leadership in Science and Technology Innovation of the third batch of the national "Ten Thousand People Plan"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Yu Chen (Shanghai University of Traditional Chinese Medicine) and Prof. Xinhua Liu (Fudan University, Shanghai, China) for kindly gifting ARPE19 and BV2 cells. This work was financially supported by the Leadership in Science and Technology Innovation of the third batch of the national "Ten Thousand People Plan" and the National Natural Science Foundation of China (81322053, 81173517, and 81573679 to L.J.). The authors declare no conflicts of interest.	Adams DJ, 2014, ACS CHEM BIOL, V9, P2247, DOI 10.1021/cb500347p; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS7, DOI 10.2337/dc18-S001; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Arroba AI, 2017, ACTA DIABETOL, V54, P527, DOI 10.1007/s00592-017-0984-z; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bharadwaj AS, 2013, PROG RETIN EYE RES, V32, P102, DOI 10.1016/j.preteyeres.2012.08.004; Campbell M, 2013, ADV EXP MED BIOL, V763, P70; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen LQ, 2015, ANNU REV BIOCHEM, V84, P865, DOI 10.1146/annurev-biochem-060614-033904; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chinese Pharmacopeia Commission, 2010, PHARMACOPOEIA PEOPLE, V1, P150; Coughlin BA, 2017, VISION RES, V139, P93, DOI 10.1016/j.visres.2017.03.013; Cunha-Vaz J, 2011, EUR J OPHTHALMOL, V21, pS3, DOI 10.5301/EJO.2010.6049; CUNHAVAZ JG, 1976, DOC OPHTHALMOL, V41, P287, DOI 10.1007/BF00146764; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fischer AJ, 2015, GLIA, V63, P313, DOI 10.1002/glia.22752; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gologorsky D, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/629452; Gong CY, 2014, VASC PHARMACOL, V62, P134, DOI 10.1016/j.vph.2014.04.007; Ioacara S, 2009, DIABETES RES CLIN PR, V86, P146, DOI 10.1016/j.diabres.2009.08.012; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jiang XS, 2014, J NEUROSCI RES, V92, P424, DOI 10.1002/jnr.23337; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Lin FL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00326; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Okunuki Y, 2018, P NATL ACAD SCI USA, V115, pE6264, DOI 10.1073/pnas.1719601115; Popiolek-Barczyk K, 2016, CURR MED CHEM, V23, P2908, DOI 10.2174/0929867323666160607120124; Rashid K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00176; Scanlon PH, 2013, MIDDLE EAST AFR J OP, V20, P293, DOI 10.4103/0974-9233.120007; Semeraro F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/582060; SHAKIB M, 1966, EXP EYE RES, V5, P229, DOI 10.1016/S0014-4835(66)80011-8; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Ting DSW, 2016, CLIN EXP OPHTHALMOL, V44, P260, DOI 10.1111/ceo.12696; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Wang YH, 2017, CELL PHYSIOL BIOCHEM, V44, P479, DOI 10.1159/000485085; Willis JR, 2017, JAMA OPHTHALMOL, V135, P926, DOI 10.1001/jamaophthalmol.2017.2553; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yu Z., 2016, SCI REP, V6; Yu ZY, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/518317; Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65; Zhang Q, 2016, BRIT J OPHTHALMOL, V100, P1443, DOI 10.1136/bjophthalmol-2015-308199; Zhu SH, 2017, INFLAMMATION, V40, P1475, DOI 10.1007/s10753-017-0571-z	50	42	46	3	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11776	11790		10.1096/fj.201802614RRR	http://dx.doi.org/10.1096/fj.201802614RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365278	Bronze, Green Published			2022-12-26	WOS:000507461600016
J	Atkinson, JM; Ye, YS; Gebru, MT; Liu, Q; Zhou, SH; Young, MM; Takahashi, Y; Lin, Q; Tian, F; Wang, HG				Atkinson, Jennifer M.; Ye, Yansheng; Gebru, Melat T.; Liu, Qiang; Zhou, Shouhao; Young, Megan M.; Takahashi, Yoshinori; Lin, Qing; Tian, Fang; Wang, Hong-Gang			Time-resolved FRET and NMR analyses reveal selective binding of peptides containing the LC3-interacting region to ATG8 family proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; peptide interaction; nuclear magnetic resonance (NMR); fluorescence resonance energy transfer (FRET); mitophagy; protein-protein interaction; Atg8; LC3; LIR	STRUCTURAL BASIS; LIR MOTIF; ENDOPLASMIC-RETICULUM; AUTOPHAGY; FYCO1; PHOSPHORYLATION; DEGRADATION; MITOPHAGY; RESTRICTS; SENSORS	Selective autophagy sequesters cytoplasmic cargo for lysosomal degradation via the binding of autophagy receptors to Atg8 (autophagy-related 8) family proteins on the autophagic membrane. The sole yeast Atg8 gene has six mAtg8 (mammalian Atg8) homologs, including the MAP1LC3 (microtubule-associated protein-1 light chain 3) family and the GABA receptor-associated proteins. Selective autophagy receptors interact with two conserved hydrophobic pockets (termed the W-site and L-site) of mATG8 proteins through a linear motif called the LC3-interacting region (LIR) with the general composition (W/F/Y)XX(I/L/V). To address a lack in our knowledge regarding LIR peptide specificity toward each mATG8 homolog, here we used competitive time-resolved FRET to sensitively and quantitatively characterize the interactions between LIRs and mAtg8. We report that 14 representative LIR-containing peptides display differential binding affinities toward the mAtg8 proteins and identified the LIR domain peptide of TP53INP1 as exhibiting high affinity for all six mATG8 proteins. Using peptide truncation studies, we found that both N- and C-terminal acidic residues, as well as the C-terminal Cys residue of the TP53INP1 LIR peptide, are required for its high-affinity binding to LC3A and LC3B, whereas binding to the GABARAP subfamily proteins was facilitated by residues either N-terminal or C-terminal to the core motif. Finally, we used NMR chemical shift perturbation analysis to gain molecular insights into these findings. Collectively, our results may aid in the development of molecules that selectively disrupt specific mATG8-LIR interactions to dissect the biological roles of the six mATG8 homologs for potential therapeutic applications.	[Atkinson, Jennifer M.; Gebru, Melat T.; Liu, Qiang; Young, Megan M.; Takahashi, Yoshinori; Wang, Hong-Gang] Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Ye, Yansheng; Tian, Fang] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Zhou, Shouhao] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Lin, Qing] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wang, HG (corresponding author), Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA.; Tian, F (corresponding author), Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	ftian@psu.edu; huw11@psu.edu	tian, fang/AAT-6626-2021; Atkinson, Jennifer/AAE-5466-2019; Wang, Hong-Gang/A-3018-2015	Atkinson, Jennifer/0000-0001-5164-5114; YE, YANSHENG/0000-0001-9478-6056; Takahashi, Yoshinori/0000-0002-8004-4817; Wang, Hong-Gang/0000-0003-0551-0571	National Institutes of Health [CA222349, GM127954, GM105963, GM127730]; Hyundai Hope on Wheels; Lois High Berstler Research Endowment Fund; Four Diamonds Fund of the Pennsylvania State University; NATIONAL CANCER INSTITUTE [R01CA222349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127730, R01GM105963, R01GM127954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels; Lois High Berstler Research Endowment Fund; Four Diamonds Fund of the Pennsylvania State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants CA222349 and GM127954 (to H.-G. W.) and GM105963 and GM127730 (to F. T.), Hyundai Hope on Wheels, the Lois High Berstler Research Endowment Fund, and the Four Diamonds Fund of the Pennsylvania State University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cheng XF, 2016, AUTOPHAGY, V12, P1330, DOI 10.1080/15548627.2016.1185590; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuang Y, 2016, AUTOPHAGY, V12, P2363, DOI 10.1080/15548627.2016.1238552; Kumeta H, 2010, J BIOMOL NMR, V47, P237, DOI 10.1007/s10858-010-9420-1; Lee YK, 2017, EMBO J, V36, P1100, DOI 10.15252/embj.201696315; Li JC, 2018, NAT CHEM BIOL, V14, P778, DOI 10.1038/s41589-018-0082-8; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Lystad AH, 2014, EMBO REP, V15, P557, DOI 10.1002/embr.201338003; Mancias JD, 2016, J MOL BIOL, V428, P1659, DOI 10.1016/j.jmb.2016.02.027; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Olsvik HL, 2015, J BIOL CHEM, V290, P29361, DOI 10.1074/jbc.M115.686915; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rogov VV, 2017, EMBO REP, V18, P1382, DOI 10.15252/embr.201643587; Sakurai S, 2017, ACTA CRYSTALLOGR F, V73, P130, DOI 10.1107/S2053230X17001911; Stolz A, 2017, EMBO J, V36, P549, DOI 10.15252/embj.201695063; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zens B, 2015, METHODS, V75, P37, DOI 10.1016/j.ymeth.2014.11.004	32	8	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14033	14042		10.1074/jbc.RA119.008723	http://dx.doi.org/10.1074/jbc.RA119.008723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31362979	Green Published, hybrid			2022-12-26	WOS:000490729800017
J	Shen, Z; Wang, G; Yang, YL; Shi, JL; Fang, LR; Li, F; Xiao, SB; Fu, ZF; Peng, GQ				Shen, Zhou; Wang, Gang; Yang, Yiling; Shi, Jiale; Fang, Liurong; Li, Fang; Xiao, Shaobo; Fu, Zhen F.; Peng, Guiqing			A conserved region of nonstructural protein 1 from alphacoronaviruses inhibits host gene expression and is critical for viral virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein motif; pathogenesis; crystal structure; virulence factor; virus; coronavirus; host gene expression; immune evasion; nonstructural protein 1 (nsp1); transmissible gastroenteritis virus (TGEV)	RESPIRATORY SYNDROME CORONAVIRUS; EPIDEMIC DIARRHEA VIRUS; RATIONAL DESIGN; BINDING PROTEIN; NSP1 PROTEINS; I INTERFERON; PATHOGENESIS; REPLICATION; RNA; IMMUNIZATION	Coronaviruses are enveloped, single-stranded RNA viruses that are distributed worldwide. They include transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV), and the human coronaviruses severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), many of which seriously endanger human health and well-being. Only alphacoronaviruses and betacoronaviruses harbor nonstructural protein 1 (nsp1), which performs multiple functions in inhibiting antiviral host responses. The role of the C terminus of betacoronavirus nsp1 in virulence has been characterized, but the location of the alphacoronavirus nsp1 region that is important for virulence remains unclear. Here, using TGEV nsp1 as a model to explore the function of this protein in alphacoronaviruses, we demonstrate that alphacoronavirus nsp1 inhibits host gene expression. Solving the crystal structure of full-length TGEV at 1.85-angstrom resolution and conducting several biochemical analyses, we observed that a specific motif (amino acids 91-95) of alphacoronavirus nsp1 is a conserved region that inhibits host protein synthesis. Using a reverse-genetics system based on CRISPR/Cas9 technology to construct a recombinant TGEV in which this specific nsp1 motif was altered, we found that this mutation does not affect virus replication in cell culture but significantly reduces TGEV pathogenicity in pigs. Taken together, our findings suggest that alphacoronavirus nsp1 is an essential virulence determinant, providing a potential paradigm for the development of a new attenuated vaccine based on modified nsp1.	[Shen, Zhou; Wang, Gang; Yang, Yiling; Shi, Jiale; Fang, Liurong; Xiao, Shaobo; Fu, Zhen F.; Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China; [Shen, Zhou; Wang, Gang; Yang, Yiling; Shi, Jiale; Fang, Liurong; Xiao, Shaobo; Fu, Zhen F.; Peng, Guiqing] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China; [Li, Fang] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Fu, Zhen F.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Peng, Guiqing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia; Huazhong Agricultural University	Peng, GQ (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.	penggq@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188; Shen, Zhou/0000-0001-8772-2978	National Natural Science Foundation of China [31873020, 31722056]; National Key Research and Development Plan of China [2018YFD0500102]; Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program [2662017PY028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China; Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program	This work was supported by National Natural Science Foundation of China Grants 31873020 and 31722056, National Key Research and Development Plan of China Grant 2018YFD0500102, and Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation Program 2662017PY028. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Almeida MS, 2006, J BIOMOL NMR, V36, P46, DOI 10.1007/s10858-006-9018-9; Cai H, 2016, J VIROL, V90, P7323, DOI 10.1128/JVI.00755-16; De Diego ML, 2014, VIRUS RES, V194, P124, DOI 10.1016/j.virusres.2014.07.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Fett C, 2013, J VIROL, V87, P6551, DOI 10.1128/JVI.00087-13; Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143; Grell L, 2006, BIOCHEM MOL BIOL EDU, V34, P402, DOI 10.1002/bmb.2006.494034062672; Guan BJ, 2012, J VIROL, V86, P4631, DOI 10.1128/JVI.06265-11; Gustin KM, 2009, J VIROL, V83, P6087, DOI 10.1128/JVI.00160-09; Huang C, 2011, J VIROL, V85, P638, DOI 10.1128/JVI.01806-10; Jansson AM, 2013, J VIROL, V87, P2949, DOI 10.1128/JVI.03163-12; Jimenez-Guardeno JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004320; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Lamirande EW, 2008, J VIROL, V82, P7721, DOI 10.1128/JVI.00304-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061166; Liu YF, 2016, FEBS J, V283, P899, DOI 10.1111/febs.13642; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; Lokugamage KG, 2015, J VIROL, V89, P10970, DOI 10.1128/JVI.01352-15; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Netland J, 2010, VIROLOGY, V399, P120, DOI 10.1016/j.virol.2010.01.004; Nicolodi C, 2019, VACCINE, V37, P3722, DOI 10.1016/j.vaccine.2019.05.013; Park HS, 2018, J VIROL, V92, DOI [10.1128/JVI.00022-18, 10.1128/jvi.00022-18]; Pasieka TJ, 2008, J VIROL, V82, P5527, DOI 10.1128/JVI.02047-07; Patnaik S, 2019, BIOORG MED CHEM LETT, V29, P1113, DOI 10.1016/j.bmcl.2019.02.027; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Shen Z, 2018, J VIROL, V92, DOI 10.1128/JVI.01896-17; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Tohya Y, 2009, J VIROL, V83, P5282, DOI 10.1128/JVI.02485-08; Wang G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040313; Wang YJ, 2010, INFECT GENET EVOL, V10, P919, DOI 10.1016/j.meegid.2010.05.014; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; Zhang QZ, 2017, VIROLOGY, V510, P111, DOI 10.1016/j.virol.2017.07.009; Zhang QZ, 2016, VIROLOGY, V489, P252, DOI 10.1016/j.virol.2015.12.010; Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	46	35	38	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13606	13618		10.1074/jbc.RA119.009713	http://dx.doi.org/10.1074/jbc.RA119.009713			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350335	hybrid, Green Published			2022-12-26	WOS:000486418600008
J	Pongjantarasatian, S; Kadegasem, P; Sasanakul, W; Sangiamsuntorn, K; Borwornpinyo, S; Sirachainan, N; Chuansumrit, A; Tanratana, P; Hongeng, S				Pongjantarasatian, Sarai; Kadegasem, Praguywan; Sasanakul, Werasak; Sangiamsuntorn, Khanit; Borwornpinyo, Suparerk; Sirachainan, Nongnuch; Chuansumrit, Ampaiwan; Tanratana, Pansakorn; Hongeng, Suradej			Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line	PLOS ONE			English	Article							ESTABLISHMENT; HEMOPHILIA; DEFICIENCY; EXPRESSION; VARIANTS; PROTEINS; MOUSE	Human mesenchymal stem cells (hMSCs) have the potential to differentiate into hepatocyte-like cells, indicating that these cells may be the new target cell of interest to produce biopharmaceuticals. Our group recently established a hMSC-derived immortalized hepatocyte-like cell line (imHC) that demonstrates several liver-specific phenotypes. However, the ability of imHC to produce coagulation factors has not been characterized. Here, we examined the potential for imHC as a source of coagulation protein production by investigating the ability of imHC to produce human factor VII (FVII) using a lentiviral transduction system. Our results showed that imHC secreted a low amount of FVII (similar to 22 ng/mL) into culture supernatant. Moreover, FVII from the transduced imHC (0.11 +/- 0.005 IU/mL) demonstrated a similar coagulant activity compared with FVII from transduced HEK293T cells (0.12 +/- 0.004 IU/mL) as determined by chromogenic assay. We demonstrate for the first time, to the best of our knowledge, that imHC produced FVII, albeit at a low level, indicating the unique characteristic of hepatocytes. Our study suggests the possibility of using imHC for the production of coagulation proteins.	[Pongjantarasatian, Sarai] Mahidol Univ, Fac Sci, Mol Med Program, Bangkok, Thailand; [Kadegasem, Praguywan; Sasanakul, Werasak; Sirachainan, Nongnuch; Chuansumrit, Ampaiwan; Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Hematol Oncol,Dept Pediat, Bangkok, Thailand; [Sangiamsuntorn, Khanit] Mahidol Univ, Fac Pharm, Dept Biochem, Bangkok, Thailand; [Borwornpinyo, Suparerk] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand; [Borwornpinyo, Suparerk] Mahidol Univ, Fac Sci, Excellent Ctr Drug Discovery, Bangkok, Thailand; [Tanratana, Pansakorn] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Tanratana, P (corresponding author), Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok, Thailand.	pansakorn.tan@mahidol.ac.th		Hongeng, Suradej/0000-0002-7376-9393; Tanratana, Pansakorn/0000-0002-9434-2719; Borwornpinyo, Suparerk/0000-0001-6211-3615; Sa-ngiamsuntorn, Khanit/0000-0001-7010-345X	Mahidol University; Children Cancer Fund	Mahidol University; Children Cancer Fund	Suradej Hongeng received funding from Mahidol University and Children Cancer Fund under the patronage of HRH Princess Soamsawali.	Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Branchini A, 2012, HAEMATOL-HEMATOL J, V97, P705, DOI 10.3324/haematol.2011.049403; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; de Freitas MCC, 2017, PROTEIN EXPRES PURIF, V137, P26, DOI 10.1016/j.pep.2017.06.012; Deurholt T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-89; Dongiovanni P, 2008, AM J PATHOL, V172, P738, DOI 10.2353/ajpath.2008.070097; Fliedl L, 2015, NEW BIOTECHNOL, V32, P673, DOI 10.1016/j.nbt.2014.11.005; FORTE TM, 1989, J LIPID RES, V30, P817; Freguia CF, 2004, HAEMATOLOGICA, V89, P1504; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; Hariparsad N, 2008, DRUG METAB DISPOS, V36, P1046, DOI 10.1124/dmd.108.020677; Hedner U, 2006, J BIOTECHNOL, V124, P747, DOI 10.1016/j.jbiotec.2006.03.042; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lentz SR, 2014, J THROMB HAEMOST, V12, P1244, DOI 10.1111/jth.12634; Mao J, 2013, J GENET SYNDR GEN S1, DOI [10.4172/2157-7412.S1-014, DOI 10.4172/2157-7412.S1-014]; Marcos-Contreras OA, 2016, BLOOD, V127, P565, DOI 10.1182/blood-2015-09-671420; Meier M, 2007, J ENDOCRINOL, V193, P45, DOI 10.1677/joe.1.07087; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; Napolitano M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6040038; PEDERSEN AH, 1989, BIOCHEMISTRY-US, V28, P9331, DOI 10.1021/bi00450a013; Perry  DJ, 2002, BRIT J HAEMATOL, V118, P689, DOI 10.1046/j.1365-2141.2002.03545.x; Pewkliang Y, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2198-4; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; Reid Y, 2009, IN VITRO CELL DEV-AN, V45, P535, DOI 10.1007/s11626-009-9219-0; Sa-ngiamsuntorn K, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-89; Sakoda T, 2007, PREP BIOCHEM BIOTECH, V37, P1, DOI 10.1080/10826060601039345; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Toso R, 2002, BIOCHEM J, V363, P411, DOI 10.1042/0264-6021:3630411; Tsuruga Y, 2008, CELL TRANSPLANT, V17, P1083, DOI 10.3727/096368908786991542; Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; WILDGOOSE P, 1992, BLOOD, V80, P25; Wongkajornsilp A, 2012, METHODS MOL BIOL, V826, P73, DOI 10.1007/978-1-61779-468-1_7; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Yamamoto Y, 2008, FEBS J, V275, P1260, DOI 10.1111/j.1742-4658.2008.06287.x; Zemel R, 2009, LIVER INT, V29, P1326, DOI 10.1111/j.1478-3231.2009.02054.x	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220825	10.1371/journal.pone.0220825	http://dx.doi.org/10.1371/journal.pone.0220825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381603	Green Published, gold, Green Submitted			2022-12-26	WOS:000484993600037
J	Bruns, DR; Tatman, PD; Kalkur, RS; Brown, RD; Stenmark, KR; Buttrick, PM; Walker, LA				Bruns, Danielle R.; Tatman, Philip D.; Kalkur, Roshni S.; Brown, R. Dale; Stenmark, Kurt R.; Buttrick, Peter M.; Walker, Lori A.			The right ventricular fibroblast secretome drives cardiomyocyte dedifferentiation	PLOS ONE			English	Article							PERIOSTIN EXPRESSION; MYOCARDIAL FIBROSIS; EJECTION FRACTION; CALF MODEL; HEART; EXOSOMES; SURVIVAL; SERUM; PROLIFERATION; CYTOKINES	Rationale In virtually all models of heart failure, prognosis is determined by right ventricular (RV) function; thus, understanding the cellular mechanisms contributing to RV dysfunction is critical. Whole organ remodeling is associated with cell-specific changes, including cardiomyocyte dedifferentiation and activation of cardiac fibroblasts (Cfib) which in turn is linked to disorganization of cytoskeletal proteins and loss of sarcomeric structures. However, how these cellular changes contribute to RV function remains unknown. We've previously shown significant organ-level RV dysfunction in a large animal model of pulmonary hypertension (PH) which was not mirrored by reduced function of isolated cardiomyocytes. We hypothesized that factors produced by the endogenous Cfib contribute to global RV dysfunction by generating a heterogeneous cellular environment populated by dedifferentiated cells. Objective To determine the effect of Cfib conditioned media (CM) from the PH calf (PH-CM) on adult rat ventricular myocytes (ARVM) in culture. Methods and results Brief exposure (<2 days) to PH-CM results in rapid, marked dedifferentiation of ARVM to a neonatal-like phenotype exhibiting spontaneous contractile behavior. Dedifferentiated cells maintain viability for over 30 days with continued expression of cardiomyocyte proteins including TnI and alpha-actinin yet exhibit myofibroblast characteristics including expression of a-smooth muscle actin. Using a bioinformatics approach to identify factor(s) that contribute to dedifferentiation, we found activation of the PH Cfib results in a unique transcriptome correlating with factors both in the secretome and with activated pathways in the dedifferentiated myocyte. Further, we identified upregulation of periostin in the Cfib and CM, and demonstrate that periostin is sufficient to drive cardiomyocyte dedifferentiation. Conclusions These data suggest that paracrine factor(s) released by Cfib from the PH calf signal a phenotypic transformation in a population of cardiomyocytes that likely contributes to RV dysfunction. Therapies targeting this process, such as inhibition of periostin, have the potential to prevent RV dysfunction.	[Bruns, Danielle R.; Tatman, Philip D.; Kalkur, Roshni S.; Buttrick, Peter M.; Walker, Lori A.] Univ Colorado Denver, Dept Med Cardiol, Aurora, CO 80204 USA; [Tatman, Philip D.] Med Scientist Training Program, Aurora, CO USA; [Brown, R. Dale; Stenmark, Kurt R.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Walker, LA (corresponding author), Univ Colorado Denver, Dept Med Cardiol, Aurora, CO 80204 USA.	lori.walker@ucdenver.edu	stenmark, kurt/AAH-3124-2022; stenmark, kurt/AFI-6776-2022; Walker, Lori/J-7098-2013	Walker, Lori/0000-0003-2556-8076	American Heart Association [17POST32720003]; National Institutes of Health [HL014985]; Temple Hoyne Buell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple Hoyne Buell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by American Heart Association 17POST32720003 (DRB), National Institutes of Health HL014985 (KRS) and the Temple Hoyne Buell Foundation (PMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Batlle M, 2009, TRANSPL P, V41, P2231, DOI 10.1016/j.transproceed.2009.06.009; Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Dispersyn GD, 2002, EUR HEART J, V23, P849, DOI 10.1053/euhj.2001.2963; Gillan L, 2002, CANCER RES, V62, P5358; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Guan J, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0084-3; HEGEWISCH S, 1990, LANCET, V335, P294, DOI 10.1016/0140-6736(90)90115-L; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Hunter KS, 2010, J APPL PHYSIOL, V108, P968, DOI 10.1152/japplphysiol.01173.2009; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lemler MS, 2000, AM J PHYSIOL-HEART C, V279, pH1365; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034; Lorts A, 2009, CIRC RES, V104, pE1, DOI 10.1161/CIRCRESAHA.108.188649; Malik ZA, 2013, AM J PHYSIOL-HEART C, V304, pH954, DOI 10.1152/ajpheart.00835.2012; Neuss M, 1996, CELL TISSUE RES, V286, P145, DOI 10.1007/s004410050683; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Port JD, 2011, PHYSIOL GENOMICS, V43, P1087, DOI 10.1152/physiolgenomics.00074.2011; Roche PL, 2015, COMPR PHYSIOL, V5, P721, DOI 10.1002/cphy.c140044; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Rucker-Martin C, 2002, CARDIOVASC RES, V55, P38, DOI 10.1016/S0008-6363(02)00338-3; Sakata Y, 2008, BASIC RES CARDIOL, V103, P60, DOI 10.1007/s00395-007-0689-5; Schwanekamp JA, 2016, ARTERIOSCL THROM VAS, V36, P60, DOI 10.1161/ATVBAHA.115.306397; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; SOLTIS RD, 1979, IMMUNOLOGY, V36, P37; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; STENMARK K R, 1988, Chest, V93, p127S, DOI 10.1378/chest.93.3.127S; Stumpf C, 2003, CLIN SCI, V105, P45, DOI 10.1042/CS20020359; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; Taniyama Y, 2016, HYPERTENSION, V67, P356, DOI 10.1161/HYPERTENSIONAHA.115.06265; VOLZ A, 1991, J MOL CELL CARDIOL, V23, P161, DOI 10.1016/0022-2828(91)90103-S; Walker LA, 2011, AM J PHYSIOL-HEART C, V301, pH832, DOI 10.1152/ajpheart.00249.2011; Weber KT, 2016, AM J MED SCI, V352, P428, DOI 10.1016/j.amjms.2016.05.026; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Wu H, 2016, MOL MED REP, V14, P776, DOI 10.3892/mmr.2016.5308; Xu JY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00494; York M, 2011, CURR OPIN RHEUMATOL, V23, P536, DOI 10.1097/BOR.0b013e32834ba6a7; Zhao S, 2014, J CARDIOL, V63, P373, DOI 10.1016/j.jjcc.2013.09.013; Zhong JY, 2014, LAB INVEST, V94, P633, DOI 10.1038/labinvest.2014.51; ZUCKERMAN BD, 1991, J APPL PHYSIOL, V70, P859, DOI 10.1152/jappl.1991.70.2.859; ZUCKERMAN BD, 1992, J APPL PHYSIOL, V72, P2118, DOI 10.1152/jappl.1992.72.6.2118	45	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220573	10.1371/journal.pone.0220573	http://dx.doi.org/10.1371/journal.pone.0220573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374110	gold, Green Published, Green Submitted			2022-12-26	WOS:000484991500021
J	Hsu, YC; Yang, HY; Huang, WT; Chen, SCC; Lee, HS				Hsu, Yung-Chu; Yang, Hsin-Yi; Huang, Wan-Ting; Chen, Solomon Chih-Cheng; Lee, Herng-Sheng			Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study	PLOS ONE			English	Article							DOPAMINE NEURONS; ASSOCIATION; PREVALENCE; EPIDEMIOLOGY; SEROTONIN; MOVEMENTS; ADULTS	Previous research has suggested an association between antidepressants use and clinical restless legs syndrome (RLS) in patients, but there has never been a single study investigating the risk of RLS in irritable bowel syndrome (IBS) patients treated with antidepressants. Hence, we aimed to explore the association between IBS and RLS and to examine the risk of RLS in IBS patients treated with antidepressants. With the use of the National Health Insurance Research Database of Taiwan, 27,437 adults aged. 20 years with newly diagnosed IBS (ICD-9-CM Code 564.1) and gender-and age-matched 54,874 controls without IBS were enrolled between 2000 and 2012. All patients were followed-up until RLS diagnosis, withdrawal from the National Health Insurance program, or end of 2013. We used the Cox proportional hazards model to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) of RLS. RLS was more prevalent in IBS patients than in the non-IBS group (7.57 versus 3.36 per 10,000 person-years), with an increased risk of RLS (adjusted HR [aHR], 1.91; 95% CI, 1.52-2.40). Multivariate Cox proportional hazards analysis identified older age (age, 51-65 years; aHR, 1.67; 95% CI, 1.09-2.56; and age > 65; aHR, 1.59; 95% CI, 1.02-2.48), hypothyroidism (aHR, 4.24; 95% CI, 1.92-9.37), CAD (aHR, 1.70; 95% CI, 1.17-2.48), and depression (aHR, 3.15; 95% CI, 2.14-4.64) as independent RLS risk factors in IBS patients. In addition, the male SSRIs users were associated with significantly higher risk of RLS (aHR, 3.05 95% CI, 1.34-6.92). Our study showed that the IBS group has higher risk of RLS. Moreover, SSRIs use may increase the risk of RLS in male IBS patients.	[Hsu, Yung-Chu] Chia Yi Christian Hosp, Dept Internal Med, Div Neurol, Ditmanson Med Fdn, Chiayi, Taiwan; [Yang, Hsin-Yi; Huang, Wan-Ting] Chia Yi Christian Hosp, Clin Med Res Ctr, Ditmanson Med Fdn, Chiayi, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Chen, Solomon Chih-Cheng] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Pediat, Kaohsiung, Taiwan; [Lee, Herng-Sheng] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan	Taipei Medical University; Kaohsiung Medical University; Kaohsiung Veterans General Hospital	Yang, HY (corresponding author), Chia Yi Christian Hosp, Clin Med Res Ctr, Ditmanson Med Fdn, Chiayi, Taiwan.; Lee, HS (corresponding author), Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan.	cych13018@gmail.com; herngsheng131419@gmail.com		Yang, Hsin-Yi/0000-0002-8571-5202				Acar BA, 2018, SINGAP MED J, V59, P539, DOI 10.11622/smedj.2018010; Acay A, 2016, WIEN KLIN WOCHENSCHR, V128, pS604, DOI 10.1007/s00508-016-1065-y; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Basu PP, 2011, WORLD J GASTROENTERO, V17, P4404, DOI 10.3748/wjg.v17.i39.4404; Baughman KR, 2009, MOVEMENT DISORD, V24, P1054, DOI 10.1002/mds.22517; Borji R, 2012, J NEUROGASTROENTEROL, V18, P426, DOI 10.5056/jnm.2012.18.4.426; Brown LK, 2005, SLEEP MED, V6, P443, DOI 10.1016/j.sleep.2005.03.005; Chen BR, 2018, J GASTROENTEROL, V53, P807, DOI 10.1007/s00535-018-1476-9; Chen Longtu, 2017, Anesth Pain Med, V7, pe42747, DOI 10.5812/aapm.42747; Clouse RE, 2003, GUT, V52, P598, DOI 10.1136/gut.52.4.598; Connor JR, 2011, BRAIN, V134, P959, DOI 10.1093/brain/awr012; Cozma-Petrut A, 2017, WORLD J GASTROENTERO, V23, P3771, DOI 10.3748/wjg.v23.i21.3771; Cui X, 2013, NEUROSCIENCE, V236, P77, DOI 10.1016/j.neuroscience.2013.01.035; Dhawan V, 2006, POSTGRAD MED J, V82, P626, DOI 10.1136/pgmj.2006.045690; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Ford AC, 2009, GUT, V58, P367, DOI 10.1136/gut.2008.163162; Ford AC, 2017, NEW ENGL J MED, V376, P2566, DOI 10.1056/NEJMra1607547; Guo SY, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00171; Hsiao CW, 2014, EUR J INTERN MED, V25, P82, DOI 10.1016/j.ejim.2013.11.005; Khan FH, 2017, J NEUROL, V264, P1634, DOI 10.1007/s00415-017-8431-1; Khayyat Yasir, 2015, Oman Med J, V30, P115, DOI 10.5001/omj.2015.25; Kolla BP, 2018, SLEEP MED REV, V38, P131, DOI 10.1016/j.smrv.2017.06.002; Lai SW, 2014, EUR J EPIDEMIOL, V29, P57, DOI [10.1007/s10654-014-9878-3, 10.1007/s10654-014-9903-6]; Lee HB, 2008, J NEUROPSYCH CLIN N, V20, P101, DOI 10.1176/jnp.2008.20.1.101; Leutgeb U, 2002, EUR J MED RES, V7, P368; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; McKenzie YA, 2016, J HUM NUTR DIET, V29, P549, DOI 10.1111/jhn.12385; Nellesen D, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.03.2640; Norgaard M, 2011, BRIT J CANCER, V104, P1202, DOI 10.1038/bjc.2011.65; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Patatanian E, 2018, ANN PHARMACOTHER, V52, P662, DOI 10.1177/1060028018760296; Pimentel M, 2004, ANN RHEUM DIS, V63, P450, DOI 10.1136/ard.2003.011502; Rothdach AJ, 2000, NEUROLOGY, V54, P1064, DOI 10.1212/WNL.54.5.1064; Rottach KG, 2008, J PSYCHIATR RES, V43, P70, DOI 10.1016/j.jpsychires.2008.02.006; Schlesinger I, 2009, MOVEMENT DISORD, V24, P1587, DOI 10.1002/mds.22486; Sramek JJ, 2016, DIALOGUES CLIN NEURO, V18, P447; Szentkiralyi A, 2011, SLEEP MED, V12, P815, DOI 10.1016/j.sleep.2011.06.016; Tan EK, 2004, PARKINSONISM RELAT D, V10, P149, DOI 10.1016/j.parkreldis.2003.11.003; Tasdemir M, 2010, SLEEP MED, V11, P82, DOI 10.1016/j.sleep.2008.10.008; Trenkwalder C, 2016, NEUROLOGY, V86, P1336, DOI 10.1212/WNL.0000000000002542; Trotti LM, 2012, BRAIN BEHAV IMMUN, V26, P1239, DOI 10.1016/j.bbi.2012.06.003; Varim C, 2016, SINGAP MED J, V57, P514, DOI 10.11622/smedj.2016154; Weinstock LB, 2008, DIGEST DIS SCI, V53, P1252, DOI 10.1007/s10620-007-0021-0; Weinstock LB, 2012, SLEEP MED REV, V16, P341, DOI 10.1016/j.smrv.2011.09.003; Weinstock LB, 2011, SLEEP MED, V12, P610, DOI 10.1016/j.sleep.2011.03.007; Weinstock LB, 2010, SLEEP MED, V11, P427, DOI 10.1016/j.sleep.2009.06.005; Winkelmann J, 2017, SLEEP MED, V31, P18, DOI 10.1016/j.sleep.2016.10.012; Xie C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127815; Yang FC, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002646; Yang FC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002109; Yun CH, 2012, J SLEEP RES, V21, P569, DOI 10.1111/j.1365-2869.2012.01011.x; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9; Zhou FM, 2005, NEURON, V46, P65, DOI 10.1016/j.neuron.2005.02.010	55	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220641	10.1371/journal.pone.0220641	http://dx.doi.org/10.1371/journal.pone.0220641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369638	gold, Green Submitted, Green Published			2022-12-26	WOS:000484987900074
J	Lee, JG; Kim, SA; Eun, CS; Han, DS; Kim, YS; Choi, BY; Song, KS; Kim, HJ; Park, CH				Lee, Jae Gon; Kim, Shin Ah; Eun, Chang Soo; Han, Dong Soo; Kim, Young Sung; Choi, Bo Youl; Song, Kyu Sang; Kim, Hyun Ja; Park, Chan Hyuk			Impact of age on stage-specific mortality in patients with gastric cancer: A long-term prospective cohort study	PLOS ONE			English	Article							CLINICOPATHOLOGICAL CHARACTERISTICS; PROGNOSIS; SURVIVAL; YOUNG; OUTCOMES; MUCOSA; SCORE	Controversies exist regarding the impact of age on gastric cancer-related mortality according to cancer stage. In our prospective cohort study, we evaluated the impact of age on stage-specific mortality in patients with gastric cancer. Between 2002 and 2006, patients with newly diagnosed gastric cancer were recruited from two university-affiliated hospitals in Korea. Follow-up data were updated regularly based on medical records and telephone surveys. Patients were classified into four subgroups according to age: < 50, 50-59, 60-69, and 70-79 years. A total of 448 patients were followed up for 81.6 months (interquartile range, 25.0-139.3 months). The number of patients with stage I, II, III, and IV disease was 247, 74, 88, and 39, respectively. Overall, age was an independent risk factor for gastric cancer-specific mortality (hazard ratio [HR], [95% confidence interval (CI)]: 1.53 [0.91-2.57], 1.88 [1.21-2.91], and 2.64 [1.69-4.14] in the 50-59, 60-69, and 70-79 years groups, respectively, with the < 50 years group as reference). In patients with stage I and II gastric cancer, the 70-79 years group was associated with a significantly higher rate of cancer-specific mortality than the < 50 years group (stage I: HR [95% CI], 9.55 [2.11-43.12]; stage II: HR [95% CI], 7.17 [2.32-22.18]). However, age was not an independently associated factor for cancer-specific mortality in patients with stage III and IV gastric cancer. Although age was an independent risk factor for gastric cancer-related mortality in patients with gastric cancer, its impact may differ depending on the stage of cancer.	[Lee, Jae Gon; Eun, Chang Soo; Han, Dong Soo; Park, Chan Hyuk] Hanyang Univ, Coll Med, Dept Internal Med, Guri Hosp, Guri, Peoples R China; [Kim, Shin Ah; Kim, Hyun Ja] Gangneung Wonju Natl Univ, Dept Food & Nutr, Kangnung, South Korea; [Kim, Young Sung] KRIBB, Genome Editing Res Ctr, Daejeon, South Korea; [Kim, Young Sung] UST, Korea & Dept Funct Genom, Daejeon, South Korea; [Choi, Bo Youl] Hanyang Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Coll Med, Dept Pathol, Daejeon, South Korea	Hanyang University; Kangnung Wonju National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Hanyang University; Chungnam National University	Park, CH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Guri Hosp, Guri, Peoples R China.; Kim, HJ (corresponding author), Gangneung Wonju Natl Univ, Dept Food & Nutr, Kangnung, South Korea.	wisekim@gwnu.ac.kr; yesable7@gmail.com	Han, Dong Soo/P-1753-2015; Park, Chan Hyuk/I-1794-2016; Lee, Jae Gon/AAE-7558-2022; Han, Dong Soo/AHD-6285-2022	Park, Chan Hyuk/0000-0003-3824-3481; Han, Dong Soo/0000-0001-7103-3318	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A3B03032996]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: 2017R1D1A3B03032996, grant receiver: HJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2016, J SURG RES, V202, P428, DOI 10.1016/j.jss.2016.02.043; American Joint Committee on Cancer, DESK REF; Ariake K, 2014, J SURG ONCOL, V109, P586, DOI 10.1002/jso.23542; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujiwara Y, 2017, WORLD J GASTRO ONCOL, V9, P257, DOI 10.4251/wjgo.v9.i6.257; Hamilton SR, 2000, WHO CLASSIFICATION T; Isobe T, 2013, ONCOL REP, V30, P43, DOI 10.3892/or.2013.2467; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Kim KH, 2014, WORLD J GASTROENTERO, V20, P3369, DOI 10.3748/wjg.v20.i12.3369; Kubota T, 2014, ANN SURG ONCOL, V21, P891, DOI 10.1245/s10434-013-3384-9; Lai JF, 2008, ANN SURG ONCOL, V15, P1464, DOI 10.1245/s10434-008-9809-1; Levi Edi, 2014, World J Gastrointest Pathophysiol, V5, P366, DOI 10.4291/wjgp.v5.i3.366; Llanos O, 2006, WORLD J SURG, V30, P17, DOI 10.1007/s00268-005-7935-5; Nakamura R, 2011, INT J CLIN ONCOL, V16, P328, DOI 10.1007/s10147-011-0185-7; Nashimoto A, 2013, INT J CLIN ONCOL, V18, P969, DOI 10.1007/s10147-012-0498-1; Nelen SD, 2018, BRIT J SURG, V105, P1163, DOI 10.1002/bjs.10836; Orsenigo E, 2007, GASTRIC CANCER, V10, P39, DOI 10.1007/s10120-006-0409-0; Schlesinger-Raab A, 2017, VISC MED, V33, P245, DOI 10.1159/000477104; Schwarz RE, 2007, ANN SURG ONCOL, V14, P317, DOI 10.1245/s10434-006-9218-2; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Song P, 2016, ONCOTARGET, V7, P48614, DOI 10.18632/oncotarget.9548; Sonnenberg A, 2015, CLIN GASTROENTEROL H, V13, P2276, DOI 10.1016/j.cgh.2015.02.020; Tarnawski AS, 2014, J GASTROEN HEPATOL, V29, P112, DOI 10.1111/jgh.12734; Tavares A, 2013, PATHOL ONCOL RES, V19, P111, DOI 10.1007/s12253-012-9530-z; Wagner AD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub4	26	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220660	10.1371/journal.pone.0220660	http://dx.doi.org/10.1371/journal.pone.0220660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369631	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900077
J	Urrutia, I; Martinez, R; Rica, I; de LaPiscina, IM; Garcia-Castano, A; Aguayo, A; Calvo, B; Castano, L; Fernandez-Ramos, C; Nunez, J; Casanovas-Marsal, JO; Grau, G; Rodriguez-Estevez, A; Vela, A; Velasco-Vielba, O; Ferrer, M; Lou, GM; Barrio, R; Garcia-Cuartero, B; Martin-Frias, M; Gonzalez, A; Caimari, M; de Sotto, D; Campos, A; Clemente, M; Gomez-Gila, AL				Urrutia, Ines; Martinez, Rosa; Rica, Itxaso; Martinez de LaPiscina, Idoia; Garcia-Castano, Alejandro; Aguayo, Anibal; Calvo, Begona; Castano, Luis; Fernandez-Ramos, Concepcion; Nunez, Javier; Oriol Casanovas-Marsal, J.; Grau, Gema; Rodriguez-Estevez, Amaia; Vela, Amaia; Velasco-Vielba, Olaia; Ferrer, Marta; Lou, Gracia M.; Barrio, Raquel; Garcia-Cuartero, Beatriz; Martin-Frias, Maria; Gonzalez, Amparo; Caimari, Maria; de Sotto, Diego; Campos, Ariadna; Clemente, Maria; Gomez-Gila, Ana L.		Spanish Pediat Diabet Collaborativ	Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes?	PLOS ONE			English	Article							INSULIN GENE-MUTATIONS; RARE VARIANTS; YOUNG MODY; ONSET; CHILDREN; MELLITUS; ADOLESCENTS; AUTOANTIBODIES; DIAGNOSIS; AGE	Objective Monogenic diabetes can be misdiagnosed as type 1 or type 2 diabetes in children. The right diagnosis is crucial for both therapeutic choice and prognosis and influences genetic counseling. The main objective of this study was to search for monogenic diabetes in Spanish pediatric patients suspected of type 1 diabetes with lack of autoimmunity at the onset of the disease. We also evaluated the extra value of ZnT8A in addition to the classical IAA, GADA and IA2A autoantibodies to improve the accuracy of type 1 diabetes diagnosis. Methods Four hundred Spanish pediatric patients with recent-onset diabetes (mean age 8.9 +/- 3.9 years) were analyzed for IAA, GADA, IA2A and ZnT8A pancreatic-autoantibodies and HLA-DRB1 alleles. Patients without autoimmunity and those with only ZnT8A positive were screened for 12 monogenic diabetes genes by next generation sequencing. Results ZnT8A testing increased the number of autoantibody-positive patients from 373 (93.3%) to 377 (94.3%). An isolated positivity for ZnT8A allowed diagnosing autoimmune diabetes in 14.8% (4/27) of pediatric patients negative for the rest of the antibodies tested. At least 2 of the 23 patients with no detectable autoimmunity (8%) carried heterozygous pathogenic variants: one previously reported missense variant in the INS gene (p.Gly32Ser) and one novel frameshift variant (p.Val264fs) in the HNF1A gene. One variant of uncertain significance was also found. Carriers of pathogenic variants had HLA-DRB1 risk alleles for autoimmune diabetes and clinical characteristics compatible with type 1 diabetes except for the absence of autoimmunity. Conclusion ZnT8A determination improves the diagnosis of autoimmune diabetes in pediatrics. At least 8% of pediatric patients suspected of type 1 diabetes and with undetectable autoimmunity have monogenic diabetes and can benefit from the correct diagnosis of the disease by genetic study.	[Urrutia, Ines; Martinez, Rosa; Rica, Itxaso; Martinez de LaPiscina, Idoia; Garcia-Castano, Alejandro; Aguayo, Anibal; Calvo, Begona; Castano, Luis] Univ Basque Country, Biocruces Bizkaia Hlth Res Inst, Cruces Univ Hosp, Bizkaia, Spain; [Urrutia, Ines; Martinez, Rosa; Rica, Itxaso; Martinez de LaPiscina, Idoia; Garcia-Castano, Alejandro; Aguayo, Anibal; Castano, Luis] Inst Salud Carlos III, CIBERER, CIBERDEM, Madrid, Spain; [Rica, Itxaso] Cruces Univ Hosp, Pediat Endocrinol Serv, Osakidetza, Bizkaia, Spain; [Fernandez-Ramos, Concepcion; Nunez, Javier] Hosp Univ Basurto, Bizkaia, Spain; [Oriol Casanovas-Marsal, J.; Grau, Gema; Rodriguez-Estevez, Amaia; Vela, Amaia; Velasco-Vielba, Olaia] Hosp Univ Cruces, Bizkaia, Spain; [Ferrer, Marta; Lou, Gracia M.] Hosp Univ Miguel Servet, Zaragoza, Spain; [Barrio, Raquel; Garcia-Cuartero, Beatriz; Martin-Frias, Maria] Hosp Univ Ramon y Cajal, Madrid, Spain; [Gonzalez, Amparo] Hosp Univ Severo Ochoa, Madrid, Spain; [Caimari, Maria; de Sotto, Diego] Hosp Univ Son Espases, Palma De Mallorca, Spain; [Campos, Ariadna; Clemente, Maria] Hosp Univ Vall dHebron, Barcelona, Spain; [Gomez-Gila, Ana L.] Hosp Univ Virgen del Rocio, Seville, Spain	Hospital Universitario Cruces; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBERER; Instituto de Salud Carlos III; Hospital Universitario Cruces; Basurto Hospital; Hospital Universitario Cruces; Miguel Servet University Hospital; Hospital Universitario Ramon y Cajal; Severo Ochoa University Hospital; Hospital Universitari Son Espases; Hospital Universitari Vall d'Hebron; Virgen del Rocio University Hospital	Castano, L (corresponding author), Univ Basque Country, Biocruces Bizkaia Hlth Res Inst, Cruces Univ Hosp, Bizkaia, Spain.; Castano, L (corresponding author), Inst Salud Carlos III, CIBERER, CIBERDEM, Madrid, Spain.	lcastano@osakidetza.eus	de LaPiscina, Idoia Martinez/AAB-6067-2019	de LaPiscina, Idoia Martinez/0000-0001-8943-1429; Martinez, Rosa/0000-0003-3800-531X; Castano, Luis/0000-0003-0437-9401; Urrutia, Ines Maria/0000-0001-5386-8776	Menarini Group Spain [BCA/16/030]; University of the Basque Country, UPV/EHU [IT795-13]; Department of Health of the Basque Government [GV2016111035]; ISCIII [PI14/01104]; FEDER (European Funds for Regional Development)	Menarini Group Spain(Menarini Group); University of the Basque Country, UPV/EHU; Department of Health of the Basque Government; ISCIII(Instituto de Salud Carlos III); FEDER (European Funds for Regional Development)(European Commission)	This work was partially supported by grants from Menarini Group Spain (BCA/16/030), University of the Basque Country, UPV/EHU (IT795-13), Department of Health of the Basque Government (GV2016111035) and ISCIII (PI14/01104) integrated into the National R&D&I Plan 2013-2016 and co-financed by FEDER (European Funds for Regional Development). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2013, J PEDIATR ENDOCR MET, V26, P25, DOI 10.1515/jpem-2012-0200; Amed S, 2016, CAN J DIABETES, V40, P449, DOI 10.1016/j.jcjd.2016.03.002; Andersson C, 2014, PEDIATR DIABETES, V15, P336, DOI 10.1111/pedi.12093; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bellanne-Chantelot C, 2005, DIABETES, V54, P3126, DOI 10.2337/diabetes.54.11.3126; Bilbao JR, 2000, HORM RES, V54, P181, DOI 10.1159/000053256; Bonfanti R, 2009, DIABETES CARE, V32, P123, DOI 10.2337/dc08-0783; Brahm AJ, 2016, CAN J DIABETES, V40, P555, DOI 10.1016/j.jcjd.2016.05.010; Bravis V, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020904; Chambers C, 2016, PEDIATR DIABETES, V17, P360, DOI 10.1111/pedi.12289; Chevre JC, 1998, DIABETOLOGIA, V41, P1017, DOI 10.1007/s001250051025; Colclough K, 2013, HUM MUTAT, V34, P669, DOI 10.1002/humu.22279; Dopazo J, 2016, MOL BIOL EVOL, V33, P1205, DOI 10.1093/molbev/msw005; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Faguer S, 2011, KIDNEY INT, V80, P768, DOI 10.1038/ki.2011.225; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Gandica RG, 2015, PEDIATR DIABETES, V16, P227, DOI 10.1111/pedi.12150; Heneberg P, 2019, J DIABETES COMPLICAT, V33, P46, DOI 10.1016/j.jdiacomp.2018.10.004; Johansson BB, 2017, DIABETOLOGIA, V60, P625, DOI 10.1007/s00125-016-4167-1; Johnson SR, 2019, PEDIATR DIABETES, V20, P57, DOI 10.1111/pedi.12766; Karges B, 2007, DIABETES CARE, V30, P1613, DOI 10.2337/dc06-2618; Leighton E, 2017, DIABETES THER, V8, P475, DOI 10.1007/s13300-017-0265-4; Madariaga L, 2013, CLIN J AM SOC NEPHRO, V8, P1179, DOI 10.2215/CJN.10221012; Massa O, 2013, J PROTEOMICS, V82, P263, DOI 10.1016/j.jprot.2013.02.030; Mayer-Davis EJ, 2018, PEDIATR DIABETES, V19, P7, DOI 10.1111/pedi.12773; McDonald TJ, 2011, DIABETIC MED, V28, P1028, DOI 10.1111/j.1464-5491.2011.03287.x; Najmi LA, 2017, DIABETES, V66, P335, DOI 10.2337/db16-0460; Nicolaou N, 2016, KIDNEY INT, V89, P476, DOI 10.1038/ki.2015.319; Niechcial E, 2018, ACTA DIABETOL, V55, P287, DOI 10.1007/s00592-017-1091-x; Ostman J, 2000, DIABETIC MED, V17, P269, DOI 10.1046/j.1464-5491.2000.00265.x; Patel KA, 2019, DIABETES CARE, V42, pE16, DOI 10.2337/dc18-0373; Rajan S, 2010, AM J PHYSIOL-ENDOC M, V298, pE403, DOI 10.1152/ajpendo.00592.2009; Reinehr T, 2013, WORLD J DIABETES, V4, P270, DOI 10.4239/wjd.v4.i6.270; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rubio-Cabezas O, 2009, DIABETIC MED, V26, P1070, DOI 10.1111/j.1464-5491.2009.02812.x; Sanchez Gonzalez E, 2011, An Pediatr (Barc), V74, DOI 10.1016/j.anpedi.2010.10.005; Schober E, 2009, DIABETIC MED, V26, P466, DOI 10.1111/j.1464-5491.2009.02720.x; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Urbanova J, 2014, DIABETIC MED, V31, P466, DOI 10.1111/dme.12314; Ushijima K, 2018, PEDIATR DIABETES, V19, P243, DOI 10.1111/pedi.12544; Vaxillaire M, 2016, J DIABETES, V8, P782, DOI 10.1111/1753-0407.12446; Verkauskiene R, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0145-3; Vicinanza A, 2019, PEDIATR DIABETES, V20, P584, DOI 10.1111/pedi.12864; Wang J, 2007, J CLIN ENDOCR METAB, V92, P88, DOI 10.1210/jc.2006-1494; Wasserman H, 2016, PEDIATR DIABETES, V17, P535, DOI 10.1111/pedi.12335; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Winter WE, 2011, CLIN CHEM, V57, P168, DOI 10.1373/clinchem.2010.148205; Wolfsdorf JI, 2018, PEDIATR DIABETES, V19, P155, DOI 10.1111/pedi.12701; Zimmermann MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170822	51	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220634	10.1371/journal.pone.0220634	http://dx.doi.org/10.1371/journal.pone.0220634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365591	Green Published, Green Submitted, gold			2022-12-26	WOS:000484983600060
J	Yang, WT; Zhao, ZX; Li, B; Zheng, PS				Yang, Wen-Ting; Zhao, Zong-Xia; Li, Bin; Zheng, Peng-Sheng			NF-YA transcriptionally activates the expression of SOX2 in cervical cancer stem cells	PLOS ONE			English	Article							SELF-RENEWAL; CARCINOMA; GROWTH	Roles for SOX2 have been extensively studied in several types of cancer, including colorectal cancer, glioblastoma and breast cancer, with particular emphasis placed on the roles of SOX2 in cancer stem cell. Our previous study identified SOX2 as a marker in cervical cancer stem cells driven by a full promoter element of SOX2 EGFP reporter. Here, dual-luciferase reporter and mutagenesis analyses were employed, identifying key cis-elements in the SOX2 promoter, including binding sites for SOX2, OCT4 and NF-YA factors in SOX2 promoter. Mutagenesis analysis provided additional evidence to show that one high affinitybinding domain CCAAT box was precisely recognized and bound by the transcription factor NF-YA. Furthermore, overexpression of NF-YA in primitive cervical cancer cells SiHa and C33A significantly activated the transcription and the protein expression of SOX2. Collectively, our data identified NF-YA box CCAAT as a key cis-element in the SOX2 promoter, suggesting that NF-YA is a potent cellular regulator in the maintenance of SOX2-positive cervical cancer stem cell by specific transcriptional activation of SOX2.	[Yang, Wen-Ting; Zhao, Zong-Xia; Li, Bin; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Zheng, Peng-Sheng] Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Ministry of Education, China	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.; Zheng, PS (corresponding author), Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China.	zpsheng@mail.xjtu.edu.cn			Natural Science in Shaanxi Province [2018JM7126114]; National Natural Science Foundation of China [81302278]	Natural Science in Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant to Dr. Wen-Ting Yang from Basic Research Program of Natural Science in Shaanxi Province (2018JM7126114) and the National Natural Science Foundation of China (No. 81302278).	Alqahtani H, 2016, CELL SIGNAL, V28, P42, DOI 10.1016/j.cellsig.2015.11.004; Bareiss PM, 2013, CANCER RES, V73, P5544, DOI 10.1158/0008-5472.CAN-12-4177; Bautch VL, 2010, NATURE, V468, P770, DOI 10.1038/468770a; Beier Christoph P, 2011, Front Biosci (Elite Ed), V3, P701, DOI 10.2741/e280; Bora-Singhal N, 2015, NEOPLASIA, V17, P538, DOI 10.1016/j.neo.2015.07.001; Bulstrode H, 2017, GENE DEV, V31, P757, DOI 10.1101/gad.293027.116; Bungartz G, 2012, BLOOD, V119, P1380, DOI 10.1182/blood-2011-06-359406; Chhabra R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26292-w; Dai C, 2015, J BIOL CHEM, V290, P22423, DOI 10.1074/jbc.M115.642710; Greten FR, 2017, NATURE, V543, P626, DOI 10.1038/543626a; Gurtner A, 2017, BBA-GENE REGUL MECH, V1860, P604, DOI 10.1016/j.bbagrm.2016.12.005; Kashii-Magaribuchi K, 2016, ACTA HISTOCHEM CYTOC, V49, P149, DOI 10.1267/ahc.16031; Kassem Neemat M, 2008, J Egypt Natl Canc Inst, V20, P209; Lee YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121207; Liu XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087092; Moeinvaziri F, 2015, IUBMB LIFE, V67, P880, DOI 10.1002/iub.1443; Mojsin M, 2015, BIOCHEMISTRY-MOSCOW+, V80, P202, DOI 10.1134/S0006297915020066; Oliveira CS, 2012, REPROD DOMEST ANIM, V47, P428, DOI 10.1111/j.1439-0531.2011.01896.x; Petrovic I, 2009, MOL BIOL REP, V36, P993, DOI 10.1007/s11033-008-9272-x; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Serra E, 1998, NUCLEIC ACIDS RES, V26, P3800, DOI 10.1093/nar/26.16.3800; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Stewart CJR, 2016, INT J GYNECOL PATHOL, V35, P566, DOI 10.1097/PGP.0000000000000273; Taniguchi J, 2017, NUCLEIC ACIDS RES, V45, P9219, DOI 10.1093/nar/gkx693; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tyagi A, 2016, CLIN CANCER RES, V22, P4170, DOI 10.1158/1078-0432.CCR-15-2574; Wen YP, 2017, CANCER SCI, V108, P719, DOI 10.1111/cas.13186; Zhang HT, 2014, BBA-GENE REGUL MECH, V1839, P1330, DOI 10.1016/j.bbagrm.2014.09.015; Zhang XY, 2019, J CELL PHYSIOL, V234, P6758, DOI 10.1002/jcp.27423	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0215494	10.1371/journal.pone.0215494	http://dx.doi.org/10.1371/journal.pone.0215494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365524	Green Submitted, gold, Green Published			2022-12-26	WOS:000484983600001
J	Older, CE; Diesel, AB; Lawhon, SD; Queiroz, CRR; Henker, LC; Hoffmann, AR				Older, Caitlin E.; Diesel, Alison B.; Lawhon, Sara D.; Queiroz, Cintia R. R.; Henker, Luan C.; Hoffmann, Aline Rodrigues			The feline cutaneous and oral microbiota are influenced by breed and environment	PLOS ONE			English	Article							MALASSEZIA SPP. YEASTS; DEVON REX; SKIN MICROBIOME; BACTERIAL; HEALTHY; CATS; DIVERSITY; CARRIAGE; FUNGAL; IDENTIFICATION	Previous research revealed the feline skin bacterial microbiota to be site-specific and the fungal microbiota to be individual-specific. The effect of other factors, such as genotype and environment, have not yet been studied in cats, but have been shown to be potentially important in shaping the cutaneous microbiota of other animals. Therefore, the objectives of this study were to evaluate the effect of these factors on the bacterial and fungal microbiota of feline skin and oral cavity. The influence of genotype was assessed through the analysis of different cat breeds, and the influence of environment through comparison of indoor and outdoor cats. DNA was extracted from skin and oral swabs, and bacterial and fungal next-generation sequencing were performed. Analysis of the skin microbiota of different cat breeds revealed significant differences in alpha diversity, with Sphynx and Bengal cats having the most diverse communities. Many taxa were found to be differentially abundant between cat breeds, including Veillonellaceae and Malassezia spp. Outdoor environment exposure had considerable influence on beta diversity, especially in the oral cavity, and resulted in numerous differentially abundant taxa. Our findings indicate that the oral bacterial microbiota and both fungal and bacterial microbiota of feline skin are influenced by breed, and to a lesser degree, environment.	[Older, Caitlin E.; Lawhon, Sara D.; Queiroz, Cintia R. R.; Henker, Luan C.; Hoffmann, Aline Rodrigues] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Diesel, Alison B.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Hoffmann, AR (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.	arodrigues@cvm.tamu.edu	Older, Caitlin E./ABH-7775-2020; Lawhon, Sara D./G-5147-2011; Henker, Luan Cleber/ABC-2083-2020	Older, Caitlin E./0000-0001-7007-5815; Lawhon, Sara D./0000-0001-9154-8909; Henker, Luan Cleber/0000-0001-6556-2010				Adler CJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0169-y; Ahman S, 2007, MED MYCOL, V45, P449, DOI 10.1080/13693780701377170; Bauer R, 2001, MYCOTA COMPREHENSI B, V7B; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bond R, 2008, VET DERMATOL, V19, P299, DOI 10.1111/j.1365-3164.2008.00695.x; Byrd AL, 2018, NAT REV MICROBIOL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castelino M, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0927-4; Cheng YY, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0143-0; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cusco A, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0355-6; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Dolieslager SMJ, 2011, VET MICROBIOL, V148, P93, DOI 10.1016/j.vetmic.2010.08.002; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Elliott DR, 2005, J CLIN MICROBIOL, V43, P5470, DOI 10.1128/JCM.43.11.5470-5476.2005; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Gandolfi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067105; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Gao Z, 2010, J CLIN MICROBIOL, V48, P3575, DOI 10.1128/JCM.00597-10; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Harris S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136986; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; KROGH HV, 1976, NORD VET MED, V28, P459; Lai PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180969; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lemieux-Labonte V, 2016, PEERJ, V4, DOI 10.7717/peerj.2430; Lewis D. T., 1991, Veterinary Dermatology, V2, P53, DOI 10.1111/j.1365-3164.1991.tb00111.x; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; LOVE DN, 1979, J MED MICROBIOL, V12, P207, DOI 10.1099/00222615-12-2-207; LOVE DN, 1990, VET MICROBIOL, V22, P267, DOI 10.1016/0378-1135(90)90114-B; LOVE DN, 1989, VET MICROBIOL, V19, P275, DOI 10.1016/0378-1135(89)90073-4; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ma J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-257; MALLONEE DH, 1988, ARCH ORAL BIOL, V33, P677, DOI 10.1016/0003-9969(88)90123-9; Marchandin H., 2014, PROKARYOTES, P433, DOI DOI 10.1007/978-3-642-30120-9_361; Marchandin H, 2010, INT J SYST EVOL MICR, V60, P1271, DOI 10.1099/ijs.0.013102-0; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Meason-Smith C, 2017, VET DERMATOL, V28, P71, DOI 10.1111/vde.12373; Meason-Smith C, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv139; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Misic AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0052-7; O'Mahony R, 2005, VET MICROBIOL, V109, P285, DOI 10.1016/j.vetmic.2005.06.003; Oh C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131468; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Older CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178555; Pierezan F, 2016, VET DERMATOL, V27, P332, DOI 10.1111/vde.12366; Rodrigues Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083197; Ross AA, 2018, P NATL ACAD SCI USA, V115, pE5786, DOI 10.1073/pnas.1801302115; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schinasi L, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-54; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sitarik AR, 2018, INDOOR AIR, V28, P539, DOI 10.1111/ina.12456; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; SPARKES AH, 1993, VET REC, V133, P57, DOI 10.1136/vr.133.3.57; Sturgeon A, 2014, VET J, V201, P223, DOI 10.1016/j.tvjl.2014.01.024; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tong M, 2014, ISME J, V8, P2193, DOI 10.1038/ismej.2014.64; Vuran E, 2014, MYCOPATHOLOGIA, V177, P41, DOI 10.1007/s11046-013-9704-6; WEBSTER GF, 1981, APPL ENVIRON MICROB, V41, P1269, DOI 10.1128/AEM.41.5.1269-1270.1981; Weese SJ, 2015, VET RES, V46, DOI 10.1186/s13567-014-0140-5; Westling K, 2006, J INFECTION, V53, P403, DOI 10.1016/j.jinf.2006.01.001; Ying S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141842; Zeeuwen Patrick L J M, 2017, J Invest Dermatol, V137, P961, DOI 10.1016/j.jid.2016.11.013; Zhang ES, 2011, MICROBIOL IMMUNOL, V55, P625, DOI 10.1111/j.1348-0421.2011.00364.x	75	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220463	10.1371/journal.pone.0220463	http://dx.doi.org/10.1371/journal.pone.0220463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361788	Green Published, Green Submitted, gold			2022-12-26	WOS:000484981300030
J	Zhang, L; Peterson, TE; Lu, VM; Parney, IF; Daniels, DJ				Zhang, Liang; Peterson, Timothy E.; Lu, Victor M.; Parney, Ian F.; Daniels, David J.			Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; GROWTH-FACTOR; STEM-CELLS; CANCER; GLIOBLASTOMA; ACTIVATION; INTERLEUKIN-6; APOPTOSIS; PHOSPHORYLATION; RECEPTOR	Abnormal activation of signal transducer and activator of transcription 3 ( STAT3) transcription factor has been observed in many human cancers with roles in tumor initiation, progression, drug resistance, angiogenesis and immunosuppression. STAT3 is constitutively activated in a variety of cancers including adult high grade gliomas ( aHGGs) such as glioblastoma ( GBM), and pediatric high grade gliomas ( pHGG). Inhibiting STAT3 is a promising target-specific chemotherapeutic strategy for tumors with aberrant STAT3 signaling. Here we investigated the antitumor effects of novel pyrazole-based STAT3 pathway inhibitors named MNS1 ( Mayo Neurosurgery 1) in both pediatric and adult HGG tumor cells. MNS1 compounds selectively decreased cell viability and proliferation in patient-derived HGG cells with minimal toxicity on normal human astrocytes. These inhibitors selectively blocked IL-6-induced STAT3 phosphorylation and nuclear localization of pSTAT3 without affecting other signaling molecules including Akt, STAT1, JAK2 or ERK1/2 phosphorylation. Functional analysis showed that MNS1 compounds induced apoptosis and decrease tumor migration. The anti-tumor effects extended into a murine pHGG ( diffuse intrinsic pontine glioma) patient derived xenograft, and systemic toxicity was not evident during dose escalation in mice. These results support further development of STAT3 inhibitors for both pediatric and adult HGG.	[Zhang, Liang; Peterson, Timothy E.; Lu, Victor M.; Parney, Ian F.; Daniels, David J.] Mayo Clin, Dept Neurosurg, Rochester, MN 55902 USA	Mayo Clinic	Daniels, DJ (corresponding author), Mayo Clin, Dept Neurosurg, Rochester, MN 55902 USA.	daniels.david@mayo.edu			NIH [T32NS07494]; NINDS [K08NS092891]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS092891] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	DJD received support via NIH Training Grant T32NS07494 and a K08NS092891 award through NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa T, 2013, INT J ONCOL, V43, P219, DOI 10.3892/ijo.2013.1916; Ball S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018820; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Center MDAC, 2013, JAK2 INH WP1066 TREA; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Eason DD, 2001, J IMMUNOL, V166, P1041, DOI 10.4049/jimmunol.166.2.1041; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Griesinger AM, 2015, CANCER IMMUNOL RES, V3, P1165, DOI 10.1158/2326-6066.CIR-15-0061; Haftchenary S, 2013, ACS MED CHEM LETT, V4, P1102, DOI 10.1021/ml4003138; Hashizume R, 2012, J NEURO-ONCOL, V110, P305, DOI 10.1007/s11060-012-0973-6; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Kohsaka S, 2012, MOL CANCER THER, V11, P1289, DOI 10.1158/1535-7163.MCT-11-0801; Kumar R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179012; Lin GS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0924-5; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Liu QL, 2010, J NEURO-ONCOL, V100, P165, DOI 10.1007/s11060-010-0158-0; Liu Y, 2010, CELL CYCLE, V9, P3423, DOI 10.4161/cc.9.17.12946; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; McFarland BC, 2011, MOL CANCER THER, V10, P2384, DOI 10.1158/1535-7163.MCT-11-0480; Meel MH, 2018, CELL MOL LIFE SCI, V75, P871, DOI 10.1007/s00018-017-2714-7; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Oh DY, 2015, CANCER RES TREAT, V47, P607, DOI 10.4143/crt.2014.249; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Sai K, 2012, J NEURO-ONCOL, V107, P487, DOI 10.1007/s11060-011-0786-z; Saidi A, 2009, INT J CANCER, V125, P1054, DOI 10.1002/ijc.24380; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Swiatek-Machado K., 2012, CANC BIOL THERAPY, V13; Wan SS, 2014, GASTROENTEROLOGY, V147, P1393, DOI 10.1053/j.gastro.2014.08.039; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Weissenberger J, 2004, ONCOGENE, V23, P3308, DOI 10.1038/sj.onc.1207455; Weissenberger J, 2010, CLIN CANCER RES, V16, P5781, DOI 10.1158/1078-0432.CCR-10-0446; Welby JP, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00092; Wong ALA, 2017, EXPERT OPIN INV DRUG, V26, P883, DOI 10.1080/13543784.2017.1351941; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu DD, 2013, BIOORGAN MED CHEM, V21, P4266, DOI 10.1016/j.bmc.2013.04.069; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang XL, 2013, CANCER RES, V73, P1922, DOI 10.1158/0008-5472.CAN-12-3175; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220569	10.1371/journal.pone.0220569	http://dx.doi.org/10.1371/journal.pone.0220569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361777	gold, Green Submitted, Green Published			2022-12-26	WOS:000484981300043
J	Martinez-Mas, J; Bueno-Crespo, A; Khazendar, S; Remezal-Solano, M; Martinez-Cendan, JP; Jassim, S; Du, HB; Al Assam, H; Bourne, T; Timmerman, D				Martinez-Mas, Jose; Bueno-Crespo, Andres; Khazendar, Shan; Remezal-Solano, Manuel; Martinez-Cendan, Juan-Pedro; Jassim, Sabah; Du, Hongbo; Al Assam, Hisham; Bourne, Tom; Timmerman, Dirk			Evaluation of machine learning methods with Fourier Transform features for classifying ovarian tumors based on ultrasound images	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; MODELS; CANCER	Introduction Ovarian tumors are the most common diagnostic challenge for gynecologists and ultrasound examination has become the main technique for assessment of ovarian pathology and for preoperative distinction between malignant and benign ovarian tumors. However, ultrasonography is highly examiner-dependent and there may be an important variability between two different specialists when examining the same case. The objective of this work is the evaluation of different well-known Machine Learning (ML) systems to perform the automatic categorization of ovarian tumors from ultrasound images. Methods We have used a real patient database whose input features have been extracted from 348 images, from the IOTA tumor images database, holding together with the class labels of the images. For each patient case and ultrasound image, its input features have been previously extracted using Fourier descriptors computed on the Region Of Interest (ROI). Then, four ML techniques are considered for performing the classification stage: K-Nearest Neighbors (KNN), Linear Discriminant (LD), Support Vector Machine (SVM) and Extreme Learning Machine (ELM). Results According to our obtained results, the KNN classifier provides inaccurate predictions (less than 60% of accuracy) independently of the size of the local approximation, whereas the classifiers based on LD, SVM and ELM are robust in this biomedical classification (more than 85% of accuracy). Conclusions ML methods can be efficiently used for developing the classification stage in computer-aided diagnosis systems of ovarian tumor from ultrasound images. These approaches are able to provide automatic classification with a high rate of accuracy. Future work should aim at enhancing the classifier design using ensemble techniques. Another ongoing work is to exploit different kind of features extracted from ultrasound images.	[Martinez-Mas, Jose; Remezal-Solano, Manuel] Virgen de la Arrixaca Univ Clin Hosp, Dept Obstet & Gynecol, Murcia, Spain; [Martinez-Mas, Jose] Univ Catolica Murcia UCAM, Hlth Sci PhD Program, Murcia, Spain; [Bueno-Crespo, Andres] Catholic Univ Murcia UCAM, Dept Comp Sci, Murcia, Spain; [Khazendar, Shan] Univ Sulaimani, Dept Adm & Econ, Kurdistan, Iraq; [Remezal-Solano, Manuel; Martinez-Cendan, Juan-Pedro] Catholic Univ Murcia UCAM, Dept Med Obstet & Gynecol, Murcia, Spain; [Martinez-Cendan, Juan-Pedro] Santa Lucia Univ Gen Hosp, Dept Obstet & Gynecol, Cartagena, Spain; [Jassim, Sabah; Du, Hongbo; Al Assam, Hisham] Buckingham Univ, Dept Appl Comp, Buckingham, England; [Bourne, Tom] Queen Charlottes & Chelsea Hosp, Imperial Coll, Dept Canc & Surg, London, England; [Bourne, Tom; Timmerman, Dirk] Univ Hosp KU Leuven, Dept Dev & Regenerat Obstet & Gynecol, Leuven, Belgium	Hospital Clinico Universitario Virgen de la Arrixaca; Universidad Catolica de Murcia; Universidad Catolica de Murcia; University of Sulimanyah; Universidad Catolica de Murcia; University of Buckingham; Imperial College London; KU Leuven; University Hospital Leuven	Martinez-Mas, J (corresponding author), Virgen de la Arrixaca Univ Clin Hosp, Dept Obstet & Gynecol, Murcia, Spain.; Martinez-Mas, J (corresponding author), Univ Catolica Murcia UCAM, Hlth Sci PhD Program, Murcia, Spain.	jmartinezmas@sego.es	Bourne, Tom/I-6478-2012; Bueno-Crespo, Andrés/AAB-2204-2019; Timmerman, Dirk/AAD-2363-2019; Bueno-Crespo, Andrés/O-5423-2016	Bourne, Tom/0000-0003-1421-6059; Bueno-Crespo, Andrés/0000-0003-1734-6852; Timmerman, Dirk/0000-0002-3707-6645; Bueno-Crespo, Andrés/0000-0003-1734-6852; Martinez-Mas, Jose/0000-0002-8506-9933	Spanish MINECO [TIN2016-78799-P]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; Catholic University of Murcia; University Centre of Defence at the Spanish Air Force Academy; Obstetrics and Gynecology Department of Virgen de la Arrixaca University Clinic Hospital; Obstetrics and Gynecology Department of Santa Lucia University General Hospital	Spanish MINECO(Spanish Government); National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; Catholic University of Murcia; University Centre of Defence at the Spanish Air Force Academy; Obstetrics and Gynecology Department of Virgen de la Arrixaca University Clinic Hospital; Obstetrics and Gynecology Department of Santa Lucia University General Hospital	This work is supported by the Spanish MINECO under grant TIN2016-78799-P. TB is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. DT is a Senior Clinical Investigator of the Research Foundation - Flanders (Belgium) (FWO). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Spanish Ministries.; We thank Buckingham University and the IOTA group too for their collaboration by providing us the input feature database which has been studied in this work. We also thank Catholic University of Murcia, University Centre of Defence at the Spanish Air Force Academy, Obstetrics and Gynecology Department of Virgen de la Arrixaca University Clinic Hospital, and Obstetrics and Gynecology Department of Santa Lucia University General Hospital for their support for this research work.	Alpaydin E., 2010, INTRO MACHINE LEARNI; Berek J. S., 2015, BEREK NOVAKS GYNECOL; Bishop CM., 2010, BISHOP PATTERN RECOG; Garcia-Laencina PJ, 2015, COMPUT BIOL MED, V59, P125, DOI 10.1016/j.compbiomed.2015.02.006; Garcia-Laencina PJ, 2014, 13 MED C MED BIOL EN, P746; Gonzales R. C., 1992, DIGITAL IMAGE PROCES; Huang GB, 2007, NEUROCOMPUTING, V70, P3056, DOI 10.1016/j.neucom.2007.02.009; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2011, INT J MACH LEARN CYB, V2, P107, DOI 10.1007/s13042-011-0019-y; Igelnik B, 1997, IEEE T NEURAL NETWOR, V8, P454; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kaijser J, 2014, HUM REPROD UPDATE, V20, P449, DOI 10.1093/humupd/dmt059; Khazendar S, 2015, FACTS VIEWS VIS OBGY, V7, P7; Khazendar S., 2014, 2014 6th Computer Science and Electronic Engineering Conference (CEEC). Proceedings, P148, DOI 10.1109/CEEC.2014.6958571; Khazendar S, 2016, THESIS; Mateo F, 2008, P EUR S TIM SER PRED, P57; Meys EMJ, 2016, EUR J CANCER, V58, P17, DOI 10.1016/j.ejca.2016.01.007; Miche Y, 2009, P 17 EUR S ART NEUR, V1, P177; Miche Y, ESANN, P247; Miche Y, 2008, LECT NOTES COMPUT SC, V5163, P145, DOI 10.1007/978-3-540-87536-9_16; Miche Y, 2010, IEEE T NEURAL NETWOR, V21, P158, DOI 10.1109/TNN.2009.2036259; PAO YH, 1994, NEUROCOMPUTING, V6, P163, DOI 10.1016/0925-2312(94)90053-1; Rao C.R., 1971, GEN INVERSE MATRICES, V7; Rodriguez-Bermudez G, 2013, INTERNATIONAL JOURNA, V23, P135; Roldan F, 1998, B ONCOLOGICO, V8; Rong HJ, 2008, NEUROCOMPUTING, V72, P359, DOI 10.1016/j.neucom.2008.01.005; SERRE D, 2002, MATRICES THEORY APPL; Simila T, 2005, LECT NOTES COMPUT SC, V3697, P97; Timmerman D, 2008, ULTRASOUND OBST GYN, V31, P681, DOI 10.1002/uog.5365; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Timmerman D, 1999, ULTRASOUND OBST GYN, V13, P17, DOI 10.1046/j.1469-0705.1999.13010017.x; Timmerman D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6839; Yazbek J, 2010, ULTRASOUND OBST GYN, V35, P89, DOI 10.1002/uog.7335	33	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0219388	10.1371/journal.pone.0219388	http://dx.doi.org/10.1371/journal.pone.0219388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348783	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000484979500007
J	Mehrabi, A; Dixon, S; Sandler, M				Mehrabi, Adib; Dixon, Simon; Sandler, Mark			Vocal imitation of percussion sounds: On the perceptual similarity between imitations and imitated sounds	PLOS ONE			English	Article							IDENTIFICATION; CATEGORIZATION; RETRIEVAL	Recent studies have demonstrated the effectiveness of the voice for communicating sonic ideas, and the accuracy with which it can be used to imitate acoustic instruments, synthesised sounds and environmental sounds. However, there has been little research on vocal imitation of percussion sounds, particularly concerning the perceptual similarity between imitations and the sounds being imitated. In the present study we address this by investigating how accurately musicians can vocally imitate percussion sounds, in terms of whether listeners consider the imitations 'more similar' to the imitated sounds than to other same-category sounds. In a vocal production task, 14 musicians imitated 30 drum sounds from five categories (cymbals, hats, kicks, snares, toms). Listeners were then asked to rate the similarity between the imitations and same-category drum sounds via web based listening test. We found that imitated sounds received the highest similarity ratings for 16 of the 30 sounds. The similarity between a given drum sound and its imitation was generally rated higher than for imitations of another same-category sound, however for some drum categories (snares and toms) certain sounds were consistently considered most similar to the imitations, irrespective of the sound being imitated. Finally, we apply an existing auditory image based measure for perceptual similarity between same-category drum sounds, to model the similarity ratings using linear mixed effect regression. The results indicate that this measure is a good predictor of perceptual similarity between imitations and imitated sounds, when compared to acoustic features containing only temporal or spectral features.	[Mehrabi, Adib; Dixon, Simon; Sandler, Mark] Queen Mary Univ London, Dept Linguist, London, England; [Mehrabi, Adib] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England	University of London; Queen Mary University London; University College London; University of London; Queen Mary University London	Mehrabi, A (corresponding author), Queen Mary Univ London, Dept Linguist, London, England.; Mehrabi, A (corresponding author), Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England.	a.mehrabi@qmul.ac.uk		Sandler, Mark/0000-0002-5691-8107	Engineering and Physical sciences research council in the UK [EP/G03723X/1]	Engineering and Physical sciences research council in the UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was received from the Engineering and Physical sciences research council in the UK (https://www.epsrc.ac.uk/) under grant number EP/G03723X/1. Author MS is the PI on this grant, and author AM received funding in form of a stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Kristina, 2015, P 33 ANN ACM C HUM F, P2295, DOI DOI 10.1145/2702613.2732868; Atherton M., 2007, P IN INT C MUS COMM, P15; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Blancas David Sanchez, 2014, P 53 AUD ENG SOC C L, P2; Cartwright M, 2015, P 33 ANN ACM C HUM F; Cartwright M, 2016, INT CONF ACOUST SPEE, P619, DOI 10.1109/ICASSP.2016.7471749; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dessein A., 2009, P 6 C SOUND MUS COMP, P213; Edmiston P, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2709; Flexer A, 2012, P 13 INT SOC MUS INF, P175; FXpansion Audio UK Ltd, 2013, BFD VERS 3; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GREY JM, 1977, J ACOUST SOC AM, V61, P1270, DOI 10.1121/1.381428; Gygi B, 2007, PERCEPT PSYCHOPHYS, V69, P839, DOI 10.3758/BF03193921; Hashimoto T, 2006, NEUROIMAGE, V31, P1762, DOI 10.1016/j.neuroimage.2006.02.019; International Telecommunication Union, 2003, 15341 ITU; Kapur Ajay, 2004, P 5 INT C MUSIC INFO, P170; Kokkinaki T, 2000, J REPROD INFANT PSYC, V18, P173, DOI 10.1080/713683042; Kraft S, 2014, P LIN AUD C KARLSR G; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Lederer K., 2005, THESIS; Lemaitre Guillaume, 2015, Journal of the Acoustical Society of America, V137, DOI 10.1121/1.4920282; Lemaitre G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168167; Lemaitre G, 2014, J ACOUST SOC AM, V135, P862, DOI 10.1121/1.4861245; Lemaitre G, 2011, ECOL PSYCHOL, V23, P267, DOI 10.1080/10407413.2011.617225; Lemaitre G, 2010, J EXP PSYCHOL-APPL, V16, P16, DOI 10.1037/a0018762; Lewis J., 2009, CRADLE LANGUAGE, V12, P236; Logan B., 2000, P INT SOC MUS INF RE; Marchetto E, 2015, P 18 INT C DIG AUD E; MCADAMS S, 1995, PSYCHOL RES-PSYCH FO, V58, P177, DOI 10.1007/BF00419633; Mehrabi A, 2017, J ACOUST SOC AM, V141, P783, DOI 10.1121/1.4974825; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Pampalk E, 2008, IEEE T AUDIO SPEECH, V16, P408, DOI 10.1109/TASL.2007.910783; Perlman M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20961-6; Proctor M, 2013, J ACOUST SOC AM, V133, P1043, DOI 10.1121/1.4773865; R Core Team, 2021, R LANGUAGE ENV STAT; Rocchesso D, 2016, J AUDIO ENG SOC, V64, P474, DOI 10.17743/jaes.2016.0026; Roma Gerard, 2015, P 1 WEB AUD C PAR FR; Scavone G, 2001, P INT S MUS AC PER I, P487; Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x; Seabold S, 2010, P 9 PYTHON SCI C; Siedenburg K, 2016, J NEW MUSIC RES, V45, P27, DOI 10.1080/09298215.2015.1132737; Sinyor E, 2005, P INT C MUS INF RETR, P672; Sobkowiak W., 1990, STUDIA ANGLICA POSNA, V23, P15; Sporer T, 2009, P 127 AUD ENG SOC CO, P323; Stowell D., 2010, MAKING MUSIC REAL TI; Stowell D, 2008, C4DMTR0801 U LOND; Sundberg J., 1989, SCI SINGING VOICE; Terasawa H, 2005, IEEE WORK APPL SIG, P323, DOI 10.1109/ASPAA.2005.1540234; TERHARDT E, 1979, HEARING RES, V1, P155, DOI 10.1016/0378-5955(79)90025-X; Tindale A., 2004, CLASSIFICATION SNARE; Zacharakis A., 2013, MUSICAL TIMBRE BRIDG; Zhang YC, 2016, J AUDIO ENG SOC, V64, P533, DOI 10.17743/jaes.2016.0013; Zhang YC, 2016, INT CONF ACOUST SPEE, P2269, DOI 10.1109/ICASSP.2016.7472081; Zhang YW, 2015, POWDER METALL IND, V25, P1	56	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219955	10.1371/journal.pone.0219955	http://dx.doi.org/10.1371/journal.pone.0219955			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344080	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900042
J	Shrestha, A; Duwadi, D; Jukosky, J; Fiering, SN				Shrestha, Anishma; Duwadi, Deepesh; Jukosky, James; Fiering, Steven N.			Cecropin-like antimicrobial peptide protects mice from lethal E. coli infection	PLOS ONE			English	Article							MEMBRANE	Resistance of pathogenic bacteria to standard antibiotics is an issue of great concern, and new treatments for bacterial infections are needed. Antimicrobial peptides (AMPs) are small, cationic, and amphipathic molecules expressed by metazoans that kill pathogens. They are a key part of the innate immune system in both vertebrates and invertebrates. Due to their low toxicity and broad antimicrobial activities, there has been increasing attention to their therapeutic usage. Our previous research demonstrated that four peptides-DAN1, DAN2, HOLO1 and LOUDEF1-derived from recently sequenced arthropod genomes exhibited potent antimicrobial effects in-vitro. In this study, we show that DAN2 protected 100% of mice when it was administered at a concentration of 20 mg/kg thirty minutes after the inoculation of a lethal dose of E. coli intraperitoneally. Lower concentrations of DAN2-10mg/kg and 5mg/kg protected more than 2/3s of the mice. All three dose levels reduced bacterial loads in blood and peritoneal fluid by 10-fold or more when counted six hours after bacterial challenge. We determined that DAN2 acts by compromising the integrity of the E. coli membrane. This study supports the potential of DAN2 peptide as a therapeutic agent for treating antibiotic resistant Gram-negative bacterial infections.	[Shrestha, Anishma; Duwadi, Deepesh; Jukosky, James] Colby Sawyer Coll, New London, NH USA; [Fiering, Steven N.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [Shrestha, Anishma] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Duwadi, Deepesh] Geisel Sch Med Dartmouth, Hanover, NH USA	Dartmouth College; Tufts University; Dartmouth College	Fiering, SN (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.	fiering@dartmouth.edu		Fiering, Steven/0000-0003-0624-974X	National Institutes of Health, National Institute of General Medical Sciences, IDeA Program, NH-INBRE [P20GM103506]; Norris Cotton Cancer Center;  [5 P30 CA023108-38]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103506] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences, IDeA Program, NH-INBRE; Norris Cotton Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Institute of General Medical Sciences, IDeA Program, NH-INBRE, P20GM103506 to SF and JJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Department of Natural Science at Colby-Sawyer College for their continuous support, Jennifer Fields and the Dartmouth Mouse Modeling Shared Resource for mice related assistance, and Gary A. Ward and Mikayla Kravetz Hernandez and the DartLab Immune Monitoring and Flow Cytometry Shared Resource for flow cytometry assay. Shared resources at Dartmouth are supported by the Norris Cotton Cancer Center and the supporting grant 5 P30 CA023108-38.	[Anonymous], 2016, SCI REP; Bechinger B, 2017, J DENT RES, V96, P254, DOI 10.1177/0022034516679973; Buchmann K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00459; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Carpenter CF, 2004, CLIN INFECT DIS, V38, P994, DOI 10.1086/383472; Cheng KT, 2018, MOLECULES, V23, DOI 10.3390/molecules23040800; Choi KY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00149; Conte M, 2007, WORLD J MICROB BIOT, V23, P1679, DOI 10.1007/s11274-007-9415-6; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; da Costa JP, 2015, APPL MICROBIOL BIOT, V99, P2023, DOI 10.1007/s00253-015-6375-x; Deptula M, 2018, MOLECULES, V23, DOI 10.3390/molecules23020414; Duwadi D, 2018, PEPTIDES, V103, P26, DOI 10.1016/j.peptides.2018.01.017; Erlendsdottir H, 2001, ANTIMICROB AGENTS CH, V45, P1078, DOI 10.1128/AAC.45.4.1078-1085.2001; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F; Giacometti A, 2001, CRIT CARE MED, V29, P1666, DOI 10.1097/00003246-200109000-00002; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haney EF, 2015, PEPTIDES, V71, P276, DOI 10.1016/j.peptides.2015.03.015; Jang WS, 2006, FEBS LETT, V580, P1490, DOI 10.1016/j.febslet.2006.01.041; Kamysz W, 2003, ACTA BIOCHIM POL, V50, P461; Kim J., 2017, ANTIMICROBIAL PEPTID, V2nd, DOI [10.1007/978-3-319-29785-9_6, DOI 10.1007/978-3-319-29785-9_6]; Kumar P, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010004; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Le CF, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02340-16; Lee E, 2013, BMB REP, V46, P282, DOI 10.5483/BMBRep.2013.46.5.252; Luo WT, 2016, RSC ADV, V6, P13600, DOI 10.1039/c5ra24808f; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Notariale R, 2018, ACTA BIOCHIM POL, V65, P585, DOI 10.18388/abp.2018_2638; Organizacion Mundial de la Salud, 2018, HIGH LEV ANT RES FOU, P1; Piscopo M, 2020, NAT PROD RES, V34, P2607, DOI 10.1080/14786419.2018.1543686; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Saravolatz LD, 2017, LETT APPL MICROBIOL, V65, P410, DOI 10.1111/lam.12792; Sun Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/167572; Teixeira LD, 2013, PEPTIDES, V42, P144, DOI 10.1016/j.peptides.2013.02.001; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; WANG E, 2015, PARASITE VECTOR, V86, P1, DOI DOI 10.1016/J.JPDC.2015.07.008; Wang JR, 2018, PEERJ, V6, DOI 10.7717/peerj.5369; Wei L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3000-8; Wei L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1149-y; WHO, 2018, ANT RES FACT SHEET; Wu QH, 2018, TOXINS, V10, DOI 10.3390/toxins10110461; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017	49	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220344	10.1371/journal.pone.0220344	http://dx.doi.org/10.1371/journal.pone.0220344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344137	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900090
J	Yang, X; Ji, GX; Wang, C; Zuo, JP; Yang, HQ; Xu, JH; Chen, RS				Yang, Xu; Ji, Guangxing; Wang, Chong; Zuo, Jingping; Yang, Haiqing; Xu, Jianhua; Chen, Ruishan			Modeling nitrogen and phosphorus export with InVEST model in Bosten Lake basin of Northwest China	PLOS ONE			English	Article							NONPOINT-SOURCE POLLUTION; WATER-QUALITY; ECOSYSTEM SERVICES; CLIMATE-CHANGE; RIVER-BASIN; KAIDU RIVER; GROUNDWATER QUALITY; XINJIANG; TEMPERATURE; EVOLUTION	Bosten Lake is an important region of Northwest China that has transformed from a freshwater lake to a saltwater lake since the 1970s. The water quality in the Bosten Lake basin is important for social and economic development, and nitrogen (N) and phosphorus (P) are the key indicators of water quality. The land use data, precipitation data and Digital Elevation Model (DEM) data with the Integrated Valuation of Ecosystem Services and Tradeoffs (InVEST) model were used to simulate the N and P exports of the Bosten Lake basin. The spatial and temporal dynamics of nitrogen and phosphorus exports, and the response of nitrogen and phosphorus exports to land use change and precipitation change were analyzed between 2000 and 2015. The results show that the amount of N and P exports increased during 2000-2015, and the N and P exports are mainly distributed around Bosten Lake. The N and P exports are greatly affected by cultivated land, built-up areas and grassland, while they are less affected by other land use types. The high precipitation areas with small exports of N and P are mainly distributed in mountain areas, while small precipitation areas with large exports of N and P are distributed in plains where the cultivated land and built-up areas are concentrated. The InVEST model can be used in Northwest China, and the statistical downscaling of reanalysis precipitation data can be used in the InVEST model to improve the simulation accuracy in the data scarce regions of Northwest China.	[Yang, Xu; Ji, Guangxing; Zuo, Jingping; Yang, Haiqing; Xu, Jianhua; Chen, Ruishan] East China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai, Peoples R China; [Yang, Xu; Zuo, Jingping; Yang, Haiqing; Xu, Jianhua] China Normal Univ, Res Ctr East West Cooperat China, Shanghai, Peoples R China; [Yang, Xu; Ji, Guangxing; Zuo, Jingping; Yang, Haiqing; Xu, Jianhua; Chen, Ruishan] China Normal Univ, Sch Geog Sci, Shanghai, Peoples R China; [Wang, Chong] Shanghai Univ Engn Sci, Sch Social Sci, Shanghai, Peoples R China	East China Normal University; East China Normal University; East China Normal University; Shanghai University of Engineering Science	Xu, JH; Chen, RS (corresponding author), East China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai, Peoples R China.; Xu, JH (corresponding author), China Normal Univ, Res Ctr East West Cooperat China, Shanghai, Peoples R China.; Xu, JH; Chen, RS (corresponding author), China Normal Univ, Sch Geog Sci, Shanghai, Peoples R China.	jhxu@geo.ecnu.edu.cn; rschen@geo.ecnu.edu.cn	zuo, jingping/GZB-1752-2022; Xu, Jianhua/I-1869-2019; Xu, Jianhua/B-1062-2009	zuo, jingping/0000-0002-5276-2547; Xu, Jianhua/0000-0001-6134-4833	National Natural Science Foundation of China [41871025, 41630859]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (Grant No. 41871025, 41630859). The funder had important roles in study design, data collection and analysis of the manuscript.	[陈亚宁 Chen Yaning], 2014, [地理学报, Acta Geographica Sinica], V69, P1295; [陈亚宁 Chen Yaning], 2012, [干旱区地理, Arid Land Geography], V35, P1; Duan WL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188889; Duan WL, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8020133; Duan WL, 2013, SCI TOTAL ENVIRON, V461, P499, DOI 10.1016/j.scitotenv.2013.05.022; Eziz M, 2012, RES SOIL WATER CONSE, V19, P138; Eziz M, 2014, J GLACIOL GEOCRYOL, V36, P670; Fu AH, 2013, QUATERN INT, V311, P117, DOI 10.1016/j.quaint.2013.08.041; Georgakakos KP, 2014, J HYDROL, V519, P2978, DOI 10.1016/j.jhydrol.2014.05.032; Getirana ACV, 2011, J HYDROL, V404, P304, DOI 10.1016/j.jhydrol.2011.04.037; Hoyer R, 2014, APPL GEOGR, V53, P402, DOI 10.1016/j.apgeog.2014.06.023; JENSEN HS, 1992, LIMNOL OCEANOGR, V37, P577, DOI 10.4319/lo.1992.37.3.0577; JENSEN HS, 1992, HYDROBIOLOGIA, V235, P731, DOI 10.1007/BF00026261; Keeler BL, 2012, P NATL ACAD SCI USA, V109, P18619, DOI 10.1073/pnas.1215991109; Keller AA, 2015, J ENVIRON MANAGE, V156, P23, DOI 10.1016/j.jenvman.2015.03.017; Leh MDK, 2013, AGR ECOSYST ENVIRON, V165, P6, DOI 10.1016/j.agee.2012.12.001; Li Huai-en, 2003, Journal of Xi'an University of Technology, V19, P307; [李怀恩 Li Huaien], 2011, [水力发电学报, Journal of Hydroelectric Engineering], V30, P240; Li PY, 2010, E-J CHEM, V7, pS209; [李文红 Li Wenhong], 2003, [农业环境科学学报, Journal of Agro-environment Science], V22, P170; Liu GD, 2005, AGR ECOSYST ENVIRON, V107, P211, DOI 10.1016/j.agee.2004.11.010; Liu ZF, 2011, INT J CLIMATOL, V31, P2006, DOI 10.1002/joc.2211; Ma J, 2007, ARID ENV MONIT, V21, P92; Ma JZ, 2009, J ENVIRON MANAGE, V90, P1168, DOI 10.1016/j.jenvman.2008.05.007; Mahmood R, 2013, THEOR APPL CLIMATOL, V113, P27, DOI 10.1007/s00704-012-0765-0; Mishra A, 2009, J ENVIRON ENG, V135, P92, DOI 10.1061/(ASCE)0733-9372(2009)135:2(92); Nagrengerile, 2017, GUANGDONG AGR SCI, V44, P98; Ongley ED, 2010, ENVIRON POLLUT, V158, P1159, DOI 10.1016/j.envpol.2009.10.047; PAOLA JD, 1995, IEEE T GEOSCI REMOTE, V33, P981, DOI 10.1109/36.406684; Qin DJ, 2011, J HYDROL, V405, P194, DOI 10.1016/j.jhydrol.2011.05.023; Redhead JW, 2018, SCI TOTAL ENVIRON, V610, P666, DOI 10.1016/j.scitotenv.2017.08.092; Rozenstein O, 2011, APPL GEOGR, V31, P533, DOI 10.1016/j.apgeog.2010.11.006; Rusuli Y, 2015, ENVIRON EARTH SCI, V74, P2499, DOI 10.1007/s12665-015-4257-2; Santhi C, 2001, J AM WATER RESOUR AS, V37, P1169, DOI 10.1111/j.1752-1688.2001.tb03630.x; [尚丽民 Shang Limin], 2014, [环境工程学报, Chinese Journal of Environmental Engineering], V8, P891; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Singh KP, 2005, ANAL CHIM ACTA, V538, P355, DOI 10.1016/j.aca.2005.02.006; Terrado M, 2014, ECOL INDIC, V37, P199, DOI 10.1016/j.ecolind.2013.01.016; Wang C, 2019, J EARTH SYST SCI, V128, DOI 10.1007/s12040-019-1117-6; Wang C, 2018, CLIM DYNAM, V50, P2829, DOI 10.1007/s00382-017-3775-x; [王大尚 Wang Dashang], 2014, [生态学报, Acta Ecologica Sinica], V34, P70; Wang SX, 2013, ENVIRON MONIT ASSESS, V185, P7469, DOI 10.1007/s10661-013-3113-7; Wu JL, 2013, SCI GEOGRAPHICA SINI, V33, P231; Xie Guijuan, 2011, Hupo Kexue, V23, P837; Xu JH, 2018, ARAB J GEOSCI, V11, DOI 10.1007/s12517-018-3784-z; Xu JH, 2016, HYDROL EARTH SYST SC, V20, P1447, DOI 10.5194/hess-20-1447-2016; Xu JH, 2008, CHINESE GEOGR SCI, V18, P331, DOI 10.1007/s11769-008-0331-y; Xu ZX, 2013, IAHS-AISH P, V359, P80; Yao JQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27466-2; Yi S, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100798; [应兰兰 Ying Lanlan], 2010, [水资源与水工程学报, Journal of Water Resources and Water Engineering], V21, P90; Yu ZT, 2015, BIOGEOSCIENCES, V12, P6605, DOI 10.5194/bg-12-6605-2015; Zhu GF, 2008, HYDROGEOL J, V16, P167, DOI 10.1007/s10040-007-0216-7; Zhi-Hong Z, 2006, J ENVIRON SCI, V18, P1020, DOI 10.1016/S1001-0742(06)60032-6; Zuo QT, 2006, HYDROLOG SCI J, V51, P432, DOI 10.1623/hysj.51.3.432	55	8	9	20	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220299	10.1371/journal.pone.0220299	http://dx.doi.org/10.1371/journal.pone.0220299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344114	Green Submitted, gold, Green Published			2022-12-26	WOS:000484977900078
J	Bauer, KM; Dicovitsky, R; Pellegrini, M; Zhaxybayeva, O; Ragusa, MJ				Bauer, Katherine M.; Dicovitsky, Rose; Pellegrini, Maria; Zhaxybayeva, Olga; Ragusa, Michael J.			The structure of a highly-conserved picocyanobacterial protein reveals a Tudor domain with an RNA-binding function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; RNA-binding protein; protein?nucleic acid interaction; nuclear magnetic resonance (NMR); cyanobacteria	NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; HYPERCONSERVED PROTEIN; MARINE CYANOBACTERIA; PROCHLOROCOCCUS; SYNECHOCOCCUS; GENERATION; BACKBONE; DATABASE; PROGRAM	Cyanobacteria of the Prochlorococcus and marine Synechococcus genera are the most abundant photosynthetic microbes in the ocean. Intriguingly, the genomes of these bacteria are strongly divergent even within each genus, both in gene content and at the amino acid level of the encoded proteins. One striking exception to this is a 62-amino-acid protein, termed Prochlorococcus/Synechococcus hyper-conserved protein (PSHCP). PSHCP is not only found in all sequenced Prochlorococcus and marine Synechococcus genomes, but it is also nearly 100% identical in its amino acid sequence across all sampled genomes. Such universal distribution and sequence conservation suggest an essential cellular role of PSHCP in these bacteria. However, its function is unknown. Here, we used NMR spectroscopy to determine its structure, finding that 53 of the 62 amino acids in PSHCP form a Tudor domain, whereas the remainder of the protein is disordered. NMR titration experiments revealed that PSHCP has only a weak affinity for DNA, but an 18.5-fold higher affinity for tRNA, hinting at an involvement of PSHCP in translation. Isothermal titration calorimetry experiments further revealed that PSHCP also binds single-stranded, double-stranded, and hairpin RNAs. These results provide the first insight into the structure and function of PSHCP, suggesting that PSHCP appears to be an RNA-binding protein that can recognize a broad array of RNA molecules.	[Bauer, Katherine M.; Ragusa, Michael J.] Dartmouth Coll, Geisel Sch Med, Dept Biochem & Cell Biol, Hanover, NH 03755 USA; [Dicovitsky, Rose; Pellegrini, Maria; Ragusa, Michael J.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Zhaxybayeva, Olga] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Zhaxybayeva, Olga] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Ragusa, MJ (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Biochem & Cell Biol, Hanover, NH 03755 USA.; Ragusa, MJ (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	michael.j.ragusa@dartmouth.edu		Ragusa, Michael/0000-0002-0231-0876	Dartmouth start-up funds; National Institutes of Health [GM113132, GM128663]; Simons Foundation Investigator in Mathematical Modeling of Living Systems Award [327936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113132, R35GM128663] Funding Source: NIH RePORTER	Dartmouth start-up funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Investigator in Mathematical Modeling of Living Systems Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Dartmouth start-up funds, National Institutes of Health Grants GM113132 and GM128663 (to M. J. R.), and by the Simons Foundation Investigator in Mathematical Modeling of Living Systems Award 327936 (to O. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berube PM, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.154; Biller SJ, 2015, NAT REV MICROBIOL, V13, P13, DOI 10.1038/nrmicro3378; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Chisholm SW, 2017, CURR BIOL, V27, pR447, DOI 10.1016/j.cub.2017.02.043; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Gong WB, 2014, J BIOL CHEM, V289, P4882, DOI 10.1074/jbc.M113.501940; Gonzalez GM, 2017, RNA, V23, P696, DOI 10.1261/rna.060343.116; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Klahn S, 2010, ENVIRON MICROBIOL, V12, P83, DOI 10.1111/j.1462-2920.2009.02045.x; Komarek J, 2014, PRESLIA, V86, P295; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kutovaya OA, 2010, J BASIC MICROB, V50, P227, DOI 10.1002/jobm.200900337; Lancelot N, 2007, NUCLEIC ACIDS RES, V35, P5898, DOI 10.1093/nar/gkm607; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1266, DOI 10.1038/nsmb.2435; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shimojo H, 2008, J MOL BIOL, V378, P987, DOI 10.1016/j.jmb.2008.03.021; Smirnov A, 2017, EMBO J, V36, P1029, DOI 10.15252/embj.201696127; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Usher KM, 2004, SYMBIOSIS, V36, P183; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71; Whidden CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109327; Zhaxybayeva O, 2007, FEMS MICROBIOL LETT, V274, P30, DOI 10.1111/j.1574-6968.2007.00806.x; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032	48	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14333	14344		10.1074/jbc.RA119.007938	http://dx.doi.org/10.1074/jbc.RA119.007938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31391250	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000499248200015
J	Liu, GY; Ma, XC; Wang, Z; Wakae, K; Yuan, YC; He, ZP; Yoshiyama, H; Iizasa, H; Zhang, H; Matsuda, M; Sugiyama, R; Yuan, ZY; Muramatsu, M; Li, LH				Liu, Guangyan; Ma, Xiancai; Wang, Zhe; Wakae, Kousho; Yuan, Yaochang; He, Zhangping; Yoshiyama, Hironori; Iizasa, Hisashi; Zhang, Hui; Matsuda, Mami; Sugiyama, Ryuichi; Yuan, Zhiyu; Muramatsu, Masamichi; Li, Linghua			Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; hepatitis B virus (HBV; Hep B); microRNA (miRNA); p53; cytidine deaminase; RNA editing; ADAR1; cyclin G1; HBV; miR-122; p53	CELL-LINE; P53 GENE; EXPRESSION; TRANSCRIPTION; BINDING; MECHANISMS; RECRUITS; REVERSE; COMPLEX; DICER	Adenosine deaminases acting on RNA-1 (ADAR1) involves adenosine to inosine RNA editing and microRNA processing. ADAR1 is known to be involved in the replication of various viruses, including hepatitis C and D. However, the role of ADAR1 in hepatitis B virus (HBV) infection has not yet been elucidated. Here, for the first time, we demonstrated ADAR1 antiviral activity against HBV. ADAR1 has two splicing isoforms in human hepatocytes: constitutive p110 protein and interferon-alpha (IFN-alpha)-responsive p150 protein. We found that overexpression of ADAR1 decreased HBV RNA in an HBV culture model. A catalytic-site mutant ADAR1 also decreased HBV RNA levels, whereas another adenosine deaminases that act on the RNA (ADAR) family protein, ADAR2, did not. Moreover, the induction of ADAR1 by stimulation with IFN-alpha also reduced HBV RNA levels. Decreases in endogenous ADAR1 expression by knock-down or knock-out increased HBV RNA levels. A major hepatocyte-specific microRNA, miRNA-122, was found to be positively correlated with ADAR1 expression, and exogenous miRNA-122 decreased both HBV RNA and DNA, whereas, conversely, transfection with a miRNA-122 inhibitor increased them. The reduction of HBV RNA by ADAR1 expression was abrogated by p53 knock-down, suggesting the involvement of p53 in the ADAR1-mediated reduction of HBV RNA. This study demonstrated, for the first time, that ADAR1 plays an antiviral role against HBV infection by increasing the level of miRNA-122 in hepatocytes.	[Liu, Guangyan; Yuan, Zhiyu] Shenyang Med Coll, Coll Basic Med Sci, Shenyang 110034, Liaoning, Peoples R China; [Liu, Guangyan; Ma, Xiancai; Yuan, Yaochang; He, Zhangping; Zhang, Hui] Sun Yat Sen Univ, Minist Educ, Zhongshan Sch Med, Inst Human Virol,Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Guangyan; Wang, Zhe; Wakae, Kousho; Muramatsu, Masamichi] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan; [Wang, Zhe] Dalian Univ, Affiliated Zhongshan Hosp, Dept Med Oncol, Dalian 116001, Peoples R China; [Wang, Zhe] Dalian Univ, Key Lab Biomarker High Throughput Screening & Tar, Dalian 116001, Peoples R China; [Yoshiyama, Hironori; Iizasa, Hisashi] Shimane Univ, Fac Med, Dept Microbiol, Izumo, Shimane 6938501, Japan; [Matsuda, Mami; Sugiyama, Ryuichi; Muramatsu, Masamichi] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1648640, Japan; [Li, Linghua] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou 510060, Guangdong, Peoples R China	Shenyang Medical College; Sun Yat Sen University; Kanazawa University; Dalian University; Dalian University; Shimane University; National Institute of Infectious Diseases (NIID); Guangzhou Medical University	Li, LH (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou 510060, Guangdong, Peoples R China.; Muramatsu, M (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 11628640, Japan.	muramatu@med.kanazawa-u.ac.jp; llheliza@126.com	Yoshiyama, Hironori/H-5674-2019	Yoshiyama, Hironori/0000-0001-7588-278X; liu, guangyan/0000-0002-5891-1830; Iizasa, Hisashi/0000-0002-9202-2666; Ma, Xiancai/0000-0002-4934-4221	National Natural Science Foundation of China [81501753, 81702856]; Natural Science Foundation of Guangdong Province China [2017A030310231]; Liaoning Provincial Natural Science Foundation of China [20180530041]; Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED) [18fk0310103j0302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province China(National Natural Science Foundation of Guangdong Province); Liaoning Provincial Natural Science Foundation of China; Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by National Natural Science Foundation of China Grant 81702856, Natural Science Foundation of Guangdong Province China Grant 2017A030310231, Liaoning Provincial Natural Science Foundation of China Grant 20180530041, and National Natural Science Foundation of China Grant 81501753, and the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED) Grant 18fk0310103j0302. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P369; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Biswas N, 2012, VIROLOGY, V422, P265, DOI 10.1016/j.virol.2011.10.024; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Cai TT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006503; Casey JL, 2012, CURR TOP MICROBIOL, V353, P123, DOI 10.1007/82_2011_146; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cho CJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040799; CROWE JS, 1994, J INFECT DIS, V169, P875, DOI 10.1093/infdis/169.4.875; Dixit U, 2015, J VIROL, V89, P7905, DOI 10.1128/JVI.00729-15; Ferir G, 2008, REV MED VIROL, V18, P19, DOI 10.1002/rmv.554; George CX, 2014, J INTERF CYTOK RES, V34, P437, DOI 10.1089/jir.2014.0001; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gomes AR, 2015, CLIN MOL HEPATOL, V21, P257, DOI 10.3350/cmh.2015.21.3.257; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Hsieh JL, 2003, CLIN CANCER RES, V9, P338; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Kim HY, 2004, VIROLOGY, V322, P22, DOI 10.1016/j.virol.2004.01.009; Kitamura K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003361; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kwon S, 2016, BIOCHEM BIOPH RES CO, V479, P74, DOI 10.1016/j.bbrc.2016.09.035; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Liang GX, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004780; Liang GX, 2013, P NATL ACAD SCI USA, V110, P2246, DOI 10.1073/pnas.1221921110; Liu Y, 1996, J VIROL, V70, P1961, DOI 10.1128/JVI.70.3.1961-1968.1996; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Nguyen DH, 2008, J CELL PHYSIOL, V216, P289, DOI 10.1002/jcp.21416; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Ori A, 1998, EMBO J, V17, P544, DOI 10.1093/emboj/17.2.544; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Piscopo DM, 2008, CANCER RES, V68, P5581, DOI 10.1158/0008-5472.CAN-07-6346; PUISIEUX A, 1995, P NATL ACAD SCI USA, V92, P1342, DOI 10.1073/pnas.92.5.1342; Pujantell M, 2018, ANTIVIR RES, V156, P116, DOI 10.1016/j.antiviral.2018.05.012; Qu JH, 2005, WORLD J GASTROENTERO, V11, P6212, DOI 10.3748/wjg.v11.i39.6212; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; Taylor DR, 2005, J VIROL, V79, P6291, DOI 10.1128/JVI.79.10.6291-6298.2005; Tsai KN, 2018, TRENDS MICROBIOL, V26, P33, DOI 10.1016/j.tim.2017.07.006; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wu FL, 2011, VIRUS GENES, V42, P157, DOI 10.1007/s11262-010-0555-7; Wu XP, 2014, LIVER INT, V34, P1560, DOI 10.1111/liv.12444; Wu XP, 2012, ANTIVIR RES, V94, P272, DOI 10.1016/j.antiviral.2012.03.004	52	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14043	14054		10.1074/jbc.RA119.007970	http://dx.doi.org/10.1074/jbc.RA119.007970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366735	hybrid, Green Published			2022-12-26	WOS:000490729800018
J	Iverson, AR; Fujisaki, I; Lamont, MM; Hart, KM				Iverson, Autumn R.; Fujisaki, Ikuko; Lamont, Margaret M.; Hart, Kristen M.			Loggerhead sea turtle (Caretta caretta) diving changes with productivity, behavioral mode, and sea surface temperature	PLOS ONE			English	Article							TUNA THUNNUS-THYNNUS; LEPIDOCHELYS-OLIVACEA; SUBMERGENCE PATTERNS; MEDITERRANEAN SEA; FORAGING BEHAVIOR; BUOYANCY CONTROL; CHELONIA-MYDAS; DIVE BEHAVIOR; MOVEMENTS; ECOLOGY	The relationship between dive behavior and oceanographic conditions is not well understood for marine predators, especially sea turtles. We tagged loggerhead turtles (Caretta caretta) with satellite-linked depth loggers in the Gulf of Mexico, where there is a minimal amount of dive data for this species. We tested for associations between four measurements of dive behavior (total daily dive frequency, frequency of dives to the bottom, frequency of long dives and time-at-depth) and both oceanographic conditions (sea surface temperature [SST], net primary productivity [NPP]) and behavioral mode (inter-nesting, migration, or foraging). From 2011-2013 we obtained 26 tracks from 25 adult female loggerheads tagged after nesting in the Gulf of Mexico. All turtles remained in the Gulf of Mexico and spent about 10% of their time at the surface (10% during inter-nesting, 14% during migration, 9% during foraging). Mean total dive frequency was 41.9 times per day. Most dives were <= 25 m and between 30-40 min. During inter-nesting and foraging, turtles dived to the bottom 95% of days. SST was an important explanatory variable for all dive patterns; higher SST was associated with more dives per day, more long dives and more dives to the seafloor. Increases in NPP were associated with more long dives and more dives to the bottom, while lower NPP resulted in an increased frequency of overall diving. Longer dives occurred more frequently during migration and a higher proportion of dives reached the seafloor during foraging when SST and NPP were higher. Our study stresses the importance of the interplay between SST and foraging resources for influencing dive behavior.	[Iverson, Autumn R.] US Geol Survey, Cherokee Nat Technol, Contracted Wetland & Aquat Res Ctr, Davie, FL 33314 USA; [Fujisaki, Ikuko] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Lamont, Margaret M.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA; [Hart, Kristen M.] US Geol Survey, Wetland & Aquat Res Ctr, Davie, FL USA	United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Iverson, AR (corresponding author), US Geol Survey, Cherokee Nat Technol, Contracted Wetland & Aquat Res Ctr, Davie, FL 33314 USA.	ariverson@contractor.usgs.gov		Iverson, Autumn/0000-0002-8353-6745	Natural Resource Damage Assessment (NRDA); U.S. Geological Survey Priority Ecosystem Science Program (PES)	Natural Resource Damage Assessment (NRDA); U.S. Geological Survey Priority Ecosystem Science Program (PES)	This work was supported by the Natural Resource Damage Assessment (NRDA) to KMH; and the U.S. Geological Survey Priority Ecosystem Science Program (PES) to KMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NMFSSEFSC57992 NOAA; Bauer RK, 2017, DEEP-SEA RES PT II, V141, P248, DOI 10.1016/j.dsr2.2017.04.006; Bjorndal K.A., 1997, BIOL SEA TURTLES, V1, P199; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Blumenthal J.M., 2006, ENDANGER SPECIES RES, V2, P51, DOI [DOI 10.3354/ESR00044, 10.3354/esr002051]; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Casale P, 2008, MAR ECOL PROG SER, V372, P265, DOI 10.3354/meps07702; Chambault P, 2016, PROG OCEANOGR, V142, P58, DOI 10.1016/j.pocean.2016.01.006; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Dalleau M, 2014, MAR BIOL, V161, P1835, DOI 10.1007/s00227-014-2465-z; DODGE KL, 2014, ATLANTIC OCEAN, V9, DOI DOI 10.1371/JOURNAL.PONE.0091726; Enstipp MR, 2016, FUNCT ECOL, V30, P1810, DOI 10.1111/1365-2435.12667; FELGER RS, 1976, SCIENCE, V191, P283, DOI 10.1126/science.191.4224.283; Foley AM, 2014, MAR BIOL, V161, P1251, DOI 10.1007/s00227-014-2415-9; Foley AM, 2013, ENDANGER SPECIES RES, V21, P129, DOI 10.3354/esr00512; Fuentes MMPB, 2015, J EXP MAR BIOL ECOL, V471, P77, DOI 10.1016/j.jembe.2015.05.003; Godley BJ, 2003, J EXP MAR BIOL ECOL, V287, P119, DOI 10.1016/S0022-0981(02)00547-6; Hardy RF, 2014, CAN J FISH AQUAT SCI, V71, P1924, DOI 10.1139/cjfas-2014-0128; Hart KM, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00336; Hart KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103453; Hart KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066921; Hatase H, 2007, J ZOOL, V273, P46, DOI 10.1111/j.1469-7998.2007.00298.x; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hochscheid S, 2004, PHYSIOL BIOCHEM ZOOL, V77, P209, DOI 10.1086/381472; Hochscheid S, 2010, J EXP BIOL, V213, P1328, DOI 10.1242/jeb.037184; Hochscheid S, 2007, MAR ECOL PROG SER, V340, P287, DOI 10.3354/meps340287; Hochscheid S, 2014, J EXP MAR BIOL ECOL, V450, P118, DOI 10.1016/j.jembe.2013.10.016; Houghton JDR, 2000, J MAR BIOL ASSOC UK, V80, P761, DOI 10.1017/S002531540000271X; Houghton JDR, 2002, MAR ECOL PROG SER, V227, P63, DOI 10.3354/meps227063; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Lamont MM, 2018, ECOLOGY, V99, P2621, DOI 10.1002/ecy.2439; Lamont MM, 2015, HERPETOL CONSERV BIO, V10, P26; Lutcavage M.E., 1997, BIOL SEA TURTLES, VI; Manickchand-Heileman S, 1998, ESTUAR COAST SHELF S, V46, P885, DOI 10.1006/ecss.1997.0324; McIntyre T, 2011, MAR ECOL PROG SER, V441, P257, DOI 10.3354/meps09383; MENDONCA MT, 1983, COPEIA, P1013, DOI 10.2307/1445104; Minamikawa S, 2000, J EXP BIOL, V203, P2967; Minamikawa S, 1997, J ETHOL, V15, P109, DOI 10.1007/BF02769396; Narazaki T, 2015, MAR BIOL, V162, P1251, DOI 10.1007/s00227-015-2666-0; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; NMFS & USFWS, 2008, REC PLAN NORTHW ATL; Okuyama J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0040; Patel SH, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00254; Patel SH, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00358.1; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; R Core Team, 2018, R LANG ENV STAT COMP; RENAUD ML, 1994, B MAR SCI, V55, P1; Richards Paul M., 2011, Endangered Species Research, V15, P151, DOI 10.3354/esr00379; Roxy MK, 2016, GEOPHYS RES LETT, V43, P826, DOI 10.1002/2015GL066979; Southwood AL, 2006, CAN J ZOOL, V84, P125, DOI 10.1139/Z05-185; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Thomson JA, 2013, BIOL CONSERV, V165, P154, DOI 10.1016/j.biocon.2013.06.005; Tucker Anton D., 2009, Marine Turtle Newsletter, P16; Turtle Expert Working Group, 2009, ASS LOGG TURTL POP W; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Wilson M, 2017, J EXP BIOL, V220, P3432, DOI 10.1242/jeb.162644	59	6	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220372	10.1371/journal.pone.0220372	http://dx.doi.org/10.1371/journal.pone.0220372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390354	Green Published, Green Submitted, gold			2022-12-26	WOS:000484999400018
J	Rocha, LS; Silva, DM; Silva, MP; Vidigal, PMP; Silva, JCF; Guerra, ST; Ribeiro, MG; Mendes, TAD; Ribon, AD				Rocha, Lis S.; Silva, Danielle M.; Silva, Monica P.; Vidigal, Pedro Marcus P.; Silva, Jose Cleydson F.; Guerra, Simony T.; Ribeiro, Marcio G.; Mendes, Tiago Antonio de O.; Ribon, Andrea de B.			Comparative genomics of Staphylococcus aureus associated with subclinical and clinical bovine mastitis	PLOS ONE			English	Article							INTRAMAMMARY INFECTIONS; VIRULENCE FACTORS; SIGNAL PEPTIDES; RISK-FACTORS; DAIRY FARMS; PREDICTION; SEQUENCE; IDENTIFICATION; ANNOTATION; ALIGNMENT	Many efforts have been made to understand the pathogenesis of bovine mastitis to reduce losses and promote animal welfare. Staphylococcus aureus may cause bovine clinical mastitis, but it is mainly associated with subclinical infection, which is usually persistent and can easily reoccur. Here, we conducted a comparative genomic analysis between strains of S. aureus causing subclinical infection (Sau170, 302, 1269, 1364), previously sequenced by our group, and two well-characterized strains causing clinical mastitis (N305 and RF122) to find differences that could be linked to mastitis outcome. A total of 146 virulence-associated genes were compared and no appreciable differences were found between the bacteria. However, several nonsynonymous single nucleotide polymorphisms (SNPs) were identified in genes present in the subclinical strains when compared to RF122 and N305, especially in genes encoding host immune evasion and surface proteins. The secreted and surface proteins predicted by in silico tools were compared through multidimensional scaling analysis (MDS), revealing a high degree of similarity among the strains. The comparison of orthologous genes by OrthoMCL identified a membrane transporter and a lipoprotein as exclusive of bacteria belonging to the subclinical and clinical groups, respectively. No hit was found in RF122 and N305 for the membrane transporter using BLAST algorithm. For the lipoprotein, sequences of Sau170, 302, 1269, and 1364 with identities between 68-73% were found in the MDS dataset. A conserved region found only in the lipoprotein genes of RF122 and N305 was used for primer design. Although the polymerase chain reaction (PCR) on field isolates of S. aureus did not validate the findings for the transporter, the lipoprotein was able to separate the clinical from the subclinical isolates. These results show that sequence variation among bovine S. aureus, and not only the presence/absence of virulence factors, is an important aspect to consider when comparing isolates causing different mastitis outcomes.	[Rocha, Lis S.; Silva, Danielle M.; Silva, Monica P.; Mendes, Tiago Antonio de O.; Ribon, Andrea de B.] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Vidigal, Pedro Marcus P.] Univ Fed Vicosa, Nucleo Anal Biomol, Vicosa, MG, Brazil; [Silva, Jose Cleydson F.] Univ Fed Vicosa, Inst Nacl Ciencia & Tecnol Interacoes Planta Prag, Vicosa, MG, Brazil; [Guerra, Simony T.; Ribeiro, Marcio G.] UNESP Botucatu, Fac Med Vet & Zootecnia, Dept Higiene Vet & Saude Publ, Botucatu, SP, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Estadual Paulista	Ribon, AD (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil.	abribon@ufv.br	Silva, Cleydson/AAR-8163-2020; Ribon, Andrea O. B./C-8318-2017; Vidigal, Pedro Marcus/G-3100-2011; Garcia Ribeiro, Márcio/GLV-6457-2022; Mendes, Tiago/AAG-1709-2021	Ribon, Andrea O. B./0000-0001-8485-3075; Vidigal, Pedro Marcus/0000-0002-5116-9856; Garcia Ribeiro, Márcio/0000-0003-2682-9389; Mendes, Tiago/0000-0002-5569-4893; Silva, Jose Cleydson F/0000-0001-5435-702X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ 00-582-16]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research received funding from the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (https://fapemig.br/pt/) (APQ 00-582-16) awarded to A.O.B.R, and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (https://www.capes.gov.br/) Scholarship awarded to LSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00074-17; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amare A., 2016, FOOD SCI QUAL MANAG, V52, P56; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Capra E, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0931-8; Collery MM, 2009, J MED MICROBIOL, V58, P13, DOI 10.1099/jmm.0.005215-0; Constable P.D., 2016, DIS MAMMARY GLAND VE, P1994; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabres-Klein MH, 2014, EUR J CLIN MICROBIOL, V33, P2095, DOI 10.1007/s10096-014-2181-0; Haveri M, 2007, J APPL MICROBIOL, V103, P993, DOI 10.1111/j.1365-2672.2007.03356.x; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hisatsune J, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomea.00852-17, 10.1128/genomeA.00852-17]; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langley RJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006549; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Loffler B, 2014, INT J MED MICROBIOL, V304, P170, DOI 10.1016/j.ijmm.2013.11.011; Maddamsetti R, 2015, MOL BIOL EVOL, V32, P2897, DOI 10.1093/molbev/msv161; Marklevitz J, 2016, BIOINFORMATION, V12, P254, DOI 10.6026/97320630012254; McCarthy AJ, 2013, INFECT GENET EVOL, V19, P7, DOI 10.1016/j.meegid.2013.06.012; Mdegela RH, 2009, J S AFR VET ASSOC, V80, P163; Nguyen MT, 2016, MICROBIOL MOL BIOL R, V80, P891, DOI 10.1128/MMBR.00028-16; Nguyen MT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004984; Muller P, 2010, INFECT IMMUN, V78, P4243, DOI 10.1128/IAI.00538-10; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nibret Moges, 2012, Global Veterinaria, V9, P441; Ono HK, 2008, INFECT IMMUN, V76, P4999, DOI 10.1128/IAI.00045-08; Ortega E, 2010, TOXINS, V2, P2117, DOI 10.3390/toxins2082117; Ote I, 2011, VET MICROBIOL, V153, P285, DOI 10.1016/j.vetmic.2011.05.042; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Pele J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-133; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peton V, 2014, VET RES, V45, DOI 10.1186/s13567-014-0106-7; Piccinini R, 2012, J DAIRY RES, V79, P249, DOI 10.1017/S002202991200009X; Pinzon-Sanchez C, 2011, J DAIRY SCI, V94, P3397, DOI 10.3168/jds.2010-3925; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Rainard P, 2018, TRANSBOUND EMERG DIS, V65, P149, DOI 10.1111/tbed.12698; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09; Schmidt T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00511; Schukken YH, 2011, VET IMMUNOL IMMUNOP, V144, P270, DOI 10.1016/j.vetimm.2011.08.022; Siddiquee N. U., 2013, Bangladesh Journal of Veterinary Medicine, V11, P37; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva DM, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01594-15; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith EM, 2005, J CLIN MICROBIOL, V43, P4737, DOI 10.1128/JCM.43.9.4737-4743.2005; Sogawa K, 2017, BIOCONTROL SCI, V22, P163, DOI 10.4265/bio.22.163; Stach CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154762; Stutz K, 2011, J CLIN MICROBIOL, V49, P638, DOI 10.1128/JCM.01148-10; SUTRA L, 1994, J MED MICROBIOL, V40, P79, DOI 10.1099/00222615-40-2-79; Swofford David L., 1996, P407; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Veh KA, 2015, J DAIRY SCI, V98, P155, DOI 10.3168/jds.2014-8044; Vrieling M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37759; Whelehan CJ, 2011, VET IMMUNOL IMMUNOP, V140, P181, DOI 10.1016/j.vetimm.2010.11.013; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zecconi A, 2006, MICROB PATHOGENESIS, V40, P177, DOI 10.1016/j.micpath.2006.01.001	62	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220804	10.1371/journal.pone.0220804	http://dx.doi.org/10.1371/journal.pone.0220804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390381	Green Submitted, Green Published, gold			2022-12-26	WOS:000484999400029
J	Skugor, A; Kjos, NP; Sundaram, AYM; Mydland, LT; Anestad, R; Tauson, AH; Overland, M				Skugor, Adrijana; Kjos, Nils Petter; Sundaram, Arvind Y. M.; Mydland, Liv Torunn; Anestad, Ragnhild; Tauson, Anne-Helene; Overland, Margareth			Effects of long-term feeding of rapeseed meal on skeletal muscle transcriptome, production efficiency and meat quality traits in Norwegian Landrace growing-finishing pigs	PLOS ONE			English	Article							SYMPOSIUM EXTRACELLULAR-MATRIX; PYRUVATE-DEHYDROGENASE KINASE; GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; DIVERGENT SELECTION; GROWTH-PERFORMANCE; ENERGY-METABOLISM; IN-VIVO; PROTEIN; FIBER	This study was performed to investigate the effects of dietary inclusion of 20% rapeseed meal (RSM) as an alternative to soybean meal (SBM) in a three-month feeding experiment with growing finishing pigs. Dietary alteration affected growth performance, several carcass traits and transcriptional responses in the skeletal muscle, but did not affect measured meat quality traits. In general, pigs fed the RSM test diet exhibited reduced growth performance compared to pigs on SBM control diet. Significant transcriptional changes in the skeletal muscle of growing pigs fed RSM diet were likely the consequence of an increased amount of fiber and higher polyunsaturated fatty acids, and presence of bioactive phytochemicals, such as glucosinolates. RNAseq pipeline using Tophat2-Cuffdiff identified 57 upregulated and 63 downregulated genes in RSM compared to SBM pigs. Significantly enriched among downregulated pathways was p53-mediated signalling involved in cellular proliferation, while activation of negative growth regulators (IER5, KLF10, BTG2, KLF11, RETREG1, PRUNE2) in RSM fed pigs provided further evidence for reduced proliferation and increased cellular death, in accordance with the observed reduction in performance traits. Upregulation of well-known metabolic controllers (PDK4, UCP3, ESRRG and ESRRB), involved in energy homeostasis (glucose and lipid metabolism, and mitochondrial function), suggested less available energy and nutrients in RSM pigs. Furthermore, several genes supported more pronounced proteolysis (ABTB1, OTUD1, PADI2, SPP1) and reduced protein synthesis (THBS1, HSF4, AP1S2) in RSM muscle tissue. In parallel, higher levels of NR4A3, PDK4 and FGF21, and a drop in adropin, ELOVL6 and CIDEC/FSP27 indicated increased lipolysis and fatty acid oxidation, reflective of lower dressing percentage. Finally, pigs exposed to RSM showed greater expression level of genes responsive to oxidative stress, indicated by upregulation of GPX1, GPX2, and TXNIP.	[Skugor, Adrijana; Kjos, Nils Petter; Mydland, Liv Torunn; Anestad, Ragnhild; Tauson, Anne-Helene; Overland, Margareth] Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Norway; [Sundaram, Arvind Y. M.] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Tauson, Anne-Helene] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark	Norwegian University of Life Sciences; University of Oslo; University of Copenhagen	Skugor, A (corresponding author), Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Norway.	adrijana.skugor@nmbu.no	Mydland, Liv Torunn/AAO-2783-2020	Sundaram, Arvind/0000-0002-3007-7784	FeedMileage-Efficient use of Feed Resources for a Sustainable Norwegian Food Production (Research Council of Norway, Oslo, Norway) [233685/E50]; Foods of Norway, Centre for Research-based Innovation (Research Council of Norway) [237841/030]; SusPig ERA-Net (Research Council of Norway, Oslo, Norway) [272334/E50]; Research Council of Norway; Southeastern Regional Health Authorities	FeedMileage-Efficient use of Feed Resources for a Sustainable Norwegian Food Production (Research Council of Norway, Oslo, Norway); Foods of Norway, Centre for Research-based Innovation (Research Council of Norway); SusPig ERA-Net (Research Council of Norway, Oslo, Norway)(Research Council of Norway); Research Council of Norway(Research Council of Norway); Southeastern Regional Health Authorities	Funding for this research was provided by the FeedMileage-Efficient use of Feed Resources for a Sustainable Norwegian Food Production (Research Council of Norway, Oslo, Norway; grant no. 233685/E50), Foods of Norway, Centre for Research-based Innovation (Research Council of Norway; grant no. 237841/030), and SusPig ERA-Net (Research Council of Norway, Oslo, Norway; grant no. 272334/E50) projects.; The sequencing service was provided by the Norwegian Sequencing Centre (www.sequencing.uio.no), a national technology platform hosted by the Oslo University Hospital and the University of Oslo and supported by the "Functional Genomics" and "Infrastructure" programs of the Research Council of Norway and the Southeastern Regional Health Authorities.	Agyekum AK, 2017, ENGINEERING-PRC, V3, P716, DOI 10.1016/J.ENG.2017.03.010; Alhawiti NM, 2017, CURR DRUG TARGETS, V18, P1095, DOI 10.2174/1389450118666170130145514; Ali ZA, 2014, J CLIN INVEST, V124, P5159, DOI 10.1172/JCI77484; Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Anderson S, 2007, J AOAC INT, V90, P1073; Anderssohn AM, 2011, INVEST OPHTH VIS SCI, V52, P7548, DOI 10.1167/iovs.11-7723; [Anonymous], [No title captured]; [Anonymous], 2016, ASIAN J ANIM VET ADV, DOI DOI 10.3923/AJAVA.2016.89.97; Association of Official Analytical Chemists AOAC, 1990, OFFICIAL METHODS ANA, P1102; Ayuso M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167858; Ayuso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145162; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Baudet C, 2008, J NEUROSCI, V28, P963, DOI 10.1523/JNEUROSCI.4489-07.2008; Behlke-Steinert S, 2009, CELL CYCLE, V8, P2211, DOI 10.4161/cc.8.14.8979; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Bushnell B., BBTOOLS SOFTWARE PAC; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; Christensen LB, 2003, MEAT SCI, V63, P469, DOI 10.1016/S0309-1740(02)00106-7; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; Conte C, 2009, NUCLEIC ACIDS RES, V37, P5267, DOI 10.1093/nar/gkp550; Corominas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053687; Costford SR, 2007, APPL PHYSIOL NUTR ME, V32, P884, DOI 10.1139/H07-063; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; de Nanclares MP, 2017, LIVEST SCI, V203, P1, DOI 10.1016/j.livsci.2017.06.008; Deckx S, 2016, FASEB J, V30, P2651, DOI 10.1096/fj.201500096R; Dekkers JC, 2010, 9 WORLD C GEN APPL L; Ding KK, 2009, RADIAT ENVIRON BIOPH, V48, P205, DOI 10.1007/s00411-009-0213-4; Do DN, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00307; Du M, 2012, J ANIM SCI, V90, P922, DOI 10.2527/jas.2011-4937; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.590; Eriksson IS, 2005, INT J LIFE CYCLE ASS, V10, P143, DOI 10.1065/lca2004.06.160; Fan WW, 2018, CELL REP, V22, P2521, DOI 10.1016/j.celrep.2018.02.047; Fan WW, 2013, J MOL ENDOCRINOL, V51, pT87, DOI 10.1530/JME-13-0258; Faure J, 2013, MEAT SCI, V93, P37, DOI 10.1016/j.meatsci.2012.07.006; Feng Z, 2007, GENE, V403, P170, DOI 10.1016/j.gene.2007.08.009; Cardoso TF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3986-x; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gameiro PA, 2018, CELL REP, V24, P1415, DOI 10.1016/j.celrep.2018.07.021; Gao S, 2015, MOL METAB, V4, P310, DOI 10.1016/j.molmet.2015.01.005; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Grumati P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217364; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Hai T, 1999, GENE EXPRESSION, V7, P321; HALLIWELL B, 1995, CRIT REV FOOD SCI, V35, P7, DOI 10.1080/10408399509527682; Hamidi T, 2012, CLIN CANCER RES, V18, P5234, DOI 10.1158/1078-0432.CCR-12-0026; Hamill RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-453; Hand LE, 2013, ENDOCRINOLOGY, V154, P2081, DOI 10.1210/en.2012-2051; Inanc B, 2013, MOL BIOL CELL, V24, P2645, DOI 10.1091/mbc.E13-03-0149; International Organization for Standardization, 1998, 98311998 ISO; Jan AT, 2016, INT J BIOCHEM CELL B, V80, P66, DOI 10.1016/j.biocel.2016.09.023; Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020; Jing L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11953; Jorgensen H, 1996, BRIT J NUTR, V75, P365, DOI 10.1079/BJN19960140; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaur N, 2014, J FOOD SCI TECH MYS, V51, P2289, DOI 10.1007/s13197-012-0677-0; Kawasaki E, 2011, J PHYSIOL SCI, V61, P1, DOI 10.1007/s12576-010-0114-y; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knight RD, 2011, DEVELOPMENT, V138, P2015, DOI 10.1242/dev.061002; KNUDSEN KEB, 1991, BRIT J NUTR, V65, P217, DOI 10.1079/BJN19910082; Knudsen KEB, 2014, POULTRY SCI, V93, P2380, DOI 10.3382/ps.2014-03902; Kojima M, 2018, PLOS ONE, V13; Kolstad K, 1996, LIVEST PROD SCI, V47, P23, DOI 10.1016/S0301-6226(96)01007-X; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Landero JL, 2011, ANIM FEED SCI TECH, V170, P136, DOI 10.1016/j.anifeedsci.2011.08.003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsson VJ, 2018, J CELL SCI, V131, DOI 10.1242/jcs.211664; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Liaw L, 1998, J CLIN INVEST, V101, P1468; Lindberg JE, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-15; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; MAWSON R, 1994, NAHRUNG, V38, P167, DOI 10.1002/food.19940380209; McCullough MJ, 2011, NEUROSCIENCE, V174, P234, DOI 10.1016/j.neuroscience.2010.11.016; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Mejicanos G., 2016, Journal of Animal Science and Technology, V58, P7, DOI 10.1186/s40781-016-0085-5; Messerschmidt U, 2014, ANIM FEED SCI TECH, V187, P68, DOI 10.1016/j.anifeedsci.2013.10.009; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Micheli L, 2011, J BIOL CHEM, V286, P5691, DOI 10.1074/jbc.M110.162842; Miyake M, 2011, J CELL PHYSIOL, V226, P1128, DOI 10.1002/jcp.22434; Montagne L, 2014, J ANIM SCI, V92, P1512, DOI 10.2527/jas.2013-6623; Moyle LA, 2016, ELIFE, V5, DOI 10.7554/eLife.11405; Napierala JS, 2017, DIS MODEL MECH, V10, P1353, DOI 10.1242/dmm.030536; Narasimhan A, 2018, J CACHEXIA SARCOPENI, V9, P60, DOI 10.1002/jcsm.12235; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Noblet J, 2001, ANIM FEED SCI TECH, V90, P35, DOI 10.1016/S0377-8401(01)00195-X; Noblet J, 2013, ANIMAL, V7, P1259, DOI 10.1017/S1751731113000463; Nyachoti CM, 2000, LIVEST PROD SCI, V65, P229, DOI 10.1016/S0301-6226(00)00157-3; O'Farrell M, 2010, J NEAR INFRARED SPEC, V18, P135, DOI 10.1255/jnirs.876; Oczkowicz M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5265-x; Oczkowicz M, 2016, ANN ANIM SCI, V16, P1073, DOI 10.1515/aoas-2016-0033; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ogluszka M, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0552-8; Orzechowski A, 2002, REPROD NUTR DEV, V42, P461, DOI [10.1051/rnd:2002034, 10.1051/rnd:2002037]; Overland M, 2000, J ANIM SCI, V78, P1875; Pagel CN, 2014, J CELL COMMUN SIGNAL, V8, P95, DOI 10.1007/s12079-013-0217-3; Patience JF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0031-2; Pearen MA, 2013, MOL ENDOCRINOL, V27, P1897, DOI 10.1210/me.2013-1205; Perez de Nanclares M, 2018, ANIMAL INT J ANIMAL, P1; POTKINS ZV, 1991, BRIT J NUTR, V65, P391, DOI 10.1079/BJN19910100; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Qin S, 2017, ENGINEERING-PRC, V3, P738, DOI 10.1016/J.ENG.2017.03.011; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; Robertson NG, 2000, GENOMICS, V66, P242, DOI 10.1006/geno.2000.6224; Santini E, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan0665; SAS, 1990, US GUID; SAUVAGEAU M, 2013, CUMMERBUND ANAL EXPL, V2, DOI DOI 10.7554/ELIFE.01749; Sauvant D., 2004, Tables of composition and nutritional value of feed materials: pigs, poultry, cattle, sheep, goats, rabbits, horses and fish; Schedle K., 2016, Die Bodenkultur: Journal of Land Management, Food and Environment, V67, P45, DOI 10.1515/boku-2016-0005; Scheffler TL, 2016, J ANIM SCI, V94, P3601, DOI 10.2527/jas.2015-0055; SCHOENE F, 1990, Endocrinologia Experimentalis, V24, P415; Seno MMG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-345; Sfyri P, 2015, NEUROMUSCULAR DISORD, V25, pS185, DOI 10.1016/j.nmd.2015.06.009; Shukunami C, 2016, JPN DENT SCI REV, V52, P84, DOI 10.1016/j.jdsr.2016.04.003; Sidyakin AA, 2018, J MOL NEUROSCI, V65, P28, DOI 10.1007/s12031-018-1064-8; Silva Figueiredo P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101158; Singh R, 2014, J BIOL CHEM, V289, P19383, DOI 10.1074/jbc.M114.575159; Sirri R, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0297-2; Skugor Stanko, 2016, Parasit Vectors, V9, P639; Spittau B, 2012, CELL TISSUE RES, V347, P65, DOI 10.1007/s00441-011-1186-6; Stinckens A, 2008, ANIM GENET, V39, P586, DOI 10.1111/j.1365-2052.2008.01774.x; TAO X, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0184120; Tatsumi Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.568; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; Tizioto PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep39493; Tosetti F, 2009, INT J CANCER, V125, P1997, DOI 10.1002/ijc.24677; Tripathi MK, 2007, ANIM FEED SCI TECH, V132, P1, DOI 10.1016/j.anifeedsci.2006.03.003; Triphathi M. K., 2017, J ADV DAIRY RES, V5, P180, DOI DOI 10.4172/2329-888X.1000180; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Turner DC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40787-0; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valgimigli L, 2009, ENVIRON MOL MUTAGEN, V50, P222, DOI 10.1002/em.20468; Velleman SG, 2012, J ANIM SCI, V90, P936, DOI 10.2527/jas.2011-4497; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Vig AP, 2009, LWT-FOOD SCI TECHNOL, V42, P1561, DOI 10.1016/j.lwt.2009.05.023; Vincent A, 2015, J ANIM SCI, V93, P2745, DOI 10.2527/jas.2015-8928; Vitali M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204869; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wan XB, 2016, SCI REP-UK, V6, DOI 10.1038/srep36589; Weightman R, 2014, HGCA RESEARCH REVIEW, V80, P58; Weiss N, 2015, GEN PHYSIOL BIOPHYS, V34, P101, DOI 10.4149/gpb_2015011; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Yang LX, 2004, NEUROSCIENCE, V128, P497, DOI 10.1016/j.neuroscience.2004.06.067; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhou C, 2015, FASEB J, V29, P4083, DOI 10.1096/fj.14-267500	161	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220441	10.1371/journal.pone.0220441	http://dx.doi.org/10.1371/journal.pone.0220441			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390356	gold, Green Published, Green Submitted			2022-12-26	WOS:000484999400019
J	Martinez, RH; Lansner, A; Herman, P				Martinez, Ramon H.; Lansner, Anders; Herman, Pawel			Probabilistic associative learning suffices for learning the temporal structure of multiple sequences	PLOS ONE			English	Article							VISUAL-CORTEX; SPARSE CODE; TIME; NETWORK; MEMORY; MODEL; DISAMBIGUATION; NEURONS; REPLAY; REPRESENTATION	From memorizing a musical tune to navigating a well known route, many of our underlying behaviors have a strong temporal component. While the mechanisms behind the sequential nature of the underlying brain activity are likely multifarious and multi-scale, in this work we attempt to characterize to what degree some of this properties can be explained as a consequence of simple associative learning. To this end, we employ a parsimonious firing-rate attractor network equipped with the Hebbian-like Bayesian Confidence Propagating Neural Network (BCPNN) learning rule relying on synaptic traces with asymmetric temporal characteristics. The proposed network model is able to encode and reproduce temporal aspects of the input, and offers internal control of the recall dynamics by gain modulation. We provide an analytical characterisation of the relationship between the structure of the weight matrix, the dynamical network parameters and the temporal aspects of sequence recall. We also present a computational study of the performance of the system under the effects of noise for an extensive region of the parameter space. Finally, we show how the inclusion of modularity in our network structure facilitates the learning and recall of multiple overlapping sequences even in a noisy regime.	[Martinez, Ramon H.; Lansner, Anders; Herman, Pawel] KTH Royal Inst Technol, Computat Brain Sci Lab, Stockholm, Sweden; [Lansner, Anders] Stockholm Univ, Math Dept, Stockholm, Sweden	Royal Institute of Technology; Stockholm University	Martinez, RH (corresponding author), KTH Royal Inst Technol, Computat Brain Sci Lab, Stockholm, Sweden.	rhmm@kth.se	; Lansner, Anders/E-4824-2016	Martinez Mayorquin, Ramon Heberto/0000-0002-5937-7537; Lansner, Anders/0000-0002-2358-7815; Herman, Pawel/0000-0001-6553-823X	Swedish Science Council (Vetenskapsradet) [VR2018-05360]; Swedish e-Science Research Center (SeRC); EuroSPIN Erasmus Mundus doctoral programme	Swedish Science Council (Vetenskapsradet)(Swedish Research Council); Swedish e-Science Research Center (SeRC); EuroSPIN Erasmus Mundus doctoral programme	This work was supported by grants from the Swedish Science Council (Vetenskapsradet, VR2018-05360), Swedish e-Science Research Center (SeRC) and the EuroSPIN Erasmus Mundus doctoral programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Agster KL, 2002, J NEUROSCI, V22, P5760; AMARI SI, 1972, IEEE T COMPUT, VC 21, P1197, DOI 10.1109/T-C.1972.223477; Amit Daniel J., 1992, MODELING BRAIN FUNCT; Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; Bakhurin KI, 2017, J NEUROSCI, V37, P854, DOI 10.1523/JNEUROSCI.1789-16.2016; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bhalla US, 2017, DENDRITES DEEP LEARN; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Byrnes S, 2011, NEURAL COMPUT, V23, P2567, DOI 10.1162/NECO_a_00184; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; CARR CE, 1990, J NEUROSCI, V10, P3227; Chrysanthidis N, 2018, BIORXIV; COOLEN ACC, 1988, EUROPHYS LETT, V7, P281, DOI 10.1209/0295-5075/7/3/016; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Dhawale AK, 2017, ELIFE, V6, DOI 10.7554/eLife.27702; Dominey PF, 2000, LANG COGNITIVE PROC, V15, P87, DOI 10.1080/016909600386129; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fiebig F, 2017, J NEUROSCI, V37, P83, DOI 10.1523/JNEUROSCI.1989-16.2016; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Foldiak Peter, 2003, HDB BRAIN THEORY NEU; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; FUKUSHIMA K, 1973, KYBERNETIK, V12, P58, DOI 10.1007/BF00272461; Golombek DA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0465; Gouvea TS, 2015, ELIFE, V4, DOI 10.7554/eLife.11386; GUYON I, 1988, PHYS REV A, V38, P6365, DOI 10.1103/PhysRevA.38.6365; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hawkins J, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00023; HERZ AV, 1989, BIOL CYBERN, V60, P457, DOI 10.1007/BF00204701; Holthoff K, 2010, J PHYSIOL-LONDON, V588, P1085, DOI 10.1113/jphysiol.2009.184960; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Johnson HA, 2010, NAT NEUROSCI, V13, P917, DOI 10.1038/nn.2579; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kuhn R, 1991, MODELS NEURAL NETWOR, P213; Lansner A., 1989, International Journal of Neural Systems, V1, P77, DOI 10.1142/S0129065789000499; Lansner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073776; Lansner A, 2009, TRENDS NEUROSCI, V32, P178, DOI 10.1016/j.tins.2008.12.002; Lapish CC, 2008, P NATL ACAD SCI USA, V105, P11963, DOI 10.1073/pnas.0804045105; Lawrence M, 2006, NEUROCOMPUTING, V69, P634, DOI 10.1016/j.neucom.2005.12.003; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lipton PA, 2007, J NEUROSCI, V27, P5787, DOI 10.1523/JNEUROSCI.1063-07.2007; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; MacDonald CJ, 2013, J NEUROSCI, V33, P14607, DOI 10.1523/JNEUROSCI.1537-13.2013; Meli C, 2013, NETWORK-COMP NEURAL, V24, P129, DOI 10.3109/0954898X.2013.859323; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Miller KD, 2012, NEURAL COMPUT, V24, P25, DOI 10.1162/NECO_a_00221; Minai AA, 1994, P 1994 WORLD C NEUR, V4, P176; Mostafa H, 2014, NEURAL COMPUT, V26, P1973, DOI 10.1162/NECO_a_00619; Murray JM, 2017, ELIFE, V6, DOI 10.7554/eLife.26084; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakajima T, 2009, J NEUROPHYSIOL, V101, P1883, DOI 10.1152/jn.90636.2008; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pasupathy R, 2010, OPER RES, V58, P889, DOI 10.1287/opre.1090.0773; Paton JJ, 2018, NEURON, V98, P687, DOI 10.1016/j.neuron.2018.03.045; Pereira U, 2018, BIORXIV; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rueda-Orozcol PE, 2015, NAT NEUROSCI, V18, P453, DOI 10.1038/nn.3924; Samura T, 2008, NEUROCOMPUTING, V71, P3176, DOI 10.1016/j.neucom.2008.04.026; Sandberg A, 2002, NETWORK-COMP NEURAL, V13, P179, DOI 10.1088/0954-898X/13/2/302; Seidemann E, 1996, J NEUROSCI, V16, P752; Sohal VS, 1998, HIPPOCAMPUS, V8, P171, DOI 10.1002/(SICI)1098-1063(1998)8:2<171::AID-HIPO9>3.0.CO;2-O; SOMPOLINSKY H, 1986, PHYS REV LETT, V57, P2861, DOI 10.1103/PhysRevLett.57.2861; Spreizer S, 2018, BIORXIV; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Tully PJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004954; Tully Philip J, 2014, Front Synaptic Neurosci, V6, P8, DOI 10.3389/fnsyn.2014.00008; van Hemmen JL, 1991, MODELS NEURAL NETWOR; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Veliz-Cuba A, 2015, J COMPUT NEUROSCI, V39, P235, DOI 10.1007/s10827-015-0574-4; Verduzco-Flores SO, 2012, J COMPUT NEUROSCI, V32, P403, DOI 10.1007/s10827-011-0360-x; Wang Q, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005632; WILLWACHER G, 1982, BIOL CYBERN, V43, P115, DOI 10.1007/BF00336974; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Xu XM, 2016, J PHYSIOL-LONDON, V594, P1891, DOI 10.1113/JP271891	89	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220161	10.1371/journal.pone.0220161	http://dx.doi.org/10.1371/journal.pone.0220161			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369571	gold, Green Submitted, Green Published			2022-12-26	WOS:000484987900031
J	Bennett, CL; Schooley, B; Taylor, MA; Witherspoon, BJ; Godwin, A; Vemula, J; Ausdenmoore, HC; Sartor, O; Yang, YT; Armitage, JO; Hrushesky, WJ; Restaino, J; Thomsen, HS; Yarnold, PR; Young, T; Knopf, KB; Chen, B				Bennett, Charles L.; Schooley, Benjamin; Taylor, Matthew A.; Witherspoon, Bartlett J.; Godwin, Ashley; Vemula, Jayanth; Ausdenmoore, Henry C.; Sartor, Oliver; Yang, Y. Tony; Armitage, James O.; Hrushesky, William J.; Restaino, John; Thomsen, Henrik S.; Yarnold, Paul R.; Young, Terence; Knopf, Kevin B.; Chen, Brian			Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions	PLOS ONE			English	Article							SOUTHERN NETWORK; FOOD; PHARMACOVIGILANCE; FUTURE; SAFETY; RADAR	Oncology-associated adverse drug/device reactions can be fatal. Some clinicians who treat single patients with severe oncology-associated toxicities have researched case series and published this information. We investigated motivations and experiences of select individuals leading such efforts. Clinicians treating individual patients who developed oncology-associated serious adverse drug events were asked to participate. Inclusion criteria included having index patient information, reporting case series, and being collaborative with investigators from two National Institutes of Health funded pharmacovigilance networks. Thirty-minute interviews addressed investigational motivation, feedback from pharmaceutical manufacturers, FDA personnel, and academic leadership, and recommendations for improving pharmacovigilance. Responses were analyzed using constant comparative methods of qualitative analysis. Overall, 18 clinicians met inclusion criteria and 14 interviewees are included. Primary motivations were scientific curiosity, expressed by six clinicians. A less common theme was public health related (three clinicians). Six clinicians received feedback characterized as supportive from academic leaders, while four clinicians received feedback characterized as negative. Three clinicians reported that following the case series publication they were invited to speak at academic institutions worldwide. Responses from pharmaceutical manufacturers were characterized as negative by 12 clinicians. One clinician's wife called the post-reporting time the "Maalox month," while another clinician reported that the manufacturer collaboratively offered to identify additional cases of the toxicity. Responses from FDA employees were characterized as collaborative for two clinicians, neutral for five clinicians, unresponsive for negative by six clinicians. Three clinicians endorsed developing improved reporting mechanisms for individual physicians, while 11 clinicians endorsed safety activities that should be undertaken by persons other than a motivated clinician who personally treats a patient with a severe adverse drug/device reaction. Our study provides some of the first reports of clinician motivations and experiences with reporting serious or potentially fatal oncology-associated adverse drug or device reactions. Overall, it appears that negative feedback from pharmaceutical manufacturers and mixed feedback from the academic community and/or the FDA were reported. Big data, registries, Data Safety Monitoring Boards, and pharmacogenetic studies may facilitate improved pharmacovigilance efforts for oncology-associated adverse drug reactions. These initiatives overcome concerns related to complacency, indifference, ignorance, and system-level problems as barriers to documenting and reporting adverse drug events-barriers that have been previously reported for clinician reporting of serious adverse drug reactions.	[Bennett, Charles L.; Godwin, Ashley; Vemula, Jayanth; Ausdenmoore, Henry C.; Restaino, John; Yarnold, Paul R.; Chen, Brian] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA; [Schooley, Benjamin] Univ South Carolina, Coll Engn & Comp, Columbia, SC 29208 USA; [Taylor, Matthew A.; Hrushesky, William J.] Univ South Carolina, Sch Med, Columbia, SC 29208 USA; [Witherspoon, Bartlett J.] Univ South Carolina, Med Univ, Charleston, SC 29208 USA; [Sartor, Oliver] Tulane Univ, Sch Med, Los Angeles, CA USA; [Yang, Y. Tony] George Washington Univ, Washington, DC USA; [Armitage, James O.] Univ Nebraska Med Ctr, Omaha, NE USA; [Hrushesky, William J.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Thomsen, Henrik S.] Copenhagen Univ Hosp, Herlev, Denmark; [Young, Terence] Drug Safety, Oakville, ON, Canada; [Knopf, Kevin B.] Alameda Hlth Syst, Oakland, CA USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; Tulane University; George Washington University; University of Nebraska System; University of Nebraska Medical Center; University of South Carolina System; University of South Carolina Columbia; University of Copenhagen	Bennett, CL (corresponding author), Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA.	bennettc@cop.sc.edu	; Taylor, Matthew/R-4450-2018	Witherspoon, Bartlett/0000-0002-5882-6265; Chen, Brian/0000-0001-6384-1673; Hrushesky, William/0000-0002-0955-3192; Yarnold, Paul/0000-0002-1648-739X; Taylor, Matthew/0000-0001-7503-4094	National Cancer Institute [1R01CA102713-01 CLB]; American Cancer Society [IRG-13-043-01]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society)	This work received support from the National Cancer Institute (1R01CA102713-01 CLB), https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci; The American Cancer Society (IRG-13-043-01), https://www.cancer.org/.	[Anonymous], 2017, MED DEV CANC RISK LE; Baldo P, 2014, J EVAL CLIN PRACT, V20, P559, DOI 10.1111/jep.12184; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Bennett CL, 2007, ARCH INTERN MED, V167, P1041, DOI 10.1001/archinte.167.10.1041; Bennett CL, 2012, J GEN INTERN MED, V27, P1697, DOI 10.1007/s11606-012-2098-1; Bennett CL, 2005, JAMA-J AM MED ASSOC, V293, P2131, DOI 10.1001/jama.293.17.2131; Bennett CL, 2006, JAMA-J AM MED ASSOC, V296, P2555; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Hermanson T, 2014, J CLIN ONCOL, V32, P3591, DOI 10.1200/JCO.2014.57.2404; Kesselheim AS, 2010, NEW ENGL J MED, V362, P1832, DOI 10.1056/NEJMsr0912039; Lu KZ, 2014, ADV PHARMACOEPIDEMIO, V3; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Moore TJ, 2012, SEMIN THROMB HEMOST, V38, P905, DOI 10.1055/s-0032-1328890; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Platt R, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2343; Sabol RA, 2017, CANCER MED-US, V6, P1541, DOI 10.1002/cam4.1098; Slutsky AS, 2004, NEW ENGL J MED, V350, P1143, DOI 10.1056/NEJMsb033476; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Waldum HL, 2018, GUT, V67, DOI 10.1136/gutjnl-2017-315629; WILLMS DG, 1990, MED ANTHROPOL Q, V4, P391, DOI 10.1525/maq.1990.4.4.02a00020; WOOSLEY RL, 1994, NEW ENGL J MED, V330, P1394	21	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219521	10.1371/journal.pone.0219521	http://dx.doi.org/10.1371/journal.pone.0219521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365527	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600011
J	Lee, Y; Lee, KS				Lee, Yeji; Lee, Kang-Sook			Association of alcohol and drug use with use of electronic cigarettes and heat-not-burn tobacco products among Korean adolescents	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; SOCIOECONOMIC-STATUS; PROBLEM BEHAVIORS; UNITED-STATES; SUBSTANCE USE; RISK-FACTORS; DUAL-USE; SMOKING; CONSUMPTION; POPULATION	Background The tobacco industry has aggressively introduced new and diverse products in the market, including electronic cigarettes (e-cigarettes) and heat-not-burn (HNB) tobacco products, to which adolescents are readily susceptible. Conventional cigarettes have a well-established relationship with adolescent risky behaviors such as alcohol and drug use; however, no studies exist on the association between alcohol consumption and use of e-cigarettes or HNB tobacco products among Korean adolescents. This study evaluated alcohol-related behaviors and drug use in relation to whether a Korean nationally representative adolescent sample had ever used e-cigarettes and HNB tobacco products. Methods Data from the 2018 Korean Youth Risk Behavior Web-based Survey were analyzed. The final study sample comprised 60,040 adolescents. Chi-square and logistic regression were used to examine whether the ever having used e-cigarettes and HNB tobacco products was associated with alcohol-related behaviors and drug use. P-values for trends were calculated to examine the dose-response relationship for each variable. Results Respondents with higher drinking frequency, drinking quantity, alcohol intoxication, alcohol availability, and drug use were more likely to report having used e-cigarettes and HNB tobacco products, thus implying a significant relationship between substance use and novel tobacco product (P <.001). Conclusions Our findings suggest that at-risk adolescents who are engaged in other forms of risk-taking behaviors are prone to attract the experimentation with e-cigarettes or HNB tobacco products. Thus, smoking cessation programs related to substance use should be implemented, and there is an urgent need to monitor and regulate these products effectively.	[Lee, Yeji] Catholic Univ Korea, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Lee, Kang-Sook] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Lee, KS (corresponding author), Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea.	leekangs@catholic.ac.kr						[Anonymous], 2014, CA-CANCER J CLIN, V64, P169, DOI 10.3322/caac.21228; Auer R, 2017, JAMA INTERN MED, V177, P1050, DOI 10.1001/jamainternmed.2017.1419; Azagba S, 2018, ADDICT BEHAV, V79, P166, DOI 10.1016/j.addbeh.2017.12.028; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Barrington-Trimis JL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0379; Barrington-Trimis JL, 2015, PEDIATRICS, V136, P308, DOI 10.1542/peds.2015-0639; Bauld L, 2016, NICOTINE TOB RES, V18, P102, DOI 10.1093/ntr/ntv132; Bhatnagar A, 2019, CIRCULATION, V139, pE937, DOI 10.1161/CIR.0000000000000669; Bunnell RE, 2015, NICOTINE TOB RES, V17, P228, DOI 10.1093/ntr/ntu166; Byeon KH, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018046; Camenga DR, 2014, J ADOLESCENT HEALTH, V55, P588, DOI 10.1016/j.jadohealth.2014.06.016; Caputi TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185735; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Curran KA, 2018, CLIN PEDIATR, V57, P1191, DOI 10.1177/0009922818769405; Dautzenberg B, 2013, OPEN J RESP DIS, V3, P21, DOI DOI 10.4236/0JRD.2013.31004; De Leon J, 2007, ALCOHOL ALCOHOLISM, V42, P252, DOI 10.1093/alcalc/agm029; Dutra LM, 2014, J ADOLESCENT HEALTH, V55, P595, DOI 10.1016/j.jadohealth.2014.08.010; Escobedo LG, 1997, ARCH PEDIAT ADOL MED, V151, P66, DOI 10.1001/archpedi.1997.02170380070011; Exum ML, 2006, J CRIM JUST, V34, P131, DOI 10.1016/j.jcrimjus.2006.01.008; Gilman SE, 2003, J EPIDEMIOL COMMUN H, V57, P802, DOI 10.1136/jech.57.10.802; Goniewicz ML, 2014, J ADOLESCENT HEALTH, V55, P713, DOI 10.1016/j.jadohealth.2014.07.015; Hendlin YH, 2017, ANN INTERN MED, V167, P278, DOI 10.7326/M17-0759; Hibell B., 2012, SUBSTANCE USE STUDEN; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hughes K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1618-4; Jamal A, 2017, MMWR-MORBID MORTAL W, V66, P597, DOI 10.15585/mmwr.mm6623a1; Kim J, 2018, TOB CONTROL, V27, pS74, DOI 10.1136/tobaccocontrol-2018-054390; Kim M, 2018, TOB CONTROL, V27, pE76, DOI 10.1136/tobaccocontrol-2017-053965; Kim Y, 2016, INT J EPIDEMIOL, V45, DOI 10.1093/ije/dyw070; Kinnunen JM, 2015, TOB CONTROL, V24, pE264, DOI 10.1136/tobaccocontrol-2013-051512; Korea Centers for Disease Control and Prevention, 2008, COMP WEIGHT SAMPL DE; Korea Centers for Disease Control and Prevention, 2018, STAT AD HLTH REL BEH; Korea Centers for Disease Control and Prevention, 2018, STAT 14 KOR YOUTH RI; Korea Centers for Disease Control and Prevention, 2009, REL VAL KOR YOUTH RI; Korea Ministry of Economy and Finance, 2018, TOB MARK TRENDS; Kristjansson AL, 2015, J ADOLESCENT HEALTH, V57, P562, DOI 10.1016/j.jadohealth.2015.07.014; Liang WB, 2011, DRUG ALCOHOL REV, V30, P524, DOI 10.1111/j.1465-3362.2010.00281.x; Liu XQ, 2019, TOB CONTROL, V28, P113, DOI 10.1136/tobaccocontrol-2017-054054; McCabe SE, 2017, J ADOLESCENT HEALTH, V61, P155, DOI 10.1016/j.jadohealth.2017.02.004; McKelvey K, 2018, TOB CONTROL, V27, pS41, DOI 10.1136/tobaccocontrol-2018-054596; Miyazaki Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191008; Montreuil Annie, 2017, CMAJ Open, V5, pE460, DOI 10.9778/cmajo.20160167; Moore G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007072; Nyman AL, 2018, TOB CONTROL, V27, pS55, DOI 10.1136/tobaccocontrol-2018-054323; Pulvers K, 2018, DRUG ALCOHOL DEPEN, V189, P80, DOI 10.1016/j.drugalcdep.2018.04.031; Shepherd Jonathan, 2007, Crim Behav Ment Health, V17, P250; Simon Patricia, 2017, Tob Regul Sci, V3, P115, DOI 10.18001/TRS.3.1.12; Soneji S, 2017, JAMA PEDIATR, V171, P788, DOI 10.1001/jamapediatrics.2017.1488; Sung DJ, 2016, CENT EUR J PUBL HEAL, V24, P45, DOI 10.21101/cejph.a4292; Tabuchi T, 2018, TOB CONTROL, V27, pE25, DOI 10.1136/tobaccocontrol-2017-053947; Tabuchi T, 2016, ADDICTION, V111, P706, DOI 10.1111/add.13231; Trinidad DR, 2017, PREV MED, V101, P8, DOI 10.1016/j.ypmed.2017.05.010; Wellman RJ, 2018, INT J PUBLIC HEALTH, V63, P125, DOI 10.1007/s00038-017-1051-9; White J, 2015, J ADOLESCENT HEALTH, V56, P522, DOI 10.1016/j.jadohealth.2015.01.022; Wills TA, 2015, PEDIATRICS, V135, pE43, DOI 10.1542/peds.2014-0760; Wilson N, 2012, NEW ZEAL MED J, V125, P34; World Health Organization, 2018, AIR POLL CHILD HLTH; Wu YS, 2020, TOB CONTROL, V29, P277, DOI 10.1136/tobaccocontrol-2018-054719	59	8	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220241	10.1371/journal.pone.0220241	http://dx.doi.org/10.1371/journal.pone.0220241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365564	Green Published, Green Submitted, gold			2022-12-26	WOS:000484983600031
J	Sisma-Ventura, G; Tutken, T; Peters, STM; Bialik, OM; Zohar, I; Pack, A				Sisma-Ventura, Guy; Tuetken, Thomas; Peters, Stefan T. M.; Bialik, Or M.; Zohar, Irit; Pack, Andreas			Past aquatic environments in the Levant inferred from stable isotope compositions of carbonate and phosphate in fish teeth	PLOS ONE			English	Article							ARCHAEOLOGICAL SITES; STRONTIUM ISOTOPES; BIOGENIC APATITE; BONE APATITE; SHARK TEETH; FOOD-WEB; OXYGEN; WATER; SEA; FRACTIONATION	Here we explore the carbon and oxygen isotope compositions of the co-existing carbonate and phosphate fractions of fish tooth enameloid as a tool to reconstruct past aquatic fish environments and harvesting grounds. The enameloid oxygen isotope compositions of the phosphate fraction (delta O-18(PO4)) vary by as much as similar to 4 parts per thousand for migratory marine fish such as gilt-head seabream (Sparus aurata), predominantly reflecting the different saline habitats it occupies during its life cycle. The offset in enameloid Delta O-18(CO3-PO4) values of modern marine Sparidae and freshwater Cyprinidae from the Southeast Mediterranean region vary between 8.1 and 11.0 parts per thousand, similar to values reported for modern sharks. The mean delta C-13 of modern adult S. aurata and Cyprinus carpio teeth of 0.1 +/- 0.4 parts per thousand and -6.1 +/- 0.7 parts per thousand, respectively, mainly reflect the difference in delta C-13 of dissolved inorganic carbon (DIC) of the ambient water and dietary carbon sources. The enameloid Delta O-18(CO3-PO4) and delta C-13 values of ancient S. aurata (Holocene) and fossil Luciobarbus sp. (Cyprinidae; mid Pleistocene) teeth agree well with those of modern specimens, implying little diagenetic alteration of these tooth samples. Paired delta O-18(PO4)-delta C-13 data from ancient S. aurata teeth indicate that hypersaline water bodies formed in the Levant region during the Late Holocene from typical Mediterranean coastal water with high evaporation rates and limited carbon input from terrestrial sources. Sparid tooth stable isotopes further suggest that coastal lagoons in the Eastern Mediterranean had already formed by the Early Holocene and were influenced by terrestrial carbon sources. Overall, combined enameloid oxygen and carbon isotope analysis of fish teeth is a powerful tool to infer the hydrologic evolution of aquatic environments and assess past fishing grounds of human populations in antiquity.	[Sisma-Ventura, Guy] Israel Oceanog & Limnol Res, Haifa, Israel; [Sisma-Ventura, Guy; Peters, Stefan T. M.; Pack, Andreas] Georg August Univ Gottingen, Dept Isotope Geol, Gottingen, Germany; [Tuetken, Thomas] Johannes Gutenberg Univ Mainz, Inst Geosci, Mainz, Germany; [Bialik, Or M.] Univ Haifa, Charney Sch Marine Sci, Dept Marine Geosci, Haifa, Israel; [Zohar, Irit] Oranim Acad Coll, Qiryat Tivon, Israel	Israel Oceanographic & Limnological Research Institute; University of Gottingen; Johannes Gutenberg University of Mainz; University of Haifa	Sisma-Ventura, G (corresponding author), Israel Oceanog & Limnol Res, Haifa, Israel.; Sisma-Ventura, G; Pack, A (corresponding author), Georg August Univ Gottingen, Dept Isotope Geol, Gottingen, Germany.; Tutken, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Geosci, Mainz, Germany.	guy.siv@ocean.org.il; tuetken@uni-mainz.de; Andreas.Pack@geo.uni-goettingen.de	Tütken, Thomas/E-4988-2010	Peters, Stefan/0000-0001-6502-8723; Pack, Andreas/0000-0002-2618-2768; Tutken, Thomas/0000-0002-2590-8600; Bialik, Or M./0000-0003-1915-7297; Zohar, Irit/0000-0002-5943-2751	Irene Levi Sala CARE Archaeological foundation; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [681450]; German Science Foundation [PA909/15-1]	Irene Levi Sala CARE Archaeological foundation; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); German Science Foundation(German Research Foundation (DFG))	This work was supported by: Irene Levi Sala CARE Archaeological foundation (the establishment of the reference collection), to IZ; This project received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No 681450) to TT; this project received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No 681450) to TT; and this project received funding from the German Science Foundation (grant No PA909/15-1) to AP.	Aguilera O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182740; Ahmed S. M., 2011, EGYPT J AQUAT BIOL F, V15, P57; Andrade JP, 1996, AQUACULT INT, V4, P129, DOI 10.1007/BF00140594; Belmaker M, 2010, J HUM EVOL, V58, P79, DOI 10.1016/j.jhevol.2009.08.004; Bialik OM, 2016, ANTHROPOCENE, V16, P42, DOI 10.1016/j.ancene.2016.08.001; Bryant JD, 1996, GEOCHIM COSMOCHIM AC, V60, P5145; Carlier A, 2007, ESTUAR COAST SHELF S, V72, P1, DOI 10.1016/j.ecss.2006.10.001; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Chenery C, 2010, J ARCHAEOL SCI, V37, P150, DOI 10.1016/j.jas.2009.09.025; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dettman DL, 2001, GEOLOGY, V29, P31, DOI 10.1130/0091-7613(2001)029<0031:SSIEFA>2.0.CO;2; Dufour E, 2007, J ARCHAEOL SCI, V34, P1226, DOI 10.1016/j.jas.2006.10.014; Elliott JC, 2002, REV MINERAL GEOCHEM, V48, P427, DOI 10.2138/rmg.2002.48.11; Elyashiv H, 2016, HOLOCENE, V26, P248, DOI 10.1177/0959683615608687; Enax J, 2014, ACTA BIOMATER, V10, P3959, DOI 10.1016/j.actbio.2014.04.028; Fanelli E, 2015, BIOL INVASIONS, V17, P2163, DOI 10.1007/s10530-015-0868-5; Fischer J, 2013, CHEM GEOL, V342, P44, DOI 10.1016/j.chemgeo.2013.01.022; Gehler A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049531; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; Guy SV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32468-1; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; Iacumin P, 1996, EARTH PLANET SC LETT, V142, P1, DOI 10.1016/0012-821X(96)00093-3; Klug Stefanie, 2010, Palaeobiodiversity Palaeoenvironments, V90, P241, DOI 10.1007/s12549-010-0032-2; Koch P.L., 1994, P63; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; KOLODNY Y, 1988, PALAEOGEOGR PALAEOCL, V64, P59, DOI 10.1016/0031-0182(88)90142-3; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; LECUYER C, 1993, PALAEOGEOGR PALAEOCL, V105, P235, DOI 10.1016/0031-0182(93)90085-W; Lecuyer C, 2003, PALAEOGEOGR PALAEOCL, V193, P457, DOI 10.1016/S0031-0182(03)00261-X; Lecuyer C, 2013, CHEM GEOL, V347, P217, DOI 10.1016/j.chemgeo.2013.03.008; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; LONGINELLI A, 1973, EARTH PLANET SC LETT, V19, P373, DOI 10.1016/0012-821X(73)90088-5; Martin C, 2008, PALAEOGEOGR PALAEOCL, V266, P183, DOI 10.1016/j.palaeo.2008.03.039; MIAKE Y, 1991, CALCIFIED TISSUE INT, V48, P204, DOI 10.1007/BF02570556; Otero O, 2011, GEOLOGY, V39, P435, DOI 10.1130/G31212.1; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Pellegrini M, 2011, PALAEOGEOGR PALAEOCL, V310, P71, DOI 10.1016/j.palaeo.2011.02.023; Porat Naomi, 2008, Israel Journal of Earth Sciences, V57, P21, DOI 10.1560/IJES.57.1.21; Puceat E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000823; Puceat E, 2010, EARTH PLANET SC LETT, V298, P135, DOI 10.1016/j.epsl.2010.07.034; Reinhardt EG, 2001, J COASTAL RES, V17, P431; Sharp Z., 2007, PRINCIPLES STABLE IS; Sharp ZD, 2000, AM J SCI, V300, P222, DOI 10.2475/ajs.300.3.222; Sisma-Ventura G, 2016, J MARINE SYST, V158, P13, DOI 10.1016/j.jmarsys.2016.01.012; Sisma-Ventura G, 2015, J ARCHAEOL SCI, V64, P46, DOI 10.1016/j.jas.2015.10.004; Sisma-Ventura G, 2014, GEOPHYS RES LETT, V41, P5158, DOI 10.1002/2014GL060393; Sivan D, 2001, PALAEOGEOGR PALAEOCL, V167, P101, DOI 10.1016/S0031-0182(00)00234-0; Sivan D, 2011, QUATERNARY RES, V76, P83, DOI 10.1016/j.yqres.2011.04.006; STILLER M, 1974, LIMNOL OCEANOGR, V19, P849, DOI 10.4319/lo.1974.19.5.0849; SUGA S, 1992, HARD TISSUE MINERALIZATION AND DEMINERALIZATION, P17; SUGA S, 1993, J DENT RES, V72, P912, DOI 10.1177/00220345930720051301; Suga S., 1991, HARD TISSUE MINERALI; TALBOT MR, 1990, CHEM GEOL, V80, P261, DOI 10.1016/0168-9622(90)90009-2; Tancioni L, 2003, ESTUAR COAST SHELF S, V57, P469, DOI 10.1016/S0272-7714(02)00376-1; Tutken T, 2006, PALAEOGEOGR PALAEOCL, V241, P457, DOI 10.1016/j.palaeo.2006.04.007; van Baal RR, 2013, PALAEOGEOGR PALAEOCL, V392, P71, DOI 10.1016/j.palaeo.2013.08.020; Vennemann TW, 2002, CHEM GEOL, V185, P321, DOI 10.1016/S0009-2541(01)00413-2; Vennemann TW, 2001, GEOCHIM COSMOCHIM AC, V65, P1583, DOI 10.1016/S0016-7037(00)00629-3; Wacker U, 2016, CHEM GEOL, V443, P97, DOI 10.1016/j.chemgeo.2016.09.009; WASSEF E, 1985, Cybium, V9, P233; Zacke A, 2009, J GEOL SOC LONDON, V166, P969, DOI 10.1144/0016-76492008-068; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; ZOHARY T, 1994, LIMNOL OCEANOGR, V39, P1030, DOI 10.4319/lo.1994.39.5.1030	64	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220390	10.1371/journal.pone.0220390	http://dx.doi.org/10.1371/journal.pone.0220390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365545	Green Published, Green Submitted, gold			2022-12-26	WOS:000484983600043
J	Yen, HY; Li, C				Yen, Hsin-Yen; Li, Ching			Determinants of physical activity: A path model based on an ecological model of active living	PLOS ONE			English	Article							BODY-MASS INDEX; PUBLIC-HEALTH; URBAN DESIGN; BUILT ENVIRONMENT; PARK AVAILABILITY; NEIGHBORHOOD; ADULTS; TIME; BELIEFS; QUALITY	Maintaining physical activity is necessary to promote health in our daily lives. The Ecological Model of Active Living was proposed to examine whether individuals participate in active living. The purpose of this study was to understand the determinants of physical activity and create a predictive path model of the intrapersonal, perceived environment, behavior settings, and policy environment domains. Data were obtained from open government data and questionnaires, including the International Physical Activity Questionnaire, Health Belief Model Inventory, Physical Activity Neighborhood Environment Survey, and Accessibility of Open Spaces. Participants comprised 1085 healthy adults who completed a self-reported internet survey. An analysis of the intrapersonal domain revealed that the variables of female, an older age, and a low educational level, and individuals with obesity or cardiometabolic diseases presented lower odds ratios for active living. We found significant statistical support for our path model (The Ecological Model of Active Living), with a predictive power of 23.1%. The predictive path model is a good approach to quantitatively measure the impacts of various determinants on active living that suggests further lines of research in approaches for modeling relationships.	[Yen, Hsin-Yen] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan; [Li, Ching] Natl Taiwan Normal Univ, Grad Inst Sport Leisure & Hospitality Management, Taipei, Taiwan	Taipei Medical University; National Taiwan Normal University	Yen, HY (corresponding author), Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan.	t94002@ntnu.edu.tw			Ministry of Science and Technology, Taiwan [NSC-105-2410-H-003-049]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work (Dr. Ching Li's Project) was supported by the Ministry of Science and Technology, Taiwan under Grant [NSC-105-2410-H-003-049].	Abdi Jalal, 2014, Glob J Health Sci, V7, P215, DOI 10.5539/gjhs.v7n3p215; Akpinar A, 2016, URBAN FOR URBAN GREE, V16, P76, DOI 10.1016/j.ufug.2016.01.011; Atkinson Kaitlin, 2016, Prev Med Rep, V3, P40, DOI 10.1016/j.pmedr.2015.11.009; Ball K, 2015, HEALTH PROMOT INT, V30, P8, DOI 10.1093/heapro/dav022; Bannister F, 2015, GOV INFORM Q, V32, P1, DOI 10.1016/j.giq.2014.10.003; Carlson JA, 2016, HEALTH PLACE, V38, P48, DOI 10.1016/j.healthplace.2016.01.001; Caspersen CJ, 2000, MED SCI SPORTS EXERC; Chaudhury H, 2016, SOC SCI MED, V149, P104, DOI 10.1016/j.socscimed.2015.12.011; Christian H, 2011, PREV MED, V53, P57, DOI 10.1016/j.ypmed.2011.05.004; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; Farrington JL, 2015, HEALTH PROMOT INT, V30, pi86, DOI 10.1093/heapro/dav038; Garza KB, 2013, RES SOC ADMIN PHARM, V9, P851, DOI 10.1016/j.sapharm.2012.12.001; Gibson JM, 2015, HEALTH PLACE, V35, P79, DOI 10.1016/j.healthplace.2015.07.005; Gilderbloom JI, 2015, CITIES, V42, P13, DOI 10.1016/j.cities.2014.08.001; Hayslip B, 1996, J AGING PHYS ACTIV, V4, P307, DOI 10.1123/japa.4.4.307; Hill R., 1998, INTERPERSONAL COMPUT, V6, P1; Kaczynski AT, 2011, PREV MED, V52, P23, DOI 10.1016/j.ypmed.2010.10.003; Kassen M, 2014, INFORM DEV, V30, P51, DOI 10.1177/0266666912473620; King KA., 2014, ARCH EXERCISE HLTH D, V4, DOI [10.5628/aehd.v4i2.153, DOI 10.5628/AEHD.V4I2.153]; Kolbe-Alexander TL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1853-8; Koohsari MJ, 2015, HEALTH PLACE, V33, P75, DOI 10.1016/j.healthplace.2015.02.009; Koohsari MJ, 2013, CITIES, V35, P294, DOI 10.1016/j.cities.2013.07.001; Kwak L, 2016, J SCI MED SPORT, V19, P482, DOI 10.1016/j.jsams.2015.05.008; Lee HS, 2016, LANDSCAPE URBAN PLAN, V148, P51, DOI 10.1016/j.landurbplan.2015.12.011; Liu YM., 2004, DEV VERIFICATION VAL; Loef Bette, 2016, Prev Med Rep, V3, P30, DOI 10.1016/j.pmedr.2015.11.008; Lovasi GS, 2012, AM J PREV MED, V43, P378, DOI 10.1016/j.amepre.2012.06.018; Magoc D, 2016, HISPANIC J BEHAV SCI, V38, P279, DOI 10.1177/0739986316637355; Mahmood A, 2012, SOC SCI MED, V74, P1180, DOI 10.1016/j.socscimed.2011.12.039; Meyer OL, 2014, AM J PUBLIC HEALTH, V104, P1734, DOI 10.2105/AJPH.2014.302003; National Statistics, 2015, IND COUNT CIT; Rahmati-Najarkolaei F, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.18879; Ribeiro AI, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1879-y; Sallis J., 2015, HLTH BEHAV THEORY RE, V5th ed.; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sallis JF, 2016, PHYS ACTIVITY NEIGHB; Shaw BA, 2008, J AGING HEALTH, V20, P767, DOI 10.1177/0898264308321081; Smits A, 2015, GYNECOL ONCOL, V139, P148, DOI 10.1016/j.ygyno.2015.08.005; Su CH, 2004, J PHYS ED SPORT, V15, P115; Van Holle V, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0110-3; Veitch J, 2016, HEALTH PLACE, V38, P96, DOI 10.1016/j.healthplace.2015.12.004; Zhang J, 2015, HEALTH SERV RES, V50, P1550, DOI 10.1111/1475-6773.12285; Zhou Y, 2014, GYNECOL ONCOL, V133, P4, DOI 10.1016/j.ygyno.2014.01.033	45	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220314	10.1371/journal.pone.0220314	http://dx.doi.org/10.1371/journal.pone.0220314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WC	31348815	Green Published, gold, Green Submitted			2022-12-26	WOS:000484979500029
J	Torres, LG; de Resende, MDV; Azevedo, CF; Silva, FFE; de Oliveira, EJ				Torres, Livia Gomes; Vilela de Resende, Marcos Deon; Azevedo, Camila Ferreira; Fonseca e Silva, Fabyano; de Oliveira, Eder Jorge			Genomic selection for productive traits in biparental cassava breeding populations	PLOS ONE			English	Article							PREDICTION	Cassava improvement using traditional breeding strategies is slow due to the species' long breeding cycle. However, the use of genomic selection can lead to a shorter breeding cycle. This study aimed to estimate genetic parameters for productive traits based on pedigree (pedigree and phenotypic information) and genomic (markers and phenotypic information) analyses using biparental crosses at different stages of selection. A total of 290 clones were genotyped and phenotyped for fresh root yield (FRY), dry matter content (DMC), dry yield (DY), fresh shoot yield (FSY) and harvest index (HI). The clones were evaluated in clonal evaluation trials (CET), preliminary yield trials (PYT), advanced yield trials (AYT) and uniform yield trials (UYT), from 2013 to 2018 in ten locations. The breeding stages were analyzed as follows: one stage (CET), two stages (CET and PYT), three stages (CET, PYT and AYT) and four stages (CET, PYT, AYT and UYT). The genomic predictions were analyzed via k-fold cross-validation based on the genomic best linear unbiased prediction (GBLUP) considering a model with genetic additive effects and genotype x location interactions. Genomic and pedigree accuracies were moderate to high (0.56-0.72 and 0.62-0.78, respectively) for important starch-related traits such as DY and FRY; when considering one breeding stage (CET) with the aim of early selection, the genomic accuracies ranged from 0.60 (DMC) to 0.71 (HI). Moreover, the correlations between the genomic estimation breeding values of one-stage genomic analysis and the estimated breeding values of the four-stage (full data set) pedigree analysis were high for all traits as well as for a selection index including all traits. The results indicate great possibilities for genomic selection in cassava, especially for selection early in the breeding cycle (saving time and effort).	[Torres, Livia Gomes] Univ Fed Vicosa, Dept Plant Sci, Vicosa, MG, Brazil; [Vilela de Resende, Marcos Deon] Univ Fed Vicosa, Dept Forestry Engn, Vicosa, MG, Brazil; [Vilela de Resende, Marcos Deon] Embrapa Florestas, Colombo, Parana, Brazil; [Vilela de Resende, Marcos Deon; Azevedo, Camila Ferreira] Univ Fed Vicosa, Dept Stat, Vicosa, MG, Brazil; [Fonseca e Silva, Fabyano] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [de Oliveira, Eder Jorge] Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	de Oliveira, EJ (corresponding author), Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil.	eder.oliveira@embrapa.br	Silva, Fabyano Fonseca/D-8158-2017; Silva, Fabyano/Y-9223-2019; Azevedo, Camila Ferreira/AGE-4725-2022; Oliveira, Eder Jorge/N-2216-2017	Azevedo, Camila Ferreira/0000-0003-0438-5123; Oliveira, Eder Jorge/0000-0001-8992-7459	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); NEXTGEN Cassava project by the Bill & Melinda Gates Foundation; UK Department for International Development	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); NEXTGEN Cassava project by the Bill & Melinda Gates Foundation; UK Department for International Development	LGT was supported by scholarships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) MDVR, FFS and EJO was supported by research productivity scholarships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The authors are grateful for the financial support provided by Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This work was also partially supported by the NEXTGEN Cassava project, through a grant to Cornell University by the Bill & Melinda Gates Foundation and the UK Department for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PESQUI AGROPECUARIA, DOI DOI 10.5216/PAT.V37I3.1867; Brito AC, 2017, J AGR SCI-CAMBRIDGE, V155, P1424, DOI 10.1017/S0021859617000612; Carvalho PRN, 2007, REV RAIZES AMIDO TRO; Ceballos H, 2016, FRONT PLANT SCI, V7, DOI [10.3359/fpls.2016.01227, 10.3389/fpls.2016.01227]; Ceballos H, 2015, THEOR APPL GENET, V128, P1647, DOI 10.1007/s00122-015-2555-4; Covarrubias-Pazaran G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156744; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; de Oliveira EJ, 2012, EUPHYTICA, V187, P263, DOI 10.1007/s10681-012-0722-0; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Farias ARN, 2006, ASPECTOS SOCIOECONOM; Jennings DL, 2002, BREEDING CROP IMPROV; Barandica OJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01649; Karlstrom A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00604; KAWANO K, 1987, CROP SCI, V27, P69, DOI 10.2135/cropsci1987.0011183X002700010018x; KAWANO K, 1978, CROP SCI, V18, P377, DOI 10.2135/cropsci1978.0011183X001800030006x; Kayondo SI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19696-1; Ly D, 2013, CROP SCI, V53, P1312, DOI 10.2135/cropsci2012.11.0653; Meuwissen THE, 2001, GENETICS, V157, P1819; Ojulong H, 2008, EUPHYTICA, V160, P119, DOI 10.1007/s10681-007-9590-4; Oliveira EJ, 2014, GENET MOL RES, V13, P6683, DOI 10.4238/2014.August.28.13; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; R Core Team, R LANG ENV STAT COMP; Resende M.D.V, 2007, SELEGEN REML BLUP SI; Resende MDV, 2015, GENETICA QUANTITATIV; Resende MDV, 2017, DESAFIOS BIOMETRICOS, P67; Saithong T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137602; Sakurai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074056; Sanginga N., 2015, FEEDING AFRICA; Souza LS, 2006, ASPECTOS SOCIOECON M; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wolfe M. D, 2017, PLANT GENOME, V10, P1	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220245	10.1371/journal.pone.0220245	http://dx.doi.org/10.1371/journal.pone.0220245			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344109	Green Submitted, gold, Green Published			2022-12-26	WOS:000484977900074
J	Chen, JL; Zhou, RP; Liang, YM; Fu, XJ; Wang, DR; Wang, C				Chen, Jialin; Zhou, Renpeng; Liang, Yimin; Fu, Xiujun; Wang, Danru; Wang, Chen			Blockade of lncRNA-ASLNCS5088-enriched exosome generation in M2 macrophages by GW4869 dampens the effect of M2 macrophages on orchestrating fibroblast activation	FASEB JOURNAL			English	Article						hypertrophic scar; exosome inhibitor; TGF-beta 1; microRNA; glutaminase	DEPLETION; REPAIR; CELLS	In hypertrophic scar (HS) formation, the type 2 immune response induces the alternatively activated macrophages (M2), which manipulate fibroblasts to differentiate into myofibroblasts with active biologic functions and proliferation. Myofibroblasts express a-smooth muscle actin (a-SMA) and synthesize and produce additional collagen type I and collagen type III, inducing HS formation. However, studies on the mechanism of M2 macrophage modulation are only based on the recognition of profibrotic factors such as TGF-beta 1 secreted by macrophages. The influence of exosomes from M2 macrophages on scar formation is still unknown. Both M2 macrophages and myofibroblasts highly express glutaminases (GLSs). GLS is a critical enzyme in glutaminolysis and is important for M2 macrophage and fibroblast polarization. In this study, we found that in a TGF-beta 1-stimulated coculture system, a long noncoding RNA (lncRNA) named lncRNA-ASLNCS5088 was enriched in M2 macrophage-derived exosomes. This lncRNA could be transferred with high efficiency to fibroblasts and acted as an endogenous sponge to adsorb microRNA-200c-3p, resulting in increased GLS and alpha-SMA expression. Pretreatment with GW4869, which impairs M2 macrophage exosome synthesis, ameliorated these pathologic changes in fibroblasts in vitro. Local injection in the late scar formation period with GW4869 reduced alpha-SMA + fibroblasts and alleviated the fibrosis of tissue after wound healing in vivo.	[Chen, Jialin; Zhou, Renpeng; Liang, Yimin; Fu, Xiujun; Wang, Danru; Wang, Chen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Wang, DR; Wang, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.	wangdanru1776@163.com; wangchen1075@163.com		Chen, Jialin/0000-0001-8445-0823				Barile L, 2017, PHARMACOL THERAPEUT, V174, P63, DOI 10.1016/j.pharmthera.2017.02.020; Bernard K, 2018, J BIOL CHEM, V293, P1218, DOI 10.1074/jbc.RA117.000444; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Hesketh M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071545; Hewson Chris, 2016, Noncoding RNA Res, V1, P3, DOI 10.1016/j.ncrna.2016.06.001; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kant S, 2019, ADV SKIN WOUND CARE, V32, P26, DOI 10.1097/01.ASW.0000547415.38888.c4; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Klinkert K, 2017, EUR SURG RES, V58, P109, DOI 10.1159/000451078; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kogure Takayuki, 2013, Genes Cancer, V4, P261, DOI 10.1177/1947601913499020; Li-Tsang CWP, 2005, BURNS, V31, P610, DOI 10.1016/j.burns.2005.01.022; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Marshall CD, 2018, ADV WOUND CARE, V7, P29, DOI 10.1089/wound.2016.0696; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naderi-Meshkin H, 2019, BIOINFORMATICS, V35, P352, DOI 10.1093/bioinformatics/bty527; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Shook B, 2016, J INVEST DERMATOL, V136, P1885, DOI 10.1016/j.jid.2016.05.107; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Zhang ZT, 2019, EUR J PHARM BIOPHARM, V137, P122, DOI 10.1016/j.ejpb.2019.02.009; Zhu ZS, 2016, WOUND REPAIR REGEN, V24, P644, DOI 10.1111/wrr.12442	33	45	47	2	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12200	12212		10.1096/fj.201901610	http://dx.doi.org/10.1096/fj.201901610			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373848	Green Published, Bronze			2022-12-26	WOS:000507461600047
J	Xia, W; Ci, SS; Li, MH; Wang, MN; Dianov, GL; Ma, Z; Li, LL; Hua, K; Alagamuthu, KK; Qing, LH; Luo, LB; Edick, AM; Liu, LJ; Hu, ZG; He, LF; Pan, FY; Guo, ZG				Xia, Wen; Ci, Shusheng; Li, Menghan; Wang, Meina; Dianov, Grigory L.; Ma, Zhuang; Li, Lulu; Hua, Ke; Alagamuthu, Karthick Kumar; Qing, Lihong; Luo, Libo; Edick, Ashlin M.; Liu, Lingjie; Hu, Zhigang; He, Lingfeng; Pan, Feiyan; Guo, Zhigang			Two-way crosstalk between BER and c-NHEJ repair pathway is mediated by Pol-beta and Ku70	FASEB JOURNAL			English	Article						DNA repair; base excision repair; double-strand break	BASE EXCISION-REPAIR; DNA-POLYMERASE-BETA; STRAND BREAK REPAIR; END-JOINING PATHWAYS; HOMOLOGOUS RECOMBINATION; PROTEIN; DAMAGE; MAINTENANCE; MECHANISM; COMPLEX	Multiple DNA repair pathways may be involved in the removal of the same DNA lesion caused by endogenous or exogenous agents. Although distinct DNA repair machinery fulfill overlapping roles in the repair of DNA lesions, the mechanisms coordinating different pathways have not been investigated in detail. Here, we show that Ku70, a core protein of nonhomologous end-joining (NHEJ) repair pathway, can directly interact with DNA polymerase-beta (Pol-beta), a central player in the DNA base excision repair (BER), and this physical complex not only promotes the polymerase activity of Pol-beta and BER efficiency but also enhances the classic NHEJ repair. Moreover, we find that DNA damages caused by methyl methanesulfonate (MMS) or etoposide promote the formation of Ku70-Pol-beta complexes at the repair foci. Furthermore, suppression of endogenous Ku70 expression by small interfering RNA reduces BER efficiency and leads to higher sensitivity to MMS and accumulation of the DNA strand breaks. Similarly, Pol-beta knockdown impairs total-NHEJ capacity but only has a slight influence on alternative NHEJ. These results suggest that Pol-beta and Ku70 coordinate 2-way crosstalk between the BER and NHEJ pathways.	[Xia, Wen; Ci, Shusheng; Li, Menghan; Wang, Meina; Dianov, Grigory L.; Ma, Zhuang; Li, Lulu; Hua, Ke; Alagamuthu, Karthick Kumar; Hu, Zhigang; He, Lingfeng; Pan, Feiyan; Guo, Zhigang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 WenYuan Rd, Nanjing 210023, Peoples R China; [Dianov, Grigory L.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia; [Dianov, Grigory L.] Univ Oxford, Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England; [Qing, Lihong; Luo, Libo] Seventh Peoples Hosp, Changzhou, Jiangsu, Peoples R China; [Edick, Ashlin M.] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada; [Liu, Lingjie] Southern Univ Sci & Technol, Coll Life Sci, Shenzhen, Peoples R China	Nanjing Normal University; Novosibirsk State University; University of Oxford; McGill University; Southern University of Science & Technology	Pan, FY; Guo, ZG (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 WenYuan Rd, Nanjing 210023, Peoples R China.	panfeiyan@njnu.edu.cn; guozgang@gmail.com	kumar, Alagamuthu Karthick/X-4468-2019	He, Lingfeng/0000-0002-9668-419X	National Natural Science Foundation of China [81872284]; Changzhou Science and Technology Program [CE20175035]; Jiangsu Key Research and Development Program [BE2018714]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [18KJA180006]; National Nature Science Foundation [31701179]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Russian Foundation for Basic Research (RFBR) [19-04-00067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Science and Technology Program; Jiangsu Key Research and Development Program; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	The authors thank Dr. Songbai Liu (Suzhou Vocational Health College, Suzhou, China) for providing the U2OS EJ5-GFP cell line, and Dr. Jun Huang (Zhejiang University, Hangzhou, China) for providing the U2OS alt-NHEJ-EGFP cell line, which were very helpful for testing NHEJ efficiency in vivo. This work was supported by the National Natural Science Foundation of China (81872284), the Changzhou Science and Technology Program (CE20175035), the Jiangsu Key Research and Development Program (Grant BE2018714), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (18KJA180006), the National Nature Science Foundation (31701179), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. G.L.D. was funded by the Russian Foundation for Basic Research (RFBR) according to Research Project No 19-04-00067. The authors declare no conflicts of interest.	Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Beard WA, 2006, METHOD ENZYMOL, V408, P91, DOI 10.1016/S0076-6879(06)08007-4; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Budke B, 2013, J MED CHEM, V56, P254, DOI 10.1021/jm301565b; Cabelof DC, 2003, CANCER RES, V63, P5799; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Fan W, 2004, BIOCHEM BIOPH RES CO, V323, P1328, DOI 10.1016/j.bbrc.2004.09.002; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Guo ZG, 2009, NUCLEIC ACIDS RES, V37, P3431, DOI 10.1093/nar/gkp201; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng105; Pan FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28614; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Parsons JL, 2011, MOL CELL, V41, P609, DOI 10.1016/j.molcel.2011.02.016; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Ray S, 2018, NUCLEIC ACIDS RES, V46, P242, DOI 10.1093/nar/gkx1147; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Shahi A, 2011, NUCLEIC ACIDS RES, V39, P2130, DOI 10.1093/nar/gkq1095; Simonelli V, 2017, ONCOTARGET, V8, P84827, DOI 10.18632/oncotarget.10185; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stauffer W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33592-8; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wang B, 2014, CELL DEATH DIFFER, V21, P1160, DOI 10.1038/cdd.2014.42; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Wang HC, 2003, NUCLEIC ACIDS RES, V31, P5377, DOI 10.1093/nar/gkg728; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Zhou T, 2016, ONCOTARGET, V7, P6902, DOI 10.18632/oncotarget.6849	51	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11668	11681		10.1096/fj.201900308R	http://dx.doi.org/10.1096/fj.201900308R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31348687	Green Published, Bronze			2022-12-26	WOS:000507461600008
J	Mohamed, YF; Scott, NE; Molinaro, A; Creuzenet, C; Ortega, X; Lertmemongkolchai, G; Tunney, MM; Green, H; Jones, AM; DeShazer, D; Currie, BJ; Foster, LJ; Ingram, R; De Castro, C; Valvano, MA				Mohamed, Yasmine Fathy; Scott, Nichollas E.; Molinaro, Antonio; Creuzenet, Carole; Ortega, Ximena; Lertmemongkolchai, Ganjana; Tunney, Michael M.; Green, Heather; Jones, Andrew M.; DeShazer, David; Currie, Bart J.; Foster, Leonard J.; Ingram, Rebecca; De Castro, Cristina; Valvano, Miguel A.			A general protein O-glycosylation machinery conserved in Burkholderia species improves bacterial fitness and elicits glycan immunogenicity in humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; glycosylation; nuclear magnetic resonance (NMR); immunogenicity; bacteria; Burkholderia; galleria mellonella; glanders; melioidosis; phenotypic arrays	GO EXTRACTION TIPS; CAMPYLOBACTER-JEJUNI; ANTIBIOTIC-RESISTANCE; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; CENOCEPACIA; EXPRESSION; FRACTIONATION; SYSTEM; SUGAR	The Burkholderia genus encompasses many Gram-negative bacteria living in the rhizosphere. Some Burkholderia species can cause life-threatening human infections, highlighting the need for clinical interventions targeting specific lipopolysaccharide proteins. Burkholderia cenocepacia O-linked protein glycosylation has been reported, but the chemical structure of the O-glycan and the machinery required for its biosynthesis are unknown and could reveal potential therapeutic targets. Here, using bioinformatics approaches, gene-knockout mutants, purified recombinant proteins, LC-MS-based analyses of O-glycans, and NMR-based structural analyses, we identified a B. cenocepacia O-glycosylation (ogc) gene cluster necessary for synthesis, assembly, and membrane translocation of a lipid-linked O-glycan, as well as its structure, which consists of a beta-Gal-(1,3)-alpha-GalNAc-(1,3)-beta-GalNAc trisaccharide. We demonstrate that the ogc cluster is conserved in the Burkholderia genus, and we confirm the production of glycoproteins with similar glycans in the Burkholderia species: B. thailandensis, B. gladioli, and B. pseudomallei. Furthermore, we show that absence of protein O-glycosylation severely affects bacterial fitness and accelerates bacterial clearance in a Galleria mellonella larva infection model. Finally, our experiments revealed that patients infected with B. cenocepacia, Burkholderia multivorans, B. pseudomallei, or Burkholderia mallei develop O-glycan-specific antibodies. Together, these results highlight the importance of general protein O-glycosylation in the biology of the Burkholderia genus and its potential as a target for inhibition or immunotherapy approaches to control Burkholderia infections.	[Mohamed, Yasmine Fathy; Ingram, Rebecca; Valvano, Miguel A.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland; [Mohamed, Yasmine Fathy] Alexandria Univ, Dept Microbiol & Immunol, Fac Pharm, Alexandria 21561, Egypt; [Scott, Nichollas E.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Scott, Nichollas E.; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Molinaro, Antonio] Univ Naples Federico II, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy; [Creuzenet, Carole; Ortega, Ximena] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Lertmemongkolchai, Ganjana] Khon Kaen Univ, Mekong Hlth Sci Res Inst, Ctr Res & Dev, Med Diagnost Labs, Khon Kaen, Thailand; [Tunney, Michael M.] Queens Univ Belfast, Sch Pharm, Halo Res Grp, Belfast BT9 7BL, Antrim, North Ireland; [Green, Heather; Jones, Andrew M.] Univ Hosp South Manchester NHS Fdn Trust, Manchester Adult Cyst Fibrosis Ctr, Manchester M23 9LT, Lancs, England; [DeShazer, David] US Army, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA; [Currie, Bart J.] Royal Darwin Hosp, Menzies Sch Hlth Res, Darwin, NT 0818, Australia; [Currie, Bart J.] Royal Darwin Hosp, Infect Dis Dept, Darwin, NT 0818, Australia; [De Castro, Cristina] Univ Naples Federico II, Dept Agr Sci, Via Univ 100, I-80055 Portici, Italy	Queens University Belfast; Egyptian Knowledge Bank (EKB); Alexandria University; University of Melbourne; University of British Columbia; University of Naples Federico II; Western University (University of Western Ontario); Khon Kaen University; Queens University Belfast; Wythenshawe Hospital NHS Foundation Trust; Charles Darwin University; Menzies School of Health Research; University of Naples Federico II	Valvano, MA (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland.	m.valvano@qub.ac.uk	De Castro, Cristina/I-5899-2012; Mohamed, Yasmine/O-4638-2017	De Castro, Cristina/0000-0002-5147-1756; Mohamed, Yasmine/0000-0002-8630-7016; Lertmemongkolchai, Ganjana/0000-0001-6972-585X; jones, andrew/0000-0003-3232-1055; Scott, Nichollas/0000-0003-2556-8316; Creuzenet, Carole/0000-0002-7435-5862	Canadian Institutes of Health Research; UK Medical Research Council [CD1617-CIC04]; Queen's University Belfast, Belfast, United Kingdom; National Health and Medical Research Council of Australia (NHMRC) [APP1100164, APP1037373]; MRC [MC_PC_17175] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Queen's University Belfast, Belfast, United Kingdom; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by a grant from the Canadian Institutes of Health Research (to M. A. V. and C. C.) and from the UK Medical Research Council Confidence in Concept Project CD1617-CIC04 (to M. A. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an International Ph.D. Scholarship from Queen's University Belfast, Belfast BT9 1NN, United Kingdom.; Supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1100164 and an Overseas (Biomedical) Fellowship APP1037373.	Andrejko M, 2008, FOLIA MICROBIOL, V53, P147, DOI 10.1007/s12223-008-0021-2; Aubert DF, 2014, METHODS MOL BIOL, V1197, P311, DOI 10.1007/978-1-4939-1261-2_18; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Butty FD, 2009, BIOCHEMISTRY-US, V48, P7764, DOI 10.1021/bi901065t; Cain JA, 2019, MOL CELL PROTEOMICS, V18, P715, DOI 10.1074/mcp.RA118.001199; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Eberl Leo, 2016, F1000Res, V5, DOI 10.12688/f1000research.8221.1; Eichler J, 2017, TRENDS MICROBIOL, V25, P662, DOI 10.1016/j.tim.2017.03.001; El-Halfawy OM, 2014, ANTIMICROB AGENTS CH, V58, P4162, DOI 10.1128/AAC.02649-14; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; Gebhart C, 2012, GLYCOBIOLOGY, V22, P962, DOI 10.1093/glycob/cws059; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gislason AS, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000140; Good DM, 2010, PROTEOMICS, V10, P164, DOI 10.1002/pmic.200900570; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Ireland PM, 2014, MICROB PATHOGENESIS, V67-68, P55, DOI [10.1016/j.micpath.2014.01.001, 10]; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; KAZANAS N, 1968, APPL MICROBIOL, V16, P128, DOI 10.1128/AEM.16.1.128-132.1968; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; Limmathurotsakul Direk, 2015, Emerg Infect Dis, V21, DOI 10.3201/eid2106.141480; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Lipsitz Rebecca, 2012, Emerg Infect Dis, V18, pe2, DOI 10.3201/eid1812.120638; Lithgow KV, 2014, MOL MICROBIOL, V92, P116, DOI 10.1111/mmi.12540; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Losada L, 2010, GENOME BIOL EVOL, V2, P102, DOI 10.1093/gbe/evq003; Lukose V, 2017, GLYCOBIOLOGY, V27, P820, DOI 10.1093/glycob/cwx064; Marolda Cristina L., 2006, V347, P237; Moule MG, 2014, MBIO, V5, DOI 10.1128/mBio.00926-13; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Ortega X, 2005, J BACTERIOL, V187, P1324, DOI 10.1128/JB.187.4.1324-1333.2005; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Regan KH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009876.pub3; Rhodes KA, 2016, DRUG RESIST UPDATE, V28, P82, DOI 10.1016/j.drup.2016.07.003; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Schaffer C, 2017, FEMS MICROBIOL REV, V41, P49, DOI 10.1093/femsre/fuw036; Scoffone VC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01592; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Stepper J, 2011, FEBS LETT, V585, P645, DOI 10.1016/j.febslet.2011.01.023; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Valguarnera E, 2016, J MOL BIOL, V428, P3206, DOI 10.1016/j.jmb.2016.04.013; Valvano MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P729, DOI 10.1134/S0006297911070029; Vertyporokh L, 2017, ACTA BIOCHIM POL, V64, P273, DOI 10.18388/abp.2016_1376; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wiersinga WJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.107; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; York GM, 1998, J BACTERIOL, V180, P4184, DOI 10.1128/JB.180.16.4184-4191.1998	64	15	15	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13248	13268		10.1074/jbc.RA119.009671	http://dx.doi.org/10.1074/jbc.RA119.009671			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31350337	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000486417200005
J	Pamphlett, R; Jew, SK; Cherepanoff, S				Pamphlett, Roger; Jew, Stephen Kum; Cherepanoff, Svetlana			Mercury in the retina and optic nerve following prenatal exposure to mercury vapor	PLOS ONE			English	Article							FIBER LAYER; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; SYSTEMIC EXPOSURE; OXIDATIVE DAMAGE; BRAIN; ACCUMULATION; MOUSE; FETAL; ABNORMALITIES	Damage to the retina and optic nerve is found in some neurodegenerative disorders, but it is unclear whether the optic pathway and central nervous system (CNS) are affected by the same injurious agent, or whether optic pathway damage is due to retrograde degeneration following the CNS damage. Finding an environmental agent that could be responsible for the optic pathway damage would support the hypothesis that this environmental toxicant also triggers the CNS lesions. Toxic metals have been implicated in neurodegenerative disorders, and mercury has been found in the retina and optic nerve of experimentally-exposed animals. Therefore, to see if mercury exposure in the prenatal period could be one link between optic pathway damage and human CNS disorders of later life, we examined the retina and optic nerve of neonatal mice that had been exposed prenatally to mercury vapor, using a technique, autometallography, that detects the presence of mercury within cells. Pregnant mice were exposed to a non-toxic dose of mercury vapor for four hours a day for five days in late gestation, when the mouse placenta most closely resembles the human placenta. The neonatal offspring were sacrificed one day after birth and gapless serial sections of formalin-fixed paraffin-embedded blocks containing the eyes were stained with silver nitrate autometallography to detect inorganic mercury. Mercury was seen in the nuclear membranes of retinal ganglion cells and endothelial cells. A smaller amount of mercury was present in the retinal inner plexiform and inner nuclear layers. Mercury was conspicuous in the peripapillary retinal pigment epithelium. In the optic nerve, mercury was seen in the nuclear membranes and processes of glia and in endothelial cells. Optic pathway and CNS endothelial cells contained mercury. In conclusion, mercury is taken up preferentially by fetal retinal ganglion cells, optic nerve glial cells, the retinal pigment epithelium, and endothelial cells. Mercury induces free radical formation, autoimmunity, and genetic and epigenetic changes, so these findings raise the possibility that mercury plays a part in the pathogenesis of degenerative CNS disorders that also affect the retina and optic nerve.	[Pamphlett, Roger; Jew, Stephen Kum] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Cherepanoff, Svetlana] St Vincents Hosp, Sydpath, Sydney, NSW, Australia; [Cherepanoff, Svetlana] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia; [Cherepanoff, Svetlana] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia	University of Sydney; University of Sydney; St Vincents Hospital Sydney; University of Sydney; University of New South Wales Sydney	Pamphlett, R (corresponding author), Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au		Pamphlett, Roger/0000-0003-3326-7273	Aimee Stacy Memorial bequest; Ignacy Burnett bequest	Aimee Stacy Memorial bequest; Ignacy Burnett bequest	RP is supported by the Aimee Stacy Memorial and Ignacy Burnett bequests.	Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; BERLIN M, 1963, ARCH ENVIRON HEALTH, V6, P610, DOI 10.1080/00039896.1963.10663449; BERLIN M, 1963, ARCH ENVIRON HEALTH, V6, P589, DOI 10.1080/00039896.1963.10663447; Bilak S, 2019, HUM EXP TOXICOL, V38, P814, DOI 10.1177/0960327119842637; Bjorklund G, 2017, ENVIRON RES, V159, P545, DOI 10.1016/j.envres.2017.08.051; Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007; Bridges CC, 2007, TOXICOL APPL PHARM, V221, P251, DOI 10.1016/j.taap.2007.03.004; Bridges CC, 2017, ARCH TOXICOL, V91, P63, DOI 10.1007/s00204-016-1803-y; Burton Erik V, 2011, Pathophysiology, V18, P81, DOI 10.1016/j.pathophys.2010.04.009; Cardenas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00384-5; Cariccio VL, 2019, BIOL TRACE ELEM RES, V187, P341, DOI 10.1007/s12011-018-1380-4; CHANG LW, 1972, EXP NEUROL, V35, P122, DOI 10.1016/0014-4886(72)90064-7; Chang P, 2016, INVEST OPHTH VIS SCI, V57, P2277, DOI 10.1167/iovs.15-18629; Chow BW, 2017, NEURON, V93, P1325, DOI 10.1016/j.neuron.2017.02.043; CLARKSON TW, 1972, BIOL NEONATE, V21, P239; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Cohen SY, 2016, RETINA-J RET VIT DIS, V36, P458, DOI 10.1097/IAE.0000000000000741; Crespo-Lopez ME, 2009, PHARMACOL RES, V60, P212, DOI 10.1016/j.phrs.2009.02.011; DANSCHER G, 1994, NEUROPATH APPL NEURO, V20, P454, DOI 10.1111/j.1365-2990.1994.tb00996.x; Ekinci M, 2014, MED SCI MONITOR, V20, P1284, DOI 10.12659/MSM.890756; El-Sherbeeny AM, 2006, CUTAN OCUL TOXICOL, V25, P173, DOI 10.1080/15569520600860215; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Fahrenkrog B, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120232; Fawzi AA, 2014, AMYOTROPH LAT SCL FR, V15, P569, DOI 10.3109/21678421.2014.951941; Fyfe I, 2018, NAT REV NEUROL, V14, P449, DOI 10.1038/s41582-018-0044-5; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Garbuzova-Davis S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00021; Gray MT, 2015, J CEREBR BLOOD F MET, V35, P747, DOI 10.1038/jcbfm.2015.32; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Holson JF, 2005, CRIT REV TOXICOL, V35, P739, DOI 10.1080/10408440591007412; Huber G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013403; Hubers A, 2016, J NEURAL TRANSM, V123, P281, DOI 10.1007/s00702-015-1483-4; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; KHAYAT A, 1984, ACTA PHARMACOL TOX, V55, P145; Khayat A, 1983, J APPL TOXICOL, V3, P66, DOI 10.1002/jat.2550030203; Ko F, 2018, JAMA NEUROL, V75, P1198, DOI 10.1001/jamaneurol.2018.1578; Korbas M, 2008, P NATL ACAD SCI USA, V105, P12108, DOI 10.1073/pnas.0803147105; Korbas M, 2013, ACS CHEM BIOL, V8, P2256, DOI 10.1021/cb4004805; Kullmann JAP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122874; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; LUND BO, 1991, BIOCHEM PHARMACOL, V42, pS181, DOI 10.1016/0006-2952(91)90408-W; Manjunath V, 2011, OPHTHALMOLOGY, V118, P531, DOI 10.1016/j.ophtha.2010.07.013; MOLLERMADSEN B, 1992, ARCH TOXICOL, V66, P79, DOI 10.1007/BF02342499; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Mukherjee N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185242; Mutlu U, 2018, JAMA NEUROL, V75, P1256, DOI 10.1001/jamaneurol.2018.1563; Pamphlett R, 2001, NEUROTOXICOL TERATOL, V23, P191, DOI 10.1016/S0892-0362(00)00122-7; Pamphlett R, 1998, J NEUROL SCI, V159, P121, DOI 10.1016/S0022-510X(98)00161-0; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203627; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Porter LF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0608-2; Rodriguez-Farre E, 2016, REGUL TOXICOL PHARM, V79, P108, DOI 10.1016/j.yrtph.2015.12.015; Rothman AL, 2015, AM J OPHTHALMOL, V160, P1296, DOI 10.1016/j.ajo.2015.09.015; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Sakamoto M, 2018, ENVIRON RES, V167, P15, DOI 10.1016/j.envres.2018.06.038; Smith RS, 2002, RES METH MUT M SER, P45; Solan TD, 2014, J PERINAT MED, V42, P725, DOI 10.1515/jpm-2013-0349; Tartaglione AM, 2016, CURR TOP BEHAV NEURO, V29, P231, DOI 10.1007/7854_2015_416; Toimela TA, 2001, TOXICOL IN VITRO, V15, P7, DOI 10.1016/S0887-2333(00)00057-6; ULSHAFER RJ, 1990, ARCH OPHTHALMOL-CHIC, V108, P113, DOI 10.1001/archopht.1990.01070030119041; Vas J, 2008, ANN NY ACAD SCI, V1143, P240, DOI 10.1196/annals.1443.022; Volland S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125631; Wang GY, 2013, J ADOLESCENT HEALTH, V52, pS14, DOI 10.1016/j.jadohealth.2012.04.019; Warfvinge K, 1996, TOXICOLOGY, V107, P189, DOI 10.1016/0300-483X(95)03257-G; WARFVINGE K, 1995, INT J EXP PATHOL, V76, P29; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Yoshida M, 2002, TOHOKU J EXP MED, V196, P79, DOI 10.1620/tjem.196.79; Yoshida M, 1997, TOXICOLOGY, V119, P193, DOI 10.1016/S0300-483X(96)03611-6	73	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220859	10.1371/journal.pone.0220859	http://dx.doi.org/10.1371/journal.pone.0220859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390377	Green Published, Green Submitted, gold			2022-12-26	WOS:000484999400033
J	Yoshino, H; Yin, GW; Kawaguchi, R; Popov, KI; Temple, B; Sasaki, M; Kofuji, S; Wolfe, K; Kofuji, K; Okumura, K; Randhawa, J; Malhotra, A; Majd, N; Ikeda, Y; Shimada, H; Kahoud, ER; Haviv, S; Iwase, S; Asara, JM; Campbell, SL; Sasaki, AT				Yoshino, Hirofumi; Yin, Guowei; Kawaguchi, Risa; Popov, Konstantin, I; Temple, Brenda; Sasaki, Mika; Kofuji, Satoshi; Wolfe, Kara; Kofuji, Kaori; Okumura, Koichi; Randhawa, Jaskirat; Malhotra, Akshiv; Majd, Nazanin; Ikeda, Yoshiki; Shimada, Hiroko; Kahoud, Emily Rose; Haviv, Sasson; Iwase, Shigeki; Asara, John M.; Campbell, Sharon L.; Sasaki, Atsuo T.			Identification of lysine methylation in the core GTPase domain by GoMADScan	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; K-RAS; COSTELLO-SYNDROME; KRAS MUTATIONS; HISTONE ACETYLATION; H-RAS; CANCER; ONCOGENES; PROTEINS; ISOFORMS	RAS is the founding member of a superfamily of GTPases and regulates signaling pathways involved in cellular growth control. While recent studies have shown that the activation state of RAS can be controlled by lysine ubiquitylation and acetylation, the existence of lysine methylation of the RAS superfamily GTPases remains unexplored. In contrast to acetylation, methylation does not alter the side chain charge and it has been challenging to deduce its impact on protein structure by conventional amino acid substitutions. Herein, we investigate lysine methylation on RAS and RAS-related GTPases. We developed GoMADScan (Go language-based Modification Associated Database Scanner), a new user-friendly application that scans and extracts posttranslationally modified peptides from databases. The GoMADScan search on PhosphoSitePlus databases identified methylation of conserved lysine residues in the core GTPase domain of RAS superfamily GTPases, including residues corresponding to RAS Lys-5, Lys-16, and Lys-117. To follow up on these observations, we immunoprecipitated endogenous RAS from HEK293T cells, conducted mass spectrometric analysis and found that RAS residues, Lys-5 and Lys-147, undergo dimethylation and monomethylation, respectively. Since mutations of Lys-5 have been found in cancers and RASopathies, we set up molecular dynamics (MD) simulations to assess the putative impact of Lys-5 dimethylation on RAS structure. Results from our MD analyses predict that dimethylation of Lys-5 does not significantly alter RAS conformation, suggesting that Lys-5 methylation may alter existing protein interactions or create a docking site to foster new interactions. Taken together, our findings uncover the existence of lysine methylation as a novel posttranslational modification associated with RAS and the RAS superfamily GTPases, and putative impact of Lys-5 dimethylation on RAS structure.	[Yoshino, Hirofumi; Kawaguchi, Risa; Sasaki, Mika; Kofuji, Satoshi; Wolfe, Kara; Kofuji, Kaori; Okumura, Koichi; Randhawa, Jaskirat; Malhotra, Akshiv; Ikeda, Yoshiki; Shimada, Hiroko; Sasaki, Atsuo T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Hematol & Oncol, Cincinnati, OH 45267 USA; [Yin, Guowei; Popov, Konstantin, I; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA; [Yin, Guowei; Popov, Konstantin, I; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27515 USA; [Kawaguchi, Risa] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan; [Temple, Brenda] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC 27515 USA; [Majd, Nazanin] Univ Cincinnati, Dept Neurol, Coll Med, Cincinnati, OH USA; [Kahoud, Emily Rose; Iwase, Shigeki; Asara, John M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Kahoud, Emily Rose; Iwase, Shigeki; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Haviv, Sasson] Univ Michigan, Dept Human Genet, 5815 Med Sci 2, Ann Arbor, MI 48109 USA; [Sasaki, Atsuo T.] Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA; [Sasaki, Atsuo T.] UC Gardner Neurosci Inst, Brain Tumor Ctr, Dept Neurosurg, Cincinnati, OH 45229 USA; [Sasaki, Atsuo T.] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	University System of Ohio; University of Cincinnati; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Tokyo; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Cincinnati; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; University System of Ohio; University of Cincinnati; Keio University	Sasaki, AT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Hematol & Oncol, Cincinnati, OH 45267 USA.; Campbell, SL (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA.; Campbell, SL (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27515 USA.; Sasaki, AT (corresponding author), Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA.; Sasaki, AT (corresponding author), UC Gardner Neurosci Inst, Brain Tumor Ctr, Dept Neurosurg, Cincinnati, OH 45229 USA.; Sasaki, AT (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	campbesl@med.unc.edu; atsuo.sasaki@uc.edu	Iwase, Shigeki/J-8294-2019	Iwase, Shigeki/0000-0003-2280-7422; campbell, sharon/0000-0003-0311-409X; Sasaki, Atsuo/0000-0003-2963-4501; Yin, Guowei/0000-0003-2669-7160; Kawaguchi, Risa Karakida/0000-0003-1764-5721	Kanae Foundation; Uehara Memorial Foundation; University of Cincinnati startup fund; Marlene Harris-Ride Cincinnati Breast Cancer Grant [R21NS100077, 1R01NS089815]; NIH [5P01CA120964]; UC Brain Tumor Center MTP fund;  [14J00402];  [R01 GM106227];  [P01CA203567]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA016086, P01CA203657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089815, R21NS100077] Funding Source: NIH RePORTER	Kanae Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); University of Cincinnati startup fund; Marlene Harris-Ride Cincinnati Breast Cancer Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Brain Tumor Center MTP fund; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	S. K. was supported, in part, by the Kanae Foundation. H. Y. was supported by the Uehara Memorial Foundation. R. K. by Grant-in Aid for JSPS Fellows [Grant Number 14J00402]. The work is supported in part by R01 GM106227 and P01CA203567 (S.L.C.), the Kanae foundation, the University of Cincinnati startup fund, UC Brain Tumor Center MTP fund, Marlene Harris-Ride Cincinnati Breast Cancer Grant, R21NS100077 and 1R01NS089815 (A.T.S.). J.M.A. is supported in part by NIH grant 5P01CA120964.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahearn I, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031484; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Alam H, 2015, CELL MOL LIFE SCI, V72, P4577, DOI 10.1007/s00018-015-2023-y; AMARO AM, 1984, J BACTERIOL, V158, P84, DOI 10.1128/JB.158.1.84-93.1984; AMBLER RP, 1959, NATURE, V184, P56, DOI 10.1038/184056b0; AMES GFL, 1979, J BIOL CHEM, V254, P9947; Baker R, 2013, J BIOL CHEM, V288, P36856, DOI 10.1074/jbc.C113.525691; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Bernardes GJL, 2008, J AM CHEM SOC, V130, P5052, DOI 10.1021/ja800800p; Bertola DR, 2012, CLIN GENET, V81, P595, DOI 10.1111/j.1399-0004.2011.01764.x; Bertola DR, 2007, J HUM GENET, V52, P521, DOI 10.1007/s10038-007-0146-1; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bigenzahn JW, 2018, SCIENCE, V362, P1171, DOI 10.1126/science.aap8210; Borrie SC, 2017, ANNU REV GENOM HUM G, V18, P115, DOI 10.1146/annurev-genom-091416-035332; BOS JL, 1989, CANCER RES, V49, P4682; Case, 2016, AMBER 2016 REFERENCE, P1, DOI DOI 10.13140/RG.2.2.27958.70729; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cruz-Migoni A, 2019, P NATL ACAD SCI USA, V116, P2545, DOI 10.1073/pnas.1811360116; DELANGE RJ, 1970, J BIOL CHEM, V245, P3325; Denayer E, 2008, HUM MUTAT, V29, P232, DOI 10.1002/humu.20616; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; HALLBERG B, 1994, J BIOL CHEM, V269, P3913; HARDY MF, 1970, BIOCHEM J, V120, P653, DOI 10.1042/bj1200653; Hennig A, 2015, BIOL CHEM, V396, P831, DOI 10.1515/hsz-2014-0257; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Homma Y, 2019, J CELL BIOL, V218, P2035, DOI 10.1083/jcb.201810134; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Hunter JC, 2014, P NATL ACAD SCI USA, V111, P8895, DOI 10.1073/pnas.1404639111; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jinesh GG, 2018, ONCOGENE, V37, P839, DOI 10.1038/onc.2017.377; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Knyphausen P, 2016, BIOL CHEM, V397, P1071, DOI 10.1515/hsz-2016-0118; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lee SH, 2003, ONCOGENE, V22, P6942, DOI 10.1038/sj.onc.1206749; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; LITALIEN JJ, 1981, J BIOL CHEM, V256, P8092; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lo FS, 2009, EUR J PEDIATR, V168, P919, DOI 10.1007/s00431-008-0858-z; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malumbres M, 2003, NAT REV CANC; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; Niihori T, 2011, J HUM GENET, V56, P707, DOI 10.1038/jhg.2011.85; Nussinov R, 2018, CANCER RES, V78, P593, DOI 10.1158/0008-5472.CAN-17-2727; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Papamokos GV, 2012, BIOPHYS J, V102, P1926, DOI 10.1016/j.bpj.2012.03.030; Papke B, 2017, SCIENCE, V355, P1158, DOI 10.1126/science.aam7622; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Sasaki AT, 2009, METHODS MOL BIOL, V571, P333, DOI 10.1007/978-1-60761-198-1_23; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Song HY, 2016, ONCOTARGET, V7, P80336, DOI 10.18632/oncotarget.12015; Steklov M, 2018, SCIENCE, V362, P1177, DOI 10.1126/science.aap7607; Stenmark H, 2001, GENOME BIOL, V2; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sumita K, 2014, J BIOL CHEM, V289, P3950, DOI 10.1074/jbc.M113.531178; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Welsch ME, 2017, CELL, V168, P878, DOI 10.1016/j.cell.2017.02.006; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Zenker M, 2007, J MED GENET, V44, P131, DOI 10.1136/jmg.2006.046300	94	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0219436	10.1371/journal.pone.0219436	http://dx.doi.org/10.1371/journal.pone.0219436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390367	Green Published, gold, Green Submitted			2022-12-26	WOS:000484999400006
J	Darwich, L; Vidal, A; Seminati, C; Albamonte, A; Casado, A; Lopez, F; Molina-Lopez, RA; Migura-Garcia, L				Darwich, Laila; Vidal, Anna; Seminati, Chiara; Albamonte, Andreu; Casado, Alba; Lopez, Ferran; Molina-Lopez, Rafael A.; Migura-Garcia, Lourdes			High prevalence and diversity of extended-spectrum beta-lactamase and emergence of OXA-48 producing Enterobacterales in wildlife in Catalonia	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; CTX-M; SALMONELLA; ANIMALS; STRAINS; SPAIN; BIRDS; FOOD; INFECTIONS	Most of the studies focused on antimicrobial resistance (AMR) performed in wildlife describe Escherichia coli as the principal indicator of the selective pressure. In the present study, several species of Enterobacterales with a large panel of cephalosporin resistant (CR) genes have been isolated from wildlife in Catalonia. A total of 307 wild animals were examined to determine the prevalence of CR enterobacteria, AMR phenotypes and the presence of common carbapenem and CR genes. The overall prevalence of CR-phenotype was 13% (40/307): 17.3% in wild mammals (18/104) and 11.5% in wild birds (22/191) (p< 0.01). Hedgehogs showed the highest prevalence (13.5% of 104) of the mammal specimens, and raptors the highest in bird specimen (7.3% of 191). Although CR E. coli was the most frequently isolated (45%), other CR- Enterobacterales like Klebsiella pneumoniae (20%), Citrobacter freundii (15%), Enterobacter cloacae (5%), Proteus mirabilis (5%), Providencia spp (5%) and Serratia marcescens (2.5%) were also isolated. A high diversity of CR genes was identified among the isolates, with 50% yielding blaCMY-2, 23% blaSHV-12, 20% blaCMY-1 and 18% blaCTX-M-15. Additionally, resistance to carbapenems associated to OXA-48 gene was found. Most of the CR isolates, principally K. pneumoniae and C. freundii, were multiresistant with co-resistance to fluoroquinolones, tetracycline, sulphonamides and aminoglycosides. This study reports high prevalence of Enterobacterales harbouring a variety of CR genes and OXA-48 mediated-carbapenem resistance, all of them frequently associated to nosocomial human infections, for the first time in wild mammals and wild birds. Implementation of control measures to reduce the impact of anthropogenic pressure in the environment is urgently needed.	[Darwich, Laila; Vidal, Anna; Seminati, Chiara; Albamonte, Andreu; Casado, Alba; Lopez, Ferran] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Cerdanyola Del Valles, Spain; [Darwich, Laila; Migura-Garcia, Lourdes] IRTA UAB, CReSA, IRTA, Campus Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain; [Molina-Lopez, Rafael A.] Catalan Wildlife Serv, Ctr Fauna Salvatge Torreferrussa, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Darwich, L (corresponding author), Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Cerdanyola Del Valles, Spain.; Darwich, L (corresponding author), IRTA UAB, CReSA, IRTA, Campus Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain.	laila.darwich@uab.cat	Darwich, Laila/F-5330-2016; Migura-Garcia, Lourdes/E-3560-2016; Casado, Alba/AGY-6067-2022	Darwich, Laila/0000-0001-9027-9452; Migura-Garcia, Lourdes/0000-0003-2935-928X; Casado, Alba/0000-0002-1172-3728; Molina Lopez, Rafael/0000-0002-9043-2346	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA); European Social Fund; PIF grant from the Universitat Autonoma de Barcelona	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Social Fund(European Social Fund (ESF)); PIF grant from the Universitat Autonoma de Barcelona	The contract of LMG was supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the European Social Fund. AV was supported by a PIF grant from the Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala L, 2016, MICROB ECOL, V72, P861, DOI 10.1007/s00248-015-0718-0; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Alonso CA, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix097; Alonso CA, 2017, J ANTIMICROB CHEMOTH, V72, P1589, DOI 10.1093/jac/dkx024; Annavajhala MK, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00044; Aracil-Garcia B, 2017, ENFERM INFEC MICR CL, V35, P478, DOI [10.1016/j.eimce.2017.08.007, 10.1016/j.eimc.2016.06.007]; Arlet G, 1997, FEMS MICROBIOL LETT, V152, P163, DOI 10.1111/j.1574-6968.1997.tb10423.x; Atterby C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190380; Ben Sallem R, 2013, VECTOR-BORNE ZOONOT, V13, P98, DOI 10.1089/vbz.2012.1047; Ben Yahia H, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1163-2; Bonnedahl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141315; Bonnedahl J, 2014, EMERG INFECT DIS, V20, P897, DOI 10.3201/eid2005.130325; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Canton R, 2019, REV ESP QUIM, V32, P145; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Criatovao F, 2017, FEMS MICROBIOL LETT, V364, P49; Davin-Regli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00392; Dessi A, 2009, J CHEMOTHERAPY, V21, P493, DOI 10.1179/joc.2009.21.5.493; Diaz MA, 2010, J CLIN MICROBIOL, V48, P2840, DOI 10.1128/JCM.02147-09; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x; Dorado-Garcia A, 2018, J ANTIMICROB CHEMOTH, V73, P339, DOI 10.1093/jac/dkx397; Fernandez J, 2015, INT J ANTIMICROB AG, V46, P469, DOI 10.1016/j.ijantimicag.2015.07.003; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P2954, DOI 10.1093/jac/dkt260; Garcia-Menino I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02659; Grundmann H, 2017, LANCET INFECT DIS, V17, P153, DOI 10.1016/S1473-3099(16)30257-2; Guenther S, 2017, J ANTIMICROB CHEMOTH, V72, P1289, DOI 10.1093/jac/dkw585; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Hasan B, 2016, MICROB DRUG RESIST, V22, P682, DOI 10.1089/mdr.2015.0323; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Huijbers PMC, 2015, ENVIRON SCI TECHNOL, V49, P11993, DOI 10.1021/acs.est.5b02566; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jouini A, 2007, J ANTIMICROB CHEMOTH, V60, P1137, DOI 10.1093/jac/dkm316; Kim J, 1998, J CLIN MICROBIOL, V36, P1446, DOI 10.1128/JCM.36.5.1446-1449.1998; Liakopoulos A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01374; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Merino I, 2016, J ANTIMICROB CHEMOTH, V71, P2125, DOI 10.1093/jac/dkw133; Miro E, 2002, ANTIMICROB AGENTS CH, V46, P3991, DOI 10.1128/AAC.46.12.3991-3994.2002; Mohsin M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02476; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Oteo J, 2018, MICROB DRUG RESIST, V24, P932, DOI 10.1089/mdr.2018.0004; Parker D, 2016, LETT APPL MICROBIOL, V63, P11, DOI 10.1111/lam.12589; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Ranjan KP, 2013, UROL ANNALS, V5, P313; Rashid Mahmudur, 2015, Infection Ecology & Epidemiology, V5, P26712, DOI 10.3402/iee.v5.26712; Raza S, 2017, ECOHEALTH, V14, P182, DOI 10.1007/s10393-016-1204-y; Rebelo AR, 2018, EUROSURVEILLANCE, V23, P29, DOI 10.2807/1560-7917.ES.2018.23.6.17-00672; Simoes RR, 2010, EMERG INFECT DIS, V16, P110, DOI 10.3201/eid1601.090896; Skov RL, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.9.30155; Smet A, 2010, FEMS MICROBIOL REV, V34, P295, DOI 10.1111/j.1574-6976.2009.00198.x; Stedt J, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0166-3; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Veldman K, 2013, APPL ENVIRON MICROB, V79, P7556, DOI 10.1128/AEM.01880-13; Vergara A, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02071-16; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009	57	34	34	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0210686	10.1371/journal.pone.0210686	http://dx.doi.org/10.1371/journal.pone.0210686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381578	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600001
J	Altamura, C; Paolucci, M; Brunelli, N; Rizzo, AC; Cecchi, G; Assenza, F; Silvestrini, M; Vernieri, F				Altamura, Claudia; Paolucci, Matteo; Brunelli, Nicoletta; Rizzo, Angelo Cascio; Cecchi, Gianluca; Assenza, Federica; Silvestrini, Mauro; Vernieri, Fabrizio			Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura	PLOS ONE			English	Article							TRANSCRANIAL DOPPLER; STROKE; RISK; SUPERSENSITIVITY; HEMODYNAMICS; INFARCTS	Patent Foramen Ovale and impaired cerebral hemodynamics were proposed among the pathophysiological mechanisms explaining the increased risk for stroke in patients with Migraine with Aura (MA). Our study aimed at comparing the vasomotor reactivity (VMR) of the anterior and the posterior cerebral circulation in patients with Migraine with Aura, in patients with acute vascular ischemic accidents, and in controls. We hypothesized that VMR in MA patients is preserved in the anterior circulation and reduced in the posterior circulation. We prospectively assessed with Transcranial Doppler the vasomotor reactivity to breath holding of the Middle and Posterior Cerebral Arteries (MCA, PCA) in MA patients, in acute vascular patients and healthy controls. We also evaluated the possible effect of clinical characteristics of MA (attack frequency, aura length or type, disease history), vascular factors and the presence of right-to-left shunt on VMR. Diverging from our hypothesis, MA patients displayed a higher breath-holding index (BHI) than controls in the MCA (1.84 +/- 0.47%/s vs 1.53 +/- 0.47%/s, p = .001) as well as in the PCA (1.87 +/- 0.65%/s vs 1.47 +/- 0.44%/s, p<.001). In MA patients, MCA BHI was higher in those with large right-to-left shunts (2.09 +/- 0.42 vs 1.79 +/- 0.47, p=.046) and lower in those taking estrogens (1.30 +/- 0.30%/s vs 1.9 +/- 0.45%/s, p = .009). We did not observe an effect of MA characteristics on BHI. The increased BHI in MA patients with large right-to-left shunts could be explained by the vasoactive effect in the cerebral circulation of substances bypassing the deactivating pulmonary filters or by a constitutional trait of the vascular system associating persistent right-to-left shunts and hyper-reactive hemodynamics. Our results discourage the hypothesis that altered hemodynamics contribute to increasing the stroke risk in all MA patients. However, estrogens can lower VMR, curtailing the hemodynamic resources of MA patients.	[Altamura, Claudia; Paolucci, Matteo; Brunelli, Nicoletta; Rizzo, Angelo Cascio; Cecchi, Gianluca; Assenza, Federica; Vernieri, Fabrizio] Campus Biomed Univ Rome, Clin Neurol Headache & Neurosonol Unit, Rome, Italy; [Silvestrini, Mauro] Marche Polytech Univ, Dept Expt & Clin Med, Neurol Clin, Ancona, Italy	University Campus Bio-Medico - Rome Italy; Marche Polytechnic University	Altamura, C (corresponding author), Campus Biomed Univ Rome, Clin Neurol Headache & Neurosonol Unit, Rome, Italy.	c.altamura@unicampus.it	Altamura, Claudia/J-1156-2019; Brunelli, Nicoletta/ABE-1864-2020; Silvestrini, Mauro/AAB-3838-2019; Paolucci, Matteo/AAE-2722-2019	Altamura, Claudia/0000-0002-5934-5535; Paolucci, Matteo/0000-0002-5347-378X; Cascio Rizzo, Angelo/0000-0002-3258-5061; Brunelli, Nicoletta/0000-0002-8590-9015				Altamura C, 2018, NEUROL SCI, V39, pS101, DOI 10.1007/s10072-018-3354-x; Altamura C, 2018, NEUROL SCI, V39, pS87, DOI 10.1007/s10072-018-3351-0; Androulakis XM, 2016, NEUROLOGY, V87, P2527, DOI 10.1212/WNL.0000000000003428; Bartolini M, 2005, FUNCT NEUROL, V20, P209; Buratti L, 2016, J CEREBR BLOOD F MET, V36, P1804, DOI 10.1177/0271678X15613526; Diomedi M, 2001, J NEUROL SCI, V185, P49, DOI 10.1016/S0022-510X(01)00462-2; Fiermonte G, 1999, CEPHALALGIA, V19, P492, DOI 10.1046/j.1468-2982.1999.019005492.x; Frederiksen SD, 2019, J CEREBR BLOOD F MET, V39, P610, DOI 10.1177/0271678X17747188; Gaist D, 2016, BRAIN, V139, P2015, DOI 10.1093/brain/aww099; Goadsby Peter J, 2013, Handb Clin Neurol, V117, P193, DOI 10.1016/B978-0-444-53491-0.00016-X; Gollion C, 2019, CEPHALALGIA, V39, P635, DOI 10.1177/0333102418806861; Grimsrud KW, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0716-2; Guo ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104849; Hodkinson DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137971; Homma S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.86; Jauss M, 2000, CEREBROVASC DIS, V10, P490, DOI 10.1159/000016119; Jiang XH, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1022-7; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Li LX, 2015, NEUROLOGY, V85, P1444, DOI 10.1212/WNL.0000000000002059; Lokkegaard E, 2017, STROKE, V48, P2266, DOI 10.1161/STROKEAHA.117.017132; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Magalhaes JE, 2018, HEADACHE, V58, P1277, DOI 10.1111/head.13378; Mahmoud AN, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020498; Mawet J, 2015, NEUROLOGY, V85, P1945, DOI 10.1212/WNL.0000000000002166; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; OLESEN J, 1993, NEUROREPORT, V4, P1027, DOI 10.1097/00001756-199308000-00008; Park TH, 2013, J STROKE CEREBROVASC, V22, P482, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.006; Perko D, 2011, ACTA NEUROL SCAND, V124, P269, DOI 10.1111/j.1600-0404.2010.01468.x; Pezzini A, 2018, STROKE, V49, P573, DOI 10.1161/STROKEAHA.118.020554; Rajan R, 2015, J NEUROL NEUROSUR PS, V86, P1253, DOI 10.1136/jnnp-2014-309571; Reinhard M, 2014, NEUROLOGY, V83, P1424, DOI 10.1212/WNL.0000000000000888; Rivera-Lara L, 2017, ANESTHESIOLOGY, V126, P1187, DOI 10.1097/ALN.0000000000001625; Sacco S, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0815-1; Sacco S, 2012, J HEADACHE PAIN, V13, P177, DOI 10.1007/s10194-012-0424-y; Schulte LH, 2016, BRAIN, V139, P1987, DOI 10.1093/brain/aww097; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Silvestrini M, 2004, HEADACHE, V44, P29, DOI 10.1111/j.1526-4610.2004.04006.x; THOMSEN LL, 1995, CEPHALALGIA, V15, P211, DOI 10.1046/j.1468-2982.1995.015003211.x; THOMSEN LL, 1995, CLIN AUTON RES, V5, P243, DOI 10.1007/BF01818887; THOMSEN LL, 1993, CEPHALALGIA, V13, P395, DOI 10.1046/j.1468-2982.1993.1306395.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vernieri F, 2008, CEPHALALGIA, V28, P689, DOI 10.1111/j.1468-2982.2008.01579.x; Vernieri F, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-18	43	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220637	10.1371/journal.pone.0220637	http://dx.doi.org/10.1371/journal.pone.0220637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369637	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900072
J	Anaba, UC; Sam-Agudu, NA; Ramadhani, HO; Torbunde, N; Abimiku, A; Dakum, P; Aliyu, SH; Charurat, M				Anaba, Udochisom C.; Sam-Agudu, Nadia A.; Ramadhani, Habib O.; Torbunde, Nguavese; Abimiku, Alash'le; Dakum, Patrick; Aliyu, Sani H.; Charurat, Manhattan			Missed opportunities for early infant diagnosis of HIV in rural North-Central Nigeria: A cascade analysis from the INSPIRE MoMent study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; MENTOR MOTHER PROGRAMS; IMPLEMENTATION RESEARCH; EXPOSED INFANTS; PREVENTION; LINKAGE; IMPACT; PMTCT; WOMEN; CARE	Background Early identification of HIV-infected infants for treatment is critical for survival. Efficient uptake of early infant diagnosis (EID) requires timely presentation of HIV-exposed infants, same-day sample collection, and prompt release of results. The MoMent (Mother Mentor) Nigeria study investigated the impact of structured peer support on EID presentation and maternal retention. This cascade analysis highlights missed opportunities for EID and infant treatment initiation during the study. Methods HIV-infected pregnant women and their infants were recruited at 20 rural Primary Healthcare Centers. Routine infant HIV DNA PCR testing was performed at centralized laboratories using dried blood spot (DBS) samples ideally collected by age two months. EID outcomes data were abstracted from study case report forms and facility registers. Descriptive statistics summarized gaps and missed opportunities in the EID cascade. Results Out of 497 women enrolled, delivery data was available for 445 (90.8%), to whom 415 of 455 (91.2%) infants were live-born. Out of 408 live-born infants with available data, 341 (83.6%) presented for DBS sampling at least once. Only 75.4% (257/341) were sampled, with 81.7% (210/257) sampled at first presentation. Only 199/257 (77.4%) sampled infants had results available up to 28 months post-collection. Two (1.0%) of the 199 infants tested HIV-positive; one infant died before treatment initiation and the other was lost to follow-up. Conclusions While nearly 85% of infants presented for sampling, there were multiple missed opportunities, largely due to health system and not necessarily patient-level failures. These included infants presenting without being sampled, presenting multiple times before samples were collected, and getting sampled but results not forthcoming. Finally, neither of the two HIV-positive infants were linked to treatment within the follow-up period, which may have led to the death of one. To facilitate patient compliance and HIV-free infant survival, quality improvement approaches should be optimized for EID commodity availability, consistent DBS sample collection, efficient processing/result release, and prompt infant treatment initiation.	[Anaba, Udochisom C.; Sam-Agudu, Nadia A.; Abimiku, Alash'le] Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Federal Capital, Nigeria; [Sam-Agudu, Nadia A.; Ramadhani, Habib O.; Abimiku, Alash'le; Dakum, Patrick; Charurat, Manhattan] Univ Maryland, Sch Med, Inst Human Virol, Div Epidemiol & Prevent, Baltimore, MD 21201 USA; [Sam-Agudu, Nadia A.; Torbunde, Nguavese; Dakum, Patrick] Inst Human Virol Nigeria, Prevent Care & Treatment Unit, Abuja, Federal Capital, Nigeria; [Aliyu, Sani H.] Natl Agcy Control AIDS, Off Director Gen, Abuja, Nigeria; [Sam-Agudu, Nadia A.] Maternal & Newborn Hlth Populat Council, Washington, DC 20008 USA	University System of Maryland; University of Maryland Baltimore	Sam-Agudu, NA (corresponding author), Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Federal Capital, Nigeria.; Sam-Agudu, NA (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Div Epidemiol & Prevent, Baltimore, MD 21201 USA.; Sam-Agudu, NA (corresponding author), Inst Human Virol Nigeria, Prevent Care & Treatment Unit, Abuja, Federal Capital, Nigeria.; Sam-Agudu, NA (corresponding author), Maternal & Newborn Hlth Populat Council, Washington, DC 20008 USA.	nsamagudu@ihvnigeria.org		Anaba, Udochisom/0000-0002-2590-5231; Adejuyigbe, Ebunoluwa/0000-0002-8671-4965	World Health Organization [WHO RPC 531]	World Health Organization(World Health Organization)	The MoMent Nigeria study was funded by the World Health Organization through an award to NASA (WHO RPC 531) for the INtegrating and Scaling up PMTCT through Implementation REsearch (INSPIRE) initiative from Global Affairs Canada. http://www.who.int/hiv/pub/journal_articles/inspire-intro/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka DA, 2016, INT J STD AIDS, V27, P1338, DOI 10.1177/0956462416665027; Aliyu M. H., 2014, JAIDS, Journal of Acquired Immune Deficiency Syndromes, V67, pe19, DOI 10.1097/QAI.0000000000000215; [Anonymous], HIV EST UNC BOUNDS 1; Bhardwaj S, 2015, CURR HIV-AIDS REP, V12, P246, DOI 10.1007/s11904-015-0260-1; Blais P, 2014, JAIDS-J ACQ IMM DEF, V67, pS105, DOI 10.1097/QAI.0000000000000357; Central Statistics Office (CSO), 2017, ETHN EQ QUEST CENS 2; Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; Chi BH, 2013, CURR HIV-AIDS REP, V10, P124, DOI 10.1007/s11904-013-0154-z; Coulibaly M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111240; Essajee S, 2017, JAIDS J ACQUIRED IMM, V75; Federal Ministry of Health Nigeria, 2016, NAT GUID HIV PREV TR; Federal Ministry of Health (Nigeria), 2014, 2014 NAT SER PREV SE; Federal Ministry of Health Nigeria, 2014, INT NAT GUID HIV PRE; Feucht UD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1265; Ghadrshenas A, 2013, AIDS, V27, pS197, DOI 10.1097/QAD.0000000000000104; Girma M, 2017, TROP MED INT HEALTH, V22, P765, DOI 10.1111/tmi.12881; Hamilton E, 2017, JAIDS-J ACQ IMM DEF, V75, pS27, DOI 10.1097/QAI.0000000000001325; Inalegwu Auchi, 2016, World J Virol, V5, P73, DOI 10.5501/wjv.v5.i2.73; Isah HO, 2014, 8 INTEREST INT WORKS, P45; Jani IV, 2019, CURR OPIN HIV AIDS, V14, P55, DOI 10.1097/COH.0000000000000511; Jean-Philippe P, 2017, AIDS, V31, P1797, DOI 10.1097/QAD.0000000000001561; National Agency for the Control of AIDS,, 2017, NAT STRAT FRAM HIV A; National agency for the control of AIDS, 2016, FACT SHEET PREV MOTH; National Agency for the Control of AIDS (Nigeria), 2010, 2010 2015 HIV AIDS S; Nations United, 2016, SUST DEV KNOWL PLATF; OWIREDU MN, 2017, J ACQUIR IMMUNE D S2, V75, pS24; Pharr JR, 2016, JAIDS-J ACQ IMM DEF, V72, pS154, DOI 10.1097/QAI.0000000000001051; Phiri NA, 2017, PUBLIC HEALTH ACTION, V7, P83, DOI 10.5588/pha.16.0119; Population Reference Bureau, 2018, WORLD POP DAT SHEET; Rollins N, 2014, JAIDS-J ACQ IMM DEF, V67, pS108, DOI 10.1097/QAI.0000000000000358; Sam-Agudu NA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1417-2; Sam-Agudu NA, 2017, JAIDS-J ACQ IMM DEF, V75, pS173, DOI [10.1097/QAI.0000000000001346, 10.1097/qai.0000000000001346]; Sam-Agudu NA, 2017, JAIDS-J ACQ IMM DEF, V75, pS182, DOI [10.1097/QAI.0000000000001345, 10.1097/qai.0000000000001345]; Sam-Agudu NA, 2014, JAIDS-J ACQ IMM DEF, V67, pS132, DOI 10.1097/QAI.0000000000000331; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Suksomboon N, 2007, J CLIN PHARM THER, V32, P293, DOI 10.1111/j.1365-2710.2007.00825.x; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; UNAIDS, 2016, FAST TRACK AIDS FREE; UNAIDS, 2018, AIDSINFO EL MOTH TO; UNAIDS, 2018, AIDSINFO TREATM CASC; UNAIDS, 2017, AIDSINFO COUNTR FACT; UNAIDS, 2018, ACT INN SOL BUILD MO; UNICEF, 2016, CHILD SURV 5 MORT; WHO, 2016, MAK EV BAB COUNT AUD; WHO, 2013, SMS PRINT AID EARL I; Woldesenbet SA, 2015, JAIDS-J ACQ IMM DEF, V68, pe26, DOI 10.1097/QAI.0000000000000460; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2010, WHO REC DIAGN HIV IN	48	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220616	10.1371/journal.pone.0220616	http://dx.doi.org/10.1371/journal.pone.0220616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365571	Green Submitted, Green Published, gold			2022-12-26	WOS:000484983600058
J	Zheng, XZ; Wang, BY; Zhao, J				Zheng, Xuezhao; Wang, Baoyuan; Zhao, Ju			High-precision positioning of mine personnel based on wireless pulse technology	PLOS ONE			English	Article							RANGING ALGORITHM; COAL	Aiming at addressing current problems of the low accuracy, long delay, and complex arrangement of positioning systems for coal mine workers, a high-precision personnel positioning method based on two round trips of a radio pulse is proposed, and the influencing factors of the positioning by experiments. A matrix is established by taking the transmission timing of the wireless pulse, the preprocessing time of the label, and the receiving time as elements. The result of the matrix calculation shows that the position of the label is related to the above three factors. Experiments are carried out to simulate base station intervals of 20-90 m on an underground roadway. The results show that when the spacing of the positioning base stations is 70 m, the average positioning error is a minimum of 0.0302 m and the positioning delay is a minimum of 0.43 s. In the same experimental environment, after 60 days of continuous operation, it is found that the mean change in the positioning accuracy of the two-round-trip system is within +/- 0.0003 m while the delay change is within +/- 0.03 s, showing good system stability.	[Zheng, Xuezhao; Wang, Baoyuan; Zhao, Ju] Xian Univ Sci & Technol, Sch Safety Sci & Engn, Xian, Shaanxi, Peoples R China; [Zheng, Xuezhao; Wang, Baoyuan; Zhao, Ju] Minist Educ China, Key Lab Western Mine & Hazard Prevent, Xian, Shaanxi, Peoples R China	Xi'an University of Science & Technology; Ministry of Education, China	Zheng, XZ (corresponding author), Xian Univ Sci & Technol, Sch Safety Sci & Engn, Xian, Shaanxi, Peoples R China.; Zheng, XZ (corresponding author), Minist Educ China, Key Lab Western Mine & Hazard Prevent, Xian, Shaanxi, Peoples R China.	zhengxuezhao@xust.edu.cn			National Key R&D Program of China [2018YFC0808201]; Natural Science Basic Research Program of Shaanxi [2018JQ5080, 2018JM5009]; Special scientific research project of Shaanxi Provincial Education Department [17JK0495]	National Key R&D Program of China; Natural Science Basic Research Program of Shaanxi; Special scientific research project of Shaanxi Provincial Education Department	This work was supported financially by the following funds: National Key R&D Program of China (2018YFC0808201); Natural Science Basic Research Program of Shaanxi (2018JQ5080; 2018JM5009); Special scientific research project of Shaanxi Provincial Education Department (17JK0495).	Awad A, 2007, 10 EUR C DIG SYST DE, DOI 10.1109/DSD.2007.4341511; Bai Xuhua, 2012, J CHINA COAL SOC, V4, P12; [陈鑫 Chen Xin], 2012, [运筹与管理, Operations Research and Management Science], V21, P73; Fujiwara R, 2007, P 2007 INT C ULTR SE; Fujiwara R, 2008, IEICE T COMMUN, VE91B, P518, DOI 10.1093/ietcom/e91-b.2.518; Guo J, 2019, PROCESS SAF ENVIRON, V126, P223, DOI 10.1016/j.psep.2019.04.014; Guo J, 2018, INT J HEAT TECHNOL, V36, P1336, DOI 10.18280/ijht.360424; Halber A., 2018, MATH MODELLING ENG P, V5, P93, DOI [10.18280/mmep.050206, DOI 10.18280/MMEP.050206]; Jiang ES, 2018, THESIS; Ke B., 2014, THESIS; Kim H, 2009, IEEE COMMUN LETT, V13, P486, DOI 10.1109/LCOMM.2009.090093; Li M, 2009, ACM T SENSOR NETWORK, V5, DOI 10.1145/1498915.1498916; Liu N., 2006, THESIS; Mizugaki K, COMM SYST 22 CM ERR, DOI [10.1109/RWS.2007.351866, DOI 10.1109/RWS.2007.351866]; Nam YS, 2009, ETRI J, V31, P466, DOI 10.4218/etrij.09.0208.0305; Ndoh M, 2004, VTC2004-FALL: 2004 IEEE 60TH VEHICULAR TECHNOLOGY CONFERENCE, VOLS 1-7, P3584; Neirynck D, 2016, WORKS POSIT NAVIGAT; Niculescu D, 2001, GLOB TELECOMM CONF, P2926, DOI 10.1109/GLOCOM.2001.965964; [钱鸣高 Qian Minggao], 2018, [煤炭学报, Journal of China Coal Society], V43, P1; Rashed ANZ, 2014, INT J COMMUN SYST, V27, P3416, DOI 10.1002/dac.2550; Rong Peng, 2006, 2006 3rd Annual IEEE Communications Society Conference on Sensor and Ad Hoc Communications and Networks (IEEE Cat. No. 06EX1523), P374; [孙继平 Sun Jiping], 2011, [煤炭学报, Journal of China Coal Society], V36, P313; [孙哲星 Sun Zhexing], 2018, [煤炭学报, Journal of China Coal Society], V43, P1464; [王德明 Wang Deming], 2018, [煤炭学报, Journal of China Coal Society], V43, P137; Wang DW, 2010 IEEE C ROB AUT, DOI [10.1109/RAMECH.2010.5513188, DOI 10.1109/RAMECH.2010.5513188]; [谢和平 Xie Heiping], 2018, [煤炭学报, Journal of China Coal Society], V43, P1210; Yin WT, 2017, SAFETY SCI, V92, P173, DOI 10.1016/j.ssci.2016.09.018; Yu K, 2009, GROUND BASED WIRELES, DOI [10.1002/9780470747988, DOI 10.1002/9780470747988]; Zheng XZ, 2019, POWDER TECHNOL, V344, P842, DOI 10.1016/j.powtec.2018.12.064	29	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220471	10.1371/journal.pone.0220471	http://dx.doi.org/10.1371/journal.pone.0220471			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365552	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600047
J	Podlaha, O; Wu, G; Downie, B; Ramamurthy, R; Gaggar, A; Subramanian, M; Ye, ZS; Jiang, ZS				Podlaha, Ondrej; Wu, George; Downie, Bryan; Ramamurthy, Raghuraman; Gaggar, Anuj; Subramanian, Mani; Ye, Zhishen; Jiang, Zhaoshi			Genomic modeling of hepatitis B virus integration frequency in the human genome	PLOS ONE			English	Article							RECURRENT MUTATIONS; HBV; EPIDEMIOLOGY; MECHANISMS; ANTIGEN; DNA	Hepatitis B infection is a world-wide public health burden causing serious liver complications. Previous studies suggest that hepatitis B integration into the human genome plays a crucial role in triggering oncogenic process and may also constitutively produce viral antigens. Despite the progress in HBV biology and sequencing technology, our fundamental understanding of how many hepatocytes in the liver actually carry viral integrations is still lacking. Herein we provide evidence that the HBV virus integrates with a lower-bound frequency of 0.84 per diploid genome in hepatitis B positive hepatocellular cancer patients. Moreover, we calculate that integrated viral DNA generates similar to 80% of the HBsAg transcripts in these patients. These results underscore the need to re-evaluate the clinical end-point and treatment strategies for chronic hepatitis B patients.	[Podlaha, Ondrej; Wu, George; Downie, Bryan; Ramamurthy, Raghuraman; Gaggar, Anuj; Subramanian, Mani; Ye, Zhishen; Jiang, Zhaoshi] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences	Jiang, ZS (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	Zhaoshi.Jiang@gilead.com			Gilead Sciences	Gilead Sciences(Gilead Sciences)	This research was supported by Gilead Sciences. The funder provided support in the form of salaries for authors O.P., G.W., B.D., R.R., A.G., M.S., Z.Y, and Z.J, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gish RG, 2015, ANTIVIR RES, V121, P97, DOI 10.1016/j.antiviral.2015.06.019; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Habig JW, 2003, J VIROL, V77, P12401, DOI 10.1128/JVI.77.23.12401-12411.2003; Hoang JK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004433; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mason WS, 2016, GASTROENTEROLOGY, V151, P986, DOI 10.1053/j.gastro.2016.07.012; Matsui T, 2016, J HEPATOL, V64, pS527, DOI 10.1016/S0168-8278(16)00931-4; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Samal J, 2012, CLIN MICROBIOL REV, V25, P142, DOI 10.1128/CMR.00018-11; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Wooddell CI, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0241; Zeisel MB, 2015, GUT, V64, P1314, DOI 10.1136/gutjnl-2014-308943	27	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220376	10.1371/journal.pone.0220376	http://dx.doi.org/10.1371/journal.pone.0220376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356634	gold, Green Submitted, Green Published			2022-12-26	WOS:000484047000027
J	Alahmed, Z; Lobelo, F				Alahmed, Zahra; Lobelo, Felipe			Correlates of physical activity counseling provided by physicians: A cross-sectional study in Eastern Province, Saudi Arabia	PLOS ONE			English	Article							PRIMARY-CARE; ACTIVITY PROMOTION; DISEASE; DIET	Background Physical inactivity is a major health issue in Saudi Arabia (SA). Being physically active can improve overall health and prevent the risk of noncommunicable diseases and their consequences. The objective of this study was to assess the knowledge, attitudes, and practices of primary health care physicians in SA toward physical activity (PA) and identify the correlates of PA counseling provided by physicians. Methods A cross-sectional study was conducted in four main cities of Eastern Province, SA (Al-Khobar, Dammam, Qatif, and Safwa). A total of 147 physicians (44%) filled out self-reported surveys that were used in the assessment of the aims. Results Overall, 59.9% of the physicians believed that PA promotion to patients was their responsibility, and 53.7% of the physicians felt confident in their ability to provide PA counseling. However, the physicians indicated that lack of time, inadequate referral services for PA, and inadequate training in PA counseling are barriers to providing PA counseling to their patients. Only 5.4% of the physicians had excellent knowledge about PA recommendations. Female physicians were more likely to promote PA than male physicians (OR, 3.72; 95% CI, 1.10-12.58; P = .03) and more likely to assess PA in pediatric patients (OR, 2.61; 95% CI, 1.03-6.61; P = .04). Compared to other specialties, family physicians were more likely to provide general PA counseling to patients without chronic diseases (OR, 8.86; 95% CI, 1.86-42.13; P = .006). Physicians who saw fewer adult patients were more likely to systematically track/follow-up on the PA of patients (OR, 3.13; 95% CI, 1.14-8.58; P = .03) and to promote PA to pediatric patients (OR, 2.87; 95% CI, 1.37-6.00; P = .005). Conclusions Training medical staff in PA counseling and strengthening the health care workforce and infrastructure can help physicians improve their counseling practice.	[Alahmed, Zahra] Minist Hlth, Publ Hlth, Riyadh, Eastern Provinc, Saudi Arabia; [Lobelo, Felipe] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Lobelo, Felipe] Emory Univ, Exercise Med Global Res & Collaborat Ctr, Atlanta, GA 30322 USA	Ministry of Health - Saudi Arabia; Emory University; Rollins School Public Health; Emory University	Alahmed, Z (corresponding author), Minist Hlth, Publ Hlth, Riyadh, Eastern Provinc, Saudi Arabia.	Zahraa.alahmed@gmail.com	Lobelo, R.L Felipe/AAB-2264-2021	Lobelo, R.L Felipe/0000-0003-4185-7193; Al-Ahmed, Zahra/0000-0002-2449-7280				Al Reshidi FS, 2016, INT J HEALTH SCI-IJH, V10, P39, DOI 10.12816/0031215; Al-Nahdi F., 2006, PHYS ACTIVITY COUNSE; Al-Othaimeen A. I., 2007, Eastern Mediterranean Health Journal, V13, P441; Al-Shammari MA, 2016, INT J MED SCI PUBLIC, V5, P9; Aljaberi A., 2014, MED J CAIRO U, V82, P207; Alzahrani A. A., 2015, International Journal of Medical Science and Public Health, V4, P805; Banday Altaf H, 2015, Mater Sociomed, V27, P263, DOI 10.5455/msm.2015.27.263-266; Berra K, 2015, JAMA-J AM MED ASSOC, V314, P2617, DOI 10.1001/jama.2015.16244; Buffart LM, 2009, BRIT J SPORT MED, V43, P1149, DOI 10.1136/bjsm.2008.049577; Edwards RT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1021; Elley Raina, 2004, N Z Med J, V117, pU1216; Graham RC, 2005, ERGONOMICS, V48, P1411, DOI 10.1080/00140130500101064; Hebert ET, 2012, BRIT J SPORT MED, V46, P625, DOI 10.1136/bjsports-2011-090734; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Lobelo F, 2016, AM J LIFESTYLE MED, V10, P36, DOI 10.1177/1559827613520120; MOH, 2015, STAT YB 1436H; Murphy SM, 2012, J EPIDEMIOL COMMUN H, V66, P745, DOI 10.1136/jech-2011-200689; Nassar SAA, 2013, SAUDI J SPORTS MED, V13, P17; Oberg EB, 2009, J ROY COLL PHYS EDIN, V39, P290, DOI 10.4997/JRCPE.2009.422; Sanchez A, 2015, PREV MED, V76, pS56, DOI 10.1016/j.ypmed.2014.09.012; Smith AW, 2011, AM J PREV MED, V41, P33, DOI 10.1016/j.amepre.2011.03.017; van der Ploeg HP, 2007, AUST FAM PHYSICIAN, V36, P871; World Health Organization, 2016, SAUD AR DIAB COUNTR	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220396	10.1371/journal.pone.0220396	http://dx.doi.org/10.1371/journal.pone.0220396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344113	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900097
J	Paton, GD; Shoffner, AV; Wilson, AM; Gagne, SA				Paton, Grant D.; Shoffner, Alexandra V.; Wilson, Andrew M.; Gagne, Sara A.			The traits that predict the magnitude and spatial scale of forest bird responses to urbanization intensity	PLOS ONE			English	Article							NEST PREDATION; LAND-USE; URBAN; ABUNDANCE; FRAGMENTATION; SELECTION; MATRIX; PRODUCTIVITY; BIODIVERSITY; DIVERSITY	As humans continue moving to urban areas, there is a growing need to understand the effects of urban intensification on native wildlife populations. Forest species in remnant habitat are particularly vulnerable to urban intensification, but the mechanisms behind these effects are poorly understood. An understanding of how species traits, as proxies for mechanisms, mediate the effects of urban intensification on forest species can help fill this knowledge gap. Using a large point count dataset from the Second Pennsylvania Breeding Bird Atlas, we tested for the effects of species traits on the magnitude and spatial scale of the responses of 58 forest bird species to urbanization intensity in landscapes surrounding count locations. Average urbanization intensity effect size across species was -0.36 +/- 0.49 (SE) and average scale of effect of urbanization intensity was 4.87 +/- 5.95 km. Resident forest bird species that are granivorous or frugivorous, cavity-nesting, and have larger clutch sizes and more fledglings per clutch had more positive associations with increasing urbanization intensity in landscapes. In addition, the effect of urbanization intensity on forest birds manifested most strongly at larger spatial scales for granivorous, frugivorous, or omnivorous species that are cavity-nesting, have larger clutch sizes and longer wingspans, and flock in larger numbers. To our knowledge, the present study represents the first direct tests of the effects of species traits on both the magnitude and spatial scale of the effect of urbanization on forest birds, as well as the first evidence that migratory status, clutch size, wingspan, and fledglings per clutch are important determinants of the responses of forest birds to urbanization. We discuss the possible mechanisms underlying our results and their implications for forest bird conservation in urbanizing landscapes.	[Paton, Grant D.; Gagne, Sara A.] Univ N Carolina, Dept Geog & Earth Sci, Charlotte, NC 28223 USA; [Shoffner, Alexandra V.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Wilson, Andrew M.] Gettysburg Coll, Environm Studies Dept, Gettysburg, PA 17325 USA	University of North Carolina; University of North Carolina Charlotte; Michigan State University; Gettysburg College	Paton, GD (corresponding author), Univ N Carolina, Dept Geog & Earth Sci, Charlotte, NC 28223 USA.	gpaton@uncc.edu		, Sara A./0000-0003-4385-7189				Albright TA, 2017, RES UPD FS, V132, P1; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; [Anonymous], 2018, GLOBAL PHYLOGENY BIR; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Barton K., 2017, R PACKAGE VERSION, V1; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Behney Michael Sue, 2014, PENNSYLVANIA POPULAT; Belaire JA, 2014, ECOL APPL, V24, P2132, DOI 10.1890/13-2259.1; Blewett CM, 2005, CONDOR, V107, P678, DOI 10.1650/0010-5422(2005)107[0678:EOUSOS]2.0.CO;2; Boersma P., 2018, PRAAT DOING PHONETIC; Brown LM, 2015, J APPL ECOL, V52, P1455, DOI 10.1111/1365-2664.12521; Cade BS, 2015, ECOLOGY, V96, P2370, DOI 10.1890/14-1639.1; Carpenter A, 1996, WORLD ALMANAC US; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Conole LE, 2011, LANDSCAPE URBAN PLAN, V100, P11, DOI 10.1016/j.landurbplan.2010.11.007; Cooper H, 2009, HDB RES SYNTHESIS ME; Croci S, 2008, CONDOR, V110, P223, DOI 10.1525/cond.2008.8409; Davis A, 2014, EMU, V114, P295, DOI 10.1071/MU13065; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dunford W, 2005, LANDSCAPE ECOL, V20, P497, DOI 10.1007/s10980-004-5650-5; Erickson Wallace P., 2005, U S Forest Service General Technical Report PSW, V191, P1029; ESRI, 2016, ARCGIS DESKT VERS 10; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Goodwin SE, 2011, CONSERV BIOL, V25, P406, DOI 10.1111/j.1523-1739.2010.01602.x; Hemborg C, 2001, OECOLOGIA, V129, P206, DOI 10.1007/s004420100710; Hunter MCR, 2012, LANDSCAPE URBAN PLAN, V105, P407, DOI 10.1016/j.landurbplan.2012.01.013; Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jokimaki J, 2000, CONDOR, V102, P838, DOI 10.1650/0010-5422(2000)102[0838:ANPAAO]2.0.CO;2; Jokimaki J, 2016, URBAN ECOSYST, V19, P1565, DOI 10.1007/s11252-014-0423-7; Jokimaki J, 1998, LANDSCAPE URBAN PLAN, V39, P253, DOI 10.1016/S0169-2046(97)00089-3; Jokimaki J, 2018, LANDSCAPE URBAN PLAN, V178, P73, DOI 10.1016/j.landurbplan.2018.05.020; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Kaufman, 2001, LIVES N AM BIRDS; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; Klingbeil BT, 2016, BIODIVERS CONSERV, V25, P2687, DOI 10.1007/s10531-016-1195-6; Kluza DA, 2000, ANIM CONSERV, V3, P15, DOI 10.1017/S1367943000000706; Kosinski Z, 2001, ORNIS FENNICA, V78, P175; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Le Roux DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099403; Legendre P, 1998, NUMERICAL ECOLOGY 24; Lepczyk CA, 2004, BIOL CONSERV, V115, P191, DOI 10.1016/S0006-3207(03)00107-1; Lewis CA, 2013, ARCH ENVIRON CON TOX, V64, P327, DOI 10.1007/s00244-012-9830-z; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Loss SR, 2009, BIOL CONSERV, V142, P2578, DOI 10.1016/j.biocon.2009.06.004; Luginbuhl JM, 2001, J FIELD ORNITHOL, V72, P556, DOI 10.1648/0273-8570-72.4.556; Maldonado-Coelho M, 2004, BIOL CONSERV, V116, P19, DOI 10.1016/S0006-3207(03)00169-1; Marra PP, 2016, CAT WARS DEVASTATING; Mason J, 2007, LANDSCAPE URBAN PLAN, V80, P153, DOI 10.1016/j.landurbplan.2006.07.002; McGarigal K., 2012, TECH REP; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meffert PJ, 2013, LANDSCAPE ECOL, V28, P943, DOI 10.1007/s10980-013-9867-z; Minor Emily, 2010, Urban Ecosystems, V13, P51, DOI 10.1007/s11252-009-0103-1; Moller AP, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P54; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Nakazawa M., 2017, PACKAGE FMSB FUNCTIO; Orme D., 2018, R PACKAGE VERSION, V5, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pennsylvania Department of Conservation and Natural Resources, 2006, PAMAP PROGR 3 2 FT D; Peterson RT, 2002, PETERSON FIELD GUIDE; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; Planillo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118604; Posa MRC, 2006, BIOL CONSERV, V129, P256, DOI 10.1016/j.biocon.2005.10.041; Reale Joseph A., 2005, Urban Habitats, V3, P1; Rhoads AF, 2005, TREES OF PENNSYLVANIA: A COMPLETE REFERENCE GUIDE, P1; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rodewald PG, 2015, BIRDS N AM; Rytwinski T, 2011, ECOL APPL, V21, P589, DOI 10.1890/10-0968.1; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shoffner A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35276-9; Soler JJ, 1998, EVOL ECOL, V12, P427, DOI 10.1023/A:1006520821219; Suarez-Rubio M, 2011, J ORNITHOL, V152, P461, DOI 10.1007/s10336-010-0605-x; Suhonen J, 2015, LANDSCAPE URBAN PLAN, V137, P13, DOI 10.1016/j.landurbplan.2014.12.012; Team RC, 2016, R LANG ENV STAT COMP; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; Thorington KK, 2003, ECOGRAPHY, V26, P188, DOI 10.1034/j.1600-0587.2003.03351.x; Tittler R, 2009, ECOGRAPHY, V32, P1051, DOI 10.1111/j.1600-0587.2009.05680.x; Tomasevic JA, 2017, URBAN ECOSYST, V20, P435, DOI 10.1007/s11252-016-0605-6; U.S. Census Bureau P. D., 2019, ANN ESTIMATES RESIDE; United Nations, 2014, DEMOGR RES; Vignoli L., 2013, Web Ecology, V13, P49; Wang YP, 2008, CAN J ZOOL, V86, P676, DOI 10.1139/Z08-045; Wheatley M, 2009, ECOL COMPLEX, V6, P150, DOI 10.1016/j.ecocom.2008.10.011; WILCOVE DS, 1985, ECOLOGY, V66, P1211, DOI 10.2307/1939174; Wilcoxen TE, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov058; Wilson A.M., 2012, 2 ATLAS BREEDING BIR; Wilson AM, 2017, ECOL EVOL, V7, P6582, DOI 10.1002/ece3.3201; Zuckerberg B, 2012, J WILDLIFE MANAGE, V76, P1072, DOI 10.1002/jwmg.326	95	6	6	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220120	10.1371/journal.pone.0220120	http://dx.doi.org/10.1371/journal.pone.0220120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344134	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900057
J	Pi, HF; Liu, MY; Xi, Y; Chen, MY; Tian, L; Xie, J; Chen, ML; Wang, Z; Yang, M; Yu, ZP; Zhou, Z; Gao, F				Pi, Huifeng; Liu, Mengyu; Xi, Yu; Chen, Mengyan; Tian, Li; Xie, Jia; Chen, Mingliang; Wang, Zhen; Yang, Min; Yu, Zhengping; Zhou, Zhou; Gao, Feng			Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery	FASEB JOURNAL			English	Article						swimming; ingenuity pathway analysis; NAFLD; quantitative proteomic analysis	FATTY LIVER-DISEASE; LIPID-METABOLISM; AEROBIC EXERCISE; PHYSICAL-ACTIVITY; PROTEIN; DIET; HEPATOCYTE; STRESS; MICE; HEPATOTOXICITY	Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent diseases worldwide. Exercise is a first-line therapy and an important preventive measure for patients with NAFLD, but the underlying mechanisms are not clear. C57BL/6 mice were fed a high-fat diet (HFD) and subjected to 12 wk swimming exercise. Exercise protected against hepatic lipid accumulation and alleviated hepatocyte damage in HFD mice. Tandem mass tag- based quantitative proteomic analyses and ingenuity pathway analysis revealed that exercise down-regulated fatty acid-binding protein (FABP)1 signaling pathway, which was most closely associated with lipid metabolism. Moreover, exercise significantly decreased FABP1 expression, and liver-specific overexpression of FABP1 abolished the protective effect of exercise in NAFLD mice. Specifically, exercise significantly increased autophagic flux via restoring lysosomal function, including lysosomal proteolysis and lysosomal acidification maintenance, contributing to enhancement in autophagic clearance and subsequently alleviation of hepatic steatosis. Conversely, Fabp1 overexpression in the mouse liver blocked the protective effect of exercise via inhibiting autophagy flux. The present study identified FABP1 inhibition-mediated replenishment of the autophagy-lysosomal machinery as a novel endogenous mechanism whereby long-term exercise improves lipid homeostasis and ameliorates hepatic steatosis in NAFLD.	[Pi, Huifeng; Wang, Zhen; Gao, Feng] Fourth Mil Med Univ, Sch Aerosp Med, Xian, Peoples R China; [Pi, Huifeng; Liu, Mengyu; Chen, Mengyan; Tian, Li; Xie, Jia; Yu, Zhengping] Third Mil Med Univ, Dept Occupat Hlth, Chongqing, Peoples R China; [Chen, Mingliang] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Chen, Mingliang] Third Mil Med Univ, Southwest Hosp, Minist Educ, Southwest Canc Ctr,Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Yang, Min] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Xi, Yu; Zhou, Zhou] Zhejiang Univ, Sch Med, Dept Environm Med, Hangzhou, Peoples R China; [Xi, Yu; Zhou, Zhou] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Emergency Med, Hangzhou, Peoples R China	Air Force Military Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University; Zhejiang University; Zhejiang University	Gao, F (corresponding author), Fourth Mil Med Univ, Sch Aerosp Med, Xian, Peoples R China.; Zhou, Z (corresponding author), Zhejiang Univ, Sch Med, Dept Environm Med, Hangzhou, Peoples R China.	lunazhou@zju.edu.cn; fgao@fmmu.edu.cn	Chen, Mingliang/AGH-3195-2022		National Postdoctoral Program for Innovative Talents [BX201700107]; National Natural Science Foundation of China [81870273]	National Postdoctoral Program for Innovative Talents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Postdoctoral Program for Innovative Talents (BX201700107 to H.P.) and the National Natural Science Foundation of China (81870273 to F.G.). The authors declare no conflicts of interest.	Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Botezelli JD, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-116; Cardoso GH, 2018, INFLAMMATION, V41, P2060, DOI 10.1007/s10753-018-0849-9; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chen AP, 2013, HEPATOLOGY, V57, P2202, DOI 10.1002/hep.26318; Chun SK, 2017, EXERC SPORT SCI REV, V45, P181, DOI 10.1249/JES.0000000000000116; Dallak MA, 2018, ULTRASTRUCT PATHOL, V42, P155, DOI 10.1080/01913123.2017.1422581; Fan TF, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12457; Farah BL, 2016, J HEPATOL, V64, P370, DOI 10.1016/j.jhep.2015.10.008; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Ghareghani P, 2018, OBES RES CLIN PRACT, V12, P80, DOI 10.1016/j.orcp.2017.01.004; Goncalves IO, 2016, APPL PHYSIOL NUTR ME, V41, P298, DOI 10.1139/apnm-2015-0470; Guo R, 2015, HEPATOB PANCREAT DIS, V14, P139, DOI 10.1016/S1499-3872(15)60355-1; Guo YZ, 2018, CARDIOVASC RES, V114, P979, DOI 10.1093/cvr/cvy052; Hashida R, 2017, J HEPATOL, V66, P142, DOI 10.1016/j.jhep.2016.08.023; Hou ZX, 2019, CIRC RES, V124, P1386, DOI 10.1161/CIRCRESAHA.118.314635; Hung YH, 2019, BBA-MOL CELL BIOL L, V1864, P587, DOI 10.1016/j.bbalip.2018.10.007; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Katsagoni CN, 2017, METABOLISM, V68, P119, DOI 10.1016/j.metabol.2016.12.006; Kim HS, 2017, J HEPATOL, V66, P664, DOI 10.1016/j.jhep.2016.11.024; Kim H, 2019, FASEB J, V33, P7896, DOI 10.1096/fj.201802528R; Klein ZA, 2017, NEURON, V95, P281, DOI 10.1016/j.neuron.2017.06.026; Li M, 2016, J PINEAL RES, V61, P353, DOI 10.1111/jpi.12353; Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V580, P41, DOI 10.1016/j.abb.2015.06.009; Martinez-Lopez N, 2015, ANNU REV NUTR, V35, P215, DOI 10.1146/annurev-nutr-071813-105336; Martins DF, 2017, MOL NEUROBIOL, V54, P5620, DOI 10.1007/s12035-016-0095-9; Mukai T, 2017, FEBS OPEN BIO, V7, P1009, DOI 10.1002/2211-5463.12240; Orlicky DJ, 2019, J PHYSIOL-LONDON, V597, P1565, DOI 10.1113/JP277140; Park MY, 2015, J SCI FOOD AGR, V95, P828, DOI 10.1002/jsfa.6973; Pi H., 2019, J CELL MOL MED; Pi HF, 2019, AUTOPHAGY, V15, P565, DOI 10.1080/15548627.2018.1531198; Pi HF, 2017, SCI REP-UK, V7, DOI 10.1038/srep43466; Pi HF, 2015, AUTOPHAGY, V11, P1037, DOI 10.1080/15548627.2015.1052208; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Romero-Gomez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016; Rosa-Caldwell ME, 2017, APPL PHYSIOL NUTR ME, V42, P148, DOI 10.1139/apnm-2016-0280; Sakr Hussein F., 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P61, DOI 10.1515/jbcpp-2017-0069; Shi Y, 2015, AUTOPHAGY, V11, P769, DOI 10.1080/15548627.2015.1034411; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Stefan N, 2019, LANCET DIABETES ENDO, V7, P313, DOI 10.1016/S2213-8587(18)30154-2; Straczkowski M, 2001, DIABETES METAB, V27, P19; Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185; Vila L, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.39; Wang B, 2017, CAN J PHYSIOL PHARM, V95, P667, DOI 10.1139/cjpp-2016-0611; Wang GQ, 2015, J LIPID RES, V56, P2238, DOI 10.1194/jlr.R056705; Wang LL, 2017, MOL GENET METAB, V120, P299, DOI 10.1016/j.ymgme.2017.02.011; Wang XJ, 2018, FASEB J, V32, P37, DOI 10.1096/fj.201601393R; Wolfrum C, 1999, BBA-MOL CELL BIOL L, V1437, P194, DOI 10.1016/S1388-1981(99)00008-6; Wu H, 2015, BIOCHEM BIOPH RES CO, V458, P862, DOI 10.1016/j.bbrc.2015.02.046; Wu YL, 2017, CELL PHYSIOL BIOCHEM, V44, P2243, DOI 10.1159/000486058; Wu YL, 2016, J VIROL, V90, P1729, DOI 10.1128/JVI.02604-15; Xing WJ, 2013, AM J PHYSIOL-HEART C, V305, pH1111, DOI 10.1152/ajpheart.00290.2013; Younossi ZM, 2018, HEPATOLOGY, V68, P2405, DOI 10.1002/hep.30125; Zeng XL, 2019, ANTIOXID REDOX SIGN, V30, P163, DOI 10.1089/ars.2017.7172; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8; Zhang QJ, 2007, CARDIOVASC RES, V75, P369, DOI 10.1016/j.cardiores.2007.04.015; Zhao DJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4079041; Zheng F, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-018-0933-z	60	18	22	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11870	11883		10.1096/fj.201900812R	http://dx.doi.org/10.1096/fj.201900812R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366243	Green Published, Bronze			2022-12-26	WOS:000507461600023
J	Eisemann, T; Langelier, MF; Pascal, JM				Eisemann, Travis; Langelier, Marie-France; Pascal, John M.			Structural and functional analysis of parameters governing tankyrase-1 interaction with telomeric repeat-binding factor 1 and GDP-mannose 4,6-dehydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; protein-protein interaction; post-translational modification (PTM); enzyme mechanism; enzyme structure; GDP-mannose dehydratase; GMD; poly(ADP-ribose) polymerase; tankyrase; telomere repeat factor 1; TRF1	STERILE ALPHA-MOTIF; POLY(ADP-RIBOSE) POLYMERASE; ADP-RIBOSYLATION; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; DOMAIN; TRF1; INHIBITION; POLYMERIZATION; IRAP	Human tankyrase-1 (TNKS) is a member of the poly(ADP-ribose) polymerase (PARP) superfamily of proteins that posttranslationally modify themselves and target proteins with ADP-ribose (termed PARylation). The TNKS ankyrin repeat domain mediates interactions with a growing number of structurally and functionally diverse binding partners, linking TNKS activity to multiple critical cell processes, including Wnt signaling, Golgi trafficking, and telomere maintenance. However, some binding partners can engage TNKS without being modified, suggesting that separate parameters influence TNKS interaction and PARylation. Here, we present an analysis of the sequence and structural features governing TNKS interactions with two model binding partners: the PARylated partner telomeric repeat-binding factor 1 (TRF1) and the non-PARylated partner GDP-mannose 4,6-dehydratase (GMD). Using a combination of TNKS-binding assays, PARP activity assays, and analytical ultracentrifugation sedimentation analysis, we found that both the specific sequence of a given TNKS-binding peptide motif and the quaternary structure of individual binding partners play important roles in TNKS interactions. We demonstrate that GMD forms stable 1:1 complexes with the TNKS ankyrin repeat domain; yet, consistent with results from previous studies, we were unable to detect GMD modification. We also report in vitro evidence that TNKS primarily directs PAR modification to glutamate/aspartate residues. Our results suggest that TNKS-binding partners possess unique sequence and structural features that control binding and PARylation. Ultimately, our findings highlight the binding partner:ankyrin repeat domain interface as a viable target for inhibition of TNKS activity.	[Eisemann, Travis] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Langelier, Marie-France; Pascal, John M.] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3T 1J4, Canada	Jefferson University; Universite de Montreal	Pascal, JM (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3T 1J4, Canada.	john.pascal@umontreal.ca			NCI, National Institutes of Health [P30 CA56036]; NIGMS, National Institutes of Health [OD017987]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Interactions facility, which is supported in part by NCI, National Institutes of Health Grant P30 CA56036 and NIGMS, National Institutes of Health Grant OD017987. We thank Dr. Susan Smith and Dr. David Chen for the kind gifts of the GMD and TRF1 plasmids, respectively. We thank Dr. Ivan Ahel for the kind gift of the human PARG expression plasmid and purified TARG1 and ARH3 proteins. We also thank Dr. Karen Knudsen for access to the LI-COR Biosciences gel imager.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allen JG, 2016, ACS CHEM BIOL, V11, P2734, DOI 10.1021/acschembio.6b00460; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bae JY, 2003, J BIOL CHEM, V278, P5195, DOI 10.1074/jbc.M201988200; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bisht KK, 2012, MOL CELL BIOL, V32, P3044, DOI 10.1128/MCB.00258-12; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chapman JD, 2013, J PROTEOME RES, V12, P1868, DOI 10.1021/pr301219h; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Crawford K, 2018, CRIT REV BIOCHEM MOL, V53, P64, DOI 10.1080/10409238.2017.1394265; DaRosa PA, 2018, PROTEIN SCI, V27, P1057, DOI 10.1002/pro.3413; De Rycker M, 2004, MOL CELL BIOL, V24, P9802, DOI 10.1128/MCB.24.22.9802-9812.2004; De Rycker M, 2003, BIOCHEM J, V372, P87, DOI 10.1042/BJ20021450; Distler A, 2013, ANN RHEUM DIS, V72, P1575, DOI 10.1136/annrheumdis-2012-202275; Eisemann T, 2016, STRUCTURE, V24, P1679, DOI 10.1016/j.str.2016.07.014; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Fan C, 2018, BIOCHEM BIOPH RES CO, V503, P1780, DOI 10.1016/j.bbrc.2018.07.113; Fontana P, 2017, ELIFE, V6, DOI 10.7554/eLife.28533; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kernstock S, 2006, ACTA CRYSTALLOGR F, V62, P224, DOI 10.1107/S1744309106003435; Kulak O, 2015, MOL CELL BIOL, V35, P2425, DOI 10.1128/MCB.00392-15; Langelier MF, 2013, CURR OPIN STRUC BIOL, V23, P134, DOI 10.1016/j.sbi.2013.01.003; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li B, 2016, ACTA CRYSTALLOGR F, V72, P320, DOI 10.1107/S2053230X16004131; Lupo B, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0226-9; Lupo B, 2014, BBA-REV CANCER, V1846, P201, DOI 10.1016/j.bbcan.2014.07.004; Mariotti L, 2016, MOL CELL, V63, P498, DOI 10.1016/j.molcel.2016.06.019; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Riccio AA, 2016, STRUCTURE, V24, P1573, DOI 10.1016/j.str.2016.06.022; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seimiya H, 2005, CANCER CELL, V7, P25, DOI 10.1016/j.ccr.2004.11.021; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Steffen JD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00301; Thorsell AG, 2017, J MED CHEM, V60, P1262, DOI 10.1021/acs.jmedchem.6b00990; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Wang C, 2014, AM J PHYSIOL-CELL PH, V307, pC234, DOI 10.1152/ajpcell.00366.2013; Xu WS, 2017, J AM CHEM SOC, V139, P2245, DOI 10.1021/jacs.6b10234	52	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14574	14590		10.1074/jbc.RA119.009200	http://dx.doi.org/10.1074/jbc.RA119.009200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31375564	hybrid, Green Published			2022-12-26	WOS:000497955000007
J	Stapane, L; Le Roy, N; Hincke, MT; Gautron, J				Stapane, Lilian; Le Roy, Nathalie; Hincke, Maxwell T.; Gautron, Joel			The glycoproteins EDIL3 and MFGE8 regulate vesicle-mediated eggshell calcification in a new model for avian biomineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomineralization; calcium transport; extracellular vesicles; protein evolution; glycoprotein; avian eggshell; EGF-like repeats and discoidin-like domains 3 (EDIL3); milk fat globule-EGF factor 8 (MFGE8); uterine fluid; vesicular transport	AMORPHOUS CALCIUM-CARBONATE; PROTEOMIC ANALYSIS; UTERINE FLUID; MATRIX VESICLES; QUANTITATIVE PROTEOMICS; EXTRACELLULAR-MATRIX; SHELL FORMATION; MEMBRANE-PROTEINS; LACTADHERIN BINDS; ORGANIC MATRIX	The avian eggshell is a critical physical barrier, which permits extra-uterine development of the embryo. Its formation involves the fastest known biomineralization process in vertebrates. The eggshell consists of proteins and proteoglycans that interact with the mineral phase to impart its specific microstructure and mechanical properties. In this study, we investigated the role of epidermal growth factor (EGF)-like repeats and discoidin-like domains 3 (EDIL3) and milk fat globule-EGF factor 8 (MFGE8), two glycoproteins that are consistently detected in eggshell proteomes. We verified their common evolutionary history and identified the timing of the duplication event giving rise to these two distinct proteins. Edil3/mfge8 chromosomal locations revealed a nested syntenous relationship with other genes (hapln1/hapln3 and vcan/acan) that are also involved in vertebrate calcification. EDIL3 and MFGE8 proteins possess EGF-like and coagulation factor 5/8 (F5/8C) domains, and their 3D structures predicted that they bind calcium and extracellular vesicles. In chicken, we confirmed the presence of EDIL3 and MFGE8 proteins in eggshell, uterine fluid, and uterus. We observed that only edil3 is overexpressed in tissues in which eggshell mineralization takes place and that this overexpression occurs only at the onset of shell calcification. We therefore propose a model in which EDIL3 and, to a lesser extent, MFGE8 proteins guide vesicles containing amorphous calcium carbonate to the mineralization site. This model was supported by the observation that extracellular vesicles accumulate in uterine fluid during eggshell calcification and that they contain high levels of calcium, carbon, and oxygen that correspond to calcium carbonate.	[Stapane, Lilian; Le Roy, Nathalie; Gautron, Joel] Univ Tours, INRA, BOA, F-37380 Nouzilly, France; [Hincke, Maxwell T.] Univ Ottawa, Dept Cellular & Mol Med, Dept Innovat Med Educ, Ottawa, ON K1H 8M5, Canada	INRAE; Universite de Tours; University of Ottawa	Gautron, J (corresponding author), Univ Tours, INRA, BOA, F-37380 Nouzilly, France.	joel.gautron@inra.fr	Le Roy, Nathalie/J-8151-2016; Gautron, Joel/A-1753-2017	Le Roy, Nathalie/0000-0002-7840-0018; Gautron, Joel/0000-0001-7800-0578	Canadian Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2016-04410]; Universite Francois Rabelais de Tours; Region Centre Val de Loire	Canadian Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universite Francois Rabelais de Tours; Region Centre Val de Loire(Region Centre-Val de Loire)	This work was supported in part by Canadian Natural Sciences and Engineering Research Council (NSERC) Discovery Program RGPIN-2016-04410 (to M. H.) and Universite Francois Rabelais de Tours and the Region Centre Val de Loire (to L. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Ahmed TAE, 2017, J PROTEOMICS, V155, P49, DOI 10.1016/j.jprot.2017.01.002; Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; ANDERSON HC, 1969, J CELL BIOL, V41, P59, DOI 10.1083/jcb.41.1.59; Ankra-Badu Georgina A., 2005, In Silico Biology, V5, P593; Aoka Y, 2002, MICROVASC RES, V64, P148, DOI 10.1006/mvre.2002.2414; ARAD Z, 1989, AM J PHYSIOL, V257, pR732, DOI 10.1152/ajpregu.1989.257.4.R732; ARIAS JL, 1993, INT REV CYTOL, V145, P217, DOI 10.1016/S0074-7696(08)60428-3; Balcerzak M, 2008, PROTEOMICS, V8, P192, DOI 10.1002/pmic.200700612; Bottini M, 2018, BBA-GEN SUBJECTS, V1862, P532, DOI 10.1016/j.bbagen.2017.11.005; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Brionne A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-220; Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207; Chien YC, 2009, J STRUCT BIOL, V168, P527, DOI 10.1016/j.jsb.2009.07.005; Cordeiro CMM, 2016, J PROTEOMICS, V130, P11, DOI 10.1016/j.jprot.2015.08.014; Dennis JE, 1996, J MORPHOL, V228, P287, DOI 10.1002/(SICI)1097-4687(199606)228:3<287::AID-JMOR2>3.0.CO;2-#; Dominguez-Vera JM, 2000, POULTRY SCI, V79, P901, DOI 10.1093/ps/79.6.901; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Fernandez MS, 1997, MATRIX BIOL, V16, P13, DOI 10.1016/S0945-053X(97)90112-8; Fraser AC, 1998, BRIT POULTRY SCI, V39, P225, DOI 10.1080/00071669889169; Freeman CL, 2010, ANGEW CHEM INT EDIT, V49, P5135, DOI 10.1002/anie.201000679; Gatti JL, 2005, BIOL REPROD, V72, P1452, DOI 10.1095/biolreprod.104.036426; Gautron J, 2019, FOOD CHEM FUNCT ANAL, V14, P259; Gautron J, 2001, CONNECT TISSUE RES, V42, P255, DOI 10.3109/03008200109016840; Gautron J, 1997, CONNECT TISSUE RES, V36, P195, DOI 10.3109/03008209709160220; Gautron J., 2018, ANR IMPACT REPORT; Genge BR, 2007, J BIOL CHEM, V282, P26035, DOI 10.1074/jbc.M701057200; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; HAMILTON RMG, 1986, FOOD MICROSTRUCT, V5, P99; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; Hasegawa T, 2017, JPN DENT SCI REV, V53, P34, DOI 10.1016/j.jdsr.2016.09.002; Hernandez-Hernandez A, 2008, CRYST GROWTH DES, V8, P4330, DOI 10.1021/cg800786s; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; Hincke MT, 2008, J HISTOCHEM CYTOCHEM, V56, P467, DOI 10.1369/jhc.2008.950576; Hincke MT, 2012, FRONT BIOSCI-LANDMRK, V17, P1266, DOI 10.2741/3985; Hincke MT, 1999, J BIOL CHEM, V274, P32915, DOI 10.1074/jbc.274.46.32915; HUNTER GK, 1988, ARCH BIOCHEM BIOPHYS, V260, P161, DOI 10.1016/0003-9861(88)90437-7; Hvarregaard J, 1996, EUR J BIOCHEM, V240, P628, DOI 10.1111/j.1432-1033.1996.0628h.x; Jonchere Vincent, 2012, BMC Physiology, V12, P10, DOI 10.1186/1472-6793-12-10; Kaweewong K, 2013, PROTEIN J, V32, P297, DOI 10.1007/s10930-013-9487-0; Kerschnitzki M, 2016, J STRUCT BIOL, V195, P82, DOI 10.1016/j.jsb.2016.04.011; Kerschnitzki M, 2016, BONE, V83, P65, DOI 10.1016/j.bone.2015.10.009; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kirsch T, 1997, BIOCHEMISTRY-US, V36, P3359, DOI 10.1021/bi9626867; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAROCCA D, 1991, CANCER RES, V51, P4994; Lee JE, 2016, J PROTEOMICS, V131, P17, DOI 10.1016/j.jprot.2015.10.005; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Luquet G, 2012, ZOOKEYS, P103, DOI 10.3897/zookeys.176.2318; Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014; Mann K, 2007, PROTEOMICS, V7, P106, DOI 10.1002/pmic.200600635; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; Mann K, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0078-1; Mann K, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-40; Marie P, 2015, J PROTEOMICS, V126, P140, DOI 10.1016/j.jprot.2015.05.034; Marie P, 2015, J PROTEOMICS, V113, P178, DOI 10.1016/j.jprot.2014.09.024; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Merolli A, 2009, MOLECULES, V14, P5367, DOI 10.3390/molecules14125367; Miksik I, 2014, ANAL BIOANAL CHEM, V406, P7633, DOI 10.1007/s00216-014-8213-x; Miksik I, 2010, ANAL BIOANAL CHEM, V397, P205, DOI 10.1007/s00216-009-3326-3; Morhayim J, 2014, ARCH BIOCHEM BIOPHYS, V561, P38, DOI 10.1016/j.abb.2014.05.011; Nakano T, 2002, POULTRY SCI, V81, P709, DOI 10.1093/ps/81.5.709; Nakano T, 2001, POULTRY SCI, V80, P681, DOI 10.1093/ps/80.5.681; NYS Y, 1986, GEN COMP ENDOCR, V64, P293, DOI 10.1016/0016-6480(86)90016-X; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Nys Y, 2011, WOODHEAD PUBL FOOD S, P83; Nys Y, 1999, POULT AVIAN BIOL REV, V10, P143; NYS Y, 1991, POULTRY SCI, V70, P1236, DOI 10.3382/ps.0701236; Oshima K, 1999, BIOCHEM BIOPH RES CO, V254, P522, DOI 10.1006/bbrc.1998.0107; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Oshima K., 2014, MFG E8 INFLAMMATION, P1; Otzen DE, 2012, BBA-BIOMEMBRANES, V1818, P1019, DOI 10.1016/j.bbamem.2011.08.032; Packard Mary J., 1997, P265, DOI 10.1016/B978-012676460-4/50009-3; Pathan M, 2019, NUCLEIC ACIDS RES, V47, pD516, DOI 10.1093/nar/gky1029; Pavlopoulou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013781; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Pipich V, 2008, J AM CHEM SOC, V130, P6879, DOI 10.1021/ja801798h; Podlaha O, 2006, MOL BIOL EVOL, V23, P1828, DOI 10.1093/molbev/msl066; Rambaut A., 2009, FIGTREE V143; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Rodriguez-Navarro AB, 2015, J STRUCT BIOL, V190, P291, DOI 10.1016/j.jsb.2015.04.014; ROJAS E, 1992, BONE MINER, V17, P214, DOI 10.1016/0169-6009(92)90739-Z; Romer A. S., 1957, Scientific Monthly New York, V85, P57; Rose-Martel M, 2012, J PROTEOMICS, V75, P2697, DOI 10.1016/j.jprot.2012.03.019; Rosenthal AK, 2011, ARTHRITIS RHEUM-US, V63, P401, DOI 10.1002/art.30120; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; Shapiro IM, 2015, BONE, V79, P29, DOI 10.1016/j.bone.2015.05.013; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Shibata S, 2003, J ANAT, V203, P425, DOI 10.1046/j.1469-7580.2003.00226.x; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Sun CJ, 2013, PROTEOMICS, V13, P3523, DOI 10.1002/pmic.201300286; Tester CC, 2011, CRYSTENGCOMM, V13, P3975, DOI 10.1039/c1ce05153a; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thouverey C, 2011, J PROTEOMICS, V74, P1123, DOI 10.1016/j.jprot.2011.04.005; Tuiskula-Haavisto M, 2002, POULTRY SCI, V81, P919, DOI 10.1093/ps/81.7.919; Vidavsky N, 2015, J STRUCT BIOL, V192, P358, DOI 10.1016/j.jsb.2015.09.017; Voinescu AE, 2007, LANGMUIR, V23, P12269, DOI 10.1021/la701892v; Waqas MY, 2016, POULTRY SCI, V95, P2112, DOI 10.3382/ps/pew141; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; WUTHIER RE, 1992, BONE MINER, V17, P290, DOI 10.1016/0169-6009(92)90753-Z; WYBURN GM, 1973, Q J EXP PHYSIOL CMS, V58, P143; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Ye H, 2013, BBA-BIOMEMBRANES, V1828, P1083, DOI 10.1016/j.bbamem.2012.12.009; Zhong JP, 2003, J CLIN INVEST, V112, P30, DOI 10.1172/JCI200317034; Zhu F, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201900011; Zou XL, 2008, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-33	113	12	12	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14526	14545		10.1074/jbc.RA119.009799	http://dx.doi.org/10.1074/jbc.RA119.009799			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31358619	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000497955000004
J	Han, EH; Singh, P; Lee, IK; Urrutia, R; Chi, YI				Han, Eun Hee; Singh, Puja; Lee, In-Kyu; Urrutia, Raul; Chi, Young-In			ErbB3-binding protein 1 (EBP1) represses HNF4 alpha-mediated transcription and insulin secretion in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; gene regulation; insulin secretion; diabetes; protein complex; metabolic regulation; corepressor; EBP1; HNF4alpha; pancreatic beta-cell; protein-protein interaction	NUCLEAR FACTOR 4-ALPHA; X-RAY-DIFFRACTION; BINDING-PROTEIN; GLUCOSE-METABOLISM; STRUCTURAL BASIS; LXXLL MOTIF; RECEPTOR; EXPRESSION; GENE; ERBB3	HNF4 alpha (hepatocyte nuclear factor 4 alpha) is one of the master regulators of pancreatic beta-cell development and function, and mutations in the HNF4 alpha gene are well-known monogenic causes of diabetes. As a member of the nuclear receptor family, HNF4 alpha exerts its gene regulatory function through various molecular interactions; however, there is a paucity of knowledge of the different functional complexes in which HNF4 alpha participates. Here, to find HNF4 alpha-binding proteins in pancreatic beta-cells, we used yeast two-hybrid screening, a mammalian two-hybrid assay, and glutathione S-transferase pulldown approaches, which identified EBP1 (ErbB3-binding protein 1) as a factor that binds HNF4 alpha in a LXXLL motif-mediated manner. In the beta-cells, EBP1 suppressed the expression of HNF4 alpha target genes that are implicated in insulin secretion, which is impaired in HNF4 alpha mutation-driven diabetes. The crystal structure of the HNF4 alpha ligand-binding domain in complex with a peptide harboring the EBP1 LXXLL motif at 3.15 angstrom resolution hinted at the molecular basis of the repression. The details of the structure suggested that EBP1's LXXLL motif competes with HNF4 alpha coactivators for the same binding pocket and thereby prevents recruitment of additional transcriptional coactivators. These findings provide further evidence that EBP1 plays multiple cellular roles and is involved in nuclear receptor-mediated gene regulation. Selective disruption of the HNF4 alpha-EBP1 interaction or tissue-specific EBP1 inactivation can enhance HNF4 alpha activities and thereby improve insulin secretion in beta-cells, potentially representing a new strategy for managing diabetes and related metabolic disorders.	[Han, Eun Hee; Singh, Puja; Chi, Young-In] Univ Minnesota, Hormel Inst, Sect Struct Biol, 801 16th Ave NE, Austin, MN 55912 USA; [Han, Eun Hee] Korea Basic Sci Inst, Div Life Sci, Drug & Dis Target Grp, Cheongju 28119, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea; [Urrutia, Raul; Chi, Young-In] Med Coll Wisconsin, Genom Sci & Precis Med Ctr, Div Res, Dept Surg, Milwaukee, WI 53226 USA	University of Minnesota System; Korea Basic Science Institute (KBSI); Kyungpook National University; Kyungpook National University Hospital; Medical College of Wisconsin	Chi, YI (corresponding author), Med Coll Wisconsin, Genom Sci & Precis Med Ctr, Div Res, Dept Surg, Milwaukee, WI 53226 USA.	ychi@mcw.edu	Lee, In-Kyu/AAR-6374-2021	Chi, Young-In/0000-0001-9220-9511	American Diabetes Association Grant [7-08-CD-03]; Commonwealth of Kentucky Diabetes Research Trust Fund [KDR-PP09-09]; Brain Pool Program - Ministry of Science and ICT through the National Research Foundation of Korea [2018H1D3A2000849]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI16C1501]; Bio & Medical Technology Development Program of the National Research Foundation - Korean Government [NRF-2016M3A9B6902872]; Theodore W. Batterman Family Foundation; Advancing a Healthier Wisconsin Endowment	American Diabetes Association Grant(American Diabetes Association); Commonwealth of Kentucky Diabetes Research Trust Fund; Brain Pool Program - Ministry of Science and ICT through the National Research Foundation of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation - Korean Government; Theodore W. Batterman Family Foundation; Advancing a Healthier Wisconsin Endowment	This work was supported by American Diabetes Association Grant 7-08-CD-03; Commonwealth of Kentucky Diabetes Research Trust Fund Grant KDR-PP09-09; Brain Pool Program Grant 2018H1D3A2000849 funded by the Ministry of Science and ICT through the National Research Foundation of Korea (to Y.-I. C.); Korea Health Technology R&D Project Grant HI16C1501 through the Korea Health Industry Development Institute funded by the Ministry of Health & Welfare, Republic of Korea; and the Bio & Medical Technology Development Program of the National Research Foundation funded by Korean Government Grant NRF-2016M3A9B6902872 (to I.-K. L.). This study was also supported in part by the Theodore W. Batterman Family Foundation and the Advancing a Healthier Wisconsin Endowment to the Precision Medicine Simulation Unit of the Genomic Sciences and Precision Medicine Center at the Medical College of Wisconsin. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190; Ghosh A, 2013, ONCOL REP, V29, P1161, DOI 10.3892/or.2012.2186; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Haider S, 2005, J MOL CELL CARDIOL, V38, P927, DOI 10.1016/j.yjmcc.2005.01.007; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Han EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044007; He HC, 2013, MOL BIOL REP, V40, P3799, DOI 10.1007/s11033-012-2458-2; Hu BY, 2014, MOL CELL BIOCHEM, V396, P175, DOI 10.1007/s11010-014-2153-9; Imajo M, 2010, GENES CELLS, V15, P1089, DOI 10.1111/j.1365-2443.2010.01445.x; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Jobichen C, 2014, ACTA CRYSTALLOGR F, V70, P1296, DOI 10.1107/S2053230X14014381; Ko HR, 2016, INT J CANCER, V139, P1202, DOI 10.1002/ijc.30165; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kowalinski E, 2007, FEBS LETT, V581, P4450, DOI 10.1016/j.febslet.2007.08.024; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Liu L, 2015, GENET MOL RES, V14, P5496, DOI 10.4238/2015.May.22.20; Liu ZX, 2006, P NATL ACAD SCI USA, V103, P10917, DOI 10.1073/pnas.0602923103; Liu ZX, 2009, MOL BIOL CELL, V20, P757, DOI 10.1091/mbc.E08-09-0983; Loinder K, 2005, J STEROID BIOCHEM, V97, P322, DOI 10.1016/j.jsbmb.2005.06.031; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; Maeda Y, 2002, MOL ENDOCRINOL, V16, P1502, DOI 10.1210/me.16.7.1502; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; Mei Y, 2014, ONCOGENE, V33, P3839, DOI 10.1038/onc.2013.354; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; Mori Y, 2001, CANCER RES, V61, P6046; Neilson KM, 2017, DEV BIOL, V421, P171, DOI 10.1016/j.ydbio.2016.11.021; Nguyen L. X., 2016, CLIN CANC RES; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen K, 2001, BEST PRACT RES CL EN, V15, P309, DOI 10.1053/beem.2001.0148; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pisapia L, 2015, INT J ONCOL, V47, P481, DOI 10.3892/ijo.2015.3051; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Rha GB, 2009, J BIOL CHEM, V284, P35165, DOI 10.1074/jbc.M109.052506; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9; Sladek FM, 2001, NUCL RECEPTORS GENET; Squatrito M, 2006, BIOCHEM BIOPH RES CO, V344, P859, DOI 10.1016/j.bbrc.2006.03.205; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Sun J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-499; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Wang YL, 2017, CANCER RES, V77, P1983, DOI 10.1158/0008-5472.CAN-16-2246; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang F, 2015, MOL CELL ENDOCRINOL, V411, P75, DOI 10.1016/j.mce.2015.04.013; Zhang YX, 2010, CANCER RES, V70, P240, DOI 10.1158/0008-5472.CAN-09-2904; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zhang YX, 2005, P NATL ACAD SCI USA, V102, P9890, DOI 10.1073/pnas.0503829102; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318; Zhang YX, 2002, ONCOGENE, V21, P5609, DOI 10.1038/sj.onc.1205638; Zhou H, 2011, ANTICANCER RES, V31, P3129	73	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13983	13994		10.1074/jbc.RA119.009558	http://dx.doi.org/10.1074/jbc.RA119.009558			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31362984	hybrid, Green Published			2022-12-26	WOS:000490729800013
J	Pouladi, N; Abdolahi, S; Farajzadeh, D; Feizi, MAH				Pouladi, Nasser; Abdolahi, Sepehr; Farajzadeh, Davoud; Feizi, Mohammad Ali Hosseinpour			Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; TP53 GENE; RISK; ASSOCIATION; REGION; POLYMORPHISMS; REGULATOR; VARIANTS; PATHWAY; ROLES	Among the cancer susceptibility genes, TP53 is one of the crucial genes involved in cell cycle regulations and, therefore, it greatly affects breast cancer initiation and progression. In addition, WRAP53-a natural antisense transcript-regulates TP53 transcription and, as a protein, modulates the normal cell cycle, which results in breast cancer susceptibility. In this study, we aimed to analyze a haplotype comprising four SNPs, including rs1042522, rs17878362, rs2287499, and rs2287498, which are located at 5' regions of the TP53 and WRAP53 genes, in 118 patients and 110 healthy controls of the Iranian-Azeri population. In silico studies were conducted using the SIFT, Polyphen2, Fanthmm, RNAsnp, and SNP&GO online servers. Linkage disequilibrium (LD) and D' for each combination of the markers were calculated via the Haploview program. Our results showed that the GA(1)CC haplotype was the most frequent in the studied population. Additionally, no significant LD between any pairwise haplotypes was observed. The GA(1)CC and CA(2)GC haplotypes were significantly associated with breast cancer susceptibility. Moreover, the in silico analysis revealed the negative effects of rs2287499 and rs1042522 on WRAP53 and P53, respectively. In conclusion, the CA(1)GC haplotype was strongly identified as a breast cancer risk factor, and the GA(1)CC haplotype was assumed to be a protective factor against breast cancer risk. Hence, these markers may potentially be used as molecular prognostic and predictive biomarkers for breast cancer.	[Pouladi, Nasser; Abdolahi, Sepehr; Farajzadeh, Davoud] Azarbaijan Shahid Madani Univ, Fac Basic Sci, Dept Biol, Tabriz, Iran; [Pouladi, Nasser; Farajzadeh, Davoud] Azarbaijan Shahid Madani Univ, Dept Mol Biol & Canc Res, Tabriz, Iran; [Feizi, Mohammad Ali Hosseinpour] Tabriz Univ, Fac Nat Sci, Dept Anim Biol, Tabriz, Iran	Azarbaijan Shahid Madani University; Azarbaijan Shahid Madani University; University of Tabriz	Pouladi, N (corresponding author), Azarbaijan Shahid Madani Univ, Fac Basic Sci, Dept Biol, Tabriz, Iran.; Pouladi, N (corresponding author), Azarbaijan Shahid Madani Univ, Dept Mol Biol & Canc Res, Tabriz, Iran.	srna52@gmail.com	Abdolahi, Sepehr/Y-2643-2019; Abdolahi, Sepehr/ABE-3231-2020; Farajzadeh, Davoud/W-2236-2017; Farajzadeh, Davoud/AAQ-5732-2021; Pouladi, Nasser/AAP-4036-2021	Abdolahi, Sepehr/0000-0002-5565-6096; Abdolahi, Sepehr/0000-0002-5565-6096; Farajzadeh, Davoud/0000-0002-9267-4277; Pouladi, Nasser/0000-0001-8125-5352				Alonso S, 2010, HUM HERED, V69, P34, DOI 10.1159/000243152; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellazzo A, 2018, BREAST CANCER-TARGET, V10, P101, DOI 10.2147/BCTT.S145826; Bonab AS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0168-4; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buyru N, 2007, CANCER DETECT PREV, V31, P207, DOI 10.1016/j.cdp.2007.04.004; Cao HY, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15037976; Dehghan R, 2015, PATHOL ONCOL RES, V21, P449, DOI 10.1007/s12253-014-9846-y; Dehghan Roghayeh, 2015, Asian Pac J Cancer Prev, V16, P3073; Devi KR, 2015, TUMOR BIOL, V36, P9995, DOI 10.1007/s13277-015-3795-2; Edvardsen H, 2018, BIORXIV; Enwerem II, 2014, BIOL OPEN, V3, P240, DOI 10.1242/bio.20147443; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Farnebo M, 2009, CELL CYCLE, V8, P2343, DOI 10.4161/cc.8.15.9223; Vitiello GAF, 2018, J CANCER RES CLIN, V144, P645, DOI 10.1007/s00432-018-2585-9; Hao WM, 2018, EUR J MED RES, V23, DOI 10.1186/s40001-018-0345-6; Henriksson S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00091; Joruiz SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026039; Kim G., 2014, ONCOGENE, V34, P671, DOI DOI 10.1038/0NC.2014.4; Leroy B, 2017, CANCER RES, V77, P1250, DOI 10.1158/0008-5472.CAN-16-2179; Lin HY, 2013, UROL ONCOL-SEMIN ORI, V31, P1231, DOI 10.1016/j.urolonc.2011.11.031; Medrek K, 2013, MOL BIOL REP, V40, P2145, DOI 10.1007/s11033-012-2273-9; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Ni XQ, 2005, NEUROSCI LETT, V388, P173, DOI 10.1016/j.neulet.2005.06.050; Nikkhoo A, 2019, J CELL BIOCHEM, V120, P9300, DOI 10.1002/jcb.28205; Pouladi N, 2019, META GENE, V19, P117, DOI 10.1016/j.mgene.2018.11.009; Pouladi N, 2013, ASIAN PAC J CANCER P, V14, P3503, DOI 10.7314/APJCP.2013.14.6.3503; Rassoolzadeh H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.172; Stracquadanio G, 2016, NAT REV CANCER, V16, P251, DOI 10.1038/nrc.2016.15; Sung H, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0055-9; Surowy H, 2018, INT J CANCER, V142, P757, DOI 10.1002/ijc.31105; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Uehara I, 2018, CANCERS, V10, DOI 10.3390/cancers10070219; Vymetalkova V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134463; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Yuan JM, 2011, ASIAN PAC J CANCER P, V12, P3465; Zee RYL, 2004, HUM GENET, V114, P386, DOI 10.1007/s00439-003-1080-8; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220727	10.1371/journal.pone.0220727	http://dx.doi.org/10.1371/journal.pone.0220727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31387111	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100034
J	Carbone, E; Meneghetti, C; Borella, E				Carbone, Elena; Meneghetti, Chiara; Borella, Erika			The influence of personality traits and facets on visuo-spatial task performance and self-assessed visuo-spatial inclinations in young and older adults	PLOS ONE			English	Article							SPATIAL ABILITIES; INDIVIDUAL-DIFFERENCES; COGNITIVE PERFORMANCE; MENTAL ROTATION; INTELLIGENCE; MEMORY; BIG-5; ASSOCIATIONS; METAANALYSIS; ENGAGEMENT	Aims Personality traits are suggested to influence adults' cognitive performance, but little is known about their association with visuo-spatial competence, in terms of those visuo-spatial abilities and inclinations crucial to remaining autonomous, especially with aging. This study newly investigated whether, and to what extent, major traits and narrower facets of personality influence young and older adults' performance in the so-called objective visuo-spatial abilities (mental rotation and visuo-spatial working memory [VSWM]), and self-assessed visuo-spatial inclinations (pleasure and anxiety in exploring places). Method Seventy young adults (18-35 years old) and 70 older adults (65-75 years old) completed the Big-Five questionnaire, objective rotation and VSWM tasks, and spatial self-assessments on pleasure and anxiety in exploring places. Results Hierarchical regression models confirmed that age negatively predicted the variance in objective visuo-spatial tasks, but not in self-assessed visuo-spatial inclinations, while only the latter were slightly influenced by gender (in favor of men). Further, both objective visuo-spatial abilities (albeit modestly) and self-assessed visuo-spatial inclinations were predicted by higher Conscientiousness. The latter were also predicted by higher Emotional Stability. Finally, a better objective visuo-spatial performance was explained (again modestly) by lower Dynamism and Politeness, and higher Emotion Control, while higher Perseverance, Emotion Control and Cooperativeness explained a moderate part of the variance in the positive self-assessed visuo-spatial inclinations. Conclusions Our findings indicate that, beyond age and gender, some personality traits and facets predict self-assessed visuo-spatial inclinations to a larger extent than objective visuo-spatial performance. These results are discussed within the spatial cognition and aging framework.	[Carbone, Elena; Meneghetti, Chiara; Borella, Erika] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Carbone, E (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	elena.carbone@phd.unipd.it	Meneghetti, Chiara/D-1691-2014; CARBONE, ELENA/ABB-6361-2020	Meneghetti, Chiara/0000-0002-4232-4244; CARBONE, ELENA/0000-0003-4141-3824; Meneghetti, Chiara/0000-0002-1838-7958; , ERIKA/0000-0001-8943-2958				Ackerman Phillip L, 2018, J Intell, V6, DOI 10.3390/jintelligence6010002; Ackerman PL, 1997, PSYCHOL BULL, V121, P219, DOI 10.1037/0033-2909.121.2.219; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baker TJ, 2006, PERS INDIV DIFFER, V41, P861, DOI 10.1016/j.paid.2006.02.017; Borella E, 2014, DEV PSYCHOL, V50, P384, DOI 10.1037/a0033818; BRYANT KJ, 1982, J PERS SOC PSYCHOL, V43, P1318, DOI 10.1037/0022-3514.43.6.1318; Caprara GV, 2006, POLIT PSYCHOL, V27, P1, DOI 10.1111/j.1467-9221.2006.00447.x; CAPRARA GV, 1993, PERS INDIV DIFFER, V15, P281, DOI 10.1016/0191-8869(93)90218-R; Caselli RJ, 2018, J AM GERIATR SOC, V66, P671, DOI 10.1111/jgs.15182; Chapman BP, 2017, AM J GERIAT PSYCHIAT, V25, P900, DOI 10.1016/j.jagp.2017.03.006; Colom R, 2005, INTELLIGENCE, V33, P623, DOI 10.1016/j.intell.2005.05.006; Condon DM, 2015, PERS INDIV DIFFER, V86, P38, DOI 10.1016/j.paid.2015.05.023; Corsi P., 1972, THESIS; Costa P.T., 1992, PERS INDIVID DIF, V13, P653, DOI [10.1016/0191-8869(92)90236-I, DOI 10.1016/0191-8869(92)90236-I]; Costa PT, 2019, ANNU REV PSYCHOL, V70, P423, DOI 10.1146/annurev-psych-010418-103244; Curtis RG, 2015, AGING NEUROPSYCHOL C, V22, P42, DOI 10.1080/13825585.2014.888392; De Beni R., 2008, PORTFOLIO VALUTAZION; De Beni R., 2014, VISUO SPATIAL ABILIT; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Graham EK, 2014, PERS INDIV DIFFER, V59, P89, DOI 10.1016/j.paid.2013.11.011; Graham EK, 2012, J GERONTOL B-PSYCHOL, V67, P545, DOI 10.1093/geronb/gbr149; Hegarty M, 2006, INTELLIGENCE, V34, P151, DOI 10.1016/j.intell.2005.09.005; Hegarty M., 2005, CAM BRIDGE HDB VISUO, P121, DOI DOI 10.1017/CBO9780511610448.005; Hess TM, 2014, PERSPECT PSYCHOL SCI, V9, P388, DOI 10.1177/1745691614527465; HOFSTEE WKB, 1992, J PERS SOC PSYCHOL, V63, P146, DOI 10.1037/0022-3514.63.1.146; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Kaltner S, 2016, ADV COGN PSYCHOL, V12, P67, DOI 10.5709/acp-0187-y; Klencklen G, 2012, AGEING RES REV, V11, P123, DOI 10.1016/j.arr.2011.10.001; Kretzschmar Andre, 2018, J Intell, V6, DOI 10.3390/jintelligence6030030; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Low LF, 2013, AM J GERIAT PSYCHIAT, V21, P713, DOI 10.1016/j.jagp.2012.08.004; Luchetti M, 2016, J GERONTOL B-PSYCHOL, V71, P591, DOI 10.1093/geronb/gbu184; Mammarella I. C., 2008, BVS CORSI BATTERIA V; Mammarella IC, 2013, LEARN INDIVID DIFFER, V25, P99, DOI 10.1016/j.lindif.2013.01.014; Martinez K, 2011, INTELLIGENCE, V39, P473, DOI 10.1016/j.intell.2011.09.001; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; McCrae RR, 2015, PERS SOC PSYCHOL REV, V19, P97, DOI 10.1177/1088868314541857; Meneghetti C, 2014, LEARN INDIVID DIFFER, V35, P113, DOI 10.1016/j.lindif.2014.07.006; Moe A, 2009, PERS INDIV DIFFER, V46, P187, DOI 10.1016/j.paid.2008.09.030; Mottus R, 2017, J PERS SOC PSYCHOL, V112, P474, DOI 10.1037/pspp0000100; Muffato V, 2019, PSYCHOL RES-PSYCH FO, V83, P1836, DOI 10.1007/s00426-018-1033-4; Muffato V, 2016, J ENVIRON PSYCHOL, V47, P230, DOI 10.1016/j.jenvp.2016.07.003; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Pazzaglia F, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00225; Reeve CL, 2006, INTELLIGENCE, V34, P387, DOI 10.1016/j.intell.2005.11.001; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Salimi Shirin, 2018, Alzheimers Dement (Amst), V10, P66, DOI 10.1016/j.dadm.2017.10.004; Schaie KW, 2004, AGING NEUROPSYCHOL C, V11, P304, DOI 10.1080/13825580490511134; Sharp ES, 2010, PSYCHOL AGING, V25, P60, DOI 10.1037/a0018748; Soubelet A, 2011, DEV PSYCHOL, V47, P303, DOI 10.1037/a0021816; Soubelet A, 2010, PERS INDIV DIFFER, V49, P896, DOI 10.1016/j.paid.2010.07.026; Techentin C, 2014, EXP AGING RES, V40, P395, DOI 10.1080/0361073X.2014.926773; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Voyer D, 2017, PSYCHON B REV, V24, P307, DOI 10.3758/s13423-016-1085-7; Wang L, 2014, LEARN INDIVID DIFFER, V36, P140, DOI 10.1016/j.lindif.2014.10.006; Waris O, 2018, PERS INDIV DIFFER, V130, P26, DOI 10.1016/j.paid.2018.03.027; Wyllie DS, 1996, PROF GEOGR, V48, P166, DOI 10.1111/j.0033-0124.1996.00166.x	63	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220525	10.1371/journal.pone.0220525	http://dx.doi.org/10.1371/journal.pone.0220525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381616	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600021
J	Nukui, Y; Yamana, T; Masuo, M; Tateishi, T; Kishino, M; Tateishi, U; Tomita, M; Hasegawa, T; Aritsu, T; Miyazaki, Y				Nukui, Yoshihisa; Yamana, Takashi; Masuo, Masahiro; Tateishi, Tomoya; Kishino, Mitsuhiro; Tateishi, Ukihide; Tomita, Makoto; Hasegawa, Takehiro; Aritsu, Takashi; Miyazaki, Yasunari			Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitis	PLOS ONE			English	Article							AVIAN ANTIGEN; CHEMOKINE; FIBROSIS; KL-6; EXPRESSION; PREDICTS; CXCR3; LUNG	The clinical course of chronic hypersensitivity pneumonitis (HP) with fibrosis is similar to that of idiopathic pulmonary fibrosis (IPF). Current research is expected to identify biomarkers effective in predicting the deterioration of lung function in a clinical setting. Our group analyzed the relationships between the following parameters in chronic bird-related HP: patient characteristics, serum markers, lung function, HRCT findings, BALF profiles, and the worsening of lung function. We also analyzed serum levels of CXCL9, CCL17, and Krebs von den Lungen 6 (KL-6) as serum markers. Patients showing declines in vital capacity (VC) of over 5% at 6 months after first admission were categorized as the "decline group"; the others were categorized as the "stable group." The serum level of CCL17 and the percentage of BALF macrophages were significantly higher in the decline group compared to the stable group. Serum levels of CXCL9 and CCL17 were significant variables in a multivariate logistic regression analysis of factors associated with VC decline. Patients with a chemokine profile combining lower serum CXCL9 and higher serum CCL17 exhibited significantly larger VC decline in a cluster analysis. Higher serum CCL17 and lower serum CXCL9 were important predictors of worsening lung function in patients with chronic bird-related HP.	[Nukui, Yoshihisa; Yamana, Takashi; Masuo, Masahiro; Tateishi, Tomoya; Miyazaki, Yasunari] Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Kishino, Mitsuhiro; Tateishi, Ukihide] Tokyo Med & Dent Univ, Dept Diagnost Radiol, Bunkyo Ku, Tokyo, Japan; [Tomita, Makoto] Tokyo Med & Dent Univ, Dept Clin Res Ctr, Bunkyo Ku, Tokyo, Japan; [Hasegawa, Takehiro; Aritsu, Takashi] Sysmex Corp, Nishi Ku, Kobe, Hyogo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Sysmex Corporation	Miyazaki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.	miyazaki.pilm@tmd.ac.jp	; MIYAZAKI, YASUNARI/B-7847-2015	Tateishi, Tomoya/0000-0001-5402-3185; Hasegawa, Takehiro/0000-0002-4635-4942; Yamana, Takashi/0000-0001-8833-2322; MIYAZAKI, YASUNARI/0000-0002-9073-9815	Sysmex Corp.	Sysmex Corp.	Y. M. received funding from from the Sysmex Corp. T. H. and T. A. are employees of Sysmex Corporation. T. H. contributed to the analysis and interpretation of the data. T. H. and T. A. contributed to the measurement of CXCL9, CCL17, and KL-6.; Serum levels of CXCL9, CCL17, and KL-6 were measured by Sysmex Corp. Funding from the Sysmex Corp. is gratefully acknowledged.	Agostini C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-20; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; Chiba S, 2016, CHEST, V149, P1473, DOI 10.1016/j.chest.2015.12.030; FINK JN, 1984, J ALLERGY CLIN IMMUN, V74, P1, DOI 10.1016/0091-6749(84)90077-0; Ishizuka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137978; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kishi M, 2008, THORAX, V63, P810, DOI 10.1136/thx.2007.086074; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Miyazaki Y, 2016, EXPERT REV CLIN IMMU, V12, P953, DOI 10.1080/1744666X.2016.1182426; Miyazaki Y, 2008, CHEST, V134, P1265, DOI 10.1378/chest.08-0866; Nance S, 2005, EUR J IMMUNOL, V35, P1928, DOI 10.1002/eji.200425762; Nance S, 2004, EUR J IMMUNOL, V34, P677, DOI 10.1002/eji.200324634; O'Beirne SL, 2015, J IMMUNOL, V195, P2788, DOI 10.4049/jimmunol.1402008; Ohnishi H, 2003, THORAX, V58, P872, DOI 10.1136/thorax.58.10.872; Ohtani Y, 2000, CHEST, V118, P1382, DOI 10.1378/chest.118.5.1382; Ohtani Y, 2005, THORAX, V60, P665, DOI 10.1136/thx.2004.027326; Okamoto T, 2015, RESP MED, V109, P1576, DOI 10.1016/j.rmed.2015.10.005; Pechkovsky DV, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-75; Pignatti P, 2006, AM J RESP CRIT CARE, V173, P310, DOI 10.1164/rccm.200502-244OC; ROLAND M, 2011, AM J RESP CRIT CARE, V184, P1382; Salisbury ML, 2017, AM J RESP CRIT CARE, V196, P690, DOI 10.1164/rccm.201608-1675PP; Sekiya T, 2000, J IMMUNOL, V165, P2205, DOI 10.4049/jimmunol.165.4.2205; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Sema M, 2018, IMMUN INFLAMM DIS, V6, P154, DOI 10.1002/iid3.202; Shinoda H, 2009, RESPIRATION, V78, P285, DOI 10.1159/000207617; Tateishi T, 2011, J COMPUT ASSIST TOMO, V35, P272, DOI 10.1097/RCT.0b013e318209c5a6; Tsutsui T, 2015, ANN AM THORAC SOC, V12, P1013, DOI 10.1513/AnnalsATS.201412-569OC; Walsh SLF, 2014, THORAX, V69, P216, DOI 10.1136/thoraxjnl-2013-203843; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680, DOI 10.1164/ajrccm.158.5.9803115; Yoshizawa Y, 1999, J ALLERGY CLIN IMMUN, V103, P315, DOI 10.1016/S0091-6749(99)70507-5; Zappala CJ, 2010, EUR RESPIR J, V35, P830, DOI 10.1183/09031936.00155108	34	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220462	10.1371/journal.pone.0220462	http://dx.doi.org/10.1371/journal.pone.0220462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369605	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900052
J	Ferguson, HS; Owen, A; Hahn, AC; Torrance, J; DeBruine, LM; Jones, BC				Ferguson, Hannah S.; Owen, Anya; Hahn, Amanda C.; Torrance, Jaimie; DeBruine, Lisa M.; Jones, Benedict C.			Context-specific effects of facial dominance and trustworthiness on hypothetical leadership decisions	PLOS ONE			English	Article							EVOLUTIONARY-PSYCHOLOGY; FACES	Social judgments of faces predict important social outcomes, including leadership decisions. Previous work suggests that facial cues associated with perceptions of dominance and trustworthiness have context-specific effects on leadership decisions. Facial cues linked to perceived dominance have been found to be preferred in leaders for hypothetical wartime contexts and facial cues linked to perceived trustworthiness have been found to be preferred in leaders for hypothetical peacetime contexts. Here we sought to replicate these effects using images of women's faces, as previous studies have primarily focused on perceptions of leadership abilities from male faces, with only a handful of these including female faces. Consistent with previous work, a linear mixed effects model demonstrated that more trust-worthy-looking faces were preferred in leaders during times of peace and more dominant-looking faces were preferred in leaders during times of war. These results provide converging evidence for context-specific effects of facial cues on hypothetical leadership judgments.	[Ferguson, Hannah S.; Hahn, Amanda C.] Humboldt State Univ, Dept Psychol, Arcata, CA 95521 USA; [Owen, Anya; Hahn, Amanda C.; Torrance, Jaimie; DeBruine, Lisa M.; Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	California State University System; California State Polytechnic University, Humboldt; University of Glasgow	Hahn, AC (corresponding author), Humboldt State Univ, Dept Psychol, Arcata, CA 95521 USA.; Hahn, AC (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	amanda.hahn@humboldt.edu	Hahn, Amanda C/AAH-1106-2021; DeBruine, Lisa M/A-6990-2008; Jones, Benedict/A-7850-2008	Hahn, Amanda C/0000-0002-4555-7924; DeBruine, Lisa M/0000-0002-7523-5539; Jones, Benedict/0000-0001-7777-0220	European Research Council [647910 KINSHIP]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by European Research Council grant #647910 KINSHIP to Lisa M DeBruine (https://erc.europa.eu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Carpinella CM, 2016, POLIT COMMUN, V33, P21, DOI 10.1080/10584609.2014.958260; Hahn AC, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0148; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Little AC, 2012, Q J EXP PSYCHOL, V65, P2018, DOI 10.1080/17470218.2012.677048; Morrison D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185093; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Re DE, 2013, EVOL PSYCHOL-US, V11, P89, DOI 10.1177/147470491301100109; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Spisak BR, 2012, LEADERSHIP QUART, V23, P273, DOI 10.1016/j.leaqua.2011.08.006; Spisak BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030399; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Van Vugt M, 2008, PSYCHOL SCI, V19, P854, DOI 10.1111/j.1467-9280.2008.02168.x; Van Vugt M, 2015, CURR DIR PSYCHOL SCI, V24, P484, DOI 10.1177/0963721415601971; Wang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161114; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006	18	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0214261	10.1371/journal.pone.0214261	http://dx.doi.org/10.1371/journal.pone.0214261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV1OL	31356614	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000484047000002
J	Abass, A; Lopes, BT; Eliasy, A; Salomao, M; Wu, R; Whites, L; Jones, S; Clamps, J; Ambrosio, R; Elsheikh, A				Abass, Ahmed; Lopes, Bernardo T.; Eliasy, Ashkan; Salomao, Marcella; Wu, Richard; Whites, Lynn; Jones, Steve; Clamps, John; Ambrosio, Renato, Jr.; Elsheikh, Ahmed			Artefact-free topography based scleral-asymmetry	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ARTIFICIAL TEARS; CONTACT-LENSES; CORNEAL; SHAPE; EYES; OCT	Purpose To present a three-dimensional non-parametric method for detecting scleral asymmetry using corneoscleral topography data that are free of edge-effect artefacts. Methods The study included 88 participants aged 23 to 65 years (37.7 +/- 9.7), 47 women and 41 men. The eye topography data were exported from the Eye Surface Profiler software in MATLAB binary data container format then processed by custom built MATLAB codes entirely independent from the profiler software. Scleral asymmetry was determined initially from the unprocessed topography before being determined again after removing the edge-effect noise. Topography data were levelled around the limbus, then edge-effect was eliminated using a robust statistical moving median technique. In addition to comparing raw elevation data, scleral elevation was also compared through fitting a sphere to every single scleral surface and determining the relative elevation from the best-fit sphere reference surface. Results When considering the averaged raw topography elevation data in the scleral section of the eye at radius 8 mm, the average raw elevations of the right eyes' sclera were -1.5 +/- 1.77, -1.87 +/- 2.12, -1.36 +/- 1.82 and -1.57 +/- 1.87 mm. In the left eyes at the same radius the average raw elevations were -1.62 +/- 1.78, -1.82 +/- 2.07, -1.28 +/- 1.76 and -1.68 +/- 1.93 mm. While, when considering the average raw elevation of the sclera after removing the edge effect, the average raw elevations of the right eyes were -3.71 +/- 0.25, -4.06 +/- 0.23, -3.95 +/- 0.19 and -3.95 +/- 0.23 mm. In the left eyes at the same radius the average raw elevations were -3.71 +/- 0.19, -3.97 +/- 0.22, -3.96 +/- 0.19 and -3.96 +/- 0.18 mm in the nasal, temporal, superior and inferior sides respectively. Maximum raw elevation asymmetry in the averaged scleral raw elevation was 1.6647 +/- 0.9015 mm in right eyes and 1.0358 +/- 0.6842 mm in left eyes, both detected at -38 degrees to the nasal side. Best-fit sphere-based relative elevation showed that sclera is more elevated in three main meridians at angles -40 degrees, 76 degrees, and 170 degrees in right eyes and -40 degrees, 76 degrees, and 170 degrees in left eyes, all measured from the nasal meridian. Maximum recorded relative elevation asymmetries were 0.0844 +/- 0.0355 mm and 0.068 +/- 0.0607 mm at angular positions 76 degrees and 63.5 degrees for right and left eyes in turn. Conclusions It is not possible to use corneoscleral topography data to predict the scleral shape without considering a method of removing the edge-effect from the topography data. The nasal side of the sclera is higher than the temporal side, therefore, rotationally symmetric scleral contact lenses are more likely to be translated towards the temporal side. The scleral shape is best described by levelled raw elevation rather than relative elevation.	[Abass, Ahmed; Lopes, Bernardo T.; Eliasy, Ashkan; Jones, Steve; Elsheikh, Ahmed] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Lopes, Bernardo T.; Salomao, Marcella; Ambrosio, Renato, Jr.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Wu, Richard] Cent Taiwan Univ Sci & Technol, Taichung, Taiwan; [Wu, Richard] Pacific Univ, Coll Optometry, Forest Grove, OR USA; [Whites, Lynn; Clamps, John] UltraVis CLPL, Leighton Buzzard, England; [Ambrosio, Renato, Jr.] Fed Univ State Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Elsheikh, Ahmed] Moorfields Eye Hosp NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England; [Elsheikh, Ahmed] UCL Inst Ophthalmol, London, England; [Elsheikh, Ahmed] Beihang Univ, Sch Biol Sci & Biomed Engn, Beijing, Peoples R China	University of Liverpool; Universidade Federal de Sao Paulo (UNIFESP); Central Taiwan University Science & Technology; University of London; King's College London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Beihang University	Abass, A (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.	A.Abass@liverpool.ac.uk	Elsheikh, Ahmed/AAT-1476-2020; Eliasy, Ashkan/AAF-4941-2019; Abass, Ahmed/S-3107-2019	Elsheikh, Ahmed/0000-0001-7456-1749; Eliasy, Ashkan/0000-0002-4473-1900; Abass, Ahmed/0000-0002-8622-4632; Salomao, Marcella/0000-0001-8330-6432				Abass A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207710; Abass A, 2018, CURR EYE RES, V43, P1404, DOI 10.1080/02713683.2018.1500609; Applegate RA, 2009, J CATARACT REFR SURG, V35, P139, DOI 10.1016/j.jcrs.2008.09.014; Arvo J., 1992, GRAPHICS GEMS, P117; Awadalla MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206684; Bandlitz S, 2017, CONTACT LENS ANTERIO, V40, P242, DOI 10.1016/j.clae.2017.04.006; Bekerman I, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/503645; Chhablani J, 2014, SAUDI J OPHTHALMOL, V28, P81, DOI 10.1016/j.sjopt.2014.02.010; Choi HJ, 2014, OPTOMETRY VISION SCI, V91, P793, DOI 10.1097/OPX.0000000000000298; Consejo A, 2018, OPHTHAL PHYSL OPT, V38, P609, DOI 10.1111/opo.12587; Consejo A, 2019, ACTA OPHTHALMOL, V97, pE266, DOI 10.1111/aos.13901; Consejo A, 2018, CORNEA, V37, P1047, DOI 10.1097/ICO.0000000000001565; Consejo A, 2017, OPHTHAL PHYSL OPT, V37, P263, DOI 10.1111/opo.12377; Danjo Y, 1995, ACTA OPHTHALMOL SCAN, V73, P501; Freddo T.F., 2017, ANATOMY EYE ORBIT CL; Gross H., 2005, HDB OPTICAL SYSTEMS, V4; Hall LA, 2013, INVEST OPHTH VIS SCI, V54, P3691, DOI 10.1167/iovs.13-11657; Hall LA, 2011, INVEST OPHTH VIS SCI, V52, P6801, DOI 10.1167/iovs.11-7177; Hastings GD, 2019, OPTOMETRY VISION SCI, V96, P238, DOI 10.1097/OPX.0000000000001365; Hickson-Curran S, 2016, CLIN EXP OPTOM, V99, P149, DOI 10.1111/cxo.12336; Ho J, 2009, OPHTHALMOLOGY, V116, P1960, DOI 10.1016/j.ophtha.2009.03.034; Iskander DR, 2016, OPHTHAL PHYSL OPT, V36, P266, DOI 10.1111/opo.12292; Jesus DA, 2014, 7 EUR WORLD M VIS PH; Jogi R., 2008, BASIC OPHTHALMOLOGY, DOI [10.1016/j.ophtha.2008.07.018, DOI 10.1016/J.OPHTHA.2008.07.018]; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093551; Keller P.R., 1997, CLIN EXP OPTOM, V80, P18, DOI [10.1111/j.1444-0938.1997.tb04843.x, DOI 10.1111/J.1444-0938.1997.TB04843.X]; Liu ZG, 1999, OPHTHALMOLOGY, V106, P939, DOI 10.1016/S0161-6420(99)00513-8; Maurice DM, 1962, VEGETATIVE PHYSL BIO, P289, DOI DOI 10.1016/B978-1-4832-3090-0.50013-7; Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X; Mejia-Barbosa Y, 2001, OPTOMETRY VISION SCI, V78, P240, DOI 10.1097/00006324-200104000-00013; Nau CB, 2018, EYE CONTACT LENS, V44, pS210, DOI 10.1097/ICL.0000000000000382; Otten HM, 2018, OPTOMETRY VISION SCI, V95, P515, DOI 10.1097/OPX.0000000000001228; PAVLOPOULOS GP, 1995, AM J OPHTHALMOL, V119, P712, DOI 10.1016/S0002-9394(14)72775-8; Pinero DP, 2019, CONTACT LENS ANTERIO, V42, P75, DOI 10.1016/j.clae.2018.05.005; Plainis S, 2013, OPTOMETRY VISION SCI, V90, P1066, DOI 10.1097/OPX.0000000000000030; Puzyeyeva O, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/764183; Ray R, 2005, AM J OPHTHALMOL, V139, P18, DOI 10.1016/j.ajo.2004.07.050; Ritzmann M, 2018, CONTACT LENS ANTERIO, V41, P205, DOI 10.1016/j.clae.2017.10.010; Schachar RA, 2017, OPHTHAL PHYSL OPT, V37, P624, DOI 10.1111/opo.12395; Shen MX, 2011, INVEST OPHTH VIS SCI, V52, P4091, DOI 10.1167/iovs.10-6507; Smit G., 1970, EYE VISUAL OPTICAL I; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Tan B, 2014, OPTOMETRY VISION SCI, V91, P650, DOI 10.1097/OPX.0000000000000267; Targowski P, 2005, OPT COMMUN, V249, P357, DOI 10.1016/j.optcom.2005.01.016; Targowski P, 2003, OPTICAL COHERENCE TO, V2003; Vincent SJ, 2019, CLIN EXP OPTOM, V102, P224, DOI 10.1111/cxo.12814; Vincent SJ, 2019, CONTACT LENS ANTERIO, V42, P462, DOI 10.1016/j.clae.2019.04.005; Visser ES, 2006, OPTOMETRY VISION SCI, V83, P233, DOI 10.1097/01.opx.0000214297.38421.15; Visser Esther-Simone, 2007, Eye Contact Lens, V33, P21, DOI 10.1097/01.icl.0000228964.74647.25; Visser ES, 2013, OPTOMETRY VISION SCI, V90, P1078, DOI 10.1097/OPX.0000000000000018; Walker MK, 2016, CONTACT LENS ANTERIO, V39, P88, DOI 10.1016/j.clae.2015.08.003; Wang RK, 2006, PHYS MED BIOL, V51, P3231, DOI 10.1088/0031-9155/51/12/015; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4	53	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0219789	10.1371/journal.pone.0219789	http://dx.doi.org/10.1371/journal.pone.0219789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348792	Green Published, gold, Green Submitted			2022-12-26	WOS:000484979500011
J	Schmid, AS; Neri, D				Schmid, Anja Sophie; Neri, Dario			Design and characterisation of a novel interleukin-15 receptor alpha fusion protein and analysis of interleukin-15 complexation	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; IL-15; SUPERAGONIST; FIBRONECTIN; DOMAIN; TUMORS; CELLS; TRANS	Interleukin-15 (IL15) is one of the most important cytokines currently being considered for cancer therapy applications. It is thought that by administering IL15 in complex with its cognate receptor alpha chain (IL15R alpha) its biological activity could be increased manifold. We produced a fusion protein of mouse IL15R alpha and the F8 antibody, that targets the alternatively-spliced extra-domain A (EDA) of fibronectin, which is overexpressed in many types of cancer. The fusion protein F8IL15R alpha was cloned, expressed and characterized in vitro and its ability to bind to mouse IL15 was assessed with both size exclusion chromatography (SEC) and surface plasmon resonance (SPR) experiments. Furthermore, mouse and human IL15 and their corresponding Fc fused IL15R alpha subunits were purchased, characterized and used to compare the capacity of F8IL15R alpha to generate complexes. Surprisingly, none of the IL15R alpha fusion proteins showed IL15 complexation on SEC. However, on SPR, F8IL15R alpha displayed the ability to bind IL15. In a cell-based activity assay none of the IL15R alpha fusions were able to increase cellular proliferation in combination with IL15 compared to IL15 alone. A better understanding of the molecular requirements for effective IL15 signalling are likely to be important for the development of IL15-based biopharmaceuticals.	[Schmid, Anja Sophie; Neri, Dario] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Vladimir Prelog Weg, Zurich, Switzerland	ETH Zurich	Neri, D (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Vladimir Prelog Weg, Zurich, Switzerland.	neri@pharma.ethz.ch			ETH Zurich; Swiss National Science Foundation [310030B_163479/1]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [607603]	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	D.N. is grateful to ETH Zurich, the Swiss National Science Foundation [Project Nr. 310030B_163479/1] and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [grant agreement No 607603] for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bootz F, 2016, DRUG DISCOV TODAY, V21, P180, DOI 10.1016/j.drudis.2015.10.012; Bristol-MeyersSquibb, 2019, OR AB; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Frey K, 2010, J UROLOGY, V184, P2540, DOI 10.1016/j.juro.2010.07.030; Hacker DL, 2013, PROTEIN EXPRES PURIF, V92, P67, DOI 10.1016/j.pep.2013.09.001; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Hemmerle T, 2014, CANCER IMMUNOL RES, V2, P559, DOI 10.1158/2326-6066.CIR-13-0182; Huang HM, 2018, PROTEIN EXPRES PURIF, V148, P30, DOI 10.1016/j.pep.2018.03.010; Hutmacher C, 2018, ADV DRUG DELIV REV; Kaspar M, 2007, CANCER RES, V67, P4940, DOI 10.1158/0008-5472.CAN-07-0283; Kermer V, 2012, MOL CANCER THER, V11, P1279, DOI 10.1158/1535-7163.MCT-12-0019; Margolin K, 2018, CLIN CANCER RES, V24, P5552, DOI 10.1158/1078-0432.CCR-18-0945; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Olsen SK, 2007, J BIOL CHEM, V282, P37191, DOI 10.1074/jbc.M706150200; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Robinson TO, 2017, IMMUNOL LETT, V190, P159, DOI 10.1016/j.imlet.2017.08.010; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Rybak JN, 2007, CANCER RES, V67, P10948, DOI 10.1158/0008-5472.CAN-07-1436; Schwager K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2814; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Taylor NP, GENENTECH PAYS XENCO; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Waldmann TA, 2011, BLOOD, V117, P4787, DOI 10.1182/blood-2010-10-311456; Wrangle JM, 2018, LANCET ONCOL, V19, P694, DOI 10.1016/S1470-2045(18)30148-7	27	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0219313	10.1371/journal.pone.0219313	http://dx.doi.org/10.1371/journal.pone.0219313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348785	Green Submitted, Green Published, gold			2022-12-26	WOS:000484979500006
J	Wang, QM; Yang, YT; Wang, YR; Gao, B; Xi, XG; Hou, XM				Wang, Qing-Man; Yang, Yan-Tao; Wang, Yi-Ran; Gao, Bo; Xi, Xuguang; Hou, Xi-Miao			Human replication protein A induces dynamic changes in single-stranded DNA and RNA structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; DNA-protein interaction; DNA structure; single-molecule biophysics; enzyme mechanism; molecular dynamics; fluorescence resonance energy transfer (FRET); DNA recombination; DNA replication; replication protein A	BINDING; RPA; SSDNA; MECHANISM; SUBUNIT; DOMAINS; PRIMER; ARCHITECTURE; HELICASE; POLARITY	Replication protein A (RPA) is the major eukaryotic ssDNA-binding protein and has essential roles in genome maintenance. RPA binds to ssDNA through multiple modes, and recent studies have suggested that the RPA-ssDNA interaction is dynamic. However, how RPA alternates between different binding modes and modifies ssDNA structures in this dynamic interaction remains unknown. Here, we used single-molecule FRET to systematically investigate the interaction between human RPA and ssDNA. We show that RPA can adopt different types of binding complexes with ssDNAs of different lengths, leading to the straightening or bending of the ssDNAs, depending on both the length and structure of the ssDNA substrate and the RPA concentration. Importantly, we noted that some of the complexes are highly dynamic, whereas others appear relatively static. On the basis of the above observations, we propose a model explaining how RPA dynamically engages with ssDNA. Of note, fluorescence anisotropy indicated that RPA can also associate with RNA but with a lower binding affinity than with ssDNA. At the single-molecule level, we observed that RPA is undergoing rapid and repetitive associations with and dissociation from the RNA. This study may provide new insights into the rich dynamics of RPA binding to ssDNA and RNA.	[Wang, Qing-Man; Yang, Yan-Tao; Wang, Yi-Ran; Gao, Bo; Xi, Xuguang; Hou, Xi-Miao] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Wang, Qing-Man; Yang, Yan-Tao; Wang, Yi-Ran; Gao, Bo; Xi, Xuguang; Hou, Xi-Miao] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Xi, Xuguang] Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, 61 Ave President Wilson, F-94235 Cachan, France	Northwest A&F University - China; Northwest A&F University - China; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Hou, XM (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Hou, XM (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	houximiao@nwsuaf.edu.cn	Wang, Yin/HCI-9352-2022; Wang, Yixuan/GZK-6559-2022; Hou, Xi-Miao/AAA-7919-2021; Wang, Yu/GZL-9655-2022; wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Xi, Xu Guang/AAK-4511-2020; wang, yixuan/GXW-2866-2022		Chinese Universities Scientific Fund [Z109021718]; National Natural Science Foundation of China [11574252]	Chinese Universities Scientific Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Universities Scientific Fund Grant Z109021718 and National Natural Science Foundation of China Grant 11574252. The authors declare that they have no conflicts of interest with the contents of this article.	Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Bain FE, 2018, METHOD ENZYMOL, V600, P439, DOI 10.1016/bs.mie.2017.11.016; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; Blackwell LJ, 1996, MOL CELL BIOL, V16, P4798; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Brosey CA, 2009, J AM CHEM SOC, V131, P6346, DOI 10.1021/ja9013634; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09296; Chen R, 2016, NUCLEIC ACIDS RES, V44, P5758, DOI 10.1093/nar/gkw339; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Iftode C, 2000, BIOCHEMISTRY-US, V39, P11970, DOI 10.1021/bi0005761; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kaniecki K, 2018, NAT REV GENET, V19, P191, DOI 10.1038/nrg.2017.92; Kemmerich FE, 2016, NUCLEIC ACIDS RES, V44, P5837, DOI 10.1093/nar/gkw187; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kolpashchikov DM, 2001, NUCLEIC ACIDS RES, V29, P373, DOI 10.1093/nar/29.2.373; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Lavrik OI, 1999, NUCLEIC ACIDS RES, V27, P4235, DOI 10.1093/nar/27.21.4235; Liu Y, 2011, MOL CELL BIOL, V31, P4298, DOI 10.1128/MCB.05737-11; Ma CJ, 2017, NUCLEIC ACIDS RES, V45, P749, DOI 10.1093/nar/gkw1125; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Pestryakov PE, 2004, NUCLEIC ACIDS RES, V32, P1894, DOI 10.1093/nar/gkh346; Pestryakov PE, 2003, J BIOL CHEM, V278, P17515, DOI 10.1074/jbc.M301265200; Pokhrel N, 2017, NUCLEIC ACIDS RES, V45, P9413, DOI 10.1093/nar/gkx598; Pretto DI, 2010, BIOCHEMISTRY-US, V49, P2880, DOI 10.1021/bi9019934; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Salas TR, 2009, NUCLEIC ACIDS RES, V37, P38, DOI 10.1093/nar/gkn895; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sugitani N, 2015, PROG BIOPHYS MOL BIO, V117, P206, DOI 10.1016/j.pbiomolbio.2014.12.001; Witosch J, 2014, NUCLEIC ACIDS RES, V42, P12912, DOI 10.1093/nar/gku960; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yates LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07883-7; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	50	13	13	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13915	13927		10.1074/jbc.RA119.009737	http://dx.doi.org/10.1074/jbc.RA119.009737			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31350334	Green Published, hybrid			2022-12-26	WOS:000490729800007
J	Dizhoor, AM; Olshevskaya, EV; Peshenko, IV				Dizhoor, Alexander M.; Olshevskaya, Elena V.; Peshenko, Igor V.			Retinal guanylyl cyclase activation by calcium sensor proteins mediates photoreceptor degeneration in an rd3 mouse model of congenital human blindness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vision; guanylate cyclase (guanylyl cyclase); phototransduction; calcium-binding protein; eye; retinal degeneration; GCAP; RD3; RetGC	1 RETGC1; CRYSTAL-STRUCTURE; ROD; GCAPS; SENSITIVITY; EXPRESSION; CLONING; PHOTOTRANSDUCTION; LOCALIZATION; TRAFFICKING	Deficiency of RD3 (retinal degeneration 3) protein causes recessive blindness and photoreceptor degeneration in humans and in the rd3 mouse strain, but the disease mechanism is unclear. Here, we present evidence that RD3 protects photoreceptors from degeneration by competing with guanylyl cyclase-activating proteins (GCAPs), which are calcium sensor proteins for retinal membrane guanylyl cyclase (RetGC). RetGC activity in rd3/rd3 retinas was drastically reduced but stimulated by the endogenous GCAPs at low Ca2+ concentrations. RetGC activity completely failed to accelerate in rd3/rd3GCAPs(-/-) hybrid photoreceptors, whose photoresponses remained drastically suppressed compared with the WT. However, similar to 70% of the hybrid rd3/rd3GCAPs(-/-) photoreceptors survived past 6 months, in stark contrast to <5% in the nonhybrid rd3/rd3 retinas. GFP-tagged human RD3 inhibited GCAP-dependent activation of RetGC in vitro similarly to the untagged RD3. When transgenically expressed in rd3/rd3 mouse retinas under control of the rhodopsin promoter, the RD3GFP construct increased RetGC levels to near normal levels, restored dark-adapted photoresponses, and rescued rods from degeneration. The fluorescence of RD3GFP in rd3/rd3RD3GFP(+) retinas was mostly restricted to the rod photoreceptor inner segments, whereas GCAP1 immunofluorescence was concentrated predominantly in the outer segment. However, RD3GFP became distributed to the outer segments when bred into a GCAPs(-/-) genetic background. These results support the hypothesis that an essential biological function of RD3 is competition with GCAPs that inhibits premature cyclase activation in the inner segment. Our findings also indicate that the fast rate of degeneration in RD3-deficient photoreceptors results from the lack of this inhibition.	[Dizhoor, Alexander M.; Olshevskaya, Elena V.; Peshenko, Igor V.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416,8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY011522]; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY011522 and by the Pennsylvania Department of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Dizhoor AM, 2016, J BIOL CHEM, V291, P24504, DOI 10.1074/jbc.M116.755553; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Horton R. M., 1991, PRACTICAL APPROACH, P217; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2019, J BIOL CHEM, V294, P3476, DOI 10.1074/jbc.RA118.006180; Peshenko IV, 2019, J BIOL CHEM, V294, P2318, DOI 10.1074/jbc.RA118.006106; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sato S, 2018, J NEUROSCI, V38, P2990, DOI 10.1523/JNEUROSCI.2985-17.2018; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00052; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	48	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13729	13739		10.1074/jbc.RA119.009948	http://dx.doi.org/10.1074/jbc.RA119.009948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346032	hybrid, Green Published			2022-12-26	WOS:000486418600018
J	Li, C; Zhang, Z; Peng, Y; Gao, HX; Wang, YX; Zhao, J; Pan, CL				Li, Chao; Zhang, Zheng; Peng, Yu; Gao, Hanxiang; Wang, Yongxiang; Zhao, Jing; Pan, Chenliang			Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; ARTERY-DISEASE; ESC GUIDELINES; ST; REFLECTS; FAILURE; NGAL; ATHEROSCLEROSIS; EXPRESSION	Objective This study aimed to compare the levels of plasma neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase (MMP)-9, high-sensitivity C-reactive protein (hs-CRP), and interleukin (IL)-1 beta across different clinical presentations of coronary artery disease and to evaluate the relationship between those biomarkers and the severity of coronary artery lesions in patients without kidney disease. Methods We examined 365 eligible patients who underwent coronary angiography. A total of 124 ST-segment elevation myocardial infarction (STEMI) patients, 117 stable angina pectoris (SAP) patients and 124 patients without atherosclerotic plaques were enrolled in the study. Plasma NGAL, MMP-9, hs-CRP, and IL-1 beta were measured in all patients using the enzyme-linked immunosorbent assay (ELISA) method. According to the SYNTAX score, the STEMI patients and SAP patients were divided into another set of 2 groups: a high score group (>= 33, n = 29) and a low score group (< 33, n = 212). The relationship between those biomarkers and the severity of coronary stenosis was examined by Spearman correlation analysis; the ability for NGAL to discriminate severe coronary stenosis was examined by receiver operating characteristic (ROC) curve; the influencing factors for the SYNTAX score were determined by logistic regression analysis. Results Plasma NGAL, MMP-9, and hs-CRP levels in STEMI patients were higher than in the SAP patients and control subjects (P< 0.05, respectively), and plasma NGAL and hs-CRP levels were significantly higher in the SAP patients than in control subjects (P< 0.05, respectively), while plasma IL-1 beta was similar among the 3 groups (P> 0.05, respectively). The SYNTAX score was positively related to NGAL (r = 0.363, P< 0.001), MMP-9 (r = 0.377, P< 0.001), and hs-CRP (r = 0.163, P< 0.011); the SYNTAX score was not related to IL-1 beta (r = -0.043, P = 0.510). Plasma NGAL was positively related to MMP-9 (r = 0.601, P< 0.001) and IL-1 beta (r = 0.159, P = 0.014). The area under the ROC curve for NGAL discriminating severe coronary stenosis was 0.838 (95% CI: 0.752-0.923, P< 0.001), which was greater than that for MMP-9 [0.818, (95% CI: 0.724-0.912, P< 0.001)], IL-1 beta [0.485, (95% CI: 0.369-0.601, P = 0.791)], and hs-CRP [0.607, (95% CI: 0.492-0.722, P = 0.061)]. Multivariate regression analysis showed that plasma NGAL levels were independently related to high SYNTAX scores [OR = 1.109, (95% CI: 1.104-1.114), P< 0.001]. Conclusion Plasma NGAL, MMP-9, and hs-CRP levels in STEMI patients were higher than those in the SAP patients and control subjects. NGAL had a better ability to discriminate severe coronary stenosis than MMP-9, IL-1 beta, and hs-CRP. NGAL may be a novel biomarker to aid in risk stratification in coronary heart disease patients.	[Li, Chao] Lanzhou Univ, Clin Coll 1, Lanzhou, Gansu, Peoples R China; [Li, Chao; Zhang, Zheng; Peng, Yu; Gao, Hanxiang; Wang, Yongxiang; Zhao, Jing; Pan, Chenliang] Lanzhou Univ, Hosp 1, Dept Cardiol, Lanzhou, Gansu, Peoples R China; [Li, Chao] Gansu Key Lab Cardiovasc Dis, Lanzhou, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Zhang, Z (corresponding author), Lanzhou Univ, Hosp 1, Dept Cardiol, Lanzhou, Gansu, Peoples R China.	Zhangccu@163.com						Ahmadi A, 2015, CIRC RES, V117, P99, DOI 10.1161/CIRCRESAHA.117.305637; Boekhorst BCT, 2011, CARDIOVASC RES, V89, P680, DOI 10.1093/cvr/cvq340; Bolignano D, 2008, KIDNEY BLOOD PRESS R, V31, P255, DOI 10.1159/000143726; Bundhun PK, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007140; [全国eGFR课题协作组 Chinese eGFR Investigation Collaboration], 2006, [中华肾脏病杂志, Chinese Journal of Nephrology], V22, P589; Chong JJH, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011028; Cruz DN, 2012, CLIN CHEM LAB MED, V50, P1533, DOI 10.1515/cclm-2012-0307; Ding LM, 2010, CIRC J, V74, P523, DOI 10.1253/circj.CJ-09-0485; Dong L, 2015, AM J CARDIOL, V115, P860, DOI 10.1016/j.amjcard.2015.01.008; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Hong MK, 2004, CIRCULATION, V110, P928, DOI 10.1161/01.CIR.0000139858.69915.2E; Kafkas N, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/189797; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Katagiri M, 2016, HEART VESSELS, V31, P1595, DOI 10.1007/s00380-015-0776-8; Kirbis S, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0054-9; Kunutsor SK, 2018, CLIN CHIM ACTA, V486, P66, DOI 10.1016/j.cca.2018.07.034; Lahiri A, 2018, INDIAN HEART J, V70, P220, DOI 10.1016/j.ihj.2017.06.005; Lim YM, 2017, CORONARY ARTERY DIS, V28, P690, DOI 10.1097/MCA.0000000000000542; Lindberg S, 2016, CARDIORENAL MED, V6, P180, DOI 10.1159/000443846; Lindberg S, 2012, J AM COLL CARDIOL, V60, P339, DOI 10.1016/j.jacc.2012.04.017; Loftus IM, 2000, STROKE, V31, P40, DOI 10.1161/01.STR.31.1.40; Ma QQ, 2016, EUR REV MED PHARMACO, V20, P4294; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mortara A, 2013, J CARDIOVASC MED, V14, P629, DOI 10.2459/JCM.0b013e3283629ca6; Nymo SH, 2018, INT J CARDIOL, V262, P79, DOI 10.1016/j.ijcard.2018.03.028; Sahinarslan A, 2011, CORONARY ARTERY DIS, V22, P333, DOI 10.1097/MCA.0b013e3283472a71; Sano T, 2003, CIRCULATION, V108, P282, DOI 10.1161/01.CIR.0000079173.84669.4F; Sivalingam Z, 2018, SCAND J CLIN LAB INV, V78, P470, DOI 10.1080/00365513.2018.1499956; Soylu K, 2015, ANATOL J CARDIOL, V15, P450, DOI 10.5152/akd.2014.5513; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002; Woitas RP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171574; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088; Zografos T, 2009, AM J CARDIOL, V104, P917, DOI 10.1016/j.amjcard.2009.05.023	35	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220841	10.1371/journal.pone.0220841	http://dx.doi.org/10.1371/journal.pone.0220841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31387110	gold, Green Published, Green Submitted			2022-12-26	WOS:000484997100038
J	Carregaro, AB; Ferrari, BG; da Silva, ANE; Xavier, NV; Duarte, JMB				Carregaro, Adriano B.; Ferrari, Barbara G.; da Silva, Andre N. E.; Xavier, Nathalia, V; Duarte, Jose M. B.			Azaperone and xylazine: A pharmacological combination to facilitate captive deer management for red brocket deer (Mazama americana)	PLOS ONE			English	Article							WHITE-TAILED DEER; TILETAMINE-ZOLAZEPAM; CERVUS-ELAPHUS; BLOOD-GAS; ACID-BASE; MEDETOMIDINE; IMMOBILIZATION; KETAMINE; ANESTHESIA; BUTORPHANOL	The care and management of deer in captivity is challenging, especially in the case of red brocket deer (Mazama americana), whose routine management using physical restraint is difficult. Our study evaluated the effects of azaperone and xylazine combination for immobilizing red brocket deer and allow for the standard capture and handling protocols (e.g., biological material, horn cutting, and trimming) to be conducted safely. Six adult, captive, red brocket deer received an intramuscular injection of either 1 mg/kg azaperone and 0.5 mg/kg xylazine (AX0.5) or 1 mg/kg azaperone and 1 mg/kg xylazine (AX1.0). Sedation latency, sternal recumbency, safe handling, and quality of the sedation were evaluated to provide an overview of how the immobilizing drugs affected managing the species in captivity. Additionally, heart rate, respiratory rate, mean arterial pressure, rectal temperature, pH, PaO2, PaCO2, SaO(2), HCO3-, BE, Na+, K+ and serum lactate were also measured. The latency period of the animals in the AX0.5 group was greater than that of the animals in the AX1.0 group (7 +/- 6.6 min vs. 5 +/- 2.0 min), as was the time for them to assume sternal recumbency (12 +/- 9.7 min vs. 6 +/- 3.1 min). However, the time after the initial dose at which the animals could safely be handled (14 +/- 4.5 min vs. 12 +/- 5.2 min), and the time until the end of the safe handling period (75 +/- 12.3 min vs. 85 +/- 6.8 min) were similar for both groups. Animals in both groups showed physiological stability during all evaluations, but hypoxemia was observed in one animal in each group. We conclude that both drug combinations are safe and effective at sedating red brocket deer in captivity and suggest that the procedure be performed with oxygen supplementation to reduce the potential for hypoxia.	[Carregaro, Adriano B.; Ferrari, Barbara G.; da Silva, Andre N. E.; Xavier, Nathalia, V] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil; [Duarte, Jose M. B.] Sao Paulo State Univ UNESP, Fac Agr & Vet Sci, Deer Res & Conservat Ctr NUPECCE, Dept Anim Sci, Jaboticabal, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Carregaro, AB (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil.	carregaro@usp.br	Duarte, José Maurício Barbanti/AAG-5149-2019; Carregaro, Adriano Bonfim/C-2832-2012	Duarte, José Maurício Barbanti/0000-0002-7805-0265; Carregaro, Adriano Bonfim/0000-0002-0580-0467				Abril VV, 2010, CYTOGENET GENOME RES, V128, P177, DOI 10.1159/000298819; Auer U, 2010, J WILDLIFE DIS, V46, P1196, DOI 10.7589/0090-3558-46.4.1196; Barbanti Duarte Jose Mauricio, 2010, P218; Catao-Dias Jose Luiz, 2010, P324; Caulkett NA, 2000, CAN J VET RES, V64, P64; Caulkett NA, 1997, CAN VET J, V38, P389; Cursino MS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-40; Duarte JMB, 2006, TRATADO ANIMAIS SELV, P641; Duarte JMB, 2016, IUCN RED LIST THREAT, V8235, P1; Duarte JMB, 2009, ENDANGERED FAUNA STA, P645; Fahlman A, 2014, J ZOO WILDLIFE MED, V45, P272, DOI 10.1638/2013-0097R.1; Flôres Fabíola Niederauer, 2009, Cienc. Rural, V39, P1101, DOI 10.1590/S0103-84782009000400022; KREEGER TJ, 1986, J WILDLIFE DIS, V22, P407, DOI 10.7589/0090-3558-22.3.407; Lemke KA, 2004, CAN VET J, V45, P475; Mich PM, 2008, J ZOO WILDLIFE MED, V39, P480, DOI 10.1638/2007-0150.1; Miller BF, 2004, J WILDLIFE DIS, V40, P533, DOI 10.7589/0090-3558-40.3.533; Monteith KL, 2012, J WILDLIFE MANAGE, V76, P1412, DOI 10.1002/jwmg.383; Muller LI, 2012, J WILDLIFE DIS, V48, P477, DOI 10.7589/0090-3558-48.2.477; Navas-Suarez PE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198670; PINHO MP, 2010, NEOTROPICAL CERVIDOL, P228; Posner LP, 2005, J ZOO WILDLIFE MED, V36, P642, DOI 10.1638/04-072.1; Salviano MB, 2017, BIOL REPROD, V96, P1279, DOI 10.1093/biolre/iox041; Sente C, 2014, J WILDLIFE DIS, V50, P359, DOI 10.7589/2012-10-267; Siegal-Willott J, 2009, J WILDLIFE DIS, V45, P468, DOI 10.7589/0090-3558-45.2.468; Smith KM, 2006, J ZOO WILDLIFE MED, V37, P513, DOI 10.1638/06-027.1; Stewart JL, 2018, J FISH WILDL MANAG, V9, P631, DOI 10.3996/032018-JFWM-025; Suzuki M, 2001, J WILDLIFE DIS, V37, P366, DOI 10.7589/0090-3558-37.2.366; VANWOERKENS LJ, 1990, BRIT J ANAESTH, V65, P393, DOI 10.1093/bja/65.3.393; Varela DM, 2015, NEOTROPICAL CERVIDOL, P151; Wilson PR, 1996, NEW ZEAL VET J, V44, P81, DOI 10.1080/00480169.1996.35941; Wolfe LL, 2014, J WILDLIFE DIS, V50, P676, DOI 10.7589/2014-02-026	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220288	10.1371/journal.pone.0220288	http://dx.doi.org/10.1371/journal.pone.0220288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374096	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500008
J	Bergt, S; Grub, A; Mueller, M; Bajorat, R; Barilar, I; Vollmar, B; Roesner, JP; Wagner, NM				Bergt, Stefan; Grub, Andrea; Mueller, Melanie; Bajorat, Rika; Barilar, Ivan; Vollmar, Brigitte; Roesner, Jan Patrick; Wagner, Nana-Maria			Toll-like receptor 4 deficiency or inhibition does not modulate survival and neurofunctional outcome in a murine model of cardiac arrest and resuscitation	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; NEUROLOGICAL REHABILITATION; BRAIN-INJURY; MICE; MANAGEMENT; CARE	Background Patients experiencing cardiac arrest (CA) and cardiopulmonary resuscitation (CPR) often die or suffer from severe neurological impairment. Post resuscitation syndrome is characterized by a systemic inflammatory response. Toll-like receptor 4 (TLR4) is a major mediator of inflammation and TLR4 has been implicated in the pathogenesis of post-resuscitation encephalopathy. The aim of this study was to evaluate whether TLR4 deficiency or inhibition can modulate survival and neurofunctional outcome after CA/CPR. Methods Following intubation and central venous cannulation, CA was induced in wild type (C57Bl/6J, n = 38), TLR4 deficient (TLR4(-/-), n = 37) and TLR4 antibody treated mice (5mg/kg MTS510, n = 15) by high potassium. After 10min, CPR was performed using a modified sewing machine until return of spontaneous circulation (ROSC). Cytokines and cerebral TNFalpha levels were measured 8h after CA/CPR. Survival, early neurological recovery, locomotion, spatial learning and memory were assessed over a period of 28 days. Results Following CA/CPR, all mice exhibited ROSC and 31.5% of wild type mice survived until day 28. Compared to wild type mice, neither TLR4(-/-) nor MTS510 treated wild type mice had statistically significant altered survival following CA/ CPR (51.3 and 26.7%, P = 0.104 and P = 0.423 vs. WT, respectively). Antibody-treated but not TLR4(-/-) mice had higher IL-1 beta and IL-6 levels and TLR4(-/-) mice had higher IL-10 and cerebral TNFalpha levels. No differences existed between mice of all groups in early neurological recovery, locomotion, spatial learning ability or remembrance. Conclusion Therapeutic strategies targeting TLR4 may not be suitable for the reduction of mortality or neurofunctional impairment after CA/CPR.	[Bergt, Stefan; Grub, Andrea; Bajorat, Rika; Roesner, Jan Patrick] Rostock Univ, Clin Anesthesiol & Crit Care Med, Med Ctr, Rostock, Germany; [Mueller, Melanie; Wagner, Nana-Maria] Univ Hosp Muenster, Clin Anesthesiol Intens Care Med & Pain Therapy, Munster, Germany; [Barilar, Ivan] Res Ctr Borstel, Prior Area Infect, Mol & Expt Mycobacteriol, Borstel, Germany; [Vollmar, Brigitte] Rostock Univ, Inst Expt Surg, Med Ctr, Rostock, Germany	University of Rostock; University of Munster; Forschungszentrum Borstel; University of Rostock	Wagner, NM (corresponding author), Univ Hosp Muenster, Clin Anesthesiol Intens Care Med & Pain Therapy, Munster, Germany.	nmwagner@uni-muenster.de	Wagner, Nana-Maria/AAB-3953-2021	Wagner, Nana-Maria/0000-0002-4610-6666	departmental funds of the Clinic for Anesthesiology and Critical Care Medicine, Rostock, Germany	departmental funds of the Clinic for Anesthesiology and Critical Care Medicine, Rostock, Germany	The study was funded by departmental funds of the Clinic for Anesthesiology and Critical Care Medicine, Rostock, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella BS, 2004, CIRCULATION, V109, P2786, DOI 10.1161/01.CIR.0000131940.19833.85; Andresen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148428; Asmussen A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1340-3; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bergt S, 2017, JACC BASIC TRANSLATI, V105; Bergt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074944; DECKER MW, 1989, BRAIN RES, V477, P29, DOI 10.1016/0006-8993(89)91391-7; Dvoriantchikova G, 2010, MOL VIS, V16, P1907; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Gesuete R, 2014, J NEUROPATH EXP NEUR, V73, P378, DOI 10.1097/NEN.0000000000000068; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Jiang H, 2017, CANCER IMMUNOL IMMUN, V66, P1037, DOI 10.1007/s00262-017-2003-1; Krupinski J, 2007, BIOMARK INSIGHTS, V2, P361; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Liu FD, 2013, ACTA PHARMACOL SIN, V34, P1121, DOI 10.1038/aps.2013.89; Maramattom BV, 2005, NEUROLOGIST, V11, P234, DOI 10.1097/01.nrl.0000159985.07242.22; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Neigh GN, 2004, J CEREBR BLOOD F MET, V24, P372, DOI 10.1097/00004647-200404000-00002; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; NIEMANN JT, 1984, ANN EMERG MED, V13, P849, DOI 10.1016/S0196-0644(84)80458-8; Oda Y, 2012, RESUSCITATION, V83, P1006, DOI 10.1016/j.resuscitation.2012.01.030; Orr JS, 2012, DIABETES; Packard AEB, 2012, J CEREBR BLOOD F MET, V32, P2193, DOI 10.1038/jcbfm.2012.140; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Pusswald G, 2000, RESUSCITATION, V47, P241, DOI 10.1016/S0300-9572(00)00240-9; Puttgen HA, 2009, CURR OPIN CRIT CARE, V15, P118, DOI 10.1097/MCC.0b013e328326077c; Shi X, 2017, NEUROSCIENCE, V360, P128, DOI 10.1016/j.neuroscience.2017.07.052; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Thaete LG, 2013, REPRODUCTION; Wang Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/124614; Xu L, 2015, CHINESE MED J-PEKING, V128, P2646, DOI 10.4103/0366-6999.166024; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220404	10.1371/journal.pone.0220404	http://dx.doi.org/10.1371/journal.pone.0220404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369614	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900046
J	Chao, WC; Lin, CH; Chen, YM; Jiang, RS; Chen, HH				Chao, Wen-Cheng; Lin, Ching-Heng; Chen, Yi-Ming; Jiang, Rong-San; Chen, Hsin-Hua			Association between tonsillitis and newly diagnosed ankylosing spondylitis: A nationwide, population-based, case-control study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PERIODONTITIS; APPENDECTOMY; MICROBIOME; INFECTION; HLA-B27; RISK	Objectives To investigate the association between tonsillitis and the risk of newly diagnosed ankylosing spondylitis (AS). Methods We used 2003-2012 data from Taiwan's National Health Insurance Research Database to conduct this nationwide, population-based, case-control study. We identified AS patients newly diagnosed between 2005 to 2012 as the study group and selected age, sex and index-year matched (1: 6) non-AS individuals as controls. The association between tonsillitis and risk of newly diagnosed AS was determined by calculating odds ratios (ORs) with 95% confidence intervals (CIs) using conditional logistic regression analysis. Results We identified 37,002 newly diagnosed AS cases and 222,012 matched non-AS controls. Patients with AS were more likely to have tonsillitis (aOR 1.46, 95% CI 1.43-1.50), appendicitis (aOR 1.29, 95% CI 1.13-1.48) and periodontitis (aOR 1.35, 95% CI 1.31-1.38) than non-AS control subjects. The association between tonsillitis and AS was consistent using varying definitions for tonsillitis, and we further found that a high frequency of visits for tonsillitis, a high medical cost for tonsillitis and a long interval between diagnosis were associated with newly diagnosed AS in a dose-response manner. Furthermore, the association between tonsillitis and AS appeared to be stronger in females (aOR 1.59, 95% CI 1.53-1.65) than those in males (aOR 1.39, 95% CI 1.35-1.44). Conclusions The present study revealed an association between AS risk and prior tonsillitis and indicates the need for vigilance of AS-associated symptoms in patients who had been diagnosed with tonsillitis, particularly in females.	[Chao, Wen-Cheng; Lin, Ching-Heng; Chen, Yi-Ming; Jiang, Rong-San; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chao, Wen-Cheng] Hung Kuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan; [Chao, Wen-Cheng] Natl Changhua Univ Educ, Dept Business Adm, Changhua, Taiwan; [Lin, Ching-Heng] Natl Taipei Univ Nursing & Hlth Sci, Dept Healthcare Management, Taipei, Taiwan; [Lin, Ching-Heng] Fu Jen Catholic Univ, Coll Med, Dept Publ Hlth, New Taipei, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Jiang, Rong-San] Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan; [Jiang, Rong-San] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chen, Hsin-Hua] Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; Hungkuang University; National Changhua University of Education; National Taipei University of Nursing & Health Science (NTUNHS); Fu Jen Catholic University; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tunghai University	Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.; Chen, HH (corresponding author), Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan.	shc5555@hotmail.com	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Chao, Wen-Cheng/0000-0001-9631-8934	Taichung Veterans General Hospital, Taiwan [TCVGH-1057329D]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1057329D). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; [Anonymous], 2015, THE NATIONAL HEALTH; Blair AB, 2015, AM J OTOLARYNG, V36, P517, DOI 10.1016/j.amjoto.2015.03.002; Burke Kristin E, 2017, Curr Gastroenterol Rep, V19, P21, DOI 10.1007/s11894-017-0562-0; Campisi L, 2016, NAT IMMUNOL, V17, P1084, DOI 10.1038/ni.3512; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chen HH, 2011, CLINICS, V66, P251, DOI 10.1590/S1807-59322011000200012; Ciccia F, 2012, ARTHRITIS RHEUM-US, V64, P1869, DOI 10.1002/art.34355; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Dean LE, 2014, RHEUMATOLOGY, V53, P650, DOI 10.1093/rheumatology/ket387; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kawano M, 2003, ARTHRITIS RHEUM-US, V48, P2483, DOI 10.1002/art.11212; Keller JJ, 2013, ARTHRITIS RHEUM-US, V65, P167, DOI 10.1002/art.37746; Kobayashi S, 2011, ADV OTO-RHINO-LARYNG, V72, P79, DOI 10.1159/000324612; Kordeluk S, 2011, OTOLARYNG HEAD NECK, V145, P940, DOI 10.1177/0194599811415802; Lau AS, 2014, ANN ROY COLL SURG, V96, P307, DOI 10.1308/003588414X13946184900363; Lin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105684; Lindstrom U, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1141-8; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Millington AJ, 2014, ANN ROY COLL SURG, V96, P586, DOI 10.1308/003588414X13946184901966; Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Picchianti-Diamanti A, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02696; Reveille JD, 2013, AM J MED SCI, V345, P431, DOI 10.1097/MAJ.0b013e318294457f; Rizzetto L, 2018, J AUTOIMMUN, V92, P12, DOI 10.1016/j.jaut.2018.05.008; Rosenbaum JT, 2011, ARTHRITIS RHEUM-US, V63, P3195, DOI 10.1002/art.30558; Salo M, 2017, INT J COLORECTAL DIS, V32, P19, DOI 10.1007/s00384-016-2639-x; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Tzeng YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126816; Yang LH, 2016, INT J MOL SCI, V17, DOI [10.3390/ijms17030403, 10.3390/ijms17122126]	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220721	10.1371/journal.pone.0220721	http://dx.doi.org/10.1371/journal.pone.0220721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369625	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900081
J	Ruiz, HH; Becker, S; Bai, Y; Cortes-Burgos, LA; Eckersdorff, MM; Macdonald, LE; Croll, SD				Ruiz, Henry H.; Becker, Stephanie; Bai, Yu; Cortes-Burgos, Luz A.; Eckersdorff, Melissa M.; Macdonald, Lynn E.; Croll, Susan D.			Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model	PLOS ONE			English	Article							NEUROPEPTIDE-Y; ULCERATIVE-COLITIS; MURINE COLITIS; NERVOUS-SYSTEM; ANIMAL-MODELS; CELLS; MICE	Administration of dextran sodium sulfate (DSS) to rodents at varying concentrations and exposure times is commonly used to model human inflammatory bowel disease (IBD). Currently, the criteria used to assess IBD-like pathology seldom include surrogate measures of visceral pain. Thus, we sought to standardize the model and then identify surrogate measures to assess effects on visceral pain. We used various 4% DSS protocols and evaluated effects on weight loss, colon pathology, biochemistry, RNA signature, and open field behavior. We then tested the therapeutic potential of NPY Y1 and/or Y2 receptor inhibition for the treatment of IBD pathology using this expanded panel of outcome measures. DSS caused weight loss and colon shrinkage, increased colon NPY and inflammatory cytokine expression, altered behaviors in the open field and induced a distinct gene metasignature that significantly overlapped with that of human IBD patients. Inhibition of Y1 and/or Y2 receptors failed to improve gross colon pathology. Y1 antagonism significantly attenuated colon inflammatory cytokine expression without altering pain-associated behaviors while Y2 antagonism significantly inhibited pain-associated behaviors in spite of a limited effect on inflammatory markers. A protocol using 7 days of 4% DSS most closely modeled human IBD pathology. In this model, rearing behavior potentially represents a tool for evaluating visceral pain/discomfort that may be pharmacologically dissociable from other features of pathology. The finding that two different NPY receptor antagonists exhibited different efficacy profiles highlights the benefit of including a variety of outcome measures in IBD efficacy studies to most fully evaluate the therapeutic potential of experimental treatments.	[Ruiz, Henry H.; Becker, Stephanie; Bai, Yu; Cortes-Burgos, Luz A.; Eckersdorff, Melissa M.; Macdonald, Lynn E.; Croll, Susan D.] Regeneron Pharmaceut, Neurosci, Tarrytown, NY 10591 USA; [Ruiz, Henry H.; Croll, Susan D.] CUNY, Grad Ctr, Grad Program Neuropsychol, New York, NY 10017 USA; [Croll, Susan D.] CUNY, Queens Coll, Psychol, Flushing, NY 11367 USA	Regeneron; City University of New York (CUNY) System; City University of New York (CUNY) System; Queens College NY (CUNY)	Croll, SD (corresponding author), Regeneron Pharmaceut, Neurosci, Tarrytown, NY 10591 USA.; Croll, SD (corresponding author), CUNY, Grad Ctr, Grad Program Neuropsychol, New York, NY 10017 USA.; Croll, SD (corresponding author), CUNY, Queens Coll, Psychol, Flushing, NY 11367 USA.	Susan.croll@regeneron.com	Ruiz, Henry H./AAA-1872-2020	Ruiz, Henry H./0000-0002-0213-6759; Becker, Stephanie/0000-0003-0565-5930; Croll, Susan/0000-0002-3949-1877	Regeneron Pharmaceuticals	Regeneron Pharmaceuticals(Regeneron)	All work presented here was funded by Regeneron Pharmaceuticals.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; AlSharari SD, 2013, J PHARMACOL EXP THER, V344, P207, DOI 10.1124/jpet.112.198796; Ananthakrishnan AN, 2010, J CLIN GASTROENTEROL, V44, P272, DOI 10.1097/MCG.0b013e3181b2682a; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bedoui S, 2008, J NEUROIMMUNOL, V195, P88, DOI 10.1016/j.jneuroim.2008.01.012; Bielefeldt K, 2009, INFLAMM BOWEL DIS, V15, P778, DOI 10.1002/ibd.20848; Boisse L, 2009, CLIN EXP PHARMACOL P, V36, P1026, DOI 10.1111/j.1440-1681.2009.05242.x; Browning KN, 2014, COMPR PHYSIOL, V4, P1339, DOI 10.1002/cphy.c130055; Chandrasekharan B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003304; Chidlow JH, 2006, AM J PATHOL, V169, P2014, DOI 10.2353/ajpath.2006.051021; Cross RK, 2005, AM J GASTROENTEROL, V100, P2225, DOI 10.1111/j.1572-0241.2005.00256.x; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; Di Giovangiulio M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00590; El-Salhy M, 2016, NEUROPEPTIDES, V55, P137, DOI 10.1016/j.npep.2015.09.005; Furlan R, 2006, AM J PHYSIOL-REG I, V290, pR224, DOI 10.1152/ajpregu.00442.2005; Gohil Kunj, 2014, P T, V39, P576; Goyal N, 2014, INFLAMMOPHARMACOLOGY, V22, P219, DOI 10.1007/s10787-014-0207-y; Hassani H, 2005, AM J PHYSIOL-GASTR L, V288, pG550, DOI 10.1152/ajpgi.00182.2004; HOYLE CHV, 1989, J ANAT, V166, P7; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Michel MC, 1998, PHARMACOL REV, V50, P143; Mitic K, 2011, PEPTIDES, V32, P1626, DOI 10.1016/j.peptides.2011.06.007; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Nair DG, 2014, J CELL MOL MED, V18, P444, DOI 10.1111/jcmm.12193; Nave H, 2004, J NEUROIMMUNOL, V155, P1, DOI 10.1016/j.jneuroim.2004.05.009; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Pang XH, 2010, INT J COLORECTAL DIS, V25, P1047, DOI 10.1007/s00384-010-0964-z; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Sartor RB, 1997, ALIMENT PHARM THERAP, V11, P89; Sharma P, 2009, DIGEST DIS SCI, V54, P853, DOI 10.1007/s10620-008-0424-6; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; Specian RD, FUNCTIONAL BIOL INTE; Taylor CT, 2007, AUTON NEUROSCI-BASIC, V133, P104, DOI 10.1016/j.autneu.2006.11.005; Ten Hove T, 2002, DIGEST DIS SCI, V47, P2056, DOI 10.1023/A:1019629013945; Valatas V, 2013, AM J PHYSIOL-GASTR L, V305, pG763, DOI 10.1152/ajpgi.00004.2013; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220156	10.1371/journal.pone.0220156	http://dx.doi.org/10.1371/journal.pone.0220156			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369588	gold, Green Submitted, Green Published			2022-12-26	WOS:000484987900030
J	Zakrzewski, AC; Wisniewski, MG; Williams, HL; Berry, JM				Zakrzewski, Alexandria C.; Wisniewski, Matthew G.; Williams, Helen L.; Berry, Jane M.			Artificial neural networks reveal individual differences in metacognitive monitoring of memory	PLOS ONE			English	Article							ADULT AGE-DIFFERENCES; ASSOCIATIVE MEMORY; OLDER-ADULTS; EPISODIC MEMORY; WORKING-MEMORY; RECOGNITION MEMORY; DEFICIT; SUPPORT; YOUNGER; STRATEGY	Previous work supports an age-specific impairment for recognition memory of pairs of words and other stimuli. The present study tested the generalization of an associative deficit across word, name, and nonword stimulus types in younger and older adults. Participants completed associative and item memory tests in one of three stimulus conditions and made metacognitive ratings of perceptions of self-efficacy, task success ("postdictions"), strategy success, task effort, difficulty, fatigue, and stamina. Surprisingly, no support was found for an age-related associative deficit on any of the stimulus types. We analyzed our data further using a multilayer perceptron artificial neural network. The network was trained to classify individuals as younger or older and its hidden unit activities were examined to identify data patterns that distinguished younger from older participants. Analysis of hidden unit activities revealed that the network was able to correctly classify by identifying three different clusters of participants, with two qualitatively different groups of older individuals. One cluster of older individuals found the tasks to be relatively easy, they believed they had performed well, and their beliefs were accurate. The other cluster of older individuals found the tasks to be difficult, believed they were performing relatively poorly, yet their beliefs did not map accurately onto their performance. Crucially, data from the associative task were more useful for neural networks to discriminate between younger and older adults than data from the item task. This work underscores the importance of considering both individual and age differences as well as metacognitive responses in the context of associative memory paradigms.	[Zakrzewski, Alexandria C.; Wisniewski, Matthew G.] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA; [Williams, Helen L.] Keele Univ, Sch Psychol, Keele, Staffs, England; [Berry, Jane M.] Univ Richmond, Dept Psychol, Richmond, VA 23173 USA	Kansas State University; Keele University; University of Richmond	Zakrzewski, AC (corresponding author), Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA.	aczakrzewski@ksu.edu		Williams, Helen/0000-0001-6318-4263; Zakrzewski, Alexandria/0000-0002-0169-2761	MacEldin Trawick Professorship in Psychology; MacEldin Trawick Postdoctoral Fellowship in Psychology	MacEldin Trawick Professorship in Psychology; MacEldin Trawick Postdoctoral Fellowship in Psychology	MacEldin Trawick Professorship in Psychology (Jane M. Berry) and MacEldin Trawick Postdoctoral Fellowship in Psychology (Alexandria C. Zakrzewski and Helen L. Williams). URL for the funding source is: https://provost.richmond.edu/faculty-development/recognition/endowed-chairs/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein PC, 1999, J GEN PSYCHOL, V126, P149, DOI 10.1080/00221309909595358; Angel L, 2010, BRAIN RES, V1335, P41, DOI 10.1016/j.brainres.2010.03.040; Badham SP, 2015, PSYCHON B REV, V22, P141, DOI 10.3758/s13423-014-0672-8; Badham SP, 2012, PSYCHOL AGING, V27, P141, DOI 10.1037/a0023924; Badham SP, 2011, PSYCHOL AGING, V26, P689, DOI 10.1037/a0022205; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Bastin C, 2006, EXP AGING RES, V32, P61, DOI 10.1080/03610730500326291; Bender AR, 2017, PSYCHOL AGING, V32, P489, DOI 10.1037/pag0000185; Bender AR, 2012, PSYCHOL AGING, V27, P691, DOI 10.1037/a0026714; Bender AR, 2010, PSYCHOL AGING, V25, P940, DOI 10.1037/a0020595; Berry JM, 2013, AGING NEUROPSYCHOL C, V20, P592, DOI 10.1080/13825585.2012.761670; BERRY JM, 1989, DEV PSYCHOL, V25, P701, DOI 10.1037/0012-1649.25.5.701; BORKOWSKI JG, 1987, INTELLIGENCE, V11, P61, DOI 10.1016/0160-2896(87)90027-4; Canestrari RE, PSYCHOL FUNCTIONING, DOI [10.1037/0278-7393.29.5.826, DOI 10.1037/0278-7393.29.5.826]; Castel AD, 2005, PSYCHOL AGING, V20, P718, DOI 10.1037/0882-7974.20.4.718; Cawley GC, 2003, PATTERN RECOGN, V36, P2585, DOI 10.1016/S0031-3203(03)00136-5; Chalfonte BL, 1996, MEM COGNITION, V24, P403, DOI 10.3758/BF03200930; COHEN IL, 1994, BIOL PSYCHIAT, V36, P5, DOI 10.1016/0006-3223(94)90057-4; Cohn M, 2008, PSYCHOL AGING, V23, P93, DOI 10.1037/0882-7974.23.1.93; Craik F. I. M., 1986, HUMAN MEMORY COGNITI; CRAIK FIM, 1983, PHILOS T ROY SOC B, V302, P341, DOI 10.1098/rstb.1983.0059; Daniels KA, 2009, PSYCHOL AGING, V24, P494, DOI 10.1037/a0015269; Dawson M. R. W., 2004, MINDS MACHINES CONNE; DeLong CM, 2014, ANIM COGN, V17, P543, DOI 10.1007/s10071-013-0685-0; Dunlosky J, 2005, DEV PSYCHOL, V41, P389, DOI 10.1037/0012-1649.41.2.389; DUTTWEILER PC, 1984, EDUC PSYCHOL MEAS, V44, P209, DOI 10.1177/0013164484442004; Eakin DK, 2014, AGING NEUROPSYCHOL C, V21, P27, DOI 10.1080/13825585.2013.775217; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; ERBER JT, 1974, J GERONTOL, V29, P177, DOI 10.1093/geronj/29.2.177; Fox MC, 2016, PSYCHOL AGING, V31, P471, DOI 10.1037/pag0000111; Geurten M, 2019, AGING NEUROPSYCHOL C, V26, P424, DOI 10.1080/13825585.2018.1464114; GORDON SK, 1974, J GERONTOL, V29, P64, DOI 10.1093/geronj/29.1.64; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Guillette LM, 2010, J COMP PSYCHOL, V124, P109, DOI 10.1037/a0017741; Haber S., 2012, THESIS; Halamish V, 2011, PSYCHOL AGING, V26, P631, DOI 10.1037/a0022852; Hertzog C, 2004, PSYCHOL LEARN MOTIV, V45, P215, DOI 10.1016/S0079-7421(03)45006-8; Hertzog C, 2002, PSYCHOL AGING, V17, P209, DOI 10.1037//0882-7974.17.2.209; Hertzog C., 2000, HDB AGING COGNITION, P417; Hertzog C, 2011, CURR DIR PSYCHOL SCI, V20, P167, DOI 10.1177/0963721411409026; Hess TM, 2003, J GERONTOL B-PSYCHOL, V58, pP3, DOI 10.1093/geronb/58.1.P3; HOCKLEY WE, 1994, MEM COGNITION, V22, P713, DOI 10.3758/BF03209256; Hudes R, 2019, PSYCHOL AGING, V34, P587, DOI 10.1037/pag0000340; HULICKA IM, 1967, J GERONTOL, V22, P46; Kausler D. H., 1994, LEARNING MEMORY NORM, P276; Kearns M, 1999, NEURAL COMPUT, V11, P1427, DOI 10.1162/089976699300016304; Kilb A, 2014, WORKING MEMORY AGEIN, P64; LACHMAN JL, 1979, DEV PSYCHOL, V15, P543, DOI 10.1037/0012-1649.15.5.543; Light LL, 2000, DEBATES PSYCHOL, P238; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; McGillivray S, 2017, EXP AGING RES, V43, P233, DOI 10.1080/0361073X.2017.1298956; McNamara DS, 2001, MEM COGNITION, V29, P10, DOI 10.3758/BF03195736; Mercado, 2011, INT J COMP PSYCHOL, V24, P4, DOI DOI 10.1016/J.JEBDP.2005.01.011; Narzisi A, 2015, NEUROPSYCH DIS TREAT, V11, P1587, DOI 10.2147/NDT.S81233; Naveh-Benjamin M, 2004, PSYCHON B REV, V11, P1067, DOI 10.3758/BF03196738; Naveh-Benjamin M, 2004, PSYCHOL AGING, V19, P541, DOI 10.1037/0882-7974.19.3.541; Naveh-Benjamin M, 2003, MEM COGNITION, V31, P1021, DOI 10.3758/BF03196123; Naveh-Benjamin M, 2003, J EXP PSYCHOL LEARN, V29, P826, DOI 10.1037/0278-7393.29.5.826; Naveh-Benjamin M, 2002, AGING NEUROPSYCHOL C, V9, P276, DOI 10.1076/anec.9.4.276.8773; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Naveh-Benjamin M., 2016, ENCY ADULTHOOD AGING; Naveh-Benjamin M, 2007, PSYCHOL AGING, V22, P202, DOI 10.1037/0882-7974.22.1.202; Naveh-Benjamin M, 2012, MEM COGNITION, V40, P551, DOI 10.3758/s13421-011-0169-x; Naveh-Benjamin M, 2009, MEMORY, V17, P220, DOI 10.1080/09658210802222183; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Old SR, 2012, PSYCHOL AGING, V27, P462, DOI 10.1037/a0025194; Palmer EC, 2014, CONSCIOUS COGN, V28, P151, DOI 10.1016/j.concog.2014.06.007; Patterson MM, 2010, PSYCHOL AGING, V25, P235, DOI 10.1037/a0016046; Peterson DJ, 2017, J MEM LANG, V92, P79, DOI 10.1016/j.jml.2016.05.007; Rahhal TA, 2001, PSYCHOL AGING, V16, P697, DOI 10.1037//0882-7974.16.4.697; ROHWER WD, 1982, J EXP CHILD PSYCHOL, V33, P492, DOI 10.1016/0022-0965(82)90061-3; Rosi A, 2019, OPEN PSYCHOL, V1, P200, DOI [10.1515/PSYCH-2018-0014, DOI 10.1515/PSYCH-2018-0014]; SALTHOUSE TA, 1991, PSYCHOL SCI, V2, P179, DOI 10.1111/j.1467-9280.1991.tb00127.x; Sastoque LG, 2019, ACTA PSYCHOL, V192, P73, DOI 10.1016/j.actpsy.2018.11.002; Sharps MJ, 1997, J GENET PSYCHOL, V158, P347, DOI 10.1080/00221329709596673; Shing YL, 2008, J EXP PSYCHOL GEN, V137, P495, DOI 10.1037/0096-3445.137.3.495; Singhal D., 2001, READING MATRIX, V1, P1; Smyth AC, 2016, PSYCHOL AGING, V31, P1, DOI 10.1037/a0039071; Tauber SK, 2015, METACOGNITION OLDER, P1; Wechsler D., 1981, PSYCHOMETRIC TRADITI; Wisniewski MG, 2014, BEHAV PROCESS, V104, P26, DOI 10.1016/j.beproc.2014.01.007; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	85	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220526	10.1371/journal.pone.0220526	http://dx.doi.org/10.1371/journal.pone.0220526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365587	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000484983600052
J	Christensen, NL; Dahl, JS; Carter-Storch, R; Jensen, K; Pecini, R; Steffensen, FH; Sondergaard, EV; Videbaek, LM; Moller, JE				Christensen, Nicolaj Lyhne; Dahl, Jordi Sanchez; Carter-Storch, Rasmus; Jensen, Kurt; Pecini, Redi; Steffensen, Flemming Hald; Sondergaard, Eva Vad; Videbaek, Lars Melgaard; Moller, Jacob Eifer			Association between left ventricular diastolic function and right ventricular function and morphology in asymptomatic aortic stenosis	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; VALVE-REPLACEMENT; PROGNOSTIC VALUE; HEART-FAILURE; EXERCISE; RECOMMENDATIONS; DYSFUNCTION	Background Aortic stenosis (AS) is a progressive disease in which left ventricular (LV) diastolic dysfunction is common. However, the association between diastolic dysfunction and right ventricular (RV) loading conditions and function has not been investigated in asymptomatic AS patients. Methods and findings A total of 41 patients underwent right heart catheterization and simultaneous echocardiography at rest and during maximal supine exercise, stratified according to resting diastolic function. Cardiac chamber size and morphology was assessed using cardiac magnetic resonance imaging (cMRI). RV stroke work index, pulmonary artery (PA) compliance, PA elastance, PA pulsatility index, and right atrial pressure (RAP) were calculated at rest and maximal exercise. Ten patients (24%) had normal LV filling pattern, 20 patients (49%) had grade 1, and 11 patients (27%) had grade 2 diastolic dysfunction. Compared to patients with normal diastolic filling pattern, patients with diastolic dysfunction had lower RV end-diastolic volume (66 +/- 11 ml/m(2) vs. 79 +/- 15 ml/m(2), p = 0.02) and end-systolic volume (25 +/- 7 ml/m(2) vs. 32 +/- 9 ml/m(2), p = 0.04). An increase in mean RAP to >= 15 mmHg following exercise was not seen in patients with normal LV filling, compared to 4 patients (20%) with mild and 7 patients (63%) with moderate diastolic dysfunction (p = 0.003). PA pressure and PA elastance was increased in grade 2 diastolic dysfunction and correlated with RV volume and maximal oxygen consumption (r = -0.71, p < 0.001). Conclusions Moderate diastolic dysfunction is associated with increased RV afterload (elastance), which is compensated at rest, but is associated with increased RAP and inversely related to maximal oxygen consumption during maximal exercise.	[Christensen, Nicolaj Lyhne; Dahl, Jordi Sanchez; Carter-Storch, Rasmus; Pecini, Redi; Sondergaard, Eva Vad; Videbaek, Lars Melgaard; Moller, Jacob Eifer] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Jensen, Kurt] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Steffensen, Flemming Hald] Lillebaelt Hosp, Dept Cardiol, Vejle, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Moller, JE (corresponding author), Odense Univ Hosp, Dept Cardiol, Odense, Denmark.	Jacob.moeller1@rsyd.dk	Steffensen, Flemming Hald/AAH-8742-2020	Moller, Jacob Eifer/0000-0003-2873-5845; Jensen, Kurt/0000-0001-9014-2093; Steffensen, Flemming Hald/0000-0003-0252-6631; Christensen, Nicolaj Lyhne/0000-0002-4895-0588; Carter-Storch, Rasmus/0000-0002-0359-8728	Danish Heart Foundation; Odense University Hospital; Region of Southern Denmark Research Funds; A and E Danielsens Foundation, Copenhagen; Dir. Bonnelycke Foundation, Copenhagen	Danish Heart Foundation; Odense University Hospital; Region of Southern Denmark Research Funds; A and E Danielsens Foundation, Copenhagen; Dir. Bonnelycke Foundation, Copenhagen	The work was supported by: The Danish Heart Foundation (NLC); Odense University Hospital Free Research Fund. Region of Southern Denmark Research Funds; A and E Danielsens Foundation, Copenhagen. Dir. Bonnelycke Foundation, Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alston RP, 2015, OXFORD TXB CARDIOTHO, pxix; Amin Ahmad, 2011, Congest Heart Fail, V17, P288, DOI 10.1111/j.1751-7133.2011.00222.x; Andersen MJ, 2012, CIRC-HEART FAIL, V5, P444, DOI 10.1161/CIRCHEARTFAILURE.112.967919; Betocchi S, 2000, Heart Fail Rev, V5, P333, DOI 10.1023/A:1026559113044; Biner S, 2010, JACC-CARDIOVASC IMAG, V3, P899, DOI 10.1016/j.jcmg.2010.07.005; Borlaug BA, 2011, HEART, V97, P964, DOI 10.1136/hrt.2010.212787; Briand M, 2005, J AM COLL CARDIOL, V46, P291, DOI 10.1016/j.jacc.2004.10.081; BRUCE RA, 1974, AM J CARDIOL, V33, P715, DOI 10.1016/0002-9149(74)90211-2; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Chang SA, 2010, J THORAC CARDIOV SUR, V140, P1361, DOI 10.1016/j.jtcvs.2010.02.022; Christensen NL, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005156; Dalsgaard M, 2009, J AM SOC ECHOCARDIOG, V22, P343, DOI 10.1016/j.echo.2009.01.007; Ghio Stefano, 2015, Glob Cardiol Sci Pract, V2015, P58, DOI 10.5339/gcsp.2015.58; HESS OM, 1993, CIRCULATION, V87, P73; Kawel-Boehm N, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0111-7; LAKS MM, 1967, CIRC RES, V20, P565, DOI 10.1161/01.RES.20.5.565; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lund O, 1997, EUR HEART J, V18, P1977; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Rain S, 2013, CIRCULATION, V128, P2016, DOI 10.1161/CIRCULATIONAHA.113.001873; Santamore WP, 1998, PROG CARDIOVASC DIS, V40, P289, DOI 10.1016/S0033-0620(98)80049-2; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; TAYLOR RR, 1967, AM J PHYSIOL, V213, P711, DOI 10.1152/ajplegacy.1967.213.3.711; VILLARI B, 1993, J AM COLL CARDIOL, V22, P1477, DOI 10.1016/0735-1097(93)90560-N	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0215364	10.1371/journal.pone.0215364	http://dx.doi.org/10.1371/journal.pone.0215364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361748	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300005
J	Sahoo, UK; Singh, SL; Gogoi, A; Kenye, A; Sahoo, SS				Sahoo, Uttam Kumar; Singh, Soibam Lanabir; Gogoi, Anudip; Kenye, Alice; Sahoo, Snehasudha S.			Active and passive soil organic carbon pools as affected by different land use types in Mizoram, Northeast India	PLOS ONE			English	Article							ATMOSPHERIC CO2; CLIMATE-CHANGE; MATTER; FRACTIONS; SEQUESTRATION; LABILE; QUALITY; SYSTEMS; FOREST; STOCKS	Soil organic carbon plays an important role in the stability and fertility of soil and is influenced by different management practice. We quantified active and passive carbon pools from total soil organic carbon (TOC) in seven different land use systems of northeast India. TOC was highest (2.75%) in natural forest and lowest in grassland (1.31%) and it decreased with increasing depth in different pools of lability. Very Labile Carbon (VLC) fraction ranged from 36.11 to 42.74% of TOC across different land use system. Active carbon (AC) pool was highest in Wet Rice Cultivation (61.64%) and lowest (58.71%) in natural forest. Higher AC pools (VLC and less labile) in most land use systems barring natural forests suggest that the land use systems in the region are vulnerable to land use change and must adopt suitable management practice to harness carbon sequestration.	[Sahoo, Uttam Kumar; Singh, Soibam Lanabir; Gogoi, Anudip; Kenye, Alice] Mizoram Univ, Sch Earth Sci & Nat Resource Management, Dept Forestry, Aizawl, Mizoram, India; [Singh, Soibam Lanabir] Dr Rajendra Prasad Cent Agr Univ, Dept Forestry, Samastipur, Bihar, India; [Sahoo, Snehasudha S.] Indian Inst Sci Educ & Res, Mohanpur, W Bengal, India	Mizoram University; Indian Institute of Science Education & Research (IISER) - Kolkata	Sahoo, UK (corresponding author), Mizoram Univ, Sch Earth Sci & Nat Resource Management, Dept Forestry, Aizawl, Mizoram, India.	uksahoo_2003@rediffmail.com	Sahoo, Uttam Kumar/AAY-7076-2021	Sahoo, Uttam kumar/0000-0002-6524-1775; Gogoi, Anudip/0000-0003-2553-0078	Department of Science and Technology, Government of India, New Delhi [DST/IS-STAC/CO2-SR-227/14 (G)-AICP-AFOLU-IV]	Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India))	UKS received the grant to carry out this research (Grant No. DST/IS-STAC/CO2-SR-227/14 (G)-AICP-AFOLU-IV) from Department of Science and Technology, Government of India, New Delhi (www.dst.gov.in).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J PLANT BIOL SOIL HL; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Belay-Tedla A, 2009, SOIL BIOL BIOCHEM, V41, P110, DOI 10.1016/j.soilbio.2008.10.003; Benbi DK, 2015, GEODERMA, V237, P149, DOI 10.1016/j.geoderma.2014.09.002; Bhattacharyya T, 2008, CURR SCI INDIA, V95, P482; BIEDERBECK VO, 1994, SOIL BIOL BIOCHEM, V26, P1647, DOI 10.1016/0038-0717(94)90317-4; Binarani RK., 2010, J EXPT SCI, V1, P1; Brovkin V, 2004, GLOBAL CHANGE BIOL, V10, P1253, DOI 10.1111/j.1365-2486.2004.00812.x; Bruun TB, 2015, LAND DEGRAD DEV, V26, P272, DOI 10.1002/ldr.2205; Chan KY, 2001, SOIL SCI, V166, P61, DOI 10.1097/00010694-200101000-00009; Choudhury BU, 2013, CURR SCI INDIA, V104, P604; Collins HP, 2000, SOIL BIOL BIOCHEM, V32, P157, DOI 10.1016/S0038-0717(99)00136-4; Conteh A, 1997, AUST J SOIL RES, V35, P881, DOI 10.1071/S96107; Dawson JJC, 2007, SCI TOTAL ENVIRON, V382, P165, DOI 10.1016/j.scitotenv.2007.03.023; DeGryze S, 2004, GLOBAL CHANGE BIOL, V10, P1120, DOI 10.1111/j.1529-8817.2003.00786.x; Dey S. K., 2005, Indian Forester, V131, P1429; Duval ME, 2013, SOIL TILL RES, V131, P11, DOI 10.1016/j.still.2013.03.001; Fan SH, 2016, FORESTS, V7, DOI 10.3390/f7070142; Fichtner A, 2014, SOIL BIOL BIOCHEM, V70, P79, DOI 10.1016/j.soilbio.2013.12.015; Figueiredo CC, 2013, SOIL RES, V51, P133, DOI 10.1071/SR12186; Golchin A, 2008, AUST J SOIL RES, V46, P27, DOI 10.1071/SR07049; GOLCHIN A, 1995, AUST J SOIL RES, V33, P975, DOI 10.1071/SR9950975; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; He, 2006, WATER RESOUR DEV RES, V6, P33; Hombegowda HC, 2016, SOIL-GERMANY, V2, P13, DOI 10.5194/soil-2-13-2016; Iqbal S, 2016, CURR SCI INDIA, V110, P771; Jackson ML, 1973, SOIL CHEM ANAL, P495; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Lal R, 2008, ENERG ENVIRON SCI, V1, P86, DOI 10.1039/b809492f; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2002, LAND DEGRAD DEV, V13, P469, DOI 10.1002/ldr.531; Lal R, 2011, FOOD POLICY, V36, pS33, DOI 10.1016/j.foodpol.2010.12.001; Lenka NK, 2012, AGR ECOSYST ENVIRON, V150, P54, DOI 10.1016/j.agee.2012.01.003; Lungmuana, 2018, SOIL RES, V56, P615, DOI 10.1071/SR18031; McLauchlan K, 2006, ECOSYSTEMS, V9, P1364, DOI 10.1007/s10021-005-0135-1; NATH A K, 1976, Journal of the Indian Society of Soil Science, V24, P279; Nath AJ, 2018, SCI TOTAL ENVIRON, V624, P908, DOI 10.1016/j.scitotenv.2017.12.199; Negash M, 2015, PLANT SOIL, V393, P95, DOI 10.1007/s11104-015-2469-6; Nunes RS, 2011, MANAGEMENT SYSTEMS C; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Peichl M, 2006, AGROFOREST SYST, V66, P243, DOI 10.1007/s10457-005-0361-8; Poeplau C, 2017, SOIL-GERMANY, V3, P61, DOI 10.5194/soil-3-61-2017; Poeplau C, 2013, GEODERMA, V192, P189, DOI 10.1016/j.geoderma.2012.08.003; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Post WM, 2001, CLIMATIC CHANGE, V51, P73, DOI 10.1023/A:1017514802028; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Saljnikov E., 2013, SOIL PROCESS CURR TR; Sheng H, 2015, SOIL BIOL BIOCHEM, V88, P148, DOI 10.1016/j.soilbio.2015.05.015; SINGH O P, 1991, Journal of the Indian Society of Soil Science, V39, P739; Singh OP, 1993, J INDIAN SOC SOIL SC, V31, P657; Singh S, 2009, MANUAL SPATIAL ASSES; Singh S. L., 2018, Journal of Environmental Protection, V9, P912, DOI 10.4236/jep.2018.99057; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; Thong P., 2016, J PLANT BIOL SOIL HL, V3, P8; Turner J, 2005, FOREST ECOL MANAG, V220, P259, DOI 10.1016/j.foreco.2005.08.025; van Straaten O, 2015, P NATL ACAD SCI USA, V112, P9956, DOI 10.1073/pnas.1504628112; Vieira FCB, 2007, SOIL TILL RES, V96, P195, DOI 10.1016/j.still.2007.06.007; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang QK, 2013, ANN FOREST SCI, V70, P579, DOI 10.1007/s13595-013-0294-8; Wang W, 2014, GEODERMA, V232, P459, DOI 10.1016/j.geoderma.2014.06.004; Wei XR, 2013, SOIL BIOL BIOCHEM, V57, P876, DOI 10.1016/j.soilbio.2012.10.020; Wei Z, 2017, J GEOGRAPH SCI, V27, P999; Wiesenberg GLB, 2010, GEODERMA, V156, P267, DOI 10.1016/j.geoderma.2010.02.026; Xi X., 2011, GEOSCI FRONT, V2, P115; Xiang HM, 2015, FORESTS, V6, P2703, DOI 10.3390/f6082703; Zhang J, 2014, CATENA, V115, P79, DOI 10.1016/j.catena.2013.11.019	70	37	37	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0219969	10.1371/journal.pone.0219969	http://dx.doi.org/10.1371/journal.pone.0219969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361769	gold, Green Published, Green Submitted			2022-12-26	WOS:000484981300020
J	Mathipa, MG; Bhunia, AK; Thantsha, MS				Mathipa, Moloko G.; Bhunia, Arun K.; Thantsha, Mapitsi S.			Internalin AB-expressing recombinant Lactobacillus casei protects Caco-2 cells from Listeria monocytogenes-induced damages under simulated intestinal conditions	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; PERMEABILITY ESTIMATION; SALMONELLA-TYPHIMURIUM; ORAL IMMUNIZATION; IN-VITRO; PROBIOTICS; SURFACE; ENTRY; FLUID; ACID	Background Listeria monocytogenes is an intracellular foodborne pathogen that employs a number of strategies to survive challenging gastrointestinal conditions. It proliferates in the gut and subsequently causes listeriosis in high-risk individuals. Therefore, inhibition of its adherence to the intestinal receptors is crucial in controlling its infection. In this study, the effect of our previously developed recombinant Lactobacillus casei strain expressing invasion protein, Internalin AB of L. monocytogenes (Lbc(InlAB)) on epithelial infection processes of the latter under simulated intestinal conditions was investigated. Materials and methods The confluent Caco-2 cell monolayer was pre-exposed to different L. casei strains at a multiplicity of exposure (MOE) of 10 for various periods before infection with L. monocytogenes at a multiplicity of infection (MOI) of 10 under simulated intestinal conditions. Subsequently, L. monocytogenes adhesion, invasion, and translocation, cytotoxicity and impact on tight junction integrity of the Caco-2 cells were analyzed. Results Under the simulated gastrointestinal condition, Lbc(InlAB) showed a significant increase (p<0.0001) in adherence to, invasion and translocation through the Caco-2 cells when compared with the wild type strain. Although Lbc(InlAB) strain exhibited enhanced inhibition of L. monocytogenes, it was not able to displace L. monocytogenes cells already attached to the monolayer. Additionally, pre-exposure to Lbc(InlAB) reduced L. monocytogenes-mediated cytotoxicity and protected the tight junction barrier function. Conclusion The recombinant L. casei expressing InlAB shows potential for use as a prophylactic intervention strategy for targeted control of L. monocytogenes during the intestinal phase of infection.	[Mathipa, Moloko G.; Thantsha, Mapitsi S.] Univ Pretoria, Dept Biochem Genet & Microbiol, Pretoria, South Africa; [Mathipa, Moloko G.; Bhunia, Arun K.] Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, W Lafayette, IN 47907 USA; [Bhunia, Arun K.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Bhunia, Arun K.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	University of Pretoria; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Thantsha, MS (corresponding author), Univ Pretoria, Dept Biochem Genet & Microbiol, Pretoria, South Africa.	mapitsi.thantsha@up.ac.za	Bhunia, Arun K./K-7639-2012; Thantsha, Mapitsi M.S./A-8546-2011	Bhunia, Arun K./0000-0003-3640-1554; Thantsha, Mapitsi M.S./0000-0002-6212-2770; Mathipa-Mdakane, Moloko Gloria/0000-0002-2554-8641	National Research Foundation [102107]; University of Pretoria; U.S. Department of Agriculture National Institute of Food and Agriculture [1000028]; USDA Agricultural Research Service [59-8072-6-001]	National Research Foundation; University of Pretoria; U.S. Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research was supported in part by the funds from The National Research Foundation (Grant no. 102107) with the University of Pretoria providing financial aid to Moloko Mathipa to conduct research at Purdue University; the U.S. Department of Agriculture National Institute of Food and Agriculture (Hatch accession no. 1000028); and USDA Agricultural Research Service, under Agreement No. 59-8072-6-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalaradjou MAR, 2013, BIOENGINEERED, V4, P379, DOI 10.4161/bioe.23574; Amalaradjou MAR, 2012, ADV FOOD NUTR RES, V67, P185, DOI 10.1016/B978-0-12-394598-3.00005-8; [Anonymous], 2002, GUIDELINES EVALUATIO; Barmpalia-Davis IM, 2008, APPL ENVIRON MICROB, V74, P5563, DOI 10.1128/AEM.00319-08; Begley M, 2002, APPL ENVIRON MICROB, V68, P6005, DOI 10.1128/AEM.68.12.6005-6012.2002; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Bernbom N, 2006, APPL ENVIRON MICROB, V72, P239, DOI 10.1128/AEM.72.1.239-244.2006; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Brouwers J, 2006, J PHARM SCI-US, V95, P372, DOI 10.1002/jps.20553; Collado MC, 2010, BIOACTIVE FOODS IN PROMOTING HEALTH: PROBIOTICS AND PREBIOTICS, P353, DOI 10.1016/B978-0-12-374938-3.00023-2; Chiba S, 2011, MICROBIOL IMMUNOL, V55, P123, DOI 10.1111/j.1348-0421.2010.00292.x; Chu H, 2005, MICROBIOL IMMUNOL, V49, P943, DOI 10.1111/j.1348-0421.2005.tb03687.x; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Dressman JB, 1998, PHARMACEUT RES, V15, P11, DOI 10.1023/A:1011984216775; Drolia R, 2019, TRENDS MICROBIOL, V27, P408, DOI 10.1016/j.tim.2018.12.007; Drolia R, 2018, CELL HOST MICROBE, V23, P470, DOI 10.1016/j.chom.2018.03.004; Formato G, 2007, J FOOD PROTECT, V70, P65, DOI 10.4315/0362-028X-70.1.65; Fossati L, 2008, INT J PHARM, V360, P148, DOI 10.1016/j.ijpharm.2008.04.034; Fujiwara S, 2001, INT J FOOD MICROBIOL, V67, P97, DOI 10.1016/S0168-1605(01)00432-9; Gahan CGM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00009; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Galia E, 1998, PHARMACEUT RES, V15, P698, DOI 10.1023/A:1011910801212; Gamboa JM, 2013, ADV DRUG DELIVER REV, V65, P800, DOI 10.1016/j.addr.2013.01.003; Gueimonde M, 2006, FOOD RES INT, V39, P467, DOI 10.1016/j.foodres.2005.10.003; Guimaraes VD, 2005, MICROBES INFECT, V7, P836, DOI 10.1016/j.micinf.2005.02.012; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Horn N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01962; Ingels F, 2004, INT J PHARMACEUT, V274, P221, DOI 10.1016/j.ijpharm.2004.01.014; Ingels F, 2002, INT J PHARMACEUT, V232, P183, DOI 10.1016/S0378-5173(01)00897-3; Jacouton E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01553; Jagadeesan B, 2010, MICROBIOL-SGM, V156, P2782, DOI 10.1099/mic.0.036509-0; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Kajikawa A, 2009, APPL ENVIRON MICROB, V75, P2727, DOI 10.1128/AEM.01916-08; Kapitza SB, 2007, EUR J PHARM BIOPHARM, V66, P146, DOI 10.1016/j.ejpb.2006.08.010; King T, 2003, INT J FOOD MICROBIOL, V84, P133, DOI 10.1016/S0168-1605(02)00404-X; Koo OK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029277; Kumar M, 2016, FUTURE MICROBIOL, V11, P585, DOI 10.2217/fmb.16.4; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Lee YK, 2002, BRIT J NUTR, V88, pS101, DOI 10.1079/BJN2002635; Lind ML, 2007, EUR J PHARM SCI, V32, P261, DOI 10.1016/j.ejps.2007.08.002; MACDONALD TT, 1980, INFECT IMMUN, V28, P516; MARCO AJ, 1992, J COMP PATHOL, V107, P1, DOI 10.1016/0021-9975(92)90090-H; Marelli B, 2011, J VIROL METHODS, V175, P28, DOI 10.1016/j.jviromet.2011.04.011; Mathipa MG, 2019, MICROB BIOTECHNOL, V12, P715, DOI 10.1111/1751-7915.13407; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Mercenier A, 2000, Curr Issues Mol Biol, V2, P17; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Natoli M, 2012, TOXICOL IN VITRO, V26, P1243, DOI 10.1016/j.tiv.2012.03.009; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; Nishikawa S, 1998, MICROBIOL IMMUNOL, V42, P325, DOI 10.1111/j.1348-0421.1998.tb02290.x; Pouwels PH, 2001, METHOD ENZYMOL, V336, P369, DOI 10.1016/S0076-6879(01)36602-8; Pron B, 1998, INFECT IMMUN, V66, P747, DOI 10.1128/IAI.66.2.747-755.1998; Sanchez B, 2011, FEMS MICROBIOL LETT, V318, P101, DOI 10.1111/j.1574-6968.2011.02244.x; Schuppler M, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/704321; Smith JL, 2013, CAN J MICROBIOL, V59, P141, DOI 10.1139/cjm-2012-0392; Sola-Oladokun B, 2017, ANNU REV FOOD SCI T, V8, P353, DOI 10.1146/annurev-food-030216-030256; Tarahomjoo S, 2012, MOL BIOTECHNOL, V51, P183, DOI 10.1007/s12033-011-9450-2; Wu CM, 2007, FEMS IMMUNOL MED MIC, V50, P354, DOI 10.1111/j.1574-695X.2007.00255.x; Wyszynska A, 2015, APPL MICROBIOL BIOT, V99, P2967, DOI [10.1007/s00253-015-6498-0, 10.1007/s00253-015-6569-2]	61	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220321	10.1371/journal.pone.0220321	http://dx.doi.org/10.1371/journal.pone.0220321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356632	gold, Green Published, Green Submitted			2022-12-26	WOS:000484047000026
J	Silfverschiold, M; Sjovall, J; Wennerberg, J; Ostensson, E; Greiff, L				Silfverschiold, Maria; Sjovall, Johanna; Wennerberg, Johan; Ostensson, Ellinor; Greiff, Lennart			Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite	PLOS ONE			English	Article							CARCINOMA; HEAD	Background The incidence of oropharyngeal cancer (OPC) is increasing, particularly human papillomavirus (HPV)-associated OPC. The aim of this study was to specify the total societal cost of OPC by HPV status, cancer stage, and subsite using a bottom-up cost-of-illness approach. Methods We analyzed 121 consecutive patients with OPC from the Southern Health Care Region of Sweden. We estimated the direct medical costs and indirect costs (e.g., disease-related morbidity and premature death) from 1 month prior to OPC diagnosis until 3 years after treatment completion. Results The mean total cost per patient was (sic)103 386 for HPV-positive and (sic)120 244 for HPV-negative OPC. Eighty-one percent of the patients analyzed were HPV-positive: Accordingly, HPV-positive OPC represented 79% of the total cost of OPC. The mean total cost of stage I, II, III, IVA, IVB, and IVC, regardless of HPV status, was (sic)59 424, (sic)57 000, (sic)69 246, (sic)115 770, (sic)234 459, and (sic)21 930, respectively, of which indirect costs were estimated at (sic)22 493 (37.8%), (sic)14 754 (25.9%), (sic)28 681 (41.4%), (sic)67 107 (58%), (sic)166 280 (70.9%), and (sic)0. Tonsillar cancer represented 64% of OPC, with a mean total cost of (sic)117 512 per patient. Conclusion The societal cost of OPC is substantial. HPV-associated OPC comprises 79% of the total cost of this disease. The data presented in this study may be used in analytical models to aid decision makers in determining the potential value of gender-neutral HPV vaccination.	[Silfverschiold, Maria; Sjovall, Johanna; Wennerberg, Johan; Greiff, Lennart] Skane Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Lund, Sweden; [Silfverschiold, Maria; Sjovall, Johanna; Wennerberg, Johan; Greiff, Lennart] Lund Univ, Dept Clin Sci, Lund, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ostensson, Ellinor] Karolinska Hosp, Dept Childrens & Womens Hlth, Stockholm, Sweden	Lund University; Skane University Hospital; Lund University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Silfverschiold, M (corresponding author), Skane Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Lund, Sweden.; Silfverschiold, M (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	maria.silfverschiold@med.lu.se		Silfverschiold, Maria/0000-0002-2853-3779	Skane County Council	Skane County Council	This work received funding from Skane County Council (www.skane.se) to LG. The Council had no role in study design, data collection and analysis, decision to publish or, preparation of the manuscript.	Cancercentrum, SVENSKT KVAL HUV HAL; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; Gold M, 1996, MED CARE, V34, pDS197; Jensen AR, 2007, RADIOTHER ONCOL, V84, P5, DOI 10.1016/j.radonc.2007.04.001; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5376; Keeping ST, 2018, CLIN OTOLARYNGOL, V43, P223, DOI 10.1111/coa.12944; Kim K, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-47; Lairson DR, 2017, CANCER EPIDEM BIOMAR, V26, P1443, DOI 10.1158/1055-9965.EPI-17-0220; Larsen CG, 2014, BRIT J CANCER, V110, P1587, DOI 10.1038/bjc.2014.42; Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001; Ostensson E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179520; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; Stenmark MH, 2017, LARYNGOSCOPE, V127, P2270, DOI 10.1002/lary.26566; Wang MB, 2015, OTOLARYNG HEAD NECK, V153, P758, DOI 10.1177/0194599815592157	16	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220534	10.1371/journal.pone.0220534	http://dx.doi.org/10.1371/journal.pone.0220534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356646	Green Published, Green Submitted, gold			2022-12-26	WOS:000484047000039
J	Guevara, G; Flores, YO; de las Heras, LF; Perera, J; Llorens, JMN				Guevara, Govinda; Olortegui Flores, Yamileth; Fernandez de las Heras, Laura; Perera, Julian; Navarro Llorens, Juana Maria			Metabolic engineering of Rhodococcus ruber Chol-4: A cell factory for testosterone production	PLOS ONE			English	Article							FUNGUS COCHLIOBOLUS-LUNATUS; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; MOLECULAR CHARACTERIZATION; MYCOBACTERIUM-SMEGMATIS; REDOX STATE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; CHOLESTEROL; 3-KETOSTEROID-DELTA-1-DEHYDROGENASE; ANDROSTENEDIONE; TRANSFORMATION	Rhodococcus ruber Chol-4 is a potent steroid degrader that has a great potential as a biotechnological tool. As proof of concept, this work presents testosterone production from 4-androstene-3,17-dione by tailoring innate catabolic enzymes of the steroid catabolism inside the strain. A R. ruber quadruple mutant was constructed in order to avoid the breakage of the steroid nucleus. At the same time, an inducible expression vector for this strain was developed. The 17-ketoreductase gene from the fungus Cochliobolus lunatus was cloned and overexpressed in this vector. The engineered strain was able to produce testosterone from 4-androstene-3,17-dione using glucose for cofactor regeneration with a molar conversion of 61%. It is important to note that 91% of the testosterone was secreted outside the cell after 3 days of cell biotransformation. The results support the idea that Rhodococcus ruber Chol-4 can be metabolically engineered and can be used for the production of steroid intermediates.	[Guevara, Govinda; Olortegui Flores, Yamileth; Fernandez de las Heras, Laura; Perera, Julian; Navarro Llorens, Juana Maria] Univ Complutense Madrid, Fac CC Biol, Dept Biochem & Mol Biol, C Jose Antonio Novais, Madrid, Spain	Complutense University of Madrid	Llorens, JMN (corresponding author), Univ Complutense Madrid, Fac CC Biol, Dept Biochem & Mol Biol, C Jose Antonio Novais, Madrid, Spain.	joana@solea.quim.ucm.es	Acosta, Flor Govinda Guevara/L-2162-2018; de las Heras, Laura Fernández/C-7652-2018; Navarro Llorens, Juana Maria/H-2933-2015	Acosta, Flor Govinda Guevara/0000-0002-1096-2612; de las Heras, Laura Fernández/0000-0002-4894-8197; Navarro Llorens, Juana Maria/0000-0002-8181-3147	MINECO, Spain [RTC-2014-2249-1]	MINECO, Spain	This work was supported by project RTC-2014-2249-1 from MINECO, Spain, to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2005, ENDOCRINOLOGY, V146, P2531, DOI 10.1210/en.2005-0061; Al Jasem Y., 2014, MEDITERR J CHEM, V3, P796, DOI [10.13171/mjc.3.2.2014.18.04.15, DOI 10.13171/MJC.3.2.2014.18.04.15]; Angelova B, 2005, ENZYME MICROB TECH, V37, P718, DOI 10.1016/j.enzmictec.2005.04.014; Bergstrand LH, 2016, MBIO, V7, DOI 10.1128/mBio.00166-16; BOGOVICH K, 1980, J BIOL CHEM, V255, P5552; Bourn WR, 2007, TUBERCULOSIS, V87, P481, DOI 10.1016/j.tube.2007.08.003; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Cassetta A, 2017, J STEROID BIOCHEM, V171, P80, DOI 10.1016/j.jsbmb.2017.02.020; Chiba K, 2007, JPN J INFECT DIS, V60, P45; Dlugovitzky DG, 2015, CAN J MICROBIOL, V61, P451, DOI 10.1139/cjm-2015-0025; Donova MV, 2005, PROCESS BIOCHEM, V40, P2253, DOI 10.1016/j.procbio.2004.09.025; Egorova OV, 2009, J MOL CATAL B-ENZYM, V57, P198, DOI 10.1016/j.molcatb.2008.09.003; de las Heras LF, 2014, J STEROID BIOCHEM, V139, P33, DOI 10.1016/j.jsbmb.2013.10.001; de las Heras LF, 2012, J STEROID BIOCHEM, V132, P271, DOI 10.1016/j.jsbmb.2012.06.005; de las Heras LF, 2009, CURR MICROBIOL, V59, P548, DOI 10.1007/s00284-009-9474-z; Fernandez-Cabezon L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00958; Fernandez-Cabezon L, 2017, MICROB BIOTECHNOL, V10, P151, DOI 10.1111/1751-7915.12433; Florin C, 1996, J BACTERIOL, V178, P3322, DOI 10.1128/jb.178.11.3322-3330.1996; Garcia JL, 2012, MICROB BIOTECHNOL, V5, P679, DOI 10.1111/j.1751-7915.2012.00331.x; Guevara G, 2017, J STEROID BIOCHEM, V172, P176, DOI 10.1016/j.jsbmb.2017.06.011; Guevara G, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0657-1; Horinouchi M, 2012, J STEROID BIOCHEM, V129, P4, DOI 10.1016/j.jsbmb.2010.10.008; ITAGAKI E, 1990, BIOCHIM BIOPHYS ACTA, V1038, P60, DOI 10.1016/0167-4838(90)90010-D; ITAGAKI E, 1990, BIOCHIM BIOPHYS ACTA, V1040, P281, DOI 10.1016/0167-4838(90)90088-W; Kristan K, 2005, MOL CELL ENDOCRINOL, V241, P80, DOI 10.1016/j.mce.2005.05.007; Kristan K, 2007, J BIOTECHNOL, V129, P123, DOI 10.1016/j.jbiotec.2006.11.025; Liu WH, 1997, J IND MICROBIOL BIOT, V19, P269, DOI 10.1038/sj.jim.2900456; Liu YY, 2017, STEROIDS, V118, P17, DOI 10.1016/j.steroids.2016.11.002; Moeller G, 2006, MOL CELL ENDOCRINOL, V248, P47, DOI 10.1016/j.mce.2005.11.031; Mutafov S, 1997, PROCESS BIOCHEM, V32, P585, DOI 10.1016/S0032-9592(97)00023-X; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Peltoketo H, 1999, J MOL ENDOCRINOL, V23, P1, DOI 10.1677/jme.0.0230001; Petrus MLC, 2014, ANTON LEEUW INT J G, V106, P127, DOI 10.1007/s10482-014-0157-9; Philipp B, 2011, APPL MICROBIOL BIOT, V89, P903, DOI 10.1007/s00253-010-2998-0; Rizner TL, 2001, MOL CELL ENDOCRINOL, V171, P193, DOI 10.1016/S0303-7207(00)00424-X; Rizner TL, 2001, CHEM-BIOL INTERACT, V130, P793, DOI 10.1016/S0009-2797(00)00235-0; Rizner TL, 2000, ARCH BIOCHEM BIOPHYS, V384, P255, DOI 10.1006/abbi.2000.2064; Rizner TL, 1999, BIOCHEM J, V337, P425; Rizner TL, 2000, COMP BIOCHEM PHYS B, V127, P53; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sherbet DP, 2007, MOL CELL ENDOCRINOL, V265, P83, DOI 10.1016/j.mce.2006.12.021; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SINGER Y, 1991, APPL MICROBIOL BIOT, V35, P731; Taniguchi H, 2017, SYN SYST BIOTECHNO, V2, P65, DOI 10.1016/j.synbio.2017.06.002; Uhia I, 2012, ENV MICROBIOL REP, V4, P168, DOI 10.1111/j.1758-2229.2011.00314.x; Venkataraman H, 2015, APPL MICROBIOL BIOT, V99, P4713, DOI 10.1007/s00253-014-6281-7; Yam KC, 2011, CAN J MICROBIOL, V57, P155, DOI 10.1139/W10-115; Zhao HM, 2003, CURR OPIN BIOTECH, V14, P583, DOI 10.1016/j.copbio.2003.09.007	48	10	10	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220492	10.1371/journal.pone.0220492	http://dx.doi.org/10.1371/journal.pone.0220492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348804	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000484979500038
J	Newcomer, ME				Newcomer, Marcia E.			Chloride to the rescue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								On the fiftieth anniversary of the discovery of the Ser-His-Asp catalytic triad, perhaps the most unusual variation on the textbook classic is described: An incomplete catalytic triad in a hydrolase is rescued by a chloride ion (Fig. 1). Structural and functional data provide compelling evidence that the active site of a phospholipase from Vibrio vulnificus employs the anion in place of the commonly observed Asp, reminding us that even well-trodden scientific ground has surprises in store.	[Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu						BLOW D, 1990, NATURE, V343, P694, DOI 10.1038/343694a0; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Kumar P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas8667; Maurus R, 2005, PROTEIN SCI, V14, P743, DOI 10.1110/ps.041079305; Shinada NK, 2019, J MED CHEM, V62, P9341, DOI 10.1021/acs.jmedchem.8b01453; Wan Y, 2019, J BIOL CHEM, V294, P11391, DOI 10.1074/jbc.RA119.008280; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0	7	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11402	11403		10.1074/jbc.H119.009687	http://dx.doi.org/10.1074/jbc.H119.009687			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31350284	Green Published, hybrid			2022-12-26	WOS:000478717600005
J	Xu, CY; Wu, XL; Lu, MP; Tang, LF; Yao, HY; Wang, JR; Ji, X; Hussain, M; Wu, JS; Wu, XM				Xu, Chengyun; Wu, Xiling; Lu, Meiping; Tang, Lanfang; Yao, Hongyi; Wang, Jirong; Ji, Xing; Hussain, Musaddique; Wu, Junsong; Wu, Ximei			Protein tyrosine phosphatase 11 acts through RhoA/ROCK to regulate eosinophil accumulation in the allergic airway	FASEB JOURNAL			English	Article						SHP2; asthma; cell migration; airway inflammation	EMBRYONIC LUNG DEVELOPMENT; FACTOR-RECEPTOR; SHP2; RHOA; ACTIVATION; ASTHMA; TARGET; MACROPHAGES; EPITHELIA; SUBSTRATE	Src homology domain 2-containing protein tyrosine phosphatase 2 (SHP2) participates in multiple cell functions including cell shape, movement, and differentiation. Therefore, we investigated the potential role of SHP2 in eosinophil recruitment into lungs in allergic airway inflammation and explored the underlying mechanism. Both SHP2 and Ras homolog family member A (RhoA) kinase were robustly activated in the airway eosinophils of children with allergic asthma and of a mouse model with allergic airway inflammation. Moreover, inhibition of SHP2 activity by its specific inhibitors reverses the dephosphorylation of p190-A Rho GTPase-activating protein and in turn attenuates RhoA/Rho-associated protein kinase (ROCK) signaling, resulting in the attenuation of eosinophil migration in response to platelet-activating factor stimulation. Specifically, SHP2 deletion in myeloid cells did not affect the number and classification of circulating leukocytes but significantly attenuated the allergen-induced inflammatory cell, especially eosinophil, infiltration into lungs, and airway hyperreactivity. Notably, genetic interaction between RhoA and SHP2 indicated that RhoA inactivation and SHP2 deletion synergistically attenuated the allergen-induced eosinophil infiltration into lungs and airway hyperreactivity, whereas overexpression of active RhoA robustly restored the SHP2 deletion-resultant attenuation of allergen-induced eosinophil recruitment into lungs and airway hyperreactivity as well. Thus, this study demonstrates that SHP2 via RhoA/ROCK signaling regulates eosinophil recruitment in allergic airway inflammation and possibly in allergic asthma.	[Xu, Chengyun; Wang, Jirong; Ji, Xing; Hussain, Musaddique; Wu, Ximei] Zhejiang Univ, Dept Pharmacol, Hangzhou, Peoples R China; [Wu, Xiling; Lu, Meiping; Tang, Lanfang] Zhejiang Univ, Dept Resp Med, Affiliated Childrens Hosp, Hangzhou, Peoples R China; [Yao, Hongyi] Zhejiang Univ, Dept Pharm, Affiliated Hosp 2, Hangzhou, Peoples R China; [Wu, Junsong] Zhejiang Univ, Dept Orthoped Surg, Affiliated Hosp 1, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Wu, JS (corresponding author), Zhejiang Univ, Dept Orthoped Surg, Affiliated Hosp 1, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Peoples R China.; Wu, XM (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, 866 Yuhangtang Rd, Hangzhou 310058, Peoples R China.	wjs1288@zju.edu.cn; xiwu@zju.edu.cn		Wu, Ximei/0000-0002-3316-893X; Hussain, Musaddique/0000-0001-8766-6339	National Natural Science Foundation of China [81170016, 81170787, 81200022, 81200023, 81270067, 81470214, 31571493, 8157080078, 81571928]; Natural Science Foundation of Zhejiang Province [LY18H150002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (81170016, 81170787, 81200022, 81200023, 81270067, 81470214, 31571493, 8157080078, and 81571928) and the Natural Science Foundation of Zhejiang Province (LY18H150002). The authors declare no conflicts of interest.	Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Amison RT, 2015, J ALLERGY CLIN IMMUN, V135, P528, DOI 10.1016/j.jaci.2014.09.032; Baker MJ, 2016, CURR OPIN HEMATOL, V23, P44, DOI 10.1097/MOH.0000000000000199; Bel EH, 2017, CHEST, V152, P1276, DOI 10.1016/j.chest.2017.05.019; Bhattacharya M, 2014, J CLIN INVEST, V124, P4895, DOI 10.1172/JCI76658; Biro M, 2014, BRIT J PHARMACOL, V171, P5491, DOI 10.1111/bph.12658; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cypcar D, 1996, J LEUKOCYTE BIOL, V60, P101, DOI 10.1002/jlb.60.1.101; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Hussain M, 2017, MOL PHARMACOL, V92, P676, DOI 10.1124/mol.117.110254; Hussain M, 2017, BBA-MOL BASIS DIS, V1863, P3226, DOI 10.1016/j.bbadis.2017.08.031; Julia V, 2015, NAT REV IMMUNOL, V15, P308, DOI 10.1038/nri3830; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Kume H, 2008, CURR MED CHEM, V15, P2876, DOI 10.2174/092986708786242831; Landolina NAC, 2014, CURR OPIN PHARMACOL, V17, P71, DOI 10.1016/j.coph.2014.07.014; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Lee HJ, 2017, J MICROBIOL IMMUNOL, V50, P145, DOI 10.1016/j.jmii.2015.05.017; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; McBrien CN, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00093; Mishra RK, 2005, ALLERGY, V60, P1204, DOI 10.1111/j.1398-9995.2005.00845.x; Pazdrak K, 2008, J IMMUNOL, V180, P4182, DOI 10.4049/jimmunol.180.6.4182; Qin XJ, 2012, ALLERGY, V67, P1547, DOI 10.1111/all.12048; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; SANJAR S, 1990, BRIT J PHARMACOL, V99, P267, DOI 10.1111/j.1476-5381.1990.tb14692.x; Tang LF, 2009, WORLD J PEDIATR, V5, P191, DOI 10.1007/s12519-009-0036-z; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Xia LX, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.74; Xu CY, 2018, MUCOSAL IMMUNOL, V11, P1306, DOI 10.1038/s41385-018-0033-4; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Yao HY, 2011, BBA-GEN SUBJECTS, V1810, P666, DOI 10.1016/j.bbagen.2011.03.020; Yao HY, 2015, ONCOTARGET, V6, P17501, DOI 10.18632/oncotarget.3766; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139	40	17	18	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11706	11720		10.1096/fj.201900698R	http://dx.doi.org/10.1096/fj.201900698R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361966	Green Published			2022-12-26	WOS:000507461600011
J	Han, X; Ren, CN; Yang, TT; Qiao, PY; Wang, L; Jiang, AF; Meng, YH; Liu, ZJ; Du, Y; Yu, ZH				Han, Xue; Ren, Chune; Yang, Tingting; Qiao, Pengyun; Wang, Li; Jiang, Aifang; Meng, Yuhan; Liu, Zhijun; Du, Yu; Yu, Zhenhai			Negative regulation of AMPK alpha 1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-GROWTH; AMPK; PHOSPHORYLATION; INHIBITION; METABOLISM; PATHWAY; FAMILY; PKM2; AKT	Endometrial cancer (EC) is one of the most common gynecologic malignancies. However, the molecular mechanisms underlying the development and progression of EC remain unclear. Here, we demonstrated that the protein proviral insertion in murine lymphomas 2 (PIM2) was necessary for maintaining EC tumorigenesis in vivo and in vitro, and could inhibit AMPK alpha 1 kinase activity in EC cells. Specifically, we found that PIM2 bound to AMPK alpha 1, and directly phosphorylated it on Thr467. Phosphorylation of AMPK alpha 1 by PIM2 led to decreasing AMPK alpha 1 kinase activity, which in turn promoted aerobic glycolysis and tumor growth. In addition, PIM2 expression positively correlated with AMPK alpha 1 Thr467 phosphorylation in EC tissues. Further, treatment with a combination of the PIM2 inhibitor SMI-4a and the AMPK alpha 1 activator AICAR could effectively inhibit tumor growth. Thus, our findings provide insight into the role of PIM2 and AMPK alpha 1 in EC and suggest that combination targeting of these proteins may represent a new strategy for EC treatment.	[Han, Xue; Ren, Chune; Yang, Tingting; Qiao, Pengyun; Wang, Li; Jiang, Aifang; Meng, Yuhan; Yu, Zhenhai] Weifang Med Univ, Dept Reprod Med, Affiliated Hosp, Weifang, Shandong, Peoples R China; [Liu, Zhijun; Du, Yu] Weifang Med Univ, Dept Med Microbiol, Weifang, Shandong, Peoples R China	Weifang Medical University; Weifang Medical University	Yu, ZH (corresponding author), Weifang Med Univ, Dept Reprod Med, Affiliated Hosp, Weifang, Shandong, Peoples R China.	tomsyu@163.com			Innovation fund of National Natural Science Foundation of China [81602440, 81602301, 81501275, 81471048]; Shandong Province College Science and Technology Plan Project [J16LL08, J17KA254]; Projects of medical and health technology development program in Shandong province [2016WS0688, 2017WS398]	Innovation fund of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province College Science and Technology Plan Project; Projects of medical and health technology development program in Shandong province	The study was supported by research grants from Innovation fund of National Natural Science Foundation of China (Grant no. 81602440, 81602301, 81501275 and 81471048), Shandong Province College Science and Technology Plan Project (Grant no. J16LL08 and J17KA254), Projects of medical and health technology development program in Shandong province (Grant no. 2016WS0688 and 2017WS398).	Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Daenthanasanmak A, 2018, J CLIN INVEST, V128, P2787, DOI 10.1172/JCI95407; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Hall DT, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708307; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hospital MA, 2018, LEUKEMIA, V32, P597, DOI 10.1038/leu.2017.284; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Kreuz S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0477-z; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nair JR, 2017, LEUKEMIA, V31, P1715, DOI 10.1038/leu.2016.379; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Onstad MA, 2016, J CLIN ONCOL, V34, P4225, DOI 10.1200/JCO.2016.69.4638; Ren CN, 2018, MOL ONCOL, V12, P690, DOI 10.1002/1878-0261.12192; Shukla K, 2017, CANCER LETT, V411, P57, DOI 10.1016/j.canlet.2017.09.031; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Wang ZP, 2010, INT J BIOCHEM CELL B, V42, P1030, DOI 10.1016/j.biocel.2010.03.012; Warfel NA, 2015, PHARMACOL THERAPEUT, V151, P41, DOI 10.1016/j.pharmthera.2015.03.001; Yang TT, 2018, ONCOGENE, V37, P5997, DOI 10.1038/s41388-018-0386-x; Ye S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2230-4; Yu ZH, 2016, BIOCHEM BIOPH RES CO, V473, P953, DOI 10.1016/j.bbrc.2016.03.160; Yu ZH, 2014, CELL SIGNAL, V26, P1560, DOI 10.1016/j.cellsig.2014.03.016; Yu ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088301; Yu ZH, 2013, J BIOL CHEM, V288, P35406, DOI 10.1074/jbc.M113.508226; Yuan JM, 2018, J BIOL CHEM, V293, P14276, DOI 10.1074/jbc.RA118.004597; Zhao YQ, 2016, ACTA PHARMACOL SIN, V37, P1237, DOI 10.1038/aps.2016.60; Zhou XK, 2017, CANCER LETT, V411, P1, DOI 10.1016/j.canlet.2017.09.027	34	16	16	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2019	38	38					6537	6549		10.1038/s41388-019-0898-z	http://dx.doi.org/10.1038/s41388-019-0898-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IY7XR	31358902				2022-12-26	WOS:000486609000005
J	Xia, ZX; Wu, SY; Wei, X; Liao, YF; Yi, P; Liu, Y; Liu, JM; Liu, JF				Xia, Zhixiong; Wu, Shiyong; Wei, Xin; Liao, Yifei; Yi, Ping; Liu, Yong; Liu, Jianmiao; Liu, Jianfeng			Hypoxic ER stress suppresses beta-catenin expression and promotes cooperation between the transcription factors XBP1 and HIF1 alpha for cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); cancer biology; hypoxia-inducible factor (HIF); X-box-binding protein 1 (XBP1); Wnt signaling	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; NEGATIVE BREAST-CANCER; ANTITUMOR IMMUNITY; INDUCIBLE FACTORS; TUMOR HYPOXIA; WNT; PATHWAY; TUMORIGENESIS; MECHANISMS	Hypoxia occurs in many human solid tumors and activates multiple cellular adaptive-response pathways, including the unfolded protein response (UPR) in the endoplasmic reticulum (ER). Wnt/beta-catenin signaling plays a critical role in tumorigenesis, and beta-catenin has been shown to enhance hypoxia-inducible factor 1 alpha (HIF1 alpha)-activated gene expression, thereby supporting cell survival during hypoxia. However, the molecular interplay between hypoxic ER stress, Wnt/beta-catenin signaling, and HIF1 alpha-mediated gene regulation during hypoxia remains incompletely understood. Here, we report that hypoxic ER stress reduces beta-catenin stability, which, in turn, enhances the activity of spliced X-box-binding protein 1 (XBP1s), a transcription factor and signal transducer of the UPR, in HIF1 alpha-mediated hypoxic responses. We observed that in the RKO colon cancer cell line, which possesses a Wnt-stimulated beta-catenin signaling cascade, increased ER stress during hypoxia is accompanied by a reduction in low-density lipoprotein receptor-related protein 6 (LRP6), and this reduction in LRP6 decreased beta-catenin accumulation and impaired Wnt/beta-catenin signaling. Of note, beta-catenin interacted with both XBP1s and HIF1 alpha, suppressing XBP1s-mediated augmentation of HIF1 alpha target gene expression. Furthermore, Wnt stimulation or beta-catenin overexpression blunted XBP1s-mediated cell survival under hypoxia. Together, these results reveal an unanticipated role for the Wnt/beta-catenin pathway in hindering hypoxic UPR-mediated responses that increase cell survival. Our findings suggest that the molecular cross-talks between hypoxic ER stress, LRP6/beta-catenin signaling, and the HIF1 alpha pathway may represent an unappreciated mechanism that enables some tumor subtypes to survive and grow in hypoxic conditions.	[Xia, Zhixiong; Wu, Shiyong; Wei, Xin; Liao, Yifei; Yi, Ping; Liu, Jianmiao; Liu, Jianfeng] Huazhong Univ Sci & Technol, Key Lab Mol Biophys MOE, Int Res Ctr Sensory Biol & Technol MOST, Cellular Signaling Lab, Wuhan 430074, Hubei, Peoples R China; [Xia, Zhixiong; Wu, Shiyong; Wei, Xin; Liao, Yifei; Yi, Ping; Liu, Jianmiao; Liu, Jianfeng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Liu, Yong] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Liu, JM; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys MOE, Int Res Ctr Sensory Biol & Technol MOST, Cellular Signaling Lab, Wuhan 430074, Hubei, Peoples R China.; Liu, JM; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	jmliu@mail.hust.edu.cn; jfliu@mail.hust.edu.cn		Yi, Ping/0000-0002-6954-102X	National Natural Science Foundation of China [91539107, 91739303, 31420103909, 81720108031, 31721002, 81872945]; Ministry of Science and Technology of China [2018YFA0507003]; Program for Introducing Talents of Discipline to the Universities of the Ministry of Education Grant [B08029]; Merieux Research Grants Program of the Institut Merieux	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program for Introducing Talents of Discipline to the Universities of the Ministry of Education Grant; Merieux Research Grants Program of the Institut Merieux	This work was supported by National Natural Science Foundation of China Grants 91539107 and 91739303 (to Jianmiao Liu) and Grants 31420103909, 81720108031, 31721002, and 81872945 (to Jianfeng Liu), Ministry of Science and Technology of China Grant 2018YFA0507003, and Program for Introducing Talents of Discipline to the Universities of the Ministry of Education Grant B08029, and the Merieux Research Grants Program of the Institut Merieux. The authors declare that they have no conflicts of interest with the contents of this article.	Bernardi R, 2014, CELL RES, V24, P904, DOI 10.1038/cr.2014.61; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Canive JM, 1996, PSYCHOPHARMACOL BULL, V32, P741; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; He X, 2003, DEV CELL, V4, P791, DOI 10.1016/S1534-5807(03)00165-5; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Lhomond S, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201707929; Li XX, 2017, ONCOGENE, V36, P6738, DOI 10.1038/onc.2017.284; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mohamed E, 2017, CANCER IMMUNOL IMMUN, V66, P1069, DOI 10.1007/s00262-017-2019-6; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Sheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08152-3; Sim JW, 2015, CANCER DISCOV, V5, P584, DOI 10.1158/2159-8290.CD-15-0480; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Uppala JK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03940-1; Verras M, 2008, MOL CELL BIOL, V28, P7212, DOI 10.1128/MCB.00947-08; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu Y, 2018, HEPATOLOGY, V68, P533, DOI 10.1002/hep.29871; Xie H, 2018, J CLIN INVEST, V128, P1300, DOI 10.1172/JCI95864; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhao N, 2018, J CLIN INVEST, V128, P1283, DOI 10.1172/JCI95873	51	27	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13811	13821		10.1074/jbc.RA119.008353	http://dx.doi.org/10.1074/jbc.RA119.008353			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350332	Green Published, hybrid			2022-12-26	WOS:000486418600025
J	Xin, LY; Zeng, YK; Sheng, S; Chea, RA; Liu, Q; Li, HY; Yang, L; Xu, LH; Chiam, KH; Liang, ZX				Xin, Lingyi; Zeng, Yukai; Sheng, Shuo; Chea, Rachel Andrea; Liu, Qiong; Li, Hoi Yeung; Yang, Liang; Xu, Linghui; Chiam, Keng-Hwee; Liang, Zhao-Xun			Regulation of flagellar motor switching by c-di-GMP phosphodiesterases in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); Pseudomonas aeruginosa (P aeruginosa); cell motility; phosphodiesterases; chemotaxis; adaptor protein; flagellum; methyltransferase; molecular motor	BIOFILM FORMATION; SWARMING MOTILITY; CYSTIC-FIBROSIS; MUTANT LIBRARY; MECHANISM; DISPERSION; REVEALS; TIME; FLEQ; PATHOGENESIS	The second messenger cyclic diguanylate (c-di-GMP) plays a prominent role in regulating flagellum-dependent motility in the single-flagellated pathogenic bacterium Pseudomonas aeruginosa. The c-di-GMP-mediated signaling pathways and mechanisms that control flagellar output remain to be fully unveiled. Studying surface-tethered and free-swimming P. aeruginosa PAO1 cells, we found that the overexpression of an exogenous diguanylate cyclase (DGC) raises the global cellular c-di-GMP concentration and thereby inhibits flagellar motor switching and decreases motor speed, reducing swimming speed and reversal frequency, respectively. We noted that the inhibiting effect of c-di-GMP on flagellar motor switching, but not motor speed, is exerted through the c-di-GMP-binding adaptor protein MapZ and associated chemotactic pathways. Among the 22 putative c-di-GMP phosphodiesterases, we found that three of them (DipA, NbdA, and RbdA) can significantly inhibit flagellar motor switching and swimming directional reversal in a MapZ-dependent manner. These results disclose a network of c-di-GMP-signaling proteins that regulate chemotactic responses and flagellar motor switching in P. aeruginosa and establish MapZ as a key signaling hub that integrates inputs from different c-di-GMP-signaling pathways to control flagellar output and bacterial motility. We rationalized these experimental findings by invoking a model that postulates the regulation of flagellar motor switching by subcellular c-di-GMP pools.	[Xin, Lingyi; Chea, Rachel Andrea; Li, Hoi Yeung; Yang, Liang; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Yang, Liang] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore 637551, Singapore; [Yang, Liang; Liang, Zhao-Xun] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Zeng, Yukai; Chiam, Keng-Hwee] ASTAR, Bioinformat Inst, 30 Biopolis St,07-01, Singapore 138671, Singapore; [Sheng, Shuo; Liu, Qiong; Xu, Linghui] South China Agr Univ, Integrat Microbiol Res Ctr, Guangdong Innovat & Entrepreneurial Res Team Soci, Guangzhou 510642, Guangdong, Peoples R China; [Xu, Linghui] South China Agr Univ, Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Guangdong, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); South China Agricultural University; South China Agricultural University	Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.; Chiam, KH (corresponding author), ASTAR, Bioinformat Inst, 30 Biopolis St,07-01, Singapore 138671, Singapore.	zxliang@ntu.edu.sg; zxliang@ntu.edu.sg	Liang, Zhao-Xun/A-2191-2011; Yang, Liang/C-8487-2011	Yang, Liang/0000-0002-2362-0128; Liang, Zhao-Xun/0000-0002-3128-1330; Li, Hoi Yeung/0000-0002-8603-1953	ARC Tier II Grant from the Ministry of Education of Singapore [MOE2015-T2-2-026]; National Basic Research Program of China Program 973 Grant [2015CB150600]; Guangdong technological innovation strategy of special funds key areas of research and development program [2018B020205003]	ARC Tier II Grant from the Ministry of Education of Singapore(Ministry of Education, Singapore); National Basic Research Program of China Program 973 Grant(National Basic Research Program of China); Guangdong technological innovation strategy of special funds key areas of research and development program	This work was supported by ARC Tier II Grant MOE2015-T2-2-026 (to Z.-X. L.) from the Ministry of Education of Singapore. The research is also supported by National Basic Research Program of China Program 973 Grant number 2015CB150600 (to L. X.) and Guangdong technological innovation strategy of special funds key areas of research and development program Grant 2018B020205003. The authors declare that they have no conflicts of interest with the contents of this article.	Alicia TGG, 2016, LAB CHIP, V16, P368, DOI 10.1039/c5lc01137j; Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Baker AE, 2016, J BACTERIOL, V198, P1837, DOI 10.1128/JB.00196-16; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Cheang QW, 2019, BIOCHEM SOC T, V47, P381, DOI 10.1042/BST20180543; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Chen YC, 2015, ENV MICROBIOL REP, V7, P498, DOI 10.1111/1758-2229.12278; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Dotsch A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-234; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Fong J, 2017, J MED CHEM, V60, P215, DOI 10.1021/acs.jmedchem.6b01025; Gjermansen M, 2006, FEMS MICROBIOL LETT, V265, P215, DOI 10.1111/j.1574-6968.2006.00493.x; Ha DG, 2014, APPL ENVIRON MICROB, V80, P3384, DOI 10.1128/AEM.00299-14; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kulasekara BR, 2013, ELIFE, V2, DOI 10.7554/eLife.01402; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Li Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004168; Li Y, 2013, J BACTERIOL, V195, P3531, DOI 10.1128/JB.01156-12; Liu C, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00515-17; Long ZC, 2014, ANALYST, V139, P5254, DOI 10.1039/c4an00877d; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL698, DOI 10.1152/ajplung.00319.2013; Lowe D. G., 2000, INT J COMPUT VISION, V60, P91; LUZAR MA, 1985, INFECT IMMUN, V50, P577, DOI 10.1128/IAI.50.2.577-582.1985; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; Matsuyama BY, 2016, P NATL ACAD SCI USA, V113, pE209, DOI 10.1073/pnas.1523148113; Mattingly AE, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01674-18; McCarter LL, 2015, J BACTERIOL, V197, P406, DOI 10.1128/JB.02483-14; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Nair HAS, 2017, J BIOL CHEM, V292, P477, DOI 10.1074/jbc.M116.746743; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ortega DR, 2017, P NATL ACAD SCI USA, V114, P12809, DOI 10.1073/pnas.1708842114; Petrova OE, 2017, METHODS MOL BIOL, V1657, P33, DOI 10.1007/978-1-4939-7240-1_4; Petrova OE, 2012, P NATL ACAD SCI USA, V109, P16690, DOI 10.1073/pnas.1207832109; Qian C, 2013, APPL ENVIRON MICROB, V79, P4734, DOI 10.1128/AEM.01027-13; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00790-16; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Roy Ankita Basu, 2013, Bio Protoc, V3; Roy AB, 2012, J BACTERIOL, V194, P2904, DOI 10.1128/JB.05346-11; Rybtke MT, 2012, APPL ENVIRON MICROB, V78, P5060, DOI 10.1128/AEM.00414-12; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sampedro I, 2015, FEMS MICROBIOL REV, V39, P17, DOI 10.1111/1574-6976.12081; Sanchez-Torres V, 2011, APPL MICROBIOL BIOT, V90, P651, DOI 10.1007/s00253-010-3074-5; Sarenko O, 2017, MBIO, V8, DOI 10.1128/mBio.01639-17; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheng S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00067; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; Wang TT, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00152-19; Xu LH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7584; Yan XF, 2018, J BIOL CHEM, V293, P100, DOI 10.1074/jbc.M117.815704	66	14	15	7	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13789	13799		10.1074/jbc.RA119.009009	http://dx.doi.org/10.1074/jbc.RA119.009009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350333	hybrid, Green Published			2022-12-26	WOS:000486418600023
J	Dornelles, A				Dornelles, Adriana			Impact of multiple food environments on body mass index	PLOS ONE			English	Article							NEIGHBORHOOD ENVIRONMENT; DIETARY-INTAKE; WEIGHT STATUS; RISK-FACTORS; OBESITY; RESTAURANTS; SCHOOL; PROXIMITY; ASSOCIATIONS; CONSUMPTION	Background Although the relationship between residential food environments and health outcomes have been extensively studied, the relationship between body mass index (BMI) and multiple food environments have not been fully explored. We examined the relationship between characteristics of three distinct food environments and BMI among elementary school employees in the metropolitan area of New Orleans, LA. We assessed the food environments around the residential and worksite neighborhoods and the commuting corridors. Research methodology/principal findings This study combined data from three different sources: individual and worksite data (ACTION), food retailer database (Dunn and Bradstreet), and the U.S. Census TIGER/Line Files. Spatial and hierarchical analyses were performed to explore the impact of predictors at the individual and environmental levels on BMI. When the three food environments were combined, the number of supermarkets and the number of grocery stores at residential food environment had a significant association with BMI (beta = 0.56 and beta = 0.24, p < 0.01), whereas the number of full-service restaurants showed an inverse relationship with BMI (beta = -0.15, p < 0.001). For the commute corridor food environment, it was found that each additional fast-food restaurant in a vicinity of one kilometer traveled contributed to a higher BMI (beta = 0.80, p < 0.05), while adjusting for other factors. No statistical associations were found between BMI and worksite food environment. Conclusions The current study was the first to examine the relationship between BMI and food environments around residential neighborhoods, work neighborhoods, and the commuting corridor. Significant results were found between BMI and the availability of food stores around residential neighborhoods and the commuting corridor, adjusted for individual-level factors. This study expands the analysis beyond residential neighborhoods, illustrating the importance of multiple environmental factors in relation to BMI.	[Dornelles, Adriana] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Dornelles, A (corresponding author), Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA.	adriana.dornelles@asu.edu		dornelles, adriana/0000-0003-4674-3654				Abdel-Aty M., 1994, TRANSP RES REC, V1453, P46; Adam A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3985-x; An RP, 2012, AM J PREV MED, V42, P129, DOI 10.1016/j.amepre.2011.10.012; Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341; Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244; Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007; Bodor JN, 2010, J URBAN HEALTH, V87, P771, DOI 10.1007/s11524-010-9460-6; Burdette HL, 2004, PREV MED, V38, P57, DOI 10.1016/j.ypmed.2003.09.029; Cobb LK, 2015, OBESITY, V23, P1331, DOI 10.1002/oby.21118; Courtemanche C, 2011, J URBAN ECON, V69, P165, DOI 10.1016/j.jue.2010.09.005; Currie J, 2010, AM EC J EC POLICY AM, V2, P23; Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660; Dubowitz T, 2012, OBESITY, V20, P862, DOI 10.1038/oby.2011.141; Duffell J., 1988, TRAFFIC ENG CONTROL, V29, P398; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; EKELUND RB, 1991, KYKLOS, V44, P613; Ellaway A, 1997, INT J OBESITY, V21, P304, DOI 10.1038/sj.ijo.0800405; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; Gibson DM, 2011, AM J PUBLIC HEALTH, V101, P71, DOI 10.2105/AJPH.2009.187567; Hales Craig M, 2017, NCHS Data Brief, P1; Hartline-Grafton HL, 2009, J AM DIET ASSOC, V109, P1548, DOI 10.1016/j.jada.2009.06.366; Hunt MK, 2000, HEALTH EDUC BEHAV, V27, P223, DOI 10.1177/109019810002700208; Jekanowski MD, 2001, J AGR RESOUR ECON, V26, P58; Joshu CE, 2008, J EPIDEMIOL COMMUN H, V62, P202, DOI 10.1136/jech.2006.058321; Kestens Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041418; Kwate NOA, 2010, PREV MED, V51, P153, DOI 10.1016/j.ypmed.2010.04.020; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1757, DOI 10.1017/S1368980010001564; Lear SA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-117; Lemon SC, 2010, J OCCUP ENVIRON MED, V52, pS1, DOI 10.1097/JOM.0b013e3181c8527e; Leung CW, 2011, AM J PREV MED, V41, P43, DOI 10.1016/j.amepre.2011.03.013; Li HN, 2005, TRANSPORT RES REC, P162; Lopez RP, 2007, OBESITY, V15, P2111, DOI 10.1038/oby.2007.251; McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x; Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031; Mills S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182842; Moore LV, 2008, J URBAN HEALTH, V85, P206, DOI 10.1007/s11524-008-9259-x; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004; Ogden CL, 2018, MMWR-MORBID MORTAL W, V67, P186, DOI 10.15585/mmwr.mm6706a3; Papinski D, 2009, TRANSPORT RES F-TRAF, V12, P347, DOI 10.1016/j.trf.2009.04.001; Perchoux C, 2016, HEALTH PLACE, V40, P116, DOI 10.1016/j.healthplace.2016.05.004; Powell LM, 2007, AM J PREV MED, V33, pS301, DOI 10.1016/j.amepre.2007.07.007; Powell LM, 2009, ECON HUM BIOL, V7, P64, DOI 10.1016/j.ehb.2009.01.004; Reitzel LR, 2014, AM J PUBLIC HEALTH, V104, P110, DOI 10.2105/AJPH.2012.301140; Richardson AS, 2015, HEALTH PLACE, V36, P74, DOI 10.1016/j.healthplace.2015.09.003; Rose D, 2009, AM J PREV MED, V37, P214, DOI 10.1016/j.amepre.2009.04.024; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Rydell SA, 2008, J AM DIET ASSOC, V108, P2066, DOI 10.1016/j.jada.2008.09.008; Simon PA, 2008, PREV MED, V47, P284, DOI 10.1016/j.ypmed.2008.02.021; Sorensen G, 1999, AM J PUBLIC HEALTH, V89, P54, DOI 10.2105/AJPH.89.1.54; Spence JC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-192; Sturm R, 2005, PUBLIC HEALTH, V119, P1059, DOI 10.1016/j.puhe.2005.05.007; Sundquist J, 1999, INT J EPIDEMIOL, V28, P841, DOI 10.1093/ije/28.5.841; Tamers SL, 2011, PREV MED, V53, P53, DOI 10.1016/j.ypmed.2011.04.012; US Census Bureau, N AM IND CLASS SYST; Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680; Webber LS, 2007, OBESITY, V15, p48S, DOI 10.1038/oby.2007.387; Zenk SN, 2005, AM J PUBLIC HEALTH, V95, P660, DOI 10.2105/AJPH.2004.042150; Zick CD, 2009, SOC SCI MED, V69, P1493, DOI 10.1016/j.socscimed.2009.08.032	64	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0219365	10.1371/journal.pone.0219365	http://dx.doi.org/10.1371/journal.pone.0219365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390365	Green Published, Green Submitted, gold			2022-12-26	WOS:000484999400005
J	Lee, SJ; Lee, HS; Hwang, YH; Kim, JJ; Kang, KY; Kim, SJ; Kim, HK; Kim, JD; Jeong, D; Paik, MJ; Yee, ST				Lee, Sung-Ju; Lee, Hyeon-Seong; Hwang, Yun-Ho; Kim, Jong-Jin; Kang, Kyung-Yun; Kim, Seong Jin; Kim, Hong Kee; Kim, Jung Dong; Jeong, Do Hyeon; Paik, Man-Jeong; Yee, Sung-Tae			Enhanced anti-tumor immunotherapy by dissolving microneedle patch loaded ovalbumin	PLOS ONE			English	Article							T-CELL RESPONSES; HELPER-CELLS; ANTIGEN; VACCINATION; DELIVERY; SKIN; NANOPARTICLES; VACCINES; PROTEIN; IMMUNIZATION	The skin is a very suitable organ for the induction of immune responses to vaccine antigens. Antigen delivery systems to the skin by needle and syringe directly deposit the antigen into the epidermal-dermal compartment, one of the most immunocompetent sites due to the presence of professional antigen-presenting cells aimed at the induction of antigen-specific T cells. In this study, we analyzed the amount of ovalbumin as an antigen delivered to the skin by a micro-needle. When ovalbumin protein as an antigen was delivered to the skin of mice using a dissolving microneedle, it induced an immune response through the enhanced proliferation and cytokines production by the splenocytes and lymph nodes. Also, it effectively increased the ovalbumin-specific CD8(+) T cell and CD4(+) T cell population and induced an ovalbumin-specific CTL response against the graft of ovalbumin-expressing EG7 tumor cells in the immunized mice. Also, we identified the inhibition of tumor growth and prevention of tumor formation in the context of the therapeutic and prophylactic vaccine, respectively through EG-7 tumor mouse model. Finally, these data show the potential of patches as attractive antigen delivery vehicles.	[Lee, Sung-Ju; Hwang, Yun-Ho; Yee, Sung-Tae] Sunchon Natl Univ, Dept Pharm, Sunchon, South Korea; [Lee, Hyeon-Seong; Paik, Man-Jeong] Sunchon Natl Univ, Coll Pharm, Sunchon, South Korea; [Lee, Hyeon-Seong; Paik, Man-Jeong] Sunchon Natl Univ, Res Inst Life & Pharmaceut Sci, Sunchon, South Korea; [Kim, Jong-Jin] Inst for Basic Sci Korea, Ctr Self Assembly & Complex, Pohang, South Korea; [Kang, Kyung-Yun] Suncheon Res Ctr Nat Med, Sunchon, South Korea; [Kim, Seong Jin; Kim, Hong Kee; Kim, Jung Dong; Jeong, Do Hyeon] Yonsei Univ, Coll Med, Res Ctr, RAPHAS Co Ltd, 512 ABMRC, Seoul, South Korea	Sunchon National University; Sunchon National University; Sunchon National University; Institute for Basic Science - Korea (IBS); Yonsei University; Yonsei University Health System	Yee, ST (corresponding author), Sunchon Natl Univ, Dept Pharm, Sunchon, South Korea.	sungtae@sunchon.ac.kr			Sunchon National University Research Fund	Sunchon National University Research Fund	This study was supported by the Sunchon National University Research Fund in 2017. Raphas Co., Ltd. provided support in the form of salaries for authors [SJK, HKK, JDK, DHJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali OA, 2016, CANCER IMMUNOL RES, V4, P95, DOI 10.1158/2326-6066.CIR-14-0126; Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Becker PD, 2015, VACCINE, V33, P4691, DOI 10.1016/j.vaccine.2015.04.046; Boss JD., 1981, CUTANEOUS IMMUNOLOGY; Carey JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022442; Chen JZ, 2011, CELL IMMUNOL, V269, P5, DOI 10.1016/j.cellimm.2011.03.003; Fallarino F, 2000, J IMMUNOL, V165, P5495, DOI 10.4049/jimmunol.165.10.5495; Fichtelius KE, 2006, INT ARCH ALLER A IMM, V37, P607; Gerritsen WR, 2012, ANN ONCOL, V23, P22, DOI 10.1093/annonc/mds259; Glenn GM, 2000, NAT MED, V6, P1403, DOI 10.1038/82225; Gonzalez G, 2011, CURR CANCER DRUG TAR, V11, P103, DOI 10.2174/156800911793743583; Grotefend S, 2012, J PHARMACEUT BIOMED, V71, P127, DOI 10.1016/j.jpba.2012.08.024; Hamdy S, 2007, J BIOMED MATER RES A, V81A, P652, DOI 10.1002/jbm.a.31019; Han M, 2009, SENSOR ACTUAT B-CHEM, V137, P274, DOI 10.1016/j.snb.2008.11.017; Ibana JA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-66; Kang YX, 2013, PROTEIN CELL, V4, P86, DOI 10.1007/s13238-012-2111-9; Kim JJ, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2471627; Kim JJ, 2014, INT IMMUNOPHARMACOL, V21, P309, DOI 10.1016/j.intimp.2014.05.010; Kim JD, 2013, J CONTROL RELEASE, V170, P430, DOI 10.1016/j.jconrel.2013.05.026; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Ko BK, 2015, MOL ONCOL, V9, P398, DOI 10.1016/j.molonc.2014.09.007; Lee SJ, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1045-9; Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Ng HI, 2012, J CONTROL RELEASE, V162, P477, DOI 10.1016/j.jconrel.2012.07.024; Pearson FE, 2015, VACCINE, V33, P3248, DOI 10.1016/j.vaccine.2015.03.039; Rahimian S, 2015, BIOMATERIALS, V37, P469, DOI 10.1016/j.biomaterials.2014.10.043; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Silva JM, 2013, J CONTROL RELEASE, V168, P179, DOI 10.1016/j.jconrel.2013.03.010; Teunissen MBM, 2012, CURR TOP MICROBIOL, V351, P25, DOI 10.1007/82_2011_169; van der Maaden K, 2014, EUR J PHARM BIOPHARM, V88, P310, DOI 10.1016/j.ejpb.2014.05.003; Wang C, 2016, NANO LETT, V16, P2334, DOI 10.1021/acs.nanolett.5b05030; Wen ZS, 2011, MAR DRUGS, V9, P1038, DOI 10.3390/md9061038; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049; YU RC, 1994, BRIT J DERMATOL, V131, P843, DOI 10.1111/j.1365-2133.1994.tb08587.x; Zaiss DMW, 2010, VACCINE, V28, P7716, DOI 10.1016/j.vaccine.2010.08.101	39	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220382	10.1371/journal.pone.0220382	http://dx.doi.org/10.1371/journal.pone.0220382			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386690	Green Published, gold, Green Submitted			2022-12-26	WOS:000484997100020
J	Pinna, S; Lanzi, F; Cordella, A; Diana, A				Pinna, Stefania; Lanzi, Francesco; Cordella, Alessia; Diana, Alessia			Relationship between the stage of osteoarthritis before and six months after tibial tuberosity advancement procedure in dogs	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; PLATEAU LEVELING OSTEOTOMY; CANINE STIFLE JOINT; CONTACT MECHANICS; DEFICIENT STIFLES; IN-VIVO; PROGRESSION; RUPTURE; COMPLICATIONS; INSUFFICIENCY	The present retrospective study evaluated the progression of osteoarthritis in stifle joints based on the radiographic grade of osteoarthritis (OA) scored in dogs with cranial cruciate ligament rupture. The aim of the study was to search for a correlation between the stage of radiographic osteoarthritis prior to surgery and the osteoarthritis progression occurring after the tibial tuberosity advancement (TTA) procedure. It was hypothesized that the procedure carried out in dogs in the early stages of OA could reduce the OA changes. A total of 190 X-ray images obtained from the medical records of 38 dogs were evaluated. The radiographic signs of osteoarthritis of 38 stifle joints were scored from 0 to 3 in 10 specific anatomic locations. The radiographs were divided into 4 groups based on the global scores: A) no-OA, B) mild-OA, C) moderate-OA, D) severe-OA; they were assessed prior to surgery, and 1, 2, 3 and 6 months post-operatively (T0, T1, T2, T3 and T6). There were no differences in osteoarthritis progression in Groups A and C at any time. Osteoarthritis changes from T0 to T6 were statistically significant in Group B. The OA changes in the anatomic locations were investigated. The most common anatomic sites for OA changes were the patella apex, the proximal and distal trochlear ridges, and the caudal aspect of the tibial plateau assessed before surgery. After surgery, the score increased in the first three locations in 10, 9 and 11 joints, respectively; instead, the progression of osteoarthritis in the caudal aspect of the tibial plateau occurred in 23 out of 38 stifle joints. The results indicated that the TTA procedure could be effective in slowing down the OA progression when carried out in the absence of or in the early stages of disease. Therefore, an early intervention may be suggested in clinical practice to obtain minimal or no progression 6 months postoperatively.	[Pinna, Stefania; Lanzi, Francesco; Cordella, Alessia; Diana, Alessia] Univ Bologna, Sch Agr & Vet Med, Dept Vet Med Sci, Alma Mater Studiorum, Bologna, Italy	University of Bologna	Pinna, S (corresponding author), Univ Bologna, Sch Agr & Vet Med, Dept Vet Med Sci, Alma Mater Studiorum, Bologna, Italy.	stefania.pinna@unibo.it	Cordella, Alessia/AGY-6618-2022	Pinna, Stefania/0000-0002-0005-9753				Allan G, 2006, MANUAL CANINE FELINE, P71; Altman DG, 1991, PRACTICAL STAT MED R, P397; Apelt D, 2007, VET SURG, V36, P170, DOI 10.1111/j.1532-950X.2007.00250.x; BENNETT D, 1988, J SMALL ANIM PRACT, V29, P275, DOI 10.1111/j.1748-5827.1988.tb02286.x; Boudrieau RJ, 2009, VET SURG, V38, P1, DOI 10.1111/j.1532-950X.2008.00439.x; Carey K, 2005, VET COMP ORTHOPAED, V18, P235; Coulson A., 2008, ATLAS INTERPRETATIVE; COX JS, 1975, CLIN ORTHOP RELAT R, P178; Danielson B, 2016, J AM ANIM HOSP ASSOC, V52, P109, DOI 10.5326/JAAHA-MS-6194; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; Ferreira MP, 2016, VET COMP ORTHOPAED, V29, P209, DOI 10.3415/VCOT-15-01-0009; Franklin SP, 2017, JAVMA-J AM VET MED A, V251, P71, DOI 10.2460/javma.251.1.71; Gordon WJ, 2003, VET SURG, V32, P451, DOI 10.1053/jvet.2003.50051; Guerrero TG, 2011, VET SURG, V40, P839, DOI 10.1111/j.1532-950X.2011.00866.x; Hoelzler MG, 2004, VET SURG, V33, P146, DOI 10.1111/j.1532-950X.2004.04022.x; Hoffmann DE, 2006, VET COMP ORTHOPAED, V19, P219; Hurley CR, 2007, JAVMA-J AM VET MED A, V230, P1674, DOI 10.2460/javma.230.11.1674; Innes JF, 1998, J SMALL ANIM PRACT, V39, P325, DOI 10.1111/j.1748-5827.1998.tb03723.x; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Kim SE, 2008, VET SURG, V37, P111, DOI 10.1111/j.1532-950X.2007.00361.x; Kim SE, 2009, VET SURG, V38, P33, DOI 10.1111/j.1532-950X.2008.00471.x; Kowaleski MP, 2012, VET SURG SMALL ANIMA, V1, P906; Krotscheck U, 2016, VET SURG, V45, P261, DOI 10.1111/vsu.12445; Lafaver S, 2007, VET SURG, V36, P573, DOI 10.1111/j.1532-950X.2007.00307.x; Leach ES, 2018, VET SURG, V47, P566, DOI 10.1111/vsu.12790; Lineberger JA, 2005, VET COMP ORTHOPAED, V18, P13; LUKOSCHEK M, 1988, J ORTHOP RES, V6, P475, DOI 10.1002/jor.1100060403; MacDonald TL, 2013, CAN VET J, V54, P249; Mahn MM, 2005, VET SURG, V34, P318, DOI 10.1111/j.1532-950X.2005.00049.x; MARSHALL JL, 1969, CLIN ORTHOP RELAT R, P37; Montavon P.M, 2004, P 12 ESVOT C, P254; Morgan JP, 2010, VET SURG, V39, P425, DOI 10.1111/j.1532-950X.2010.00669.x; Musahl V, 2010, AM J SPORT MED, V38, P1591, DOI 10.1177/0363546510364402; NAKAMURA N, 1985, J BONE JOINT SURG BR, V67, P255, DOI 10.1302/0301-620X.67B2.3980537; Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T; Pozzi A, 2006, VET SURG, V35, P486, DOI 10.1111/j.1532-950X.2006.00180.x; Pozzi A, 2010, VET SURG, V39, P489, DOI 10.1111/j.1532-950X.2010.00662.x; Rayward RM, 2004, J SMALL ANIM PRACT, V45, P92, DOI 10.1111/j.1748-5827.2004.tb00209.x; SCAVELLI TD, 1990, J AM VET MED ASSOC, V196, P1135; Skinner OT, 2013, VET J, V196, P86, DOI 10.1016/j.tvjl.2012.08.003; SLOCUM B, 1993, VET CLIN N AM-SMALL, V23, P777, DOI 10.1016/S0195-5616(93)50082-7; Steffey MA, 2010, MECH DIS SMALL ANIMA, P731; TARVIN GB, 1981, VET SURG, V10, P94, DOI 10.1111/j.1532-950X.1981.tb00637.x; Thieman KM, 2009, VET SURG, V38, P803, DOI 10.1111/j.1532-950X.2009.00571.x; Valen S, 2017, J SMALL ANIM PRACT, V58, P109, DOI 10.1111/jsap.12619; VASSEUR PB, 1992, J AM ANIM HOSP ASSOC, V28, P129; VASSEUR PB, 1984, VET SURG, V13, P243, DOI 10.1111/j.1532-950X.1984.tb00801.x; von Pfeil DJF, 2018, JAVMA-J AM VET MED A, V253, P586, DOI 10.2460/javma.253.5.586; Warzee CC, 2001, VET SURG, V30, P278, DOI 10.1053/jvet.2001.21400; Wessely M, 2017, VET COMP ORTHOPAED, V30, P377, DOI [10.3415/VCOT-16-09-0134, 10.3415/vcot-16-09-0134]; WIDMER WR, 1994, VET RADIOL ULTRASOUN, V35, P371, DOI 10.1111/j.1740-8261.1994.tb02057.x; Wiseman-Orr ML, 2004, AM J VET RES, V65, P1077, DOI 10.2460/ajvr.2004.65.1077	52	4	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219849	10.1371/journal.pone.0219849	http://dx.doi.org/10.1371/journal.pone.0219849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386673	gold, Green Published			2022-12-26	WOS:000484997100011
J	Munisi, DZ; Nyundo, AA; Mpondo, BC				Munisi, David Zadock; Nyundo, Azan A.; Mpondo, Bonaventura C.			Knowledge, attitude and practice towards malaria among symptomatic patients attending Tumbi Referral Hospital: A cross-sectional study	PLOS ONE			English	Article							COMMUNITY KNOWLEDGE	Background Despite significant improvement in prevention and control over the past decades malaria remains a significant public health concern in Tanzania with 93% of the population being at risk. To prevent malaria infection and promote malaria free zones, understanding the community's knowledge, attitudes, and practices toward malaria control are essential. This study therefore aimed at determining the levels of understanding, and attitudes, as well as socio-cultural aspects of malaria prevention and treatment-seeking behaviours among suspected malaria patients. Methods This study was a hospital based cross-sectional study, in which patients attending Tumbi Referral Hospital with symptoms and signs that warrant inclusion of suspicion of malaria, were recruited. We used a pre-tested semi-structured questionnaire to collect participants' demographic characteristics, as well as information on their knowledge, attitudes, and practices towards malaria infection. Data were analysed using Stata Version 12.1. Results We enrolled a total of 295 respondents of which 179 (60.68%) were females. Participants' ages ranged from 1-91 years, with a mean of 31.4 years. Seventy-nine (26.8%) patients reported having malaria in the previous 28 days, with 57 (72.2%) being laboratory confirmed. Only 52 (65.8%) individuals reported taking prescribed medications for malaria. A total of 277 (93.90%) were aware of malaria, and 264 (95.31%) knew that it is transmitted by mosquito. Nearly all participants (263, 94.95%), identified sleeping under bed nets to be protective against malaria. About half of the respondents either agreed 63 (22.74%) or strongly agreed 62 (22.38%) that malaria can be transmitted like the common cold. Self-reported mosquito net use was 88.09% (244). Conclusion Despite the endemicity of malaria in our study site, patients had adequate knowledge, encouraging attitudes, and good practices related to malaria prevention and control.	[Munisi, David Zadock] Univ Dodoma, Coll Hlth Sci, Sch Med & Dent, Dept Parasitol & Entomol, Dodoma, Tanzania; [Nyundo, Azan A.] Univ Dodoma, Coll Hlth Sci, Sch Med & Dent, Dept Psychiat, Dodoma, Tanzania; [Mpondo, Bonaventura C.] Univ Dodoma, Coll Hlth Sci, Sch Med & Dent, Dept Internal Med, Dodoma, Tanzania		Munisi, DZ (corresponding author), Univ Dodoma, Coll Hlth Sci, Sch Med & Dent, Dept Parasitol & Entomol, Dodoma, Tanzania.	massugii@gmail.com	Munisi, David Zadock/S-5765-2017	Munisi, David Zadock/0000-0001-8437-7988	University of Dodoma; University of Dodoma 10th Anniversary Research Grant	University of Dodoma; University of Dodoma 10th Anniversary Research Grant	We are grateful to the University of Dodoma for providing the grant to conduct this study through the University of Dodoma 10th Anniversary Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Tumbi Regional Referral Hospital for allowing us to conduct this study at the hospital. We are grateful to the University of Dodoma for providing the grant to conduct this study through the University of Dodoma 10th Anniversary Research Grant.	Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Adedotun AA, 2010, J VECTOR DIS, V47, P155; Adongo PB, 2005, TROP MED INT HEALTH, V10, P366, DOI 10.1111/j.1365-3156.2005.01361.x; Ahmed SM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-357; Amusan VO., 2017, SCI J PUB HLTH, V5, P240, DOI [10.11648/j.sjph.20170503.22, DOI 10.11648/J.SJPH.20170503.22]; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29; Kebede DL, 2017, J TROP DIS, V5, P2; KISH L, 1965, AM SOCIOL REV, V30, P564, DOI 10.2307/2091346; Makoge V., 2016, INT J TROPICAL DIS H, V15, P1, DOI [DOI 10.9734/IJTDH/2016/24808, 10.9734/ijtdh/2016/24808]; Mazigo Humphrey D, 2010, Malar Res Treat, V2010, P794261, DOI 10.4061/2010/794261; Moon AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089814; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Musuva RM, 2014, AM J TROP MED HYG, V90, P646, DOI 10.4269/ajtmh.13-0488; Nkulikwa ZA, 2018, HLTH CARE CURRENT RE, V6, P229, DOI [10.4172/2375-4273.1000229, DOI 10.4172/2375-4273.1000229]; President's Malaria Initiative, 2017, TANZ MAL OP PLAN FY; RUEBUSH TK, 1995, B WORLD HEALTH ORGAN, V73, P229; RUEBUSH TK, 1994, AM J TROP MED HYG, V50, P85, DOI 10.4269/ajtmh.1994.50.85; Sansom C, 2009, LANCET INFECT DIS, V9, P596, DOI 10.1016/S1473-3099(09)70247-6; Singh N, 1998, CURR SCI INDIA, V75, P1386; Taremwa IM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4824-4; Tyagi Padmawati, 2005, Journal of Vector Borne Diseases, V42, P30; Tynan A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-204; Wanzira H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1360-0; WHO, 2018, WHO RECOGNIZES NATL; World Health Organization, 2017, DEPRESSION; World Health Organization, 2015, GUID TREATM MAL, Vthird; Ye Y, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-32	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220501	10.1371/journal.pone.0220501	http://dx.doi.org/10.1371/journal.pone.0220501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381600	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600020
J	Jarrett, JT				Jarrett, Joseph T.			Surprise! A hidden B-12 cofactor catalyzes a radical methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						radical; S-adenosylmethionine (SAM); iron-sulfur protein; post-translational modification; protein methylation; cobalamin; radical SAM; vitamin B12		Radical S-adenosylmethionine (SAM) (RS) methylases perform methylation reactions at unactivated carbon and phosphorus atoms. RS enzymes typically abstract a hydrogen from their substrates, generating a substrate-centered radical; class B RS methylases catalyze methyl transfer from SAM to cobalamin and then to a substrate-centered carbon or phosphorus radical. Radle et al. now show that Mmp10, an RS enzyme implicated in the methylation of Arg-285 in methyl coenzyme M reductase, binds a methylcobalamin cofactor required for methyl transfer from SAM to a peptide substrate. However, Mmp10 has little sequence homology to known methylases, suggesting this enzyme belongs to a new subclass of B-12-dependent RS methylases.	[Jarrett, Joseph T.] Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Jarrett, JT (corresponding author), Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA.	jtj@hawaii.edu		Jarrett, Joseph/0000-0002-3737-7464				Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; Boriack-Sjodin PA, 2016, BIOCHEMISTRY-US, V55, P1557, DOI 10.1021/acs.biochem.5b01129; Deobald D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25716-x; Holliday GL, 2018, METHOD ENZYMOL, V606, P1, DOI 10.1016/bs.mie.2018.06.004; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Radler MI, 2019, J BIOL CHEM, V294, P11712, DOI 10.1074/jbc.RA119.007609; Wang B, 2019, J AM CHEM SOC, V141, P5788, DOI 10.1021/jacs.8b13157; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	8	2	2	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2019	294	31					11726	11727		10.1074/jbc.H119.009976	http://dx.doi.org/10.1074/jbc.H119.009976			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY1BY	31375551	Green Published, hybrid			2022-12-26	WOS:000486127800009
J	Chen, XM; Chen, YH; Liu, CG; Li, XJ; Liu, HY; Yin, XC; Bai, XF; Ge, M; Chen, HY; Liu, M; Du, YZ; Fan, GC; Zhang, Y				Chen, Xueming; Chen, Yuhuan; Liu, Chungguo; Li, Xiaojun; Liu, Hongyu; Yin, Xiuchen; Bai, Xiaofei; Ge, Ming; Chen, Hongyan; Liu, Ming; Du, Yuanzhao; Fan, Gencheng; Zhang, Yun			Improved one-tube RT-PCR method for simultaneous detection and genotyping of duck hepatitis A virus subtypes 1 and 3	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; MOLECULAR ANALYSIS; TYPE-1 VIRUS; ASSAY; ANTIBODIES; SEROTYPE; GOOSE; VP1	Background The cocirculation of duck hepatitis A virus subtypes 1 (DHAV-1) and 3 (DHAV-3) in ducklings has resulted in significant economic losses. Ducklings with DHAV-1 or DHAV-3 infection show similar clinical signs and gross lesions; hence, it is important to identify the viral subtypes in infected ducklings as early as possible for better clinical management. Methods and results Based on multiple 5' noncoding region (5'-NCR) sequences of DHAV-1 and DHAV-3 strain alignments, universal and type-specific primers were designed and synthesized. With three primers in one-tube reverse transcription-PCR (RT-PCR), reference DHAV-1 and DHAV-3 isolates ranging over 60 years and across many different countries were successfully amplified, indicating that the primer sequences were completely conserved. The sequence results and the sizes of amplicons from reference DHAV-1 and DHAV-3 isolates are completely correlated with their subtypes. Moreover, with this one-tube RT-PCR system, amplicon sizes from liver samples of reference DHAV-1- or DHAV-3-infected birds fit closely with their subtypes, which was determined by virus isolation and neutralization testing. No other duck-origin RNA viruses were detected. The sensitivity of viral RNA detection was 10 pg. With this system, 20% subtype 1, 45% subtype 3, and 9% coinfection of two subtypes were detected in 55 clinical samples. Conclusions and significance This novel approach could be used for rapidly typing DHAV-1 or DHAV-3 infection in routine clinical surveillance or epidemiological screening.	[Chen, Xueming; Chen, Yuhuan; Liu, Chungguo; Li, Xiaojun; Liu, Hongyu; Yin, Xiuchen; Bai, Xiaofei; Chen, Hongyan; Liu, Ming; Zhang, Yun] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China; [Chen, Yuhuan; Ge, Ming] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Du, Yuanzhao; Fan, Gencheng] YeBio Qingdao, State Key Lab Genetically Engn Vet Vaccine, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Agricultural University - China	Chen, HY; Liu, M; Zhang, Y (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China.	hychen02@126.com; liuming04@126.com; yunzhang03@yahoo.com			National Natural Science Foundation of China [31670153]; National Key Technologies R&D Program from the State Key Lab of Genetically Engineered Veterinary Vaccine [2016YFD0500100, CAAS-XTCX2016011-04-9, AGVSKL-ZD-201804]; National Key Technologies RD Program [2016YFD0500100, CAAS-XTCX2016011-04-9]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program from the State Key Lab of Genetically Engineered Veterinary Vaccine; National Key Technologies RD Program(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (31670153), National Key Technologies R&D Program (2016YFD0500100), CAAS-XTCX2016011-04-9, and AGVSKL-ZD-201804 from the State Key Lab of Genetically Engineered Veterinary Vaccine. Yun Zhang supervised and provided the funding the National Natural Science Foundation of China (31670153), National Key Technologies R&D Program (2016YFD0500100), and CAAS-XTCX2016011-04-9 and Ming Liu supervised and provided the funding AGVSKL-ZD-201804 for the study. We declared that commercial company eBio of Qingdao did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. It only provided financial support in the form of research materials. The specific roles of DYZ and CGF are articulated in the 'author contributions' section.	Chen LL, 2013, J VIROL METHODS, V192, P12, DOI 10.1016/j.jviromet.2013.04.012; Doan HT, 2006, J INFECT DEV COUNTR, V10, P988; Fu Y, 2008, VET MICROBIOL, V131, P247, DOI 10.1016/j.vetmic.2008.03.011; Hu Q, 2016, J VIROL METHODS, V236, P207, DOI 10.1016/j.jviromet.2016.07.011; Huang QX, 2012, J CLIN MICROBIOL, V50, P3318, DOI 10.1128/JCM.01080-12; HWANG J, 1969, AM J VET RES, V30, P861; Kim MC, 2007, ARCH VIROL, V152, P2059, DOI 10.1007/s00705-007-1023-0; Kim MC, 2008, AVIAN PATHOL, V37, P171, DOI 10.1080/03079450801918670; Kim MC, 2007, AVIAN DIS, V51, P540, DOI 10.1637/0005-2086(2007)51[540:DOORTC]2.0.CO;2; Kim MC, 2006, J GEN VIROL, V87, P3307, DOI 10.1099/vir.0.81804-0; Li CF, 2014, J VIROL METHODS, V196, P193, DOI 10.1016/j.jviromet.2013.11.009; Li XJ, 2017, VIRUS RES, V227, P240, DOI 10.1016/j.virusres.2016.10.018; Liu CG, 2013, VET MICROBIOL, V167, P296, DOI 10.1016/j.vetmic.2013.09.004; Liu M, 2012, J VIROL, V86, P3398, DOI 10.1128/JVI.07086-11; Liu M, 2011, VET MICROBIOL, V152, P280, DOI 10.1016/j.vetmic.2011.05.015; Liu M, 2010, J VIROL METHODS, V169, P66, DOI 10.1016/j.jviromet.2010.06.018; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saha K, 2013, J VIROL METHODS, V193, P521, DOI 10.1016/j.jviromet.2013.07.029; Shen YL, 2015, J VIROL METHODS, V225, P30, DOI 10.1016/j.jviromet.2015.08.016; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tseng CH, 2007, VIRUS RES, V126, P19, DOI 10.1016/j.virusres.2007.01.012; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Wang LY, 2008, VIRUS GENES, V37, P52, DOI 10.1007/s11262-008-0233-1; Wen XJ, 2014, POULTRY SCI, V93, P2184, DOI 10.3382/ps.2014-04024; Woolcock PR, 2003, DIS POULTRY; Wu XJ, 2017, INT J AEROSPACE ENG, V2017, P1, DOI 10.1155/2017/8107190; Wu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118041; Yang M, 2008, J VIROL METHODS, V153, P55, DOI 10.1016/j.jviromet.2008.06.012; Zhang TT, 2014, J VIROL METHODS, V208, P166, DOI 10.1016/j.jviromet.2014.07.035; Zhang Y, 2006, ARCH VIROL, V151, P1525, DOI 10.1007/s00705-006-0731-1	30	4	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219750	10.1371/journal.pone.0219750	http://dx.doi.org/10.1371/journal.pone.0219750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369566	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900016
J	Chauhan, A; Pandey, N; Desai, A; Raithatha, N; Patel, P; Choxi, Y; Kapadia, R; Khandelwal, R; Jain, N				Chauhan, Alex; Pandey, Nilesh; Desai, Ajesh; Raithatha, Nitin; Patel, Purvi; Choxi, Yesha; Kapadia, Rutul; Khandelwal, Ronak; Jain, Neeraj			Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibility	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CHLAMYDIA-TRACHOMATIS; HUMAN-PAPILLOMAVIRUS; GASTRIC-CANCER; HPV INFECTION; RISK; MUTATIONS; VARIANTS; WOMEN; CD14	Background Cervicitis is one of the major health problems amongst women caused by infection of various pathogens including Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV) as well as human papillomavirus (HPV), and persistent cervical inflammation is one of the etiologic agents of cervical cancer. Toll-like receptors (TLRs) play an important role in the recognition and subsequent elimination of these pathogens. Variations in the Toll-like receptor genes influence susceptibility to pathogens as well as disease progression independently. Methods Ten single nucleotide polymorphisms, five each of TLR4 and TLR9 genes were analyzed among 130 cervicitis patients and 150 controls either using polymerase chain reactionrestriction fragment length polymorphism or allele specific-PCR. Results T. vaginalis infection was found at the highest frequency (30.7%) as compared to C. trachomatis (1.5%), N. gonorrhoeae (2.3%) and HPV (4.6%) infections in cervicitis patients. TLR4 rs11536889 CC (age-adjusted OR, 2.469 [95% CI, 1.499 to 4.065]; p < 0.001) and TLR9 rs187084 TC (age-adjusted OR, 2.165 [95% CI, 1.267-3.699]; p = 0.005) genotypes showed the higher distribution in cervicitis patients compared to controls. In addition, TLR4 rs11536889 C allele was shown to increase the risk of cervicitis (age-adjusted OR, 1.632 [95% CI, 1.132 to 2.352]; p = 0.009) compared to controls. The TLR4 haplotype GCA (OR, 0.6 [95% CI, 0.38-0.95]; p = 0.0272) and TLR9 haplotype GTA (OR, 1.99 [95% CI, 1.14-3.48]; p = 0.014) were found to be associated with decreased and increased risk of cervicitis respectively. Conclusions TLR4 and TLR9 polymorphisms, as well as haplotypes were shown to modulate the cervicitis risk.	[Chauhan, Alex; Pandey, Nilesh; Jain, Neeraj] Charotar Univ Sci & Technol CHARUSAT, PD Patel Inst Appl Sci, Anand, Gujarat, India; [Desai, Ajesh; Choxi, Yesha; Kapadia, Rutul] GMERS Med Coll & Hosp, Dept Obstet & Gynaecol, Ahmadabad, Gujarat, India; [Raithatha, Nitin] Shree Krishna Hosp, Pramukh Swami Med Coll, Dept Obstet & Gynaecol, Karamsad, India; [Patel, Purvi; Khandelwal, Ronak] Sir Sayajirao Gen Hosp & Med Coll Baroda, Dept Obstet & Gynaecol, Vadodara, India	Charotar University of Science & Technology - Charusat; Maharaja Sayajirao University Baroda; Baroda Medical College	Jain, N (corresponding author), Charotar Univ Sci & Technol CHARUSAT, PD Patel Inst Appl Sci, Anand, Gujarat, India.	neerajjain.as@charusat.ac.in	jain, Neeraj/AAG-2577-2020; Jain, Neeraj/AAW-4264-2020; raithatha, nitin/AAW-6115-2021	jain, Neeraj/0000-0002-1415-3652; raithatha, nitin/0000-0002-2557-6298; Chauhan, Alex/0000-0001-7439-3247; Pandey, Nilesh/0000-0003-2937-3268	Charotar University of Science and Technology (CHARUSAT)	Charotar University of Science and Technology (CHARUSAT)	This work was financially supported by Charotar University of Science and Technology (CHARUSAT) which was awarded to NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsamed H, 2013, FUTURE MICROBIOL, V8, P1129, DOI 10.2217/fmb.13.80; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; Berntsson M, 2013, ACTA DERM-VENEREOL, V93, P230, DOI 10.2340/00015555-1536; Botez M, 2012, MED-SURG J, V116, P1131; Budulac SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043124; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Castle Philip E, 2004, J Low Genit Tract Dis, V8, P224, DOI 10.1097/00128360-200407000-00011; Chen YC, 2013, CANCER CAUSE CONTROL, V24, P175, DOI 10.1007/s10552-012-0103-y; Cooper David N, 2010, Hum Genomics, V4, P284; CORREA P, 1992, CANCER RES, V52, P6735; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; den Hartog JE, 2006, HUM REPROD UPDATE, V12, P719, DOI 10.1093/humupd/dml030; Dutta SK, 2017, VIROLOGY, V511, P207, DOI 10.1016/j.virol.2017.08.009; Evans MF, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-10; Fernandes JV, 2015, LINK CHRONIC INFLAMM, P1015, DOI [10.3892/ol.2015.2884, DOI 10.3892/OL.2015.2884]; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goktas EF, 2016, CAN J MICROBIOL, V62, P617, DOI 10.1139/cjm-2016-0129; Green MR, 2012, MOL CLONING LAB MANU, V1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hishida A, 2009, HELICOBACTER, V14, P47, DOI 10.1111/j.1523-5378.2009.00659.x; Hunt R, 2009, SILENT SYNONYMOUS SN; Jain N, 2005, CHEST, V128, P3999, DOI 10.1378/chest.128.6.3999; Jin Y, 2017, MAMM GENOME, V28, P213, DOI 10.1007/s00335-017-9691-x; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lai ZZ, 2013, J INT MED RES, V41, P1027, DOI 10.1177/0300060513483398; Laisk T, 2010, J REPROD IMMUNOL, V87, P74, DOI 10.1016/j.jri.2010.06.001; Lee GY, 2005, INT J GYNECOL CANCER, V15, P81, DOI 10.1111/j.1048-891x.2005.14417.x; Lee PL, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-5; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Lusk MJ, 2008, CURR OPIN INFECT DIS, V21, P49, DOI 10.1097/QCO.0b013e3282f3d988; Meena NK, 2013, J CLIN GASTROENTEROL, V47, P773, DOI 10.1097/MCG.0b013e31828a6e93; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Mirzaie-Kashani E, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.9930; Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098; Oliveira LB, 2013, J GEN VIROL, V94, P1858, DOI 10.1099/vir.0.052811-0; Pandey T, 2014, INT J ASIAN BUS INF, V5, P1, DOI 10.4018/ijabim.2014070101; PARASHARI A, 1995, APMIS, V103, P273, DOI 10.1111/j.1699-0463.1995.tb01106.x; Parida S, 2014, EUR J CANCER PREV, V23, P432, DOI 10.1097/CEJ.0000000000000023; Pellati D, 2008, EUR J OBSTET GYN R B, V140, P3, DOI 10.1016/j.ejogrb.2008.03.009; Pridmore AC, 2003, INFECT IMMUN, V71, P3901, DOI 10.1128/IAI.71.7.3901-3908.2003; Prokopakis P, 2002, ONCOL REP, V9, P129; Royse KE, 2012, J REPROD IMMUNOL, V96, P84, DOI 10.1016/j.jri.2012.08.002; Singh K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/318686; Solis AS, 2008, FRONT BIOSCI-LANDMRK, V13, P1926, DOI 10.2741/2812; Song D, 2015, ONCOL LETT, V10, P600, DOI 10.3892/ol.2015.3295; Sonnex C, 2010, INT J STD AIDS, V21, P153, DOI 10.1258/ijsa.2009.009525; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Sutherland AM, 2005, CRIT CARE MED, V33, P638, DOI [10.1097/01.CCM.0000156242.44356.C5, 10.1097/01.ccm.0000156242.44356.c5]; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Taylor BD, 2013, J INFECT DIS, V207, P940, DOI 10.1093/infdis/jis922; Taylor BD, 2012, J INFECT DIS, V205, P603, DOI 10.1093/infdis/jir822; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Triantafilou K, 2004, J VIROL, V78, P11313, DOI 10.1128/JVI.78.20.11313-11320.2004; Ujevic B, 2009, ARH HIG RADA TOKSIKO, V60, P197, DOI 10.2478/10004-1254-60-2009-1916; Verweij SP, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv107; [王旭 WANG Xu], 2009, [空军工程大学学报. 自然科学版, Journal of Air Force Engineering University. Natural Science Edition], V10, P1; Workowski KA, 2015, MMWR; Zhang Zuo-Feng, 1995, Annals of Epidemiology, V5, P325, DOI 10.1016/1047-2797(94)00101-X; Zhou L, 2011, TRANSPL INFECT DIS, V13, P250, DOI 10.1111/j.1399-3062.2010.00574.x	65	11	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220330	10.1371/journal.pone.0220330	http://dx.doi.org/10.1371/journal.pone.0220330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365550	Green Submitted, Green Published, gold			2022-12-26	WOS:000484983600037
J	Alrejaye, N; Gao, J; Hatcher, D; Oberoi, S				Alrejaye, Najla; Gao, Jonathan; Hatcher, David; Oberoi, Snehlata			Effect of maxillary expansion and protraction on the oropharyngeal airway in individuals with non-syndromic cleft palate with or without cleft lip	PLOS ONE			English	Article							PHARYNGEAL AIRWAY; NASAL AIRWAY; VOLUME	Introduction The aim of this study was to evaluate three dimensionally the effect of the combined maxillary expansion and protraction treatment on oropharyngeal airway in children with non-syndromic cleft palate with or without cleft lip (CP/L). Methods CBCT data of 18 preadolescent individuals (ages, 8.4 +/- 1.7 years) with CP/L, who underwent Phase I orthodontic maxillary expansion with protraction, were compared before and after treatment. The average length of treatment was 24.1 +/- 7.6 months. The airway volume and minimal cross-sectional area (MCA) were determined using 3DMD Vultus imaging software with cross-sectional areas calculated for each 2-mm over the entire length of the airway. A control group of 8 preadolescent individuals (ages, 8.7 +/- 2.6 years) with CP/L was used for comparison. Results There was a statistically significant increase in pharyngeal airway volume after phase I orthodontic treatment in both groups, however, there was no statistically significant change in minimal cross-sectional area in neither study nor control group. Conclusion The findings showed that maxillary expansion and protraction did not have a significant effect on increasing oropharyngeal volume and MCA in patients with CP/L.	[Alrejaye, Najla] King Abdul Aziz Med City, Dept Orthodont, Riyadh, Saudi Arabia; [Gao, Jonathan; Hatcher, David; Oberoi, Snehlata] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, Div Orthodont, San Francisco, CA 94143 USA	King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University of California System; University of California San Francisco	Oberoi, S (corresponding author), Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, Div Orthodont, San Francisco, CA 94143 USA.	sneha.oberoi@ucsf.edu						Abramson Z, 2009, J CRANIOFAC SURG, V20, P657, DOI 10.1097/SCS.0b013e318193d521; ADUSS H, 1967, ARCHIV OTOLARYNGOL, V85, P53; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Cheung T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043405; DRETTNER B, 1960, Acta Otolaryngol, V52, P131; Fastuca R, 2015, ANGLE ORTHOD, V85, P955, DOI 10.2319/072014-504.1; Fu Z, 2016, AM J ORTHOD DENTOFAC, V149, P673, DOI 10.1016/j.ajodo.2015.10.024; Gandedkar NH, 2017, CLEFT PALATE-CRAN J, V54, P509, DOI 10.1597/16-013; HAIRFIELD WM, 1988, CLEFT PALATE J, V25, P135; Karia H, 2017, AM J ORTHOD DENTOFAC, V152, P371, DOI 10.1016/j.ajodo.2016.12.026; Trindade IEK, 2010, J CRANIOFAC SURG, V21, P306, DOI 10.1097/SCS.0b013e3181cf5f5f; Mordente CM, 2016, ANGLE ORTHOD, V86, P617, DOI 10.2319/032015-174.1; Schendel SA, 2012, J ORAL MAXIL SURG, V70, P2174, DOI 10.1016/j.joms.2011.10.013; Shapira Y, 1999, ANGLE ORTHOD, V69, P523; Sheng CM, 2009, ANGLE ORTHOD, V79, P484, DOI 10.2319/062308-328.1; Starbuck JM, 2014, CLIN ANAT, V27, P999, DOI 10.1002/ca.22428; Warren D W, 1969, Cleft Palate J, V6, P134; WARREN DW, 1992, CLEFT PALATE-CRAN J, V29, P511, DOI 10.1597/1545-1569(1992)029<0511:NAIBAS>2.3.CO;2; Zhao Y, 2010, AM J ORTHOD DENTOFAC, V137, pS71, DOI 10.1016/j.ajodo.2008.08.026	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0213328	10.1371/journal.pone.0213328	http://dx.doi.org/10.1371/journal.pone.0213328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361754	Green Published, Green Submitted, gold			2022-12-26	WOS:000484981300003
J	Martinez, AC; Lima, AOD; Terol, JMM; Garcia, OJM; Rodriguez, CR; Mochon, LG; de la Nuez, PC; Fosalba, NA				Caro Martinez, Araceli; de Labry Lima, Antonio Olry; Munoz Terol, Jose Manuel; Mendoza Garcia, Oscar Javier; Remon Rodriguez, Cesar; Garcia Mochon, Leticia; Castro de la Nuez, Pablo; Areste Fosalba, Nuria			Optimal start in dialysis shows increased survival in patients with chronic kidney disease	PLOS ONE			English	Article							IMPACT; INITIATION; CARE	Objective To compare the survival among patients with chronic kidney disease who had optimal starts of renal replacement therapy, dialysis or hemodialysis, with patients who had suboptimal starts. Methods A retrospective cohort consisting of > 18 year-old patients who started renal replacement therapy, using peritoneal dialysis or hemodialysis, in any public hospital or associated center of the Andalusian Public Health System, between the 1st of January of 2006 and the 15th of March of 2017. The optimal start was defined when all the following criteria were met: a planned dialysis start, a minimum of six-month follow-up by a nephrologist, and a first dialysis method coinciding with the one registered at 90 days. The information was obtained from the registry of the Information System of the Transplant Autonomic Coordination of Andalusia. Results A total of 10,692 patients were studied. 4,377 (40.9%) of these patients died. A total of 4,937 patients (46.17%) achieved optimal starts of renal replacement therapy and showed higher survival rates (HR 0.669; 95% CI 0.628-0.712) in the multivariate analysis of Cox regression model. Conclusions Patients with an optimal start of renal replacement therapy have a greater survival than those who had a non-optimal start. Therefore, the necessary measures should be encouraged to increase the optimal start of the patient in dialysis.	[Caro Martinez, Araceli; de Labry Lima, Antonio Olry; Mendoza Garcia, Oscar Javier; Garcia Mochon, Leticia] Campus Univ Cartuja, EASP, Granada, Spain; [de Labry Lima, Antonio Olry; Garcia Mochon, Leticia] CIBERESP, Granada, Spain; [de Labry Lima, Antonio Olry; Garcia Mochon, Leticia] Univ Granada, Hosp Univ Granada, Inst Invest Biosanit Ibs, Granada, Spain; [Munoz Terol, Jose Manuel] Hosp Univ Virgen Rocio, Seville, Spain; [Remon Rodriguez, Cesar] Hosp Univ Puerto Real, Cadiz, Spain; [Castro de la Nuez, Pablo] CATA, Seville, Spain; [Areste Fosalba, Nuria] Hosp Univ Virgen Macarena, Seville, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Virgen del Rocio University Hospital; Universidad de Cadiz; Hospital Universitario Puerto Real; Hospital Universitario Virgen Macarena	Lima, AOD (corresponding author), Campus Univ Cartuja, EASP, Granada, Spain.; Lima, AOD (corresponding author), CIBERESP, Granada, Spain.; Lima, AOD (corresponding author), Univ Granada, Hosp Univ Granada, Inst Invest Biosanit Ibs, Granada, Spain.	antonio.olrylabry.easp@juntadeandalcia.es	Olry, Antonio/AAR-7602-2020; Areste-Fosalba, Nuria/ABH-7097-2020; Garcia, Leticia/AGV-7679-2022	Remon-Rodriguez, Cesar/0000-0001-8232-6060; ARESTE-FOSALBA, NURIA/0000-0003-3107-2253; Olry de Labry Lima, Antonio/0000-0001-5448-1370				Alcazar R, 2008, NEFROLOGIA, V28, P273; Brown PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130080; Buck J, 2007, NEPHROL DIAL TRANSPL, V22, P3240, DOI 10.1093/ndt/gfm387; Castro de la Nuez P, 2016, SISTEMA INFORM COORD; Coentrao L, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-88; Couchoud C, 2007, NEPHROL DIAL TRANSPL, V22, P3246, DOI 10.1093/ndt/gfm400; Curtis BM, 2005, NEPHROL DIAL TRANSPL, V20, P147, DOI 10.1093/ndt/gfh585; Escobar EM, 2016, NEFROLOGIA, V36, P97, DOI 10.1016/j.nefro.2015.10.020; Gorriz JL, 2002, NEFROLOGIA, V22, P49; Henry SL, 2017, J RENAL CARE, V43, P143, DOI 10.1111/jorc.12202; Kessler M, 2003, AM J KIDNEY DIS, V42, P474, DOI 10.1016/S0272-6386(03)00805-9; Liu FX, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000293; Lopez-Vargas PA, 2016, AM J KIDNEY DIS, V68, P353, DOI 10.1053/j.ajkd.2016.01.022; Lorenzo-Sellares V, 2014, NEFROLOGIA, V34, P458, DOI 10.3265/Nefrologia.pre2014.Apr.12501; Machowska A, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-016-0419-z; Machowska A, 2016, PATIENT PREFER ADHER, V10, P2229, DOI 10.2147/PPA.S119243; Marron B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155987; Marron B, 2006, NEPHROL DIAL TRANSPL, V21, DOI 10.1093/ndt/gfl191; Mendelssohn DC, 2011, NEPHROL DIAL TRANSPL, V26, P2959, DOI 10.1093/ndt/gfq843; Mendelssohn DC, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-22; Mendelssohn DC, 2002, PERITON DIALYSIS INT, V22, P5; Metcalfe W, 2003, QJM-INT J MED, V96, P899, DOI 10.1093/qjmed/hcg155; Prieto-Velasco M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138811; Roca-Tey R, 2016, J VASC ACCESS, V17, P20, DOI 10.5301/jva.5000468; Seras M, 2015, SESION HEMODIALISIS, V5, P448	25	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0219037	10.1371/journal.pone.0219037	http://dx.doi.org/10.1371/journal.pone.0219037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361758	Green Published, gold			2022-12-26	WOS:000484981300009
J	Yu, MF; Wang, JL; Yi, JM; Ma, L				Yu, Meng-Fei; Wang, Ju-Long; Yi, Jian-Ming; Ma, Lin			Sodium butyrate interrupts the maturation of oocytes and enhances the development of preimplantation embryos	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; IN-VITRO DEVELOPMENT; HISTONE ACETYLATION; GENE-EXPRESSION; CLONED EMBRYOS; BLASTOCYST PRODUCTION; H3 METHYLATION; DONOR CELLS; TRICHOSTATIN; CHROMATIN	Histone acetylation is one of the most important posttranslational modifications that contribute to transcriptional initiation and chromatin remodeling. In the present study, we aimed to investigate the effect of sodium butyrate (NaBu), a natural histone deacetylase inhibitor (HDACi), on the maturation of oocytes, preimplantation embryonic development, and expression of important developmental genes. The results indicated that NaBu decreased the rates of GVBD and the first polar body extrusion (PBE) in vitro in a dose-dependent manner. Meanwhile, NaBu treatment led to an abnormality in the spindle apparatus in oocytes in MI. However, the ratio of phosphor-extracellular signal-regulated kinases (p-ERK)/ERK significantly decreased in oocytes treated with 2.0 mM NaBu for 8 h. Furthermore, NaBu treatment at 2.0 mM improved the quality of embryos and the mRNA expression levels of important developmental genes such as HDAC1, Sox2, and Pou5f1. These data suggest that although a high concentration NaBu will impede the meiosis of oocytes, 2.0 mM NaBu will promote the development of embryos in vitro. Further investigation is needed to clarify the direct/indirect effects of NaBu on the regulation of important developmental genes and their subsequent impacts on full-term development in mammals.	[Yu, Meng-Fei] South Cent Univ Nationalities, Coll Life Sci, Hubei Prov Key Lab Protect & Applicat Special Pla, Wuhan, Hubei, Peoples R China; [Yu, Meng-Fei] South Cent Univ Nationalities, Coll Life Sci, Key Lab State Ethn Affairs Commiss Biol Technol, Wuhan, Hubei, Peoples R China; [Wang, Ju-Long; Yi, Jian-Ming] Huazhong Agr Univ, Coll Anim Sci, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Hubei, Peoples R China; [Wang, Ju-Long] Wuhu Inst Technol, Sch Biotechnol, Wuhu, Peoples R China; [Ma, Lin] Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China	South Central Minzu University; South Central Minzu University; Huazhong Agricultural University; Wuhu Institute of Technology; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Yi, JM (corresponding author), Huazhong Agr Univ, Coll Anim Sci, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Hubei, Peoples R China.; Ma, L (corresponding author), Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China.	yijm@hzau.edu.ac.cn; malin@wbgcas.cn		Ma, Lin/0000-0002-9857-5253	National Key Research and Development Program of China [2016YFD0500507]; Fundamental Research Funds for the Central Universities, South-Central University for Nationalities [CZY19020]; Open Project of Hubei Provincial Key Laboratory for Protection and Application of Special Plant Germplasm in Wuling Area of China [WLSP201903]; fund for Key laboratory Construction of Hubei Province [2018BFC360]	National Key Research and Development Program of China; Fundamental Research Funds for the Central Universities, South-Central University for Nationalities; Open Project of Hubei Provincial Key Laboratory for Protection and Application of Special Plant Germplasm in Wuling Area of China; fund for Key laboratory Construction of Hubei Province	This research was supported by National Key Research and Development Program of China (Grant No. 2016YFD0500507 to JMY), the Fundamental Research Funds for the Central Universities, South-Central University for Nationalities (Grant No. CZY19020 to MFY), the Open Project of Hubei Provincial Key Laboratory for Protection and Application of Special Plant Germplasm in Wuling Area of China (WLSP201903 to LM), and fund for Key laboratory Construction of Hubei Province (Grant No. 2018BFC360 to MFY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Joseph H, 2010, REPROD TOXICOL, V30, P566, DOI 10.1016/j.reprotox.2010.07.003; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Bui HT, 2007, REPRODUCTION, V133, P371, DOI 10.1530/REP-06-0099; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; Chang HJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191433; Costa-Borges N, 2010, CELL REPROGRAM, V12, P437, DOI 10.1089/cell.2009.0108; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Ghare SS, 2014, J IMMUNOL, V193, P412, DOI 10.4049/jimmunol.1400055; Gomez MC, 2011, CELL REPROGRAM, V13, P315, DOI 10.1089/cell.2010.0111; Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599; Han BS, 2013, EXP THER MED, V5, P1281, DOI 10.3892/etm.2013.1018; Hu MW, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006513; Jafarpour F, 2011, CELL REPROGRAM, V13, P483, DOI 10.1089/cell.2011.0005; Kim JM, 2003, J CELL BIOL, V162, P37, DOI 10.1083/jcb.200303047; KOSHIHARA Y, 1981, BIOCHIM BIOPHYS ACTA, V664, P278; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krapivinsky G, 2017, P NATL ACAD SCI USA, V114, pE7092, DOI 10.1073/pnas.1708427114; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Li R, 2006, BIOL REPROD, V75, P226, DOI 10.1095/biolreprod.106.052514; Liu LM, 2012, CELL BIOL INT, V36, P483, DOI 10.1042/CBI20110220; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; McManus KJ, 2006, BIOCHEM CELL BIOL, V84, P640, DOI 10.1139/O06-086; Osada T, 2013, BIOCHEM BIOPH RES CO, V434, P15, DOI 10.1016/j.bbrc.2013.03.074; Qin Zu-Xing, 2012, Yichuan, V34, P342, DOI 10.3724/SP.J.1005.2012.00342; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Shi LH, 2008, DEV DYNAM, V237, P640, DOI 10.1002/dvdy.21450; Shi W, 2003, BIOL REPROD, V69, P301, DOI 10.1095/biolreprod.102.012112; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun L, 2009, J BIOL CHEM, V284, P20184, DOI 10.1074/jbc.M109.004515; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tsuji Y, 2009, ZYGOTE, V17, P109, DOI 10.1017/S0967199408005133; Velker BAM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096602; Wang Q, 2006, CELL CYCLE, V5, P766, DOI 10.4161/cc.5.7.2627; Wen NN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206224; Wittayarat M, 2017, ANIM SCI J, V88, P593, DOI 10.1111/asj.12676; Wu X, 2008, ANIM BIOTECHNOL, V19, P211, DOI 10.1080/10495390802271482; Xiong XR, 2015, ZYGOTE, V23, P19, DOI 10.1017/S0967199413000245; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Yu MF, 2018, J S CENTRAL U NATION, V37, P24; Zhang HL, 2014, CELL REPROGRAM, V16, P54, DOI 10.1089/cell.2013.0027; Zhang T, 2017, DEVELOPMENT, V144, P305, DOI 10.1242/dev.141135; Zhang YH, 2007, CLONING STEM CELLS, V9, P357, DOI 10.1089/clo.2006.0090; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220479	10.1371/journal.pone.0220479	http://dx.doi.org/10.1371/journal.pone.0220479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356635	Green Submitted, Green Published, gold			2022-12-26	WOS:000484047000035
J	Malhotra, S; Kant, S; Ahamed, F; Rath, R; Kalaivani, M; Gupta, SK; Ramadass, S; Pathak, VK; Jaiswal, A; Parthasarath, R; Acharya, BP; Dwarakanathan, V				Malhotra, Sumit; Kant, Shashi; Ahamed, Farhad; Rath, Ramashankar; Kalaivani, Mani; Gupta, Sanjeev Kumar; Ramadass, S.; Pathak, Vineet Kumar; Jaiswal, Abhishek; Parthasarath, Raghavan; Acharya, Bhabani Prasad; Dwarakanathan, Vignesh			Health behaviors, outcomes and their relationships among young men aged 18-24 years in a rural area of north India: A cross-sectional study	PLOS ONE			English	Article							COLLEGE-STUDENTS; SUBSTANCE USE; PREVALENCE; INJURIES; SURVEILLANCE; ADOLESCENTS; DISTRICT; YOUTH; SEX	Background There is limited information related to health behaviors and their related factors among young men in rural setting of India. This study was conducted to investigate multiple health risk behaviors and outcomes among young men aged 18-24 years in rural India. Methods This was a community-based cross-sectional survey conducted in the Ballabgarh block of Faridabad district, Haryana, India. Information regarding socio-demographic details, substance use, injury & violence, mental health and sexual behaviors were collected using a semi-structured interview schedule. Age adjusted prevalence estimates of behaviors and outcomes are computed along with 95% Confidence Intervals. Mediation analysis was carried out to examine relationships between socio-demographic variables, select behaviors and outcomes reported in the study. Results A total of 836 young men participated in the study, with mean (SD) age of 20.6 (1.9) years. The age-adjusted prevalence (with 95% Confidence Interval) for ever use of tobacco, alcohol, and other substances was 34.2% (33.9, 34.5), 23.4% (23.2, 23.6), and 4.5% (4.4, 4.5), respectively. Loneliness and suicidal thoughts were reported by 237 and 35 youth men with age adjusted prevalence as 28.6%, 95% CI: 28.4-28.8 and 4.3%, 95% CI: 4.23-4.31, respectively. A total of 330 young men met serious injury in past one year (prevalence 39.3%, 95% CI: 39.01-39.67). Almost one-third of men (prevalence 30.6%, 95% CI: 30.34-30.85) had engaged in pre-marital sexual intercourse. Current substance use was found to be significant mediator for associations with socio-demographic variables studied for dependent variables viz. pre-marital sexual intercourse and serious injury. Conclusion High prevalence of various risk behaviors and outcomes was found in young men aged 18-24 years in our rural setting. It is imperative that multi-component health intervention package be rolled out to address these.	[Malhotra, Sumit; Kant, Shashi; Ahamed, Farhad; Rath, Ramashankar; Gupta, Sanjeev Kumar; Ramadass, S.; Pathak, Vineet Kumar; Jaiswal, Abhishek; Parthasarath, Raghavan; Acharya, Bhabani Prasad; Dwarakanathan, Vignesh] All India Inst Med Sci, Ctr Community Med, New Delhi, India; [Kalaivani, Mani] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Malhotra, S (corresponding author), All India Inst Med Sci, Ctr Community Med, New Delhi, India.	drsumitaiims2012@gmail.com	Rath, Rama Shankar/ABG-3695-2020; Jaiswal, Abhishek/AAF-9126-2021; Sathiyamoorthy, Ramadass/AAA-3735-2022	Jaiswal, Abhishek/0000-0002-1289-5425; Sathiyamoorthy, Ramadass/0000-0002-9528-5787; Gupta, Sanjeev/0000-0002-2014-5333; Parthasarathy, Raghavan/0000-0001-6173-2238; Pathak, Vineet Kumar/0000-0003-2788-8399; Malhotra, Sumit/0000-0002-4979-5700	All India Institute of Medical Sciences, New Delhi [A-502]	All India Institute of Medical Sciences, New Delhi	The project was funded as intramural project by All India Institute of Medical Sciences, New Delhi, which was awarded to Dr. Sumit Malhotra, Project Grant No: A-502; All authors received their salary from All India Institute of Medical Sciences, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2007, INT FAM PLAN PERSPEC, V33, P150, DOI 10.1363/ifpp.33.150.07; [Anonymous], 2015, LANCET, V386, P2227, DOI 10.1016/S0140-6736(15)01160-5; [Anonymous], 2015, DISTRICT FACT SHEET; [Anonymous], 2017, YOUTH IND; [Anonymous], 2015, STAT FACT SHEET; [Anonymous], 2017, NIMHANS PUBLICATION, V128; [Anonymous], 2018, ROAD TRAFF ACC; BASS JL, 1985, PEDIATR CLIN N AM, V32, P31; Bhattarai D, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0137-2; Centers for Disease Control and Prevention, 2017, AD SCH HLTH YOUTH RI; Chiao C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-527; Coleman LM, 2005, ARCH SEX BEHAV, V34, P649, DOI 10.1007/s10508-005-7917-6; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Dariotis JK, 2015, EXP CLIN PSYCHOPHARM, V23, P49, DOI 10.1037/a0038399; Dave Viral R, 2013, Int J High Risk Behav Addict, V2, P112, DOI 10.5812/ijhrba.11855; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Gupta S, 2013, J CLIN DIAGN RES, V7, P1632, DOI 10.7860/JCDR/2013/6441.3215; Gururaj G., NIMHANS PUBLICATION, V129; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; International Institute for Population Sciences (IIPS) and Population Council, 2010, YOUTH IND SIT NEEDS; Kant S, 2013, INT J EPIDEMIOL, V42, P758, DOI 10.1093/ije/dyt055; Khadr SN, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011961; Khosla V, 2008, INDIAN J MED RES, V128, P79; Kumar GA, 2011, AIDS BEHAV, V15, P228, DOI 10.1007/s10461-010-9757-1; Lakshmi P V M, 2016, Inj Epidemiol, V3, P24; Ministry of Health gender elderly and children., 2018, UN REP TANZ NAT AD H; Ministry of Youth Affairs and Sports Government of India, 2014, NAT YOUTH POL; Mohanan Padma, 2014, Sultan Qaboos Univ Med J, V14, pe104; Mushtaq R., 2014, J CLIN DIAGNOSTIC RE, V8, P1, DOI DOI 10.7860/JCDR/2014/10077.4828; Noroozi Mahnaz, 2014, Iran J Nurs Midwifery Res, V19, P424; Parashar S, 2007, FACT SHEET; Patel V, 2001, NATL MED J INDIA, V14, P263; Sharma Rahul, 2008, Indian J Community Med, V33, P85, DOI 10.4103/0970-0218.40874; Sharma Rahul, 2008, Indian J Psychiatry, V50, P30, DOI 10.4103/0019-5545.39756; Singh A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114073; Spirito A, 2000, AM J DRUG ALCOHOL AB, V26, P113, DOI 10.1081/ADA-100100594; Spring B, 2012, J PUBLIC HEALTH-UK, V34, pI3, DOI 10.1093/pubmed/fdr111; Stickley A, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0829-2; Sunitha S, 2014, INDIAN J MED RES, V140, P185; Tamura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039527; UNOSSC, 2017, S S ACT CIT FRIENDL; Vaishya R, 2017, INDIAN J ORTHOP, V51, P485, DOI 10.4103/ortho.IJOrtho_431_17; WHO, 2018, AD HLTH RISKS SOL; World Health Organization, 2013, NONC DIS THEIR RISK; World Health Organization, 2014, WHO HLTH TOP SUBST A	45	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220285	10.1371/journal.pone.0220285	http://dx.doi.org/10.1371/journal.pone.0220285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WC	31348808	Green Published, Green Submitted, gold			2022-12-26	WOS:000484979500025
J	Straub, D; Elferink, RPJO; Jansen, PLM; Bergman, JJGHM; Parikh, K; Krishnadath, KK				Straub, Danielle; Elferink, Ronald P. J. Oude; Jansen, Peter L. M.; Bergman, Jacques J. G. H. M.; Parikh, Kaushal; Krishnadath, Kausilia K.			Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model	PLOS ONE			English	Article							ESOPHAGEAL SUBMUCOSAL GLANDS; BARRETTS-ESOPHAGUS; STEM-CELLS; GASTROESOPHAGEAL-REFLUX; SMALL-INTESTINE; EPITHELIUM; IDENTIFICATION; REGENERATION; EXPRESSION; PROGENITOR	Bile acid reflux is known to be associated with the development of Barrett's esophagus and esophageal adenocarcinoma (EAC), yet the role of specific bile acids and the mechanism behind the metaplastic changes is unclear. Here, we demonstrate that multi-layered glandular structures at the squamo-columnar junction in mice contain multiple cell lineages, which resemble the human esophageal submucosal gland ducts. Exposing mice to patient's refluxates induced expansion of multi-layered glandular structures and development of columnar metaplasia at the squamo-columnar junction. The glycine conjugated bile acids induced an intestinal type of metaplasia more typical for Barrett's esophagus. Through lineage tracing, we excluded the involvement of K5(+), DCLK1(+), and LGR5(+) progenitor cells as the primary source in the development of the glandular metaplastic epithelium. We show that the mechanism behind development of metaplasia involves crypt fission and may be independent of stem cell proliferation. Our findings support the hypothesis that in humans, BE arises from non-squamous cells residing in submucosal gland ducts and that induction of intestinal type of metaplasia is most effectively induced by glycine-conjugated bile acids. These novel insights may lead to more effective strategies to prevent development of Barrett's esophagus and esophageal adenocarcinoma.	[Straub, Danielle; Krishnadath, Kausilia K.] Acad Med Ctr, CEMM, Amsterdam, Netherlands; [Elferink, Ronald P. J. Oude] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Jansen, Peter L. M.] Acad Med Ctr, Dept Gastrointestinal & Liver Dis, Amsterdam, Netherlands; [Bergman, Jacques J. G. H. M.; Krishnadath, Kausilia K.] Acad Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands; [Parikh, Kaushal] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford	Krishnadath, KK (corresponding author), Acad Med Ctr, CEMM, Amsterdam, Netherlands.; Krishnadath, KK (corresponding author), Acad Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands.	k.k.krishnadath@amc.uva.nl	Bergman, Jacques/AAS-2500-2021	Bergman, Jacques/0000-0001-7548-6955; Parikh, Kaushal/0000-0002-3247-3676	 [ERC-2011-StG-282079];  [ERC-2016-POC-737612];  [KWF4745]	; ; 	This work was supported by ERC-2011-StG-282079, received by KK, DS and KP; ERC-2016-POC-737612, received by KK, DS and KWF4745, received by KK and DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AM, 2014, CELL REP, V8, P940, DOI 10.1016/j.celrep.2014.07.019; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Biddleston LR, 1998, AM J SURG PATHOL, V22, P239, DOI 10.1097/00000478-199802000-00013; BREMNER CG, 1970, SURGERY, V68, P209; Bus P, 2012, CELL ONCOL, V35, P149, DOI 10.1007/s13402-012-0076-6; CAREY MC, 1984, HEPATOLOGY, V4, pS66, DOI 10.1002/hep.1840040812; Chen XX, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-1; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Clemons NJ, 2012, AM J PHYSIOL-GASTR L, V303, pG1335, DOI 10.1152/ajpgi.00291.2012; Coad RA, 2005, J PATHOL, V206, P388, DOI 10.1002/path.1804; DeMars CJ, 2011, GASTROENTEROLOGY, V140, pS75; Fitzgerald RC, 2002, GUT, V51, P316, DOI 10.1136/gut.51.3.316; Fujimitsu Y, 1996, JPN J CANCER RES, V87, P1199, DOI 10.1111/j.1349-7006.1996.tb03133.x; Garman KS, 2017, CELL MOL GASTROENTER, V4, P153, DOI 10.1016/j.jcmgh.2017.01.016; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Hu Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169691; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Iber D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130088; Jang BG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127300; Jankowski JAZ, 2018, LANCET, V392, P400, DOI 10.1016/S0140-6736(18)31388-6; Jiang M, 2017, NATURE, V550, P529, DOI 10.1038/nature24269; KAUER WKH, 1995, ANN SURG, V222, P525; Kruger L, 2017, AM J PHYSIOL-GASTR L, V313, pG180, DOI 10.1152/ajpgi.00036.2017; Kunne C, 2013, HEPATOLOGY, V57, P1509, DOI 10.1002/hep.26133; Langlands AJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002491; Leedham SJ, 2008, GUT, V57, P1041, DOI 10.1136/gut.2007.143339; Liang CC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-2; Long JD, 1999, AM J GASTROENTEROL, V94, P2818, DOI 10.1111/j.1572-0241.1999.1422_b.x; Macke RA, 2011, ANN NY ACAD SCI, V1232, P392, DOI 10.1111/j.1749-6632.2011.06061.x; Mari L, 2014, CELL REP, V7, P1197, DOI 10.1016/j.celrep.2014.03.074; Mason RJ, 1999, HEPATO-GASTROENTEROL, V46, P48; McDonald SAC, 2015, CELL MOL GASTROENTER, V1, P41, DOI 10.1016/j.jcmgh.2014.10.001; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Milano F, 2007, GASTROENTEROLOGY, V132, P2412, DOI 10.1053/j.gastro.2007.03.026; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Nehra D, 1999, GUT, V44, P598, DOI 10.1136/gut.44.5.598; Prunier C, 2019, TRENDS CANCER, V5, P66, DOI 10.1016/j.trecan.2018.10.010; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x; SCHIFF ER, 1972, J CLIN INVEST, V51, P1351, DOI 10.1172/JCI106931; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; STEIN HJ, 1994, AM J SURG, V167, P163, DOI 10.1016/0002-9610(94)90068-X; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108; Van Klinken BJW, 1999, AM J PHYSIOL-GASTR L, V276, pG115, DOI 10.1152/ajpgi.1999.276.1.G115; Vega KJ, 2012, J GASTROEN HEPATOL, V27, P773, DOI 10.1111/j.1440-1746.2011.06928.x; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Willet SG, 2018, EMBO J, V37, DOI 10.15252/embj.201798311; Zhou G, 2009, SCAND J GASTROENTERO, V44, P926, DOI 10.1080/00365520902998661	51	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220050	10.1371/journal.pone.0220050	http://dx.doi.org/10.1371/journal.pone.0220050			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348796	Green Submitted, gold, Green Published			2022-12-26	WOS:000484979500018
J	Poveda-Martinez, D; Aguirre, MB; Logarzo, G; Calderon, L; de la Colina, A; Hight, S; Triapitsyn, S; Diaz-Soltero, H; Hasson, E				Poveda-Martinez, Daniel; Aguirre, Maria Belen; Logarzo, Guillermo; Calderon, Luciano; de la Colina, Alicia; Hight, Stephen; Triapitsyn, Serguei; Diaz-Soltero, Hilda; Hasson, Esteban			Untangling the Hypogeococcus pungens species complex (Hemiptera: Pseudococcidae) for Argentina, Australia, and Puerto Rico based on host plant associations and genetic evidence	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; BEMISIA-TABACI; MOLECULAR PHYLOGENY; MITOCHONDRIAL; HOMOPTERA; COCCOIDEA; APHIDIDAE; MEALYBUGS; NUCLEAR; DIFFERENTIATION	Hypogeococcus pungens, a mealybug native of southern South America, is devastating native cacti in Puerto Rico and threatening cactus diversity in the Caribbean, and potentially in Central and North America. The taxonomic status of H. pungens is controversial since it has been reported feeding not only on Cactaceae but also on other plant families throughout its distribution range. However, in Australia, where the species had been exported from Argentina to control weedy American cacti, it was never found on host plants other than Cactaceae. These conflicting pieces of evidence not only cast doubt on the species identity that invaded Puerto Rico, but also have a negative impact on the search for natural enemies to be used in biological control programs against this pest. Here we present reproductive incompatibility and phylogenetic evidences that give support to the hypothesis that H. pungens is a species complex in which divergence appears to be driven by the host plants. The nuclear EF1 alpha and 18S and the mitochondrial COI genes were used as markers to evaluate the phylogenetic relationships among H. pungens populations collected in Argentina, Australia and Puerto Rico feeding on Cactaceae and/or Amaranthaceae. Additionally, we conducted reciprocal crosses between mealybugs from both hosts. Species delimitation analysis revealed two well-supported putative species within H. pungens, one including mealybugs feeding on Amaranthaceae (H. pungens sensu stricto), and a new undescribed species using Cactaceae as hosts. Additionally, we found asymmetric reproductive incompatibility between these putative species suggesting recent reproductive isolation. The Bayesian species delimitation also suggested that the Australian mealybug population may derive from another undescribed species. Overall, the patterns of genetic differentiation may be interpreted as the result of recent speciation events prompted by host plant shifts. Finally, the finding of a single haplotype in the Puerto Rico population suggests only one invasive event. We still need to identify the geographical origin of the pest in order to enable the use of biological control to reduce the threat to cacti diversity in the Caribbean.	[Poveda-Martinez, Daniel; Aguirre, Maria Belen; Logarzo, Guillermo; Calderon, Luciano] Fdn Estudio Especies Invasivas FuEDEI, Hurlingham, Buenos Aires, Argentina; [Poveda-Martinez, Daniel; de la Colina, Alicia; Hasson, Esteban] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IEGEBA, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Poveda-Martinez, Daniel; Aguirre, Maria Belen; Calderon, Luciano; de la Colina, Alicia; Hasson, Esteban] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Poveda-Martinez, Daniel] Univ Quindio, Grp Invest Evoluc Ecol & Conservac EECO, Armenia, Armenia; [Hight, Stephen] USDA ARS, Tallahassee, FL USA; [Triapitsyn, Serguei] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Diaz-Soltero, Hilda] USDA, San Juan, PR USA; [Calderon, Luciano] IBAM, Mendoza, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); United States Department of Agriculture (USDA); University of California System; University of California Riverside; United States Department of Agriculture (USDA)	Poveda-Martinez, D; Aguirre, MB (corresponding author), Fdn Estudio Especies Invasivas FuEDEI, Hurlingham, Buenos Aires, Argentina.; Poveda-Martinez, D (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, IEGEBA, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina.; Poveda-Martinez, D; Aguirre, MB (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Poveda-Martinez, D (corresponding author), Univ Quindio, Grp Invest Evoluc Ecol & Conservac EECO, Armenia, Armenia.	danielpovedam@gmail.com; mbaguirre@conicet.gov.ar	Calderon, Luciano/O-7470-2014; Poveda Martínez, Daniel/HGU-5174-2022; Hight, Stephen/AAT-2763-2020	Aguirre, Maria/0000-0002-3773-8805; Hight, Stephen/0000-0003-0832-394X; de la Colina, Maria Alicia/0000-0003-4564-2229; Poveda-Martinez, Daniel/0000-0003-3657-8421	USDAAPHIS Invasive Species Coordination Program 2014 to 2016 [APH-HQ-16-0181]; USDAAPHIS Farm Bill [17: 6.0385.01]	USDAAPHIS Invasive Species Coordination Program 2014 to 2016; USDAAPHIS Farm Bill	This study was supported by the USDAAPHIS Invasive Species Coordination Program from 2014 to 2016 (APH-HQ-16-0181), and USDAAPHIS Farm Bill funding for fiscal year 2017 (Farm Bill FY 17: 6.0385.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre MB, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew043; Barbosa LD, 2014, PEST MANAG SCI, V70, P1440, DOI 10.1002/ps.3731; Ben-Dov Y., 1994, SYSTEMATIC CATALOGUE; Bouckaert R, DENSITREE; Brady Sean G., 2000, P131; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Chu D, 2008, INSECT SCI, V15, P115, DOI 10.1111/j.1744-7917.2008.00191.x; Claps LE, 2001, J PROF ASSOC CACTUS, V4, P77; Coeur d'Acier A, 2008, ZOOL SCR, V37, P175, DOI 10.1111/j.1463-6409.2007.00317.x; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Daane KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193852; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dorchin N, 2015, ZOOL J LINN SOC-LOND, V174, P265, DOI 10.1111/zoj.12234; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ebel ER, 2015, MOL ECOL, V24, P2392, DOI 10.1111/mec.13168; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Forbes AA, 2017, EVOLUTION, V71, P1126, DOI 10.1111/evo.13164; Funk DJ, 2011, MOL ECOL, V20, P4671, DOI 10.1111/j.1365-294X.2011.05311.x; German-Ramirez E, 2014, FLA ENTOMOL, V97, P320, DOI 10.1653/024.097.0151; Gibbs J., 2018, EUR J TAXON; Granara de Willink M.C., 1981, NEOTROPICA, V27, P61; Halbert S., 1996, TRIOLOGY, V35, P2; Hamon AB, 1984, ENTOMOLOGY CIRCULAR, P263; Hasson E, 2019, J HERED, V110, P46, DOI 10.1093/jhered/esy043; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hernandez-Vera G, 2010, MOL ECOL, V19, P2286, DOI 10.1111/j.1365-294X.2010.04639.x; Hodges A., 2009, HYPOGEOCOCCUS PUNGEN; Hoelmer KA, 2005, BIOL CONTROL, V34, P255, DOI 10.1016/j.biocontrol.2005.05.001; HOSKING J R, 1988, Plant Protection Quarterly, V3, P115; Julien MH, 1999, BIOL CONTROL WEEDS W; Kapli P, 2017, BIOINFORMATICS, V33, P1630, DOI 10.1093/bioinformatics/btx025; Kim H, 2008, MOL CELL, V25; Klein H, 1999, AFR ENTOMOL, P3; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lavinia PD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186845; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Lee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063817; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Matsubayashi KW, 2011, J EVOLUTION BIOL, V24, P1421, DOI 10.1111/j.1420-9101.2011.02274.x; Matsubayashi KW, 2013, BIOL J LINN SOC, V110, P606, DOI 10.1111/bij.12150; Mazzeo  G, 2008, P 11 INT S SCAL INS, P149; McFadyen R. E., 1981, Proceedings of the 5th International Symposium on Biological Control of Weeds., P589; McFadyen R. E., 1978, Council of Australian Weed Science Societies; Australia, Council of Australian Weed Science Societies: Proceedings of the first conference of the Council of Australian Weed Science Societies held at National Science Centre, Parkville, Victoria 12-14 April 1978., P108; McFadyen RC, 2012, BIOLOGICAL CONTROL OF WEEDS IN AUSTRALIA, P274; MCFADYEN RE, 1979, ENTOMOPHAGA, V24, P281, DOI 10.1007/BF02374242; McFadyen REC, 1998, ANNU REV ENTOMOL, V43, P369, DOI 10.1146/annurev.ento.43.1.369; Miller M.A., 2010, P GAT COMP ENV WORKS; MORAN VC, 1991, AGR ECOSYST ENVIRON, V37, P37, DOI 10.1016/0167-8809(91)90138-N; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ramirez CP, 2018, BIOL J LINN SOC, V123, P712; Richards NK, 2017, PEST MANAG SCI, V73, P2334, DOI 10.1002/ps.4620; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rung A, 2008, ANN ENTOMOL SOC AM, V101, P525, DOI 10.1603/0013-8746(2008)101[525:MIOTCR]2.0.CO;2; Rung A, 2009, J ECON ENTOMOL, V102, P8, DOI 10.1603/029.102.0102; Segarra-Carmona AE, 2010, J AGR U PUERTO RICO, V94, P183; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Soto A, PHYTOPARASITICA; Soudi S, 2016, EVOLUTION, V70, P471, DOI 10.1111/evo.12846; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SUSS L, 1986, INFORMATORE FITOPATO, V10, P43; Tomley A. J., 1984, P 6 INT S BIOL CONTR, P843; Triapitsyn SV, 2018, FLA ENTOMOL, V101, P411, DOI 10.1653/024.101.0320; VONDOHLEN CD, 1995, J MOL EVOL, V41, P211, DOI 10.1007/BF00170675; Wang XB, 2016, ANN ENTOMOL SOC AM, V109, P438, DOI 10.1093/aesa/saw009; Williams D., 1992, MEALYBUGS CENTRAL S; WILLIAMS DJ, 1973, B ENTOMOL RES, V62, P565, DOI 10.1017/S0007485300005460; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xue HJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05436; Yo June Lee, 2010, SYST ENTOMOL, V35, P277; Yu GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16309-1; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zimmermann H. G., 2010, Cactaceas y Suculentas Mexicanas, V55, P4; Zimmermann H. G., 2010, Cactus and Succulent Journal, V82, P105, DOI 10.2985/015.082.0303	79	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220366	10.1371/journal.pone.0220366	http://dx.doi.org/10.1371/journal.pone.0220366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344099	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900092
J	Furigo, IC; de Souza, GO; Teixeira, PDS; Guadagnini, D; Frazao, R; List, EO; Kopchick, JJ; Prada, PO; Donato, J				Furigo, Isadora C.; de Souza, Gabriel O.; Teixeira, Pryscila D. S.; Guadagnini, Dioze; Frazao, Renata; List, Edward O.; Kopchick, John J.; Prada, Patricia O.; Donato, Jose, Jr.			Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons	FASEB JOURNAL			English	Article						autonomic nervous system; counter-regulatory response; cytokine; GH; hypothalamus	ACTIVATED PROTEIN-KINASE; HEPATIC GLUCOSE-PRODUCTION; FEEDING RESPONSES; SENSING NEURONS; RECEPTOR GHR; LEPTIN; CELLS; BRAIN; REVEALS; LESIONS	Growth hormone (GH) is secreted during hypoglycemia, and GH-responsive neurons are found in brain areas containing glucose-sensing neurons that regulate the counter-regulatory response (CRR). However, whether GH modulates the CRR to hypoglycemia via specific neuronal populations is currently unknown. Mice carrying ablation of GH receptor (GHR) either in leptin receptor (LepR)- or steroidogenic factor-1 (SF1)-expressing cells were studied. We also investigated the importance of signal transducer and activator of transcription 5 (STAT5) signaling in SF1 cells for the CRR. GHR ablation in LepR cells led to impaired capacity to recover from insulin-induced hypoglycemia and to a blunted CRR caused by 2-deoxy-D-glucose (2DG) administration. GHR inactivation in SF1 cells, which include ventromedial hypothalamic neurons, also attenuated the CRR. The reduced CRR was prevented by parasympathetic blockers. Additionally, infusion of 2DG produced an abnormal hyperactivity of parasympathetic preganglionic neurons, whereas the 2DG-induced activation of anterior bed nucleus of the stria terminalis neurons was reduced in mice without GHR in SF1 cells. Mice carrying ablation of Stat5 a/b genes in SF1 cells showed no defects in the CRR. In summary, GHR expression in SF1 cells is required for a normal CRR, and these effects are largely independent of STAT5 pathway.	[Furigo, Isadora C.; de Souza, Gabriel O.; Teixeira, Pryscila D. S.; Donato, Jose, Jr.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Av Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, Brazil; [Frazao, Renata] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Guadagnini, Dioze; Prada, Patricia O.] Univ Estadual Campinas, Sch Appl Sci, Limeira, Brazil; [List, Edward O.; Kopchick, John J.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA; [List, Edward O.; Kopchick, John J.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Donato, J (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Av Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, Brazil.	jdonato@icb.usp.br	Donato, Jose/ABB-3686-2020; Donato, Jose/A-9662-2010; Furigo, Isadora/G-3575-2016; Orefice de Souza, Gabriel/GVS-4178-2022; Frazao, Renata/D-1374-2012	Donato, Jose/0000-0002-4166-7608; Furigo, Isadora/0000-0002-4387-3878; Orefice de Souza, Gabriel/0000-0003-2534-542X; de Oliveira Prada, Patricia/0000-0002-4245-8867; Frazao, Renata/0000-0002-0877-8453	Sao Paulo Research Foundation (FAPESP) [17/02983-2, 16/09679-4, 17/18498-6, 18/20087-7, 17/218408]; Pfizer, Inc.; U.S. National Institutes of Health, National Institute on Aging [R01AG059779]; NATIONAL INSTITUTE ON AGING [R01AG059779] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pfizer, Inc.(Pfizer); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ana Maria P. Campos (Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil) for expert technical assistance. This work was supported by the Sao Paulo Research Foundation (FAPESP; Grants 17/02983-2 to J.D.; 16/09679-4 to I.C.F.; 17/18498-6 and 18/20087-7 to P.O.P.; and 17/218408 to R.F.), Pfizer, Inc. [2017 Global Advancing Science Through Pfizer-Investigator Research Exchange (ASPIRE) Young Investigator Research Award to J.D.], and U.S. National Institutes of Health, National Institute on Aging, Grant R01AG059779 (to J.J.K. and E.O.L.). The authors declare no conflicts of interest.	BALKAN B, 1991, AM J PHYSIOL, V260, pR368, DOI 10.1152/ajpregu.1991.260.2.R368; BICK T, 1992, ENDOCRINOLOGY, V131, P423, DOI 10.1210/en.131.1.423; Buonfiglio DC, 2015, HORM BEHAV, V71, P60, DOI 10.1016/j.yhbeh.2015.04.004; Cady G, 2017, MOL METAB, V6, P393, DOI 10.1016/j.molmet.2017.03.001; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Clegg DJ, 2003, PHYSIOL BEHAV, V78, P331, DOI 10.1016/S0031-9384(02)01000-4; Coutinho EA, 2017, DIABETES, V66, P2372, DOI 10.2337/db16-1344; D'souza AM, 2017, MOL METAB, V6, P1052, DOI 10.1016/j.molmet.2017.04.011; Dehkhoda F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00035; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dong HW, 2006, J COMP NEUROL, V494, P142, DOI 10.1002/cne.20788; Faber CL, 2018, DIABETES, V67, P2518, DOI 10.2337/db18-0380; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Flak JN, 2014, NAT NEUROSCI, V17, P1744, DOI 10.1038/nn.3861; Furigo IC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09022-2; Furigo IC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08607-1; Furigo IC, 2018, BRAIN STRUCT FUNCT, V223, P2229, DOI 10.1007/s00429-018-1627-z; Furigo IC, 2017, BRAIN STRUCT FUNCT, V222, P341, DOI 10.1007/s00429-016-1221-1; Furigo IC, 2016, MOL CELL ENDOCRINOL, V438, P70, DOI 10.1016/j.mce.2016.04.019; Garfield AS, 2014, CELL METAB, V20, P1030, DOI 10.1016/j.cmet.2014.11.006; GREENWOOFC, 1966, NATURE, V210, P540, DOI DOI 10.1038/210540A0; Han SM, 2005, DIABETOLOGIA, V48, P2170, DOI 10.1007/s00125-005-1913-1; Huang LL, 2014, J NEUROSCI, V34, P16309, DOI 10.1523/JNEUROSCI.4622-13.2014; Hussain K, 2003, J CLIN ENDOCR METAB, V88, P3715, DOI 10.1210/jc.2003-030137; IKEDA H, 1980, AM J PHYSIOL, V239, pE379, DOI 10.1152/ajpendo.1980.239.5.E379; Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x; Kim KW, 2012, J CLIN INVEST, V122, P2578, DOI 10.1172/JCI62848; LAURSEN T, 1995, J CLIN ENDOCR METAB, V80, P2410, DOI 10.1210/jc.80.8.2410; Li RL, 2012, J BIOL CHEM, V287, P17942, DOI 10.1074/jbc.M112.358051; Liao ST, 2016, ENDOCRINE, V54, P169, DOI 10.1007/s12020-016-1060-0; LILJENQUIST JE, 1977, J CLIN INVEST, V59, P369, DOI 10.1172/JCI108649; Lin J, 2000, DOMEST ANIM ENDOCRIN, V19, P53, DOI 10.1016/S0739-7240(00)00064-3; Lindberg D, 2013, J COMP NEUROL, V521, P3167, DOI 10.1002/cne.23338; List EO, 2015, AGING-US, V7, P500, DOI 10.18632/aging.100766; List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086; List EO, 2013, MOL ENDOCRINOL, V27, P524, DOI 10.1210/me.2012-1330; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; McCrimmon RJ, 2004, DIABETES, V53, P1953, DOI 10.2337/diabetes.53.8.1953; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; McCrimmon RJ, 2006, DIABETES, V55, P1755, DOI 10.2337/db05-1359; Meek TH, 2016, P NATL ACAD SCI USA, V113, pE2073, DOI 10.1073/pnas.1521160113; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Mittenbuhler MJ, 2018, MOL METAB, V17, P122, DOI 10.1016/j.molmet.2018.08.010; Mizuno K, 2017, HEPATOL RES, V47, P160, DOI 10.1111/hepr.12760; Ozawa Y, 2011, PEPTIDES, V32, P763, DOI 10.1016/j.peptides.2010.12.009; Paes AMA, 2006, INT J NEUROSCI, V116, P1295, DOI 10.1080/00207450600920910; Pedroso JAB, 2017, J ENDOCRINOL, V235, P207, DOI 10.1530/JOE-17-0255; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Ramos-Lobo AM, 2017, NEUROSCIENCE, V365, P114, DOI 10.1016/j.neuroscience.2017.09.048; Ramos-Lobo Angela M, 2017, Temperature (Austin), V4, P258, DOI 10.1080/23328940.2017.1327003; RIZZA RA, 1979, J CLIN INVEST, V64, P62, DOI 10.1172/JCI109464; ROHNERJEANRENAUD F, 1983, J AUTONOM NERV SYST, V9, P173, DOI 10.1016/0165-1838(83)90139-X; ROTH J, 1963, SCIENCE, V140, P987, DOI 10.1126/science.140.3570.987; Routh VH, 2010, SENSORS-BASEL, V10, P9002, DOI 10.3390/s101009002; Rupp AC, 2018, MOL METAB, V14, P130, DOI 10.1016/j.molmet.2018.06.001; SAKAGUCHI T, 1990, INT J OBESITY, V14, P127; Sakharova AA, 2008, J CLIN ENDOCR METAB, V93, P2755, DOI 10.1210/jc.2008-0079; Seoane-Collazo P, 2015, ENDOCRINE, V50, P276, DOI 10.1007/s12020-015-0658-y; SHIMAZU T, 1966, NATURE, V210, P1178, DOI 10.1038/2101178a0; Silveira MA, 2017, MOL CELL ENDOCRINOL, V448, P55, DOI 10.1016/j.mce.2017.03.024; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Steyn FJ, 2012, ENDOCRINOLOGY, V153, P273, DOI 10.1210/en.2011-1681; Suzuki Y, 2014, DIABETES, V63, P1637, DOI 10.2337/db13-0636; SZABO AJ, 1983, AM J PHYSIOL, V244, pE467, DOI 10.1152/ajpendo.1983.244.5.E467; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tennese AA, 2011, ENDOCRINOLOGY, V152, P967, DOI 10.1210/en.2010-0709; THOMPSON CI, 1979, PHYSIOL BEHAV, V23, P187, DOI 10.1016/0031-9384(79)90142-2; Valensi P, 2003, OBES RES, V11, P54, DOI 10.1038/oby.2003.10; Verberne AJM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00038; WINKLER B, 1964, AM J PHYSIOL, V206, P174, DOI 10.1152/ajplegacy.1964.206.1.174; Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006; Zanotto T. M., 2016, MOL METAB, V6, P206; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	76	20	20	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11909	11924		10.1096/fj.201901315R	http://dx.doi.org/10.1096/fj.201901315R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366244	Bronze, Green Published			2022-12-26	WOS:000507461600026
J	Ramesh, M; Campos, JC; Lee, P; Song, Y; Hernandez, G; Sin, J; Tucker, KC; Saadaeijahromi, H; Gurney, M; Ferreira, JCB; Andres, AM				Ramesh, Mridula; Campos, Juliane C.; Lee, Pamela; Song, Yang; Hernandez, Genaro; Sin, Jon; Tucker, Kyle C.; Saadaeijahromi, Hannaneh; Gurney, Michael; Ferreira, Julio C. B.; Andres, Allen M.			Mitophagy protects against statin-mediated skeletal muscle toxicity	FASEB JOURNAL			English	Article						myopathy; simvastatin; mitochondria	FOXO TRANSCRIPTION FACTORS; MITOCHONDRIAL-FUNCTION; UBIQUITIN LIGASES; AUTOPHAGY; PARKIN; ACTIVATION; MECHANISM; PROMOTES; CELLS; DEGRADATION	The deleterious effects of statins on skeletal muscle are well known, but the mechanism associated with these effects remains unresolved. Statins are associated with mitochondrial damage, which may contribute to muscle myopathy. Here we demonstrate that simvastatin induces mitophagy in skeletal muscle cells and hypothesized that attenuating this process by silencing the mitophagy adapter p62/sequestosome-1 (SQSTM1) might mitigate myotoxicity. Surprisingly, silencing p62/SQSTM1 in differentiated C2C12 muscle cells exacerbated rather than attenuated myotoxicity. This inhibition of mitophagy in the face of statin challenge correlated with increased release of cytochrome c to the cytosol, activation of caspase-3, and lactate dehydrogenase (LDH) release. Correspondingly, targeted knockdown of Parkin, a canonical E3 ubiquitin ligase important for mitophagy, mirrored the effects of p62/SQSTM1 silencing. To corroborate these findings in vivo, we treated Parkin knockout mice with simvastatin for 2 wk. In line with our findings in vitro, these mitophagy-compromised mice displayed reduced spontaneous activity, loss of grip strength, and increased circulating levels of muscle damage marker LDH. Our findings demonstrate that mitophagy is an important mechanism to resist statin-induced skeletal muscle damage.	[Ramesh, Mridula; Lee, Pamela; Hernandez, Genaro; Gurney, Michael] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA; [Campos, Juliane C.; Song, Yang; Sin, Jon; Tucker, Kyle C.; Saadaeijahromi, Hannaneh; Andres, Allen M.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Campos, Juliane C.; Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil	California State University System; San Diego State University; Cedars Sinai Medical Center; Universidade de Sao Paulo	Andres, AM (corresponding author), Cedars Sinai Heart Inst, Adv Hlth Sci Pavil,127 South San Vicente Blvd, Los Angeles, CA 90048 USA.	allen.andres@cshs.org	Ferreira, Julio Cesar Batista/AEU-0494-2022; Ferreira, Julio Cesar Batista/I-3177-2012; Ferreira, Julio/L-4687-2019; Campos, Juliane/G-5997-2014	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Campos, Juliane/0000-0003-0075-7209; Hernandez, Genaro/0000-0003-3666-8769	American Heart Association (AHA) [15SDG23230013]; Sao Paulo Research Foundation [2016/01633-5]	American Heart Association (AHA)(American Heart Association); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by American Heart Association (AHA) Scientist Development Grant 15SDG23230013 (to A.M.A.), and a fellowship from Sao Paulo Research Foundation (2016/01633-5 to J.C.C.). The authors declare no conflicts of interest.	Andres AM, 2014, ANTIOXID REDOX SIGN, V21, P1960, DOI 10.1089/ars.2013.5416; Araki M, 2012, EUR J PHARMACOL, V674, P95, DOI 10.1016/j.ejphar.2011.10.044; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Armour Ryan, 2013, J Clin Neuromuscul Dis, V14, P103, DOI 10.1097/CND.0b013e3182852558; Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen CCW, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0157-y; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gensler S, 2001, NUCLEIC ACIDS RES, V29, P3657, DOI 10.1093/nar/29.17.3657; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gouspillou G, 2018, J PHYSIOL-LONDON, V596, P2565, DOI 10.1113/JP275604; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Hansen KE, 2005, ARCH INTERN MED, V165, P2671, DOI 10.1001/archinte.165.22.2671; Huang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022689; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McGinnis B, 2007, ANN PHARMACOTHER, V41, P1805, DOI 10.1345/aph.1K209; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Mullen PJ, 2011, BBA-MOL CELL RES, V1813, P2079, DOI 10.1016/j.bbamcr.2011.07.019; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Ogura Takeharu, 2007, Journal of Toxicological Sciences, V32, P57, DOI 10.2131/jts.32.57; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Parikh A, 2010, PROSTATE, V70, P971, DOI 10.1002/pros.21131; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Poluzzi E, 2008, EUR J CLIN PHARMACOL, V64, P425, DOI 10.1007/s00228-007-0428-8; Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sathasivam S, 2012, EUR J INTERN MED, V23, P317, DOI 10.1016/j.ejim.2012.01.004; Sebori R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9179270; Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004; Shalansky SJ, 2004, ANN PHARMACOTHER, V38, P1363, DOI 10.1345/aph.1E071; Siddals KW, 2004, J BIOL CHEM, V279, P38353, DOI 10.1074/jbc.M404838200; Sinzinger H, 2002, J CARDIOVASC PHARM, V40, P163, DOI 10.1097/00005344-200208000-00001; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tiwari A, 2006, EXPERT OPIN DRUG SAF, V5, P651, DOI 10.1517/14740338.5.5.651; Tomasetti M, 1999, BIOFACTORS, V9, P231, DOI 10.1002/biof.5520090218; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vaughan RA, 2013, EUR J PHARMACOL, V711, P1, DOI 10.1016/j.ejphar.2013.04.009; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	62	11	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11857	11869		10.1096/fj.201900807RR	http://dx.doi.org/10.1096/fj.201900807RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365836	Green Published			2022-12-26	WOS:000507461600022
J	Rosell-Garcia, T; Palomo-Alvarez, O; Rodriguez-Pascual, F				Rosell-Garcia, Tamara; Palomo-Alvarez, Oscar; Rodriguez-Pascual, Fernando			A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor?1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix (ECM); hypoxia; transforming growth factor beta (TGF-beta); fibrosis; lysyl hydroxylase; procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 (PLOD2); pulmonary fibroblast; telopeptide hydroxylation	CROSS-LINKING; LYSINE HYDROXYLATION; TISSUE DISTRIBUTION; FACTOR BETA-1; COLLAGEN; EXPRESSION; IDENTIFICATION; GENE; BINDING; LOCALIZATION	Collagens are extracellular matrix (ECM) proteins that support the structural and biomechanical integrity of many tissues. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) encodes the only lysyl hydroxylase (LH) isoform that specifically hydroxylates lysine residues in collagen telopeptides, a post-translational modification required for the formation of stabilized cross-links. PLOD2 expression is induced by hypoxia and transforming growth factor-?1 (TGF-?1), well-known stimuli for the formation of a fibrotic ECM, which can lead to pathological fibrosis underlying several diseases. Here, using human and murine fibroblasts, we studied the molecular determinants underlying hypoxia? and TGF-?1?induced PLOD2 expression and its impact on collagen biosynthesis. Deletion mapping and mutagenesis analysis identified specific binding sites for hypoxia-inducible factors (HIF) and TGF-?1?activated SMAD proteins on the human PLOD2 gene promoter that were required for these stimuli to induce PLOD2 expression. Interestingly, our experiments also revealed that HIF signaling plays a preponderant role in the SMAD pathway, as intact HIF sites were absolutely required for TGF-?1 to exert its effect on SMAD-binding sites. We also found that silencing PLOD2 expression did not alter soluble collagen accumulation in the extracellular medium, but it effectively abolished the deposition into the insoluble collagen matrix. Taken together, our findings reveal the existence of a hierarchical relationship between the HIF and SMAD signaling pathways for hypoxia? and TGF-?1?mediated regulation of PLOD2 expression, a key event in the deposition of collagen into the ECM.	[Rosell-Garcia, Tamara; Palomo-Alvarez, Oscar; Rodriguez-Pascual, Fernando] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Nicolas Cabrera 1, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rodriguez-Pascual, F (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Nicolas Cabrera 1, E-28049 Madrid, Spain.	frodriguez@cbm.csic.es	Rosell-Garcia, Tamara/E-7212-2015	Rosell-Garcia, Tamara/0000-0001-8784-2769; Rodriguez-Pascual, Fernando/0000-0002-9765-9578	Ministerio de Economia y Competitividad (Plan Nacional de I+D+I) [SAF2015-65679-R]	Ministerio de Economia y Competitividad (Plan Nacional de I+D+I)	This work was supported by grants from the Ministerio de Economia y Competitividad (Plan Nacional de I+D+I: SAF2015-65679-R) (to F. R.-P.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2018, NATURE, V562, P367, DOI DOI 10.1038/S41586-018-0590-4; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bentovim L, 2012, DEVELOPMENT, V139, P4473, DOI 10.1242/dev.083881; Busnadiego O, 2013, MOL CELL BIOL, V33, P2388, DOI 10.1128/MCB.00036-13; Chen CP, 2005, J CLIN ENDOCR METAB, V90, P1083, DOI 10.1210/jc.2004-0803; Chen YL, 2015, J CLIN INVEST, V125, P1147, DOI 10.1172/JCI74725; Devkota AK, 2019, SLAS DISCOV, V24, P484, DOI 10.1177/2472555218817057; Downes NL, 2018, MOL THER, V26, P1735, DOI 10.1016/j.ymthe.2018.05.004; Dunn LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006896; Engel J, 2011, BIOL EXTRACELL MATR, P1, DOI 10.1007/978-3-642-16555-9_1; Fratzl P., 2008, P1, DOI 10.1007/978-0-387-73906-9_1; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; Gjaltema RAF, 2015, J BIOL CHEM, V290, P28465, DOI 10.1074/jbc.M114.634311; Gonzalez-Santamaria J, 2016, CARDIOVASC RES, V109, P67, DOI 10.1093/cvr/cvv214; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Hanna C, 2013, AM J PHYSIOL-RENAL, V305, pF1323, DOI 10.1152/ajprenal.00155.2013; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; IHME A, 1984, J INVEST DERMATOL, V83, P161, DOI 10.1111/1523-1747.ep12263502; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Lee MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29311; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Mizutani A, 2011, J BIOL CHEM, V286, P29848, DOI 10.1074/jbc.M110.217745; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; Puig M, 2015, MOL CANCER RES, V13, P161, DOI 10.1158/1541-7786.MCR-14-0155; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Rosell-Garcia T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29236-6; Rosell-Garcia T, 2019, J BIOL CHEM, V294, P11087, DOI 10.1074/jbc.RA119.007806; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Schilter H, 2019, J CELL MOL MED, V23, P1759, DOI 10.1111/jcmm.14074; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; Uzawa K, 1999, J BONE MINER RES, V14, P1272, DOI 10.1359/jbmr.1999.14.8.1272; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/BSE0520113, 10.1042/bse0520113]; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	55	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14308	14318		10.1074/jbc.RA119.007674	http://dx.doi.org/10.1074/jbc.RA119.007674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31391253	hybrid, Green Published			2022-12-26	WOS:000499248200013
J	Sun, XW; Su, VL; Calderwood, DA				Sun, Xiaowen; Su, Valerie L.; Calderwood, David A.			The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine; threonine-protein kinase PAK1; serine; threonine-protein kinase PAK6; cell adhesion; Cdc42; adherens junction; cell signaling; small GTPase; cell-cell contact; intrinsically disordered region; subcellular localization	PAK ACTIVATION; CDC42; INHIBITION; MECHANISM; COMPLEX; COLOCALIZATION; ADHESIONS; EFFECTOR; PIX; RAC	p21-activated kinases (PAKs) are serine/threonine kinase effectors of the small GTPases Rac and Cdc42 and major participants in cell adhesion, motility, and survival. Type II PAKs (PAK4, -5, and -6) are recruited to cell?cell boundaries, where they regulate adhesion dynamics and colony escape. In contrast, the type I PAK, PAK1, does not localize to cell?cell contacts. We have now found that the other type I PAKs (PAK2 and PAK3) also fail to target to cell?cell junctions. PAKs contain extensive similarities in sequence and domain organization; therefore, focusing on PAK1 and PAK6, we used chimeras and truncation mutants to investigate their differences in localization. We observed that a weakly conserved sequence region (the variable region), located between the Cdc42-binding CRIB domain and the kinase domain, inhibits PAK1 targeting to cell?cell junctions. Accordingly, substitution of the PAK1 variable region with that from PAK6 or removal of this region of PAK1 resulted in its localization to cell?cell contacts. We further show that Cdc42 binding is required, but not sufficient, to direct PAKs to cell?cell contacts and that an N-terminal polybasic sequence is necessary for PAK1 recruitment to cell?cell contacts, but only if the variable region?mediated inhibition is released. We propose that all PAKs contain cell?cell boundary?targeting motifs but that the variable region prevents type I PAK accumulation at junctions. This highlights the importance of this poorly conserved, largely disordered region in PAK regulation and raises the possibility that variable region inhibition may be released by cellular signals.	[Sun, Xiaowen; Su, Valerie L.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, POB 208066,333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University	Sun, XW (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	xiaowen.sun@pfizer.com; david.calderwood@yale.edu		Su, Valerie/0000-0003-2919-0162; Calderwood, David/0000-0002-0791-4142	NINDS, National Institutes of Health (NIH) [R01NS085078]; NIGMS, NIH [R01GM068600]; NHLBI, NIH [F31HL143831]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL143831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600, T32GM007324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER	NINDS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health (NIH), Grant R01NS085078 and NIGMS, NIH, Grant R01GM068600 (to D. A. C.) and NHLBI, NIH, Grant F31HL143831 (to V. L. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Field Jeffrey, 2012, Cell Logist, V2, P54; Fram S, 2014, CELL MOL LIFE SCI, V71, P2759, DOI 10.1007/s00018-013-1528-5; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077818; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Ha BH, 2018, P NATL ACAD SCI USA, V115, P531, DOI 10.1073/pnas.1717437115; Ha BH, 2015, J BIOL CHEM, V290, P12975, DOI 10.1074/jbc.R115.650416; Ha BH, 2012, P NATL ACAD SCI USA, V109, P16107, DOI 10.1073/pnas.1214447109; Ismail AF, 2017, BIOCHEM J, V474, P1333, DOI 10.1042/BCJ20160875; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kadry YA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221184; King H, 2014, INT REV CEL MOL BIO, V309, P347, DOI 10.1016/B978-0-12-800255-1.00007-7; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Morse EM, 2016, J CELL SCI, V129, P380, DOI 10.1242/jcs.177493; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Rane Chetan K, 2014, Small GTPases, V5, DOI 10.4161/sgtp.28003; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rousseau V, 2003, J BIOL CHEM, V278, P3912, DOI 10.1074/jbc.M207251200; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Selamat W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129634; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Ye Diana Zi, 2012, Cell Logist, V2, P105; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	43	3	3	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14319	14332		10.1074/jbc.RA119.007692	http://dx.doi.org/10.1074/jbc.RA119.007692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31391252	hybrid, Green Published			2022-12-26	WOS:000499248200014
J	Spangler, JB; Moraga, I; Jude, KM; Savvides, CS; Garcia, KC				Spangler, Jamie B.; Moraga, Ignacio; Jude, Kevin M.; Savvides, Christina S.; Garcia, K. Christopher			A strategy for the selection of monovalent antibodies that span protein dimer interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; dimerization; cytokine; immunology; structural biology; directed evolution; interleukin-2; interleukin-4; ligand-receptor interactions; cell signaling	ERYTHROPOIETIN RECEPTOR; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; SURFACE DISPLAY; GROWTH-HORMONE; IL-2 RECEPTOR; T-CELL; INTERLEUKIN-2; ACTIVATION; ALPHA	Ligand-induced dimerization is the predominant mechanism through which secreted proteins activate cell surface receptors to transmit essential biological signals. Cytokines are a large class of soluble proteins that dimerize transmembrane receptors into precise signaling topologies, but there is a need for alternative, engineerable ligand scaffolds that specifically recognize and stabilize these protein interactions. Recombinant antibodies can potentially serve as robust and versatile platforms for cytokine complex stabilization, and their specificity allows for tunable modulation of dimerization equilibrium. Here, we devised an evolutionary strategy to isolate monovalent antibody fragments that bridge together two different receptor subunits in a cytokine-receptor complex, precisely as the receptors are disposed in their natural signaling orientations. To do this, we screened a naive antibody library against a stabilized ligand-receptor ternary complex that acted as a "molecular cast" of the natural receptor dimer conformation. Our selections elicited "stapler" single-chain variable fragments (scFvs) of antibodies that specifically engage the interleukin-4 receptor heterodimer. The 3.1 angstrom resolution crystal structure of one such stapler revealed that, as intended, this scFv recognizes a composite epitope between the two receptors as they are positioned in the complex. Extending our approach, we evolved a stapler scFv that specifically binds to and stabilizes the interface between the interleukin-2 cytokine and one of its receptor subunits, leading to a 15-fold enhancement in interaction affinity. This demonstration that scFvs can be selected to recognize epitopes that span protein interfaces presents new opportunities to engineer structurally defined antibodies for a broad range of research and therapeutic applications.	[Spangler, Jamie B.; Moraga, Ignacio; Jude, Kevin M.; Savvides, Christina S.; Garcia, K. Christopher] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Spangler, Jamie B.; Moraga, Ignacio; Jude, Kevin M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Spangler, Jamie B.; Moraga, Ignacio; Jude, Kevin M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Savvides, Christina S.] Stanford Univ, Sch Med, Dept Biol, Stanford, CA 94305 USA; [Spangler, Jamie B.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Spangler, Jamie B.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Johns Hopkins University; Johns Hopkins University	Spangler, JB; Garcia, KC (corresponding author), Howard Hughes Med Inst, Stanford, CA 94305 USA.	jamie.spangler@jhu.edu; kcgarcia@stanford.edu		Savvides, Christina/0000-0002-6606-1207; Spangler, Jamie/0000-0001-8187-3732; Moraga, Ignacio/0000-0001-9909-0701; Jude, Kevin/0000-0002-3675-5136	National Institutes of Health [R01 AI51321]; Mathers Fund; Ludwig Foundation; Leukemia and Lymphoma Society Career Development Program fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Fund; Ludwig Foundation; Leukemia and Lymphoma Society Career Development Program fellowship(Leukemia and Lymphoma Society)	This work was supported by National Institutes of Health Grant R01 AI51321 (to K. C. G.), the Mathers Fund, and the Ludwig Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a Leukemia and Lymphoma Society Career Development Program fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adams R, 2017, SCI REP-UK, V7, DOI 10.1038/srep37716; Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Bankovich AJ, 2007, SCIENCE, V316, P291, DOI 10.1126/science.1139412; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delgoffe GM, 2011, CURR OPIN IMMUNOL, V23, P632, DOI 10.1016/j.coi.2011.07.013; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Frederickson S, 2006, P NATL ACAD SCI USA, V103, P14307, DOI 10.1073/pnas.0602658103; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Junttila IS, 2012, NAT CHEM BIOL, V8, P990, DOI [10.1038/NCHEMBIO.1096, 10.1038/nchembio.1096]; Kai M, 2008, NAT BIOTECHNOL, V26, P209, DOI 10.1038/nbt1376; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuruganti S, 2016, J BIOL CHEM, V291, P447, DOI 10.1074/jbc.M115.665943; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moraga I, 2017, ELIFE, V6, DOI 10.7554/eLife.22882; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muller-Newen G, 2000, J BIOL CHEM, V275, P4579, DOI 10.1074/jbc.275.7.4579; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nakano K, 2009, J IMMUNOL METHODS, V347, P31, DOI 10.1016/j.jim.2009.05.012; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Overwijk WW, 2009, CLIN IMMUNOL, V132, P153, DOI 10.1016/j.clim.2009.03.512; Pellegrini M, 2010, TRENDS PHARMACOL SCI, V31, P356, DOI 10.1016/j.tips.2010.05.003; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; Shanafelt AB, 2000, NAT BIOTECHNOL, V18, P1197, DOI 10.1038/81199; Shusterman S, 2010, J CLIN ONCOL, V28, P4969, DOI 10.1200/JCO.2009.27.8861; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; Tzeng A, 2015, P NATL ACAD SCI USA, V112, P3320, DOI 10.1073/pnas.1416159112; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; YODOI J, 1985, J IMMUNOL, V134, P1623; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhang HK, 2012, P NATL ACAD SCI USA, V109, P15728, DOI 10.1073/pnas.1214275109	67	9	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13876	13886		10.1074/jbc.RA119.009213	http://dx.doi.org/10.1074/jbc.RA119.009213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31387945	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000490729800003
J	Schakel, L; Veldhuijzen, DS; van Middendorp, H; Manai, M; Meeuwis, SH; Van Dessel, P; Evers, AWM				Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Manai, Meriem; Meeuwis, Stefanie H.; Van Dessel, Pieter; Evers, Andrea W. M.			Can verbal suggestions strengthen the effects of a relaxation intervention?	PLOS ONE			English	Article							STRESS-MANAGEMENT INTERVENTION; RESPONSES; PLACEBO; REACTIVITY; REDUCTION; PANAS	Short stress management interventions such as relaxation therapy have demonstrated preliminary effectiveness in reducing stress-related problems. A promising tool to strengthen the effectiveness of relaxation-based interventions is the use of verbal suggestions, as previous research provided evidence that verbal suggestions can induce positive outcome expectancies, facilitate adaptive responses to stress and improve health outcomes. The present experimental proof-of-concept study aimed to investigate the effects of a brief relaxation intervention and specifically the role of verbal suggestions on stress-related outcomes assessed by self-report questionnaires and psychophysiological data. 120 participants (mean age = 22.1 years) were randomized to one of four intervention conditions: a brief relaxation intervention plus verbal suggestions condition, a brief relaxation intervention only condition, a verbal suggestions only condition, and a control condition. Afterwards, participants were subjected to a psychosocial stress challenge to assess reactivity to a stressful event. Immediately after both relaxation interventions (with and without verbal suggestions), lower self-reported state anxiety was found compared to the control condition, but no differences were observed in response to the stressor. The verbal suggestions only condition did not impact state anxiety. No significant effects were found for verbal suggestion interventions on cortisol, alpha amylase, heart rate and skin conductance. This is the first study investigating the role of verbal suggestions in the effectiveness of a brief relaxation intervention. Although this experimental proof-of-concept study provides support for the effectiveness of a brief relaxation intervention in lowering state anxiety directly after the intervention, the effects did not impact the response to a subsequent stressor and we did not observe any evidence for the add-on effectiveness of verbal suggestions. The effectiveness of brief relaxation interventions on stress responses should be investigated further in future research by incorporating interventions that are tailored to the specific stress challenge and various types of verbal suggestions.	[Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Manai, Meriem; Meeuwis, Stefanie H.; Evers, Andrea W. M.] Leiden Univ, Inst Psychol, Fac Social & Behav Sci, Hlth Med & Neu Ropsychol Unit, Leiden, Netherlands; [Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Manai, Meriem; Meeuwis, Stefanie H.; Evers, Andrea W. M.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Van Dessel, Pieter] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium; [Evers, Andrea W. M.] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schakel, L (corresponding author), Leiden Univ, Inst Psychol, Fac Social & Behav Sci, Hlth Med & Neu Ropsychol Unit, Leiden, Netherlands.; Schakel, L (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	l.schakel@fsw.leidenuniv.nl	Van Dessel, Pieter/Q-1917-2019; Evers, Andrea/GWV-9705-2022	Van Dessel, Pieter/0000-0002-3401-780X; Manai, Meriem/0000-0002-4684-9224; Veldhuijzen, Dieuwke S. (Judy)/0000-0001-9046-1019	European Research Council [ERC-2013-CoG-617700_EXPECT HEAL-TH]; NWO Vici Grant [016.Vici.170.152]	European Research Council(European Research Council (ERC)European Commission); NWO Vici Grant(Netherlands Organization for Scientific Research (NWO))	This study was funded by a European Research Council Consolidator Grant (ERC-2013-CoG-617700_EXPECT HEAL-TH) and a NWO Vici Grant (016.Vici.170.152), both granted to AWME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2014, NEUROSCI BIOBEHAV R, V38, P94, DOI 10.1016/j.neubiorev.2013.11.005; [Anonymous], 1982, TIJDSCHR PSYCHIAT; Bartels DJP, 2016, EUR J PAIN, V20, P8, DOI 10.1002/ejp.750; Blease C, 2016, BIOETHICS, V30, P407, DOI 10.1111/bioe.12245; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 2002, PSYCHOSOM MED, V64, P302, DOI 10.1097/00006842-200203000-00014; Cohen S., 1988, PERCEIVED STRESS PRO; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Colloca L, 2011, CURR OPIN PSYCHIATR, V24, P149, DOI 10.1097/YCO.0b013e328343803b; Creswell JD, 2014, PSYCHONEUROENDOCRINO, V44, P1, DOI 10.1016/j.psyneuen.2014.02.007; Cruess DG, 2015, INT J STRESS MANAGE, V22, P270, DOI 10.1037/a0039130; Evers AWM, 2018, PSYCHOTHER PSYCHOSOM, V87, P204, DOI 10.1159/000490354; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gaab J, 2003, PSYCHONEUROENDOCRINO, V28, P767, DOI 10.1016/S0306-4530(02)00069-0; Hartrick Craig T, 2003, Pain Pract, V3, P310; KERCHER K, 1992, RES AGING, V14, P131, DOI 10.1177/0164027592142001; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McRae AL, 2006, HUM PSYCHOPHARM CLIN, V21, P377, DOI 10.1002/hup.778; Nagele E, 2014, J HYPERTENS, V32, P1936, DOI 10.1097/HJH.0000000000000298; Peerdeman KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139563; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Richardson KM, 2008, J OCCUP HEALTH PSYCH, V13, P69, DOI 10.1037/1076-8998.13.1.69; Rohrmann S, 2002, PSYCHOL HEALTH, V17, P583, DOI 10.1080/08870440290025795; Rohrmann S, 1999, INT J PSYCHOPHYSIOL, V33, P149, DOI 10.1016/S0167-8760(99)00036-7; Schakel L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201309; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sharma M, 2014, J EVID-BASED INTEGR, V19, P271, DOI 10.1177/2156587214543143; Sjak-Shie EE, 2016, PHYSIODATA TOOLBOX V; Skvortsova A, 2018, PSYCHOSOM MED, V80, P353, DOI 10.1097/PSY.0000000000000571; van Dixhoorn J J, 1999, J Cardiopulm Rehabil, V19, P178, DOI 10.1097/00008483-199905000-00005; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yamakawa K, 2009, BIOL PSYCHOL, V82, P25, DOI 10.1016/j.biopsycho.2009.05.001	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220112	10.1371/journal.pone.0220112	http://dx.doi.org/10.1371/journal.pone.0220112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390349	Green Published, gold			2022-12-26	WOS:000484999400011
J	Ren, JC; Cui, JP; Luo, MK; Liu, H; Hao, PF; Wang, X; Zhang, GH				Ren, Jingchao; Cui, Jun-peng; Luo, Mengkai; Liu, Huan; Hao, Pengfei; Wang, Xiao; Zhang, Guang-hui			The prevalence and persistence of aberrant promoter DNA methylation in benzene-exposed Chinese workers	PLOS ONE			English	Article							REPAIR GENES; MICRONUCLEUS FREQUENCIES; HYPOMETHYLATION; RISK; MGMT; LEUKEMIA; DAMAGE; LEVEL; HMLH1; GENOTOXICITY	Aberrant DNA methylation patterns are common in cancers and environmental pollutant exposed subjects. Up to date, few studies have examined the aberrant DNA methylation patterns in benzene exposed workers. We recruited 141 benzene-exposed workers, including 83 benzene-exposed workers from a shoe factory in Wenzhou and 58 workers from a painting workshop in Wuhu, 35 workers in Wuhu were followed from 2009 to 2013, and 48 indoor workers as controls from Wenzhou. We used high-resolution melting (HRM) to quantitate human samples of DNA methylation in long interspersed nuclear element-1 (LINE-1), (6)-methylguanine-DNA methyltransferase (MGMT), and DNA mismatch repair gene human mutator L homologue 1 (hMLH1). AML-5 cells were treated with benzoquinone (BQ) and hydroquinone (HQ), and the promoter methylation of MGMT and hMLH1 was detected using the bisulfite sequencing PCR method. The degree of LINE-1 methylation in benzene-exposed workers was significantly lower than that of the controls (p<0.001), and the degree of MGMT (p<0.001) and hMLH1 (p = 0.01) methylation was significantly higher than that of the controls. The in vitro study validated the aberrant hypermethylation of hMLH1 after treatment with BQ. Among the cohort workers who were followed from 2009 to 2013, the LINE1 methylation elevated in 2013 than 2009 (p = 0.004), and premotor methylation in hMLH1 reduced in 2013 than 2009 (p = 0.045) with the reduction of the benzene exposure. This study provides evidence that benzene exposure can induce LINE-1 hypomethylation and DNA repair gene hypermethylation.	[Ren, Jingchao; Cui, Jun-peng; Luo, Mengkai; Liu, Huan; Wang, Xiao; Zhang, Guang-hui] Xinxiang Med Univ, Sch Publ Hlth, Henan Int Collaborat Lab Hlth Effects & Intervent, Med, Xinxiang, Henan, Peoples R China; [Hao, Pengfei] Xinxiang Ctr Dis Control & Prevent, Xinxiang, Henan, Peoples R China	Xinxiang Medical University	Wang, X; Zhang, GH (corresponding author), Xinxiang Med Univ, Sch Publ Hlth, Henan Int Collaborat Lab Hlth Effects & Intervent, Med, Xinxiang, Henan, Peoples R China.	whz@xxmu.edu.cn; zhgh221@163.com			National Natural Science Foundation of China [NSFC 81602836]; Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine [XTCX-2015-PY3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine	This work was supported by the National Natural Science Foundation of China (NSFC 81602836), and the Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine (XTCX-2015-PY3).; We sincerely thank Professor Xia Zhao-lin for his help on this work! This work was supported by the National Natural Science Foundation of China (NSFC 81602836), the Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine (XTCX-2015-PY3).	Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Candiloro ILM, 2011, EPIGENETICS-US, V6, P501, DOI 10.4161/epi.6.4.14853; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Deng GR, 1999, CANCER RES, V59, P2029; Derks S, 2006, CELL ONCOL, V28, P247; Duan HW, 2013, ARCH TOXICOL, V87, P2013, DOI 10.1007/s00204-013-1046-0; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Esteller M, 2004, ONCOGENE, V23, P1, DOI 10.1038/sj.onc.1207316; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; Fenech M, 2005, METH MOLEC MED, V111, P3; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; FENECH M, 1993, MUTAT RES, V285, P35, DOI 10.1016/0027-5107(93)90049-L; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Glass DC, 2003, EPIDEMIOLOGY, V14, P569, DOI 10.1097/01.ede.0000082001.05563.e0; Goethel G, 2014, MUTAT RES-GEN TOX EN, V770, P61, DOI 10.1016/j.mrgentox.2014.05.008; Hornung R W, 1989, Toxicol Ind Health, V5, P1153; Hu JJ, 2014, ENVIRON TOXICOL, V29, P108, DOI 10.1002/tox.20777; Ji F, 2010, CARCINOGENESIS, V31, P648, DOI 10.1093/carcin/bgq015; Ji Z, 2010, LEUKEMIA, V24, P986, DOI 10.1038/leu.2010.43; Kristensen LS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn113; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Lewis C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202462; Li J, 2017, BIOMARKERS, V22, P470, DOI 10.1080/1354750X.2016.1274335; Lovreglio P, 2014, MUTAT RES-GEN TOX EN, V770, P55, DOI 10.1016/j.mrgentox.2014.04.022; Malentacchi F, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp383; McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Psofaki V, 2010, WORLD J GASTROENTERO, V16, P3553, DOI 10.3748/wjg.v16.i28.3553; Rinsky RA, 2002, AM J IND MED, V42, P474, DOI 10.1002/ajim.10138; RINSKY RA, 1987, NEW ENGL J MED, V316, P1044, DOI 10.1056/NEJM198704233161702; Rota F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040735; Schiffman C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205427; Seow WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050471; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Toyooka S, 2003, CLIN CANCER RES, V9, P3034; Tse M Yat, 2011, BMC Res Notes, V4, P565, DOI 10.1186/1756-0500-4-565; Vlaanderen J, 2011, ENVIRON HEALTH PERSP, V119, P159, DOI 10.1289/ehp.1002318; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2010, EXPERT REV MOL DIAGN, V10, P575, DOI [10.1586/erm.10.46, 10.1586/ERM.10.46]; Wu F, 2013, INT J OCCUP MED ENV, V26, P173, DOI 10.2478/S13382-013-0079-1; Zhang C, 2013, TOXICOL APPL PHARM, V271, P78, DOI 10.1016/j.taap.2013.04.025; Zhang GH, 2017, ENVIRON MOL MUTAGEN, V58, P678, DOI 10.1002/em.22136; Zhang GH, 2016, J OCCUP ENVIRON MED, V58, pE39, DOI 10.1097/JOM.0000000000000639; Zhang GH, 2014, INT J HYG ENVIR HEAL, V217, P726, DOI 10.1016/j.ijheh.2014.03.003; Zhang HG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199689	48	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220500	10.1371/journal.pone.0220500	http://dx.doi.org/10.1371/journal.pone.0220500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381583	Green Submitted, gold, Green Published			2022-12-26	WOS:000484993600019
J	Adams, B; Fidler, K; Demoes, N; Aguiar, EJ; Ducharme, SW; McCullough, AK; Moore, CC; Tudor-Locke, C; Thomas, D				Adams, Bryan; Fidler, Katie; Demoes, Noah; Aguiar, Elroy J.; Ducharme, Scott W.; McCullough, Aston K.; Moore, Christopher C.; Tudor-Locke, Catrine; Thomas, Diana			Cardiometabolic thresholds for peak 30-min cadence and steps/day	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; METABOLIC SYNDROME; STEPPING CADENCE; RISK; ACCUMULATION; ADULTS; HEALTH	Purpose To provide empirically-supported thresholds for step-based intensity (i.e., peak 30-min cadence; average of the top 30 steps/min in a day) and steps/day in relation to cardiometabolic health outcomes. Methods Receiver operating characteristic curve analysis was applied to the National Health and Nutrition Examination Survey (NHANES) 2005-2006 accelerometer-derived step data to determine steps/day and peak 30-min cadence as risk screening values (i.e., thresholds) for fasting glucose, body mass index, waist circumference, high blood pressure, triglycerides, and HDL cholesterol. Thresholds for peak 30-min cadence and steps/day were derived that, when exceeded, classify the absence of each cardiometabolic risk factor. Additionally, logistic regression models that included the influence of age and smoking were developed using the sample weights, primary sampling units (PSUs), and stratification variables provided by the NHANES survey. Finally, a decision tree analysis was performed to delineate criteria for at-risk versus healthy populations using cadence bands. Results Peak 30-min cadence thresholds across cardiometabolic outcomes ranged from 66-72 steps/min. Steps/day thresholds ranged from 4325-6192 steps/day. Higher thresholds were observed in men compared to women. In men, higher steps/day thresholds were observed in age ranges of 30- 39, while in women, higher thresholds were observed in the age-range 50-59 years. Decision trees for classifying being at low risk for metabolic syndrome contained one risk-free leaf at higher cadence bands, specifically for any time accumulated at >= 120 steps/min. Conclusions Minimum thresholds representing absence of cardiometabolic risk range from 4325-6192 steps/day and 66-72 steps/min for peak 30-min cadence. Any time accumulated at >= 120 steps/min was associated with an absence of cardiometabolic risk. Although based on cross-sectional data, these thresholds represent potentially important and clinically interpretable daily physical activity goals.	[Adams, Bryan; Fidler, Katie; Demoes, Noah; Thomas, Diana] US Mil Acad, Dept Math Sci, West Point, NY 10996 USA; [Aguiar, Elroy J.; Ducharme, Scott W.; McCullough, Aston K.; Moore, Christopher C.; Tudor-Locke, Catrine] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Kinesiol, Amherst, MA 01003 USA	United States Department of Defense; United States Army; United States Military Academy; University of Massachusetts System; University of Massachusetts Amherst	Thomas, D (corresponding author), US Mil Acad, Dept Math Sci, West Point, NY 10996 USA.	diana.thomas@usma.edu	Tudor-Locke, Catrine/AAC-2829-2021	Aguiar, Elroy/0000-0003-4763-0491; Moore, Christopher/0000-0001-6027-1732; Thomas, Diana/0000-0003-2641-9304				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; [Anonymous], 2018, INTRO RECURSIVE PART; [Anonymous], 2018, 2018 PHYSICAL ACTIVI; Barreira TV, 2016, J SCI MED SPORT, V19, P227, DOI 10.1016/j.jsams.2015.01.008; Breiman L, 1993, CLASSIFICATION REGRE; Centers for Disease Control and Prevention, 2020, ADOLESCENT HEALTH; Dall PM, 2013, MED SCI SPORT EXER, V45, P1995, DOI 10.1249/MSS.0b013e3182955780; Fuzeki E, 2017, SPORTS MED, V47, P1769, DOI 10.1007/s40279-017-0724-0; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gennuso KP, 2015, DIABETOLOGIA, V58, P485, DOI 10.1007/s00125-014-3453-z; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Lee IM, 2019, JAMA INTERN MED, V179, P1105, DOI 10.1001/jamainternmed.2019.0899; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; National Health and Nutrition Examination Survey (NHANES), 2016, ANTHR PROC MAN; Rowlands AV, 2007, MED SCI SPORT EXER, V39, P716, DOI 10.1249/mss.0b013e318031126c; Schuna JM, 2013, MED SCI SPORT EXER, V45, P914, DOI 10.1249/MSS.0b013e31827e47ac; Sisson SB, 2010, AM J PREV MED, V38, P575, DOI 10.1016/j.amepre.2010.02.015; Toth LP, 2018, MED SCI SPORT EXER, V50, P1315, DOI 10.1249/MSS.0000000000001569; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2008, J PHYS ACT HEALTH, V5, pS126, DOI 10.1123/jpah.5.s1.s126; Tudor-Locke C, 2017, MED SCI SPORT EXER, V49, P283, DOI 10.1249/MSS.0000000000001100; Tudor-Locke C, 2012, J PHYS ACT HEALTH, V9, P1125, DOI 10.1123/jpah.9.8.1125; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; Tudor-Locke C, 2012, SPORTS MED, V42, P381, DOI 10.2165/11599170-000000000-00000; Tudor-Locke C, 2011, PREV MED, V53, P178, DOI 10.1016/j.ypmed.2011.06.004; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; Westerterp KR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00090; Williams PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078777; 2000, OBESITY PREVENTING M	34	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0219933	10.1371/journal.pone.0219933	http://dx.doi.org/10.1371/journal.pone.0219933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374078	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500003
J	Sharma, S; Tomar, S; Dharne, M; Ganesan, V; Smith, A; Yang, YF; Waggoner, L; Wang, YH; Hogan, SP				Sharma, Sribava; Tomar, Sunil; Dharne, Mayuri; Ganesan, Varsha; Smith, Andrew; Yang, Yanfen; Waggoner, Lisa; Wang, Yui-Hsi; Hogan, Simon P.			Deletion of Delta dblGata motif leads to increased predisposition and severity of IgE-mediated food-induced anaphylaxis response	PLOS ONE			English	Article							FC-EPSILON-RI; ERYTHROID TRANSCRIPTION FACTOR; MAST-CELL DIFFERENTIATION; FACTOR GATA-1; EXPRESSION; EOSINOPHILS; RECEPTOR; ALLERGY; PROMOTER; ROLES	Background Previous studies have revealed an important role for the transcription factor GATA-1 in mast cell maturation and degranulation. However, there have been conflicting reports with respect to the requirement of GATA-1 function in mast cell dependent inflammatory processes. Herein, we examine the requirement of GATA-1 signaling in mast cell effector function and IgE-mast cell-dependent anaphylaxis. Objective To study the requirement of GATA-1 dependent signaling in the development and severity of IgE-mast cell-dependent anaphylaxis in mice. Methods Wild type (Balb/c) and mutant Delta dblGata (Balb/c) mice were employed to study the role of GATA-1 signaling in in vitro IgE-mediated activation of bone marrow derived mast cells (BMMCs). Murine models of passive IgE-mediated and oral antigen-induced IgE-mediated anaphylaxis were employed in mice. Frequency of steady state mast cells in various tissues (duodenum, ear, and tongue), peritoneal cavity, and clinical symptoms (diarrhea, shock, and mast cell activation) and intestinal Type 2 immune cell analysis including CD4(+) Th-2 cells, type 2 innate lymphoid cells (ILC2), and IL-9 secreting mucosal mast cells (MMC9) were assessed Results In vitro analysis revealed that Delta dblGata BMMCs exhibit a reduced maturation rate, decreased expression of Fc epsilon RI alpha, and degranulation capacity when compared to their wildtype (WT) counterparts. These in vitro differences did not impact tissue resident mast cell numbers, total IgE, and susceptibility to or severity of IgE-mediated passive anaphylaxis. Surprisingly, Delta dblGata mice were more susceptible to IgE-mast cell-mediated oral antigen induced anaphylaxis. The increased allergic response was associated with increased Type 2 immunity (antigen-specific IgE, and CD4(+) T(H)2 cells), MMC9 cells and small intestine (SI) mast cell load. Conclusion Diminished GATA-1 activity results in reduced in vitro mast cell Fc epsilon RI alpha expression, proliferation, and degranulation activity. However, in vivo, diminished GATA-1 activity results in normal homeostatic tissue mast cell levels and increased antigen-induced CD4(+) Th2 and iMMC9 cell levels and heightened IgE-mast cell mediated reactions.	[Sharma, Sribava; Tomar, Sunil; Dharne, Mayuri; Ganesan, Varsha; Smith, Andrew; Yang, Yanfen; Waggoner, Lisa; Wang, Yui-Hsi; Hogan, Simon P.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol,Coll Med, Cincinnati, OH 45221 USA; [Sharma, Sribava] Univ Cincinnati, Dept Pediat, Immunobiol Grad Program, Div Immunobiol,Coll Med, Cincinnati, OH USA; [Tomar, Sunil; Ganesan, Varsha; Hogan, Simon P.] Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, Michigan Med, Ann Arbor, MI 48109 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; University of Cincinnati; University of Michigan System; University of Michigan	Hogan, SP (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol,Coll Med, Cincinnati, OH 45221 USA.; Hogan, SP (corresponding author), Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, Michigan Med, Ann Arbor, MI 48109 USA.	sihogan@med.umich.edu		Sharma, Sribava/0000-0001-5562-1179	DoD [W81XWH-15-1-051730]; NIH [R01 AI073553, DK090119]; Mary H Weiser Food Allergy Center; MFARA; Food Allergy Research Education	DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary H Weiser Food Allergy Center; MFARA; Food Allergy Research Education	This work was supported by DoD W81XWH-15-1-051730, NIH R01 AI073553 and DK090119, Mary H Weiser Food Allergy Center, MFARA and Food Allergy Research & Education (S.P.H.).	Ahrens R, 2012, AM J PATHOL, V180, P1535, DOI 10.1016/j.ajpath.2011.12.036; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Baba Y, 2012, ALLERGOL INT, V61, P461, DOI 10.2332/allergolint.12-OA-0424; Barnstein BO, 2006, J IMMUNOL, V177, P3421, DOI 10.4049/jimmunol.177.5.3421; Bartnikas LM, 2013, J ALLERGY CLIN IMMUN, V131, P451, DOI 10.1016/j.jaci.2012.11.032; Benede S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190453; Berin MC, 2015, CLIN EXP ALLERGY, V45, P1483, DOI 10.1111/cea.12598; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Deo SS, 2010, LUNG INDIA, V27, P66, DOI 10.4103/0970-2113.63609; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Elishmereni M, 2013, ALLERGY, V68, P171, DOI 10.1111/all.12059; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Forbes E, 2004, GASTROENTEROLOGY, V127, P105, DOI 10.1053/j.gastro.2004.03.057; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hogan SP, 2012, SEMIN IMMUNOPATHOL, V34, P643, DOI 10.1007/s00281-012-0320-1; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Hussain M, 2018, J ALLERGY CLIN IMMUN, V141, P223, DOI 10.1016/j.jaci.2017.02.035; Inage E, 2014, J IMMUNOL, V192, P3936, DOI 10.4049/jimmunol.1302366; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V131, P1555, DOI 10.1016/j.jaci.2013.02.043; Koyasu S, 2011, IMMUNOLOGY, V132, P475, DOI 10.1111/j.1365-2567.2011.03413.x; Kuehn Hye Sun, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0738s91; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Li Y, 2017, J ALLERGY CLIN IMMUN, V24, P32917; Li YP, 2018, J ALLERGY CLIN IMMUN, V142, P1173, DOI 10.1016/j.jaci.2017.10.043; MacGlashan D, 2008, CURR OPIN IMMUNOL, V20, P717, DOI 10.1016/j.coi.2008.08.004; Maeda K, 2003, J IMMUNOL, V170, P334, DOI 10.4049/jimmunol.170.1.334; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Minai-Fleminger Y, 2010, CELL TISSUE RES, V341, P405, DOI 10.1007/s00441-010-1010-8; Morii E, 2004, BLOOD, V104, P1656, DOI 10.1182/blood-2004-01-0247; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Nishiyama C, 1999, J IMMUNOL, V163, P623; Nishiyama C, 2005, INT IMMUNOL, V17, P847, DOI 10.1093/intimm/dxh278; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Ohmori S, 2015, BLOOD, V125, P3306, DOI 10.1182/blood-2014-11-612465; Ohneda K, 2014, MOL CELL BIOL, V34, P1812, DOI 10.1128/MCB.01524-13; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Piliponsky AM, 2001, J ALLERGY CLIN IMMUN, V107, P993, DOI 10.1067/mai.2001.114656; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Wakabayashi J, 2003, GENES CELLS, V8, P619, DOI 10.1046/j.1365-2443.2003.00658.x; Yamani A, 2018, J ALLERGY CLIN IMMUN, V142, P1159, DOI 10.1016/j.jaci.2017.08.046; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; ZON LI, 1991, J BIOL CHEM, V266, P22948	61	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219375	10.1371/journal.pone.0219375	http://dx.doi.org/10.1371/journal.pone.0219375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369572	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900013
J	Chen, GQ; Wu, JT; Chen, GC; Lu, YY; Ren, W; Xu, W; Xu, XM; Wu, ZG; Guan, YX; Zheng, Y; Qiu, BF				Chen, Guoqian; Wu, Jiatao; Chen, Guocai; Lu, Yanyan; Ren, Wei; Xu, Wu; Xu, Xuemeng; Wu, Zugui; Guan, Yingxin; Zheng, Yi; Qiu, Bofan			Reliability of a portable device for quantifying tone and stiffness of quadriceps femoris and patellar tendon at different knee flexion angles	PLOS ONE			English	Article							MUSCLE TONE; ACHILLES-TENDON; POSITIONS; MALES; ANKLE	The reliability of MyotonPRO that can monitor the mechanical properties of tissues is still unclear. This study aimed to analyze the within-day inter-operator and between-day intraoperator reliability of MyotonPRO for assessing tone and stiffness of quadriceps femoris and patellar tendon at different knee angles. The tone and stiffness of healthy participants (15 males and 15 females, aged 24.7 +/- 1.6 years) in the supine and resting position were measured using the MyotonPRO device. The measurements were quantified at 0 degrees, 30 degrees, 60 degrees, and 90 degrees of knee flexion. The intraclass correlation coefficient (ICC), standard error of measurement (SEM), and minimal detectable change (MDC) were calculated and a Bland-Altman analysis was conducted to estimate reliability. The results indicated excellent interoperator reliability (ICC > 0.78) and good to excellent intra-operator reliability (ICC > 0.41). The inter-operator SEM measurements ranged between 0.1-0.9 Hz and 3.8-37.9 N/m, and intra-operator SEM ranged between 0.5-1.3 Hz and 7.9-52.0 N/m. The inter-operator MDC ranged between 0.3-2.5 Hz and 10.5-105.1 N/m, and intra-operator SEM ranged between 1.1-3.3 Hz and 21.9-144.1 N/m. The agreement of inter-operator was better than that of intra-operator. The study concluded that MyotonPRO is a reliable device to detect the tone and stiffness of quadriceps femoris and patellar tendon.	[Chen, Guoqian; Wu, Jiatao; Chen, Guocai; Lu, Yanyan; Wu, Zugui; Guan, Yingxin; Zheng, Yi; Qiu, Bofan] Guangzhou Univ Chinese Med, Clin Med Sch 5, Guangzhou, Guangdong, Peoples R China; [Ren, Wei] Guangdong Second Tradit Chinese Med Hosp, Guangzhou, Guangdong, Peoples R China; [Xu, Wu; Xu, Xuemeng] Guangdong Second Tradit Chinese Med Hosp, Orthoped Dept, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine	Xu, XM (corresponding author), Guangdong Second Tradit Chinese Med Hosp, Orthoped Dept, Guangzhou, Guangdong, Peoples R China.	xuxuemeng@163.com						Agyapong-Badu S, 2016, ARCH GERONTOL GERIAT, V62, P59, DOI 10.1016/j.archger.2015.09.011; Aird L, 2012, ARCH GERONTOL GERIAT, V55, pE31, DOI 10.1016/j.archger.2012.03.005; Alamaki A, 2007, PHYSIOL MEAS, V28, P793, DOI 10.1088/0967-3334/28/8/003; Alvarez-Diaz P, 2016, KNEE SURG SPORT TR A, V24, P2264, DOI 10.1007/s00167-014-3319-4; Atkinson G, 2001, J SPORT SCI, V19, P811, DOI 10.1080/026404101317015447; Bentley S, 1996, SPORTS MED, V21, P409, DOI 10.2165/00007256-199621060-00003; Bialas P, 2019, PATIENT EDUC COUNS, V102, P134, DOI 10.1016/j.pec.2018.08.017; Bizzini M, 2003, CLIN BIOMECH, V18, P459, DOI 10.1016/S0268-0033(03)00042-1; Young FC, 2018, J DANCE MED SCI, V22, P179, DOI 10.12678/1089-313X.22.4.179; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Demetrashvili N, 2016, STAT METHODS MED RES, V25, P2359, DOI 10.1177/0962280214522787; Frohlich-Zwahlen AK, 2014, J ELECTROMYOGR KINES, V24, P762, DOI 10.1016/j.jelekin.2014.06.007; Fryer Gary, 2009, Osteopath Med Prim Care, V3, P4, DOI 10.1186/1750-4732-3-4; Furlan L, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00095; Gao J, 2017, ULTRASOUND MED BIOL, V43, P1729, DOI 10.1016/j.ultrasmedbio.2017.04.011; Hu XQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32418-x; Huang JP, 2018, MED SCI MONITOR, V24, P7570, DOI 10.12659/MSM.909550; James Mullix MW, 2012, WORKING PAPERS HLTH; Ko CY, 2018, J BIOMECH, V73, P60, DOI 10.1016/j.jbiomech.2018.03.026; Kuszewski MT, 2019, PHYSICIAN SPORTSMED, V47, P91, DOI 10.1080/00913847.2018.1527171; Liu CL, 2018, MED SCI MONITOR, V24, P4876, DOI 10.12659/MSM.909531; Lo WLA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14107-3; Marusiak J, 2011, MOVEMENT DISORD, V26, P2119, DOI 10.1002/mds.23841; Masi AT, 2008, J BODYW MOV THER, V12, P320, DOI 10.1016/j.jbmt.2008.05.007; Miller EM, 2013, J BIOMECH, V46, P801, DOI 10.1016/j.jbiomech.2012.11.023; Portney L.G., 2015, APPL PRACTICE, V3rd; Qiu WB, 2015, IEEE ENG MED BIO, P3847, DOI 10.1109/EMBC.2015.7319233; Sandra Agyapong-Badu LA, 2013, WORKING PAPERS HLTH; Sohirad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184463; To T, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-29; Van Deun B, 2019, ALZ DIS ASSOC DIS, V33, P54, DOI 10.1097/WAD.0000000000000278; Van Deun B, 2018, J GERIATR PHYS THER, V41, P194, DOI 10.1519/JPT.0000000000000119; Williams W R, 1880, J Anat Physiol, V14, P178; Xu JF, 2018, J SPORT HEALTH SCI, V7, P245, DOI 10.1016/j.jshs.2016.07.001	34	14	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220521	10.1371/journal.pone.0220521	http://dx.doi.org/10.1371/journal.pone.0220521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365582	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600051
J	Netter, A; Mancini, J; Buffat, C; Agostini, A; Perrin, J; Courbiere, B				Netter, Antoine; Mancini, Julien; Buffat, Christophe; Agostini, Aubert; Perrin, Jeanne; Courbiere, Blandine			Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?	PLOS ONE			English	Article							MICRONIZED PROGESTERONE; VAGINAL PROGESTERONE; OVARIAN STIMULATION; CYCLES; HYPERSTIMULATION; IMPLANTATION; TECHNOLOGY; PROTOCOL	Objective We sought to determine whether the early luteal serum progesterone (P4) level predicts the success of IVF treatment with oral dydrogesterone for luteal support. Method This retrospective monocentric cohort study included 242 women who underwent IVF treatment with fresh embryo transfer (ET) between July 2017 and June 2018. The population was unselected, and women were treated according to our unit's usual stimulation protocols. For the luteal phase support (LPS), all women were supplemented with a 10 mg three-times-daily dose of oral dydrogesterone beginning on the day of oocyte pick-up (OPU). Blood sampling was performed on the day of ET (Day 2-3 after OPU) to determine the early luteal serum progesterone level. Results ROC curve analysis allowed us to determine two thresholds for the prediction of live birth using the early P4 level. Women who had early luteal P4 levels greater than 252 nmol/l had a significantly higher live birth rate (27.1%) than women with early luteal P4 between 115 and 252 nmol/l (17.2%) and women with early luteal P4 below 115 nmol/l (6.0%; p = 0.011). After a multiple regression analysis, an early luteal P4 level greater than 252 nmol/l was still associated with a higher chance of a live birth than a P4 between 115 and 252 nmol/l (OR = 0.40 [0.18-0.91]; p = 0.028) or a P4 below 115 nmol/l (OR = 0.10 [0.01-0.52]; p = 0.006). Conclusions Our study suggests a positive association between early P4 levels and reproductive outcomes in IVF using oral dydrogesterone for luteal support. The inconsistencies between our results and those of other studies suggest that extrapolation is impractical. Further larger prospective cohort studies should be conducted to determine reliable thresholds that could be used to personalize luteal phase support.	[Netter, Antoine; Agostini, Aubert; Perrin, Jeanne; Courbiere, Blandine] AP HM La Concept, Dept Gynecol Obstet & Reprod Med, Pole Femmes Parents Enfants, Marseille, France; [Mancini, Julien] Aix Marseille Univ, La Timone Hosp, APHM, INSERM,IRD,SESSTIM,BIOSTIC,Publ Hlth Dept, Marseille, France; [Buffat, Christophe] Hop Conception, Lab Biochim & Biol Mol, Marseille, France; [Perrin, Jeanne; Courbiere, Blandine] Aix Marseille Univ, Avignon Univ, CNRS, IRD,Inst Mediterrane Biodivers & Ecol Marine & Co, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Netter, A (corresponding author), AP HM La Concept, Dept Gynecol Obstet & Reprod Med, Pole Femmes Parents Enfants, Marseille, France.	antoine.netter@gmail.com	Netter, Antoine/ABB-8570-2020; Mancini, Julien/G-6263-2011; Agostini, Aubert/AAG-6898-2021	Mancini, Julien/0000-0001-9500-8598; Netter, Antoine/0000-0002-3532-0800				Abbott B. V., 2017, FILM COATED TABLETS, DOI [10.1016/J.JSBMB.2005.08.012, DOI 10.1016/J.JSBMB.2005.08.012]; Abdel-Hamid ME, 2006, CHROMATOGRAPHIA, V64, P287, DOI 10.1365/s10337-006-0035-3; Alsbjerg B, 2018, REPROD BIOMED ONLINE, V37, P641, DOI 10.1016/j.rbmo.2018.08.022; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Andersen CY, 2014, REPROD BIOMED ONLINE, V28, P552, DOI 10.1016/j.rbmo.2014.01.012; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Chakravarty BN, 2005, J STEROID BIOCHEM, V97, P416, DOI 10.1016/j.jsbmb.2005.08.012; Child T, 2018, REPROD BIOMED ONLINE, V36, P630, DOI 10.1016/j.rbmo.2018.02.001; Cicinelli E, 2000, OBSTET GYNECOL, V95, P403, DOI 10.1016/S0029-7844(99)00542-6; Fauser BC, 2002, J CLIN ENDOCR METAB, V87, P709, DOI 10.1210/jc.87.2.709; Ganesh A, 2011, FERTIL STERIL, V95, P1961, DOI 10.1016/j.fertnstert.2011.01.148; Gibbons WE, 1998, FERTIL STERIL, V69, P96, DOI 10.1016/S0015-0282(97)00457-3; Griesinger G, 2019, REPROD BIOMED ONLINE, V38, P249, DOI 10.1016/j.rbmo.2018.11.017; Griesinger G, 2018, FERTIL STERIL, V109, P756, DOI 10.1016/j.fertnstert.2018.03.034; Kushnir VA, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-016-0225-2; Labarta E, 2017, HUM REPROD, V32, P2437, DOI 10.1093/humrep/dex316; Mol BW, 2018, FERTIL STERIL, V109, P968, DOI 10.1016/j.fertnstert.2018.04.037; Patki A, 2007, GYNECOL ENDOCRINOL, V23, P68, DOI 10.1080/09513590701584857; Paulson RJ, 2014, J CLIN ENDOCR METAB, V99, P4241, DOI 10.1210/jc.2013-3937; Saharkhiz N, 2016, GYNECOL ENDOCRINOL, V32, P213, DOI 10.3109/09513590.2015.1110136; Thomsen LH, 2018, HUM REPROD, V33, P1506, DOI 10.1093/humrep/dey226; Tomic V, 2015, EUR J OBSTET GYN R B, V186, P49, DOI 10.1016/j.ejogrb.2014.11.002; Tournaye H, 2017, HUM REPROD, V32, P1019, DOI 10.1093/humrep/dex023; van der Linden M, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009154.pub2, 10.1002/14651858.CD009154.pub3]; Venetis CA, 2018, HUM REPROD, V33, P2312, DOI 10.1093/humrep/dey311; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Yovich JL, 2015, REPROD BIOMED ONLINE, V31, P180, DOI 10.1016/j.rbmo.2015.05.005; Yu S, 2018, HUM REPROD, V33, P229, DOI 10.1093/humrep/dex367; Zhu XX, 2017, FERTIL STERIL, V108, P505, DOI 10.1016/j.fertnstert.2017.06.017	29	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220450	10.1371/journal.pone.0220450	http://dx.doi.org/10.1371/journal.pone.0220450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361764	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300029
J	Enrile, F; Besio, G; Stocchino, A; Magaldi, MG				Enrile, Francesco; Besio, Giovanni; Stocchino, Alessandro; Magaldi, Marcello G.			Influence of initial conditions on absolute and relative dispersion in semi-enclosed basins	PLOS ONE			English	Article							MEAN FLOW DECOMPOSITION; TROPICAL PACIFIC-OCEAN; SURFACE CIRCULATION; DRIFTER OBSERVATIONS; ADRIATIC SEA; RADAR; MODEL	Absolute and relative dispersion are fundamental quantities employed in order to assess the mixing strength of a basin. There exists a time scale called Lagrangian Integral Scale associated to absolute dispersion that highlights the occurrence of the transition from a quadratic dependence on time to a linear dependence on time. Such a time scale is commonly adopted as an indicator of the duration needed to lose the influence of the initial conditions. This work aims to show that in a semi-enclosed basin the choice of the formulation in order to calculate the absolute dispersion can lead to different results. Moreover, the influence of initial conditions can persist beyond the Lagrangian Integral Scale. Such an influence can be appreciated by evaluating absolute and relative dispersion recursively by changing the initial conditions. Furthermore, finite-size Lyapunov exponents characterize the different regimes of the basin.	[Enrile, Francesco; Besio, Giovanni; Stocchino, Alessandro] Univ Genoa, Dipartimento Ingn Civile Chim & Ambientale, Genoa, Italy; [Magaldi, Marcello G.] ISMAR CNR, SS Lerici, Lerici, SP, Italy; [Magaldi, Marcello G.] Johns Hopkins Univ, Earth & Planetary Sci, Baltimore, MD USA	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Johns Hopkins University	Enrile, F (corresponding author), Univ Genoa, Dipartimento Ingn Civile Chim & Ambientale, Genoa, Italy.	francesco.enrile@hotmail.it	Stocchino, Alessandro/AAX-2603-2020	Stocchino, Alessandro/0000-0001-6087-4250; Enrile, Francesco/0000-0002-2447-4425; Besio, Giovanni/0000-0002-0522-9635				Adrian RJ, 2000, EXP FLUIDS, V29, P275, DOI 10.1007/s003489900087; Artale V, 1997, PHYS FLUIDS, V9, P3162, DOI 10.1063/1.869433; BABIANO A, 1990, J FLUID MECH, V214, P535, DOI 10.1017/S0022112090000258; Bauer S, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000613; Bauer S, 1998, J GEOPHYS RES-OCEANS, V103, P30855, DOI 10.1029/1998JC900009; Bellomo L, 2015, J OPER OCEANOGR, V8, P95, DOI 10.1080/1755876X.2015.1087184; Cosoli S, 2013, J GEOPHYS RES-OCEANS, V118, P6183, DOI 10.1002/2013JC009261; DAVIS RE, 1985, J GEOPHYS RES-OCEANS, V90, P4741, DOI 10.1029/JC090iC03p04741; Davis RE, 1998, J GEOPHYS RES-OCEANS, V103, P24619, DOI 10.1029/98JC01913; Enrile F, 2018, CONT SHELF RES, V167, P125, DOI 10.1016/j.csr.2018.04.016; Fratantoni DM, 2001, J GEOPHYS RES-OCEANS, V106, P22067, DOI 10.1029/2000JC000730; Gille ST, 2003, J PHYS OCEANOGR, V33, P1167, DOI 10.1175/1520-0485(2003)033<1167:FOOTSO>2.0.CO;2; Guala M, 2007, J FLUID MECH, V574, P405, DOI 10.1017/S0022112006004204; Haza AC, 2008, OCEAN MODEL, V22, P48, DOI 10.1016/j.ocemod.2008.01.006; Jakobsen PK, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001554; KRAICHNAN RH, 1966, PHYS FLUIDS, V9, P1937, DOI 10.1063/1.1761547; LaCasce JH, 2000, J MAR RES, V58, P61, DOI 10.1357/002224000321511205; Lavender KL, 2000, NATURE, V407, P66, DOI 10.1038/35024048; Lekien F, 2005, PHYSICA D, V210, P1, DOI 10.1016/j.physd.2005.06.023; Malacic V, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004904; Malai V., 2001, PHYS OCEANOGRAPHY AD, P167, DOI DOI 10.1007/978-94-015-9819-4_6; Mariano A, 2016, STAT PROPERTIES SURF, V121; Mentaschi L, 2013, J COASTAL RES, P1551, DOI 10.2112/SI65-262.1; Poulain PM, 1999, J MARINE SYST, V20, P231, DOI 10.1016/S0924-7963(98)00084-0; Provenzale A, 1999, ANNU REV FLUID MECH, V31, P55, DOI 10.1146/annurev.fluid.31.1.55; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Schroeder K, 2011, DEEP-SEA RES PT I, V58, P209, DOI 10.1016/j.dsr.2010.11.004; Stocchino A, 2011, J FLUID MECH, V675, P168, DOI 10.1017/S0022112011000127; ZIMMERMAN JTF, 1986, NETH J SEA RES, V20, P133, DOI 10.1016/0077-7579(86)90037-2	30	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0217073	10.1371/journal.pone.0217073	http://dx.doi.org/10.1371/journal.pone.0217073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348774	Green Submitted, Green Published, gold			2022-12-26	WOS:000484979500004
J	Naviaux, RK; Naviaux, JC; Li, KF; Wang, L; Monk, JM; Bright, AT; Koslik, HJ; Ritchie, JB; Golomb, BA				Naviaux, Robert K.; Naviaux, Jane C.; Li, Kefeng; Wang, Lin; Monk, Jonathan M.; Bright, A. Taylor; Koslik, Hayley J.; Ritchie, Janis B.; Golomb, Beatrice A.			Metabolic features of Gulf War illness	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; FALSE DISCOVERY RATE; PYRIDOSTIGMINE BROMIDE; VETERANS; CERAMIDE; SYMPTOMS; MITOCHONDRIA; DYSFUNCTION; POPULATION; SERUM	Background More than 230,000 veterans-about 1/3 of US personnel deployed in the 1990-1991 Persian Gulf War-developed chronic, multi-symptom health problems now called "Gulf War illness" (GWI), for which mechanisms and objective diagnostic signatures continue to be sought. Methods Targeted, broad-spectrum serum metabolomics was used to gain insights into the biology of GWI. 40 male participants, included 20 veterans who met both Kansas and CDC diagnostic criteria for GWI and 20 nonveteran controls without similar symptoms that were 1:1 matched to GWI cases by age, sex, and ethnicity. Serum samples were collected and archived at -80 degrees C prior to testing. 358 metabolites from 46 biochemical pathways were measured by hydrophilic interaction liquid chromatography and tandem mass spectrometry. Results Veterans with GWI, compared to healthy controls, had abnormalities in 8 of 46 biochemical pathways interrogated. Lipid abnormalities accounted for 78% of the metabolic impact. Fifteen ceramides and sphingomyelins, and four phosphatidylcholine lipids were increased. Five of the 8 pathways were shared with the previously reported metabolic phenotype of males with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). However, 4 of the 5 shared pathways were regulated in opposite directions; key pathways that were up-regulated in GWI were down-regulated in ME/CFS. The single pathway regulated in the same direction was purines, which were decreased. Conclusions Our data show that despite heterogeneous exposure histories, a metabolic phenotype of GWI was clearly distinguished from controls. Metabolomic differences between GWI and ME/CFS show that common clinical symptoms like fatigue can have different chemical mechanisms and different diagnostic implications. Larger studies will be needed to validate these findings.	[Naviaux, Robert K.; Naviaux, Jane C.; Li, Kefeng; Wang, Lin; Monk, Jonathan M.; Bright, A. Taylor] Univ Calif San Diego, Sch Med, Mitochondria & Metab Dis Ctr, San Diego, CA 92103 USA; [Naviaux, Robert K.; Li, Kefeng; Wang, Lin; Monk, Jonathan M.; Bright, A. Taylor] Univ Calif San Diego, Sch Med, Dept Med, Div Med Genet, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Pediat, Div Genet, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Pathol, Div Comparat Pathol, San Diego, CA 92103 USA; [Naviaux, Jane C.] Univ Calif San Diego, Sch Med, Dept Neurosci, Div Pediat Neurol, San Diego, CA 92103 USA; [Koslik, Hayley J.; Ritchie, Janis B.; Golomb, Beatrice A.] Univ Calif San Diego, Sch Med, Dept Med, Div Gen Internal Med, San Diego, CA 92103 USA; [Bright, A. Taylor] TEC Biosci Inc, Lexington, KY USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Mitochondria & Metab Dis Ctr, San Diego, CA 92103 USA.; Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Med Genet, San Diego, CA 92103 USA.; Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Div Genet, San Diego, CA 92103 USA.; Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, Div Comparat Pathol, San Diego, CA 92103 USA.; Golomb, BA (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Gen Internal Med, San Diego, CA 92103 USA.	naviaux@ucsd.edu; bgolomb@ucsd.edu	Li, Kefeng/U-9431-2018	Li, Kefeng/0000-0002-7233-4347	Department of Defense [CDMRP GWI GW093063, CDMRP GW150066]; UCSD Christini Fund; Wright Family Foundation; Lennox Foundation; UCSD Mitochondrial Disease Research Fund	Department of Defense(United States Department of Defense); UCSD Christini Fund; Wright Family Foundation; Lennox Foundation; UCSD Mitochondrial Disease Research Fund	Veteran study visits and sample collection were funded by the Department of Defense, CDMRP GWI GW093063 and CDMRP GW150066 to BAG. Metabolomic work was supported in part by the UCSD Christini Fund, The Wright Family Foundation, The Lennox Foundation, and the UCSD Mitochondrial Disease Research Fund to RKN. Funding for the mass spectrometers used in this study was provided by a gift from the Jane Botsford-Johnson Foundation to RKN.	Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abou-Donia MB, 2017, NEUROTOXICOLOGY TERA; Airola MV, 2017, P NATL ACAD SCI USA, V114, pE5549, DOI 10.1073/pnas.1705134114; Amin MM, 2010, SLEEP BREATH; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binns JH, 2004, RES ADVISORY COMMITT; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Blanchard MS, 2006, AM J EPIDEMIOL, V163, P66, DOI 10.1093/aje/kwj008; Blasco H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198116; Blau N, 2005, PHYS GUIDE LAB DIAGN; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnstock G, 2018, BIOCHEM PHARMACOL, V151, P157, DOI 10.1016/j.bcp.2017.07.016; Cecchine G., 2000, REV SCI LIT IT PERTA, V8; Chao LL, 2016, NEUROTOXICOLOGY, V53, P246, DOI 10.1016/j.neuro.2016.02.009; Chao LDL, 2011, NEUROTOXICOLOGY, V32, P814, DOI 10.1016/j.neuro.2011.06.006; Chen Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184832; Chiricozzi E, 2018, J LEUKOCYTE BIOL, V103, P445, DOI 10.1002/JLB.3MR0717-269R; Chong J, 2018, NUCL ACIDS RES; Ciccone DS, 2008, J HEALTH PSYCHOL, V13, P529, DOI 10.1177/1359105308088525; Craddock TJA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0111-3; Emmerich T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176634; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Fernandez-Ayala DJM, 2000, ANTIOXID REDOX SIGN, V2, P263, DOI 10.1089/ars.2000.2.2-263; Filzmoser P, 2009, J CHEMOMETR, V23, P160, DOI 10.1002/cem.1225; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Ghiassian SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27414; Golomb BA, 2014, NEURAL COMPUT, V26, P2594, DOI 10.1162/NECO_a_00659; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Graves J. C., 2008, GULF WAR ILLNESS HLT; Gray GC, 2002, AM J EPIDEMIOL, V155, P1033, DOI 10.1093/aje/155.11.1033; Haley RN, 2004, AM J MED, V117, P469, DOI 10.1016/j.amjmed.2004.03.041; Haley RW, 2013, JAMA NEUROL, V70, P191, DOI 10.1001/jamaneurol.2013.596; Hammad Samar M, 2012, Neurobiol Lipids, V10, P2; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannan KL, 2000, BLOOD COAGUL FIBRIN, V11, P673, DOI 10.1097/00001721-200010000-00013; Heaton KJ, 2007, NEUROTOXICOLOGY, V28, P761, DOI 10.1016/j.neuro.2007.03.006; Horner RD, 2008, NEUROEPIDEMIOLOGY, V31, P28, DOI 10.1159/000136648; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Institute of Medicine, 2014, CHRON MULT ILLN GULF; Ismail K, 2007, PSYCHOL MED, P1; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Johnson GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157855; Johnson GJ, 2013, BLOOD COAGUL FIBRINO; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Khan F, 2004, CLIN SCI, V106, P183, DOI 10.1042/CS20030246; Koslik HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092887; Kroenke K, 1998, J OCCUP ENVIRON MED, V40, P520, DOI 10.1097/00043764-199806000-00004; Kumari N, 2013, ADV EXP MED BIOL, V775, P19, DOI 10.1007/978-1-4614-6130-2_2; Lagace Thomas A, 2015, Lipid Insights, V8, P65, DOI 10.4137/LPI.S31746; Lambert IH, 2015, ACTA PHYSIOL, V213, P191, DOI 10.1111/apha.12365; Li KF, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1264-1; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Liu XY, 2018, ANAL CHIM ACTA, V1037, P293, DOI 10.1016/j.aca.2018.03.009; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Magni G, 2017, CURRENT MED CHEM; Masino SA, 2012, EPILEPSY RES, V100, P229, DOI 10.1016/j.eplepsyres.2011.07.014; Matthan NR, 2010, J LIPID RES, V51, P2826, DOI 10.1194/jlr.D007534; McCauley LA, 2002, AM J PREV MED, V23, P200, DOI 10.1016/S0749-3797(02)00497-X; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Menon PM, 2004, BRAIN RES, V1009, P189, DOI 10.1016/j.brainres.2004.02.063; Myhill S, 2009, INT J CLIN EXP MED, V2, P1; Nagy-Szakal D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28477-9; Naviaux RK, 2018, MITOCHONDRION, V43, P1, DOI 10.1016/j.mito.2017.12.007; Naviaux RK, 2019, MITOCHONDRION, V46, P278, DOI 10.1016/j.mito.2018.08.001; Naviaux RK, 2016, P NATL ACAD SCI USA, V113, pE5472, DOI 10.1073/pnas.1607571113; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135; Paoletti L, 2011, IUBMB LIFE, V63, P714, DOI 10.1002/iub.521; Papucci L, 2003, J BIOL CHEM, V278, P28220, DOI 10.1074/jbc.M302297200; Peakman M, 2006, PHILOS T R SOC B, V361, P681, DOI 10.1098/rstb.2006.1826; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Schrader M, 2017, CELL DEATH DIFFER, V24, P1148, DOI 10.1038/cdd.2017.23; Scriver C.R., 2001, METABOLIC MOL BASIS, VEighth; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Szymanska Ewa, 2012, Metabolomics, V8, P3; Tafesse FG, 2014, J CELL SCI, V127, P445, DOI 10.1242/jcs.138933; Tahmaz N, 2003, ANN OCCUP HYG, V47, P261, DOI 10.1093/annhyg/meg042; Thomas HV, 2006, PSYCHOL MED, V36, P735, DOI 10.1017/S0033291705006975; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Vojdani A, 2004, ENVIRON HEALTH PERSP, V112, P840, DOI 10.1289/ehp.6881; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999; Zhao X, 2014, EMBO REP, V15, P518, DOI 10.1002/embr.201338271	91	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0219531	10.1371/journal.pone.0219531	http://dx.doi.org/10.1371/journal.pone.0219531			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WC	31348786	Green Published, gold			2022-12-26	WOS:000484979500009
J	Kitanaka, N; Nakano, R; Sugiura, K; Kitanaka, T; Namba, S; Konno, T; Nakayama, T; Sugiya, H				Kitanaka, Nanako; Nakano, Rei; Sugiura, Kanae; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Nakayama, Tomohiro; Sugiya, Hiroshi			Interleukin-1 beta promotes interleulin-6 expression via ERK1/2 signaling pathway in canine dermal fibroblasts	PLOS ONE			English	Article							IL-6 EXPRESSION; HEALING-PROCESS; GROWTH-FACTORS; PROTEIN; CYTOKINES; SKIN; ACTIVATION; ERK2; IL-1-BETA; DOGS	Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of the immune response and inflammation. In this study, we investigated effect of the proinflammatory cytokine interleukin-1 beta (IL-1 beta) on IL-6 expression in canine dermal fibroblasts. IL-1 beta induced IL-6 mRNA expression and protein release in a time-and dose-dependent manner. When cells were treated with inhibitors of mitogen-activated protein kinases (MAPKs), the extracellular signal-regulated kinase (ERK) inhibitor FR180240 inhibited IL-1 beta-induced IL-6 mRNA expression, but not SP600125 or SKF86002, which are c-Jun N-terminal kinase (JNK) and p38 MAPK inhibitors, respectively. In cells treated with U0126, an inhibitor of MAPK/ERK kinase (MEK), which activates ERK, IL-1 beta-induced IL-6 mRNA expression was also inhibited. IL-1 beta stimulated ERK1/2 phosphorylation. In cells transfected with ERK1 and ERK2 isoform siRNAs, IL-1 beta-induced IL-6 mRNA expression was reduced. These observations suggest that IL-1 beta induces IL-6 expression via ERK1/2 signaling pathway in canine dermal fibroblasts.	[Kitanaka, Nanako; Nakano, Rei; Sugiura, Kanae; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Lab Vet Biochem, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Nakano, Rei] RIKEN Ctr Integrat Med Sci, Lab Cellular Funct Convers Technol, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa, Japan; [Nakayama, Tomohiro] Nihon Univ, Lab Vet Radiotherapy, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan	Nihon University; RIKEN; Nihon University	Sugiya, H (corresponding author), Nihon Univ, Lab Vet Biochem, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Nakayama, Tomohiro/GYU-0303-2022		Ministry of Education, Science, Sports, and Culture of Japan [19K06389, 18K14594]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	TN: 19K06389, the Ministry of Education, Science, Sports, and Culture of Japan, https://www.jsps.go.jp/j-grantsinaid/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RN: 18K14594, the Ministry of Education, Science, Sports, and Culture of Japan, https://www.jsps.go.jp/j-grantsinaid/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOXMAN I, 1993, J INVEST DERMATOL, V101, P316, DOI 10.1111/1523-1747.ep12365474; Boxman ILA, 1996, ARCH DERMATOL RES, V288, P391, DOI 10.1007/BF02507108; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinson CW, 2016, MOL IMMUNOL, V79, P47, DOI 10.1016/j.molimm.2016.09.020; Busca R, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00053; Calabrese LH, 2014, NAT REV RHEUMATOL, V10, P720, DOI 10.1038/nrrheum.2014.127; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; CORAN AG, 1992, J SURG RES, V53, P272, DOI 10.1016/0022-4804(92)90047-4; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Floras ANK, 2014, J VET INTERN MED, V28, P1447, DOI 10.1111/jvim.12409; Foster JD, 2014, J VET INTERN MED, V28, P905, DOI 10.1111/jvim.12351; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; FUGGER L, 1989, J IMMUNOGENET, V16, P461; Gallucci RM, 2004, J INVEST DERMATOL, V122, P764, DOI 10.1111/j.0022-202X.2004.22323.x; Grellner W, 2000, FORENSIC SCI INT, V113, P251, DOI 10.1016/S0379-0738(00)00218-8; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kirchmeyer M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2569; Kitanaka T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39914; Kloesch B, 2010, CELL BIOL INT, V34, P477, DOI 10.1042/CBI20090436; KOCH AE, 1993, PATHOBIOLOGY, V61, P239, DOI 10.1159/000163802; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lee JD, 2009, INT IMMUNOPHARMACOL, V9, P268, DOI 10.1016/j.intimp.2008.11.005; LEMAY DR, 1990, AM J PHYSIOL, V259, pR126, DOI 10.1152/ajpregu.1990.259.1.R126; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li FF, 2009, BIOCHEM BIOPH RES CO, V382, P259, DOI 10.1016/j.bbrc.2009.02.165; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Liu XF, 2015, EXP CELL RES, V331, P223, DOI 10.1016/j.yexcr.2014.08.040; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MELOCHE S, 1995, J CELL PHYSIOL, V163, P577, DOI 10.1002/jcp.1041630319; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Mwanza T, 1996, JPN J VET RES, V44, P179; Nakano R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26473-7; Namba S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182923; NEUNER P, 1991, J INVEST DERMATOL, V97, P27, DOI 10.1111/1523-1747.ep12477880; Paquet P, 1996, INT ARCH ALLERGY IMM, V109, P308, DOI 10.1159/000237257; Radtke S, 2013, J CELL SCI, V126, P2381, DOI 10.1242/jcs.115832; Rau S, 2007, VET CLIN PATH, V36, P253, DOI 10.1111/j.1939-165X.2007.tb00220.x; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Safra N, 2016, VET IMMUNOL IMMUNOP, V179, P32, DOI 10.1016/j.vetimm.2016.08.003; Sawamura D, 1998, J IMMUNOL, V161, P5633; Shin J, 2013, CELL SIGNAL, V25, P2540, DOI 10.1016/j.cellsig.2013.08.014; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Tanabe K, 2014, INT J MOL MED, V34, P1032, DOI 10.3892/ijmm.2014.1863; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tracy LE, 2016, ADV WOUND CARE, V5, P119, DOI 10.1089/wound.2014.0561; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Wang XP, 2004, J INVEST DERMATOL, V123, P124, DOI 10.1111/j.0022-202X.2004.22736.x; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Westra J, 2004, ANN RHEUM DIS, V63, P1453, DOI 10.1136/ard.2003.013011; YAMAMOTO T, 1995, J INVEST DERMATOL, V104, P784, DOI 10.1111/1523-1747.ep12606990; YAMASHITA K, 1994, J VET MED SCI, V56, P487, DOI 10.1292/jvms.56.487; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092	59	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220262	10.1371/journal.pone.0220262	http://dx.doi.org/10.1371/journal.pone.0220262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344106	Green Submitted, Green Published, gold			2022-12-26	WOS:000484977900075
J	Wichert, R; Scharfenberg, F; Colmorgen, C; Koudelka, T; Schwarz, J; Wetzel, S; Potempa, B; Potempa, J; Bartsch, JW; Sagi, I; Tholey, A; Saftig, P; Rose-John, S; Becker-Pauly, C				Wichert, Rielana; Scharfenberg, Franka; Colmorgen, Cynthia; Koudelka, Tomas; Schwarz, Jeanette; Wetzel, Sebastian; Potempa, Barbara; Potempa, Jan; Bartsch, Joerg W.; Sagi, Irit; Tholey, Andreas; Saftig, Paul; Rose-John, Stefan; Becker-Pauly, Christoph			Meprin beta induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage	FASEB JOURNAL			English	Article						proteolysis; zymogen activation; inflammation; ADAM	ALPHA-CONVERTING-ENZYME; ADAM10; SECRETASE; PROTEIN; IRHOM2; TACE; PHOSPHORYLATION; INHIBITION; DISRUPTION; ACTIVATION	Meprin beta is a membrane-bound metalloprotease involved in extracellular matrix assembly and inflammatory processes in health and disease. A disintegrin and metalloproteinase (ADAM)10 and ADAM17 are physiologic relevant sheddases of inactive promeprin beta, which influences its substrate repertoire and subsequent biologic functions. Proteomic analysis also revealed several ADAMs as putative meprin beta substrates. Here, we demonstrate specific N-terminal processing of ADAM9, 10, and 17 by meprin beta and identify cleavage sites within their prodomains. Because ADAM prodomains can act as specific inhibitors, we postulate a role for meprin beta in the regulation of ADAM activities. Indeed, prodomain cleavage by meprin beta caused increased ADAM protease activities, as observed by peptide-based cleavage assays and demonstrated by increased ectodomain shedding activity. Direct interaction of meprin beta and ADAM proteases could be shown by immunofluorescence microscopy and immunoprecipitation experiments. As demonstrated by a bacterial activator of meprin beta and additional measurement of TNF-alpha shedding on bone marrow-derived macrophages, meprin beta/ADAM protease interactions likely influence inflammatory conditions. Thus, we identified a novel proteolytic pathway of meprin beta with ADAM proteases to control protease activities at the cell surface as part of the protease web.	[Wichert, Rielana; Scharfenberg, Franka; Colmorgen, Cynthia; Schwarz, Jeanette; Wetzel, Sebastian; Saftig, Paul; Rose-John, Stefan; Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, Kiel, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Kiel, Germany; [Potempa, Barbara; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Bartsch, Joerg W.] Philipps Univ Marburg, Dept Neurosurg, Marburg, Germany; [Sagi, Irit] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel	University of Kiel; University of Kiel; Jagiellonian University; University of Louisville; Philipps University Marburg; Weizmann Institute of Science	Becker-Pauly, C (corresponding author), Univ Kiel, Inst Biochem, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Scharfenberg, Franka/AAS-9798-2021; Saftig, Paul/A-7966-2010; Becker-Pauly, Christoph/B-7569-2011; Potempa, Jan/AAA-6850-2021	Bartsch, Prof. Joerg Walter/0000-0002-2773-3357	Deutsche Forschungsgemeinschaft (DFG) [BE4086/2-2, SFB 877]; DFG Excellence Cluster [306]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Excellence Cluster(German Research Foundation (DFG))	The authors thank Carl P. Blobel (Weill Cornell Medical College, New York, NY, USA) for providing the C-terminal anti-ADAM9 antibody and alkaline phosphatase-tagged shedding constructs. The authors also thank Athena Chalaris-Rissmann (Biochemical Institute, University of Kiel) for providing the N-and C-terminal tagged ADAM constructs. In addition, the authors thank Britta Hansen (Biochemical Institute, University of Kiel) for excellent technical support. This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants BE4086/2-2 (to C. B.-P.), SFB 877 (Proteolysis as a Regulatory Event in Pathophysiology, Projects A1, A3, A9, and Z2), and DFG Excellence Cluster No. 306 "Inflammation at Interfaces." The authors declare no conflicts of interest.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Arnold P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44053; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bedau T, 2017, ONCOTARGET, V8, P54873, DOI 10.18632/oncotarget.18966; Bedau T, 2017, FASEB J, V31, P1226, DOI 10.1096/fj.201601113R; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cavadas M, 2017, CELL REP, V21, P745, DOI 10.1016/j.celrep.2017.09.074; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Grieve AG, 2017, ELIFE, V6, DOI 10.7554/eLife.23968; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Meier A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004343; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Moss ML, 2011, J BIOL CHEM, V286, P40443, DOI 10.1074/jbc.M111.280495; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Scharfenberg F., 2019, CELL MOL LIFE SCI; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Seegar TCM, 2017, CELL, V171, P1638, DOI 10.1016/j.cell.2017.11.014; Seipold L, 2018, CELL MOL LIFE SCI, V75, P3251, DOI 10.1007/s00018-018-2791-2; Seipold L, 2017, BBA-MOL CELL RES, V1864, P217, DOI 10.1016/j.bbamcr.2016.11.003; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sztukowska M, 2012, BIOL CHEM, V393, P971, DOI 10.1515/hsz-2012-0175; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Veillard F, 2015, BIOL CHEM, V396, P377, DOI 10.1515/hsz-2014-0304; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wichert R, 2017, CELL REP, V21, P2090, DOI 10.1016/j.celrep.2017.10.087; Wong E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35598; Wong ET, 2015, J BIOL CHEM, V290, P12135, DOI 10.1074/jbc.M114.624072; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	53	11	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11925	11940		10.1096/fj.201801371R	http://dx.doi.org/10.1096/fj.201801371R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31381863	Bronze, Green Published			2022-12-26	WOS:000507461600027
J	Ye, H; Qian, L; Zhu, SY; Deng, SR; Wang, X; Zhu, J; Chan, GL; Yu, Y; Han, W				Ye, Hao; Qian, Lan; Zhu, Shunying; Deng, Shaorong; Wang, Xia; Zhu, Jiang; Chan, Gerald L.; Yu, Yan; Han, Wei			IL-1Ra protects hematopoietic cells from chemotoxicity through p53-induced quiescence	FASEB JOURNAL			English	Article						rhIL-1Ra; chemotherapy; neutropenia; cell cycle arrest; hematopoietic progenitor cell	INTERLEUKIN-1 RECEPTOR; TRANSCRIPTIONAL REGULATION; TGF-BETA; CANCER; STEM; P53; PROLIFERATION; TOXICITY; CHEMOTHERAPY; SUPPRESSION	The protection of constantly proliferating gut epithelia and hematopoietic tissues from cytotoxicity could improve conventional chemotherapy efficacy and widen its therapeutic window. Previously, we reported that, in mouse models, pretreatment of recombinant human IL-1 receptor antagonist (rhIL-1Ra) protected both types of vulnerable tissues from chemotherapeutics. Here, we showed that rhIL-1Ra treatment up-regulated the protein levels of phosphorylated p38, p53, and p21 and induced transient hematopoietic stem/progenitor cell (HS/PC) quiescence. Knockout of IL-1 receptor I (IL-1RI), p53, or p21 alleles and pharmacological inactivation of p38 mapped the rhIL-1Ra pathway in the induction of HS/PC quiescence. Therefore, rhIL-1Ra administration before but not after chemotherapy alleviated 5-fluorouracil-induced neutropenia. In addition, in vivo and in vitro cell proliferation assays revealed that the rhIL-1Ra treatment did not affect cancer cell proliferation or chemosensitivity. Lastly, we propose an IL-1/IL-1Ra pathway (IL-1RI -> p38 -> p53 -> p21), which regulates HS/PC quiescence. The rhIL-1Ra may provide a new route for p53-based cyclotherapy, which spares normal cells but kills cancer cells during chemotherapy.	[Ye, Hao; Qian, Lan; Deng, Shaorong; Wang, Xia; Han, Wei] Shanghai Jiao Tong Univ, Sch Pharm, Lab Regener, Shanghai, Peoples R China; [Zhu, Shunying] Shanghai Jiao Tong Univ, Natl Infrastruct Translat Med, Shanghai, Peoples R China; [Zhu, Jiang] Shanghai Jiao Tong Univ, Blood Res Inst, Sch Med, Ruijin Hosp, Shanghai, Peoples R China; [Yu, Yan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Municipal Key Lab Vet Biotechnol, Shanghai, Peoples R China; [Chan, Gerald L.] Peking Univ, Morningside Peking Univ Joint Lab Integrat Pathob, Beijing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Peking University	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biotechnol, Room 3-405,800 Dongchuan Rd, Shanghai 200240, Peoples R China.; Han, W (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Room 6-212,800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yanyu@sjtu.edu.cn; weihan@sjtu.edu.cn			National Science and Technology Major Project [2018ZX09733001-001-004]; National Natural Science Foundation of China [30901873]; Shanghai Science and Technology Committee [111431921300]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grants from the National Science and Technology Major Project (2018ZX09733001-001-004), the National Natural Science Foundation of China (30901873), and the Shanghai Science and Technology Committee (111431921300). The authors declare no conflicts of interest.	Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Blagosklonny MV, 2002, CELL CYCLE, V1, P375, DOI 10.4161/cc.1.6.259; Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Blagosklonny MV, 2001, CANCER RES, V61, P4301; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Carey A, 2017, CELL REP, V18, P3204, DOI 10.1016/j.celrep.2017.03.018; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GALLAGHER R, 1979, BLOOD, V54, P713; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; He SH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3986; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang LJ, 2011, P NATL ACAD SCI USA, V108, P1897, DOI 10.1073/pnas.1019059108; Johnson A, 2013, CURR OPIN CELL BIOL, V25, P717, DOI 10.1016/j.ceb.2013.07.010; Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008; Khemissa F, 2016, DIGEST LIVER DIS, V48, P327, DOI 10.1016/j.dld.2015.11.025; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Qian L, 2013, BIOMED PHARMACOTHER, V67, P108, DOI 10.1016/j.biopha.2012.11.002; Rao B, 2013, BRIT J CANCER, V109, P2954, DOI 10.1038/bjc.2013.702; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rumman M, 2015, STEM CELLS, V33, P2903, DOI 10.1002/stem.2056; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Taylor SJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam8060; van Leeuwen IMM, 2012, ONCOTARGET, V3, P596; Velardi E, 2018, NAT MED, V24, P239, DOI 10.1038/nm.4470; Wang X, 2014, PHARMACOL RES, V82, P21, DOI 10.1016/j.phrs.2014.03.007; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xiang D, 2011, CANCER CHEMOTH PHARM, V67, P1445, DOI 10.1007/s00280-010-1439-1; Yu HJ, 2016, AM J TRANSL RES, V8, P1237; Zhang J, 2009, BIOMED PHARMACOTHER, V63, P501, DOI 10.1016/j.biopha.2008.09.014; Zhang Y, 2015, CANCER BIOL THER, V16, P1775, DOI 10.1080/15384047.2015.1095404	46	2	2	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12135	12145		10.1096/fj.201900788RR	http://dx.doi.org/10.1096/fj.201900788RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373847	Green Published, Bronze			2022-12-26	WOS:000507461600042
J	Potter, GE; Wong, J; Sugimoto, J; Diallo, A; Victor, JC; Neuzil, K; Halloran, ME				Potter, Gail E.; Wong, Jimmy; Sugimoto, Jonathan; Diallo, Aldiouma; Victor, John C.; Neuzil, Kathleen; Halloran, M. Elizabeth			Networks of face-to-face social contacts in Niakhar, Senegal	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SUPER-SPREADERS; INFECTIOUS-DISEASE; TRANSMISSION; STRATEGIES; IGNORABILITY; HOUSEHOLD; PATTERNS; SARS	We present the first analysis of face-to-face contact network data from Niakhar, Senegal. Participants in a cluster-randomized influenza vaccine trial were interviewed about their contact patterns when they reported symptoms during their weekly household surveillance visit. We employ a negative binomial model to estimate effects of covariates on contact degree. We estimate the mean contact degree for asymptomatic Niakhar residents to be 16.5 (95% C.I. 14.3, 18.7) in the morning and 14.8 in the afternoon (95% C.I. 12.7, 16.9). We estimate that symptomatic people make 10% fewer contacts than asymptomatic people (95% C.I. 5%, 16%; p = 0.006), and those aged 0-5 make 33% fewer contacts than adults (95% C.I. 29%, 37%; p < 0.001). By explicitly modelling the partial rounding pattern observed in our data, we make inference for both the underlying (true) distribution of contacts as well as for the reported distribution. We created an estimator for homophily by compound (household) membership and estimate that 48% of contacts by symptomatic people are made to their own compound members in the morning (95% CI, 45%, 52%) and 60% in the afternoon/evening (95% CI, 56%, 64%). We did not find a significant effect of symptom status on compound homophily. We compare our findings to those from other countries and make design recommendations for future surveys.	[Potter, Gail E.] Emmes Co, Rockville, MD 20850 USA; [Potter, Gail E.; Wong, Jimmy] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Sugimoto, Jonathan; Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Diallo, Aldiouma] Inst Rech Dev, Niakhar, Senegal; [Victor, John C.] PATH, Seattle, WA USA; [Neuzil, Kathleen] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	California State University System; California Polytechnic State University San Luis Obispo; Fred Hutchinson Cancer Center; Institut de Recherche pour le Developpement (IRD); University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle	Potter, GE (corresponding author), Emmes Co, Rockville, MD 20850 USA.; Potter, GE (corresponding author), Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA.	gpotter@emmes.com		Potter, Gail/0000-0001-6667-6992	General Medical Sciences/National Institute of Health [U01-GM070749]; Thomas Francis Global Health Fellowship; National Institute of General Medical Sciences/National Institute of Health [U54 GM111274]; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention [1U01IP000174]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM111274] Funding Source: NIH RePORTER	General Medical Sciences/National Institute of Health; Thomas Francis Global Health Fellowship; National Institute of General Medical Sciences/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GEP was supported previously by General Medical Sciences/National Institute of Health U01-GM070749 (PI MEH, https://www.nigms.nih.gov/) and received a Thomas Francis Global Health Fellowship (https://globalhealth.washington.edu/connect/funding-for-fieldwork). JW received no specific funding for this work. JS was supported by National Institute of General Medical Sciences/National Institute of Health U54 GM111274 (PI MEH, https://www.nigms.nih.gov/) and received a Thomas Francis Jr. Global Health Fellowship (https://globalhealth.washington.edu/connect/funding-for-fieldwork), and was also supported previously by U01-GM070749 (PI MEH). JCV, KN and AD were supported by grant 1U01IP000174 (CoAg between CDC and PATH, PI JCV) funded by National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (www.cdc.gov, https://www.path.org/). MEH was supported by National Institute of General Medical Sciences/National Institute of Health U54 GM111274 (PI MEH, https://www.nigms.nih.gov/), and previously received U01-GM070749 (PI MEH). PATH was involved in conceptualization, funding acquisition, project administration, resources, supervision, and writing. The Emmes Company did not play a role in the design of the study. The Emmes Company was contracted to perform data cleaning and data analysis of the clinical trial data (but not the social contact network data) for this study before GEP joined the Emmes Company (in October 2015). After GEP joined the Emmes Company, the sole support from Emmes for this social network analysis manuscript was in the form of salary support for GEP. The specific roles of GEP are articulated in the 'author contributions' section. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Barclay VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087042; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Beraud G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133203; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Danon L, 2012, J R SOC INTERFACE, V9, P2826, DOI 10.1098/rsif.2012.0357; Delaunay V, 2013, INT J EPIDEMIOL, V42, P1002, DOI 10.1093/ije/dyt100; Diop-Ousmane M., 2019, CLIN INFECT DIS, DOI [10.1093/cid/ciz066, DOI 10.1093/CID/CIZ066]; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Genois M, 2015, NETW SCI, V3, P326, DOI 10.1017/nws.2015.10; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Grijalva CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118457; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; HEITJAN DF, 1993, BIOMETRICS, V49, P1099, DOI 10.2307/2532251; HEITJAN DF, 1991, ANN STAT, V19, P2244, DOI 10.1214/aos/1176348396; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kiti MC, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0084-2; Kiti MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104786; Leecaster M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153690; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Melegaro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170459; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Meyer S, 2017, BIOSTATISTICS, V18, P338, DOI 10.1093/biostatistics/kxw051; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pellis L, 2015, EPIDEMICS-NETH, V10, P58, DOI 10.1016/j.epidem.2014.07.003; Potter GE, 2012, ANN APPL STAT, V6, P1, DOI 10.1214/11-AOAS505; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Rolls DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1237-9; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rubin DB, 2004, MULTIPLE IMPUTATION; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Smieszek T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-136; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113711; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Van Kerckhove K, 2013, AM J EPIDEMIOL, V178, P1655, DOI 10.1093/aje/kwt196; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220443	10.1371/journal.pone.0220443	http://dx.doi.org/10.1371/journal.pone.0220443			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386686	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100021
J	Duy, SV; Munoz, G; Dinh, QT; Do, DT; Simon, DF; Sauve, S				Sung Vo Duy; Munoz, Gabriel; Quoc Tuc Dinh; Dat Tien Do; Simon, Dana F.; Sauve, Sebastien			Analysis of the neurotoxin beta-N-methylamino-L-alanine (BMAA) and isomers in surface water by FMOC derivatization liquid chromatography high resolution mass spectrometry	PLOS ONE			English	Article							DANSYL CHLORIDE DERIVATIZATION; PRECOLUMN DERIVATIZATION; CYANOBACTERIAL BLOOMS; FRESH-WATER; ACID; MICROCYSTINS; GLYPHOSATE; CYANOTOXINS; VALIDATION; QUANTIFICATION	The neurotoxin beta-N-methylamino-L-alanine (BMAA), suspected to trigger neurodegenerative diseases, can be produced during cyanobacterial bloom events and subsequently affect ecosystems and water sources. Some of its isomers including beta-amino-N-methylalanine (BAMA), N-(2-aminoethyl) glycine (AEG), and 2,4-diaminobutyric acid (DAB) may show different toxicities than BMAA. Here, we set out to provide a fast and sensitive method for the monitoring of AEG, BAMA, DAB and BMAA in surface waters. A procedure based on aqueous derivatization with 9-fluorenylmethyl chloroformate (FMOC-Cl) was investigated for this purpose. Under optimized conditions, a small aqueous sample aliquot (5 mL) was spiked with BMAA-d3 internal standard, subjected to FMOC-Cl derivatization, centrifuged, and analyzed. The high-throughput instrumental method (10 min per sample) involved on-line pre-concentration and desalting coupled to ultra-high-performance liquid chromatography high-resolution mass spectrometry (UHPLC-HRMS). Chromatographic gradient and mobile phases were adjusted to obtain suitable separation of the 4 isomers. The method limits of detection were in the range of 2-5 ng L-1. In-matrix validation parameters including linearity range, accuracy, precision, and matrix effects were assessed. The method was applied to surface water samples (n = 82) collected at a large spatial scale in lakes and rivers in Canada. DAB was found in > 70% of samples at variable concentrations (< 3-1,900 ng L-1), the highest concentrations corresponding to lake samples in cyanobacterial bloom periods. BMAA was only reported (110 ng L-1) at one HAB-impacted location. This is one of the first studies to report on the profiles of AEG, BAMA, DAB, and BMAA in background and impacted surface waters.	[Sung Vo Duy; Munoz, Gabriel; Quoc Tuc Dinh; Dat Tien Do; Simon, Dana F.; Sauve, Sebastien] Univ Montreal, Dept Chem, Montreal, PQ, Canada	Universite de Montreal	Sauve, S (corresponding author), Univ Montreal, Dept Chem, Montreal, PQ, Canada.	sebastien.sauve@umontreal.ca		Simon, Dana/0000-0003-3725-2482	Genome Canada; Genome Quebec; Natural Sciences and Engineering Research Council of Canada (NSERC-CRSNG) [STPGP 478774]; Quebec Research Fund (FRQ) [PR-183278]; Canada Foundation for Innovation (CFI) [30044]	Genome Canada(Genome Canada); Genome Quebec; Natural Sciences and Engineering Research Council of Canada (NSERC-CRSNG)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Research Fund (FRQ); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This study was conducted under the framework of the ATRAPP project (Algal Blooms, Treatment, Risk Assessment, Prediction and Prevention through Genomics), with financial support from Genome Canada and Genome Quebec to SS. We thank the Natural Sciences and Engineering Research Council of Canada (NSERC-CRSNG) for funding to SS (STPGP 478774), the Quebec Research Fund (FRQ) for funding to SS (PR-183278), and the Canada Foundation for Innovation (CFI) for their financial support to SS (30044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted under the framework of the ATRAPP project (Algal Blooms, Treatment, Risk Assessment, Prediction and Prevention through Genomics), with financial support from Genome Canada and Genome Quebec. We thank the Natural Sciences and Engineering Research Council of Canada (NSERC-CRSNG; STPGP 478774), the Quebec Research Fund (FRQ; PR-183278), and the Canada Foundation for Innovation (CFI; 30044) for their financial support. We thank N. Fortin and C. Greer (National Research Council Canada, Montreal, QC, Canada), M. Larsen and J. J. Venkiteswaran (Wilfrid Laurier University, Waterloo, ON, Canada), E. McAlister and H. Baulch (University of Saskatchewan, Saskatoon, SK, Canada), D. Taylor (Nova Scotia Environment, Halifax, NS, Canada), as well as Barry Husk (BlueLeaf Inc., Drummondville, QC, Canada) for their help in obtaining the field samples. We thank the NSERC Canadian Lake Pulse Network for sharing samples collected on 7 lakes. The authors gratefully acknowledge the crew from the Lampsilis research vessel, F. Guillemette and G. Cabana (Universite du Quebec a Trois-Rivieres, Trois-Rivieres, QC, Canada), and all those who participated in the sampling campaigns. We also acknowledge technical support from Thermo Fisher Scientific and Phytronix Technologies.	[Anonymous], 2017, SANTE118132017 SANCO; Anumol T, 2015, TALANTA, V132, P77, DOI 10.1016/j.talanta.2014.08.011; Banack SA, 2011, TOXICON, V57, P730, DOI 10.1016/j.toxicon.2011.02.005; Banack SA, 2003, NEUROLOGY, V61, P387, DOI 10.1212/01.WNL.0000078320.18564.9F; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; Banack SA, 2018, NEUROTOX RES, V33, P184, DOI 10.1007/s12640-017-9744-7; Beach DG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18392-w; Beach DG, 2015, ANAL BIOANAL CHEM, V407, P8397, DOI 10.1007/s00216-015-9012-8; Beltran E, 2012, J CHROMATOGR A, V1266, P61, DOI 10.1016/j.chroma.2012.10.017; Birbeck JA, 2019, TOXINS, V11, DOI 10.3390/toxins11010013; Bishop SL, 2018, NEUROTOX RES, V33, P133, DOI 10.1007/s12640-017-9820-z; Blahova L, 2017, TOXICON, V133, P48, DOI 10.1016/j.toxicon.2017.04.011; Chatziefthimiou AD, 2016, TOXICON, V114, P75, DOI 10.1016/j.toxicon.2016.02.016; Cohen SA, 2012, ANALYST, V137, P1991, DOI 10.1039/c2an16250d; Davis DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213346; Druart C, 2011, ANAL BIOANAL CHEM, V399, P1725, DOI 10.1007/s00216-010-4468-z; Dufour V, 2017, CHIMIE ANALYTIQUE EN, P1; Faassen EJ, 2014, TOXINS, V6, P1109, DOI 10.3390/toxins6031109; Faassen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065260; Faassen EJ, 2009, AMYOTROPH LATERAL SC, V10, P79, DOI 10.3109/17482960903272967; Fan H, 2015, ENVIRON SCI POLLUT R, V22, P5943, DOI 10.1007/s11356-014-3766-y; Fayad PB, 2015, TOXICON, V108, P167, DOI 10.1016/j.toxicon.2015.10.010; Foss AJ, 2018, TOXICON, V152, P150, DOI 10.1016/j.toxicon.2018.07.028; Freuze I, 2007, J CHROMATOGR A, V1175, P197, DOI 10.1016/j.chroma.2007.10.092; Goeury K, 2019, J CHROMATOGR A, V1591, P87, DOI 10.1016/j.chroma.2019.01.016; Gonzalez O, 2014, J CHROMATOGR A, V1353, P10, DOI 10.1016/j.chroma.2014.03.077; Gurbuz F, 2016, SCI TOTAL ENVIRON, V562, P860, DOI 10.1016/j.scitotenv.2016.04.027; Hanke I, 2008, ANAL BIOANAL CHEM, V391, P2265, DOI 10.1007/s00216-008-2134-5; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA110, DOI 10.1289/ehp.120-a110; Jiang LY, 2013, ANAL BIOANAL CHEM, V405, P1283, DOI 10.1007/s00216-012-6550-1; Jiang LY, 2012, ANAL BIOANAL CHEM, V403, P1719, DOI 10.1007/s00216-012-5966-y; Kabore HA, 2018, SCI TOTAL ENVIRON, V616, P1089, DOI 10.1016/j.scitotenv.2017.10.210; Kerrin ES, 2017, ANAL BIOANAL CHEM, V409, P1481, DOI 10.1007/s00216-016-0091-y; KISBY GE, 1988, J NEUROSCI METH, V26, P45, DOI 10.1016/0165-0270(88)90128-8; Koh HJ, 2011, B KOREAN CHEM SOC, V32, P3799, DOI 10.5012/bkcs.2011.32.10.3799; Lance E, 2018, TOXINS, V10, DOI 10.3390/toxins10020083; Lee JI, 2006, J CHROMATOGR A, V1116, P57, DOI 10.1016/j.chroma.2006.03.053; Main BJ, 2018, HARMFUL ALGAE, V74, P10, DOI 10.1016/j.hal.2018.03.004; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Matuszewski BK, 2006, J CHROMATOGR B, V830, P293, DOI 10.1016/j.jchromb.2005.11.009; Meriluoto J., 2017, HDB CYANOBACTERIAL M; Metcalf JS, 2008, ENVIRON MICROBIOL, V10, P702, DOI 10.1111/j.1462-2920.2007.01492.x; Montiel-Leon JM, 2019, ENVIRON POLLUT, V250, P29, DOI 10.1016/j.envpol.2019.03.125; Montiel-Leon JM, 2018, ANAL BIOANAL CHEM, V410, P2765, DOI 10.1007/s00216-018-0957-2; MOTEKAITIS RJ, 1982, CAN J CHEM, V60, P1207, DOI 10.1139/v82-179; Munoz G, 2017, J CHROMATOGR A, V1516, P9, DOI 10.1016/j.chroma.2017.07.096; Munoz G, 2015, ANAL CHIM ACTA, V881, P98, DOI 10.1016/j.aca.2015.04.015; Nedelkoska TV, 2004, ANAL CHIM ACTA, V511, P145, DOI 10.1016/j.aca.2004.01.027; Nunn PB, 2017, PHYTOCHEMISTRY, V144, P253, DOI 10.1016/j.phytochem.2017.09.015; Ploux O, 2017, HDB CYANOBACTERIAL M; Poiger T, 2017, ENVIRON SCI POLLUT R, V24, P1588, DOI 10.1007/s11356-016-7835-2; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; RIDEOUT JM, 1983, J LIQ CHROMATOGR, V6, P383, DOI 10.1080/01483918308066898; Roy-Lachapelle A, 2015, ANAL BIOANAL CHEM, V407, P5487, DOI 10.1007/s00216-015-8722-2; Rutkowska M, 2019, TRAC-TREND ANAL CHEM, V112, P112, DOI 10.1016/j.trac.2019.01.001; Salomonsson ML, 2013, ANAL METHODS-UK, V5, P4865, DOI 10.1039/c3ay40657a; Scott LL, 2018, TOXINS, V10, DOI 10.3390/toxins10010022; Shoemaker JA, 2015, 544 EPA; Turner AD, 2018, J CHROMATOGR B, V1074, P111, DOI 10.1016/j.jchromb.2017.12.032; Violi JP, 2019, ECOTOX ENVIRON SAFE, V172, P72, DOI 10.1016/j.ecoenv.2019.01.046; Vyas KJ, 2009, AMYOTROPH LATERAL SC, V10, P50, DOI 10.3109/17482960903268742; Wang JG, 2010, J HAZARD MATER, V176, P333, DOI 10.1016/j.jhazmat.2009.11.032	62	8	8	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220698	10.1371/journal.pone.0220698	http://dx.doi.org/10.1371/journal.pone.0220698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386693	Green Submitted, Green Published, gold			2022-12-26	WOS:000484997100032
J	Liu, YZ; Manners, J; Bittar, Y; Chou, SHY; Gopalakrishnan, V				Liu, Yuzhe; Manners, Jody; Bittar, Yazan; Chou, Sherry H-Y; Gopalakrishnan, Vanathi			Towards precision critical care management of blood pressure in hemorrhagic stroke patients using dynamic linear models	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTRACEREBRAL HEMORRHAGE; HYPERTENSION; GUIDELINES; LABETALOL; PROFESSIONALS; PHARMACOKINETICS; NICARDIPINE	Finding optimal blood pressure (BP) target and BP treatment after acute ischemic or hemorrhagic strokes is an area of controversy and a significant unmet need in the critical care of stroke victims. Numerous large prospective clinical trials have been done to address this question but have generated neutral or conflicting results. One major limitation that may have contributed to so many neutral or conflicting clinical trial results is the "one-size fit all" approach to BP targets, while the optimal BP target likely varies between individuals. We address this problem with the Acute Intervention Model of Blood Pressure (AIM-BP) framework: an individualized, human interpretable model of BP and its control in the acute care setting. The framework consists of two components: one, a model of BP homeostasis and the various effects that perturb it; and two, a parameter estimator that can learn clinically important model parameters on a patient by patient basis. By estimating the parameters of the AIM-BP model for a given patient, the effectiveness of antihypertensive medication can be quantified separately from the patient's spontaneous BP trends. We hypothesize that the AIM-BP is a sufficient framework for estimating parameters of a homeostasis perturbation model of a stroke patient's BP time course and the AIM-BP parameter estimator can do so as accurately and consistently as a state-of-the-art maximum likelihood estimation method. We demonstrate that this is the case in a proof of concept of the AIM-BP framework, using simulated clinical scenarios modeled on stroke patients from real world intensive care datasets.	[Liu, Yuzhe; Gopalakrishnan, Vanathi] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [Manners, Jody] Naval Med Ctr Portsmouth, Dept Neurol, Portsmouth, VA USA; [Bittar, Yazan] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Chou, Sherry H-Y] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Chou, Sherry H-Y] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Chou, Sherry H-Y] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Defense; United States Navy; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YZ (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	y.liu@pitt.edu		Liu, Brian/0000-0003-2102-4848; Gopalakrishnan, Vanathi/0000-0002-7813-4055	National Library of Medicine [NLM 2T15LM007059]; National Institute of Health [1K23-NS073806]; University of Pittsburgh Dean's Faculty Advancement ward; Edge Therapeutics; National Institute of General Medical Sciences [R01GM100387]; UPMC Academic Foundation Award; Merck; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100387] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007059] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Dean's Faculty Advancement ward; Edge Therapeutics(General Electric); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UPMC Academic Foundation Award; Merck(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Author YL gratefully acknowledges the National Library of Medicine (https://www.nlm.nih.gov/) for training grant NLM 2T15LM007059. Author SHYC received research support from the National Institute of Health (https://www.ninds.nih.gov/, 1K23-NS073806), The University of Pittsburgh Dean's Faculty Advancement ward and UPMC Academic Foundation Award. SHYC also received support from Edge Therapeutics as site principal investigator for the NEWTON 2 study and from Merck for consultation. Author VG gratefully acknowledges a grant from the National Institute of General Medical Sciences, Award Number R01GM100387 (https://www.nigms.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; We would like to thank the National Library of Medicine for funding this work (NLM 2T15LM007059).	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Alqadri SL, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0426-7; Anderson CS, 2016, NEW ENGL J MED, V374, P2313, DOI 10.1056/NEJMoa1515510; Appleton JP, 2016, STROKE VASC NEUROL, V1, P72, DOI 10.1136/svn-2016-000020; Bath PMW, 2015, LANCET, V385, P617, DOI 10.1016/S0140-6736(14)61121-1; Bowry Ritvij, 2014, Neurol Clin Pract, V4, P419; BRITTON M, 1986, STROKE, V17, P861, DOI 10.1161/01.STR.17.5.861; Butcher K, 2016, STROKE, V47, P3065, DOI 10.1161/STROKEAHA.116.015060; CARLIN BP, 1992, J AM STAT ASSOC, V87, P493, DOI 10.2307/2290282; CARTER CK, 1994, BIOMETRIKA, V81, P541; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; CHAUVIN M, 1987, BRIT J ANAESTH, V59, P1250, DOI 10.1093/bja/59.10.1250; Curran MP, 2006, DRUGS, V66, P1755, DOI 10.2165/00003495-200666130-00010; de Castilho FM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180060; Fearnhead P, 2011, CH CRC HANDB MOD STA, P513; GRAHAM DJM, 1985, BRIT J CLIN PHARMACO, V20, pS23, DOI 10.1111/j.1365-2125.1985.tb05141.x; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; LALONDE RL, 1990, CLIN PHARMACOL THER, V48, P509, DOI 10.1038/clpt.1990.187; Lau EHY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038346; Lehman LWH, 2018, IEEE J BIOMED HEALTH, V22, P56, DOI 10.1109/JBHI.2016.2636808; Lehman LWH, 2015, IEEE J BIOMED HEALTH, V19, P1068, DOI 10.1109/JBHI.2014.2330827; Lehman LWH, 2013, IEEE ENG MED BIO, P7072, DOI 10.1109/EMBC.2013.6611187; Lehman LWH, 2013, CRIT CARE MED, V41, P34, DOI 10.1097/CCM.0b013e318265ea46; Li Q, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-13; Liu ZT, 2016, AAAI CONF ARTIF INTE, P1273; Liu ZT, 2015, AAAI CONF ARTIF INTE, P1798; MacDougall J, 2006, STAT BIOL HEALTH, P127; Mahdi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003384; Mancia G, 2012, HYPERTENSION, V60, P512, DOI 10.1161/HYPERTENSIONAHA.112.194340; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; McManus M, 2016, J CLIN NEUROL, V12, P137, DOI 10.3988/jcn.2016.12.2.137; Petris G, 2009, USE R, P1, DOI 10.1007/b135794_1; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Raphan T, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00096; Ribezzo S, 2014, SCI WORLD J, DOI 10.1155/2014/353628; RICHARDS DA, 1977, EUR J CLIN PHARMACOL, V11, P85, DOI 10.1007/BF00562897; SAOTOME T, 1993, J CLIN PHARMACOL, V33, P979, DOI 10.1002/j.1552-4604.1993.tb01933.x; Schoemaker RC, 1998, J PHARMACOKINET BIOP, V26, P581, DOI 10.1023/A:1023277201179; SERLIN MJ, 1979, BRIT J CLIN PHARMACO, V7, P165, DOI 10.1111/j.1365-2125.1979.tb00916.x; Stevens SL, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4098; Strbian D, 2016, STROKE, V47, P3063, DOI 10.1161/STROKEAHA.116.015594; WALLACE JD, 1981, JAMA-J AM MED ASSOC, V246, P2177, DOI 10.1001/jama.246.19.2177; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; WILSON DJ, 1983, AM J MED, V75, P95, DOI 10.1016/0002-9343(83)90141-9; Wu J, 2017, STAT METHODS MED RES; Yapps B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08137-0	48	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220283	10.1371/journal.pone.0220283	http://dx.doi.org/10.1371/journal.pone.0220283			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381589	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600014
J	Zappi, DC; Moro, MF; Walker, B; Meagher, T; Viana, PL; Mota, NFO; Watanabe, MTC; Lughadha, EN				Zappi, Daniela C.; Moro, Marcelo F.; Walker, Barnaby; Meagher, Thomas; Viana, Pedro L.; Mota, Nara F. O.; Watanabe, Mauricio T. C.; Lughadha, Eimear Nic			Plotting a future for Amazonian canga vegetation in a campo rupestre context	PLOS ONE			English	Article							TREE; COMMUNITY; IRONSTONE; DIVERSITY; FRAMEWORK; RECOVERY; ECOLOGY	In order to establish effective conservation strategy, drivers of local and regional patterns of biodiversity need to be understood. The composition of local biodiversity is dependent on a number of factors including evolution and redistribution of lineages through dispersal and environmental heterogeneity. Brazilian canga is characterised by a ferrugineous substrate, found both in the Iron Quadrangle of Minas Gerais and in the Carajas mountains in Amazonia. Canga is one of several specialised habitat types comprising Brazilian campo rupestre, a montane vegetation found within or adjacent to several major Brazilian bioregions, including the Atlantic Forest and Amazonia, with exceptionally high levels of diversity and endemism arising from both history of dispersal and environmental variation. In order to inform biodiversity conservation for canga, and more broadly for campo rupestre, we performed floristic and phylogenetic analyses investigating affinities between 28 sites on different substrates (canga and quartzite) and geographic locations (Carajas, Para[Amazonia]; Cadeia do Espinhaco, Minas Gerais; Chapada Diamantina, Bahia). Through analysis of 11204 occurrences of 4705 species of angiosperms, we found that Amazonian Carajas canga plant communities formed a cohesive group, distinct from species assemblages found in Eastern Brazil (Minas Gerais, Bahia), either on canga or quartzite. The phylogenetic megatree of species across all sites investigated shows associations between certain clades and Amazonian canga, with few shared species between the Amazonian Carajas and Eastern Brazil sites, while the floristic comparison shows high levels of heterogeneity between sites. The need for reserves for Amazonian Carajas canga has been recognized and addressed by the creation of a national park. However, current sampling does not provide sufficient reassurance that the canga areas now benefitting from full legal protection adequately represent the regional canga flora.	[Zappi, Daniela C.; Mota, Nara F. O.; Watanabe, Mauricio T. C.] Inst Tecnol Vale, Belem, Para, Brazil; [Zappi, Daniela C.; Viana, Pedro L.; Mota, Nara F. O.] Museu Paraense Emilio Goeldi, Coordenacao Bot, Belem, Para, Brazil; [Moro, Marcelo F.] Univ Fed Ceara, Inst Ciencias Mar Labomar, Fortaleza, Ceara, Brazil; [Walker, Barnaby; Lughadha, Eimear Nic] Royal Bot Gardens, Conservat Sci Dept, Richmond, Surrey, England; [Meagher, Thomas] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Museu Paraense Emilio Goeldi; Universidade Federal do Ceara; Royal Botanic Gardens, Kew; University of St Andrews	Zappi, DC (corresponding author), Inst Tecnol Vale, Belem, Para, Brazil.; Zappi, DC (corresponding author), Museu Paraense Emilio Goeldi, Coordenacao Bot, Belem, Para, Brazil.	daniela.zappi14@gmail.com	Viana, Pedro/S-3127-2019; Zappi, Daniela C./F-9007-2015; Moro, Marcelo F/J-9882-2012; Nic Lughadha, Eimear/N-4560-2014	Zappi, Daniela C./0000-0001-6755-2238; Moro, Marcelo F/0000-0003-4527-346X; WATANABE, MAURICIO/0000-0001-9690-5565; Walker, Barnaby/0000-0002-3884-671X; Nic Lughadha, Eimear/0000-0002-8806-4345	CNPq [455505/2014-4]; MPEG/ITVDS/FADESP [01205.000250/2014-10]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BR-88887/130640/2016-00]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MPEG/ITVDS/FADESP; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq project (455505/2014-4) to all authors; The MPEG/ITVDS/FADESP Term of Agreement (01205.000250/2014-10); DCZ - CNPq productivity grant; NFOM - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR-88887/130640/2016-00).	Absaber AN, 1986, CARAJAS DESAFIO POLI, P88; AUSTIN D F, 1981, Acta Amazonica, V11, P291; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borregaard MK, 2014, METHODS ECOL EVOL, V5, P1225, DOI 10.1111/2041-210X.12283; Bustamante MMC, 2016, GLOBAL CHANGE BIOL, V22, P92, DOI 10.1111/gcb.13087; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carvalho GH, 2010, PLANTMINER WEB TOOL, DOI [10.1016/j.envsoft.2009.11.014, DOI 10.1016/J.ENVSOFT.2009.11.014]; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Porto MFD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00211015; Dexter KG, 2017, P NATL ACAD SCI USA, V114, P2645, DOI 10.1073/pnas.1613655114; Duarte LDS, 2012, ECOGRAPHY, V35, P952, DOI 10.1111/j.1600-0587.2011.07193.x; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Freitas L, 2016, PHYTOKEYS, P65, DOI 10.3897/phytokeys.58.5643; Gastauer M, 2017, ACTA BOT BRAS, V31, P191, DOI 10.1590/0102-33062016abb0306; Gibson N, 2012, J ARID ENVIRON, V77, P25, DOI 10.1016/j.jaridenv.2011.08.021; Giulietti AM, 1987, B BOT U SAO PAULO, V9, P1, DOI DOI 10.11606/ISSN.2316-9052.V9I0P1-151; Giulietti AM., 2018, GUIA ESPECIES INVASO; Gotelli Nicholas J., 2011, P39; Hopper SD, 2016, PLANT SOIL, V403, P167, DOI 10.1007/s11104-015-2764-2; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Jacobi CM, 2007, BIODIVERS CONSERV, V16, P2185, DOI 10.1007/s10531-007-9156-8; Jacobi CM, 2008, REV ARVORE, V32, P345, DOI 10.1590/S0100-67622008000200017; KING R M, 1980, Phytologia, V47, P113; KING R M, 1980, Phytologia, V47, P110; KIRKBRIDE J H JR, 1980, Acta Amazonica, V10, P97; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lohmann Lúcia G., 2018, Rodriguésia, V69, P1063, DOI 10.1590/2175-7860201869313; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Monteiro DA, 2018, FLORA CANGAS SERRA C, P69; Moro MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119166; Moro MF, 2012, ACTA BOT BRAS, V26, P991, DOI 10.1590/S0102-33062012000400029; Mota Nara Furtado de Oliveira, 2018, Rodriguésia, V69, P1435, DOI 10.1590/2175-7860201869336; Ometto JP, 2014, CLIMATIC CHANGE, V124, P545, DOI 10.1007/s10584-014-1058-7; Pereira AV, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001635; Peres CA, 2010, BIOL CONSERV, V143, P2314, DOI 10.1016/j.biocon.2010.01.021; Pifano Daniel Salgado, 2010, Biota Neotrop., V10, P55, DOI 10.1590/S1676-06032010000100005; Pimm SL, 2010, NAT CONSERVACAO, V8, P71, DOI 10.4322/natcon.00801011; Pirani JR, 2009, B BOT, V27; R Core Team, 2018, R LANG ENV STAT COMP; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Silva Manoela F. F. De, 1996, Acta Amazonica, V26, P17; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Stannard BL., 1995, FLORA PICO ALMAS; Takahasi Adriana, 2014, Hoehnea, V41, P515, DOI 10.1590/2236-8906-63/2013; Taylor P.G., 1989, KEW B, V14, P1; Messias MCTB, 2013, FOLIA GEOBOT, V48, P509, DOI 10.1007/s12224-013-9154-4; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Viana Pedro Lage, 2007, Rodriguésia, V58, P157, DOI 10.1590/2175-7860200758112; Viana Pedro Lage, 2016, Rodriguésia, V67, P1107, DOI 10.1590/2175-7860201667501; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Workman D., 2018, WORLDSTOPEXPORTS; Zappi D. C., 2017, PAISAGENS PLANTAS CA; Zappi Daniela C., 2003, Boletim de Botanica da Universidade de Sao Paulo, V21, P345; Zappi DC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02141; Zappi Daniela C., 2015, Rodriguésia, V66, P1085, DOI 10.1590/2175-7860201566411	57	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219753	10.1371/journal.pone.0219753	http://dx.doi.org/10.1371/journal.pone.0219753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381566	gold, Green Published, Green Submitted			2022-12-26	WOS:000484993600006
J	Caversaccio, M; Wimmer, W; Anso, J; Mantokoudis, G; Gerber, N; Rathgeb, C; Schneider, D; Hermann, J; Wagner, F; Scheidegger, O; Huth, M; Anschuetz, L; Kompis, M; Williamson, T; Bell, B; Gavaghan, K; Weber, S				Caversaccio, Marco; Wimmer, Wilhelm; Anso, Juan; Mantokoudis, Georgios; Gerber, Nicolas; Rathgeb, Christoph; Schneider, Daniel; Hermann, Jan; Wagner, Franca; Scheidegger, Olivier; Huth, Markus; Anschuetz, Lukas; Kompis, Martin; Williamson, Tom; Bell, Brett; Gavaghan, Kate; Weber, Stefan			Robotic middle ear access for cochlear implantation: First in man	PLOS ONE			English	Article							INSERTION; TOOL	To demonstrate the feasibility of robotic middle ear access in a clinical setting, nine adult patients with severe-to-profound hearing loss indicated for cochlear implantation were included in this clinical trial. A keyhole access tunnel to the tympanic cavity and targeting the round window was planned based on preoperatively acquired computed tomography image data and robotically drilled to the level of the facial recess. Intraoperative imaging was performed to confirm sufficient distance of the drilling trajectory to relevant anatomy. Robotic drilling continued toward the round window. The cochlear access was manually created by the surgeon. Electrode arrays were inserted through the keyhole tunnel under microscopic supervision via a tympanomeatal flap. All patients were successfully implanted with a cochlear implant. In 9 of 9 patients the robotic drilling was planned and performed to the level of the facial recess. In 3 patients, the procedure was reverted to a conventional approach for safety reasons. No change in facial nerve function compared to baseline measurements was observed. Robotic keyhole access for cochlear implantation is feasible. Further improvements to workflow complexity, duration of surgery, and usability including safety assessments are required to enable wider adoption of the procedure.	[Caversaccio, Marco; Wimmer, Wilhelm; Mantokoudis, Georgios; Huth, Markus; Anschuetz, Lukas; Kompis, Martin] Univ Bern, Bern Univ Hosp, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, Bern, Switzerland; [Caversaccio, Marco; Wimmer, Wilhelm; Rathgeb, Christoph] Univ Bern, ARTORG Ctr Biomed Engn Res, Hearing Res Lab, Bern, Switzerland; [Anso, Juan; Gerber, Nicolas; Schneider, Daniel; Hermann, Jan; Williamson, Tom; Bell, Brett; Gavaghan, Kate; Weber, Stefan] Univ Bern, ARTORG Ctr Biomed Engn Res, Image Guided Therapy, Bern, Switzerland; [Wagner, Franca] Univ Bern, Bern Univ Hosp, Dept Diagnost & Intervent Neuroradiol, Inselspital, Bern, Switzerland; [Scheidegger, Olivier] Univ Bern, Bern Univ Hosp, Dept Neurol, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Wimmer, W (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, Bern, Switzerland.; Wimmer, W (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Hearing Res Lab, Bern, Switzerland.	wilhelm.wimmer@artorg.unibe.ch	Anschuetz, Lukas/X-3595-2019; Scheidegger, Olivier/AAF-8714-2020; Anso, Juan/X-4992-2019; Mantokoudis, Georgios/J-6318-2013; Gerber, Kate/GSD-6162-2022	Anschuetz, Lukas/0000-0001-6927-0664; Scheidegger, Olivier/0000-0003-3925-5142; Anso, Juan/0000-0001-9127-0396; Caversaccio, Marco/0000-0002-7090-8087; Mantokoudis, Georgios/0000-0003-2268-7811; Gerber, Kate/0000-0003-4086-4973; Wimmer, Wilhelm/0000-0001-5392-2074	Swiss National Science Foundation (project NCCR Co-Me); Swiss Commission for Technology and Innovation [MIRACI 17618.1]; European Commission (project HEAR-EU) [304857]; Swiss Nano-Tera initiative (project HearRestore); MED-EL GmbH (Innsbruck, Austria); CAScination AG (Bern, Switzerland); Xoran Technologies (Ann Arbor, USA); University of Bern; Inselspital University hospital Bern	Swiss National Science Foundation (project NCCR Co-Me)(Swiss National Science Foundation (SNSF)); Swiss Commission for Technology and Innovation; European Commission (project HEAR-EU); Swiss Nano-Tera initiative (project HearRestore); MED-EL GmbH (Innsbruck, Austria); CAScination AG (Bern, Switzerland); Xoran Technologies (Ann Arbor, USA); University of Bern; Inselspital University hospital Bern	Work leading to this clinical study was supported by the Swiss National Science Foundation (project NCCR Co-Me), the Swiss Commission for Technology and Innovation (project MIRACI 17618.1), the European Commission (project HEAR-EU, 304857), the Swiss Nano-Tera initiative (project HearRestore), MED-EL GmbH (Innsbruck, Austria), CAScination AG (Bern, Switzerland), and Xoran Technologies (Ann Arbor, USA). The study itself was solely funded by institutional support of the University of Bern and the Inselspital University hospital Bern. Support by commercial partners was provided in the form of research material and in-kind contributions. None of the commercial funders had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anschuetz L, 2018, OTOL NEUROTOL, V39, pE996, DOI 10.1097/MAO.0000000000002034; Anso J, 2018, ANN BIOMED ENG, V46, P1568, DOI 10.1007/s10439-018-2094-7; Anso J, 2016, OTOL NEUROTOL, V37, P89, DOI 10.1097/MAO.0000000000000914; Bell B, 2013, OTOL NEUROTOL, V34, P1284, DOI 10.1097/MAO.0b013e31829561b6; Brand Y, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13909; Caversaccio M, 2017, ACTA OTO-LARYNGOL, V137, P447, DOI 10.1080/00016489.2017.1278573; Crowson MG, 2017, AUDIOL NEURO-OTOL, V22, P236, DOI 10.1159/000481767; Feldmann A, 2016, ANN BIOMED ENG, V44, P1576, DOI 10.1007/s10439-015-1450-0; Gerber N, 2014, INT J COMPUT ASS RAD, V9, P11, DOI 10.1007/s11548-013-0908-5; Gerber N, 2013, IEEE T BIO-MED ENG, V60, P960, DOI 10.1109/TBME.2013.2241063; Hausler R, 2002, ACTA OTO-LARYNGOL, V122, P715, DOI 10.1080/00016480260349773; House WF., 1976, ANN OTO RHINOL LARYN, V85, pS1; Kiratzidis T, 2002, ORL-J OTO-RHIN-LARYN, V64, P413, DOI 10.1159/000067577; Labadie RF, 2014, LARYNGOSCOPE, V124, P1915, DOI 10.1002/lary.24520; Marchioni D, 2014, EUR ARCH OTO-RHINO-L, V271, P959, DOI 10.1007/s00405-013-2490-4; Migirov Lela, 2010, Cochlear Implants Int, V11 Suppl 1, P195, DOI 10.1179/146701010X12671177818786; Muller J, 2017, HNO, V65, P561, DOI 10.1007/s00106-017-0370-8; Rathgeb C, 2019, INT J COMPUT ASS RAD, V14, P83, DOI 10.1007/s11548-018-1834-3; Roland JT, 2018, LARYNGOSCOPE, V128, P1939, DOI 10.1002/lary.27073; Ross BG, 1996, OTOLARYNG HEAD NECK, V114, P380, DOI 10.1016/S0194-5998(96)70206-1; Skarzynski H, 2013, ACTA OTO-LARYNGOL, V133, P3, DOI 10.3109/00016489.2013.869059; Stenin I, 2017, INT J COMPUT ASS RAD, V12, P889, DOI 10.1007/s11548-017-1533-5; Weber S, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aal4916; Williamson T, 2017, OTOL NEUROTOL, V38, P759, DOI 10.1097/MAO.0000000000001357; Williamson TM, 2013, IEEE T BIO-MED ENG, V60, P969, DOI 10.1109/TBME.2012.2235439; Wimmer W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/596498; Wimmer W, 2014, AUDIOL NEURO-OTOL, V19, P22, DOI 10.1159/000356165; Yang GZ, SCI ROBOT, V2; Zeh R, 2015, HNO, V63, P557, DOI 10.1007/s00106-015-0037-2	29	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220543	10.1371/journal.pone.0220543	http://dx.doi.org/10.1371/journal.pone.0220543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374092	Green Submitted, Green Published, gold			2022-12-26	WOS:000484991500016
J	Raliou, M; Dembele, D; Duvel, A; Bolifraud, P; Aubert, J; Mary-Huard, T; Rocha, D; Piumi, F; Mockly, S; Heppelmann, M; Dieuzy-Labaye, I; Zieger, P; Smith, DGE; Schuberth, HJ; Sheldon, IM; Sandra, O				Raliou, Mariam; Dembele, Doulaye; Duevel, Anna; Bolifraud, Philippe; Aubert, Julie; Mary-Huard, Tristan; Rocha, Dominique; Piumi, Francois; Mockly, Sophie; Heppelmann, Maike; Dieuzy-Labaye, Isabelle; Zieger, Peter; Smith, David G. E.; Schuberth, Hans-Joachim; Sheldon, Iain Martin; Sandra, Olivier			Subclinical endometritis in dairy cattle is associated with distinct mRNA expression patterns in blood and endometrium	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PERIPHERAL-BLOOD; INFLAMMATORY CYTOKINES; BOVINE; COWS; ATHEROSCLEROSIS; LEUKOCYTES; APOPTOSIS; S100A8; CELLS	Cattle with subclinical endometritis (SCE) are sub-fertile and diagnosing subclinical uterine disease remains a challenge. The hypothesis for this study was that endometrial inflammation is reflected in mRNA expression patterns of peripheral blood leucocytes. Transcriptome profiles were evaluated in healthy cows and in cows with SCE using circulating white blood cells (WBC) and endometrial biopsy samples collected from the same animals at 45-55 days postpartum. Bioinformatic analyses of microarray-based transcriptional data identified gene profiles associated with distinct biological functions in circulating WBC and endometrium. In circulating WBC, SCE promotes a pro-inflammatory environment, whereas functions related to tissue remodeling are also affected in the endometrium. Nineteen differentially expressed genes associated with SCE were common to both circulating WBC and the endometrium. Among these genes, transcript abundance of immune factors C3, C2, LTF, PF4 and TRAPPC13 were up-regulated in SCE cows at 45-55 days postpartum. Moreover, mRNA expression of C3, CXCL8, LTF, TLR2 and TRAPPC13 was temporally regulated during the postpartum period in circulating WBC of healthy cows compared with SCE cows. This observation might indicate an advantageous modulation of the immune system in healthy animals. The transcript abundance of these genes represents a potential source of indicators for postpartum uterine health.	[Raliou, Mariam; Bolifraud, Philippe; Piumi, Francois; Mockly, Sophie; Sandra, Olivier] Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France; [Dembele, Doulaye] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104, Inserm 964, Illkirch Graffenstaden, France; [Duevel, Anna; Schuberth, Hans-Joachim] Univ Vet Med, Fdn Hannover, Immunol Unit, Hannover, Germany; [Aubert, Julie; Mary-Huard, Tristan] AgroParisTech, UMR MIA 518, Paris, France; [Rocha, Dominique] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France; [Heppelmann, Maike] Univ Vet Med Hannover, Clin Cattle, Endocrinol Lab, Hannover, Germany; [Dieuzy-Labaye, Isabelle] Zoetis, Zaventem, Belgium; [Zieger, Peter] Zoetis, Berlin, Germany; [Smith, David G. E.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Sheldon, Iain Martin] Swansea Univ, Swansea Univ Med Sch, Inst Life Sci, Swansea, W Glam, Wales; [Piumi, Francois] Ecole Natl Vet Alfort, UPE, INRA,UMR Virol, ENVA,ANSES, Maisons Alfort, France; [Mockly, Sophie] Univ Montpellier, Inst Genet Humaine, CNRS UMR9002, Montpellier, France; [Dieuzy-Labaye, Isabelle] OIE Org Mondiale Sante Anim, Paris, France	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Veterinary Medicine Hannover, Foundation; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Veterinary Medicine Hannover, Foundation; Zoetis; Zoetis; University of Glasgow; Swansea University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Raliou, M; Sandra, O (corresponding author), Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France.	mariam.raliou@inra.fr; olivier.sandra@inra.fr	AUBERT, Julie/AAJ-8960-2021; Sheldon, I Martin/E-1567-2013; Schuberth, Hans-Joachim/AAE-4845-2020; Rocha, Dominique/R-5546-2019; Dembele, Doulaye/O-6513-2017	AUBERT, Julie/0000-0001-5203-5748; Sheldon, I Martin/0000-0001-7902-5558; Rocha, Dominique/0000-0003-4998-9641; PIUMI, Francois/0000-0001-6036-7662; Raliou, Mariam/0000-0002-3828-1421; Dembele, Doulaye/0000-0003-3879-6940	ERA-NET EMIDA (Coordination of European Research on Emerging and Major Infectious Diseases of Livestock); UK Biotechnology and Biological Sciences Research Council; BBSRC [BB/I017283/1, BB/K006592/1] Funding Source: UKRI	ERA-NET EMIDA (Coordination of European Research on Emerging and Major Infectious Diseases of Livestock); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was funded by the ERA-NET EMIDA (Coordination of European Research on Emerging and Major Infectious Diseases of Livestock), 2010. IMS was supported by the UK Biotechnology and Biological Sciences Research Council Grant BB/1017240/.	Al-Gubory KH, 2017, THERIOGENOLOGY, V99, P111, DOI 10.1016/j.theriogenology.2017.05.017; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Baber I, 2011, INFECT GENET EVOL, V11, P765, DOI 10.1016/j.meegid.2010.10.008; Baker JR, 2011, DEV DYNAM, V240, P2194, DOI 10.1002/dvdy.22709; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Benjamini Y, 1995, CONTROLLING FALSE DI, DOI [10.1176/ajp.156.6, DOI 10.1176/AJP.156.6]; Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bondurant RH, 1999, J ANIM SCI, V77, P101; Brodzki P, 2015, THERIOGENOLOGY, V84, P11, DOI 10.1016/j.theriogenology.2015.02.006; Calder PC, 2013, BRIT J NUTR, V109, pS1, DOI 10.1017/S0007114512005119; Chow WN, 2009, MOL REPROD DEV, V76, P647, DOI 10.1002/mrd.21013; Credille BC, 2015, RES VET SCI, V101, P6, DOI 10.1016/j.rvsc.2015.05.013; Davies D, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-53; Dembele D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-14; Duvel A, 2014, THERIOGENOLOGY, V81, P906, DOI 10.1016/j.theriogenology.2014.01.007; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Foley C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1967-5; Gabler C, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-152; Galvao KN, 2012, THERIOGENOLOGY, V77, P356, DOI 10.1016/j.theriogenology.2011.08.008; Galvao KN, 2011, THERIOGENOLOGY, V76, P290, DOI 10.1016/j.theriogenology.2011.02.006; Ghasemi F, 2012, THERIOGENOLOGY, V78, P1538, DOI 10.1016/j.theriogenology.2012.06.022; Gilbert RO, 2005, THERIOGENOLOGY, V64, P1879, DOI 10.1016/j.theriogenology.2005.04.022; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Ishii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080297; Kannaki TR, 2011, ANIM REPROD SCI, V125, P1, DOI 10.1016/j.anireprosci.2011.03.008; KEHRLI ME, 1989, AM J VET RES, V50, P215; KEHRLI ME, 1989, AM J VET RES, V50, P207; Kim JJ, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00020; Kimura K, 1999, J DAIRY SCI, V82, P315, DOI 10.3168/jds.S0022-0302(99)75238-0; Kiracofe G H, 1980, J Anim Sci, V51 Suppl 2, P16; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lewis GS, 2003, J ANIM SCI, V81, P285; Lokki AI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00589; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; McGuire K, 2006, ANIM GENET, V37, P47, DOI 10.1111/j.1365-2052.2005.01364.x; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; Muller MP, 2017, J DAIRY SCI, V100, P1987, DOI 10.3168/jds.2016-11506; Naderi S, 2018, ANIM GENET, V49, P178, DOI 10.1111/age.12661; Passey RJ, 1999, J IMMUNOL, V163, P2209; Peter S, 2015, J PHYSIOL PHARMACOL, V66, P449; Pomeroy B, 2017, VET RES, V48, DOI 10.1186/s13567-017-0415-8; Ramirez-Peinado S, 2017, J CELL SCI, V130, P2251, DOI 10.1242/jcs.199521; Ramos RS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0036-x; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Salilew-Wondim D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2513-9; Sheldon IM, 2009, REPROD DOMEST ANIM, V44, P1, DOI 10.1111/j.1439-0531.2009.01465.x; Sheldon IM, 2008, VET J, V176, P115, DOI 10.1016/j.tvjl.2007.12.031; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Shuster DE, 1997, INFECT IMMUN, V65, P3286, DOI 10.1128/IAI.65.8.3286-3292.1997; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Swain DK, 2014, VET RES COMMUN, V38, P209, DOI 10.1007/s11259-014-9606-1; Ueno K, 2015, CIRC J, V79, P1349, DOI 10.1253/circj.CJ-14-1323; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagener K, 2017, THERIOGENOLOGY, V94, P21, DOI 10.1016/j.theriogenology.2017.02.005; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Ye L, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006323; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	65	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220244	10.1371/journal.pone.0220244	http://dx.doi.org/10.1371/journal.pone.0220244			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374089	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000484991500005
J	Singh, S; Bermudez-Contreras, E; Nazari, M; Sutherland, RJ; Mohajerani, MH				Singh, Surjeet; Bermudez-Contreras, Edgar; Nazari, Mojtaba; Sutherland, Robert J.; Mohajerani, Majid H.			Low-cost solution for rodent home-cage behaviour monitoring	PLOS ONE			English	Article							TRANSGENIC MOUSE MODELS; SLEEP-WAKE BEHAVIOR; MICE; TRACKING; IDENTIFICATION; HUNTINGTONS; RESOLUTION; DISEASE; SIGNALS; SYSTEM	In the current research on measuring complex behaviours/phenotyping in rodents, most of the experimental design requires the experimenter to remove the animal from its homecage environment and place it in an unfamiliar apparatus (novel environment). This interaction may influence behaviour, general well-being, and the metabolism of the animal, affecting the phenotypic outcome even if the data collection method is automated. Most of the commercially available solutions for home-cage monitoring are expensive and usually lack the flexibility to be incorporated with existing home-cages. Here we present a low-cost solution for monitoring home-cage behaviour of rodents that can be easily incorporated to practically any available rodent home-cage. To demonstrate the use of our system, we reliably predict the sleep/wake state of mice in their home-cage using only video. We validate these results using hippocampal local field potential (LFP) and electromyography (EMG) data. Our approach provides a low-cost flexible methodology for high-throughput studies of sleep, circadian rhythm and rodent behaviour with minimal experimenter interference.	[Singh, Surjeet; Bermudez-Contreras, Edgar; Nazari, Mojtaba; Sutherland, Robert J.; Mohajerani, Majid H.] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB, Canada	University of Lethbridge	Sutherland, RJ; Mohajerani, MH (corresponding author), Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB, Canada.	robert.sutherland@uleth.ca; mohajerani@uleth.ca	Contreras, Edgar Bermudez/AAB-2566-2019; singh, surjeet/AAI-3872-2020	Contreras, Edgar Bermudez/0000-0002-4937-1780; singh, surjeet/0000-0002-4646-2089; Mohajerani, Majid H./0000-0003-0964-2977	Natural Sciences and Engineering Research Council of Canada (NSERC) [40352, RGPIN-2017-03857]; Campus Alberta for Innovation Program Chair; Alberta Alzheimer Research Program; Alzheimer Society of Canada; NSERC Discovery Grant; Alberta Neuroscience Program Grant	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Campus Alberta for Innovation Program Chair; Alberta Alzheimer Research Program; Alzheimer Society of Canada; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Neuroscience Program Grant	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant #40352 and #RGPIN-2017-03857 (MHM), Campus Alberta for Innovation Program Chair, Alberta Alzheimer Research Program, Alzheimer Society of Canada (MHM), NSERC Discovery Grant and Alberta Neuroscience Program Grant (RJS). Some of the authors (EBC, MHM, and RJS) have a financial interest in the company "NeuroCage Systems Inc." that is developing a product "Homecage Monitoring System" whose initial design was inspired by the results presented in this work. The funders and this company had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant #40352 and #RGPIN-2017-03857 (MHM), Campus Alberta for Innovation Program Chair, Alberta Alzheimer Research Program, Alzheimer Society of Canada (MHM), NSERC Discovery Grant and Alberta Neuroscience Program Grant (RJS).	Aoki R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01371-0; Bains RS, 2018, J NEUROSCI METH, V300, P37, DOI 10.1016/j.jneumeth.2017.04.014; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Bermudez-Contreras E, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.2.025005; Bourel M, 2014, COMPUT STAT DATA AN, V79, P149, DOI 10.1016/j.csda.2014.05.004; Brown L, 2016, COMPASS CONTINUOUS O; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dandan S, 2016, 2016 3RD INTERNATION; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Eckel-Mahan Kristin, 2015, Curr Protoc Mouse Biol, V5, P271, DOI 10.1002/9780470942390.mo140229; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Flores AE, 2007, IEEE T BIO-MED ENG, V54, P225, DOI 10.1109/TBME.2006.886938; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Godbehere AB, 2012, P AMER CONTR CONF, P4305; Goodman S, 2002, NATURE, V417, P684, DOI 10.1038/417684a; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hawkins P, 2002, LAB ANIM-UK, V36, P378, DOI 10.1258/002367702320389044; Hong WZ, 2015, P NATL ACAD SCI USA, V112, pE5351, DOI 10.1073/pnas.1515982112; Howerton CL, 2012, J NEUROSCI METH, V209, P74, DOI 10.1016/j.jneumeth.2012.06.001; Jafari Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09799-6; Jaliy Udesang K., 2014, INT J INNOVATIVE RES, V2; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Jones D, 2017, PICAMERA PURE PYTHON; KaewTraKulPong P, 2002, VIDEO-BASED SURVEILLANCE SYSTEMS: COMPUTER VISION AND DISTRIBUTED PROCESSING, P135; Lee JQ, 2017, HIPPOCAMPUS, V27, P951, DOI 10.1002/hipo.22759; Littin K, 2008, P ROY SOC B-BIOL SCI, V275, P1865, DOI 10.1098/rspb.2008.0388; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; McShane BB, 2012, SLEEP, V35, P433, DOI 10.5665/sleep.1712; Mehla J, 2018, J ALZHEIMERS DIS, V61, P283, DOI 10.3233/JAD-170635; Melchior S, RASPICAM DOCUMENTATI; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Murphy TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11611; Noorshams O, 2017, AUTOMATED SYSTEMS AS; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Poddar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083171; Redfern WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181068; Richter H, 2008, BEHAV BRAIN RES, V190, P74, DOI 10.1016/j.bbr.2008.02.005; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Salem GH, 2015, BEHAV RES METHODS, V47, P235, DOI 10.3758/s13428-014-0451-5; Singh S, 2016, BEHAV BRAIN RES, V299, P141, DOI 10.1016/j.bbr.2015.11.023; Spruijt Berry M, 2006, Drug Discov Today Technol, V3, P231, DOI 10.1016/j.ddtec.2006.06.010; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Storch C, 2004, J NEUROSCI METH, V133, P173, DOI 10.1016/j.jneumeth.2003.10.008; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Vecchio Laura M, 2018, Brain Plast, V4, P17, DOI 10.3233/BPL-180069; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; Whishaw IQ, 2017, EXP BRAIN RES, V235, P1919, DOI 10.1007/s00221-017-4925-4; Winter Y, 2011, J NEUROSCI METH, V196, P276, DOI 10.1016/j.jneumeth.2011.01.017; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zivkovic Z, 2006, PATTERN RECOGN LETT, V27, P773, DOI 10.1016/j.patrec.2005.11.005; Zivkovic Z, 2004, INT C PATT RECOG, P28, DOI 10.1109/ICPR.2004.1333992	57	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220751	10.1371/journal.pone.0220751	http://dx.doi.org/10.1371/journal.pone.0220751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374097	gold, Green Submitted, Green Published			2022-12-26	WOS:000484991500031
J	Stevenson, SA; Ciucci, MR; Kelm-Nelson, CA				Stevenson, Sharon A.; Ciucci, Michelle R.; Kelm-Nelson, Cynthia A.			Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease	PLOS ONE			English	Article							50-KHZ ULTRASONIC VOCALIZATIONS; VENTRAL TEGMENTAL AREA; INTENSIVE VOICE TREATMENT; NUCLEUS-ACCUMBENS; GABA NEURONS; LARGE-SAMPLE; DOPAMINE; COMMUNICATION; SPEECH; REWARD	The neural mechanisms underlying behavioral therapy for vocal acoustic deficits in patients with Parkinson disease is unknown. A primary hypothesis is that voice therapy may modulate mesolimbic brainstem regions, including the ventral tegmental area (VTA). The VTA is implicated in ultrasonic call peak frequency, involved in rewarding behaviors, and impacted by Parkinsonism. We tested the hypothesis that chronic (daily) behavioral vocal exercise of male Pink1-/- rats would alter ultrasonic vocalization acoustics and mesolimbic neurochemistry (catecholamines, GABA, mu-opioid receptor) compared to three different controls: sham-exercised Pink1-/-, unexercised Pink1-/-, and unexercised wildtype (WT) rats. A subhypothesis is that sham-exercise rats may exhibit changes to VTA neurochemistry as a result of a type or rewarding intervention. Results demonstrate that average bandwidth (frequency range) of ultrasonic vocalizations did not differ between WT, Pink1-/- no exercise vs. sham and vocal-exercise rats. However, average peak frequency is significantly reduced in vocal-exercised Pink1-/- rats compared to Pink1-/- no exercise, and WT groups. Unexpectedly, there were no significant acoustic differences between the vocal- and sham-exercised groups. There were no differences in catecholamine protein concentrations or tyrosine hydroxylase mRNA expression in the VTA between any of the groups. However, there was significant upregulation of all GABA-related genes in both vocal- and sham-exercised Pink1-/- rats (Gad1, Gad2, Gls, Glul); this finding was confirmed with follow up quantitative Western blotting for GAD. Additionally, there were differential results for mu-opioid receptor quantification in the VTA: vocal-exercised Pink1-/- rats showed increased mRNA expression for mu-opioid receptors whereas Western blotting indicated decreased protein levels in all Pink1-/- rats compared to WT controls suggesting the possible onset of pathology in this model. These data demonstrate modulatory effects of a rewarding behavioral paradigm on ultrasonic vocalization peak frequency. The results suggest that neuromodulators such as GABA and opioid activity, as well as the rewarding aspects of therapy may play a key role in shaping vocal treatments.	[Stevenson, Sharon A.; Ciucci, Michelle R.; Kelm-Nelson, Cynthia A.] Univ Wisconsin, Dept Surg, Div Otolaryngol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kelm-Nelson, CA (corresponding author), Univ Wisconsin, Dept Surg, Div Otolaryngol, Madison, WI 53706 USA.	CAKelm@wisc.edu	Ciucci, Michelle/O-9144-2016	Ciucci, Michelle/0000-0002-9913-8784; Kelm-Nelson, Cynthia/0000-0001-6670-2177	National Institutes of Health-National Institute on Deafness and Other Communication Disorders [R01 DC014358]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC016135, F32DC014399, R01DC014358] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by: R21 DC016135, National Institutes of Health-National Institute on Deafness and Other Communication Disorders (https://www.nidcd.nih.gov/) to CKN; and by R01 DC014358, National Institutes of Health-National Institute on Deafness and Other Communication Disorders (https://www.nidcd.nih.gov/) to MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberico SL, 2015, BASAL GANGLIA, V5, P51, DOI 10.1016/j.baga.2015.06.001; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Behrman A, 2006, AM J SPEECH-LANG PAT, V15, P215, DOI 10.1044/1058-0360(2006/020); Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bialy M, 2000, BEHAV NEUROSCI, V114, P983, DOI 10.1037//0735-7044.114.5.983; Blaszczyk JW, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00269; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bressan RA, 2005, ACTA PSYCHIAT SCAND, V111, P14, DOI 10.1111/j.1600-0447.2005.00540.x; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brudzynski SM, 2002, J COMP PSYCHOL, V116, P73, DOI 10.1037//0735-7036.116.1.73; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Brudzynski SM, 2009, ILAR J, V50, P43, DOI 10.1093/ilar.50.1.43; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Caminiti SP, 2017, NEUROIMAGE-CLIN, V14, P734, DOI 10.1016/j.nicl.2017.03.011; CHINAGLIA G, 1992, NEUROSCIENCE, V49, P317, DOI 10.1016/0306-4522(92)90099-N; Ciucci MR, 2007, BEHAV BRAIN RES, V182, P284, DOI 10.1016/j.bbr.2007.02.020; Ciucci MR, 2013, SEMIN SPEECH LANG, V34, P185, DOI 10.1055/s-0033-1358367; Ciucci Michelle R, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS172, DOI 10.1016/j.parkreldis.2008.04.027; Clucci MR, 2009, BEHAV NEUROSCI, V123, P328, DOI 10.1037/a0014593; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cullen KP, 2018, DYSPHAGIA, V33, P749, DOI 10.1007/s00455-018-9896-5; Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; De Letter M, 2006, ACTA NEUROL BELG, V106, P19; De Letter M, 2007, CLIN LINGUIST PHONET, V21, P783, DOI 10.1080/02699200701538181; Fleming SM, 2012, BEHAV BRAIN RES, V231, P317, DOI 10.1016/j.bbr.2012.02.034; Fox Cynthia M., 2006, Seminars in Speech and Language, V27, P283, DOI 10.1055/s-2006-955118; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; GAUTHIER L, 1987, AM J OCCUP THER, V41, P360, DOI 10.5014/ajot.41.6.360; Grant LM, 2015, J NEUROSCI RES, V93, P1713, DOI 10.1002/jnr.23625; Grant LM, 2015, BEHAV BRAIN RES, V291, P361, DOI 10.1016/j.bbr.2015.05.042; Grant LM, 2018, BEHAV NEUROSCI; Groppe SE, 2013, BIOL PSYCHIAT, V74, P172, DOI 10.1016/j.biopsych.2012.12.023; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Johnson AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2835; Kelm-Nelson CA, 2018, NEUROSCIENCE, V379, P126, DOI 10.1016/j.neuroscience.2018.02.027; Kelm-Nelson CA, 2016, DATA BRIEF, V8, P360, DOI 10.1016/j.dib.2016.05.056; Kelm-Nelson CA, 2016, NEUROSCI LETT, V621, P75, DOI 10.1016/j.neulet.2016.04.003; Kelm-Nelson CA, 2016, BEHAV BRAIN RES, V307, P54, DOI 10.1016/j.bbr.2016.03.006; Kelm-Nelson CA, 2015, J PARKINSON DIS, V5, P749, DOI 10.3233/JPD-150688; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65; LOGEMANN JA, 1978, J SPEECH HEAR DISORD, V43, P47, DOI 10.1044/jshd.4301.47; Lopuch S, 2011, J COMP PSYCHOL, V125, P250, DOI 10.1037/a0021532; Marien MM, 1994, NORADRENERGIC MECH P; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; McGinnis MY, 2003, PHYSIOL BEHAV, V80, P81, DOI 10.1016/S0031-9384(03)00227-0; Miller N, 2006, AGE AGEING, V35, P235, DOI 10.1093/ageing/afj053; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Nikulina EM, 2005, NEUROPSYCHOPHARMACOL, V30, P1096, DOI 10.1038/sj.npp.1300658; Pinto S, 2004, LANCET NEUROL, V3, P547, DOI 10.1016/S1474-4422(04)00854-3; Plowman-Prine EK, 2009, NEUROREHABILITATION, V24, P131, DOI 10.3233/NRE-2009-0462; Pultorak JD, 2016, SOC NEUROSCI-UK, V11, P365, DOI 10.1080/17470919.2015.1086434; Ramig L, 2001, J NEUROL NEURSURG PS, V71, P793; Ramig LO, 2001, MOVEMENT DISORD, V16, P79, DOI 10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H; Ringel LE, 2013, BEHAV BRAIN RES, V252, P252, DOI 10.1016/j.bbr.2013.06.006; Russell JA, 2010, BRAIN RES, V1341, P3, DOI 10.1016/j.brainres.2010.03.029; SANDYK R, 1985, MED HYPOTHESES, V16, P361, DOI 10.1016/0306-9877(85)90055-6; Sapir S, 2007, J SPEECH LANG HEAR R, V50, P899, DOI 10.1044/1092-4388(2007/064); Sapir S, 2008, CURR OPIN OTOLARYNGO, V16, P205, DOI 10.1097/MOO.0b013e3282febd3a; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P435, DOI 10.1038/nrn.2017.62; Snoeren EMS, 2014, J COMP PSYCHOL, V128, P40, DOI 10.1037/a0033204; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Thompson B, 2006, BEHAV BRAIN RES, V168, P64, DOI 10.1016/j.bbr.2005.10.012; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Villeneuve LM, 2016, MOL NEUROBIOL, V53, P171, DOI 10.1007/s12035-014-8927-y; Willadsen M, 2014, J COMP PSYCHOL, V128, P56, DOI 10.1037/a0034778; Wohr M, 2008, PHYSIOL BEHAV, V93, P766, DOI 10.1016/j.physbeh.2007.11.031; Wright JM, 2012, NEUROPSYCHOPHARMACOL, V37, P808, DOI 10.1038/npp.2011.258; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	80	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220734	10.1371/journal.pone.0220734	http://dx.doi.org/10.1371/journal.pone.0220734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374106	Green Published, gold, Green Submitted			2022-12-26	WOS:000484991500029
J	Suarez-Sanchez, P; Garcia, B; Nzang, J; Ncogo, P; Riloha, M; Berzosa, P; Benito, A; Romay-Barja, M				Suarez-Sanchez, Pablo; Garcia, Belen; Nzang, Jesus; Ncogo, Policarpo; Riloha, Matilde; Berzosa, Pedro; Benito, Agustin; Romay-Barja, Maria			Failures in the case management of children with uncomplicated malaria in Bata district of Equatorial Guinea and associated factors	PLOS ONE			English	Article							RESISTANCE; ARTEMISININ; ARTEMETHER	Background In Equatorial Guinea, malaria continues to be one of the main causes of morbidity and mortality among children. The National Therapeutic Guide established artesunate-amodiaquine (ASAQ) as first-line treatment for uncomplicated malaria, but compliance with this treatment is low. The aim of this study was to assess, for the first time, the performance of public healthcare workers in the diagnosis and treatment of uncomplicated malaria, their compliance with first-line Malaria National Therapeutic Guide and the associated factors. Methods A cross-sectional survey was conducted at the nine public health facilities in the Bata District of Equatorial Guinea to assess the management of uncomplicated malaria in children < 15 years of age. Bivariate and multivariate statistical analyses were used to determine the recommended treatment compliance and related factors. Results A total of 227 children with uncomplicated malaria were recorded from 9 public health facilities. Most of the treatments prescribed (83.3%) did not follow the first-line treatment recommended for uncomplicated malaria. The diagnosis was established with parasite confirmation in 182 cases (80.2%). After adjustment for other variables, children under 2 months of age, the use of parasite confirmation to the diagnosis of malaria and being familiar with the national therapeutic guide were significantly associated with the prescription of the first-line recommended treatment. Cases attended at the hospital or in a health facility with ASAQ in the pharmacy at the time of the study were also more likely to be prescribed with the recommended treatment, but with non-significant association after adjustment for other variables. Conclusions This study identified the factors associated with the low compliance with the first-line treatment by the public healthcare facilities of Bata District of Equatorial Guinea. It seems necessary to improve case management of children with uncomplicated malaria; to reinforce the use of Malaria National Therapeutic Guide and to inform about the danger of using artemisinin monotherapy. Furthermore, it is crucial to provide recommended first-line treatment to the pharmacies of all public health facilities to ensure access to this treatment.	[Suarez-Sanchez, Pablo; Garcia, Belen; Berzosa, Pedro; Benito, Agustin; Romay-Barja, Maria] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Suarez-Sanchez, Pablo] Hosp Clin San Carlos, Serv Med Prevent, Madrid, Spain; [Nzang, Jesus; Ncogo, Policarpo] Ctr Referencia Control Endemias, Malabo, Equat Guinea; [Riloha, Matilde] Minist Salud & Bienestar Social, Malabo, Equat Guinea; [Berzosa, Pedro; Benito, Agustin; Romay-Barja, Maria] RICET, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Hospital Clinico San Carlos	Romay-Barja, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain.; Romay-Barja, M (corresponding author), RICET, Madrid, Spain.	mromay@isciii.es		Suarez Sanchez, Pablo/0000-0001-7617-6799; Berzosa, Pedro/0000-0002-8768-717X; Garcia Fernandez, Belen/0000-0001-6317-6984; Romay-Barja, Maria/0000-0002-0177-6885; Benito, Agustin/0000-0001-8229-5540	Agencia Espanola de Cooperacion Internacional [AECID2017/CTR/0900237]; Tropical Diseases Research Network [RD16CIII/003/001RICET]	Agencia Espanola de Cooperacion Internacional; Tropical Diseases Research Network	This study was funded by the by the Agencia Espanola de Cooperacion Internacional AECID2017/CTR/0900237 (http://www.aecid.es/ES) and the Tropical Diseases Research Network RD16CIII/003/001RICET (https://www.ricet.es/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; [Anonymous], 2001, ANT DRUG COMB THER; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Banek K, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2370-x; Berzosa P, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1672-0; Bilal JA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0575-9; Chuma J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-243; Ezenduka CC, 2014, J PHARM POLICY PRACT, V7, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1186/2052-3211-7-1; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; Hensen B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-218; HURWITZ ES, 1981, LANCET, V1, P1068; Instituto Nacional de Estadistica de Guinea Ecuatorial INEGE, 2018, GUIN EC CIFR 2018; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Ministerio de Sanidad y Bienestar Social y Ministerio de Economia Planificacion e Inversiones Publicas Guinea Ecuatorial, 2012, ENCUESTA DEMOGRAFICA; Minsiterio de Sanidad y Bienestar Social, 2014, GUIA TER NAC PAL GUI; Namuyinga RJ, 2017, MALARIA J, V16, P1; Nauli TS, 2014, EMERGENCE SPREAD ART, P1; Ncogo P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0986-7; Oswald D., 2014, REV SOC STUD, V1, P53, DOI DOI 10.21586/ROSS0000004; Reeler AV, 2000, B WORLD HEALTH ORGAN, V78, P135; Rehman AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-154; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Romay-Barja M, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2254-0; Romay-Barja M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135887; Salomao CA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0996-5; Wang LT, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2454-7; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 1996, PARASITOL TODAY, V12, P399, DOI 10.1016/0169-4758(96)10055-7; WHO, 2018, WORLD MAL REP 2018; Williams HA, 1999, TROP MED INT HEALTH, V4, P641, DOI 10.1046/j.1365-3156.1999.00471.x; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; World Health Organization, 1999, GUIDELINES FOR FOLLO; World Health Organization, 2013, VIT MIN NUTR INF SYS, P1; World Health Organization, 2015, GUID TREATM MAL; Zurovac D, 2005, BRIT MED J, V331, P734, DOI 10.1136/bmj.331.7519.734; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220789	10.1371/journal.pone.0220789	http://dx.doi.org/10.1371/journal.pone.0220789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374107	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500033
J	Lung, JH; Hung, MS; Lin, YC; Lee, KF; Jiang, YY; Huang, SL; Fang, YH; Lu, MS; Lin, CK; Yang, TM; Lin, PY; Hsieh, MJ; Tsai, YH				Lung, Jrhau; Hung, Ming-Szu; Lin, Yu-Ching; Lee, Kam-Fai; Jiang, Yuan Yuan; Huang, Shao-Lan; Fang, Yu-Hung; Lu, Ming-Shian; Lin, Chin-Kuo; Yang, Tsung-Ming; Lin, Paul Yann; Hsieh, Meng-Jer; Tsai, Ying Huang			MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population	PLOS ONE			English	Article							OVEREXPRESSION; CARCINOMA; CMET; PROTOONCOGENE; EXPRESSION; RESISTANCE; INHIBITORS; SURVIVAL; TARGET; OCCURS	Somatic mutations of MET gene are emerging as important driver mutations for lung cancers. To identify the common clinicopathological features of MET exon 14 skipping mutations and amplification and clarify whether the two MET gene alterations cause protein overexpression were investigated using 196 lung cancer samples of Taiwan through real time-qPCR/sequencing, fluorescence in situ hybridization, and immunohistochemistry. The two MET gene alterations are both present in low frequency, similar to 1%, in the studied lung cancer population of Taiwan. MET exon 14 skipping mutations were identified from two early-stage patients, who were both relatively advanced in age, and did not carry other driver mutations. One was an adenocarcinoma and the other was a rare carcinosarcoma. Three gene amplifications cases were identified. Neither of the two MET gene alterations would lead to protein overexpression; hence, direct detection in nucleic acid level would be a preferred and straightforward solution for the identification of skipping mutations. The presence of MET exon 14 mutations in minor histological types of lung cancers urge to extend screening scope of this mutation in lung cancer and treatment response evaluation in clinical trials. These would be important next steps for the success of MET target therapy in clinical practice.	[Lung, Jrhau; Huang, Shao-Lan] Chang Gung Mem Hosp, Dept Med Res & Dev, Chiayi Branch, Chiayi, Taiwan; [Hung, Ming-Szu; Lin, Yu-Ching; Jiang, Yuan Yuan; Fang, Yu-Hung; Lin, Chin-Kuo; Yang, Tsung-Ming; Hsieh, Meng-Jer; Tsai, Ying Huang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi Branch, Chiayi, Taiwan; [Hung, Ming-Szu; Lin, Yu-Ching] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Hung, Ming-Szu; Lin, Yu-Ching] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan; [Lee, Kam-Fai] Chang Gung Mem Hosp, Dept Pathol, Chiayi Branch, Chiayi, Taiwan; [Lu, Ming-Shian] Chang Gung Mem Hosp, Dept Surg, Div Thorac & Cardiovasc Surg, Chiayi Branch, Chiayi, Taiwan; [Lin, Paul Yann] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Anat Pathol, Chiayi, Taiwan; [Hsieh, Meng-Jer] Chang Gung Univ, Coll Med, Dept Resp Care, Taoyuan, Taiwan; [Tsai, Ying Huang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Linkou Branch, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Chang Gung University; Chang Gung Memorial Hospital	Tsai, YH (corresponding author), Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi Branch, Chiayi, Taiwan.; Tsai, YH (corresponding author), Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Linkou Branch, Linkou, Taiwan.	chestmed@cgmh.org.tw	jiang, anyi/GPT-0379-2022	Lin, Chin-Kuo/0000-0002-5940-3715; Fang, Yu Hung/0000-0002-3971-6191; Hsieh, Meng-Jer/0000-0002-2077-0470	Chang Gung Memorial Hospital, Chiayi, Taiwan [CORPG6F0021-3, CMRPG6F0471-3]	Chang Gung Memorial Hospital, Chiayi, Taiwan(Chang Gung Memorial Hospital)	This work was supported by the Chang Gung Memorial Hospital, Chiayi, Taiwan (to YHT, Grant No: CORPG6F0021-3; to JL, Grant No: CMRPG6F0471-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad MM, 2016, J CLIN ONCOL, V34, P721, DOI 10.1200/JCO.2015.63.4600; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Brambilla E, 2015, WORLD CANC REPORT 20; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; DIRENZO MF, 1992, ONCOGENE, V7, P2549; Drilon A, 2017, J THORAC ONCOL, V12, P15, DOI 10.1016/j.jtho.2016.10.014; Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285; Fujita S, 1997, JPN J CLIN ONCOL, V27, P378, DOI 10.1093/jjco/27.6.378; Gow CH, 2017, LUNG CANCER, V103, P82, DOI 10.1016/j.lungcan.2016.12.001; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Huang TJ, 2001, ACTA ONCOL, V40, P638; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lai GG, 2019, J CLIN ONCOL, V37, P876, DOI 10.1200/JCO.18.00177; Lee GD, 2017, J THORAC ONCOL, V12, P1233, DOI 10.1016/j.jtho.2017.04.031; Lewandowska MA, 2013, INT J CLIN EXP PATHO, V6, P2675; Liu SY, 2016, J THORAC ONCOL, V11, P1503, DOI 10.1016/j.jtho.2016.05.016; Liu XW, 2016, J CLIN ONCOL, V34, P794, DOI 10.1200/JCO.2015.62.0674; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Ozasa H, 2014, CANCER SCI, V105, P1032, DOI 10.1111/cas.12447; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Preusser M, 2014, HISTOPATHOLOGY, V65, P684, DOI 10.1111/his.12475; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; Reungwetwattana T, 2017, LUNG CANCER, V103, P27, DOI 10.1016/j.lungcan.2016.11.011; Reungwetwattana T, 2015, TRANSL LUNG CANCER R, V4, P820, DOI 10.3978/j.issn.2218-6751.2015.12.03; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Schrock AB, 2016, J THORAC ONCOL, V11, P1493, DOI 10.1016/j.jtho.2016.06.004; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sweeney P, 2002, J UROLOGY, V168, P51, DOI 10.1016/S0022-5347(05)64830-6; Tong JH, 2016, CLIN CANCER RES, V22, P3048, DOI 10.1158/1078-0432.CCR-15-2061; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Van der Steen N, 2016, J THORAC ONCOL, V11, P1423, DOI 10.1016/j.jtho.2016.05.005; Zheng DF, 2016, ONCOTARGET, V7, P41691, DOI 10.18632/oncotarget.9541	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220670	10.1371/journal.pone.0220670	http://dx.doi.org/10.1371/journal.pone.0220670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369639	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900079
J	MacRae, ER; Clasen, T; Dasmohapatra, M; Caruso, BA				MacRae, Elizabeth R.; Clasen, Thomas; Dasmohapatra, Munmun; Caruso, Bethany A.			'It's like a burden on the head': Redefining adequate menstrual hygiene management throughout women's varied life stages in Odisha, India	PLOS ONE			English	Article							SANITATION EXPERIENCES; HEALTH; GIRLS; SCHOOLS	There has been growing recognition of menstrual hygiene management (MHM) as a significant public health issue. However, research has predominately focused on the experiences of adolescent girls in school settings. The purpose of this research is to examine detailed accounts of menstruation for women in rural Odisha, India at various life stages with a view toward improving international monitoring of MHM. Focus group discussions and in-depth interviews were conducted to understand women's experiences of menstruation across four life stages (unmarried women, recently married women, married women, and older women). Thematic analysis was used to identify menstruation-related challenges and needs. We found women voiced needs that aligned with those captured by the WHO/UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP) definition for MHM: access to clean materials, privacy for changing materials, soap and water for bathing, and disposal facilities for materials. However, we also found women require materials that are not only clean but comfortable and reliable; soap and water for more than bathing; privacy for the full spectrum of menstruation-related practices, not just when changing; and disposal facilities that are private and safe, not just accessible. Additionally, we identified needs that extend beyond the existing definition: pain management, social support, and an enabling sociocultural environment. Overall, women representing all life stages discussed menstruation challenges, including bathing, pain, and washing, drying, and storing cloth materials. Cloth management challenges were most acute for unmarried and recently married women, who were concerned that practices could reveal their menstrual status and harm their reputations, thus informing their preference for disposable materials, if attainable. We propose a revised definition of adequate MHM for this population that more comprehensively captures their needs. This definition may also prove useful for other populations, future research, creating measures of assessment, and guiding interventions and program priorities.	[MacRae, Elizabeth R.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Clasen, Thomas; Caruso, Bethany A.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Clasen, Thomas; Dasmohapatra, Munmun] London Sch Hyg & Trop Med, London, England	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of London; London School of Hygiene & Tropical Medicine	MacRae, ER (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	lizzy.macrae@gmail.com		Caruso, Bethany/0000-0001-9738-9857	Bill & Melinda Gates Foundation (BMGF); NIH/NIGMS Institutional Research and Academic Career Development Award (IRACDA) [5K12-GM000680-18]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); NIH/NIGMS Institutional Research and Academic Career Development Award (IRACDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was made possible with funding from the Bill & Melinda Gates Foundation (BMGF). The BMGF had no role in research design, data collection, analysis, interpretation of findings or the decision to submit this article. BAC was funded in part by the NIH/NIGMS Institutional Research and Academic Career Development Award (IRACDA), 5K12-GM000680-18. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MU, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015508; Alexander KT, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081682; Baker KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188234; Borgatti SP., 1999, ELICITATION TECHNIQU, P15; Caruso B, 2013, WASH SCH EMPOWERS GI; Caruso BA, 2018, SSM-POPUL HLTH, V5, P257, DOI 10.1016/j.ssmph.2018.06.005; Caruso BA, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000414; Caruso BA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070755; Chandra-Mouli V, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0293-6; Clasen T, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-7; Crawford M, 2014, CULT HEALTH SEX, V16, P426, DOI 10.1080/13691058.2014.887147; Crofts T, 2012, J WATER SANIT HYG DE, V2, P50, DOI 10.2166/washdev.2012.067; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Ellis A., 2016, Waterlines, V35, P306, DOI 10.3362/1756-3488.2016.022; Farage MA., 2011, EXPERT REV OBSTET GY, V6, P127, DOI [10.1586/eog.11.1, DOI 10.1586/EOG.11.1, DOI 10.1586/eog.11.1]; Girod C, 2017, J URBAN HEALTH, V94, P835, DOI 10.1007/s11524-017-0189-3; Haver J, 2013, WASH SCH EMPOWERS GI; Hennegan J, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002803; Hennegan J, 2018, REPROD HEALTH MATTER, V26, DOI 10.1080/09688080.2018.1484220; Hennegan J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050905; Hennegan J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012596; Hennink MM, 2007, INTERNATIONAL FOCUS GROUP RESEARCH: A HANDBOOK FOR THE HEALTH AND SOCIAL SCIENCES, P1, DOI 10.1017/CBO9780511619458; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Hulland KRS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141883; JMP, 2012, M REP JMP POST 2015; Joshi D, 2011, ENVIRON URBAN, V23, P91, DOI 10.1177/0956247811398602; Kaur R, 2018, J ENV PUBLIC HLTH, V2018, P9; Khanna A, 2005, J HEALTH MANAG, V7, P91, DOI 10.1177/097206340400700103; Kumar A, 2011, SOC WORK PUBLIC HLTH, V26, P594, DOI 10.1080/19371918.2010.525144; Long J., 2013, WASH SCH EMPOWERS GI; Long J. L., 2015, Waterlines, V34, P68, DOI 10.3362/1756-3488.2015.007; Loughnan L., 2016, Waterlines, V35, P228, DOI 10.3362/1756-3488.2016.019; Mahon T., 2015, Waterlines, V34, P7, DOI 10.3362/1756-3488.2015.002; Mahon T., 2010, Gender and Development, V18, P99, DOI 10.1080/13552071003600083; Mason L., 2015, Waterlines, V34, P15, DOI 10.3362/1756-3488.2015.003; Mason L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079132; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Oruko K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144321; Phillips-Howard PA, 2015, J WOMENS HLTH, V24; Phillips-Howard PA, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.33032; Phillips-Howard PA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013229; Routray P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178042; Routray P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2206-3; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Schmitt ML, 2018, WATER-SUI, V10, DOI 10.3390/w10091193; Schmitt ML, 2017, CONFL HEALTH, V11, DOI 10.1186/s13031-017-0121-1; Sclar GD, 2018, SOC SCI MED, V217, P121, DOI 10.1016/j.socscimed.2018.09.016; Sommer M., 2016, Waterlines, V35, P245, DOI 10.3362/1756-3488.2016.024; Sommer M., 2018, J INT HUMANITARIAN A, V3, P6, DOI [10.1186/S41018-018-0034-7, DOI 10.1186/S41018-018-0034-7, 10.1186/s41018-018-0034-7]; Sommer M, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000405; Sommer M, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0379-8; Sommer M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001962; Sommer M, 2015, COMPARE, V45, P589, DOI 10.1080/03057925.2013.871399; Sommer M, 2015, AM J PUBLIC HEALTH, V105, P1302, DOI 10.2105/AJPH.2014.302525; Sommer M, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0009-8; Sommer M, 2013, J WATER SANIT HYG DE, V3, P283, DOI 10.2166/washdev.2013.101; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; Sommer M, 2010, J ADOLESCENCE, V33, P521, DOI 10.1016/j.adolescence.2009.03.008; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Thakur H, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00072; Trinies V, 2015, WATERLINES, V34; UNICEF, 2015, WASH SCH EMP GIRLS E; UNICEF, 2014, WASH SCH EMP GIRLS E; UNICEF Columbia University, 2014, MHM 10 ADV MHM AG WA; UNICEF Columbia University, 2014, WASH SCH EMP GIRLS E; UNICEF University E, 2013, WASH SCH EMP GIRLS E; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290; VanLeeuwen C, 2018, INT J WOMENS HEALTH, V10, P169, DOI 10.2147/IJWH.S135587; WB, 2016, OD POV GROWTH IN IND; WB, 2016, OD GEND IND STAT BRE; Wilson E, 2018, LANCET CHILD ADOLESC, V2, pE17, DOI 10.1016/S2352-4642(18)30209-8	71	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220114	10.1371/journal.pone.0220114	http://dx.doi.org/10.1371/journal.pone.0220114			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369595	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000484987900024
J	Vickman, O; Erives, A				Vickman, Oliver; Erives, Albert			Episodic evolution of a eukaryotic NADK repertoire of ancient provenance	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; ORGANELLES; MRBAYES; KINASE; SPORULATION; MITOSOMES; BIOLOGY; ORIGIN; MODEL	NAD kinase (NADK) is the sole enzyme that phosphorylates nicotinamide adenine dinucleotide (NAD+/NADH) into NADP+/NADPH, which provides the chemical reducing power in anabolic (biosynthetic) pathways. While prokaryotes typically encode a single NADK, eukaryotes encode multiple NADKs. How these different NADK genes are all related to each other and those of prokaryotes is not known. Here we conduct phylogenetic analysis of NADK genes and identify major clade-defining patterns of NADK evolution. First, almost all eukaryotic NADK genes belong to one of two ancient eukaryotic sister clades corresponding to cytosolic ("cyto") and mitochondrial ("mito") clades. Secondly, we find that the cyto-clade NADK gene is duplicated in connection with loss of the mito-clade NADK gene in several eukaryotic clades or with acquisition of plastids in Archaeplastida. Thirdly, we find that horizontal gene transfers from proteobacteria have replaced mitochondrial NADK genes in only a few rare cases. Last, we find that the eukaryotic cyto and mito paralogs are unrelated to independent duplications that occurred in sporulating bacteria, once in mycelial Actinobacteria and once in aerobic endospore-forming Firmicutes. Altogether these findings show that the eukaryotic NADK gene repertoire is ancient and evolves episodically with major evolutionary transitions.	[Vickman, Oliver; Erives, Albert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Erives, A (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	albert-erives@uiowa.edu		Vickman, Oliver/0000-0002-1221-8408				Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1; Ando T, 2011, J BIOL CHEM, V286, P29984, DOI 10.1074/jbc.M111.249011; Bergey DH., 2001, BERGEYS MANUAL SYSTE; Blaxter M, 2015, PARASITOLOGY, V142, pS26, DOI 10.1017/S0031182014000791; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Chai MF, 2005, PLANT MOL BIOL, V59, P553, DOI 10.1007/s11103-005-6802-y; Chandra G, 2014, FEMS MICROBIOL REV, V38, P345, DOI 10.1111/1574-6976.12047; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Erives AJ, 2015, DEV GENES EVOL, V225, P259, DOI 10.1007/s00427-015-0508-1; Fontecilla-Camps JC, 2019, ANGEW CHEM INT EDIT, V58, P42, DOI 10.1002/anie.201808438; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hashida SN, 2009, ANN BOT-LONDON, V103, P819, DOI 10.1093/aob/mcp019; Huang KY, 2019, J MICROBIOL IMMUNOL, V52, P630, DOI 10.1016/j.jmii.2017.10.005; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Kawai S, 2001, EUR J BIOCHEM, V268, P4359, DOI 10.1046/j.1432-1327.2001.02358.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Li BB, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00379; Li J, 2009, PROTEOMICS, V9, P4539, DOI 10.1002/pmic.200900101; Ling C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060667; Makiuchi T, 2014, BIOCHIMIE, V100, P3, DOI 10.1016/j.biochi.2013.11.018; Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5; Martincova E, 2015, MOL CELL BIOL, V35, P2864, DOI 10.1128/MCB.00448-15; MCGUINNESS ET, 1985, INT J BIOCHEM, V17, P1, DOI 10.1016/0020-711X(85)90079-5; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Tocheva EI, 2016, NAT REV MICROBIOL, V14, P535, DOI 10.1038/nrmicro.2016.85; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Waller JC, 2010, PLANTA, V231, P305, DOI 10.1007/s00425-009-1047-7; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07949; Weiss MC, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.116, 10.1038/NMICROBIOL.2016.116]; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Williams CF, 2013, TRENDS PARASITOL, V29, P311, DOI 10.1016/j.pt.2013.04.004; Yague P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086296; Yague P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060665; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Zhang R, 2015, J CELL PHYSIOL, V230, P1697, DOI 10.1002/jcp.24926	49	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220447	10.1371/journal.pone.0220447	http://dx.doi.org/10.1371/journal.pone.0220447			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369599	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900050
J	Gimenes, FRE; Baysari, M; Walter, S; Moreira, LA; de Carvalho, REFL; Miasso, AI; Faleiros, F; Westbrook, J				Escobar Gimenes, Fernando Raphael; Baysari, Melissa; Walter, Scott; Moreira, Leticia Alves; Fontenele Lima de Carvalho, Rhanna Emanuela; Miasso, Adriana Inocenti; Faleiros, Fabiana; Westbrook, Johanna			Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study	PLOS ONE			English	Article							INTERNAL-MEDICINE WARD; INTENSIVE-CARE-UNIT; HOSPITALIZED-PATIENTS; GENERAL MEDICINE; PREVALENCE; POLYPHARMACY; MEDICATION; ERRORS	Aims The primary aims were to determine the rate of potential drug-drug interactions (pDDIs) in patients with nasally placed feeding tubes (NPFT) and the factors significantly associated with pDDIs. The secondary aim was to assess the change in pDDIs for patients between admission and discharge. Material and methods This multicentre study applied a cross-sectional design and was conducted in six Brazilian hospitals, from October 2016 to July 2018. Data from patients with NPFT were collected through electronic forms. All regular medications prescribed were recorded. Medications were classified according to the World Health Organization (WHO) Anatomical Therapeutic Chemical code. Drug-drug interaction screening software was used to screen patients' medications for pDDIs. Negative binomial regression was used to account for the over dispersed nature of the pDDI count. Since the number of pDDIs was closely related to the number of prescribed medications, we modelled the rate of pDDIs with the count of pDDIs as the numerator and the number of prescribed medications as the denominator; six variables were considered for inclusion: time (admission or discharge), patient age, patient gender, age-adjusted Charlson Comorbidity Index (CCI) score, type of prescription (electronic or handwritten) and patient care complexity. To account for correlation within the two time points (admission and discharge) for each patient a generalised estimating equations approach was used to adjust the standard error estimates. To test the change in pDDI rate between admission and discharge a full model of six variables was fitted to generate an adjusted estimate. Results In this study, 327 patients were included. At least one pDDI was found in more than 91% of patients on admission and discharge and most of these pDDIs were classified as major severity. Three factors were significantly associated with the rate of pDDIs per medication: patient age, patient care complexity and prescription type (handwritten vs electronic). There was no evidence of a difference in pDDI rate between admission and discharge. Conclusion Patients with a NPFT are at high risk of pDDIs. Drug interaction screening tools and computerized clinical decision support systems could be effective risk mitigation strategies for this patient group.	[Escobar Gimenes, Fernando Raphael; Moreira, Leticia Alves; Faleiros, Fabiana] Univ Sao Paulo Ribeirao Preto, Coll Nursing, Dept Gen & Specialized Nursing, Ribeirao Preto, SP, Brazil; [Baysari, Melissa; Walter, Scott; Westbrook, Johanna] Macquarie Univ, Australian Inst Hlth Innovat, Ctr Hlth Syst & Safety Res, Sydney, NSW, Australia; [Fontenele Lima de Carvalho, Rhanna Emanuela] Univ Estadual Ceara, Fortaleza, Ceara, Brazil; [Miasso, Adriana Inocenti] Univ Sao Paulo Ribeirao Preto, Coll Nursing, Dept Psychiat Nursing & Human Sci, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Macquarie University; Universidade Estadual do Ceara; Universidade de Sao Paulo	Gimenes, FRE (corresponding author), Univ Sao Paulo Ribeirao Preto, Coll Nursing, Dept Gen & Specialized Nursing, Ribeirao Preto, SP, Brazil.	fregimenes@eerp.usp.br	Westbrook, Johanna I/J-9045-2018; Faleiros, FABIANA/F-6038-2013; Gimenes, Fernanda Raphael Escobar/F-6692-2012; Miasso, Adriana I/H-2790-2012	Westbrook, Johanna I/0000-0003-1083-8192; Faleiros, FABIANA/0000-0003-3723-7944; Gimenes, Fernanda Raphael Escobar/0000-0002-5174-112X; Miasso, Adriana I/0000-0003-1726-7169; Baysari, Melissa/0000-0003-1645-9126	Scope Global PTY LTA [6396 2018]; Centre for Health Systems and Safety Research (CHSSR); Australian Institute for Health Innovation; Macquarie University	Scope Global PTY LTA; Centre for Health Systems and Safety Research (CHSSR); Australian Institute for Health Innovation; Macquarie University	FREG received the 2018 Australia Awards-Endeavour Research Fellowship (Recipient ID number: 6396 2018) from Scope Global PTY LTA. The Centre for Health Systems and Safety Research (CHSSR), Australian Institute for Health Innovation, from Macquarie University, supported the Research Fellowship Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The principal investigator wishes to thank the Centre for Health Systems and Safety Research (CHSSR), Australian Institute for Health Innovation, from Macquarie University, for supporting the Research Fellowship Program. We also wish to thank Thalyta Cardoso Alux Teixeira, Adriane Pinto de Medeiros, Ligia Menezes de Freitas and Patricia Rezende do Prado for supporting data collection at the hospital sites.	Ahmad A, 2015, J CLIN DIAGN RES, V9, pFC10, DOI 10.7860/JCDR/2015/11264.5608; Santos TRA, 2017, GERIATR GERONTOL INT, V17, P2336, DOI 10.1111/ggi.13070; Bajracharya N, 2018, J YOUNG PHARM, V10, P450, DOI 10.5530/jyp.2018.10.98; Bethi Y, 2018, EUR J HOSP PHARM, V25, P317, DOI 10.1136/ejhpharm-2017-001272; Bhagavathula Akshaya Srikanth, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS204, DOI 10.12980/APJTB.4.2014C1172; Boullata JI, 2017, JPEN-PARENTER ENTER, V41, P15, DOI 10.1177/0148607116673053; Bucsa C, 2013, EUR J INTERN MED, V24, P27, DOI 10.1016/j.ejim.2012.09.011; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Melo DO, 2016, BRAZ J PHARM SCI, V52, P391, DOI [10.1590/S1984-82502016000300005, 10.1590/s1984-82502016000300005]; de Moura CS, 2012, REV SAUDE PUBL, V46, P1082, DOI 10.1590/S0034-89102013005000001; de Wit HAJM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2376-1; Dookeeram D, 2017, INT J CLIN PHARM-NET, V39, P1119, DOI 10.1007/s11096-017-0520-9; Egger SS, 2003, EUR J CLIN PHARMACOL, V58, P773, DOI 10.1007/s00228-002-0557-z; Fokter N, 2010, WIEN KLIN WOCHENSCHR, V122, P81, DOI 10.1007/s00508-009-1251-2; Foroughinia F, 2016, J RES PHARM PRACT, V5, P285, DOI 10.4103/2279-042X.192455; Fugulin F, 2002, THESIS; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Gujjarlamudi Hima Bindu, 2016, J Midlife Health, V7, P105; Heineck I, 2009, PHARM WORLD SCI, V31, P145, DOI 10.1007/s11096-008-9268-6; Huang YQ, 2014, J ZHEJIANG UNIV-SC B, V15, P58, DOI 10.1631/jzus.B1300109; Hurkens KPGM, 2017, INT J HOSP PHARM, V2, P1; Ismail M, 2016, INT J CLIN PHARM-NET, V38, P1052, DOI 10.1007/s11096-016-0340-3; Ismail M, 2013, INT J CLIN PHARM-NET, V35, P455, DOI 10.1007/s11096-013-9764-1; Jankovic SM, 2018, J CRIT CARE, V43, P1, DOI 10.1016/j.jcrc.2017.08.021; Jazbar J, 2018, RES SOC ADMIN PHARM, V14, P572, DOI 10.1016/j.sapharm.2017.07.004; Khandeparkar Akshay, 2017, Perspect Clin Res, V8, P180, DOI 10.4103/picr.PICR_132_16; Kovacevic M, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.13005; Lonergan MT, 2010, AGE AGEING, V39, P495, DOI 10.1093/ageing/afq037; Lu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17357; McEvoy DS, 2017, J AM MED INFORM ASSN, V24, P331, DOI 10.1093/jamia/ocw114; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Nuckols TK, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-56; Ojo O, 2015, NUTRIENTS, V7, P2524, DOI 10.3390/nu7042524; Onatade R, 2013, DRUG AGING, V30, P729, DOI 10.1007/s40266-013-0097-5; Pasina L, 2013, PHARMACOEPIDEM DR S, V22, P1054, DOI 10.1002/pds.3510; Radley DC, 2013, J AM MED INFORM ASSN, V20, P470, DOI 10.1136/amiajnl-2012-001241; Saleem A, 2017, INTEGR PHARM RES PRA, V6, P71, DOI 10.2147/IPRP.S128816; Shakeel F, 2018, SAUDI MED J, V39, P1207, DOI 10.15537/smj.2018.12.23430; Singh S, 2018, INT J BASIC CLIN PHA, V7, P655; Stoll P, 2015, INT J CLIN PHARM-NET, V37, P475, DOI 10.1007/s11096-015-0083-6; Straubhaar B, 2006, DRUG SAFETY, V29, P79, DOI 10.2165/00002018-200629010-00006; Tesfaye ZT, 2017, DRUG HEALTHC PATIENT, V9, P71, DOI 10.2147/DHPS.S126336; Thomson Reuters (Healthcare), 2018, IBM MICR US GUID; Thomson Reuters (Healthcare), 2011, MICR DRUG REAX SYST, V148; Viktil KK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001461; Vonbach P, 2008, PHARM WORLD SCI, V30, P367, DOI 10.1007/s11096-008-9191-x; Westbrook JI, 2013, J AM MED INFORM ASSN, V20, P1159, DOI 10.1136/amiajnl-2013-001745; White R, 2015, HUM TECHN C IHTC2015, P1; Yasu T, 2018, GERIATR GERONTOL INT, V18, P187, DOI 10.1111/ggi.13181; Zheng WY, 2018, EUR J CLIN PHARMACOL, V74, P15, DOI 10.1007/s00228-017-2357-5	50	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220248	10.1371/journal.pone.0220248	http://dx.doi.org/10.1371/journal.pone.0220248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365563	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600032
J	Andresen, AMS; Lutfi, E; Ruyter, B; Berge, G; Gjoen, T				Santos Andresen, Adriana Magalhaes; Lutfi, Esmail; Ruyter, Bente; Berge, Gerd; Gjoen, Tor			Interaction between dietary fatty acids and genotype on immune response in Atlantic salmon (Salmo salar) after vaccination: A transcriptome study	PLOS ONE			English	Article							GENE-EXPRESSION; FISH-OIL; HEAD KIDNEY; MACROPHAGE FUNCTION; DISEASE RESISTANCE; LIPID-COMPOSITION; INNATE IMMUNITY; SOYBEAN OIL; N-3; L.	A pivotal matter to aquaculture is the sourcing of sustainable resources as ingredients to aquafeeds. Levels of plant delivered oils as source of fatty acids (FA) in aquafeeds have reached around 70% resulting in reduced levels of long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in salmon fillet composition. EPA and DHA can modulate inflammation and immune response, so it is crucial to understand how fish immune response is affected by low LC n-3 PUFA diet and if this diet can have a detrimental effect on vaccine response. Atlantic salmon (Salmo salar) can produce EPA/DHA from alpha-linolenic acid (ALA) and this endogenous capacity can be explored to develop families with higher tolerance to low LC n-3 PUFA diets. Here we analyze innate and adaptive immune response in Atlantic salmon to a commercial vaccine after being fed low levels of EPA and DHA, and we also compare three strains of salmon selected by their endogenous capacity of synthesizing LC-n-3 PUFA. A total of 2,890 differentially expressed genes (DEGs) were identified (p-value adjusted < 0.1) when comparing vaccinated fish against control non-vaccinated. Gene ontology (GO) and KEGG analysis with 442 up/downregulated genes revealed that most DEGs were both related to immune response as well as part of important immune related pathways, as "Toll-like receptor" and "Cytokine-Cytokine interaction". Adaptive response was also addressed by measuring antigen specific IgM, and titers were significantly higher than in the preimmune fish at 62 days post-immunization. However, diet and strain had no/little effect on vaccine-specific IgM or innate immune responses. Atlantic salmon therefore display robustness in its response to vaccination even when feed low levels of LC n-3 PUFA.	[Santos Andresen, Adriana Magalhaes; Gjoen, Tor] Univ Oslo, Dept Pharm, Sect Pharmacol & Pharmaceut Biosci, Oslo, Norway; [Lutfi, Esmail; Ruyter, Bente; Berge, Gerd] Nofima Norwegian Inst Food Fisheries & Aquacultur, As, Norway	University of Oslo; Nofima	Gjoen, T (corresponding author), Univ Oslo, Dept Pharm, Sect Pharmacol & Pharmaceut Biosci, Oslo, Norway.	tor.gjoen@farmasi.uio.no	Lutfi, Esmail/J-3529-2017; Gjoen, Tor/F-2740-2013	Lutfi, Esmail/0000-0002-0208-9075; Magalhaes Santos Andresen, Adriana/0000-0003-1194-6558; Gjoen, Tor/0000-0003-4040-5793	Norwegian Seafood research program (FHF) [901282]	Norwegian Seafood research program (FHF)	This project was funded by grant No. 901282 (Optihealth) from The Norwegian Seafood research program (FHF). Authors awarded Bente Ruyter, Gerd Berge and Tor Gjoen.	[Anonymous], FAO YB FISH AQ STAT; Arnemo M, 2017, FISH PHYSIOL BIOCHEM, V43, P1065, DOI 10.1007/s10695-017-0353-4; Bell JG, 1996, PROSTAG LEUKOTR ESS, V54, P173, DOI 10.1016/S0952-3278(96)90013-7; Bell JG, 1997, LIPIDS, V32, P515, DOI 10.1007/s11745-997-0066-4; Bell JG, 2003, J NUTR, V133, P2793, DOI 10.1093/jn/133.9.2793; Berge GM, 2015, BETYDNING GENETISK B; Betancor MB, 2018, BRIT J NUTR, V119, P1378, DOI 10.1017/S0007114518001125; Booman M, 2014, FISH SHELLFISH IMMUN, V41, P52, DOI 10.1016/j.fsi.2014.05.017; Bou M, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.28; Caballero-Solares A, 2017, FISH SHELLFISH IMMUN, V64, P24, DOI 10.1016/j.fsi.2017.02.040; Calder PC, 1999, LIPIDS, V34, pS137, DOI 10.1007/BF02562264; Calder PC, 1998, BRAZ J MED BIOL RES, V31, P467, DOI 10.1590/S0100-879X1998000400002; Calder PC, 2013, P NUTR SOC, V72, P299, DOI 10.1017/S0029665113001286; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Das S, 2015, CELL STRESS CHAPERON, V20, P73, DOI 10.1007/s12192-014-0527-2; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; FAO, 2016, CONTR FOOD SEC NUTR; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; FRIEDMAN A, 1995, POULTRY SCI, V74, P1463, DOI 10.3382/ps.0741463; Friedman A, 1997, BRIT POULTRY SCI, V38, P342, DOI 10.1080/00071669708418000; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gaylord Gibson T., 2010, Bulletin of Fisheries Research Agency, P9; Gjoen T, 2004, FISH PHYSIOL BIOCHEM, V30, P149, DOI 10.1007/s10695-005-4318-7; Gjoen T, 2007, COMP BIOCHEM PHYS B, V148, P103, DOI 10.1016/j.cbpb.2007.04.021; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Grisdale-Helland B, 2002, AQUACULTURE, V207, P311, DOI 10.1016/S0044-8486(01)00743-8; Hagan T, 2015, VACCINE, V33, P5294, DOI 10.1016/j.vaccine.2015.03.072; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Haugland O, 2005, VACCINE, V23, P5488, DOI 10.1016/j.vaccine.2005.07.034; Hogenkamp A, 2011, J NUTR, V141, P698, DOI 10.3945/jn.110.135863; Holen E, 2018, FISH SHELLFISH IMMUN, V72, P57, DOI 10.1016/j.fsi.2017.10.040; Horn SS, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0394-x; Hsu E, 2006, J IMMUNOL, V177, P2452, DOI 10.4049/jimmunol.177.4.2452; Hsu YJ, 2013, FISH SHELLFISH IMMUN, V35, P1891, DOI 10.1016/j.fsi.2013.09.020; Hvattum E, 2000, J CHROMATOGR B, V748, P137, DOI 10.1016/S0378-4347(00)00359-5; HWANG D, 1989, FASEB J, V3, P2052, DOI 10.1096/fasebj.3.9.2501132; Izumi T, 2002, J BIOCHEM, V132, P1; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Jorgensen SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-179; Jorgensen SM, 2007, FISH SHELLFISH IMMUN, V23, P576, DOI 10.1016/j.fsi.2007.01.005; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kelley DS, 1997, LIPIDS, V32, P449, DOI 10.1007/s11745-997-0059-3; Kim EJ, 2012, IMMUNOLOGY, V135, P226, DOI 10.1111/j.1365-2567.2011.03528.x; Kjaer MA, 2008, BBA-MOL CELL BIOL L, V1781, P112, DOI 10.1016/j.bbalip.2007.12.004; Kjaer MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168230; Korver DR, 1997, J NUTR, V127, P2039, DOI 10.1093/jn/127.10.2039; Krzysiek R, 1999, J IMMUNOL, V162, P4455; Leaver MJ, 2011, COMP BIOCHEM PHYS D, V6, P62, DOI 10.1016/j.cbd.2010.04.002; Lund H, 2019, MOL IMMUNOL, V106, P99, DOI 10.1016/j.molimm.2018.12.018; Metochis CP, 2016, FISH SHELLFISH IMMUN, V59, P83, DOI 10.1016/j.fsi.2016.10.016; Millan A, 2011, MAR BIOTECHNOL, V13, P1099, DOI 10.1007/s10126-011-9374-7; Miller MR, 2008, J NUTR, V138, P2179, DOI 10.3945/jn.108.091702; Miller MR, 2008, NUTR RES REV, V21, P85, DOI 10.1017/S0954422408102414; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rebl A, 2018, FISH SHELLFISH IMMUN, V77, P328, DOI 10.1016/j.fsi.2018.04.016; Rosenlund G, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.10; Ruyter B, 2003, LIPIDS, V38, P833, DOI 10.1007/s11745-003-1133-6; Ruyter B, 2000, AQUACULT NUTR, V6, P119; Sanden M, 2011, J AGR FOOD CHEM, V59, P12697, DOI 10.1021/jf203289s; Sarker PK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201315; Schiotz BL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-91; Schlechtriem C, 2007, AQUAC RES, V38, P1045, DOI 10.1111/j.1365-2109.2007.01759.x; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Sobhkhez M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204924; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Thompson KD, 1996, AQUACULT NUTR, V2, P21, DOI 10.1111/j.1365-2095.1996.tb00004.x; THUVANDER A, 1990, DEV COMP IMMUNOL, V14, P415, DOI 10.1016/0145-305X(90)90034-C; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Torstensen BE, 2005, J AGR FOOD CHEM, V53, P10166, DOI 10.1021/jf051308i; Trattner S, 2011, PHYSIOL RES, V60, P125, DOI 10.33549/physiolres.932068; Trichet VV, 2010, AQUAC RES, V41, P356, DOI 10.1111/j.1365-2109.2009.02374.x; Turini ME, 2001, EUR J NUTR, V40, P56, DOI 10.1007/s003940170016; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Wang ZL, 2011, MAR GENOM, V4, P229, DOI 10.1016/j.margen.2011.06.004; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wu DY, 1998, P NUTR SOC, V57, P503, DOI 10.1079/PNS19980074; Xu C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1302-1; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang XQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169042; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006; Zuo RT, 2012, FISH SHELLFISH IMMUN, V32, P249, DOI 10.1016/j.fsi.2011.11.005	90	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219625	10.1371/journal.pone.0219625	http://dx.doi.org/10.1371/journal.pone.0219625			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365530	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600013
J	Kuo, PJ; Rau, CS; Wu, SC; Lu, TH; Wu, YC; Chien, PC; Wu, CJ; Lin, CW; Tsai, CW; Hsieh, CH; Huang, CY				Kuo, Pao-Jen; Rau, Cheng-Shyuan; Wu, Shao-Chun; Lu, Tsu-Hsiang; Wu, Yi-Chan; Chien, Peng-Chen; Wu, Chia-Jung; Lin, Chia-Wei; Tsai, Chia-Wen; Hsieh, Ching-Hua; Huang, Chun-Ying			Metagenomic analysis of the effects of toll-like receptors on bacterial infection in the peritoneal cavity following cecum ligation and puncture in mice	PLOS ONE			English	Article							NF-KAPPA-B; MACROPHAGE PHAGOCYTOSIS; PSEUDOMONAS-AERUGINOSA; METABOLIC SYNDROME; CLEARANCE; PERSISTENCE; INHIBITION; MICROBIOTA; INDUCTION; HALOMONAS	Objective To establish the composition of bacteria in mice following cecum ligation and puncture (CLP) through metagenomic analysis and investigate the role of TLRs on the composition of bacteria. Methods Total DNA extraction was done from the ascites, blood, and fecal samples from C57BL/6 mice sacrificed at 0, 4, 8, and 16 h, as well as from Tlr2(-/-), Tlr4(-/-), Tlr5(-/-), and NF-kappa B-/- mice sacrificed at 16 h following CLP. Amplification of the V3-V4 regions of the bacterial 16S rRNA genes by PCR and the Illumina MiSeq sequencer was used for deep sequencing. Hierarchical clustering of the isolates was performed with Ward's method using Euclidean distances. The relative abundance according to operational taxonomic unit (OTU) number or taxa was used to compare the richness among subgroups in the experiments. Results There were 18 taxa that had significantly different abundances among the different samples of the C57BL/6 mice at 16 h following CLP. Various dynamic changes in the infectious bacteria inside the peritoneal cavity after CLP were found. While knockout of Tlr5 and NF-kappa B impaired the ability of bacterial clearance inside the peritoneal cavity for some kinds of bacteria found in the C57BL/6 mice, the knockout of Tlr4 enhanced clearance for other kinds of bacteria, and they presented excessive abundance in the peritoneal cavity despite their scarce abundance in the stool. Conclusion NF-kappa B and TLRs are involved in bacterial clearance and in the expression pattern of the bacterial abundance inside the peritoneal cavity during polymicrobial infection.	[Kuo, Pao-Jen; Lu, Tsu-Hsiang; Wu, Yi-Chan; Chien, Peng-Chen; Wu, Chia-Jung; Lin, Chia-Wei; Tsai, Chia-Wen; Hsieh, Ching-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Plast Surg, Kaohsiung, Taiwan; [Kuo, Pao-Jen; Rau, Cheng-Shyuan; Wu, Shao-Chun; Lu, Tsu-Hsiang; Wu, Yi-Chan; Chien, Peng-Chen; Wu, Chia-Jung; Lin, Chia-Wei; Tsai, Chia-Wen; Hsieh, Ching-Hua; Huang, Chun-Ying] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Rau, Cheng-Shyuan] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Wu, Shao-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Huang, Chun-Ying] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Trauma Surg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hsieh, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Plast Surg, Kaohsiung, Taiwan.; Hsieh, CH; Huang, CY (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Huang, CY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Trauma Surg, Kaohsiung, Taiwan.	m93chinghua@gmail.com; junyinhaung@yahoo.com.tw		WU, Shaochun/0000-0002-0984-6921	Chang Gung Memorial Hospital [CMRPG8F0401, CMRPG8F0402, CMRPG8E1431]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The work was supported by Chang Gung Memorial Hospital (CMRPG8F0401, CMRPG8F0402 to C-YH and CMRPG8E1431 to C-HH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anand RJ, 2007, J PEDIATR SURG, V42, P927, DOI 10.1016/j.jpedsurg.2007.01.023; Anas AA, 2016, AM J PHYSIOL-LUNG C, V311, pL219, DOI 10.1152/ajplung.00078.2016; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Brown MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1201, DOI 10.2741/1304; Cendra MD, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00130; Chan JZM, 2012, NAT BIOTECHNOL, V30, P1068, DOI 10.1038/nbt.2410; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Courtine E, 2012, INNATE IMMUN-LONDON, V18, P753, DOI 10.1177/1753425912440296; Courtine E, 2011, INFECT IMMUN, V79, P1848, DOI 10.1128/IAI.00021-11; Cristofaro P, 2003, EXPERT OPIN THER TAR, V7, P603, DOI 10.1517/14728222.7.5.603; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; Decuypere S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004470; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Etienne-Mesmin L, 2016, CELL MOL GASTROENTER, V2, P584, DOI 10.1016/j.jcmgh.2016.04.007; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Floyd M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005987; Garcia M, 2018, VIRULENCE, V9, P1163, DOI 10.1080/21505594.2018.1480830; Giogha C, 2014, CYTOKINE GROWTH F R, V25, P235, DOI 10.1016/j.cytogfr.2013.12.012; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; He HQ, 2006, MOL IMMUNOL, V43, P783, DOI 10.1016/j.molimm.2005.07.002; Hosoi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012537; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hutton MJH, 2010, ISLETS, V2, P104, DOI 10.4161/isl.2.2.11209; IMAMURA S, 1975, J INVEST DERMATOL, V65, P244, DOI 10.1111/1523-1747.ep12598264; Iwanaga N, 2015, J INFECT DIS, V212, P1150, DOI 10.1093/infdis/jiv157; Jiang D., 2013, TIST, V4, P1, DOI DOI 10.1128/GEN0MEA.00080-12; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Kellermayer R, 2011, FASEB J, V25, P1449, DOI 10.1096/fj.10-172205; Kim KK, 2010, INT J SYST EVOL MICR, V60, P369, DOI 10.1099/ijs.0.004424-0; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kujiraoka M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00685; Lavezzo E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-554; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lluch J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142334; Lu P, 2018, MUCOSAL IMMUNOL, V11, P727, DOI 10.1038/mi.2017.114; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; Neely CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085623; Nguyen VP, 2014, J INNATE IMMUN, V6, P377, DOI 10.1159/000356408; Pei JW, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00115; RAQIB R, 1995, INFECT IMMUN, V63, P289, DOI 10.1128/IAI.63.1.289-296.1995; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rutanga JP, 2018, EXPERT REV MOL DIAGN, V18, P749, DOI 10.1080/14737159.2018.1498786; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sodhi CP, 2012, GASTROENTEROLOGY, V143, P708, DOI 10.1053/j.gastro.2012.05.053; Stevens DA, 2009, MEDICINE, V88, P244, DOI 10.1097/MD.0b013e3181aede29; Takeuchi F, 2014, JPN J INFECT DIS, V67, P62, DOI 10.7883/yoken.67.62; van Lieshout MHP, 2014, INFLAMM RES, V63, P927, DOI 10.1007/s00011-014-0766-9; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	57	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220398	10.1371/journal.pone.0220398	http://dx.doi.org/10.1371/journal.pone.0220398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348811	Green Submitted, Green Published, gold			2022-12-26	WOS:000484979500033
J	Goto, A; Komiya, K; Kan, T; Honjo, K; Uchida, S; Takikawa, S; Yoshimatsu, T; Fujimoto, K; Johkoh, T; Kadota, J				Goto, Akihiko; Komiya, Kosaku; Kan, Takamasa; Honjo, Kokoro; Uchida, Sonoe; Takikawa, Shuichi; Yoshimatsu, Tetsuyuki; Fujimoto, Kiminori; Johkoh, Takeshi; Kadota, Jun-ichi			Factors associated with atypical radiological findings of pulmonary tuberculosis	PLOS ONE			English	Article							IMAGES	Background Unusual radiological images may delay diagnosis of pulmonary tuberculosis. This study aimed to analyze the risk factors for an atypical radiological image in patients with pulmonary tuberculosis. Methods We retrospectively analyzed data from patients admitted to one hospital from January 2013 to December 2016 for sputum smear-positive lung tuberculosis who underwent chest computed tomography (CT) on admission. Patients whose sputum cultures were positive for general bacteria were excluded. Patient characteristics and laboratory data were compared between patients with cavity and those without and between patients with upper predominant lung involvement and those without. Results This study included 94 (93%) of 101 patients who underwent chest CT. The non-cavity group was older, had a greater number of females, had a lower C-reactive protein (CRP) level, and had a lower glomerular filtration rate. Multivariate analysis showed that a low CRP level (OR 0.808; 95% CI 0.674-0.967; p = 0.020) significantly predicted non-cavity pulmonary tuberculosis. The non-upper predominant lung involvement group was older and had a greater number of females, poorer performance status, a higher CRP level, and a lower serum albumin level. A poor performance status (OR 2.155; 95% CI 1.257-3.693; p = 0.005) was found to significantly predict pulmonary tuberculosis with non-upper predominant lung distributions. Conclusions A low CRP level and poor performance status were associated with non-cavity and non-upper predominant lung distribution, respectively, in patients with pulmonary tuberculosis. Tuberculosis patients with these characteristics may present unusual chest images.	[Goto, Akihiko; Komiya, Kosaku; Kan, Takamasa; Honjo, Kokoro; Uchida, Sonoe; Takikawa, Shuichi; Yoshimatsu, Tetsuyuki] Natl Hosp Org Nishi Beppu Hosp, Internal Med, Tsurumi Ku, Beppu, Oita, Japan; [Goto, Akihiko; Komiya, Kosaku; Kan, Takamasa; Honjo, Kokoro; Uchida, Sonoe; Kadota, Jun-ichi] Oita Univ, Fac Med, Resp Med & Infect Dis, Oita, Japan; [Fujimoto, Kiminori] Kurume Univ, Sch Med, Radiol, 67 Asahimachi, Kurume, Fukuoka, Japan; [Johkoh, Takeshi] Kansai Rosai Hosp, Radiol, Amagasaki, Hyogo, Japan	Oita University; Kurume University; Kansai Rosai Hospital	Komiya, K (corresponding author), Natl Hosp Org Nishi Beppu Hosp, Internal Med, Tsurumi Ku, Beppu, Oita, Japan.; Komiya, K (corresponding author), Oita Univ, Fac Med, Resp Med & Infect Dis, Oita, Japan.	komiyakh1@oita-u.ac.jp		goto, akihiko/0000-0002-4875-9599				Costa Christopher R, 2012, Am J Orthop (Belle Mead NJ), V41, P160; Deponti GN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-538; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; IKEZOE J, 1992, AM J ROENTGENOL, V159, P1175, DOI 10.2214/ajr.159.6.1442377; Kan T, 2019, J INFECT CHEMOTHER, V25, P714, DOI 10.1016/j.jiac.2019.03.022; Komiya K, 2013, GERIATR GERONTOL INT, V13, P580, DOI 10.1111/j.1447-0594.2012.00940.x; Leung AN, 1996, RADIOLOGY, V198, P687, DOI 10.1148/radiology.198.3.8628855; Li J, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0284-4; Mathur M, 2017, J CLIN DIAGN RES, V11, pTC6, DOI 10.7860/JCDR/2017/28183.10535; MILLER WT, 1993, SEMIN ROENTGENOL, V28, P109, DOI 10.1016/S0037-198X(05)80100-2; Nakanishi M, 2010, EUR J RADIOL, V73, P545, DOI 10.1016/j.ejrad.2008.12.009; Nyren S, 2010, ANESTHESIOLOGY, V112, P682, DOI 10.1097/ALN.0b013e3181cf40c8; Ohrui T, 2005, TOHOKU J EXP MED, V207, P3, DOI 10.1620/tjem.207.3; OKAMURA JM, 1990, J CLIN LAB ANAL, V4, P231, DOI 10.1002/jcla.1860040316; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Perez-Guzman C, 2000, AM J RESP CRIT CARE, V162, P1738, DOI 10.1164/ajrccm.162.5.2001040; Perez-Guzman C, 2001, INT J TUBERC LUNG D, V5, P455; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869; ROTHLIN E., 1952, SCHWEIZ ZEITSCHR ALLG PATH U BAKT, V15, P690; SELIGMANN M, 1987, ANN INTERN MED, V107, P234, DOI 10.7326/0003-4819-107-2-234; SMITH DT, 1954, AM REV TUBERC PULM, V70, P547	22	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220346	10.1371/journal.pone.0220346	http://dx.doi.org/10.1371/journal.pone.0220346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344108	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900091
J	Park, Y; Nam, HY; Baek, S; Lee, SH; Lee, JH				Park, Yujeong; Nam, Hwa Yeun; Baek, Sunghoon; Lee, Si Hyeock; Lee, Joon-Ho			Population genetic structure of Bemisia tabaci MED (Hemiptera: Aleyrodidae) in Korea	PLOS ONE			English	Article							MICROSATELLITE LOCI; ALLELE FREQUENCY; MITOCHONDRIAL; SOFTWARE; BIOTYPE; COMPLEX; MARKERS; SYSTEMATICS; DIVERSITY; INSIGHTS	The sweet potato whitefly, Bemisia tabaci (Gennadius) (Hemiptera: Aleyrodidae) is a major agricultural pest that causes economic damages worldwide. In particular, B. tabaci MED (Mediterranean) has resulted in serious economic losses in tomato production of Korea. In this study, 1,145 B. tabaci MED females from 35 tomato greenhouses in different geographic regions were collected from 2016 to 2018 (17 populations in 2016, 13 in 2017, and five in 2018) and analyzed to investigate their population genetic structures using eight microsatellite markers. The average number of alleles per population (N-A) ranged from 2.000 to 5.875, the expected heterozygosity (H-E) ranged from 0.218 to 0.600, the observed heterozygosity (H-O) ranged from 0.061 to 0.580, and the fixation index inbreeding coefficient (F-IS) ranged from -0.391 to 0.872 over the three years of the study. Some significant correlation (p < 0.05) was present between genetic differentiations (F-ST) and geographical distance, and a comparatively high proportion of variation was found among the B. tabaci MED populations. The B. tabaci MED populations were divided into two well-differentiated genetic clusters within different geographic regions. Interestingly, its genetic structures converged into one genetic cluster during just one year. The reasons for this genetic change were speculated to arise from different fitness, insecticide resistance, and insect movement by human activities.	[Park, Yujeong; Nam, Hwa Yeun; Baek, Sunghoon; Lee, Si Hyeock; Lee, Joon-Ho] Seoul Natl Univ, Dept Agr Biotechnol, Entomol Program, Seoul, South Korea; [Lee, Si Hyeock; Lee, Joon-Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, JH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Entomol Program, Seoul, South Korea.; Lee, JH (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	jh7lee@snu.ac.kr			Rural Development Administration [PJ01194804]; Brain Korea 21 Plus project	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Brain Korea 21 Plus project	This research was funded by grants from the Rural Development Administration (project no. PJ01194804) and by the Brain Korea 21 Plus project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Ben Abdelkrim A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185724; Boopathi T, 2014, FLA ENTOMOL, V97, P1115, DOI 10.1653/024.097.0318; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Byrne DN, 1999, AGR FOREST METEOROL, V97, P309, DOI 10.1016/S0168-1923(99)00074-X; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chessel D., 2004, R NEWS, V4, P5; Chu D, 2011, B ENTOMOL RES, V101, P467, DOI 10.1017/S0007485311000022; Chu D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04396; Cullingham CI, 2012, ECOL EVOL, V2, P908, DOI 10.1002/ece3.102; Dalmon A, 2008, HEREDITY, V100, P316, DOI 10.1038/sj.hdy.6801080; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2003, MOL ECOL NOTES, V3, P40, DOI 10.1046/j.1471-8286.2003.00344.x; Delatte H, 2005, B ENTOMOL RES, V95, P29, DOI 10.1079/BER2004337; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deperi SI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194398; Diaz F, 2015, INSECT SCI, V22, P483, DOI 10.1111/1744-7917.12129; Dickey AM, 2013, J ECON ENTOMOL, V106, P1355, DOI 10.1603/EC12512; Dinsdale A, 2012, B ENTOMOL RES, V102, P539, DOI 10.1017/S0007485312000077; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Gauthier N, 2014, PEST MANAG SCI, V70, P1477, DOI 10.1002/ps.3733; Hadjistylli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165105; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Karsten M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054281; Khan MS, 2012, PLANT PATHOLOGY J, V28, P123, DOI [10.5423/PPJ.RW.11.2011.0219, 10.5423/PPJ.2012.28.2.123]; Kim H, 2017, BIOL INVASIONS, V19, P597, DOI 10.1007/s10530-016-1299-7; Kim KS, 2006, ENVIRON ENTOMOL, V35, P813, DOI 10.1603/0046-225X-35.4.813; Lee MinHo, 2005, Korean Journal of Applied Entomology, V44, P169; Lee Myeong-Lyeol, 2000, Korean Journal of Applied Entomology, V39, P5; Lee W, 2016, J ASIA-PAC ENTOMOL, V19, P23, DOI 10.1016/j.aspen.2015.11.006; Lee W, 2014, FLA ENTOMOL, V97, P155, DOI 10.1653/024.097.0121; Lee YoungSu, 2002, Journal of Asia-Pacific Entomology, V5, P117, DOI 10.1016/S1226-8615(08)60140-5; Li M, 2010, INT J PEST MANAGE, V56, P275, DOI 10.1080/09670871003743428; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; MANTEL N, 1967, CANCER RES, V27, P209; Mouton L, 2015, PEST MANAG SCI, V71, P452, DOI 10.1002/ps.3834; Oliveira EJ, 2006, GENET MOL BIOL, V29, P294, DOI 10.1590/S1415-47572006000200018; Park S, 2008, EXCEL MICROSATELLITE; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rollins LA, 2006, WILDLIFE RES, V33, P251, DOI 10.1071/WR05106; Simon B, 2003, B ENTOMOL RES, V93, P259, DOI 10.1079/BER2003233; Streito JC, 2017, INSECT SCI, V24, P859, DOI 10.1111/1744-7917.12370; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Tahiri A, 2013, ECOL EVOL, V3, P2619, DOI 10.1002/ece3.655; Tsagkarakou A, 2003, MOL ECOL NOTES, V3, P196, DOI 10.1046/j.1471-8286.2003.00393.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; 2012, EVOLUTIONARY BIOINFO, V8, P1	60	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220327	10.1371/journal.pone.0220327	http://dx.doi.org/10.1371/journal.pone.0220327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344119	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900085
J	Zhang, J; Xia, F; Zhao, HF; Peng, K; Liu, HY; Meng, XW; Chen, C; Ji, FH				Zhang, Juan; Xia, Fan; Zhao, Haifeng; Peng, Ke; Liu, Huayue; Meng, Xiaowen; Chen, Chen; Ji, Fuhai			Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; PROTECTS; STIMULATION; ALPHA; HEART	Objectives Dexmedetomidine (DEX) is a selective a2-adrenoceptor agonist that has anti-inflammatory and cardioprotective effects in myocardial ischemia/reperfusion (I/R) injury. The present study aimed to investigate the underlying mechanism by which DEX protects against myocardial I/R. Methods Sprague Dawley rats were subjected to either sham operation or myocardial I/R, which was induced by ligating the left anterior descending coronary artery for 30 min followed by reperfusion for 120 min. Rats were treated with either DEX or saline prior to surgery. We measured heart infarct size, serum cardiac Troponin I (cTnI), cardiac High mobility group box-1 (HMGB1) expression, myocardial apoptosis and cytokine production of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha). Besides, we evaluated the heart function at 4 weeks post-reperfusion by echocardiography. Unilateral vagotomy or inhibition of the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) with methyllycaconitine (MLA) was applied to investigate whether DEX-induced cardioprotection is mediated via the cholinergic anti-inflammatory pathway. Cardiac-selective overexpression of HMGB1 was administered to further confirm if HMGB1 is a key anti-inflammatory target during DEX-induced cardioprotection. Results DEX pretreatment significantly attenuated I/R-induced cardiac damage, as evidenced by decreases in short-term injury indicators including myocardial infarct size, cTnI release, myocardial apoptosis, cardiac HMGB1 expression, IL-6 and TNF-alpha production, as well as improvement on long-term cardiac function at 4 weeks post-reperfusion. These effects were partially reversed by either unilateral vagotomy or methyllycaconitine treatment. Besides, cardiac HMGB1-overexpression nearly abolished DEX-induced cardioprotection. Conclusions DEX pretreatment protects against myocardial I/R by inhibiting cardiac HMGB1 production and activating the cholinergic anti-inflammatory pathway.	[Zhang, Juan; Xia, Fan; Peng, Ke; Liu, Huayue; Meng, Xiaowen; Chen, Chen; Ji, Fuhai] Soochow Univ, Dept Anesthesiol, Affiliated Hosp 1, Suzhou, Peoples R China; [Zhao, Haifeng] Nanjing Med Univ, Suzhou Sci & Technol Town Hosp, Dept Pathol, Suzhou Hosp, Suzhou, Peoples R China	Soochow University - China; Nanjing Medical University	Ji, FH (corresponding author), Soochow Univ, Dept Anesthesiol, Affiliated Hosp 1, Suzhou, Peoples R China.	jifuhaisuda@163.com		xia, fan/0000-0001-6464-5818; liu, huayue/0000-0002-1504-1310	National Natural Science Foundation of China [81601666, 81471835, 81671880, 81601659, 81701098]; Jiangsu Provincial Medical Youth Talents Program [QNRC2016741]; Jiangsu Provincial Medical Innovation Team [CXTDA2017043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Medical Youth Talents Program; Jiangsu Provincial Medical Innovation Team	This study was supported, in part, by grants from the National Natural Science Foundation of China (81601666 to JZ, 81471835 and 81671880 to FJ, 81601659 to KP, 81701098 to XM), the Jiangsu Provincial Medical Youth Talents Program (QNRC2016741 to KP), and the Jiangsu Provincial Medical Innovation Team (CXTDA2017043 to FJ). URL: National Natural Science Foundation of China: https://isisn.nsfc.gov.cn/egrantweb/Jiangsu Provincial Medical Youth Talents Program & Jiangsu Provincial Medical Innovation Team: http://wskj.jswst.gov.cn; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bazzani C, 2002, RESUSCITATION, V52, P109, DOI 10.1016/S0300-9572(01)00436-1; Dorge H, 2002, J MOL CELL CARDIOL, V34, P51, DOI 10.1006/jmcc.2001.1489; Douglas JY, 2012, PROG RETIN EYE RES, V31, P481, DOI 10.1016/j.preteyeres.2012.04.005; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046; Fromes Y, 1999, GENE THER, V6, P683, DOI 10.1038/sj.gt.3300853; Gao JM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1674613; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; Gruntman AM, 2013, CURR PROTOC MICROBIO; Haubner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009350; Ji FH, 2013, CIRCULATION, V127, P1576, DOI 10.1161/CIRCULATIONAHA.112.000936; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kong WL, 2017, AM J TRANSL RES, V9, P5040; Li XF, 2016, CELL PHYSIOL BIOCHEM, V39, P1850, DOI 10.1159/000447884; Ma Anlun, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P20; Obayah GM, 2010, EUR J ANAESTH, V27, P280, DOI 10.1097/EJA.0b013e3283347c15; ORITA H, 1993, J SURG RES, V55, P654, DOI 10.1006/jsre.1993.1199; Qin CX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14232; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheer CS, 2017, JAMA-J AM MED ASSOC, V318, P479, DOI 10.1001/jama.2017.7853; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Sharp DB, 2014, BRAIN RES, V1574, P1, DOI 10.1016/j.brainres.2014.06.010; Stamm C, 2001, CIRCULATION, V104, pI350; Tanskanen PE, 2006, BRIT J ANAESTH, V97, P658, DOI 10.1093/bja/ael220; Wang SL, 2017, BIOMED PHARMACOTHER, V93, P1337, DOI 10.1016/j.biopha.2017.06.051; Wang Z, 2014, CIRC-HEART FAIL, V7, P1014, DOI 10.1161/CIRCHEARTFAILURE.114.001564; Wu H, 2015, CELL PHYSIOL BIOCHEM, V35, P2320, DOI 10.1159/000374035; Xiang H, 2014, INFLAMMATION, V37, P1763, DOI 10.1007/s10753-014-9906-1; Zhang J, 2017, COMPOS COMMUN, V4, P1, DOI 10.1016/j.coco.2017.02.005; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15503; Zhu YJ, 2016, BRAIN RES, V1644, P1, DOI 10.1016/j.brainres.2016.04.074	34	18	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0218726	10.1371/journal.pone.0218726	http://dx.doi.org/10.1371/journal.pone.0218726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344138	gold, Green Submitted, Green Published			2022-12-26	WOS:000484977900008
J	Bigman, LS; Horovitz, A				Bigman, Lavi S.; Horovitz, Amnon			Reconciling the controversy regarding the functional importance of bullet- and football-shaped GroE complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperonin; protein folding; GroEL; kinetics; bioinformatics; molecular machines; PSIPRED	ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; CHAPERONIN; PREDICTION; CAGE	The chaperonin GroEL and its co-chaperonin GroES form both GroEL-GroES bullet-shaped and GroEL-GroES(2) football-shaped complexes. The residence time of protein substrates in the cavities of these complexes is about 10 and 1 s, respectively. There has been much controversy regarding which of these complexes is the main functional form. Here, we show using computational analysis that GroEL protein substrates have a bimodal distribution of folding times, which matches these residence times, thereby suggesting that both bullet-shaped and football-shaped complexes are functional. More generally, co-existing complexes with different stoichiometries are not mutually exclusive with respect to having a functional role and can complement each other.	[Bigman, Lavi S.; Horovitz, Amnon] Weizmann Inst Sci, Dept Struct Biol, IL-7610001 Rehovot, Israel	Weizmann Institute of Science	Horovitz, A (corresponding author), Weizmann Inst Sci, Dept Struct Biol, IL-7610001 Rehovot, Israel.	Amnon.Horovitz@weizmann.ac.il		Bigman, Lavi S./0000-0003-0645-3206	United States-Israel Binational Science Foundation [2015170]; Minerva Foundation; Federal German Ministry for Education and Research; Kimmelman Center for Biomolecular Structure and Assembly	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Kimmelman Center for Biomolecular Structure and Assembly	This work was supported by United States-Israel Binational Science Foundation Grant 2015170 and the Minerva Foundation with funding from the Federal German Ministry for Education and Research and the Kimmelman Center for Biomolecular Structure and Assembly. The authors declare that they have no conflicts of interest with the contents of this article.	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azia A, 2012, FEBS J, V279, P543, DOI 10.1111/j.1742-4658.2011.08458.x; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Chorev DS, 2015, PROTEOMICS, V15, P2777, DOI 10.1002/pmic.201400517; Fei X, 2014, P NATL ACAD SCI USA, V111, P12775, DOI 10.1073/pnas.1412922111; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Haldar S, 2015, J MOL BIOL, V427, P2244, DOI 10.1016/j.jmb.2015.04.009; HARRIS JR, 1994, J STRUCT BIOL, V112, P216, DOI 10.1006/jsbi.1994.1022; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; Horwich AL, 2011, NAT MED, V17, P1211, DOI 10.1038/nm.2468; ISHII N, 1991, J BIOCHEM-TOKYO, V110, P905; Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koike-Takeshita A, 2014, J MOL BIOL, V426, P3634, DOI 10.1016/j.jmb.2014.08.017; LLORCA O, 1994, FEBS LETT, V345, P181, DOI 10.1016/0014-5793(94)00432-3; Noshiro D, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0180; Priestley M. B., 1981, SPECTRAL ANAL TIME S, P375; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Schwarz D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192619; Taguchi H, 2015, J MOL BIOL, V427, P2912, DOI 10.1016/j.jmb.2015.04.007; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Weaver J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15934; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110; Ye X, 2013, P NATL ACAD SCI USA, V110, pE4289, DOI 10.1073/pnas.1317702110; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	30	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13527	13529		10.1074/jbc.AC119.010299	http://dx.doi.org/10.1074/jbc.AC119.010299			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31371450	hybrid, Green Published			2022-12-26	WOS:000486418600001
J	Manalastas-Cantos, K; Kschonsak, M; Haering, CH; Svergun, DI				Manalastas-Cantos, Karen; Kschonsak, Marc; Haering, Christian H.; Svergun, Dmitri I.			Solution structure and flexibility of the condensin HEAT-repeat subunit Ycg1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small-angle X-ray scattering (SAXS); structural model; conformational change; oligomer; DNA binding protein; condensin; dynamic light scattering (DLS); HEAT-repeat; protein flexibility; size exclusion chromatography with multiangle static light scattering (SEC-MALS)	SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; COMPLEXES; CONFERS; DNA	High-resolution structural analysis of flexible proteins is frequently challenging and requires the synergistic application of different experimental techniques. For these proteins, small-angle X-ray scattering (SAXS) allows for a quantitative assessment and modeling of potentially flexible and heterogeneous structural states. Here, we report SAXS characterization of the condensin HEAT-repeat subunit Ycg1(Cnd3) in solution, complementing currently available high-resolution crystallographic models. We show that the free Ycg1 subunit is flexible in solution but becomes considerably more rigid when bound to its kleisin-binding partner protein Brn1(Cnd2). The analysis of SAXS and dynamic and static multiangle light scattering data furthermore reveals that Ycg1 tends to oligomerize with increasing concentrations in the absence of Brn1. Based on these data, we present a model of the free Ycg1 protein constructed by normal mode analysis, as well as tentative models of Ycg1 dimers and tetramers. These models enable visualization of the conformational transitions that Ycg1 has to undergo to adopt a closed rigid shape and thereby create a DNA-binding surface in the condensin complex.	[Manalastas-Cantos, Karen; Svergun, Dmitri I.] Hamburg Unit, European Mol Biol Lab, D-22607 Hamburg, Germany; [Kschonsak, Marc; Haering, Christian H.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Manalastas-Cantos, Karen] EMBL, Heidelberg, Germany; [Manalastas-Cantos, Karen] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Kschonsak, Marc] Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Roche Holding; Genentech	Svergun, DI (corresponding author), European Mol Biol Lab, Hamburg Outstn, D-22607 Hamburg, Germany.	svergun@embl-hamburg.de		Haering, Christian/0000-0001-8301-1722; Manalastas-Cantos, Karen/0000-0002-5483-9616; Svergun, Dmitri/0000-0003-0830-5696	German Research Foundation [HA 5853/2-1]; European Union Horizon 2020 Programme iNEXT Grant [653706]; European Research Council Consolidator Grant [681365]	German Research Foundation(German Research Foundation (DFG)); European Union Horizon 2020 Programme iNEXT Grant; European Research Council Consolidator Grant(European Research Council (ERC))	This work was supported by German Research Foundation Grant HA 5853/2-1 (to C. H. H.) and by European Union Horizon 2020 Programme iNEXT Grant through Project 653706 (to D. I. S.) and European Research Council Consolidator Grant 681365 (to C. H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Doughty TW, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006216; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Hara K, 2019, EMBO REP, V20, DOI 10.15252/embr.201847183; Houlard M, 2015, NAT CELL BIOL, V17, P771, DOI 10.1038/ncb3167; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kschonsak M, 2017, CELL, V171, P588, DOI 10.1016/j.cell.2017.09.008; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Piazza I, 2014, NAT STRUCT MOL BIOL, V21, P560, DOI 10.1038/nsmb.2831; Romier C, 2006, ACTA CRYSTALLOGR D, V62, P1232, DOI 10.1107/S0907444906031003; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659; Yoshimura SH, 2016, J CELL SCI, V129, P3963, DOI 10.1242/jcs.185710	32	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13822	13829		10.1074/jbc.RA119.008661	http://dx.doi.org/10.1074/jbc.RA119.008661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350339	Green Published, hybrid			2022-12-26	WOS:000486418600026
J	Gonciarz, W; Krupa, A; Hinc, K; Obuchowski, M; Moran, AP; Gajewski, A; Chmiela, M				Gonciarz, Weronika; Krupa, Agnieszka; Hinc, Krzysztof; Obuchowski, Michel; Moran, Anthony P.; Gajewski, Adrian; Chmiela, Magdalena			The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts	PLOS ONE			English	Article							NEUTROPHIL-ACTIVATING PROTEIN; IMMUNE-RESPONSE; GUINEA-PIGS; CYTOKINE EXPRESSION; DENDRITIC CELLS; T-CELLS; LIPOPOLYSACCHARIDE; CAGA; PERSISTENCE; INTERLEUKIN-8	Background Helicobacter pylori colonizes the human gastric mucosa, causing chronic inflammation, peptic ulcers and gastric cancer. A cascade of harmful processes results from the interaction of these bacteria with the gastric epithelium. Aim To investigate these processes in terms of upregulation of oxidative stress and cell apoptosis and downregulation of the pro-regenerative activity of cells. Methods We employed an in vivo guinea pig model at 7 or 28 days postinoculation with H. pylori, corresponding to an acute or chronic stage of infection, respectively, and an in vitro model of guinea pig primary gastric epithelial cells and fibroblasts treated with bacterial components: glycine acid extract (GE), urease subunit A (UreA), cytotoxin-associated gene A protein (CagA) and lipopolysaccharide (LPS). Cells were evaluated for metabolic activity (MTT reduction), myeloperoxidase (MPO) and metalloproteinase (MMP-9) secretion, lipid peroxidation (4-hydroxynonenal (4HNE)), migration (wound healing), proliferation (Ki-67 antigen) and cell apoptosis (TUNEL assay; Bcl-xL, Bax, Bcl-2 expression; caspase 3 cleavage). Results Significant infiltration of the gastric mucosa by inflammatory cells in vivo in response to H. pylori was accompanied by oxidative stress and cell apoptosis, which were more intense 7 than 28 days after inoculation. The increase in cell proliferation was more intense in chronic than acute infection. H. pylori components GE, CagA, UreA, and LPS upregulated oxidative stress and apoptosis. Only H. pylori LPS inhibited cell migration and proliferation, which was accompanied by the upregulation of MMP-9. Conclusions H. pylori infection induces cell apoptosis in conjunction with increased oxidative stress. Elevated apoptosis protects against deleterious inflammation and neoplasia; however, it reduces cell integrity. Upregulation of cell migration and proliferation in response to injury in the milieu of GE, CagA or UreA facilitates tissue regeneration but increases the risk of neoplasia. By comparison, downregulation of cell regeneration by H. pylori LPS may promote chronic inflammation.	[Gonciarz, Weronika; Krupa, Agnieszka; Gajewski, Adrian; Chmiela, Magdalena] Univ Lodz, Fac Biol & Environm Protect, Inst Microbiol Biotechnol & Immunol, Dept Immunol & Infect Biol, Lodz, Poland; [Hinc, Krzysztof; Obuchowski, Michel] Med Univ Gdansk, Intercoll Fac Biotechnol UG MUG, Lab Mol Bacteriol, Gdansk, Poland; [Moran, Anthony P.] Natl Univ Ireland Galway, Sch Nat Sci, Dept Microbiol, Galway, Ireland	University of Lodz; Fahrenheit Universities; Medical University Gdansk; Ollscoil na Gaillimhe-University of Galway	Chmiela, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Inst Microbiol Biotechnol & Immunol, Dept Immunol & Infect Biol, Lodz, Poland.	magdalena.chmiela@biol.uni.lodz.pl	Hinc, Krzysztof/B-9543-2014; Gajewski, Adrian/AAN-9957-2021; Obuchowski, Michal/F-5836-2011	Hinc, Krzysztof/0000-0002-6067-7852; Gajewski, Adrian/0000-0001-7445-9752; Obuchowski, Michal/0000-0001-5410-2350; Gonciarz, Weronika/0000-0002-5231-5341; Krupa, Agnieszka/0000-0003-1303-4608; Chmiela, Magdalena/0000-0002-5447-2922				Allen LAH, 2007, CELL MICROBIOL, V9, P817, DOI 10.1111/j.1462-5822.2007.00906.x; Amedei A, 2006, J CLIN INVEST, V116, P1092, DOI 10.1172/JCI27177; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Backhed F, 2003, INFECT IMMUN, V71, P3357, DOI 10.1128/IAI.71.6.3357-3360.2003; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Beswick EJ, 2006, INFECT IMMUN, V74, P1148, DOI 10.1128/IAI.74.2.1148-1155.2006; Bimczok D, 2013, J IMMUNOL, V190, P6626, DOI 10.4049/jimmunol.1203330; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Caron TJ, 2015, WORLD J GASTROENTERO, V21, P11411, DOI 10.3748/wjg.v21.i40.11411; Cheng HH, 2012, WORLD J GASTROENTERO, V18, P34, DOI 10.3748/wjg.v18.i1.34; Chmiela M, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0480-y; Chmiela M, 2017, WORLD J GASTROENTERO, V23, P1521, DOI 10.3748/wjg.v23.i9.1521; Chmiela M, 2014, WORLD J GASTROENTERO, V20, P9882, DOI 10.3748/wjg.v20.i29.9882; Cho SJ, 2003, TOXICON, V42, P601, DOI 10.1016/j.toxicon.2003.08.003; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Czkwianianc Elzbieta, 1997, Central-European Journal of Immunology, V22, P240; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Du SY, 2016, J MICROBIOL IMMUNOL, V49, P636, DOI 10.1016/j.jmii.2014.05.011; Ernst PB, 2006, GASTROENTEROLOGY, V130, P188, DOI 10.1053/j.gastro.2005.06.032; EVANS GS, 1992, J CELL SCI, V101, P219; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Florence JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171427; Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921; Gonciarz W, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0515-z; Grebowska A, 2008, POL J MICROBIOL, V57, P185; Hatakeyama M, 2017, P JPN ACAD B-PHYS, V93, P196, DOI 10.2183/pjab.93.013; Hinc K, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-2; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Honig A, 2000, ANTICANCER RES, V20, P1641; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Kaebisch R, 2014, J IMMUNOL, V192, P316, DOI 10.4049/jimmunol.1302476; Kelly PJ, 2008, STROKE, V39, P100, DOI 10.1161/STROKEAHA.107.488189; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Kronsteiner B, 2013, INFECT IMMUN, V81, P3803, DOI 10.1128/IAI.00660-13; Lai WC, 2003, J IMMUNOL, V170, P6244, DOI 10.4049/jimmunol.170.12.6244; Lamb A, 2013, J CELL BIOCHEM, V114, P491, DOI 10.1002/jcb.24389; Lee A, 1999, MOL MED TODAY, V5, P500, DOI 10.1016/S1357-4310(99)01591-9; Li HL, 2012, MOL MED REP, V6, P774, DOI 10.3892/mmr.2012.1010; Lina TT, 2014, WORLD J GASTROENTERO, V20, P12753, DOI 10.3748/wjg.v20.i36.12753; LOGAN SM, 1983, INFECT IMMUN, V42, P675, DOI 10.1128/IAI.42.2.675-682.1983; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Miszczyk E, 2011, POST HIG MED DOSW, V68, P603, DOI DOI 10.5604/17322693.1102583; Miszczyk E, 2014, ACTA BIOCHIM POL, V61, P295; Miszczyk E, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/206463; Mnich E, 2016, WORLD J GASTROENTERO, V22, P7536, DOI 10.3748/wjg.v22.i33.7536; Mnich E, 2015, ACTA BIOCHIM POL, V62, P641, DOI 10.18388/abp.2015_1045; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Nedrud JG, 1999, FEMS IMMUNOL MED MIC, V24, P243, DOI 10.1111/j.1574-695X.1999.tb01290.x; Nishioka H, 2003, EUR J IMMUNOL, V33, P840, DOI 10.1002/eji.200323726; Paziak-Domanska B, 2000, CELL IMMUNOL, V202, P136, DOI 10.1006/cimm.2000.1654; Perfetto B, 2004, RES MICROBIOL, V155, P259, DOI 10.1016/j.resmic.2004.01.007; Pierzchalski P, 2009, J PHYSIOL PHARMACOL, V60, P119; Ramarao N, 2001, INFECT IMMUN, V69, P2604, DOI 10.1128/IAI.69.4.2604-2611.2001; Rechcinski T, 1997, MICROBIOL IMMUNOL, V41, P387, DOI 10.1111/j.1348-0421.1997.tb01869.x; Rijpkema SG, 2001, FEMS IMMUNOL MED MIC, V30, P151, DOI 10.1016/S0928-8244(00)00248-0; Rudnicka K, 2015, INNATE IMMUN-LONDON, V21, P127, DOI 10.1177/1753425913518225; Rudnicka K, 2013, APMIS, V121, P806, DOI 10.1111/apm.12120; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Schwartz JT, 2006, J LEUKOCYTE BIOL, V79, P1214, DOI 10.1189/jlb.0106030; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Sjunnesson H, 2003, APMIS, V111, P634, DOI 10.1034/j.1600-0463.2003.1110606.x; Slomiany BL, 1999, BIOCHEM BIOPH RES CO, V261, P15, DOI 10.1006/bbrc.1999.1003; Smith RS, 1997, AM J PATHOL, V151, P317; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Stromberg E, 2003, FEMS IMMUNOL MED MIC, V36, P159, DOI 10.1016/S0928-8244(03)00026-9; Sturegard E, 1998, J MED MICROBIOL, V47, P1123, DOI 10.1099/00222615-47-12-1123; Subhash VV, 2015, MICROBIOL-SGM, V161, P1150, DOI 10.1099/mic.0.000066; Sun YQ, 2004, HELICOBACTER, V9, P217, DOI 10.1111/j.1083-4389.2004.00227.x; Tan MP, 2008, INFECT IMMUN, V76, P1289, DOI 10.1128/IAI.00779-07; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Tanahashi T, 2000, INFECT IMMUN, V68, P664, DOI 10.1128/IAI.68.2.664-671.2000; TERANO A, 1982, GASTROENTEROLOGY, V83, P1280; Walencka M, 2015, ACTA BIOCHIM POL, V62, P697, DOI 10.18388/abp.2015_1110; Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454; WARREN JR, 1983, LANCET, V1, P1273; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Wroblewski LE, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-29; XIANG Z, 1993, EUR J CLIN MICROBIOL, V12, P739, DOI 10.1007/BF02098460; Yang JCh, 2011, GASTRITIS GASTRIC CA, DOI [10.5772/24767, DOI 10.5772/24767]	88	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220636	10.1371/journal.pone.0220636	http://dx.doi.org/10.1371/journal.pone.0220636			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390383	Green Published, Green Submitted, gold			2022-12-26	WOS:000484999400024
J	Lindsey, RC; Cheng, SH; Mohan, S				Lindsey, Richard C.; Cheng, Shaohong; Mohan, Subburaman			Vitamin C effects on 5-hydroxymethylcytosine and gene expression in osteoblasts and chondrocytes: Potential involvement of PHD2	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ASCORBIC-ACID; PROTEASOMAL DEGRADATION; ALKALINE-PHOSPHATASE; OSTERIX EXPRESSION; PROLYL HYDROXYLASE; IN-VITRO; DIFFERENTIATION; COLLAGEN; ACTIVATION	Vitamin C (ascorbic acid, AA) is a well-known regulator of bone and cartilage metabolism. However, the mechanisms of AA's action in these tissues are only partly understood. In this study, we confirmed that AA contributes to bone and cartilage metabolism by showing decreased articular cartilage and trabecular bone in AA-deficient spontaneous fracture (sfx) mutant mice. In vitro, we found that AA exerts differential effects on chondrocyte and osteoblast differentiation. Since AA is known to increase levels of 5-hydroxymethylcytosine (5-hmC) and induce DNA demethylation via the ten-eleven translocases (TETs), and since prolyl hydroxylase domain-containing protein 2 (PHD2), a known mediator of AA's effects in these tissues, is part of the same enzyme family as the TETs, we next investigated whether increases in 5-hmC might mediate some of these effects. All TETs and PHDs are expressed in chondrocytes and osteoblasts, and PHD2 is localized in both the cytoplasm and nucleus of the cell, lending plausibility to the hypothesis of altered 5-hmC content in these cells. We found that AA treatment increased levels of 5-hmC in both cell types globally, notably including promoter regions of osteoblast differentiation genes. Furthermore, inhibition of PHD2 decreased 5-hmC levels in chondrocyte differentiation gene promoters, and knockdown of Phd2 in chondrocytes reduced global 5-hmC levels, suggesting for the first time that PHD2 may itself directly mediate increases in 5-hmC in chondrocyte and osteoblast genes. Further investigation of this mechanism could lead to novel therapeutic approaches to treat debilitating diseases such as osteoarthritis and osteoporosis.	[Lindsey, Richard C.; Cheng, Shaohong; Mohan, Subburaman] VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Lindsey, Richard C.; Mohan, Subburaman] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92354 USA; [Lindsey, Richard C.; Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Orthoped, Loma Linda, CA 92354 USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Mohan, S (corresponding author), VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Dept Orthoped, Loma Linda, CA 92354 USA.	subburaman.mohan@va.gov		Lindsey, Richard/0000-0001-9911-4136	US Department of Veterans Affairs BLR&D merit review grant [101-BX-001396]; NIH [2 R25 GM060507]; US Department of Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001396] Funding Source: NIH RePORTER	US Department of Veterans Affairs BLR&D merit review grant(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by funding from the US Department of Veterans Affairs BLR&D merit review grant (101-BX-001396) to SM and NIH grant 2 R25 GM060507 to the Loma Linda University Center for Health Disparities and Molecular Medicine. Salary support for SM is provided by a Senior Research Career Scientist Award from the US Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding from the US Department of Veterans Affairs BLR&D merit review grant (101-BX-001396) to SM and NIH grant 2 R25 GM060507 to the Loma Linda University Center for Health Disparities and Molecular Medicine. Salary support for SM is provided by a Senior Research Career Scientist Award from the US Department of Veterans Affairs.	Aghajanian P, 2015, J BONE MINER RES, V30, P1945, DOI 10.1002/jbmr.2709; [Anonymous], 2019, R LANG ENV STAT COMP; Beamer WG, 2000, BONE, V27, P619, DOI 10.1016/S8756-3282(00)00369-0; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Buo AM, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.21; Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323; Cheng SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep45408; Cheng SH, 2014, J BONE MINER RES, V29, P2276, DOI 10.1002/jbmr.2258; Cheng SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032887; DANIEL JC, 1984, J CELL BIOL, V99, P1960, DOI 10.1083/jcb.99.6.1960; Depping R, 2015, J MOL MED, V93, P599, DOI 10.1007/s00109-015-1276-0; Digaleh H, 2013, CELL MOL LIFE SCI, V70, P4681, DOI 10.1007/s00018-013-1409-y; Ezura Y, 2009, ARTHRITIS RHEUM, V60, P1416, DOI 10.1002/art.24472; Fan LH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/239356; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1990, J BONE MINER RES, V5, P1157; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Hadzir SN, 2014, CYTOTHERAPY, V16, P674, DOI 10.1016/j.jcyt.2013.07.013; Hall SL, 1998, CALCIFIED TISSUE INT, V63, P183, DOI 10.1007/s002239900512; HARADA S, 1991, J BONE MINER RES, V6, P903; Ilich JZ, 2003, EUR J CLIN NUTR, V57, P554, DOI 10.1038/sj.ejcn.1601577; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Jiao Y, 2005, MAMM GENOME, V16, P20, DOI 10.1007/s00335-004-2414-0; KAWAI T, 1992, J BIOL CHEM, V267, P21973; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; LEBOY PS, 1989, J BIOL CHEM, V264, P17281; Leveille SG, 1997, J EPIDEMIOL COMMUN H, V51, P479, DOI 10.1136/jech.51.5.479; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Malmir H, 2018, BRIT J NUTR, V119, P847, DOI [10.1017/S0007114518000430, 10.1017/s0007114518000430]; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; MIZUSHIMA Y, 1984, EXPERIENTIA, V40, P359, DOI 10.1007/BF01952551; Mohan S, 2005, J BONE MINER RES, V20, P1597, DOI 10.1359/JBMR.050406; New SA, 1997, AM J CLIN NUTR, V65, P1831, DOI 10.1093/ajcn/65.6.1831; New SA, 2000, AM J CLIN NUTR, V71, P142; Osipyants AI, 2018, BIOCHIMIE, V147, P46, DOI 10.1016/j.biochi.2017.12.011; Otsuka E, 1999, AM J PHYSIOL-CELL PH, V277, pC132, DOI 10.1152/ajpcell.1999.277.1.C132; Prynne CJ, 2006, AM J CLIN NUTR, V83, P1420, DOI 10.1093/ajcn/83.6.1420; Sanghi D, 2015, J AM COLL NUTR, V34, P15, DOI 10.1080/07315724.2013.875439; Simon JA, 2001, AM J EPIDEMIOL, V154, P427, DOI 10.1093/aje/154.5.427; Sugiura M, 2011, OSTEOPOROSIS INT, V22, P143, DOI 10.1007/s00198-010-1239-9; Takamizawa S, 2004, CELL BIOL INT, V28, P255, DOI 10.1016/j.cellbi.2004.01.010; Taylor SEB, 2016, J BONE MINER RES, V31, P524, DOI 10.1002/jbmr.2711; Taylor SEB, 2014, ARTHRITIS RHEUMATOL, V66, P90, DOI 10.1002/art.38200; Temu TM, 2010, AM J PHYSIOL-ENDOC M, V299, pE325, DOI 10.1152/ajpendo.00145.2010; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Wolf RL, 2005, AM J CLIN NUTR, V82, P581, DOI 10.1093/ajcn/82.3.581; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xing WR, 2007, J BIOL CHEM, V282, P22052, DOI 10.1074/jbc.M702614200; Xing WR, 2011, PHYSIOL GENOMICS, V43, P749, DOI 10.1152/physiolgenomics.00229.2010; Xing WR, 1998, MOL ENDOCRINOL, V12, P1310, DOI 10.1210/me.12.9.1310; Young JI, 2015, ANNU REV NUTR, V35, P545, DOI 10.1146/annurev-nutr-071714-034228	57	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220653	10.1371/journal.pone.0220653	http://dx.doi.org/10.1371/journal.pone.0220653			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390373	Green Published, gold, Green Submitted			2022-12-26	WOS:000484999400026
J	Holm, J; Eiermann, B; Kimland, E; Mannheimer, B				Holm, Johan; Eiermann, Birgit; Kimland, Elin; Mannheimer, Buster			Prevalence of potential drug-drug interactions in Swedish pediatric outpatients	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; PRESCRIPTIONS; POLYPHARMACY; CARE	Purpose To describe the occurrence of potential drug-drug interactions (DDIs) in prescribed drugs, dispensed to pediatric outpatients in Sweden. Methods A cross sectional study was conducted based on data from a national register of prescribed drugs, dispensed at pharmacies, to children 0-17 years old. The study period was January 1 to April 30, 2010. Drug dispensing data was linked to the DDI database SFINX. Prevalence and frequencies of potential interactions were investigated, and drugs commonly involved in interactions were identified. The study focused on clinically relevant potential interactions, class D (should be avoided), and class C (can be handled, e.g. by dose adjustment). Results In the Swedish pediatric population, 0 to 17 years of age, 12% (n = 231 078) of children had at least two dispensed drugs. In this group of patients, 0.14% had potential D-interactions and 1,3% had potential C-interactions. The number of D- and C-interactions that may lead to reduced effects were 181 (52%), and 1224 (32%) respectively. The ten most frequent drugs were involved in 78% and 65% of all potential D-, and C-interactions respectively. Furthermore, 80%, and 58% of the D-, and C-interactions respectively occurred in patients aged 12 to 17. Conclusions We identified a limited number of drugs that were represented in the majority of potential interactions. Interactions that can lead to a reduced treatment effect constituted approximately half of D-interactions, and a third of C-interactions. The frequency of potential interactions was higher in older children. The results may contribute to increased prescriber awareness of important potential drug interactions among pediatric outpatients.	[Holm, Johan; Eiermann, Birgit] Karolinska Univ Hosp Huddinge, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden; [Eiermann, Birgit] Inera AB, Swedish Assoc Local Author & Reg, Stockholm, Sweden; [Kimland, Elin] Swedish Med Prod Agcy, Uppsala, Sweden; [Mannheimer, Buster] Karolinska Inst, Dept Clin Sci & Educ Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Medical Products Agency; Karolinska Institutet	Holm, J (corresponding author), Karolinska Univ Hosp Huddinge, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden.	johan.holm@ki.se		Holm, Johan/0000-0001-6398-7672	Karolinska Institutet; Swedish Foundation for Clinical Pharmacology and Pharmacotherapy; Swedish Society for Medical Research; Stockholm County Council	Karolinska Institutet(Karolinska Institutet); Swedish Foundation for Clinical Pharmacology and Pharmacotherapy; Swedish Society for Medical Research; Stockholm County Council(Stockholm County Council)	No specific funding has been received for this study. General research grants have been received from Karolinska Institutet (www.ki.se), the Swedish Foundation for Clinical Pharmacology and Pharmacotherapy, Stockholm County Council (www.sll.se), and the Swedish Society for Medical Research (www.ssmf.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk TE, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26410; Bazzano ATF, 2009, ACAD PEDIATR, V9, P81, DOI 10.1016/j.acap.2008.11.010; Bottiger Y, 2009, EUR J CLIN PHARMACOL, V65, P627, DOI 10.1007/s00228-008-0612-5; Dai DW, 2016, PEDIATR CRIT CARE ME, V17, pE218, DOI 10.1097/PCC.0000000000000684; Espinosa MAFD, 2014, INT J CLIN PHARM-NET, V36, P1160, DOI 10.1007/s11096-014-0011-1; Feinstein J, 2015, PEDIATRICS, V135, pE99, DOI 10.1542/peds.2014-2015; Feudtner C, 2012, ARCH PEDIAT ADOL MED, V166, P9, DOI 10.1001/archpediatrics.2011.161; Holm J, 2014, EUR J CLIN PHARMACOL, V70, P1375, DOI 10.1007/s00228-014-1745-3; Ismail M, 2017, J CRIT CARE, V40, P243, DOI 10.1016/j.jcrc.2017.04.028; Kimland E, 2012, ACTA PAEDIATR, V101, P772, DOI 10.1111/j.1651-2227.2012.02656.x; Langerova P, 2013, EUR J PEDIATR, V172, P631, DOI 10.1007/s00431-013-1933-7; Lebowitz Mollie Blazar, 2016, Hosp Pediatr, V6, P282, DOI 10.1542/hpeds.2015-0249; Lisby S M, 1987, Hosp Pharm, V22, P356; Mannheimer B, 2010, J INTERN MED, V268, P540, DOI 10.1111/j.1365-2796.2010.02303.x; Mannheimer B, 2010, BRIT J CLIN PHARMACO, V69, P411, DOI 10.1111/j.1365-2125.2009.03598.x; Morales-Rios O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190882; Novak PH, 2005, BRIT J CLIN PHARMACO, V59, P712, DOI 10.1111/j.1365-2125.2004.02237.x; Ogawa R, 2011, DRUGS, V71, P1839, DOI 10.2165/11593990-000000000-00000; Olsson J, 2011, ACTA PAEDIATR, V100, P1272, DOI 10.1111/j.1651-2227.2011.02287.x; Oshikoya KA, 2016, EXPERT REV CLIN PHAR, V9, P1505, DOI 10.1080/17512433.2016.1232619; R Core Team, 2018, MOA SIGNED MANILA BA; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P801, DOI 10.1007/s00228-011-1183-4; Shah SS, 2007, ARCH PEDIAT ADOL MED, V161, P282, DOI 10.1001/archpedi.161.3.282; Sjoqvist F., 1997, European Journal of Clinical Pharmacology, V52, pA126; Statistics Sweden, 2018, STAT DAT; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO collaborating centre for drug statistics methodology, 2018, ATC STRUCT PRINC; Yeh ML, 2014, COMPUT METH PROG BIO, V113, P15, DOI 10.1016/j.cmpb.2013.07.016	28	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220685	10.1371/journal.pone.0220685	http://dx.doi.org/10.1371/journal.pone.0220685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381591	Green Submitted, Green Published, gold			2022-12-26	WOS:000484993600029
J	Boswald, LF; Klein, C; Dobenecker, B; Kienzle, E				Boeswald, Linda Franziska; Klein, Carmen; Dobenecker, Britta; Kienzle, Ellen			Factorial calculation of calcium and phosphorus requirements of growing dogs	PLOS ONE			English	Article							VITAMIN-D; FECAL CALCIUM; METABOLISM; DIET; NUTRIENT; ENERGY; DIGESTIBILITY; DEFICIENCY; ABSORPTION; EXCRETION	Calcium and phosphorus requirements for growing dogs can be calculated by different methods. The current standard feeding recommendations are based on experimental data derived from young giant breed puppies. In order to determine the absolute requirement, an extrapolation via metabolisable energy requirement is recommended. Another approach is to calculate the requirement factorially, taking into account the endogenous losses and the amount of calcium and phosphorus retained due to tissue accretion during growth as well as the expected availability of these nutrients. The working hypothesis was that both methods are valid and lead to comparable results in young puppies of a high mature body weight (BW). Yet, deviations for other age and mature BW groups were expected. Thus, the aim of the present study was to compare the results of both methods using exemplary puppies of different age and mature BW groups. The hypotheses could be verified for calcium. The extrapolated requirements overestimate the factorial requirements by up to 59.7% for puppies <60kg mature BW and/or >6 months of age. In case of phosphorus requirement, the deviations between both methods are overall very high in all stages. Taking into account the potentially harmful effects of calcium and phosphorus excess, the feeding recommendations based on the extrapolation should be reconsidered.	[Boeswald, Linda Franziska; Klein, Carmen; Dobenecker, Britta; Kienzle, Ellen] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Chair Anim Nutr & Dietet, Munich, Germany	University of Munich	Boswald, LF (corresponding author), Ludwig Maximilians Univ Munchen, Dept Vet Sci, Chair Anim Nutr & Dietet, Munich, Germany.	linda.boeswald@lmu.de	Böswald, Linda/AAN-2058-2020	Böswald, Linda/0000-0002-5363-335X; Dobenecker, Britta/0000-0003-0534-4219				Becker N, 2012, TIERAERZTL PRAX K H, V40, P135; Boswald LF, 2018, J ANIM PHYSIOL AN N, V102, P370, DOI 10.1111/jpn.12844; BURGER IH, 1991, J NUTR, V121, pS18, DOI 10.1093/jn/121.suppl_11.S18; CAMPBELL JR, 1965, BRIT J NUTR, V19, P339, DOI 10.1079/BJN19650032; Dobenecker B, 2006, J ANIM PHYSIOL AN N, V90, P394, DOI 10.1111/j.1439-0396.2006.00618.x; Dobenecker B, 1998, J ANIM PHYSIOL AN N, V80, P76, DOI 10.1111/j.1439-0396.1998.tb00506.x; Dobenecker B, 2004, J NUTR, V134, p2151S, DOI 10.1093/jn/134.8.2151S; Dobenecker B, 2010, J ANIM PHYSIOL AN N, V94, pe109, DOI 10.1111/j.1439-0396.2010.00989.x; Dobenecker B, 2002, J NUTR, V132, p1665S, DOI 10.1093/jn/132.6.1665S; Dobenecker B, 2011, BRIT J NUTR, V106, pS142, DOI 10.1017/S0007114511002959; Flachowsky G., 2004, Kraftfutter, V87, P260; GERSHOFF SN, 1958, J NUTR, V64, P303, DOI 10.1093/jn/64.2.303; GOEDEGEBUURE SA, 1986, VET PATHOL, V23, P594, DOI 10.1177/030098588602300508; Goodman SA, 1998, RECENT ADV CANINE FE, V3, P3; HAZEWINKEL HAW, 1989, J SMALL ANIM PRACT, V30, P625, DOI 10.1111/j.1748-5827.1989.tb01493.x; HAZEWINKEL HAW, 1991, J NUTR, V121, pS99, DOI 10.1093/jn/121.suppl_11.S99; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Hedhammar A, 1978, NUTRITION OF THE DOG; JENKINS KJ, 1960, J NUTR, V70, P235, DOI 10.1093/jn/70.2.235; Kamphues J., 2014, SUPPLEMENTE TIERERNA, Vtwelfth; Kiefer-Hecker B, 2018, J ANIM PHYSIOL AN N, V102, P789, DOI 10.1111/jpn.12868; Kienzle E, 1998, J NUTR, V128, p2609S, DOI [10.1093/jn/128.12.2609S, 10.1093/jn/128.12.2598S, 10.1093/jn/128.12.2680S]; KIENZLE E, 1991, J NUTR, V121, pS122, DOI 10.1093/jn/121.suppl_11.S122; Kienzle E, 1989, J NUTR, V128, p2680S; Kirchge&beta;ner M., 2014, TIERERNAHRUNG, V14th; Klein C, 2019, J ANIM PHYSL A UNPUB; Kober N, 2017, P 21 C ESVCN CIR UK; Kolle P, 2006, TIERAERZTL PRAX K H, V34, P104; Laflamme DP, 2001, COMPENDIUM CONTINUIN, V23, P66; LAUTEN SD, 1998, RECENT ADV CANINE FE, V2, P63; LIU CH, 1953, J GERONTOL, V8, P264; Lupatsch I, 2009, BASICS, P417, DOI 10.1533/9781845696474.3.417; Mack JK, 2015, J ANIM PHYSIOL AN N, V99, P801, DOI 10.1111/jpn.12294; Meyer H, 1983, ERNAHRUNG HUNDES; Morgan AF, 1933, AM J PHYSIOL, V105, P621, DOI 10.1152/ajplegacy.1933.105.3.621; Morgan AF, 1930, J BIOL CHEM, V85, P687; NAP RC, 1993, J NUTR, V123, P1826, DOI 10.1093/jn/123.11.1826; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Schmitt S, 2018, J ANIM PHYSIOL AN N, V102, pE798, DOI 10.1111/jpn.12837; Schoenmakers I, 1999, VET QUART, V21, P147, DOI 10.1080/01652176.1999.9695010; Shohl AT, 1928, J BIOL CHEM, V76, P633; Slater MR., 1991, VET COMP ORTHOPAED T, V4, P100; Smith MC, 1940, J NUTR, V20, P19, DOI 10.1093/jn/20.1.19; Society of Nutrition Physiolog (GfE), 2006, EMPF EN NAHRST SCHW, P112; Society of Nutrition Physiology (GfE), 1989, EN NUTR REQ 5 DOGS; Zentek J, 1992, J VET MED; Zentek J., 2016, ERNAHRUNG HUNDES	47	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220305	10.1371/journal.pone.0220305	http://dx.doi.org/10.1371/journal.pone.0220305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374084	Green Published, gold, Green Submitted			2022-12-26	WOS:000484991500009
J	Jiang, WD; Yuan, PC				Jiang, Wei-dong; Yuan, Ping-cheng			Molecular network-based identification of competing endogenous RNAs in bladder cancer	PLOS ONE			English	Article							INVASIVE UROTHELIAL CARCINOMA; CIRCULAR RNAS; EAU GUIDELINES; METASTASIS; PROLIFERATION; PREDICTION; MIGRATION; PROMOTES; INSIGHTS; ABUNDANT	Background Circular RNAs (circRNAs) have been shown to interact with microRNAs (miRNA) as competitive endogenous RNAs (ceRNAs) to regulate target gene expression and participate in tumorigenesis. However, the role of circRNA-mediated ceRNAs in bladder cancer (BC) remains unknown. Accordingly, the aim of this study was to elucidate the regulatory mechanisms in BC based on construction of the ceRNA network. Methods The RNA expression profiles were obtained from public datasets in the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) database, and were used to establish a circRNA-miRNA-mRNA network. The interactions among proteins were analyzed using the STRING database and hubgenes were extracted using the cytoHubba application. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of differentially expressed mRNAs in BC and normal tissue samples were performed to determine the functions of the intersecting mRNAs. Results A total of 27 circRNAs, 76 miRNAs, and 4744 mRNAs were found to be differentially expressed between BC and normal tissues. The circRNA-miRNA-mRNA ceRNA network was established based on 21 circRNAs, 14 miRNAs, and 150 mRNAs differentially expressed in BC. We also established a protein-protein interaction network and identified 10 hubgenes, which were used to construct circRNA-miRNA-hubgene regulatory modules. The most enriched biological process GO term was strand displacement (P<0.05), and the homologous recombination and Fanconi anemia pathways were significantly enriched (P<0.05) for the differentially expressed genes in BC. Conclusions We screened several dysregulated circRNAs and established a circRNA-associated ceRNA network by bioinformatics analysis. The identified ceRNAs are likely critical in the pathogenesis of BC and may serve as future therapeutic biomarkers.	[Jiang, Wei-dong; Yuan, Ping-cheng] Hubei Polytech Univ, Huangshi Cent Hosp, Dept Urol, Affiliated Hosp,Edong Healthcare Grp, Huangshi, Hubei, Peoples R China; [Jiang, Wei-dong; Yuan, Ping-cheng] Hubei Polytech Univ, Huangshi Cent Hosp, Hubei Key Lab Kidney Dis Pathogenesis & Intervent, Affiliated Hosp,Edong Healthcare Grp, Huangshi, Hubei, Peoples R China	Hubei Polytechnic University; Hubei Polytechnic University	Yuan, PC (corresponding author), Hubei Polytech Univ, Huangshi Cent Hosp, Dept Urol, Affiliated Hosp,Edong Healthcare Grp, Huangshi, Hubei, Peoples R China.	dryuanpc@sina.com						Amin MB, 2015, MODERN PATHOL, V28, P612, DOI 10.1038/modpathol.2014.158; Babjuk M, 2017, EUR UROL, V71, pE173, DOI 10.1016/j.eururo.2016.11.029; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Bandettini WP, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-83; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Chen X, 2018, CLIN CANCER RES, V24, P6319, DOI 10.1158/1078-0432.CCR-18-1270; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006418; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chen X, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005912; Clark PE, 2016, J NATL COMPR CANC NE, V14, P1213, DOI 10.6004/jnccn.2016.0131; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Du LT, 2017, ONCOTARGET, V8, P40832, DOI 10.18632/oncotarget.16586; Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023; Huang WP, 2018, GENE, V678, P337, DOI 10.1016/j.gene.2018.08.036; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jiang YJ, 2019, AM J TRANSL RES, V11, P1644; Jin Y, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20187811, 10.1590/1414-431x20187811]; Kang M, 2017, ONCOTARGET, V8, P12891, DOI 10.18632/oncotarget.14179; Kristensen LS, 2018, ONCOGENE, V37, P555, DOI 10.1038/onc.2017.361; Li JQ, 2015, AM J CANCER RES, V5, P472; Li P, 2018, CELL PHYSIOL BIOCHEM, V46, P1606, DOI 10.1159/000489208; Li WT, 2018, NEOPLASIA, V20, P364, DOI 10.1016/j.neo.2018.01.008; Li Y, 2019, METHODS, V166, P4, DOI 10.1016/j.ymeth.2019.04.008; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14270; Liu J, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0630-y; Liu M, 2018, EUR REV MED PHARMACO, V22, P8248, DOI 10.26355/eurrev_201812_16519; Lv CF, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1726-x; Madubata CJ, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0032-5; Pla A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006185; Qiao BL, 2013, CANCER RES, V73, P1611, DOI 10.1158/0008-5472.CAN-12-1170; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Wei YP, 2016, TUMOR BIOL, V37, P12555, DOI 10.1007/s13277-016-5121-z; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu Z, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0039-0; Xu XW, 2017, ONCOTARGET, V8, P91674, DOI 10.18632/oncotarget.21748; Xu ZQ, 2018, J CELL BIOCHEM, V119, P3317, DOI 10.1002/jcb.26492; Yang C, 2019, CANCER SCI, V110, P99, DOI 10.1111/cas.13857; Yang CD, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0771-7; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu HH, 2018, NEW ADVANCES IN GEOTECHNICAL ENGINEERING, P455; Zhang G, 2018, J CELL BIOCHEM, DOI [10.1002/jcb.28224, DOI 10.1002/JCB.28224]; Zhang J, 2018, ELEVATED EXPRESSION, DOI [10.1002/jcb.28224, DOI 10.1002/JCB.28224]; Zhang X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1132-6; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8; Zhou BS, 2018, CELL CYCLE, V17, P2644, DOI 10.1080/15384101.2018.1553354; Zhuang C, 2019, BMB REPORTS	50	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220118	10.1371/journal.pone.0220118	http://dx.doi.org/10.1371/journal.pone.0220118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369587	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900026
J	Yeware, A; Gample, S; Agrawal, S; Sarkar, D				Yeware, Amar; Gample, Suwarna; Agrawal, Sonia; Sarkar, Dhiman			Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis	PLOS ONE			English	Article							DORMANCY; MODEL; BIOSYNTHESIS; ADAPTATION; METHIONINE; HYPOXIA; CELLS; VIVO	Depletion of oxygen levels is a well-accepted model for induction of non-replicating, persistent states in mycobacteria. Increasing the stress levels in mycobacterium bacilli facilitates their entry into a non-cultivable, dormant state. In this study, it was shown that diphenyleneiodonium, an inhibitor of NADH oxidase, induced a viable, but non-culturable state in mycobacteria, having similar features to dormant bacilli, like loss of acid-fastness, upregulation of stress-regulated genes and decreased superoxide levels as compared to actively growing bacilli. Comprehensive, untargeted metabolic profiling also confirmed a decrease in biogenesis of amino acids, NAD, unsaturated fatty acids and nucleotides. Additionally, an increase in the level of lactate, fumarate, succinate and pentose phosphate pathways along with increased mycothiol and sulfate metabolites, similar to dormant bacilli, was observed in the granuloma. These non-cultivable bacilli were resuscitated by supplementation of fetal bovine serum, regaining their culturability in liquid as well as on agar medium. This study focused on the effect of diphenyleneiodonium treatment in causing mycobacteria to rapidly transition from an active state into a viable, but non-cultivable state, and comparing their characteristics with dormant phenotypes.	[Yeware, Amar; Gample, Suwarna; Agrawal, Sonia; Sarkar, Dhiman] Acad Sci & Innovat Res AcSIR, Ghaziabad, India; [Yeware, Amar; Gample, Suwarna; Agrawal, Sonia; Sarkar, Dhiman] Natl Chem Lab, Organ Chem Div, Combi Chem Bio Resource Ctr, Pune, Maharashtra, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Sarkar, D (corresponding author), Acad Sci & Innovat Res AcSIR, Ghaziabad, India.; Sarkar, D (corresponding author), Natl Chem Lab, Organ Chem Div, Combi Chem Bio Resource Ctr, Pune, Maharashtra, India.	d.sarkar@ncl.res.in	Sarkar, Dhiman/AAK-7481-2020; Yeware, Amar/J-6346-2019	Sarkar, Dhiman/0000-0002-3912-1104; Yeware, Amar/0000-0003-1729-9865; Agrawal, Sonia/0000-0003-1528-7166	Council of Scientific and Industrial Research (CSIR) India [BSC0103, CSC0406]; DSTINSPIRE; UGC; CSIR	Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India); DSTINSPIRE(Department of Science & Technology (India)); UGC(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Council of Scientific and Industrial Research (CSIR) India through grant aid projects BSC0103 and CSC0406 supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the Center for Applications of Mass Spectrometry (CAMS) NCL Innovation Park, Pune, India for using UPLC system. AY, SG and SA are thankful to DSTINSPIRE, CSIR, and UGC for their research fellowships, respectively.	Akhtar S, 2011, ANAL BIOCHEM, V417, P286, DOI 10.1016/j.ab.2011.06.028; Ayrapetyan M, 2015, TRENDS MICROBIOL, V23, P7, DOI 10.1016/j.tim.2014.09.004; Belisle John T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6_1; Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649; Berney M, 2015, P NATL ACAD SCI USA, V112, P10008, DOI 10.1073/pnas.1513033112; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bloomfield G, 2003, J CELL SCI, V116, P3387, DOI 10.1242/jcs.00649; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Boshoff Helena I M, 2010, Drug Discov Today Dis Mech, V7, pe75, DOI 10.1016/j.ddmec.2010.09.008; Brennan RJ, 1997, MUTAGENESIS, V12, P215, DOI 10.1093/mutage/12.4.215; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dhillon J, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-51; Drapal M, 2016, MICROBIOL-SGM, V162, P1456, DOI 10.1099/mic.0.000325; Eoh H, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.84; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Khan A, 2008, J MICROBIOL METH, V73, P62, DOI 10.1016/j.mimet.2008.01.015; Lakshminarayana SB, 2015, J ANTIMICROB CHEMOTH, V70, P857, DOI 10.1093/jac/dku457; Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Patti GJ, 2014, METABOLOMICS, V10, P737, DOI 10.1007/s11306-013-0608-8; RAHMAN I, 1994, APPL ENVIRON MICROB, V60, P3573, DOI 10.1128/AEM.60.10.3573-3578.1994; Salina EG, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140106; Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Sikri K, 2013, CURR SCI, V105, P5; Sikri K, 2018, REDOX BIOL, V15, P452, DOI 10.1016/j.redox.2017.12.020; Singh U, 2011, J MICROBIOL METH, V84, P202, DOI 10.1016/j.mimet.2010.11.013; Singhal A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02264; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Yeware A, 2018, TUBERCULOSIS, V110, P15, DOI 10.1016/j.tube.2018.02.008; Yeware AM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00105	43	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220628	10.1371/journal.pone.0220628	http://dx.doi.org/10.1371/journal.pone.0220628			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369628	gold, Green Submitted, Green Published			2022-12-26	WOS:000484987900070
J	Kotze, A; Smith, RM; Moodley, Y; Luikart, G; Birss, C; Van Wyk, AM; Grobler, JP; Dalton, DL				Kotze, Antoinette; Smith, Rae M.; Moodley, Yoshan; Luikart, Gordon; Birss, Coral; Van Wyk, Anna M.; Grobler, J. Paul; Dalton, Desire L.			Lessons for conservation management: Monitoring temporal changes in genetic diversity of Cape mountain zebra (Equus zebra zebra)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; NATURE-RESERVE; SOUTH-AFRICA; SOFTWARE; PROGRAM; BOTTLENECKS; SELECTION; INSIGHTS; HABITAT; DRIFT	The Cape mountain zebra (Equus zebra zebra) is a subspecies of mountain zebra endemic to South Africa. The Cape mountain zebra experienced near extinction in the early 1900's and their numbers have since recovered to more than 4,800 individuals. However, there are still threats to their long-term persistence. A previous study reported that Cape mountain zebra had low genetic diversity in three relict populations and that urgent conservation management actions were needed to mitigate the risk of further loss. As these suggestions went largely unheeded, we undertook the present study, fifteen years later to determine the impact of management on genetic diversity in three key populations. Our results show a substantial loss of heterozygosity across the Cape mountain zebra populations studied. The most severe losses occurred at De Hoop Nature Reserve where expected heterozygosity reduced by 22.85% from 0.385 to 0.297. This is alarming, as the De Hoop Nature Reserve was previously identified as the most genetically diverse population owing to its founders originating from two of the three remaining relict stocks. Furthermore, we observed a complete loss of multiple private alleles from all populations, and a related reduction in genetic structure across the subspecies. These losses could lead to inbreeding depression and reduce the evolutionary potential of the Cape mountain zebra. We recommend immediate implementation of evidence-based genetic management and monitoring to prevent further losses, which could jeopardise the long term survival of Cape mountain zebra, especially in the face of habitat and climate change and emerging diseases.	[Kotze, Antoinette; Smith, Rae M.; Van Wyk, Anna M.; Dalton, Desire L.] South African Natl Biodivers Inst, Natl Zool Garden, Pretoria, South Africa; [Kotze, Antoinette; Smith, Rae M.; Grobler, J. Paul; Dalton, Desire L.] Univ Free State, Dept Genet, Bloemfontein, South Africa; [Moodley, Yoshan] Univ Venda, Dept Zool, Thohoyandou, South Africa; [Luikart, Gordon] Univ Montana, Div Biol Sci, Flathead Lake Biol Stn, Missoula, MT 59812 USA; [Luikart, Gordon] Univ Montana, Coll Forestry & Conservat, Fish & Wildlife Genom Grp, Wildlife Program, Missoula, MT 59812 USA; [Birss, Coral] CapeNature, Gatesville, South Africa	South African National Biodiversity Institute; University of the Free State; University of Venda; University of Montana System; University of Montana; University of Montana System; University of Montana	Dalton, DL (corresponding author), South African Natl Biodivers Inst, Natl Zool Garden, Pretoria, South Africa.; Dalton, DL (corresponding author), Univ Free State, Dept Genet, Bloemfontein, South Africa.	d.dalton@sanbi.org.za		Grobler, Paul/0000-0002-5913-7031; Moodley, Yoshan/0000-0003-4216-2924; Smith, Rae/0000-0002-1379-3949; van Wyk, Anna Magrieta/0000-0002-8406-9317; Dalton, Desire Lee/0000-0001-5975-6425	National Research Foundation (NRF) [UID118734]	National Research Foundation (NRF)	Rae M. Smith was supported as a doctoral candidate under the Postgraduate Development Programme of the National Research Foundation (NRF) (grant no. UID118734).	[Anonymous], 2002, EQUIDS ZEBRAS ASSES; Birss C, 2018, BIODIVERSITY MANAGEM, P1; CITES, 2016, CONS PROP AM APP 1 2; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fisher RA, 1930, GENETICAL THEORY NAT; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hill RA, 2009, ANIM CONSERV, V12, P518, DOI 10.1111/j.1469-1795.2009.00332.x; Hrabar H., 2015, CAPE MOUNTAIN ZEBRA; Hrabar H, 2016, RED LIST MAMMALS S A, P1; Hrabar H, 2013, ORYX, V47, P403, DOI 10.1017/S0030605311002018; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KRIMBAS CB, 1971, EVOLUTION, V25, P454, DOI 10.1111/j.1558-5646.1971.tb01904.x; Lea JMD, 2016, BIOL CONSERV, V203, P207, DOI 10.1016/j.biocon.2016.09.017; Lombard L., 2016, TRAVELER24; Lorenzen ED, 2008, MOL ECOL, V17, P2812, DOI 10.1111/j.1365-294X.2008.03781.x; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Marais HJ, 2007, J S AFR VET ASSOC, V78, P145; Milla JCG, 1970, AFRICAN WILDLIFE, V24, P16; Millar JCG, 1970, AFRICAN WILDLIFE, V24, P104; Moodley Y, 2005, CONSERV GENET, V6, P953, DOI 10.1007/s10592-005-9083-8; MOODLEY Y, 2002, POPULATION STRUCTURI; National Research Council (NRC), 2013, EST ADJ APPR MAN LEV, P195; NEI M, 1981, GENETICS, V98, P625; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PENZHORN BL, 1982, S AFR J WILDL RES, V12, P48; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Rice WR, 1989, H AM SOCIOL REV, V78, P1, DOI [10.1111/j.0014-3820.2001.tb00731.x, DOI 10.1111/J.0014-3820.2001.TB00731.X]; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sasidharan S. P., 2006, Transactions of the Royal Society of South Africa, V61, P11, DOI 10.1080/00359190609519189; Sasidharan SP, 2011, S AFR J WILDL RES, V41, P36, DOI 10.3957/056.041.0117; Smith RK, 2008, AFR J ECOL, V46, P207, DOI 10.1111/j.1365-2028.2007.00893.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vlok JHJ, 2005, 1064410304 CRIT EC P; Waples RS, 2007, GENETICS, V175, P219, DOI 10.1534/genetics.106.065300; WAPLES RS, 1989, GENETICS, V121, P379; Watson LH, 2007, S AFR J WILDL RES, V37, P31, DOI 10.3957/0379-4369-37.1.31; Watson LH, 2005, BIOL CONSERV, V122, P173, DOI 10.1016/j.biocon.2004.06.014; Winkler A., 1995, Koedoe, V38, P83; Wright S, 1931, GENETICS, V16, P0097; Zachos FE, 2016, J HERED, V107, P318, DOI 10.1093/jhered/esw011	54	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220331	10.1371/journal.pone.0220331	http://dx.doi.org/10.1371/journal.pone.0220331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365543	Green Published, Green Submitted, gold			2022-12-26	WOS:000484983600038
J	Munoz, CA; Coleman, GJ; Hemsworth, PH; Campbell, AJD; Doyle, RE				Munoz, Carolina A.; Coleman, Grahame J.; Hemsworth, Paul H.; Campbell, Angus J. D.; Doyle, Rebecca E.			Positive attitudes, positive outcomes: The relationship between farmer attitudes, management behaviour and sheep welfare	PLOS ONE			English	Article							HUMANS; PRODUCTIVITY; STOCKPERSONS; EWES; PIGS	This study examined the relationships between the attitudes and the management behaviour of the farmer and the on-farm welfare of their ewes. To our knowledge, this is the first study investigating these relationships in extensive sheep farming systems. Thirty-two sheep farmers and 6200 ewes were sampled across Victoria, Australia. Questionnaire interviews and on-farm animal welfare assessments were conducted. The ewes were assessed at two-time points, mid-pregnancy and weaning. To examine relationships between farmer and ewe variables, categorical principal component analyses, correlations and logistic regressions were used. The main findings of this study indicate relationships between farmer attitudes and management behaviour, consistent with findings from other more intensive livestock industries. Farmers were more likely to check the body condition of their ewes (Odds ratio = 2.37, P = 0.03), perform ultrasound pregnancy diagnosis (Odds ratio = 1.16, P = 0.02) and test for egg count before deworming sheep (Odds ratio = 2.88, P = 0.01) if they perceived these activities were important/valuable. In addition, farmers that performed these activities had a more active management style, and ewes in better welfare: fewer lame ewes at mid-pregnancy (r = -0.38 P = 0.04), and fewer ewes in need of further care at mid-pregnancy and weaning respectively (r = -0.47, P = 0.01; r = -0.50, P = 0.01). When combining the qualitative and quantitative analyses, behavioural attitudes (attitudes towards specific management behaviours) and perceived behavioural control (perceived barriers to performing the behaviour) emerged as the two main drivers underpinning farmer management behaviour. The results of this study indicate that the way farmers manage their ewes influences welfare outcomes, and management decisions are influenced by attitudes towards management practices. These findings demonstrate the opportunity to create change in farmer management behaviour and improve sheep welfare via targeted education programs.	[Munoz, Carolina A.; Coleman, Grahame J.; Hemsworth, Paul H.; Doyle, Rebecca E.] Univ Melbourne, Anim Welf Sci Ctr, Melbourne, Vic, Australia; [Campbell, Angus J. D.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Munoz, CA (corresponding author), Univ Melbourne, Anim Welf Sci Ctr, Melbourne, Vic, Australia.	munoz.c@unimelb.edu.au	Campbell, Angus J D/F-7671-2014	Campbell, Angus J D/0000-0002-3907-5048; Hemsworth, Paul/0000-0002-0211-0751; Munoz Gallardo, Carolina Andrea/0000-0001-5489-1417	Meat & Livestock Australia Ltd (MLA); Australian Commonwealth Government	Meat & Livestock Australia Ltd (MLA); Australian Commonwealth Government(Australian Government)	This research was funded by Meat & Livestock Australia Ltd (MLA), and by red meat producers and the Australian Commonwealth Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DB, 1995, AUST VET J, V72, P75, DOI [10.1111/j.1751-0813.1995.tb15340.x, 10.1111/j.1751-0813.1995.tb15341.x]; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Animal Welfare Indicators (AWIN), 2015, AWIN WELF ASS PROT S, P80, DOI [10.13130/AWIN_SHEEP_2015, DOI 10.13130/AWIN_SHEEP_2015]; BARNETT JL, 1993, APPL ANIM BEHAV SCI, V37, P139, DOI 10.1016/0168-1591(93)90106-Y; Breuer K, 2000, APPL ANIM BEHAV SCI, V66, P273, DOI 10.1016/S0168-1591(99)00097-0; Calavas D, 1998, VET RES, V29, P129; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Coleman GJ, 2014, REV SCI TECH OIE, V33, P131, DOI 10.20506/rst.33.1.2257; Coleman GJ, 1998, APPL ANIM BEHAV SCI, V58, P63, DOI 10.1016/S0168-1591(96)01168-9; Coleman GJ, 2000, APPL ANIM BEHAV SCI, V66, P11, DOI 10.1016/S0168-1591(99)00073-8; Doughty AK, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7040028; Dwyer C, 2014, P 6 INT C ASS AN WEL; Dwyer CM, 2009, SMALL RUMINANT RES, V86, P14, DOI 10.1016/j.smallrumres.2009.09.010; Dwyer CM, 2008, INTRO ANIMAL WELFARE, P1; Ferguson M., 2011, LIFETIME WOOL EWE MA, V2nd, P14; GONYOU HW, 1986, APPL ANIM BEHAV SCI, V16, P269, DOI 10.1016/0168-1591(86)90119-X; Hemsworth LM, 2012, WELFARE RECREATIONAL; Hemsworth PH, 2011, HUMAN-LIVESTOCK INTERACTIONS, 2ND EDITION: THE STOCKPERSON AND THE PRODUCTIVITY AND WELFARE OF INTENSIVELY FARMED ANIMALS, P1, DOI 10.1079/9781845936730.0000; Hemsworth PH, 2002, J ANIM SCI, V80, P68; HEMSWORTH PH, 1989, APPL ANIM BEHAV SCI, V23, P301, DOI 10.1016/0168-1591(89)90099-3; HEMSWORTH PH, 1981, LIVEST PROD SCI, V8, P67, DOI 10.1016/0301-6226(81)90031-2; Hemsworth PH, 2000, J ANIM SCI, V78, P2821; Hemsworth PH, 2018, ANIM WELFARE, DOI [10.7120/09627286.27.4.327, DOI 10.7120/09627286.27.4.327]; Howard K, 2018, NATL PRODUCER SURVEY; Jones A, 2011, ANIM PROD SCI, V51, P857, DOI 10.1071/EA08303; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; LYNCH JJ, 1980, APPL ANIM ETHOL, V6, P163, DOI 10.1016/0304-3762(80)90067-X; Meat & Livestock Australia, 2016, NAT PROD SURV CATTL; MUNOZ C, 2018, ANIMALS-BASEL, V8, DOI DOI 10.3390/ANI8010008; Munoz CA, 2016, ED 50 C INT SOC APPL, P311; Munoz CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218603; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nowak R, 2006, REPROD NUTR DEV, V46, P431, DOI 10.1051/rnd:2006023; Phillips C. J. C., 2010, J INT FARM MANAG, V5, P1; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P219, DOI 10.1177/875647939000600404; Waiblinger S, 2002, APPL ANIM BEHAV SCI, V79, P195, DOI 10.1016/S0168-1591(02)00155-7; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Wassink GJ, 2010, PREV VET MED, V96, P65, DOI 10.1016/j.prevetmed.2010.06.002; Yoccoz N.G., 1991, B ECOL SOC AM, V72, P106	41	22	22	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220455	10.1371/journal.pone.0220455	http://dx.doi.org/10.1371/journal.pone.0220455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365546	Green Published, gold			2022-12-26	WOS:000484983600046
J	Sadiq, A; Bostan, N; Bokhari, H; Matthijnssens, J; Yinda, KC; Raza, S; Nawaz, T				Sadiq, Asma; Bostan, Nazish; Bokhari, Habib; Matthijnssens, Jelle; Yinda, Kwe Claude; Raza, Saqlain; Nawaz, Tayyab			Molecular characterization of human group A rotavirus genotypes circulating in Rawalpindi, Islamabad, Pakistan during 2015-2016	PLOS ONE			English	Article							EQUINE-LIKE; G3 ROTAVIRUS; GENETIC-HETEROGENEITY; ACUTE GASTROENTERITIS; PHYLOGENETIC ANALYSIS; ACUTE DIARRHEA; STRAINS; CHILDREN; VACCINE; G12	Group A rotaviruses (RVA) are one of the major causes of acute gastroenteritis (AGE) in young children worldwide. Owing to lack of proper surveillance programs and health facilities, developing countries of Asia and Africa carry a disproportionately heavy share of the RVA disease burden. The aim of this hospital-based study was to investigate the circulation of RVA genotypes in Rawalpindi and Islamabad, Pakistan in 2015 and 2016, prior to the implementation of RVA vaccine. 639 faecal samples collected from children under 10 years of age hospitalized with AGE were tested for RVA antigen by ELISA. Among 171 ELISA positive samples, 143 were successfully screened for RT-PCR and sequencing. The prevalence of RVA was found to be 26.8% with the highest frequency (34.9%) found among children of age group 6-11 months. The most predominant circulating genotypes were G3P[8] (22.4%) followed by G12P[6] (20.3%), G2P[4] (12.6%), G1P[8] (11.9%), G9P[6] (11.9%), G3P[4] (9.1%), G1P[6] (4.2%), G9P[8] (4.2%), and G3P[6] (0.7%). A single mixed genotype G1G3P[8] was also detected. The findings of this study provide baseline data, that will help to assess if future vaccination campaigns using currently available RVA vaccine will reduce RVA disease burden and instigate evolutionary changes in the overall RVA biology. The high prevalence of RVA infections in Pakistan require to improve and strengthen the surveillance and monitoring system for RVA. This will provide useful information for health authorities in planning public health care strategies to mitigate the disease burden caused by RVA.	[Sadiq, Asma; Bostan, Nazish; Bokhari, Habib; Raza, Saqlain; Nawaz, Tayyab] COMSATS Univ CUI, Dept Biosci, Islamabad, Pakistan; [Matthijnssens, Jelle; Yinda, Kwe Claude] Univ Leuven, KU Leuven, Rega Inst Med Res, Dept Microbiol & Immunol,Lab Viral Metagenom, Leuven, Belgium; [Yinda, Kwe Claude] NIAID, Lab Virol, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA	COMSATS University Islamabad (CUI); KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bostan, N (corresponding author), COMSATS Univ CUI, Dept Biosci, Islamabad, Pakistan.	nazishbostan@comsats.edu.pk	Bostan, Nazish/AAU-3262-2021; Raza, Saqlain/X-3612-2018; Raza, Saqlain/AAA-1888-2022	Bostan, Nazish/0000-0003-2226-5440; Raza, Saqlain/0000-0002-9899-5653; 	Higher Education Comission of Pakistan (HEC) [2BM1-196]	Higher Education Comission of Pakistan (HEC)	This research was funded by ASMA SADIQ, 2BM1-196, the Higher Education Comission of Pakistan (HEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal A., 2010, JRMC, V14, P33; Alam MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067998; Alam MM, 2009, VIRUS RES, V144, P280, DOI 10.1016/j.virusres.2009.03.015; Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Angkeabos N, 2018, VACCINE, V36, P7856, DOI 10.1016/j.vaccine.2018.03.032; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; Ansari S, 2013, J MED MICROBIOL, V62, P114, DOI 10.1099/jmm.0.048124-0; Arora R, 2009, VIRUS RES, V146, P36, DOI 10.1016/j.virusres.2009.08.007; Aydin H, 2017, GASTROENTEROL REV, V12, P122, DOI 10.5114/pg.2016.59423; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Bennett A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190256; Bonica MB, 2015, VIRUSES-BASEL, V7, P844, DOI 10.3390/v7020844; Bwogi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178855; Chan-It W, 2018, J MED VIROL, V90, P477, DOI 10.1002/jmv.24985; Clark AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188267; Clark A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183392; Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352; Damanka S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0523-5; Dennehy PH, 2012, CURR OPIN PEDIATR, V24, P76, DOI 10.1097/MOP.0b013e32834ee594; Desselberger U, 2014, VIRUS RES, V190, P75, DOI 10.1016/j.virusres.2014.06.016; Dhital S, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0858-0; Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8; Durmaz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113674; Esona MD, 2010, EMERG INFECT DIS, V16, P1844, DOI 10.3201/eid1612.101089; Fidhow AM, 2017, PAN AFRICAN MED J S1, V28; Gasparinho C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176046; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Giri S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6406-0; Gomez MM, 2013, INFECT GENET EVOL, V19, P395, DOI 10.1016/j.meegid.2013.03.028; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Habib MI, 2014, JCPSP-J COLL PHYSICI, V24, P114, DOI 02.2014/JCPSP.114117; Heylen E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14658; Thanh HD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24511-y; Hussain A, 2016, IRAN J PUBLIC HEALTH, V45, P1658; Ide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124965; Iftikhar T, 2012, J MED VIROL, V84, P2003, DOI 10.1002/jmv.23402; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Kazi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108221; Kirkwood CD, 2019, VACCINE, V37, P7328, DOI 10.1016/j.vaccine.2017.03.076; Komoto S, 2018, J MED VIROL, V90, P890, DOI 10.1002/jmv.25016; Komoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148416; Kotloff KL, 2017, VACCINE, V35, P6783, DOI 10.1016/j.vaccine.2017.07.036; Lee WT, 2012, KAOHSIUNG J MED SCI, V28, P595, DOI 10.1016/j.kjms.2012.04.025; Tort LFL, 2010, J CLIN VIROL, V47, P345, DOI 10.1016/j.jcv.2009.12.018; Lopman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041720; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malasao R, 2015, VIRUS GENES, V50, P129, DOI 10.1007/s11262-014-1135-z; Maneekarn Niwat, 2014, VirusDisease, V25, P201, DOI 10.1007/s13337-014-0201-4; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2010, VIROLOGY, V403, P111, DOI 10.1016/j.virol.2010.04.004; Matthijnssens J, 2010, EMERG INFECT DIS, V16, P625, DOI 10.3201/eid1604.091591; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Medici MC, 2016, INFECT GENET EVOL, V40, P253, DOI 10.1016/j.meegid.2016.03.013; Mo ZJ, 2017, VACCINE, V35, P5897, DOI 10.1016/j.vaccine.2017.08.081; Nakawesi JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-69; Nyaga MM, 2015, INFECT GENET EVOL, V31, P321, DOI 10.1016/j.meegid.2015.02.011; Nyaga MM, 2014, VIRUS GENES, V49, P196, DOI 10.1007/s11262-014-1091-7; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Phan TG, 2007, INFECT GENET EVOL, V7, P656, DOI 10.1016/j.meegid.2007.05.001; Pietsch C, 2018, INFECT GENET EVOL, V57, P46, DOI 10.1016/j.meegid.2017.11.007; Pongsuwanna Y, 2002, J CLIN MICROBIOL, V40, P1390, DOI 10.1128/JCM.40.4.1390-1394.2002; Qazi R, 2009, VACCINE, V27, pF25, DOI 10.1016/j.vaccine.2009.08.064; Rahman M, 2005, J CLIN VIROL, V33, P1, DOI 10.1016/j.jcv.2004.09.020; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; RCWG, 2018, LAB VIR MET; Rheingans R, 2018, VACCINE, V36, P7780, DOI 10.1016/j.vaccine.2018.02.008; Rota Council, 2017, GLOB INTR STAT; Sadiq A, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.2003; Samdan A, 2018, VACCINE, V36, P7883, DOI 10.1016/j.vaccine.2018.02.010; Guerra SFS, 2016, J GEN VIROL, V97, P3131, DOI 10.1099/jgv.0.000626; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Satter SM, 2017, PEDIATR INFECT DIS J, V36, P168, DOI 10.1097/INF.0000000000001381; Selvarajan S, 2017, INDIAN J MED MICROBI, V35, P221, DOI 10.4103/ijmm.IJMM_16_51; Simmonds MK, 2008, J CLIN VIROL, V42, P368, DOI 10.1016/j.jcv.2008.02.011; Steyer A, 2014, INFECT GENET EVOL, V28, P413, DOI 10.1016/j.meegid.2014.06.021; Tamim S, 2013, INFECT GENET EVOL, V14, P161, DOI 10.1016/j.meegid.2012.10.009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANIGUCHI K, 1990, J VIROL, V64, P5640, DOI 10.1128/JVI.64.11.5640-5644.1990; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Tian Y, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3411-3; Umair M, 2017, INFECT GENET EVOL, V53, P160, DOI 10.1016/j.meegid.2017.05.009; URASAWA S, 1990, ARCH VIROL, V113, P279, DOI 10.1007/BF01316680; Van PL, 2011, ARCH VIROL, V156, P511, DOI 10.1007/s00705-010-0865-z; Wangchuk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110795; WHO, 2014, GLOB RAT SURV INF B, V10; World Health Organization, 2009, Weekly Epidemiological Record, V84, P517; World Health Organization, 2002, GEN PORT 1 HOSP BAS; World Health Organization (WHO), 2016, EST ROT DEATHS CHILD; Wu FT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40731; Wu FT, 2011, J MED VIROL, V83, P1279, DOI 10.1002/jmv.22052; Yinda CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34209; Zeller M, 2015, GENOME BIOL EVOL, V7, P2473, DOI 10.1093/gbe/evv157; Zeller M, 2015, MOL BIOL EVOL, V32, P2060, DOI 10.1093/molbev/msv088; Zeller M, 2012, J CLIN MICROBIOL, V50, P966, DOI 10.1128/JCM.05590-11	100	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220387	10.1371/journal.pone.0220387	http://dx.doi.org/10.1371/journal.pone.0220387			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361761	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000484981300026
J	Alkoaik, FN				Alkoaik, Fahad N.			Integrating aeration and rotation processes to accelerate composting of agricultural residues	PLOS ONE			English	Article							MUNICIPAL SOLID-WASTE; STABILITY	The active phase of conventional static composting systems varies dramatically, ranging from several weeks to several months. Therefore, this study was to examine the effect of a combined continuous aeration-rotation process on shortening the active phase of composted material. A mixture of tomato plant residues with 20%-chicken manure (v/v) was composted in two identical pilot-scale bioreactors. One of them was static, and the other was continuously rotated at 3 rpm; each was supplied with continuous aeration. Compost temperatures (T-c) were measured throughout the composting process; the moisture content (MC) and carbon/nitrogen ratio (C/N) were measured at the beginning and end of the experiment. The quality and stage of compost were evaluated at the end of the experiment using Dewar, Solvita, and visual tests. Continuous aeration-rotation significantly reduced the active phase period to 4.5 days, increased the compost temperature (T-c) to 60 degrees C after 3 days of operation, and remained at 50-65 degrees C for approximately 3 consecutive days (thermophilic stage). In contrast, compost in the static bioreactor remained in the mesophilic stage (T-c < 45 degrees C). During the composting process, the C/N ratio was reduced from 30/1 to 23/1 in the rotating bioreactor, while it remained at 30/1 in the static bioreactor, indicating that the nitrogen content was not a limiting factor affecting the composting process. The MC was within the optimum range for microorganisms (58-61%) for both bioreactors. After the active phase had ended in the rotating bioreactor, the compost was inactive and ready for further maturation, while compost from the static bioreactor was still immature and active. These results show that the proposed method can be done on a commercial scale to significantly reduce the composting period and to enhance the compost stability and productivity.	[Alkoaik, Fahad N.] King Saud Univ, Coll Food & Agr Sci, Dept Agr Engn, Riyadh, Saudi Arabia	King Saud University	Alkoaik, FN (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Agr Engn, Riyadh, Saudi Arabia.	falkoaik@ksu.edu.sa			National Plan for Science, Technology and Innovation (NSTIP) [12-ENV-2814-02]	National Plan for Science, Technology and Innovation (NSTIP)	This research was funded by the National Plan for Science, Technology and Innovation (NSTIP), 12-ENV-2814-02 to FNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkoaik FN, 2018, ENERGIES, V11, DOI 10.3390/en11020449; Alkoaik FN, 2014, J PURE APPL MICROBIO, V8, P409; [Anonymous], AGR STAT ANN BOOK AS; [Anonymous], 2009, DEWAR SELF HEATING T; Bazrafshan E., 2016, HLTH SCOPE, V5, P1, DOI DOI 10.17795/jhealthscope-33202; Cabanas-Vargas DD, 2005, INGENIERIA, V9-2, P25; Chen ZQ, 2015, J ENVIRON SCI-CHINA, V37, P172, DOI 10.1016/j.jes.2015.03.020; de Oliveira MM, 2018, CIENC AGROTEC, V42, P653, DOI 10.1590/1413-70542018426021818; Elcik H, 2016, SIGMA J ENG NAT SCI, V34, P211; ElNesr Mohammad, 2010, American Journal of Environmental Sciences, V6, P535, DOI 10.3844/ajessp.2010.535.547; Escobar N, 2015, MICROBIAL DIVERSITY, P70, DOI [10.17706/ijbbb.2015.5.2, DOI 10.17706/IJBBB.2015.5.2, DOI 10.17706/IJBBB.2015.5.2.70-79]; Estevez-Schwarz I, 2012, POL J ENVIRON STUD, V21, P855; Gao MC, 2010, CHEMOSPHERE, V78, P614, DOI 10.1016/j.chemosphere.2009.10.056; Haug T.R., 1993, PRACTICAL HDB COMPOS; Hwang EY, 2006, J IND ENG CHEM, V12, P694; Jindo K, 2012, BIORESOURCE TECHNOL, V110, P396, DOI 10.1016/j.biortech.2012.01.120; Kalamdhad Ajay S., 2008, International Journal of Environment and Waste Management, V2, P24, DOI 10.1504/IJEWM.2008.016989; Kalamdhad AS, 2008, RESOUR CONSERV RECY, V52, P829, DOI 10.1016/j.resconrec.2007.12.003; Kalamdhad AS, 2009, BIORESOURCE TECHNOL, V100, P6442, DOI 10.1016/j.biortech.2009.07.030; Kalamdhad AS, 2009, CHEMOSPHERE, V74, P1327, DOI 10.1016/j.chemosphere.2008.11.058; Khan MAI, 2009, WASTE MANAGE, V29, P2969, DOI 10.1016/j.wasman.2009.06.021; Madan S., 2012, INT J APPL SCI ENG R, V1, P415; Maskan M, 2001, J FOOD ENG, V48, P169, DOI 10.1016/S0260-8774(00)00154-0; Pane C, 2015, CHEM BIOL TECHNOL AG, V2, DOI 10.1186/s40538-014-0026-9; Perez-Murcia MD, 2005, COMMUN SOIL SCI PLAN, V36, P571, DOI 10.1081/CSS-200043286; Rasapoor M, 2016, J ENVIRON MANAGE, V184, P528, DOI 10.1016/j.jenvman.2016.10.029; Said-Pullicino D, 2007, BIORESOURCE TECHNOL, V98, P1822, DOI 10.1016/j.biortech.2006.06.018; Snow A., 2006, CAN BIOSYST ENG, V48; Tajima K., 2003, JPN J FARM WORK RES, V38, P207, DOI [10.4035/jsfwr.38.207, DOI 10.4035/JSFWR.38.207]; Tchobanoglous G., 2002, HDB SOLID WASTE MANA, V2nd; Tiquia SM, 2010, CHEMOSPHERE, V79, P506, DOI 10.1016/j.chemosphere.2010.02.040; Togun A. O., 2004, FOOD AGR ENV, V2, P310; Varma VS, 2015, INT J ENVIRON SCI TE, V12, P2015, DOI 10.1007/s13762-014-0582-3; Vuorinen AH, 1997, AGR ECOSYST ENVIRON, V66, P19, DOI 10.1016/S0167-8809(97)00069-8; WERL, 2018, GUID SOLV TEST COMP	35	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220343	10.1371/journal.pone.0220343	http://dx.doi.org/10.1371/journal.pone.0220343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344136	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900089
J	Liou, CJ; Dai, YW; Wang, CL; Fang, LW; Huang, WC				Liou, Chian-Jiun; Dai, Yi-Wen; Wang, Chia-Ling; Fang, Li-Wen; Huang, Wen-Chung			Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway	FASEB JOURNAL			English	Article						HepG2; lipogenesis; lipolysis; hepatic steatosis	ADIPOSE-TISSUE; TRANSCRIPTIONAL REGULATION; GROWTH-FACTOR; DIET; ACCUMULATION; INFLAMMATION; CELLS; DYSREGULATION; METABOLISM; LIPOLYSIS	Maslinic acid is a pentacyclic triterpenoid that is distributed in the peel of olives. Previous studies found that maslinic acid inhibited inflammatory response and antioxidant effects. We investigated whether maslinic acid ameliorates nonalcoholic fatty liver disease in mice with high-fat-diet (HFD)-induced obesity and evaluated the regulation of lipogenesis in hepatocytes. Male C57BL/6 mice fed a normal diet or HFD (60% fat, w/w) were tested for 16 wk. After the fourth week, mice were injected intraperitoneally with maslinic acid for 12 wk. In another experiment, HepG2 cells were treated with oleic acid to induce lipid accumulation or maslinic acid to evaluate lipogenesis. Maslinic acid significantly reduced body weight compared with HFD-fed mice. Maslinic acid reduced liver weight and liver lipid accumulation and improved hepatocyte steatosis. Furthermore, serum glucose, leptin, and free fatty acid concentrations significantly reduced, but the serum adiponectin concentration was higher, in the maslinic acid group than in the HFD group. In liver tissue, maslinic acid suppressed transcription factors involved in lipogenesis and increased adipose triglyceride lipase. In vitro, maslinic acid decreased lipogenesis by activating AMPK. These findings suggest that maslinic acid acts against hepatic steatosis by regulating enzyme activity involved in lipogenesis, lipolysis, and fatty acid oxidation in the liver.	[Liou, Chian-Jiun] Chang Gung Univ Sci & Technol, Dept Nursing, Res Ctr Chinese Herbal Med, Div Basic Med Sci, Taoyuan, Taiwan; [Dai, Yi-Wen; Wang, Chia-Ling; Huang, Wen-Chung] Chang Gung Univ Sci & Technol, Coll Human Ecol, Grad Inst Hlth Ind Technol, Res Ctr Food & Cosmet Safety, Taoyuan, Taiwan; [Liou, Chian-Jiun; Huang, Wen-Chung] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Fang, Li-Wen] I Shou Univ, Dept Nutr, Kaohsiung, Taiwan	Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; I Shou University	Huang, WC (corresponding author), Chang Gung Univ Sci & Technol, Res Ctr Food & Cosmet Safety, Res Ctr Chinese Herbal Med, Grad Inst Hlth Ind Technol,Coll Human Ecol, 261 Wenhua Ist Rd, Taoyuan 33303, Taiwan.	wchuang@mail.cgust.edu.tw			Chang Gung Memorial Hospital [CMRPF1H0022, CMRPF1G0232, CMRPF1H0042]; Ministry of Science and Technology in Taiwan [106-2320-B-255-007-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported, in part, by grants from Chang Gung Memorial Hospital (CMRPF1H0022, CMRPF1G0232, and CMRPF1H0042) and the Ministry of Science and Technology in Taiwan (106-2320-B-255-007-MY3). The authors declare no conflicts of interest.	Asrih M, 2015, CELL PHYSIOL BIOCHEM, V37, P1767, DOI 10.1159/000438540; Bujanda L, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-40; Chang YH, 2018, BIOCHEM BIOPH RES CO, V495, P197, DOI 10.1016/j.bbrc.2017.11.022; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Fukumitsu S, 2016, MOL NUTR FOOD RES, V60, P399, DOI 10.1002/mnfr.201500465; Hazlehurst JM, 2016, METABOLISM, V65, P1096, DOI 10.1016/j.metabol.2016.01.001; Huang WC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030218; Huang WC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00134; Huang WC, 2013, MOL NUTR FOOD RES, V57, P1803, DOI 10.1002/mnfr.201300001; Ippagunta SM, 2018, J NUTR, V148, P510, DOI 10.1093/jn/nxy022; Kim B, 2017, J NUTR BIOCHEM, V43, P27, DOI 10.1016/j.jnutbio.2016.01.006; Kitade H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040387; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kobori M, 2016, MOL NUTR FOOD RES, V60, P300, DOI 10.1002/mnfr.201500595; Lee JW, 2012, J LIPID RES, V53, P1277, DOI 10.1194/jlr.M022897; Lei P, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800795; Li M, 2017, MOL MED REP, V16, P680, DOI 10.3892/mmr.2017.6637; Liou CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050447; Liou CJ, 2018, CELL PHYSIOL BIOCHEM, V49, P1870, DOI 10.1159/000493650; Liou CJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00635; Liou CJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00589; Liou CJ, 2011, J CLIN IMMUNOL, V31, P656, DOI 10.1007/s10875-011-9529-3; LIU L, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/607531; Lopez M, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12996; Merola N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101062; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Norris GH, 2017, NUTR REV, V75, P274, DOI 10.1093/nutrit/nux004; Perez-Jimenez A, 2016, PHYTOMEDICINE, V23, P1301, DOI 10.1016/j.phymed.2016.07.001; Pisonero-Vaquero S, 2015, MOL NUTR FOOD RES, V59, P879, DOI 10.1002/mnfr.201400913; Qin XF, 2014, MOL CELL BIOCHEM, V390, P61, DOI 10.1007/s11010-013-1956-4; Sanchez-Gonzalez M, 2013, MOL NUTR FOOD RES, V57, P339, DOI 10.1002/mnfr.201200481; Saponaro C, 2015, NUTRIENTS, V7, P9453, DOI 10.3390/nu7115475; Shaw RJ, 2013, NAT MED, V19, P1570, DOI 10.1038/nm.3414; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tian YL, 2016, MOL CELL BIOCHEM, V422, P75, DOI 10.1007/s11010-016-2807-x; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122; Yang SM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/429207; Yang YW, 2015, J AGR FOOD CHEM, V63, P10243, DOI 10.1021/acs.jafc.5b04156; Zhang YL, 2017, MOL METAB, V6, P138, DOI 10.1016/j.molmet.2016.11.002; Zhang YY, 2017, MAR DRUGS, V15, DOI 10.3390/md15060163; Zhu W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-35; Zhu Y, 2016, ACTA PHARM SIN B, V6, P409, DOI 10.1016/j.apsb.2016.07.008	48	34	35	5	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11791	11803		10.1096/fj.201900413RRR	http://dx.doi.org/10.1096/fj.201900413RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361524	Green Published			2022-12-26	WOS:000507461600017
J	Wessely, A; Waltera, A; Reichert, TE; Stockl, S; Grassel, S; Bauer, RJ				Wessely, Anja; Waltera, Anna; Reichert, Torsten E.; Stoeckl, Sabine; Graessel, Susanne; Bauer, Richard J.			Induction of ALP and MMP9 activity facilitates invasive behavior in heterogeneous human BMSC and HNSCC 3D spheroids	FASEB JOURNAL			English	Article						mesenchymal stem cells; HNSCC; matrix-metalloproteinase; RUNX2; spheroid culture	SQUAMOUS-CELL CARCINOMA; MESENCHYMAL STEM-CELLS; ALKALINE-PHOSPHATASE; BONE-MARROW; FACTOR RUNX2; CANCER; HEAD; TRANSCRIPTION; METASTASIS; EXPRESSION	Mesenchymal stem cells (MSCs) are multipotent progenitor cells capable of differentiating into adipocytic, osteogenic, chondrogenic, and myogenic lineages. There is growing evidence that MSCs home into the tumor microenvironment attracted by a variety of signals such as chemokines, growth factors, and cytokines. Tumor-homing stem cells may originate from bone marrow-derived MSCs (BMSCs) or adipose tissue-derived MSCs. Recent scientific data suggest that MSCs in combination with tumor cells can either promote or inhibit tumorigenic behavior. In head and neck squamous cell carcinoma (HNSCC), BMSCs are reported to be enriched with a potential negative role. Here, we evaluated the effect of BMSCs from 4 different donors in combination with 4 HNSCC cell lines in a 3-dimensional multicellular spheroid model. Heterogeneous combinations revealed an up-regulation of gene and protein expression of osteogenic markers runt-related transcription factor 2 (RUNX2) and alkaline phosphatase (ALP) together with a substantial secretion of matrix metalloproteinase 9. Moreover, heterogenous BMSC/tumor spheroids showed increased invasion compared with homogenous spheroids in a Boyden chamber invasion assay. Furthermore, inhibition of ALP resulted in a substantially decreased spreading of heterogeneous spheroids on laminin-rich matrix. In summary, our data suggest a prometastatic effect of BMSCs combined with HNSCC.	[Wessely, Anja] Ludwig Maximilian Univ Munich, Univ Hosp, Dept Dermatol & Allergy, Munich, Germany; [Waltera, Anna; Reichert, Torsten E.; Bauer, Richard J.] Univ Hosp Regensburg, Dept Oral & Maxillofacial Surg, Regensburg, Germany; [Stoeckl, Sabine; Graessel, Susanne] Univ Hosp Regensburg, Ctr Med Biotechnol, Dept Orthoped Surg, Expt Orthoped, Regensburg, Germany; [Bauer, Richard J.] Univ Hosp Regensburg, Ctr Med Biotechnol, Dept Oral & Maxillofacial Surg, Regensburg, Germany	University of Munich; University of Regensburg; University of Regensburg; University of Regensburg	Bauer, RJ (corresponding author), Univ Hosp Regensburg, Biopk 9, D-93053 Regensburg, Germany.	richard.bauer@ukr.de		Wessely, Anja/0000-0003-1940-5115	German Research Foundation (DFG) [GR1301/18-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank Brigitta Hauer (Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany) for excellent technical assistance. This work was supported by a German Research Foundation (DFG) grant to S.G. (GR1301/18-1). The authors declare no conflicts of interest.	Acharya S, 2017, SOUTH ASIAN J CANCER, V6, P125, DOI 10.4103/2278-330X.214574; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Albergaria A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055749; Anthony DF, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-10; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bassi Enio Jose, 2011, World J Stem Cells, V3, P1, DOI 10.4252/wjsc.v3.i1.1; Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Bedal KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086777; Cai C, 2017, APPL BIOCHEM BIOTECH, V183, P444, DOI 10.1007/s12010-017-2456-x; Chang WM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41131; Clutter SD, 2005, EXP HEMATOL, V33, P1192, DOI 10.1016/j.exphem.2005.06.022; Cornelissen AS, 2015, IMMUNOL LETT, V168, P159, DOI 10.1016/j.imlet.2015.06.019; De Boeck A, 2010, ORAL ONCOL, V46, P336, DOI 10.1016/j.oraloncology.2010.01.016; de Jong RJB, 2001, HEAD NECK-J SCI SPEC, V23, P718; FARLEY JR, 1991, METABOLISM, V40, P664, DOI 10.1016/0026-0495(91)90081-7; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Ganapathi MK, 2016, INT J CANCER, V138, P679, DOI 10.1002/ijc.29815; Gonzalez ME, 2017, CELL REP, V18, P1215, DOI 10.1016/j.celrep.2016.12.079; Li HC, 2006, WORLD J GASTROENTERO, V12, P363, DOI 10.3748/wjg.v12.i3.363; Heikkila P, 2006, INT J CANCER, V118, P2202, DOI 10.1002/ijc.21540; Henriques ACG, 2012, J ORAL SCI, V54, P105, DOI 10.2334/josnusd.54.105; HEO DS, 1989, CANCER RES, V49, P5167; Hill BS, 2017, ONCOTARGET, V8, P73296, DOI 10.18632/oncotarget.20265; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Hutchinson L, 2011, STEM CELLS DEV, V20, P11, DOI 10.1089/scd.2010.0139; Iwai S, 2008, ORAL DIS, V14, P144, DOI 10.1111/j.1601-0825.2007.01360.x; Javed A, 1999, MOL CELL BIOL, V19, P7491; KAWASHIMA A, 1993, J CANCER RES CLIN, V120, P35, DOI 10.1007/BF01200722; Kayed H, 2007, BRIT J CANCER, V97, P1106, DOI 10.1038/sj.bjc.6603984; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Koontongkaew S, 2013, J CANCER, V4, P66, DOI 10.7150/jca.5112; Lee HP, 2015, ONCOTARGET, V6, P36746, DOI 10.18632/oncotarget.5479; Li WP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/456534; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Liotta F, 2015, BRIT J CANCER, V112, P745, DOI 10.1038/bjc.2015.15; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Matheu A, 2012, CANCER RES, V72, P1301, DOI 10.1158/0008-5472.CAN-11-3660; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Ogbureke KUE, 2012, ONCOTARGET, V3, P286; Oremek GM, 2003, ANTICANCER RES, V23, P987; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Rao SR, 2017, BRIT J CANCER, V116, P227, DOI 10.1038/bjc.2016.402; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Tamamura R, 2013, ACTA HISTOCHEM, V115, P113, DOI 10.1016/j.acthis.2012.05.001; Van Kilsdonk JWJ, 2010, MELANOMA RES, V20, P372, DOI 10.1097/CMR.0b013e32833d8d70; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; WEI JS, 1993, CLIN CHEM, V39, P540; Weng JJ, 2013, BBA-GEN SUBJECTS, V1830, P2839, DOI 10.1016/j.bbagen.2012.12.021; Yang LP, 2016, HUM GENE THER, V27, P267, DOI 10.1089/hum.2015.135; Zielske SP, 2009, INT J RADIAT ONCOL, V75, P843, DOI 10.1016/j.ijrobp.2008.06.1953	57	20	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11884	11893		10.1096/fj.201900925R	http://dx.doi.org/10.1096/fj.201900925R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366234	Green Published, Bronze			2022-12-26	WOS:000507461600024
J	Goritzer, K; Turupcu, A; Maresch, D; Novak, J; Altmann, F; Oostenbrink, C; Obinger, C; Strasser, R				Goeritzer, Kathrin; Turupcu, Ayseguel; Maresch, Daniel; Novak, Jan; Altmann, Friedrich; Oostenbrink, Chris; Obinger, Christian; Strasser, Richard			Distinct Fc alpha receptor N-glycans modulate the binding affinity to immunoglobulin A (IgA) antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycosylation; glycoprotein structure; immunoglobulin A (IgA); Fc receptor; molecular modeling; antibody; recombinant protein expression; adaptive immunity; posttranslational modifications	GROMOS 53A6(GLYC); GAMMA-RIII; X-RAY; GLYCOSYLATION; IGG1; OLIGOSACCHARIDES; IDENTIFICATION; FUCOSE; CELLS; FAB	Human immunoglobulin A (IgA) is the most prevalent antibody class at mucosal sites with an important role in mucosal defense. Little is known about the impact of N-glycan modifications of IgA1 and IgA2 on binding to the Fc alpha receptor (Fc alpha RI), which is also heavily glycosylated at its extracellular domain. Here, we transiently expressed human epidermal growth factor receptor 2 (HER2)-binding monomeric IgA1, IgA2m(1), and IgA2m(2) variants in Nicotiana benthamiana Delta XT/FT plants lacking the enzymes responsible for generating nonhuman N-glycan structures. By coinfiltrating IgA with the respective glycan-modifying enzymes, we generated IgA carrying distinct homogenous N-glycans. We demonstrate that distinctly different N-glycan profiles did not influence antigen binding or the overall structure and integrity of the IgA antibodies but did affect their thermal stability. Using size-exclusion chromatography, differential scanning and isothermal titration calorimetry, surface plasmon resonance spectroscopy, and molecular modeling, we probed distinct IgA1 and IgA2 glycoforms for binding to four different Fc alpha RI glycoforms and investigated the thermodynamics and kinetics of complex formation. Our results suggest that different N-glycans on the receptor significantly contribute to binding affinities for its cognate ligand. We also noted that full-length IgA and Fc alpha RI form a mixture of 1:1 and 1:2 complexes tending toward a 1:1 stoichiometry due to different IgA tailpiece conformations that make it less likely that both binding sites are simultaneously occupied. In conclusion, N-glycans of human IgA do not affect its structure and integrity but its thermal stability, and Fc alpha RI N-glycans significantly modulate binding affinity to IgA.	[Goeritzer, Kathrin; Strasser, Richard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria; [Turupcu, Ayseguel; Oostenbrink, Chris] Univ Nat Resources & Life Sci, Dept Mat Sci & Proc Engn, Muthgasse 18, A-1190 Vienna, Austria; [Maresch, Daniel; Altmann, Friedrich; Obinger, Christian] Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria; [Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Alabama System; University of Alabama Birmingham	Strasser, R (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	richard.strasser@boku.ac.at	Strasser, Richard/AAD-2916-2020; Oostenbrink, Chris/S-8002-2019; Obinger, Christian/AAV-3173-2021; TURUPCU, AYSEGUL/AAA-4494-2020	Oostenbrink, Chris/0000-0002-4232-2556; TURUPCU, AYSEGUL/0000-0002-8526-0797; Obinger, Christian/0000-0002-7133-3430; Altmann, Friedrich/0000-0002-0112-7877; Goritzer, Kathrin/0000-0003-3742-028X; Strasser, Richard/0000-0001-8764-6530	Austrian Science Fund (FWF) [(W1224)]; FWF [P31920-B32]; Equipment-BOKU Vienna Institute of Biotechnology (EQ-BOKU VIBT) GmbH; University of Natural Resources and Life Sciences (BOKU) Core Facility Biomolecular and Cellular Analysis	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Equipment-BOKU Vienna Institute of Biotechnology (EQ-BOKU VIBT) GmbH; University of Natural Resources and Life Sciences (BOKU) Core Facility Biomolecular and Cellular Analysis	This work was supported by the Austrian Science Fund (FWF) (Doctoral Program BioToP-Biomolecular Technology of Proteins (W1224)) and by FWF Project P31920-B32. This project was further supported by Equipment-BOKU Vienna Institute of Biotechnology (EQ-BOKU VIBT) GmbH and the University of Natural Resources and Life Sciences (BOKU) Core Facility Biomolecular and Cellular Analysis. The authors declare that they have no conflicts of interest with the contents of this article.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Basset C, 1999, SCAND J IMMUNOL, V50, P572; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Borrok MJ, 2012, ACS CHEM BIOL, V7, P1596, DOI 10.1021/cb300130k; Brandsma AM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00704; CARAYANNOPOULOS L, 1994, P NATL ACAD SCI USA, V91, P8348, DOI 10.1073/pnas.91.18.8348; Castilho A, 2018, PLANT BIOTECHNOL J, V16, P1700, DOI 10.1111/pbi.12906; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; CODUTI PL, 1977, ANAL BIOCHEM, V78, P9, DOI 10.1016/0003-2697(77)90003-3; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; Dicker M, 2016, BIOENGINEERED, V7, P484, DOI 10.1080/21655979.2016.1201251; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Geissmann F, 2001, J IMMUNOL, V166, P346, DOI 10.4049/jimmunol.166.1.346; Goritzer K, 2017, J PROTEOME RES, V16, P2560, DOI 10.1021/acs.jproteome.7b00121; Gomes MM, 2008, BIOCHEMISTRY-US, V47, P11285, DOI 10.1021/bi801185b; Hansen HS, 2010, J COMPUT CHEM, V31, P1, DOI 10.1002/jcc.21253; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Hayes JM, 2017, MOL CELL PROTEOMICS, V16, P1770, DOI 10.1074/mcp.M117.066944; Hayes JM, 2014, J PROTEOME RES, V13, P5471, DOI 10.1021/pr500414q; Heineke MH, 2017, EUR J CLIN INVEST, V47, P184, DOI 10.1111/eci.12716; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; Hui GK, 2015, BIOCHEM J, V471, P167, DOI 10.1042/BJ20150612; Karnoup AS, 2005, GLYCOBIOLOGY, V15, P965, DOI 10.1093/glycob/cwi077; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lepore R, 2017, NUCLEIC ACIDS RES, V45, pW17, DOI 10.1093/nar/gkx334; Lobner E, 2017, STRUCTURE, V25, P878, DOI 10.1016/j.str.2017.04.014; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Morton HC, 1996, IMMUNOGENETICS, V43, P246, DOI 10.1007/s002510050057; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Oortwijn BD, 2007, MOL IMMUNOL, V44, P966, DOI 10.1016/j.molimm.2006.03.014; Patel KR, 2018, J BIOL CHEM, V293, P3477, DOI 10.1074/jbc.RA117.001207; Pleass RJ, 1999, J BIOL CHEM, V274, P23508, DOI 10.1074/jbc.274.33.23508; Pol-Fachin L, 2014, J COMPUT CHEM, V35, P2087, DOI 10.1002/jcc.23721; Pol-Fachin L, 2012, J CHEM THEORY COMPUT, V8, P4681, DOI 10.1021/ct300479h; Posgai MT, 2018, P NATL ACAD SCI USA, V115, pE8882, DOI 10.1073/pnas.1807478115; Reif MM, 2012, J CHEM THEORY COMPUT, V8, P3705, DOI 10.1021/ct300156h; Rouwendal GJA, 2016, MABS-AUSTIN, V8, P74, DOI 10.1080/19420862.2015.1102812; Schmid N, 2012, COMPUT PHYS COMMUN, V183, P890, DOI 10.1016/j.cpc.2011.12.014; Schoberer J, 2013, PLANT PHYSIOL, V161, P1737, DOI 10.1104/pp.112.210757; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shin YJ, 2017, PLANT BIOTECHNOL J, V15, P197, DOI 10.1111/pbi.12602; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00363; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Turupcu A, 2017, J CHEM INF MODEL, V57, P2222, DOI 10.1021/acs.jcim.7b00351; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; Wines BD, 1999, J IMMUNOL, V162, P2146; Woof JM, 2011, MUCOSAL IMMUNOL, V4, P590, DOI 10.1038/mi.2011.39; Xue J, 2010, GLYCOBIOLOGY, V20, P905, DOI 10.1093/glycob/cwq048	55	17	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13995	14008		10.1074/jbc.RA119.009954	http://dx.doi.org/10.1074/jbc.RA119.009954			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31362986	Green Published, hybrid			2022-12-26	WOS:000490729800014
J	Carlos, MD; Cavaletti, ACL; Caldas, CP				Carlos, Marcelo de Jesus; Lima Cavaletti, Ana Carolina; Caldas, Celia Pereira			Hospitalization of the aged due to stroke: An ecological perspective	PLOS ONE			English	Article							HEALTH-CARE; GLOBAL BURDEN; RISK-FACTORS; BRAZIL; POPULATION; PREVALENCE; DETERMINANTS; DISEASES	Contextual variables have been associated with the incidence of stroke, but their association with hospitalization of older persons remains unclear. This study evaluated the association between social context variables and hospitalization of 60 years old and older patients due to stroke in Rio de Janeiro, Brazil. An ecological cross-sectional study was conducted, with secondary data from the Brazilian Hospital Information System from 2006 to 2014. Hospitalization rates were calculated and categorized by tertiles. For subsequent analyzes, the polar extremes method was used to select the groups with extremes values. After that, Student t or Mann-Whitney tests were used to compare the contextual variables and the hospitalization rates clusters. Then, a Binary Logistic Regression analysis was used to assess the association between hospitalization rates clusters and the contextual variables. The total number of hospitalizations was 82 796; the hospitalization rate varied in extremes groups from the lowest (3.49) to the highest (11.95) (p< 0.001). The highest rates group was positively associated with the proportion of elderly (p< 0.001), the illiteracy rate of the aged (p = 0.01), primary care coverage (p< 0.001) and ambulatory care for hypertension and diabetes, while the income ratio showed negative association with the highest rates of hospitalization (p = 0.01). In the multivariate analysis, only the proportion of elderly (OR = 1.55; 95% CI 1.07-2.25), primary care coverage (OR = 1.05; 95% CI 1.01-1.11) and income ratio (OR = 0.82; 95% CI 0.67-0.99) maintained the association. In conclusion, contextual variables in the three dimensions studied were associated with the rate of hospitalization of aged due to stroke in the municipalities in Rio de Janeiro State. Transitional care and other improvements in both the health care and social services are demanded.	[Carlos, Marcelo de Jesus; Lima Cavaletti, Ana Carolina; Caldas, Celia Pereira] Univ Estado Rio De Janeiro, Med Sci Coll, Postgrad Program Med Sci, Rio De Janeiro, RJ, Brazil; [Caldas, Celia Pereira] Univ Estado Rio De Janeiro, Nursing Sch, Dept Aging, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Carlos, MD (corresponding author), Univ Estado Rio De Janeiro, Med Sci Coll, Postgrad Program Med Sci, Rio De Janeiro, RJ, Brazil.	marcelojcarlos@gmail.com	Caldas, Celia/K-5370-2019	Caldas, Celia/0000-0001-6903-1778; Carlos, Marcelo/0000-0002-8810-3092				Adami F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152739; Afonso MPD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015322; Bittencourt Sonia Azevedo, 2006, Cad. Saúde Pública, V22, P19, DOI 10.1590/S0102-311X2006000100003; Bousquat A, 2017, CIENC SAUDE COLETIVA, V22, P1141, DOI 10.1590/1413-81232017224.28632016; Cabral NL, 2011, NEUROEPIDEMIOLOGY, V36, P258, DOI 10.1159/000328865; Cavalini LT, 2008, INT J EPIDEMIOL, V37, P775, DOI 10.1093/ije/dyn088; Copstein L, 2013, ARQ NEURO-PSIQUIAT, V71, P294, DOI 10.1590/0004-282X20130024; da Rocha PR, 2015, REV ESC ENFERM USP, V49, P127, DOI 10.1590/S0080-623420150000100017; Silva AMD, 2017, REV SAUDE PUBL, V51, DOI [10.1590/s1518-8787.2017051000243, 10.1590/S1518-8787.2017051000243]; Campos GWD, 2016, CIENC SAUDE COLETIVA, V21, P2655, DOI 10.1590/1413-81232015219.18922016; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Lentsck MH, 2015, REV LAT-AM ENFERM, V23, P611, DOI 10.1590/0104-1169.0078.2595; Lima Cavaletti Ana Carolina, 2018, Value Health Reg Issues, V17, P8, DOI 10.1016/j.vhri.2017.12.002; Lopes Johnnatas Mikael, 2016, Rev. bras. epidemiol., V19, P122, DOI 10.1590/1980-5497201600010011; Lotufo PA, 2015, SAO PAULO MED J, V133, P457, DOI 10.1590/1516-3180.2015.13360510; Macinko James, 2018, Saúde debate, V42, P18, DOI 10.1590/0103-11042018s102; Marmot M, 2016, ANN EPIDEMIOL, V26, P238, DOI 10.1016/j.annepidem.2016.02.003; Marmot M, 2011, B WORLD HEALTH ORGAN, V89, P702, DOI 10.2471/BLT.11.094862; Marques AP, 2014, REV SAUDE PUBL, V48, P817, DOI 10.1590/S0034-8910.2014048005133; Melo Eduardo Alves, 2018, Saúde debate, V42, P38, DOI 10.1590/0103-11042018s103; Moffat K, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0344-4; de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X; Morosini Márcia Valéria Guimarães Cardoso, 2018, Saúde debate, V42, P11, DOI 10.1590/0103-1104201811601; Moura EC, 2009, REV PANAM SALUD PUBL, V26, P17, DOI 10.1590/S1020-49892009000700003; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Pereira ABCND, 2009, CAD SAUDE PUBLICA, V25, P1929, DOI 10.1590/S0102-311X2009000900007; Norrving B, 2013, NEUROLOGY, V80, pS5, DOI 10.1212/WNL.0b013e3182762397; Nunes BP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2505-8; O'Cathain A, 2014, BMJ QUAL SAF, V23, P47, DOI 10.1136/bmjqs-2013-002003; Pedigo A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-644; Perez LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166304; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Pinto LF, 2018, CIENC SAUDE COLETIVA, V23, P1903, DOI 10.1590/1413-81232018236.05592018; Ribeiro IJS, 2018, J STROKE CEREBROVASC, V27, P1616, DOI 10.1016/j.jstrokecerebrovasdis.2018.01.013; Rocha Suelen Alves, 2016, Physis, V26, P87, DOI 10.1590/S0103-73312016000100007; Rodriguez F, 2013, J COMMUN HEALTH, V38, P451, DOI 10.1007/s10900-012-9640-2; Rolim Cristina Lúcia Rocha Cubas, 2012, Rev. bras. epidemiol., V15, P179, DOI 10.1590/S1415-790X2012000100016; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Stubbs B, 2017, PSYCHOL MED, V47, P2107, DOI 10.1017/S0033291717000551; Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190; World Health Organization, 2008, GUIA GLOB CID AM DO	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220833	10.1371/journal.pone.0220833	http://dx.doi.org/10.1371/journal.pone.0220833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390380	Green Submitted, gold, Green Published			2022-12-26	WOS:000484999400031
J	Tedder, RS; Dicks, S; Ijaz, S; de Souza, NCS; de Paula, AV; Levy, F; Medialdea-Carrera, R; Levi, JE; Pannuti, CS; de Sequeira, PC; Brown, DWG; Lumb, IU				Tedder, Richard S.; Dicks, Steve; Ijaz, Samreen; Santiago de Souza, Nathalia Caroline; de Paula, Anderson Vincente; Levy, Flavia; Medialdea-Carrera, Raquel; Levi, Jose Eduardo; Pannuti, Claudio S.; de Sequeira, Patricia Carvalho; Brown, David W. G.; Lumb, Ines Ushiro			Modulated Zika virus NS1 conjugate offers advantages for accurate detection of Zika virus specific antibody in double antigen binding and Ig capture enzyme immunoassays	PLOS ONE			English	Article							TRANSMISSION; INFECTION; DISEASE; ASSAY	The accurate diagnosis and seroprevalence investigations of Zika virus (ZKV) infections remain complex due to cross reactivity with other flaviviruses. Two assay formats, both using labelled Zika virus NS1 antigen as a revealing agent (a double antigen binding assay, DABA, and an immunoglobulin Ig capture assay, G capture) were initially developed and compared with the indirect EuroimmunZ assay for the detection of anti-Zika antibody. Of 147 pre-Zika period serum samples, 39 (27%) were reactive in the EuroimmunZ or the DABA assays, 28 sera concordantly so. Such false reactivity was influenced by the serotype of Dengue virus (DV) to which individuals had been exposed to. Thus, of sera from patients undergoing secondary Dengue virus infection of known serotype, 91%, 45% and 28% of Dengue virus serotype 2, 3 and 4 respectively were reactive in one or more of the three assays. A novel method of quenching false sero-reactivity was therefore developed for the DABA and G capture assays. Initial addition of a single homologous Dengue virus serotype 3 NS1Ag quench significantly ablated false reactivities in the pre-Zika period sera. An equipotent quadrivalent quench comprising homologous Dengue virus serotypes 1 to 4 NS1Ag was shown to be optimum yet retained sensitivity for the detection of specific anti-Zika antibody. Comparing DABA and G capture assays using quenched and unquenched conjugates in comparison with EuroimmunZ early in the course of PCR-confirmed infection indicated that a significant component of the apparent early anti-ZIKA antibody response is likely to be due to a Zika virus-driven anamnestic anti-Dengue virus response. The increased specificity provided by homologous antigen quenching is likely to provide a significant improvement in sero-diagnostics and to be of clinical value.	[Tedder, Richard S.; Dicks, Steve; Ijaz, Samreen; Brown, David W. G.; Lumb, Ines Ushiro] Publ Hlth England, Blood Borne Virus Unit, Virus Reference Dept, London, England; [Tedder, Richard S.; Dicks, Steve; Lumb, Ines Ushiro] NHS Blood & Transplant, Microbiol Serv, London, England; [Tedder, Richard S.] UCL, London, England; [Santiago de Souza, Nathalia Caroline; de Paula, Anderson Vincente; Levi, Jose Eduardo; Pannuti, Claudio S.] Univ Sao Paulo, Inst Med Trop, Virol Lab LIM HCFMUSP, Sao Paulo, Brazil; [Levy, Flavia; de Sequeira, Patricia Carvalho; Brown, David W. G.] Fiocruz MS, Flavivirus Reference Lab, IOC, Rio De Janeiro, Brazil; [Medialdea-Carrera, Raquel] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England; [Tedder, Richard S.] Imperial Coll London, Fac Med, Dept Infect Dis, London, England	Public Health England; University of London; University College London; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; University of Liverpool; Imperial College London	Ijaz, S (corresponding author), Publ Hlth England, Blood Borne Virus Unit, Virus Reference Dept, London, England.	samreen.ijaz@phe.gov.uk		Tedder, Richard/0000-0002-9672-5721; Medialdea-Carrera, Raquel/0000-0002-0371-5138; De Paula, Anderson Vicente/0000-0002-7919-3516; Ijaz, Samreen/0000-0001-6658-3542	Medical Research Council Zika Rapid Response award [MC_PC_15093]; Public Health England Pipeline fund [PLF 1819-115/RA]; European Union's horizon 2020 research and innovation programme [734857]; Zikaction; Zikaplan [734584]	Medical Research Council Zika Rapid Response award; Public Health England Pipeline fund; European Union's horizon 2020 research and innovation programme; Zikaction; Zikaplan	This work was supported by Medical Research Council Zika Rapid Response award (MC_PC_15093) to RST, SI, DWGB, IUL, https://mrc.ukri.org/; Public Health England Pipeline fund (PLF 1819-115/RA) to RST, SI, https://www.gov.uk/government/organisations/public-health-england. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank colleagues in Diasorin for the kind gift of the conjugate diluent. DB is partially funded by European Union's horizon 2020 research and innovation programme (grant agreement no. 734857), Zikaction and Zikaplan consortia (grant agreement 734584). RMC is affiliated to the NIHR HPRU in Emerging and Zoonotic Infections at University of Liverpool in partnership with PHE, in collaboration with LSHTM.	Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114; Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681; Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2; BROWN DWG, 1994, BRIT MED J, V308, P1015, DOI 10.1136/bmj.308.6935.1015; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Glynn JR, 2017, LANCET INFECT DIS, V17, P645, DOI 10.1016/S1473-3099(17)30111-1; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Mead PS, 2016, NEW ENGL J MED, V378, P1377; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262; Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006; Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Tedder RS, 2018, TRANSFUSION, V58, P1289, DOI 10.1111/trf.14580	19	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0215708	10.1371/journal.pone.0215708	http://dx.doi.org/10.1371/journal.pone.0215708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374094	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500001
J	Valente, KP; Almeida, BL; Lazzarini, TR; de Souza, VF; Ribeiro, TDC; de Moraes, RAG; Pereira, TSS; Guandalini, VR				Valente, Katarina Papera; Almeida, Betullya Lucas; Lazzarini, Thailiny Ricati; de Souza, Vanusa Felicio; Chaves Ribeiro, Thamirys de Souza; Guedes de Moraes, Rafael Araujo; Silva Pereira, Taisa Sabrina; Guandalini, Valdete Regina			Association of Adductor Pollicis Muscle Thickness and Handgrip Strength with nutritional status in cancer patients	PLOS ONE			English	Article							MALNUTRITION; PREDICTOR; MASS; DYNAMOMETRY; MOBILITY; DECLINE; LENGTH; STAY	Background and aim Malnutrition is common in patients with cancer, and its early diagnosis can reduce or prevent further complications and improve the clinical and nutritional prognosis. Adductor Pollicis Muscle Thickness (APMT) and Handgrip Strength have been explored in this population to identify a reduction in strength and muscle mass prior to the use of conventional methods. We aimed to correlate APMT and Handgrip Strength with conventional anthropometric variables in cancer patients and verify their association with nutritional status as determined by the Patient-Generated Subjective Global Assessment (PG-SGA). Methods A cross-sectional study was conducted with 80 patients diagnosed with cancer who were candidates for surgery. Nutritional status was obtained from the PG-SGA. Conventional anthropometric measurements were taken, as well as APMT and Handgrip Strength. Pearson's correlation analysis and multivariate linear regression were applied to detect the influence of variables on APMT and HGS. A significance level of 5.0% was considered. Results A high prevalence of malnutrition and the need for dietotherapic intervention was found, identified by the PG-SGA. Correlations between APMT and Handgrip Strength with anthropometric variables and with the PG-SGA score were observed. After regression adjustments, the variables that interacted with APMT were TSF and AC, and the PG-SGA score, corrected Muscle Arm Area (CAMA), and age interacted with Handgrip Strength. Conclusion Correlations between anthropometric measurements and the PG-SGA score with APMT and Handgrip Strength were observed, even after adjusting for age and sex. These associations demonstrate that APMT and Handgrip Strength can be used with criterion in patients with cancer as complementary methods to evaluate nutritional risk and the need for nutritional intervention.	[Valente, Katarina Papera; Almeida, Betullya Lucas; Lazzarini, Thailiny Ricati; de Souza, Vanusa Felicio; Chaves Ribeiro, Thamirys de Souza; Guandalini, Valdete Regina] Univ Fed Espirito Santo, Dept Integrated Educ, Vitoria, ES, Brazil; [Guedes de Moraes, Rafael Araujo] Univ Cassiano Antonio Moraes Hosp, Vitoria, ES, Brazil; [Silva Pereira, Taisa Sabrina] Univ Americas Puebla, Ex Hacienda Sta Catarina Martir S-N, Cholula, Mexico	Universidade Federal do Espirito Santo; Universidad Americas Puebla (UDLAP)	Guandalini, VR (corresponding author), Univ Fed Espirito Santo, Dept Integrated Educ, Vitoria, ES, Brazil.; Pereira, TSS (corresponding author), Univ Americas Puebla, Ex Hacienda Sta Catarina Martir S-N, Cholula, Mexico.	taisa.silva@udlap.mx; valdete.guandalini@ufes.br	Guandalini, Valdete Regina/E-5165-2017; Pereira, Taísa Sabrina Silva/AAB-3715-2021	Guandalini, Valdete Regina/0000-0003-2266-6113; Pereira, Taísa Sabrina Silva/0000-0002-5922-7424	University Hospital Cassiano Antonio Moraes; Health Sciences Center/Federal University of Espirito Santo	University Hospital Cassiano Antonio Moraes; Health Sciences Center/Federal University of Espirito Santo	The authors would like to acknowledge the University Hospital Cassiano Antonio Moraes and the Health Sciences Center/Federal University of Espirito Santo for all support and assistance throughout the research. The authors also thank our study participants for their permission.	Alkan SB, 2018, SUPPORT CARE CANCER, V26, P2441, DOI 10.1007/s00520-018-4082-8; Allard JP, 2016, CLIN NUTR, V35, P144, DOI 10.1016/j.clnu.2015.01.009; Arends J, 2017, CLIN NUTR, V36, P11, DOI 10.1016/j.clnu.2016.07.015; Arvandi M, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0381-4; Barata AT, 2017, NUTR CANCER, V69, P154, DOI 10.1080/01635581.2017.1250923; Bragagnolo Rosalia, 2009, Rev. Col. Bras. Cir., V36, P371; Cruz A, 2019, ANIMAL, V13, P1358, DOI [10.1017/S1751731118003282, 10.1017/s1751731118003282]; Datema FR, 2011, ORAL ONCOL, V47, P910, DOI 10.1016/j.oraloncology.2011.06.510; Fess EE., 1992, CLIN ASSESSMENT RECO, P41; Fukuda Y, 2015, ANN SURG ONCOL, V22, pS778, DOI 10.1245/s10434-015-4820-9; Ghorabi S, 2016, NUTR CLIN PRACT, V31, P523, DOI 10.1177/0884533615621547; Gonzalez MC, 2010, CLIN NUTR, V29, P268, DOI 10.1016/j.clnu.2009.08.012; Gonzalez MC, 2015, CLIN NUTR, V34, P1025, DOI 10.1016/j.clnu.2014.11.006; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Guerra RS, 2015, JPEN-PARENTER ENTER, V39, P322, DOI 10.1177/0148607113514113; Jager-Wittenaar H, 2017, CURR OPIN CLIN NUTR, V20, P322, DOI 10.1097/MCO.0000000000000389; Karst Fernanda Pickrodt, 2015, Rev. bras. ter. intensiva, V27, P369, DOI 10.5935/0103-507X.20150062; Lameu Edson Braga, 2004, Rev. Hosp. Clin., V59, P57, DOI 10.1590/S0041-87812004000200002; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lipina C, 2017, J CACHEXIA SARCOPENI, V8, P190, DOI 10.1002/jcsm.12144; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; Martin L, 2020, JPEN-PARENTER ENTER, V44, P227, DOI 10.1002/jpen.1597; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Olguin T, 2017, CLIN NUTR ESPEN, V17, P28, DOI 10.1016/j.clnesp.2016.12.001; Opanga Yvonne, 2017, BMC Nutr, V3, P63, DOI 10.1186/s40795-017-0181-z; Ottery FD, 1996, NUTRITION, V12, pS15, DOI 10.1016/0899-9007(95)00067-4; Ozorio GA, 2017, NUTR CANCER, V69, P772, DOI 10.1080/01635581.2017.1321130; Pereira TG, 2018, CLIN NUTR ESPEN, V24, P165, DOI 10.1016/j.clnesp.2017.10.013; Pinho NB, 2018, CLIN NUTR, P1, DOI [10.1016/j.clnu.2018.05.010, DOI 10.1016/J.CLNU.2018.05.010]; Planas M, 2016, SUPPORT CARE CANCER, V24, P429, DOI 10.1007/s00520-015-2813-7; Poziomyck AK, 2018, ABCD-ARQ BRAS CIR DI, V31, DOI 10.1590/0102-672020180001e1340; Prado CMM, 2014, JPEN-PARENTER ENTER, V38, P940, DOI 10.1177/0148607114550189; Sampaio RMM, 2012, REV BRAS PROMOC SAUD, V25, P111; Sealy MJ, 2016, J CLIN EPIDEMIOL, V76, P125, DOI 10.1016/j.jclinepi.2016.02.020; Sharma Dibyendu, 2015, Asian Pac J Cancer Prev, V16, P8173; Shu-Fen CL, 2015, ASIA PAC J CLIN NUTR, V24, P605, DOI 10.6133/apjcn.2015.24.4.22; de Melo CYSV, 2014, ABCD-ARQ BRAS CIR DI, V27, P13, DOI 10.1590/s0102-67202014000100004; Souza NC, 2020, CLIN NUTR, V39, P484, DOI 10.1016/j.clnu.2019.02.026; Torres BT, 2018, NUTR HOSP, V35, P384, DOI 10.20960/nh.1315; Valente KP, 2016, EINSTEIN-SAO PAULO, V14, P18, DOI 10.1590/S1679-45082016AO3596; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; World Health Organization, 1995, WHO PHYS STAT US INT; World Health Organization, 2002, ACT AG POL FRAM; Zhang XS, 2017, BIOMED ENVIRON SCI, V30, P802, DOI 10.3967/bes2017.108; Zhou JD, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0054-8	47	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220334	10.1371/journal.pone.0220334	http://dx.doi.org/10.1371/journal.pone.0220334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374093	Green Submitted, Green Published, gold			2022-12-26	WOS:000484991500010
J	Khachatryan, N; Pistilli, M; Maguire, MG; Salowe, RJ; Fertig, RM; Moore, T; Gudiseva, HV; Chavali, VRM; Collins, DW; Daniel, E; Murphy, W; Henderer, JD; Lehman, A; Cui, Q; Addis, V; Sankar, PS; Miller-Ellis, EG; O'Brien, JM				Khachatryan, Naira; Pistilli, Maxwell; Maguire, Maureen G.; Salowe, Rebecca J.; Fertig, Raymond M.; Moore, Tanisha; Gudiseva, Harini, V; Chavali, Venkata R. M.; Collins, David W.; Daniel, Ebenezer; Murphy, Windell; Henderer, Jeffrey D.; Lehman, Amanda; Cui, Qi; Addis, Victoria; Sankar, Prithvi S.; Miller-Ellis, Eydie G.; O'Brien, Joan M.			Primary Open-Angle African American Glaucoma Genetics (POAAGG) Study: gender and risk of POAG in African Americans	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; REFRACTIVE ERROR; BLOOD-PRESSURE; PREVALENCE; EYE; ASSOCIATIONS; PREDICTORS; MENOPAUSE; INDEX	The purpose of this study was to investigate the association between gender and primary open-angle glaucoma (POAG) among African Americans and to assess demographic, systemic, and behavioral factors that may contribute to differences between genders. The Primary Open-Angle African American Glaucoma Genetics (POAAGG) study had a case-control design and included African Americans 35 years and older, recruited from the greater Philadelphia, Pennsylvania. Diagnosis of POAG was based on evidence of both glaucomatous optic nerve damage and characteristic visual field loss. Demographic and behavioral information, history of systemic diseases and anthropometric measurements were obtained at study enrollment. Gender differences in risk of POAG were examined using multivariate logistic regression. A total of 2,290 POAG cases and 2,538 controls were included in the study. The percentage of men among cases was higher than among controls (38.6% vs 30.3%, P<0.001). The subjects' mean age at enrollment was significantly higher for cases compared to controls (70.2 +/- 11.3 vs. 61.6 +/- 11.8 years, P<0.003). Cases had lower rates of diabetes (40% vs. 46%, P<0.001), higher rates of systemic hypertension (80% vs. 72%, P<0.001), and lower body mass index (BMI) (29.7 +/- 6.7 vs. 31.9 +/- 7.4, P<0.001) than controls. In the final multivariable model, male gender was significantly associated with POAG risk (OR, 1.64; 95% CI, 1.44-1.87; P<0.001), after adjusting for age, systemic hypertension, diabetes, and BMI. Within the POAAGG study, men were at higher risk of having POAG than women. Pending genetic results from this study will be used to better understand the underlying genetic variations that may account for these differences.	[Khachatryan, Naira; Pistilli, Maxwell; Maguire, Maureen G.; Salowe, Rebecca J.; Fertig, Raymond M.; Moore, Tanisha; Gudiseva, Harini, V; Chavali, Venkata R. M.; Collins, David W.; Daniel, Ebenezer; Lehman, Amanda; Cui, Qi; Addis, Victoria; Sankar, Prithvi S.; Miller-Ellis, Eydie G.; O'Brien, Joan M.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Henderer, Jeffrey D.] Temple Univ, Dept Ophthalmol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	O'Brien, JM (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.	joan.obrien@uphs.upenn.edu	Cui, Qi/AAU-7327-2020; Cui, Qi/AAQ-7761-2021	Cui, Qi/0000-0002-5338-0401	National Eye Institute, Bethesda, Maryland [1RO1EY023557-01]; Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Vision Research Core Grant [P30 EY001583]; F.M. Kirby Foundation; Research to Prevent Blindness; UPenn Hospital Board of Women Visitors; Paul and Evanina Bell Mackall Foundation Trust; National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM; National Eye Institute, National Institutes of Health, Department of Health and Human Services [HHSN260220700001C, HHSN263201200001C]; NATIONAL EYE INSTITUTE [R01EY023557, P30EY001583, K12EY015398] Funding Source: NIH RePORTER	National Eye Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Vision Research Core Grant; F.M. Kirby Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); UPenn Hospital Board of Women Visitors; Paul and Evanina Bell Mackall Foundation Trust; National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM; National Eye Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, Bethesda, Maryland (grant 1RO1EY023557-01) and the Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Funds also come from the Vision Research Core Grant (P30 EY001583), F.M. Kirby Foundation, Research to Prevent Blindness, The UPenn Hospital Board of Women Visitors, The Paul and Evanina Bell Mackall Foundation Trust, and the National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM and contract Nos. HHSN260220700001C and HHSN263201200001C. The sponsor or funding organization had no role in the design or conduct of this research.	BULPITT CJ, 1975, BRIT J OPHTHALMOL, V59, P717, DOI 10.1136/bjo.59.12.717; Chan MPY, 2016, OPHTHALMOLOGY, V123, P771, DOI 10.1016/j.ophtha.2015.11.031; Charlson ES, 2015, OPHTHALMOLOGY, V122, P711, DOI 10.1016/j.ophtha.2014.11.015; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Doshi V, 2008, OPHTHALMOLOGY, V115, P639, DOI 10.1016/j.ophtha.2007.05.032; Foster PJ, 2010, BRIT J OPHTHALMOL, V94, P827, DOI 10.1136/bjo.2009.163899; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Gupta P, 2016, INVEST OPHTH VIS SCI, V57, P2905, DOI 10.1167/iovs.15-18469; Henderson KD, 2008, AM J EPIDEMIOL, V167, P1287, DOI 10.1093/aje/kwn046; Hulsman CAA, 2001, AM J EPIDEMIOL, V154, P138, DOI 10.1093/aje/154.2.138; Hulsman CAA, 2007, ARCH OPHTHALMOL-CHIC, V125, P805, DOI 10.1001/archopht.125.6.805; KAHN HA, 1977, AM J EPIDEMIOL, V106, P33, DOI 10.1093/oxfordjournals.aje.a112429; Kaimbo DKW, 2001, J CLIN EPIDEMIOL, V54, P166, DOI 10.1016/S0895-4356(00)00291-2; Kaimbo Wa Kaimbo D, 1997, Bull Soc Belge Ophtalmol, V267, P29; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813, DOI 10.1093/oxfordjournals.aje.a117078; Khawaja AP, 2013, INVEST OPHTH VIS SCI, V54, P5028, DOI 10.1167/iovs.13-11971; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; McKnight KK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.014; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Mitchell P, 2004, J GLAUCOMA, V13, P319, DOI 10.1097/00061198-200408000-00010; Omoti AE, 2009, MIDDLE EAST AFR J OP, V16, P146, DOI 10.4103/0974-9233.56229; Parikh R, 2017, ETHN HLTH, P1; Pasquale LR, 2007, J GLAUCOMA, V16, P598, DOI 10.1097/IJG.0b013e318064c82d; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Schmidl D, 2015, CURR EYE RES, V40, P201, DOI 10.3109/02713683.2014.906625; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Vajaranant TS, 2012, MENOPAUSE, V19, P942, DOI 10.1097/gme.0b013e3182443137; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026; Viana LC, 2011, ARCH GYNECOL OBSTET, V283, P569, DOI 10.1007/s00404-010-1403-7; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; ZANG EA, 1994, NUTR CANCER, V21, P247, DOI 10.1080/01635589409514323; Zetterberg M, 2016, MATURITAS, V83, P19, DOI 10.1016/j.maturitas.2015.10.005	38	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218804	10.1371/journal.pone.0218804	http://dx.doi.org/10.1371/journal.pone.0218804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369581	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900011
J	Carlsson, AM; Curry, P; Elkin, B; Russell, D; Veitch, A; Branigan, M; Campbell, M; Croft, B; Cuyler, C; Cote, SD; Leclerc, LM; Tryland, M; Nymo, IH; Kutz, SJ				Carlsson, A. M.; Curry, P.; Elkin, B.; Russell, D.; Veitch, A.; Branigan, M.; Campbell, M.; Croft, B.; Cuyler, C.; Cote, S. D.; Leclerc, L-M; Tryland, M.; Nymo, I. H.; Kutz, S. J.			Multi-pathogen serological survey of migratory caribou herds: A snapshot in time	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; WEST-NILE-VIRUS; RANGIFER-TARANDUS-GROENLANDICUS; CERVID HERPESVIRUS 2; NEOSPORA-CANINUM; TOXOPLASMA-GONDII; INFECTIOUS-DISEASES; CLIMATE-CHANGE; BOVINE HERPESVIRUS-1; FILTER-PAPER	Pathogens can impact host survival, fecundity, and population dynamics even when no obvious disease is observed. Few baseline data on pathogen prevalence and diversity of caribou are available, which hampers our ability to track changes over time and evaluate impacts on caribou health. Archived blood samples collected from ten migratory caribou herds in Canada and two in Greenland were used to test for exposure to pathogens that have the potential to effect population productivity, are zoonotic or are emerging. Relationships between seroprevalence and individual, population, and other health parameters were also examined. For adult caribou, the highest overall seroprevalence was for alphaherpesvirus (49%, n = 722), pestivirus (49%, n = 572) and Neospora caninum (27%, n = 452). Lower seroprevalence was found for parainfluenza virus type 3 (9%, n = 708), Brucella suis (2%, n = 758), and Toxoplasma gondii (2%, n = 706). No animal tested positive for antibodies against West Nile virus (n = 418) or bovine respiratory syncytial virus (n = 417). This extensive multi-pathogen survey of migratory caribou herds provides evidence that caribou are exposed to pathogens that may have impacts on herd health and revealed potential interactions between pathogens as well as geographical differences in pathogen exposure that could be linked to the bio-geographical history of caribou. Caribou are a keystone species and the socio-economic cornerstone of many indigenous cultures across the North. The results from this study highlight the urgent need for a better understanding of pathogen diversity and the impact of pathogens on caribou health.	[Carlsson, A. M.; Curry, P.; Kutz, S. J.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Elkin, B.; Veitch, A.; Branigan, M.; Croft, B.] Govt Northwest Terr, Environm & Nat Resources, Yellowknife, AB, Canada; [Russell, D.] CircumArct Rangifer Monitoring & Assessment Netwo, Whitehorse, YT, Canada; [Campbell, M.; Leclerc, L-M] Govt Nunavut, Dept Environm, Igaluit, NU, Canada; [Cuyler, C.] Greenland Inst Nat Resources, Nuuk, Greenland; [Cote, S. D.] Univ Laval, Dept Biol, Caribou Ungava, Quebec City, PQ, Canada; [Cote, S. D.] Univ Laval, Ctr Etud Nord, Quebec City, PQ, Canada; [Tryland, M.; Nymo, I. H.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Kutz, S. J.] Canadian Wildlife Hlth Cooperat, Calgary, AB, Canada; [Carlsson, A. M.] Swedish Museum Nat Hist, Dept Environm Res & Monitoring, Stockholm, Sweden; [Nymo, I. H.] Norwegian Vet Inst, Sect Pathol Oslo & Tromso, Tromso, Norway	University of Calgary; Greenland Institute of Natural Resources; Laval University; Laval University; UiT The Arctic University of Tromso; Swedish Museum of Natural History; Norwegian Veterinary Institute	Carlsson, AM (corresponding author), Univ Calgary, Fac Vet Med, Calgary, AB, Canada.; Carlsson, AM (corresponding author), Swedish Museum Nat Hist, Dept Environm Res & Monitoring, Stockholm, Sweden.	anja.carlsson@nrm.se		Nymo, Ingebjorg Helena/0000-0002-4844-8344; kutz, susan/0000-0003-2352-8687; Tryland, Morten/0000-0001-5394-5196	Polar Knowledge Canada; International Polar Year; NSERC Special Research Opportunity Program; NSERC Discovery grant; NSERC Northern Supplement, Environment Canada/Natural Resources Canada; Caribou Ungava; Ministere des Forets, de la faune et des parcs of Quebec; Nasivik Centre for Inuit Health and Changing Environments (Canadian Institutes of Health Research); Alberta Innovates Technology Futures; University of Calgary Faculty of Veterinary Medicine; Liber Ero Fellowship	Polar Knowledge Canada; International Polar Year; NSERC Special Research Opportunity Program; NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Northern Supplement, Environment Canada/Natural Resources Canada; Caribou Ungava; Ministere des Forets, de la faune et des parcs of Quebec; Nasivik Centre for Inuit Health and Changing Environments (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures; University of Calgary Faculty of Veterinary Medicine; Liber Ero Fellowship	Funding for this research was provided by Polar Knowledge Canada, International Polar Year Funding to the Circum-Arctic Rangifer Monitoring and Assessment Network (CARMA, https://carma.caff.is/), NSERC Special Research Opportunity Program, NSERC Discovery grant, NSERC Northern Supplement, Environment Canada/Natural Resources Canada, Caribou Ungava, the Ministere des Forets, de la faune et des parcs of Quebec, Nasivik Centre for Inuit Health and Changing Environments (Canadian Institutes of Health Research), Alberta Innovates Technology Futures, the University of Calgary Faculty of Veterinary Medicine, the Liber Ero Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Atwood TC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13496-9; Avalos-Ramirez R, 2001, VIROLOGY, V286, P456, DOI 10.1006/viro.2001.1001; Bachand N, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3408-9; Bartels CJM, 1999, THERIOGENOLOGY, V52, P247, DOI 10.1016/S0093-691X(99)00126-0; Biswas S, 2013, VET QUART, V33, P68, DOI 10.1080/01652176.2013.799301; Bjorkman C, 2000, VET J, V159, P201, DOI 10.1053/tvjl.1999.0446; Blanchong JA, 2016, J WILDLIFE MANAGE, V80, P593, DOI 10.1002/jwmg.1064; Blitvich BJ, 2003, J CLIN MICROBIOL, V41, P2676, DOI 10.1128/JCM.41.6.2676-2679.2003; Bondo KJ, 2019, J WILDLIFE DIS, V55, P544, DOI 10.7589/2018-01-018; Bouchard E, 2017, INT J PARASITOL-PAR, V6, P234, DOI 10.1016/j.ijppaw.2017.08.004; Brackenbury LS, 2003, VET MICROBIOL, V96, P337, DOI 10.1016/j.vetmic.2003.09.004; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Campbell JR, 2004, VET CLIN N AM-FOOD A, V20, P39, DOI 10.1016/j.cvfa.2003.11.003; Campbell M, 2013, RES UPDATE DEP ENV P; Carlsson A, 2016, ONE HLTH CASE STUDIE; Carlsson A.M., 2018, REINDEER CARIBOU HLT, P315; CircumArctic Rangifer Monitoring Assessment Network, 2008, RANG HLTH BOD COND M; COSEWIC, 2016, COSEWIC ASS STAT REP; [ COSEWIC] COMMITTEE ON THE STATUS OF ENDANGERED WILDLIFE IN CANADA, 2019, COSEWIC ASS STAT REP; Cote SD, 2012, NUNAVIK NUNATSIAVUT, P249; Curry PS, 2014, J WILDLIFE DIS, V50, P297, DOI 10.7589/2012-02-047; Curry PS, 2011, J WILDLIFE DIS, V47, P12, DOI 10.7589/0090-3558-47.1.12; Curry PS, 2012, BLOOD FILTER PAPER M; das Neves CG, 2010, VET MICROBIOL, V143, P70, DOI 10.1016/j.vetmic.2010.02.015; das Neves CG, 2009, VET MICROBIOL, V139, P262, DOI 10.1016/j.vetmic.2009.06.013; das Neves CG, 2009, VIRUS RES, V145, P321, DOI 10.1016/j.virusres.2009.08.002; das Neves CG, 2009, J CLIN MICROBIOL, V47, P1309, DOI 10.1128/JCM.02416-08; Das Neves CG, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-9; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Dubey JP, 2011, VET PARASITOL, V181, P382, DOI 10.1016/j.vetpar.2011.05.018; Dubey JP, 2002, VET PARASITOL, V110, P131, DOI 10.1016/S0304-4017(02)00320-5; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Dudley JP, 2015, ECOHEALTH, V12, P713, DOI 10.1007/s10393-015-1036-1; DURHAM PJK, 1990, CAN VET J, V31, P815; EDWARDS S, 1986, VET RES COMMUN, V10, P297, DOI 10.1007/BF02213992; EKKOMMONEN C, 1986, ACTA VET SCAND, V27, P299; ELAZHARY M A S Y, 1981, Journal of Wildlife Diseases, V17, P609; Evans AL, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-5; Ferguson MAD, 1997, J WILDLIFE DIS, V33, P536, DOI 10.7589/0090-3558-33.3.536; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; FORBES LB, 1991, CAN VET J, V32, P686; Froelich K., 2000, Rangifer, V20, P83; Gall D, 2004, REV SCI TECH OIE, V23, P989; Gilbert AT, 2013, ECOHEALTH, V10, P298, DOI 10.1007/s10393-013-0856-0; Gottdenker NL, 2014, ECOHEALTH, V11, P619, DOI 10.1007/s10393-014-0941-z; Grissett GP, 2015, J VET INTERN MED, V29, P770, DOI 10.1111/jvim.12597; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Gunn A., 1991, WILDLIFE DIS PARASIT; He Q, 2004, AUST VET J, V82, P99, DOI 10.1111/j.1751-0813.2004.tb14656.x; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Hellard E, 2015, TRENDS PARASITOL, V31, P640, DOI 10.1016/j.pt.2015.07.005; Hoberg EP, 2012, ADV PARASIT, V79, P1, DOI 10.1016/B978-0-12-398457-9.00001-9; Jenkins EJ, 2015, TRENDS PARASITOL; Jenkins EJ, 2013, ADV PARASIT, V82, P33, DOI 10.1016/B978-0-12-407706-5.00002-2; Jepsen BI, 2002, CONSERV GENET, V3, P401, DOI 10.1023/A:1020523303815; Johnson D, 2010, J WILDLIFE DIS, V46, P1096, DOI 10.7589/0090-3558-46.4.1096; Jordan LT, 2003, J WILDLIFE DIS, V39, P216, DOI 10.7589/0090-3558-39.1.216; Jordan Peter A., 1998, Rangifer, V18, P169; Kangbai J., 2017, J TROP DIS, V5, P2, DOI [DOI 10.4172/2329-891X.1000244, 10.4172/2329-891X.1000244]; Kautto AH, 2012, VET MICROBIOL, V156, P64, DOI 10.1016/j.vetmic.2011.10.018; Kock RA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao2314; Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742; Kutz SJ, 2001, J PARASITOL, V87, P439, DOI 10.1645/0022-3395(2001)087[0439:POTGAI]2.0.CO;2; Kutz SJ, 2018, REINDEER CARIBOU HLT, DOI 10.1201/9780429489617; Kutz S, 2015, CAN VET J, V56, P560; Kutz Susan, 2013, Rangifer, V33, P91; Kutz SJ, 2013, GLOBAL CHANGE BIOL, V19, P3254, DOI 10.1111/gcb.12315; Kutz SJ, 2012, ADV PARASIT, V79, P99, DOI 10.1016/B978-0-12-398457-9.00002-0; Kutz SJ, 2009, VET PARASITOL, V163, P217, DOI 10.1016/j.vetpar.2009.06.008; Lanyon SR, 2014, VET J, V199, P201, DOI 10.1016/j.tvjl.2013.07.024; Larska M, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.07787, 10.3389/fmicb.2015.01187]; Lillehaug A, 2003, J WILDLIFE DIS, V39, P779, DOI 10.7589/0090-3558-39.4.779; LILLIE LE, 1974, CAN VET J, V15, P233; Lindberg ALE, 2003, VET QUART, V25, P1; Duong C, 2008, VET J, V175, P390, DOI 10.1016/j.tvjl.2006.01.016; Mallen C, 2017, EVENT MANAGEMENT IN SPORT, RECREATION AND TOURISM: THEORETICAL AND PRACTICAL DIMENSIONS, 3RD EDITION, P1; Mascarelli PE, 2015, RES VET SCI, V99, P58, DOI 10.1016/j.rvsc.2014.12.011; MEYER ME, 1966, AM J VET RES, V27, P353; Molina V, 2013, RES VET SCI, V95, P115, DOI 10.1016/j.rvsc.2013.02.018; MORTON J K, 1990, Rangifer, V10, P75; Murray DL, 1997, J ANIM ECOL, V66, P250, DOI 10.2307/6026; NETTLETON PF, 1995, BRIT VET J, V151, P615, DOI 10.1016/S0007-1935(95)80145-6; Nutall M, 2005, HUNTING HERDING FISH; Nymo IH, 2013, J VET DIAGN INVEST, V25, P369, DOI 10.1177/1040638713485073; Oksanen A, 1996, J PARASITOL, V82, P843, DOI 10.2307/3283904; Palmer MV, 2004, J VET DIAGN INVEST, V16, P219, DOI 10.1177/104063870401600307; Parkinson AJ, 2005, INT J CIRCUMPOLAR HL, V64; Pedersen AB, 2015, TRENDS PARASITOL, V31, P200, DOI 10.1016/j.pt.2015.02.004; Pioz M, 2008, OECOLOGIA, V155, P691, DOI 10.1007/s00442-007-0942-5; Preece ND, 2017, BIOL CONSERV, V214, P136, DOI 10.1016/j.biocon.2017.08.014; Rehbinder Claes, 1992, Rangifer, V12, P191; Rhyan JC, 2013, REV SCI TECH OIE, V32, P127; Ridpath J, 2010, VET CLIN N AM-FOOD A, V26, P335, DOI 10.1016/j.cvfa.2010.04.003; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Risalde MA, 2013, AM J VET RES, V74, P598, DOI 10.2460/ajvr.74.4.598; Rockborn G, 1990, RANGIFER, V10, P373, DOI [10.7557/2.10.3.882, DOI 10.7557/2.10.3.882]; Roed Knut H., 2005, Rangifer, V25, P19; Russell DE, 2015, ARCTIC, V68, P6, DOI 10.14430/arctic4496; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Sergeant ESG, 2018, EPITOOLS EPIDEMIOLOG; Simard AA, 2016, CAN J ZOOL, V94, P607, DOI 10.1139/cjz-2015-0190; Stahl K, 2006, PREV VET MED, V75, P177, DOI 10.1016/j.prevetmed.2006.02.006; Steele Jillian, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P197, DOI 10.1016/j.ijppaw.2013.05.002; Stephen C, 2014, J WILDLIFE DIS, V50, P427, DOI 10.7589/2013-11-305; Stieve E, 2010, J WILDLIFE DIS, V46, P348, DOI 10.7589/0090-3558-46.2.348; Stuen S., 1993, Rangifer, V13, P215; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tomaselli M, 2018, BIOL CONSERV, V217, P337, DOI 10.1016/j.biocon.2017.11.010; Tryland Morten, 2005, Rangifer, V25, P75; Tryland M, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0291-2; Tryland M, 2009, J CLIN MICROBIOL, V47, P3707, DOI 10.1128/JCM.01198-09; VANDERPOEL WHM, 1995, ARCH VIROL, V140, P1549, DOI 10.1007/BF01322529; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Yannic G, 2014, NAT CLIM CHANGE, V4, P132, DOI 10.1038/NCLIMATE2074; ZARNKE RL, 1983, J WILDLIFE DIS, V19, P324, DOI 10.7589/0090-3558-19.4.324; Zarnke RL, 2001, J WILDLIFE DIS, V37, P36, DOI 10.7589/0090-3558-37.1.36	123	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219838	10.1371/journal.pone.0219838	http://dx.doi.org/10.1371/journal.pone.0219838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365561	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600020
J	Grabarczyk, EE; Gill, SA				Grabarczyk, Erin E.; Gill, Sharon A.			Anthropogenic noise affects male house wren response to but not detection of territorial intruders	PLOS ONE			English	Article							GREAT TIT; SONG ORGANIZATION; TROGLODYTES-AEDON; DEFENSE; CALLS; INFORMATION; BEHAVIOR; MASKING; BIRD	Anthropogenic noise decreases signal active space, or the area over which male bird song can be detected in the environment. For territorial males, noise may make it more difficult to detect and assess territorial challenges, which in turn may increase defense costs and influence whether males maintain territory ownership. We tested the hypothesis that noise affects the ability of male house wrens (Troglodytes aedon) near active nests to detect intruders and alters responses to them. We broadcast pre-recorded male song and pink noise on territories to simulate intrusions with and without noise, as well as to noise alone. We measured detection by how long males took to sing or approach the speaker after the start of a playback. To measure whether playbacks changed male behavior, we compared their vocal responses before and during treatments, as well as compared mean vocal responses and the number of flyovers and attacks on the speaker during treatments. Noise did not affect a male's ability to detect an intruder on his territory. Males altered their responses to simulated intruders with and without noise compared to the noise-only treatment by singing longer songs at faster rates. Males increased peak frequency of songs during intrusions without noise compared to noise-only treatments, but frequency during intruder plus noise treatments did not differ from either. When confronting simulated intruders in noise, males increased the number of attacks on the speaker compared to intruders without noise, possibly because they were less able to assess intruders via songs and relied on close encounters for information. Although noise did not affect intruder detection, noise affected some aspects of singing and aggressive responses, which may be related to the challenge of discriminating and assessing territorial threats under elevated noise.	[Grabarczyk, Erin E.; Gill, Sharon A.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA	Western Michigan University	Grabarczyk, EE (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	erin.e.grabarczyk@wmich.edu		Grabarczyk, Erin/0000-0002-7659-8366	National Science Foundation [1257699]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (Grant no. 1257699) to SAG and K. Naghshineh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Bermudez-Cuamatzin E, 2009, BEHAVIOUR, V146, P1269, DOI 10.1163/156853909X423104; Bradbury Jack W., 1998, pi; Brumm H, ADVANC STUDY BEHAV, V35, P151; Brumm H, 2006, J COMP PHYSIOL A, V192, P1279, DOI 10.1007/s00359-006-0158-x; Cardoso GC, 2012, BEHAV ECOL, V23, P237, DOI 10.1093/beheco/arr200; Curry CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22253-5; Egnor SER, 2007, J COMP PHYSIOL A, V193, P477, DOI 10.1007/s00359-006-0205-7; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fischer JD, 2015, CONSERV BIOL, V29, P1246, DOI 10.1111/cobi.12451; FREED LA, 1986, BEHAV ECOL SOCIOBIOL, V19, P197; Gentry KE, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1916; Gill SA, 2015, BEHAV ECOL, V26, P328, DOI 10.1093/beheco/aru219; Grabarczyk E. E., 2018, J ECOACOUSTICS, V2, pLHGRVC, DOI 10.22261/JEA.LHGRVC; Grabarczyk EE, 2020, BIOACOUSTICS, V29, P518, DOI 10.1080/09524622.2019.1621209; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; Hanna D, 2011, J EXP BIOL, V214, P3549, DOI 10.1242/jeb.060194; JOHNSON LS, 1989, ORNIS SCAND, V20, P89, DOI 10.2307/3676873; JOHNSON LS, 1991, BEHAVIOUR, V116, P190, DOI 10.1163/156853991X00030; JOHNSON LS, 1990, AUK, V107, P781, DOI 10.2307/4088013; Kern JM, 2016, ENVIRON POLLUT, V218, P988, DOI 10.1016/j.envpol.2016.08.049; Kleist NJ, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1259; Klump GM, 1996, BIRD COMMUNICATION N; KROODSMA DE, 1977, AM NAT, V111, P995, DOI 10.1086/283228; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LaZerte SE, 2017, PEERJ, V5, DOI 10.7717/peerj.3257; Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824; Lenske AK, 2014, BEHAV PROCESS, V105, P28, DOI 10.1016/j.beproc.2014.02.015; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; McIntyre E, 2014, ANIM BEHAV, V87, P85, DOI 10.1016/j.anbehav.2013.10.013; McMullen H, 2014, BEHAV PROCESS, V103, P125, DOI 10.1016/j.beproc.2013.12.001; McNett GD, 2010, BEHAV ECOL SOCIOBIOL, V64, P2043, DOI 10.1007/s00265-010-1018-9; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Naguib M, 2010, ANIM BEHAV, V80, pE11, DOI 10.1016/j.anbehav.2010.06.001; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Phillips JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25834-6; Pohl NU, 2013, J COMP PHYSIOL A, V199, P239, DOI 10.1007/s00359-012-0789-z; Pohl NU, 2012, ANIM BEHAV, V83, P711, DOI 10.1016/j.anbehav.2011.12.019; Pohl NU, 2009, ANIM BEHAV, V78, P1293, DOI 10.1016/j.anbehav.2009.09.005; Proppe DS, 2017, J ECOACOUST, V1; Radford AN, 2014, BEHAV ECOL, V25, P1022, DOI [10.1093/beheco/aru029, 10.1093/beheco/art102]; Rendall D, 2013, AUK, V130, P617, DOI 10.1525/auk.2013.13069; Schmidt R, 2007, J ANIM ECOL, V76, P168, DOI 10.1111/j.1365-2656.2006.01182.x; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Sih A, 2016, CURR OPIN BEHAV SCI, V12, P109, DOI 10.1016/j.cobeha.2016.09.014; STODDARD PK, 1991, BEHAV ECOL SOCIOBIOL, V29, P211, DOI 10.1007/BF00166403; Stuart CJ, 2019, SOCIAL FACTORS NOT A; Templeton CN, 2016, CURR BIOL, V26, pR1173, DOI 10.1016/j.cub.2016.09.058; Tove M. H., 1988, PATTERNS SINGING HOU; Verzijden MN, 2010, J EXP BIOL, V213, P2575, DOI 10.1242/jeb.038299; Wiley RH, 2013, SIGNAL DETECTION NOI; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zwart MC, 2016, BEHAV ECOL, V27, P101, DOI 10.1093/beheco/arv128	57	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220576	10.1371/journal.pone.0220576	http://dx.doi.org/10.1371/journal.pone.0220576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365593	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600057
J	Eggermont, F; Verdonschot, N; van der Linden, Y; Tanck, E				Eggermont, Florieke; Verdonschot, Nico; van der Linden, Yvette; Tanck, Esther			Calibration with or without phantom for fracture risk prediction in cancer patients with femoral bone metastases using CT-based finite element models	PLOS ONE			English	Article							STRENGTH; DENSITY; ATTENUATION; IMPROVES; LESIONS; SCANS; BMD	The objective of this study was to develop a new calibration method that enables calibration of Hounsfield units ( HU) to bone mineral densities ( BMD) without the use of a calibration phantom for fracture risk prediction of femurs with metastases using CT-based finite element ( FE) models. Fifty-seven advanced cancer patients ( 67 femurs with bone metastases) were CT scanned atop a separate calibration phantom using a standardized protocol. Nonlinear isotropic FE models were constructed based on the phantom calibration and on two phantomless calibration methods: the "air-fat-muscle" and "non-patient-specific" calibration. For air-fat-muscle calibration, peaks for air, fat and muscle tissue were extracted from a histogram of the HU in a standardized region of interest including the patient's right leg and surrounding air. These CT peaks were linearly fitted to reference "BMD" values of the corresponding tissues to obtain a calibration function. For non-patient-specific calibration, an average phantom calibration function was used for all patients. FE failure loads were compared between phantom and phantomless calibrations. There were no differences in failure loads between phantom and air-fat-muscle calibration ( p = 0.8), whereas there was a significant difference between phantom and non-patient-specific calibration ( p<0.001). Although this study was not designed to investigate this, in four patients who were scanned using an aberrant reconstruction kernel, the effect of the different kernel seemed to be smaller for the air-fat-muscle calibration compared to the non-patient-specific calibration. With the air-fat-muscle calibration, clinical implementation of the FE model as tool for fracture risk assessment will be easier from a practical and financial viewpoint, since FE models can be made using everyday clinical CT scans without the need of concurrent scanning of calibration phantoms.	[Eggermont, Florieke; Verdonschot, Nico; Tanck, Esther] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Orthopaed Res Lab, Nijmegen, Netherlands; [Verdonschot, Nico] Univ Twente, Lab Biomech Engn, Enschede, Netherlands; [van der Linden, Yvette] Leiden Univ, Med Ctr, Dept Radiotherapy, Leiden, Netherlands	Radboud University Nijmegen; University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Eggermont, F (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Orthopaed Res Lab, Nijmegen, Netherlands.	Florieke.Eggermont@radboudumc.nl	Eggermont, Florieke/A-1715-2016; van der linden, yvette/O-1517-2013; Verdonschot, N.J.J./H-8104-2014; Tanck, E.J.M./L-4682-2015	Eggermont, Florieke/0000-0002-5033-3941; van der linden, yvette/0000-0002-9003-6124; Verdonschot, N.J.J./0000-0002-7531-6523; Tanck, Esther/0000-0002-3263-0045	Dutch Cancer Society [KUN 2012-5591]; Dutch Science Foundation NWO-STW [NPG.06778]; Fonds NutsOhra [1102-071]	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Science Foundation NWO-STW(Netherlands Organization for Scientific Research (NWO)); Fonds NutsOhra	This work was supported by the Dutch Cancer Society (www.kwf.nl, KUN 2012-5591) to FE, the Dutch Science Foundation NWO-STW (www.nwo.nl, NPG.06778) to ET, and Fonds NutsOhra (www.fnozorgvoorkansen.nl, 1102-071) to ET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubrey J, 2014, ACTA PHYSIOL, V210, P489, DOI 10.1111/apha.12224; Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; Boden S D, 1989, J Digit Imaging, V2, P31; Boomsma MF, 2015, SKELETAL RADIOL, V44, P1597, DOI 10.1007/s00256-015-2206-5; Budoff MJ, 2013, RADIOLOGY, V267, P830, DOI 10.1148/radiol.13111987; Carpenter RD, 2014, MED ENG PHYS, V36, P1225, DOI 10.1016/j.medengphy.2014.06.010; Derikx LC, 2012, J BONE JOINT SURG BR, V94B, P1135, DOI 10.1302/0301-620X.94B8.28449; Derikx LC, 2011, COMPUT METHOD BIOMEC, V14, P183, DOI 10.1080/10255842.2010.542463; Eggermont F, 2018, BONE JOINT RES, V7, P430, DOI 10.1302/2046-3758.76.BJR-2017-0325.R2; Eggermont F, 2018, J ORTHOP RES, V36, P2288, DOI 10.1002/jor.23890; Eggermont F, 2017, ADV RADIAT ONCOL, V2, P53, DOI 10.1016/j.adro.2016.11.001; Free J, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aad66a; Giambini H, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031572; Goodheart JR, 2015, J ORTHOP RES, V33, P1226, DOI 10.1002/jor.22887; Habashy AH, 2011, BONE, V48, P1087, DOI 10.1016/j.bone.2010.12.012; Keyak JH, 2005, CLIN ORTHOP RELAT R, P161, DOI 10.1097/01.blo.0000174736.50964.3b; Keyak JH, 2005, CLIN ORTHOP RELAT R, P219, DOI 10.1097/01.blo.0000164400.37905.22; Lee DC, 2017, BONE, V103, P325, DOI 10.1016/j.bone.2017.07.029; Lee YH, 2019, COMPUT MATH METHOD M, V2019, DOI 10.1155/2019/4102410; LEVI C, 1982, AM J ROENTGENOL, V139, P443, DOI 10.2214/ajr.139.3.443; Mueller DK, 2011, EUR J RADIOL, V79, P375, DOI 10.1016/j.ejrad.2010.02.008; Sande EPS, 2010, PHYS MED BIOL, V55, P5123, DOI 10.1088/0031-9155/55/17/015; Tanck E, 2009, BONE, V45, P777, DOI 10.1016/j.bone.2009.06.009; Van der Linden YM, 2004, J BONE JOINT SURG BR, V86B, P566, DOI 10.1302/0301-620X.86B4.14703; van der Linden YM, 2003, RADIOTHER ONCOL, V69, P21, DOI 10.1016/S0167-8140(03)00232-9; Weaver AA, 2015, TRAFFIC INJ PREV, V16, pS153, DOI 10.1080/15389588.2015.1054029	26	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220564	10.1371/journal.pone.0220564	http://dx.doi.org/10.1371/journal.pone.0220564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361790	gold, Green Published, Green Submitted			2022-12-26	WOS:000484981300042
J	Park, HC; Lee, YK; Cho, A; Han, CH; Noh, JW; Shin, YJ; Bae, SH; Kim, H				Park, Hayne Cho; Lee, Young-Ki; Cho, AJin; Han, Chae Hoon; Noh, Jung-Woo; Shin, Young Joo; Bae, So Hyun; Kim, Hakyoung			Diabetic retinopathy is a prognostic factor for progression of chronic kidney disease in the patients with type 2 diabetes mellitus	PLOS ONE			English	Article							RENAL-FUNCTION; MICROALBUMINURIA; INSUFFICIENCY; ASSOCIATION; PREVALENCE; EQUATION	Since both retinopathy and nephropathy are major diabetic microvascular complications, we investigated whether severity of diabetic retinopathy (DR) has adverse effects on renal function and albuminuria in the patients with type 2 diabetes mellitus (DM). We screened 2,197 adult patients with type 2 DM who had undergone fundus exam between August 2006 and February 2014. Among them, 1,592 subjects with available serial renal function and albuminuria measurement were included in the analysis. DR status was classified as no DR, non-proliferative DR (NPDR), and proliferative DR (PDR). The risk of CKD progression was assessed according to DR severity. A total of 384 (24.1%) had NPDR and 202 (12.7%) had PDR at either eye. The mean follow-up period was 5.6 +/- 2.1 years. DR was associated with lower body mass index, lower plasma hemoglobin, lower serum albumin level, longer duration of DM, poorer control of blood sugar, lower estimated glomerular filtration rate (eGFR), and greater amount of albuminuria. Interestingly, baseline DR severity was associated with faster renal function decline and greater albuminuria progression. In multivariate analysis, NPDR had 2.9 times and PDR had 16.6 times higher risk for CKD progression. Our findings showed that baseline DR severity is a prognostic factor for future CKD progression in type 2 DM patients. Therefore, clinicians must evaluate DR severity at the first visit and closely monitor renal function and albuminuria in the subjects with severe DR.	[Park, Hayne Cho; Lee, Young-Ki; Cho, AJin; Han, Chae Hoon; Noh, Jung-Woo] Kangnam Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Park, Hayne Cho; Lee, Young-Ki; Cho, AJin; Noh, Jung-Woo] Hallym Univ, Kidney Res Inst, Seoul, South Korea; [Shin, Young Joo; Bae, So Hyun; Kim, Hakyoung] Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea	Hallym University	Lee, YK (corresponding author), Kangnam Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea.; Lee, YK (corresponding author), Hallym Univ, Kidney Res Inst, Seoul, South Korea.	km2071@naver.com		Park, Hayne Cho/0000-0002-1128-3750				Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2013, Kidney Int Suppl (2011), V3, P19; [Anonymous], 2013, Kidney Int Suppl (2011), V3, P63; [Anonymous], 1991, Ophthalmology, V98, P823; Close CF, 1999, DIABETIC MED, V16, P918; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Grunwald JE, 2012, ARCH OPHTHALMOL-CHIC, V130, P1136, DOI 10.1001/archophthalmol.2012.1800; Hwang HS, 2015, DIABETES RES CLIN PR, V109, P312, DOI 10.1016/j.diabres.2015.05.013; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MATHIESEN ER, 1995, DIABETIC MED, V12, P482, DOI 10.1111/j.1464-5491.1995.tb00528.x; Matsuyama K, 2008, MOL VIS, V14, P992; Mckay GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22360-3; Moriya T, 2016, J DIABETES COMPLICAT, V30, P1111, DOI 10.1016/j.jdiacomp.2016.04.007; Park YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125338; PARVING HH, 1988, BMJ-BRIT MED J, V296, P156, DOI 10.1136/bmj.296.6616.156; Penno G, 2012, DIABETES CARE, V35, P2317, DOI 10.2337/dc12-0628; Rodriguez-Poncelas A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149448; Romero-Aroca P, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/5637130; Trevisan R, 2002, DIABETES CARE, V25, P2026, DOI 10.2337/diacare.25.11.2026; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wolf G, 2007, CLIN NEPHROL, V68, P81; Yang JK, 2017, DIABETES CARE, V40, P253, DOI 10.2337/dc16-1529; Zhang HY, 2014, INT UROL NEPHROL, V46, P1375, DOI 10.1007/s11255-014-0675-4	27	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220506	10.1371/journal.pone.0220506	http://dx.doi.org/10.1371/journal.pone.0220506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356653	Green Published, gold, Green Submitted			2022-12-26	WOS:000484047000037
J	Wang, MZ; Wang, Y; Liu, YH; Wang, HL; Xin, X; Li, JD; Hao, Y; Han, LL; Yu, F; Zheng, CY; Shen, C				Wang, Mingzhen; Wang, Yu; Liu, Yuehong; Wang, Hailong; Xin, Xiu; Li, Jiadai; Hao, Yao; Han, Lingling; Yu, Fang; Zheng, Congyi; Shen, Chao			SPSB2 inhibits hepatitis C virus replication by targeting NS5A for ubiquitination and degradation	PLOS ONE			English	Article							CELLULAR COFACTORS; CUL5-RBX2 MODULES; BOX; DOMAIN; PROTEINS; HYPERPHOSPHORYLATION; PHOSPHORYLATION; UBIQUITYLATION; RESTRICTS; INFECTION	Hepatitis C virus (HCV) replication involves many viral and host factors. Host factor SPRY domain-and SOCS box-containing protein 2(SPSB2) belongs to SPSB family, and it recruits target proteins by the SPRY domain and forms E3 ubiquitin ligase complexes by the SOCS box. As an adaptor protein, it can regulate the host's response to infection, but little is known about whether SPSB2 plays a role in HCV replication. In the present study, we found that HCV infection significantly upregulated the mRNA and protein levels of SPSB2 in HCVcc-infected cells. Exogenous expression of SPSB2 in hepatoma cells decreased HCV RNA and protein levels which depended on the SOCS box, while knockdown of endogenous SPSB2 increased HCV RNA and protein levels. Additionally, we demonstrated that SPSB2 interacted with HCV structural protein E1 and nonstructural protein protein 5A (NS5A) via the C-terminal portion of the SPSB2 SPRY domain. Furthermore, SPSB2 induced NS5A ubiquitination and mediated NS5A degradation. Collectively, this study discovered host factor SPSB2 significantly inhibits HCV replication by interacting and degrading NS5A.	[Wang, Mingzhen; Wang, Yu; Liu, Yuehong; Wang, Hailong; Xin, Xiu; Li, Jiadai; Hao, Yao; Han, Lingling; Zheng, Congyi; Shen, Chao] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Yu, Fang] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China; [Zheng, Congyi; Shen, Chao] Wuhan Univ, China Ctr Type Culture Collect, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Shen, C (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China.; Shen, C (corresponding author), Wuhan Univ, China Ctr Type Culture Collect, Wuhan, Hubei, Peoples R China.	shenchao@whu.edu.cn			National Natural Sciences Foundation of China [31370185]; National Basic Research Program of China [2011CB504800]; National Infrastructure of Natural Resources for Science and Technology Program [2011-572]; National Science and Technology Infrastructure Grant [NSTI-CR15, NSTI-CR16]; Fundamental Research Funds for the Central Universities [2042018kf0241]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Infrastructure of Natural Resources for Science and Technology Program; National Science and Technology Infrastructure Grant; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Sciences Foundation of China (No. 31370185), the National Basic Research Program of China (No. 2011CB504800), the National Infrastructure of Natural Resources for Science and Technology Program (No. 2011-572) to Prof. C Zheng, and the National Science and Technology Infrastructure Grant NSTI-CR15 and NSTI-CR16 and the Fundamental Research Funds for the Central Universities (2042018kf0241) to Dr. Chao Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2014, J GEN VIROL, V95, P363, DOI 10.1099/vir.0.054569-0; Chen J, 2016, BIOCHEM BIOPH RES CO, V470, P697, DOI 10.1016/j.bbrc.2016.01.076; D'Cruz AA, 2013, PROTEIN SCI, V22, P1, DOI 10.1002/pro.2185; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003; Haddad JG, 2017, J VIROL, V91, DOI 10.1128/JVI.00048-17; Hilgenfeldt EG, 2015, WORLD J HEPATOL, V7, P1953, DOI 10.4254/wjh.v7.i15.1953; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hou WH, 2010, GASTROENTEROLOGY, V138, P1909, DOI 10.1053/j.gastro.2009.11.001; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kim N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10631; Kogiso T, 2019, JGH OPEN, V3, P52, DOI 10.1002/jgh3.12105; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu J, 2015, BBA-REV CANCER, V1855, P50, DOI 10.1016/j.bbcan.2014.11.005; Liu S, 2015, J BIOL CHEM, V290, P17894, DOI 10.1074/jbc.M114.607184; Liu Y, 2018, ONCOGENE, V37, P768, DOI 10.1038/onc.2017.370; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Okumura F, 2017, MOL BIOL CELL, V28, P3532, DOI 10.1091/mbc.E17-07-0450; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Raja R, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007701; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Reiss S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003359; Romero-Brey I, 2015, MBIO, V6, DOI 10.1128/mBio.00759-15; Shirakura M, 2007, J VIROL, V81, P1174, DOI 10.1128/JVI.01684-06; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Wang DK, 2005, J BIOL CHEM, V280, P16393, DOI 10.1074/jbc.M413897200; Wang F, 2017, CELL RES, V27, P540, DOI 10.1038/cr.2017.7; Wang HL, 2018, ARCH VIROL, V163, P1429, DOI 10.1007/s00705-018-3748-3; Wang SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep32336; Xiong W, 2015, J VIROL, V89, P7385, DOI 10.1128/JVI.00567-15; Xue BB, 2016, J VIROL, V90, P6832, DOI 10.1128/JVI.00352-16; Yang C, 2015, CELLULAR MOL IMMUNOL, V13, P94, DOI [10.1073/pnas.95.1.114, DOI 10.1073/PNAS.95.1.114]; Zayas M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005376	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219989	10.1371/journal.pone.0219989	http://dx.doi.org/10.1371/journal.pone.0219989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344133	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900045
J	Guo, LJ; Bramkamp, M				Guo, Lijun; Bramkamp, Marc			Bacterial dynamin-like protein DynA mediates lipid and content mixing	FASEB JOURNAL			English	Article						Bacillus subtilis; membrane fusion; lipid tethering; hemifusion; phospholipid preference	MITOCHONDRIAL FUSION; MEMBRANE; SNARE; FISSION; MECHANISM; REQUIRES	Many bacterial species contain dynamin-like proteins (DLPs). However, so far the functional mechanisms of bacterial DLPs are poorly understood. DynA in Bacillus subtilis is a 2-headed DLP, mediating nucleotide-independent membrane tethering in vitro and contributing to the innate immunity of bacteria against membrane stress and phage infection. Here, we employed content mixing and lipid mixing assays in reconstituted systems to study if DynA induces membrane full fusion, characterize its subunits in membrane fusion, and further test the possibility that GTP hydrolysis of DynA may act on the fusion-through-hemifusion pathway. Our results based on fluorescence resonance energy transfer indicated that DynA could induce aqueous content mixing even in the absence of GTP. Moreover, DynA-induced membrane fusion in vitro is a thermo-promoted slow process, and it has phospholipid and membrane curvature preferences. The D1 part of DynA is crucial for membrane binding and fusion, whereas D2 subunit plays a role in facilitating membrane fusion. Surprisingly, digestion of DynA mediated an instant rise of content exchange, supporting the assumption that disassembly of DynA is a driving force for fusion-through-hemifusion. DynA is a rare example of a membrane fusion catalyst that lacks a transmembrane domain and hence sets this system apart from well-characterized fusion systems such as the soluble N-ethyl maleimide sensitive factor attachment protein receptor complexes.	[Guo, Lijun; Bramkamp, Marc] Ludwig Maximilians Univ Munchen, Fak Biol, Planegg Martinsried, Germany	University of Munich	Bramkamp, M (corresponding author), LMU Munchen, Fak Biol, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany.	marc.bramkamp@lmu.de		Bramkamp, Marc/0000-0002-7704-3266	China Scholarship Council (CSC); Deutsche Forschungsgemeinschaft (DFG) [INST 86/1452-1, BR2915/4-1]	China Scholarship Council (CSC)(China Scholarship Council); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors acknowledge funding from the China Scholarship Council (CSC; fellowship to L.G.) and the Deutsche Forschungsgemeinschaft (DFG; INST 86/1452-1 and BR2915/4-1 to M.B.). The authors are grateful for the help of Giacomo Giacomelli and Helge Feddersen [Ludwig-Maximilians-Universit at (LMU) Munchen] for fluorescence microscopy and usage of ImageJ, and Dr. Karin Schubert (LMU Munchen) for HPLC. The authors declare no conflicts of interest.	Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Anton F, 2013, MOL CELL, V49, P487, DOI 10.1016/j.molcel.2012.12.003; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bohuszewicz O, 2016, J STRUCT BIOL, V196, P3, DOI 10.1016/j.jsb.2016.05.010; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Bramkamp M, 2012, BIOL CHEM, V393, P1203, DOI 10.1515/hsz-2012-0185; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Chi RJ, 2014, J CELL BIOL, V204, P793, DOI 10.1083/jcb.201309084; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Daste F, 2018, EMBO REP, V19, DOI 10.15252/embr.201643637; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Harner M, 2018, J BIOL CHEM, V293, P1346, DOI 10.1074/jbc.RA117.000791; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jilly R, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00206; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kweon DH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00065; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu JW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05523-8; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Michie KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107211; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Ngo CC, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12791; OPDENKAMP JA, 1969, J BACTERIOL, V99, P298, DOI 10.1128/JB.99.1.298-303.1969; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prince A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41346; Risselada HJ, 2014, P NATL ACAD SCI USA, V111, P11043, DOI 10.1073/pnas.1323221111; Sawant P, 2016, ENVIRON MICROBIOL, V18, P2705, DOI 10.1111/1462-2920.13110; Schlimpert S, 2017, P NATL ACAD SCI USA, V114, pE6176, DOI 10.1073/pnas.1704612114; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Song HF, 2017, ELIFE, V6, DOI [10.7554/elife.21492, 10.7554/eLife.21492]; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Toyofuku M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00492-w; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Wu Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00315; Yu JJQ, 2008, VIROLOGY, V379, P78, DOI 10.1016/j.virol.2008.05.030; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.03251; Zucchi PC, 2011, MOL BIOL CELL, V22, P4635, DOI 10.1091/mbc.E11-08-0680	48	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11746	11757		10.1096/fj.201900844RR	http://dx.doi.org/10.1096/fj.201900844RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361971	Green Submitted, Green Published, Bronze			2022-12-26	WOS:000507461600014
J	Hasan, M; Kanna, MS; Jun, W; Ramkrishnan, AS; Iqbal, Z; Lee, Y; Li, Y				Hasan, Mahadi; Kanna, Murugappan Suresh; Jun, Wang; Ramkrishnan, Aruna Surendran; Iqbal, Zafar; Lee, Youngjin; Li, Ying			Schema-like learning and memory consolidation acting through myelination	FASEB JOURNAL			English	Article						brain oscillations; anterior cingulate cortex; hippocampus; myelin plasticity; circuitry synchronization	ANTERIOR CINGULATE CORTEX; WHITE-MATTER; DECISION-MAKING; NERVOUS-SYSTEM; PHASE-LOCKING; HIPPOCAMPAL; PLASTICITY; OSCILLATIONS; IMPAIRMENT; ACTIVATION	Memory is a dynamic brain function that is continually processed after encoding. Although psychologic concepts of mental schema are now well established, they have rarely been considered in animal studies. We used a behavior paradigm of multiple flavor-place paired associates (PAs) and showed that memory schema facilitates fast acquisition of new PAs in a single trial. The hippocampus is necessary for the encoding of new PAs and for memory retrieval within a certain time window-24 h following new PA consolidation. Whereas the anterior cingulate cortex (ACC) plays a critical role for dynamic PA learning and consolidation during training sessions, ACC is essential in schema representation and activation. New myelin generation is essential for learning. Neural activity in the cortical regions impacts myelination by regulating oligodendrocyte (OL) proliferation, differentiation, and myelin formation. Here, we show that newly formed OL progenitor cells and mature OLs are increased following repeated PA learning and that establishment of the memory schema is associated with enhanced myelin strength in the ACC region. Furthermore, to ensure that myelination is necessary for the acquisition of paired-associate learning, ACC lysolecithin-induced demyelination revealed impaired PA learning associated with decrease in ACC theta band power and reduced spike-field coherence and phase-locking in ACC.	[Hasan, Mahadi; Kanna, Murugappan Suresh; Jun, Wang; Ramkrishnan, Aruna Surendran; Iqbal, Zafar; Lee, Youngjin; Li, Ying] City Univ Hong Kong, Dept Biomed Sci, Kowloon,Tat Chee Ave, Hong Kong 999077, Peoples R China; [Hasan, Mahadi; Kanna, Murugappan Suresh; Jun, Wang; Ramkrishnan, Aruna Surendran; Iqbal, Zafar; Lee, Youngjin; Li, Ying] City Univ Hong Kong, Ctr Biosyst Neurosci & Nanotechnol, Kowloon, Hong Kong, Peoples R China; [Jun, Wang] Zhejiang Univ, Sch Basic Med Sci, Sch Med, Hangzhou, Peoples R China	City University of Hong Kong; City University of Hong Kong; Zhejiang University	Li, Y (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon,Tat Chee Ave, Hong Kong 999077, Peoples R China.	yingli@cityu.edu.hk	Iqbal, Zafar/S-9011-2018	LEE, Youngjin/0000-0002-5942-6204; LI, Ying/0000-0003-3683-9695; Ramkrishnan, Aruna Surendran/0000-0002-8335-0510; Murugappan, Suresh Kanna/0000-0003-0734-4634	Research Grants Council (RGC) of Hong Kong [11100914, 11166116, 11101315, 160713]; National Natural Science Foundation of China (NSFC) [N_CityU114/17, 3171101014]; RGC [N_CityU114/17, 3171101014]; Innovation and Technology Support Programme [ITS/300/15]; City University of Hong Kong Neuroscience Research Infrastructure [9610211]; Centre for Biosystems, Neuroscience, and Nanotechnology [9360148]	Research Grants Council (RGC) of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); RGC(Hong Kong Research Grants Council); Innovation and Technology Support Programme; City University of Hong Kong Neuroscience Research Infrastructure(City University of Hong Kong); Centre for Biosystems, Neuroscience, and Nanotechnology	This work was supported by the Research Grants Council (RGC) of Hong Kong (11100914, 11166116, 11101315, and 160713), the National Natural Science Foundation of China (NSFC) and RGC Joint Research Scheme (N_CityU114/17 and 3171101014), the Innovation and Technology Support Programme (ITS/300/15), City University of Hong Kong Neuroscience Research Infrastructure (9610211), and Centre for Biosystems, Neuroscience, and Nanotechnology (9360148). The authors express their gratitude to Dr. Thomas A. Cleland and Dr. David Smith (Department of of Psychology, Cornell University, Ithaca, NY, USA) for their valuable comments during our preliminary data presentation. The authors declare no conflicts of interest.	Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cao B, 2016, EXP NEUROL, V286, P21, DOI 10.1016/j.expneurol.2016.09.010; Cao B, 2016, NEUROBIOL LEARN MEM, V136, P74, DOI 10.1016/j.nlm.2016.09.015; Cao B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35135; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fan J, 2009, GASTROENTEROLOGY, V136, P1732, DOI 10.1053/j.gastro.2009.01.069; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Fields RD, 2013, NATURE, V501, P25, DOI 10.1038/501025a; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Ghosh VE, 2014, J NEUROSCI, V34, P12057, DOI 10.1523/JNEUROSCI.0740-14.2014; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; HALL SM, 1972, J CELL SCI, V10, P535; Hill RA, 2018, NAT NEUROSCI, V21, P683, DOI 10.1038/s41593-018-0120-6; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Huntenburg JM, 2017, CEREB CORTEX, V27, P981, DOI 10.1093/cercor/bhx030; Knierim JJ, 2015, CURR BIOL, V25, pR1116, DOI 10.1016/j.cub.2015.10.049; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10962; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Majd AM, 2018, BEHAV BRAIN RES, V336, P111, DOI 10.1016/j.bbr.2017.08.046; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Mitew S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02719-2; Moncada D, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/650780; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Mu L, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0125-y; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Plemel JR, 2018, GLIA, V66, P327, DOI 10.1002/glia.23245; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Richards BA, 2014, NAT NEUROSCI, V17, P981, DOI 10.1038/nn.3736; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sampaio-Baptista C, 2017, NEURON, V96, P1239, DOI 10.1016/j.neuron.2017.11.026; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Sanchez MM, 1998, BRAIN RES, V812, P38, DOI 10.1016/S0006-8993(98)00857-9; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Schlichting ML, 2015, CURR OPIN BEHAV SCI, V1, P1, DOI 10.1016/j.cobeha.2014.07.005; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Squire LR, 2007, SCIENCE, V316, P57, DOI 10.1126/science.1141812; Takehara-Nishiuchi K, 2008, SCIENCE, V322, P960, DOI 10.1126/science.1161299; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Tomlinson L, 2016, NEUROPHARMACOLOGY, V110, P548, DOI 10.1016/j.neuropharm.2015.09.016; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; von Nicolai C, 2014, J NEUROSCI, V34, P5938, DOI 10.1523/JNEUROSCI.5007-13.2014; Wang J, 2017, CELL REP, V21, P2407, DOI 10.1016/j.celrep.2017.11.012; Wang J, 2015, CEREB CORTEX, V25, P859, DOI 10.1093/cercor/bht273; Wang SH, 2012, LEARN MEMORY, V19, P315, DOI 10.1101/lm.026336.112; Xiao L, 2016, NAT NEUROSCI, V19, P1210, DOI 10.1038/nn.4351; Yang YJ, 2017, CEREB CORTEX, V27, P2871, DOI 10.1093/cercor/bhw121; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010	63	16	17	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11758	11775		10.1096/fj.201900910R	http://dx.doi.org/10.1096/fj.201900910R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366238	hybrid, Green Published			2022-12-26	WOS:000507461600015
J	Masmudi-Martin, M; Navarro-Lobato, I; Lopez-Aranda, MF; Delgado, G; Martin-Montanez, E; Quiros-Ortega, ME; Carretero-Rey, M; Narvaez, L; Garcia-Garrido, MF; Posadas, S; Lopez-Tellez, JF; Blanco, E; Jimenez-Recuerda, I; Granados-Duran, P; Paez-Rueda, J; Lopez, JC; Khan, ZU				Masmudi-Martin, Mariam; Navarro-Lobato, Irene; Lopez-Aranda, Manuel F.; Delgado, Gloria; Martin-Montanez, Elisa; Quiros-Ortega, Maria E.; Carretero-Rey, Marta; Narvaez, Lucia; Garcia-Garrido, Maria F.; Posadas, Sinforiano; Lopez-Tellez, Juan F.; Blanco, Eduardo; Jimenez-Recuerda, Inmaculada; Granados-Duran, Pablo; Paez-Rueda, Jose; Lopez, Juan C.; Khan, Zafar U.			RGS14(414) treatment induces memory enhancement and rescues episodic memory deficits	FASEB JOURNAL			English	Article						cognitive dysfunction; BDNF; memory circuit activation; recovery of memory functions; behavioral performance	NEUROTROPHIC FACTOR; SPATIAL MEMORY; RECOGNITION MEMORY; PERIRHINAL CORTEX; D-CYCLOSERINE; GOLOCO MOTIF; AGING BRAIN; BDNF; MECHANISMS; PLASTICITY	Memory deficits affect a large proportion of the human population and are associated with aging and many neurologic, neurodegenerative, and psychiatric diseases. Treatment of this mental disorder has been disappointing because all potential candidates studied thus far have failed to produce consistent effects across various types of memory and have shown limited to no effects on memory deficits. Here, we show that the promotion of neuronal arborization through the expression of the regulator of G-protein signaling 14 of 414 amino acids (RGS14(414)) not only induced robust enhancement of multiple types of memory but was also sufficient for the recovery of recognition, spatial, and temporal memory, which are kinds of episodic memory that are primarily affected in patients or individuals with memory dysfunction. We observed that a surge in neuronal arborization was mediated by up-regulation of brain-derived neurotrophic factor (BDNF) signaling and that the deletion of BDNF abrogated both neuronal arborization activation and memory enhancement. The activation of BDNF-dependent neuronal arborization generated almost 2-fold increases in synapse numbers in dendrites of pyramidal neurons and in neurites of nonpyramidal neurons. This increase in synaptic connections might have evoked reorganization within neuronal circuits and eventually supported an increase in the activity of such circuits. Thus, in addition to showing the potential of RGS14(414) for rescuing memory deficits, our results suggest that a boost in circuit activity could facilitate memory enhancement and the reversal of memory deficits.	[Masmudi-Martin, Mariam; Navarro-Lobato, Irene; Lopez-Aranda, Manuel F.; Delgado, Gloria; Quiros-Ortega, Maria E.; Carretero-Rey, Marta; Narvaez, Lucia; Garcia-Garrido, Maria F.; Posadas, Sinforiano; Lopez-Tellez, Juan F.; Jimenez-Recuerda, Inmaculada; Granados-Duran, Pablo; Paez-Rueda, Jose; Khan, Zafar U.] Univ Malaga, Ctr Invest Med Sanitaria CIMES, Lab Neurobiol, Calle Marqu es Beccaria,3 Campus Teatinos S-N, Malaga 29010, Spain; [Masmudi-Martin, Mariam; Navarro-Lobato, Irene; Lopez-Aranda, Manuel F.; Delgado, Gloria; Quiros-Ortega, Maria E.; Carretero-Rey, Marta; Narvaez, Lucia; Garcia-Garrido, Maria F.; Posadas, Sinforiano; Lopez-Tellez, Juan F.; Jimenez-Recuerda, Inmaculada; Granados-Duran, Pablo; Khan, Zafar U.] Univ Malaga, Dept Med, Malaga, Spain; [Martin-Montanez, Elisa] Univ Malaga, Dept Pharmacol, Fac Med, Campus Teatinos, Malaga, Spain; [Martin-Montanez, Elisa; Khan, Zafar U.] Univ Malaga, Inst Biomed Res Malaga IBIMA, Malaga, Spain; [Blanco, Eduardo] Univ Lleida, Dept Pedag & Psychol, Lleida, Spain; [Lopez, Juan C.] Univ Seville, Fac Psychol, Dept Expt Psychol, Anim Behav & Neurosci Lab, Seville, Spain; [Khan, Zafar U.] Inst Hlth Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Lopez-Aranda, Manuel F.] Univ Calif Los Angeles, Gonda Neurosci & Genet Ctr, Los Angeles, CA USA; [Garcia-Garrido, Maria F.] Univ Exeter, Med Sch, Hatherly Labs, Exeter, Devon, England	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universitat de Lleida; University of Sevilla; CIBERNED; University of California System; University of California Los Angeles; University of Exeter	Khan, ZU (corresponding author), Univ Malaga, Ctr Invest Med Sanitaria CIMES, Lab Neurobiol, Calle Marqu es Beccaria,3 Campus Teatinos S-N, Malaga 29010, Spain.	zkhan@uma.es	López-Aranda, Manuel F./GNM-7102-2022; Calvo, Eduardo Blanco/H-5805-2013; Lopez, Juan C/H-6028-2015; Martín-Montañez, Elisa/H-8999-2017; Al-Masmudi Martin, Mariam/B-1119-2016; KHAN, Zafaruddin/J-6217-2012	López-Aranda, Manuel F./0000-0001-9063-0740; Calvo, Eduardo Blanco/0000-0003-0357-1151; Martín-Montañez, Elisa/0000-0002-3637-3285; Garcia Garrido, Maria/0000-0002-2656-6382; Lopez-Garcia, Juan-Carlos/0000-0001-8106-5006; Al-Masmudi Martin, Mariam/0000-0001-5005-9199; KHAN, Zafaruddin/0000-0003-0742-399X; Lopez-Tellez, Juan Felix/0000-0003-4115-3380	Ministerio de Economia y Competitividad [BFU2013-43458-R]; Junta de Andalucia [P12-CTS-1694, PI-0542-2013]	Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia(Junta de Andalucia)	The authors thank Zafar I. Bashir [Medical Research Council (MRC) Centre for Synaptic Plasticity, University of Bristol, Bristol, United Kingdom] for reading and providing critical feedback during the preparation of the manuscript. This research was supported by grants from the Ministerio de Economia y Competitividad (BFU2013-43458-R) and Junta de Andalucia (P12-CTS-1694 and PI-0542-2013 to Z.U. K.). The authors thank C. Vivar Rios [Laboratory of Neurobiology, Centro de Investigaciones Medico Sanitaria (CIMES), University of Malaga] for help preparing graphs and figures for this manuscript. The authors declare no conflicts of interest.	Andero R, 2014, PROG MOL BIOL TRANSL, V122, P169, DOI 10.1016/B978-0-12-420170-5.00006-4; Bailey CH, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021758; BAXTER MG, 1994, NEUROBIOL AGING, V15, P207, DOI 10.1016/0197-4580(94)90114-7; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bibb JA, 2010, J NEUROSCI, V30, P14987, DOI 10.1523/JNEUROSCI.4419-10.2010; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Brickman AM., 2009, HDB NEUROSCIENCE AGI, V1, P175, DOI [10.1016/B978-008045046-9.00745-2, DOI 10.1016/B978, DOI 10.1016/B978-008045046-9.00745-2]; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cacciamani L, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00092; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Daselaar SM, 2003, NEUROBIOL AGING, V24, P1005, DOI 10.1016/S0197-4580(03)00032-0; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Evans PR, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0353-17.2018; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Harward SC, 2016, NATURE, V538, P99, DOI 10.1038/nature19766; Hock C, 2000, J NEURAL TRANSM-SUPP, P171; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Kalisch R, 2009, CEREB CORTEX, V19, P187, DOI 10.1093/cercor/bhn076; Khan ZU, 2014, PROG MOL BIOL TRANSL, V122, P1, DOI 10.1016/B978-0-12-420170-5.00001-5; Khan ZU, 1998, P NATL ACAD SCI USA, V95, P7731, DOI 10.1073/pnas.95.13.7731; KHAN ZU, 1993, J NEUROCHEM, V60, P961, DOI 10.1111/j.1471-4159.1993.tb03243.x; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kowianski P, 2018, CELL MOL NEUROBIOL, V38, P579, DOI 10.1007/s10571-017-0510-4; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Linssen AMW, 2012, PSYCHOPHARMACOLOGY, V221, P611, DOI 10.1007/s00213-011-2605-9; Lopez-Aranda MF, 2006, EUR J NEUROSCI, V23, P2971, DOI 10.1111/j.1460-9568.2006.04838.x; Lopez-Aranda MF, 2009, SCIENCE, V325, P87, DOI 10.1126/science.1170869; Lynch G, 2006, CURR OPIN PHARMACOL, V6, P82, DOI 10.1016/j.coph.2005.09.005; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murray EA, 2001, CURR OPIN NEUROBIOL, V11, P188, DOI 10.1016/S0959-4388(00)00195-1; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Nolan BC, 2005, BEHAV NEUROSCI, V119, P190, DOI 10.1037/0735-7044.119.1.190; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; Robitsek RJ, 2008, J NEUROSCI, V28, P8945, DOI 10.1523/JNEUROSCI.1893-08.2008; Samson RD, 2013, EUR J NEUROSCI, V37, P1903, DOI 10.1111/ejn.12183; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stern SA, 2013, WIRES SYST BIOL MED, V5, P37, DOI 10.1002/wsbm.1196; Traissard N, 2007, NEUROPSYCHOPHARMACOL, V32, P851, DOI 10.1038/sj.npp.1301116; Tronel S, 2003, J NEUROSCI, V23, P5472; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang L, 2015, J NEUROSCI, V35, P8384, DOI 10.1523/JNEUROSCI.4682-14.2015; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004	58	4	5	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11804	11820		10.1096/fj.201900429RR	http://dx.doi.org/10.1096/fj.201900429RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365833	Bronze			2022-12-26	WOS:000507461600018
J	Watanabe, Y; Nagai, Y; Honda, H; Okamoto, N; Yanagibashi, T; Ogasawara, M; Yamamoto, S; Imamura, R; Takasaki, I; Hara, H; Sasahara, M; Arita, M; Hida, S; Taniguchi, S; Suda, T; Takatsu, K				Watanabe, Yasuharu; Nagai, Yoshinori; Honda, Hiroe; Okamoto, Naoki; Yanagibashi, Tsutomu; Ogasawara, Masaru; Yamamoto, Seiji; Imamura, Ryu; Takasaki, Ichiro; Hara, Hiromitsu; Sasahara, Masakiyo; Arita, Makoto; Hida, Shigeaki; Taniguchi, Shun'ichiro; Suda, Takashi; Takatsu, Kiyoshi			Bidirectional crosstalk between neutrophils and adipocytes promotes adipose tissue inflammation	FASEB JOURNAL			English	Article						IL-1 beta inflammasome; metabolic disorder; fatty acid	NLRP3 INFLAMMASOME; INSULIN-RESISTANCE; CUTTING EDGE; TARGETED DISRUPTION; PATTERN-RECOGNITION; INNATE IMMUNITY; ACTIVATION; RECEPTOR; INTERLEUKIN-1-BETA; MACROPHAGES	Chronic activation of the IL-1 beta system in adipose tissue on metabolic disorders is well demonstrated. However, a mechanism for its expression and activation in the tissue has remained unexplored. Here, we demonstrate that IL-1 beta transcript was enriched in neutrophils of white adipose tissue (WAT) from lean mice. Mechanistically, the interaction of neutrophils with adipocytes induced IL-1 beta expression via NF-kappa B pathway. Lipolysis of adipocytes accumulated neutrophils prior to macrophages in WAT and produced high levels of IL-1 beta via an inflammasome pathway. Leukotriene B-4 (LTB4) production in WAT also contributed to neutrophil accumulation. Furthermore, an LTB4-inflammasome axis contributed to the expression of chemotactic molecules involved in high-fat diet-induced macrophage infiltration into WAT. We have identified previously unappreciated roles for neutrophils in the development of adipose tissue inflammation: robust IL-1 beta production and infiltration of macrophages to initiate chronic inflammation.	[Watanabe, Yasuharu; Nagai, Yoshinori; Honda, Hiroe; Okamoto, Naoki; Yanagibashi, Tsutomu; Takatsu, Kiyoshi] Univ Toyama, Dept Immunobiol & Pharmacol Genet, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Yamamoto, Seiji; Sasahara, Masakiyo] Univ Toyama, Dept Pathol, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Takasaki, Ichiro] Univ Toyama, Dept Pharmacol, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Watanabe, Yasuharu; Honda, Hiroe; Yanagibashi, Tsutomu; Ogasawara, Masaru; Takatsu, Kiyoshi] Toyama Prefectural Inst Pharmaceut Res, 17-1 Nakataikouyama, Toyama 9390363, Japan; [Nagai, Yoshinori] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Nagai, Yoshinori] Toyama Prefectural Univ, Dept Pharmaceut Engn, Fac Engn, 5180 Kurokawa, Toyama 9390398, Japan; [Okamoto, Naoki] Teika Pharmaceut Co, Toyama, Japan; [Imamura, Ryu; Suda, Takashi] Kanazawa Univ, Div Immunol & Mol Biol, Canc Res Inst, Kanazawa, Ishikawa, Japan; [Hara, Hiromitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, Kagoshima, Japan; [Arita, Makoto] Riken Ctr Integrat Med Sci IMS, Lab Metabol, Yokohama, Kanagawa, Japan; [Arita, Makoto] Yokohama Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa, Japan; [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan; [Taniguchi, Shun'ichiro] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Hlth Sci, Nagoya, Aichi, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Dept Comprehens Canc Therapy, Sch Med, Matsumoto, Nagano, Japan; [Imamura, Ryu] Kanazawa Univ, Div Tumor Dynam & Regulat, Canc Res Inst, Kanazawa, Ishikawa, Japan	University of Toyama; University of Toyama; University of Toyama; Japan Science & Technology Agency (JST); Toyama Prefectural University; Kanazawa University; Kagoshima University; RIKEN; Yokohama City University; Keio University; Nagoya City University; Shinshu University; Kanazawa University	Takatsu, K (corresponding author), Toyama Prefectural Inst Pharmaceut Res, 17-1 Nakataikouyama, Toyama 9390363, Japan.; Nagai, Y (corresponding author), Toyama Prefectural Univ, Dept Pharmaceut Engn, Fac Engn, 5180 Kurokawa, Toyama 9390398, Japan.	ynagai@pu-toyama.ac.jp; kiyoshi.takatsu@pref.toyama.lg.jp		Arita, Makoto/0000-0001-9902-0463	Japan Society for the Promotion of Science (JSPS Kakenhi) [JP16K19532, JP15K08527]; Presto, Japan Science and Technology Agency (JST); Hokuriku Life Science Cluster, Ministry of Education, Culture, Sports, Science and Technology (MEXT) Regional Innovation Strategy Support Program; Takeda Science Foundation; First Bank of Toyama Scholarship Foundation; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science (JSPS Kakenhi)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Presto, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Hokuriku Life Science Cluster, Ministry of Education, Culture, Sports, Science and Technology (MEXT) Regional Innovation Strategy Support Program; Takeda Science Foundation(Takeda Science Foundation (TSF)); First Bank of Toyama Scholarship Foundation; Tokyo Biochemical Research Foundation	The authors thank all members of the University of Toyama and Toyama Prefectural Institute for Pharmaceutical Research laboratories for helpful discussions. The authors are grateful to Dr. Shizuo Akira (Immunology Frontier Research Center, Osaka University, Osaka, Japan) for providing Tlr<SUP>-/-</SUP>, Myd88<SUP>-/-</SUP>, and Ticam1<SUP>-/-</SUP> mice. The authors also thank Dr. Kensuke Miyake (The University of Tokyo, Tokyo, Japan) and Dr. Hiroko Tsutsui (Hyogo Medical College, Hyogo, Japan) for providing Rp105<SUP>-/-</SUP> mice and Casp1<SUP>-/-</SUP> mice, respectively; Dr. Paul W. Kincade (Oklahoma Medical Research Foundation, Oklahoma City, OK, USA) for critical review of the manuscript; and Michelle Kahmeyer-Gabbe (Edanz Group, Fukoka, Japan; www.edanz.com/ac) for editing a draft of this manuscript. The authors sincerely thank Toyama Prefecture for laboratory support. This work was also supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS Kakenhi Grants JP16K19532 to Y.W. and JP15K08527 to Y.N.), and grants from Presto, Japan Science and Technology Agency (JST; to Y.N.), Hokuriku Life Science Cluster, Ministry of Education, Culture, Sports, Science and Technology (MEXT) Regional Innovation Strategy Support Program (to K.T.), Takeda Science Foundation (to Y.W.), First Bank of Toyama Scholarship Foundation (Y.W.), and the Tokyo Biochemical Research Foundation (to Y.W.). Y.N. and K.T. are joint senior authors. The authors declare no conflicts of interest.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amaral FA, 2012, ARTHRITIS RHEUM-US, V64, P474, DOI 10.1002/art.33355; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Flach RJR, 2013, J BIOL CHEM, V288, P2882, DOI 10.1074/jbc.M112.412346; Flaherty SE, 2019, SCIENCE, V363, P989, DOI 10.1126/science.aaw2586; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Harada H, 2010, J MOL BIOL, V400, P838, DOI 10.1016/j.jmb.2010.05.063; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Honda H, 2014, J LEUKOCYTE BIOL, V96, P1087, DOI 10.1189/jlb.3A0114-005RR; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kaur H, 2013, METAB SYNDR RELAT D, V11, P128, DOI 10.1089/met.2012.0179; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sanada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep38697; Sekimoto R, 2015, P NATL ACAD SCI USA, V112, pE2058, DOI 10.1073/pnas.1409480112; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tynan GA, 2014, DIABETES, V63, P2037, DOI 10.2337/db13-1476; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Watanabe Y, 2012, DIABETES, V61, P1199, DOI 10.2337/db11-1182; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	49	27	27	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11821	11835		10.1096/fj.201900477RR	http://dx.doi.org/10.1096/fj.201900477RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31355683	Bronze			2022-12-26	WOS:000507461600019
J	Brancaccio, M; Russo, M; Masullo, M; Palumbo, A; Russo, GL; Castellano, I				Brancaccio, Mariarita; Russo, Maria; Masullo, Mariorosario; Palumbo, Anna; Russo, Gian Luigi; Castellano, Immacolata			Sulfur-containing histidine compounds inhibit gamma-glutamyl transpeptidase activity in human cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; enzyme inhibitor; enzyme kinetics; thiol; apoptosis; ergothioneine; GGT-positive cells; glutamyl transpeptidase; marine drugs; ovothiol	B16 MELANOMA-CELLS; OVOTHIOL-A; AUTOPHAGY; GLUTATHIONE; SITE; TRANSFERASE; GGSTOP; MERCAPTOHISTIDINES; RESISTANCE; EXPRESSION	gamma-Glutamyl transpeptidase (GGT) is an enzyme located on the surface of cellular membranes and involved in GSH metabolism and maintenance of redox homeostasis. High GGT expression on tumor cells is associated with increased cell proliferation and resistance against chemotherapy. GGT inhibitors evaluated so far in clinical trials are too toxic for human use. In this study, using enzyme kinetics analyses, we demonstrate that ovothiols, 5(N pi)-methyl thiohistidines of marine origin, act as noncompetitive inhibitors of GGT, with an apparent K-i of 21 mu m, when we fixed the concentrations of the donor substrate. We found that these compounds are more potent than the known GGT inhibitor 6-diazo-5-oxo-L-norleucine and are not toxic toward human embryonic cells. In particular, cellular process-specific fluorescence-based assays revealed that ovothiols induce a mixed cell-death phenotype of apoptosis and autophagy in GGT-overexpressing cell lines, including human liver cancer and chronic B leukemic cells. The findings of our study provide the basis for further development of 5-thiohistidines as therapeutics for GGT-positive tumors and highlight that GGT inhibition is involved in autophagy.	[Brancaccio, Mariarita; Palumbo, Anna; Russo, Gian Luigi; Castellano, Immacolata] Staz Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, I-80121 Naples, Italy; [Russo, Maria; Russo, Gian Luigi] CNR, Inst Food Sci, I-83100 Avellino, Italy; [Masullo, Mariorosario] Univ Naples Parthenope, Dept Movement Sci & Wellbeing, I-80133 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Parthenope University Naples	Castellano, I (corresponding author), Staz Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, I-80121 Naples, Italy.	immacolata.castellano@szn.it	Brancaccio, Mariarita/AAC-4285-2021; RUSSO, GIAN LUIGI/GQB-0962-2022; Russo, Maria/AAJ-9424-2020; Castellano, Immacolata/AAD-5523-2019; Russo, Maria/AAT-9082-2021; russo, maria/E-8585-2011; Masullo, Mariorosario/H-4884-2016	Brancaccio, Mariarita/0000-0002-4161-512X; Russo, Maria/0000-0001-8385-9184; russo, maria/0000-0001-8385-9184; Masullo, Mariorosario/0000-0003-4485-7383; Palumbo, Anna/0000-0002-5972-5589; Castellano, Immacolata/0000-0002-4274-6738; RUSSO, GIAN LUIGI/0000-0001-9321-1613	Stazione Zoologica Anton Dohrn; Institute of Food Sciences	Stazione Zoologica Anton Dohrn; Institute of Food Sciences	This work was supported by Stazione Zoologica Anton Dohrn and the Institute of Food Sciences. The content of this study has been partially reported in the Italian Patent Application RBI15865-IT.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; Benlloch M, 2006, J BIOL CHEM, V281, P69, DOI 10.1074/jbc.M507471200; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brancaccio M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5045734; Braunshausen A, 2011, J AM CHEM SOC, V133, P1757, DOI 10.1021/ja109378e; Castellano I., 2013, GAMMA GLUTAMYL TRANS; Castellano I, 2018, NAT PROD REP, V35, P1241, DOI 10.1039/c8np00045j; Castellano I, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2087373; Castellano I, 2016, SCI REP-UK, V6, DOI 10.1038/srep21506; Castellano I, 2012, CELL MOL LIFE SCI, V69, P3381, DOI 10.1007/s00018-012-0988-3; Corti A, 2010, ANTICANCER RES, V30, P1169; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; Crowley L.C., 2016, COLD SPRING HARB PRO, V9, P1, DOI 10.1101/pdb.prot087205; Daunay S, 2016, ORG BIOMOL CHEM, V14, P10473, DOI 10.1039/c6ob01870j; Gewirtz DA, 2016, CANCER RES, V76, P5610, DOI 10.1158/0008-5472.CAN-16-0722; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Han L, 2007, BIOCHEMISTRY-US, V46, P1432, DOI 10.1021/bi061890j; Han LY, 2006, BIOORGAN MED CHEM, V14, P6043, DOI 10.1016/j.bmc.2006.05.008; Hanigan MH, 2014, ADV CANCER RES, V122, P103, DOI 10.1016/B978-0-12-420117-0.00003-7; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; HOLLER TP, 1988, J AM CHEM SOC, V110, P4837, DOI 10.1021/ja00222a057; HOLLER TP, 1989, J ORG CHEM, V54, P4570, DOI 10.1021/jo00280a022; HOLLER TP, 1987, J ORG CHEM, V52, P4420, DOI 10.1021/jo00228a060; Jacob C, 2006, NAT PROD REP, V23, P851, DOI 10.1039/b609523m; Kamiyama A, 2016, BIOORGAN MED CHEM, V24, P5340, DOI 10.1016/j.bmc.2016.08.050; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lherbet C, 2004, ORG BIOMOL CHEM, V2, P238, DOI 10.1039/b310767a; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; LYONS SD, 1990, J BIOL CHEM, V265, P11377; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mena S, 2007, CLIN CANCER RES, V13, P2658, DOI 10.1158/1078-0432.CCR-06-2642; Naowarojna N, 2018, ORG LETT, V20, P5427, DOI 10.1021/acs.orglett.8b02332; O'Neill EC, 2015, MOL BIOSYST, V11, P2808, DOI 10.1039/c5mb00319a; Palumbo A., 2018, BLUE BIOTECHNOLOGY P, P583, DOI DOI 10.1002/9783527801718.CH18; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; Rohl I, 1999, Z NATURFORSCH C, V54, P1145; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Ruoso P, 2004, CANCER CHEMOTH PHARM, V54, P49, DOI 10.1007/s00280-004-0776-3; Russo GL, 2014, MAR DRUGS, V12, P4069, DOI 10.3390/md12074069; Russo M, 2017, ONCOTARGET, V8, P42571, DOI 10.18632/oncotarget.17246; SCHWARZE PE, 1985, EXP CELL RES, V157, P15, DOI 10.1016/0014-4827(85)90148-X; Seebeck FP, 2013, CHIMIA, V67, P333, DOI 10.2533/chimia.2013.333; SELMANREIMER S, 1991, J BIOL CHEM, V266, P182; SHAPIRO BM, 1991, SCIENCE, V252, P533, DOI 10.1126/science.1850548; Shimamura Y, 2019, ANTICANCER RES, V39, P201, DOI 10.21873/anticanres.13098; SPIES HSC, 1994, EUR J BIOCHEM, V224, P203, DOI 10.1111/j.1432-1033.1994.tb20013.x; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; TAYLOR SA, 1991, J CLIN ONCOL, V9, P1476, DOI 10.1200/JCO.1991.9.8.1476; Tedesco I, 2013, FOOD CHEM TOXICOL, V60, P377, DOI 10.1016/j.fct.2013.07.078; Terzyan SS, 2017, PROTEIN SCI, V26, P1196, DOI 10.1002/pro.3172; Terzyan SS, 2015, J BIOL CHEM, V290, P17576, DOI 10.1074/jbc.M115.659680; TURNER E, 1988, SCIENCE, V242, P939, DOI 10.1126/science.3187533; Tuzova M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00179; Westley AM, 1996, J BIOL CHEM, V271, P5347, DOI 10.1074/jbc.271.10.5347; Yamamoto S, 2011, J PHARMACOL EXP THER, V339, P945, DOI 10.1124/jpet.111.183004	60	23	23	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14603	14614		10.1074/jbc.RA119.009304	http://dx.doi.org/10.1074/jbc.RA119.009304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31375562	Green Published, hybrid			2022-12-26	WOS:000497955000009
J	Juanola, O; Ferrusquia-Acosta, J; Garcia-Villalba, R; Zapater, P; Magaz, M; Marin, A; Olivas, P; Baiges, A; Bellot, P; Turon, F; Hernandez-Gea, V; Gonzalez-Navajas, JM; Tomas-Barberan, FA; Garcia-Pagan, JC; Frances, R				Juanola, Oriol; Ferrusquia-Acosta, Jose; Garcia-Villalba, Rocio; Zapater, Pedro; Magaz, Marta; Marin, Alicia; Olivas, Pol; Baiges, Anna; Bellot, Pablo; Turon, Fanny; Hernandez-Gea, Virginia; Gonzalez-Navajas, Jose M.; Tomas-Barberan, Francisco A.; Garcia-Pagan, Juan C.; Frances, Ruben			Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis	FASEB JOURNAL			English	Article						SCFAs; liver; hemodynamics; cytokines	CHAIN FATTY-ACIDS; HUMAN GUT MICROBIOME; BACTERIAL TRANSLOCATION; LIVER-DISEASE; METABOLISM; HEALTH; NUTRITION; RECEPTOR; ARTICLE; DIET	Short-chain fatty acids (SCFAs) are gut microbiota-derived products that participate in maintaining the gut barrier integrity and host's immune response. We hypothesize that reduced SCFA levels are associated with systemic inflammation, endotoxemia, and more severe hemodynamic alterations in cirrhosis. Patients with cirrhosis referred for a hepatic venous pressure gradient (HVPG) measurement (n = 62) or a transjugular intrahepatic portosystemic shunt placement (n = 12) were included. SCFAs were measured in portal (when available), hepatic, and peripheral blood samples by GC-MS. Serum endotoxins, proinflammatory cytokines, and NO levels were quantified. SCFA levels were significantly higher in portal vs. hepatic and peripheral blood. There were inverse relationships between SCFAs and the severity of disease. SCFAs (mainly butyric acid) inversely correlated with the model for end-stage liver disease score and were further reduced in patients with history of ascites, hepatic encephalopathy, and spontaneous bacterial peritonitis. There was an inverse relationship between butyric acid and HVPG values. SCFAs were directly related with systemic vascular resistance and inversely with cardiac index. Butyric acid inversely correlated with inflammatory markers and serum endotoxin. A global reduction in the blood levels of SCFA in patients with cirrhosis is associated with a more advanced liver disease, suggesting its contribution to disease progression.-Juanola, O., Ferrusquia-Acosta, J., Garcia-Villalba, R., Zapater, P., Magaz, M., Marin, A., Olivas, P., Baiges, A., Bellot, P., Turon, F., Hernandez-Gea, V., Gonzalez-Navajas, J. M., Tomas-Barberan, F. A., Garcia-Pagan, J. C., Frances, R. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.	[Juanola, Oriol; Zapater, Pedro; Frances, Ruben] Univ Miguel Hernandez, Grp Inmunobiol Hepat & Intestinal, Dept Med Clin, Alacant, Spain; [Juanola, Oriol; Zapater, Pedro; Bellot, Pablo; Gonzalez-Navajas, Jose M.; Frances, Ruben] Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biorned Alicante ISABIAL, Alicante, Spain; [Ferrusquia-Acosta, Jose; Magaz, Marta; Olivas, Pol; Baiges, Anna; Turon, Fanny; Hernandez-Gea, Virginia; Garcia-Pagan, Juan C.] Univ Barcelona, Inst Investc Biomed August Pi & Sunyer IDIBAPS, Liver Unit, Hepat Hemodynam Lab,Hosp Clin, Barcelona, Spain; [Ferrusquia-Acosta, Jose; Zapater, Pedro; Magaz, Marta; Olivas, Pol; Baiges, Anna; Bellot, Pablo; Turon, Fanny; Hernandez-Gea, Virginia; Gonzalez-Navajas, Jose M.; Garcia-Pagan, Juan C.; Frances, Ruben] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Garcia-Villalba, Rocio; Marin, Alicia; Tomas-Barberan, Francisco A.] CSIC, CEBAS, Qual Safety & Bioact Plant Foods, Murcia, Spain	Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Frances, R (corresponding author), Univ Miguel Hernandez, Dept Med Clin, Grp Inmunobiol Hepat & Intestinal, CIBERehd, Carretera Alicante Valencia Km 8-7, Alacant 03550, Spain.	rfrances@umh.es	González-Navajas, Jose Manuel/AAB-1575-2019; Zapater, Pedro/H-8450-2019; Francés, Rubén/V-4120-2019; Tomas-Barberan, Francisco/D-6686-2011; Ferrusquia-Acosta, Jose/P-4297-2015	González-Navajas, Jose Manuel/0000-0002-1591-939X; Zapater, Pedro/0000-0001-7927-858X; Francés, Rubén/0000-0001-5105-1201; Tomas-Barberan, Francisco/0000-0002-0790-1739; Garcia Villalba, Rocio/0000-0003-1883-1673; Magaz, Marta/0000-0002-9787-1739; Olivas, Pol/0000-0002-1919-0284; Juanola, Oriol/0000-0001-7432-8808; Ferrusquia-Acosta, Jose/0000-0001-8034-1291; Baiges, Anna/0000-0002-6963-9203; BELLOT, PABLO/0000-0001-8307-1813	Instituto de Salud Carlos III [PI16/0967, PIE15/00027]; Ministry of Education and Science [FEDER "Una manera de hacer Europa"] [SAF-2016-75767-R]; Conselleria de Educacion, Generalitat Valenciana, Valencia, Spain [PROMETEO 2016/001]; Instituto de Salud Carlos III Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministry of Education and Science [FEDER "Una manera de hacer Europa"]; Conselleria de Educacion, Generalitat Valenciana, Valencia, Spain; Instituto de Salud Carlos III Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)	This study was funded by Instituto de Salud Carlos III (Grants PI16/0967 and PIE15/00027)), the Ministry of Education and Science [(SAF-2016-75767-R) FEDER "Una manera de hacer Europa"], and PROMETEO 2016/001 (Conselleria de Educacion, Generalitat Valenciana, Valencia, Spain). The Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by the Instituto de Salud Carlos III. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) takes part in the Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya. J.C.G.-P. and R.F. share senior authorship. The authors declare no conflicts of interest.	Arnoldussen IAC, 2017, INT J OBESITY, V41, P935, DOI 10.1038/ijo.2017.52; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arroyo V, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.41; Bajaj JS, 2018, HEPATOLOGY, V68, P1549, DOI 10.1002/hep.30037; Bajaj JS, 2014, AM J PHYSIOL-GASTR L, V307, pG951, DOI 10.1152/ajpgi.00268.2014; Bashiardes S, 2016, MOL METAB, V5, P782, DOI 10.1016/j.molmet.2016.06.003; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cheung K, 2012, CLIN GASTROENTEROL H, V10, P117, DOI 10.1016/j.cgh.2011.08.016; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Davis BC, 2017, SEMIN LIVER DIS, V37, P128, DOI 10.1055/s-0037-1602763; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Gomez-Hurtado I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023037; Gunsar F, 2006, ALIMENT PHARM THER, V24, P563, DOI 10.1111/j.1365-2036.2006.03003.x; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jenkins DJA, 1998, J AM COLL NUTR, V17, P609, DOI 10.1080/07315724.1998.10718810; Jin M., 2019, LIVER INT; Juanola O, 2018, HEPATOL COMMUN, V2, P1610, DOI 10.1002/hep4.1268; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kles KA, 2006, GASTROENTEROLOGY, V130, pS100, DOI 10.1053/j.gastro.2005.11.048; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mehta G, 2014, J HEPATOL, V61, P155, DOI 10.1016/j.jhep.2014.03.014; Munoz L, 2018, HEPATOLOGY; Onori L, 2001, DIGEST DIS SCI, V46, P2084, DOI 10.1023/A:1011982024849; Pluznick JL, 2014, GUT MICROBES, V5, P202, DOI 10.4161/gmic.27492; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; Rockey DC, 2014, HEPATOLOGY, V59, P1073, DOI 10.1002/hep.26611; ROTH RI, 1990, J LAB CLIN MED, V116, P153; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; WENNMALM A, 1993, CIRC RES, V73, P1121, DOI 10.1161/01.RES.73.6.1121; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wiest R, 2014, J HEPATOL, V60, P197, DOI 10.1016/j.jhep.2013.07.044; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Ye JZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01967; Yoon S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061329; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	52	44	48	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11595	11605		10.1096/fj.201901327R	http://dx.doi.org/10.1096/fj.201901327R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31345057	Bronze			2022-12-26	WOS:000489166300081
J	Johnson, CA; Walklate, J; Svicevic, M; Mijailovich, SM; Vera, C; Karabina, A; Leinwand, LA; Geeves, MA				Johnson, Chloe A.; Walklate, Jonathan; Svicevic, Marina; Mijailovich, Srboljub M.; Vera, Carlos; Karabina, Anastasia; Leinwand, Leslie A.; Geeves, Michael A.			The ATPase cycle of human muscle myosin II isoforms: Adaptation of a single mechanochemical cycle for different physiological roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; myosin; cardiac muscle; skeletal muscle; computer modeling; ATP economy; developmental muscle; fast muscle; slow muscle; developmental myosin; adult skeletal myosin; cardiac myosin; ATPase	BETA-CARDIAC MYOSIN; FIBER TYPES; SHORTENING VELOCITY; SKELETAL; ACTIN; FAMILY; SLOW; EXPRESSION; KINETICS; RABBIT	Striated muscle myosins are encoded by a large gene family in all mammals, including humans. These isoforms define several of the key characteristics of the different striated muscle fiber types, including maximum shortening velocity. We have previously used recombinant isoforms of the motor domains of seven different human myosin isoforms to define the actin?myosin cross-bridge cycle in solution. Here, we present data on an eighth isoform, the perinatal, which has not previously been characterized. The perinatal is distinct from the embryonic isoform, appearing to have features in common with the adult fast-muscle isoforms, including weak affinity of ADP for actin?myosin and fast ADP release. We go on to use a recently developed modeling approach, MUSICO, to explore how well the experimentally defined cross-bridge cycles for each isoform in solution can predict the characteristics of muscle fiber contraction, including duty ratio, shortening velocity, ATP economy, and load dependence of these parameters. The work shows that the parameters of the cross-bridge cycle predict many of the major characteristics of each muscle fiber type and raises the question of what sequence changes are responsible for these characteristics.	[Johnson, Chloe A.; Walklate, Jonathan; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Svicevic, Marina] Univ Kragujevac, Fac Sci, Kragujevac 34000, Serbia; [Mijailovich, Srboljub M.] IIT, Dept Biol, Chicago, IL 60616 USA; [Vera, Carlos; Karabina, Anastasia; Leinwand, Leslie A.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Vera, Carlos; Karabina, Anastasia; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Kent; University of Kragujevac; Illinois Institute of Technology; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Geeves, MA (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.; Leinwand, LA (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.; Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@colorado.edu; m.a.geeves@kent.ac.uk		Vera, Carlos/0000-0003-1207-4878; Johnson, Chloe/0000-0003-0856-5041; Svicevic, Marina/0000-0003-2791-3849; LEINWAND, LESLIE/0000-0003-1470-4810	National Institutes of Health [GM29090, HL117138]; European Union Horizon 2020 Research and Innovation Programme [777204]; MyoKardia, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union Horizon 2020 Research and Innovation Programme; MyoKardia, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM29090 (to L. A. L.) and HL117138 (to L. A. L.) and European Union Horizon 2020 Research and Innovation Programme under Grant agreement No. 777204, SILICOFCM (to M. A. G., J. W., and S. M. M.). This article reflects only the author's view. The European Commission is not responsible for any use that may be made of the information it contains. L. A. L. owns stock in MyoKardia, Inc and has received research funding from the company. The authors declare that they have no conflicts of interest with the contents of this article.	AcakpoSatchivi LJR, 1997, J CELL BIOL, V139, P1219, DOI 10.1083/jcb.139.5.1219; Alpert NR, 2002, AM J PHYSIOL-HEART C, V283, pH1446, DOI 10.1152/ajpheart.00274.2002; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; Bloemink MJ, 2013, J BIOL CHEM, V288, P27469, DOI 10.1074/jbc.M113.488130; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Brueckner JK, 1996, J MUSCLE RES CELL M, V17, P297; Chikuni K., 2002, Animal Science Journal, V73, P257, DOI 10.1046/j.1344-3941.2002.00035.x; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P4239, DOI 10.1007/s00018-012-1111-5; Greenberg MJ, 2014, BIOPHYS J, V107, pL41, DOI 10.1016/j.bpj.2014.11.005; Haraksingh RR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1155; He ZH, 2000, BIOPHYS J, V79, P945, DOI 10.1016/S0006-3495(00)76349-1; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Houdusse A, 2016, TRENDS BIOCHEM SCI, V41, P989, DOI 10.1016/j.tibs.2016.09.006; Iorga B, 2007, J BIOL CHEM, V282, P3559, DOI 10.1074/jbc.M608191200; Johnson C.A., 2019, CARDIAC CONTRACTION, DOI [10.1101/680413, DOI 10.1101/680413]; Liu C, 2018, NAT STRUCT MOL BIOL, V25, P505, DOI 10.1038/s41594-018-0069-x; Mijailovich SM, 2017, BIOPHYS J, V112, P984, DOI 10.1016/j.bpj.2017.01.021; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Oldfors A, 2007, NEUROMUSCULAR DISORD, V17, P355, DOI 10.1016/j.nmd.2007.02.008; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; SARTORE S, 1987, J MUSCLE RES CELL M, V8, P161, DOI 10.1007/BF01753992; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SLEEP JA, 1980, BIOCHEMISTRY-US, V19, P1276, DOI 10.1021/bi00548a002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sung JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8931; Toniolo L, 2004, J EXP BIOL, V207, P1875, DOI 10.1242/jeb.00950; Ujfalusi Z, 2018, J BIOL CHEM, V293, P9017, DOI 10.1074/jbc.RA118.001938; VANBUREN P, 1995, CIRC RES, V77, P439, DOI 10.1161/01.RES.77.2.439; Walklate J, 2016, J BIOL CHEM, V291, P10318, DOI 10.1074/jbc.M115.707489; Walklate J, 2015, ANAL BIOCHEM, V476, P11, DOI 10.1016/j.ab.2015.01.020; Weiss A, 1999, J MOL BIOL, V290, P61, DOI 10.1006/jmbi.1999.2865; WHITE HD, 1976, BIOCHEMISTRY-US, V15, P5818, DOI 10.1021/bi00671a020	38	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14267	14278		10.1074/jbc.RA119.009825	http://dx.doi.org/10.1074/jbc.RA119.009825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31387944	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-26	WOS:000499248200010
J	Gopal, U; Mowery, Y; Young, K; Pizzo, SV				Gopal, Udhayakumar; Mowery, Yvonne; Young, Kenneth; Pizzo, Salvatore Vincent			Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						selective internal radiation therapy (SIRT); cell signaling; cell surface receptor; phosphotyrosine signaling; tumor cell biology; 70 kilodalton heat shock protein (Hsp70); C38 mAb; CS-GRP78; pancreatic ductal adenocarcinoma (PDAC); radiation therapy; YAP; TAZ signaling; PDAC cell motility and invasion	COOH-TERMINAL DOMAIN; STEM-LIKE CELLS; HIPPO PATHWAY; ACTIVATED ALPHA(2)-MACROGLOBULIN; SIZE-CONTROL; GROWTH; YAP; PHOSPHORYLATION; LIGATION; TAZ	Ionizing radiation (IR) can promote migration and invasion of cancer cells, but the basis for this phenomenon has not been fully elucidated. IR increases expression of glucose-regulated protein 78kDa (GRP78) on the surface of cancer cells (CS-GRP78), and this up-regulation is associated with more aggressive behavior, radioresistance, and recurrence of cancer. Here, using various biochemical and immunological methods, including flow cytometry, cell proliferation and migration assays, Rho activation and quantitative RT-PCR assays, we investigated the mechanism by which CS-GRP78 contributes to radioresistance in pancreatic ductal adenocarcinoma (PDAC) cells. We found that activated alpha(2)-Macroglobulin (alpha M-2*) a ligand of the CS-GRP78 receptor, induces formation of the AKT kinase (AKT)/DLC1 Rho-GTPase-activating protein (DLC1) complex and thereby increases Rho activation. Further, CS-GRP78 activated the transcriptional coactivators Yes-associated protein (YAP) and tafazzin (TAZ) in a Rho-dependent manner, promoting motility and invasiveness of PDAC cells. We observed that radiation-induced CS-GRP78 stimulates the nuclear accumulation of YAP/TAZ and increases YAP/TAZ target gene expressions. Remarkably, targeting CS-GRP78 with C38 monoclonal antibody (Mab) enhanced radiosensitivity and increased the efficacy of radiation therapy by curtailing PDAC cell motility and invasion. These findings reveal that CS-GRP78 acts upstream of YAP/TAZ signaling and promote migration and radiation-resistance in PDAC cells. We therefore conclude that, C38 Mab is a promising candidate for use in combination with radiation therapy to manage PDAC.	[Gopal, Udhayakumar; Pizzo, Salvatore Vincent] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Mowery, Yvonne; Young, Kenneth] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; Duke University	Gopal, U (corresponding author), Duke Univ, Med Ctr, Box 3712, Durham, NC 27710 USA.	Udhayakumar.gopal@duke.edu; Salvatore.pizzo@duke.edu		gopal, Udhayakumar/0000-0003-2110-0601				Aguiar DP, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-61; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chin VT, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.17; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dadey DYA, 2017, CLIN CANCER RES, V23, P2556, DOI 10.1158/1078-0432.CCR-16-1935; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; De Ruysscher D, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0064-5; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Edwards DN, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan4667; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gopal U., 2018, CELL SURFACE GRP78 N, P9, DOI DOI 10.1016/B978-0-12-812351-5.00002-7; Gopal U, 2017, ONCOTARGET, V8, P107947, DOI 10.18632/oncotarget.22431; Gopal U, 2016, J BIOL CHEM, V291, P10904, DOI 10.1074/jbc.M115.708131; Haga Raquel B, 2016, Small GTPases, V7, P207; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong X, 2014, EMBO J, V33, P2447, DOI 10.15252/embj.201489385; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Ko FCF, 2010, GASTROENTEROLOGY, V139, P1397, DOI 10.1053/j.gastro.2010.06.051; Leconet W, 2017, CLIN CANCER RES, V23, P2806, DOI 10.1158/1078-0432.CCR-16-1316; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lin YG, 2015, ONCOGENE, V34, P5418, DOI 10.1038/onc.2015.4; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mason DE, 2019, J CELL BIOL, V218, P1369, DOI 10.1083/jcb.201806065; Minata M, 2019, CELL REP, V26, P1893, DOI 10.1016/j.celrep.2019.01.076; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Mo LH, 2015, MOL CANCER THER, V14, P747, DOI 10.1158/1535-7163.MCT-14-0579; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Neoptolemos JP, 2018, NAT REV GASTRO HEPAT, V15, P332, DOI 10.1038/s41575-018-0005-x; Panciera T, 2016, CELL STEM CELL, V19, P725, DOI 10.1016/j.stem.2016.08.009; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Qiang L, 2019, J CELL BIOL, V218, P317, DOI 10.1083/jcb.201802032; Ravi A, 2015, J BIOL CHEM, V290, P4149, DOI 10.1074/jbc.M114.616839; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Tripathi BK, 2017, J CELL BIOL, V216, P4255, DOI 10.1083/jcb.201703105; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang FQ, 2015, J BIOL CHEM, V290, P8232, DOI 10.1074/jbc.M114.623074; Zhang L, 2019, ONCOGENE, V38, P2788, DOI 10.1038/s41388-018-0626-0; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	56	22	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13939	13952		10.1074/jbc.RA119.009091	http://dx.doi.org/10.1074/jbc.RA119.009091			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31358620	hybrid, Green Published			2022-12-26	WOS:000490729800009
J	Heumuller, SE; Talantikite, M; Napoli, M; Armengaud, J; Morgelin, M; Hartmann, U; Sengle, G; Paulsson, M; Moali, C; Wagener, R				Heumueller, Stefanie Elisabeth; Talantikite, Maya; Napoli, Manon; Armengaud, Jean; Moergelin, Matthias; Hartmann, Ursula; Sengle, Gerhard; Paulsson, Mats; Moali, Catherine; Wagener, Raimund			C-terminal proteolysis of the collagen VI alpha 3 chain by BMP-1 and proprotein convertase(s) releases endotrophin in fragments of different sizes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix protein; electron microscopy (EM); muscular dystrophy; protein processing; BMP-1; microfibrils; proprotein convertase; collagen VI; Kunitz domain; endotrophin; Pro-C6	MORPHOGENETIC PROTEIN-1 PROCESSES; EXTRACELLULAR-MATRIX TURNOVER; PROCOLLAGEN-VII; DOMAIN; CLEAVAGE; MICE; DEFICIENCY; BIOMARKERS; COL6A3; ACTIVATION	The assembly of collagen VI microfibrils is a multistep process in which proteolytic processing within the C-terminal globular region of the collagen VI alpha 3 chain plays a major role. However, the mechanisms involved remain elusive. Moreover, C5, the short and most C-terminal domain of the alpha 3 chain, recently has been proposed to be released as an adipokine that enhances tumor progression, fibrosis, inflammation, and insulin resistance and has been named "endotrophin." Serum endotrophin could be a useful biomarker to monitor the progression of such disorders as chronic obstructive pulmonary disease, systemic sclerosis, and kidney diseases. Here, using biochemical and isotopic MS-based analyses, we found that the extracellular metalloproteinase bone morphogenetic protein 1 (BMP-1) is involved in endotrophin release and determined the exact BMP-1 cleavage site. Moreover, we provide evidence that several endotrophin-containing fragments are present in various tissues and body fluids. Among these, a large C2-C5 fragment, which contained endotrophin, was released by furin-like proprotein convertase cleavage. By using immunofluorescence microscopy and EM, we also demonstrate that these proteolytic maturations occur after secretion of collagen VI tetramers and during microfibril assembly. Differential localization of N- and C-terminal regions of the collagen VI alpha 3 chain revealed that cleavage products are deposited in tissue and cell cultures. The detailed information on the processing of the collagen VI alpha 3 chain reported here provides a basis for unraveling the function of endotrophin (C5) and larger endotrophin-containing fragments and for refining their use as biomarkers of disease progression.	[Heumueller, Stefanie Elisabeth; Hartmann, Ursula; Sengle, Gerhard; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Sengle, Gerhard; Paulsson, Mats; Wagener, Raimund] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Talantikite, Maya; Napoli, Manon; Moali, Catherine] Univ Lyon, CNRS, UMR5305, Tissue Biol & Therapeut Engn Lab, F-69367 Lyon, France; [Armengaud, Jean] Commissariat Energie Atom CEA Marcoule, Innovat Technol Detect & Diagnost Lab, DRF, JOLIOT,DMTS,SPI,Li2D, F-30200 Bagnols Sur Ceze, France; [Moergelin, Matthias] Colzyx AB, SE-22381 Lund, Sweden; [Sengle, Gerhard; Paulsson, Mats; Wagener, Raimund] CCMB, D-50931 Cologne, Germany; [Sengle, Gerhard] Fac Med, Dept Pediat & Adolescent Med, Expt Neonatol, D-50931 Cologne, Germany; [Sengle, Gerhard] Univ Hosp Cologne, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CEA; University of Cologne; University of Cologne	Moali, C (corresponding author), Tissue Biol & Therapeut Engn Lab LBTI, 7 Passage Vercors, F-69367 Lyon 7, France.; Wagener, R (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	catherine.moali@ibcp.fr; raimund.wagener@uni-koeln.de		ARMENGAUD, Jean/0000-0003-1589-445X; MOALI, Catherine/0000-0003-2479-4290	German Research Council [SFB 829-B2, FOR 2722-B1, SFB829/B11, SFB829/B12, FOR 2722-M2]; Region Rhone-Alpes Auvergne; CNRS; University of Lyon	German Research Council(German Research Foundation (DFG)); Region Rhone-Alpes Auvergne(Region Auvergne-Rhone-Alpes); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lyon	This study was supported by German Research Council Grants SFB 829-B2 and FOR 2722-B1 (to R. W. and M. P.) and Grants SFB829/B11 and B12 and FOR 2722-M2 (to G. S.), by the Region Rhone-Alpes Auvergne (to M. T. and C. M.), and by CNRS and the University of Lyon (to C. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; Alexopoulos LG, 2009, ARTHRITIS RHEUM-US, V60, P771, DOI 10.1002/art.24293; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; Beecher N, 2011, J BIOL CHEM, V286, P40266, DOI 10.1074/jbc.M111.265595; Bekhouche M, 2016, FASEB J, V30, P1741, DOI 10.1096/fj.15-279869; Bihlet AR, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0509-x; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Breibeck J, 2018, BIOPOLYMERS, V109, DOI 10.1002/bip.23069; Builles N, 2006, BIO-MED MATER ENG, V16, pS95; Cescon M, 2018, ACTA NEUROPATHOL, V136, P483, DOI 10.1007/s00401-018-1860-9; Cescon M, 2015, J CELL SCI, V128, P3525, DOI 10.1242/jcs.169748; Chen PW, 2015, J INVEST DERMATOL, V135, P2358, DOI 10.1038/jid.2015.187; Chen PW, 2015, ACTA NEUROPATHOL, V129, P97, DOI 10.1007/s00401-014-1369-9; Chen PW, 2014, FASEB J, V28, P1145, DOI 10.1096/fj.13-239533; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Christensen SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033397; Colombo M, 2003, BIOCHEMISTRY-US, V42, P11434, DOI 10.1021/bi034925d; Dassah M, 2014, J CELL SCI, V127, P828, DOI 10.1242/jcs.137802; Delolme F, 2015, CELL MOL LIFE SCI, V72, P1009, DOI 10.1007/s00018-014-1733-x; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Fenton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175200; Fitzgerald J, 2001, J BIOL CHEM, V276, P187, DOI 10.1074/jbc.M008173200; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hung CW, 2016, J PROTEOMICS, V138, P136, DOI 10.1016/j.jprot.2016.02.031; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Izu Y, 2012, TISSUE CELL, V44, P1, DOI 10.1016/j.tice.2011.08.002; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Juhl P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207324; Karsdal MA, 2017, DIABETOLOGIA, V60, P50, DOI 10.1007/s00125-016-4094-1; Kim B, 2011, J BIOL CHEM, V286, P29014, DOI 10.1074/jbc.M111.252585; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lee C, 2019, J PATHOL, V247, P99, DOI 10.1002/path.5172; Lettmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105686; Luther DJ, 2012, CIRC RES, V110, P851, DOI 10.1161/CIRCRESAHA.111.252734; Maass T, 2016, J BIOL CHEM, V291, P5247, DOI 10.1074/jbc.M115.705160; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; MAYER U, 1994, EUR J BIOCHEM, V225, P573, DOI 10.1111/j.1432-1033.1994.00573.x; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Nielsen SH, 2018, EUR J PREV CARDIOL, V25, P719, DOI 10.1177/2047487318758750; Pan TC, 2014, J BIOL CHEM, V289, P10293, DOI 10.1074/jbc.M114.549311; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Park J, 2013, EMBO MOL MED, V5, P935, DOI 10.1002/emmm.201202006; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Rasmussen DGK, 2018, DIABETES CARE, V41, P1493, DOI 10.2337/dc17-2392; Rasmussen DGK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17470-3; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; ROTH J, 1980, J HISTOCHEM CYTOCHEM, V28, P55, DOI 10.1177/28.1.6153194; Sand JMB, 2016, CLIN BIOCHEM, V49, P1144, DOI 10.1016/j.clinbiochem.2016.09.003; Sand JMB, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0225-3; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Schlapschy M, 2013, PROTEIN ENG DES SEL, V26, P489, DOI 10.1093/protein/gzt023; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051; Stolz D, 2017, CHEST, V151, P47, DOI 10.1016/j.chest.2016.08.1440; Stribos EGD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175898; Sun K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4485; Sun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144525; Szlama G, 2016, FEBS J, V283, P4515, DOI 10.1111/febs.13938; Talantikite M, 2018, FEBS OPEN BIO, V8, P2011, DOI 10.1002/2211-5463.12540; Vadon-Le Goff S, 2015, MATRIX BIOL, V44-46, P14, DOI 10.1016/j.matbio.2015.02.006; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; Wagener R, 2009, MATRIX BIOL, V28, P307, DOI 10.1016/j.matbio.2009.05.003	71	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13769	13780		10.1074/jbc.RA119.008641	http://dx.doi.org/10.1074/jbc.RA119.008641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346034	Green Published, hybrid			2022-12-26	WOS:000486418600021
J	Brand, GD; Ramada, MHS; Manickchand, JR; Correa, R; Ribeiro, DJS; Santos, MA; Vasconcelos, AG; Abrao, FY; Prates, MV; Murad, AM; Fh, JLC; Leite, JRSA; Magalhaes, KG; Oliveira, AL; Bloch, C				Brand, Guilherme D.; Ramada, Marcelo H. S.; Manickchand, Julia R.; Correa, Rafael; Ribeiro, Dalila J. S.; Santos, Michele A.; Vasconcelos, Andreanne G.; Abrao, Fernando Y.; Prates, Maura, V; Murad, Andre M.; Cardozo Fh, Jose L.; Leite, Jose Roberto S. A.; Magalhaes, Kelly G.; Oliveira, Aline L.; Bloch Jr, Carlos			Intragenic antimicrobial peptides (IAPs) from human proteins with potent antimicrobial and anti-inflammatory activity	PLOS ONE			English	Article							FROG; ULTRAVIOLET; IMMUNITY; INNATE; MODEL; LL-37	Following the treads of our previous works on the unveiling of bioactive peptides encrypted in plant proteins from diverse species, the present manuscript reports the occurrence of four proof-of-concept intragenic antimicrobial peptides in human proteins, named Hs IAPs. These IAPs were prospected using the software Kamal, synthesized by solid phase chemistry, and had their interactions with model phospholipid vesicles investigated by differential scanning calorimetry and circular dichroism. Their antimicrobial activity against bacteria, yeasts and filamentous fungi was determined, along with their cytotoxicity towards erythrocytes. Our data demonstrates that Hs IAPs are capable to bind model membranes while attaining alpha-helical structure, and to inhibit the growth of microorganisms at concentrations as low as 1 mu M. Hs02, a novel sixteen residue long internal peptide (KWAVRIIRKFIKGFIS-NH2) derived from the unconventional myosin 1h protein, was further investigated in its capacity to inhibit lipopolysaccharide-induced release of TNF-alpha in murine macrophages. Hs02 presented potent anti-inflammatory activity, inhibiting the release of TNF-alpha in LPS-primed cells at the lowest assayed concentration, 0.1 mu M. A three-dimensional solution structure of Hs02 bound to DPC micelles was determined by Nuclear Magnetic Resonance. Our work exemplifies how the human genome can be mined for molecules with biotechnological potential in human health and demonstrates that IAPs are actual alternatives to antimicrobial peptides as pharmaceutical agents or in their many other putative applications.	[Brand, Guilherme D.; Manickchand, Julia R.] Univ Brasilia, Inst Quim, LSAB, Brasilia, DF, Brazil; [Ramada, Marcelo H. S.] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Ramada, Marcelo H. S.] Univ Catolica Brasilia, Programa Posgrad Gerontol, Brasilia, DF, Brazil; [Ramada, Marcelo H. S.; Prates, Maura, V; Murad, Andre M.; Cardozo Fh, Jose L.; Bloch Jr, Carlos] Embrapa Recursos Genet & Biotecnol, LEM, Brasilia, DF, Brazil; [Correa, Rafael; Ribeiro, Dalila J. S.; Magalhaes, Kelly G.] Univ Brasilia, Inst Biol, Lab Imunol & Inflamacao, LIMI, Brasilia, DF, Brazil; [Santos, Michele A.; Oliveira, Aline L.] Univ Brasilia, Inst Quim, LRMN, Brasilia, DF, Brazil; [Vasconcelos, Andreanne G.; Leite, Jose Roberto S. A.] Univ Brasilia, Fac Med, NuPMIA, Nucleo Pesquisa Morfol & Imunol Aplicada, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil; [Abrao, Fernando Y.] FacUnicamps, Fac Farm, Goiania, Go, Brazil; [Cardozo Fh, Jose L.] Inst Matogrossense Algodao, Dept Fitopatol, Primavera Do Leste, MT, Brazil	Universidade de Brasilia; Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Brand, GD (corresponding author), Univ Brasilia, Inst Quim, LSAB, Brasilia, DF, Brazil.	gdbrand@unb.br	Brand, Guilherme/B-5603-2015; Oliveira, Aline L/D-2953-2012; Ramada, Marcelo H.S./G-7543-2015; Prates, Maura/S-8399-2019; Murad, Andre M/C-4459-2017; Bloch, Carlos/S-8375-2019; Abrão, Fernando/AGY-2416-2022; Magalhaes, Kelly G/A-6966-2010; Leite, Jose Roberto/H-9065-2013	Brand, Guilherme/0000-0002-1615-0009; Oliveira, Aline L/0000-0002-6928-078X; Ramada, Marcelo H.S./0000-0001-9738-3412; Prates, Maura/0000-0002-0206-5890; Murad, Andre M/0000-0002-7055-9462; Abrão, Fernando/0000-0002-0553-0946; Magalhaes, Kelly G/0000-0002-7435-5272; Manickchand, Julia/0000-0002-3225-2072; Gomes Vasconcelos, Andreanne/0000-0002-9651-1598; Correa, Rafael/0000-0003-2989-2383; Bloch Jr, Carlos/0000-0003-2799-6883; Leite, Jose Roberto/0000-0002-1096-3236	Fundacao de amparo a pesquisa do DF (FAP-DF) [0193.000866/2015, 0193.001566/2017]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [563712/2010-4, 557761/2009-3]; Financiadora de Estudos e Projetos (FINEP) [0110073600]	Fundacao de amparo a pesquisa do DF (FAP-DF); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by: GDB Fundacao de amparo a pesquisa do DF (FAP-DF, www.fap.df.gov.br/) grant 0193.000866/2015; ALO - Fundacao de amparo a pesquisa do DF (FAP-DF, www.fap.df.gov.br/) grant 0193.001566/2017; MAS - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES, www.capes. gov. br/pt/) - Finance Code 001; CB Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br/) grants 563712/2010-4 and 557761/2009-3, Financiadora de Estudos e Projetos (FINEP, http://www.finep.gov.br/) grant 0110073600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript..	[Anonymous], 2008, M38A2 CLSI, V28, P29; [Anonymous], [No title captured]; Barbosa EA, 2015, RAPID COMMUN MASS SP, V29, P2061, DOI 10.1002/rcm.7313; Bjorstad A, 2005, ANTIMICROB AGENTS CH, V49, P3889, DOI 10.1128/AAC.49.9.3889-3895.2005; Brand GD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19566-w; Brand GD, 2002, J BIOL CHEM, V277, P49332, DOI 10.1074/jbc.M209289200; Brand GD, 2007, ESTRATEGIAS PROSPECC; Brand GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045848; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chan WC, 2000, FMOC SOLID PHASE PEP; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Clinical and Laboratory Standards Institute, 2008, M27A3 CLSI, V28, P1; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Conlon JM, 2004, BIOCHEM BIOPH RES CO, V320, P170, DOI 10.1016/j.bbrc.2004.05.141; Dale CS, 2005, MEM I OSWALDO CRUZ, V100, P105, DOI 10.1590/S0074-02762005000900017; den Brok MH, 2018, TRENDS IMMUNOL, V39, P380, DOI 10.1016/j.it.2018.01.012; dos Santos RC, 2018, FOOD RES INT, V105, P184, DOI 10.1016/j.foodres.2017.10.045; Duplantier AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00143; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167; Giuliani A, 2010, METHODS MOL BIOL, V618, P137, DOI 10.1007/978-1-60761-594-1_10; Gronberg A, 2014, WOUND REPAIR REGEN, V22, P613, DOI 10.1111/wrr.12211; Hancock REW, 2016, NAT REV IMMUNOL, V16, P321, DOI 10.1038/nri.2016.29; Iorga A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051018; Ivanov VT, 1997, BIOPOLYMERS, V43, P171; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; KIRSCHENBAUM DM, 1975, ANAL BIOCHEM, V64, P186, DOI 10.1016/0003-2697(75)90420-0; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Li LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182057; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Norris M, 2016, J BIOMOL NMR, V65, P205, DOI 10.1007/s10858-016-0049-6; Pahlman LI, 2013, THROMB HAEMOSTASIS, V109, P930, DOI 10.1160/TH12-10-0739; Phelan M, 2009, INT DAIRY J, V19, P643, DOI 10.1016/j.idairyj.2009.06.001; Ramada MHS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13685-6; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Sato A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153130; Seto GWJ, 2007, BBA-BIOMEMBRANES, V1768, P2787, DOI 10.1016/j.bbamem.2007.07.018; Skinner SP, 2015, ACTA CRYSTALLOGR D, V71, P154, DOI 10.1107/S1399004714026662; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Taylor D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081224; Tsai C-J, 2008, PROTEIN SCI, V6, P24, DOI DOI 10.1002/PR0.5560060104; Tsai CJ, 1998, FOLD DES, V3, pR71, DOI 10.1016/S1359-0278(98)00032-7; Tsai CJ, 2000, P NATL ACAD SCI USA, V97, P12038, DOI 10.1073/pnas.97.22.12038; Tsai CJ, 1997, PROTEIN SCI, V6, P1426, DOI 10.1002/pro.5560060707; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang GS, 2014, PHARMACEUTICALS-BASE, V7, P545, DOI 10.3390/ph7050545; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, NMR PROTEINS NUCL AC; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306	55	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220656	10.1371/journal.pone.0220656	http://dx.doi.org/10.1371/journal.pone.0220656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386688	Green Submitted, Green Published, gold			2022-12-26	WOS:000484997100029
J	Berkowic, D; Markman, S				Berkowic, Daniel; Markman, Shai			Weighing density and kinship: Aggressive behavior and time allocation in fire salamander (Salamandra infraimmaculata)	PLOS ONE			English	Article							KIN RECOGNITION; GROUP-SIZE; CANNIBALISM; LARVAE; EVOLUTION; DYNAMICS; PATTERNS; FITNESS; FOOD	Kin-biased behavior (that is responding differentially to kin and non-kin) is thought to be adaptive in many social interactions. One example of this kin bias is behaving less aggressively toward a relative than a non-relative, a behavior which yields inclusive fitness benefits. However, data are lacking about the ability of animals to weigh their preference for kinship and the density of conspecifics simultaneously and to respond accordingly. Fire salamanders (Salamandra infraimmaculata) larviposit in high densities in ponds. Thus, larvae of different females confront competition and predation by other larvae. We studied whether larvae prefer their kin over particular density or vice versa. We experimentally used a transparent glass aquarium with inner chambers to test the responses of a focal larva toward its siblings and non-siblings. Specifically, we quantified the time a focal larva spent near its siblings or non-siblings, presented in varying densities, and the aggression level it demonstrated. We found that focal larvae spent more time near non-siblings if non-sibling and sibling groups were of equal density. The focal larvae were also more aggressive toward non-siblings. The results may be explained by the cannibalistic nature of these larvae: high density may provide more opportunities for food, especially when non-siblings are present. Further explanations for these findings may include other advantages of staying in a larger group and/or the stronger olfactory and visual stimulation offered by groups compared to a single individual. These findings suggest that larvae make differential responses toward conspecifics depending simultaneously on the level of relatedness and the density of the group. Such responses have important implications for social-aggregation decisions and may especially affect the fitness of cannibalistic species.	[Berkowic, Daniel; Markman, Shai] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Tivon, Israel	University of Haifa	Markman, S (corresponding author), Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Tivon, Israel.	markmans@research.haifa.ac.il		Markman, Shai/0000-0002-0484-3801				Alon A., 1984, REPTILES AMPHIBANS, V5; Anderson TL, 2017, OECOLOGIA, V185, P475, DOI 10.1007/s00442-017-3954-9; Bateson P., 1983, MATE CHOICE; Bilde T, 2007, J EVOLUTION BIOL, V20, P2412, DOI 10.1111/j.1420-9101.2007.01407.x; Blaustein L, 1996, OIKOS, V76, P392, DOI 10.2307/3546211; Caspers BA, 2011, AMPHIBIA-REPTILIA, V32, P503, DOI 10.1163/156853811X603265; DEGANI G, 1980, HYDROBIOLOGIA, V75, P123, DOI 10.1007/BF00007425; DEGANI G, 1993, ISRAEL J ZOOL, V39, P125; Degani G, 1996, SALAMANDER SO LIMIT; Di Maggio R, 2013, J ORNITHOL, V154, P901, DOI 10.1007/s10336-013-0954-3; Ebensperger LA, 2012, J ANIM ECOL, V81, P1013, DOI 10.1111/j.1365-2656.2012.01973.x; Eitam A, 2005, OECOLOGIA, V146, P36, DOI 10.1007/s00442-005-0185-2; Gibbons ME, 2003, HERPETOLOGICA, V59, P322, DOI 10.1655/02-53; Gramapurohit NP, 2004, J HERPETOL, V38, P594, DOI 10.1670/53-03N; GREIGSMITH PW, 1988, IBIS, V130, P1, DOI 10.1111/j.1474-919X.1988.tb00950.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hepper PG., 1991, KIN RECOGNITION; Ibanez A, 2014, AMPHIBIA-REPTILIA, V35, P189, DOI 10.1163/15685381-00002941; Kimball RT, 2003, AUK, V120, P717, DOI 10.1642/0004-8038(2003)120[0717:OAEOCB]2.0.CO;2; Markman S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1149, DOI 10.1007/s00265-009-0765-y; Michimae H, 2001, BEHAV ECOL SOCIOBIOL, V50, P339, DOI 10.1007/s002650100368; PFENNIG DW, 1993, NATURE, V362, P836, DOI 10.1038/362836a0; Pfennig DW, 1997, BIOSCIENCE, V47, P667, DOI 10.2307/1313207; PFENNIG DW, 1994, BEHAV ECOL, V5, P225, DOI 10.1093/beheco/5.2.225; Quirici V, 2013, ACTA ETHOL, V16, P1, DOI 10.1007/s10211-012-0131-3; Reques R, 1996, HERPETOL J, V6, P15; Ricci L, 2013, ANIM BEHAV, V86, P245, DOI 10.1016/j.anbehav.2013.04.011; RICHNER H, 1992, ECOLOGY, V73, P330, DOI 10.2307/1938744; Roberts SJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P1995, DOI 10.1007/s00265-013-1607-5; Sadeh A, 2015, OECOLOGIA, V179, P425, DOI 10.1007/s00442-015-3366-7; Sadeh A, 2012, EVOL ECOL RES, V14, P113; Sadeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015602; Sadeh A, 2009, ECOL LETT, V12, P1158, DOI 10.1111/j.1461-0248.2009.01371.x; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Sorato E, 2012, ANIM BEHAV, V84, P823, DOI 10.1016/j.anbehav.2012.07.003; Switzer PV, 2000, BEHAVIOUR, V137, P401, DOI 10.1163/156853900502141; Templeton A.R., 1986, P105; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; WALLS SC, 1991, AM NAT, V138, P1027, DOI 10.1086/285266; WALLS SC, 1987, CAN J ZOOL, V65, P2938, DOI 10.1139/z87-446; WARBURG MR, 1992, HERPETOL J, V2, P54; Wildy EL, 2001, OECOLOGIA, V128, P202, DOI 10.1007/s004420100641; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x	44	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220499	10.1371/journal.pone.0220499	http://dx.doi.org/10.1371/journal.pone.0220499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381581	Green Published, gold, Green Submitted			2022-12-26	WOS:000484993600018
J	Jaworek, H; Kubanova, K; Koudelakova, V; Slavkovsky, R; Drabek, J; Hajduch, M				Jaworek, Hana; Kubanova, Katerina; Koudelakova, Vladimira; Slavkovsky, Rastislav; Drabek, Jiri; Hajduch, Marian			Pitfalls of commercially available HPV tests in HPV68a detection	PLOS ONE			English	Article							CERVICAL-CANCER; GENOTYPES; IMPACT	Background Human papillomavirus 68 (HPV68) is a probable carcinogenic HPV genotype which is included in almost all HPV screening assays and exists as two genetically variable subtypes (HPV68a and HPV68b). Routine HPV sample testing has shown that the cobas 4800 HPV Test (Roche) provides higher false-negative rates for HPV68 status than PapilloCheck HPV-Screening (Greiner Bio-One). The aim of our study was to evaluate the efficacy of cobas 4800 in HPV68 detection. Methods A total of 2,145 cervical/cervicovaginal samples from women aged 17-88 were tested for HPV68 status using the cobas 4800 and PapilloCheck HPV tests. Viral load was assessed by quantitative PCR in all of the HPV68-positive cases. HPV68a/b subtyping was performed with real-time PCR followed by high resolution melting curve analysis, and was subsequently confirmed by Sanger sequencing. Results Cobas 4800 detected HPV positivity in only 13/33 HPV68 single-genotype infection cases. Viral load was comparable across both tested subgroups. HRM analysis and Sanger sequencing identified the HPV68a subtype in all of the 20 instances of cobas 4800 false negatives. HPV68a and HPV68b were detected in 3/13 and 10/13 cases identified as other HPV-positive by cobas 4800. Conclusion The HPV68a subtype was missed by cobas 4800 in more than 85% of all HPV68a-positive cases. Therefore, commercially available assays may underestimate HPV68 prevalence.	[Jaworek, Hana; Kubanova, Katerina; Koudelakova, Vladimira; Slavkovsky, Rastislav; Drabek, Jiri; Hajduch, Marian] Palacky Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic; [Drabek, Jiri; Hajduch, Marian] Canc Res Czech Republ, Olomouc, Czech Republic	Palacky University Olomouc	Koudelakova, V; Hajduch, M (corresponding author), Palacky Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic.; Hajduch, M (corresponding author), Canc Res Czech Republ, Olomouc, Czech Republic.	vladimira.koudelakova@upol.cz; marian.hajduch@upol.cz	Hajduch, Marian/J-4015-2014; Drabek, Jiri/A-6135-2008	Hajduch, Marian/0000-0002-4834-908X; Koudelakova, Vladimira/0000-0001-5842-7478; Drabek, Jiri/0000-0002-5747-6478; Kubanova, Katerina/0000-0002-9489-9998; Jaworek, Hana/0000-0001-6263-0049	Czech Ministry of Education, Youth and Sports [NPS I LO1304, CZ.02.1.01/0.0/0.0/16_019/0000868, LM2015064]; Technological Agency of the Czech Republic [TE02000058]; charity Cancer Research Czech Republic	Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Technological Agency of the Czech Republic; charity Cancer Research Czech Republic	This study was supported by the Czech Ministry of Education, Youth and Sports grant NPS I LO1304 (JD, RS, VK, MH), CZ.02.1.01/0.0/0.0/16_019/0000868 (VK) and LM2015064 (MH), Technological Agency of the Czech Republic TE02000058 (VK, HJ) and charity Cancer Research Czech Republic (MH, JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista JE, 2017, INT J INFECT DIS, V55, P51, DOI 10.1016/j.ijid.2017.01.001; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dwight ZL, 2014, HUM MUTAT, V35, P278, DOI 10.1002/humu.22494; Eklund C, 2014, J CLIN MICROBIOL, V52, P449, DOI 10.1128/JCM.02453-13; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; Estrade C, 2014, J CLIN MICROBIOL, V52, P4033, DOI 10.1128/JCM.01950-14; Greiner Bio-One, 2012, PAPILLOCHECK HIGH RI; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Halec G, 2014, J PATHOL, V234, P441, DOI 10.1002/path.4405; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P9; Jaworek H, 2020, BIOMED PAP, V164, P71, DOI 10.5507/bp.2018.079; Jaworek H, 2018, J MOL DIAGN, V20, P849, DOI 10.1016/j.jmoldx.2018.07.004; Kim Na Rae, 2014, Korean J Pathol, V48, P43, DOI 10.4132/KoreanJPathol.2014.48.1.43; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Longuet M, 1996, J CLIN MICROBIOL, V34, P738, DOI 10.1128/JCM.34.3.738-744.1996; Monsonego J, 2015, GYNECOL ONCOL, V137, P47, DOI 10.1016/j.ygyno.2015.01.551; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nadace pro Vyzkum Rakoviny, LETS COMB CANC TOG; Rao A, 2013, J CLIN MICROBIOL, V51, P1478, DOI 10.1128/JCM.03386-12; Schiffman M, 2005, J NATL CANCER I, V97, P147, DOI 10.1093/jnci/dji014; Nascimento MDSB, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-017-0499-3; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; Xu L, 2018, J CLIN VIROL, V98, P37, DOI 10.1016/j.jcv.2017.12.001	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220373	10.1371/journal.pone.0220373	http://dx.doi.org/10.1371/journal.pone.0220373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381580	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600016
J	Milanovic, V; Osimani, A; Cardinali, F; Litta-Mulondo, A; Vignaroli, C; Citterio, B; Mangiaterra, G; Aquilanti, L; Garofalo, C; Biavasco, F; Cocolin, L; Ferrocino, I; Di Cagno, R; Turroni, S; Lazzi, C; Pellegrini, N; Clementi, F				Milanovic, Vesna; Osimani, Andrea; Cardinali, Federica; Litta-Mulondo, Alice; Vignaroli, Carla; Citterio, Barbara; Mangiaterra, Gianmarco; Aquilanti, Lucia; Garofalo, Cristiana; Biavasco, Francesca; Cocolin, Luca; Ferrocino, Ilario; Di Cagno, Raffaella; Turroni, Silvia; Lazzi, Camilla; Pellegrini, Nicoletta; Clementi, Francesca			Erythromycin-resistant lactic acid bacteria in the healthy gut of vegans, ovo-lacto vegetarians and omnivores	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ENTEROCOCCUS-FAECIUM; ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANT; VIRULENCE FACTORS; GENES; FOOD; MICROBIOTA; DIVERSITY; CHAIN	Diet can affect the diversity and composition of gut microbiota. Usage of antibiotics in food production and in human or veterinary medicine has resulted in the emergence of commensal antibiotic resistant bacteria in the human gut. The incidence of erythromycin-resistant lactic acid bacteria (LAB) in the feces of healthy vegans, ovo-lacto vegetarians and omnivores was analyzed. Overall, 155 LAB were isolated and characterized for their phenotypic and genotypic resistance to erythromycin. The isolates belonged to 11 different species within the Enterococcus and Streptococcus genera. Enterococcus faecium was the dominant species in isolates from all the dietary categories. Only 97 out of 155 isolates were resistant to erythromycin after Minimum Inhibitory Concentration (MIC) determination; among them, 19 isolates (7 from vegans, 4 from ovo-lacto vegetarians and 8 from omnivores) carried the erm(B) gene. The copresence of erm(B) and erm(A) genes was only observed in Enterococcus avium from omnivores. Moreover, the transferability of erythromycin resistance genes using multidrug-resistant (MDR) cultures selected from the three groups was assessed, and four out of six isolates were able to transfer the erm(B) gene. Overall, isolates obtained from the omnivore samples showed resistance to a greater number of antibiotics and carried more tested antibiotic resistance genes compared to the isolates from ovo-lacto vegetarians and vegans. In conclusion, our results show that diet does not significantly affect the occurrence of erythromycin-resistant bacteria and that commensal strains may act as a reservoir of antibiotic resistance (AR) genes and as a source of antibiotic resistance spreading.	[Milanovic, Vesna; Osimani, Andrea; Cardinali, Federica; Litta-Mulondo, Alice; Aquilanti, Lucia; Garofalo, Cristiana; Clementi, Francesca] Univ Politecn Marche, Dipartimento Sci Agr Alimentari Ambientali, Ancona, Italy; [Litta-Mulondo, Alice; Vignaroli, Carla; Mangiaterra, Gianmarco; Biavasco, Francesca] Univ Politecn Marche, Dipartimento Sci Vitae & Ambiente, Ancona, Italy; [Citterio, Barbara] Univ Urbino Carlo Bo, Dept Biomol Sci, Biotechnol Sect, Urbino, Italy; [Cocolin, Luca; Ferrocino, Ilario] Univ Turin, Dept Agr Forest & Food Sci DISAFA, Grugliasco, Italy; [Di Cagno, Raffaella] Libera Univ Bolzano, Fac Sci & Technol, Bolzano, Italy; [Turroni, Silvia] Univ Bologna, Dept Pharm & Biotechnol, Alma Mater Studiorum, Bologna, Italy; [Lazzi, Camilla; Pellegrini, Nicoletta] Univ Parma, Dept Food Sci, Parma, Italy	Marche Polytechnic University; Marche Polytechnic University; University of Urbino; University of Turin; Free University of Bozen-Bolzano; University of Bologna; University of Parma	Aquilanti, L (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari Ambientali, Ancona, Italy.	l.aquilanti@univpm.it	Cocolin, Luca/H-5091-2012; Citterio, Barbara/AAB-2237-2019; Turroni, Silvia/J-7195-2016	Cocolin, Luca/0000-0003-4799-7074; Citterio, Barbara/0000-0003-3346-6379; Turroni, Silvia/0000-0003-2345-9482; Mangiaterra, Gianmarco/0000-0001-5035-5879; FERROCINO, ILARIO/0000-0002-1657-0054; Milanovic, Vesna/0000-0001-8548-366X	Italian Ministry of University and Research (MIUR) PRIN 2010-2011 program (project: "Microorganisms in foods and in humans: study of the microbiota and the related metabolome as affected by omnivore, vegetarian or vegan diets")	Italian Ministry of University and Research (MIUR) PRIN 2010-2011 program (project: "Microorganisms in foods and in humans: study of the microbiota and the related metabolome as affected by omnivore, vegetarian or vegan diets")	This study was funded by the Italian Ministry of University and Research (MIUR) PRIN 2010-2011 program (project: "Microorganisms in foods and in humans: study of the microbiota and the related metabolome as affected by omnivore, vegetarian or vegan diets"). The funders played no role in the design of the study, the data collection and analysis, the decision to publish or in the preparation of the manuscript.	Aarts H, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00754; Abriouel H, 2008, INT J FOOD MICROBIOL, V123, P38, DOI 10.1016/j.ijfoodmicro.2007.11.067; Acar JF, 2006, REV SCI TECH OIE, V25, P775, DOI 10.20506/rst.25.2.1695; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aquilanti L, 2004, SOIL BIOL BIOCHEM, V36, P1475, DOI 10.1016/j.soilbio.2004.04.024; Badosa E, 2008, J SCI FOOD AGR, V88, P605, DOI 10.1002/jsfa.3124; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Bengtsson-Palme J, 2017, CURR OPIN FOOD SCI, V14, P66, DOI 10.1016/j.cofs.2017.01.010; Brenciani A, 2014, J ANTIMICROB CHEMOTH, V69, P1197, DOI 10.1093/jac/dkt495; Card RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086428; Cittterio B, 2017, FOOD CONTROL, V82, P184, DOI 10.1016/j.foodcont.2017.06.022; CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1; CLSI, 2020, PERF STAND ANT SUSC, V40; CLSI, 2015, METHODS FOR DILUTION; COYKENDALL AL, 1989, CLIN MICROBIOL REV, V2, P315, DOI 10.1128/CMR.2.3.315-328.1989; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; Devarajan N, 2015, ENVIRON SCI TECHNOL, V49, P6528, DOI 10.1021/acs.est.5b01031; Devirgiliis C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00301; Di Sante L, 2017, J ANTIMICROB CHEMOTH, V72, P2447, DOI 10.1093/jac/dkx197; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Economou V, 2015, INFECT DRUG RESIST, V8, P49, DOI 10.2147/IDR.S55778; Ferrocino I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128669; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Garofalo C, 2007, INT J FOOD MICROBIOL, V113, P75, DOI 10.1016/j.ijfoodmicro.2006.07.015; Gomes BC, 2008, FOOD MICROBIOL, V25, P668, DOI 10.1016/j.fm.2008.03.008; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Harmsen HJM, 2016, ADV EXP MED BIOL, V902, P95, DOI 10.1007/978-3-319-31248-4_7; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kim MS, 2013, ENV MICROBIOL REP, V5, P765, DOI 10.1111/1758-2229.12079; Lebreton F., 2014, ENTEROCOCCI COMMENSA, P5; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Losasso C, 2018, INT J ANTIMICROB AG, V52, P702, DOI 10.1016/j.ijantimicag.2018.07.023; Macovei L, 2007, APPL ENVIRON MICROB, V73, P6740, DOI 10.1128/AEM.01444-07; Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6; Milanovic V, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601098; Morroni G, 2019, J ANTIMICROB CHEMOTH, V74, P843, DOI 10.1093/jac/dky549; Osimani A, 2015, INT J FOOD MICROBIOL, V194, P62, DOI 10.1016/j.ijfoodmicro.2014.11.011; Pagadala S, 2015, INT J FOOD MICROBIOL, V196, P98, DOI 10.1016/j.ijfoodmicro.2014.12.005; Perez-Pulido R, 2006, FOOD CHEM TOXICOL, V44, P2070, DOI 10.1016/j.fct.2006.07.008; Portillo A, 2000, ANTIMICROB AGENTS CH, V44, P967, DOI 10.1128/AAC.44.4.967-971.2000; Riboldi GP, 2008, J BASIC MICROB, V48, P31, DOI 10.1002/jobm.200700226; Rolain JM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00173; San Millan A, 2018, TRENDS MICROBIOL, V26, P978, DOI 10.1016/j.tim.2018.06.007; Valenzuela AS, 2013, FOODBORNE PATHOG DIS, V10, P143, DOI 10.1089/fpd.2012.1279; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Stoll C, 2012, ENVIRON SCI TECHNOL, V46, P9716, DOI 10.1021/es302020s; Trivedi K, 2011, VET MED-CZECH, V56, P352, DOI 10.17221/1584-VETMED; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; vandenBraak N, 1997, LANCET, V350, P146, DOI 10.1016/S0140-6736(05)61856-9; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; Vignaroli C, 2013, ENVIRON SCI TECHNOL, V47, P13772, DOI 10.1021/es4019139; Vignaroli C, 2011, CURR MICROBIOL, V62, P1438, DOI 10.1007/s00284-011-9880-x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; World Health Organization, 2014, GLOBAL REPORT ON SUR; Wu GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24030; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9	63	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220549	10.1371/journal.pone.0220549	http://dx.doi.org/10.1371/journal.pone.0220549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374082	Green Published, gold			2022-12-26	WOS:000484991500017
J	Gebremariam, A; Addissie, A; Worku, A; Assefa, M; Kantelhardt, EJ; Jemal, A				Gebremariam, Alem; Addissie, Adamu; Worku, Alemayehu; Assefa, Mathewos; Kantelhardt, Eva Johanna; Jemal, Ahmedin			Perspectives of patients, family members, and health care providers on late diagnosis of breast cancer in Ethiopia: A qualitative study	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; WOMEN; INDIA; DELAY	Background Most women with breast cancer in Ethiopia are diagnosed at an advanced stage of the disease, but the reasons for this have not been systematically investigated. This study, therefore, aimed to explore the main reasons for diagnosis of advanced stage breast cancer from the perspective of patients, family members, and health care providers. Methods A qualitative study with in-depth interviews was conducted with 23 selected participants at Tikur Anbessa Specialized Hospital, Oncology Clinic using a semi-structured interview guide. These participants were 13 breast cancer patients, 5 family members, and 5 health care providers. Data were transcribed into English, coded and analyzed using thematic analysis. Results Awareness about the causes, risk, initial symptoms, early detection methods, and treatment of breast cancer were uncommon, and misconceptions about the disease prevailed among breast cancer patients and family members. There was a sense of hopelessness and uncertainty about the effectiveness of conventional medicine amongst patients and family members. Consequently, performing spiritual acts (using holy water) or seeking care from traditional healers recurred amongst the interviewees. Not taking initial symptoms of breast cancer seriously by the patients, reliance on traditional medicines, competing priorities, financial hardship, older age, fear of diagnosis of cancer, and weak health systems (e.g., delay in referral and long waiting period for consultation) were noted as the main contributors to late diagnosis. In contrast, persuasion by family members and friends, higher educational attainment, and prior experience of neighboring women with breast cancer were mentioned to be facilitators of early diagnosis of breast cancer. Conclusions The causes of late diagnosis of breast cancer in Ethiopia are multi-factorial and include individual, cultural, and health system factors. Interventions targeting these factors could alleviate the misconceptions and knowledge gap about breast cancer in the community, and shorten waiting time between symptom recognition and diagnosis of breast cancer.	[Gebremariam, Alem] Adigrat Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Adigrat, Ethiopia; [Gebremariam, Alem; Addissie, Adamu; Worku, Alemayehu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Assefa, Mathewos] Addis Ababa Univ, Radiotherapy Ctr, Sch Med, Addis Ababa, Ethiopia; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany; [Jemal, Ahmedin] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA	Addis Ababa University; Addis Ababa University; Martin Luther University Halle Wittenberg; American Cancer Society	Gebremariam, A (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Adigrat, Ethiopia.; Gebremariam, A (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia.	alemg25@gmail.com		Gebremariam, Alem/0000-0003-2173-6685	Intramural Research Department of the American Cancer Society	Intramural Research Department of the American Cancer Society	This project is supported by the Intramural Research Department of the American Cancer Society. The funder has no role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.	Abeje S, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-018-0695-9; Astalin PK, 2013, INT J SOC SCI INTERD, V2, P118; Atuhairwe C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5183-5; Awas T, 2009, P 16 INT C ETH STUD, V3, P711; Begashaw B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161014; Birhan W, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-39; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; Black E, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-018-0446-6; Bodapati SL, 2013, ASIAN PAC J CANCER P, V14, P5817, DOI 10.7314/APJCP.2013.14.10.5817; Bonsu AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212806; Clegg-Lamptey J N A, 2009, West Afr J Med, V28, P114; Deressa BT, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5612-6; Dye TD, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/908547; Dye TD, 2010, CANCER-AM CANCER SOC, V116, P577, DOI 10.1002/cncr.24776; Dye TD, 2011, GLOB PUBLIC HEALTH, V6, P719, DOI 10.1080/17441692.2010.510479; El Saghir NS, 2011, BREAST, V20, pS3, DOI 10.1016/j.breast.2011.02.006; Espina C, 2017, ANN EPIDEMIOL, V27, P659, DOI 10.1016/j.annepidem.2017.09.007; Federal Ministry of Health Ethiopia, NAT CANC CONTR PLAN; Frie KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207928; Frie KG, 2018, BREAST CARE, V13, P39, DOI 10.1159/000481087; Gebremariam A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027034; Hammarberg K, 2016, HUM REPROD, V31, P498, DOI 10.1093/humrep/dev334; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Joffe M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192071; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Kisuya J, 2015, HEALTH EDUC RES, V30, P786, DOI 10.1093/her/cyv043; Magana-Valladares L, 2018, J CANCER EDUC, V33, P160, DOI 10.1007/s13187-016-1065-7; Maghous A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2394-y; Manglona Rosa Duenas, 2010, Calif J Health Promot, V8, P90; McQueen A, 2008, HEALTH PSYCHOL, V27, P68, DOI 10.1037/0278-6133.27.1.68; Montazeri A, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-32; Pace LE, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00098; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Park E, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3965-2; Poum A, 2014, J EPIDEMIOL, V24, P102, DOI 10.2188/jea.JE20130090; Rastad H, 2012, ASIAN PAC J CANCER P, V13, P4511, DOI 10.7314/APJCP.2012.13.9.4511; Reeler AV, 2008, CLIN ONCOL-UK, V20, P191, DOI 10.1016/j.clon.2007.11.012; Sathwara JA, 2017, INDIAN J MED PAEDIAT, V38, P277, DOI 10.4103/ijmpo.ijmpo_15_16; Sharma K, 2013, J ONCOL, V2013, DOI 10.1155/2013/206367; Smit A, 2019, SOC SCI MED, V222, P231, DOI 10.1016/j.socscimed.2019.01.020; Smith MA, 2016, CLIN J ONCOL NURS, V20, P427, DOI 10.1188/16.CJON.427-432; Timotewos G, 2018, CANCER EPIDEMIOL, V53, P93, DOI 10.1016/j.canep.2018.01.008; Trotter RT, 2012, PREV MED, V55, P398, DOI 10.1016/j.ypmed.2012.07.003; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; World Health Organization, 2011, GLOB STAT REP ALC HL; Yi M, 2012, J ADV NURS, V68, P1100, DOI 10.1111/j.1365-2648.2011.05815.x; Yusoff N, 2011, ASIAN PAC J CANCER P, V12, P2563	47	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220769	10.1371/journal.pone.0220769	http://dx.doi.org/10.1371/journal.pone.0220769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369640	Green Submitted, gold, Green Published			2022-12-26	WOS:000484987900086
J	Kamali, AM; Saadi, ZK; Yahyavi, SS; Zarifkar, A; Aligholi, H; Nami, M				Kamali, Ali-Mohammad; Saadi, Zahra Kheradmand; Yahyavi, Seyedeh-Saeedeh; Zarifkar, Asadollah; Aligholi, Hadi; Nami, Mohammad			Transcranial direct current stimulation to enhance athletic performance outcome in experienced bodybuilders	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; ISOMETRIC STRENGTH; BRAIN-STIMULATION; WORKING-MEMORY; MODULATION; EXCITABILITY; ACTIVATION; TASK; TDCS; MECHANISMS	Transcranial direct current stimulation (tDCS) is currently under investigation as a promising technique for enhancement of athletic performance through modulating cortical excitability. Through consecutive randomization, 12 experienced bodybuilders were randomly assigned to two arms receiving either sham or real tDCS over the primary motor cortex (leg area) and left temporal cortex (T3) for 13 minutes in the first session. After 72 hours, both groups received the inverse stimulation. After the brain stimulation, cerebral hemodynamic response (using frontopolar hemoencephalography) was examined upon taking three computer-based cognitive tasks i.e. reasoning, memory and verbal ability using the Cambridge Brain Science-Cognitive Platform. Subsequently, the bodybuilders performed knee extension exercise while performance indicators including one-repetition maximum (1RM), muscular endurance (SEI), heart rate (ECG), motivation (VAS), surface electromyography over quadriceps femoris muscle (sEMG) and perceived exertion (RPE) were evaluated. The real tDCS vs. sham group showed decreased RPE and HR mean scores by 14.2% and 4.9%, respectively. Regarding muscular strength, endurance, and electrical activity, the 1RM, SEI, and sEMG factors improved by 4.4%, 16.9%, and % 5.8, respectively. Meanwhile, compared to sham, real tDCS did not affect the athletes' motivation. Incidentally, it turned out that subjects who underwent T3 anodal stimulation outperformed in memory (p = 0.02) and verbal functions (0.02) as well as their corresponding frontopolar hemodynamic response [(memory HEG (p = 0.001) and verbal HEG (p = 0.003)]. Our findings suggest that simultaneous tDCS-induced excitation over the M1 leg area and left temporal area may potentially improve the overall athletic performance in experienced bodybuilders.	[Kamali, Ali-Mohammad; Yahyavi, Seyedeh-Saeedeh; Zarifkar, Asadollah; Aligholi, Hadi; Nami, Mohammad] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Shiraz, Iran; [Kamali, Ali-Mohammad; Saadi, Zahra Kheradmand; Yahyavi, Seyedeh-Saeedeh; Aligholi, Hadi; Nami, Mohammad] Iranian Neurosci Soc, DANA Brain Hlth Inst, Fars Branch, Shiraz, Iran; [Kamali, Ali-Mohammad; Saadi, Zahra Kheradmand; Yahyavi, Seyedeh-Saeedeh; Nami, Mohammad] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Neurosci Lab,NSL Brain Cognit & Behav, Shiraz, Iran; [Kamali, Ali-Mohammad; Yahyavi, Seyedeh-Saeedeh] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran; [Saadi, Zahra Kheradmand] Shiraz Univ, Dept Foreign Languages & Literature, Shiraz, Iran; [Zarifkar, Asadollah] Shiraz Univ Med Sci, Dept Physiol, Sch Med, Shiraz, Iran; [Nami, Mohammad] Senses Cultural Fdn, Acad Hlth, Sacramento, CA 95826 USA	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University; Shiraz University of Medical Science	Nami, M (corresponding author), Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Shiraz, Iran.; Nami, M (corresponding author), Iranian Neurosci Soc, DANA Brain Hlth Inst, Fars Branch, Shiraz, Iran.; Nami, M (corresponding author), Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Neurosci Lab,NSL Brain Cognit & Behav, Shiraz, Iran.; Nami, M (corresponding author), Senses Cultural Fdn, Acad Hlth, Sacramento, CA 95826 USA.	torabinami@sums.ac.ir	zarifkar, asadollah/U-6873-2017; Nami, Mohammad/AAL-6280-2021	zarifkar, asadollah/0000-0002-2684-6712; Nami, Mohammad/0000-0003-1410-5340; Leo, TJ/0000-0002-9525-6572	Shiraz University of Medical Sciences [1396-01-74-14298]	Shiraz University of Medical Sciences	This work was supported by Shiraz University of Medical Sciences under the grant No. 1396-01-74-14298.	Angius L, 2016, NEUROSCIENCE, V339, P363, DOI 10.1016/j.neuroscience.2016.10.028; Angius L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00090; Baudewig J, 2001, MAGN RESON MED, V45, P196, DOI 10.1002/1522-2594(200102)45:2<196::AID-MRM1026>3.0.CO;2-1; Bigliassi M, 2016, PHYSIOL BEHAV, V158, P128, DOI 10.1016/j.physbeh.2016.03.001; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Borducchi DMM, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00183; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; Colzato LS, 2017, J COGN ENHANCE, V1, P73, DOI 10.1007/s41465-016-0003-2; Davis NJ, 2013, SPORTS MED, V43, P649, DOI 10.1007/s40279-013-0027-z; Devinsky Orrin, 2004, Epilepsy Curr, V4, P43, DOI 10.1111/j.1535-7597.2004.42001.x; Dutta A, 2014, NEUROREHABILITATION, V34, P789, DOI 10.3233/NRE-141077; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Furley PA, 2012, J SPORT EXERCISE PSY, V34, P322, DOI 10.1123/jsep.34.3.322; Furuya S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-35; Geiger M, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2219-6; Grospretre S, 2016, EUR J SPORT SCI, V16, P317, DOI 10.1080/17461391.2015.1024756; Hall JE, 2015, GUYTON HALL TXB MED; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Hazime FA, 2017, INT J SPORTS PHYS TH, V12, P402; Hermens HJ, 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI [10.1016/S1050-6411(00)00027-4, DOI 10.1016/S1050-6411(00)00027-4]; Hilz MJ, 2002, BRAIN, V125, P985, DOI 10.1093/brain/awf092; Jang SH, 2009, NEUROSCI LETT, V460, P117, DOI 10.1016/j.neulet.2009.05.037; Kamali A-M, 2018, CEREBELLUM, P1, DOI [10.1007/s12311-018-0919-4, DOI 10.1007/S12311-018-0919-4]; Kamali AM, 2019, CEREBELLUM, V18, P119, DOI 10.1007/s12311-018-0967-9; Kaminski E, 2016, CLIN NEUROPHYSIOL, V127, P2455, DOI 10.1016/j.clinph.2016.03.018; Kan B, 2013, APPL PHYSIOL NUTR ME, V38, P734, DOI 10.1139/apnm-2012-0412; Kaski D, 2014, NEUROSCI LETT, V568, P39, DOI 10.1016/j.neulet.2014.03.043; Kelsey JL., 1996, METHODS OBSERVATIONA; Krishnan C, 2014, BRAIN STIMUL, V7, P443, DOI 10.1016/j.brs.2014.01.057; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; LeSuer DA, 1997, J STRENGTH COND RES, V11, P211; Lewthwaite R, 2017, CURR OPIN PSYCHOL, V16, P38, DOI 10.1016/j.copsyc.2017.04.005; Medeiros L. F., 2012, NEUROBIOLOGICAL EFFE; Meinzer M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00253; Montenegro RA, 2011, NEUROSCI LETT, V497, P32, DOI 10.1016/j.neulet.2011.04.019; Moran A.P., 2016, PSYCHOL CONCENTRATIO; Muthalib M, 2013, ADV EXP MED BIOL, V789, P73, DOI 10.1007/978-1-4614-7411-1_11; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Noakes TD, 2011, SPORTS MED, V41, P263, DOI 10.2165/11583950-000000000-00000; Okano AH, 2013, BRIT J SPORT MED; Okano AH, 2015, BRIT J SPORT MED, V49, P1213, DOI 10.1136/bjsports-2012-091658; Oki K, 2001, J GERIATRIC PHYS THE; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Rroji O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127270; Serra-Sala M., 2012, J NEUROTHER, V16, P183, DOI [10.1080/10874208.2012.705754, DOI 10.1080/10874208.2012.705754]; Simons HD, 1999, J COLL STUDENT DEV, V40, P151; Sloan RP, 2009, AM J PUBLIC HEALTH, V99, P921, DOI 10.2105/AJPH.2007.133165; Sohn MK, 2013, ANN REHABIL MED-ARM, V37, P759, DOI 10.5535/arm.2013.37.6.759; Soutschek A, 2018, BIOL PSYCHIAT, V84, P38, DOI 10.1016/j.biopsych.2017.11.007; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Tanaka S, 2009, EXP BRAIN RES, V196, P459, DOI 10.1007/s00221-009-1863-9; Toomim H., 2005, J NEUROTHER, V8, P5, DOI DOI 10.1300/J184V08N03_; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH424, DOI 10.1152/ajpheart.1998.274.2.H424; Vitor-Costa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144916; Williams PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081418; Wulf G, 2016, PSYCHON B REV, V23, P1382, DOI 10.3758/s13423-015-0999-9; Zhou JH, 2014, EUR J NEUROSCI, V39, P1343, DOI 10.1111/ejn.12492; Zhou P, 2004, J NEUROPHYSIOL, V92, P2878, DOI 10.1152/jn.00367.2004; Zhu FF, 2015, BRAIN STIMUL, V8, P784, DOI 10.1016/j.brs.2015.02.005; Ziemann U, 1998, J NEUROSCI, V18, P7000	66	22	22	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220363	10.1371/journal.pone.0220363	http://dx.doi.org/10.1371/journal.pone.0220363			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369607	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900043
J	Schenk, M; Kropfl, JM; Hoermann-Kroepfl, M; Weiss, G				Schenk, Michael; Kropfl, Julia Maria; Hoermann-Kroepfl, Martina; Weiss, Gregor			Endometriosis accelerates synchronization of early embryo cell divisions but does not change morphokinetic dynamics in endometriosis patients	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTION; BLASTOCYST FORMATION; OOCYTE QUALITY; CLEAVAGE; IMPACT; IMPLANTATION; PREDICTORS; WOMEN	Objective The pathology of endometriosis and its impact on embryo development is still a black box in reproductive medicine. In this time-lapse study we investigated the influence of endometriosis on morphokinetic parameters of embryo development, taking variables of dynamic monitoring into account. Furthermore we evaluated reproductive medicine treatment outcome such as fetal heartbeat and live birth rate. Methods 1148 embryos (control: n = 596, endometriosis: n = 552) were retrospectively analyzed. Patients were stimulated with GnRH antagonist protocol. After fertilization, embryos were incubated in a time-lapse system (EmbryoScope). Results The mixed-model analysis revealed a significant main effect of time (p< 0.001), with posthoc tests showing that any time needed to reach a specific developmental stage was significantly different from all the others (all p< 0.001). Embryos of endometriosis patients showed the same absolute morphokinetic time parameters as the control group, however, synchronization of early embryo cell divisions (s2) was faster in endometriosis patients compared to the control group. Conclusion In general, endometriosis does not induce changes in early embryo morphokinetics. However, observed acceleration in cell cycle synchronization of embryo cleavage patterns might be a missing explanation for contradicting results in literature regarding the impairments in reproductive medicine treatment outcome of endometriosis patients.	[Schenk, Michael; Hoermann-Kroepfl, Martina; Weiss, Gregor] Kinderwunsch Inst Schenk GmbH, Dobl, Austria; [Schenk, Michael] Med Univ Graz, Inst Human Genet, Graz, Austria; [Kropfl, Julia Maria] Swiss Fed Inst Technol, Exercise Physiol Lab, Inst Human Movement Sci & Sport, Zurich, Switzerland	Medical University of Graz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Weiss, G (corresponding author), Kinderwunsch Inst Schenk GmbH, Dobl, Austria.	gregor.weiss@kinderwunsch-institut.at	Kröpfl, Julia Maria/ABE-5570-2020	Kröpfl, Julia Maria/0000-0002-9613-7268				Alviggi C, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-9; Armstrong S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011320.pub3; Balaban B, 2011, HUM REPROD, V26, pI24; Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366; Boynukalin FK, 2019, SYST BIOL REPROD MED, V65, P250, DOI 10.1080/19396368.2019.1573275; Burney RO, 2012, FERTIL STERIL, V98; Cetinkaya M, 2015, J ASSIST REPROD GEN, V32, P27, DOI 10.1007/s10815-014-0341-x; Chawla M, 2015, J ASSIST REPROD GEN, V32, P69, DOI 10.1007/s10815-014-0372-3; Ciray HN, 2014, HUM REPROD, V29, P2650, DOI 10.1093/humrep/deu278; Fauser BCJM, 2008, HUM REPROD UPDATE, V14, P1, DOI 10.1093/humupd/dmm034; Freis A, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0307-9; Goud PT, 2014, FERTIL STERIL, V102, P151, DOI 10.1016/j.fertnstert.2014.03.053; Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093; Huppertz B, 2016, OPEN J BIORESOUR, V3; Johnson NP, 2016, HUM REPROD OXF ENGL; Liu E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012019; Lundin K, 2001, HUM REPROD, V16, P2652, DOI 10.1093/humrep/16.12.2652; Martins WP, 2017, ULTRASOUND OBST GYN, V49, P583, DOI 10.1002/uog.17327; Milewski R, 2015, J ASSIST REPROD GEN, V32, P571, DOI 10.1007/s10815-015-0440-3; Nisenblat V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012179; Pop-Trajkovic S, 2014, TAIWAN J OBSTET GYNE, V53, P224, DOI 10.1016/j.tjog.2013.10.040; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031; Rogers PAW, 2009, REPROD SCI, V16, P335, DOI 10.1177/1933719108330568; Rubio I, 2012, FERTIL STERIL, V98, P1458, DOI 10.1016/j.fertnstert.2012.07.1135; Sanchez AM, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0341-4; Schenk M, 2016, J ASSIST REPROD GENE; Schenk M, 2017, J ASSIST REPROD GENE; SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578; VerMilyea MD, 2014, REPROD BIOMED ONLINE, V29, P729, DOI 10.1016/j.rbmo.2014.09.005; Wissing ML, 2014, REPROD BIOMED ONLINE, V28, P508, DOI 10.1016/j.rbmo.2013.11.017; Xu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10779; Yland J, 2019, HUM REPROD, V34, P549, DOI 10.1093/humrep/dey374	32	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220529	10.1371/journal.pone.0220529	http://dx.doi.org/10.1371/journal.pone.0220529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369616	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900062
J	Moroney, KM; O'Connell, K; Meikle-Janney, P; O'Brien, SBG; Walker, GM; Lee, WT				Moroney, Kevin M.; O'Connell, Ken; Meikle-Janney, Paul; O'Brien, Stephen B. G.; Walker, Gavin M.; Lee, William T.			Analysing extraction uniformity from porous coffee beds using mathematical modelling and computational fluid dynamics approaches	PLOS ONE			English	Article							TIME-RESOLVED EXTRACTION; CAFFEINE INFUSION; ESPRESSO COFFEE; GROUND COFFEE; KINETICS; MECHANISM; QUANTIFICATION; TRIGONELLINE	Achieving a uniform extraction of soluble material from a porous matrix is a generic problem in various separation and filtration operations, with applications in the food processing, chemical and pharmaceutical industries. This paper describes models of fluid flow and transport of soluble material within a packed granular bed in the context of coffee extraction. Coffee extraction is described by diffusion of soluble material from particles of one or more representative sizes into fluid flowing through the packed bed. One-dimensional flow models are compared to computational fluid dynamics (CFD) models. A fine and a coarse coffee grind are considered. Model results are compared to experimental data for a packed cylindrical coffee bed and the influence of a change in geometry to a truncated cone is considered. Non-uniform flow in the truncated cone causes significant variation in the local extraction level. Coffee extraction levels during brewing are analysed using extraction maps and the degree of variation is represented on the industry standard coffee brewing control chart. A high variation in extraction yield can be expected to impart bitter flavours into the brew and thus is an important variable to quantify.	[Moroney, Kevin M.] Univ Limerick, Bernal Inst, SSPC, Limerick, Ireland; [Moroney, Kevin M.; O'Brien, Stephen B. G.; Lee, William T.] Univ Limerick, Dept Math & Stat, MACSI, Limerick, Ireland; [O'Connell, Ken; Walker, Gavin M.] Univ Limerick, Dept Chem Sci, Limerick, Ireland; [Meikle-Janney, Paul] Dark Woods Coffee, Holme Mills,West Slaithwaite Rd, Huddersfield, W Yorkshire, England; [Lee, William T.] Univ Huddersfield, Huddersfield, W Yorkshire, England	University of Limerick; University of Limerick; University of Limerick; University of Huddersfield	Moroney, KM (corresponding author), Univ Limerick, Bernal Inst, SSPC, Limerick, Ireland.; Moroney, KM (corresponding author), Univ Limerick, Dept Math & Stat, MACSI, Limerick, Ireland.	kevin.moroney@ul.ie	Moroney, Kevin M/N-7072-2017; Lee, William/B-7988-2011	Moroney, Kevin M/0000-0002-4573-5137; Lee, William/0000-0003-4200-407X	Science Foundation Ireland 'Modelling of Multi-Phase Transport Processes to Enable Automation in Manufacturing, (MOMEnTUM)'; European Regional Development Fund [14/SP/2750]; Dairy Processing Technology Centre - Enterprise Ireland [TC 2014 0016]; MACSI, the Mathematics Applications Consortium for Science and Industry - Science Foundation Ireland [12/IA/1683]	Science Foundation Ireland 'Modelling of Multi-Phase Transport Processes to Enable Automation in Manufacturing, (MOMEnTUM)'; European Regional Development Fund(European Commission); Dairy Processing Technology Centre - Enterprise Ireland; MACSI, the Mathematics Applications Consortium for Science and Industry - Science Foundation Ireland(Science Foundation Ireland)	This publication has emanated from research supported in part by a research grant from Science Foundation Ireland (http://www.sfi.ie/) 'Modelling of Multi-Phase Transport Processes to Enable Automation in Manufacturing, (MOMEnTUM)' awarded to GW and SOB and is co-funded under the European Regional Development Fund under Grant Number 14/SP/2750. The authors also acknowledge support from the Dairy Processing Technology Centre (https://dptc.ie/), supported by Enterprise Ireland (https://enterprise-ireland.com/en/) grant agreement number TC 2014 0016 awarded to GW. This work was also supported by MACSI, the Mathematics Applications Consortium for Science and Industry (www.macsi.ul.ie), funded by the Science Foundation Ireland Investigator Award 12/IA/1683 awarded to SOB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PMJ is an employee at Dark Woods Coffee Ltd., United Kingdom. Dark Woods Coffee Ltd provided support in the form of salary for author PMJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association SC, 2017 US SPEC COFF CO; Bogacki P., 1989, APPL MATH LETT, V2, P321, DOI [10.1016/0893-9659(89)90079-7, DOI 10.1016/0893-9659(89)90079-7]; Caprioli G, 2014, INT J FOOD SCI NUTR, V65, P465, DOI 10.3109/09637486.2013.873890; Corrochano BR, 2015, J FOOD ENG, V150, P106, DOI 10.1016/j.jfoodeng.2014.11.006; Espinoza-Perez JD, 2007, J FOOD ENG, V81, P72, DOI 10.1016/j.jfoodeng.2006.10.011; Fadai NT, 2017, INT J HEAT MASS TRAN, V104, P787, DOI 10.1016/j.ijheatmasstransfer.2016.08.083; Fasano A, 1999, SIAM J MATH ANAL, V31, P251, DOI 10.1137/S0036141098336698; Fasano A, 2000, MODEL SIMUL SCI ENG, P241; FASANO A., 2000, LECT NOTES MATH, V1734, P79, DOI DOI 10.1007/BFB0103976; Fasano A., 2010, REND I MAT U TRIESTE, V42, P65; Fluent A., 2017, ANSYS FLUENT THEORY; Fuller M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18247-4; Gloess AN, 2013, EUR FOOD RES TECHNOL, V236, P607, DOI 10.1007/s00217-013-1917-x; Inc VST, COFFEETOOLS ANDR QUI; Jaganyi D, 2000, J SCI FOOD AGR, V80, P85, DOI 10.1002/(SICI)1097-0010(20000101)80:1<85::AID-JSFA489>3.0.CO;2-#; Kuhn M, 2017, J FOOD ENG, V206, P37, DOI 10.1016/j.jfoodeng.2017.03.002; LEE TA, 1992, J FOOD SCI, V57, P1417, DOI 10.1111/j.1365-2621.1992.tb06872.x; Lockhart EE., 1957, SOLUBLE SOLIDS BEVER; Mateus ML, 2007, J AGR FOOD CHEM, V55, P10117, DOI 10.1021/jf071901v; Melrose J, 2018, J AGR FOOD CHEM, V66, P5301, DOI 10.1021/acs.jafc.7b04848; Moroney KM, 2016, SIAM J APPL MATH, V76, P2196, DOI 10.1137/15M1036658; Moroney KM, 2015, CHEM ENG SCI, V137, P216, DOI 10.1016/j.ces.2015.06.003; Moroney KM, 2016, J MATH IND, V7, DOI 10.1186/s13362-016-0024-6; Moroney KM, 2016, HEAT MASS TRANSFER D; Roache PJ, 1997, ANNU REV FLUID MECH, V29, P123, DOI 10.1146/annurev.fluid.29.1.123; ROACHE PJ, 1994, J FLUID ENG-T ASME, V116, P405, DOI 10.1115/1.2910291; Roman Corrochano B, 2017, ADV ENG UNDERSTANDIN; Sanchez-Lopez JA, 2014, ANAL CHEM, V86, P11696, DOI 10.1021/ac502992k; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Smrke S, 2018, J AGR FOOD CHEM, V66, P5293, DOI 10.1021/acs.jafc.7b03310; SPIRO M, 1985, J SCI FOOD AGR, V36, P871, DOI 10.1002/jsfa.2740360917; SPIRO M, 1984, J SCI FOOD AGR, V35, P925, DOI 10.1002/jsfa.2740350818; Spiro M, 1997, J SCI FOOD AGR, V74, P416, DOI 10.1002/(SICI)1097-0010(199707)74:3<416::AID-JSFA868>3.0.CO;2-0; SPIRO M, 1984, J SCI FOOD AGR, V35, P915, DOI 10.1002/jsfa.2740350817; SPIRO M, 1989, J SCI FOOD AGR, V46, P349, DOI 10.1002/jsfa.2740460313; Stack P, 2013, EUROPEAN EXTRACTION; Uman E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24483; Voilley A., 1980, Journal of Food Process Engineering, V3, P185, DOI 10.1111/j.1745-4530.1979.tb00238.x; Wang XJ, 2016, FOOD RES INT, V89, P797, DOI 10.1016/j.foodres.2016.09.031	39	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219906	10.1371/journal.pone.0219906	http://dx.doi.org/10.1371/journal.pone.0219906			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365538	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600022
J	Bach, A; Conzen, C; Schubert, GA; Bleilevens, C; Lindauer, U				Bach, Annika; Conzen, Catharina; Schubert, Gerrit Alexander; Bleilevens, Christian; Lindauer, Ute			Acute changes of pro-inflammatory markers and corticosterone in experimental subarachnoid haemorrhage: A prerequisite for severity assessment	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; PLASMA-CORTICOSTERONE; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; ANIMAL-MODELS; BRAIN-INJURY; FACTOR-ALPHA; VASOSPASM; INTERLEUKIN-6	Many details of the pathophysiology of subarachnoid haemorrhage (SAH) still remain unknown, making animal experiments an indispensable tool for assessment of diagnostics and therapy. For animal protection and project authorization, one needs objective measures to evaluate the severity and burden in each model. Corticosterone is described as a sensitive stress parameter reflecting the acute burden, and inflammatory markers can be used for assessment of the extent of the brain lesion. However, the brain lesion itself may activate the hypothalamic-pituitary-adrenal-axis early after SAH, as shown for ischemic stroke, probably interfering with early inflammatory processes, thus complicating the assessment of severity and burden on the basis of corticosterone and inflammation. To assess the suitability of these markers in SAH, we evaluated the courses of corticosterone, IL-6 and TNF-alpha up to 6h in an acute model simulating SAH in continuously anaesthetized rats, lacking the pain and stress induced impact on these parameters. Animals were randomly allocated to sham or SAH. SAH was induced by cisterna magna blood-injection, and intracranial pressure and cerebral blood flow were measured under continuous isoflurane/fentanyl anaesthesia. Withdrawn at predetermined time points, blood was analysed by commercial ELISA kits. After 6h the brain was removed for western blot analysis of IL-6 and TNF-alpha. Serum corticosterone levels were low with no significant difference between sham and SAH. No activation of the HPA-axis was detectable, rendering corticosterone a potentially useful parameter for stress assessment in future chronic studies. Blood IL-6 and TNF-alpha increased in both groups over time, with IL-6 increasing significantly more in SAH compared to sham towards the end of the observation period. In the basal cortex, IL-6 and TNF-alpha increased only in SAH. The proinflammatory response seems to start locally in the brain, reflected by an increase in peripheral blood. An additional surgery-induced systemic inflammatory response should be considered.	[Bach, Annika; Conzen, Catharina; Lindauer, Ute] Rhein Westfal TH Aachen, Univ Hosp Aachen, Translat Neurosurg & Neurobiol, Aachen, Germany; [Conzen, Catharina; Schubert, Gerrit Alexander; Lindauer, Ute] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Neurosurg, Aachen, Germany; [Bleilevens, Christian] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Lindauer, U (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Translat Neurosurg & Neurobiol, Aachen, Germany.; Lindauer, U (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Neurosurg, Aachen, Germany.	ulindauer@ukaachen.de	Bleilevens, Christian/AAG-8034-2020; Schubert, Gerrit Alexander/Q-9192-2017	Bleilevens, Christian/0000-0002-2104-1843; Schubert, Gerrit Alexander/0000-0001-9135-6042	Deutsche Forschungsgemeinschaft [LI588/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant number LI588/5-1 to UL, Deutsche Forschungsgemeinschaft, www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buttini M, 1996, NEUROSCIENCE, V71, P1, DOI 10.1016/0306-4522(95)00414-9; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Conzen C, 2018, TRANSL STROKE RES, V9, P284, DOI 10.1007/s12975-017-0585-8; de la Tremblaye PB, 2014, HORM BEHAV, V65, P273, DOI 10.1016/j.yhbeh.2014.01.003; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Duris K, 2019, TRANSL STROKE RES, V10, P308, DOI 10.1007/s12975-018-0641-z; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Foreman B, 2016, J CLIN NEUROPHYSIOL, V33, P174, DOI 10.1097/WNP.0000000000000273; Gaetani P, 1998, NEUROL RES, V20, P337, DOI 10.1080/01616412.1998.11740528; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Gruber A, 2000, J NEUROSURG ANESTH, V12, P297, DOI 10.1097/00008506-200010000-00001; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Hollig A, 2015, CLIN NEUROL NEUROSUR, V138, P177, DOI 10.1016/j.clineuro.2015.08.030; Hoellig A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123398; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; Kato H, 2009, ANESTH ANALG, V108, P288, DOI 10.1213/ane.0b013e318187bb93; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mathiesen T, 1997, J NEUROSURG, V87, P215, DOI 10.3171/jns.1997.87.2.0215; Megyesi JF, 2000, NEUROSURGERY, V46, P448, DOI 10.1097/00006123-200002000-00035; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mracsko E, 2014, BRAIN BEHAV IMMUN, V41, P200, DOI 10.1016/j.bbi.2014.05.015; Osuka K, 1998, ACTA NEUROCHIR, V140, P943, DOI 10.1007/s007010050197; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Schoch B, 2007, NEUROSURGERY, V60, P828, DOI 10.1227/01.NEU.0000255440.21495.80; SEGGIE JA, 1975, CAN J PHYSIOL PHARM, V53, P629, DOI 10.1139/y75-087; Sehba FA, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/615154; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; SMITH CJ, 2004, BMC NEUROL, V4; Suzuki S, 1999, J CEREBR BLOOD F MET, V19, P1256, DOI 10.1097/00004647-199911000-00010; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220467	10.1371/journal.pone.0220467	http://dx.doi.org/10.1371/journal.pone.0220467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361786	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300031
J	Jobby, R; Jha, P; Gupta, A; Gupte, A; Desai, N				Jobby, Renitta; Jha, Pamela; Gupta, Anand; Gupte, Arpita; Desai, Neetin			Biotransformation of chromium by root nodule bacteria Sinorhizobium sp. SAR1	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; PSEUDOMONAS-AERUGINOSA; AQUEOUS-SOLUTION; BIOSORPTION; REMOVAL; CR(VI); REDUCTION; ADSORPTION; GROWTH; COPPER(II)	The present study aims to address the problem of chromium (Cr) toxicity by providing important insights into the mechanisms involved in its bioremediation. Among the 22 Rhizobium and Sinorhizobium isolates obtained from Sesbania sesban root nodules, Sinorhizobium sp. SAR1 (JX174035.1) tolerated the maximum Cr concentration (1mM) and hence was used for further studies. The excess secretion of extra polymeric substances, as seen from scanning electron micrographs, could be a probable mechanism of adaptation to the Cr stress. The Energy dispersive X-ray spectroscopy data did not show any peaks of Cr. The biosorption studies done on the isolate gave maximum adsorption capacity as 285.71mg/g. The isotherm studies showed a better fit to Langmuir isotherm. The Weber and Morris plot established that the phenomenon of adsorption was governed by film diffusion mechanism. The FTIR analysis suggested the role of cell wall components and extracellular polymeric substances in Cr adsorption to the biomass of Sinorhizobium. On the basis of these results a compiled mechanism of Cr (VI) adsorption and its biotransformation into Cr (III) by Sinorhizobium sp. SAR1 is explained. This work outlines a comprehensive detail for the exact phenomenon of Cr biotransformation by Sinorhizobium sp. SAR1. These results may further help in developing and enhancing effective bioremediation approaches.	[Jobby, Renitta; Jha, Pamela; Gupta, Anand; Desai, Neetin] Amity Univ, Amity Inst Biotechnol, Mumbai Pune Expressway, Mumbai, Maharashtra, India; [Gupte, Arpita] DY Patil Univ, Sch Biotechnol & Bioinformat, CBD, Sect 15-50, Belapur, Navi Mumbai, India		Desai, N (corresponding author), Amity Univ, Amity Inst Biotechnol, Mumbai Pune Expressway, Mumbai, Maharashtra, India.	ndesai@mum.amity.edu	Jha, Pamela/AAV-4614-2021; Jobby, Renitta/Y-2232-2019; Gupte, Arpita/ABD-7995-2021	Jha, Pamela/0000-0003-2958-5033; Jobby, Renitta/0000-0002-4804-5174; Gupte, Arpita/0000-0003-4520-5782; Desai, Neetin/0000-0002-1763-9041				Abou-Shanab RAI, 2007, CHEMOSPHERE, V68, P360, DOI 10.1016/j.chemosphere.2006.12.051; AKSU Z, 1992, ENVIRON TECHNOL, V13, P579, DOI 10.1080/09593339209385186; Ashraf MA, 2011, AFR J BIOTECHNOL, V10, P2163; Bagwell CE, 2008, APPL ENVIRON MICROB, V74, P1376, DOI 10.1128/AEM.02175-07; Batool R, 2012, J MICROBIOL BIOTECHN, V22, P547, DOI 10.4014/jmb.1108.08029; Beveridge T. J, 1989, METAL IONS BACTERIA; Browning CL, 2017, TOXICOL APPL PHARM, V331, P101, DOI 10.1016/j.taap.2017.05.030; Burno BYM, 2008, MINER ENG, V21, P65; Cervantes C, 2001, FEMS MICROBIOL REV, V25, P335, DOI 10.1111/j.1574-6976.2001.tb00581.x; Chen BY, 2000, INT BIODETER BIODEGR, V46, P11, DOI 10.1016/S0964-8305(00)00054-8; Choudhary B, 2018, J ENVIRON CHEM ENG, V6, P2335, DOI 10.1016/j.jece.2018.03.028; Daifullah AAM, 2007, J HAZARD MATER, V147, P633, DOI 10.1016/j.jhazmat.2007.01.062; Gadi R., 2012, J ENV CHEM ECOTOXICO, V4, P137, DOI [10.5897/JECE11.076, DOI 10.5897/JECE11.076, DOI 10.5897/JECE12.003]; Gode F, 2006, J HAZARD MATER, V136, P330, DOI 10.1016/j.jhazmat.2005.12.021; GUIBAL E, 1994, REACT POLYM, V23, P147, DOI 10.1016/0923-1137(94)90015-9; Han X, 2007, J HAZARD MATER, V146, P65, DOI 10.1016/j.jhazmat.2006.11.053; Helmann JD, 2007, MOL MICROBIOLOGY HEA, V6, P37; Horsfall M, 2005, AFR J BIOTECHNOL, V4, P191; Jobby R., 2015, INT J ADV RES, V3, P706; Jobby R, 2018, CHEMOSPHERE, V207, P255, DOI 10.1016/j.chemosphere.2018.05.050; Joo JH, 2010, INT BIODETER BIODEGR, V64, P734, DOI 10.1016/j.ibiod.2010.08.007; Jooste S, 2000, WATER SA, V26, P159; Karthik C, 2017, MICROBIOL RES, V204, P65, DOI 10.1016/j.micres.2017.07.008; Karthik C, 2017, ARCH AGRON SOIL SCI, V63, P1058, DOI 10.1080/03650340.2016.1261116; Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2; Lahari SB, 2011, IRAN J ENVIRON HEALT, V8, P383; Langley S, 1999, APPL ENVIRON MICROB, V65, P489; Loukidou MX, 2004, J CHEM TECHNOL BIOT, V79, P711, DOI 10.1002/jctb.1043; Madigan M. T., 2000, BROCK BIOL MICROORGA; McLean JS, 1999, INTERACTIONS SOIL PA; Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0; NIETO JJ, 1987, APPL ENVIRON MICROB, V53, P1199, DOI 10.1128/AEM.53.5.1199-1202.1987; Oves M, 2013, EUR J SOIL BIOL, V56, P72, DOI 10.1016/j.ejsobi.2013.02.002; Papp J.F., 2004, 10 INT FERR C CAP TO, P770; Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042; Prabhakaran SK, 2009, IND ENG CHEM RES, V48, P2113, DOI 10.1021/ie801380h; Rani A, 2008, IEEE INT CONF NETWOR, P207; Netzahuatl-Munoz AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137086; Singh DB, 1996, COLLOID SURFACE A, V111, P49, DOI 10.1016/0927-7757(95)03468-4; Srinath T, 2002, CHEMOSPHERE, V48, P427, DOI 10.1016/S0045-6535(02)00089-9; Tamil Nadu Pollution Control Board, 2010, REV ACT PLAN CRIT PO; Thacker U, 2005, WORLD J MICROB BIOT, V21, P891, DOI 10.1007/s11274-004-6557-7; Thatheyus A.J., 2016, SCI INT, V4, P74, DOI DOI 10.17311/SCIINTL.2016.74.79; Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X; Vendruscolo F, 2017, INT BIODETER BIODEGR, V119, P87, DOI 10.1016/j.ibiod.2016.10.008; Viti C, 2014, FEMS MICROBIOL REV, V38, P633, DOI 10.1111/1574-6976.12051; VOLESKY B, 1994, BIOTECHNOL BIOENG, V43, P1010, DOI 10.1002/bit.260431103; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Zhang J, 2018, ENVIRON POLLUT, V237, P740, DOI 10.1016/j.envpol.2017.10.120; Ziagova M, 2007, BIORESOURCE TECHNOL, V98, P2859, DOI 10.1016/j.biortech.2006.09.043	50	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0219387	10.1371/journal.pone.0219387	http://dx.doi.org/10.1371/journal.pone.0219387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361751	Green Submitted, gold, Green Published			2022-12-26	WOS:000484981300011
J	Molinet, J; Cubillos, FA; Salinas, F; Liti, G; Martinez, C				Molinet, Jennifer; Cubillos, Francisco A.; Salinas, Francisco; Liti, Gianni; Martinez, Claudio			Genetic variants of TORC1 signaling pathway affect nitrogen consumption in Saccharomyces cerevisiae during alcoholic fermentation	PLOS ONE			English	Article							AMINO-ACID; WINE YEAST; CATABOLITE REPRESSION; TRANSCRIPTION; GROWTH; EXPRESSION; COMPLEX; MODEL; IDENTIFICATION; TRANSPORTERS	In the alcoholic fermentation process, Saccharomyces cerevisiae strains present differences in their nitrogen consumption profiles, these phenotypic outcomes have complex genetic and molecular architectures. In this sense, variations in nitrogen signaling pathways regulated by TORC1 represent one of the main sources of phenotypic diversity in nitrogen consumption. This emphasizes the possible roles that allelic variants from the TORC1 pathway have in the nitrogen consumption differences observed in yeast during the alcoholic fermentation. Here, we studied the allelic diversity in the TORC1 pathway across four yeast strains and determined how these polymorphisms directly impact nitrogen consumption during alcoholic fermentation. Using a reciprocal hemizygosity approach combined with phenotyping under fermentative conditions, we found that allelic variants of GTR1, TOR2, SIT4, SAP185, EAP1, NPR1 and SCH9 underlie differences in the ammonium and amino acids consumption phenotypes. Among these, GTR1 alleles from the Wine/European and West African genetic backgrounds showed the greatest effects on ammonium and amino acid consumption, respectively. Furthermore, we identified allelic variants of SAP185, TOR2, SCH9 and NPR1 from an oak isolate that increased the amino acid consumption preference over ammonium; representing putative candidates coming from a non-domesticated strain that could be used for genetic improvement programs. In conclusion, our results demonstrated that a large number of allelic variants within the TORC1 pathway significantly impacts on regulatory mechanisms of nitrogen assimilation during alcoholic fermentation.	[Molinet, Jennifer; Martinez, Claudio] Univ Santiago Chile USACH, Dept Ciencia & Tecnol Alimentos, Santiago, Chile; [Cubillos, Francisco A.; Salinas, Francisco] Millennium Inst Integrat Biol iBio, Santiago, Chile; [Cubillos, Francisco A.] Univ Santiago Chile USACH, Fac Quim & Biol, Dept Biol, Santiago, Chile; [Cubillos, Francisco A.; Salinas, Francisco; Martinez, Claudio] Univ Santiago Chile USACH, CECTA, Santiago, Chile; [Salinas, Francisco] Univ Austral Chile, Fac Ciencias, Inst Bioquim & Microbiol, Valdivia, Chile; [Liti, Gianni] Univ Cote dAzur, NSERM, CNRS, IRCAN, Nice, France	Universidad de Santiago de Chile; Universidad de Santiago de Chile; Universidad de Santiago de Chile; Universidad Austral de Chile; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Martinez, C (corresponding author), Univ Santiago Chile USACH, Dept Ciencia & Tecnol Alimentos, Santiago, Chile.; Martinez, C (corresponding author), Univ Santiago Chile USACH, CECTA, Santiago, Chile.	claudio.martinez@usach.cl	Salinas, Francisco/W-3269-2017; Molinet, Jennifer/AAI-3636-2020; Salinas, Francisco/AAP-9439-2020	Salinas, Francisco/0000-0002-8391-8145; Salinas, Francisco/0000-0002-8391-8145; Molinet, Jennifer/0000-0001-9716-4455	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Programa Formacion de Capital Humano Avanzado (PCHA) Doctorado Nacional [2014-21140935]; Programa de Cooperacion Cientifica ECOS/CONICYT [C13B02]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1150522, 11170158]; Programa de Cooperacion Internacional (CONICYT/PCI) [REDI170239]; "Direccion de Investigacion Cientifica y Tecnologica" (DICYT) of the "Universidad de Santiago de Chile" (USACH) grant [081571MF2_POSTDOC]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Programa Formacion de Capital Humano Avanzado (PCHA) Doctorado Nacional; Programa de Cooperacion Cientifica ECOS/CONICYT; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Cooperacion Internacional (CONICYT/PCI); "Direccion de Investigacion Cientifica y Tecnologica" (DICYT) of the "Universidad de Santiago de Chile" (USACH) grant	This work was supported by the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Programa Formacion de Capital Humano Avanzado (PCHA) Doctorado Nacional [grant 2014-21140935 to J.M.], Programa de Cooperacion Cientifica ECOS/CONICYT [grant C13B02 to F.A.C., C.M. and G.L.], Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [grant 1150522 to C.M. and 11170158 to F.S.] and Programa de Cooperacion Internacional (CONICYT/PCI) [grant REDI170239 to F.S., G.L. and C.M.]; "Direccion de Investigacion Cientifica y Tecnologica" (DICYT) of the "Universidad de Santiago de Chile" (USACH) grant 081571MF2_POSTDOC to C.M.	Barbosa C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122709; Bell SJ, 2005, AUST J GRAPE WINE R, V11, P242, DOI 10.1111/j.1755-0238.2005.tb00028.x; Beltran G, 2004, FEMS YEAST RES, V4, P625, DOI 10.1016/j.femsyr.2003.12.004; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; Bergstrom A, 2014, MOL BIOL EVOL, V31, P872, DOI 10.1093/molbev/msu037; Boeckstaens M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005382; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brice C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192383; Brice C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-495; Brice C, 2014, APPL ENVIRON MICROB, V80, P1330, DOI 10.1128/AEM.03856-13; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chen JCY, 2006, CURR GENET, V49, P281, DOI 10.1007/s00294-005-0055-9; Chiva R, 2009, J APPL MICROBIOL, V107, P235, DOI 10.1111/j.1365-2672.2009.04201.x; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Contreras A, 2012, WORLD J MICROB BIOT, V28, P1107, DOI 10.1007/s11274-011-0911-3; Crepin L, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02617-16; Crepin L, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0109-0; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; Cubillos FA, 2017, G3-GENES GENOM GENET, V7, P1693, DOI 10.1534/g3.117.042127; Cubillos FA, 2013, GENETICS, V195, P1141, DOI 10.1534/genetics.113.155515; Cubillos FA, 2009, FEMS YEAST RES, V9, P1217, DOI 10.1111/j.1567-1364.2009.00583.x; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Fay JC, 2013, CURR OPIN GENET DEV, V23, P672, DOI 10.1016/j.gde.2013.10.005; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gertz J, 2010, THEOR POPUL BIOL, V77, P1, DOI 10.1016/j.tpb.2009.10.002; Gomez-Alonso S, 2007, J AGR FOOD CHEM, V55, P608, DOI 10.1021/jf062820m; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Gournas C, 2016, ADV EXP MED BIOL, V892, P69, DOI 10.1007/978-3-319-25304-6_4; Gutierrez A, 2016, APPL MICROBIOL BIOT, V100, P3255, DOI 10.1007/s00253-015-7273-y; Gutierrez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067166; Gutierrez A, 2012, FOOD MICROBIOL, V31, P25, DOI 10.1016/j.fm.2012.02.012; Hong JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004041; Ibstedt S, 2015, MOL BIOL EVOL, V32, P153, DOI 10.1093/molbev/msu285; Jara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086533; Kessi-Perez EI, 2019, YEAST, V36, P65, DOI 10.1002/yea.3351; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; MacDonald C, 2017, J CELL BIOL, V216, P3275, DOI 10.1083/jcb.201702177; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Martinez C, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue4-fulltext-8; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Nelissen B, 1997, FEMS MICROBIOL REV, V21, P113, DOI 10.1111/j.1574-6976.1997.tb00347.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nghe P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03644-8; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; Ono J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002591; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Rohde JR, 2004, MOL CELL BIOL, V24, P8332, DOI 10.1128/MCB.24.19.8332-8341.2004; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Saerens SMG, 2008, APPL MICROBIOL BIOT, V80, P1039, DOI 10.1007/s00253-008-1645-5; Salinas F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21849; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Sengottaiyan P, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-11; Shin CS, 2009, J CELL SCI, V122, P2089, DOI 10.1242/jcs.047191; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Tesniere C, 2015, APPL MICROBIOL BIOT, V99, P7025, DOI 10.1007/s00253-015-6810-z; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Torrea D, 2011, FOOD CHEM, V127, P1072, DOI 10.1016/j.foodchem.2011.01.092; Treusch S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004913; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-552; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang WP, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00040-17; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	75	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220515	10.1371/journal.pone.0220515	http://dx.doi.org/10.1371/journal.pone.0220515			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348805	Green Published, gold			2022-12-26	WOS:000484979500039
J	Felizardo, RJF; de Almeida, DC; Pereira, RL; Watanabe, IKM; Doimo, NTS; Ribeiro, WR; Cenedeze, MA; Hiyane, MI; Amano, MT; Braga, TT; Ferreira, CM; Parmigiani, RB; Andrade-Oliveira, V; Volpini, RA; Vinolo, MAR; Marino, E; Robert, R; Mackay, CR; Camara, NOS				Felizardo, Raphael J. F.; de Almeida, Danilo C.; Pereira, Rafael L.; Watanabe, Ingrid K. M.; Doimo, Nayara T. S.; Ribeiro, Willian R.; Cenedeze, Marcos A.; Hiyane, Meire I.; Amano, Mariane T.; Braga, Tarcio T.; Ferreira, Caroline M.; Parmigiani, Raphael B.; Andrade-Oliveira, Vinicius; Volpini, Rildo A.; Vinolo, Marco Aurelio R.; Marino, Eliana; Robert, Remy; Mackay, Charles R.; Camara, Niels O. S.			Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms	FASEB JOURNAL			English	Article						glomerulopathy; podocyte; ADR nephropathy; SCFA	CHAIN FATTY-ACIDS; DIETARY FIBER; SODIUM-BUTYRATE; INFLAMMATION; RECEPTOR; ACTIVATION; GLOMERULOSCLEROSIS; ACETYLATION; PROGRESSION; EXPRESSION	Butyrate is a short-chain fatty acid derived from the metabolism of indigestible carbohydrates by the gut microbiota. Butyrate contributes to gut homeostasis, but it may also control inflammatory responses and host physiology in other tissues. Butyrate inhibits histone deacetylases, thereby affecting gene transcription, and also signals through the metabolite-sensing G protein receptor (GPR)109a. We produced an mAb to mouse GPR109a and found high expression on podocytes in the kidney. Wild-type and Gpr109a(-/-) mice were induced to develop nephropathy by a single injection of Adriamycin and treated with sodium butyrate or high butyrate-releasing high-amylose maize starch diet. Butyrate improved proteinuria by preserving podocyte at glomerular basement membrane and attenuated glomerulosclerosis and tissue inflammation. This protective phenotype was associated with increased podocyte-related proteins and a normalized pattern of acetylation and methylation at promoter sites of genes essential for podocyte function. We found that GPR109a is expressed by podocytes, and the use of Gpr109a(-/-) mice showed that the protective effects of butyrate depended on GPR109a expression. A prebiotic diet that releases high amounts of butyrate also proved highly effective for protection against kidney disease. Butyrate and GPR109a play a role in the pathogenesis of kidney disease and provide one of the important molecular connections between diet, the gut microbiota, and kidney disease.	[Felizardo, Raphael J. F.; de Almeida, Danilo C.; Watanabe, Ingrid K. M.; Cenedeze, Marcos A.; Camara, Niels O. S.] Univ Fed Sao Paulo, Dept Med, Nephrol Div, Sao Paulo, Brazil; [Felizardo, Raphael J. F.; de Almeida, Danilo C.; Watanabe, Ingrid K. M.; Hiyane, Meire I.; Amano, Mariane T.; Braga, Tarcio T.; Andrade-Oliveira, Vinicius; Camara, Niels O. S.] Univ Sao Paulo, Fac Med, Inst Biomed Sci 4, Dept Immunol, Sao Paulo, Brazil; [Volpini, Rildo A.] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, LIM12, Sao Paulo, Brazil; [Felizardo, Raphael J. F.; Marino, Eliana; Robert, Remy; Mackay, Charles R.] Monash Univ, Dept Biochem & Mol Biol, Biodiscovery Inst, Clayton, Vic, Australia; [Pereira, Rafael L.] Univ Fed Parana, Dept Physiol, Curitiba, Parana, Brazil; [Doimo, Nayara T. S.; Amano, Mariane T.] Hosp Sirio Liban es, Ctr Mol Oncol, Sao Paulo, Brazil; [Ribeiro, Willian R.; Ferreira, Caroline M.] Univ Fed Sao Paulo, Inst Environm Chem & Pharmaceut Sci, Dept Pharmaceut Sci, Diadema, Brazil; [Parmigiani, Raphael B.] Idengene Med Diagnost, Sao Paulo, Brazil; [Vinolo, Marco Aurelio R.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Campinas, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Monash University; Universidade Federal do Parana; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas	Mackay, CR (corresponding author), Monash Univ, Fac Med Nursing & Hlth Serv, Biodiscovery Res Inst, Dept Microbiol, Wellington Rd, Clayton, Vic 3800, Australia.; Camara, NOS (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Av Prof Lineu Prestes 1730, BR-05508000 Sao Paulo, Brazil.	charles.mackay@monash.edu; niels@icb.usp	PARMIGIANI, RAPHAEL B/A-7475-2014; Volpini, Rildo Aparecido/L-5690-2019; robert, remy/E-6881-2012; Braga, Tarcio/AAG-4475-2020; de Almeida, Danilo/AAK-2399-2021; Mariño, Eliana/GPK-6544-2022; Mackay, Charles R/A-9673-2008; de Andrade Oliveira, Vinicius/S-1176-2019; Vinolo, Marco Aurélio R/K-3753-2012; Braga, Tarcio T/E-4827-2014; Felizardo, Raphael J F/B-3844-2016; Ribeiro, Willian/AAC-1656-2021; Volpini, Rildo A/B-7521-2013; Olsen Saraiva Camara, Niels/AAX-3269-2020; Marino, Eliana/C-5135-2011	PARMIGIANI, RAPHAEL B/0000-0001-8360-3584; Volpini, Rildo Aparecido/0000-0001-6611-2249; robert, remy/0000-0003-2416-9268; Mackay, Charles R/0000-0002-6338-7340; de Andrade Oliveira, Vinicius/0000-0002-0426-1828; Braga, Tarcio T/0000-0002-2989-1076; Felizardo, Raphael J F/0000-0001-9650-6273; Volpini, Rildo A/0000-0001-6611-2249; Olsen Saraiva Camara, Niels/0000-0001-5436-1248; AMANO, MARIANE/0000-0003-4321-3375; Rodrigues Ribeiro, Willian/0000-0001-5080-956X; Marino, Eliana/0000-0001-5371-8778	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/15205-4, 2012/50410-8, 2012/02270-2, 2014/13135-4, 2017/06222-06, 2017/05264-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, (CNPq); Instituto Nacional de Ciencia e Tecnologia (INCT) REGENERA; National Health and Medical Research Council of Australia; Coordenacao de Aperfeicoamento de Pessoal de N'ivel Superior-Brasil (CAPES) [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (INCT) REGENERA; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Coordenacao de Aperfeicoamento de Pessoal de N'ivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Paulo Albe (Institute of Biomedical Sciences IV, Universidade de Sao Paulo, Sao Paulo, Brazil) for preparing the histology slides, Caroline Ang and Linda Mason (both from Biodiscovery Institute, Monash University, Melbourne, Australia) for technical assistance, and Centro de Facilidades de Apoio a Pesquisa (CEFAP-USP). This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Grants 2012/15205-4, 2012/50410-8, 2012/02270-2, 2014/13135-4, 2017/06222-06, and 2017/05264-7), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, (CNPq), Instituto Nacional de Ciencia e Tecnologia (INCT) REGENERA, and the National Health and Medical Research Council of Australia. This study was also financed, in part, by the Coordenacao de Aperfeicoamento de Pessoal de N ' ivel Superior-Brasil (CAPES), Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Andrade-Oliveira V, 2015, J AM SOC NEPHROL, V26, P1877, DOI 10.1681/ASN.2014030288; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Blattner SM, 2013, KIDNEY INT, V84, P920, DOI 10.1038/ki.2013.175; Burford JL, 2014, J CLIN INVEST, V124, P2050, DOI 10.1172/JCI71702; Chauveau P, 2018, NEPHROL DIAL TRANSPL, V33, P725, DOI 10.1093/ndt/gfx085; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; Correa-Costa M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/291024; de Almeida DC, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00645; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Felizardo RJF, 2019, PHARMACOL RES, V141, P366, DOI 10.1016/j.phrs.2019.01.019; Felizardo RJF, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.36; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Jang HR, 2009, AM J PHYSIOL-RENAL, V297, pF1457, DOI 10.1152/ajprenal.90769.2008; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Krishnamurthy VMR, 2012, KIDNEY INT, V81, P300, DOI 10.1038/ki.2011.355; Lefevre GM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001142; Lin CL, 2014, J AM SOC NEPHROL, V25, P1698, DOI 10.1681/ASN.2013050527; Liu F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33676; Liu N, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00121; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Machado RA, 2012, NEPHROL DIAL TRANSPL, V27, P3136, DOI 10.1093/ndt/gfr807; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Marino E, 2017, NAT IMMUNOL, V18, P1271, DOI 10.1038/ni1117-1271c; Marques FZ, 2017, CIRCULATION, V135, P964, DOI [10.1161/CIRCULATIONAHA.116.024545, 10.1161/circulationaha.116.024545]; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mendes E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01732; Pereira RL, 2014, DIS MODEL MECH, V7, P701, DOI 10.1242/dmm.014548; Perico L, 2016, NAT REV NEPHROL, V12, P692, DOI 10.1038/nrneph.2016.127; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Rossaint J, 2016, J CLIN INVEST, V126, P962, DOI 10.1172/JCI83470; Sayyed SG, 2010, NEPHROL DIAL TRANSPL, V25, P1811, DOI 10.1093/ndt/gfp730; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Streja E, 2015, AM J KIDNEY DIS, V65, P785, DOI 10.1053/j.ajkd.2014.11.033; Sun XF, 2013, EUR J PHARMACOL, V707, P147, DOI 10.1016/j.ejphar.2013.03.018; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Tan JK, 2017, ANNU REV IMMUNOL, V35, P371, DOI 10.1146/annurev-immunol-051116-052235; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Ueda H, 2001, J BIOL CHEM, V276, P6846, DOI 10.1074/jbc.M007541200; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Verbeke K, 2010, EUR J CLIN NUTR, V64, P678, DOI 10.1038/ejcn.2010.92; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Wang XJ, 2014, KIDNEY INT, V86, P712, DOI 10.1038/ki.2014.111; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	60	45	47	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11894	11908		10.1096/fj.201901080R	http://dx.doi.org/10.1096/fj.201901080R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366236				2022-12-26	WOS:000507461600025
J	Fink, BD; Yu, LP; Sivitz, WI				Fink, Brian D.; Yu, Liping; Sivitz, William I.			Modulation of complex II-energized respiration in muscle, heart, and brown adipose mitochondria by oxaloacetate and complex I electron flow	FASEB JOURNAL			English	Article						mitochondrial respiratory chain; brown adipose tissue; succinate dehydrogenase; S1QEL 1.1	HYDROGEN-PEROXIDE; REACTIVE OXYGEN; TISSUE; SUCCINATE; OXIDATION; IDENTIFICATION; SUPEROXIDE; INHIBITION; ACTIVATION; BRAIN	We recently reported that membrane potential (Delta Psi) primarily determines the relationship of complex II-supported respiration by isolated skeletal muscle mitochondria to ADP concentrations. We observed that O-2 flux peaked at low ADP concentration ([ADP]) (high Delta Psi) before declining at higher [ADP] (low Delta Psi). The decline resulted from oxaloacetate (OAA) accumulation and inhibition of succinate dehydrogenase. This prompted us to question the effect of incremental [ADP] on respiration in interscapular brown adipose tissue (IBAT) mitochondria, wherein Delta Psi is intrinsically low because of uncoupling protein 1 (UCP1). We found that succinate-energized IBAT mitochondria, even in the absence of ADP, accumulate OAA and manifest limited respiration, similar to muscle mitochondria at high [ADP]. This could be prevented by guanosine 5'-diphosphate inhibition of UCP1. NAD + cycling with NADH requires complex I electron flow and is needed to form OAA. Therefore, to assess the role of electron transit, we perturbed flow using a small molecule, N1-(3-acetamidophenyl)-N2-(2-(4-methyl-2-(p-tolyl) thiazol-5-yl)ethyl)oxalamide. We observed decreased OAA, increased NADH/NAD(+), and increased succinatesupported mitochondrial respiration under conditions of low Delta Psi (IBAT) but not high Delta Psi (heart). In summary, complex II-energized respiration in IBAT mitochondria is tempered by complex I-derived OAA in a manner dependent on UCP1. These dynamics depend on electron transit in complex I.	[Fink, Brian D.; Sivitz, William I.] Univ Iowa, Vet Affairs Hlth Care Syst, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA USA; [Yu, Liping] Univ Iowa, Vet Affairs Hlth Care Syst, Dept Biochem, Iowa City, IA USA; [Yu, Liping] Univ Iowa, Vet Affairs Hlth Care Syst, NMR Core Facil, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sivitz, WI (corresponding author), Univ Iowa, Dept Internal Med, Div Endocrinol & Metab, E401-6 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	william-sivitz@uiowa.edu		Fink, Brian/0000-0002-1149-7935; Sivitz, William/0000-0002-7829-0189	U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service [2 I01 BX000285-05]; Iowa Fraternal Order of the Eagles	U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); Iowa Fraternal Order of the Eagles	This work was supported by Merit Review Award 2 I01 BX000285-05 from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service, and by the Iowa Fraternal Order of the Eagles. The authors declare no conflicts of interest.	Al Kadhi O, 2017, J ANAL METHODS CHEM, V2017, DOI 10.1155/2017/5391832; AZZONE GF, 1960, NATURE, V188, P552, DOI 10.1038/188552a0; Bai F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154982; Banba A, 2019, J BIOL CHEM, V294, P6550, DOI 10.1074/jbc.RA119.007687; Brand MD, 2016, CELL METAB, V24, P582, DOI 10.1016/j.cmet.2016.08.012; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; CHANCE B, 1962, J BIOL CHEM, V237, P3540; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fink BD, 2018, J BIOL CHEM, V293, P19932, DOI 10.1074/jbc.RA118.005144; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Panov AV, 2010, B EXP BIOL MED+, V149, P187, DOI 10.1007/s10517-010-0904-5; Panov AV, 2011, AM J PHYSIOL-REG I, V300, pR844, DOI 10.1152/ajpregu.00528.2010; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; SCHOLLMEYER P, 1961, BIOCHEM BIOPH RES CO, V4, P43, DOI 10.1016/0006-291X(61)90252-2; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WOJTCZAK AB, 1964, BIOCHIM BIOPHYS ACTA, V89, P560, DOI 10.1016/0926-6569(64)90088-4; WOJTCZAK L, 1972, ACTA BIOCHIM POL, V19, P227; Wong HS, 2019, FREE RADICAL BIO MED, V130, P140, DOI 10.1016/j.freeradbiomed.2018.10.448; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Yu Liping, 2015, Methods Mol Biol, V1264, P149, DOI 10.1007/978-1-4939-2257-4_14; Yu LP, 2014, J BIOENERG BIOMEMBR, V46, P33, DOI 10.1007/s10863-013-9530-z; Yu LP, 2013, DIABETES, V62, P1833, DOI 10.2337/db12-1152; Zimmermann M, 2014, ANAL CHEM, V86, P3232, DOI 10.1021/ac500472c	32	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11696	11705		10.1096/fj.201900690R	http://dx.doi.org/10.1096/fj.201900690R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361970	Green Published, Bronze			2022-12-26	WOS:000507461600010
J	Lang, I; Jung, M; Niemeyer, BA; Ruth, P; Engel, J				Lang, Isabelle; Jung, Martin; Niemeyer, Barbara A.; Ruth, Peter; Engel, Jutta			Expression of the LRRC52 gamma subunit (gamma 2) may provide Ca2+ -independent activation of BK currents in mouse inner hair cells	FASEB JOURNAL			English	Article						KCNMA; Ca(v)1.3; cochlea; proximity ligation assay; hearing	POTASSIUM CHANNELS; SYNAPTIC-TRANSMISSION; CA(V)1.3 CHANNELS; AUXILIARY SUBUNIT; SPLICE VARIANTS; MICE LACKING; MODULATION; OTOFERLIN; DEAFNESS; BETA	Mammalian inner hair cells (IHCs) transduce sound into depolarization and transmitter release. Big conductance and voltage- and Ca2+-activated K+ (BK) channels are responsible for fast membrane repolarization and small time constants of mature IHCs. For unknown reasons, they activate at around -75 mV with a voltage of half-maximum activation (V-half) of -50 mV although being largely insensitive to Ca2+ influx. Ca2+-independent activation of BK channels was observed by others in heterologous expression systems if y subunits leucine-rich repeat-containing protein (LRRC)26 (gamma 1) and LRRC52 (gamma 2) were coexpressed with the pore-forming BK alpha subunit, which shifted V-half by -140 and -100 mV, respectively. Using nested PCR, we consistently detected transcripts for LRRC52 but not for LRRC26 in IHCs of 3-wk-old mice. Confocal immunohistochemistry showed synchronous up-regulation of LRRC52 protein with BK alpha at the onset of hearing. Colocalization of LRRC52 protein and BK alpha at the IHC neck within 540 nm was specified using an in situ proximity ligation assay. Mice deficient for the voltage-gated Ca(v)1.3 Ca2+ channel encoded by Cacnald do not express BK alpha protein. LRRC52 protein was neither expressed in IHCs of BK alpha nor in IHCs of Ca(v)1.3 knockout mice. Together, LRRC52 is a gamma 2 subunit of BK channel complexes and is a strong candidate for causing the Ca2+ -independent activation of BK currents at negative membrane potentials in mouse IHCs.	[Lang, Isabelle; Engel, Jutta] Saarland Univ, Hearing Res, Homburg, Germany; [Jung, Martin] Saarland Univ, Mol Biophys, Dept Biophys, Homburg, Germany; [Jung, Martin] Saarland Univ, CIPMM, Homburg, Germany; [Niemeyer, Barbara A.] Saarland Univ, Dept Biochem & Mol Biol, Homburg, Germany; [Ruth, Peter] Univ Tubingen, Dept Pharmacol Toxicol & Clin Pharm, Inst Pharm, Tubingen, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Engel, J (corresponding author), Saarland Univ, Sch Med, Dept Biophys, CIPMM, Kirrberger St 100,Bldg 48, D-66421 Homburg, Germany.	jutta.engel@uni-saarland.de	Niemeyer, Barbara A./AAL-8972-2021; Jung, Martin/D-2207-2012; Jung, Martin/AAM-4547-2021	Jung, Martin/0000-0002-1482-7020; Jung, Martin/0000-0002-1482-7020; Niemeyer, Barbara A./0000-0002-6963-0575	German Research Foundation (DFG); International Research Training Group (IRTG) 1830; Collaborative Research Center [(SFB) 894 A4, SFB 1027]; Saarland University	German Research Foundation (DFG)(German Research Foundation (DFG)); International Research Training Group (IRTG) 1830; Collaborative Research Center; Saarland University	The authors thank Jennifer Ihl, Kerstin Fischer, and Angela Di Turi (Saarland University) for excellent technical assistance, Marlen Dierich (Philipps University Marburg, Marburg, and Saarland University) for providing a proximity ligation assay protocol for the organ of Corti, Dalia Alansary (Saarland University) for help with the sequencing process, Petra Wei beta gerber and Femke Lux (both from Saarland University) for providing tissue cryosections, Veit Flockerzi (Saarland University) for providing a claudin-14 antibody, and Stefan Munkner (Saarland University) for help and discussion. This work was supported by the German Research Foundation (DFG), the International Research Training Group (IRTG) 1830, the Collaborative Research Center (SFB) 894 A4 (to J.E.), P3 (to M.J.), SFB 1027 (to B.A.N.), and Saarland University. The authors declare no conflicts of interest.	Almassy J, 2012, MOL PHARMACOL, V81, P21, DOI 10.1124/mol.111.075234; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bortolozzi M, 2018, NEUROSCI LETT, V663, P18, DOI 10.1016/j.neulet.2017.09.059; Brandt A, 2003, J NEUROSCI, V23, P10832; Martin JZD, 2010, J NEUROSCI, V30, P12157, DOI 10.1523/JNEUROSCI.2541-10.2010; Duncker SV, 2013, J NEUROSCI, V33, P9508, DOI 10.1523/JNEUROSCI.5689-12.2013; Eckrich S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00225; EHRET G, 1985, ACTA OTO-LARYNGOL, P31; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Evanson KW, 2014, CIRC RES, V115, P423, DOI 10.1161/CIRCRESAHA.115.303407; Fell B, 2016, J NEUROSCI, V36, P11024, DOI 10.1523/JNEUROSCI.3468-14.2016; Fettiplace R, 2017, COMPR PHYSIOL, V7, P1197, DOI 10.1002/cphy.c160049; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Gonzalez-Perez V, 2019, ANNU REV PHYSIOL, V81, P113, DOI 10.1146/annurev-physiol-022516-034038; Gonzalez-Perez V, 2014, P NATL ACAD SCI USA, V111, P4868, DOI 10.1073/pnas.1322123111; Hafidi A, 2005, NEUROSCIENCE, V130, P475, DOI 10.1016/j.neuroscience.2004.09.038; Housley GD, 2006, J MEMBRANE BIOL, V209, P89, DOI 10.1007/s00232-005-0835-7; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; Kang HW, 2011, BBA-BIOMEMBRANES, V1808, P1629, DOI 10.1016/j.bbamem.2010.11.014; Kearney G, 2019, J NEUROSCI, V39, P3360, DOI 10.1523/JNEUROSCI.2746-18.2019; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; KROS CJ, 1990, J PHYSIOL-LONDON, V421, P263, DOI 10.1113/jphysiol.1990.sp017944; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kurt S, 2012, FASEB J, V26, P3834, DOI 10.1096/fj.11-200535; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; Li Q, 2016, INT REV NEUROBIOL, V128, P51, DOI 10.1016/bs.irn.2016.03.015; Li Q, 2016, J GEN PHYSIOL, V147, P337, DOI 10.1085/jgp.201511551; Li Q, 2015, J GEN PHYSIOL, V145, P543, DOI 10.1085/jgp.201511356; Manley G. A., 2004, EVOLUTION VERTEBRATE, V22; Marcotti W, 2004, J PHYSIOL-LONDON, V557, P613, DOI 10.1113/jphysiol.2003.060137; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Oliver D, 2003, J NEUROSCI, V23, P2141; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; Pangrsic T, 2012, TRENDS NEUROSCI, V35, P671, DOI 10.1016/j.tins.2012.08.002; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Pyott SJ, 2016, INT REV NEUROBIOL, V128, P369, DOI 10.1016/bs.irn.2016.03.016; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Ramanathan K, 2000, J NEUROSCI, V20, P1675; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rutherford MA, 2015, SYNAPSE, V69, P242, DOI 10.1002/syn.21812; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sakai Y, 2011, J NEUROSCI RES, V89, P1747, DOI 10.1002/jnr.22713; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shipston MJ, 2016, INT REV NEUROBIOL, V128, P91, DOI 10.1016/bs.irn.2016.02.012; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Thurm H, 2005, J PHYSIOL-LONDON, V569, P137, DOI 10.1113/jphysiol.2005.094680; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; vonBekesy G., 1960, EXPT HEARING; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wersinger E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013836; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Wong AB, 2014, EMBO J, V33, P247, DOI 10.1002/embj.201387110; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yang CT, 2017, P NATL ACAD SCI USA, V114, pE3739, DOI 10.1073/pnas.1703081114; Yang CT, 2011, P NATL ACAD SCI USA, V108, P19419, DOI 10.1073/pnas.1111104108; Zeng XH, 2015, P NATL ACAD SCI USA, V112, P2599, DOI 10.1073/pnas.1423869112; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108	71	3	3	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11721	11734		10.1096/fj.201900701RR	http://dx.doi.org/10.1096/fj.201900701RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31348683	Bronze			2022-12-26	WOS:000507461600012
J	Wallace, RVS; Martinez, R; Rowe, T				Wallace, Rachel V. S.; Martinez, Ricardo; Rowe, Timothy			First record of a basal mammaliamorph from the early Late Triassic Ischigualasto Formation of Argentina	PLOS ONE			English	Article							GRANDE-DO-SUL; FOSSIL EVIDENCE; CYNODONT; BRAZIL; THERAPSIDA; EVOLUTION; EUCYNODONTIA; MAMMALIAFORM; ORIGIN; TRITHELEDONTIDAE	We describe a new probainognathian cynodont, Pseudotherium argentinus, from the early Late Triassic Ischigualasto Formation of Argentina. Pseudotherium adds to a growing assemblage of small Triassic cynodonts that offers new insight into events leading up to the origin of crown Mammalia and the successively more inclusive Mammaliaformes and Mammaliamorpha. Using high-resolution X-ray computed tomography, we illustrate and describe the holotype and only known specimen, which consists of a well-preserved isolated skull. It preserves apomorphic features of the orbit and braincase. Prefrontal and vestigial postorbital bones are present, despite the absence of an ossified postorbital bar. As in Brasilitherium riograndensis, thin turbinal-like bones are present in the nasopharyngeal passage, and we discuss impediments to establishing their identity and function. Compared to more basal cynodonts, the cochlea is elongated but uncoiled and in this and other features it resembles basal mammaliamorphs. Our analysis found weak support for Pseudotherium as the sister taxon of Tritylodontidae. However, a broader assessment of its relationships in light of additional character data from the literature and unpublished computed tomography data suggest that it may be more realistic to view the relationships of Pseudotherium as an unresolved polytomy with tritylodontids, and the taxa referred to as tritheledontids and brasilodontids (groups of variable membership and questionable monophyly). Thus, Pseudotherium may lie just inside or just outside of Mammaliamorpha, and there is also weak character support for its sister taxon relationship with Brasilitherium. Our results amplify previous conclusions that phylogenetic relationships in this adaptive radiation of small cynodonts will remain somewhat uncertain until more complete specimens are recovered, and until high-resolution CT scans of existing specimens become available to the larger community. Toward that goal, we make the CT dataset for the holotype of Pseudotherium argentinus publically available under a Creative Commons license at www.DigiMorph.org.	[Wallace, Rachel V. S.; Rowe, Timothy] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Martinez, Ricardo] Univ Nacl San Juan, Inst & Museo Ciencias Nat, Div Paleontol Vertebrados, San Juan, Argentina; [Wallace, Rachel V. S.] Univ Texas Austin, Dept Med Educ, Dell Med Sch, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Universidad Nacional de San Juan; University of Texas System; University of Texas Austin	Wallace, RVS (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.; Wallace, RVS (corresponding author), Univ Texas Austin, Dept Med Educ, Dell Med Sch, Austin, TX 78712 USA.	Rachel.Wallace@austin.utexas.edu		Wallace, Rachel/0000-0003-3160-5865	National Science Foundation Division of Earth Sciences [EAR 1258878]; Geology Foundation of the Jackson School of Geosciences	National Science Foundation Division of Earth Sciences(National Science Foundation (NSF)); Geology Foundation of the Jackson School of Geosciences	TBR received funding for scanning from the National Science Foundation Division of Earth Sciences (EAR 1258878) (https://www.nsf.gov/div/index.jsp?div=EAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TBR and RVSW received funding for scanning and computing resources from the Geology Foundation of the Jackson School of Geosciences (http://www.jsg.utexas.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2007, PALAEONTOLOGY, V50, P591, DOI 10.1111/j.1475-4983.2007.00646.x; Barghusen HR, 1986, ECOLOGY BIOL MAMMAL, P256; Benoit J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25604; Bonaparte J.F., 1980, 2 C ARG PAL BIOESTR, P123; BONAPARTE JF, 1975, J PALEONTOL, V49, P931; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Bonaparte JF, 2006, B N M MUS NAT HIST S, V37, P533; Bonaparte JF, 2001, B MUS COMP ZOOL HARV, V156, P37; Bonaparte JF, 2013, HIST NAT, V2, P5; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bonaparte JF, 2013, HIST BIOL, V25, P643, DOI 10.1080/08912963.2012.731154; Bonaparte JF, 2010, REV BRAS PALEONTOLOG, V13, P233, DOI 10.4072/rbp.2010.3.07; Broom, 1932, MAMMAL LIKE REPTILES; Broom R., 1936, Annals of the Transvaal Museum, V18, P349; Broom R, 1929, P LINN SOC, P688; Broom R., 1912, ANN S AFR MUS, V7, P334; Cantino P.D., 2003, PHYLOCODE PHYLOGENET; Carlson WD, 2003, GEOL SOC SPEC PUBL, V215, P7, DOI 10.1144/GSL.SP.2003.215.01.02; Crompton AW, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1269116; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; CROMPTON AW, 1985, ZOOL J LINN SOC-LOND, V85, P99, DOI 10.1111/j.1096-3642.1985.tb01500.x; Crompton AW, 1955, RES NASIONALE MUSEUM, V1, P150; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Davies TG, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0194; de Beer G., 1937, DEV VERTEBRATE SKULL; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Estes R., 1961, Bulletin of the Museum of Comparative Zoology, V125, P165; FOURIE S, 1974, Annals of the South African Museum, V65, P337; Garrett EC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2828; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; HAUGHTON S. H., 1954, PALEONTOL AFRICANA, V2, P1; Hopson JA, 1986, ANAL RAPSID RELATION, P83; Hopson James A., 2001, Bulletin of the Museum of Comparative Zoology, V156, P5; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Kemp T.S, 1982, MAMMAL LIKE REPTILES; KEMP TS, 1983, ZOOL J LINN SOC-LOND, V77, P353, DOI 10.1111/j.1096-3642.1983.tb00859.x; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Lillegraven JA, 1979, MESOZOIC MAMMALS 1 2; Liu J, 2010, J MAMM EVOL, V17, P151, DOI 10.1007/s10914-010-9136-8; Lucas Spencer G., 1993, Journal of Vertebrate Paleontology, V13, P309; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2016, SPRINGER HANDB AUDIT, V59, P139, DOI 10.1007/978-3-319-46661-3_6; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P113, DOI 10.1080/02724634.1995.10011211; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinelli AG, 2017, CONTRIBUICAO CONHECI; Martinelli AG, 2007, J VERTEBR PALEONTOL, V27, P442, DOI 10.1671/0272-4634(2007)27[442:OCMETF]2.0.CO;2; Martinelli AG, 2017, PAP PALAEONTOL, V3, P401, DOI 10.1002/spp2.1081; Martinelli AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162945; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P271, DOI 10.1080/02724634.1996.10011314; Oliveira T.V., 2011, PALAEONTOL Z, V85, P67, DOI DOI 10.1007/S12542-010-0078-5; Rodrigues PG, 2014, PALAEONTOL Z, V88, P329, DOI 10.1007/s12542-013-0200-6; Rodrigues PG, 2013, J MAMM EVOL, V20, P291, DOI 10.1007/s10914-012-9221-2; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Romer A. S., 1970, Breviora, VNo. 344, P1; Romer A.S, 1956, OSTEOLOGY REPTILIA; Rougier G.W., 1992, Journal of Vertebrate Paleontology, V12, P188; ROWE T, 1992, SYST BIOL, V41, P372, DOI 10.2307/2992573; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe T, 1997, GEOTIMES, V42, P23; ROWE T, 1993, MAMMAL PHYLOGENY, P129; Rowe T, 1995, THRINAXODON DIGITAL, P547; Rowe T.B., 2017, EVOLUTION NERVOUS SY, P1; Rowe TB, 1986, OSTEOLOGICAL DIAGNOS; Rowe Timothy, 1996, Memoirs of the California Academy of Sciences, V20, P71; Rowe Timothy B., 2005, Journal of Mammalian Evolution, V12, P303, DOI 10.1007/s10914-005-5731-5; Rowe TB, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.40; Rowe TB, 2016, J COMP NEUROL, V524, P471, DOI 10.1002/cne.23802; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Ruf I, 2014, ANAT REC, V297, P2018, DOI 10.1002/ar.23022; Shepherd GM, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00100; SHUBIN NH, 1991, SCIENCE, V251, P1063, DOI 10.1126/science.251.4997.1063; Sidor CA, 2006, J PALEONTOL, V80, P10; Silva JEMR, 2018, OCCUPATIONAL SAFETY AND HYGIENE VI, P1; Soares M. H. F. B., 2004, THESIS; Soares MB, 2014, AN ACAD BRAS CIENC, V86, P1673, DOI 10.1590/0001-3765201420140455; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; SUES H-D, 1986, Bulletin of the Museum of Comparative Zoology, V151, P217; Sues Hans-Dieter, 2001, Bulletin of the Museum of Comparative Zoology, V156, P37; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tatarinov L.P., 1963, PALEONTOL ZH, V4, P46; van Bemmelen JF, 1901, DENKSCHR MEDNATURW G, V3, P729; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Watson D. M. S., 1913, Geological Magazine London (5), V10; Wible J.R., 1991, Journal of Vertebrate Paleontology, V11, P1; Zander R. H., 2004, PHYLOINFORMATICS, V2, P1	100	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0218791	10.1371/journal.pone.0218791	http://dx.doi.org/10.1371/journal.pone.0218791			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390368	Green Submitted, Green Published, gold			2022-12-26	WOS:000484999400004
J	Nair, AV; Wei, YH; Paunescu, TG; Bouley, R; Brown, D				Nair, Anil, V; Wei Yanhong; Paunescu, Teodor G.; Bouley, Richard; Brown, Dennis			Sex-dependent differences in water homeostasis in wild-type and V-ATPase B1-subunit deficient mice	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT CONFERENCE; RENAL INTERCALATED CELLS; BODY-FLUID; EXPRESSION; HYPONATREMIA; VASOPRESSIN; PHYSIOLOGY; STATEMENT; INSIGHTS; HORMONES	Men tend to dehydrate more than women after prolonged exercise, possibly due to lower water intake and higher perspiration rate. Women are prone to exercise-associated hyponatremia, primarily attributed to the higher water consumption causing hypervolemia. Since aquaporin-2 (AQP2) water channels in the kidney collecting duct (CD) principal cells (PCs) are involved in maintaining water balance, we investigated their role in sex-dependent water homeostasis in wild-type (WT) C57BL/6 mice. Because CD intercalated cells (ICs) may also be involved in water balance, we also assessed the urine concentrating ability of V-ATPase B1 subunit-deficient (Atp6v1b1(-/-)) mice. Upon 12-hour water deprivation, urine osmolality increased by 59% in WT female mice and by only 28% in males. This difference was abolished in Atp6v1b1(-/-) mice, in which dehydration induced a similar to 30% increase in urine osmolarity in both sexes. AQP2 levels were highest in WT females; female Atp6v1b1(-/-) mice had substantially lower AQP2 expression than WT females, comparable to the low AQP2 levels seen in both Atp6v1b1(-/-) and WT males. After dehydration, AQP2 relocates towards the PC apical pole, especially in the inner stripe and inner medulla, and to a greater extent in WT females than in WT males. This apparent sex-dependent concentrating advantage was absent in Atp6v1b1(-/-) females, whose reduced AQP2 apical relocation was similar to WT males. Accordingly, female mice concentrate urine better than males upon dehydration due to increased AQP2 expression and mobilization. Moreover, our data support the involvement of ICs in water homeostasis, at least partly mediated by V-ATPase, in a sex-dependent manner.	[Nair, Anil, V; Wei Yanhong; Paunescu, Teodor G.; Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA; [Nair, Anil, V; Wei Yanhong; Paunescu, Teodor G.; Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Nair, Anil, V; Wei Yanhong; Paunescu, Teodor G.; Bouley, Richard; Brown, Dennis] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Nair, AV (corresponding author), Massachusetts Gen Hosp, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA.	avnair@mgh.harvard.edu	Paunescu, Teodor/AAX-7533-2020	Paunescu, Teodor/0000-0003-0227-9028	Centre for the Study of Inflammatory Bowel Disease [DK043351 NIH]; Boston Area Diabetes and Endocrinology Research Center [DK057521 NIH];  [5R01DK096586 NIH];  [R56DK042956 NIH];  [S10 OD021577-01 NIH]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042956, R01DK096586] Funding Source: NIH RePORTER	Centre for the Study of Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 5R01DK096586 NIH, R56DK042956 NIH, S10 OD021577-01 NIH to DB, Centre for the Study of Inflammatory Bowel Disease DK043351 NIH, and Boston Area Diabetes and Endocrinology Research Center DK057521 NIH.r The Microscopy core facility of the Massachusetts General Hospital (MGH) Program in Membrane Biology receives support by a Centre for the Study of Inflammatory Bowel Disease and a Boston Area Diabetes and Endocrinology Research Center.	Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Dickinson H, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-21; Eijsvogels TMH, 2013, SCAND J MED SCI SPOR, V23, P198, DOI 10.1111/j.1600-0838.2011.01371.x; Eladari D, 2012, ANNU REV PHYSIOL, V74, P325, DOI 10.1146/annurev-physiol-020911-153225; Fenton RA, 2013, CURR OPIN NEPHROL HY, V22, P551, DOI 10.1097/MNH.0b013e328364000d; Finberg KE, 2005, P NATL ACAD SCI USA, V102, P13616, DOI 10.1073/pnas.0506769102; Gueutin V, 2013, J CLIN INVEST, V123, P4219, DOI 10.1172/JCI63492; Hatano R, 2012, AM J PHYSIOL-RENAL, V302, pF342, DOI 10.1152/ajprenal.00366.2011; HAYLOR J, 1980, J PHYSIOL-LONDON, V298, P383, DOI 10.1113/jphysiol.1980.sp013088; Herak-Kramberger CM, 2015, AM J PHYSIOL-RENAL, V308, pF809, DOI 10.1152/ajprenal.00368.2014; Hew-Butler T, 2008, CLIN J SPORT MED, V18, P111, DOI 10.1097/JSM.0b013e318168ff31; Hew-Butler T, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00021; Hew-Butler T, 2015, CLIN J SPORT MED, V25, P303, DOI 10.1097/JSM.0000000000000221; Knepper MA, 1997, AM J PHYSIOL-RENAL, V272, pF3, DOI 10.1152/ajprenal.1997.272.1.F3; Liu J, 2011, AM J PHYSIOL-RENAL, V300, pF433, DOI 10.1152/ajprenal.00199.2010; Nair AV, 2015, ACS NANO, V9, P3641, DOI 10.1021/acsnano.5b00428; Olesen ETB, 2013, J AM SOC NEPHROL, V24, P169, DOI 10.1681/ASN.2012020217; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2007, AM J PHYSIOL-RENAL, V293, pF1915, DOI 10.1152/ajprenal.00160.2007; Paunescu TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045395; Rosner MH, 2007, CLIN J AM SOC NEPHRO, V2, P151, DOI 10.2215/CJN.02730806; Sasaki S, 2012, MOL ASPECTS MED, V33, P535, DOI 10.1016/j.mam.2012.03.004; Soleimani M, 2015, NEPHROL DIAL TRANSPL, V30, P1257, DOI 10.1093/ndt/gfu307; Stachenfeld NS, 2009, J APPL PHYSIOL, V107, P864, DOI 10.1152/japplphysiol.91211.2008; Stachenfeld NS, 2001, J APPL PHYSIOL, V91, P1893, DOI 10.1152/jappl.2001.91.4.1893; Vedovelli L, 2013, AM J PHYSIOL-RENAL, V304, pF522, DOI 10.1152/ajprenal.00394.2012; Wall SM, 2017, KIDNEY RES CLIN PRAC, V36, P305, DOI 10.23876/j.krcp.2017.36.4.305; Wang YX, 1997, AM J PHYSIOL-REG I, V272, pR370, DOI 10.1152/ajpregu.1997.272.1.R370; WEBER PC, 1979, KLIN WOCHENSCHR, V57, P1021, DOI 10.1007/BF01479987	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219940	10.1371/journal.pone.0219940	http://dx.doi.org/10.1371/journal.pone.0219940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386675	Green Submitted, gold, Green Published			2022-12-26	WOS:000484997100012
J	Villasenor-Altamirano, AB; Watson, JD; Prokopec, SD; Yao, CQ; Boutros, PC; Pohjanvirta, R; Valdes-Flores, J; Elizondo, G				Villasenor-Altamirano, Ana B.; Watson, John D.; Prokopec, Stephenie D.; Yao, Cindy Q.; Boutros, Paul C.; Pohjanvirta, Raimo; Valdes-Flores, Jesus; Elizondo, Guillermo			2,3,7,8-Tetrachlorodibenzo-p-dioxin modifies alternative splicing in mouse liver	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; AH RECEPTOR; BINDING DOMAIN; EXPRESSION; TCDD; EXON; IDENTIFICATION; DISRUPTION; MECHANISMS; REPRESSOR	Alternative splicing is a co-transcriptional mechanism that generates protein diversity by including or excluding exons in different combinations, thereby expanding the diversity of protein isoforms of a single gene. Abnormalities in this process can result in deleterious effects to human health, and several xenobiotics are known to interfere with splicing regulation through multiple mechanisms. These changes could lead to human diseases such as cancer, neurological disorders, autoimmune diseases, and developmental disorders. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental contaminant generated as a byproduct of various industrial activities. Exposure to this dioxin has been linked to a wide range of pathologies through the alteration of multiple cellular processes. However, the effects of TCDD exposure on alternative splicing have not yet been studied. Here, we investigated whether a single po. dose of 5 mu g/kg or 500 mu g/kg TCDD influence hepatic alternative splicing in adult male C57BL/6Kou mouse. We identified several genes whose alternative splicing of precursor messenger RNAs was modified following TCDD exposure. In particular, we demonstrated that alternative splicing of Cyp1a1, Ahrr, and Actn1 was significantly altered after TCDD treatment. These findings show that the exposure to TCDD has an impact on alternative-splicing, and suggest a new avenue for understanding TCDD-mediated toxicity and pathogenesis.	[Villasenor-Altamirano, Ana B.; Elizondo, Guillermo] IPN, CINVESTAN, Natl Polytech Inst, Cell Biol Dept,Ctr Res & Adv Studies, Mexico City, DF, Mexico; [Villasenor-Altamirano, Ana B.] Univ Nacl Autonoma Mexico, Int Lab Human Genome Res, Queretaro, Mexico; [Watson, John D.; Prokopec, Stephenie D.; Yao, Cindy Q.; Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Yao, Cindy Q.; Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Pohjanvirta, Raimo] Natl Inst Hlth & Welf, Lab Toxicol, Kuopio, Finland; [Pohjanvirta, Raimo] Univ Helsinki, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Valdes-Flores, Jesus] IPN, CINVESTAV, Natl Polytech Inst, Biochem Dept,Ctr Res & Adv Studies, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; University of Helsinki; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Elizondo, G (corresponding author), IPN, CINVESTAN, Natl Polytech Inst, Cell Biol Dept,Ctr Res & Adv Studies, Mexico City, DF, Mexico.	gazuela@cinvestav.mx		Pohjanvirta, Raimo/0000-0003-0952-5746; Villasenor Altamirano, Ana Beatriz/0000-0002-3940-5617	Terry Fox Research Institute; CIHR New Investigator Awards; Consejo Nacional de Ciencia y Tecnologia [153377, 280897]	Terry Fox Research Institute; CIHR New Investigator Awards(Canadian Institutes of Health Research (CIHR)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by Terry Fox Research Institute and CIHR New Investigator Awards, to PCB; and Consejo Nacional de Ciencia y Tecnologia grant 153377 and 280897, GE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward LL, 2002, J EXPO ANAL ENV EPID, V12, P319, DOI 10.1038/sj.jea.7500233; Boutros PC, 2011, TOXICOL APPL PHARM, V251, P119, DOI 10.1016/j.taap.2010.12.010; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen R, 2017, METAB BRAIN DIS, V32, P667, DOI 10.1007/s11011-017-0007-3; Chopra M, 2011, CRIT REV TOXICOL, V41, P292, DOI 10.3109/10408444.2010.524635; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; Falahatpisheh MH, 2003, ONCOGENE, V22, P2160, DOI 10.1038/sj.onc.1206238; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Hsu LC, 1996, GENE EXPRESSION, V6, P87; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karchner SI, 2009, MOL CELL BIOL, V29, P3465, DOI 10.1128/MCB.00206-09; Kommaddi RP, 2007, J NEUROCHEM, V102, P867, DOI 10.1111/j.1471-4159.2007.04599.x; Kumar MB, 1999, J BIOL CHEM, V274, P22155, DOI 10.1074/jbc.274.32.22155; Leung YK, 2005, CANCER RES, V65, P3726, DOI 10.1158/0008-5472.CAN-04-3771; MANZ A, 1991, LANCET, V338, P959, DOI 10.1016/0140-6736(91)91835-I; Martin EA, 2015, ELIFE, V4, DOI 10.7554/eLife.09395; Moffat ID, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-263; Murphy ACH, 2016, FEBS LETT, V590, P685, DOI 10.1002/1873-3468.12101; Nazarov PV, 2017, BMC GENOMICS, V18, P1, DOI [10.1186/s12864-016-3406-7, DOI 10.1186/S12864-016-3406-7]; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; P'ng C, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2610-2; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; Placencio VR, 2015, CANCER RES, V75, P2969, DOI 10.1158/0008-5472.CAN-15-0876; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; Powers BE, 2005, GENES BRAIN BEHAV, V4, P51, DOI 10.1111/j.1601-183X.2004.00098.x; Prochazkova J, 2011, TOXICOL SCI, V122, P349, DOI 10.1093/toxsci/kfr129; Prokopec SD, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3446-z; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Rasche A, 2010, BIOINFORMATICS, V26, P84, DOI 10.1093/bioinformatics/btp626; Rawson RL, 2017, CURR OPIN NEUROBIOL, V45, P39, DOI 10.1016/j.conb.2017.03.006; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Southby J, 1999, MOL CELL BIOL, V19, P2699; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; WAITES GT, 1992, J BIOL CHEM, V267, P6263; Wang C, 2017, J CRANIO MAXILL SURG, V45, P678, DOI 10.1016/j.jcms.2017.02.004; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047; Wu YG, 2013, MOL CELL BIOL, V33, P2817, DOI 10.1128/MCB.00011-13; Yan CL, 2010, MUTAT RES-FUND MOL M, V686, P47, DOI 10.1016/j.mrfmmm.2010.01.015; Yuan XG, 2016, MOL MED REP, V14, P1139, DOI 10.3892/mmr.2016.5348; Zaharieva E, 2012, TOXICOLOGY, V296, P1, DOI 10.1016/j.tox.2012.01.014	48	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219747	10.1371/journal.pone.0219747	http://dx.doi.org/10.1371/journal.pone.0219747			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386671	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100009
J	Morato, GO; Rocha, AG; Chung, DG; da Conceicao, MEBAM; Minto, BW; Padilha, JG; Dias, LGGG				Morato, Glaucia O.; Rocha, Artur G.; Chung, Denise G.; da Conceicao, Maria E. B. A. M.; Minto, Bruno W.; Padilha Filho, Joao G.; Dias, Luis G. G. G.			Lyophilized and gamma-sterilized allogeneic bone implant used as a spacer for advancement of a modified tibial tuberosity in the treatment of cranial cruciate ligament disease in dogs	PLOS ONE			English	Article							PLATEAU LEVELING OSTEOTOMY; COMPLICATIONS	The objective of this study was to evaluate the use of a lyophilized and gamma-sterilized allogeneic freeze-dried bone wedge as a spacer for advancement of a modified tibial tuberosity (mTTA) in 16 knees that were clinically diagnosed with cranial cruciate ligament disease. Patients underwent radiography before the surgical procedure as well as immediately after surgery and at 30, 60, 90 and 120 days post-surgery, and their locomotion was evaluated at the same time points except for the immediate postoperative period. The surgical wounds were evaluated for signs of infection and rejection of the bone implant. Locomotion was graded on a scale of 0-5, with 0 indicating no limping and 5 indicating limb functional impotence. The "tibial-tibial bone-tibial implant" interfaces were evaluated radiographically, and each interface was assigned scores of 0-3, with 0 indicating no contact between the implant and adjacent bone and 3 indicating a bone bridge throughout the interface. The patients showed good clinical and radiographic recovery. The lyophilized bone spacer allowed for easy storage and transport and rapid and satisfactory execution of mTTA while showing resistance to drilling and fixation with screws in 87.5% of cases and a mean surgical time of 45.9 minutes. No immunogenic reactions were observed in 93.7% of the cases. One patient presented infection of the surgical focus, which showed remission after antimicrobial therapy. All patients showed functional recovery of the operated limb, with the number of clinically healthy patients being higher than those with claudication at 120 days (p <= 0.05). In all patients, it was possible to verify the incorporation of the bone implant into the tibia. Bone union occurred progressively, and the degrees of bone union observed on radiographs at postoperative days 60, 90, and 120 were significantly greater (p < 0.05) than those observed in the immediate postoperative period and at 30 days.	[Morato, Glaucia O.; Chung, Denise G.] Autonomus Vet Med, Descalvado, SP, Brazil; [Rocha, Artur G.] Ctr Univ Cent Paulista Unicep, Hosp Vet Univ, Sao Carlos, SP, Brazil; [da Conceicao, Maria E. B. A. M.; Minto, Bruno W.; Padilha Filho, Joao G.; Dias, Luis G. G. G.] Sao Paulo State Univ Julio de Mesquite Filho, Coll Agr Sci & Vet Med, Dept Clin & Anim Surg, Div Vet Surg, Jaboticabal Campus, Sao Paulo, Brazil	Centro Universitario Central Paulista; Universidade Estadual Paulista	Dias, LGGG (corresponding author), Sao Paulo State Univ Julio de Mesquite Filho, Coll Agr Sci & Vet Med, Dept Clin & Anim Surg, Div Vet Surg, Jaboticabal Campus, Sao Paulo, Brazil.	gustavogosuen@gmail.com	Dias, Luís Gustavo Gosuen Gonçalves/AGM-6576-2022; minto, bruno w/G-1186-2012	Dias, Luís Gustavo Gosuen Gonçalves/0000-0003-3993-1649; minto, bruno w/0000-0002-8808-4127; Bastos Andrade Moutinho da Conceicao, Maria Eduarda/0000-0002-6939-2183	National Council for Scientific and Technological Development (CNPq)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author of this paper (GOM) had recived a salary of National Council for Scientific and Technological Development (CNPq), which promoted an additional bank rate to by stuffs related to the project or pay some personal or institutional service.	Bander NB, 2018, J AM ANIM HOSP ASSOC, V54, P85, DOI [10.5326/JAAHA-MS-6532, 10.5326/jaaha-ms-6532]; Boudrieau RJ, 2011, VET SURG, V40, P641, DOI 10.1111/j.1532-950X.2011.00845.x; Christopher SA, 2013, VET SURG, V42, P329, DOI 10.1111/j.1532-950X.2013.12001.x; Costa M, 2017, VET SURG, V46, P494, DOI 10.1111/vsu.12649; Dal-Bo IS, 2013, ACTA SCI VET, V41, P1; Finkemeier CG., 2002, J BONE JOINT SURG, V84, P649; Gallagher AD, 2012, VET SURG, V41, P705, DOI 10.1111/j.1532-950X.2012.00971.x; Hedeiros RM, 2018, ARQ BRAS MED VET ZOO, V70, P1053, DOI 10.1590/1678-4162-9594; Innes JF, 2010, VET COMP ORTHOPAED, V23, P393, DOI 10.3415/VCOT-10-02-0022; Kim SE, 2009, VET SURG, V38, P23, DOI 10.1111/j.1532-950X.2008.00470.x; Lafaver S, 2007, VET SURG, V36, P573, DOI 10.1111/j.1532-950X.2007.00307.x; Medeiros RM, 2016, VET MED-CZECH, V61, P382, DOI 10.17221/168/2015-VETMED; Minier K, 2014, VET COMP ORTHOPAED, V27, P411, DOI 10.3415/VCOT-14-03-0036; Montavon P. M., 2002, 1st World Orthopaedic Veterinary Congress Proceedings, Munich, Germany, 5-8 September 2002, P152; Morato GO, 2012, BRA J AN SCI, V5, P346; Morato GO, 2017, INVESTIGACAO, V16, P1; Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x; Robinson D, 2017, VET SURG SMALL ANIMA, P2185; Rocha AG, 2012, WORLD ORTH VET C BOL, V16, P454; Tepic S., 2002, 1st World Orthopaedic Veterinary Congress Proceedings, Munich, Germany, 5-8 September 2002, P189; Wang Hong, 2015, Zhonghua Kou Qiang Yi Xue Za Zhi, V50, P720	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220291	10.1371/journal.pone.0220291	http://dx.doi.org/10.1371/journal.pone.0220291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381582	gold, Green Published, Green Submitted			2022-12-26	WOS:000484993600015
J	Hamaneh, MB; Yu, YK				Hamaneh, Mehdi B.; Yu, Yi-Kuo			Exploring induced pluripotency in human fibroblasts via construction, validation, and application of a gene regulatory network	PLOS ONE			English	Article							HUMAN SOMATIC-CELLS; STEM-CELLS; TRANSCRIPTIONAL REGULATION; SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; OCT4; INDUCTION; SOX2; KLF4	Reprogramming of somatic cells to induced pluripotent stem cells, by overexpressing certain factors referred to as the reprogramming factors, can revolutionize regenerative medicine. To provide a coherent description of induced pluripotency from the gene regulation perspective, we use 35 microarray datasets to construct a reprogramming gene regulatory network. Comprising 276 nodes and 4471 links, the resulting network is, to the best of our knowledge, the largest gene regulatory network constructed for human fibroblast reprogramming and it is the only one built using a large number of experimental datasets. To build the network, a model that relates the expression profiles of the initial (fibroblast) and final (induced pluripotent stem cell) states is proposed and the model parameters (link strengths) are fitted using the experimental data. Twenty nine additional experimental datasets are collectively used to test the model/network, and good agreement between experimental and predicted gene expression profiles is found. We show that the model in conjunction with the constructed network can make useful predictions. For example, we demonstrate that our approach can incorporate the effect of reprogramming factor stoichiometry and that its predictions are consistent with the experimentally observed trends in reprogramming efficiency when the stoichiometric ratios vary. Using our model/network, we also suggest new (not used in training of the model) candidate sets of reprogramming factors, many of which have already been experimentally verified. These results suggest our model/network can potentially be used in devising new recipes for induced pluripotency with higher efficiencies. Additionally, we classify the links of the network into three classes of different importance, prioritizing them for experimental verification. We show that many of the links in the top ranked class are experimentally known to be important in reprogramming. Finally, comparing with other methods, we show that using our model is advantageous.	[Hamaneh, Mehdi B.; Yu, Yi-Kuo] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yu, YK (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	yyu@ncbi.nlm.nih.gov		Yu, Yi-Kuo/0000-0002-6213-7665	National Institutes of Health [ZIA LM092404]; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the intramural research program of the National Institutes of Health through the grant ZIA LM092404 awarded to YKY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Chai LE, 2014, COMPUT BIOL MED, V48, P55, DOI 10.1016/j.compbiomed.2014.02.011; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chang R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002300; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Declercq J, 2013, STEM CELLS DEV, V22, P2017, DOI 10.1089/scd.2012.0651; Duren ZN, 2012, CHIN CONTR CONF, P7437; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gracio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060240; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jones E., 2001, SCIPY OPEN SOURCE SC; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kim SI, 2015, STEM CELL REP, V4, P727, DOI 10.1016/j.stemcr.2015.02.004; Kumar A, 2012, J MOL CELL BIOL, V4, P252, DOI 10.1093/jmcb/mjs015; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Marbach D, 2016, NAT METHODS, V13, P366, DOI [10.1038/NMETH.3799, 10.1038/nmeth.3799]; Mitra MK, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0706; Miyamoto T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004476; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Nakaki F, 2014, TRENDS BIOCHEM SCI, V39, P289, DOI 10.1016/j.tibs.2014.04.003; Nishimura K, 2014, STEM CELL REP, V3, P915, DOI 10.1016/j.stemcr.2014.08.014; Ohnuki M, 2014, P NATL ACAD SCI USA, V111, P12426, DOI 10.1073/pnas.1413299111; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yamaguchi S, 2011, STEM CELL RES, V6, P177, DOI 10.1016/j.scr.2010.09.004; Yang HM, 2007, J CELL BIOCHEM, V101, P1198, DOI 10.1002/jcb.21244; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang B, 2014, P NATL ACAD SCI USA, V111, P10185, DOI 10.1073/pnas.1408561111; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220742	10.1371/journal.pone.0220742	http://dx.doi.org/10.1371/journal.pone.0220742			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374103	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500030
J	Harada, A; Taniguchi, F; Amano, H; Kurozawa, Y; Ideno, Y; Hayashi, K; Harada, T; Kawamoto, T; Ohya, Y; Kishi, R; Yaegashi, N; Hashimoto, K; Inadera, H; Yamagata, Z; Mori, C; Ito, S; Kamijima, M; Nakayama, T; Iso, H; Shima, M; Hirooka, Y; Suganuma, N; Kusuhara, K; Katoh, T				Harada, Akashi; Taniguchi, Fuminori; Amano, Hiroki; Kurozawa, Youichi; Ideno, Yuki; Hayashi, Kunihiko; Harada, Tasuku; Kawamoto, Toshihiro; Ohya, Yukihiro; Kishi, Reiko; Yaegashi, Nobuo; Hashimoto, Koichi; Inadera, Hidekuni; Yamagata, Zentaro; Mori, Chisato; Ito, Shuichi; Kamijima, Michihiro; Nakayama, Takeo; Iso, Hiroyasu; Shima, Masayuki; Hirooka, Yasuaki; Suganuma, Narufumi; Kusuhara, Koichi; Katoh, Takahiko		Japan Environm Childrens Study Grp	Adverse obstetrical outcomes for women with endometriosis and adenomyosis: A large cohort of the Japan Environment and Children's Study	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; PREGNANCY OUTCOMES; UTERINE ADENOMYOSIS; PERINATAL OUTCOMES; SPIRAL ARTERIES; INFERTILITY; SUBFERTILITY; ASSOCIATION; PREVALENCE	Background Because of the increased number of diagnosed cases of endometriosis or adenomyosis resulting in infertility, many women require assisted reproductive technology (ART) to become pregnant. However, incidences of obstetric complications are increased for women who conceive using ART. There has been no prospective cohort study examining the influence of endometriosis and adenomyosis on obstetric outcomes after adjusting for the confounding influence of ART therapy. Objective This study evaluated the impact of endometriosis and adenomyosis on the incidence of adverse pregnancy outcomes. Study design Data were obtained from a prospective cohort study, known as the Japan Environment and Children's Study (JECS), of the incidence of obstetric complications for women with endometriosis and adenomyosis. The data of 103,099 pregnancies that resulted in live birth or stillbirth or that were terminated through abortion between February 2011 and July 2014 in Japan were included. Results Women with endometriosis or adenomyosis were at increased risk for complications during pregnancy compared to those without a medical history of endometriosis (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.23 to 1.41) or adenomyosis (OR, 1.72; 95% CI, 1.37 to 2.16). Our analysis showed that the adjusted ORs for obstetric complications of pregnant women who conceived naturally or after infertility treatment that did not involve ART therapy were 1.26 (CI, 1.17 to 1.35) for pregnant women with a history of endometriosis and 1.52 (CI, 1.19 to 1.94) for those with a history of adenomyosis. Conclusions The presence of endometriosis and adenomyosis significantly increased the prevalence of obstetric complications after adjusting for the influence of ART outcomes.	[Harada, Akashi; Taniguchi, Fuminori; Harada, Tasuku] Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori, Japan; [Amano, Hiroki; Kurozawa, Youichi] Tottori Univ, Fac Med, Dept Publ Hlth, Yonago, Tottori, Japan; [Ideno, Yuki; Hayashi, Kunihiko] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci & Environm Hlth Sci, Maebashi, Gunma, Japan; [Ohya, Yukihiro] Med Support Ctr, Tokyo, Japan; [Kishi, Reiko] Hokkaido Reg Ctr, Sapporo, Hokkaido, Japan; [Yaegashi, Nobuo] Miyagi Reg Ctr, Sendai, Miyagi, Japan; [Hashimoto, Koichi] Fukushima Reg Ctr, Fukushima, Japan; [Inadera, Hidekuni] Toyama Reg Ctr, Toyama, Japan; [Yamagata, Zentaro] Koushin Reg Ctr, Tokyo, Japan; [Mori, Chisato] Chiba Reg Ctr, Chiba, Japan; [Ito, Shuichi] Kanagawa Reg Ctr, Yokohama, Kanagawa, Japan; [Kamijima, Michihiro] Aichi Reg Ctr, Nagoya, Aichi, Japan; [Nakayama, Takeo] Kyoto Reg Ctr, Kyoto, Japan; [Iso, Hiroyasu] Osaka Reg Ctr, Osaka, Japan; [Shima, Masayuki] Hyogo Reg Ctr, Kobe, Hyogo, Japan; [Hirooka, Yasuaki] Tottori Reg Ctr, Tottori, Japan; [Suganuma, Narufumi] Kochi Reg Ctr, Kochi, Japan; [Kusuhara, Koichi] Fukuoka Reg Ctr, Fukuoka, Fukuoka, Japan; [Katoh, Takahiko] South Kyushu Okinawa Reg Ctr, Naha, Okinawa, Japan	Tottori University; Tottori University; Gunma University	Harada, T (corresponding author), Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori, Japan.	tasuku@med.tottori-u.ac.jp	NAKAYAMA, Takeo/HCH-0537-2022	Hayashi, Kunihiko/0000-0003-4648-3936				Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Aris A, 2014, GYNECOL ENDOCRINOL, V30, P34, DOI 10.3109/09513590.2013.848425; Benagiano G, 2014, HUM REPROD UPDATE, V20, P386, DOI 10.1093/humupd/dmt052; Brosens I, 2013, PLACENTA, V34, P100, DOI 10.1016/j.placenta.2012.11.017; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; D'Hooghe TM, 2003, SEMIN REPROD MED, V21, P243; DOMMISSE J, 1992, BRIT J OBSTET GYNAEC, V99, P651, DOI 10.1111/j.1471-0528.1992.tb13848.x; Dueholm M, 2017, ACTA OBSTET GYN SCAN, V96, P715, DOI 10.1111/aogs.13158; Harada T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168476; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Juang CM, 2007, BJOG-INT J OBSTET GY, V114, P165, DOI 10.1111/j.1471-0528.2006.01186.x; Kanatani KT, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004863; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Khine Yin Mon, 2016, Reproductive Medicine and Biology, V15, P217, DOI 10.1007/s12522-016-0237-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; Kramer MS, 1997, OBSTET GYNECOL, V89, P221, DOI 10.1016/S0029-7844(96)00478-4; Larsen SB, 2011, EUR J OBSTET GYN R B, V157, P206, DOI 10.1016/j.ejogrb.2011.03.003; Levy G, 2013, J RADIOL DIAGN INTER, V94, P3, DOI 10.1016/j.diii.2012.10.012; Maggiore ULR, 2016, HUM REPROD UPDATE, V22, P70, DOI 10.1093/humupd/dmv045; Maheshwari A, 2012, HUM REPROD UPDATE, V18, P374, DOI 10.1093/humupd/dms006; MAJOR CA, 1995, AM J OBSTET GYNECOL, V172, P672, DOI 10.1016/0002-9378(95)90591-X; Martinez-Conejero JA, 2011, FERTIL STERIL, V96, P943, DOI 10.1016/j.fertnstert.2011.07.1088; Michikawa T, 2018, J EPIDEMIOL, V28, P99, DOI 10.2188/jea.JE20170018; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Mochimaru A, 2015, J OBSTET GYNAECOL RE, V41, P529, DOI 10.1111/jog.12604; Naftalin J, 2012, HUM REPROD, V27, P3432, DOI 10.1093/humrep/des332; Osteen KG, 1996, SEMIN REPROD ENDOCR, V14, P247, DOI 10.1055/s-2007-1016334; Pierce BT, 2000, AM J OBSTET GYNECOL, V183, P863, DOI 10.1067/mob.2000.108887; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Reinhold C, 1999, RADIOGRAPHICS, V19, pS147, DOI 10.1148/radiographics.19.suppl_1.g99oc13s147; ROSSMAN F, 1983, OBSTET GYNECOL, V62, P519; Stephansson O, 2009, HUM REPROD, V24, P2341, DOI 10.1093/humrep/dep186; Wu Y, 2006, ENDOCRINOLOGY, V147, P232, DOI 10.1210/en.2005-0426; Yorifuji T, 2013, J OBSTET GYNAECOL RE, V39, P1480, DOI 10.1111/jog.12088	39	24	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220256	10.1371/journal.pone.0220256	http://dx.doi.org/10.1371/journal.pone.0220256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374085	Green Published, gold, Green Submitted			2022-12-26	WOS:000484991500006
J	Abba, C; Campanelli, R; Catarsi, P; Villani, L; Abbonante, V; Sesta, MA; Barosi, G; Rosti, V; Massa, M				Abba, Carlotta; Campanelli, Rita; Catarsi, Paolo; Villani, Laura; Abbonante, Vittorio; Sesta, Melanie Antonietta; Barosi, Giovanni; Rosti, Vittorio; Massa, Margherita			Constitutive STAT5 phosphorylation in CD34(+) cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity	PLOS ONE			English	Article							INTERNATIONAL WORKING GROUP; HEMATOPOIETIC STEM; INTERFERON-GAMMA; MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; PATHWAY ACTIVATION; POLYCYTHEMIA-VERA; JAK2 MUTATION; EXPRESSION; CONTRIBUTES	Primary Myelofibrosis (PMF) is a myeloproliferative disorder associated with JAK2V617F, Calreticulin (CALR) indels, and MPLW515L/K mutations activating the tyrosine kinase JAK2 and its downstream signaling pathway. The nature of signaling abnormalities in primary cells from PMF patients is poorly understood, since most of the work has been performed in cell lines or animal models. By flow cytometry we measured constitutive and cytokine induced phosphorylation of STAT5, STAT3, and ERK1/2 in circulating CD34(+) cells from 57 patients with PMF (20 with prefibrotic-PMF) and 13 healthy controls (CTRLs). Levels of constitutive and TPO induced p-STAT5, and IL6 induced p-STAT3 were higher in patients than in CTRLs. Constitutive p-STAT5 values were lower in CALR than homozygous JAK2V617F mutated CD34(+) cells from PMF patients. Moreover, constitutive p-STAT5 and IL6 induced p-STAT3 values correlated directly with circulating CD34(+) cell number/L, and inversely with the frequency of circulating CD34(+) cells expressing CXCR4. Constitutive p-STAT5 values of CD34(+) cells were also inversely correlated with hemoglobin levels. When the patients were divided according with presence/absence of JAK2V617F mutation, all the correlations described characterized the JAK2V617F+ patients with prefibrotic-PMF (P-PMF). In conclusion, increased constitutive p-STAT5 and IL6 induced p-STAT3 values in circulating CD34(+) cells characterize patients with PMF. Constitutive p-STAT5 and IL6 induced p-STAT3 values correlate with circulating CD34(+) cell number/L, the frequency of circulating CD34(+) cells expressing CXCR4 and hemoglobin levels within the prefibrotic JAK2V617F(+) patient population. Our data point toward a complex activation of STAT5-dependent pathways in the stem/progenitor cell compartment, that characterize the phenotypic diversity of PMF.	[Abba, Carlotta; Campanelli, Rita; Catarsi, Paolo; Villani, Laura; Barosi, Giovanni; Rosti, Vittorio] IRCCS, Ctr Study Myelofibrosis, Lab Biochem Biotechnol & Adv Diag, Policlin San Matteo Fdn, Pavia, Italy; [Abbonante, Vittorio; Sesta, Melanie Antonietta; Massa, Margherita] IRCCS, Lab Biochem Biotechnol & Adv Diag, Policlin San Matteo Fdn, Pavia, Italy; [Abbonante, Vittorio] Univ Pavia, Dept Mol Med, Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia	Massa, M (corresponding author), IRCCS, Lab Biochem Biotechnol & Adv Diag, Policlin San Matteo Fdn, Pavia, Italy.	m.massa@smatteo.pv.it	Rosti, Vittorio/K-1743-2018; Massa, Margherita/K-4682-2016; Catarsi, Paolo/J-4463-2016; Villani, Laura/K-1794-2018; Abbonante, Vittorio/AAA-9303-2020; Barosi, Giovanni/AAI-1714-2019; Abbà, Carlotta/Y-9169-2019; Campanelli, Rita/K-4686-2016	Rosti, Vittorio/0000-0003-4195-2289; Massa, Margherita/0000-0001-8037-0439; Catarsi, Paolo/0000-0002-1862-8168; Villani, Laura/0000-0003-4199-5633; Abbonante, Vittorio/0000-0001-8066-9895; Abbà, Carlotta/0000-0002-4173-7055; Campanelli, Rita/0000-0003-4923-2761	Associazione Italiana Ricerca sul Cancro (AIRC) [10005]; Ricerca Corrente Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo [874, 08054517]; Ricerca Finalizzata Italian Ministry of Health [GR-2016-02363136]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ricerca Corrente Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo; Ricerca Finalizzata Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) project number 10005 "Special Program Molecular Clinical Oncology 5x1000" to Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative (AGIMM) (A detailed description of the AGIMM project is available at http://www. progettoagimm. it), received by GB; by Ricerca Corrente Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, project number 874, code number 08054517, received by VR (Vittorio Rosti) (www.sanmatteo.org); and by Ricerca Finalizzata Italian Ministry of Health, project number GR-2016-02363136, received by VA (Vittorio Abbonante). The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Anand S, 2011, BLOOD, V118, P1610, DOI 10.1182/blood-2011-02-335042; Anand S, 2011, BLOOD, V118, P177, DOI 10.1182/blood-2010-12-327593; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barosi G, 2017, LEUKEMIA RES, V60, P18, DOI 10.1016/j.leukres.2017.06.004; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; Glembotsky AC, 2010, EUR J HAEMATOL, V84, P398, DOI 10.1111/j.1600-0609.2010.01421.x; Grimwade LF, 2009, BRIT J HAEMATOL, V147, P495, DOI 10.1111/j.1365-2141.2009.07870.x; Hamilton A, 2006, LEUKEMIA, V20, P1035, DOI 10.1038/sj.leu.2404189; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112786; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kleppe M, 2015, CANCER DISCOV, V5, P316, DOI 10.1158/2159-8290.CD-14-0736; Kota J, 2008, LEUKEMIA, V22, P1828, DOI 10.1038/leu.2008.236; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Mesa RA, 2006, LEUKEMIA, V20, P1800, DOI 10.1038/sj.leu.2404338; Morales-Mantilla DE, 2018, CURR STEM CELL REP, V4, P264, DOI 10.1007/s40778-018-0139-3; Moucadel V, 2005, J BIOL CHEM, V280, P13364, DOI 10.1074/jbc.M407326200; Nangalia J, 2017, BLOOD, V130, P2475, DOI 10.1182/blood-2017-06-782037; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Poletto V, 2012, BLOOD, V120, P3112, DOI 10.1182/blood-2012-05-433466; Rampal R, 2014, BLOOD, V123, pE123, DOI 10.1182/blood-2014-02-554634; Roder S, 2001, EXP HEMATOL, V29, P694, DOI 10.1016/S0301-472X(01)00637-3; Rosti V, 2007, BLOOD CELL MOL DIS, V38, P280, DOI 10.1016/j.bcmd.2007.01.003; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Tvorogov D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3834; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zeng WH, 2006, BLOOD, V107, P167, DOI 10.1182/blood-2005-05-1884	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220189	10.1371/journal.pone.0220189	http://dx.doi.org/10.1371/journal.pone.0220189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369569	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900035
J	Siebers, N; Kruse, J				Siebers, Nina; Kruse, Jens			Short-term impacts of forest clear-cut on soil structure and consequences for organic matter composition and nutrient speciation: A case study	PLOS ONE			English	Article							SULFUR SPECIATION; LAND-USE; SEQUENTIAL EXTRACTION; DENSITY FRACTIONS; NEW-ZEALAND; PHOSPHORUS; CARBON; STABILITY; NITROGEN; SPECTROSCOPY	Clear-cuts of forests severely affect soil structure and thus soil organic matter (SOM) and nutrient cycling dynamics therein, though with yet unknown consequences for SOM composition as well as phosphorus (P) and sulfur (S) chemical form within the soil microaggregate size fraction. To determine the effects of conventional clear-cutting on soil chemistry in a Cambisol of the Wu <spacing diaeresis> stebach Forest (northwestern Germany), we sampled the mineral Aand B-horizons prior to clear-cut as well as 10 and 24 month thereafter. We measured the SOM composition of soil microaggregates using pyrolysis field ionization mass spectrometry (Py-FIMS), as well as P and S chemical form and speciation using wet-chemical extractions and X-ray absorption near edge structure (XANES) spectroscopy. We found that clear-cut led to an increase of the microaggregate size fraction up to 6% due to break-down of macroaggregates and initially significantly increased total elemental concentrations (C, N, P, S) due to the introduction of slash-residues. The SOM of slash-residues consisted to a substantial amount of sterols and was generally found to be of low thermal stability and probably did not contribute to aggregate stability. Deterioration of the aggregate structure probably led to an exposure of originally inaccessible sites within aggregates to the attack by soil microorganisms and thus to an increased P and S turnover as reflected in a significantly reduction of available P proportions (4 to 7%) and a reduction of the most reduced S forms (5%). A probable increased microbial activity and contribution to SOM after clear-cut is also reflected in the significantly increasing hexose: pentose ratio by 0.25 between 10 and 24 month after clear-cut, significantly increasing the general thermal stability of SOM in the microaggregate size fraction and believed to contribute to aggregate stability. This indicated that a first deterioration of the aggregate structure after clear-cut might in the long-term be remediated with time.	[Siebers, Nina; Kruse, Jens] Forschungszentrum Julich, Inst Bio & Geosci IBG 3, Agrosphere Inst, Julich, Germany; [Kruse, Jens] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, Bonn, Germany	Helmholtz Association; Research Center Julich; University of Bonn	Siebers, N (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci IBG 3, Agrosphere Inst, Julich, Germany.	n.siebers@fz-juelich.de		Kruse, Jens/0000-0003-1011-3298; Siebers, Nina/0000-0002-6431-0046	Helmholtz-Post-doctorate Program "Bioaccessibility of soil nutrients in relation to aggregate microstructure" [PD-122]; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Helmholtz-Post-doctorate Program "Bioaccessibility of soil nutrients in relation to aggregate microstructure"; Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	NS received fundings for this study from the Helmholtz-Post-doctorate Program "Bioaccessibility of soil nutrients in relation to aggregate microstructure", PD-122. The funders did not play a role for the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.r We gratefully acknowledge Inge Wiekenkamp, Hela Brixius, and Werner Kupper (FZJ) for helping with soil sampling. We thank Kai-Uwe Eckhardt and Peter Leinweber (Soil Science Group, University of Rostock) for providing and discussing Py-FIMS data. Additionally, special thanks to Stephanie Sosada (FZJ) for helping with P and S fractionation. The P and S Kedge XANES research described in this paper was performed at the Canadian Light Source (CLS), which is supported by the Canadian Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research. The authors would like to thank one of the best beamline scientist team, i. e., Yongfeng Hu, Qunfeng Xiao, and Aimee Maclennan at CLS for technical support. We would also like to thank Pee Narf.	Al-Kaisi MM, 2014, J SOIL WATER CONSERV, V69, P574, DOI 10.2489/jswc.69.6.574; Amelung W., 2018, SCHEFFERSCHACHTSCHAB, P491, DOI [10.1007/978-3-662-55871-3, DOI 10.1007/978-3-662-55871-3, 10.1007/978-3-662-55871-3_9, DOI 10.1007/978-3-662-55871-3_9]; AUTRY AR, 1990, CAN J FOREST RES, V20, P337, DOI 10.1139/x90-049; BEYER L, 1993, J ANAL APPL PYROL, V27, P169, DOI 10.1016/0165-2370(93)80007-M; Bhupinderpal-Singh, 2004, EUR J SOIL SCI, V55, P79, DOI [10.1046/j.1365-2389.2003.00552.x, 10.1046/j.1351-0754.2003.0552.x]; Blanco J.A., 2018, SOIL MANAGEMENT CLIM, P237, DOI [10.1016/B978-0-12-812128-3.00016-1, DOI 10.1016/B978-0-12-812128-3.00016-1]; Bogena HR, 2015, SCI CHINA EARTH SCI, V58, P61, DOI 10.1007/s11430-014-4911-7; Bogena HR, 2010, VADOSE ZONE J, V9, P1002, DOI 10.2136/vzj2009.0173; Boyle JR, 1976, TAPPI ANNUAL MEETING, P29; Calvin S, 2018, XAFS FOR EVERYONE, DOI [10.1201/b14843, DOI 10.1201/B14843]; Chen B, 1997, FRESEN J ANAL CHEM, V357, P941, DOI 10.1007/s002160050278; Chen CM, 2018, SOIL SYST, V2, DOI 10.3390/soilsystems2010016; CORNELL RM, 1979, CLAY CLAY MINER, V27, P402, DOI 10.1346/CCMN.1979.0270602; CORTINA J, 1994, FOREST ECOL MANAG, V70, P299, DOI 10.1016/0378-1127(94)90095-7; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Etmann M., 2009, DENDROLOGISCHE AUFNA; Finer L, 2003, FOREST ECOL MANAG, V174, P51, DOI 10.1016/S0378-1127(02)00019-1; FRENEY J R, 1971, Soil Biology and Biochemistry, V3, P133, DOI 10.1016/0038-0717(71)90006-X; FRENEY JR, 1969, J SCI FOOD AGR, V20, P440, DOI 10.1002/jsfa.2740200718; FRENEY JR, 1961, AUST J AGR RES, V12, P424, DOI 10.1071/AR9610424; Gerard F, 2016, GEODERMA, V262, P213, DOI 10.1016/j.geoderma.2015.08.036; Gottselig N, 2017, GLOBAL BIOGEOCHEM CY, V31, P1592, DOI 10.1002/2017GB005657; Groenendijk FM, 2002, GEODERMA, V108, P91, DOI 10.1016/S0016-7061(02)00125-8; GUGGENBERGER G, 1994, EUR J SOIL SCI, V45, P449, DOI 10.1111/j.1365-2389.1994.tb00530.x; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; HEMPFLING R, 1989, SCI TOTAL ENVIRON, V81-2, P31, DOI 10.1016/0048-9697(89)90108-3; HEMPFLING R, 1991, BIOGEOCHEMISTRY, V13, P27; Hempfling R., 1988, CHARAKTERISIERUNG VE; Hu YF, 2010, AIP CONF PROC, V1234, P343, DOI 10.1063/1.3463208; HUNTINGTON TG, 1990, FOREST ECOL MANAG, V31, P193, DOI 10.1016/0378-1127(90)90067-L; Julich D, 2017, FORESTS, V8, DOI 10.3390/f8010019; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Knuti LL, 1984, PRENTICE HALL AGR SE; Kruse J, 2015, J PLANT NUTR SOIL SC, V178, P43, DOI 10.1002/jpln.201400327; Lacroix EM, 2016, SOIL SCI, V181, P202, DOI 10.1097/SS.0000000000000147; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lang F, 2017, BIOGEOCHEMISTRY, V136, P5, DOI 10.1007/s10533-017-0375-0; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; Leemans R., 2003, MILLENNIUM ECOSYSTEM; Lilienfein J, 2000, GEODERMA, V96, P31, DOI 10.1016/S0016-7061(00)00002-1; Lobe I, 2011, GEODERMA, V162, P251, DOI 10.1016/j.geoderma.2011.02.001; Ludwig M, 2015, SOIL BIOL BIOCHEM, V81, P311, DOI 10.1016/j.soilbio.2014.12.002; McDowell RW, 2006, GEODERMA, V130, P176, DOI 10.1016/j.geoderma.2005.01.020; MENGEL K, 1994, Z PFLANZ BODENKUNDE, V157, P233, DOI 10.1002/jpln.19941570311; Nave LE, 2010, FOREST ECOL MANAG, V259, P857, DOI 10.1016/j.foreco.2009.12.009; Negassa W, 2009, J PLANT NUTR SOIL SC, V172, P305, DOI 10.1002/jpln.200800223; Nieminen Mika, 1998, Boreal Environment Research, V3, P9; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Ohlinger R, 1996, SOIL SAMPLING SAMPLE, P7; Olsson BA, 1996, FOREST ECOL MANAG, V82, P19, DOI 10.1016/0378-1127(95)03697-0; Pennock DJ, 1997, CAN J SOIL SCI, V77, P211, DOI 10.4141/S96-112; Piirainen S, 2004, BIOGEOCHEMISTRY, V69, P405, DOI 10.1023/B:BIOG.0000031061.80421.1b; Prietzel J, 2008, EUR J SOIL SCI, V59, P730, DOI 10.1111/j.1365-2389.2008.01034.x; Prietzel J, 2016, J PLANT NUTR SOIL SC, V179, P168, DOI 10.1002/jpln.201500472; Prietzel J, 2009, J PLANT NUTR SOIL SC, V172, P393, DOI 10.1002/jpln.200800054; QUEVAUVILLER P, 2002, METHODOLOGIES SOIL S, P21, DOI DOI 10.1039/9781847551412-00028; Ranius T, 2018, J ENVIRON MANAGE, V209, P409, DOI 10.1016/j.jenvman.2017.12.048; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rosenqvist L, 2007, ENV EFFECTS AFFOREST, P79, DOI DOI 10.1007/1-4020-4568-94; Scherer HW, 2009, J PLANT NUTR SOIL SC, V172, P326, DOI 10.1002/jpln.200900037; Schnitzer M, 1995, ADV AGRON, V55, P167, DOI 10.1016/S0065-2113(08)60540-4; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Schulten H.-R., 1998, Biology and Fertility of Soils, V26, P1, DOI 10.1007/s003740050335; Schulten HR, 1999, EUR J SOIL SCI, V50, P237, DOI 10.1046/j.1365-2389.1999.00241.x; Schulten HR, 1998, STRUCTURE SURFACE RE; Shan XQ, 1997, SCI TOTAL ENVIRON, V199, P237, DOI 10.1016/S0048-9697(97)05465-X; Siebers N, 2018, GEODERMA, V313, P163, DOI [10., 10.1016/j.geoderma.2017.10.028]; Siebers N, 2018, GEODERMA, V315, P59, DOI 10.1016/j.geoderma.2017.11.024; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Six J, 2000, SOIL SCI SOC AM J, V64, P1042, DOI 10.2136/sssaj2000.6431042x; Six J, 2016, ENCY ENV MANAGEMENT, P1872, DOI [10.1081/e-eem-120001812, DOI 10.1081/E-EEM-120001812]; Sleutel S, 2008, BIOGEOCHEMISTRY, V89, P253, DOI 10.1007/s10533-008-9217-4; Smolander A, 2001, BIOL FERT SOILS, V33, P190, DOI 10.1007/s003740000307; Solomon D, 2003, SOIL SCI SOC AM J, V67, P1721, DOI 10.2136/sssaj2003.1721; SPAANS EJA, 1989, HYDROL PROCESS, V3, P383, DOI 10.1002/hyp.3360030409; Spielvogel S, 2006, SOIL SCI SOC AM J, V70, P2130, DOI 10.2136/sssaj2005.0027; Stutter MI, 2015, GEODERMA, V257, P29, DOI 10.1016/j.geoderma.2015.03.020; Thomas D, 2016, J ENVIRON MANAGE, V165, P243, DOI 10.1016/j.jenvman.2015.09.039; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Totsche KU, 2018, J PLANT NUTR SOIL SC, V181, P104, DOI 10.1002/jpln.201600451; Virto I, 2008, GEODERMA, V146, P326, DOI 10.1016/j.geoderma.2008.05.021; Vitousek P. M., 1981, Ecological Bulletins, V33, P631; Vodyanitskii YN, 2016, EURASIAN SOIL SCI+, V49, P796, DOI 10.1134/S1064229316070127; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wu B, 2017, J ENVIRON QUAL, V46, P1510, DOI 10.2134/jeq2017.05.0193; Xu JM, 2006, SOIL BIOL BIOCHEM, V38, P709, DOI 10.1016/j.soilbio.2005.06.022; Yanai RD, 1998, FOREST ECOL MANAG, V104, P281, DOI 10.1016/S0378-1127(97)00256-9; Zacharias S, 2011, VADOSE ZONE J, V10, P955, DOI 10.2136/vzj2010.0139	89	14	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220476	10.1371/journal.pone.0220476	http://dx.doi.org/10.1371/journal.pone.0220476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369652	Green Submitted, gold, Green Published			2022-12-26	WOS:000484987900055
J	Gonzalez-Escalona, N; Allard, MA; Brown, EW; Sharma, S; Hoffmann, M				Gonzalez-Escalona, Narjol; Allard, Marc A.; Brown, Eric W.; Sharma, Shashi; Hoffmann, Maria			Nanopore sequencing for fast determination of plasmids, phages, virulence markers, and antimicrobial resistance genes in Shiga toxin-producing Escherichia coli	PLOS ONE			English	Article							REAL-TIME; GENOME; OUTBREAK; CATTLE; O26; IDENTIFICATION; VISUALIZATION; PATHOGENS; MINION; CLONE	Whole genome sequencing can provide essential public health information. However, it is now known that widely used short-read methods have the potential to miss some randomly-distributed segments of genomes. This can prevent phages, plasmids, and virulence factors from being detected or properly identified. Here, we compared assemblies of three complete Shiga toxin-producing Escherichia coli (STEC) O26:H11/H-genomes from two different sequence types (ST21 and 29), each acquired using the Nextera XT MiSeq, MinION nanopore-based sequencing, and Pacific Biosciences (PacBio) sequencing. Each closed genome consisted of a single chromosome, approximately 5.7 Mb for CFSAN027343, 5.6 Mb for CFSAN027346, and 5.4 MB for CFSAN027350. However, short-read whole genome sequencing (WGS) using Nextera XT MiSeq failed to identify some virulence genes in plasmids and on the chromosome, both of which were detected using the long-read platforms. Results from long-read MinION and PacBio allowed us to identify differences in plasmid content: a single 88 kb plasmid in CFSAN027343; a 157kb plasmid in CFSAN027350; and two plasmids in CFSAN027346 (one 95 Kb, one 72 Kb). These data enabled rapid characterization of the virulome, detection of antimicrobial genes, and composition/location of Stx phages. Taken together, positive correlations between the two long-read methods for determining plasmids, virulome, antimicrobial resistance genes, and phage composition support MinION sequencing as one accurate and economical option for closing STEC genomes and identifying specific virulence markers.	[Gonzalez-Escalona, Narjol; Allard, Marc A.; Brown, Eric W.; Sharma, Shashi; Hoffmann, Maria] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Gonzalez-Escalona, N (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	narjol.gonzalez-escalona@fda.hhs.gov	Gonzalez-Escalona, Narjol/H-6161-2019; Gonzalez-Escalona, Narjol/A-7598-2009	Gonzalez-Escalona, Narjol/0000-0003-4568-0022; 	FDA Foods Science and Research Intramural Program; MCMi Challenge Grants Program [2018-646]	FDA Foods Science and Research Intramural Program; MCMi Challenge Grants Program	This work was supported by the FDA Foods Science and Research Intramural Program and a grant to NGE from the MCMi Challenge Grants Program Proposal #2018-646. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Benitez-Paez A, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0111-z; Bielaszewska M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/cid/cit055; Bletz S, 2013, GENOME BIOL EVOL, V5, P1807, DOI 10.1093/gbe/evt136; Bonanno L, 2015, APPL ENVIRON MICROB, V81, P3712, DOI 10.1128/AEM.00077-15; Brown BL, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix007; Bugarel M, 2011, APPL ENVIRON MICROB, V77, P2275, DOI 10.1128/AEM.02832-10; Cepeda-Molero M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006706; Chase-Topping ME, 2012, EMERG INFECT DIS, V18, P439, DOI 10.3201/eid1803.111236; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Dallman TJ, 2015, EPIDEMIOL INFECT, V143, P1672, DOI 10.1017/S0950268814002696; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delannoy S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01625; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Fratarnico PM, 2011, INT J MED MICROBIOL, V301, P192, DOI 10.1016/j.ijmm.2010.09.002; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Giordano F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03996-z; Gonzalez-Escalona N, 2016, EMERG INFECT DIS, V22, P1235, DOI 10.3201/eid2207.151896; Gonzalez-Escalona N, 2016, APPL ENVIRON MICROB, V82, P3900, DOI 10.1128/AEM.00498-16; Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9; Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796; Hoffmann M, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GEN0MEA.01068-13; Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297; Etcheverria AI, 2013, VIRULENCE, V4, P366, DOI 10.4161/viru.24642; Ishijima N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43136; Jain M, 2018, NAT BIOTECHNOL, V36, P338, DOI 10.1038/nbt.4060; Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0; Jenkins C, 2008, J APPL MICROBIOL, V104, P14, DOI 10.1111/j.1365-2672.2007.03465.x; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Judge K, 2015, J ANTIMICROB CHEMOTH, V70, P2775, DOI 10.1093/jac/dkv206; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Loman NJ, 2015, NAT METHODS, V12, P303, DOI 10.1038/nmeth.3327; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]; Lorenz SC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00846-16; Lorenz SC, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1094-3; Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004; Martinez-Urtaza J, 2017, MBIO, V8, DOI 10.1128/mBio.01425-17; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Norris AL, 2016, CANCER BIOL THER, V17, P246, DOI 10.1080/15384047.2016.1139236; Ogura Y, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000141; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Strauss L, 2017, P NATL ACAD SCI USA, V114, pE10596, DOI 10.1073/pnas.1702472114; Tilgner H, 2015, NAT BIOTECHNOL, V33, P736, DOI 10.1038/nbt.3242; van der Helm E, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1328; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zweifel C, 2013, APPL ENVIRON MICROB, V79, P5411, DOI 10.1128/AEM.01728-13	62	29	29	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220494	10.1371/journal.pone.0220494	http://dx.doi.org/10.1371/journal.pone.0220494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361781	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300034
J	Covarrubias, G; He, F; Raghunathan, S; Turan, O; Peiris, PM; Schiemann, WP; Karathanasis, E				Covarrubias, Gil; He, Felicia; Raghunathan, Shruti; Turan, Oguz; Peiris, Pubudu M.; Schiemann, William P.; Karathanasis, Efstathios			Effective treatment of cancer metastasis using a dual-ligand nanoparticle	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; NEGATIVE BREAST-CANCER; FACTOR RECEPTOR; ACTIVATION; MICROENVIRONMENT; HETEROGENEITY; NANOCARRIERS; STRATEGIES; PLATELETS; SURVIVAL	Metastasis is responsible for the majority of deaths of breast cancer patients. While cytotoxic drugs are available with high potency to kill breast cancer cells, they are not designed to specifically seek and navigate in the dynamic and continuously changing microenvironment of metastatic disease. To effectively delivery chemotherapeutic agents to metastasis, we designed a dual-ligand nanoparticle loaded with doxorubicin by using two different types of ligands targeting EGFR and alpha(v)ss(3) integrin. Metastatic cancer cells continuously change resulting in heterogeneity even across adjacent micrometastatic regions with variable expression of these targetable receptors. Using a mouse model of breast cancer metastasis, in vivo and ex vivo imaging showed that both EGFR and alpha(v)ss(3) integrin-targeting were required to reliably direct the nanoparticle to metastasis and capture the spread and exact topology of the disease. Survival studies compared the anticancer efficacy of the standard drug, EGFR-targeting nanoparticle, alpha(v)ss(3) integrin-targeting nanoparticle and the dual-ligand nanoparticle. While all the other treatments produced moderate therapeutic outcomes, treatment with the dual-ligand nanoparticle yielded significant improvement and event-free survival in a mouse model of breast cancer metastasis.	[Covarrubias, Gil; He, Felicia; Raghunathan, Shruti; Turan, Oguz; Peiris, Pubudu M.; Karathanasis, Efstathios] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Schiemann, William P.; Karathanasis, Efstathios] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Karathanasis, E (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.; Karathanasis, E (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	stathis@case.edu		Karathanasis, Efstathios/0000-0001-7484-7552	National Cancer Institute [R01CA177716, U01CA198892]; NIH Interdisciplinary Biomedical Imaging Training Program [T32EB007509]; NATIONAL CANCER INSTITUTE [R01CA177716, U01CA198892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007509] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Interdisciplinary Biomedical Imaging Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by grants from the National Cancer Institute (R01CA177716, U01CA198892) and the Prayers from Maria Children's Glioma Foundation (E.K.). G. C. was supported by the NIH Interdisciplinary Biomedical Imaging Training Program (T32EB007509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Covarrubias G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204296; Doolittle E, 2015, ACS NANO, V9, P8012, DOI 10.1021/acsnano.5b01552; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gooding AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12716-6; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Huebschman Michael L, 2015, Breast Cancer (Dove Med Press), V7, P231, DOI 10.2147/BCTT.S87041; Hyodo K, 2012, US Patent Application, Patent No. [201200581782012, 20120058178]; Karathanasis E, 2008, BIOMATERIALS, V29, P4815, DOI 10.1016/j.biomaterials.2008.08.036; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kondapaka SB, 1997, INT J CANCER, V70, P722, DOI 10.1002/(SICI)1097-0215(19970317)70:6<722::AID-IJC15>3.3.CO;2-5; LICHTNER RB, 1995, ONCOGENE, V10, P1823; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; MARTINAZZI M, 1993, J CLIN PATHOL, V46, P1009, DOI 10.1136/jcp.46.11.1009; Martinez-Revollar G, 2015, EXP CELL RES, V339, P67, DOI 10.1016/j.yexcr.2015.10.006; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; McNeeley KM, 2009, BIOMATERIALS, V30, P3986, DOI 10.1016/j.biomaterials.2009.04.012; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; MORRIS VL, 1993, CLIN EXP METASTAS, V11, P103, DOI 10.1007/BF00880071; NEWBY JC, 1995, BRIT J CANCER, V71, P1237, DOI 10.1038/bjc.1995.239; Norton KA, 2015, AM J CANCER RES, V5, P1295; O'Reilly EA, 2015, BBA CLIN, V3, P257, DOI 10.1016/j.bbacli.2015.03.003; Pawlowski V, 2000, CLIN CANCER RES, V6, P4217; Peiris PM, 2018, NANOSCALE, V10, P6861, DOI 10.1039/c8nr02513d; Peiris PM, 2015, J PHARM SCI-US, V104, P2600, DOI 10.1002/jps.24518; Peiris PM, 2015, CANCER RES, V75, P1356, DOI 10.1158/0008-5472.CAN-14-1540; Peiris PM, 2014, J CONTROL RELEASE, V173, P51, DOI 10.1016/j.jconrel.2013.10.031; Peiris PM, 2012, ACS NANO, V6, P8783, DOI 10.1021/nn303833p; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Toy R, 2014, ADV DRUG DELIVER REV, V76, P79, DOI 10.1016/j.addr.2014.08.002; Toy R, 2013, ACS NANO, V7, P3118, DOI 10.1021/nn3053439; Turner T, 1996, CLIN EXP METASTAS, V14, P409, DOI 10.1007/BF00123400; Ueno NT, 2011, J CANCER, V2, P324, DOI 10.7150/jca.2.324; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Wendt MK, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3623; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; Zhang QB, 2010, INT J CANCER, V126, P2534, DOI 10.1002/ijc.24979	48	16	16	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220474	10.1371/journal.pone.0220474	http://dx.doi.org/10.1371/journal.pone.0220474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356633	Green Submitted, Green Published, gold			2022-12-26	WOS:000484047000034
J	Karava, M; Bracharz, F; Kabisch, J				Karava, Marianna; Bracharz, Felix; Kabisch, Johannes			Quantification and isolation of Bacillus subtilis spores using cell sorting and automated gating	PLOS ONE			English	Article							FLOW-CYTOMETRY; GENE-EXPRESSION; SPORULATION; PROTEINS; FLUORESCENCE; GERMINATION; INITIATION; THRESHOLD; MECHANISM; GROWTH	The Gram-positive bacterium Bacillus subtilis is able to form endospores which have a variety of biotechnological applications. Due to this ability, B. subtilis is as well a model organism for cellular differentiation processes. Sporulating cultures of B. subtilis form sub-populations which include vegetative cells, sporulating cells and spores. In order to readily and rapidly quantify spore formation we employed flow cytometric and fluorescence activated cell sorting techniques in combination with nucleic acid fluorescent staining in order to investigate the distribution of sporulating cultures on a single cell level. Automated gating procedures using Gaussian mixture modeling (GMM) were employed to avoid subjective gating and allow for the simultaneous measurement of controls. We utilized the presented method for monitoring sporulation over time in germination deficient strains harboring different genome modifications. A decrease in the sporulation efficiency of strain Bs02018, utilized for the display of sfGFP on the spores surface was observed. On the contrary, a double knock-out mutant of the phosphatase gene encoding Spo0E and of the spore killing factor SkfA (Bs02025) exhibited the highest sporulation efficiency, as within 24 h of cultivation in sporulation medium, cultures of BS02025 already consisted of 80% spores as opposed to 18% for the control strain. We confirmed the identity of the different subpopulations formed during sporulation by employing sorting and microscopy.	[Karava, Marianna; Bracharz, Felix; Kabisch, Johannes] Tech Univ Darmstadt, Inst Biol, Comp Aided Synthet Biol, Darmstadt, Germany	Technical University of Darmstadt	Kabisch, J (corresponding author), Tech Univ Darmstadt, Inst Biol, Comp Aided Synthet Biol, Darmstadt, Germany.	kabisch@bio.tu-darmstadt.de		Karava, Marianna/0000-0001-9147-4153	BMBF grant Cascade Kit [FKZ: 031B0579A]; FNR grant [FKZ: 22007413]; LOEWE CompuGene grant	BMBF grant Cascade Kit; FNR grant(Luxembourg National Research Fund); LOEWE CompuGene grant	MK is supported by the BMBF grant Cascade Kit (FKZ: 031B0579A) and FB is supported by the FNR grant (FKZ: 22007413). JK is supported by a LOEWE CompuGene grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar WR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01636; Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Ambriz-Avina V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/461941; Beaton D., 2018, GEN MINIMUM COVARIAN, V11, DOI [10.1101/333005, DOI 10.1101/333005]; Boedigheimer MJ, 2008, CYTOM PART A, V73A, P421, DOI 10.1002/cyto.a.20553; Branska B, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1096-x; Burel JG, 2017, J IMMUNOL, V198, P1748, DOI 10.4049/jimmunol.1601750; Cattoni DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076268; Cerca F, 2011, CAN J MICROBIOL, V57, P850, DOI [10.1139/W11-078, 10.1139/w11-078]; CHUNG JD, 1994, J BACTERIOL, V176, P1977, DOI 10.1128/jb.176.7.1977-1984.1994; Comas-Riu J, 2002, J APPL MICROBIOL, V92, P475, DOI 10.1046/j.1365-2672.2002.01549.x; COOK AM, 1962, J GEN MICROBIOL, V29, P97, DOI 10.1099/00221287-29-1-97; De Gelder J, 2007, ANAL BIOANAL CHEM, V389, P2143, DOI 10.1007/s00216-007-1616-1; Driks A, 2016, BACTERIAL SPORE, P179, DOI 10.1128/microbiolspec.TBS-0023-2016; Gonzalez-Pastor JE, 2011, FEMS MICROBIOL REV, V35, P415, DOI 10.1111/j.1574-6976.2010.00253.x; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Filip Z, 2004, MICROBIOL RES, V159, P257, DOI 10.1016/j.micres.2004.05.002; Filzmoser P, 2011, ANAL CHIM ACTA, V705, P2, DOI 10.1016/j.aca.2011.03.055; Finak Greg, 2009, Advances in Bioinformatics, V2009, P247646, DOI 10.1155/2009/247646; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hammes F, 2010, ANAL BIOANAL CHEM, V397, P1083, DOI 10.1007/s00216-010-3646-3; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Imamura D, 2011, J BIOCHEM, V149, P665, DOI 10.1093/jb/mvr027; Imamura D, 2010, J BACTERIOL, V192, P518, DOI 10.1128/JB.01103-09; Isticato R, 2016, BACTERIAL SPORE, P351, DOI 10.1128/microbiolspec.TBS-0011-2012; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kumpfmuller J, 2013, J MICROBIOL METH, V95, P350, DOI 10.1016/j.mimet.2013.10.003; Laflamme C, 2006, J FLUORESC, V16, P733, DOI 10.1007/s10895-006-0129-1; Lee G, 2012, COMPUT STAT DATA AN, V56, P2816, DOI 10.1016/j.csda.2012.03.003; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Li YF, 2013, J BACTERIOL, V195, P2530, DOI 10.1128/JB.00259-13; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Magge A, 2009, J APPL MICROBIOL, V106, P814, DOI 10.1111/j.1365-2672.2008.04048.x; McBride S, 2004, J BACTERIOL, V186, P1999, DOI 10.1128/JB.186.7.1999-2005.2004; Messerschmidt K, 2016, ANAL BIOCHEM, V509, P24, DOI 10.1016/j.ab.2016.05.029; Nadler F, 2019, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00207; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; OHLSEN KL, 1994, P NATL ACAD SCI USA, V91, P1756, DOI 10.1073/pnas.91.5.1756; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; PEREGO M, 1991, J BACTERIOL, V173, P2514, DOI 10.1128/jb.173.8.2514-2520.1991; Van P, 2018, BIOINFORMATICS, V34, P3951, DOI 10.1093/bioinformatics/bty441; Piggot P, 2002, BACILLUS SUBTILIS IT, P483; Plomp M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108560; POGLIANO K, 1995, MOL MICROBIOL, V18, P459, DOI 10.1111/j.1365-2958.1995.mmi_18030459.x; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Scrucca L, 2016, R J, V8, P289; SEKIGUCHI J, 1995, J BACTERIOL, V177, P5582, DOI 10.1128/jb.177.19.5582-5589.1995; Setlow B, 2001, J BACTERIOL, V183, P4894, DOI 10.1128/JB.183.16.4894-4899.2001; Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49, DOI 10.1177/002215549704500107; Tracy BP, 2008, APPL ENVIRON MICROB, V74, P7497, DOI 10.1128/AEM.01626-08; Veal DA, 2000, J IMMUNOL METHODS, V243, P191, DOI 10.1016/S0022-1759(00)00234-9; Veening JW, 2009, GENE DEV, V23, P1959, DOI 10.1101/gad.528209; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, V2, P241, DOI [10.1007/978-3-319-24277-4_12, DOI 10.1007/978-3-319-24277-4_12, 10.1007/978-3-319-24277- 4_12]; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, P11, DOI DOI 10.1007/978-3-319-24277-4_2; Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147; Zheng XL, 2017, FOOD SCI BIOTECHNOL, V26, P167, DOI 10.1007/s10068-017-0022-5	61	10	12	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0219892	10.1371/journal.pone.0219892	http://dx.doi.org/10.1371/journal.pone.0219892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356641	Green Published, Green Submitted, gold			2022-12-26	WOS:000484047000011
J	Vleut, I; Carter, GG; Medellin, RA				Vleut, Ivar; Carter, Gerald G.; Medellin, Rodrigo A.			Movement ecology of the carnivorous woolly false vampire bat (Chrotopterus auritus) in southern Mexico	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; FORAGING BEHAVIOR; HABITAT SELECTION; HOME-RANGE; SPECIES COMPOSITION; FOOD-HABITS; CONSERVATION; CHIROPTERA; DIVERSITY; PREY	Deforestation is a critical threat to bats. The woolly false vampire bat Chrotopterus auritus is a carnivorous bat that is both an indicator species for well-conserved forests and a threatened species in Mexico and other countries due to deforestation. We currently lack the information needed to assess the effects of forest fragmentation and destruction on their populations and to develop plans for their conservation. We used GPS loggers to study the movement patterns of C. auritus in southern Mexico. We observed 72 foraging nights by GPS-tagging 10 individuals from two colonies on 32 occasions in a highly disturbed heterogeneous landscape with extensive deforestation (Hormiguero), and in a more homogeneous, well-preserved forested landscape (Monterrey). Tracked false vampire bats averaged a home range of 108.24 ha, a core foraging area of 3.78 ha and average maximum flight distances of 2.06 km. The bats ranged farther and flew significantly longer distances in Hormiguero than in Monterrey, with males flying longer and more variable distances. They used the well-preserved semi-deciduous forest more often than secondary forest and agricultural fields for traveling and foraging, but the bats occasionally moved and hunted along the borders of secondary forest and agricultural fields adjacent to semi-deciduous conserved forest areas. Although this carnivorous bat might cope with some fragmentation, we suggest that large well-preserved forested areas are highly important for its conservation.	[Vleut, Ivar; Medellin, Rodrigo A.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico; [Carter, Gerald G.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	Universidad Nacional Autonoma de Mexico; University System of Ohio; Ohio State University	Vleut, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico.	ivar8207@gmail.com			National Geographic Expeditions Council [ECO785-16]; Rufford foundation RSG grant [19232-1]; DGAPA-UNAM	National Geographic Expeditions Council; Rufford foundation RSG grant; DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by: RAM, National Geographic Expeditions Council ECO785-16, https://www.nationalgeographic.org/grants; IV, Rufford foundation RSG grant 19232-1, https://www.rufford.org/rsg/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The main author wishes to thank DGAPA-UNAM for giving a postdoctoral fellowship for the period of the study.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; [Anonymous], SCIENCE; de la Torre JA, 2017, BIOL CONSERV, V206, P270, DOI 10.1016/j.biocon.2016.11.034; AUDET D, 1991, BIOTROPICA, V23, P63, DOI 10.2307/2388689; BARCLAY RMR, 1989, BEHAV ECOL SOCIOBIOL, V24, P31, DOI 10.1007/BF00300115; Barquez R, 2015, IUCN RED LIST THREAT; Bernard E, 2001, STUD NEOTROP FAUNA E, V36, P177, DOI 10.1076/snfe.36.3.177.2125; Bernard E, 2001, J TROP ECOL, V17, P115, DOI 10.1017/S0266467401001079; Bernard E, 2007, BIOL CONSERV, V134, P332, DOI 10.1016/j.biocon.2006.07.021; Bonato V, 2004, J MAMMAL, V85, P708, DOI 10.1644/BWG-121; Boose ER, 2003, LOWLAND MAYA AREA: THREE MILLENNIA AT THE HUMAN-WILDLAND INTERFACE, P495; Bordignon MO, 2005, REV BRAS ZOOL, V22, P1207, DOI 10.1590/S0101-81752005000400058; Borkin KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086163; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calhoun J. B., 1958, CALCULATION HOME RAN; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Christie JE, 2014, ACTA CHIROPTEROL, V16, P369, DOI 10.3161/150811014X687323; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cvikel N, 2015, CURR BIOL, V25, P206, DOI 10.1016/j.cub.2014.11.010; daFonseca GA, 1988, BIOL NATURAL HIST BR; DAFONSECA GAB, 1990, BIOL CONSERV, V53, P265, DOI 10.1016/0006-3207(90)90097-9; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; de la Pena-Cuellar E, 2012, BIODIVERS CONSERV, V21, P1381, DOI 10.1007/s10531-012-0249-7; Denisse S, NOM059SEMARNAT2010 D; Diaz G.B., 2000, LIBRO ROJO MAMIFEROS, P1; Estrada A, 2002, BIOL CONSERV, V103, P237, DOI 10.1016/S0006-3207(01)00135-5; FENTON MB, 1992, BIOTROPICA, V24, P440, DOI 10.2307/2388615; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; FENTON MB, 1990, BIOTROPICA, V22, P2, DOI 10.2307/2388713; Folan WJ, 1992, PROGRAMA MANEJO RESE, V4; GATES JE, 1978, ECOLOGY, V59, P871, DOI 10.2307/1938540; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; HEITHAUS ER, 1975, ECOLOGY, V56, P841, DOI 10.2307/1936295; Hoffmann M, 2010, SCIENCE; JENNRICH RI, 1969, J THEOR BIOL, V22, P227, DOI 10.1016/0022-5193(69)90002-2; Kalko EKV, 1999, BIOTROPICA, V31, P344, DOI 10.1111/j.1744-7429.1999.tb00146.x; Kenward R, WILDLIFE RADIO TAGGI; Kniowski AB, 2014, J WILDLIFE MANAGE, V78, P503, DOI 10.1002/jwmg.677; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; KURTA A, 1987, PHYSIOL ZOOL, V60, P386, DOI 10.1086/physzool.60.4.30157900; Kurta A., 1987, Symposia of the Zoological Society of London, P79; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LAURANCE WF, 1994, BIOL CONSERV, V69, P23, DOI 10.1016/0006-3207(94)90325-5; Levin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054987; Lopez-Gonzalez C, 2005, MURCIELAGOS PARAGUAY; Martinez E., 2002, B SOC BOT MEXICO, V71, P7, DOI DOI 10.17129/B0TSCI.1660; Medellin R.A., 1989, Mammalian Species, P1; MEDELLIN RA, 1988, J MAMMAL, V69, P841, DOI 10.2307/1381644; MEDELLIN RA, 1994, CONSERV BIOL, V8, P780, DOI 10.1046/j.1523-1739.1994.08030780.x; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Munin RL, 2012, ACTA CHIROPTEROL, V14, P195, DOI 10.3161/150811012X654871; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Nogueira M. R., 2006, CHIROPTERA NEOTROPIC, V12, P286; Norberg, 1981, S ZOOL SOC LOND, V48, P173; NORBERG UM, 1988, BIOL J LINN SOC, V33, P383, DOI 10.1111/j.1095-8312.1988.tb00451.x; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Ortencio H, 2014, STUD NEOTROP FAUNA E, V49, P169, DOI 10.1080/01650521.2014.950834; Pennington TD, 2005, TROPICAL TREES MEXIC; Perez-Salicrup D.R., 2004, INTEGRATED LAND CHAN, P63; Reid F. A., 2009, FIELD GUIDE MAMMALS; Rex K, 2008, BIOL J LINN SOC, V94, P617, DOI 10.1111/j.1095-8312.2008.01014.x; Ripperger SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120535; Roeleke M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28961; Russo D, 2002, BIOL CONSERV, V107, P71, DOI 10.1016/S0006-3207(02)00047-2; Sa-Neto RJ, 2013, J ARID ENVIRON, V90, P88, DOI 10.1016/j.jaridenv.2012.10.007; SAZIMA I, 1978, J MAMMAL, V59, P617, DOI 10.2307/1380238; Schaalje GB, 2002, J AGRIC BIOL ENVIR S, V7, P512, DOI 10.1198/108571102726; Sheil D, 2003, TRENDS ECOL EVOL, V18, P18, DOI 10.1016/S0169-5347(02)00005-8; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; South AB, 2006, RANGES 7 SOFTWARE AN; Stebbings R.E., 1982, Symposia of the Zoological Society of London, V49, P161; Talamoni SA, 2013, BRAZ J BIOL, V73, P309, DOI 10.1590/S1519-69842013000200011; TIDEMANN CR, 1985, AUST J ZOOL, V33, P705, DOI 10.1071/ZO9850705; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TUTTLE MD, 1967, J MAMMAL, V48, P319, DOI 10.2307/1378041; Uieda W, 2007, REV BRAS ZOOL, V24, P844, DOI 10.1590/S0101-81752007000300035; VAUGHAN TA, 1976, J MAMMAL, V57, P227, DOI 10.2307/1379685; VAUGHAN TA, 1986, J MAMMAL, V67, P91, DOI 10.2307/1381005; VEHRENCAMP SL, 1977, J MAMMAL, V58, P469, DOI 10.2307/1379995; Vleut I, 2012, J MAMMAL, V93, P1469, DOI 10.1644/12-MAMM-A-005.1; Weatherhead PJ, 2004, J AVIAN BIOL, V35, P185, DOI 10.1111/j.0908-8857.2004.03336.x; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; Wilson Don E., 1996, P613; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zeale MRK, 2012, J MAMMAL, V93, P1110, DOI 10.1644/11-MAMM-A-366.1	91	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220504	10.1371/journal.pone.0220504	http://dx.doi.org/10.1371/journal.pone.0220504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356644	gold, Green Submitted, Green Published			2022-12-26	WOS:000484047000036
J	Li, Y; Wang, X; Zhang, H; Wang, SL; Ye, XS; Shi, L; Xu, FS; Ding, GD				Li, Yu; Wang, Xue; Zhang, Hao; Wang, Sheliang; Ye, Xiangsheng; Shi, Lei; Xu, Fangsen; Ding, Guangda			Molecular identification of the phosphate transporter family 1 (PHT1) genes and their expression profiles in response to phosphorus deprivation and other abiotic stresses in Brassica napus	PLOS ONE			English	Article							CROSS-TALK; ARABIDOPSIS; STARVATION; AVAILABILITY; MECHANISMS; AUXIN; TRANSLOCATION; ARCHITECTURE; ACQUISITION; EVOLUTION	Phosphate (Pi) transporters play critical roles in Pi acquisition and homeostasis. However, little is known about these transporters in oilseed rape. Therefore, the aim of the present study was to characterize the members of the PHT1 gene family in allotetraploid Brassica napus and to analyze their expression profiles in response to environmental stresses. In total, 49 PHT1 family members were identified in B. napus, including 27 genes in the A subgenome and 22 in the C subgenome. Most of the PHT1 proteins were predicted to localize to the plasma membrane. Phylogenetic analysis suggested that the members of the PHT1 gene family can be divided into seven clades, with the introns/exons and protein motifs conserved in each clade. Collinearity analysis revealed that most of the BnaPHT1 genes shared syntenic relationships with PHT1 members in Arabidopsis thaliana, B. rapa, and B. oleracea, and that whole-genome duplication (polyploidy) played a major driving force for BnaPHT1 evolution in addition to segmental duplication. Transcript abundance analysis showed that a broad range of expression patterns of individual BnaPHT1 genes occurred in response to phosphorus (P) deficiency. In addition, the expression levels of BnaPHT1 genes can be regulated by different nutrient stresses, including nitrogen (N), potassium (K), sulfur (S) and iron (Fe) stresses. Moveover, salt and drought stresses can regulate the transcript abundances of BnaPHT1s, as well as phytohormones including auxin and cytokinin. Gene coexpression analysis based on the RNA-seq data implied that BnaPHT1s might cooperate with each other as well as with other genes to regulate nutrient homeostasis in B. napus. Further analysis of the promoters revealed that GT-1, DRE and P1BS elements are widely distributed within the promoter regions of BnaPHT1 genes. Our results indicate that BnaPHT1s might be involved in cross-talk for sensing the external status of P, N, K, S and Fe, as well as salt and drought stresses. Moreover, these processes might be mediated by phytohormones. Our findings provide the first step in the complex genetic dissection of the Pi transport system in plants and implicate multiple transcriptional regulation, which probably refers to new roles of PHT1 genes in B. napus.	[Li, Yu; Wang, Xue; Zhang, Hao; Wang, Sheliang; Shi, Lei; Xu, Fangsen; Ding, Guangda] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Li, Yu; Wang, Xue; Zhang, Hao; Wang, Sheliang; Ye, Xiangsheng; Shi, Lei; Xu, Fangsen; Ding, Guangda] Huazhong Agr Univ, Key Lab Arable Land Conservat Middle & Lower Reac, Coll Resources & Environm, Microelement Res Ctr,Minist Agr & Rural Affairs, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Ding, GD (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.; Ding, GD (corresponding author), Huazhong Agr Univ, Key Lab Arable Land Conservat Middle & Lower Reac, Coll Resources & Environm, Microelement Res Ctr,Minist Agr & Rural Affairs, Wuhan, Hubei, Peoples R China.	dgd@mail.hzau.edu.cn	Ding, Guangda/ABG-3651-2020; Ding, Guangda/AAH-5026-2021	Ding, Guangda/0000-0003-3702-5087; 	National Natural Science Foundation of China [31672215]; National Key Research and Development Program of China [2017YFD0200100, 2017YFD0200103]; Fundamental Research Funds for the Central Universities of China [2662019PY013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was financially supported by grants from the National Natural Science Foundation of China (31672215), the National Key Research and Development Program of China (2017YFD0200100 and 2017YFD0200103), and the Fundamental Research Funds for the Central Universities of China (2662019PY013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; Baek D, 2017, MOL CELLS, V40, P697, DOI 10.14348/molcells.2017.0192; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chang MX, 2019, PLANT PHYSIOL, V179, P656, DOI 10.1104/pp.18.01097; Chen AQ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-61; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Ding GD, 2012, ANN BOT-LONDON, V109, P747, DOI 10.1093/aob/mcr323; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Forni C, 2017, PLANT SOIL, V410, P335, DOI 10.1007/s11104-016-3007-x; Franco-Zorrilla JM, 2005, PLANT PHYSIOL, V138, P847, DOI 10.1104/pp.105.060517; Grun A, 2018, PLANT BIOLOGY, V20, P374, DOI 10.1111/plb.12668; Gu MA, 2016, MOL PLANT, V9, P396, DOI 10.1016/j.molp.2015.12.012; Hammond JP, 2004, ANN BOT-LONDON, V94, P323, DOI 10.1093/aob/mch156; Hawkesford M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P135, DOI 10.1016/B978-0-12-384905-2.00006-6; Huang KL, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1765-3; Jia HF, 2017, J EXP BOT, V68, P5057, DOI 10.1093/jxb/erx317; Karthikeyan AS, 2002, PLANT PHYSIOL, V130, P221, DOI 10.1104/pp.020007; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lambers H, 2015, ANNU PLANT REV, V48, P3, DOI 10.1002/9781118958841.ch1; Lee SC, 2008, MOL CELLS, V26, P595; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nagarajan VK, 2011, PLANT PHYSIOL, V156, P1149, DOI 10.1104/pp.111.174805; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Qin L, 2012, PLANT PHYSIOL, V159, P1634, DOI 10.1104/pp.112.199786; Rai V, 2015, PLANT CELL PHYSIOL, V56, P1107, DOI 10.1093/pcp/pcv035; Remy E, 2012, NEW PHYTOL, V195, P356, DOI 10.1111/j.1469-8137.2012.04167.x; Ren F, 2014, PLANT MOL BIOL, V86, P595, DOI 10.1007/s11103-014-0249-y; Richardson AE, 2009, CROP PASTURE SCI, V60, P124, DOI 10.1071/CP07125; Rodenas R, 2017, PHYSIOL PLANTARUM, V160, P410, DOI 10.1111/ppl.12558; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Shen CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112906; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Sun SB, 2012, PLANT PHYSIOL, V159, P1571, DOI 10.1104/pp.112.196345; Sun TT, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00426; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng W, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00543; Walder F, 2015, NEW PHYTOL, V205, P1632, DOI 10.1111/nph.13292; Wang H, 2014, PLANT PHYSIOL, V164, P2020, DOI 10.1104/pp.113.235077; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Xie T, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4880-x; Yong HY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/467395; Zhang CX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01398	54	20	20	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220374	10.1371/journal.pone.0220374	http://dx.doi.org/10.1371/journal.pone.0220374			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344115	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900094
J	Yingst, JM; Foulds, J; Veldheer, S; Hrabovsky, S; Trushin, N; Eissenberg, TT; Williams, J; Richie, JP; Nichols, TT; Wilson, SJ; Hobkirk, AL				Yingst, Jessica M.; Foulds, Jonathan; Veldheer, Susan; Hrabovsky, Shari; Trushin, Neil; Eissenberg, Thomas T.; Williams, Jill; Richie, John P.; Nichols, Travis T.; Wilson, Stephen J.; Hobkirk, Andrea L.			Nicotine absorption during electronic cigarette use among regular users	PLOS ONE			English	Article							COMBUSTIBLE CIGARETTES; HEART-RATE; DELIVERY; PREFERENCES; TOBACCO; 2ND-GENERATION; WITHDRAWAL; DEPENDENCE; PROFILES; SMOKING	Background The capability of electronic cigarette devices (e-cigs) to deliver nicotine is key to their potential to replace combustible cigarettes. We compared nicotine delivery and subjective effects associated with the use of two classes of e-cigarettes and cigarettes. Methods 14 e-cigarette users were instructed to vape their own e-cigarette device every 20 seconds for 10 minutes while blood was drawn at 1, 2, 4, 6, 8, 10,12, and 15 minutes after initiating vaping. Users rated withdrawal symptoms and side effects before and after vaping. E-cigarette devices were classified as first-generation (same size as cigarette, no activation button) or advanced (larger than cigarette with an activation button). Separately, 10 cigarette smokers completed a similar protocol. Fisher's Exact Test and two-sided t-tests were used as appropriate to determine differences in outcomes between first-generation e-cigarette users, advanced e-cigarette users, and smokers. Results Compared to first-generation devices, advanced devices were associated with greater serum nicotine C-max (ng/ml) (11.5 v. 2.8, p = 0.0231) and greater nicotine boost (ng/ml) (10.8 v. 1.8, p = 0.0177). Overall, e-cigarettes users experienced a significant reduction in withdrawal and craving, although there were no significant differences between users of first-generation and advanced devices. Comparing e-cigarettes overall to cigarettes, cigarettes were associated with greater C-max (25.9 v. 9.0, p = 0.0043) and greater nicotine boost (21.0 v. 8.2, p = 0.0128). Conclusions Advanced e-cigarettes delivered significantly more nicotine than first-generation devices but less than combustible cigarettes. Overall, e-cigarette use was associated with a reduction in withdrawal and craving with no reported side effects. The wide variation in nicotine absorption from different e-cigarette devices should be considered in studies of e-cigarettes for smoking cessation.	[Yingst, Jessica M.; Foulds, Jonathan; Veldheer, Susan; Hrabovsky, Shari; Trushin, Neil; Richie, John P.; Hobkirk, Andrea L.] Penn State Univ, Dept Publ Hlth Sci, Tobacco Ctr Regulatory Sci, Coll Med, Hershey, PA 17033 USA; [Eissenberg, Thomas T.] Virginia Commonwealth Univ, Dept Psychol, Ctr Study Tobacco Prod, Box 2018, Richmond, VA 23284 USA; [Williams, Jill] Rutgers Robert Wood Johnson Med Sch, Div Addict Psychiat, New Brunswick, NJ USA; [Nichols, Travis T.; Wilson, Stephen J.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Virginia Commonwealth University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yingst, JM (corresponding author), Penn State Univ, Dept Publ Hlth Sci, Tobacco Ctr Regulatory Sci, Coll Med, Hershey, PA 17033 USA.	jyingst@phs.psu.edu	Yingst, Jessica/AAL-3810-2021; Foulds, Jonathan/AAM-6750-2021	Foulds, Jonathan/0000-0003-2296-0726; Yingst, Jessica/0000-0003-3028-668X; Veldheer, Susan/0000-0001-6592-9249; Richie, John/0000-0001-8239-2850	Penn State Clinical & Translational Science Institute, Pennsylvania State University CTSA (NIH/NCATS) [UL1 TR000127]; Penn State Hershey Cancer Institute; Penn State Social Science Research Institute; National Institute on Drug Abuse of the National Institutes of Health (NIH-NIDA); Center for Tobacco Products of the U.S. Food and Drug Administration [P50DA036107, P50DA036105]; Penn State Clinical & Translational Science Institute (NIH/NIDA) [K23DA045081]; FDA/NIH [P50DA036105]; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036107, P50DA036105, K23DA045081] Funding Source: NIH RePORTER	Penn State Clinical & Translational Science Institute, Pennsylvania State University CTSA (NIH/NCATS); Penn State Hershey Cancer Institute; Penn State Social Science Research Institute; National Institute on Drug Abuse of the National Institutes of Health (NIH-NIDA); Center for Tobacco Products of the U.S. Food and Drug Administration; Penn State Clinical & Translational Science Institute (NIH/NIDA); FDA/NIH; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project and the data collection tools for survey responses were supported by the Penn State Clinical & Translational Science Institute, Pennsylvania State University CTSA (NIH/NCATS Grant Number UL1 TR000127). Additional support was provided by the Penn State Hershey Cancer Institute and the Penn State Social Science Research Institute. JF, JY, SV, SH, NT, JR are primarily funded by the National Institute on Drug Abuse of the National Institutes of Health (NIH-NIDA) and the Center for Tobacco Products of the U.S. Food and Drug Administration (under Award Numbers P50DA036107, P50DA036105). ALH is supported by the Penn State Clinical & Translational Science Institute (NIH/NIDA Grant Number K23DA045081). TE is supported by FDA/NIH grant P50DA036105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breland A, 2017, ANN NY ACAD SCI, V1394, P5, DOI 10.1111/nyas.12977; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Chaffee BW, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3594; Coleman B., 2018, TOB CONTROL TOBACCOC, DOI [10.1136/tobaccocontrol-2017-05417, DOI 10.1136/TOBACCOCONTROL-2017-05417]; Coleman BN, 2017, TOB CONTROL, V26, pe117, DOI 10.1136/tobaccocontrol-2016-053462; Dawkins L, 2015, ADDICTION, V110, P669, DOI 10.1111/add.12807; Dawkins L, 2014, PSYCHOPHARMACOLOGY, V231, P401, DOI 10.1007/s00213-013-3249-8; Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150; Etter JF, 2015, DRUG ALCOHOL DEPEN, V147, P68, DOI 10.1016/j.drugalcdep.2014.12.007; Farsalinos KE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04133; Foulds J, 2011, INT J CLIN PRACT, V65, P1037, DOI 10.1111/j.1742-1241.2011.02751.x; Foulds J, 2015, NICOTINE TOB RES, V17, P186, DOI 10.1093/ntr/ntu204; Hajek P, 2014, NICOTINE TOB RES; Hajek P, 2017, PSYCHOPHARMACOLOGY, V234, P773, DOI 10.1007/s00213-016-4512-6; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Helen GS, 2017, DRUG ALCOHOL DEPEN, V178, P391, DOI 10.1016/j.drugalcdep.2017.05.042; Helen GS, 2016, ADDICTION, V111, P535, DOI 10.1111/add.13183; Hiler M, 2017, EXP CLIN PSYCHOPHARM, V25, P380, DOI 10.1037/pha0000140; Hobkirk AL, 2017, BRAIN RES B, V32, DOI [10.1016/j.brainresbull.2015.10.003, DOI 10.1016/J.BRAINRESBULL.2015.10.003]; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Hughes JR, 2018, ADDICT BEHAV; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Liu G, 2017, PREV MED; Morean ME, 2018, ADDICT BEHAV; National Academies of Sciences Engineering and Medicine, 2018, PUBL HLTH CONS E CIG; National Center for Chronic Disease Prevention and Health Promo- tion (U.S.) Office on Smoking and Health, 2014, HLTH CONSMOK 50 YE; Nichols TT, 2016, BRAIN RES BULL, V123, P23, DOI 10.1016/j.brainresbull.2015.10.003; Pericot-Valverde I, 2017, PREV MED, V104, P92, DOI 10.1016/j.ypmed.2017.07.014; Ramoa CP, 2016, TOB CONTROL, V25, pE6, DOI 10.1136/tobaccocontrol-2015-052447; Spindle TR, 2018, DRUG ALCOHOL DEPEN, V188, P193, DOI 10.1016/j.drugalcdep.2018.03.042; St Helen Gideon, 2016, Tob Regul Sci, V2, P363, DOI 10.18001/TRS.2.4.8; Stiles MF, 2017, PSYCHOPHARMACOLOGY, V234, P2643, DOI 10.1007/s00213-017-4665-y; United States Food and Drug Administration (FDA), 2018, HLTH INN SAF FAM FDA; Vansickel AR, 2010, CANCER EPIDEM BIOMAR, V19, P1945, DOI 10.1158/1055-9965.EPI-10-0288; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; Wagener TL, 2017, TOB CONTROL, V26, pE23, DOI 10.1136/tobaccocontrol-2016-053041; Williams JM, 2010, NICOTINE TOB RES, V12, P855, DOI 10.1093/ntr/ntq102; Yingst JM, 2015, NICOTINE TOB RES, V17, P1242, DOI 10.1093/ntr/ntv052; Zare S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194145	40	39	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220300	10.1371/journal.pone.0220300	http://dx.doi.org/10.1371/journal.pone.0220300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344110	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900079
J	Radhi, OA; Davidson, S; Scott, F; Zeng, RX; Jones, DH; Tomkinson, NCO; Yu, J; Chan, EYW				Radhi, Ohood A.; Davidson, Scott; Scott, Fiona; Zeng, Run X.; Jones, D. Heulyn; Tomkinson, Nicholas C. O.; Yu, Jun; Chan, Edmond Y. W.			Inhibition of the ULK1 protein complex suppresses Staphylococcus-induced autophagy and cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; Staphylococcus aureus (S; aureus); Salmonella enterica; infection; bacterial pathogenesis; autophagy-related protein 13 (ATG13); bacterial virulence; intracellular pathogen; Unc-51-like autophagy-activating kinase 1 (ULK1); xenophagy	SALMONELLA INFECTION; AUREUS MRSA; NDP52; RECRUITMENT; ACTIVATION; HOST; LC3; BACTERIA; PHOSPHORYLATION; ASSOCIATION	Autophagy plays multiple roles in host cells challenged with extracellular pathogens. Here, we aimed to explore whether autophagy inhibition could prevent bacterial infections. We first confirmed widely distinct patterns of autophagy responses in host cells infected with Staphylococcus aureus, as compared with Salmonella. Only infection with Staphylococcus produced strong accumulation of lipidated autophagy-related protein LC3B (LC3B-II). Infection with virulent Staphylococcus strains induced formation of p62-positive aggregates, suggestive of accumulated ubiquitinated targets. During Salmonella infection, bacteria remain enclosed by lysosomal-associated membrane protein 2 (LAMP2)-positive lysosomes, whereas virulent Staphylococcus apparently exited from enlarged lysosomes and invaded the cytoplasm. Surprisingly, Staphylococcus appeared to escape from the lysosome without generation of membrane-damage signals as detected by galectin-3 recruitment. In contrast, Salmonella infection produced high levels of lysosomal damage, consistent with a downstream antibacterial xenophagy response. Finally, we studied the Unc-51?like autophagy-activating kinase 1 (ULK1) regulatory complex, including the essential subunit autophagy-related protein 13 (ATG13). Infection of cells with either Staphylococcus or Salmonella led to recruitment of ATG13 to sites of cytosolic bacterial cells to promote autophagosome formation. Of note, genetic targeting of ATG13 suppressed autophagy and the ability of Staphylococcus to infect and kill host cells. Two different ULK1 inhibitors also prevented Staphylococcus intracellular replication and host cell death. Interestingly, inhibition of the ULK1 pathway had the opposite effect on Salmonella, sensitizing cells to the infection. Our results suggest that ULK1 inhibitors may offer a potential strategy to impede cellular infection by S. aureus.	[Radhi, Ohood A.; Davidson, Scott; Yu, Jun; Chan, Edmond Y. W.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Scott, Fiona; Jones, D. Heulyn; Tomkinson, Nicholas C. O.] Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland; [Zeng, Run X.; Chan, Edmond Y. W.] Queens Univ, Dept Biomed & Med Sci, Kingston, ON K7L 3N6, Canada; [Chan, Edmond Y. W.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Radhi, Ohood A.] Univ Kufa, Coll Nursing, Dept Basic Sci, Kufa, Iraq	University of Strathclyde; University of Strathclyde; Queens University - Canada; McMaster University; Queens University - Canada; University of Kufa	Chan, EYW (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland.; Chan, EYW (corresponding author), Queens Univ, Dept Biomed & Med Sci, Kingston, ON K7L 3N6, Canada.; Chan, EYW (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada.	eywc@queensu.ca		Tomkinson, Nicholas/0000-0002-5509-0133; Scott, Fiona/0000-0002-2461-4213	Iraq Ministry of Higher Education and Scientific Research; Cancer Research UK/West of Scotland Cancer Centre/Glasgow Cancer Centre; Tenovus Scotland; Natural Sciences and Engineering Research Council (NSERC) Canada; EPSRC [EP/I037229/1] Funding Source: UKRI	Iraq Ministry of Higher Education and Scientific Research; Cancer Research UK/West of Scotland Cancer Centre/Glasgow Cancer Centre; Tenovus Scotland; Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a scholarship from the Iraq Ministry of Higher Education and Scientific Research (to O. R.) and by Cancer Research UK/West of Scotland Cancer Centre/Glasgow Cancer Centre, Tenovus Scotland and Natural Sciences and Engineering Research Council (NSERC) Canada (to E. C.). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200; Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Blattner S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005857; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chauhan S, 2016, DEV CELL, V39, P13, DOI 10.1016/j.devcel.2016.08.003; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fiskin E, 2016, MOL CELL, V62, P967, DOI 10.1016/j.molcel.2016.04.015; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Gallagher LE, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.416; Grosz M, 2014, CELL MICROBIOL, V16, P451, DOI 10.1111/cmi.12233; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Horn J, 2018, INT J MED MICROBIOL, V308, P607, DOI 10.1016/j.ijmm.2017.11.009; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Huett A, 2009, J IMMUNOL, V182, P4917, DOI 10.4049/jimmunol.0803050; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Ivanov S, 2009, NAT IMMUNOL, V10, P1137, DOI 10.1038/ni1109-1137; Jia JY, 2018, MOL CELL, V70, P120, DOI 10.1016/j.molcel.2018.03.009; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Lazarus MB, 2015, BIOORGAN MED CHEM, V23, P5483, DOI 10.1016/j.bmc.2015.07.034; Lehar SM, 2015, NATURE, V527, P323, DOI 10.1038/nature16057; de Armentia MML, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00431; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Maurer K, 2015, CELL HOST MICROBE, V17, P429, DOI 10.1016/j.chom.2015.03.001; Mauthe Mario, 2012, Int J Cell Biol, V2012, P179207, DOI 10.1155/2012/179207; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Moldovan A, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12997; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Neumann Y, 2016, AUTOPHAGY, V12, P2069, DOI 10.1080/15548627.2016.1226732; Noad J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.63; Nwadike C, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00023-18; O'Keeffe KM, 2015, INFECT IMMUN, V83, P3445, DOI 10.1128/IAI.00358-15; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.C114.627778, 10.1074/jbc.A114.627778]; Polajnar M, 2017, EMBO REP, V18, P1572, DOI 10.15252/embr.201643851; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Raghukumar R, 2010, PHYTOTHER RES, V24, P1181, DOI 10.1002/ptr.3096; Sangal V, 2012, INT J ANTIMICROB AG, V40, P323, DOI 10.1016/j.ijantimicag.2012.06.007; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Schroder A, 2006, MED MICROBIOL IMMUN, V195, P185, DOI 10.1007/s00430-006-0015-0; Shahnazari S, 2011, CURR OPIN MICROBIOL, V14, P68, DOI 10.1016/j.mib.2010.11.001; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Thurston TLM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13292; Thurston TLM, 2016, EMBO J, V35, P1779, DOI 10.15252/embj.201694491; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tumbarello DA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005174; Turner NA, 2019, NAT REV MICROBIOL, V17, P203, DOI 10.1038/s41579-018-0147-4; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Vazquez CL, 2010, CELL DEATH DIFFER, V17, P421, DOI 10.1038/cdd.2009.129; Verlhac P, 2015, CELL HOST MICROBE, V17, P515, DOI 10.1016/j.chom.2015.02.008; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wang LD, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00078; Wells CL, 1998, INFECT IMMUN, V66, P2410, DOI 10.1128/IAI.66.6.2410-2419.1998; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Winchell CG, 2014, INFECT IMMUN, V82, P2229, DOI 10.1128/IAI.01236-13; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Yuk JM, 2012, EXP MOL MED, V44, P99, DOI 10.3858/emm.2012.44.2.032; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	75	7	8	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14289	14307		10.1074/jbc.RA119.008923	http://dx.doi.org/10.1074/jbc.RA119.008923			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31387948	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000499248200012
J	Lee, CB; Liao, CM; Peng, LH; Lin, CM				Lee, Chiachi Bonnie; Liao, Chen-Mao; Peng, Li-Hsin; Lin, Chih-Ming			Economic fluctuations and cardiovascular diseases: A multiple-input time series analysis	PLOS ONE			English	Article							LONG WORKING HOURS; HEART-DISEASE; RISK-FACTORS; BUSINESS CYCLES; GREAT RECESSION; AIR-POLLUTION; HEALTH; MORTALITY; ASSOCIATION; HYPERTENSION	Objectives Little is known about the gender and age differences associated with the effects of economic fluctuations on hospitalization for cardiovascular diseases. This paper investigates the impact of economic fluctuations on hospitalization for ischemic heart disease (IHD), stroke, and hypertension by age and gender between January 1996 and December 2012 in Taiwan. Methods We adopted a multiple-input time series analysis to examine the strength of the immediate and latent effects of the 17-year quarterly unemployment rates (UR), air pollution exposure (APE), gross domestic product (GDP), per capita consumption expenditure in cigarette and alcohol (ECA), and per capita healthcare expenditure (HE) on the adjusted quarterly incidence rate of hospitalization. The data used in this paper were retrieved from the National Health Insurance Research Database and the website of the Directorate-General of Budget, Accounting and Statistics (DGBAS), Executive Yuan. Results Our findings indicate that higher UR increased IHD hospitalization in young men and women and middle-aged women but reduced stroke hospitalization in young men. Higher APE increased IHD hospitalization in young men but reduced it for young women, increased stroke hospitalization in old men and middle-aged women but reduced it for young men, and increased hypertension hospitalization in middle-aged men and young women. Higher ECA reduced IHD hospitalization in middle-aged men, increased stoke hospitalization in middle-aged and old men and middle-aged women. Higher HE reduced IHD hospitalization in old men, young and old women, reduced stroke hospitalization in old women, and reduced hypertension hospitalization in young and middle-aged women. Conclusions Overall, we found that the economic fluctuations caused increased harmful effects in certain population subgroups but also brought some soothing effects to some groups.	[Lee, Chiachi Bonnie] China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan; [Liao, Chen-Mao; Peng, Li-Hsin] Ming Chuan Univ, Dept Appl Stat & Informat Sci, Taoyuan, Taiwan; [Lin, Chih-Ming] Ming Chuan Univ, Dept Healthcare Informat & Management, Taoyuan, Taiwan	China Medical University Taiwan; Ming Chuan University; Ming Chuan University	Lin, CM (corresponding author), Ming Chuan Univ, Dept Healthcare Informat & Management, Taoyuan, Taiwan.	cmlin@mail.mcu.edu.tw		Lin, Chih-Ming/0000-0001-9637-395X	Ministry of Science and Technology [MOST 105-2410-H-130-052]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by a grant from the Ministry of Science and Technology MOST 105-2410-H-130-052) https://www.most.gov.tw/? l= en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The interpretation and conclusions contained herein do not represent those of National Health Insurance Administration, Ministry of Health and Welfare and National Health Research Institutes.; This study was supported by a grant from the Ministry of Science and Technology (MOST 105-2410-H-130-052), and was based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by National Health Research Institutes.	Alliance NCD, 2016, CALL ACT WOM NONC DI; Asgeirsdottir TL, 2014, BLOOD PRESSURE, V23, P213, DOI 10.3109/08037051.2013.862913; Birgisdottir KH, 2017, DEMOGR RES, V37, P769, DOI 10.4054/DemRes.2017.37.25; Box G, 1970, STAT MODELS FORECAST; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Braendle T, 2016, HEALTH POLICY, V120, P1051, DOI 10.1016/j.healthpol.2016.07.009; Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007; Cuadra G, 2008, WORKING PAPERS; Dai XT, 2018, ATMOS ENVIRON, V186, P129, DOI 10.1016/j.atmosenv.2018.05.033; Davis ME, 2012, AM J PUBLIC HEALTH, V102, P1951, DOI 10.2105/AJPH.2012.300658; Davis ME, 2010, ENVIRON HEALTH PERSP, V118, P614, DOI 10.1289/ehp.0901145; DGBAS, 2018, UN RAT DIR GEN BUDG; DGBAS, 2010, 2010 REP MANP UT SUR; Eliason M, 2009, J HUM RESOUR, V44, P277, DOI 10.1353/jhr.2009.0020; Gan Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0371-z; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Giorginia P, 2016, CURR PHARM DESIGN, V22, P28, DOI 10.2174/1381612822666151109111712; Hackshaw A, 2018, BMJ-BRIT MED J, V360, DOI [10.1136/bmj.j5855, 10.1136/bmj.k1611]; HPA, 2017, 2016 ANN REP HLTH PR; Jofre-Bonet M, 2018, SOC SCI MED, V197, P213, DOI 10.1016/j.socscimed.2017.12.010; Kamceva Gordana, 2016, Open Access Maced J Med Sci, V4, P636, DOI 10.3889/oamjms.2016.117; Kang MY, 2012, J OCCUP ENVIRON MED, V54, P532, DOI 10.1097/JOM.0b013e31824fe192; Karagiannis R, 2017, GREEK EC OUTLOOK, V2017, P73; Khubchandani J, 2017, J COMMUN HEALTH, V42, P242, DOI 10.1007/s10900-016-0249-8; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Laliotis I, 2016, LANCET PUBLIC HEALTH, V1, pE56, DOI 10.1016/S2468-2667(16)30018-4; Lam JP, 2017, HEALTH ECON, V26, P164, DOI 10.1002/hec.3285; Lee CB, 2017, J AFFECT DISORDERS, V221, P65, DOI 10.1016/j.jad.2017.06.028; Lin RT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00198-5; Lin SJ, 2009, APPL ECON, V41, P519, DOI 10.1080/00036840701720754; LIU LM, 1982, COMMUN STAT A-THEOR, V11, P297, DOI 10.1080/03610928208828236; Margerison-Zilko Claire, 2016, Curr Epidemiol Rep, V3, P81; Markbreiter J., 2016, CVD ADVOCACY TOOLKIT; Ministry of Labor, 2018, INT LAB STAT 2018; Ministry of Labor, 2016, REP GEND LAB STAT 20; Ministry of Labor, 2016, ANN WORK HOURS AR IN; MOWH, 2017, 2016 STAT RES CAUS D; Natioanl Statistics, 2018, STAT NAT INC TAIW 20; National Statistics, 2018, NAT INC STAT NAT STA; OECD, 2018, AV ANN HOURS ACT WOR; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Peter D, 2012, 30 INT C MATH METH E; Quast T, 2014, SOC SCI MED, V109, P19, DOI 10.1016/j.socscimed.2014.03.013; Reeves A, 2014, HEALTH POLICY, V115, P1, DOI 10.1016/j.healthpol.2013.11.008; Ricci C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k934; ROTH GA, 2017, J AM COLL CARDIOL, V70, P1, DOI [DOI 10.1016/J.JACC.2017.04.052, DOI 10.1016/j.jacc.2017.04.052]; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2015, J HEALTH ECON, V42, P17, DOI 10.1016/j.jhealeco.2015.03.004; Ruhm CJ, 2003, J HEALTH ECON, V22, P637, DOI 10.1016/S0167-6296(03)00041-9; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Siervo M, 2014, PUBLIC HEALTH NUTR, V17, P587, DOI 10.1017/S1368980013000141; Sposato LA, 2012, STROKE, V43, P170, DOI 10.1161/STROKEAHA.111.632158; Stock JH, 2001, J ECON PERSPECT, V15, P101, DOI 10.1257/jep.15.4.101; Strumpf EC, 2017, SOC SCI MED, V189, P11, DOI 10.1016/j.socscimed.2017.07.016; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Su SY, 2017, HEART ASIA, V9, DOI 10.1136/heartasia-2017-010905; Svensson M, 2007, SOC SCI MED, V65, P833, DOI 10.1016/j.socscimed.2007.04.015; Virtanen M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4746; Vlachadis N, 2014, INT J CARDIOL, V176, P1367, DOI 10.1016/j.ijcard.2014.07.275; Wang DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep33960; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; World Health Organization, 2017, WORLD HEART DAY 2017; Xu AY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020168; Yang BY, 2018, ENVIRON POLLUT, V235, P576, DOI 10.1016/j.envpol.2018.01.001	64	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219358	10.1371/journal.pone.0219358	http://dx.doi.org/10.1371/journal.pone.0219358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386665	gold, Green Submitted, Green Published			2022-12-26	WOS:000484997100005
J	Grossman, C; Grossman, E; Goldbourt, U				Grossman, Chagai; Grossman, Ehud; Goldbourt, Uri			Uric acid variability at midlife as an independent predictor of coronary heart disease and all-cause mortality	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; LONG-TERM MORTALITY; CARDIOVASCULAR-DISEASE; ESSENTIAL-HYPERTENSION; BODY-WEIGHT; RISK-FACTOR; SERUM; OUTCOMES; FLUCTUATIONS; DEATH	Background Serum uric acid (SUA) has long been associated with cardiovascular disease. Variability of serum uric acid (SUA) has seldom been examined in association with long-term morbidity and mortality. Therefore, we aimed to investigate the association between SUA variability and long-term all-cause and specific-cause mortality. Methods Among 10,059 men, aged 40-65, tenured civil servants and municipal employees in Israel, 8822 participants who were examined in 1963, 1965 and 1968 had assessment of diabetic and coronary morbidity status and SUA levels. We conducted analysis examining whether the standard deviations (SD) of Z-scores of SUA across study visits predicted coronary heart disease (CHD) and mortality. Hazard ratios (HR) associated with the SD of SUA-Z were calculated for stroke, CHD mortality and all-cause mortality associated with quartiles of the above variability. Results Multivariate analysis of 18-year CHD mortality yielded a significant association with the 1963-1968 SD of SUA-Z with age adjusted HR of CHD mortality of 0.97 (95% CI, 0.8-1.19), 1.05 (95% CI, 0.87-1.28) and 1.37 (95% CI, 1.15-1.65) for quartiles 2 to 4 respectively). The results of all-cause mortality similarly and strongly indicated increasing age-adjusted mortality risk with increasing SD of SUA-Z: HR = 1.08 (95% CI, 0.97-1.21), 1.15 (1.03-1.28) and 1.37 (1.23-1.51). No association was observed between the SD of SUA-Z and stroke mortality. Conclusion In this cohort of tenured male workers, with diverse occupations, higher variability of SUA measurement taken over 5 years was clearly predictive of 18-year CHD and all-cause mortality, above and beyond the SUA levels proper.	[Grossman, Chagai] Chaim Sheba Med Ctr, Dept Internal Med F, Tel Hashomer, Israel; [Grossman, Chagai] Chaim Sheba Med Ctr, Rheumatol Unit, Tel Hashomer, Israel; [Grossman, Chagai; Grossman, Ehud] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Grossman, Ehud] Chaim Sheba Med Ctr, Dept Internal Med D, Tel Hashomer, Israel; [Grossman, Ehud] Chaim Sheba Med Ctr, Hypertens Unit, Tel Hashomer, Israel; [Goldbourt, Uri] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Grossman, C (corresponding author), Chaim Sheba Med Ctr, Dept Internal Med F, Tel Hashomer, Israel.; Grossman, C (corresponding author), Chaim Sheba Med Ctr, Rheumatol Unit, Tel Hashomer, Israel.; Grossman, C (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	chagaigr@gmail.com						Alderman M, 2004, CURR MED RES OPIN, V20, P369, DOI 10.1185/030079904125002982; Alderman MH, 2002, CURR OPIN PHARMACOL, V2, P126, DOI 10.1016/S1471-4892(02)00143-1; ANDERSON JT, 1956, CLIN CHEM, V2, P145; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Bangalore S, 2017, NEW ENGL J MED, V376, P1332, DOI 10.1056/NEJMoa1606148; Cavarretta E, 2017, AM J HYPERTENS, V30, P550, DOI 10.1093/ajh/hpx055; Ceriello A, 2017, DIABETES OBES METAB, V19, P1570, DOI 10.1111/dom.12976; Ceriello A, 2013, DIABETES CARE, V36, pS272, DOI 10.2337/dcS13-2030; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Frontoni S, 2013, DIABETES RES CLIN PR, V102, P86, DOI 10.1016/j.diabres.2013.09.007; Gerber Y, 2006, EUR J CARDIOV PREV R, V13, P193, DOI 10.1097/01.hjr.0000192745.26973.00; GERTLER MM, 1951, ANN INTERN MED, V34, P1421, DOI 10.7326/0003-4819-34-6-1421; GROEN JJ, 1968, ISRAEL J MED SCI, V4, P177; Grossman C, 2014, J CLIN HYPERTENS, V16, P424, DOI 10.1111/jch.12313; HAMM P, 1989, AM J EPIDEMIOL, V129, P312, DOI 10.1093/oxfordjournals.aje.a115135; Johnson RJ, 2005, J AM SOC NEPHROL, V16, P1909, DOI 10.1681/ASN.2005010063; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kivity S, 2013, AM J CARDIOL, V111, P1146, DOI 10.1016/j.amjcard.2012.12.034; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Lytvyn Y, 2015, CAN J DIABETES, V39, P239, DOI 10.1016/j.jcjd.2014.10.013; Mayer FJ, 2015, J STROKE CEREBROVASC, V24, P354, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.035; MEDALIE JH, 1973, J CHRON DIS, V26, P63, DOI 10.1016/0021-9681(73)90006-4; Ndrepepa G, 2013, CLIN SCI, V124, P259, DOI 10.1042/CS20120336; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Waring WS, 2000, QJM-INT J MED, V93, P707, DOI 10.1093/qjmed/93.11.707; Xu QY, 2017, SAUDI MED J, V38, P577, DOI 10.15537/smj.2017.6.17190	32	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220532	10.1371/journal.pone.0220532	http://dx.doi.org/10.1371/journal.pone.0220532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381584	gold, Green Published, Green Submitted			2022-12-26	WOS:000484993600023
J	Valente, RS; de Almeida, TG; Alves, MF; de Camargo, J; Basso, AC; Belaz, KRA; Eberlin, MN; Landim-Alvarenga, FD; Fontes, PK; Nogueira, MFG; Sudano, MJ				Valente, Roniele Santana; de Almeida, Tamie Guibu; Alves, Mayra Fernanda; de Camargo, Janine; Basso, Andrea Cristina; Anacleto Belaz, Katia Roberta; Eberlin, Marcos Nogueira; da Cruz Landim-Alvarenga, Fernanda; Fontes, Patricia Kubo; Gouveia Nogueira, Marcelo Fabio; Sudano, Mateus Jose			Modulation of long-chain Acyl-CoA synthetase on the development, lipid deposit and cryosurvival of in vitro produced bovine embryos	PLOS ONE			English	Article							LIVER-X-RECEPTOR; FATTY-ACID; L-CARNITINE; CULTURE; ACTIVATION; GENE; CRYOTOLERANCE; VITRIFICATION; ACCUMULATION; INHIBITION	In this study, we evaluated the modulation effect of long-chain Acyl-CoA synthetase during early embryo development. Bovine embryos were cultured in four groups: positive modulation (ACS+) with GW3965 hydrochloride, negative modulation (ACS-) with Triacsin C, association of both modulators (ACS +/-), and control. Embryo development rates were not altered (P>0.05) by treatments. Embryonic cytoplasmic lipid content increased in ACS+ but reduced in ACS- compared to the control (P < 0.05), whereas the membrane phospholipids profile was not altered by treatments. The total number of blastomeres did not differ (P > 0.05) between groups; however, an increased apoptotic cells percentage was found in ACS- compared to control. Twenty-four hours after warming, ACS+ and control grade I embryos presented the best hatching rates, whereas the ACS+ group equaled the hatching rates between their embryos of grades I, II and III 48 hours after warming. The relative abundance of transcripts for genes associated with lipid metabolism (ACSL3, ACSL6, ACAT1, SCD, and AUH), heatshock (HSP90AA1 and HSF1), oxidative stress (GPX4), and angiogenesis (VEGF), among other important genes for embryo development were affected by at least one of the treatments. The treatments were effective in modulating the level of transcripts for ACSL3 and the cytoplasmic lipid content. The ACS- was not effective in increasing embryonic cryosurvival, whereas ACS+ restored survival rates after vitrification of embryos with low quality, making them equivalent to embryos of excellent quality.	[Valente, Roniele Santana; de Camargo, Janine; Sudano, Mateus Jose] Fed Univ Pampa, Sch Vet Med, Uruguaiana, RS, Brazil; [Valente, Roniele Santana; Sudano, Mateus Jose] Fed Univ ABC, Ctr Nat & Human Sci, Santo Andre, SP, Brazil; [de Almeida, Tamie Guibu] Univ Sao Paulo, Dept Anim Reprod, Sao Paulo, SP, Brazil; [Alves, Mayra Fernanda; Basso, Andrea Cristina] ABS Pecplan, In Vitro Brasil, Mogi Mirim, SP, Brazil; [Anacleto Belaz, Katia Roberta] Univ Fed Uberlandia, Dept Chem, Uberlandia, MG, Brazil; [Eberlin, Marcos Nogueira] Univ Prebiteriana Mackenzie, Sch Engn, Sao Paulo, SP, Brazil; [da Cruz Landim-Alvarenga, Fernanda] Sao Paulo State Univ, Dept Anim Reprod, Botucatu, SP, Brazil; [Fontes, Patricia Kubo; Gouveia Nogueira, Marcelo Fabio] Sao Paulo State Univ, Dept Biol Sci, Assis, SP, Brazil	Universidade Federal do Pampa; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade Presbiteriana Mackenzie; Universidade Estadual Paulista; Universidade Estadual Paulista	Sudano, MJ (corresponding author), Fed Univ Pampa, Sch Vet Med, Uruguaiana, RS, Brazil.; Sudano, MJ (corresponding author), Fed Univ ABC, Ctr Nat & Human Sci, Santo Andre, SP, Brazil.	mjsudano@gmail.com	Nogueira, Marcelo Fábio Gouveia/D-9801-2012; Cristina Basso, Andrea/AHC-5589-2022; Fontes, Patricia Kubo/R-8362-2017; , M/AAZ-7804-2020; Alizadeh/AAK-1398-2021; Sudano, Mateus J/D-7614-2013	Nogueira, Marcelo Fábio Gouveia/0000-0002-2239-9652; Fontes, Patricia Kubo/0000-0002-4280-9575; , M/0000-0002-7699-4449; Sudano, Mateus J/0000-0002-7699-4449; Belaz, Katia Roberta A/0000-0003-0626-1992; Landim-Alvarenga, Fernanda/0000-0002-2420-2550; de Camargo, Janine/0000-0002-0575-056X; , Andrea Cristina Basso/0000-0002-8679-5232; Eberlin, Marcos Nogueira/0000-0003-4868-0618	CNPq, National Council of Scientific and Technological Development - Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [1, 2012/50533-2, 2019/16239-9]; Sao Paulo Research Foundation (FAPESP)	CNPq, National Council of Scientific and Technological Development - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present work was carried out with the support of CNPq, National Council of Scientific and Technological Development - Brazil, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) - financial code 1, and grant 2012/50533-2 and 2019/16239-9, Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Dong B, 2013, J LIPID RES; Edidin M, 2003, NAT REV MOL CELL BIO, V4, P414, DOI 10.1038/nrm1102; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Gomez E, 2017, REPROD FERT DEVELOP, V29, P1932, DOI 10.1071/RD16213; Gutierrez-Adan A, 2015, REPROD FERT DEVELOP, V27, P765, DOI 10.1071/RD14216; Held-Hoelker E, 2017, THERIOGENOLOGY, V96, P145, DOI 10.1016/j.theriogenology.2017.03.014; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Knitlova D, 2017, THERIOGENOLOGY, V102, P16, DOI 10.1016/j.theriogenology.2017.06.025; Krussell JS, 2001, MOL HUM REPROD, V7, P57, DOI 10.1093/molehr/7.1.57; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Kuzmany A, 2011, THERIOGENOLOGY, V75, P482, DOI 10.1016/j.theriogenology.2010.09.016; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Murillo A, 2017, REPROD BIOL, V17, P162, DOI 10.1016/j.repbio.2017.04.002; NAKAGAWA J, 1995, P NATL ACAD SCI USA, V92, P2051, DOI 10.1073/pnas.92.6.2051; Panyaboriban S, 2018, CRYOBIOLOGY, V84, P46, DOI 10.1016/j.cryobiol.2018.08.003; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Patel MB, 2008, INDIAN J PHARM SCI, V70, P135, DOI 10.4103/0250-474X.41445; Lopez-Damian EP, 2018, ANAT HISTOL EMBRYOL, V47, P435, DOI 10.1111/ahe.12382; Peck B, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0146-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pomar FJR, 2005, THERIOGENOLOGY, V63, P2254, DOI 10.1016/j.theriogenology.2004.10.015; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Sanches BV, 2013, THERIOGENOLOGY, V80, P372, DOI 10.1016/j.theriogenology.2013.04.026; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Stringfellow D, 1998, MANUAL SOC INT GERAI, V3, P180; Sudano MJ, 2013, ANIM REPROD, V10, P160; Sudano MJ, 2016, THERIOGENOLOGY, V86, P472, DOI 10.1016/j.theriogenology.2016.03.025; Sudano MJ, 2014, REPROD FERT DEVELOP, V26, P1129, DOI 10.1071/RD13099; Sudano MJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102897; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Tang Y, 2018, ONCOL LETT, V16, P1390, DOI 10.3892/ol.2018.8843; Tian GP, 2012, BIOCHIMIE, V94, P2749, DOI 10.1016/j.biochi.2012.08.018; TOMODA H, 1991, J BIOL CHEM, V266, P4214; Ufer C, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00012; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Weedon-Fekjaer MS, 2010, J LIPID RES; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Zhang Y, 2011, ROLE HEAT SHOCK FACT, P21; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	46	11	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220731	10.1371/journal.pone.0220731	http://dx.doi.org/10.1371/journal.pone.0220731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381602	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600032
J	Black, SA; McConnell, EL; McKerr, L; McClelland, JF; Little, JA; Dillenburger, K; Jackson, AJ; Anketell, PM; Saunders, KJ				Black, S. A.; McConnell, E. L.; McKerr, L.; McClelland, J. F.; Little, J. A.; Dillenburger, K.; Jackson, A. J.; Anketell, P. M.; Saunders, K. J.			In-school eyecare in special education settings has measurable benefits for children's vision and behaviour	PLOS ONE			English	Article							CEREBRAL VISUAL IMPAIRMENT; OCULAR DISORDERS; DEVELOPMENTAL DELAY; DISABILITIES; DYSFUNCTIONS; INVENTORY; BURDEN; NEEDS	Objectives To determine whether implementation of comprehensive in-school eyecare results in measurable benefits for children and young people in terms of visual status, classroom behaviours and how well their visual needs are met. Design School-based observational study. Participants & Methods 200 pupils [mean age 10 years 9 months, 70% male, majority moderate (40%) or severe (35%) learning difficulty] of a special education school in the UK. A sector-agreed in-school eyecare framework including full eye examination and cycloplegic refraction, dispensing of spectacles (as appropriate) and written reporting of outcomes to parents/teachers was applied. Classroom behaviours were observed and recorded prior to, and after, the in-school eyecare. Surveys were employed to obtain visual histories from parents/teachers. School records and statutory documents were reviewed for diagnostic and learning disability classifications. Visual function and ocular health were profiled at baseline and significant visual deficits identified. Where such deficits were previously unrecognised, untreated or not compensated for (e.g. correction of refractive error, enlargement of educational material) they were recorded as 'unmet visual need'. At follow-up, 2-5 months after initial (baseline) measures, eye examinations, parent/teacher surveys and behaviour observations were repeated. Follow-up measures were used to determine if measurable improvements were evident in visual function, ocular health, the level of unmet need and classroom behaviour following implementation of in-school eyecare. Results 199 participants completed baseline and follow-up measures. 122 (61%) participants presented with at least one significant visual or ocular health deficit and 90 (45%) participants had at least one unmet visual need. Younger pupils and those with no previous history of eyecare were more likely to demonstrate unmet visual needs at baseline (OR 1.12 95% CI 1.03 to 1.21) p = 0.012; (OR 4.44 95% CI 1.38 to 14.29 p = 0.007 respectively). On followup, the number of pupils with unmet visual needs dropped significantly to 36 (18%) (McNemar's test p< 0.001). Visual and behavioural metrics of participants without significant visual deficits or whose visual needs were adequately addressed at baseline remained relatively unchanged between baseline and follow-up (Wilcoxon signed rank p> 0.05). Where significant refractive deficits were corrected at follow-up, near visual acuity improved significantly (Wilcoxon signed rank p = 0.013), however, poor spectacle compliance was a persistent cause of unmet visual need. Off-task behaviour reduced significantly after actions to address unmet visual needs were communicated to parents and teachers (Wilcoxon signed rank p = 0.035). Conclusions The present study demonstrates for the first time measurable visual and behaviour benefits to children in special education settings when they receive comprehensive in-school eye examinations, on-site spectacle dispensing and jargon-free reporting of outcomes to teachers and parents.	[Black, S. A.; McConnell, E. L.; McClelland, J. F.; Little, J. A.; Saunders, K. J.] Ulster Univ, Sch Biomed Sci Optometry & Vis Sci, Coleraine, Londonderry, North Ireland; [McKerr, L.; Dillenburger, K.] Queens Univ, Sch Social Sci Educ & Social Work, Belfast, Antrim, North Ireland; [Jackson, A. J.; Anketell, P. M.] Hlth & Social Care Trust, Belfast, Antrim, North Ireland	Ulster University; Queens University Belfast	Black, SA (corresponding author), Ulster Univ, Sch Biomed Sci Optometry & Vis Sci, Coleraine, Londonderry, North Ireland.	sa.black@ulster.ac.uk	Jackson, Jonathan/ABH-1264-2021	Jackson, Jonathan/0000-0003-4675-0272; Little, Julie-Anne/0000-0001-5242-8066; Black, Shelley/0000-0002-3930-6483; McConnell, Emma/0000-0002-6180-418X; Dillenburger, Karola/0000-0002-3410-5949	Action Medical research [GN2429]; Department for the Economy; Vision Translational Research Group NI HSC RD	Action Medical research; Department for the Economy; Vision Translational Research Group NI HSC RD	This research was supported by Action Medical research (GN2429 to K.J.S.), the Department for the Economy to S.A.B., and the Vision Translational Research Group NI HSC R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2002, OPHTHAL PHYSL OPT, V22, P565, DOI 10.1046/j.1475-1313.2002.00080.x; Al-Bagdady M, 2009, OPHTHAL PHYSL OPT, V29, P416, DOI 10.1111/j.1475-1313.2009.00646.x; Anketell PM, 2018, OPTOMETRY VISION SCI, V95, P193, DOI 10.1097/OPX.0000000000001190; [Anonymous], 2012, E J MED; BADER D, 1980, AM J OPTOM PHYS OPT, V57, P447; Barbareza R, 2008, OPHTHALMIC PHYSL OPT, V17; Bax M., 2010, VISUAL IMPAIRMENT CH; Coyle C., 2018, ACAD J ED RES, V5, P1; Cumberland PM, 2016, JAMA OPHTHALMOL, V134, P959, DOI 10.1001/jamaophthalmol.2016.1778; CUMMINGS MF, 1988, BEHAV BRAIN RES, V29, P7, DOI 10.1016/0166-4328(88)90047-2; Das M, 2010, ARCH DIS CHILD, V95, P888, DOI 10.1136/adc.2009.159053; Dekker MJ, 2012, STRABISMUS, V20, P49, DOI 10.3109/09273972.2012.680233; Department of Health, 2010, HLTH LIV HLTH FUT FR; Department of Health, 2016, HLTH WELLBEING 2026; Donaldson LA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212733; Dutton G N, 2001, Semin Neonatol, V6, P477, DOI 10.1053/siny.2001.0078; Elliman D., 2006, HLTH ALL CHILDREN; GILLIGAN MB, 1981, AM J OCCUP THER, V35, P249, DOI 10.5014/ajot.35.4.249; Gogate P, 2011, INDIAN J OPHTHALMOL, V59, P223, DOI 10.4103/0301-4738.81036; Kaur G, 2016, J CLIN DIAGN RES, V10, pNC1, DOI 10.7860/JCDR/2016/23615.8742; Little JA, 2015, PUBLIC HEALTH, V129, P143, DOI 10.1016/j.puhe.2014.12.009; Loew S. J., 2017, J PSYCHOL ED, V12, P85; Ludlow AK, 2016, RES DEV DISABIL, V56, P108, DOI 10.1016/j.ridd.2016.05.019; Lueck AH, 2010, J VISUAL IMPAIR BLIN, V104, P585, DOI 10.1177/0145482X1010401003; Macintyre-Beon C, 2012, EYE, V26, P1393, DOI 10.1038/eye.2012.154; Martin D, 2007, TLS-TIMES LIT SUPPL, P3; McClelland JF, 2004, OPTOMETRY VISION SCI, V81, P929; McClelland JF, 2006, INVEST OPHTH VIS SCI, V47, P1824, DOI 10.1167/iovs.05-0825; McCulloch DL, 2007, DEV MED CHILD NEUROL, V49, P757, DOI 10.1111/j.1469-8749.2007.00757.x; McKillop E., 2008, BRIT IRISH ORTHOPTIC, V5, P8; Nandakumar K, 2011, CLIN EXP OPTOM, V94, P575, DOI 10.1111/j.1444-0938.2011.00650.x; Nielsen LS, 2007, ACTA OPHTHALMOL SCAN, V85, P419, DOI 10.1111/j.1600-0420.2007.00881.x; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1155, DOI 10.1136/bjo.2009.176040; Philip SS, 2014, CLIN EXP OPTOM, V97, P196, DOI 10.1111/cxo.12155; Pilling R, 2017, BRIT J OPHTHALMOLOGY, V101; Pilling RF, 2016, BRIT J OPHTHALMOL, V100, P1118, DOI 10.1136/bjophthalmol-2015-307558; Public Health England, CHILD VIS SCREEN GUI; Puri S, 2015, ARCH DIS CHILD, V100, P834, DOI 10.1136/archdischild-2014-308131; Salt A, 2014, ARCH DIS CHILD, V99, P1163, DOI 10.1136/archdischild-2013-305267; Nielsen LS, 2007, ACTA OPHTHALMOL SCAN, V85, P149, DOI 10.1111/j.1600-0420.2006.00867.x; SeeAbility, 2016, DEL EQ RIGHT SIGHT; Stoica L, 2016, RIVER PUBL SER CIRC, P3; The Royal College of Ophthalmologists, 2016, FRAM PROV EYE CAR SP; van Genderen M, 2012, STRABISMUS, V20, P78, DOI 10.3109/09273972.2012.680232; Wallace DK, 2018, OPHTHALMOLOGY, V125, P1961, DOI 10.1016/j.ophtha.2018.05.001; Winterbottom M, 2009, J ENVIRON PSYCHOL, V29, P63, DOI 10.1016/j.jenvp.2008.11.007; Woodhouse JM, 2014, ARCH DIS CHILD, V99, P500, DOI 10.1136/archdischild-2013-304866; WOODHOUSE JM, 1993, INVEST OPHTH VIS SCI, V34, P2382; World Health Organisation, 2018, ICD 11 MORT MORB STA	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220480	10.1371/journal.pone.0220480	http://dx.doi.org/10.1371/journal.pone.0220480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369627	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900056
J	Lee, HS; Thanh, TL; Ly, NK; Hung, NV; Thakur, KK; Grace, D				Hu Suk Lee; To Long Thanh; Nguyen Khanh Ly; Hung Nguyen-Viet; Thakur, Krishna K.; Grace, Delia			Seroprevalence of leptospirosis and Japanese encephalitis in swine in ten provinces of Vietnam	PLOS ONE			English	Article							MEKONG DELTA; RISK-FACTORS; WILD BOARS; VIRUS; PREVALENCE; INFECTION; PIGS; ANTIBODIES; SEROPOSITIVITY; SURVEILLANCE	Background Leptospirosis is an important zoonotic disease with a global distribution, affecting a wide range of mammalian animals and humans. Japanese encephalitis (JE) virus is the major vector-borne zoonotic disease in the Asia-Pacific region. The main objective of this study was to evaluate the seroprevalence of serovar-specific Leptospira and JE in swine from 10 provinces in Vietnam. Methods Samples were initially collected for swine influenza surveillance from March to April 2017 at large-scale farms (with at least 50 sows and/or 250 fattening pigs) with pigs that tested positive for influenza in the previous surveillance period (2015-16). Findings A total of 2,000 sera samples were analyzed from 10 provinces. Overall, the seroprevalence of leptospirosis was 21.05% (95% CI: 19.28-22.90) using a cut-off titer of >= 1:100. The apparent prevalence of JE was 73.45% (95% CI: 71.46-75.37) while the true prevalence was slightly higher (74.46%, 95% credible interval: 73.73-86.41). We found a relatively high presence of leptospirosis and JE in pigs kept on large farms. Prevalence was comparable with other studies suggesting opportunistic testing of samples collected for other surveillance purposes can be a valuable tool to better understand and prevent the potential transmission of these zoonotic diseases from pigs to people in Vietnam. Conclusion Our study provides evidence to veterinarians and animal health professionals for evidence-based practice such as diagnosis, vaccination and zoonotic control. Further investigation into the possible role of different domestic animals, wildlife species or environmental factors is needed to identify the potential risk factors and transmission routes in Vietnam.	[Hu Suk Lee; Hung Nguyen-Viet] Int Livestock Res Inst, Hanoi, Vietnam; [To Long Thanh; Nguyen Khanh Ly] Natl Ctr Vet Diag, 15-78 Duong Giai Phong Phuong Mai Dong Hanoi, Hanoi, Vietnam; [Thakur, Krishna K.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada; [Grace, Delia] Int Livestock Res Inst, Nairobi, Kenya	University of Prince Edward Island; CGIAR; International Livestock Research Institute (ILRI)	Lee, HS (corresponding author), Int Livestock Res Inst, Hanoi, Vietnam.	H.S.Lee@cgiar.org	Nguyen-Viet, Hung/AHH-2981-2022; Thakur, Krishna/H-8736-2019; Nguyen-Viet, Hung/F-6498-2012	Nguyen-Viet, Hung/0000-0003-1549-2733; Thakur, Krishna/0000-0002-9964-4273; Nguyen-Viet, Hung/0000-0001-9877-0596; Lee, Hu Suk/0000-0002-8731-9836; Grace, Delia/0000-0002-0195-9489	CGIAR Trust Fund [1111]; Australian Centre for International Agricultural Research; European Union; International Fund for Agricultural Development; government of the Netherlands; government of the New Zealand; government of the Switzerland; government of the United Kingdom; government of the United States of America; government of the Thailand; CGIAR Research Program on Agriculture for Nutrition and Health; Irish Aid	CGIAR Trust Fund(CGIAR); Australian Centre for International Agricultural Research; European Union(European Commission); International Fund for Agricultural Development; government of the Netherlands(Netherlands Government); government of the New Zealand; government of the Switzerland; government of the United Kingdom; government of the United States of America; government of the Thailand; CGIAR Research Program on Agriculture for Nutrition and Health(CGIAR); Irish Aid(CGIAR)	We acknowledge the CGIAR Trust Fund, grant no. 1111 to DG (https://www.cgiar.org/funders), the Australian Centre for International Agricultural Research, Irish Aid, the European Union, the International Fund for Agricultural Development and the governments of the Netherlands, New Zealand, Switzerland, the United Kingdom, the United States of America and Thailand for funding to the CGIAR Research Program on Climate Change, Agriculture and Food Security. The study was also supported by the CGIAR Research Program on Agriculture for Nutrition and Health, led by the International Food Policy Research Institute.	Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bolin C A, 1991, J Vet Diagn Invest, V3, P152; Boqvist S, 2005, TROP ANIM HEALTH PRO, V37, P443, DOI 10.1007/s11250-005-0300-8; Boqvist S, 2003, VET MICROBIOL, V93, P361, DOI 10.1016/S0378-1135(03)00042-7; Boqvist S, 2002, PREV VET MED, V53, P233, DOI 10.1016/S0167-5877(01)00263-X; Brown CA, 1996, J AM VET MED ASSOC, V209, P1265; BURNSTEIN T, 1954, J INFECT DIS, V94, P53, DOI 10.1093/infdis/94.1.53; Cachay E R, 2005, J Postgrad Med, V51, P174; Chang Kwo-Jiing, 2002, Journal of Microbiology Immunology and Infection, V35, P12; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Conlan JV, 2012, AM J TROP MED HYG, V86, P1077, DOI 10.4269/ajtmh.2012.11-0195; Devleesschauwer B, 2015, PACKAGE PREVALENCE; Dinh XT, 2017, OVERVIEW AGR POLLUTI; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Duong V, 2011, ACTA TROP, V120, P146, DOI 10.1016/j.actatropica.2011.07.008; ELLIS WA, 1986, VET REC, V118, P63, DOI 10.1136/vr.118.3.63; ENGLISH RV, 1993, J VIROL, V67, P5175, DOI 10.1128/JVI.67.9.5175-5186.1993; Faine S., 1994, Leptospira and leptospirosis.; FERESU SB, 1994, INT J SYST BACTERIOL, V44, P541, DOI 10.1099/00207713-44-3-541; HANSON LE, 1982, J AM VET MED ASSOC, V181, P1505; Loan HK, 2015, VECTOR-BORNE ZOONOT, V15, P56, DOI 10.1089/vbz.2014.1613; Jansen A, 2007, EMERG INFECT DIS, V13, P739, DOI 10.3201/eid1305.061302; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Kuwata R, 2013, AM J TROP MED HYG, V88, P681, DOI 10.4269/ajtmh.12-0407; Lapar M. L., 2003, IDENTIFYING BARRIERS; Laras K, 2002, AM J TROP MED HYG, V67, P278, DOI 10.4269/ajtmh.2002.67.278; Lee HS, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1044-1; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Mackenzie JS, 2007, PERSP MED V, V16, P201, DOI 10.1016/S0168-7069(06)16010-3; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Martins G, 2015, EPIDEMIOL INFECT, V143, P1538, DOI 10.1017/S0950268814002416; McGOWAN J. E., 1965, CAN VETERINARY J, V6, P243; Messam Locksley L. McV., 2008, Animal Health Research Reviews, V9, P1, DOI 10.1017/S1466252307001314; Mikaelian I, 1997, CAN VET J, V38, P440; Nations D of E and SAPDU, 2006, NAT D E SAPDU WORLD; Nguyen H., 1995, SE ASIAN J TROP ME S, V26, P47; Nguyen TY, 2010, AM J TROP MED HYG, V83, P816, DOI 10.4269/ajtmh.2010.10-0262; Okuno T, 1978, World Health Stat Q, V31, P120; Pant GR, 2006, ANN NY ACAD SCI, V1081, P124, DOI 10.1196/annals.1373.013; Patel JM, 2014, VET WORLD, V7, P999, DOI 10.14202/vetworld.2014.999-1003; Plummer M., 2004, JAGS JUST ANOTHER GI; Rocha T., 1990, VET RECORD, P126; Ruget A, 2018, TRANSBOUNDARY EMERGI; Ryan TJ, 1976, ISOLATION LEPTOSPIRE; SCHERER WF, 1959, J IMMUNOL, V83, P620; SCHERER WF, 1959, AM J TROP MED HYG, V8, P665, DOI 10.4269/ajtmh.1959.8.665; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Tarantola A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002533; Thakur KK, 2012, ZOONOSES PUBLIC HLTH, V59, P393, DOI 10.1111/j.1863-2378.2012.01456.x; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; Trautwein G, 1994, Tierarztl Prax, V22, P63; Vale-Goncalves HM, 2015, EPIDEMIOL INFECT, V143, P2126, DOI 10.1017/S0950268814003331; Van CTB, 1998, T ROY SOC TROP MED H, V92, P625, DOI 10.1016/S0035-9203(98)90787-8; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; World Health Organization (WHO), JAPANESE ENCEPHALITI; WPRO, 2019, QUEST ANSW JAP ENC; Yamanaka A, 2010, JPN J INFECT DIS, V63, P58	57	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0214701	10.1371/journal.pone.0214701	http://dx.doi.org/10.1371/journal.pone.0214701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369564	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900006
J	Lin, S; Zhang, HY; Hou, YL; Liu, L; Li, WH; Jiang, JP; Han, B; Zhang, SL; Sun, DX				Lin, Shan; Zhang, Hongyan; Hou, Yali; Liu, Lin; Li, Wenhui; Jiang, Jianping; Han, Bo; Zhang, Shengli; Sun, Dongxiao			SNV discovery and functional candidate gene identification for milk composition based on whole genome resequencing of Holstein bulls with extremely high and low breeding values	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DAIRY-CATTLE; ENRICHMENT ANALYSIS; CELL PROLIFERATION; WIDE ASSOCIATION; EXPRESSION; QTL; SCAN; METABOLISM; DISSECTION	We have sequenced the whole genomes of eight proven Holstein bulls from the four half-sib or full-sib families with extremely high and low estimated breeding values (EBV) for milk protein percentage (PP) and fat percentage (FP) using Illumina re-sequencing technology. Consequently, 2.3 billion raw reads were obtained with an average effective depth of 8.1x. After single nucleotide variant (SNV) calling, total 10,961,243 SNVs were identified, and 57,451 of them showed opposite fixed sites between the bulls with high and low EBVs within each family (called as common differential SNVs). Next, we annotated the common differential SNVs based on the bovine reference genome, and observed that 45,188 SNVs (78.70%) were located in the intergenic region of genes and merely 11,871 SNVs (20.67%) located within the protein-coding genes. Of them, 13,099 common differential SNVs that were within or close to protein-coding genes with less than 5 kb were chosen for identification of candidate genes for milk compositions in dairy cattle. By integrated analysis of the 2,657 genes with the GO terms and pathways related to protein and fat metabolism, and the known quantitative trait loci (QTLs) for milk protein and fat traits, we identified 17 promising candidate genes: ALG14, ATP2C1, PLD1, C3H1orf85, SNX7, MTHFD2L, CDKN2D, COL5A3, FDX1L, PIN1, FIG4, EXOC7, LASP1, PGS1, SAO, GPLD1 and MGEA5. Our findings provided an important foundation for further study and a prompt for molecular breeding of dairy cattle.	[Lin, Shan; Zhang, Hongyan; Li, Wenhui; Jiang, Jianping; Han, Bo; Zhang, Shengli; Sun, Dongxiao] China Agr Univ, Dept Anim Genet & Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Natl Engn Lab Anim Breeding,Coll Anim Sci & Techn, Beijing, Peoples R China; [Hou, Yali] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China; [Liu, Lin] Beijing Dairy Cattle Ctr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Sun, DX (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Natl Engn Lab Anim Breeding,Coll Anim Sci & Techn, Beijing, Peoples R China.	sundx@cau.edu.cn			National Natural Science Foundation of China [31872330, 31802041]; Beijing Dairy Industry Innovation Team [BAIC06-2017/2018]; Beijing Science and Technology Program [D171100002417001]; National Science and Technology Programs of China [2013AA102504]; earmarked fund for Modern Agro-industry Technology Research System [CARS-36]; Program for Changjiang Scholar and Innovation Research Team in University [IRT_15R62]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Dairy Industry Innovation Team; Beijing Science and Technology Program; National Science and Technology Programs of China; earmarked fund for Modern Agro-industry Technology Research System; Program for Changjiang Scholar and Innovation Research Team in University	This work was financially supported by the National Natural Science Foundation of China (31872330, 31802041), Beijing Dairy Industry Innovation Team (BAIC06-2017/2018), Beijing Science and Technology Program (D171100002417001), National Science and Technology Programs of China (2013AA102504), earmarked fund for Modern Agro-industry Technology Research System (CARS-36), and the Program for Changjiang Scholar and Innovation Research Team in University (IRT_15R62).	Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Ashwell MS, 2004, J DAIRY SCI, V87, P468, DOI 10.3168/jds.S0022-0302(04)73186-0; Bennewitz J, 2004, GENETICS, V168, P1019, DOI 10.1534/genetics.104.030296; Blott S, 2003, GENETICS, V163, P253; Boichard D, 2003, GENET SEL EVOL, V35, P77, DOI 10.1051/gse:2002037; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Clark AGHM, 2005, GENOME RES, V15; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Cottarel J, 2016, J GEN VIROL, V97, P69, DOI 10.1099/jgv.0.000331; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Deng YQ, 2018, DEV CELL, V47, P464, DOI 10.1016/j.devcel.2018.10.012; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Dzugasova V, 1998, CURR GENET, V34, P297, DOI 10.1007/s002940050399; Feng Zhan, 2014, Sheng Wu Gong Cheng Xue Bao, V30, P1436; Gao XD, 2008, J BIOL CHEM, V283, P32534, DOI 10.1074/jbc.M804060200; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gao YH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3636-3; GEORGES M, 1995, GENETICS, V139, P907; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Han Y, 2016, MOL CELL ENDOCRINOL, V436, P150, DOI 10.1016/j.mce.2016.07.030; Hoffmann HH, 2017, CELL HOST MICROBE, V22, P460, DOI 10.1016/j.chom.2017.09.002; Huang GR, 2011, J CLIN INVEST, V121, P769, DOI 10.1172/JCI45096; Jiang JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168946; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kong XY, 2016, ARCH PHYSIOL BIOCHEM, V122, P36, DOI 10.3109/13813455.2015.1120752; Kong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129402; Kotze-Horstmann LM, 2017, ENDOCRINE, V55, P153, DOI 10.1007/s12020-016-1089-0; Larkin DM, 2012, P NATL ACAD SCI USA, V109, P7693, DOI 10.1073/pnas.1114546109; Lebigot E, 2017, MOL GENET METAB, V122, P85, DOI 10.1016/j.ymgme.2017.08.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang RB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06634-w; Liu Y, 2018, BIOMED PHARMACOTHER, V108, P845, DOI 10.1016/j.biopha.2018.09.068; Lu D MS, 2013, J ANIM SCI, V91; Lu JS, 2012, GLYCOBIOLOGY, V22, P504, DOI 10.1093/glycob/cwr162; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Marete AG, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00522; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Minozzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080219; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Morota G, 2015, ANIM GENET, V46, P381, DOI 10.1111/age.12307; Morota G, 2016, G3-GENES GENOM GENET, V6, P2447, DOI 10.1534/g3.116.031096; Mukhopadhyay S, 2015, J BIOL CHEM, V290, P6986, DOI 10.1074/jbc.M114.622571; Nadesalingam J, 2001, MAMM GENOME, V12, P27, DOI 10.1007/s003350010232; Nakagawa H, 2017, BIOCHEM BIOPH RES CO, V490, P895, DOI 10.1016/j.bbrc.2017.06.137; Nakatsu Y, 2017, J BIOL CHEM, V292, P11886, DOI 10.1074/jbc.M117.780726; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Olsen HG, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0257-2; Park ST, 2016, INT NEUROUROL J, V20, P76, DOI 10.5213/inj.1632742.371; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peyta L, 2015, BBA-MOL CELL BIOL L, V1851, P1490, DOI 10.1016/j.bbalip.2015.08.008; Plante Y, 2001, J DAIRY SCI, V84, P1516, DOI 10.3168/jds.S0022-0302(01)70185-3; Raikwar NS, 2006, AM J PHYSIOL-ENDOC M, V290, P463, DOI 10.1152/ajpendo.00593.2004; Reinhardt TA, 2014, BIOCHEM BIOPH RES CO, V445, P417, DOI 10.1016/j.bbrc.2014.02.020; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Ron M, 2004, J DAIRY SCI, V87, P476, DOI 10.3168/jds.S0022-0302(04)73187-2; Russo V, 2012, ANIM GENET, V43, P72, DOI 10.1111/j.1365-2052.2012.02353.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schnabel RD, 2005, ANIM GENET, V36, P408, DOI 10.1111/j.1365-2052.2005.01337.x; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Suchyta SP, 2003, PHYSIOL GENOMICS, V16, P8, DOI 10.1152/physiolgenomics.00028.2003; Sui YM, 2018, ONCOL REP, V39, P473, DOI 10.3892/or.2017.6114; Utsunomiya YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064280; Viera JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157607; Viitala SM, 2003, J DAIRY SCI, V86, P1828, DOI 10.3168/jds.S0022-0302(03)73769-2; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiong XH, 2012, MOL BIOL CELL, V23, P87, DOI 10.1091/mbc.E11-05-0449; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093017; Zhou Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4699-5	78	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220629	10.1371/journal.pone.0220629	http://dx.doi.org/10.1371/journal.pone.0220629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369641	Green Submitted, gold, Green Published			2022-12-26	WOS:000484987900071
J	Wei, SC; Messina, L; Hood, J; Hughes, A; Jaenicke, T; Johnson, K; Mena, L; Scheer, S; Udeagu, CC; Wohl, A; Robertson, M; Prejean, J; Chen, M; Tang, T; Bertolli, J; Johnson, CH; Skarbinski, J				Wei, Stanley C.; Messina, Lauren; Hood, Julia; Hughes, Alison; Jaenicke, Thomas; Johnson, Kendra; Mena, Leandro; Scheer, Susan; Udeagu, Chi-Chi; Wohl, Amy; Robertson, McKaylee; Prejean, Joseph; Chen, Mi; Tang, Tian; Bertolli, Jeanne; Johnson, Christopher H.; Skarbinski, Jacek			Methods to include persons living with HIV not receiving HIV care in the Medical Monitoring Project	PLOS ONE			English	Article							UNITED-STATES; SURVEILLANCE DATA; INFECTION; SUPPRESSION; RETENTION; SYSTEM	The Medical Monitoring Project (MMP) is an HIV surveillance system that provides national estimates of HIV-related behaviors and clinical outcomes. When first implemented, MMP excluded persons living with HIV not receiving HIV care. This analysis will describe new case-surveillance-based methods to identify and recruit persons living with HIV who are out of care and at elevated risk for mortality and ongoing HIV transmission. Stratified random samples of all persons living with HIV were selected from the National HIV Surveillance System in five public health jurisdictions from 2012-2014. Sampled persons were located and contacted through seven different data sources and five methods of contact to collect interviews and medical record abstractions. Data were weighted for non-response and case reporting delay. The modified sampling methodology yielded 1159 interviews (adjusted response rate, 44.5%) and matching medical record abstractions for 1087 (93.8%). Of persons with both interview and medical record data, 264 (24.3%) would not have been included using prior MMP methods. Significant predictors were identified for successful contact (e.g., retention in care, adjusted Odds Ratio [aOR] 5.02; 95% Confidence Interval [CI] 1.98-12.73), interview (e.g. moving out of jurisdiction, aOR 0.24; 95% CI: 0.12-0.46) and case reporting delay (e.g. rural residence, aOR 3.18; 95% CI: 2.09-4.85). Case-surveillance-based sampling resulted in a comparable response rate to existing MMP methods while providing information on an important new population. These methods have since been adopted by the nationally representative MMP surveillance system, offering a model for public health program, research and surveillance endeavors seeking inclusion of all persons living with HIV.	[Wei, Stanley C.; Messina, Lauren; Robertson, McKaylee; Prejean, Joseph; Chen, Mi; Tang, Tian; Bertolli, Jeanne; Johnson, Christopher H.; Skarbinski, Jacek] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Messina, Lauren; Robertson, McKaylee] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Hood, Julia] Publ Hlth Seattle & King Cty, Prevent Div, Seattle, WA USA; [Hughes, Alison; Scheer, Susan] San Francisco Dept Publ Hlth, HIV Epidemiol & Surveillance Sect, San Francisco, CA USA; [Jaenicke, Thomas] Washington State Dept Hlth, Off Infect Dis, Tumwater, WA USA; [Johnson, Kendra; Mena, Leandro] Mississippi Dept Hlth, STD HIV Off, Jackson, MS USA; [Udeagu, Chi-Chi] New York City Dept Hlth & Mental Hyg, Bur HIV AIDS Prevent & Control, New York, NY USA; [Wohl, Amy] Los Angeles Cty Dept Publ Hlth, Program Evaluat Unit, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; San Francisco Department of Public Health; New York City Department of Health & Mental Hygiene; Los Angeles County Department of Public Health	Wei, SC (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	bge3@cdc.gov	Robertson, McKaylee/GLU-4343-2022	Robertson, McKaylee/0000-0002-8426-6572	 [5U62PS001597-02]		These public health surveillance activities were funded through CDC cooperative agreement 5U62PS001597-02.	AAPOR, 2016, STAND DEF FIN DISP C; [Anonymous], 2019, HIV SURVEILL REP SPE; Blair JM, 2014, MMWR SURVEILL SUMM, V63, P1; Buchacz Kate, 2015, Open AIDS J, V9, P123, DOI 10.2174/1874613601509010123; Bureau of AIDS Tuberculosis and Sexually Transmitted Infections Department of Disease Control Ministry of Public Health, 2019, THAIL NAT GUID HIV A; Buskin S. E., 2011, J HIV AIDS SURVEILLA, V3, P3; Buskin SE, 2014, SEX TRANSM DIS, V41, P35, DOI 10.1097/OLQ.0000000000000072; Centers for Disease Control and Prevention, 2019, BEH CLIN CHAR PERS D; Centers for Disease Control and Prevention, HIV SURV REP 2017; Centers for Disease Control and Prevention, 2018, HIV SURVEILL REP SPE; Chowdhury S, 2007, P JOINT STAT M SECT; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen SM, 2014, PUBLIC HEALTH REP, V129, P335, DOI 10.1177/003335491412900408; Dean BB, 2015, JAIDS-J ACQ IMM DEF, V68, P133, DOI 10.1097/QAI.0000000000000406; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084318; Health Resources and Services Administration, 2013, HAB HIV COR CLIN PER; Horberg MA, 2013, AIDS PATIENT CARE ST, V27, P442, DOI 10.1089/apc.2013.0073; Institute of Medicine, 2012, MONITORING HIV CARE; Institute of Medicine, 2012, MON HIV CAR US STRAT; Magnus M, 2014, AIDS CARE, V26, P367, DOI 10.1080/09540121.2013.824537; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Mokotoff E, 2004, DEV POPULATION BASED; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Osborne J. W., 2011, PRACTICAL ASSESSMENT, V16, P1; Padilla M, 2018, PUBLIC HEALTH REP, V133, P147, DOI 10.1177/0033354918754541; Sabharwal CJ, 2014, JAIDS-J ACQ IMM DEF, V65, P571, DOI 10.1097/QAI.0000000000000077; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Selik RM, 2014, MMWR RECOMM REP, V63; Song RG, 2012, JP J BIOSTAT, V7, P1; Sullivan PS, 2011, AIDS CARE, V23, P1314, DOI 10.1080/09540121.2011.555746; Sweeney P, 2013, MILBANK Q, V91, P558, DOI 10.1111/milq.12018; Wohl AR, 2017, JAIDS-J ACQ IMM DEF, V76, P158, DOI 10.1097/QAI.0000000000001482	35	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219996	10.1371/journal.pone.0219996	http://dx.doi.org/10.1371/journal.pone.0219996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369574	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900020
J	Li, HY; Zhang, CH; Liu, JY; Xie, WY; Xu, WT; Liang, F; Huang, KL; He, XY				Li, Haoyu; Zhang, Chuanhai; Liu, Junyu; Xie, Wenya; Xu, Wentao; Liang, Fei; Huang, Kunlun; He, Xiaoyun			Intraperitoneal administration of follistatin promotes adipocyte browning in high-fat diet-induced obese mice	PLOS ONE			English	Article							INCREASES ENERGY-EXPENDITURE; ADIPOSE-TISSUE; INSULIN SENSITIVITY; C57BL/6J MICE; WEIGHT-LOSS; WHITE FAT; DIFFERENTIATION; DEFICIENT; LEPTIN	With rapid economic development, the prevalence of obesity has increased remarkably worldwide. Obesity can induce a variety of metabolic diseases, such as atherosclerosis, diabetes, hypertension and coronary heart disease, which significantly endanger the health and welfare of individuals. Brown and beige fat tissues play an important role in thermogenesis in mammals. Recent studies have shown that follistatin (FST) can potentially induce the browning of white adipose tissue (WAT). In this study, high-fat diet-induced obese mice were injected with follistatin for one week to explore the effects of follistatin on browning and metabolism and to determine the mechanism. The results showed that follistatin suppressed obesity caused by a high-fat diet and increased insulin sensitivity, energy expenditure, and subcutaneous fat browning. The beneficial effects remained even after a period of withdrawal. Follistatin promoted secretion of irisin from subcutaneous fat via the AMPK-PGC1 alpha-irisin signal pathway, which induces browning of WAT, and activated the insulin pathway in beige fat thereby promoting metabolism.	[Li, Haoyu; Zhang, Chuanhai; Liu, Junyu; Xie, Wenya; Xu, Wentao; Huang, Kunlun; He, Xiaoyun] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Xu, Wentao; Huang, Kunlun; He, Xiaoyun] Minist Agr, Key Lab Safety Assessment Genetically Modified Or, Beijing, Peoples R China; [Liang, Fei] Zhejiang Acad Med Sci, Dept Reprod Physiol, Hangzhou, Zhejiang, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Zhejiang Academy of Medical Sciences	He, XY (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.; He, XY (corresponding author), Minist Agr, Key Lab Safety Assessment Genetically Modified Or, Beijing, Peoples R China.	raininghe@163.com	Zhang, Chuanhai/O-3137-2018	Zhang, Chuanhai/0000-0001-7644-2436; Kunlun, Huang/0000-0002-2350-5859; he, xiaoyun/0000-0002-9503-8532	major special projects on the cultivation of genetically modified organisms [2018ZX0801106B]; Natural Science Foundation of Zhejiang Province [LQ14C120001]; National Natural Science Fund for Young Scholar [81501241]	major special projects on the cultivation of genetically modified organisms; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Fund for Young Scholar	This work was supported by the major special projects on the cultivation of genetically modified organisms (grant number: 2018ZX0801106B) to XH, Natural Science Foundation of Zhejiang Province (LQ14C120001), and National Natural Science Fund for Young Scholar (81501241) to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Braga M, 2014, J LIPID RES, V55, P375, DOI 10.1194/jlr.M039719; Braga M, 2013, OBESITY, V21, P1180, DOI 10.1002/oby.20117; Cai CB, 2017, ONCOTARGET, V8, P34911, DOI 10.18632/oncotarget.16822; Choi SJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE1031, DOI 10.1152/ajpendo.00656.2010; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kim KK, 2014, EAT BEHAV, V15, P87, DOI 10.1016/j.eatbeh.2013.10.019; Lin J, 2017, J MOL CELL BIOL, V9, P364, DOI 10.1093/jmcb/mjx018; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Martinez-Sanchez N, 2014, BEST PRACT RES CL EN, V28, P703, DOI 10.1016/j.beem.2014.04.004; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Miller LE, 2013, J ACAD NUTR DIET, V113, P25, DOI 10.1016/j.jand.2012.08.028; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Odo S., 2013, Food and Nutrition Sciences, V4, P222; Phillips DJ, 2000, BIOESSAYS, V22, P689, DOI 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Singh R, 2017, ENDOCRINOLOGY; Singh R, 2017, ENDOCRINOLOGY, V158, P1217, DOI 10.1210/en.2016-1607; Singh R, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00060; Stewart LK, 2008, METABOLISM, V57, pS39, DOI 10.1016/j.metabol.2008.03.003; Triantafyllou GA, 2016, CIRCULATING FOLLISTA; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	32	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220310	10.1371/journal.pone.0220310	http://dx.doi.org/10.1371/journal.pone.0220310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365569	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600036
J	Corral, WDR; Aguirre, WE				Corral, Winer Daniel Reyes; Aguirre, Windsor E.			Effects of temperature and water turbulence on vertebral number and body shape in Astyanax mexicanus (Teleostei: Characidae)	PLOS ONE			English	Article							THREESPINE STICKLEBACK; MORPHOLOGICAL DIVERGENCE; GASTEROSTEUS-ACULEATUS; GENETIC-ANALYSIS; AXIAL SKELETON; LIFE-HISTORY; EVOLUTION; FISH; PLASTICITY; FORM	Environmental changes can modify the phenotypic characteristics of populations, which in turn can influence their evolutionary trajectories. In ectotherms like fishes, temperature is a particularly important environmental variable that is known to have significant impacts on the phenotype. Here, we raised specimens of the surface ecomorph of Astyanax mexicanus at temperatures of 20 degrees C, 23 degrees C, 25 degrees C, and 28 degrees C to examine how temperature influenced vertebral number and body shape. To increase biological realism, specimens were also subjected to two water turbulence regimes. Vertebral number was counted from x-rays and body shape variation was analysed using geometric morphometric methods. Temperature significantly impacted mean total vertebral number, which increased at the lowest and highest temperatures. Fish reared at lower temperatures had relatively more precaudal vertebrae while fish reared at higher temperatures had relatively more caudal vertebrae. Vertebral anomalies, especially vertebral fusions, were most frequent at the extreme temperature treatments. Temperature significantly impacted body shape as well, with fish reared at 20 degrees C being particularly divergent. Water turbulence also impacted body shape in a generally predictable manner, with specimens reared in high turbulence environments being more streamlined and having extended dorsal and anal fin bases. Variation in environmental variables thus resulted in significant changes in morphological traits known to impact fish fitness, indicating that A. mexicanus has the capacity to exhibit a range of phenotypic plasticity when challenged by environmental change. Understanding the biochemical mechanisms underlying this plasticity and whether adaptive plasticity has influenced the evolutionary radiation of the Characidae, are major directions for future research.	[Corral, Winer Daniel Reyes; Aguirre, Windsor E.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Corral, Winer Daniel Reyes] McGill Univ, Dept Biol, Montreal, PQ, Canada	DePaul University; McGill University	Corral, WDR (corresponding author), Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA.; Corral, WDR (corresponding author), McGill Univ, Dept Biol, Montreal, PQ, Canada.	winer.reyes@mail.mcgill.ca		Aguirre, Windsor/0000-0003-3641-5120	University Research Council; Graduate Research Fund at DePaul University, Chicago, IL; Fulbright fellowship	University Research Council; Graduate Research Fund at DePaul University, Chicago, IL; Fulbright fellowship	This research was funded by the University Research Council and the Graduate Research Fund at DePaul University, Chicago, IL. WDRC was partially supported by a Fulbright fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly KL, 2016, J EXP ZOOL PART A, V325, P25, DOI 10.1002/jez.1993; Aguirre WE, 2019, BIOL J LINN SOC, V126, P706, DOI 10.1093/biolinnean/blz002; Aguirre WE, 2016, EVOL ECOL RES, V17, P373; Aguirre WE, 2014, BIOL J LINN SOC, V113, P204, DOI 10.1111/bij.12316; Aguirre WE, 2009, BIOL J LINN SOC, V98, P139, DOI 10.1111/j.1095-8312.2009.01267.x; Ahn DG, 1999, EVOL DEV, V1, P100, DOI 10.1046/j.1525-142x.1999.99009.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Barriga JP, 2013, J FISH BIOL, V83, P1321, DOI 10.1111/jfb.12233; BEACHAM TD, 1990, CAN J ZOOL, V68, P225, DOI 10.1139/z90-033; Borowsky R., 2008, COLD SPRING HARB PRO, V2008, P107; Borowsky R., 2008, COLD SPRING HARB PRO, V2008; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; BRADSHAW WE, 1977, EVOLUTION, V31, P546, DOI [10.2307/2407521, 10.1111/j.1558-5646.1977.tb01044.x]; Brinsmead J, 2002, J FISH BIOL, V61, P1619, DOI 10.1006/jfbi.2002.2179; Carvajal-Quintero JD, 2015, ECOL EVOL, V5, P2608, DOI 10.1002/ece3.1539; Connolly MH, 2008, INT J DEV BIOL, V52, P71, DOI 10.1387/ijdb.062241mc; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Domenici P., 2009, FISH LOCOMOTION ECO; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Estrada M., 1999, ECOLOGY LIFE HIST ME; Fischer-Rousseau L, 2010, J EXP ZOOL PART B, V314B, P67, DOI 10.1002/jez.b.21311; FOWLER JA, 1970, Q REV BIOL, V45, P148, DOI 10.1086/406492; Franks SJ, 2012, ANNU REV GENET, P46; Fraser TWK, 2015, J FISH DIS, V38, P75, DOI 10.1111/jfd.12206; Gabriel ML, 1944, J EXP ZOOL, V95, P105, DOI 10.1002/jez.1400950108; Gallo ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041443; Georga I, 2010, J MORPHOL, V271, P1319, DOI 10.1002/jmor.10874; Georgakopoulou E, 2007, J FISH BIOL, V70, P278, DOI 10.1111/j.1095-8649.2007.01305.x; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gomez C, 2009, J EXP ZOOL PART B, V312B, P533, DOI 10.1002/jez.b.21305; Vilas LG, 2016, INT J GEOGR INF SCI, V30, P126, DOI 10.1080/13658816.2015.1072629; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Grunbaum T, 2012, DEV DYNAM, V241, P1507, DOI 10.1002/dvdy.23837; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Hynes H. B. N., 1970, ECOLOGY RUNNING WATE; Jeffery WR, 2008, EVOL DEV, V10, P265, DOI 10.1111/j.1525-142X.2008.00235.x; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Jordan DS, 1891, RELATIONS TEMPERATUR; Keogh JS, 2005, EVOLUTION, V59, P226; Kimura T, 2012, G3-GENES GENOM GENET, V2, P1317, DOI 10.1534/g3.112.003236; Kinne O., 1960, Physiological Zoology, V33, P288; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Langerhans R.B., 2010, FISH LOCOMOTION ETHO, P220; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; LINDSEY CC, 1965, CAN J ZOOLOG, V43, P99, DOI 10.1139/z65-008; LINDSEY CC, 1962, CAN J ZOOLOG, V40, P271, DOI 10.1139/z62-028; LINDSEY CC, 1981, CAN J FISH AQUAT SCI, V38, P334, DOI 10.1139/f81-044; Malato G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179432; Martinez PA, 2013, ZOOMORPHOLOGY, V132, P87, DOI 10.1007/s00435-012-0176-x; Maxwell EE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-265; McDowall RM, 2008, J BIOGEOGR, V35, P501, DOI 10.1111/j.1365-2699.2007.01823.x; McDowall RM, 2003, ENVIRON BIOL FISH, V66, P361, DOI 10.1023/A:1023902922843; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Morin-Kensicki EM, 2002, DEVELOPMENT, V129, P3851; Nonaka E, 2015, AM NAT, V186, pE126, DOI 10.1086/683231; Pakkasmaa S, 2000, EVOL ECOL, V14, P721, DOI 10.1023/A:1011691810801; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; POPPER AN, 1971, J MORPHOL, V133, P179, DOI 10.1002/jmor.1051330205; PRIMMETT DRN, 1988, DEVELOPMENT, V104, P331; Ramler D, 2014, J EVOLUTION BIOL, V27, P497, DOI 10.1111/jeb.12311; REIMCHEN TE, 1987, COPEIA, P868; Rohlf F. J., 2009, TPSREGR SHAPE REGRES; Rohlf F. J., 2013, TPSDIG2 DIGITIZE LAN; Roy MN, 1999, MECH DEVELOP, V85, P27, DOI 10.1016/S0925-4773(99)00039-8; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Seebacher F, 2015, NAT CLIM CHANGE, V5, P61, DOI 10.1038/NCLIMATE2457; Sfakianakis DG, 2011, ENVIRON BIOL FISH, V92, P197, DOI 10.1007/s10641-011-9833-z; SHAPIRO AM, 1977, ECOL ENTOMOL, V2, P217, DOI 10.1111/j.1365-2311.1977.tb00884.x; SWAIN DP, 1992, EVOLUTION, V46, P998, DOI 10.1111/j.1558-5646.1992.tb00615.x; TANING AV, 1952, BIOL REV, V27, P169, DOI 10.1111/j.1469-185X.1952.tb01392.x; Taylor EB, 1996, EVOLUTION, V50, P401, DOI [10.2307/2410810, 10.1111/j.1558-5646.1996.tb04502.x]; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Ward AB, 2007, BIOL J LINN SOC, V90, P97, DOI 10.1111/j.1095-8312.2007.00714.x; Ward AB, 2010, INTEGR COMP BIOL, V50, P1106, DOI 10.1093/icb/icq029; WEBB PW, 1976, J EXP BIOL, V65, P157; WEBB PW, 1984, SCI AM, V251, P72, DOI 10.1038/scientificamerican0784-72; West-Eberhard Mary Jane, 2003, pi; Winemiller KO, 2008, AQUAT ECOL SER, P107, DOI 10.1016/B978-012088449-0.50007-8; Witten PE, 2009, AQUACULTURE, V295, P6, DOI 10.1016/j.aquaculture.2009.06.037; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	85	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0219677	10.1371/journal.pone.0219677	http://dx.doi.org/10.1371/journal.pone.0219677			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356643	Green Published, gold, Green Submitted			2022-12-26	WOS:000484047000009
J	Liba, Z; Nohejlova, H; Capek, V; Krsek, P; Sediva, A; Kayserova, J				Liba, Zuzana; Nohejlova, Hana; Capek, Vaclav; Krsek, Pavel; Sediva, Anna; Kayserova, Jana			Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; CXCR3; GUIDELINES; CELLS; CSF; DIFFERENTIATION; DEFINITIONS; EXPRESSION; DIAGNOSIS	Background The recognition of active inflammation in the central nervous system (CNS) in the absence of infectious agents is challenging. The present study aimed to determine the diagnostic relevance of five selected chemo/cytokines in the recognition of CNS inflammation and in the context of traditional cerebrospinal fluid (CSF) biomarkers (white blood cell [WBC] counts, oligoclonal bands, protein levels, CSF/serum albumin ratios) and clinical diagnoses. Methods C-C and C-X-C motif ligands (CCL2, CXCL8, 10 and 13) and interleukin (IL) 6 levels in the CSF and serum from 37 control and 87 symptomatic children with ten different (mostly noninfectious) inflammatory CNS disorders (16 of which had follow-up samples after recovery) were determined using Luminex multiple bead technology and software. Nonparametric tests were used; p < 0.05 was considered statistically significant. Receiver operating characteristic curves were constructed to analyze controls and 1) all symptomatic samples or 2) symptomatic samples without CSF pleocytosis. Results Compared with the control CSF samples, levels of all investigated chemo/cytokines were increased in symptomatic CSF samples, and only IL-6 remained elevated in recovery samples (p <= 0.001). CSF CXCL-13 levels (> 10.9 pg/mL) were the best individual discriminatory criterion to differentiate neuroinflammation (specificity/sensitivity: 97/72% and 97/61% for samples without pleocytosis), followed by CSF WBC counts (specificity/sensitivity: 97/62%). The clinical utility of the remaining CSF chemo/cytokine levels was determined in descending order of sensitivities corresponding to thresholds that ensured 97% specificity for neuroinflammation in samples without pleocytosis (pg/mL; sensitivity %): IL-6 (3.8; 34), CXCL8 (32; 26), CXCL10 (317; 24) and CCL2 (387; 10). Different diagnosis-related patterns of CSF chemo/cytokines were observed. Conclusions The increased CSF level of CXCL13 was the marker with the greatest predictive utility for the general recognition of neuroinflammation among all of the individually investigated bio-markers. The potential clinical utility of chemo/cytokines in the differential diagnosis of neuroinflammatory diseases was identified.	[Liba, Zuzana; Nohejlova, Hana; Krsek, Pavel] Charles Univ Prague, Fac Med 2, Dept Pediat Neurol, Prague, Czech Republic; [Liba, Zuzana; Nohejlova, Hana; Capek, Vaclav; Krsek, Pavel; Sediva, Anna; Kayserova, Jana] Motol Univ Hosp, Prague, Czech Republic; [Nohejlova, Hana] Charles Univ Prague, Fac Med 2, Dept Neurol, Prague, Czech Republic; [Capek, Vaclav] Charles Univ Prague, Fac Med 2, Bioinformat Ctr, Prague, Czech Republic; [Sediva, Anna; Kayserova, Jana] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague; Charles University Prague; Charles University Prague	Liba, Z (corresponding author), Charles Univ Prague, Fac Med 2, Dept Pediat Neurol, Prague, Czech Republic.; Liba, Z (corresponding author), Motol Univ Hosp, Prague, Czech Republic.	zuzana.liba@fnmotol.cz	Sediva, Anna/AAE-2774-2019; Capek, Vaclav/D-8555-2016	Sediva, Anna/0000-0001-7730-2304; Liba, Zuzana/0000-0003-0483-8110; Capek, Vaclav/0000-0002-8574-7001; Krsek, Pavel/0000-0002-5740-3690	foundation "Neuron for Science Support" (Neuron Impulse in Medicine); MH CZ -DRO, University Hospital Motol, Prague, Czech Republic	foundation "Neuron for Science Support" (Neuron Impulse in Medicine); MH CZ -DRO, University Hospital Motol, Prague, Czech Republic	This work was supported by foundation "Neuron for Science Support" (ZL is the recipient of Neuron Impulse in Medicine, www.nfneuron.cz) and by MH CZ -DRO, University Hospital Motol, Prague, Czech Republic 00064203 (PK is the principal investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Enrique, 2015, Mult Scler J Exp Transl Clin, V1, p2055217315623800, DOI 10.1177/2055217315623800; Baunbak Egelund Gertrud, 2017, Medicine (Baltimore), V96, pe6686, DOI 10.1097/MD.0000000000006686; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Bielekova B, 2017, SEMIN PEDIATR NEUROL, V24, P229, DOI 10.1016/j.spen.2017.08.001; Bielekova B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048370; Bien CG, 2009, EPILEPSY RES, V86, P101, DOI 10.1016/j.eplepsyres.2009.06.001; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Casserly CS, 2017, AUTOIMMUN REV, V16, P294, DOI 10.1016/j.autrev.2017.01.013; Coutinho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-326; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Matas SLD, 2013, ARQ NEURO-PSIQUIAT, V71, P685, DOI 10.1590/0004-282X20130151; Deisenhammer F, 2006, EUR J NEUROL, V13, P913, DOI 10.1111/j.1468-1331.2006.01493.x; Domingues RB, 2017, EINSTEIN-SAO PAULO, V15, P100, DOI [10.1590/S1679-45082017RW3706, 10.1590/s1679-45082017rw3706]; Engelhardt B, 2004, BLOOD SPINAL CORD BR, P19; Ferraro D, 2015, J NEUROIMMUNOL, V283, P64, DOI 10.1016/j.jneuroim.2015.04.011; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Garcia-Velez M, 2013, SPAN CONF ELECTRON, P13, DOI 10.1109/CDE.2013.6481330; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Irani DN., 2016, J CLIN CELL IMMUNOL, DOI [10.4172/2155-9899.1000460, DOI 10.4172/2155-9899.1000460]; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Ishizu T, 2006, J NEUROIMMUNOL, V175, P52, DOI 10.1016/j.jneuroim.2006.03.020; Iwanowski P, 2017, J NEUROL SCI, V380, P22, DOI 10.1016/j.jns.2017.06.048; Khaibullin T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00531; Klein RS, 2004, J CELL BIOCHEM, V92, P213, DOI 10.1002/jcb.20052; Kothur K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161656; Kothur K, 2016, CYTOKINE, V77, P227, DOI 10.1016/j.cyto.2015.10.001; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Pinto VLL, 2011, BRAZ J INFECT DIS, V15, P156, DOI 10.1590/S1413-86702011000200011; Liba Z, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0507-9; Michlmayr D, 2014, INT J INTERFER CYT M, V2014, P1, DOI [10.2147/IJICMR.S35953, DOI 10.2147/IJICMR.S35953]; Michlmayr D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00264; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Mygland A, 2010, EUR J NEUROL, V17, P8, DOI 10.1111/j.1468-1331.2009.02862.x; Phares TW, 2013, J VIROL, V87, P3382, DOI 10.1128/JVI.03307-12; Pranzatelli MR, 2013, CLIN EXP IMMUNOL, V172, P427, DOI 10.1111/cei.12065; Pranzatelli MR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00557; Pranzatelli MR, 2013, J INTERF CYTOK RES, V33, P523, DOI 10.1089/jir.2012.0132; Pranzatelli MR, 2012, J NEUROIMMUNOL, V243, P81, DOI 10.1016/j.jneuroim.2011.12.014; R Development Core Team, R LANG ENV STAT COMP; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Remy MM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0948-9; Rupprecht TA, 2005, NEUROLOGY, V65, P448, DOI 10.1212/01.wnl.0000171349.06645.79; Rupprecht TA, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-42; Scarpini E, 2002, J NEUROL SCI, V195, P41, DOI 10.1016/S0022-510X(01)00680-3; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Sorensen TL, 2004, EUR J NEUROL, V11, P445, DOI 10.1111/j.1468-1331.2004.00796.x; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; van Burgel ND, 2011, J CLIN MICROBIOL, V49, P2027, DOI 10.1128/JCM.00084-11; Vazirinejad R, 2014, NEUROIMMUNOMODULAT, V21, P322, DOI 10.1159/000357780; Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458; Wang CN, 2016, SCI REP-UK, V6, DOI 10.1038/srep33569; Wells E, 2018, NAT REV NEUROL, V14, P433, DOI 10.1038/s41582-018-0024-9; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Wullschleger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072399; Zajkowska J, 2011, ADV MED SCI-POLAND, V56, P311, DOI 10.2478/v10039-011-0033-z	60	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0219987	10.1371/journal.pone.0219987	http://dx.doi.org/10.1371/journal.pone.0219987			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356620	Green Published, Green Submitted, gold			2022-12-26	WOS:000484047000012
J	Erath, BD; Peterson, SD; Weiland, KS; Plesniak, MW; Zanartu, M				Erath, Byron D.; Peterson, Sean D.; Weiland, Kelley S.; Plesniak, Michael W.; Zanartu, Matias			An acoustic source model for asymmetric intraglottal flow with application to reduced-order models of the vocal folds	PLOS ONE			English	Article							BODY-COVER MODEL; GLOTTAL FLOW; PHONATION; FIELD; JET; VIBRATION; VORTICES; AREA	The complex three-way interaction between airflow, tissue, and sound, for asymmetric vocal fold vibration, is not well understood. Current modeling efforts are not able to explain clinical observations where drastic differences in sound production are often observed, with no noticeable differences in the vocal fold kinematics. To advance this understanding, an acoustical model for voiced sound generation in the presence of asymmetric intraglottal flows is developed. The source model operates in conjunction with a wave reflection analog propagation scheme and an asymmetric flow description within the glottis. To enable comparison with prior work, the source model is evaluated using a well-studied two-mass vocal fold model. The proposed source model is evaluated through acoustic measures of interest, including radiated sound pressure level, maximum flow declination rate, and spectral tilt, and also via its effects on the vocal fold dynamics. The influence of the model, in comparison to the standard symmetric Bernoulli flow description, results in an increased transfer of energy from the fluid to the vocal folds, increased radiated sound pressure level and maximum flow declination rate, and decreased spectral tilt. These differences are most pronounced for asymmetric vocal fold configurations that mimic unilateral paresis and paralysis, where minor kinematic changes can result in significant acoustic and aerodynamic differences. The results illustrate that fluid effects arising from asymmetric glottal flow can play an important role in the acoustics of pathological voiced speech.	[Erath, Byron D.] Clarkson Univ, Dept Mech & Aeronaut Engn, Potsdam, NY 13699 USA; [Peterson, Sean D.] Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON, Canada; [Weiland, Kelley S.] Naval Surface Warfare Ctr, Dahlgren Div, Dahlgren, VA USA; [Plesniak, Michael W.] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC USA; [Zanartu, Matias] Univ Tecn Federico Santa Maria, Dept Elect Engn, Valparaiso, Chile	Clarkson University; University of Waterloo; George Washington University; Universidad Tecnica Federico Santa Maria	Erath, BD (corresponding author), Clarkson Univ, Dept Mech & Aeronaut Engn, Potsdam, NY 13699 USA.	berath@clarkson.edu	Zañartu, Matías/N-1338-2019	Zañartu, Matías/0000-0001-5581-4392	National Science Foundation [CBET 5250828903]; CONICYT [FONDECYT 1151077, BASAL FB0008]; Ontario Ministry of Research and Innovation [ER1309-269]; National Institutes of Health National Institute on Deafness and Other Communication Disorders [P50DC015446]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC015446] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); National Institutes of Health National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The following authors received funding from the National Science Foundation CBET 5250828903 (https://www.nsf.gov/funding/pgm_ summ. jsp? pims_ id= 505529): BDE, KSW, MWP. The following authors received funding from CONICYT grants FONDECYT 1151077 and BASAL FB0008 (https://www.conicyt.cl/): MZ. The following authors received funding from Ontario Ministry of Research and Innovation Grant ER1309-269 (https://www.ontario.ca/page/researchfunding): SDP. The following authors received funding from the National Institutes of Health National Institute on Deafness and Other Communication Disorders Grant P50DC015446 (https://www.nidcd.nih.gov/): BDE, SDP, MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, MORPHOMETRY HUMAN LU; Birk V, 2017, J ACOUST SOC AM, V142, P2197, DOI 10.1121/1.5007952; Chen G, 2014, COMPUT SPEECH LANG, V28, P1156, DOI 10.1016/j.csl.2013.11.006; Dejonckere PH, 2009, FOLIA PHONIATR LOGO, V61, P171, DOI 10.1159/000219952; Diaz-Cadiz ME, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112384; Dollinger M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187486; Erath BD, 2006, EXP FLUIDS, V40, P683, DOI 10.1007/s00348-006-0106-0; Erath BD, 2005, EXPT INVESTIGATION V; Erath BD, 2006, EXP FLUIDS, V41, P735, DOI 10.1007/s00348-006-0196-8; Erath BD, 2006, J ACOUST SOC AM, V120, P1000, DOI 10.1121/1.2213522; Erath BD, 2013, SPEECH COMMUN, V55, P667, DOI 10.1016/j.specom.2013.02.002; Erath BD, 2011, CHAOS, V21, DOI 10.1063/1.3615726; Erath BD, 2011, J ACOUST SOC AM, V130, P389, DOI 10.1121/1.3586785; Erath BD, 2010, INT J HEAT FLUID FL, V31, P468, DOI 10.1016/j.ijheatfluidflow.2010.02.014; Erath BD, 2010, EXP FLUIDS, V49, P131, DOI 10.1007/s00348-009-0809-0; Ford CN, 1991, PHONOSURGERY ASSESSM, P77; Galindo GE, 2017, J SPEECH LANG HEAR R, V60, P2452, DOI 10.1044/2017_JSLHR-S-16-0412; Hadwin PJ, 2016, J ACOUST SOC AM, V139, P2683, DOI 10.1121/1.4948755; Hirschberg A, 2013, J ACOUST SOC AM, V134, P9, DOI 10.1121/1.4807816; Jiang W, 2015, B 68 M AM PHYS SOC D, P341; Jiang WL, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00007; KELLY JA, 1973, NEW DIR EDUC, P1; Khosla S, 2007, ANN OTO RHINOL LARYN, V116, P217, DOI 10.1177/000348940711600310; Khosla S, 2009, LARYNGOSCOPE, V119, P216, DOI 10.1002/lary.20026; Khosla S, 2008, CURR OPIN OTOLARYNGO, V16, P183, DOI 10.1097/MOO.0b013e3282ff5fc5; Kreiman J, 2015, J ACOUST SOC AM, V138, P1, DOI 10.1121/1.4922174; Liljencrants J., 1985, SPEECH SYNTHESIS REF; Lucero JC, 2015, J ACOUST SOC AM, V137, P2970, DOI 10.1121/1.4919297; Mehta DD, 2011, J ACOUST SOC AM, V130, P3999, DOI 10.1121/1.3658441; Mittal R, 2013, ANNU REV FLUID MECH, V45, P437, DOI 10.1146/annurev-fluid-011212-140636; Mongeau L, 1997, J ACOUST SOC AM, V102, P1121, DOI 10.1121/1.419864; Neubauer J, 2007, J ACOUST SOC AM, V121, P1102, DOI 10.1121/1.2409488; Oren L, 2014, J ACOUST SOC AM, V135, P380, DOI 10.1121/1.4837222; Samlan RA, 2014, J SPEECH LANG HEAR R, V57, P1619, DOI 10.1044/2014_JSLHR-S-12-0405; Scherer RC, 2001, J ACOUST SOC AM, V109, P1616, DOI 10.1121/1.1333420; Sidlof P, 2011, EXP FLUIDS, V51, P123, DOI 10.1007/s00348-010-1031-9; Sommer DE, 2012, J ACOUST SOC AM, V132, pEL271, DOI 10.1121/1.4734013; STEINECKE I, 1995, J ACOUST SOC AM, V97, P1874, DOI 10.1121/1.412061; STORY BH, 1995, J ACOUST SOC AM, V97, P1249, DOI 10.1121/1.412234; Story Brad Hudson, 1995, PHYSL BASED SPEECH S; Takemoto H, 2006, J ACOUST SOC AM, V119, P1037, DOI 10.1121/1.2151823; Tao C, 2007, J ACOUST SOC AM, V122, P2270, DOI 10.1121/1.2773960; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; Titze IR, 2018, SPEECH COMMUN, V101, P26, DOI 10.1016/j.specom.2018.05.003; TITZE IR, 1984, J ACOUST SOC AM, V75, P570, DOI 10.1121/1.390530; Wodicka GR, 2013, J ACOUST SOC AM, V134, P913; Xue Q, 2010, J ACOUST SOC AM, V128, P818, DOI 10.1121/1.3458839; Zanartu M, 2007, J ACOUST SOC AM, V121, P1119, DOI 10.1121/1.2409491; Zhao W, 2002, J ACOUST SOC AM, V112, P2134, DOI 10.1121/1.1506693; Zheng X, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002587	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219914	10.1371/journal.pone.0219914	http://dx.doi.org/10.1371/journal.pone.0219914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344084	Green Submitted, Green Published, gold			2022-12-26	WOS:000484977900039
J	Roddy, P; Dalrymple, U; Jensen, TO; Dittrich, S; Rao, VB; Pfeffer, DA; Twohig, KA; Roberts, T; Bernal, O; Guillen, E				Roddy, Paul; Dalrymple, Ursula; Jensen, Tomas O.; Dittrich, Sabine; Rao, V. Bhargavi; Pfeffer, Daniel A.; Twohig, Katherine A.; Roberts, Teri; Bernal, Oscar; Guillen, Ethan			Quantifying the incidence of severe-febr-ileillness hospital admissions in sub-Saharan Africa	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; MALARIA; MANAGEMENT; OVERDIAGNOSIS; TANZANIA; CHILDREN; ILLNESS; DISEASE; FEVER	Severe-febrile-illness (SFI) is a common cause of morbidity and mortality across sub-Saharan Africa (SSA). The burden of SFI in SSA is currently unknown and its estimation is fraught with challenges. This is due to a lack of diagnostic capacity for SFI in SSA, and thus a dearth of baseline data on the underlying etiology of SFI cases and scant SFI-specific causativeagent prevalence data. To highlight the public health significance of SFI in SSA, we developed a Bayesian model to quantify the incidence of SFI hospital admissions in SSA. Our estimates indicate a mean population-weighted SFI-inpatient-admission incidence rate of 18.4 (6.8-31.1, 68% CrI) per 1000 people for the year 2014, across all ages within areas of SSA with stable Plasmodium falciparum transmission. We further estimated a total of 16,200,337 (5,993,249-27,321,779, 68% CrI) SFI hospital admissions. This analysis reveals the significant burden of SFI in hospitals in SSA, but also highlights the paucity of pathogen-specific prevalence and incidence data for SFI in SSA. Future improvements in pathogen-specific diagnostics for causative agents of SFI will increase the abundance of SFI-specific prevalence and incidence data, aid future estimations of SFI burden, and enable clinicians to identify SFI-specific pathogens, administer appropriate treatment and management, and facilitate appropriate antibiotic use.	[Roddy, Paul; Jensen, Tomas O.; Roberts, Teri; Bernal, Oscar; Guillen, Ethan] Febrile Illness Diagnost Programme, Med Sans Frontieres, New York, NY USA; [Dalrymple, Ursula; Pfeffer, Daniel A.; Twohig, Katherine A.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Dittrich, Sabine] FIND, Geneva, Switzerland; [Dittrich, Sabine] Univ Oxford, Nuffield Sch Med, Oxford, England; [Rao, V. Bhargavi] Med Sans Frontieres, Manson Unit MSF UK, London, England; [Pfeffer, Daniel A.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Pfeffer, Daniel A.] Charles Darwin Univ, Darwin, NT, Australia; [Roberts, Teri] Med Sans Frontieres, Access Campaign, Geneva, Switzerland	University of Oxford; Foundation For Innovative New Diagnostics; University of Oxford; Doctors Without Borders; Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Doctors Without Borders	Roddy, P (corresponding author), Febrile Illness Diagnost Programme, Med Sans Frontieres, New York, NY USA.	roddypd@gmail.com	Twohig, Katherine/AGK-7931-2022; Jensen, Tomas/AFN-5759-2022	Twohig, Katherine/0000-0001-9514-0097; Jensen, Tomas/0000-0003-0398-4431; Bernal, oscar/0000-0003-2514-3318; Rao, V. Bhargavi/0000-0002-4406-1636; Pfeffer, Daniel A./0000-0002-2204-3488				Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Baba M.M., 2009, J AM SCI, V5, P129; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Biritwum RB, 2000, ANN TROP MED PARASIT, V94, P771, DOI 10.1080/00034980020013037; Bisoffi Z, 2013, LANCET GLOB HEALTH, V1, pE11, DOI 10.1016/S2214-109X(13)70013-5; Camponovo F, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1650-6; Chandler CIR, 2008, HEALTH POLICY PLANN, V23, P170, DOI 10.1093/heapol/czm046; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Crump JA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004040; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Dailey PJ, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9010010; Dalrymple U, 2017, ELIFE, V6, DOI [10.7554/elife.29198, 10.7554/eLife.29198]; Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE), FEBR ILLN EV BROAD R; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Font F, 2001, TROP MED INT HEALTH, V6, P423, DOI 10.1046/j.1365-3156.2001.00727.x; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Koram KA, 2007, AM J TROP MED HYG, V77, P1; Kristensen K, 2016, J STAT SOFTW, V70, P1; Loonen AJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087315; Malm K, 2012, P ANN M AM SPC TROP; Maze MJ, 2018, CLIN MICROBIOL INFEC, V24, P808, DOI 10.1016/j.cmi.2018.02.011; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Nkengasong JN, 2018, LANCET, V391, P1873, DOI 10.1016/S0140-6736(18)30308-8; Nonvignon J, 2012, TROP MED INT HEALTH, V17, P951, DOI 10.1111/j.1365-3156.2012.03018.x; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Oladosu O.O., 2013, ISRN INFECT DIS, V2013, P6, DOI DOI 10.5402/2013/914675; Ombelet S, 2018, LANCET INFECT DIS, V18, pE248, DOI 10.1016/S1473-3099(18)30093-8; Penno EC, 2015, AM J TROP MED HYG, V93, P850, DOI 10.4269/ajtmh.15-0083; Prasad N, 2015, AM J TROP MED HYG, V93, P178, DOI 10.4269/ajtmh.14-0646; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; President's Malaria Initiative, 2014, GHAN MAL OP PLAN FY; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Stoler J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2025-x; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248; Van Dillen J, 2007, TROP DOCT, V37, P185, DOI 10.1258/004947507781524845; World Health Organization, 2017, DEPRESSION; World Health Organization (WHO), MULT MULT DIAGN PLAT; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160; 2013, WORLD MAL REP 2013, P1	44	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220371	10.1371/journal.pone.0220371	http://dx.doi.org/10.1371/journal.pone.0220371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344116	Green Submitted, Green Published, gold			2022-12-26	WOS:000484977900093
J	Eiraku, N; Chiba, N; Nakamura, T; Amir, MS; Seong, CH; Ohnishi, T; Kusuyama, J; Noguchi, K; Matsuguchi, T				Eiraku, Nahoko; Chiba, Norika; Nakamura, Toshiaki; Amir, Muhammad Subhan; Seong, Chang-Hwan; Ohnishi, Tomokazu; Kusuyama, Joji; Noguchi, Kazuyuki; Matsuguchi, Tetsuya			BMP9 directly induces rapid GSK3-beta phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts	FASEB JOURNAL			English	Article						endoglin; osteoblast differentiation; GIPC1	ALKALINE-PHOSPHATASE EXPRESSION; BONE MORPHOGENETIC PROTEINS; CELL-DIFFERENTIATION; ENDOGLIN; ALK1; MINERALIZATION	Bone morphogenetic protein (BMP)9 has been reported to be the most potent BMP to induce bone formation. However, the details of BMP9-transduced intracellular signaling remain ambiguous. Here, we have investigated signal transduction mechanisms of BMP9 in comparison to BMP2, another potent inducer of bone formation, in osteoblasts. In a mouse osteoblast cell line, BMP9 induced higher mRNA levels of alkaline phosphatase (ALP) and runt-related transcription factor 2 (Runx2) than BMP2 within 2 h. Unlike BMP2, BMP9 induced rapid phosphorylation of glycogen synthase kinase 3-beta (GSK3-beta) and protein kinase B (Akt) and increased the cellular protein content of beta-catenin. BMP9 moderately increased mRNA levels of several canonical Wingless-related integration site to lower degrees than BMP2. Furthermore, BMP9-induced GSK3-beta phosphorylation was not inhibited by pretreatment with actinomycin D, cycloheximide, or Brefeldin A, indicating it is independent of Wnt protein secretion. BMP9-induced GSK3-beta phosphorylation was abrogated by Akt or class I PI3K-specific inhibitors. Moreover, inactivation of GSK3-beta by LiCl did not further promote ALP and Runx2 mRNA induction by BMP9 as significantly as that by BMP2. Notably, BMP9-induced GSK3-beta phosphorylation was inhibited by small interfering RNA against endoglin and GIPC PDZ domain-containing family, member 1. Taken together, our present findings have indicated that BMP9 directly activates GSK3-beta-catenin signaling pathway through class I PI3K-Akt Axis in osteoblasts, which may be essential for the potent osteoinductive activity of BMP9.	[Eiraku, Nahoko; Nakamura, Toshiaki; Noguchi, Kazuyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Kagoshima, Japan; [Chiba, Norika; Ohnishi, Tomokazu; Kusuyama, Joji; Matsuguchi, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Biochem, Kagoshima, Japan; [Amir, Muhammad Subhan; Seong, Chang-Hwan] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Kagoshima, Japan	Kagoshima University; Kagoshima University; Kagoshima University	Matsuguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Dev Med, Dept Oral Biochem, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tmatsugu@dent.kagoshima-u.ac.jp	Kusuyama, Joji/AAQ-7547-2020; Matsuguchi, Tetsuya/HGU-0412-2022; Amir, Muhammad Subhan/AAD-3006-2021	Amir, Muhammad Subhan/0000-0002-0522-9758; Kusuyama, Joji/0000-0003-4054-1939	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare no conflicts of interest.	Bergeron E, 2009, TISSUE ENG PT A, V15, P3341, DOI 10.1089/ten.TEA.2009.0189; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Fujioka-Kobayashi M, 2017, CLIN ORAL IMPLAN RES, V28, P381, DOI 10.1111/clr.12804; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Lane JM, 2005, J ORTHOP TRAUMA, V19, pS17, DOI 10.1097/00005131-200511101-00006; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; Poniatowski LA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/137823; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Saito T, 2017, CELL REP, V19, P1917, DOI 10.1016/j.celrep.2017.05.011; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Weber D, 2014, CURR TOP DEV BIOL, V110, P285, DOI 10.1016/B978-0-12-405943-6.00008-7; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Yano M, 2012, ENDOCR J, V59, P653, DOI 10.1507/endocrj.EJ12-0022	32	15	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12124	12134		10.1096/fj.201900733RR	http://dx.doi.org/10.1096/fj.201900733RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365832	Green Published			2022-12-26	WOS:000507461600041
J	Babu, BK; Mathur, RK; Ravichandran, G; Anitha, P; Venu, MVB				Babu, B. Kalyana; Mathur, R. K.; Ravichandran, G.; Anitha, P.; Venu, M. V. B.			Genome-wide association study for leaf area, rachis length and total dry weight in oil palm (Eleaeisguineensis) using genotyping by sequencing	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; AGRONOMIC TRAITS; SNP; RICE; MAP	The marker-trait association for complex traits using genotyping by sequencing (GBS) method is being widely spread in plants. The study aimed to identify significant single nucleotide polymorphism (SNP) associations for rachis length (RL), leaf area (LA) and total dry weight (TrDW) in oil palm among diverse African germplasm. The Illumina NextSeq platform has been used for SNP genotyping and retained 4031 fully informative SNPs after applying the filter criterion. These 4031 SNPs were used for genome wide association study for the above three traits. The LD decay rates of the African germplasm using GBS data of SNP is observed to be 25 Kb at 0.45 of average pair wise correlation coefficient (r(2)). Association mapping led to the identification of seven significant associations for three traits using MLM approach at a P value of <= 0.001. Three associations were identified for total dry weight, two each for leaf area index and rachis length. The qtlLA1 was found to be highly significant at a P value of 7.39E(-05) (18.4% phenotypic variance) which is located on chromosome 4. Two QTLs (qtlLA2 and qtlRL1) were located on chromosome 1, which explained 11.9% and 12.4% of phenotypic variance respectively. Three QTLs for total dry weight were located on chromosome 2, 14 and 16, all-together explained 40% phenotypic variance. The results showed that the SNP-trait associations identified in the present study could be used in selection of elite oil palm germplasm for higher yields.	[Babu, B. Kalyana; Mathur, R. K.; Ravichandran, G.; Anitha, P.; Venu, M. V. B.] ICAR Indian Inst Oil Palm Res, Pedavegi, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Oil Palm Research	Babu, BK (corresponding author), ICAR Indian Inst Oil Palm Res, Pedavegi, Andhra Pradesh, India.	kalyan_biotek@yahoo.co.in						[Anonymous], 2011, FURTHER ADV OIL PALM; [Anonymous], [No title captured]; Babu BK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171933; Bai B, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1045-z; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Billotte N, 2010, THEOR APPL GENET, V120, P1673, DOI 10.1007/s00122-010-1284-y; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chuenpoma, 2016, THAI SCI TECH, V6, P2560; CORLEY RHV, 1971, EUPHYTICA, V20, P307, DOI 10.1007/BF00056093; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fukuoka S, 2001, THEOR APPL GENET, V103, P185, DOI 10.1007/s001220100611; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ithnin M, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1185-1; Jeennor S, 2014, TREE GENET GENOMES, V10, P1, DOI 10.1007/s11295-013-0655-3; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jin JJ, 2016, DNA RES, V23, P527, DOI 10.1093/dnares/dsw036; Kainer D, 2015, THEOR APPL GENET, V128, P2351, DOI 10.1007/s00122-015-2591-0; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Mathew LS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-285; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Murphy DJ, 2014, J OIL PALM RES, V26, P1; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Okoye M. N., 2007, 8th African Crop Science Society Conference, El-Minia, Egypt, 27-31 October 2007, P723; Pootakham W, 2015, GENOMICS, V105, P288, DOI 10.1016/j.ygeno.2015.02.002; Pritchard J, 2003, DOCUMENTATION STRUCT; Rance KA, 2001, THEOR APPL GENET, V103, P1302, DOI 10.1007/s122-001-8204-z; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Teh CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19075; Ting NC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-309; Ukoskit K, 2014, MOL BREEDING, V33, P415, DOI 10.1007/s11032-013-9959-0; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220626	10.1371/journal.pone.0220626	http://dx.doi.org/10.1371/journal.pone.0220626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390382	gold, Green Published, Green Submitted			2022-12-26	WOS:000484999400023
J	Han, SF; Liu, GX; Zhang, TW				Han, Sufang; Liu, Guoxin; Zhang, Tianwei			Mean almost periodicity and moment exponential stability of semi-discrete random cellular neural networks with fuzzy operations	PLOS ONE			English	Article							STOCHASTIC STABILITY; GLOBAL ATTRACTIVITY; SEQUENCE SOLUTION; NEUTRAL SYSTEMS; CONTINUOUS-TIME; FISHING MODEL; DISCRETE; EXISTENCE; DELAYS; DISSIPATIVITY	By using the semi-discretization technique of differential equations, the discrete analogue of a kind of cellular neural networks with stochastic perturbations and fuzzy operations is formulated, which gives a more accurate characterization for continuous-time models than that by Euler scheme. Firstly, the existence of at least one p-th mean almost periodic sequence solution of the semi-discrete stochastic models with almost periodic coefficients is investigated by using Minkowski inequality, Holder inequality and Krasnoselskii's fixed point theorem. Secondly, the p-th moment global exponential stability of the semi-discrete stochastic models is also studied by using some analytical skills and the proof of contradiction. Finally, a problem of stochastic stabilization for discrete cellular neural networks is studied.	[Han, Sufang; Liu, Guoxin] Cent S Univ, Sch Math & Stat, Changsha, Hunan, Peoples R China; [Zhang, Tianwei] Kunming Univ Sci & Technol, City Coll, Kunming, Yunnan, Peoples R China	Central South University; Kunming University of Science & Technology	Zhang, TW (corresponding author), Kunming Univ Sci & Technol, City Coll, Kunming, Yunnan, Peoples R China.	zhang@kmust.edu.cn	Zhang, Tianwei/AAV-8818-2020	Zhang, Tianwei/0000-0001-6777-1668	National Nature Science Foundation of China [11461082]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Nature Science Foundation of China (No. 11461082 to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GEORGIANMATHEMATICAL, DOI DOI 10.1007/BF02280009; [Anonymous], 1980, FIXED POINT THEOREMS; Arnold L., 1998, STOCHASTICS STOCHAST, V64, P177; Arunkumar A, 2014, ISA T, V53, P1006, DOI 10.1016/j.isatra.2014.05.002; Bezandry PH, 2010, ALMOST PERIODIC STOC; Chen AP, 2003, APPL MATH COMPUT, V134, P125, DOI 10.1016/S0096-3003(01)00274-0; Chen WH, 2006, PHYS LETT A, V358, P186, DOI 10.1016/j.physleta.2006.05.014; CHUA LO, 1988, IEEE T CIRCUITS SYST, V35, P1257, DOI 10.1109/31.7600; Diagana T, 2007, J DIFFER EQU APPL, V13, P239, DOI 10.1080/10236190601079035; Feng ZG, 2004, APPL MATH COMPUT, V154, P683; Gao S, 2019, PHYS LETT A, V383, P414, DOI 10.1016/j.physleta.2018.11.016; Han SF, 2019, OPEN MATH, V17, P385, DOI 10.1515/math-2019-0030; Hsu CF, 2016, NEUROCOMPUTING, V173, P734, DOI 10.1016/j.neucom.2015.08.024; Hu MF, 2014, NEUROCOMPUTING, V129, P476, DOI 10.1016/j.neucom.2013.09.011; Hu S., 2008, STOCHASTIC DIFFERENT; Huang ZK, 2007, NONLINEAR DYNAM, V50, P13, DOI 10.1007/s11071-006-9139-4; Huang ZK, 2014, MATH COMPUT SIMULAT, V101, P43, DOI 10.1016/j.matcom.2013.05.017; Huang ZK, 2010, MATH COMPUT MODEL, V52, P1521, DOI 10.1016/j.mcm.2010.06.013; Huang ZK, 2006, PHYS LETT A, V350, P182, DOI 10.1016/j.physleta.2005.10.022; Ji Y, 2011, ARAB J SCI ENG, V36, P1447, DOI 10.1007/s13369-011-0109-x; Kim EH, 2018, NEUROCOMPUTING, V303, P20, DOI 10.1016/j.neucom.2018.04.003; Kong FC, 2018, APPL INTELL, V48, P3332, DOI 10.1007/s10489-018-1146-x; Kuang JC, 2012, APPL INEQUALITIES, V4; Li YK, 2015, NEURAL COMPUT APPL, V26, P1073, DOI 10.1007/s00521-014-1784-9; Li YK, 2013, FUZZY SET SYST, V217, P62, DOI 10.1016/j.fss.2012.11.009; Li YK, 2012, APPL MATH MODEL, V36, P1173, DOI 10.1016/j.apm.2011.07.090; Liu D, 2017, NONLINEAR DYNAM, V90, P915, DOI 10.1007/s11071-017-3702-z; Meng FR, 2019, NEUROCOMPUTING, V325, P254, DOI 10.1016/j.neucom.2018.10.038; Mohamad S, 2000, MATH COMPUT SIMULAT, V53, P1, DOI 10.1016/S0378-4754(00)00168-3; Mohamad S, 2003, APPL MATH COMPUT, V135, P17, DOI 10.1016/S0096-3003(01)00299-5; Ramasamy S, 2016, NONLINEAR DYNAM, V85, P2777, DOI 10.1007/s11071-016-2862-6; Ren Y, 2018, STAT PROBABIL LETT, V143, P56, DOI 10.1016/j.spl.2018.07.024; Selvaraj P, 2018, NEURAL NETWORKS, V105, P154, DOI 10.1016/j.neunet.2018.05.004; Sun KY, 2015, NEURAL NETWORKS, V61, P68, DOI 10.1016/j.neunet.2014.10.002; Tudor C., 1992, STOCHASTICS STOCHAST, V38, P251, DOI DOI 10.1080/17442509208833758; Wang C, 2018, NEUROCOMPUTING, V282, P1, DOI 10.1016/j.neucom.2017.12.008; Wang C, 2014, APPL MATH COMPUT, V248, P101, DOI 10.1016/j.amc.2014.09.046; Wang JL, 2014, NEUROCOMPUTING, V142, P542, DOI 10.1016/j.neucom.2014.02.056; Wang P, 2015, NEUROCOMPUTING, V167, P76, DOI 10.1016/j.neucom.2015.04.089; Wu T, 2019, INT J ROBUST NONLIN, V29, P2525, DOI 10.1002/rnc.4510; Xiong LL, 2018, APPL MATH COMPUT, V321, P672, DOI 10.1016/j.amc.2017.11.020; Xiong LL, 2016, NONLINEAR ANAL-HYBRI, V19, P13, DOI 10.1016/j.nahs.2015.07.005; Xiong LL, 2012, J FRANKLIN I, V349, P2193, DOI 10.1016/j.jfranklin.2012.04.003; Xu C, 2016, ELECTRON J DIFFER EQ, V2016, P1; Xu CJ, 2017, NONLINEAR ANAL-MODEL, V22, P531, DOI 10.15388/NA.2017.4.8; Xu CJ, 2016, NEURAL COMPUT, V28, P2726, DOI 10.1162/NECO_a_00895; Yang T, 1996, IEEE T CIRCUITS-I, V43, P880, DOI 10.1109/81.538999; Yang XS, 2010, J FRANKLIN I, V347, P559, DOI 10.1016/j.jfranklin.2009.12.004; Zhang HY, 2019, INT J SYST SCI, V50, P970, DOI 10.1080/00207721.2019.1586005; Zhang HY, 2019, NEUROCOMPUTING, V333, P395, DOI 10.1016/j.neucom.2018.12.028; Zhang TW, 2020, INT J CONTROL, V93, P1442, DOI 10.1080/00207179.2018.1513165; Zhang TW, 2017, KYBERNETIKA, V53, P612, DOI 10.14736/kyb-2017-4-0612; Zhang TW, 2014, COMMUN NONLINEAR SCI, V19, P150, DOI 10.1016/j.cnsns.2013.06.019; Zhang TW, 2012, COMMUN NONLINEAR SCI, V17, P1408, DOI 10.1016/j.cnsns.2011.08.008; Zhang XM, 2018, IEEE T CYBERNETICS, V48, P1660, DOI 10.1109/TCYB.2017.2776283; Zhang ZQ, 2010, J FRANKLIN I, V347, P763, DOI 10.1016/j.jfranklin.2010.02.007; Zhao HY, 2007, NEUROCOMPUTING, V70, P2924, DOI 10.1016/j.neucom.2006.11.010; Zhou LQ, 2014, NONLINEAR DYNAM, V77, P41, DOI 10.1007/s11071-014-1271-y	58	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220861	10.1371/journal.pone.0220861	http://dx.doi.org/10.1371/journal.pone.0220861			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390372	gold, Green Published, Green Submitted			2022-12-26	WOS:000484999400034
J	Chaudhury, A; Dalal, AD; Sheoran, NT				Chaudhury, Ashok; Dalal, Anita Devi; Sheoran, Nayan Tara			Isolation, cloning and expression of CCA1 gene in transgenic progeny plants of Japonica rice exhibiting altered morphological traits	PLOS ONE			English	Article							CIRCADIAN CLOCK; TRANSFORMATION EFFICIENCY; MEDIATED TRANSFORMATION; PHOTOPERIODIC CONTROL; TRANSCRIPTION FACTOR; REGENERATION; L.	Circadian clock genes holds tremendous potential for breeding crops better adapted to environmental fluctuations inherent to climate change. Endogenous TOC1 promoter and CCA1 gene from rice were isolated, cloned and mobilized into pCAMBIA1300 vectors and RNAi constructs A, B and C. Embryogenic calli of varying ages derived from mature seeds of Taipei 309 were employed for Agrobacterium-mediated genetic transformation generating T0, T1 and T2 independent transgenic lines were analyzed for over-expression and repression of CCA1 gene along with various morphological traits. Six hundred and thirty two T0 transgenic plants were generated from rice calli using constructs A, B and C. T0 progeny plants derived from constructs A, B and C did not show any considerable difference in morphological traits. T1and T2 progeny plants derived from construct A exhibited over-expression of CCA1 gene, on the contrary, progeny plants derived from RNAi constructs B and C exhibited repression of CCA1 gene in qRT-PCR analysis at different time points and showed rhythmicity peaking at dawn (6: 00 AM) and lowest expression at 12: 00 Noon. T1 and T2 progeny plants derived from construct A, namely, A-17 and A-45 exhibited reduced number of tillers/panicles (6-8), reduced thousand seed weight (10.1-16.6g), decreased seed length (4.98 to 6.58mm), decreased seed width (1.1-1.8mm) as compared to wild type plants. T1 and T2 progeny plants of construct B and C showed increased number of tillers/panicles (8-19), better seed yield (4.98-28.9g), increased thousand seed weight (15.6-29.03g), slightly increased seed length (5.7-7.43mm) and slightly increased seed width (1.7-2.98mm) as compared to wild type plants. Chlorophyll content in T1 and T2 progeny plants did not show any significant difference among the three constructs, however, rhythmicity was observed over the period of time in conjunction to CCA1 gene expression. Evidence has been presented which demonstrates that endogenous repression of CCA1 gene resulted in improved morphological traits: increased number of tillers/panicle, thousand seed weight, seed size; whereas, over-expression leads to diminution in morphological traits: decreased number of tillers/panicle, thousand seed weight, seed size as compared to the wild type in T1 and T2 progeny plants. This is first report of successful regulation of endogenous CCA1 gene under control of TOC1 promoter and its effect on improved growth vigor in Japonica rice.	[Chaudhury, Ashok; Dalal, Anita Devi; Sheoran, Nayan Tara] Guru Jambheshwar Univ Sci & Technol, Bio & Nano Technol Ctr, Dept Bio & Nano Technol, Plant Mol Biol Lab, Hisar, Haryana, India	Guru Jambheshwar University of Science & Technology	Chaudhury, A (corresponding author), Guru Jambheshwar Univ Sci & Technol, Bio & Nano Technol Ctr, Dept Bio & Nano Technol, Plant Mol Biol Lab, Hisar, Haryana, India.	ashokchaudhury@hotmail.com		chaudhury, ashok/0000-0002-0383-1497	USIEF (The United States-India Educational Foundation) New Delhi [1510/FN-SR/2011]; Bureau of Educational and Cultural Affairs, U S Department of State, USA [1510/FN-SR/2011]; International Educational Exchange Program, USA [1510/FN-SR/2011]; Department of Science & Technology, Ministry of Science & Technology, Government of India, New Delhi, India [SR/FST/LSI-153/2003]; University Grants Commission, New Delhi [3-18/2009, F.3-4/2016/DRS-II (SAP-II), DBNT146299]	USIEF (The United States-India Educational Foundation) New Delhi; Bureau of Educational and Cultural Affairs, U S Department of State, USA; International Educational Exchange Program, USA; Department of Science & Technology, Ministry of Science & Technology, Government of India, New Delhi, India; University Grants Commission, New Delhi(University Grants Commission, India)	This work was supported by: 1. The Award of Fulbright Nehru Senior Research Fellowship to Prof A. Chaudhury by the USIEF (The United States-India Educational Foundation) New Delhi; Bureau of Educational and Cultural Affairs, U S Department of State, USA; International Educational Exchange Program, USA vide letter 1510/FN-SR/2011 Dated May 17, 2011; 2. FIST program, sanctioned to Prof. A. Chaudhury by the Department of Science & Technology, Ministry of Science & Technology, Government of India, New Delhi, India Vide Letter #No SR/FST/LSI-153/2003 Dated July 01, 2004; 3. SAP DRS-I and SAP DRS-II, sanctioned to Prof. A. Chaudhury by the University Grants Commission, New Delhi Vide Letter no. 3-18/2009 dated March 31, 2009 and Letter No F.3-4/2016/DRS-II (SAP-II) dated March 18, 2016; 4. JRF/SRF under Basic Scientific Research (BSR) to Ms. Anita Devi Dalal by the University Grants Commission, New Delhi Vide Letter no. DBNT146299 dated August 01, 2014.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bendix C, 2015, MOL PLANT, V8, P1135, DOI 10.1016/j.molp.2015.03.003; Chaudhury A, 2000, PLANT CELL TISS ORG, V60, P113, DOI 10.1023/A:1006456005961; Chaudhury Abed, 1999, Plant Cell, V11, P1817; CHU CC, 1975, SCI SINICA, V18, P659; Farinas B, 2011, PLANT J, V66, P318, DOI 10.1111/j.1365-313X.2011.04484.x; Han JL, 2005, PLANT SCI, V168, P73, DOI 10.1016/j.plantsci.2004.07.020; Hayama R, 2003, CURR OPIN PLANT BIOL, V6, P13, DOI 10.1016/S1369-5266(02)00011-0; Heilersig HJB, 2006, PLANT MOL BIOL, V60, P647, DOI 10.1007/s11103-005-5280-6; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hsu PY, 2014, TRENDS PLANT SCI, V19, P240, DOI 10.1016/j.tplants.2013.11.007; Htwe Nwe Nwe, 2014, Pak J Biol Sci, V17, P472, DOI 10.3923/pjbs.2014.472.481; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Huang X, 2016, NAT GENET; Karthikeyan A, 2011, PLANT SCI, V181, P258, DOI 10.1016/j.plantsci.2011.05.011; Kumari A, 2015, PLOS ONE, P1932; Kuno N, 2003, PLANT CELL, V15, P2476, DOI 10.1105/tpc.014217; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Lee HG, 2016, SCI REP-UK, V6, DOI 10.1038/srep17754; LI XQ, 1995, TRANSGENIC RES, V4, P349, DOI 10.1007/BF01972532; Liu JF, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.43; Livak KJ, 2001, METHOD; Lucca P, 2001, MOL BREEDING, V7, P43, DOI 10.1023/A:1009661014167; Meiru L, 2011, PLANT CELL TISSUE OR, P363; Mohanty A, 1999, PLANT SCI, V147, P127, DOI 10.1016/S0168-9452(99)00103-X; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Ng, 2014, PLANT CELL, P2430, DOI [10.1105/tpc.113.115980, DOI 10.1105/TPC.113.115980]; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Patel M, 2013, PLANT CELL TISS ORG, V114, P19, DOI 10.1007/s11240-013-0301-7; Pravin J., 2011, J CELL PLANT SCI, V2, P24; Rawat R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001350; Rawat R, 2009, P NATL ACAD SCI USA, V106, P16883, DOI 10.1073/pnas.0813035106; Rosato E., 2007, CIRCADIAN RHYTHMS ME, V362; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Shalit Kaneh A, 2018, P NATL ACAD SCI USA; Tan J, 2018, PLANT CELL REP, V37, P993, DOI 10.1007/s00299-018-2284-7; Tyagi AK, 1999, CRIT REV BIOTECHNOL, V19, P41, DOI 10.1080/0738-859991229198; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wang XT, 2011, PLANT CELL REP, V30, P1261, DOI 10.1007/s00299-011-1036-8; Wang ZY, 1988, CELL, P1207; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Zhang XB, 2007, PLANT J, V51, P512, DOI 10.1111/j.1365-313X.2007.03156.x	45	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220140	10.1371/journal.pone.0220140	http://dx.doi.org/10.1371/journal.pone.0220140			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381594	Green Published, gold, Green Submitted			2022-12-26	WOS:000484993600011
J	Kimmann, M; Tergast, TL; Schultalbers, M; Laser, H; Gerbel, S; Manns, MP; Cornberg, M; Maasoumy, B				Kimmann, Markus; Tergast, Tammo Lambert; Schultalbers, Marie; Laser, Hans; Gerbel, Svetlana; Manns, Michael Peter; Cornberg, Markus; Maasoumy, Benjamin			Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis	PLOS ONE			English	Article							INFECTIONS; NORFLOXACIN; PROPHYLAXIS; FAILURE; DIAGNOSIS; INCREASE; MODEL	Background & aims Bacterial infections, in particular a spontaneous bacterial peritonitis (SBP), are a major threat in patients with liver cirrhosis. Recently, it has been shown that the impact on mortality might be underestimated by established risk-scores. Onset of infection was suggested to define a distinct stage of cirrhosis. However, it remains unclear whether all stages of decompensated cirrhosis are equally affected. Moreover, if there is such a distinct stage, it must be determined whether it is reversible after the infection has resolved. In this study we aimed to further analyze the impact of a current as well as a resolved SBP in different stages of decompensated liver cirrhosis. Methods A number of 579 patients with liver cirrhosis and ascites were included. MELD-score was used to determine the stage of liver disease. Low (<15), intermediate (15-25) and high (>25) MELD-groups were compared. Patients were followed up for 90 days. Primary end-point was overall mortality. Statistical analyses were performed using the log-rank test, Cox regression and competing risk analysis. Results Mortality was significantly higher in patients with nosocomial-acquired SBP (nSBP) compared to patients without SBP (p<0.001; HR = 2.05). However, the most prominent difference in mortality was documented in the intermediate MELD-group (nSBP: p = 0.02; HR = 2.10). Importantly, mortality in nSBP patients remained increased even after the initial nSBP episode had resolved (p<0.01; HR = 1.90). Again, this was only significant in those with intermediate MELD-scores (p = 0.02; HR = 2.28). While a current as well as a resolved nSBP were significantly linked to a higher mortality, neither of them did increase the likelihood for liver transplantation. Conclusions Development of nSBP is independently associated with increased mortality supporting the concept of a distinct status of cirrhosis. Importantly, the prognosis remains unfavorable even after resolution of nSBP. This could be particularly relevant for patients with intermediate MELD-scores, who have limited chances for a donor liver.	[Kimmann, Markus; Tergast, Tammo Lambert; Schultalbers, Marie; Manns, Michael Peter; Cornberg, Markus; Maasoumy, Benjamin] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Laser, Hans; Gerbel, Svetlana] Hannover Med Sch, Ctr Informat Management ZIMT, Hannover, Germany; [Manns, Michael Peter; Cornberg, Markus; Maasoumy, Benjamin] German Ctr Infect Res, DZIF, Partner Site Hannover Braunschweig, Hannover, Germany; [Manns, Michael Peter; Cornberg, Markus] CIIM, Hannover, Germany	Hannover Medical School; Hannover Medical School; German Center for Infection Research	Maasoumy, B (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.; Maasoumy, B (corresponding author), German Ctr Infect Res, DZIF, Partner Site Hannover Braunschweig, Hannover, Germany.	maasoumy.benjamin@mh-hannover.de	Cornberg, Markus/AAN-6939-2021	Cornberg, Markus/0000-0002-9141-8001; Maasoumy, Benjamin/0000-0002-3250-3177; Kimmann, Markus/0000-0002-6403-7094	Else Kroner-Fresenius Foundation	Else Kroner-Fresenius Foundation	T.L.T. and this study were supported by the `KlinStrucMed' Programme funded by the Else Kroner-Fresenius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo J, 2013, HEPATOL INT, V7, P72, DOI 10.1007/s12072-012-9396-x; Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Arroyo V, 2016, SEMIN LIVER DIS, V36, P109, DOI 10.1055/s-0036-1583202; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Cheong HS, 2009, CLIN INFECT DIS, V48, P1230, DOI 10.1086/597585; Cholongitas E, 2017, ANN HEPATOL, V16, P584, DOI 10.5604/01.3001.0010.0298; D'Amico G, 2018, J HEPATOL, V68, P563, DOI 10.1016/j.jhep.2017.10.020; Dionigi E, 2017, AM J GASTROENTEROL, V112, P588, DOI 10.1038/ajg.2017.19; European Association for the Study of the Liver, 2018, J HEPATOL; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez J, 2017, GUT; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; Fernandez J, 2016, HEPATOLOGY, V63, P2019, DOI 10.1002/hep.28330; Fernandez J, 2012, HEPATOLOGY, V55, P1551, DOI 10.1002/hep.25532; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gerbes AL, 2011, Z GASTROENTEROL, V49, P780, DOI 10.1055/s-0031-1273404; GINES P, 1990, HEPATOLOGY, V12, P716, DOI 10.1002/hep.1840120416; Gustot T, 2015, HEPATOLOGY, V62, P243, DOI 10.1002/hep.27849; Gustot T, 2014, J HEPATOL, V61, P725, DOI 10.1016/j.jhep.2014.06.028; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Jochmans I, 2017, TRANSPLANTATION, V101, P1542, DOI 10.1097/TP.0000000000001631; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Mucke MM, 2018, LIVER INT, V38, P645, DOI 10.1111/liv.13568; Park YH, 2003, J GASTROEN HEPATOL, V18, P927, DOI 10.1046/j.1440-1746.2003.03086.x; Piano S, 2016, HEPATOLOGY, V63, P1299, DOI 10.1002/hep.27941; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Soriano G, 2011, ALIMENT PHARM THER, V33, P275, DOI 10.1111/j.1365-2036.2010.04506.x; Tergast TL, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0053-0; Tergast TL, 2018, LIVER INT; Zapater P, 2015, WORLD J GASTROENTERO, V21, P11493, DOI 10.3748/wjg.v21.i41.11493	32	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220666	10.1371/journal.pone.0220666	http://dx.doi.org/10.1371/journal.pone.0220666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374111	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500024
J	Verma, R; Pandit, SB				Verma, Rivi; Pandit, Shashi Bhushan			Unraveling the structural landscape of intra-chain domain interfaces: Implication in the evolution of domain-domain interactions	PLOS ONE			English	Article							MULTIDOMAIN PROTEINS; CLASSIFICATION; CONSERVATION; ORIENTATION; DIVERGENCE; SEQUENCES; FAMILIES; GEOMETRY; DATABASE; LINKERS	Intra-chain domain interactions are known to play a significant role in the function and stability of multidomain proteins. These interactions are mediated through a physical interaction at domain-domain interfaces (DDIs). With a motivation to understand evolution of interfaces, we have investigated similarities among DDIs. Even though interfaces of protein-protein interactions (PPIs) have been previously studied by structurally aligning interfaces, similar analyses have not yet been performed on DDIs of either multidomain proteins or PPIs. For studying the structural landscape of DDIs, we have used iAlign to structurally align intra-chain domain interfaces of domains. The interface alignment of spatially constrained domains (due to inter-domain linkers) showed that similar to 88% of these could identify a structural matching interface having similar C-alpha geometry and contact pattern despite that aligned domain pairs are not structurally related. Moreover, the mean interface similarity score (IS-score) is 0.307, which is higher compared to the average random IS-score (0.207) suggesting domain interfaces are not random. The structural space of DDIs is highly connected as similar to 84% of all possible directed edges among interfaces are found to have at most path length of 8 when 0.26 is IS-score threshold. At this threshold, similar to 83% of interfaces form the largest strongly connected component. Thus, suggesting that structural space of intra-chain domain interfaces is degenerate and highly connected, as has been found in PPI interfaces. Interestingly, searching for structural neighbors of inter-chain interfaces among intra-chain interfaces showed that similar to 86% could find a statistically significant match to intra-chain interface with a mean IS-score of 0.311. This implies that domain interfaces are degenerate whether formed within a protein or between proteins. The interface degeneracy is most likely due to limited possible ways of packing secondary structures. In principle, interface similarities can be exploited to accurately model domain interfaces in structure prediction of multidomain proteins.	[Verma, Rivi; Pandit, Shashi Bhushan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India	Indian Institute of Science Education & Research (IISER) - Mohali	Pandit, SB (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India.	shashibp@iisermohali.ac.in		Pandit, Shashi/0000-0002-1362-5136	Ministry of Human Resource Development [MHRD-140064]; Science and Engineering Research Board, Department of Science and Technology [EMR/2017/005450]; Council of Scientific and Industrial ResearchUniversity Grants Commission, Government of India; Indian Institute of Science Education and Research Mohali startup funds; Center of excellence in frontier areas of science and technology (Ministry of Human Resource Development) grant from Government of India [MHRD-14-0064]; SERB grant from Government of India [EMR/2017/005450]; Council of Scientific and Industrial Research-University Grants Commission, Government of India	Ministry of Human Resource Development; Science and Engineering Research Board, Department of Science and Technology; Council of Scientific and Industrial ResearchUniversity Grants Commission, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); Indian Institute of Science Education and Research Mohali startup funds; Center of excellence in frontier areas of science and technology (Ministry of Human Resource Development) grant from Government of India; SERB grant from Government of India; Council of Scientific and Industrial Research-University Grants Commission, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India)	This work was supported by MHRD-140064: Shashi Bhushan Pandit, Ministry of Human Resource Development, www.mhrd.gov.in; EMR/2017/005450: Shashi Bhushan Pandit, Science and Engineering Research Board, Department of Science and Technology, http://www.serb.gov.in/home.php.RV is supported by fellowship from the Council of Scientific and Industrial ResearchUniversity Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Indian Institute of Science Education and Research Mohali startup funds, and followings grants: Center of excellence in frontier areas of science and technology grant [MHRD-14-0064] (Ministry of Human Resource Development), and SERB grant [EMR/2017/005450] both from Government of India grants. RV is supported by fellowship from the Council of Scientific and Industrial Research-University Grants Commission, Government of India. We thank Dr. Nidhi for her help in editing the manuscript.	Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic G, 2001, Bioinformatics, V17 Suppl 1, pS83; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Arviv O, 2012, PROTEINS, V80, P2780, DOI 10.1002/prot.24161; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhaskara RM, 2013, J BIOMOL STRUCT DYN, V31, P1467, DOI 10.1080/07391102.2012.743438; Bhaskara RM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00040; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cui XF, 2015, BIOINFORMATICS, V31, P133, DOI 10.1093/bioinformatics/btv242; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Gao M, 2011, PROTEINS, V79, P1623, DOI 10.1002/prot.22987; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Gao M, 2010, BIOINFORMATICS, V26, P2259, DOI 10.1093/bioinformatics/btq404; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Han JH, 2006, STRUCTURE, V14, P935, DOI 10.1016/j.str.2006.01.016; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Kim WK, 2006, PLOS COMPUT BIOL, V2, P1151, DOI 10.1371/journal.pcbi.0020124; Kim WK, 2005, PROTEINS, V61, P1075, DOI 10.1002/prot.20693; Kolodny R, 2013, ANNU REV BIOPHYS, V42, P559, DOI 10.1146/annurev-biophys-083012-130432; Levy Y, 2017, BIOCHEMISTRY-US, V56, P5040, DOI 10.1021/acs.biochem.7b00666; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Littler SJ, 2005, J MOL BIOL, V345, P1265, DOI 10.1016/j.jmb.2004.11.011; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Lu H, 2003, BIOPHYS J, V84, P1895, DOI 10.1016/S0006-3495(03)74997-2; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Maheshwari S, 2015, J MOL RECOGNIT, V28, P35, DOI 10.1002/jmr.2410; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Valas RE, 2009, CURR OPIN STRUC BIOL, V19, P329, DOI 10.1016/j.sbi.2009.03.011; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wolff P, 2014, J MED CHEM, V57, P7565, DOI 10.1021/jm500467a; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220336	10.1371/journal.pone.0220336	http://dx.doi.org/10.1371/journal.pone.0220336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374091	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500011
J	Corrigan, AM; Karlsson, J; Wildenhain, J; Knerr, L; Olwegard-Halvarsson, M; Karlsson, M; Lunse, S; Wang, YH				Corrigan, Adam M.; Karlsson, Johan; Wildenhain, Jan; Knerr, Laurent; Olwegard-Halvarsson, Maria; Karlsson, Maria; Lunse, Svenja; Wang, Yinhai			IA-Lab: A MATLAB framework for efficient microscopy image analysis development, applied to quantifying intracellular transport of internalized peptide-drug conjugate	PLOS ONE			English	Article							SOFTWARE; DELIVERY; PLATFORM	This work presents a MATLAB-based software package for high-throughput microscopy image analysis development, making such development more accessible for a large user community. The toolbox provides a GUI and a number of analysis workflows, and can serve as a general framework designed to allow for easy extension. For a new application, only a minor part of the object-oriented code needs to be replaced by new components, making development efficient. This makes it possible to quickly develop solutions for analysis not available in existing tools. We show its use in making a tool for quantifying intracellular transport of internalized peptide-drug conjugates.	[Corrigan, Adam M.; Wildenhain, Jan; Wang, Yinhai] AstraZeneca, Discovery Sci R&D, Cambridge, England; [Karlsson, Johan; Lunse, Svenja] AstraZeneca, Discovery Sci R&D, Gothenburg, Sweden; [Knerr, Laurent; Olwegard-Halvarsson, Maria] AstraZeneca, Res & Early Dev Cardiovasc Renal & Metab BioPharm, Gothenburg, Sweden; [Karlsson, Maria] AstraZeneca, Res & Early Dev Resp Inflammat & Autoimmune BioPh, Gothenburg, Sweden; [Wildenhain, Jan] Syngenta, Jealotts Hill Res Ctr, Bracknell, Berks, England	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Syngenta	Corrigan, AM (corresponding author), AstraZeneca, Discovery Sci R&D, Cambridge, England.	adam.corrigan@astrazeneca.com	Wildenhain, Jan/E-5597-2011	Wildenhain, Jan/0000-0002-5461-3828; Corrigan, Adam/0000-0001-5142-6579	AstraZeneca	AstraZeneca(AstraZeneca)	All authors are or were employees of AstraZeneca. AstraZeneca provided the funding for this research and provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Du C-J, 2011, BIOMEDICAL IMAGING N; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Georgescu W, 2012, BIOINFORMATICS, V28, P138, DOI 10.1093/bioinformatics/btr633; Gilad Y, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4020011; Hodneland E, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-16; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Lelle M, 2015, MOL PHARMACEUT, V12, P4290, DOI 10.1021/acs.molpharmaceut.5b00487; Li HY, 2002, MED RES REV, V22, P225, DOI 10.1002/med.10008; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Majumdar S, 2012, MED RES REV, V32, P637, DOI 10.1002/med.20225; Ogier A, 2012, BIOINFORMATICS, V28, P1945, DOI 10.1093/bioinformatics/bts288; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Valeur E, 2017, ANGEW CHEM INT EDIT, V56, P10294, DOI 10.1002/anie.201611914; Wang Q, 2005, CELLTRACER SOFTWARE; Williams E, 2017, NAT METHODS, V14, P775, DOI [10.1038/NMETH.4326, 10.1038/nmeth.4326]	21	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220627	10.1371/journal.pone.0220627	http://dx.doi.org/10.1371/journal.pone.0220627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369634	gold, Green Submitted, Green Published			2022-12-26	WOS:000484987900069
J	van der Linden, M; Imoehl, M; Perniciaro, S				van der Linden, Mark; Imoehl, Matthias; Perniciaro, Stephanie			Limited indirect effects of an infant pneumococcal vaccination program in an aging population	PLOS ONE			English	Article							CONJUGATE VACCINE; POLYSACCHARIDE VACCINATION; ADULTS; DISEASE; 13-VALENT; CARRIAGE; HYPORESPONSIVENESS; GERMANY; OLDER	Background A general recommendation for adult pneumococcal vaccination with 23-valent polysaccharide vaccine (PPV23) for adults 60 and older has been in place in Germany since 1998, but uptake has been low. Just over a decade after the implementation of an infant pneumococcal conjugate vaccine recommendation, we examined indirect protection effects on adult invasive pneumococcal disease (IPD) in Germany. Methods and findings Reported IPD cases decreased in children under two years of age from 11.09 per 100,000 in 2003-2006 to 5.94 per 100,000 in 2017/18, while in adult age groups, reported IPD cases rose across the board, most dramatically in adults 60 years of age and over, from 1.64 to 10.08 cases per 100,000. PCV13-type IPD represents 31% of all cases in this age group, the lion's share of which is due to the rapid increase of serotype 3 IPD, which, by itself, has reached 2.11 reported cases per 100,000 and makes up 21% of all IPD cases in this age group. The two vaccine formulations currently in development (PCV15 and PCV20) would increase current (PCV13) coverage by 8.5% points and 28.0% points in children, while in adults coverage would increase by 10.4% points and 21.9% points, respectively. Conclusions While original models predicted that indirect effects of childhood vaccination would suffice for adults, it seems that the herd protection effect has reached its limit, with vaccine serotypes 4, 19F, and 19A IPD persisting in adults after initial reductions, and serotype 3 IPD not showing any herd protection effect at all.	[van der Linden, Mark; Imoehl, Matthias; Perniciaro, Stephanie] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	van der Linden, M (corresponding author), Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany.	mlinden@ukaachen.de	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313	Pfizer Pharma GmbH; Robert Koch Institute, Berlin, Germany	Pfizer Pharma GmbH(Pfizer); Robert Koch Institute, Berlin, Germany	Pneumococcal surveillance is funded in part by Pfizer Pharma GmbH and PneumoWeb is maintained and supported by the Robert Koch Institute, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Balsells E, 2018, J INFECTION, V77, P368, DOI 10.1016/j.jinf.2018.06.004; Betsch C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5787-9; Bewick T, 2012, THORAX, V67, P540, DOI 10.1136/thoraxjnl-2011-201092; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Choi EH, 2016, CLIN VACCINE IMMUNOL, V23, P162, DOI 10.1128/CVI.00591-15; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; de Celles MD, 2019, P NATL ACAD SCI USA, V116, P1802, DOI 10.1073/pnas.1812388116; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Djennad A, 2018, ECLINICALMEDICINE, V6, P42, DOI 10.1016/j.eclinm.2018.12.007; Domenech M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125636; Dominguez A, 2016, HUM VACC IMMUNOTHER, V12, P1891, DOI 10.1080/21645515.2016.1149661; Donkor ES, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00007; Falconer MA, 2013, HUM VACC IMMUNOTHER, V9, P1368, DOI 10.4161/hv.24695; Falkenhorst G, 2016, BUNDESGESUNDHEITSBLA, V59, P1623, DOI 10.1007/s00103-016-2466-9; Fedson DS, 2011, EXPERT REV VACCINES, V10, P1143, DOI [10.1586/ERV.11.99, 10.1586/erv.11.99]; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gladstone RA, 2015, VACCINE, V33, P2015, DOI 10.1016/j.vaccine.2015.03.012; Greenberg D, 2018, VACCINE, V36, P6883, DOI 10.1016/j.vaccine.2018.02.113; Hanquet G, 2019, THORAX, V74, P473, DOI 10.1136/thoraxjnl-2018-211767; Htar MTT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177985; Institute RK, 2016, EPIDEMIOL B, V36; Izurieta P, 2018, EXPERT REV VACCINES, V17, P479, DOI 10.1080/14760584.2018.1413354; Kobayashi M, 2015, MMWR-MORBID MORTAL W, V64, P944, DOI 10.15585/mmwr.mm6434a4; Koch-Institute R., 2014, EPID B, V34, P305; Kuhlmann A, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-4; Maruyama T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1004; McLaughlin JM, 2018, CLIN INFECT DIS, V67, P1498, DOI 10.1093/cid/ciy312; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Ojal J, 2017, VACCINE, V35, P4652, DOI 10.1016/j.vaccine.2017.05.088; Orsi A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071140; Pilishvili T, 2015, VACCINE, V33, pD60, DOI 10.1016/j.vaccine.2015.05.102; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P845, DOI 10.1007/s00103-013-1693-6; Poolman J, 2011, EXPERT REV VACCINES, V10, P307, DOI [10.1586/ERV.11.8, 10.1586/erv.11.8]; Prevention CfDCa, 2017, PNEUM DIS SURV REP; Reinert RR, 2005, CLIN MICROBIOL INFEC, V11, P985, DOI 10.1111/j.1469-0691.2005.01282.x; Robert Koch Institut, 2018, EPIDEMIOL B, P335; Robert Koch-Institut (RKI), 1998, EPID B, V15, P101; Salm F, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0432-z; Selva L, 2012, EUR J CLIN MICROBIOL, V31, P1487, DOI 10.1007/s10096-011-1468-7; Siber G, 2008, PNEUMOCOCCAL VACCINE; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Sings HL, 2019, CLIN INFECT DIS, V68, P2135, DOI 10.1093/cid/ciy920; Southern J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195799; Standige Impfkommission (STIKO), 2015, EPIDEMIOL B, P339; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; Van der Linden M, 2010, 7 INT S PNEUM PNEUM; van der Linden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161257; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van der Linden M, 2012, VACCINE, V30, P5880, DOI 10.1016/j.vaccine.2012.06.068; van Deursen AMM, 2018, CLIN INFECT DIS, V67, P42, DOI 10.1093/cid/ciy009; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiss S, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21057; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yang XQ, 2018, VACCINE, V36, P7574, DOI 10.1016/j.vaccine.2018.10.015	60	34	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220453	10.1371/journal.pone.0220453	http://dx.doi.org/10.1371/journal.pone.0220453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369597	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900051
J	Cho, NJ; Park, S; Islam, MI; Song, HY; Lee, EY; Gil, HW				Cho, Nam-Jun; Park, Samel; Islam, Md Imtiazul; Song, Ho-Yeon; Lee, Eun Young; Gil, Hyo-Wook			Long-term effect of medium cut-off dialyzer on middle uremic toxins and cell-free hemoglobin	PLOS ONE			English	Article							NITRIC-OXIDE BIOAVAILABILITY; HIGH-FLUX DIALYZERS; DIALYSIS PATIENTS; HEMODIALYSIS; MORTALITY; ASSOCIATION; REMOVAL; DISEASE	The medium cut-off (MCO) dialyzer has shown good clearance of large middle molecules, but its long-term effects are unclear. We investigated whether MCO hemodialysis (HD) over one year could reduce middle molecule levels and cell-free hemoglobin (CFH), without albumin loss. A prospective cohort study in 57 hemodialysis patients was conducted. The patients were assigned to the MCO dialyzer group or the high-flux dialyzer group, according to the HD machine they used. The reduction ratio (RR) and one-year changes in small and middle molecules and CFH were analyzed. Over a 12-month follow-up, MCO HD did not reduce the serum levels of middle molecules (lambda free light chain [FLC], from 135.7 +/- 39.9 to 132.0 +/- 39.1 mg/L; kappa FLC, from 168.2 +/- 58.5 to 167.7 +/- 65.8 mg/L; beta 2-microglobulin, from 25.6 +/- 9.6 to 28.4 +/- 4.8 mg/L) or albumin (from 3.96 +/- 0.31 to 3.94 +/- 0.37 g/dL). MCO HD provided excellent RR of lambda FLC (49.3 +/- 10.3%), kappa FLC (69.6 +/- 10.4%) and beta 2-microglobulin (80.9 +/- 7.3%), compared to high-flux HD. CFH was also removed well during an MCO HD session (RR of CPH, 85.5 [78.7-97.3] %), but long-term change was not significant (from 57.8 [46.2-79.1] to 62.0 [54.6-116.7] mg/L). The MCO dialyzer can be used effectively and safely in conventional HD settings, but long-term effects on large middle molecules and CFH were not significant. Further studies are needed to verify clinical benefits of the MCO dialyzer.	[Cho, Nam-Jun; Park, Samel; Lee, Eun Young; Gil, Hyo-Wook] Soonchunhyang Univ, Dept Internal Med, Cheonan Hosp, Cheonan, South Korea; [Islam, Md Imtiazul; Song, Ho-Yeon] Soonchunhyang Univ, Sch Med, Dept Microbiol & Immunol, Cheonan, South Korea	Soonchunhyang University; Soonchunhyang University	Gil, HW (corresponding author), Soonchunhyang Univ, Dept Internal Med, Cheonan Hosp, Cheonan, South Korea.	hwgil@schmc.ac.kr	ISLAM, MD IMTIAZUL/AAE-8426-2022	ISLAM, MD IMTIAZUL/0000-0002-0020-6733; Gil, Hyo-Wook/0000-0003-2550-2739; Lee, Eun Young/0000-0002-4513-9888	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C-2059-010017]; Soonchunhyang University Research Fund	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Soonchunhyang University Research Fund	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI17C-2059-010017) and Soonchunhyang University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; BERGSTROM J, 1987, LANCET, V1, P628; Boschetti-de-Fierro A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18448; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Cohen G, 1995, J AM SOC NEPHROL, V6, P1592; Desjardins L, 2013, TOXINS, V5, P2058, DOI 10.3390/toxins5112058; FAIRBANKS VF, 1992, CLIN CHEM, V38, P132; Garcia-Prieto A, 2018, CLIN KIDNEY J, V11, P742, DOI 10.1093/ckj/sfy004; Hulko M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16367; Kirsch AH, 2017, CONTRIB NEPHROL, V191, P158, DOI 10.1159/000479264; Kirsch AH, 2017, NEPHROL DIAL TRANSPL, V32, P165, DOI 10.1093/ndt/gfw310; Lamy T, 2014, BLOOD PURIFICAT, V37, P93, DOI 10.1159/000357968; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Meert N, 2011, NEPHROL DIAL TRANSPL, V26, P2624, DOI 10.1093/ndt/gfq803; Meyer C, 2010, J AM COLL CARDIOL, V55, P454, DOI 10.1016/j.jacc.2009.07.068; Polaschegg HD, 2009, SEMIN DIALYSIS, V22, P524, DOI 10.1111/j.1525-139X.2009.00616.x; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sakota R, 2015, ARTIF ORGANS, V39, P1015, DOI 10.1111/aor.12499; Shafi T, 2016, KIDNEY INT, V89, P1099, DOI 10.1016/j.kint.2015.10.011; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Vilar E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143813; Ward RA, 2006, KIDNEY INT, V69, P1431, DOI 10.1038/sj.ki.5000048; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; Zickler D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169024	27	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220448	10.1371/journal.pone.0220448	http://dx.doi.org/10.1371/journal.pone.0220448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348802	Green Submitted, Green Published, gold			2022-12-26	WOS:000484979500037
J	Liddy, C; Shoemaker, ES; Crowe, L; Boucher, LM; Rourke, SB; Rosenes, R; Bibeau, C; Kendall, CE				Liddy, Clare; Shoemaker, Esther S.; Crowe, Lois; Boucher, Lisa M.; Rourke, Sean B.; Rosenes, Ron; Bibeau, Christine; Kendall, Claire E.			How the delivery of HIV care in Canada aligns with the Chronic Care Model: A qualitative study	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; PATIENT-CENTERED CARE; PHYSICIAN SPECIALIZATION; MEDICINE ASSOCIATION; SELF-MANAGEMENT; CHRONIC ILLNESS; OF-CARE; ADOPTION; SPECIALTY; OUTCOMES	With the advent of continuous antiretroviral therapy, HIV has become a complex chronic, rather than acute, condition. The Chronic Care Model (CCM) provides an integrated approach to the delivery of care for people with chronic conditions that could therefore be applied to the delivery of care for people living with HIV. Our objective was to assess the alignment of HIV care settings with the CCM. We conducted a mixed methods study to explore structures, organization and care processes of Canadian HIV care settings. The quantitative results of phase one are published elsewhere. For phase two, we conducted semi-structured interviews with key informants from 12 HIV care settings across Canada. Irrespective of composition of the care setting or its location, HIV care in Canada is well aligned with several components of the CCM, most prominently in the areas of linkage to community resources and delivery system design with inter-professional team-based care. We propose the need for improvements in the availability of electronic clinical information systems and self-management support services to support better care delivery and health outcomes among people living with HIV in Canada.	[Liddy, Clare; Shoemaker, Esther S.; Crowe, Lois; Boucher, Lisa M.; Rosenes, Ron; Bibeau, Christine; Kendall, Claire E.] Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada; [Liddy, Clare; Shoemaker, Esther S.; Boucher, Lisa M.; Kendall, Claire E.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Shoemaker, Esther S.; Kendall, Claire E.] ICES, Toronto, ON, Canada; [Shoemaker, Esther S.; Kendall, Claire E.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Rourke, Sean B.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Rourke, Sean B.; Kendall, Claire E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada	University of Ottawa; University of Ottawa; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Kendall, CE (corresponding author), Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada.; Kendall, CE (corresponding author), Univ Ottawa, Dept Family Med, Ottawa, ON, Canada.; Kendall, CE (corresponding author), ICES, Toronto, ON, Canada.; Kendall, CE (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Kendall, CE (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	ckendall@uottawa.ca	Boucher, Lisa/GYV-4476-2022	Crowe, Lois/0000-0002-6487-5821; Liddy, Clare/0000-0003-0699-5494; Shoemaker, Esther/0000-0003-4552-4978; Kendall, Claire/0000-0003-2686-1135	Canadian Institutes of Health Research (CIHR) [FRN TT5-128270]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided through the Canadian Institutes of Health Research (CIHR) under Grant FRN TT5-128270. The authors affirm their independence from these funders. The funders played no part in the study design, collection, analysis, or interpretation of the data, in the writing of the report, or in the decision to submit the article for publication.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Backus LI, 2011, AIDS PATIENT CARE ST, V25, P203, DOI 10.1089/apc.2010.0379; Beane SN, 2014, J ASSOC NURSE AIDS C, V25, P191, DOI 10.1016/j.jana.2013.10.007; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Boyd CM, 2010, PUBLIC HLTH REV; Boyd CM, 2014, CURR OPIN HIV AIDS, V9, P419, DOI 10.1097/COH.0000000000000073; Bury John E, 2007, Proc (Bayl Univ Med Cent), V20, P118; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Cheng QJ, 2014, J AIDS CLIN RES, V5, DOI [10.1038/nature13478.The, DOI 10.1038/NATURE13478.THE]; Chu C, 2010, AIDS CARE, V22, P1522, DOI 10.1080/09540121.2010.484456; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; Deo S, 2009, MED CARE, V47, P1026, DOI 10.1097/MLR.0b013e31819a5937; Duffus WA, 2003, CLIN INFECT DIS, V36, P1577, DOI 10.1086/375070; ElZarrad MK, 2013, AM J PREV MED, V44, pS99, DOI 10.1016/j.amepre.2012.09.046; Fultz SL, 2005, CLIN INFECT DIS, V41, P738, DOI 10.1086/432621; Gallant JE, 2011, CLIN INFECT DIS, V53, P1043, DOI 10.1093/cid/cir689; Handford CD, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004348; Harris M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2102-x; Hutchinson J, 2016, INT J STD AIDS, V27, P617, DOI 10.1177/0956462415592801; Hutchison B, 2008, MILBANK Q, V86, P529, DOI [10.1111/j.1468-0009.2008.00538.x, DOI 10.1111/J.1468-0009.2008.00538.X]; Institute of Medicine, 2001, CROSS QUAL CHASM; Justice AC, 2007, TOP HIV MED, V14, P159; Justice AC, 2006, MED CARE, V44, pS52, DOI 10.1097/01.mlr.0000228003.08925.8c; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kendall CE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199395; Kendall Claire E, 2017, CMAJ Open, V5, pE673, DOI 10.9778/cmajo.20170038; Kendall CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-161; Kerr CA, 2012, AM J MED QUAL, V27, P321, DOI 10.1177/1062860611425714; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Landon BE, 2005, ARCH INTERN MED, V165, P1133, DOI 10.1001/archinte.165.10.1133; Landon BE, 2003, J GEN INTERN MED, V18, P233, DOI 10.1046/j.1525-1497.2003.20705.x; Mangili A, 2007, CLIN INFECT DIS, V44, P1368, DOI 10.1086/516616; Marceau L, 2011, J EVAL CLIN PRACT, V17, P1122, DOI 10.1111/j.1365-2753.2010.01489.x; Masindi KI, 2018, J IMMIGR MINOR HEALT, V20, P536, DOI 10.1007/s10903-017-0681-6; Pasricha A, 2013, J GEN INTERN MED, V28, P127, DOI 10.1007/s11606-012-2145-y; QSR International Pty Ltd, 2013, NVIVO QUAL DAT AN SO; Rackal JM, 2011, COCHRANE DATABASE SY, V15; Reinhold JP, 2005, AM J GASTROENTEROL, V100, P1805, DOI 10.1111/j.1572-0241.2005.50038.x; Ritchie J., 2013, QUALITATIVE RES PRAC; Robinson JH, 2008, J AM ACAD NURSE PRAC, V20, P600, DOI 10.1111/j.1745-7599.2008.00360.x; Rundall TG, 2002, BMJ-BRIT MED J, V325, P958, DOI 10.1136/bmj.325.7370.958; Sheth AN, 2006, AIDS PATIENT CARE ST, V20, P318, DOI 10.1089/apc.2006.20.318; Smith S, 1996, BRIT MED J, V312, P416, DOI 10.1136/bmj.312.7028.416; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Tu D, 2013, CAN FAM PHYSICIAN, V59, P650; Valentijn PP, 2013, INT J INTEGR CARE, V13; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Willig JH, 2008, CLIN INFECT DIS, V46, P1315, DOI 10.1086/533466; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; Wilson IB, 2005, MED CARE, V43, P12	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220516	10.1371/journal.pone.0220516	http://dx.doi.org/10.1371/journal.pone.0220516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WC	31348801	Green Submitted, Green Published, gold			2022-12-26	WOS:000484979500040
J	Vogt, J; Sheinson, D; Katavolos, P; Irimagawa, H; Tseng, M; Alatsis, KR; Proctor, WR				Vogt, Jennifer; Sheinson, Daniel; Katavolos, Paula; Irimagawa, Hiroko; Tseng, Min; Alatsis, Kathila R.; Proctor, William R.			Variance component analysis of circulating miR-122 in serum from healthy human volunteers	PLOS ONE			English	Article							INDUCED LIVER-INJURY; EMERGING BIOMARKERS; STATISTICS NOTES; MICRORNAS; EXPRESSION; INFLAMMATION; TRANSLATION; METABOLISM; MARKERS; AMINOTRANSFERASE	Micro-RNA (miR)-122 is a promising exploratory biomarker for detecting liver injury in preclinical and clinical studies. Elevations in serum or plasma have been associated with viral and autoimmune hepatitis, non-alcoholic steatohepatitis (NASH), hepatocellular carcinoma, and drug-induced liver injury (DILI). However, these associations were primarily based upon population differences between the disease state and the controls. Thus, little is known about the variability and subsequent variance components of circulating miR-122 in healthy humans, which has implications for the practical use of the biomarker clinically. To address this, we set out to perform variance components analysis of miR-122 in a cohort of 40 healthy volunteers. Employing a quantitative real-time polymerase chain reaction (qRT-PCR) assay to detect miR-122 and other circulating miRNAs in human serum, the relative expression of miR-122 was determined using two different normalization approaches: to the mean expression of a panel of several endogenous miRNAs identified using an adaptive algorithm (miRA-Norm) and to the expression of an exogenous miRNA control (Caenorhabditis elegans miR-39). Results from a longitudinal study in healthy volunteers (N = 40) demonstrated high variability with 117- and 111-fold 95% confidence reference interval, respectively. This high variability of miR-122 in serum appeared to be due in part to ethnicity, as 95% confidence reference intervals were approximately three-fold lower in volunteers that identified as Caucasian relative to those that identified as Non-Caucasian. Variance analysis revealed equivalent contributions of intra- and inter-donor variability to miR-122. Surprisingly, miR-122 exhibited the highest variability compared to other 36 abundant miRNAs in circulation; the next variable miRNA, miR-133a, demonstrated a 45- to 62-fold reference interval depending on normalization approaches. In contrast, alanine aminotransferase (ALT) activity levels in this population exhibited a 5-fold total variance, with 80% of this variance due to inter-donor sources. In conclusion, miR-122 demonstrated higher than expected variability in serum from healthy volunteers, which has implications for its potential utility as a prospective biomarker of liver damage or injury.	[Vogt, Jennifer; Katavolos, Paula; Irimagawa, Hiroko; Tseng, Min; Alatsis, Kathila R.; Proctor, William R.] Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA; [Sheinson, Daniel] Genentech Inc, Nonclin Biostat, San Francisco, CA 94080 USA; [Sheinson, Daniel] Genentech Inc, US Med Affairs, San Francisco, CA 94080 USA; [Irimagawa, Hiroko] Theravance, Dept Pharmacol, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Theravance	Proctor, WR (corresponding author), Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA.	proctorw@gene.com		Katavolos, Paula/0000-0001-7923-5328	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Funding for this study was provided by Genentech, Inc., a member of the Roche Group. All authors listed on this manuscript were employees of Genentech during the planning, experimentation, and writing phases of this manuscript. Hiroko Irimagawa is now a current employee of Theravance Biopharma. Theravance did not provide funding in any manner to this project/manuscript in regards to salaries, reagents, facilities, or other means during the preparation, data generation, or writing of this manuscript. The funding organization (e.g. Genentech, Inc.) provided support in the form of salaries, instrumentation, facilities, supplies, and other components of operations associated with this manuscript. Genentech, Inc., did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Arrese M, 2015, SEMIN LIVER DIS, V35, P43, DOI 10.1055/s-0034-1397348; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Church RJ, 2019, HEPATOLOGY, V69, P760, DOI 10.1002/hep.29802; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Ding XF, 2012, MOL MED REP, V5, P1428, DOI 10.3892/mmr.2012.838; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Hayes CN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030280; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hornby RJ, 2014, EXPERT REV CLIN PHAR, V7, P349, DOI 10.1586/17512433.2014.904201; Iorio MV, 2010, BBA-GENE REGUL MECH, V1799, P694, DOI 10.1016/j.bbagrm.2010.05.005; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Laudadio I, 2012, GASTROENTEROLOGY, V142, P119, DOI 10.1053/j.gastro.2011.09.001; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li Yu, 2012, Genomics Proteomics & Bioinformatics, V10, P246, DOI 10.1016/j.gpb.2012.07.005; Loosen SH, 2017, WORLD J HEPATOL, V9, P586, DOI 10.4254/wjh.v9.i12.586; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McDermott AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083718; Mehta N, 2013, J MOL BIOL, V425, P3609, DOI 10.1016/j.jmb.2012.10.022; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; RCore Team, 2020, R LANG ENV STAT COMP; Ricos C, 2010, BIOL VARIATION DATAB; Roderburg C, 2014, J HEPATOL, V61, P1434, DOI 10.1016/j.jhep.2014.07.017; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Schomaker S, 2013, TOXICOL SCI, V132, P276, DOI 10.1093/toxsci/kft009; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Stukrath I, 2015, ONCOTARGET, V6, P13387; Tarrant J, 2013, VET CLIN PATH, V42, P535, DOI 10.1111/vcp.12082; Thulin P, 2014, LIVER INT, V34, P367, DOI 10.1111/liv.12322; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Vliegenthart ADB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15501; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang X, 2015, MOL BIOSYST, V11, P1235, DOI 10.1039/c4mb00711e; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Wei SN, 2016, EUR J PHARMACOL, V791, P254, DOI 10.1016/j.ejphar.2016.08.038; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6; Zhu HQ, 2016, J CANCER RES CLIN, V142, P969, DOI 10.1007/s00432-016-2121-8	62	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220406	10.1371/journal.pone.0220406	http://dx.doi.org/10.1371/journal.pone.0220406			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348817	Green Submitted, Green Published, gold			2022-12-26	WOS:000484979500034
J	Li, R; Ma, SQ; Zang, CC; Zhang, WY; Liu, ZH; Sun, YC; Feng, YY				Li, Rui; Ma, Shi Qing; Zang, Cheng Cheng; Zhang, Wen Yi; Liu, Zi Hao; Sun, Ying Chun; Feng, Yi Yu			Enhanced bonding strength between lithium disilicate ceramics and resin cement by multiple surface treatments after thermal cycling	PLOS ONE			English	Article							MARGINAL ADAPTATION; MICROLEAKAGE; DURABILITY; INTERFACE; ADHESIVE; CROWNS; PRIMER	All-ceramic restoration has become a popular technology for dental restoration; however, the relative bond strength between the ceramic and resin limits its further application. Long-term high bond strength, especially after thermal cycling, is of great importance for effective restoration. The effect of physical and/or chemical surface treatments on bonding durability is seldom reported. To overcome this problem, we investigate the bond strength between lithium disilicate ceramics (LDC) and two kinds of resin cements before and after thermal cycling for a variety of surface treatments including hydrofluoric acid, two kinds of silane and a combined effect. The shear bond strength in every group is characterized by universal mechanical testing machine averaged by sixteen-time measurements. The results show that when treated with HF and a mixed silane, the LDC surface shows maximum bonding strengths of 27.1 MPa and 23.3 MPa with two different resin cements after 5000 thermal cycling, respectively, indicating an excellent ability to resist the damage induced by cyclic expansion and contraction. This long-term high bond strength is attributed to the combined effect of micromechanical interlocking (physical bonding) and the formation of Si-O-Si and -C-C-at the interface (chemical bonding). This result offers great potential for enhancing bond strength for all-ceramic restoration by optimizing the surface treatment.	[Li, Rui; Ma, Shi Qing; Zang, Cheng Cheng; Zhang, Wen Yi; Liu, Zi Hao; Sun, Ying Chun] Tianjin Med Univ, Stomatol Hosp, Dept Prosthodont, Tianjin, Peoples R China; [Feng, Yi Yu] Tianjin Univ, Sch Mat Sci & Engn, Tianjin, Peoples R China	Tianjin Medical University; Tianjin University	Li, R (corresponding author), Tianjin Med Univ, Stomatol Hosp, Dept Prosthodont, Tianjin, Peoples R China.	kqxiufulirui@tijmu.edu.cn			Natural Science Foundation of Tianjin, China [18JCYBJC95500]	Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin)	This study was supported by an award from the Natural Science Foundation of Tianjin, China (18JCYBJC95500) to RL.	Akin H, 2011, PHOTOMED LASER SURG, V29, P797, DOI 10.1089/pho.2011.3039; Albert FE, 2004, INT J PROSTHODONT, V17, P529; Ariaans K, 2016, J CLIN PERIODONTOL, V43, P173, DOI 10.1111/jcpe.12500; Borges GA, 2003, J PROSTHET DENT, V89, P479, DOI 10.1016/S0022-3913(02)52704-9; Bruzi G., 2017, APPL ADHESION SCI, V5, P17, DOI [10.1186/s40563-017-0096-6, DOI 10.1186/S40563-017-0096-6]; Conejo J., 2017, CURRENT ORAL HLTH RE, V4, P112, DOI [10.1007/s40496-017-0132-4, DOI 10.1007/S40496-017-0132-4]; Cui BC, 2017, J DENT, V62, P91, DOI 10.1016/j.jdent.2017.05.009; de Souza G, 2014, J PROSTHET DENT, V112, P895, DOI 10.1016/j.prosdent.2014.01.016; el-Mowafy O, 2001, J Can Dent Assoc, V67, P97; Gamel Rasha Eid, 2017, International Journal of Botany, V13, P1, DOI 10.3923/ijb.2017.1.14; GORODOVSKY S, 1992, J PROSTHET DENT, V68, P269, DOI 10.1016/0022-3913(92)90328-8; Gresnigt MMM, 2016, DENT MATER, V32, P607, DOI 10.1016/j.dental.2016.01.004; Guarda GB, 2013, OPER DENT, V38, P208, DOI 10.2341/11-076-L; Heintze SD, 2008, DENT MATER, V24, P1352, DOI 10.1016/j.dental.2008.02.019; Jensen M E, 1989, Compendium, V10, P336; Kang Suk-Ho, 2013, Restor Dent Endod, V38, P134, DOI 10.5395/rde.2013.38.3.134; Li R, 2015, MATER RES INNOV, V19, P1280, DOI 10.1179/1432891714Z.0000000001294; Li R, 2010, J ORAL REHABIL, V37, P560, DOI 10.1111/j.1365-2842.2010.02060.x; Li R, 2014, BIO-MED MATER ENG, V24, P2117, DOI 10.3233/BME-141022; Li RX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130081; Ozturk E, 2013, J DENT, V41, P97, DOI 10.1016/j.jdent.2012.04.005; Peutzfeldt A, 2011, OPER DENT, V36, P266, DOI 10.2341/10-236-L; Piwowarczyk A, 2004, J PROSTHET DENT, V92, P265, DOI 10.1016/j.prosdent.2004.06.027; Rosentritt M, 2004, DENT MATER, V20, P463, DOI 10.1016/j.dental.2003.05.004; Soares Carlos Jose, 2005, J Esthet Restor Dent, V17, P224, DOI 10.1111/j.1708-8240.2005.tb00119.x; SORENSEN JA, 1991, DENT MATER, V7, P118, DOI 10.1016/0109-5641(91)90057-6; Tunc EP, 2017, J ADHES SCI TECHNOL, V31, P1142, DOI 10.1080/01694243.2016.1247615; Uwalaka CO, 2018, DENT MATER, V34, P1566, DOI 10.1016/j.dental.2018.07.001; Moro AFV, 2017, J PROSTHET DENT, V118, P666, DOI 10.1016/j.prosdent.2016.12.021; Vicente M, 2016, LASER SURG MED, V48, P36, DOI 10.1002/lsm.22442; Yang YW, 2016, J DENT, V51, P56, DOI 10.1016/j.jdent.2016.05.013	31	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220466	10.1371/journal.pone.0220466	http://dx.doi.org/10.1371/journal.pone.0220466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344094	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900102
J	Wang, B; Zhang, L; Zhang, GY				Wang, Bin; Zhang, Lei; Zhang, Guoyin			A fine granularity based user collaboration algorithm for location privacy protection	PLOS ONE			English	Article								As the location trajectory contains more spatial-temporal information about the user, it will be even dangerous for jeopardizing the privacy of the user. In order to cope with the correlation, an algorithm that utilizes the query division had been proposed. In this algorithm, random blocks of query context was used, so as the adversary was obfuscated and difficult to correlate the real result. However, this algorithm fails to dispose the size of each query block, as once same size blocks were obtained by the adversary continuously, so the adversary can regard them as blocks from the same query context, and then obtains the query context to correlate the discrete locations. In view of above conditions, in this paper we propose a fine granularity block division algorithm based on the conception of granularity measurement as well as granularity layer division, so with the help of collaborative users the location privacy of the user will be protected. In this algorithm, the query context will be divided into fine granularity size of information blocks that difficult to be distinguished with others, and then these blocks will be exchanged with other collaborative users to eliminate the difference in block size. In addition, as each block is divided into fine granularity size, the adversary will be difficult to correlate the discrete locations into location trajectory, so the location privacy will be protected. At last, through security analysis and experimental verification, this granularity indistinguishable algorithm is analyzed and verified at both theoretical and practical levels, which further demonstrate the superiority of the proposed algorithm compared with other similar algorithms.	[Wang, Bin; Zhang, Lei; Zhang, Guoyin] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Wang, Bin; Zhang, Lei] Jiamusi Univ, Coll Informat Sci & Elect Technol, Jiamusi, Peoples R China	Harbin Engineering University; Jiamusi University	Zhang, L (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.; Zhang, L (corresponding author), Jiamusi Univ, Coll Informat Sci & Elect Technol, Jiamusi, Peoples R China.	8213662@163.com	张, 磊/H-5881-2018	张, 磊/0000-0001-5532-8423	University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2017149]; Basic scientific research service fee project of Heilongjiang provincial undergraduate universities [2018-KYYWF-0937]; Natural Science Fund of Heilongjiang Province for Outstanding Youth [YQ2019F018]; Special Doctor Scientific Research Fund Launch Project of Jiamusi University (Research on Privacy Protection of User Collaboration in Location Services)	University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province; Basic scientific research service fee project of Heilongjiang provincial undergraduate universities; Natural Science Fund of Heilongjiang Province for Outstanding Youth; Special Doctor Scientific Research Fund Launch Project of Jiamusi University (Research on Privacy Protection of User Collaboration in Location Services)	This work was supported by University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (project number: UNPYSCT-2017149); Basic scientific research service fee project of Heilongjiang provincial undergraduate universities (2018-KYYWF-0937); the Natural Science Fund of Heilongjiang Province for Outstanding Youth (YQ2019F018); and the Special Doctor Scientific Research Fund Launch Project of Jiamusi University (Research on Privacy Protection of User Collaboration in Location Services). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dargahi T, 2016, COMPUT COMMUN, V85, P1, DOI 10.1016/j.comcom.2016.03.002; Hwang RH, 2014, IEEE T SERV COMPUT, V7, P126, DOI 10.1109/TSC.2013.55; Lei Z, 2017, J HARBIN ENG U, V7, P1173; Li Z, 2017, 43RD EUROPEAN CONFERENCE ON OPTICAL COMMUNICATION (ECOC 2017), DOI 10.1109/TCC.2017.2764082; Li Z, WIRELESS COMMUNICATI; Li Z, 2017, IEEE TRANS BIG DATA, P1; Ma CG, 2017, J CIRCUIT SYST COMP, V26, DOI 10.1142/S0218126617501195; Ma CG, 2016, CHINA COMMUN, V13, P106, DOI 10.1109/CC.2016.7781722; Niu B, 2015, FUTURE GENER COMP SY, V49, P125, DOI 10.1016/j.future.2014.10.026; Peng T, 2017, INFORM SCIENCES, V387, P165, DOI 10.1016/j.ins.2016.08.010; Rebollo-Monedero D, 2012, IEEE T DEPEND SECURE, V9, P641, DOI 10.1109/TDSC.2012.16; Sepahkar M, 2018, WIREL NETW, V24, P283, DOI 10.1007/s11276-016-1304-1; Shokri R, 2014, IEEE T DEPEND SECURE, V11, P266, DOI 10.1109/TDSC.2013.57; Shu JG, 2021, IEEE T SERV COMPUT, V14, P235, DOI 10.1109/TSC.2018.2791601; Sun G, 2017, FUTURE GENER COMP SY, V74, P375, DOI 10.1016/j.future.2016.08.023; Vergara-Laurens IJ, 2017, IEEE INTERNET THINGS, V4, P855, DOI 10.1109/JIOT.2016.2594205; Wang Guo-Yin, 2011, Journal of Software, V22, P676, DOI 10.3724/SP.J.1001.2011.03954; Wang H, 2018, WORLD WIDE WEB, V21, P1, DOI 10.1007/s11280-017-0490-9; [徐计 Xu Ji], 2015, [计算机学报, Chinese Journal of Computers], V38, P1497; Zeberga K, 2017, J CIRCUIT SYST COMP, V26, DOI 10.1142/S0218126617500712; Zhang L, 2018, TEH VJESN, V25, P962, DOI 10.17559/TV-20160304070312; Zhang L, 2018, J CIRCUIT SYST COMP, V27, DOI 10.1142/S0218126618501797; Zhang LC, 2016, IEEE T NETW SERV MAN, V13, P335, DOI 10.1109/TNSM.2016.2559448; Zhu Haitao, 2016, 2016 IEEE 22 INT C P	24	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220278	10.1371/journal.pone.0220278	http://dx.doi.org/10.1371/journal.pone.0220278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344097	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900076
J	Gao, JQ; Perera, G; Bhadbhade, M; Halliday, GM; Dzamko, N				Gao, Jianqun; Perera, Gayathri; Bhadbhade, Megha; Halliday, Glenda M.; Dzamko, Nicolas			Autophagy activation promotes clearance of ?-synuclein inclusions in fibril-seeded human neural cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); ?-synuclein (?-synuclein); p62 (sequestosome 1 (SQSTM1)); Parkinson disease; neuron; neurodegeneration; autophagy; protein degradation; Lewy bodies; protein fibril	CHAPERONE-MEDIATED AUTOPHAGY; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; LEWY BODIES; PATHOLOGY; MACROAUTOPHAGY; TRANSMISSION; DEGRADATION; NEURONS; DYSFUNCTION	There is much interest in delineating the mechanisms by which the ?-synuclein protein accumulates in brains of individuals with Parkinson's disease (PD). Preclinical studies with rodent and primate models have indicated that fibrillar forms of ?-synuclein can initiate the propagation of endogenous ?-synuclein pathology. However, the underlying mechanisms by which ?-synuclein fibrils seed pathology remain unclear. To investigate this further, we have used exogenous fibrillar ?-synuclein to seed endogenous ?-synuclein pathology in human neuronal cell lines, including primary human neurons differentiated from induced pluripotent stem cells. Fluorescence microscopy and immunoblot analyses were used to monitor levels of ?-synuclein and key autophagy/lysosomal proteins over time in the exogenous ?-synuclein fibril-treated neurons. We observed that temporal changes in the accumulation of cytoplasmic ?-synuclein inclusions were associated with changes in the key autophagy/lysosomal markers. Of note, chloroquine-mediated blockade of autophagy increased accumulation of ?-synuclein inclusions, and rapamycin-induced activation of autophagy, or use of 5?-AMP?activated protein kinase (AMPK) agonists, promoted the clearance of fibril-mediated ?-synuclein pathology. These results suggest a key role for autophagy in clearing fibrillar ?-synuclein pathologies in human neuronal cells. We propose that our findings may help inform the development of human neural cell models for screening of potential therapeutic compounds for PD or for providing insight into the mechanisms of ?-synuclein propagation. Our results further add to existing evidence that AMPK activation may be a therapeutic option for managing PD.	[Gao, Jianqun; Perera, Gayathri; Halliday, Glenda M.; Dzamko, Nicolas] Univ Sydney, Fac Med & Hlth, Brain & Mind Ctr, ForeFront Dementia & Movement Disorders Lab,Cent, Camperdown, NSW 2050, Australia; [Gao, Jianqun; Bhadbhade, Megha; Halliday, Glenda M.; Dzamko, Nicolas] Univ New South Wales, Fac Med, Sch Med Sci, Kensington, NSW 2033, Australia; [Gao, Jianqun; Halliday, Glenda M.; Dzamko, Nicolas] Neurosci Res Australia, Randwick, NSW 2031, Australia	University of Sydney; University of New South Wales Sydney; Neuroscience Research Australia	Dzamko, N (corresponding author), Univ Sydney, Brain & Mind Ctr, Camperdown, NSW 2050, Australia.	nicolas.dzamko@sydney.edu.au	Dzamko, Nicolas/AAD-6922-2019; Halliday, Glenda M/E-8555-2011	Halliday, Glenda M/0000-0003-0422-8398; Gao, Jianqun/0000-0003-3695-4386; Dzamko, Nicolas/0000-0002-9121-0294	National Health and Medical Research Council (NHMRC) of Australia [1103757]; NHMRC [1037746, 1095127]; Forefront	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Forefront	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Grant 1103757. The Dementia and Movement Disorders Laboratory is supported by Forefront, a collaborative research group dedicated to the study of non-Alzheimer disease degenerative disorders, funded by NHMRC Program Grants 1037746 and 1095127. The authors declare that they have no conflicts of interest with the contents of this article.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Bobela W, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0220-x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Campbell P, 2018, EXPERT OPIN THER TAR, V22, P823, DOI 10.1080/14728222.2018.1517156; Cerri S, 2019, CURR MED CHEM, V26, P3702, DOI 10.2174/0929867325666180226094351; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Curry DW, 2018, J PARKINSON DIS, V8, P161, DOI 10.3233/JPD-171296; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dulovic M, 2014, NEUROBIOL DIS, V63, P1, DOI 10.1016/j.nbd.2013.11.002; Dzamko N, 2017, ACTA NEUROPATHOL, V133, P303, DOI 10.1007/s00401-016-1648-8; Flavin WP, 2017, ACTA NEUROPATHOL, V134, P629, DOI 10.1007/s00401-017-1722-x; Fussi N, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0816-2; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Grassi D, 2018, P NATL ACAD SCI USA, V115, pE2634, DOI 10.1073/pnas.1713849115; Halliday G, 2008, ACTA NEUROPATHOL, V115, P409, DOI 10.1007/s00401-008-0344-8; Jiang PZ, 2013, NEUROBIOL AGING, V34, P1504, DOI 10.1016/j.neurobiolaging.2012.11.001; Kang SS, 2017, P NATL ACAD SCI USA, V114, P1183, DOI 10.1073/pnas.1618627114; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.45; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luna E, 2018, ACTA NEUROPATHOL, V135, P855, DOI 10.1007/s00401-018-1829-8; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manecka DL, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00311; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Masaracchia C, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0578-1; Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113; Minakaki G, 2018, AUTOPHAGY, V14, P98, DOI 10.1080/15548627.2017.1395992; Murphy KE, 2015, MOVEMENT DISORD, V30, P1639, DOI 10.1002/mds.26141; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Polinski NK, 2018, J PARKINSON DIS, V8, P303, DOI 10.3233/JPD-171248; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rodriguez L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00344; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scrivo A, 2018, LANCET NEUROL, V17, P802, DOI 10.1016/S1474-4422(18)30238-2; Steiner JA, 2018, CELL TISSUE RES, V373, P161, DOI 10.1007/s00441-018-2814-1; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Tarutani A, 2016, J BIOL CHEM, V291, P18675, DOI 10.1074/jbc.M116.734707; Thakur P, 2017, P NATL ACAD SCI USA, V114, pE8284, DOI 10.1073/pnas.1710442114; Urrea L, 2018, MOL NEUROBIOL, V55, P1847, DOI 10.1007/s12035-017-0451-4; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volpicelli-Daley LA, 2014, MOL BIOL CELL, V25, P4010, DOI 10.1091/mbc.E14-02-0741; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Zhang M, 2018, AGING DIS, V9, P273, DOI 10.14336/AD.2017.0517; Zhao Y, 2018, NEUROBIOL DIS, V120, P76, DOI 10.1016/j.nbd.2018.09.003	56	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14241	14256		10.1074/jbc.RA119.008733	http://dx.doi.org/10.1074/jbc.RA119.008733			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31375560	hybrid, Green Published			2022-12-26	WOS:000499248200008
J	Mao, GG; Smyth, SS; Morris, AJ				Mao, Guogen; Smyth, Susan S.; Morris, Andrew J.			Regulation of PLPP3 gene expression by NF-kappa B family transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycerosphingolipid; lysophospholipid; glycerophospholipid; phosphatase; transcription promoter	PHOSPHATASE LPP3; PHOSPHOLIPASE-D; 1-PHOSPHATE; ACTIVATION; RECEPTORS; RESPONSES; PLAYERS; GROWTH; PPAP2B; CELLS	Lipid phosphate phosphatase 3 (LPP3), encoded by the PLPP3 gene, is an integral membrane enzyme that dephosphorylates phosphate esters of glycero- and sphingophospholipids. Cell surface LPP3 can terminate the signaling actions of bioactive lysophosphatidic acid (LPA) and sphingosine 1 phosphate, which likely explains its role in developmental angiogenesis, vascular injury responses, and cell migration. Heritable variants in the final intron PLPP3 associate with interindividual variability in coronary artery disease risk that may result from disruption of enhancer sequences that normally act in cis to increase expression of the gene. However, the mechanisms regulating PLPP3 expression are not well understood. We show that the human PLPP3 promoter contains three functional NF-kappa B response elements. All of these are required for maximal induction of PLPP3 promoter activity in reporter assays. The identified sequences recruit RelA and RelB components of the NF-kappa B transcription complex to chromatin, and these transcription factors bind to the identified target sequences in two different cell types. LPA promotes binding of Rel family transcription factors to the PLPP3 promoter and increases PLPP3 gene expression through mechanisms that are attenuated by an NF-kappa B inhibitor, LPA receptor antagonists, and inhibitors of phosphoinositide 3 kinase. These findings indicate that up-regulation of PLPP3 during inflammation and atherosclerosis results from canonical activation of the NF-kappa B signaling cascade to increase PLPP3 expression through nuclear import and binding of RelA and RelB transcription factors to the PLPP3 promoter and suggest a mechanism by which the LPP3 substrate, LPA, can regulate PLPP3 expression.	[Mao, Guogen; Smyth, Susan S.; Morris, Andrew J.] Univ Kentucky, Coll Med, Div Cardiovasc Med, Gill Heart & Vasc Inst, Lexington, KY 40536 USA; [Mao, Guogen; Smyth, Susan S.; Morris, Andrew J.] Lexington Vet Affairs Med Ctr, Lexington, KY 40536 USA	University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Morris, AJ (corresponding author), Univ Kentucky, Coll Med, Div Cardiovasc Med, Gill Heart & Vasc Inst, Lexington, KY 40536 USA.	a.j.morris@uky.edu			NHLBI, National Institutes of Health [R01 HL120507]; Veterans Health Administration [I01CX001550, 1I01BX002769]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120507] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002769, I01CX001550, I01BX001984] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Health Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from NHLBI, National Institutes of Health Grant R01 HL120507 and Veterans Health Administration Grants I01CX001550 and 1I01BX002769 (to A. J. M. and S. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcantara-Hernandez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140583; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Busnelli M, 2018, ATHEROSCLEROSIS, V271, P156, DOI 10.1016/j.atherosclerosis.2018.02.025; Busnelli M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44503; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cheng HY, 2012, ARTERIOSCL THROM VAS, V32, P24, DOI 10.1161/ATVBAHA.111.234708; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Diehl AG, 2016, TRENDS GENET, V32, P238, DOI 10.1016/j.tig.2016.02.002; Erbilgin A, 2013, J LIPID RES, V54, P1894, DOI 10.1194/jlr.M037085; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Espin-Palazon R, 2016, EXP HEMATOL, V44, P519, DOI 10.1016/j.exphem.2016.03.010; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hisano Y, 2019, PHARMACOL THERAPEUT, V193, P91, DOI 10.1016/j.pharmthera.2018.07.006; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD116, DOI 10.1093/nar/gkl1011; Li SJ, 2019, NUCLEIC ACIDS RES, V47, pW206, DOI 10.1093/nar/gkz332; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Panchatcharam M, 2014, ARTERIOSCL THROM VAS, V34, P837, DOI 10.1161/ATVBAHA.113.302335; Panchatcharam M, 2013, ARTERIOSCL THROM VAS, V33, P52, DOI 10.1161/ATVBAHA.112.300527; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Pilquil C, 2001, BIOCHEM SOC T, V29, P825; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Ren H, 2013, BBA-MOL CELL BIOL L, V1831, P126, DOI 10.1016/j.bbalip.2012.07.012; Reschen ME, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005061; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sciorra VA, 1999, MOL BIOL CELL, V10, P3863, DOI 10.1091/mbc.10.11.3863; Sciorra VA, 2002, J CELL BIOL, V159, P1039, DOI 10.1083/jcb.200205056; Selim S, 2011, CLIN SCI, V121, P565, DOI 10.1042/CS20110236; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Tang XY, 2015, J LIPID RES, V56, P2048, DOI 10.1194/jlr.R058362; Tanyi JL, 2003, CANCER RES, V63, P1073; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; Wu CQ, 2015, CIRC RES, V117, pE41, DOI 10.1161/CIRCRESAHA.117.306457; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458	39	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14009	14019		10.1074/jbc.RA119.009002	http://dx.doi.org/10.1074/jbc.RA119.009002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31362988	hybrid, Green Published			2022-12-26	WOS:000490729800015
J	Dal Bom, JP; Mazzucchetti, L; Malta, MB; Ladeia-Andrade, S; de Castro, MC; Cardoso, MA; Lourenco, BH; Manitto, AM; Abanto, J; Gimeno, SGA; Damasceno, AA; da Silva, BP; de Souza, RM				Dal Bom, Juliana Paghi; Mazzucchetti, Lalucha; Malta, Maira Barreto; Ladeia-Andrade, Simone; de Castro, Marcia Caldas; Cardoso, Marly Augusto; Lourenco, Barbara Hatzlhoffer; Manitto, Alicia Matijasevich; Abanto, Jenny; Agostinho Gimeno, Suely Godoy; Damasceno, Ana Alice; da Silva, Bruno Pereira; de Souza, Rodrigo Medeiros		MINA-Brazil Study Working Grp	Early determinants of linear growth and weight attained in the first year of life in a malaria endemic region	PLOS ONE			English	Article							BODY-MASS INDEX; CASH TRANSFER PROGRAM; CHILD UNDERNUTRITION; HEALTH; OVERWEIGHT; INCOME; AGE	We investigated linear growth and weight attained among 772 children at 10-15 months of age in the first population-based birth cohort in the Brazilian Amazon. Sociodemographic, maternal and birth characteristics were collected in interviews soon after birth at baseline. Anthropometric evaluation was conducted at 10-15 months. Multiple linear regression models were fitted for length-for-age (LAZ) and body mass index (BMI)-for-age Z scores (BAZ), considering a hierarchical conceptual framework with determinants at distal, intermediate and proximal levels, with adjustment for the child's sex and age. Mean LAZ and BAZ were 0.31 (SD: 1.13) and 0.35 (SD: 1.06), respectively. Overall, 2.2% of children were stunted and 6.6% overweight. Among socioeconomic factors, household wealth index was positively associated with LAZ (p for trend = 0.01), while children whose families received assistance from the Bolsa Familia conditional cash transfer program were 0.16 Z score thinner (95% CI: -0.31, -0.00). Maternal height and BMI were positively associated with both LAZ and BAZ at 10-15 months of age (p for trend <0.001). Child's size at birth was positively related with LAZ (p< 0.001 for both birth weight and length). BAZ was 0.34 (95% CI: 0.24, 0.44) higher, but 0.11 lower (95% CI: -0.21, -0.02), for each increase in 1 Z score of birth weight and length, respectively. Children with at least one reported malaria episode within the first year of life were 0.58 (95% CI: -1.05, -0.11) Z score shorter. Socioeconomic and intergenerational factors were consistently associated with LAZ and BAZ at 10-15 months of age. The occurrence of malaria was detrimental to linear growth. In a malaria endemic region, reduction of inequalities and disease burden over the first 1,000 days of life is essential for taking advantage of a critical window of opportunity that can redirect child growth trajectories toward better health and nutrition conditions in the long term.	[Dal Bom, Juliana Paghi] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, SP, Brazil; [Mazzucchetti, Lalucha; Malta, Maira Barreto; Cardoso, Marly Augusto; Lourenco, Barbara Hatzlhoffer] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil; [Ladeia-Andrade, Simone] Fiocruz MS, Oswaldo Cruz Inst, Rio De Janeiro, RJ, Brazil; [de Castro, Marcia Caldas] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Malta, Maira Barreto; Cardoso, Marly Augusto; Lourenco, Barbara Hatzlhoffer; Manitto, Alicia Matijasevich; Abanto, Jenny; Agostinho Gimeno, Suely Godoy] Univ Sao Paulo, Sao Paulo, Brazil; [Damasceno, Ana Alice; da Silva, Bruno Pereira; de Souza, Rodrigo Medeiros] Univ Fed Acre, Cruzeiro Do Sul, Brazil; [de Castro, Marcia Caldas] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Harvard University; Harvard T.H. Chan School of Public Health; Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health	Lourenco, BH (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil.; Lourenco, BH (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	barbaralourenco@usp.br	Castro, Marcia/S-2681-2019; LADEIA-ANDRADE, SIMONE/AGD-9884-2022; Lourenco, Barbara/H-8291-2012; Cardoso, Marly Augusto/B-8010-2013; Medeiros de Souza, Rodrigo/F-4749-2014	Castro, Marcia/0000-0003-4606-2795; LADEIA-ANDRADE, SIMONE/0000-0003-0912-5937; Lourenco, Barbara/0000-0002-2006-674X; Cardoso, Marly Augusto/0000-0003-0973-3908; Medeiros de Souza, Rodrigo/0000-0002-7775-6901	Brazilian National Council of Technological and Scientific Development, CNPq [407255/2013-3]; Sao Paulo Research Foundation, FAPESP [2016/00270-6]; Maria Cecilia Souto Vidigal Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]	Brazilian National Council of Technological and Scientific Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Maria Cecilia Souto Vidigal Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present study was funded by the Brazilian National Council of Technological and Scientific Development, CNPq (http://cnpq.br/grant 407255/2013-3; M.A.C., M.C.C.), the Sao Paulo Research Foundation, FAPESP (http://fapesp.br/-grant 2016/00270-6; M.A.C.) and the Maria Cecilia Souto Vidigal Foundation (http://www.fmcsv.org.br/-M.C.C.).This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES - http://www.capes.gov.br/) Finance Code 001, with a masters scholarship to J. P.D.B. The views expressed in the present article are those of the authors and not necessarily those of any funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Alderman H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195904; Alexandre MAA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003743; Bann D, 2014, INT J OBESITY, V38, P69, DOI 10.1038/ijo.2013.115; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brasil, 2008, PESQ NAC DEM SAUD CR; Brasil Ministerio da Saude, 2011, OR COL AN DAD ANTR S; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2015, J PEDIAT-BRAZIL, V91, P105, DOI 10.1016/j.jped.2014.10.002; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gea-Horta T, 2017, NUTR HOSP, V34, P308, DOI 10.20960/nh.327; Goncalves H, 2019, INT J EPIDEMIOL, V48, pi80, DOI 10.1093/ije/dyy233; Hug L., 2020, LEVELS TRENDS CHILD; IBGE, 2013, ATL CENS DEM 2010; Jackson BD, 2017, J NUTR, V147, p2163S, DOI 10.3945/jn.116.242289; Labrecque JA, 2018, SOC SCI MED, V211, P9, DOI 10.1016/j.socscimed.2018.05.040; Lee G, 2012, INT J EPIDEMIOL, V41, P531, DOI 10.1093/ije/dyr190; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lourenco BH, 2015, MATERN CHILD NUTR, V11, P240, DOI 10.1111/mcn.12005; Lourenco BH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-265; Menezes AMB, 2012, J EPIDEMIOL COMMUN H, V66, P149, DOI 10.1136/jech.2010.124842; Ministerio da Saude, SIT EP MAL; Mook-Kanamori DO, 2011, EUR J ENDOCRINOL, V165, P623, DOI 10.1530/EJE-11-0067; Natama HM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1187-3; Paes-Sousa R, 2011, B WORLD HEALTH ORGAN, V89, P496, DOI 10.2471/BLT.10.084202; Pincelli A, 2018, AM J TROP MED HYG, V99, P73, DOI 10.4269/ajtmh.18-0135; Reynaldi A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2657-6; Victora CG, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1431; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Villar J, 2018, AM J OBSTET GYNECOL, V218, pS841, DOI 10.1016/j.ajog.2017.11.564; WHO, 1995, EXP COMM PHYS STAT P; Woolfenden S, 2013, J PAEDIATR CHILD H, V49, pE365, DOI 10.1111/jpc.12171; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220513	10.1371/journal.pone.0220513	http://dx.doi.org/10.1371/journal.pone.0220513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386682	gold, Green Published, Green Submitted			2022-12-26	WOS:000484997100022
J	Hau, SJ; Mou, KT; Bayles, DO; Brockmeier, SL				Hau, Samantha J.; Mou, Kathy T.; Bayles, Darrell O.; Brockmeier, Susan L.			Transcriptomic differences noted in Glaesserella parasuis between growth in broth and on agar	PLOS ONE			English	Article							HAEMOPHILUS-PARASUIS; EXPRESSION; OMPA	Glaesserella parasuis is the cause of Glasser's disease in pigs and is a significant contributor to post-weaning mortality in the swine industry. Prevention of G. parasuis disease relies primarily on bacterin vaccines, which have shown good homologous protection and variable heterologous protection. Bacterin production involves large scale growth of the bacteria and proteins produced during the proliferation phase of production become important antigens that stimulate the immune response. In order to evaluate genes activated during G. parasuis growth on different media substrates, the transcriptome of broth and agar grown G. parasuis strain 29755 were sequenced and compared. The transcription of most purported virulence genes were comparable between broth and agar grown G. parasuis; however, four virulence-associated genes, including ompA and vapD, had elevated expression under agar growth, while six virulence-associate genes had elevated expression during broth growth, including several protease genes. Additionally, there were metabolic shifts toward increased protein and lipid production and increased cellular division in broth grown G. parasuis. The results contribute to the understanding of how growth substrate alters gene transcription and protein expression, which may impact vaccine efficacy if immunogens important to the protective immune response are not produced under specific in vitro conditions. While the results of this work are unable to fully elucidate which growth medium presents a transcriptome more representative of in vivo samples or best suited for bacterin production, it forms a foundation that can be used for future comparisons and provides a better understanding of the metabolic differences in broth and agar grown bacteria.	[Hau, Samantha J.; Mou, Kathy T.; Brockmeier, Susan L.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA; [Hau, Samantha J.; Mou, Kathy T.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Bayles, Darrell O.] ARS, Infect Bacterial Dis Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Department of Agriculture (USDA)	Brockmeier, SL (corresponding author), ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	susan.brockmeier@usda.gov						Ahn J, 2012, J MICROBIOL BIOTECHN, V22, P1307, DOI 10.4014/jmb.1201.01003; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aragon V, 2012, DIS SWINE, P760; Bello-Orti B, 2015, VET RES, V46, DOI 10.1186/s13567-015-0225-9; Blair JMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063912; Blanco I, 2004, VET MICROBIOL, V103, P21, DOI 10.1016/j.vetmic.2004.06.011; Brockmeier SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103787; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Daines DA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-30; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence Paulraj, 2015, J Genomics, V3, P59, DOI 10.7150/jgen.10924; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maskell D.J, 2014, BMC GENOMICS, V15, P1179, DOI 10.1186/1471-2164-15-1179; Metcalf DS, 2007, CAN J VET RES, V71, P181; MINIATS OP, 1991, CAN J VET RES, V55, P37; MINIATS OP, 1991, CAN J VET RES, V55, P33; Newman SD, 2011, PREV CHRONIC DIS, V8; Nicholson TL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205700; SMART NL, 1989, CAN J VET RES, V53, P390; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Xu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019631	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220365	10.1371/journal.pone.0220365	http://dx.doi.org/10.1371/journal.pone.0220365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386681	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100019
J	Hill, LJ; Parades, WC; Willemes, MJ; Pereira, MG; Salomon, PS; Mariath, R; Moura, RL; Atella, GC; Farina, M; Amado, GM; Salgado, LT				Hill, Lilian J.; Parades, Wladimir C.; Willemes, Maria Julia; Pereira, Miria G.; Salomon, Paulo S.; Mariath, Rodrigo; Moura, Rodrigo L.; Atella, Georgia C.; Farina, Marcos; Amado-Filho, Gilberto M.; Salgado, Leonardo T.			Acidification-induced cellular changes in Symbiodinium isolated from Mussismilia braziliensis	PLOS ONE			English	Article							OCEAN ACIDIFICATION; FATTY-ACID; THERMAL TOLERANCE; CLIMATE-CHANGE; REEF CORALS; DINOFLAGELLATE; ZOOXANTHELLAE; DIVERSITY; ATLANTIC; PHOTOSYNTHESIS	Dinoflagellates from the Symbiodiniaceae family and corals have an ecologically important endosymbiotic relationship. Scleractinian corals cannot survive for long periods without their symbionts. These algae, also known as zooxanthellae, on the other hand, thrives outside the coral cells. The free-living populations of zooxanthellae are essential for the resilience of the coral to environmental stressors such as temperature anomalies and ocean acidification. Yet, little is known about how ocean acidification may affect the free-living zooxanthellae. In this study we aimed to test morphological, physiological and biochemical responses of zooxanthellae from the Symbiodinium genus isolated from the coral Mussismilia braziliensis, endemic to the Brazilian coast, to acidification led by increased atmospheric CO2. We tested whether photosynthetic yield, cell ultrastructure, cell density and lipid profile would change after up to 16 days of exposure to pH 7.5 in an atmospheric pCO(2) of 1633 mu atm. Photosynthetic yield and cell density were negatively affected and chloroplasts showed vesiculated thylakoids, indicating morphological damage. Moreover, Symbiodinium fatty acid profile drastically changed in acidified condition, showing lower polyunsaturated fatty acids and higher saturated fatty acids contents, when compared to the control, non-acidified condition. These results show that seawater acidification as an only stressor causes significant changes in the physiology, biochemistry and ultrastructure of free-living Symbiodinium.	[Hill, Lilian J.; Parades, Wladimir C.; Willemes, Maria Julia; Mariath, Rodrigo; Amado-Filho, Gilberto M.; Salgado, Leonardo T.] Inst Pesquisas Jardim Bot Rio de Janeiro, Diretoria Pesquisas, Rio De Janeiro, Brazil; [Pereira, Miria G.] Univ Fed Rio de Janeiro UFRJ, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Salomon, Paulo S.; Moura, Rodrigo L.] Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, Brazil; [Atella, Georgia C.] Univ Fed Rio de Janeiro UFRJ, Inst Bioquim Med, Rio De Janeiro, Brazil; [Farina, Marcos] Univ Fed Rio de Janeiro UFRJ, Inst Ciencias Biomed, Rio De Janeiro, Brazil	Jardim Botanico do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Salgado, LT (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Diretoria Pesquisas, Rio De Janeiro, Brazil.	lsalgado.jbrj@gmail.com	Atella, Georgia/AAK-7897-2020; Pereira, Miria G/AAJ-9998-2021; Farina, Marcos/I-3744-2014; de Moura, Rodrigo Leao/AAL-5781-2020; Salomon, Paulo Sergio/D-3310-2011	de Moura, Rodrigo Leao/0000-0002-5597-6196; Salomon, Paulo Sergio/0000-0002-0037-6011	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Agencia Nacional do Petrleo, Gas Natural e Biocombustiveis/BRASOIL	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Agencia Nacional do Petrleo, Gas Natural e Biocombustiveis/BRASOIL	This study was financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Agencia Nacional do Petrleo, Gas Natural e Biocombustiveis/BRASOIL. GCA, GMAF, LTS, MF, PSS and RLM. received CNPq research productivity fellowships. GMAF, MF and LTS received FAPERJ research productivity fellowships.	Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Baghdasarian G, 2017, BIOL BULL-US, V232, P123, DOI 10.1086/692718; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BANASZAK AT, 1993, J PHYCOL, V29, P517, DOI 10.1111/j.1529-8817.1993.tb00153.x; Barott KL, 2015, P NATL ACAD SCI USA, V112, P607, DOI 10.1073/pnas.1413483112; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bidle KD, 2016, CURR BIOL, V26, pR594, DOI 10.1016/j.cub.2016.05.056; BLANK RJ, 1985, ENDOCYT CELL RES, V2, P113; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Carlos AA, 1999, J PHYCOL, V35, P1054, DOI 10.1046/j.1529-8817.1999.3551054.x; Castro Clovis B., 1999, Revista Brasileira de Oceanografia, V47, P87; Cheng JL, 2009, HISTOCHEM CELL BIOL, V132, P281, DOI 10.1007/s00418-009-0615-z; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Fabina NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044970; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; FRENZ J, 1989, BIOTECHNOL BIOENG, V34, P755, DOI 10.1002/bit.260340605; Fujise L, 2018, J EUKARYOT MICROBIOL, V65, P505, DOI 10.1111/jeu.12497; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Gotelli N.J., 1995, PRIMER ECOLOGY; Guiheneuf F, 2009, J EXP MAR BIOL ECOL, V369, P136, DOI 10.1016/j.jembe.2008.11.009; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hansen G, 2009, J PHYCOL, V45, P251, DOI 10.1111/j.1529-8817.2008.00621.x; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HORVATH G, 1987, BIOCHIM BIOPHYS ACTA, V891, P68, DOI 10.1016/0005-2728(87)90084-3; Jokiel PL, 2011, J EXP MAR BIOL ECOL, V409, P1, DOI 10.1016/j.jembe.2011.10.008; KLEPPEL GS, 1989, LIMNOL OCEANOGR, V34, P1331, DOI 10.4319/lo.1989.34.7.1331; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KORN ED, 1967, J CELL BIOL, V34, P627, DOI 10.1083/jcb.34.2.627; Kwok ACM, 2005, PLANT CELL PHYSIOL, V46, P1973, DOI 10.1093/pcp/pci213; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Leggat W, 1999, PLANT PHYSIOL, V121, P1247, DOI 10.1104/pp.121.4.1247; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Mansour MP, 1999, J PHYCOL, V35, P710, DOI 10.1046/j.1529-8817.1999.3540710.x; McGinley MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050439; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; Moura RL, 2013, CONT SHELF RES, V70, P109, DOI 10.1016/j.csr.2013.04.036; Muscatine L., 1990, P75; Nanjo Y, 2010, BBA-BIOENERGETICS, V1797, P1483, DOI 10.1016/j.bbabio.2010.03.014; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Papina M, 2003, COMP BIOCHEM PHYS B, V135, P533, DOI 10.1016/S1096-4959(03)00118-0; Paradas WC, 2016, PLANT CELL PHYSIOL, V57, P1008, DOI 10.1093/pcp/pcw039; Pierrot D., 2006, TECH REP; Pochon X, 2001, MAR BIOL, V139, P1069; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; POSTBEITTENMILLER D, 1992, PLANT PHYSIOL, V100, P923, DOI 10.1104/pp.100.2.923; Putnam HM, 2012, P ROY SOC B-BIOL SCI, V279, P4352, DOI 10.1098/rspb.2012.1454; Richier S, 2010, SYMBIOSIS STRESS, P651; Rocker MM, 2019, CORAL REEFS, V38, P215, DOI 10.1007/s00338-019-01768-x; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHREIBER U, 1995, PLANT CELL PHYSIOL, V36, P873, DOI 10.1093/oxfordjournals.pcp.a078833; Silva-Lima AW, 2015, MICROB ECOL, V70, P301, DOI 10.1007/s00248-015-0573-z; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P744, DOI 10.4319/lo.2000.45.3.0744; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072486; Webster NS, 2013, GLOBAL CHANGE BIOL, V19, P303, DOI 10.1111/gcb.12008; WHITNEY SM, 1995, P ROY SOC B-BIOL SCI, V259, P271, DOI 10.1098/rspb.1995.0040; Zuppini A, 2009, J EXP BOT, V60, P4189, DOI 10.1093/jxb/erp264; [No title captured]	78	5	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220130	10.1371/journal.pone.0220130	http://dx.doi.org/10.1371/journal.pone.0220130			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381568	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600010
J	van Witteloostuijn, M; Boersma, P; Wijnen, F; Rispens, J				van Witteloostuijn, Merel; Boersma, Paul; Wijnen, Frank; Rispens, Judith			Statistical learning abilities of children with dyslexia across three experimental paradigms	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; PROCEDURAL MEMORY; VISUAL-ATTENTION; READING-ABILITY; WORKING-MEMORY; LANGUAGE; DEFICIT; ACQUISITION; IMPAIRMENT; SEQUENCES	Statistical learning (SL) difficulties have been suggested to contribute to the linguistic and non-linguistic problems observed in children with dyslexia. Indeed, studies have demonstrated that children with dyslexia experience problems with SL, but the extent of the problems is unclear. We aimed to examine the performance of children with and without dyslexia across three distinct paradigms using both on-and offline measures, thereby tapping into different aspects of SL. 100 children with and without dyslexia (aged 8-11, 50 per group) completed three SL tasks: serial reaction time (SRT), visual statistical learning (VSL), and auditory nonadjacent dependency learning (A-NADL). Learning was measured through online reaction times during exposure in all tasks, and through offline questions in the VSL and A-NADL tasks. We find significant learning effects in all three tasks, from which we conclude that, collapsing over groups, children are sensitive to the statistical structures presented in the SRT, VSL and A-NADL tasks. No significant interactions of learning effect with group were found in any of the tasks, so we cannot conclude whether or not children with dyslexia perform differently on the SL tasks than their TD peers. These results are discussed in light of the proposed SL deficit in dyslexia.	[van Witteloostuijn, Merel; Boersma, Paul; Rispens, Judith] Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands; [Wijnen, Frank] Univ Utrecht, Utrecht Inst Linguist OTS, Utrecht, Netherlands	University of Amsterdam; Utrecht University	van Witteloostuijn, M (corresponding author), Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands.	M.T.G.vanWitteloostuijn@uva.nl		van Witteloostuijn, Merel/0000-0003-3159-8247; Wijnen, Frank/0000-0002-7196-6000	Netherlands Organization for Scientific Research (NWO) [276-89-005]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This paper is part of a project entitled 'Examining the contribution of procedural memory to grammar and literacy'. It was funded by the Netherlands Organization for Scientific Research (NWO): personal Vidi grant awarded to JR (Judith Rispens; grant number 276-89-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The data reported here is part of a project funded by the Netherlands Organization for Scientific Research (NWO) entitled 'Examining the contribution of procedural memory to grammar and literacy' (personal Vidi grant awarded to Judith Rispens, 276-89-005). We would like to thank all children, their parents, the primary schools (Anne Frankschool, De Binnenmeer, De Wheermolen and Het Startnest) and the dyslexia organisations (IWAL institute Amsterdam, RID institute Amersfoort) for participating in the present study. We are also grateful to Darlene Keydeniers, Iris Broedelet and Sascha Couvee (testing assistance) and Dirk Jan Vet (technical assistance). Finally, we would like to express our gratitude to Imme Lammertink for the collaboration on designing the experiments conducted in this study.	Alloway T. P., 2012, ALLOWAY WORKING MEMO; Arciuli J, 2018, CURRENT DIRECTIONS P, P1; Arciuli J, 2018, LANG SPEECH HEAR SER, V49, P634, DOI 10.1044/2018_LSHSS-STLT1-17-0135; Arciuli J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0058; Arciuli J, 2012, COGNITIVE SCI, V36, P286, DOI 10.1111/j.1551-6709.2011.01200.x; Arciuli J, 2011, DEVELOPMENTAL SCI, V14, P464, DOI 10.1111/j.1467-7687.2009.00937.x; Baguley T, 2012, SERIOUS STATS GUIDE; Baker CI, 2004, PSYCHOL SCI, V15, P460, DOI 10.1111/j.0956-7976.2004.00702.x; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Braams T, 2015, SCHOOLVAARDIGHEIDSTO; Brus B, 1972, MINUUT TEST VORM A B; Buchholz J, 2005, BRAIN COGNITION, V57, P30, DOI 10.1016/j.bandc.2004.08.017; Bussy G., 2011, REV NEUROPSYCHOL, V3, P141, DOI [10.3917/rne.033.0141, DOI 10.3917/RNE.033.0141]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowan N, 2017, DYSLEXIA, V23, P209, DOI 10.1002/dys.1557; Deroost N, 2010, J CLIN EXP NEUROPSYC, V32, P561, DOI 10.1080/13803390903313556; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Frost R, 2015, TRENDS COGN SCI, V19, P117, DOI 10.1016/j.tics.2014.12.010; Frost R, 2013, PSYCHOL SCI, V24, P1243, DOI 10.1177/0956797612472207; Gabay Y, 2015, J SPEECH LANG HEAR R, V58, P934, DOI 10.1044/2015_JSLHR-L-14-0324; Gabay Y, 2012, NEUROPSYCHOLOGIA, V50, P2435, DOI 10.1016/j.neuropsychologia.2012.06.014; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Grama IC, 2016, J PSYCHOLINGUIST RES, V45, P1427, DOI 10.1007/s10936-016-9412-8; He XJ, 2017, AM J SPEECH-LANG PAT, V26, P1080, DOI 10.1044/2017_AJSLP-15-0190; Hedenius M, 2013, RES DEV DISABIL, V34, P3924, DOI 10.1016/j.ridd.2013.08.014; Henderson LM, 2017, RES DEV DISABIL, V60, P198, DOI 10.1016/j.ridd.2016.11.002; Iao LS, 2017, J SPEECH LANG HEAR R, V60, P694, DOI 10.1044/2016_JSLHR-L-15-0232; Inacio F, 2018, ANN DYSLEXIA, V68, P1, DOI 10.1007/s11881-018-0158-x; Janacsek K, 2015, CORTEX, V64, P411, DOI 10.1016/j.cortex.2014.07.020; Jimenez-Fernandez G, 2011, ANN DYSLEXIA, V61, P85, DOI 10.1007/s11881-010-0048-3; Kelly Steve W, 2002, Dyslexia, V8, P43, DOI 10.1002/dys.208; Kerkhoff A, 2017, DEVELOPMENTAL PERSPE, P315; Kerkhoff A, 2013, J CHILD LANG, V40, P11, DOI 10.1017/S0305000912000098; Kidd E, 2018, TRENDS COGN SCI, V22, P154, DOI 10.1016/j.tics.2017.11.006; Kidd E, 2012, DEV PSYCHOL, V48, P171, DOI 10.1037/a0025405; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Kort W., 2008, CLIN EVALUATION LANG; Laasonen M, 2014, ANN DYSLEXIA, V64, P1, DOI 10.1007/s11881-013-0083-y; Lammertink I, 2018, APPLIED PSYCHOLINGUI, P1; Lopez-Barroso D, 2016, COGNITION, V152, P61, DOI 10.1016/j.cognition.2016.03.016; Lum J, 2010, AUST J PSYCHOL, V62, P139, DOI 10.1080/00049530903150547; Lum JAG, 2013, RES DEV DISABIL, V34, P3460, DOI 10.1016/j.ridd.2013.07.017; Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Misyak JB, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00031; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; Nigro L., 2015, ANN DYSLEXIA, P1, DOI [DOI 10.1007/S11881-015-0096-9, 10.1007/s11881-015-0096-9]; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Pavlidou EV, 2014, RES DEV DISABIL, V35, P1457, DOI 10.1016/j.ridd.2014.03.040; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Plante E, 2018, LANG SPEECH HEAR SER, V49, P710, DOI 10.1044/2018_LSHSS-STLT1-17-0131; R Core Team, 2021, R LANGUAGE ENV STAT; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2003, J CHILD PSYCHOL PSYC, V44, P712, DOI 10.1111/1469-7610.00157; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Raven J, 2003, HANDBOOK OF NONVERBAL ASSESSMENT, P223; Raviv L, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12593; Rispens J, 2007, INT J LANG COMM DIS, V42, P293, DOI 10.1080/13682820600988777; Roodenrys S, 2008, DYSLEXIA, V14, P1, DOI 10.1002/dys.340; Russeler J, 2006, J CLIN EXP NEUROPSYC, V28, P808, DOI 10.1080/13803390591001007; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Schittekatte M., 2007, TEACH TEST EVERYDAY; Schmalz X, 2018, SCI STUD READ, P1, DOI [10.1080/10888438.2018, DOI 10.1080/10888438.2018]; Schmalz X, 2017, ANN DYSLEXIA, V67, P147, DOI 10.1007/s11881-016-0136-0; Schneider W., 2002, E PRIME USERS GUIDE; Siegelman N, 2018, COGNITIVE SCI, V42, P692, DOI 10.1111/cogs.12556; Siegelman N, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0059; Siegelman N, 2015, J MEM LANG, V81, P105, DOI 10.1016/j.jml.2015.02.001; Sigurdardottir HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00554-5; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Singh S, 2020, ARCH PHYSIOL BIOCHEM, V126, P348, DOI 10.1080/13813455.2018.1538249; Snowling M., 2000, DYSLEXIA; Snowling M J, 2001, Dyslexia, V7, P37; Staels E, 2017, NEUROPSYCHOLOGY, V31, P371, DOI 10.1037/neu0000348; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Van den Bos K. P., 2007, CONTINU BENOEMEN WOO; van Witteloostuijn M, 2017, RES DEV DISABIL, V70, P126, DOI 10.1016/j.ridd.2017.09.006; vandenBos KP, 1994, VORM A B TEST LEESVA; vanWitteloostuijn M, FRONTIERS IN PSYCHOL; Vicari S, 2003, NEUROPSYCHOLOGIA, V41, P108, DOI 10.1016/S0028-3932(02)00082-9; Vicari S, 2005, J NEUROL, V76, P1359, DOI [10.1177/0956797611417632, DOI 10.1177/0956797611417632]; Waber DP, 2003, J EXP CHILD PSYCHOL, V84, P338, DOI 10.1016/S0022-0965(03)00030-4; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Waltzman DE, 2000, APPL PSYCHOLINGUIST, V21, P263, DOI 10.1017/S014271640000206X; West G, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12552	94	18	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220041	10.1371/journal.pone.0220041	http://dx.doi.org/10.1371/journal.pone.0220041			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381565	Green Published, gold, Green Submitted			2022-12-26	WOS:000484993600009
J	Kalka, E; Pastuszak, A; Busko, K				Kalka, Ewa; Pastuszak, Anna; Busko, Krzysztof			Secular trends in body height, body weight, BMI and fat percentage in Polish university students in a period of 50 years	PLOS ONE			English	Article							MASS INDEX; CHILDREN; ADOLESCENTS; STATURE; OBESITY	Objectives The aim of the study was to determine changes in the magnitude and direction of secular trends in body height, body weight, body mass index (BMI) and fat percentage in university students from a university of technology and a university of physical education in a period of 50 years. Methods The data were derived from the examinations of male students from the Warsaw University of Technology, conducted four times, in 1959, 1971, 1994, 2011, and male students from the Jozef Pilsudski University of Physical Education in Warsaw, who were examined in 1963, 1972, 1996, and 2012. Body height, body weight and thickness of 2 skinfolds (triceps skinfold and abdomen skinfold) were measured. Body mass index (BMI) and fat percentage (FAT%) were also calculated. Results Current university students are taller and heavier than their peers from the previous decades, with BMI remaining within the reference range. A substantial increase in fat percentage was found in both groups. Over the period of fifty years, mean fat percentage in students from the university of technology increased by 6.3% (F1,3 = 116.56, p < 0.001, eta(2) = 0.3736), whereas this increase in the students from the university of physical education rose by 3.5% (F1,3 = 72.94, p < 0.001, eta(2) = 0.3181). Conclusion Changes in secular trends in the students from both universities are likely to be linked to the dynamic economic and systematic transformation in Poland observed in the period of the last 50 years. The period of economic transformations in the last decade was more conducive to physical development of university students than the previous period of economic crises.	[Kalka, Ewa] Inst Mother & Child Hlth, Clin Children & Youth, Warsaw, Poland; [Pastuszak, Anna] Natl Res Inst, Team Projects, Inst Sport, Warsaw, Poland; [Busko, Krzysztof] Kazimierz Wielki Univ, Dept Anat & Biomech, Bydgoszcz, Poland	Institute of Sport - National Research Institute; Kazimierz Wielki University	Busko, K (corresponding author), Kazimierz Wielki Univ, Dept Anat & Biomech, Bydgoszcz, Poland.	krzysztof.busko@ukw.edu.pl	Buśko, Krzysztof/ABE-7456-2020	Buśko, Krzysztof/0000-0002-6456-3502	Ministry of Science and Higher Education (Grants of Jozef Pilsudski University of Physical Education in Warsaw) [DS-145, DM-22]	Ministry of Science and Higher Education (Grants of Jozef Pilsudski University of Physical Education in Warsaw)	The study was supported by the Ministry of Science and Higher Education (Grants of Jozef Pilsudski University of Physical Education in Warsaw No.: DS-145 and DM-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabric M, 2010, MED BIOLL SCI, V24, P19; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; Du TT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-327; Falkner F., 1986, HUMAN GROWTH, V3, P283; Hulanicka B., 1990, MONOGRAPHS I ANTHR, V7; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P520, DOI 10.3967/0895-3988.2013.07.002; Johnson W, 2013, ANN HUM BIOL, V40, P107, DOI 10.3109/03014460.2012.720710; KEYS A, 1953, PHYSIOL REV, V33, P245, DOI 10.1152/physrev.1953.33.3.245; Kolodziej H M, 2015, AM J HUM BIOL, P1, DOI [10.1002/ajhb.22646, DOI 10.1002/AJHB.22646]; Krajenska A, 2008, PHYS ACTIVITY PEOPLE, V12, P201; Larnkjaer A, 2006, ACTA PAEDIATR, V95, P754, DOI 10.1080/08035250500527323; Laska-Mierzejewska T, 2007, ANN HUM BIOL, V34, P362, DOI 10.1080/03014460701317798; Lewandowska J, 2006, HUM MOVEMENT, V7, P65; Martin R., 1957, LEHRBUCH ANTHR, V3rd; Nagel G, 2009, EUR J CLIN NUTR, V63, P1440, DOI 10.1038/ejcn.2009.86; Oberg S, 2014, ECON HUM BIOL, V15, P140, DOI 10.1016/j.ehb.2014.08.003; Padez C, 2003, ANN HUM BIOL, V30, P262, DOI 10.1080/0301446031000064530; Papaidimitriou A, 2008, OBES REV, V9, P100, DOI 10.1111/j.1467-789X.2007.00420.x; Petranovic MZ, 2014, ECON HUM BIOL, V13, P155, DOI 10.1016/j.ehb.2013.09.002; Pheasant S, 2003, ANTHROPOMETRY ERGONO; Piechaczek H., 1976, STUD PHYS ANTHR, V2, P33; Piechaczek H, 1996, PHYS ED SPORT, V40, P3; Podstawski R. S., 2012, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu - Biologia i Hodowla Zwierzat, V64, P9; Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.113.071928; Rebacz-Maron E, 2013, INT MARIT HEALTH, V64, P12; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; Stachon A, 2013, HUM MOV, V14, P205; Sun SMS, 2012, AM J HUM BIOL, V24, P506, DOI 10.1002/ajhb.22256; WHO, 2015, HLTH TOP OB OV	29	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220514	10.1371/journal.pone.0220514	http://dx.doi.org/10.1371/journal.pone.0220514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369619	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900060
J	Pennucci, R; Gucciardi, I; de Curtis, I				Pennucci, Roberta; Gucciardi, Irene; de Curtis, Ivan			Rac1 and Rac3 GTPases differently influence the morphological maturation of dendritic spines in hippocampal neurons	PLOS ONE			English	Article							RHO-GTPASES; MOLECULAR-MECHANISMS; ACTIN; SYNAPTOGENESIS; PLASTICITY; EXPRESSION; FILOPODIA; ADHESION; PROTEINS; INSIGHTS	The Rac1 and Rac3 GTPases are co-expressed in the developing nervous system, where they are involved in different aspects of neuronal development, including the formation of synapses. The deletion of both Rac genes determines a stronger reduction of dendritic spines in vitro compared to the knockout of either gene, indicating that Rac1 and Rac3 play a synergistic role in the formation of these structures. Here, we have addressed the role of each GTPase in the formation of dendritic spines by overexpressing either Rac1 or Rac3 in wildtype neurons, or by re-expressing either GTPase in double knockout hippocampal cultures. We show that the Rac3 protein is expressed with Rac1 in developing hippocampal neurons. Overexpression of either GTPase in WT neurons increases the density of dendritic spines, suggesting the involvement of both GTPases in their formation. We also found that the re-expression of either Rac1 or Rac3 in double knockout neurons is sufficient to restore spinogenesis. Rac1 is significantly more efficient than Rac3 in restoring the formation of spines. On the other hand the quantitative analysis in neurons overexpressing or reexpressing either GTPase shows that Rac3 induces a more pronounced increase in the size of the spines compared to Rac1. These enlarged spines form morphological synapses identified by the juxtaposition of postsynaptic and presynaptic markers. Thus, while Rac1 appears more efficient in inducing the formation of mature spines, Rac3 is more efficient in promoting their enlargement. Our study highlights specific roles of Rac1 and Rac3, which may be functionally relevant also to synaptic plasticity.	[Pennucci, Roberta; Gucciardi, Irene; de Curtis, Ivan] San Raffaele Vita Salute Univ, Milan, Italy; [Pennucci, Roberta; Gucciardi, Irene; de Curtis, Ivan] Ist Sci San Raffaele, Cell Adhes Unit, Div Neurosci, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	de Curtis, I (corresponding author), San Raffaele Vita Salute Univ, Milan, Italy.	decurtis.ivan@hsr.it		DE CURTIS, Ivanmatteo/0000-0002-7651-1515	Telethon Foundation, Italy [GGP12126]; AIRC, Italy [20203]	Telethon Foundation, Italy(Fondazione Telethon); AIRC, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Telethon Foundation, Italy (grant GGP12126 to IdC) and AIRC, Italy (20203 to IdC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bolis A, 2003, EUR J NEUROSCI, V18, P2417, DOI 10.1046/j.1460-9568.2003.02938.x; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Corbetta S, 2008, BEHAV BRAIN RES, V186, P246, DOI 10.1016/j.bbr.2007.08.019; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Costain G, 2019, GENET MED, V21, P1021, DOI 10.1038/s41436-018-0323-y; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fiala JC, 1998, J NEUROSCI, V18, P8900; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gualdoni S, 2007, BIOL CELL, V99, P455, DOI 10.1042/BC20060119; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Malosio ML, 1997, J NEUROSCI, V17, P6717; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MOLL J, 1991, ONCOGENE, V6, P863; Nakahata Y, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00029; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Pennucci R, 2016, CEREB CORTEX, V26, P873, DOI 10.1093/cercor/bhv274; Pennucci R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024819; Pyronneau A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan0852; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Vaghi V, 2014, CEREB CORTEX, V24, P1247, DOI 10.1093/cercor/bhs402; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zamboni V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25354-3; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	39	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220496	10.1371/journal.pone.0220496	http://dx.doi.org/10.1371/journal.pone.0220496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369617	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900058
J	Zhang, LL; Jing, XD; Chen, W; Bai, JL; Vasseur, L; He, WY; You, MS				Zhang, Lingling; Jing, Xiaodong; Chen, Wei; Bai, Jianlin; Vasseur, Liette; He, Weiyi; You, Minsheng			Selection of reference genes for expression analysis of plant-derived microRNAs in Plutella xylostella using qRT-PCR and ddPCR	PLOS ONE			English	Article							DROPLET-DIGITAL PCR; DIAMONDBACK MOTH; QUANTIFICATION; LEPIDOPTERA; NORMALIZATION; MANAGEMENT; MECHANISM; ECOLOGY; RNAS; TOOL	The establishment of an expression quantification system that can be easily applied for the comparison of microRNAs (miRNAs) from biological samples is an important step toward understanding functional mechanisms in organisms. However, there is lack of attention on the selection of reference genes for miRNA expression profiling in insect herbivores. Here, we explored the candidate reference genes in a notorious pest of cruciferous crops, Plutella xylostella, for normalization of miRNA expression in developmental stages and tissues and in response to a change of food source from artificial diet to host plant Arabidopsis thaliana. We first compared the expression levels and stability of eight small RNAs using qRT-PCR, and found that miR11 was the most suitable reference gene for expression quantification of the miRNAs. We then confirmed this finding using digital droplet PCR and further validated with a well-studied cross-kingdom miRNA derived from A. thaliana (ath-miR159a). However, none of the reference genes was applicable for all experimental conditions, and multiple reference genes were sometimes required within the same experiment. Our work provides a method for the selection of reference genes for quantification of plant-derived miRNAs, which paves the way for unveiling their roles in the insect-plant coevolution.	[Zhang, Lingling; Jing, Xiaodong; Chen, Wei; Bai, Jianlin; Vasseur, Liette; He, Weiyi; You, Minsheng] Fujian Agr & Forestry Univ, Inst Appl Ecol, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China; [Zhang, Lingling; Jing, Xiaodong; Chen, Wei; Bai, Jianlin; Vasseur, Liette; He, Weiyi; You, Minsheng] Fujian Agr & Forestry Univ, Int Joint Res Lab Ecol Pest Control, Minist Educ, Fuzhou, Fujian, Peoples R China; [Vasseur, Liette] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Brock University	He, WY; You, MS (corresponding author), Fujian Agr & Forestry Univ, Inst Appl Ecol, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China.; He, WY; You, MS (corresponding author), Fujian Agr & Forestry Univ, Int Joint Res Lab Ecol Pest Control, Minist Educ, Fuzhou, Fujian, Peoples R China.	wy.he@fafu.edu.cn; msyou@fafu.edu.cn	zhang, lingling/HDM-2189-2022; He, Weiyi/N-6148-2017	He, Weiyi/0000-0001-8659-3123; Chen, Wei/0000-0001-9570-3662	National Key R&D Program of China [2017YFD0200400]; Fujian Provincial Science and Technology Major Project [2018NZ0002-1]; Natural Science Foundation of Fujian Province [2019J01369]	National Key R&D Program of China; Fujian Provincial Science and Technology Major Project; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This study was funded by the National Key R&D Program of China (grant number 2017YFD0200400 awarded to Assoc. Prof. Weiyi He), the Fujian Provincial Science and Technology Major Project (grant number 2018NZ0002-1 awarded to Prof. Minsheng You), and the Natural Science Foundation of Fujian Province (grant number 2019J01369 awarded to Assoc. Prof. Weiyi He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boehme P, 2015, HUM GENE THER METHOD, V26, P25, DOI 10.1089/hgtb.2014.138; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Chang YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181862; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Dai TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173821; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Feng Bing, 2014, Acta Entomologica Sinica, V57, P286; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Kiseleva Y. Y., 2016, Biomeditsinskaya Khimiya, V62, P403, DOI 10.18097/PBMC20166204403; Li RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061619; Li ZY, 2016, ANNU REV ENTOMOL, V61, P277, DOI 10.1146/annurev-ento-010715-023622; Lim QE, 2011, NEUROSCIENCE, V199, P32, DOI 10.1016/j.neuroscience.2011.10.024; Lukasik A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010009; Mangolini A, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0037-0; Meuer MS, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-18840-4, DOI 10.1007/978-3-642-18840-4]; Miotto E, 2014, CANCER EPIDEM BIOMAR, V23, P2638, DOI 10.1158/1055-9965.EPI-14-0503; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Sarfraz M, 2005, BIOCONTROL SCI TECHN, V15, P763, DOI 10.1080/09583150500136956; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sokol Nicholas S., 2008, V420, P319, DOI 10.1007/978-1-59745-583-1_20; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Winde I, 2011, PHYTOCHEMISTRY, V72, P1566, DOI 10.1016/j.phytochem.2011.01.016; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Yang YH, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex007; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130	43	9	10	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220475	10.1371/journal.pone.0220475	http://dx.doi.org/10.1371/journal.pone.0220475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369618	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900054
J	Boah, M; Azupogo, F; Amportro, DA; Abada, LA				Boah, Michael; Azupogo, Fusta; Amportro, Daniel Adjei; Abada, Linda Anutua			The epidemiology of undernutrition and its determinants in children under five years in Ghana	PLOS ONE			English	Article							CHILDHOOD MALNUTRITION; LOW-INCOME; HOUSEHOLD; SURVIVAL	Background Understanding the burden and contextual risk factors is critical for developing appropriate interventions to control undernutrition. Methods This study used data from the 2014 Ghana Demographic and Health Survey to estimate the prevalence of underweight, stunting, and wasting. Single multiple logistic regressions were used to identify the factors associated with underweight, wasting and stunting. The study involved 2720 children aged 0-59 months old and mother pairs. All analyses were done in STATA/IC version 15.0. Statistical significance was set at p<0.05. Results The prevalence of underweight, wasting and stunting were 10.4%, 5.3%, and 18.4% respectively. The age of the child was associated with underweight, wasting and stunting, whereas the sex was associated with wasting and stunting. Normal or overweight/obese maternal body mass index category, high woman's autonomy and middle-class wealth index were associated with a lower odds of undernutrition. The factors that were associated with a higher odds of child undernutrition included: low birth weight (<2.5 kg), minimum dietary diversity score (MDDS), a higher (>= 4th) birth order number of child, primary educational level of husband/partner and domicile in the northern region of Ghana. Conclusion There is still a high burden of child undernutrition in Ghana. The age, sex, birth weight, birth order and the MDDS of the child were the immediate factors associated with child undernutrition. The intermediate factors that were associated with child undernutrition were mainly maternal related factors and included maternal nutritional status and autonomy. Distal level factors which were associated with a higher odds of child undernutrition were the wealth index of the household, paternal educational status and region of residence. We recommend that interventions and policies for undernutrition should address socioeconomic inequalities at the community level while factoring in women empowerment programmes.	[Boah, Michael; Abada, Linda Anutua] Ghana Hlth Serv, Bolgatanga, Upper East Regi, Ghana; [Azupogo, Fusta] Univ Dev Studies, Fac Agr, Dept Family & Consumer Sci, Tamale, Ghana; [Amportro, Daniel Adjei] Harbin Med Univ, Dept Social Med & Hlth Serv Management, Harbin, Heilongjiang, Peoples R China; [Boah, Michael] Harbin Med Univ, Chinese Ctr Endem Dis Control & Prevent, Harbin, Heilongjiang, Peoples R China	Ghana Health Service; University for Development Studies; Harbin Medical University; Harbin Medical University	Boah, M (corresponding author), Ghana Hlth Serv, Bolgatanga, Upper East Regi, Ghana.; Boah, M (corresponding author), Harbin Med Univ, Chinese Ctr Endem Dis Control & Prevent, Harbin, Heilongjiang, Peoples R China.	boahmichael@gmail.com	Boah, Michael/P-8701-2019	Boah, Michael/0000-0002-5660-2292; Azupogo, Fusta/0000-0003-0467-0856				Abizari AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183206; Aheto JMK, 2015, PAEDIATR PERINAT EP, V29, P552, DOI 10.1111/ppe.12222; Akombi BJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080863; Akombi BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177338; Ali Zakari, 2017, BMC Nutr, V3, P31, DOI 10.1186/s40795-017-0154-2; Annette P-?., 2008, SAFER WATER BETTER H; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Atsu BK, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0928-3; Awunyo-Akaba Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3283-7; Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; Bhandari T.R., 2013, J NUTR HLTH FOOD SCI, V1, P1, DOI [10.15226/jnhfs.2013.00106, DOI 10.15226/JNHFS.2013.00106]; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Fernandes ECB, 2017, REV NUTR, V30, P33, DOI 10.1590/1678-98652017000100004; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chalashika P, 2017, J HUM NUTR DIET, V30, P779, DOI 10.1111/jhn.12517; Cunha MPL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010015; Darteh EKM, 2017, NUTR HLTH, P1; Edmond K, 2016, LANCET GLOB HEALTH, V4, pE266, DOI 10.1016/S2214-109X(16)00040-1; Fentahun W, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3180-0; Fotso JC, 2006, J BIOSOC SCI, V38, P289, DOI 10.1017/S0021932005026143; Fotso Jean-Christophe, 2009, Reprod Health, V6, P9, DOI 10.1186/1742-4755-6-9; Frempong RB, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00298; Gewa CA, 2012, PUBLIC HEALTH NUTR, V15, P1029, DOI 10.1017/S136898001100245X; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Gillespie S, 2013, WOMENS EMPOWERMENT N; Glover-Amengor M, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0124-1; Habyarimana F, 2016, AFR POPUL STUD, V30, P2328, DOI [10.11564/30-2-836, DOI 10.11564/30-2-836]; Hidalgo B, 2013, AM J PUBLIC HEALTH, V103, P39, DOI 10.2105/AJPH.2012.300897; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V95, P1; Kansiime N, 2017, J NUTR METAB, V2017, DOI 10.1155/2017/3427087; Mills S, 2008, MATERN CHILD HLTH J, V12, P509, DOI 10.1007/s10995-007-0288-y; Mostafa Kamal S M, 2011, Malays J Nutr, V17, P105; Nguyen Ngoc Hien, 2009, Pakistan Journal of Nutrition, V8, P958; Nikoi E, 2013, PUBLIC HEALTH NUTR, V16, P46, DOI 10.1017/S1368980012001346; Offermann B, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00044; OlaOlorun FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098702; Osumanu IK., 2013, GHANA J GEOGR, V5, P17; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Peprah D, 2015, ENVIRON URBAN, V27, P589, DOI 10.1177/0956247815595918; Rahman MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157814; Rutstein S., 2006, GUIDE DHS STAT DEMOG; Salami A., 2010, WORKING PAPER SERIES; SCHROEDER DG, 1994, B WORLD HEALTH ORGAN, V72, P569; Shetty P., 2006, MEDICINE, V34, P524, DOI [DOI 10.1053/J.MPMED.2006.09.014, 10.1053/j.mpmed.2006.09.014]; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Smith LC, 2015, WORLD DEV, V68, P180, DOI 10.1016/j.worlddev.2014.11.014; Sulaiman Amel Abdalrhim, 2018, J Family Med Prim Care, V7, P104, DOI 10.4103/jfmpc.jfmpc_73_17; Svefors P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149700; Talukder A, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4100088; Tette EMA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2853-z; UNICEF, 1991, INDIAN J PEDIATR, V58, P13, DOI [10.1007/BF02810402, DOI 10.1007/BF02810402]; Van de Poel Ellen, 2007, INT J EQUITY HLTH, V6; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wamani H., 2007, BMC Pediatrics, V7; Wemakor A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3558-z; WHO, 2017, PROGR DRINK WAT SAN; WHO, 2006, WHO CHILD GROWTH STA; World Bank Group, 2018, LEV TRENDS CHILD MAL; World Health Organization, 2010, NUTR LANDSC INF SYST, DOI 10.1159/000362780.Interpretation	60	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219665	10.1371/journal.pone.0219665	http://dx.doi.org/10.1371/journal.pone.0219665			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365528	Green Submitted, gold, Green Published			2022-12-26	WOS:000484983600014
J	Thomson, G; Balaam, MC				Thomson, Gill; Balaam, Marie-Clare			International insights into peer support in a neonatal context: A mixed-methods study	PLOS ONE			English	Article							PRETERM INFANTS; PREMATURE BIRTH; HEALTH; CARE; PARENTS; MOTHERS; IMPACT; EXPERIENCES; PROVIDERS; RECOMMENDATIONS	Peer support is a widely used intervention that offers information and emotional support to parents during their infant's admission to the neonatal unit and/or post-discharge. Despite its widespread use, there are no comprehensive insights into the nature and types of neonatal- related peer support, or the training and support offered to peer supporters. We aimed to bridge these knowledge gaps via an international study into neonatal peer support provision. A mixed-methods study comprising an online survey was issued to peer support services/organisations, and follow-up interviews held with a purposive sample of survey respondents. Survey/interview questions explored the funding, types of peer support and the recruitment, training and support for peer supporters. Descriptive and thematic analysis was undertaken. Thirty-one managers/coordinators/trainers and 77 peer supporters completed the survey from 48 peer support organisations/services in 16 different countries; with 26 interviews undertaken with 27 survey respondents. We integrated survey and interview findings into five themes: 'background and infrastructure of peer support services', 'timing, location and nature of peer support', 'recruitment and suitability of peer supporters', 'training provision' and 'professional and emotional support'. Findings highlight variations in the types of peer support provided, training and development opportunities, supervisory and mentoring arrangements and the methods of recruitment and support for peer supporters; with these differences largely related to the size, funding, multidisciplinary involvement, and level of integration of peer support within healthcare pathways and contexts. Despite challenges, promising strategies were reported across the different services to inform macro (e.g. to facilitate management and leadership support), meso (e.g. to help embed peer support in practice) and micro (e.g. to improve training, supervision and support of peer supporters) recommendations to underpin the operationalisation and delivery of PS provision.	[Thomson, Gill] Univ Cent Lancashire, Sch Community Hlth & Midwifery, MAINN, Preston, Lancs, England; [Thomson, Gill] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [Balaam, Marie-Clare] Univ Cent Lancashire, Sch Community Hlth & Midwifery, ReaCH, Preston, Lancs, England	University of Central Lancashire; Dalarna University; University of Central Lancashire	Thomson, G (corresponding author), Univ Cent Lancashire, Sch Community Hlth & Midwifery, MAINN, Preston, Lancs, England.; Thomson, G (corresponding author), Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden.	gthomson@uclan.ac.uk		Balaam, Marie-Clare/0000-0003-4511-7352; Thomson, Gill/0000-0003-3392-8182	British Academy/Leverhulme Small Grants Award [SG152947]	British Academy/Leverhulme Small Grants Award	GT received a British Academy/Leverhulme Small Grants Award. Grant number (SG152947) -https://www.thebritishacademy.ac.uk/ba-leverhulme-small-research-grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AO, 2015, COMMUNITY MENT HLT J, V51, P424, DOI 10.1007/s10597-015-9854-8; Aiken A, 2013, MIDWIFERY, V29, pE145, DOI 10.1016/j.midw.2012.12.014; Alam J, 2010, ARCH DIS CHILD, V95, pA104; Barlow JH, 2005, BRIT J HEALTH PSYCH, V10, P589, DOI 10.1348/135910705X26317; BC First Responders Mental Health, SUPP MENT HLTH 1 RES; BLISS, 2015, HANG BAL; Boukydis CFZ, 2000, CHILD HEALTH CARE, V29, P129, DOI 10.1207/S15326888CHC2902_5; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cooper LG, 2007, J PERINATOL, V27, pS32, DOI 10.1038/sj.jp.7211840; Davis L, 2003, EARLY HUM DEV, V73, P61, DOI 10.1016/S0378-3782(03)00073-2; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Elklit A, 2007, J CLIN PSYCHOL MED S, V14, P238, DOI 10.1007/s10880-007-9077-4; Flacking R, 2007, SOC SCI MED, V64, P2405, DOI 10.1016/j.socscimed.2007.03.008; Forcada-Guex M, 2011, EARLY HUM DEV, V87, P21, DOI 10.1016/j.earlhumdev.2010.09.006; Franck LS, 2011, PEDIATRICS, V128, P510, DOI 10.1542/peds.2011-0272; Gale NK, 2018, SOC SCI MED, V196, P96, DOI 10.1016/j.socscimed.2017.11.012; Gillard SG, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-188; Gordon J., 2015, DECISION MAKERS BARR; Hall SL, 2015, J PERINATOL, V35, pS9, DOI 10.1038/jp.2015.143; Hall SL, 2016, NEWBORN INFANT NURS, V16, P69, DOI 10.1053/j.nainr.2016.03.008; Heermann Judith A, 2005, Pediatr Nurs, V31, P176; Hynan MT, 2015, J PERINATOL, V35, pS1, DOI 10.1038/jp.2015.141; Ingram J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-192; Jarrett M H, 1996, Pediatr Nurs, V22, P142; Jolly K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8287; Jones CCG, 2014, MIDWIFERY, V30, P491, DOI 10.1016/j.midw.2013.08.003; Jotzo M, 2005, PEDIATRICS, V115, P915, DOI 10.1542/peds.2004-0370; Kemp V, 2012, PSYCHIATR REHABIL J, V35, P337, DOI 10.2975/35.4.2012.337.340; Kerr SM, 2000, CHILD CARE HLTH DEV, V26, P309, DOI 10.1046/j.1365-2214.2000.00149.x; MacLellan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141122; Major J, 2018, RURAL EXT INNOV SYST, V14, P1; McLeish J, 2018, PRACTISING MIDWIFE, V21, P25; McLeish J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0685-y; Miles MS, 2007, J DEV BEHAV PEDIATR, V28, P36, DOI 10.1097/01.DBP.0000257517.52459.7a; MINDE K, 1980, J PEDIATR-US, V96, P933; Moran GS, 2012, QUAL HEALTH RES, V22, P304, DOI 10.1177/1049732311420578; Morgan J., 2011, INFANT, V7, P155; Mowbray CT, 1996, COMMUNITY MENT HLT J, V32, P47, DOI 10.1007/BF02249367; Mowbray CT, 1998, J BEHAV HEALTH SER R, V25, P397, DOI 10.1007/BF02287510; National Maternity Review, 2016, BETTER BIRTHS IMPROV; National Perinatal Association (NPA), 2016, START SUST PEER SUPP; Partnership for Maternal Newborn and Child Health (PMNCH), 2012, BORN TOO SOON GLOBAL; Peers for Progress, 2014, 2014 GLOBAL EVIDENCE; Preyde M, 2003, CAN MED ASSOC J, V168, P969; Preyde M, 2007, SOC WORK HEALTH CARE, V44, P65, DOI 10.1300/J010v44n04_05; Purdy IB, 2015, J PERINATOL, V35, pS24, DOI 10.1038/jp.2015.146; Rebeiro Gruhl K, 2015, J MENT HEALTH, V25, P1; Renfrew MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub4; Repper J., 2010, USING PERSONAL EXPER; Repper J, 2011, J MENT HEALTH, V20, P392, DOI 10.3109/09638237.2011.583947; ROMAN LA, 1995, RES NURS HEALTH, V18, P385, DOI 10.1002/nur.4770180504; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Schwartz C, 2003, PSYCHOSOM MED, V65, P778, DOI 10.1097/01.PSY.0000079378.39062.D4; Shaw RJ, 2006, PSYCHOSOMATICS, V47, P206, DOI 10.1176/appi.psy.47.3.206; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Thomson G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0039-4; Thomson G, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-84; Thomson G, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-150; Trickey H, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12559; WHO, 2018, PRET BIRTH	61	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219743	10.1371/journal.pone.0219743	http://dx.doi.org/10.1371/journal.pone.0219743			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365559	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000484983600017
J	Guo, BY; Itami, J; Oikawa, K; Motoda, Y; Kigawa, T; Numata, K				Guo, Boyang; Itami, Jun; Oikawa, Kazusato; Motoda, Yoko; Kigawa, Takanori; Numata, Keiji			Native protein delivery into rice callus using ionic complexes of protein and cell-penetrating peptides	PLOS ONE			English	Article							GENE DELIVERY; TRANSFORMATION; AGROBACTERIUM; MUTATIONS; PLANTS	Direct protein delivery into intact plants remains a challenge for the agricultural and plant science fields. Cell-penetrating peptide (CPP)-mediated protein delivery requires the binding of CPPs to a protein to carry the protein into the cell through the cell wall and lipid bilayer. Thus, we prepared ionic complexes of a CPP-containing carrier peptide and a cargo protein, namely, Citrine yellow fluorescent protein, and subsequently studied their physicochemical properties. Two types of carrier peptides, BP100(KH)(9) and BP100CH(7), were investigated for delivery efficiency into rice callus. Both BP100(KH)(9) and BP100CH(7) successfully introduced Citrine protein into rice callus cells under pressure and vacuum treatment. Moreover, delivery efficiency varied at different growth stages of rice callus; 5-day rice callus was a more efficient recipient for Citrine than 21-day callus.	[Guo, Boyang; Itami, Jun; Oikawa, Kazusato; Motoda, Yoko; Numata, Keiji] RIKEN Ctr Sustainable Resource Sci, Biomacromol Res Team, Wako, Saitama, Japan; [Kigawa, Takanori] RIKEN Ctr Biosyst Dynam Res, Lab Cellular Struct Biol, Yokohama, Kanagawa, Japan	RIKEN; RIKEN	Numata, K (corresponding author), RIKEN Ctr Sustainable Resource Sci, Biomacromol Res Team, Wako, Saitama, Japan.	keiji.numata@riken.jp	Itami, Jun/AAB-1380-2022; Kigawa, Takanori/A-7679-2010; Numata, Keiji/H-9751-2012	Kigawa, Takanori/0000-0003-0146-9719; Numata, Keiji/0000-0003-2199-7420; Oikawa, Kazusato/0000-0002-1033-9089	BASF SE; Japan Science and Technology Agency Exploratory Research for Advanced Technology (JST-ERATO) [JPMJER1602]	BASF SE(BASF); Japan Science and Technology Agency Exploratory Research for Advanced Technology (JST-ERATO)	The present study was financially supported by BASF SE and grants from the Japan Science and Technology Agency Exploratory Research for Advanced Technology (JST-ERATO; Grant No. JPMJER1602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085515; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Chuah JA, 2018, BIOMACROMOLECULES, V19, P1154, DOI 10.1021/acs.biomac.8b00016; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Daniell H, 2002, NAT BIOTECHNOL, V20, P581, DOI 10.1038/nbt0602-581; Eggenberger K, 2011, CHEMBIOCHEM, V12, P132, DOI 10.1002/cbic.201000402; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Hart SL, 1998, HUM GENE THER, V9, P575, DOI 10.1089/hum.1998.9.4-575; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jiang W, 2013, NUCLEIC ACIDS RES, V41, P1; Kanchiswamy CN, 2016, PLANT CELL REP, V35, P1469, DOI 10.1007/s00299-016-1982-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Lakshmanan M, 2015, PLANT BIOTECHNOL-NAR, V32, P39, DOI 10.5511/plantbiotechnology.14.1210b; Lakshmanan M, 2013, BIOMACROMOLECULES, V14, P10, DOI 10.1021/bm301275g; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang Z., 2017, NAT PUBL GR, V8, P1, DOI DOI 10.1038/ncomms14261; LIU MJ, 2013, ADV STUD BIOL, V5, P71; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Montesinos L, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1011-9; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Ng KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144798; Numata K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29298-6; Numata K, 2016, PLANT BIOTECHNOL-NAR, V33, P403, DOI 10.5511/plantbiotechnology.16.0929a; Numata K, 2014, PLANT BIOTECHNOL J, V12, P1027, DOI 10.1111/pbi.12208; Numata K, 2012, BIOMACROMOLECULES, V13, P3450, DOI 10.1021/bm301276k; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x	27	14	14	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0214033	10.1371/journal.pone.0214033	http://dx.doi.org/10.1371/journal.pone.0214033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361745	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300004
J	Herzog, SA; Leikauf, G; Jakse, H; Siebenhofer, A; Haeusler, M; Berghold, A				Herzog, Sereina Annik; Leikauf, Gudrun; Jakse, Heidelinde; Siebenhofer, Andrea; Haeusler, Martin; Berghold, Andrea			Prevalence of anemia in pregnant women in Styria, Austria-A retrospective analysis of mother-child examinations 2006-2014	PLOS ONE			English	Article								Background Many women suffer from anemia during their pregnancy. Austria, a central European country, has an instituted mandatory prenatal care system and therein two anemia screening tests (before end of week 16 and in weeks 25-28) are scheduled. Epidemiological data on the prevalence of anemia in pregnant women in Austria are missing. Methods We analysed data from Styria, an Austrian federal state, to determine the prevalence of anemia diagnosed in pregnant women aged 15-45 years with at least one examination in the first and second time period using the cut-off hemoglobin (Hb) concentration of 11 g/dl as recommended by the World Health Organisation (WHO). Sensitivity analyses for cut-off values with 10.5 and 7 g/dl (severe anemia) were performed. The STROBE checklist was applied for this retrospective cohort study. Results The study included anemia screening tests from 25,922 women during 31,429 pregnancies from 2006-2014. Anemia was diagnosed in either time period in 13.7% (95% confidence interval (CI) 13.4-14.1) of pregnancies, in the first time period in 2.2% (95% CI 2.0-2.2), and in the second time period in 13.0% (95% CI 12.6-13.4). The annual age-adjusted anemia prevalence showed no change over time. Reducing the cut-off value to 10.5 g/dl resulted in an anemia prevalence in either time period of 5.6% (95% CI 5.3-5.8). The pattern of a higher prevalence in the second time period remained unchanged. Severe anemia (Hb < 7 g/dl) was diagnosed in four pregnancies (0.01%). Conclusion The estimated anemia prevalence of around 14% in pregnant women in Styria (Austria) is stable over the observed time window (2006-2014) and almost all are diagnosed in the second test period (in weeks 25-28). It seems that in a developed country like Austria the first examination (before week 16) is not mandatory for pregnancy care. However, in other countries where a high prevalence of anemia is common due to risk factors such as malaria and HIV, early screening in pregnancy might be very important.	[Herzog, Sereina Annik; Leikauf, Gudrun; Berghold, Andrea] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Jakse, Heidelinde] Stmk GKK, Steiermark Gebietskrank, Styrian State Hlth Insurance Clin, Mother Child Booklet Serv, Graz, Austria; [Siebenhofer, Andrea] Med Univ Graz, Inst Gen Practice & Evidence Based Hlth Serv Res, Graz, Austria; [Siebenhofer, Andrea] Goethe Univ Frankfurt Main, Inst Gen Practice, Frankfurt, Germany; [Haeusler, Martin] Med Univ Graz, Div Obstet & Maternal Fetal Med, Dept Obstet & Gynecol, Graz, Austria; [Herzog, Sereina Annik] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO), Ctr Hlth Econ Res & Modelling Infect Dis CHERMID, Antwerp, Belgium	Medical University of Graz; Medical University of Graz; Goethe University Frankfurt; Medical University of Graz; University of Antwerp	Herzog, SA (corresponding author), Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria.; Herzog, SA (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO), Ctr Hlth Econ Res & Modelling Infect Dis CHERMID, Antwerp, Belgium.	herzog.sereina@gmail.com	Herzog, Sereina A/K-8865-2017	Herzog, Sereina A/0000-0002-5373-5866; Siebenhofer-Kroitzsch, Andrea/0000-0002-6980-2103				[Anonymous], 2001, IRON DEFICIENCY ANAE; Berghold C, 2016, EUROSURVEILLANCE, V21, P17, DOI 10.2807/1560-7917.ES.2016.21.33.30317; Bundesministerium fur Digitalisierung und Wirtschaftsstandort, MUTT KIND PASS UNT S; Bundesministerium fur Frauen und Gesundheit, 2017, WEIT MUTT KIND PASS; Bundesministerium fur Frauen und Gesundheit, 2017, MUTT KIND PASS BUND; deBenoist B, 2008, WORLDWIDE PREVALENCE; Department of Veterans Affairs/ Department of Defense, 2009, VA DOD CLIN PRACT GU; Dowdle W., 1989, MMWR MORB MORTAL WKL, V38; Ezugwu EC, 2013, J OBSTET GYNAECOL, V33, P451, DOI 10.3109/01443615.2013.771158; Kirschner W, 2016, FRAUENARZT, V57, P1124; Kozuki N, 2012, J NUTR, V142, P358, DOI 10.3945/jn.111.149237; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; National Institute for Health and Clinical Excellence, 2012, ANT CAR; R Core Team, 2021, R LANGUAGE ENV STAT; Reinsperger I, 2013, ELTERN KIND VORSOR 9; Rogerson SJ, 2017, INDIAN J MED RES, V146, P328, DOI 10.4103/ijmr.IJMR_1304_17; Spary-Kainz U, 2019, WIENER KLIN WOCHENSC; Steer PJ, 2000, AM J CLIN NUTR, V71, p1285S, DOI 10.1093/ajcn/71.5.1285s; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; WHO-WORLD HEALTH ORGANIZATION, 2014, GLOB NUTR TARG 2025; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219703	10.1371/journal.pone.0219703	http://dx.doi.org/10.1371/journal.pone.0219703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344117	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900026
J	Inglis, EC; Iannetta, D; Murias, JM				Inglis, Erin Calaine; Iannetta, Danilo; Murias, Juan M.			Evaluating the NIRS-derived microvascular O-2 extraction "reserve" in groups varying in sex and training status using leg blood flow occlusions	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; LACTATE STEADY-STATE; FUNCTION IN-VIVO; MUSCLE DEOXYGENATION; SKELETAL-MUSCLE; INCREMENTAL EXERCISE; OXIDATIVE FUNCTION; OXYGEN EXTRACTION; HEALTHY-ADULTS; EX-VIVO	It has been demonstrated that the plateau in the near-infrared spectroscopy (NIRS) derived deoxygenated hemoglobin and myoglobin (deoxy[Hb+Mb]) signal (i.e., deoxy[Hb +Mb](PLATEAU)) towards the end of a ramp-incremental (RI) test does not represent the upper-limit in O-2 extraction of the vastus lateralis (VL) muscle, given that an O-2 extraction reserve has been recently observed. This study aimed to investigate whether this O-2 extraction reserve was present in various populations and whether it exhibited sex- and/or training-related differences. Sixteen men-8 untrained (27 +/- 5 years; 83 +/- 11 kg; 179 +/- 9 cm), 8 trained (27 +/- 4 years; 82 +/- 10 kg; 182 +/- 8 cm) and 9 trained women (27 +/- 2 years; 66 +/- 10 kg; 172 +/- 6 cm) performed a RI cycling test to exhaustion. The NIRS-derived deoxy [Hb+Mb] signal was measured continuously on the VL as a proxy for O-2 extraction. A leg blood flow occlusion (i.e., ischemia) was performed at rest (LBFOCC 1) and immediately post the RI test (LBFOCC 2). No significant difference was found between the deoxy[Hb +Mb] amplitude during LBFOCC 1 and the deoxy[Hb+Mb](PLATEAU) (p>0.05) nor between baseline (bsln) deoxy[Hb+Mb] values. deoxy[Hb+Mb] amplitude during LBFOCC 2 was significantly greater than LBFOCC 1 and at deoxy[Hb+Mb](PLATEAU) (p<0.05) with group means similar to 30-45% higher than the deoxy[Hb+Mb](PLATEAU) and LBFOCC 1 (p<0.05). No significant differences were found between groups in O-2 extraction reserve, regardless of sex-or training-statusThe results of this study demonstrated the existence of an O-2 extraction reserve in different populations, and that neither sex-nor training-related differences affect the amplitude of the reserve.	[Inglis, Erin Calaine; Iannetta, Danilo; Murias, Juan M.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	University of Calgary	Murias, JM (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	jmmurias@ucalgary.ca		Inglis, Erin Calaine/0000-0003-4517-4269	Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Sciences and Engineering Research Council of Canada. Erin Calaine Inglis was supported by the Natural Sciences and Engineering Research Council - Master's award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami A, 2015, J APPL PHYSIOL, V118, P1091, DOI 10.1152/japplphysiol.00918.2014; ANDERSEN P, 1975, ACTA PHYSIOL SCAND, V95, P203, DOI 10.1111/j.1748-1716.1975.tb10043.x; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bellotti C, 2013, MED SCI SPORT EXER, V45, P1208, DOI 10.1249/MSS.0b013e3182828ab2; Black MI, 2017, J APPL PHYSIOL, V122, P446, DOI 10.1152/japplphysiol.00942.2016; Boone J, 2016, EUR J APPL PHYSIOL, V116, P2085, DOI 10.1007/s00421-016-3468-x; Boone J, 2012, SPORTS MED, V42, P511, DOI 10.2165/11599690-000000000-00000; Boone J, 2009, EUR J APPL PHYSIOL, V105, P851, DOI 10.1007/s00421-008-0969-2; Calbet JAL, 2007, J APPL PHYSIOL, V103, P969, DOI 10.1152/japplphysiol.01281.2006; Cannon DT, 2013, J APPL PHYSIOL, V115, P839, DOI 10.1152/japplphysiol.00510.2013; Celie B, 2012, EUR J APPL PHYSIOL, V112, P2369, DOI 10.1007/s00421-011-2183-x; Charkoudian N, 2004, CLIN CHEST MED, V25, P247, DOI 10.1016/j.ccm.2004.01.001; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Craig JC, 2017, J APPL PHYSIOL, V123, P1571, DOI 10.1152/japplphysiol.00207.2017; Esaki K, 2005, EUR J APPL PHYSIOL, V95, P361, DOI 10.1007/s00421-005-0008-5; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Fontana FY, 2015, J SCI MED SPORT, V18, P590, DOI 10.1016/j.jsams.2014.07.016; Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708; Grassi B, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091313; Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Iannetta D, 2018, SCAND J MED SCI SPOR, V28, P2481, DOI 10.1111/sms.13280; Iannetta D, 2018, J APPL PHYSIOL, V125, P313, DOI 10.1152/japplphysiol.00154.2018; Iannetta D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00686; Inglis EC, 2020, INT J SPORT PHYSIOL, V15, P119, DOI 10.1123/ijspp.2019-0046; Inglis EC, 2017, AM J PHYSIOL-REG I, V313, pR723, DOI 10.1152/ajpregu.00261.2017; Just TP, 2016, PHYSL REP, V4, P1, DOI [10.14814/phy2, DOI 10.14814/PHY2]; Keir DA, 2015, MED SCI SPORT EXER, V47, P1932, DOI 10.1249/MSS.0000000000000613; Kellawan JM, 2015, EUR J APPL PHYSIOL, V115, P1735, DOI 10.1007/s00421-015-3160-6; Koga S, 2007, J APPL PHYSIOL, V103, P2049, DOI 10.1152/japplphysiol.00627.2007; Lannetta D, 2017, J SCI MED SPORT, V20, P873, DOI 10.1016/j.jsams.2017.01.237; Laughlin MH, 2012, COMPR PHYSIOL, V2, P321, DOI 10.1002/cphy.c100048; LEINONEN H, 1978, SCAND J CLIN LAB INV, V38, P223, DOI 10.3109/00365517809108415; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2955, DOI 10.1113/JP272570; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; Marzorati M, 2012, MED SCI SPORT EXER, V44, P771, DOI 10.1249/MSS.0b013e31823e6579; Morales-Alamo D, 2015, J PHYSIOL-LONDON, V593, P4631, DOI 10.1113/JP270487; Murias JM, 2013, RESP PHYSIOL NEUROBI, V189, P530, DOI 10.1016/j.resp.2013.08.011; Murias JM, 2013, AM J PHYSIOL-REG I, V304, pR720, DOI 10.1152/ajpregu.00016.2013; Murias JM, 2010, MED SCI SPORT EXER, V42, P1891, DOI 10.1249/MSS.0b013e3181dd0bba; Murias JM, 2010, J APPL PHYSIOL, V108, P621, DOI 10.1152/japplphysiol.01152.2009; Okushima D, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13065; Okushima D, 2015, J APPL PHYSIOL, V119, P1313, DOI 10.1152/japplphysiol.00574.2015; Parker BA, 2007, J APPL PHYSIOL, V103, P1583, DOI 10.1152/japplphysiol.00662.2007; Porcelli S, 2010, J APPL PHYSIOL, V109, P101, DOI 10.1152/japplphysiol.00782.2009; RICHARDSON RS, 1993, J APPL PHYSIOL, V75, P1911, DOI 10.1152/jappl.1993.75.4.1911; ROCA J, 1992, J APPL PHYSIOL, V73, P1067; Ryan TE, 2014, J PHYSIOL-LONDON, V592, P3231, DOI 10.1113/jphysiol.2014.274456; Salvadego D, 2018, J PHYSIOL-LONDON, V596, P3341, DOI 10.1113/JP275605; Salvadego D, 2016, J APPL PHYSIOL, V121, P154, DOI 10.1152/japplphysiol.00832.2015; Salvadego D, 2013, J APPL PHYSIOL, V114, P1527, DOI 10.1152/japplphysiol.00883.2012; Southern WM, 2014, APPL PHYSIOL NUTR ME, V39, P521, DOI 10.1139/apnm-2013-0347; Spencer MD, 2014, J APPL PHYSIOL, V117, P1199, DOI 10.1152/japplphysiol.00060.2014; Spencer MD, 2012, EUR J APPL PHYSIOL, V112, P3349, DOI 10.1007/s00421-012-2323-y; WAGNER PD, 1991, SPORTS MED, V11, P133, DOI 10.2165/00007256-199111030-00001	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220192	10.1371/journal.pone.0220192	http://dx.doi.org/10.1371/journal.pone.0220192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344091	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900065
J	Kimura, Y; Honda, M; Sasaki, R; Yumioka, T; Iwamoto, H; Tsounapi, P; Morizane, S; Hikita, K; Osaki, M; Okada, F; Takenaka, A				Kimura, Yusuke; Honda, Masashi; Sasaki, Ryo; Yumioka, Tetsuya; Iwamoto, Hideto; Tsounapi, Panagiota; Morizane, Shuichi; Hikita, Katsuya; Osaki, Mitsuhiko; Okada, Futoshi; Takenaka, Atsushi			The circadian rhythm of bladder clock genes in the spontaneously hypersensitive rat	PLOS ONE			English	Article							EVOKED CA2+ INFLUX; MAMMALIAN CLOCK; ATP RELEASE; COORDINATION; BMAL1	Circadian expression rhythms of clock gene products in the bladder are reportedly hindered by clock gene abnormalities. However, the role of clock gene products in various pathological lower urinary tract conditions is unknown. The present study examined the relationship between clock genes and voiding dysfunction in spontaneous hypertensive rats (SHR). The voluntary voiding behavior study using metabolic cages was performed in 18-weeks old male Wistar rats (control group, n = 36) and SHR (SHR group, n = 36) under 12-h light/12-h dark conditions. Bladders were harvested every 4 h at six time points (n = 6 for each time point for each group), and we analyzed the messenger RNA (mRNA) expression of several clock genes: period 2 (Per2), cryptochrome 2 (Cry2), brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1 (Bmal1), circadian locomotor output cycles kaput (Clock), nuclear receptor subfamily 1, group D, member 1 (Rev-erba), mechanosensors: transient receptor potential vanilloid channel 1 (TRPV1), TRPV4, Piezo1, and vesicular nucleotide transporter (VNUT) using real-time polymerase chain reaction. Though 24-h urination frequency for both light and dark periods was significantly higher in the SHR group, urine volume per voiding was significantly lower versus control. In controls, urine volume per voiding was significantly lower during the dark period (active phase) than the light period (rest phase); this parameter did not significantly differ between active and rest phases for SHR. SHR bladders showed significantly higher expression of Cry2 and Clock during the active phase compared to controls. In the SHR group, TRPV1, TRPV4, Piezo1, and VNUT mRNA levels were significantly higher during the active phase compared to the control group. We speculate that Cry2 and Clock may be contributing factors in the decrease of bladder capacity during the active phase in SHR through increase of TRPV1, TRPV4, Piezo1, and VNUT expression, but further research will be necessary to elucidate the precise mechanisms.	[Kimura, Yusuke; Honda, Masashi; Yumioka, Tetsuya; Iwamoto, Hideto; Tsounapi, Panagiota; Morizane, Shuichi; Hikita, Katsuya; Takenaka, Atsushi] Tottori Univ, Fac Med, Div Urol, Yonago, Tottori, Japan; [Kimura, Yusuke; Sasaki, Ryo; Osaki, Mitsuhiko; Okada, Futoshi] Tottori Univ, Fac Med, Div Pathol Biochem, Yonago, Tottori, Japan; [Osaki, Mitsuhiko; Okada, Futoshi] Tottori Univ, Fac Med, Chromosome Engn Res Ctr, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University	Kimura, Y (corresponding author), Tottori Univ, Fac Med, Div Urol, Yonago, Tottori, Japan.; Kimura, Y (corresponding author), Tottori Univ, Fac Med, Div Pathol Biochem, Yonago, Tottori, Japan.	k.yusuke@tottori-u.ac.jp		Okada, Futoshi/0000-0003-4733-1037; Kimura, Yusuke/0000-0003-4492-0506				Apostolidis A, 2005, UROLOGY, V65, P400, DOI 10.1016/j.urology.2004.10.007; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Carley DW, 1996, PHYSIOL BEHAV, V59, P827, DOI 10.1016/0031-9384(95)02205-8; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Herrera GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012298; Ihara T, 2018, NEUROUROL URODYNAM, V37, P942, DOI 10.1002/nau.23400; Ihare T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168234; Inoue S, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.12.032; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; LEMMER B, 1993, HYPERTENSION, V22, P97, DOI 10.1161/01.HYP.22.1.97; Matono T, 2010, INT J MOL MED, V25, P875, DOI 10.3892/ijmm_00000417; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nakagomi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29761; Negoro H, 2012, NATURE COMMUNICATION, P3, DOI [10.1038/NCOMMS1812WOS:000304611400009, DOI 10.1038/NCOMMS1812WOS:000304611400009]; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sladek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046951; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tamaru T, 2000, J NEUROSCI, V20, P7525; Tarcan T, 1998, BRIT J UROL, V82, P26; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Yang SC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13602; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220381	10.1371/journal.pone.0220381	http://dx.doi.org/10.1371/journal.pone.0220381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344120	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900095
J	Mrazkova, J; Malinovska, L; Wimmerova, M				Mrazkova, Jana; Malinovska, Lenka; Wimmerova, Michaela			Microscopy examination of red blood and yeast cell agglutination induced by bacterial lectins	PLOS ONE			English	Article							AERUGINOSA PA-IIL; C-TYPE LECTIN; BINDING-PROTEIN; FUCOSE; MUTAGENESIS; AFFINITY; IDENTIFICATION; PURIFICATION; ARCHITECTURE; ASSAY	Lectins are a group of ubiquitous proteins which specifically recognize and reversibly bind sugar moieties of glycoprotein and glycolipid constituents on cell surfaces. The mutagenesis approach is often employed to characterize lectin binding properties. As lectins are not enzymes, it is not easy to perform a rapid specificity screening of mutants using chromogenic substrates. It is necessary to use different binding assays such as isothermal titration calorimetry (ITC), surface plasmon resonance (SPR), microscale thermophoresis (MST), enzyme-linked lectin assays (ELLA), or glycan arrays for their characterization. These methods often require fluorescently labeled proteins (MST), highly purified proteins (SPR) or high protein concentrations (ITC). Mutant proteins may often exhibit problematic behaviour, such as poor solubility or low stability. Lectin-based cell agglutination is a simple and low-cost technique which can overcome most of these problems. In this work, a modified method of the agglutination of human erythrocytes and yeast cells with microscopy detection was successfully used for a specificity study of the newly prepared mutant lectin RS-IIL_A22S, which experimentally completed studies on sugar preferences of lectins in the PA-IIL family. Results showed that the sensitivity of this method is comparable with ITC, is able to determine subtle differences in lectin specificity, and works directly in cell lysates. The agglutination method with microscopy detection was validated by comparison of the results with results obtained by agglutination assay in standard 96-well microtiter plate format. In contrast to this assay, the microscopic method can clearly distinguish between hemagglutination and hemolysis. Therefore, this method is suitable for examination of lectins with known hemolytic activity as well as mutant or uncharacterized lectins, which could damage red blood cells. This is due to the experimental arrangement, which includes very short sample incubation time in combination with microscopic detection of agglutinates, that are easily observed by a small portable microscope.	[Mrazkova, Jana; Wimmerova, Michaela] Masaryk Univ, Fac Sci, Dept Biochem, Brno, Czech Republic; [Mrazkova, Jana; Malinovska, Lenka; Wimmerova, Michaela] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic; [Malinovska, Lenka; Wimmerova, Michaela] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno	Wimmerova, M (corresponding author), Masaryk Univ, Fac Sci, Dept Biochem, Brno, Czech Republic.; Wimmerova, M (corresponding author), Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic.; Wimmerova, M (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	michaw@chemi.muni.cz	Malinovska, Lenka/D-7197-2012; Wimmerova, Michaela/A-4114-2010	Malinovska, Lenka/0000-0002-4211-3033; Wimmerova, Michaela/0000-0002-7108-4198; Sistkova, Jana/0000-0001-6378-1631	Czech Science Foundation [18-18964S]; Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 [LQ1601]; MEYS CR [LM2015043]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020; MEYS CR	This work was supported by the Czech Science Foundation (http://gacr.cz, 18-18964S) to LM and MW and by the Ministry of Education, Youth and Sports of the Czech Republic (http://msmt.cz) under the project CEITEC 2020 (LQ1601). CIISB research infrastructure project LM2015043 funded by MEYS CR (http://msmt.cz) is also acknowledged for the financial support of the measurements at the CF Biomolecular Interactions and Crystallization, CEITEC, Masaryk University, Brno, Czech Republic (http://bic.ceitec.eu).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-36; Adam J, 2008, J CHEM INF MODEL, V48, P2234, DOI 10.1021/ci8002107; Adamova L, 2014, MICROSC RES TECHNIQ, V77, P841, DOI 10.1002/jemt.22407; Argayosa AM, 2011, AQUACULTURE, V310, P274, DOI 10.1016/j.aquaculture.2010.11.002; Arnaud J, 2014, ANGEW CHEM INT EDIT, V53, P9267, DOI 10.1002/anie.201404568; Athamna A, 2006, J MICROBIOL METH, V65, P209, DOI 10.1016/j.mimet.2005.07.008; Audfray A, 2013, CR CHIM, V16, P482, DOI 10.1016/j.crci.2012.11.021; Bhari R, 2016, BRAZ J MICROBIOL, V47, P775, DOI 10.1016/j.bjm.2016.04.024; Bose Partha Pratim, 2016, Biochem Biophys Rep, V6, P242, DOI 10.1016/j.bbrep.2016.05.001; Coelho LCBB, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/1594074; Christie MP, 2014, FUTURE MED CHEM, V6, P2113, DOI 10.4155/fmc.14.130; COFFEY DG, 1985, J FOOD SCI, V50, P78, DOI 10.1111/j.1365-2621.1985.tb13281.x; Csavas M, 2017, CARBOHYD RES, V437, P1, DOI 10.1016/j.carres.2016.11.008; FLEMMING C, 1992, ANAL BIOCHEM, V205, P251, DOI 10.1016/0003-2697(92)90431-6; Gabius HJ, 2017, HISTOCHEM CELL BIOL, V147, P111, DOI 10.1007/s00418-016-1521-9; Gasmi L, 2017, BIOSENSORS-BASEL, V7, DOI 10.3390/bios7010012; Gilboa-Garber N, 2000, FEMS IMMUNOL MED MIC, V29, P53, DOI 10.1111/j.1574-695X.2000.tb01505.x; Gurnani P, 2016, POLYMER, V106, P229, DOI 10.1016/j.polymer.2016.08.093; Hu D, 2012, J BIOL CHEM, V287, P20313, DOI 10.1074/jbc.M112.351965; Hyono A, 2009, LANGMUIR, V25, P10873, DOI 10.1021/la900087c; Ielasi FS, 2014, GLYCOBIOLOGY, V24, P1312, DOI 10.1093/glycob/cwu075; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Kauscher U, 2012, BEILSTEIN J ORG CHEM, V8, P1543, DOI 10.3762/bjoc.8.175; Keogh D, 2014, BBA-GEN SUBJECTS, V1840, P2091, DOI 10.1016/j.bbagen.2014.01.020; Khan F, 2002, MED SCI MONITOR, V8; Kline TR, 2008, ANAL CHEM, V80, P6190, DOI 10.1021/ac800485q; Klukova L, 2014, ANAL METHODS-UK, V6, P4922, DOI 10.1039/c4ay00495g; Kosobokova EN, 2016, BIOCHEMISTRY-MOSCOW+, V81, P187, DOI 10.1134/S0006297916030019; Kovalchuk SN, 2015, FISH SHELLFISH IMMUN, V47, P565, DOI 10.1016/j.fsi.2015.09.045; Kuo JCH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24231; Lameignere E, 2008, BIOCHEM J, V411, P307, DOI [10.1042/BJ20071276, 10.1042/bj20071276]; Maierhofer C, 2007, BIOORGAN MED CHEM, V15, P7661, DOI 10.1016/j.bmc.2007.08.063; MIRELMAN D, 1980, J CLIN MICROBIOL, V11, P328, DOI 10.1128/JCM.11.4.328-331.1980; Mrazkova J, 2017, METHODS MOL BIOL, V1498, P399, DOI 10.1007/978-1-4939-6472-7_28; Munoz A, 2003, MYCOSES, V46, P85, DOI 10.1046/j.1439-0507.2003.00815.x; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Pina AS, 2014, BIOTECHNOL ADV, V32, P366, DOI 10.1016/j.biotechadv.2013.12.001; Pokorna M, 2006, BIOCHEMISTRY-US, V45, P7501, DOI 10.1021/bi060214e; Sano K, 2014, METHODS MOL BIOL, V1200, P47, DOI 10.1007/978-1-4939-1292-6_4; Seth M, 2011, AM J VET RES, V72, P203, DOI 10.2460/ajvr.72.2.203; SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949; Sivakamavalli J, 2013, FISH SHELLFISH IMMUN, V35, P689, DOI 10.1016/j.fsi.2013.05.017; Sudakevitz D, 2004, MOL MICROBIOL, V52, P691, DOI 10.1111/j.1365-2958.2004.04020.x; Sulak O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002238; Swanson MD, 2015, CELL, V163, P746, DOI 10.1016/j.cell.2015.09.056; Tsutsui S, 2007, MOL IMMUNOL, V44, P691, DOI 10.1016/j.molimm.2006.04.023; Wang L, 2017, FISH SHELLFISH IMMUN, V67, P382, DOI 10.1016/j.fsi.2017.06.012; Wang XY, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00692-17; Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006; Worstell NC, 2019, COLLOID SURFACE B, V175, P84, DOI 10.1016/j.colsurfb.2018.11.069; Yu SS, 2013, FISH SHELLFISH IMMUN, V34, P582, DOI 10.1016/j.fsi.2012.11.033; Zhang JD, 2017, ANAL BIOCHEM, V518, P94, DOI 10.1016/j.ab.2016.11.015; Zhao W, 2019, ANAL BIOCHEM, V571, P37, DOI 10.1016/j.ab.2019.02.016; Zinger-Yosovich K, 2006, MICROBIOL-SGM, V152, P457, DOI 10.1099/mic.0.28500-0	54	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220318	10.1371/journal.pone.0220318	http://dx.doi.org/10.1371/journal.pone.0220318			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344098	Green Submitted, Green Published, gold			2022-12-26	WOS:000484977900081
J	Boucsein, A; Rizwan, MZ; Tups, A				Boucsein, Alisa; Rizwan, Mohammed Z.; Tups, Alexander			Hypothalamic leptin sensitivity and health benefits of time-restricted feeding are dependent on the time of day in male mice	FASEB JOURNAL			English	Article						energy metabolism; periodic fasting; daily rhythm; biological clock; diet	CIRCADIAN ORGANIZATION; FOOD-INTAKE; RESISTANCE; METABOLISM; OBESITY; RHYTHMS; PROTEIN; CLOCK	Synchronization between biologic clocks and metabolism is crucial for most species. Here, we examined the ability of leptin, important in the control of energy metabolism, to induce leptin signaling at the molecular as well as the behavioral level throughout the 24-h day in mice fed either a control or a high-fat diet (HFD). Furthermore, we investigated the effects of time-restricted feeding (TRF; a limitation of HFD access to 6 h each day) on energy metabolism during different periods throughout the 24-h day. In control mice, molecular leptin sensitivity was highest at zeitgeber time (ZT)0 (lights on), declining during the light phase, and increasing during the dark phase. Surprisingly, leptin resistance in HFD-fed mice was only present from the middle of the dark to the middle of the light period. Specifically, when TRF occurred from ZT21 to ZT3 (when leptin resistance in HFD-fed mice was most profound), it resulted in a disruption of the daily rhythms of locomotor activity and energy expenditure and in increased plasma insulin levels compared with other TRF periods. These data provide evidence that leptin sensitivity is controlled by the circadian rhythm and that TRF periods may be most efficient when aligned with the leptin-sensitive period.	[Boucsein, Alisa; Rizwan, Mohammed Z.; Tups, Alexander] Univ Otago, Brain Hlth Res Ctr, Ctr Neuroendocrinol, Dept Physiol, Dunedin, New Zealand; [Rizwan, Mohammed Z.] Univ Otago, Sch Biomed Sci, Dept Anat, Dunedin, New Zealand; [Tups, Alexander] Philipps Univ Marburg, Dept Anim Physiol, Fac Biol, Marburg, Germany; [Rizwan, Mohammed Z.; Tups, Alexander] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand	University of Otago; University of Otago; Philipps University Marburg; University of Auckland	Tups, A (corresponding author), Univ Otago, Dept Physiol, Great King St,POB 56, Dunedin 9054, New Zealand.	alexander.tups@otago.ac.nz		Boucsein, Alisa/0000-0002-6266-8802	German Ministry of Education and Research; German Research Foundation; Royal Society of New Zealand; British Society for Neuroendocrinology	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Royal Society of New Zealand(Royal Society of New Zealand); British Society for Neuroendocrinology	This work was supported by the German Ministry of Education and Research and by the German Research Foundation (to A.T.), the Royal Society of New Zealand (to A.T. and A.B.), and the British Society for Neuroendocrinology (to A.B.). The authors declare no conflicts of interest.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Benzler J, 2013, ENDOCRINOLOGY, V154, P4737, DOI 10.1210/en.2013-1746; Benzler J, 2012, BIOCHEM J, V447, P175, DOI 10.1042/BJ20120834; Branecky KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137970; Bunney PE, 2017, PHYSIOL BEHAV, V176, P139, DOI 10.1016/j.physbeh.2017.03.040; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Coomans CP, 2013, DIABETES, V62, P1102, DOI 10.2337/db12-0507; Delahaye LB, 2018, APPL PHYSIOL NUTR ME, V43, P1033, DOI 10.1139/apnm-2017-0706; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gerhart-Hines Z, 2015, ENDOCR REV, V36, P289, DOI 10.1210/er.2015-1007; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Koch CE, 2014, J NEUROENDOCRINOL, V26, P58, DOI 10.1111/jne.12131; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Pendergast JS, 2013, EUR J NEUROSCI, V37, P1350, DOI 10.1111/ejn.12133; Piekorz R, 1998, BIOCHEM BIOPH RES CO, V250, P436, DOI 10.1006/bbrc.1998.9335; Prolo P, 1998, INT J BIOCHEM CELL B, V30, P1285, DOI 10.1016/S1357-2725(98)00094-6; Rizwan MZ, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12481; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Romanatto T, 2007, PEPTIDES, V28, P1050, DOI 10.1016/j.peptides.2007.03.006; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Skinner NJ, 2019, ENDOCRINOLOGY, V160, P2257, DOI 10.1210/en.2018-00935; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tan K, 2014, MOL METAB, V3, P694, DOI 10.1016/j.molmet.2014.07.002; Tups A, 2012, J COMP PHYSIOL B, V182, P553, DOI 10.1007/s00360-011-0637-4; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wilsey J, 2004, J ENDOCRINOL, V181, P297, DOI 10.1677/joe.0.1810297; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	46	10	10	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12175	12187		10.1096/fj.201901004R	http://dx.doi.org/10.1096/fj.201901004R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366239	Green Published, Bronze			2022-12-26	WOS:000507461600045
J	Ilyas, H; Kim, J; Lee, D; Malmsten, M; Bhunia, A				Ilyas, Humaira; Kim, JaeWoong; Lee, DongKuk; Malmsten, Martin; Bhunia, Anirban			Structural insights into the combinatorial effects of antimicrobial peptides reveal a role of aromatic-aromatic interactions in antibacterial synergism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); lipopolysaccharide (LPS); antimicrobial peptide (AMP); antibiotic resistance; peptide conformation; synergism; transferred NOESY	HOST-DEFENSE PEPTIDES; MEMBRANE INTERACTIONS; PROTEIN STRUCTURES; PLANT-DISEASE; NMR STRUCTURE; MAGAININ 2; LIPOPOLYSACCHARIDE; RESISTANCE; MICELLES; SPECTROSCOPY	The recent development of plants that overexpress antimicrobial peptides (AMPs) provides opportunities for controlling plant diseases. Because plants employ a broad-spectrum antimicrobial defense, including those based on AMPs, transgenic modification for AMP overexpression represents a potential way to utilize a defense system already present in plants. Herein, using an array of techniques and approaches, we report on VG16KRKP and KYE28, two antimicrobial peptides, which in combination exhibit synergistic antimicrobial effects against plant pathogens and are resistant against plant proteases. Investigating the structural origin of these synergistic antimicrobial effects with NMR spectroscopy of the complex formed between these two peptides and their mutated analogs, we demonstrate the formation of an unusual peptide complex, characterized by the formation of a bulky hydrophobic hub, stabilized by aromatic zippers. Using three-dimensional structure analyses of the complex in bacterial outer and inner membrane components and when bound to lipopolysaccharide (LPS) or bacterial membrane mimics, we found that this structure is key for elevating antimicrobial potency of the peptide combination. We conclude that the synergistic antimicrobial effects of VG16KRKP and KYE28 arise from the formation of a well-defined amphiphilic dimer in the presence of LPS and also in the cytoplasmic bacterial membrane environment. Together, these findings highlight a new application of solution NMR spectroscopy to solve complex structures to study peptide-peptide interactions, and they underscore the importance of structural insights for elucidating the antimicrobial effects of AMP mixtures.	[Ilyas, Humaira; Bhunia, Anirban] Bose Inst, Dept Biophys, P-1-12 CIT Scheme 7 M, Kolkata 700054, India; [Kim, JaeWoong; Lee, DongKuk] Seoul Natl Univ Sci & Technol, Dept Fine Chem, Seoul 139743, South Korea; [Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden; [Malmsten, Martin] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark	Department of Science & Technology (India); Bose Institute; Seoul National University of Science & Technology; Uppsala University; University of Copenhagen	Bhunia, A (corresponding author), Bose Inst, Dept Biophys, P-1-12 CIT Scheme 7 M, Kolkata 700054, India.; Malmsten, M (corresponding author), Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden.; Malmsten, M (corresponding author), Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark.	martin.malmsten@sund.ku.dk; bhunia@jcbose.ac.in		Ilyas, Humaira/0000-0002-5784-9086; Bhunia, Anirban/0000-0002-8752-2842; Malmsten, Martin/0000-0003-0046-5599	India-Swedish (DST-VR) Programme of Cooperation in Science & Technology Project [2015-06720, DST/INT/SWD/VR/P-02/2016]; Science and Engineering Research Board from the Government of India [EMR/2017/003457]; LEO Foundation Center for Cutaneous Drug Delivery [2016-11-01]; LEO Foundation [LF15007] Funding Source: researchfish	India-Swedish (DST-VR) Programme of Cooperation in Science & Technology Project; Science and Engineering Research Board from the Government of India; LEO Foundation Center for Cutaneous Drug Delivery; LEO Foundation	This work was supported by the India-Swedish (DST-VR) Programme of Cooperation in Science & Technology Project 2015-06720 or DST/INT/SWD/VR/P-02/2016 (to M. M. and A. B.), Science and Engineering Research Board File No. EMR/2017/003457 (to A. B.) from the Government of India, and LEO Foundation Center for Cutaneous Drug Delivery Grant 2016-11-01 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ALEXANDER D, 1993, P NATL ACAD SCI USA, V90, P7327, DOI 10.1073/pnas.90.15.7327; Anjana R, 2012, BIOINFORMATION, V8, P1220, DOI 10.6026/97320630081220; [Anonymous], 2017, PYMOL MOL GRAPHICS S; Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Bechinger B, 2012, CHEM PHYS LIPIDS, V165, P282, DOI 10.1016/j.chemphyslip.2012.01.009; Bhattacharjya S, 2010, CURR MED CHEM, V17, P3080, DOI 10.2174/092986710791959756; Bhattacharyya D, 2019, BBA-BIOMEMBRANES, V1861, P798, DOI 10.1016/j.bbamem.2019.01.011; Bhunia A, 2011, J BIOL CHEM, V286, P24394, DOI 10.1074/jbc.M110.189662; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Biswaro LS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00855; Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200; Bremmer DN, 2016, ANTIMICROB AGENTS CH, V60, P6892, DOI 10.1128/AAC.00981-16; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BROGLIE K, 1991, SCIENCE, V254, P1194, DOI 10.1126/science.254.5035.1194; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Cabrita LD, 2011, METHODS MOL BIOL, V752, P97, DOI 10.1007/978-1-60327-223-0_7; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chiang CY, 2018, MBIO, V9, DOI [10.1128/mBio.01932-17, 10.1128/mbio.01932-17]; Choi H, 2012, RES MICROBIOL, V163, P479, DOI 10.1016/j.resmic.2012.06.001; Chowdhury R, 2017, NANOSCALE, V9, P14074, DOI 10.1039/c7nr04062h; Datta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11951; Datta A, 2017, BIOCHEMISTRY-US, V56, P1348, DOI 10.1021/acs.biochem.6b01229; Datta A, 2016, BIOPHYS J, V111, P1724, DOI 10.1016/j.bpj.2016.08.032; Datta A, 2016, J BIOL CHEM, V291, P13301, DOI 10.1074/jbc.M116.719575; Datta A, 2016, J COLLOID INTERF SCI, V461, P335, DOI 10.1016/j.jcis.2015.09.036; Ghosh A, 2014, MOL BIOSYST, V10, P1596, DOI 10.1039/c4mb00111g; Goddard T. D., 2008, SPARKY3; Grassi L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02409; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hancock R. E. W., 2002, Current Drug Targets - Infectious Disorders, V2, P79, DOI 10.2174/1568005024605855; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haney EF, 2009, BBA-BIOMEMBRANES, V1788, P1639, DOI 10.1016/j.bbamem.2009.01.002; Harmouche N, 2018, BIOPHYS J, V115, P1033, DOI 10.1016/j.bpj.2018.08.009; JONGEDIJK E, 1995, EUPHYTICA, V85, P173, DOI 10.1007/BF00023946; Kalle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102577; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kovalainen M, 2015, PHARMACOL REV, V67, P541, DOI 10.1124/pr.113.008367; Lanzarotti E, 2011, J CHEM INF MODEL, V51, P1623, DOI 10.1021/ci200062e; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le CF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09761; Leber R, 2018, BIOPHYS J, V114, P1945, DOI 10.1016/j.bpj.2018.03.006; LEVY O, 1994, J CLIN INVEST, V94, P672, DOI 10.1172/JCI117384; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li JG, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00073; Li QS, 2002, PEPTIDES, V23, P1, DOI 10.1016/S0196-9781(01)00572-1; LOO RRO, 1994, PROTEIN SCI, V3, P1975, DOI 10.1002/pro.5560031109; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Makwana KM, 2015, PROTEIN SCI, V24, P1920, DOI 10.1002/pro.2814; Marquette A, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020018; Marquette A, 2016, CURR TOP MED CHEM, V16, P65, DOI 10.2174/1568026615666150703115701; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P15144, DOI 10.1021/bi9811617; MCDONNELL PA, 1993, J MAGN RESON SER B, V102, P120, DOI 10.1006/jmrb.1993.1073; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; MOR A, 1994, J BIOL CHEM, V269, P31635; Nordstrom R, 2018, J COLLOID INTERF SCI, V513, P141, DOI 10.1016/j.jcis.2017.11.014; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Peschen D, 2004, NAT BIOTECHNOL, V22, P732, DOI 10.1038/nbt970; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Ruden S, 2009, ANTIMICROB AGENTS CH, V53, P3538, DOI 10.1128/AAC.01106-08; Sahl HG, 2006, CHEM BIOL, V13, P1015, DOI 10.1016/j.chembiol.2006.10.001; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Schiller J, 2007, CURR ANAL CHEM, V3, P283, DOI 10.2174/157341107782109635; Schmidtchen A, 2011, BBA-BIOMEMBRANES, V1808, P1081, DOI 10.1016/j.bbamem.2010.12.020; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Siavoshi MA, 2018, BIOPHYS J, V114, p417A; Sjogren H, 2005, BIOPHYS J, V89, P4219, DOI 10.1529/biophysj.105.065342; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Spaulding CN, 2018, NPJ BIOFILMS MICROBI, V4, DOI 10.1038/s41522-018-0048-3; Strandberg E, 2012, BBA-BIOMEMBRANES, V1818, P1764, DOI 10.1016/j.bbamem.2012.02.027; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Strominger JL, 2009, J IMMUNOL, V182, P6633, DOI 10.4049/jimmunol.0990038; Thennarasu S, 2005, BBA-BIOMEMBRANES, V1711, P49, DOI 10.1016/j.bbamem.2005.02.010; Twomey S., 2002, INTRO MATH INVERSION; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001; Yarlagadda V, 2014, J MED CHEM, V57, P4558, DOI 10.1021/jm500270w; Yu GZ, 2016, ANTIMICROB AGENTS CH, V60, P1717, DOI 10.1128/AAC.02434-15; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zerweck J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12599-7; Zerweck J, 2016, EUR BIOPHYS J BIOPHY, V45, P535, DOI 10.1007/s00249-016-1120-7; Zhu BL, 1996, PLANTA, V198, P70	88	12	13	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14615	14633		10.1074/jbc.RA119.009955	http://dx.doi.org/10.1074/jbc.RA119.009955			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31383740	hybrid, Green Published			2022-12-26	WOS:000497955000010
J	Impellizzeri, D; Peritore, AF; Cordaro, M; Gugliandolo, E; Siracusa, R; Crupi, R; D'Amico, R; Fusco, R; Evangelista, M; Cuzzocrea, S; Di Paola, R				Impellizzeri, Daniela; Peritore, Alessio Filippo; Cordaro, Marika; Gugliandolo, Enrico; Siracusa, Rosalba; Crupi, Rosalia; D'Amico, Ramona; Fusco, Roberta; Evangelista, Maurizio; Cuzzocrea, Salvatore; Di Paola, Rosanna			The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice	FASEB JOURNAL			English	Article						neuroinflammation; oxidative stress; pain; PPAR-alpha; DPN	OXIDATIVE STRESS; SPINAL-CORD; ANTIINFLAMMATORY ACTIONS; MICROGLIA ACTIVATION; PALMITOYLETHANOLAMIDE; PAIN; STREPTOZOTOCIN; HYPERALGESIA; MODEL; NERVE	Diabetic peripheral neuropathy (DPN) is a complication of diabetes connected with morbidity and mortality. DPN presents deterioration of peripheral nerves with pain, feebleness, and loss of sensation. Particular medications might display their remedial potential by controlling neuroinflammation. Palmitoylethanolamide (PEA) is an autacoid local injury antagonist distinguished for its neuroprotective, analgesic, and anti-inflammatory properties in numerous experimental models of neuroinflammation. Based on these findings, the goal of this work was to better test the neuroprotective effects of a formulation of micronized PEA (PEA-m) and the probable mechanism of action in a mouse model of DPN induced by streptozotocin (STZ) injection. Diabetic and control animals received PEA-m (10 mg/kg) by oral gavage daily starting 2 wk from STZ injection. After 16 wk, the animals were euthanized, and blood, urine, spinal cord, and sciatic nerve tissues were collected. Our results demonstrated that after diabetes induction, PEA-m was able to reduce mechanical, thermal hyperalgesia, and motor alterations as well as reduce mast cell activation and nerve growth factor expression. In addition, PEA-m decreased neural histologic damage, oxidative and nitrosative stress, cytokine release, angiogenesis, and apoptosis. Moreover, spinal microglia activation (IBA-1), phospho-P38 MAPK, and nuclear factor NF-kappa B inflammatory pathways were also inhibited. The protective effects of PEA-m could be correlated at least in part to peroxisome proliferator-activated receptor-alpha activation. In summary, we demonstrated that PEA-m represents a new therapeutic strategy for neuroinflammation pain associated with mixed neuropathies.-Impellizzeri, D., Peritore, A. F., Cordaro, M., Gugliandolo, E., Siracusa, R., Crupi, R., D'Amico, R., Fusco, R., Evangelista, M., Cuzzocrea, S., Di Paola, R. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.	[Impellizzeri, Daniela; Peritore, Alessio Filippo; Cordaro, Marika; Gugliandolo, Enrico; Siracusa, Rosalba; Crupi, Rosalia; D'Amico, Ramona; Fusco, Roberta; Cuzzocrea, Salvatore; Di Paola, Rosanna] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy; [Evangelista, Maurizio] Univ Cattolica Sacro Cuore, Inst Anaesthesiol & Reanimat, Rome, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Saint Louis University	Cuzzocrea, S (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	salvator@unime.it	Peritore, Alessio/HGB-1327-2022; Siracusa, Rosalba/AAC-3110-2022; Gugliandolo, Enrico/AAB-9972-2019; Cordaro, Marika/K-7329-2016; D'Amico, Ramona/AAC-9061-2019; FUSCO, Roberta/AAC-1745-2019; evangelista, maurizio/G-6820-2012; di paola, rosanna/U-4356-2019	Siracusa, Rosalba/0000-0001-7868-2505; Gugliandolo, Enrico/0000-0001-6840-3154; Cordaro, Marika/0000-0002-3980-0043; D'Amico, Ramona/0000-0003-0389-3871; FUSCO, Roberta/0000-0003-0223-1403; Cuzzocrea, Salvatore/0000-0001-6131-3690; Impellizzeri, Daniela/0000-0001-9492-3161; di paola, rosanna/0000-0001-6725-8581; peritore, alessio filippo/0000-0001-8545-990X; Crupi, Rosalia/0000-0002-7629-3132				Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; AlSharari SD, 2014, TROP J PHARM RES, V13, P1429, DOI 10.4314/tjpr.v13i9.8; Atef MM, 2019, BIOCHEM PHARMACOL, V159, P1, DOI 10.1016/j.bcp.2018.11.006; Bartolucci ML, 2018, INFLAMM RES, V67, P891, DOI 10.1007/s00011-018-1179-y; Calcutt NA, 2002, INT REV NEUROBIOL, V50, P205; Campardelli R, 2017, POWDER TECHNOL, V305, P217, DOI 10.1016/j.powtec.2016.09.084; Campbell AM, 2012, BRAIN RES, V1472, P138, DOI 10.1016/j.brainres.2012.07.006; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Crupi R, 2018, MOL NEUROBIOL, V55, P8455, DOI 10.1007/s12035-018-0959-2; Cunha JM, 2008, METABOLISM, V57, P873, DOI 10.1016/j.metabol.2008.01.021; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; D'Agostino G, 2009, EUR J PHARMACOL, V613, P54, DOI 10.1016/j.ejphar.2009.04.022; De Filippis D, 2009, J CELL MOL MED, V13, P1086, DOI 10.1111/j.1582-4934.2008.00353.x; Deguchi T, 2009, DIABETIC MED, V26, P247, DOI 10.1111/j.1464-5491.2009.02680.x; Di Paola R, 2016, SHOCK, V46, P202, DOI 10.1097/SHK.0000000000000578; Doupis J, 2009, J CLIN ENDOCR METAB, V94, P2157, DOI 10.1210/jc.2008-2385; Esposito E, 2016, EUR J PHARMACOL, V782, P107, DOI 10.1016/j.ejphar.2016.03.033; Esposito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041880; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Farshid AA, 2015, AVICENNA J PHYTOMEDI, V5, P469; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Fusco Roberta, 2018, Oncotarget, V9, P31355, DOI 10.18632/oncotarget.25823; Gugliandolo E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1303-5; Impellizzeri D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0136-0; Impellizzeri D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4382; Kles KA, 2006, CURR DIABETES REV, V2, P131, DOI 10.2174/157339906776818569; Lee JY, 2019, J GINSENG RES, V43, P58, DOI 10.1016/j.jgr.2017.08.004; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Leleux J, 2014, DRUG DEV IND PHARM, V40, P289, DOI 10.3109/03639045.2013.828217; Lim H, 2017, PAIN, V158, P1666, DOI 10.1097/j.pain.0000000000000959; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Mannelli LD, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/328797; Matough F.A., 2012, SULTAN QABOOS U MED, V12, P5, DOI [10.12816/0003082, DOI 10.12816/0003082]; Mazzari S, 1996, EUR J PHARMACOL, V300, P227, DOI 10.1016/0014-2999(96)00015-5; Morgado C, 2007, DIABETES-METAB RES, V23, P644, DOI 10.1002/dmrr.751; MYERS RR, 1984, ANN NEUROL, V16, P587, DOI 10.1002/ana.410160510; O'Brien PD, 2014, ILAR J, V54, P259, DOI 10.1093/ilar/ilt052; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-20; Petrosino S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00249; Ramos KM, 2007, DIABETES, V56, P1569, DOI 10.2337/db06-1269; Sandireddy R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674987; Sawant S, 2016, CLIN ORAL INVEST, V20, P43, DOI 10.1007/s00784-015-1476-6; Sayyed SG, 2006, LIFE SCI, V79, P777, DOI 10.1016/j.lfs.2006.02.033; Schifilliti C, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/849623; Schreiber AK, 2015, WORLD J DIABETES, V6, P432, DOI 10.4239/wjd.v6.i3.432; Sekido H, 2004, BIOCHEM BIOPH RES CO, V320, P241, DOI 10.1016/j.bbrc.2004.05.159; Siniscalco D, 2011, CURR NEUROPHARMACOL, V9, P523, DOI 10.2174/157015911798376208; Siracusa R, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00871; Siracusa R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00233; Skaper SD, 2017, IMMUNOLOGY, V151, P1, DOI 10.1111/imm.12717; Skaper SD, 2014, INFLAMMOPHARMACOLOGY, V22, P79, DOI 10.1007/s10787-013-0191-7; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Sun JS, 2015, MOL MED REP, V12, P2677, DOI 10.3892/mmr.2015.3735; Tsuda M, 2016, J DIABETES INVEST, V7, P17, DOI 10.1111/jdi.12379; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent AM, 2002, ANN NY ACAD SCI, V959, P368, DOI 10.1111/j.1749-6632.2002.tb02108.x; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; Zychowska M, 2013, PHARMACOL REP, V65, P1601, DOI 10.1016/S1734-1140(13)71521-4	63	47	49	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11364	11380		10.1096/fj.201900538R	http://dx.doi.org/10.1096/fj.201900538R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31344333	Bronze			2022-12-26	WOS:000489166300064
J	Luessen, DJ; Sun, HG; McGinnis, MM; Hagstrom, M; Marrs, G; McCool, BA; Chen, R				Luessen, Deborah J.; Sun, Haiguo; McGinnis, Molly M.; Hagstrom, Michael; Marrs, Glen; McCool, Brian A.; Chen, Rong			Acute ethanol exposure reduces serotonin receptor 1A internalization by increasing ubiquitination and degradation of beta-arrestin2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alcohol; E3 ubiquitin ligase; mouse double minute2 homolog (MDM2); ubiquitylation (ubiquitination); arrestin; G-protein- receptor (GPCR); proteasome; protein degradation; receptor trafficking; serotonin 5-HT1A receptor	MU-OPIOID RECEPTORS; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; 5-HT1A; ALCOHOL; TRAFFICKING; PHOSPHORYLATION; SEGMENTATION; CONSUMPTION; ENDOCYTOSIS	Acute alcohol exposure alters the trafficking and function of many G-protein-coupled receptors (GPCRs) that are associated with aberrant behavioral responses to alcohol. However, the molecular mechanisms underlying alcohol-induced changes in GPCR function remain unclear. beta-Arrestin is a key player involved in the regulation of GPCR internalization and thus controls the magnitude and duration of GPCR signaling. Although beta-arrestin levels are influenced by various drugs of abuse, the effect of alcohol exposure on beta-arrestin expression and beta-arrestin-mediated GPCR trafficking is poorly understood. Here, we found that acute ethanol exposure increases beta-arrestin2 degradation via its increased ubiquitination in neuroblastoma-2a (N2A) cells and rat prefrontal cortex (PFC). beta-Arrestin2 ubiquitination was likely mediated by the E3 ligase MDM2 homolog (MDM2), indicated by an increased coupling between beta-arrestin2 and MDM2 in response to acute ethanol exposure in both N2A cells and rat PFC homogenates. Importantly, ethanol-induced beta-arrestin2 reduction was reversed by siRNA-mediated MDM2 knockdown or proteasome inhibition in N2A cells, suggesting beta-arrestin2 degradation is mediated by MDM2 through the proteasomal pathway. Using serotonin 5-HT1A receptors (5-HT1ARs) as a model receptor system, we found that ethanol dose-dependently inhibits 5-HT1AR internalization and that MDM2 knockdown reverses this effect. Moreover, ethanol both reduced beta-arrestin2 levels and delayed agonist-induced beta-arrestin2 recruitment to the membrane. We conclude that beta-arrestin2 dysregulation by ethanol impairs 5-HT1AR trafficking. Our findings reveal a critical molecular mechanism underlying ethanol-induced alterations in GPCR internalization and implicate beta-arrestin as a potential player mediating behavioral responses to acute alcohol exposure.	[Luessen, Deborah J.; Sun, Haiguo; McGinnis, Molly M.; Hagstrom, Michael; McCool, Brian A.; Chen, Rong] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; [Marrs, Glen; Chen, Rong] Wake Forest Sch Med, Ctr Neurobiol Addict Treatment, Winston Salem, NC 27157 USA; [Chen, Rong] Wake Forest Univ, Ctr Mol Signaling, Dept Biol, Winston Salem, NC 27106 USA	Wake Forest University; Wake Forest University; Wake Forest University	Chen, R (corresponding author), Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA.; Chen, R (corresponding author), Wake Forest Sch Med, Ctr Neurobiol Addict Treatment, Winston Salem, NC 27157 USA.; Chen, R (corresponding author), Wake Forest Univ, Ctr Mol Signaling, Dept Biol, Winston Salem, NC 27106 USA.	rchen@wakehealth.edu		McCool, Brian/0000-0002-1002-9435	National Institutes of Health [R01DA042862, P50DA006634, R01AA014445, F31AA025532, R01AA023999, T32AA007565, F31AA025514]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007565, F31AA025514, F31AA025532, R01AA023999, R01AA014445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA042862, P50DA006634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01DA042862, P50DA006634, R01AA014445, F31AA025532, R01AA023999, T32AA007565, and F31AA025514. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Bjork K, 2008, FASEB J, V22, P2552, DOI 10.1096/fj.07-102442; Blednov YA, 2008, INT J NEUROPSYCHOPH, V11, P775, DOI 10.1017/S1461145708008584; Blevins T, 1997, J NEUROCHEM, V69, P2345; BLOMQVIST O, 1994, ALCOHOL, V11, P157, DOI 10.1016/0741-8329(94)90057-4; Bouaziz E, 2014, J NEUROSCI, V34, P282, DOI 10.1523/JNEUROSCI.0186-13.2014; Burnett EJ, 2014, DRUG ALCOHOL DEPEN, V136, P135, DOI 10.1016/j.drugalcdep.2014.01.002; Chakrabarti S, 2001, P NATL ACAD SCI USA, V98, P4209, DOI 10.1073/pnas.071031798; CHANDLER LJ, 1993, J NEUROCHEM, V60, P1578, DOI 10.1111/j.1471-4159.1993.tb03326.x; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Daigle TL, 2008, J NEUROCHEM, V106, P70, DOI 10.1111/j.1471-4159.2008.05336.x; Della Rocca GJ, 1999, J BIOL CHEM, V274, P4749, DOI 10.1074/jbc.274.8.4749; Dimopoulos S, 2014, BIOINFORMATICS, V30, P2644, DOI 10.1093/bioinformatics/btu302; Eng MY, 2005, DRUG ALCOHOL DEPEN, V79, P83, DOI 10.1016/j.drugalcdep.2005.01.002; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; Ferrer-Alcon M, 2004, MOL BRAIN RES, V121, P114, DOI 10.1016/j.molbrainres.2003.11.009; Fornai F, 2008, J NEUROCHEM, V105, P1939, DOI 10.1111/j.1471-4159.2008.05284.x; Golan M, 2010, J PHARMACOL EXP THER, V332, P970, DOI 10.1124/jpet.109.160218; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hillmer AT, 2014, DRUG ALCOHOL DEPEN, V144, P119, DOI 10.1016/j.drugalcdep.2014.08.015; Jean-Charles PY, 2016, PROG MOL BIOL TRANSL, V141, P339, DOI 10.1016/bs.pmbts.2016.04.003; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kelai S, 2008, J NEUROCHEM, V107, P1660, DOI 10.1111/j.1471-4159.2008.05733.x; King AC, 2016, BIOL PSYCHIAT, V79, P489, DOI 10.1016/j.biopsych.2015.05.007; King AC, 2014, BIOL PSYCHIAT, V75, P798, DOI 10.1016/j.biopsych.2013.08.001; Kumar P, 2007, AM J PHYSIOL-CELL PH, V293, pC346, DOI 10.1152/ajpcell.00010.2007; Lack AK, 2007, J NEUROPHYSIOL, V98, P3185, DOI 10.1152/jn.00189.2007; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Li XZ, 2017, P NATL ACAD SCI USA, V114, P13477, DOI 10.1073/pnas.1708215114; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lindblad J, 2004, CYTOM PART A, V57A, P22, DOI 10.1002/cyto.a.10107; Luessen DJ, 2016, NEUROPHARMACOLOGY, V110, P297, DOI 10.1016/j.neuropharm.2016.08.009; Mendez M, 2001, MOL BRAIN RES, V94, P148, DOI 10.1016/S0169-328X(01)00232-7; Morales M, 2018, NEUROSCIENCE, V371, P277, DOI 10.1016/j.neuroscience.2017.12.005; Naassila M, 2004, NEUROPHARMACOLOGY, V46, P243, DOI 10.1016/j.neuropharm.2003.09.002; NEVO I, 1995, EUR J PHARMACOL, V281, P229, DOI 10.1016/0014-2999(95)00238-G; Newlin DB, 2010, ALCOHOL CLIN EXP RES, V34, P199, DOI 10.1111/j.1530-0277.2009.01081.x; Nguyen PT, 2012, BIOL PSYCHIAT, V71, P714, DOI 10.1016/j.biopsych.2011.11.027; Ranaweera RS, 2013, J BIOL CHEM, V288, P18939, DOI 10.1074/jbc.M113.454470; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rojas PS, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00272; Serrano A, 2011, PHARMACOL THERAPEUT, V132, P215, DOI 10.1016/j.pharmthera.2011.06.005; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wolfe SA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12867; Xiao X, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-30; Zhou FC, 1998, ALCOHOL CLIN EXP RES, V22, P266, DOI 10.1111/j.1530-0277.1998.tb03648.x; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	57	3	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14068	14080		10.1074/jbc.RA118.006583	http://dx.doi.org/10.1074/jbc.RA118.006583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366729	Green Published, hybrid			2022-12-26	WOS:000490729800020
J	Fang, X; Osipiuk, J; Chakravarthy, S; Yuan, M; Menzer, WM; Nissen, D; Liang, PD; Raba, DA; Tuz, K; Howard, AJ; Joachimiak, A; Minh, DDL; Juarez, O				Fang, Xuan; Osipiuk, Jerzy; Chakravarthy, Srinivas; Yuan, Ming; Menzer, William M.; Nissen, Devin; Liang, Pingdong; Raba, Daniel A.; Tuz, Karina; Howard, Andrew J.; Joachimiak, Andrzej; Minh, David D. L.; Juarez, Oscar			Conserved residue His-257 of Vibrio cholerae flavin transferase ApbE plays a critical role in substrate binding and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin mononucleotide (FMN); flavin adenine dinucleotide (FAD); flavoprotein; electron transfer; protein assembly; Vibrio cholerae; enzyme catalysis; enzyme mechanism; Acid base catalysis; ApbE; flavin transferase; NQR	DESULFOVIBRIO-VULGARIS FLAVODOXIN; COVALENTLY BOUND FLAVIN; NADH-QUINONE REDUCTASE; THREONINE RESIDUE; CRYSTAL-STRUCTURE; NQRC SUBUNITS; PROTEIN; FMN; FLAVOPROTEIN; MECHANISM	The flavin transferase ApbE plays essential roles in bacterial physiology, covalently incorporating FMN cofactors into numerous respiratory enzymes that use the integrated cofactors as electron carriers. In this work we performed a detailed kinetic and structural characterization of Vibrio cholerae WT ApbE and mutants of the conserved residue His-257, to understand its role in substrate binding and in the catalytic mechanism of this family. Bi-substrate kinetic experiments revealed that ApbE follows a random Bi Bi sequential kinetic mechanism, in which a ternary complex is formed, indicating that both substrates must be bound to the enzyme for the reaction to proceed. Steady-state kinetic analyses show that the turnover rates of His-257 mutants are significantly smaller than those of WT ApbE, and have increased K-m values for both substrates, indicating that the His-257 residue plays important roles in catalysis and in enzyme-substrate complex formation. Analyses of the pH dependence of ApbE activity indicate that the pK(a) of the catalytic residue (pK(ES1)) increases by 2 pH units in the His-257 mutants, suggesting that this residue plays a role in substrate deprotonation. The crystal structures of WT ApbE and an H257G mutant were determined at 1.61 and 1.92 angstrom resolutions, revealing that His-257 is located in the catalytic site and that the substitution does not produce major conformational changes. We propose a reaction mechanism in which His-257 acts as a general base that deprotonates the acceptor residue, which subsequently performs a nucleophilic attack on FAD for flavin transfer.	[Fang, Xuan; Chakravarthy, Srinivas; Yuan, Ming; Menzer, William M.; Nissen, Devin; Liang, Pingdong; Raba, Daniel A.; Tuz, Karina; Howard, Andrew J.; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Minh, David D. L.] IIT, Dept Chem, Chicago, IL 60616 USA; [Osipiuk, Jerzy; Joachimiak, Andrzej] Univ Chicago, Consortium Adv Sci & Engn, CSGID, Chicago, IL 60637 USA; [Fang, Xuan; Joachimiak, Andrzej] Argonne Natl Lab, Adv Photon Source, Struct Biol Ctr, Biosci Div, Lemont, IL 60439 USA; [Chakravarthy, Srinivas] Argonne Natl Lab, Adv Photon Source, Biophys Collaborat Access Team, Lemont, IL 60439 USA	Illinois Institute of Technology; Illinois Institute of Technology; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Juarez, O (corresponding author), IIT, Robert A Pritzker Sci Ctr, 3101 S Dearborn St, Chicago, IL 60616 USA.	ojuarez@iit.edu	Minh, David/A-4655-2009; Fang, Xuan/CAG-5381-2022	Minh, David/0000-0002-4802-2618; Fang, Xuan/0000-0001-6394-4015; Menzer, William/0000-0001-5052-3158; Juarez, Oscar/0000-0002-2915-8413; Liang, Pingdong/0000-0002-8950-5755; Tuz, Karina/0000-0002-1669-4612; Joachimiak, Andrzej/0000-0003-2535-6209	Illinois Institute of Technology startup funds; NIAID, National Institutes of Health, Department of Health and Human Services [HHSN272201200026C, HHSN272201700060C]	Illinois Institute of Technology startup funds; NIAID, National Institutes of Health, Department of Health and Human Services	This work was supported by Illinois Institute of Technology startup funds (to O. J.) and NIAID, National Institutes of Health, Department of Health and Human Services, Grant HHSN272201200026C and HHSN272201700060C. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bertsova YV, 2013, J BIOL CHEM, V288, P14276, DOI 10.1074/jbc.M113.455402; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Bogachev AV, 2018, BIOCHEM SOC T, V46, P1161, DOI 10.1042/BST20180524; Bogachev AV, 2012, MOL MICROBIOL, V86, P1452, DOI 10.1111/mmi.12067; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; Broco M, 2007, FEBS LETT, V581, P4397, DOI 10.1016/j.febslet.2007.08.009; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Deka RK, 2016, MICROBIOLOGYOPEN, V5, P21, DOI 10.1002/mbo3.306; Deka RK, 2013, J BIOL CHEM, V288, P11106, DOI 10.1074/jbc.M113.449975; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186805; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Han GW, 2006, PROTEINS, V64, P1083, DOI 10.1002/prot.20950; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Liang PD, 2018, J BIOL CHEM, V293, P510, DOI 10.1074/jbc.M117.797209; Lostao A, 2000, J BIOL CHEM, V275, P9518, DOI 10.1074/jbc.275.13.9518; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; MATHEWS FS, 1991, BIOCHEMISTRY-US, V30, P238, DOI 10.1021/bi00215a034; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murray TA, 2003, BIOCHEMISTRY-US, V42, P2307, DOI 10.1021/bi026967s; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PEELEN S, 1994, ARCH BIOCHEM BIOPHYS, V314, P291, DOI 10.1006/abbi.1994.1445; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raba DA, 2018, J BIOL CHEM, V293, P15664, DOI 10.1074/jbc.RA118.003194; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Segel I. H., 1975, ENZYME KINETICS BEHA, V1; Serebryakova MV, 2018, BIOCHIMIE, V149, P34, DOI 10.1016/j.biochi.2018.03.013; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2818; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Laer K, 2014, PROTEIN SCI, V23, P238, DOI 10.1002/pro.2397; Wagner MA, 1999, BIOCHEMISTRY-US, V38, P5588, DOI 10.1021/bi982955o; WALKER WH, 1972, EUR J BIOCHEM, V26, P279, DOI 10.1111/j.1432-1033.1972.tb01766.x; WATENPAUGH KD, 1973, P NATL ACAD SCI USA, V70, P3857, DOI 10.1073/pnas.70.12.3857; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Wong SS, 2012, CHEMISTRY OF PROTEIN AND NUCLEIC ACID CROSS-LINKING AND CONJUGATION, 2ND EDITION, P1; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhang L, 2017, BBA-BIOENERGETICS, V1858, P95, DOI 10.1016/j.bbabio.2016.11.008	63	7	7	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13800	13810		10.1074/jbc.RA119.008261	http://dx.doi.org/10.1074/jbc.RA119.008261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350338	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000486418600024
J	Lezama-Ochoa, N; Hall, MA; Pennino, MG; Stewart, JD; Lopez, J; Murua, H				Lezama-Ochoa, Nerea; Hall, Martin A.; Pennino, Maria Grazia; Stewart, Joshua D.; Lopez, Jon; Murua, Hilario			Environmental characteristics associated with the presence of the Spinetail devil ray (Mobula mobular) in the eastern tropical Pacific	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; SPATIOTEMPORAL DISTRIBUTION; SPECIES DISTRIBUTIONS; INCIDENTAL CATCH; DIVING BEHAVIOR; MANTA-BIROSTRIS; BY-CATCH; TUNA; PREDICTION; FISHERIES	In the eastern Pacific Ocean, the tropical tuna purse-seine fishery incidentally captures high numbers of five mobulid bycatch species; all of which are classified as mortalities by the Inter-American Tropical Tuna Commission due to uncertainties in post-release mortality rates. To date, the factors (operational or environmental) leading to the capture of these species by the fishery have not been well studied. Here, we developed Generalized Additive Models for fisheries observer data to analyze the relationships between the presence/absence of Mobula mobular bycatch and oceanographic conditions, the spatial and temporal variability in fishing location, and the set type (associated with dolphins, free-swimming tuna schools or floating objects). Our results suggest that chlorophyll concentration and sea surface height are the most important variables to describe the presence of M. mobular in conjunction with geographic location (latitude and longitude) and set type. Presence of the species was predicted in waters with chlorophyll concentrations between 0.5-1 mg.m(-3) and with sea surface height values close to 0; which indicates direct relationships with productive upwelling systems. Seasonally, M. mobular was observed more frequently during December-January and August-September. We also found the highest probability of presence observed in School sets, followed by Dolphin sets. Three areas were observed as important hotspots: the area close to the coastal upwelling of northern Peru, the area west to Islands Colon Archipelago (Galapagos) and the area close to the Costa Rica Dome. This information is crucial to identify the mobulids habitat and hotspots that could be managed and protected under dynamic spatial management measures to reduce the mortality of mobulid rays in the eastern Pacific purse-seine fishery and, hence, ensure the sustainability of the populations of these iconic species.	[Lezama-Ochoa, Nerea; Hall, Martin A.; Lopez, Jon] Interamer Trop Tuna Commiss, Bycatch Program, San Diego, CA 92121 USA; [Lezama-Ochoa, Nerea; Murua, Hilario] AZTI Tecnalia, Marine Res Div, Pasaia, Spain; [Pennino, Maria Grazia] IEO, Vigo, Spain; [Stewart, Joshua D.] Scripps Inst Oceanog, San Diego, CA USA; [Stewart, Joshua D.] Manta Trust, Dorchester, Dorset, England; [Murua, Hilario] ISSF, Washington, DC USA	AZTI; Spanish Institute of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	Lezama-Ochoa, N (corresponding author), Interamer Trop Tuna Commiss, Bycatch Program, San Diego, CA 92121 USA.; Lezama-Ochoa, N (corresponding author), AZTI Tecnalia, Marine Res Div, Pasaia, Spain.	nlezamaochoa@gmail.com	Johnson, Jeannie/AAD-1971-2021	Stewart, Joshua/0000-0001-6851-2289; pennino, maria grazia/0000-0002-7577-2617; Lopez, Jon/0000-0002-4172-4094	Basque Government ("Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor")	Basque Government ("Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor")(Basque Government)	This work is funded by the Basque Government ("Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor") to NLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes JMV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161444; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bigelow K, 2006, FISH RES, V77, P173, DOI 10.1016/j.fishres.2005.10.010; Bivand R, 2009, MGCV 1 3 R PACKAGE; BIVAND R, SPDEP SPATIAL DEPEND, DOI DOI 10.1007/978-3-319-02769-2_2; Borrell A, 2011, ICES J MAR SCI, V68, P547, DOI 10.1093/icesjms/fsq170; BRAUN CD, 2015, MAR BIOL, V162, P12; Braun CD, 2015, FAO FISHERIES AQUACU, V162; BRAUN CD, 2014, PLOS ONE, V9, P2, DOI DOI 10.1111/FOG.12005; Brodie S, 2015, FISH OCEANOGR, V24, P463, DOI 10.1111/fog.12122; BURGESS K, 2017, FEEDING ECOLOGY AND; Canese Simonepietro, 2011, Endangered Species Research, V14, P171, DOI 10.3354/esr00349; Carvalho FC, 2011, ICES J MAR SCI, V68, P890, DOI 10.1093/icesjms/fsr047; CELONA A, 2004, ANN SER HIST NAT, P1788; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Clark TB, 2010, PLOS ONE; CLARK TB, 2010, ABUNDANCE HOME RANGE, P2010, DOI DOI 10.1016/J.DSR2.2006.03.004; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; CROLL DA, MARINE ECOLOGY PROGR, DOI DOI 10.1111/J.1365-2419.2011.00571.X; Croll DA, 2016, VULNERABILITIES AND; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; DUFFY C, 2003, SIGHTINGS OF MOBULID, DOI DOI 10.1007/978-94-017-7499-4_3; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Escalle L, 2016, FISH OCEANOGR, V25, P433, DOI 10.1111/fog.12163; EVESON JP, 2018, DEEP SEA RESEARCH PA, DOI DOI 10.1111/FOG.12130; Fiedler PC, 2017, CORAL REEFS WORLD, V8, P59, DOI 10.1007/978-94-017-7499-4_3; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fortuna CM, 2014, SCI MAR, V78, P227, DOI 10.3989/scimar.03920.30D; FRANCIS MP, 2016, AQUAT CONSERV, DOI DOI 10.1111/FOG.12122; FREEMAN E, 2012, R PACKAGE VERSION, V1, P9, DOI DOI 10.3354/ESR00251; Gadig OBF, 2003, J MAR BIOL ASSOC UK, V83, P869, DOI 10.1017/S0025315403007914h; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; Gilly WF, 2013, ANNU REV MAR SCI, V5, P393, DOI 10.1146/annurev-marine-120710-100849; Girondot M, 2015, J MAR BIOL ASSOC UK, V95, P153, DOI 10.1017/S0025315414001398; GRIFFITHS S, DOCUMENT SAC 08 07D, P8; Griffiths TL, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P9; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hacohen-Domene A, 2015, INFLUENCIA DE FACTOR, P1; Hacohen-Domene A, 2006, CYBIUM, V30, P99; HACOHENDOMENE P, MARINE, DOI DOI 10.3354/MEPS10910; Hahlbeck N, 2017, FISH RES, V191, P154, DOI 10.1016/j.fishres.2017.03.011; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.1093/ZOOLINNEAN/ZLX018; HALL MA, 2007, FAO FISHERIES AQUACU; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.1016/J.POCEAN.2009.07.032; HALL MA, 2010, FAO FISHERIES AQUACU, V90, P969; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.1371/JOURNAL.PONE.0036834; HALL MA, 2012, FAO FISHERIES AQUACU, V465, P193, DOI DOI 10.1146/ANNUREV.ECOLSYS.110308.120159; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.3354/ESR00349; Hall MA, 2013, FAO FISHERIES AND AQ, P568; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.1016/J.ZOOL.2016.05.010; Hearn AR, 2014, SOC ECOL INTERACT GA, P23, DOI 10.1007/978-3-319-02769-2_2; Heinrichs S, 2011, MANTA RAY OF HOPE GL; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hijmans RJ, 2012, PLOS ONE, V1, P9; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Hobday AJ, 2011, DEEP-SEA RES PT II, V58, P734, DOI 10.1016/j.dsr2.2010.10.006; IATTC, 2015, ROYAL SOC OPEN SCI; *IATTC, 2009, FISHERY STATUS REPOR, V8, P133; *IATTC, DOCUMENT IATTC 89 04, P89, DOI DOI 10.3354/MEPS09900; *ISSF, 2014, SKIPPERS GUIDEBOOK T; Jaine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Jaine FRA, 2014, MAR ECOL PROG SER, V510, P73, DOI 10.3354/meps10910; JIMENEZ JA, 2017, THE THERMAL DOME OF, V106, DOI DOI 10.3354/MEPS12304; Jimenez JA, 2017, FISH RES; Jones AR, 2014, PROG OCEANOGR, V128, P30, DOI 10.1016/j.pocean.2014.08.002; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; KOHAVI R, 1995, A STUDY OF CROSS VAL, DOI DOI 10.1038/NCLIMATE1304; Lawson JM, 2017, PEERJ, V5, DOI 10.7717/peerj.3027; Lezama-Ochoa N, 2015, BIODIVERS CONSERV, V24, P2647, DOI 10.1007/s10531-015-0951-3; Lezama-Ochoa N, 2018, FAO FISHERIES AQUACU; Lezama-Ochoa N, 2018, FISH RES; LEZAMAOCHOA N, 2017, FRONTIERS IN MARINE, DOI DOI 10.3989/SCIMAR.03920.30D; LEZAMAOCHOA N, 2018, MARINE ECOLOGY, DOI DOI 10.1017/S0025315414001398; Lopez J, 2017, DEEP-SEA RES PT II, V140, P127, DOI 10.1016/j.dsr2.2017.02.007; Martinez-Rincon RO, 2015, MAR FRESHWATER RES, V66, P644, DOI 10.1071/MF14062; Martinez-Rincon RO, 2012, ECOL MODEL, V233, P20, DOI 10.1016/j.ecolmodel.2012.03.006; Mas F, 2015, MAR FRESHWATER RES, V66, P767, DOI 10.1071/MF14180; MASANGCAY SIG, 2018, FEEDING HABITS OF MO, V30, P1; Montero JT, 2016, FISH OCEANOGR, V25, P1, DOI 10.1111/fog.12130; NOTARBARTOLODISCIARA G, 1989, COPEIA, P607; NOTARBARTOLODISCIARA G, 1988, FISH B-NOAA, V86, P45; O'Malley MP, 2017, AQUAT CONSERV, V27, P394, DOI 10.1002/aqc.2670; OCHOA NHL, 2018, ENVIRONMENTAL BIOLOG, DOI DOI 10.1016/J.MARPOL.2013.09.025; OCHOA NL, 2016, FRONT MAR SCI, V3, P34; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Pardo SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33745; PAYNE MR, 2015, ICEJ MARINE SCI J, V231; Payne MR, 2015, ECOLOGY; PEARSON RG, 2007, SYNTHESIS AMERICAN M, V50, DOI DOI 10.1146/ANNUREV-MARINE-120710-100849; PERRYMAN HA, 2017, COLLECT VOL SCI PAP, V73, P1778, DOI DOI 10.1111/FOG.12163; Perryman HA, 2017, FISHERIES OCEANOGRAP, V73, P1778; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Poisson F, 2014, MAR POLICY, V44, P312, DOI 10.1016/j.marpol.2013.09.025; RINCO ROM, 2012, THESIS, DOI DOI 10.1016/J.DSR2.2017.02.007; ROHNER CA, 2017, PEER J PREPRINTS, P2167; Sampson L, 2010, J MAR BIOL ASSOC UK, V90, P969, DOI 10.1017/S0025315410000548; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; SOBRAL AFL, 2013, BIOLOGY ECOLOGY AND; STEWART JD, 2018, FRONTIERS IN MARINE, DOI DOI 10.1071/MF14180; Stewart JD, 2018, FAO FISHERIES AQUACU; Stewart JD, 2018, FAO FISHERIES AQUACU; Stewart JD, 2017, MAR ECOL PROG SER, V580, P131, DOI 10.3354/meps12304; Stewart JD, 2016, ZOOLOGY, V119, P406, DOI 10.1016/j.zool.2016.05.010; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Team R. C., 2017, R LANG ENV STAT COMP, P2016; Thorrold S.R., 2014, FAO FISHERIES AQUACU, V5, P4274; Thorrold SR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5274; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Wang L, 2018, HABITAT SUITABILITY; WANG L, 2018, FISHERIES OCEANOGRAP; White WT, 2018, ZOOL J LINN SOC-LOND, V182, P50, DOI 10.1093/zoolinnean/zlx018; WOOD S, 2006, GENERALIZED ADDITIVE, DOI DOI 10.1016/J.DSR2.2010.10.006; WOOD S, THE MGCV PACKAGE; Wood S, 2007, MODELLING THE OCEANI; Zuur A, 2009, HABITAT MODEL TO PRE; Zuur Alain F., 2009, P1	121	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220854	10.1371/journal.pone.0220854	http://dx.doi.org/10.1371/journal.pone.0220854			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390369	gold, Green Published, Green Submitted			2022-12-26	WOS:000484999400032
J	Daun, S; Mantziaris, C; Toth, T; Buschges, A; Rosjat, N				Daun, Silvia; Mantziaris, Charalampos; Toth, Tibor; Bueschges, Ansgar; Rosjat, Nils			Unravelling intra- and intersegmental neuronal connectivity between central pattern generating networks in a multi-legged locomotor system	PLOS ONE			English	Article							STICK INSECT; SPECTRAL RESPONSES; PHASE-LOCKING; WALKING; COORDINATION; MOVEMENTS; BEHAVIOR; LEGS; BRAIN; MODEL	Animal walking results from a complex interplay of central pattern generating networks (CPGs), local sensory signals expressing position, velocity and forces generated in the legs, and coordinating signals between neighboring legs. In particular, the CPGs control the activity of motoneuron (MN) pools which drive the muscles of the individual legs and are thereby responsible for the generation of rhythmic leg movements. The rhythmic activity of the CPGs as well as their connectivity can be modified by the aforementioned sensory signals. However, the precise nature of the interaction between the CPGs and these sensory signals has remained generally largely unknown. Experimental methods aiming at finding out details of these interactions often apply cholinergic agonists such as pilocarpine in order to induce rhythmic activity in the CPGs. Using this general approach, we removed the influence of sensory signals and investigated the putative connections between CPGs controlling the upward/downward movement in the different legs of the stick insect. The experimental data, i.e. the measured MN activities, underwent connectivity analysis using Dynamic Causal Modelling (DCM). This method can uncover the underlying coupling structure and strength between pairs of segmental CPGs. For the analysis we set up different coupling schemes (models) for DCM and compared them using Bayesian Model Selection (BMS). Models with contralateral connections in each segment and ipsilateral connections on both sides, as well as the coupling from the meta-to the ipsilateral prothoracic ganglion were preferred by BMS to all other types of models tested. Moreover, the intrasegmental coupling strength in the mesothoracic ganglion was the strongest and most stable in all three ganglia.	[Daun, Silvia; Toth, Tibor; Rosjat, Nils] Univ Cologne, Inst Zool, Heisenberg Res Grp Computat Neurosci Modelling Ne, Cologne, Germany; [Daun, Silvia; Rosjat, Nils] Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany; [Mantziaris, Charalampos; Bueschges, Ansgar] Univ Cologne, Inst Zool, Dept Anim Physiol, Cologne, Germany	University of Cologne; Helmholtz Association; Research Center Julich; University of Cologne	Rosjat, N (corresponding author), Univ Cologne, Inst Zool, Heisenberg Res Grp Computat Neurosci Modelling Ne, Cologne, Germany.; Rosjat, N (corresponding author), Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany.	n.rosjat@fz-juelich.de		Daun, Silvia/0000-0001-7342-1015; Mantziaris, Charalampos/0000-0003-2280-1733; Buschges, Ansgar/0000-0003-2123-1900	Deutsche Forschungsgemeinschaft [DA1953/5-2, RTG1960]; University of Cologne: CONNECT; University of Cologne Emerging Groups Initiative (CONNECT); German Excellence Initiative; German Research Foundation, Germany [DA1953/5-2]; DFG [RTG1960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Cologne: CONNECT; University of Cologne Emerging Groups Initiative (CONNECT); German Excellence Initiative; German Research Foundation, Germany(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	SD was supported by Deutsche Forschungsgemeinschaft: DA1953/5-2 (http://www.dfg.de/); SD and AB were supported by Deutsche Forschungsgemeinschaft and University of Cologne: CONNECT (http://www.dfg.de/); CM was supported by Deutsche Forschungsgemeinschaft: RTG1960 (http://www.dfg.de/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Anke Borgmann for useful discussions on the analysis. This study was funded by the University of Cologne Emerging Groups Initiative (CONNECT) within the framework of the Institutional Strategy of the University of Cologne and the German Excellence Initiative. SD gratefully acknowledges additional support from the German Research Foundation, Germany (DA1953/5-2). CM was an associate member of the RTG1960 "Neural Circuit Analysis on the Cellular and Subcellular Level" funded by the DFG.	[Anonymous], [No title captured]; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Borgmann A, 2007, J NEUROPHYSIOL, V98, P1685, DOI 10.1152/jn.00291.2007; Brunner von Wattenwyl K, 1908, INSEKTENFAMILIE PHAS; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; BUSCHGES A, 1995, J EXP BIOL, V198, P435; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; Chen CC, 2009, NEUROIMAGE, V45, P453, DOI 10.1016/j.neuroimage.2008.12.041; CRUSE H, 1990, TRENDS NEUROSCI, V13, P15, DOI 10.1016/0166-2236(90)90057-H; CRUSE H, 1976, J COMP PHYSIOL, V112, P235, DOI 10.1007/BF00606541; Daido H, 1997, INT J BIFURCAT CHAOS, V7, P807, DOI 10.1142/S0218127497000601; Daun-Gruhn S, 2011, BIOL CYBERN, V105, P71, DOI 10.1007/s00422-011-0446-6; Daun-Gruhn S, 2011, J COMPUT NEUROSCI, V31, P43, DOI 10.1007/s10827-010-0300-1; David I, 2016, BIOL OPEN, V5, P1229, DOI 10.1242/bio.018705; DEAN J, 1989, J EXP BIOL, V145, P103; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; FOTH E, 1985, BIOL CYBERN, V51, P313, DOI 10.1007/BF00336918; Friston KJ, 2012, NEUROIMAGE, V59, P439, DOI 10.1016/j.neuroimage.2011.07.048; Fuchs E, 2011, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00125; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; GRAHAM D, 1985, J EXP BIOL, V118, P287; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Hess D, 1997, J NEUROBIOL, V33, P891; Johnston Rebecca M., 2002, Invertebrate Neuroscience, V4, P175, DOI 10.1007/s10158-002-0019-4; Kiebel SJ, 2008, COGN NEURODYNAMICS, V2, P121, DOI 10.1007/s11571-008-9038-0; Knebel D, 2017, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00112; Ludwar BC, 2005, J NEUROPHYSIOL, V93, P1255, DOI 10.1152/jn.00727.2004; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mallada E, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/50/505101; Mantziaris C, 2017, J NEUROPHYSIOL, V118, P2296, DOI 10.1152/jn.00321.2017; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marple SL, 1999, IEEE T SIGNAL PROCES, V47, P2600, DOI 10.1109/78.782222; Moran RJ, 2008, NEUROIMAGE, V42, P272, DOI 10.1016/j.neuroimage.2008.01.025; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; Moran RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022790; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Penny WD, 2009, J NEUROSCI METH, V183, P19, DOI 10.1016/j.jneumeth.2009.06.029; Rigoux L, 2014, NEUROIMAGE, V84, P971, DOI 10.1016/j.neuroimage.2013.08.065; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; RYCKEBUSCH S, 1994, J NEUROPHYSIOL, V72, P2771, DOI 10.1152/jn.1994.72.6.2771; SCHMITZ J, 1986, BIOL CYBERN, V55, P25, DOI 10.1007/BF00363975; SCHMITZ J, 1988, COMP BIOCHEM PHYS A, V91, P769, DOI 10.1016/0300-9629(88)90963-2; SILLAR KT, 1987, J EXP BIOL, V131, P245; Szczecinski NS, 2018, BIORXIV; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Walz JM, 2013, J NEUROSCI, V33, P19212, DOI 10.1523/JNEUROSCI.2649-13.2013	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220767	10.1371/journal.pone.0220767	http://dx.doi.org/10.1371/journal.pone.0220767			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386699	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100036
J	Husain, B; Feltus, FA				Husain, Benafsh; Feltus, F. Alex			EdgeScaping: Mapping the spatial distribution of pairwise gene expression intensities	PLOS ONE			English	Article							COEXPRESSION NETWORK; CANCER; VALIDATION; ALGORITHM; RELEVANCE	Gene co-expression networks (GCNs) are constructed from Gene Expression Matrices (GEMs) in a bottom up approach where all gene pairs are tested for correlation within the context of the input sample set. This approach is computationally intensive for many current GEMs and may not be scalable to millions of samples. Further, traditional GCNs do not detect non-linear relationships missed by correlation tests and do not place genetic relationships in a gene expression intensity context. In this report, we propose EdgeScaping, which constructs and analyzes the pairwise gene intensity network in a holistic, top down approach where no edges are filtered. EdgeScaping uses a novel technique to convert traditional pairwise gene expression data to an image based format. This conversion not only performs feature compression, making our algorithm highly scalable, but it also allows for exploring non-linear relationships between genes by leveraging deep learning image analysis algorithms. Using the learned embedded feature space we implement a fast, efficient algorithm to cluster the entire space of gene expression relationships while retaining gene expression intensity. Since EdgeScaping does not eliminate conventionally noisy edges, it extends the identification of co-expression relationships beyond classically correlated edges to facilitate the discovery of novel or unusual expression patterns within the network. We applied EdgeScaping to a human tumor GEM to identify sets of genes that exhibit conventional and nonconventional interdependent non-linear behavior associated with brain specific tumor subtypes that would be eliminated in conventional bottom-up construction of GCNs. Edgescaping source code is available at https://github.com/bhusain/EdgeScaping under the MIT license.	[Husain, Benafsh; Feltus, F. Alex] Clemson Univ, Biomed Data Sci & Informat Program, Clemson, SC 29634 USA; [Feltus, F. Alex] Clemson Univ, Genet & Biochem Dept, Clemson, SC 29634 USA; [Feltus, F. Alex] Clemson Univ, Ctr Human Genet, Clemson, SC 29634 USA	Clemson University; Clemson University; Clemson University	Feltus, FA (corresponding author), Clemson Univ, Biomed Data Sci & Informat Program, Clemson, SC 29634 USA.; Feltus, FA (corresponding author), Clemson Univ, Genet & Biochem Dept, Clemson, SC 29634 USA.; Feltus, FA (corresponding author), Clemson Univ, Ctr Human Genet, Clemson, SC 29634 USA.	ffeltus@clemson.edu		Husain, Benafsh/0000-0002-5542-5992; Feltus, Frank/0000-0002-2123-6114	National Science Foundation Directorate for Computer and Information Science and Engineering [1659300]	National Science Foundation Directorate for Computer and Information Science and Engineering	This work was supported by National Science Foundation Directorate for Computer and Information Science and Engineering, 1659300, Dr. Frank Alexander Feltus.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen JQ, 2013, J PROTEOME RES, V12, P2354, DOI 10.1021/pr400162t; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ficklin SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09094-4; Gibson SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055871; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Guo XF, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1753; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liang MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116776; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petereit J, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0298-8; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Srihari S, 2013, BIOINFORMATICS, V29, P1553, DOI 10.1093/bioinformatics/btt191; Vempati UD, 2014, J BIOMOL SCREEN, V19, P803, DOI 10.1177/1087057114522514; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220279	10.1371/journal.pone.0220279	http://dx.doi.org/10.1371/journal.pone.0220279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386677	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100017
J	Zuo, JP; Hong, ZJ; Peng, SP; Shi, Y; Song, HQ; Li, M; Zhang, ZS				Zuo, Jianping; Hong, Zijie; Peng, Suping; Shi, Yue; Song, Hongqiang; Li, Meng; Zhang, Zishan			Investigation on failure behavior of collapse column in China's coal mine based on discontinuous deformation numerical method	PLOS ONE			English	Article							KARST COLLAPSE; ENVIRONMENTS; PREDICTION; HAZARDS	Karst collapse column is a serious geological disaster in China's coal mines. There are various karst collapse columns in coal mine areas, such as Huainan, Huaibei, Xingtai, Lu'an. And they have seriously affected mining safety and geological environment. The present research is focused on analyzing subsidence mechanism and dynamic collapse process. Based on mechanical analysis of thin plate theory, a detailed model of collapse column slipping and bending fracture is constructed to gather the critical conditions of the collapse column roof. The sensitivity parameters analysis shows that both the radius and roof thickness of cave have a great influence on the sliding instability and bending fracture. Meanwhile, the buried depth also affects bending failure. The discontinuous deformation analysis (DDA) method is used to simulate and analyze the collapse process. The numerical results indicate that the stability of inverted funnel collapse column is dominated by the bending stress of roof strata. The movement of columnar collapse column is mainly caused by sliding instability. However, the funnel collapse column is relatively stable, and does not change in the same condition. The displacement field analysis shows that the collapse range of inverted funnel collapse column is obviously larger than that of columnar collapse column, in which its maximum displacement is approximately 1.5 times that of the columnar collapse column. There is no large area collapse on the upper part of the funnel collapse column, and the block system is relatively stable. The principal stress field analysis proves the above results.	[Zuo, Jianping; Hong, Zijie; Shi, Yue; Song, Hongqiang; Li, Meng; Zhang, Zishan] China Univ Min & Technol, Sch Mech & Civil Engn, Beijing, Peoples R China; [Zuo, Jianping; Peng, Suping] China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Beijing, Peoples R China; [Peng, Suping] China Univ Min & Technol, Beijing, Peoples R China	China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology	Zuo, JP (corresponding author), China Univ Min & Technol, Sch Mech & Civil Engn, Beijing, Peoples R China.; Zuo, JP (corresponding author), China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Beijing, Peoples R China.	zjp@cumtb.edu.cn	Zhang, zs/GXN-3521-2022		National Natural Science Foundation of China [51622404, 11572343]; State Key Research Development Program of China [2016YFC0801404]; Outstanding Young Talents of Ten Thousand People Plan [W02070044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Research Development Program of China(State Key Development Program for Basic Research of China); Outstanding Young Talents of Ten Thousand People Plan	This study was supported by the National Natural Science Foundation of China, grant numbers 51622404 and 11572343 to JPZ, the State Key Research Development Program of China, grant number 2016YFC0801404 to JPZ, and by the Outstanding Young Talents of Ten Thousand People Plan, grant number W02070044 to JPZ. The had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achari G, 1999, CAN GEOTECH J, V36, P783, DOI 10.1139/cgj-36-5-783; Chen SP, 1993, CARSOLOGICA SIN, V12, P233; Feng XY, 2017, COAL GEOLOGY CHINA, V29, P70; Galve JP, 2015, GEOMORPHOLOGY, V229, P30, DOI 10.1016/j.geomorph.2014.07.035; He KQ, 2007, ENVIRON GEOL, V52, P449, DOI 10.1007/s00254-006-0478-8; He KQ, 2005, KARST COLLAPSE N CHI, P4; Hu RL, 2001, CHIN J ROCK MECH ENG, V25, P189; Intrieri E, 2015, GEOMORPHOLOGY, V241, P304, DOI 10.1016/j.geomorph.2015.04.018; Ju Y, 2007, P 8 INT C AN DISC DE, P39; Kong HL, 2018, ARAB J GEOSCI, V11, DOI 10.1007/s12517-018-3881-z; Ma D, 2015, NAT HAZARDS, V76, P1319, DOI 10.1007/s11069-014-1551-3; Nicieza CG, 2005, INT J ROCK MECH MIN, V42, P372, DOI 10.1016/j.ijrmms.2004.12.003; Peng SP, 2008, CHINESE J ROCK MECH, V27, P2762; Qian MG, 2010, GROUND PRESSURE STRA, P15; Shi G.H., 1988, THESIS; Shi J, 1998, GEOL MIN RES N CHINA, V13, P264; Sun XF., 2008, MECH MAT; Tharp TM, 2002, ENVIRON GEOL, V42, P447, DOI 10.1007/s00254-001-0504-9; Thierry P, 2005, B ENG GEOL ENVIRON, V64, P139, DOI 10.1007/s10064-004-0247-4; Troitzky GM, 1993, SINKHOLE DANGER ENG, P231; Wang HT, 1997, ENG GEOL, V48, P135, DOI 10.1016/S0013-7952(97)81918-7; Wang J. C., 2009, J MIN SAFE ENG, V26, P140; Xu ZL, 2001, CONCISE COURSE ELAST; Yin SX, 2004, J CHINA COAL SOC, V29, P183; Youssef AM, 2016, HYDROGEOL J, V24, P625, DOI 10.1007/s10040-015-1336-0; Yuan DX, 1994, KARST CHINA, P21; Yuan DX., 2002, KARST DYNAMIC SYSTEM, P185; Zhang YF, 2011, PROGR GEOPHYS, V26, P1432; Zuo JP, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-017-3190-y; Zuo JP, 2009, INT J COAL GEOL, V78, P276, DOI 10.1016/j.coal.2009.02.003; Zuo JP, 2017, J CHINA U MINING TEC, V46, P19	31	4	4	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219733	10.1371/journal.pone.0219733	http://dx.doi.org/10.1371/journal.pone.0219733			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386674	Green Published, gold, Green Submitted			2022-12-26	WOS:000484997100006
J	Reiss, S; Klackl, J; Proulx, T; Jonas, E				Reiss, Stefan; Klackl, Johannes; Proulx, Travis; Jonas, Eva			Strength of socio-political attitudes moderates electrophysiological responses to perceptual anomalies	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ALPHA OSCILLATIONS; POLITICAL-IDEOLOGY; MORTALITY SALIENCE; ATTENTION; AFFIRMATION; INCREASES; EXPOSURE; THREAT; SIMILARITIES	People with strong (vs. moderate) political attitudes have been shown to exhibit less phasic reactivity to perceptual anomalies, presumably to prevent their committed meaning systems from being challenged by novel experiences. Several researchers have proposed that (but not tested whether) firmly committed individuals also engage in more attentional suppression of anomalies, likely mediated by prestimulus alpha power. We expected participants with strong (vs. moderate) political attitudes to display increased pre-stimulus alpha power when processing perceptual anomalies. We recorded electrophysiological activity during the presentation of normal cards (control group) or both normal and anomalous playing cards (experimental group; total N = 191). In line with our predictions, the presence of anomalous playing cards in the stimulus set increased prestimulus alpha power only among individuals with strong but not moderate political attitudes. As potential markers of phasic reactivity, we also analyzed the late positive potential (LPP) and earlier components of the event-related potential, namely P1, N1, and P300. The moderating effect of extreme attitudes on ERP amplitudes remained inconclusive. Altogether, our findings support the idea that ideological conviction is related to increased tonic responses to perceptual anomalies.	[Reiss, Stefan; Klackl, Johannes; Jonas, Eva] Univ Salzburg, Dept Psychol, Salzburg, Austria; [Proulx, Travis] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales	Salzburg University; Cardiff University	Reiss, S (corresponding author), Univ Salzburg, Dept Psychol, Salzburg, Austria.	stefan.reiss@sbg.ac.at	delete, Doctoral College Imaging the Mind - to/E-5040-2018; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; Reiss, Stefan/AAA-6155-2021	Reiss, Stefan/0000-0001-8188-6664; Klackl, Johannes/0000-0003-2619-4715	Austrian Science Fund [FWF-P27457]; Doctoral College "Imaging the Mind" of the Austrian Science Fund [FWF-W1233-G17]	Austrian Science Fund(Austrian Science Fund (FWF)); Doctoral College "Imaging the Mind" of the Austrian Science Fund	Research was supported by the Austrian Science Fund (FWF-P27457). SR has been supported by the Doctoral College "Imaging the Mind" of the Austrian Science Fund (FWF-W1233-G17).	Agroskin D, 2013, J EXP SOC PSYCHOL, V49, P1144, DOI 10.1016/j.jesp.2013.05.014; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Bizumic B, 2009, EUR J SOC PSYCHOL, V39, P871, DOI 10.1002/ejsp.589; Brandt MJ, 2014, BEHAV BRAIN SCI, V37, P307, DOI 10.1017/S0140525X13002513; Brandt MJ, 2014, CURR DIR PSYCHOL SCI, V23, P27, DOI 10.1177/0963721413510932; BRANDT ME, 1991, INT J NEUROSCI, V61, P261, DOI 10.3109/00207459108990744; BRUNER JS, 1949, J PERS, V18, P206, DOI 10.1111/j.1467-6494.1949.tb01241.x; Codispoti M, 2007, J COGNITIVE NEUROSCI, V19, P577, DOI 10.1162/jocn.2007.19.4.577; Cohen F, 2017, ANAL SOC ISS PUB POL, V17, P339, DOI 10.1111/asap.12143; Dandeneau SD, 2007, J PERS SOC PSYCHOL, V93, P651, DOI 10.1037/0022-3514.93.4.651; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dennis TA, 2009, J CHILD PSYCHOL PSYC, V50, P1373, DOI 10.1111/j.1469-7610.2009.02168.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrari V, 2016, BIOL PSYCHOL, V113, P75, DOI 10.1016/j.biopsycho.2015.11.008; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Gratton G, 1983, ELECTROENCEPHALOGR C, V116, P717; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Hanslmayr S, 2005, NEUROSCI LETT, V375, P64, DOI 10.1016/j.neulet.2004.10.092; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Hirsh JB, 2012, PSYCHOL REV, V119, P304, DOI 10.1037/a0026767; Hong LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091321; Inzlicht M, 2010, PSYCHOL SCI, V21, P1184, DOI 10.1177/0956797610375451; Inzlicht M, 2009, PSYCHOL SCI, V20, P385, DOI 10.1111/j.1467-9280.2009.02305.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jonas E, 2014, ADV EXP SOC PSYCHOL, V49, P219, DOI 10.1016/B978-0-12-800052-6.00004-4; Jonas E, 2008, J PERS SOC PSYCHOL, V95, P1239, DOI 10.1037/a0013593; Jost JT, 2014, POLIT PSYCHOL, V35, P3, DOI 10.1111/pops.12162; Jost JT, 2012, MOTIV EMOTION, V36, P55, DOI 10.1007/s11031-011-9260-7; Kamp SM, 2015, PSYCHOPHYSIOLOGY, V52, P460, DOI 10.1111/psyp.12378; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Klackl J, 2014, SOC COGN AFFECT NEUR, V9, P1754, DOI 10.1093/scan/nst167; Klackl J, 2018, SOC NEUROSCI-UK, V13, P355, DOI 10.1080/17470919.2017.1308880; Klackl J, 2013, SOC COGN AFFECT NEUR, V8, P333, DOI 10.1093/scan/nss003; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Klimesch W, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00118; Ludeke SG, 2014, BEHAV BRAIN SCI, V37, P319, DOI 10.1017/S0140525X13002641; Lueders A, 2019, EUR J SOC PSYCHOL, V49, P1471, DOI 10.1002/ejsp.2580; Millisecond Software LLC, 2014, INQ 4 0 8 0, DOI [10.1002/ejsp.589, DOI 10.1002/EJSP.589]; Mouffe C, 1998, SOUNDINGS, V9, P11; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Proulx T., 2013, EXPERIENCE MEANING L, P47, DOI [10.1007/978-94-007-6527-6_4, DOI 10.1007/978-94-007-6527-6_4]; Proulx T, 2006, PSYCHOL INQ, V17, P309, DOI 10.1080/10478400701366985; Proulx T, 2017, SOC COGNITION, V35, P313, DOI 10.1521/soco.2017.35.4.313; Proulx T, 2017, J EXP SOC PSYCHOL, V70, P69, DOI 10.1016/j.jesp.2016.12.003; Proulx T, 2013, J SOC ISSUES, V69, P455, DOI 10.1111/josi.12024; Proulx T, 2012, PSYCHOL INQ, V23, P317, DOI 10.1080/1047840X.2012.702372; Proulx T, 2010, PERS SOC PSYCHOL B, V36, P817, DOI 10.1177/0146167210369896; Proulx T, 2009, PSYCHOL SCI, V20, P1125, DOI 10.1111/j.1467-9280.2009.02414.x; Proulx T, 2008, PSYCHOL SCI, V19, P1294, DOI 10.1111/j.1467-9280.2008.02238.x; R Core Team, 2021, R LANGUAGE ENV STAT; Randles D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204640; Randles D, 2011, J EXP SOC PSYCHOL, V47, P246, DOI 10.1016/j.jesp.2010.07.020; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reiss S., 2018, HDB TERROR MANAGEMEN, P449, DOI [10.1016/B978-0-12-811844-3.00019-6, DOI 10.1016/B978-0-12-811844-3.00019-6]; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Sleegers W., 2015, FRONT PSYCHOL, V5, P1568, DOI [10.3389/fpsyg.2015.01568, DOI 10.3389/FPSYG.2015.01568]; Sleegers WWA, 2015, BIOL PSYCHOL, V108, P126, DOI 10.1016/j.biopsycho.2015.03.012; TAYLOR IA, 1960, PSYCHOL MONOGR, V74, P1; Tritt SM, 2016, EMOTION, V16, P1172, DOI 10.1037/emo0000150; Tritt SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083333; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008	70	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220732	10.1371/journal.pone.0220732	http://dx.doi.org/10.1371/journal.pone.0220732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381605	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000484993600033
J	Valbusa, F; Angheben, A; Mantovani, A; Zerbato, V; Chiampan, A; Bonapace, S; Rodari, P; Agnoletti, D; Arcaro, G; Fava, C; Bisoffi, Z; Targher, G				Valbusa, Filippo; Angheben, Andrea; Mantovani, Alessandro; Zerbato, Verena; Chiampan, Andrea; Bonapace, Stefano; Rodari, Paola; Agnoletti, Davide; Arcaro, Guido; Fava, Cristiano; Bisoffi, Zeno; Targher, Giovanni			Increased aortic stiffness in adults with chronic indeterminate Chagas disease	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; TRYPANOSOMA-CRUZI INFECTION; ARTERIAL STIFFNESS; HEART-DISEASE; PATHOGENESIS; PRESSURE	An ever-increasing number of patients with chronic indeterminate Chagas disease are diagnosed with early vascular and cardiac abnormalities, as cardiovascular imaging becomes more sensitive. However, the currently available information on aortic stiffness (a prognostic marker for adverse cardiovascular outcomes) in these patients is scarce. In this study, we consecutively recruited 21 asymptomatic Bolivian adult patients with chronic indeterminate Chagas disease and 14 Bolivian adults, who were seronegative for Trypanosoma cruzi infection. No participants had a prior history of heart disease, hypertension, diabetes, chronic kidney disease or atrial fibrillation. Carotid-femoral pulse wave velocity (cf-PWV), carotid-radial PWV (cr-PWV), carotid intima-media thickness and conventional echocardiographic measurements were recorded in all participants. Patients with chronic indeterminate Chagas disease had significantly higher cf-PWV (7.9 +/- 1.3 vs. 6.4 +/- 1.1 m/s, p = 0.003) and greater HOMA-estimated insulin resistance than subjects without Chagas disease. The two groups did not significantly differ in terms of age, sex, smoking, adiposity measures, blood pressure, plasma lipids, fasting glucose levels as well as cr-PWV, carotid intima-media thickness measurements, left ventricular mass and function. Presence of chronic indeterminate Chagas disease was significantly associated with increasing cf-PWV values (beta coefficient: 1.31, 95% coefficient interval 0.44 to 2.18, p = 0.005), even after adjustment for age, sex, heart rate, systolic blood pressure and insulin resistance. In conclusion, asymptomatic Bolivian adult patients with chronic indeterminate Chagas disease have an early and marked increase in aortic stiffness, as measured by cf-PWV, when compared to Bolivian adults who were seronegative for Trypanosoma cruzi infection.	[Valbusa, Filippo; Agnoletti, Davide; Arcaro, Guido] IRCCS Sacro Cuore Don Calabria Hosp, Div Internal Med, Verona, Italy; [Angheben, Andrea; Zerbato, Verena; Rodari, Paola; Bisoffi, Zeno] IRCCS Sacro Cuore Don Calabria Hosp, Dept Infect & Trop Dis, Verona, Italy; [Mantovani, Alessandro; Targher, Giovanni] Univ & Azienda Osped Univ Integrate Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy; [Chiampan, Andrea; Bonapace, Stefano] IRCCS Sacro Cuore Don Calabria Hosp, Div Cardiol, Verona, Italy; [Fava, Cristiano] Univ Verona, Dept Med, Sect Gen Med & Hypertens, Verona, Italy; [Bisoffi, Zeno] Univ Verona, Dept Diagnost & Publ Hlth, Verona, Italy	IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Verona	Targher, G (corresponding author), Univ & Azienda Osped Univ Integrate Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy.	giovanni.targher@univr.it	Targher, Giovanni/AAB-9008-2019; Agnoletti, Davide/K-1441-2016; Mantovani, Alessandro/AAB-9015-2019; Fava, Cristiano/K-9590-2015; Rodari, Paola/D-6871-2019; Bisoffi, Zeno/B-6438-2013	Targher, Giovanni/0000-0002-4325-3900; Agnoletti, Davide/0000-0001-8108-7133; Mantovani, Alessandro/0000-0002-7271-6329; Fava, Cristiano/0000-0002-8910-7378; Rodari, Paola/0000-0001-8853-8443; Bisoffi, Zeno/0000-0001-9530-8742; Bonapace, Stefano/0000-0001-9122-2642	Italian Ministry of Health "Fondi Ricerca Corrente - Linea 3, progetto 9"	Italian Ministry of Health "Fondi Ricerca Corrente - Linea 3, progetto 9"	This work was supported by the Italian Ministry of Health "Fondi Ricerca Corrente - Linea 3, progetto 9" to IRCCS Sacro Cuore-Don Calabria Hospital of Negrar (VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angheben A, 2011, EUROSURVEILLANCE, V16, P2; Benetos A, 2010, J HYPERTENS, V28, P41, DOI 10.1097/HJH.0b013e328332b879; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Burgos JM, 2010, CLIN INFECT DIS, V51, P485, DOI 10.1086/655680; Gornik HL, 2008, CIRCULATION, V117, P3039, DOI 10.1161/CIRCULATIONAHA.107.760686; Hofmann B, 2014, J CLIN HYPERTENS, V16, P629, DOI 10.1111/jch.12382; Jerrard-Dunne P, 2008, J HYPERTENS, V26, P529, DOI 10.1097/HJH.0b013e3282f35265; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lopez M, 2018, CURR CLIN MICROBIOL, V5, P45, DOI 10.1007/s40588-018-0081-2; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Millasseau SC, 2005, HYPERTENSION, V45, P222, DOI 10.1161/01.HYP.0000154229.97341.d2; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nunes MCP, 2018, EUR HEART J-CARD IMG, V19, P459, DOI 10.1093/ehjci/jex154; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Rajzer MW, 2008, J HYPERTENS, V26, P2001, DOI 10.1097/HJH.0b013e32830a4a25; Regueiro A, 2013, INT J CARDIOL, V165, P107, DOI 10.1016/j.ijcard.2011.07.089; Repetto Ernestina Carla, 2015, PLoS Negl Trop Dis, V9, pe0004103, DOI 10.1371/journal.pntd.0004103; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Requena-Mendez A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003245; Salvi P, 2004, J HYPERTENS, V22, P2285, DOI 10.1097/00004872-200412000-00010; Silva JF, 2016, VASC PHARMACOL, V82, P73, DOI 10.1016/j.vph.2016.03.002; Sunnemark D, 1998, SCAND J IMMUNOL, V48, P480; Tanowitz HB, 2011, ADV PARASIT, V76, P235, DOI 10.1016/B978-0-12-385895-5.00010-4; Villacorta H, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-9; Zhang Y, 2014, J HYPERTENS, V32, P1572, DOI 10.1097/HJH.0000000000000187	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220689	10.1371/journal.pone.0220689	http://dx.doi.org/10.1371/journal.pone.0220689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374101	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500025
J	Choi, AN; Jang, IS; Son, SA; Jung, KH; Park, JK				Choi, An-Na; Jang, II-Seok; Son, Sung-Ae; Jung, Kyoung-Hwa; Park, Jeong-Kil			Effect of erosive and abrasive stress on sealing ability of different desensitizers: In-vitro study	PLOS ONE			English	Article							DENTIN HYPERSENSITIVITY; POTASSIUM OXALATE; TUBULE OCCLUSION; FLUORIDE VARNISH; PERMEABILITY; ADHESIVES; EFFICACY; AGENTS	This in vitro study examined the sealing ability of different desensitizing agents under a chemo-mechanical stress condition. For the study, a total of 144 extracted, caries-free human third molars were used to produce 1 mm-thick dentin discs. The specimens were divided randomly into four groups: Superseal (SS), Gluma (GL), Gluma Self-etch (GS), and Tooth Coat (TC). For each group, the permeability was measured before and after applying the desensitizer, after being exposed to Coca Cola for 5 minutes, and after 3150 strokes of a brushing abrasion. The decrease in permeability after the erosive and abrasive stress was analyzed by ANOVA and Tukey post hoc test. As a result, the dentin permeability decreased significantly for all desensitizers immediately after application (p < 0.05). SS and GS showed a significant difference in permeability reduction observed immediately after application and after acid action with Coca Cola (p < 0.05). After brushing abrasion, the permeability reduction decreased significantly for all desensitizers tested in this study (p < 0.05). TC showed the largest decrease in dentinal permeability compared to that of the other desensitizers and the differences were significant after brushing abrasion (p < 0.05). All tested desensitizers were effective in reducing dentin permeability. The behavioral characteristics under erosive and abrasive stress varied according to the products used. TC exhibited excellent sealing ability among the other desensitizers.	[Choi, An-Na; Son, Sung-Ae; Jung, Kyoung-Hwa; Park, Jeong-Kil] Pusan Natl Univ, Sch Dent, Dent Res Inst, Dept Conservat Dent, Yangsan, South Korea; [Jang, II-Seok] Pusan Natl Univ, Sch Nat Sci, Dept Microbiol, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University	Park, JK (corresponding author), Pusan Natl Univ, Sch Dent, Dent Res Inst, Dept Conservat Dent, Yangsan, South Korea.	jeongkil@pusan.ac.kr		Park, Jeongkil/0000-0001-6333-8138; An-na, Choi/0000-0003-0364-4621				ABSI EG, 1987, J CLIN PERIODONTOL, V14, P280, DOI 10.1111/j.1600-051X.1987.tb01533.x; ADDY M, 1994, ARCH ORAL BIOL, V39, pS33, DOI 10.1016/0003-9969(94)90186-4; Andrew D, 2000, J PHYSIOL-LONDON, V529, P791, DOI 10.1111/j.1469-7793.2000.00791.x; [Anonymous], J CAN DENT ASS; Arrais César Augusto Galvão, 2004, J. Appl. Oral Sci., V12, P144, DOI 10.1590/S1678-77572004000200012; Atta AM, 2011, J APPL POLYM SCI, V122, P183, DOI 10.1002/app.34052; Bacelar-Sa R, 2017, J ADHES DENT, V19, P357, DOI 10.3290/j.jad.a38866; Banomyong D, 2013, J INVESTIG CLIN DENT, V4, DOI 10.1111/j.2041-1626.2012.00144.x; Brannstrom M, 1969, Odontol Revy, V20, P15; Brunton PA, 2000, DENT MATER, V16, P351, DOI 10.1016/S0109-5641(00)00027-0; Camps J, 1998, AM J DENT, V11, P286; Canakci CF, 2007, J AM DENT ASSOC, V138, P1563, DOI 10.14219/jada.archive.2007.0105; De Munck J, 2005, J DENT RES, V84, P118, DOI 10.1177/154405910508400204; Fu B, 2007, OPER DENT, V32, P496, DOI 10.2341/06-143; Giannini Marcelo, 2015, Braz. Dent. J., V26, P3, DOI 10.1590/0103-6440201302442; Gillam D G, 1997, Adv Dent Res, V11, P487; Gillam DG, 2001, J ORAL REHABIL, V28, P1037, DOI 10.1046/j.1365-2842.2001.00775.x; Gillam DG, 2006, ENDOD TOPICS, V13, P13, DOI [10.1111/j.1601-1546.2006.00209.x, DOI 10.1111/J.1601-1546.2006.00209.X]; Guentsch A, 2012, DENT MATER, V28, P457, DOI 10.1016/j.dental.2012.01.003; HANSEN EK, 1992, SCAND J DENT RES, V100, P305; Hashimoto M, 2004, J DENT RES, V83, P843, DOI 10.1177/154405910408301104; Haywood VB, 2001, QUINTESSENCE INT, V32, P105; Hoang-Dao BT, 2009, J ORAL REHABIL, V36, P124, DOI 10.1111/j.1365-2842.2008.01907.x; Ide M, 1998, J CLIN PERIODONTOL, V25, P286, DOI 10.1111/j.1600-051X.1998.tb02442.x; Ishihata H, 2011, J APPL ORAL SCI, V19, P147, DOI 10.1590/S1678-77572011000200011; Jacobsen P L, 2001, J Contemp Dent Pract, V2, P1; Kolker Justine L, 2002, J Adhes Dent, V4, P211; Leonard Ralph H Jr, 2004, J Esthet Restor Dent, V16, P49, DOI 10.1111/j.1708-8240.2004.tb00452.x; March J., 1992, ADVANCED ORGANIC CHE; Markowitz K, 2007, J DENT RES, V86, P292, DOI 10.1177/154405910708600401; Mehta D, 2014, ACTA ODONTOL SCAND, V72, P936, DOI 10.3109/00016357.2014.923112; Morris MF, 1999, AM J DENT, V12, P72; Moszner N, 2005, DENT MATER, V21, P895, DOI 10.1016/j.dental.2005.05.001; MUZZIN KB, 1989, J PERIODONTOL, V60, P151, DOI 10.1902/jop.1989.60.3.151; Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321; PASHLEY DH, 1978, ARCH ORAL BIOL, V23, P1127, DOI 10.1016/0003-9969(78)90119-X; PASHLEY DH, 1985, ARCH ORAL BIOL, V30, P731, DOI 10.1016/0003-9969(85)90185-2; PASHLEY DH, 1978, ARCH ORAL BIOL, V23, P807, DOI 10.1016/0003-9969(78)90159-0; PASHLEY DH, 1986, J ENDODONT, V12, P465, DOI 10.1016/S0099-2399(86)80201-1; Paul SJ, 1999, J DENT, V27, P209, DOI 10.1016/S0300-5712(98)00042-6; Petersson LG, 2013, CLIN ORAL INVEST, V17, pS63, DOI 10.1007/s00784-012-0916-9; Pillon FL, 2004, J PERIODONTOL, V75, P1461, DOI 10.1902/jop.2004.75.11.1461; Qin CY, 2006, EUR J ORAL SCI, V114, P354, DOI 10.1111/j.1600-0722.2006.00382.x; Schmalz G, 2017, OPER DENT, V42, pE35, DOI 10.2341/16-068-L; Schupbach P, 1997, EUR J ORAL SCI, V105, P414, DOI 10.1111/j.1600-0722.1997.tb02138.x; Sidhu SK, 2004, AM J DENT, V17, P211; Silva SMA, 2010, OPER DENT, V35, P610, DOI 10.2341/09-202-L; Splieth CH, 2013, CLIN ORAL INVEST, V17, pS3, DOI 10.1007/s00784-012-0889-8; Talioti E, 2014, ISRN Dent, V2014, P865761, DOI 10.1155/2014/865761; Tay FR, 2003, AM J DENT, V16, P6; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; West N, 1998, J ORAL REHABIL, V25, P885, DOI 10.1046/j.1365-2842.1998.00339.x; West NX, 2013, CLIN ORAL INVEST, V17, pS9, DOI 10.1007/s00784-012-0887-x; Yilmaz HG, 2011, PHOTOMED LASER SURG, V29, P721, DOI 10.1089/pho.2010.2974; Yilmaz NA, 2017, OPEN DENT J, V11, P15, DOI 10.2174/1874210601711010015; Yiu CKY, 2005, BIOMATERIALS, V26, P6863, DOI 10.1016/j.biomaterials.2005.05.011; Zhang Y, 1998, J CLIN PERIODONTOL, V25, P884, DOI 10.1111/j.1600-051X.1998.tb02386.x; Zhou JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158400; DG	59	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220823	10.1371/journal.pone.0220823	http://dx.doi.org/10.1371/journal.pone.0220823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369650	gold, Green Published, Green Submitted			2022-12-26	WOS:000484987900088
J	Coletta, AM; Marquez, G; Thomas, P; Thoman, W; Bevers, T; Brewster, AM; Hawk, E; Basen-Engquist, K; Gilchrist, SC				Coletta, Adriana M.; Marquez, Guillermo; Thomas, Parijatham; Thoman, Whittney; Bevers, Therese; Brewster, Abenaa M.; Hawk, Ernest; Basen-Engquist, Karen; Gilchrist, Susan C.			Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors	PLOS ONE			English	Article							BREAST-CANCER; CARDIORESPIRATORY FITNESS; RISK; MORTALITY; EXERCISE; HEALTH; STRENGTH; PARADIGM; PROSTATE	Physical activity (PA) is a known behavior to reduce cancer risk and improve cancer survivorship, yet adherence to PA guidelines is poor among the general population and cancer survivors. The purpose of this study was to determine the extent to which patients referred for exercise consultation within a clinical cancer prevention setting were meeting aerobic and resistance physical activity (PA) guidelines and to identify factors associated with guideline adherence. Between 2013 and 2015, cancer prevention patients and cancer survivors were interviewed by an exercise physiologist within an Integrative Health Program at The University of Texas MD Anderson Cancer Prevention Center. PA adherence was defined as at least 150-minutes of moderate-intensity or 75-minutes of vigorous-intensity PA per week, along with resistance training at least 2 days per week. Logistic regression was used to determine factors associated with meeting or not meeting PA guidelines for aerobic exercise, resistance exercise, and aerobic and resistance exercise combined. Among 1,024 cancer prevention patients and survivors, 9% of patients adhered to guideline-based PA. Adherence to aerobic and resistance guidelines were 20% and 12%, respectively. Overweight or obesity was associated with not meeting guideline-based PA in both cancer prevention patients and cancer survivors. Among breast cancer survivors, combination treatment with surgery, radiation, and chemotherapy ('multimodal therapy') was robustly associated with not meeting aerobic guidelines (OR 2.20, 95% CI: 1.17 to 4.16). BMI and breast cancer treatment history are key determinants of PA behavior among cancer prevention patients and survivors. Poor adherence to PA guidelines is a key issue for cancer prevention patients and survivors, particularly obese patients and women who receive multimodal therapy for breast cancer. Identifying and connecting patients at highest risk of poor PA adherence with exercise programs is needed to improve PA, a key modifiable cancer risk factor.	[Coletta, Adriana M.] Huntsman Canc Inst, Canc Control & Populat Sci Program, Salt Lake City, UT USA; [Coletta, Adriana M.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT USA; [Marquez, Guillermo; Thomas, Parijatham; Thoman, Whittney; Bevers, Therese; Brewster, Abenaa M.; Gilchrist, Susan C.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Hawk, Ernest] Univ Texas MD Anderson Canc Ctr, Div OVP Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Basen-Engquist, Karen] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Gilchrist, Susan C.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gilchrist, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA.; Gilchrist, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA.	sgilchrist@mdanderson.org		Coletta, Adriana/0000-0002-2503-2792	Duncan Family; Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute; National Cancer Institute of the National Institutes of Health [R25CA057730]; NATIONAL CANCER INSTITUTE [R25CA057730, P30CA016672] Funding Source: NIH RePORTER	Duncan Family; Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a gift from the Duncan Family to the University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment. This study was also supported by the Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute. We would like to thank the National Cancer Institute of the National Institutes of Health under Award Number R25CA057730 (PI: Shine Chang, PhD) for supporting AMC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All funders had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abioye AI, 2015, BRIT J SPORT MED, V49, P224, DOI 10.1136/bjsports-2013-092778; ALBANES D, 1989, AM J PUBLIC HEALTH, V79, P744, DOI 10.2105/AJPH.79.6.744; [Anonymous], 2018, 2018 PHYSICAL ACTIVI; Crawford JJ, 2016, SUPPORT CARE CANCER, V24, P3533, DOI 10.1007/s00520-016-3173-7; Farrell SW, 2007, OBESITY, V15, P3140, DOI 10.1038/oby.2007.374; Fisher A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006853; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Forbes CC, 2015, ONCOL NURS FORUM, V42, P118, DOI 10.1188/15.ONF.42-02AP; Friedenreich CM, 2016, EUR UROL, V70, P576, DOI 10.1016/j.eururo.2015.12.032; Inoue-Choi M, 2013, CANCER EPIDEM BIOMAR, V22, P792, DOI 10.1158/1055-9965.EPI-13-0054; Irwin ML, 2008, J CLIN ONCOL, V26, P3958, DOI 10.1200/JCO.2007.15.9822; Irwin ML, 2004, MED SCI SPORT EXER, V36, P1484, DOI 10.1249/01.MSS.0000074670.03001.98; Jones LW, 2004, ANN BEHAV MED, V28, P105, DOI 10.1207/s15324796abm2802_5; Kabat GC, 2015, AM J CLIN NUTR, V101, P558, DOI 10.3945/ajcn.114.094854; Lahart IM, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011292.pub2; Lakoski SG, 2015, JAMA ONCOL, V1, P231, DOI 10.1001/jamaoncol.2015.0226; Lakoski SG, 2013, BREAST CANCER RES TR, V138, P909, DOI 10.1007/s10549-013-2478-1; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Loprinzi P, 2014, N AM J MED SCI, V6, P295, DOI 10.4103/1947-2714.136901; Mazzilli KM, 2019, MED SCI SPORT EXER, V51, P1845, DOI 10.1249/MSS.0000000000001987; McCullough ML, 2011, CANCER EPIDEM BIOMAR, V20, P1089, DOI 10.1158/1055-9965.EPI-10-1173; McTiernan A, 2003, JAMA-J AM MED ASSOC, V290, P1331, DOI 10.1001/jama.290.10.1331; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007566.pub2; Nayak P, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140067; Ottenbacher A, 2015, J PHYS ACT HEALTH, V12, P675, DOI 10.1123/jpah.2014-0003; Peel AB, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000432; Pescatello LS, 2013, ACSMS GUIDELINES FOR; Sanchis-Gomar F, 2015, CANCER PREV RES, V8, P105, DOI 10.1158/1940-6207.CAPR-14-0320; Short CE, 2014, SUPPORT CARE CANCER, V22, P2757, DOI 10.1007/s00520-014-2273-5; Smith SG, 2010, AM SURGEON, V76, P962; Tarasenko YN, 2018, CANCER CAUSE CONTROL, V29, P475, DOI 10.1007/s10552-018-1017-0; Tarasenko YN, 2017, PREV MED, V99, P211, DOI 10.1016/j.ypmed.2017.01.010; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; Thune I, 2001, MED SCI SPORT EXER, V33, pS530, DOI 10.1097/00005768-200106001-00025; Trinh L, 2018, PSYCHO-ONCOLOGY, V27, P2419, DOI 10.1002/pon.4844; Vallerand JR, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0498-7; van Vulpen JK, 2016, MATURITAS, V85, P104, DOI 10.1016/j.maturitas.2015.12.007; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7	38	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220814	10.1371/journal.pone.0220814	http://dx.doi.org/10.1371/journal.pone.0220814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369653	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900087
J	Eves, FF; Puig-Ribera, A				Eves, Frank F.; Puig-Ribera, Anna			Learnt effects of environmental cues on transport-related walking; disrupting habits with health promotion?	PLOS ONE			English	Article							OF-CHOICE PROMPTS; STAIR-RISER BANNERS; PHYSICAL-ACTIVITY; CLIMBING INTERVENTION; EVERYDAY LIFE; BEHAVIOR; EXERCISE; IMPLICIT; CONTEXT; TOLERANCE	Background In Ecological models, physical environments can be important determinants of transport-related walking. With repeated exposure to the same environment, learning of a linkage between the cues in the environment and walking should occur. Subsequent encounters with the cues can prompt the behaviour relatively automatically. No studies have experimentally tested the potential learning of this linkage between cues and behaviour. Choices between stairs and escalators in public access settings were employed to test this premise for transport-related walking. Methods Three studies investigated the effects of visual cues on stair/escalator choices (combined n = 115,062). In quasi-experimental, interrupted time-series designs, observers audited choices in public access settings. Design alone phases with art or coloured backgrounds were compared with design plus message phases in which verbal health promotion messages were superimposed on the visual cues. Analyses used bootstrapped logistic regression. Results In initial studies, the design alone phases had no effect whereas subsequent design plus message phases reduced escalator choice. In two further studies, a 5-6 week design plus message phase that reduced escalator choice preceded a design alone phase. The visual background behind the successful health promotion message was reintroduced four weeks after the intervention was removed. The visual cue of design alone reduced escalator choice after it had been paired with the verbal health promotion message. There were no differences between art and coloured backgrounds. Conclusion These studies demonstrate for the first time a learnt linkage between transport-related walking and environmental cues. Discussion focuses on the mechanisms that may underlie this learning and cues in the environment that are relevant to transport-related walking.	[Eves, Frank F.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Puig-Ribera, Anna] Univ Vic Univ Cent Catalunya, Dept Ciencies Activitat Fis, Vic, Spain	University of Birmingham; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Eves, FF (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	F.F.Eves@bham.ac.uk		Eves, Frank/0000-0002-4921-7169				Aarts, 2007, HLTH PSYCHOL REV, V1, P53, DOI [https://doi.org/10.1080/17437190701485852, DOI 10.1080/17437190701485852]; Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Allison MK, 2017, MED SCI SPORT EXER, V49, P298, DOI 10.1249/MSS.0000000000001188; Bargh J.A., 1994, HDB SOCIAL COGNITION, P1; Bauman A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012459; Bellicha A, 2015, PREV MED, V70, P3, DOI 10.1016/j.ypmed.2014.11.001; Birak KS, 2011, ALCOHOL ALCOHOLISM, V46, P686, DOI 10.1093/alcalc/agr084; BLAMEY A, 1995, BRIT MED J, V311, P289, DOI 10.1136/bmj.311.7000.289; Boreham CAG, 2005, BRIT J SPORT MED, V39, P590, DOI 10.1136/bjsm.2002.001131; Boreham CAG, 2000, PREV MED, V30, P277, DOI 10.1006/pmed.2000.0634; Boutelle KN, 2001, AM J PUBLIC HEALTH, V91, P2004, DOI 10.2105/AJPH.91.12.2004; Bouton ME, 2000, HEALTH PSYCHOL, V19, P57, DOI 10.1037/0278-6133.19.Suppl1.57; Brockmole JR, 2006, VIS COGN, V13, P99, DOI 10.1080/13506280500165188; Chun MM, 2003, J EXP PSYCHOL LEARN, V29, P224, DOI 10.1037/0278-7393.29.2.224; Danner UN, 2008, BRIT J SOC PSYCHOL, V47, P245, DOI 10.1348/014466607X230876; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Eves FF, 2008, MED SCI SPORT EXER, V40, P965, DOI 10.1249/MSS.0b013e3181659c68; Eves FF, 2008, OBES REV, V9, P83, DOI 10.1111/j.1467-789X.2007.00372.x; Eves FF, 2006, OBESITY, V14, P2210, DOI 10.1038/oby.2006.259; Eves FF, 2006, INT J EPIDEMIOL, V35, P1286, DOI 10.1093/ije/dyl141; Eves FF, 2006, PREV MED, V43, P4, DOI 10.1016/j.ypmed.2006.03.011; Eves FF, 2014, PSYCHON B REV, V21, P71, DOI 10.3758/s13423-013-0463-7; Eves FF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-423; Eves FF, 2010, AM J PREV MED, V38, P573, DOI 10.1016/j.amepre.2010.02.004; Eves FF, 2009, J ENVIRON PSYCHOL, V29, P300, DOI 10.1016/j.jenvp.2008.10.002; Gardner B, 2019, BRIT J HEALTH PSYCH, V24, P241, DOI 10.1111/bjhp.12369; Gardner B, 2015, HEALTH PSYCHOL REV, V9, P277, DOI 10.1080/17437199.2013.876238; Gardner B, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-102; Holland RW, 2006, J EXP SOC PSYCHOL, V42, P776, DOI 10.1016/j.jesp.2005.11.006; Jimenez L, 1999, J EXP PSYCHOL LEARN, V25, P236, DOI 10.1037/0278-7393.25.1.236; Jimenez L, 2001, Q J EXP PSYCHOL-A, V54, P345, DOI 10.1080/02724980042000200; Kennedy RA, 2007, J SPORT SCI MED, V6, P448; Kerr J, 2001, PREV MED, V33, P422, DOI 10.1006/pmed.2001.0908; Kerr J, 2001, AM J PUBLIC HEALTH, V91, P1192, DOI 10.2105/AJPH.91.8.1192; Kerr J., 2003, PERSPECTIVES HLTH EX, P203; Kerr NA, 2004, AM J HEALTH PROMOT, V18, P312, DOI 10.4278/0890-1171-18.4.312; Lally P, 2011, PSYCHOL HEALTH MED, V16, P484, DOI 10.1080/13548506.2011.555774; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lewis AL, 2012, PSYCHOL SPORT EXERC, V13, P126, DOI 10.1016/j.psychsport.2011.10.001; Lewis AL, 2011, ANN BEHAV MED, V42, P257, DOI 10.1007/s12160-011-9283-z; Meyer P, 2010, EUR J CARDIOV PREV R, V17, P569, DOI 10.1097/HJR.0b013e328338a4dd; MULLEN B, 1990, PERS SOC PSYCHOL B, V16, P320, DOI 10.1177/0146167290162012; Neal DT, 2012, J EXP SOC PSYCHOL, V48, P492, DOI 10.1016/j.jesp.2011.10.011; Neal DT, 2011, PERS SOC PSYCHOL B, V37, P1428, DOI 10.1177/0146167211419863; Nocon M, 2010, SCAND J PUBLIC HEALT, V38, P633, DOI 10.1177/1403494810375865; Olander EK, 2008, PREV MED, V46, P308, DOI 10.1016/j.ypmed.2007.11.009; Orbell S, 2010, HEALTH PSYCHOL, V29, P374, DOI 10.1037/a0019596; Organisation for Economic Cooperation and Development, 2014, EMPL LAB MARK STAT E; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Phillips LA, 2016, HEALTH PSYCHOL, V35, P69, DOI 10.1037/hea0000249; Puig-Ribera A, 2010, EUR J PUBLIC HEALTH, V20, P100, DOI 10.1093/eurpub/ckp059; Reynolds R, 2014, PREV MED, V67, P46, DOI 10.1016/j.ypmed.2014.06.023; SHAPIRO AP, 1986, PSYCHOPHARMACOLOGY, V88, P90, DOI 10.1007/BF00310519; Srinivasan M, 2009, CHAOS, V19, DOI 10.1063/1.3141428; Teh KC, 2002, MED SCI SPORT EXER, V34, P695, DOI 10.1097/00005768-200204000-00021; Tobias R, 2009, PSYCHOL REV, V116, P408, DOI 10.1037/a0015512; Tolman E. C., 1930, U CALIF PUBL PSYCHOL, V4, P257; US Department of Health and Human Services, 2015, STEP IT SURG GEN CAL; Verplanken B, 1997, EUR J SOC PSYCHOL, V27, P539, DOI 10.1002/(SICI)1099-0992(199709/10)27:5<539::AID-EJSP831>3.3.CO;2-1; Verplanken B., 1999, EUR REV SOC PSYCHOL, V10, P101, DOI [10.1080/14792779943000035, DOI 10.1080/14792779943000035PLEASE, DOI 10.1080/14792779943000035]; Webb OJ, 2005, AM J PUBLIC HEALTH, V95, P1543, DOI 10.2105/AJPH.2004.046235; Webb OJ, 2007, AM J HEALTH PROMOT, V22, P114, DOI 10.4278/0890-1171-22.2.114; Webb OJ, 2007, AM J HEALTH PROMOT, V22, P38, DOI 10.4278/0890-1171-22.1.38; Webb OJ, 2011, J PHYS ACT HEALTH, V8, P558, DOI 10.1123/jpah.8.4.558; Webb OJ, 2011, BRIT J HEALTH PSYCH, V16, P373, DOI 10.1348/135910710X510395; Wood W, 2002, J PERS SOC PSYCHOL, V83, P1281, DOI 10.1037/0022-3514.83.6.1281; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502	71	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220308	10.1371/journal.pone.0220308	http://dx.doi.org/10.1371/journal.pone.0220308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369609	Green Submitted, gold, Green Published			2022-12-26	WOS:000484987900041
J	Yoo, J; Chong, S; Lim, C; Heo, M; Hwang, IG				Yoo, Jeongin; Chong, Semin; Lim, Changwon; Heo, Miyoung; Hwang, In Gyu			Assessment of spatial tumor heterogeneity using CT growth patterns estimated by tumor tracking on 3D CT volumetry of multiple pulmonary metastatic nodules	PLOS ONE			English	Article								Purpose Our purpose was to assess the differences in growth rates of multiple pulmonary metastatic nodules using three-dimensional (3D) computed tomography (CT) volumetry and propose a concept of CT spatial tumor heterogeneity. Materials and methods We manually measured the largest diameter of metastatic pulmonary nodules on chest CT scans, and calculated the 3D maximum diameter and the volume using a semi-automated 3D CT volumetry of each nodule. The tumor response was assessed according to the revised RECIST 1.1. We defined a nodule as an outlier based on 1.5 times growth during follow-up. The CT spatial tumor heterogeneity was statistically analyzed by the "minimum combination t-test method" devised in our study. Results On manual measurement, the tumor response category was stable disease (SD) in all 10 patients. Of them, total 155 metastatic nodules (4-52 nodules per patient) were segmented using the 3D CT volumetry. In the 3D maximum diameter, 9 patients had SD except for one patient with partial response in the two selected nodules; for the volume, all 10 patients were SD. For the 3D maximum diameter, six patients had at least one outlier; whereas five patients had the outlier on the volume measurement. Six patients were proven to have overall CT spatial tumor heterogeneity. Conclusions The spatial tumor heterogeneity determined in a CT parametric approach could be statistically assessed. In patients with CT spatial heterogeneity, tumors with different growth rates may be neglected when the nodules are assessed according to the current guideline.	[Yoo, Jeongin] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Chong, Semin] Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea; [Lim, Changwon; Heo, Miyoung] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea; [Hwang, In Gyu] Chung Ang Univ, Dept Internal Med, Chung Ang Univ Hosp, Div Hematol Oncol,Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Chung Ang University; Chung Ang University Hospital	Chong, S (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea.	smchong337@gmail.com		Chong, Semin/0000-0002-7429-2566				[Anonymous], 2011, PREC MED BUILD KNOWL; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; CROW J, 1981, CANCER, V47, P2595, DOI 10.1002/1097-0142(19810601)47:11<2595::AID-CNCR2820471114>3.0.CO;2-Q; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Martelotto LG, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3658; Marten K, 2007, EUR RADIOL, V17, P2561, DOI 10.1007/s00330-007-0642-x; MURATA K, 1992, RADIOLOGY, V182, P331, DOI 10.1148/radiology.182.2.1732945; Suzuki C, 2008, RADIOGRAPHICS, V28, P329, DOI 10.1148/rg.282075068; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7	11	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220550	10.1371/journal.pone.0220550	http://dx.doi.org/10.1371/journal.pone.0220550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369602	gold, Green Published, Green Submitted			2022-12-26	WOS:000484987900063
J	Jaleta, M; Hodson, D; Abeyo, B; Yirga, C; Erenstein, O				Jaleta, Moti; Hodson, Dave; Abeyo, Bekele; Yirga, Chilot; Erenstein, Olaf			Smallholders' coping mechanisms with wheat rust epidemics: Lessons from Ethiopia	PLOS ONE			English	Article							FOOD SECURITY; CLIMATE-CHANGE; PLANT-DISEASE; RESISTANCE; VARIETIES; PATHOGENS; PROSPECTS; LOSSES; THREAT; PESTS	Crops are variously susceptible to biotic stresses-something expected to increase under climate change. In the case of staple crops, this potentially undermines household and national food security. We examine recent wheat rust epidemics and smallholders' coping mechanisms in Ethiopia as a case study. Wheat is a major food crop in Ethiopia widely grown by smallholders. In 2010/11 a yellow rust epidemic affected over one-third of the national wheat area. Two waves of nationally representative household level panel data collected for the preceding wheat season (2009/10) and three years after (2013/14) the occurrence of the epidemic allow us to analyze the different coping mechanisms farmers used in response. Apart from using fungicides as ex-post coping mechanism, increasing wheat area under yellow rust resistant varieties, increasing diversity of wheat varieties grown, or a combination of these strategies were the main ex-ante coping mechanisms farmers had taken in reducing the potential effects of rust re-occurrence. Large-scale dis-adoption of highly susceptible varieties and replacement with new, rust resistant varieties was observed subsequent to the 2010/11 epidemic. Multinomial logistic regression models were used to identify the key factors associated with smallholder ex-ante coping strategies. Household characteristics, level of specialization in wheat and access to improved wheat seed were the major factors that explained observed choices. There was 29-41% yield advantage in increasing wheat area to the new, resistant varieties even under normal seasons with minimum rust occurrence in the field. Continuous varietal development in responding to emerging new rust races and supporting the deployment of newly released resistant varieties could help smallholders in dealing with rust challenges and maintaining improved yields in the rust-prone environments of Ethiopia. Given the global importance of both wheat and yellow rust and climate change dynamics study findings have relevance to other regions.	[Jaleta, Moti; Abeyo, Bekele] Int Maize & Wheat Improvement Ctr CIMMYT, Addis Ababa, Ethiopia; [Hodson, Dave; Erenstein, Olaf] CIMMYT, Texcoco, Mexico; [Yirga, Chilot] EIAR, Addis Ababa, Ethiopia	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Ethiopian Institute of Agricultural Research (EIAR)	Jaleta, M (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Addis Ababa, Ethiopia.	m.jaleta@cgiar.org		Jaleta, Moti/0000-0002-3151-4018; Erenstein, Olaf/0000-0002-7491-5786	Standing Panel for Impact Assessment (SPIA); Cornell University; Bill & Melinda Gates Foundation; DFID/UK through the Durable Rust Resistance in Wheat (DRRW) project	Standing Panel for Impact Assessment (SPIA); Cornell University; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); DFID/UK through the Durable Rust Resistance in Wheat (DRRW) project	The authors would like to acknowledge the Standing Panel for Impact Assessment (SPIA) for financing the Diffusion and Impacts of Improved Varieties in Africa (DIIVA) project that supported the first survey in 2011, and Cornell University, the Bill & Melinda Gates Foundation, and DFID/UK through the Durable Rust Resistance in Wheat (DRRW) project for financing the second survey in 2014. We also acknowledge the CGIAR Research Program Wheat agri-food systems (CRP WHEAT) for supporting associated staff time. The contents and opinions expressed herein are those of the author and do not necessarily reflect the views of the donor or the authors' institution. The usual disclaimer applies. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01057; BADEBO A, 1990, NETH J PLANT PATHOL, V96, P199, DOI 10.1007/BF01974257; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; Beddow JM, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.132, 10.1038/nplants.2015.132]; Berhane G.Z.Paulos, 2011, 23 ESSP; Bishaw Z, 2017, INT J PLANT PROD, V11, P117; Caubel J, 2017, EUR J AGRON, V90, P53, DOI 10.1016/j.eja.2017.07.004; Central Statistical Agency (CSA), 2011, STAT B; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Chaves MS, 2013, FOOD SECUR, V5, P157, DOI 10.1007/s12571-013-0248-x; CSA (Central Statistical Agency), 2017, STAT B, V584; Di Falco S, 2009, AM J AGR ECON, V91, P599, DOI 10.1111/j.1467-8276.2009.01265.x; FAFCHAMPS M, 1992, AM J AGR ECON, V74, P90, DOI 10.2307/1242993; Food and Agriculture Organization of the United Nations (FAO), 2018, FOOD CHAIN CRIS EARL, V28; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Hodson DP, 2011, EUPHYTICA, V179, P93, DOI 10.1007/s10681-010-0335-4; Hulluka M., 1991, Wheat research in Ethiopia: a historical perspective., P173; Joshi AK, 2011, EUPHYTICA, V179, P187, DOI 10.1007/s10681-010-0314-9; Krupinsky JM, 2002, AGRON J, V94, P198, DOI 10.2134/agronj2002.0198; Negassa A, 2013, POTENTIAL WHEAT PROD; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Olivera P, 2015, PHYTOPATHOLOGY, V105, P917, DOI 10.1094/PHYTO-11-14-0302-FI; Saari EE, 1985, DIS DISTRIBUTION EPI, P259, DOI DOI 10.1016/B978-0-12-148402-6.50017-1; Savary S, 2019, NAT ECOL EVOL, V3, P430, DOI 10.1038/s41559-018-0793-y; Shank, 1994, WHEAT STEM RUST DROU; Singh RP, 2016, ANNU REV PHYTOPATHOL, V54, P303, DOI 10.1146/annurev-phyto-080615-095835; Singh RP, 2015, PHYTOPATHOLOGY, V105, P872, DOI 10.1094/PHYTO-01-15-0030-FI; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Suresh A., 2017, Indian Journal of Agricultural Economics, V72, P362; Tolemariam A, 2018, WHEAT VARIETAL CHANG; Vergara-Diaz O, 2015, CROP J, V3, P200, DOI 10.1016/j.cj.2015.03.003; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]	32	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219327	10.1371/journal.pone.0219327	http://dx.doi.org/10.1371/journal.pone.0219327			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365535	Green Submitted, Green Published, gold			2022-12-26	WOS:000484983600008
J	Win, KT; Okazaki, K; Ookawa, T; Yokoyama, T; Ohwaki, Y				Win, Khin Thuzar; Okazaki, Keiki; Ookawa, Taiichiro; Yokoyama, Tadashi; Ohwaki, Yoshinari			Influence of rice-husk biochar and Bacillus pumilus strain TUAT-1 on yield, biomass production, and nutrient uptake in two forage rice genotypes	PLOS ONE			English	Article							PLANT-GROWTH PROMOTION; NITROGEN-RETENTION; SOIL; CARBON; SOLUBILIZATION; EFFICIENCY; VALUES	Biochar is widely used as a soil amendment to increase crop yields. However, the impact of the interaction between the biochar and microbial inoculants (e.g., biofertilizer) on plant nutrient uptake and yield in forage rice is not fully understood. A greenhouse study was conducted to evaluate the synergistic effects of rice-husk biochar and Bacillus pumilus strain TUAT-1 biofertilizer application on growth, yield, and nutrient uptake in two forage rice genotypes; Fukuhibiki and the newly bred line, LTAT-29. Positive effects of biochar and biofertilizer, alone or in a combination, on growth traits, nutrient uptake, and yield components were dependent on the rice genotypes. Biochar and TUAT-1 biofertilizer influenced the overall growth of plants positively and increased straw and above-ground biomass in both genotypes. However, although biochar application significantly increased grain yield in LTAT-29, this was not the case in Fukuhibiki. Biochar and TUAT-1 biofertilizer, either alone or combined, significantly affected plant nutrient uptake but the effect largely depended on rice genotype. Results of this study indicate that biochar amendment and TUAT-1 biofertilizer can enhance forage rice productivity depending on genotypes, and therefore, there is a need to consider plant genetic composition when evaluating the potential for crop response to these soil amendments before application on a commercial scale.	[Win, Khin Thuzar; Okazaki, Keiki; Ohwaki, Yoshinari] Natl Agr & Food Res Org, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan; [Ookawa, Taiichiro; Yokoyama, Tadashi] Tokyo Univ Agr & Technol, Fuchu, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; Tokyo University of Agriculture & Technology	Ohwaki, Y (corresponding author), Natl Agr & Food Res Org, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan.	ohwaki@affrc.go.jp	Ookawa, Taiichiro/C-9323-2013	Win, Khin Thuzar/0000-0002-4834-078X	Project of the NARO Bio-oriented Technology Research Advancement Institution [16822446]	Project of the NARO Bio-oriented Technology Research Advancement Institution	This project is supported by grants from the Project of the NARO Bio-oriented Technology Research Advancement Institution: the special scheme project on regional developing strategy (Grant No. 16822446) to O.Y., O.K., O.T., Y.T., and K.T.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants from the Project of the NARO Bio-oriented Technology Research Advancement Institution: the special scheme project on regional developing strategy (Grant No. 16822446). The authors are grateful to Dr. Takashi Kenjo and Mr. Tomotaka Asano, Asahi Industries Co., LTD., Japan for providing TUAT-1 biofertilizer used in this study. The authors would like to thank Dr. Kaworu Ebana, The Institute of Agrobiological Science, NARO, (Tsukuba, Ibaraki, Japan) for the technical support during this study. Special thanks are also addressed to Ms. Minako Tanimura for her assistance with the experiment.	Asai H, 2009, FIELD CROP RES, V111, P81, DOI 10.1016/j.fcr.2008.10.008; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Aung HP, 2015, SCI TOTAL ENVIRON, V521, P261, DOI 10.1016/j.scitotenv.2015.03.109; Basak BB, 2009, PLANT SOIL, V317, P235, DOI 10.1007/s11104-008-9805-z; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bottini R, 2004, APPL MICROBIOL BIOT, V65, P497, DOI 10.1007/s00253-004-1696-1; Chan KY, 2007, AUST J SOIL RES, V45, P629, DOI 10.1071/SR07109; Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Cheng WG, 2018, SOIL SCI PLANT NUTR, V64, P77, DOI 10.1080/00380768.2017.1378569; Cheng Y, 2012, BIOL FERT SOILS, V48, P941, DOI 10.1007/s00374-012-0687-0; Clough TJ, 2010, J ENVIRON QUAL, V39, P1218, DOI 10.2134/jeq2010.0204; Dong D, 2015, J SOIL SEDIMENT, V15, P153, DOI 10.1007/s11368-014-0984-3; French E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23677-9; Glab T, 2016, GEODERMA, V281, P11, DOI 10.1016/j.geoderma.2016.06.028; Huang M, 2014, BIOL FERT SOILS, V50, P997, DOI 10.1007/s00374-014-0908-9; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; IUSS Working Group WRB, 2014, WORLD SOIL RES REP, V106, P109; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kanou T, 1981, J STAGE B SOC SEA WA, V35, P33, DOI [10.11457/swsj1965.35.33, DOI 10.11457/SWSJ1965.35.33]; Kato H, 2008, JARQ-JPN AGR RES Q, V42, P231, DOI 10.6090/jarq.42.231; Kloepper J. W., 1991, Beltsville Symposia in Agricultural Research, P315; Koyama S, 2016, JARQ-JPN AGR RES Q, V50, P319, DOI 10.6090/jarq.50.319; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Li H, 2015, ENVIRON PROG SUSTAIN, V34, P1467, DOI DOI 10.1002/ep.12122; Marschner P, 2004, PLANT SOIL, V264, P325, DOI 10.1023/B:PLSO.0000047767.62179.25; Marschner P, 2011, SOIL BIOL BIOCHEM, V43, P883, DOI 10.1016/j.soilbio.2011.01.005; Matsubara K, 2015, J HERED, V106, P113, DOI 10.1093/jhered/esu065; Mengel K, 1982, Principles of plant nutrition.; Menz J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21684-4; Nanzyo M., 1991, Japanese Journal of Soil Science and Plant Nutrition, V62, P41; Obara Hiroshi, 2011, Bulletin of the National Institute of Agro-Environmental Sciences, V29, P1; Ogata H, 1958, J STAGE BUNSEKI KAGA, V8, P483, DOI [10.2116/bunsekikagaku.7.483, DOI 10.2116/BUNSEKIKAGAKU.7.483]; Ogawa M, 2010, AUST J SOIL RES, V48, P489, DOI 10.1071/SR10006; Oo AZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192235; Pan JF, 2011, PHYSIOL PLANTARUM, V141, P321, DOI 10.1111/j.1399-3054.2010.01441.x; Paz-Ferreiro J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124891; Perchlik M, 2017, PLANT PHYSIOL, V175, P235, DOI 10.1104/pp.17.00608; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; Rajkovich S, 2012, BIOL FERT SOILS, V48, P271, DOI 10.1007/s00374-011-0624-7; Sadana US, 2002, J PLANT NUTR, V25, P2677, DOI 10.1081/PLN-120015531; Seerat AY, 2019, SOIL SCI PLANT NUTR, V65, P122, DOI 10.1080/00380768.2018.1551042; Sheng XF, 2006, CAN J MICROBIOL, V52, P66, DOI 10.1139/W05-117; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; Steiner C, 2008, J PLANT NUTR SOIL SC, V171, P893, DOI 10.1002/jpln.200625199; Swain MR, 2012, AGR RES, V1, P273, DOI 10.1007/s40003-012-0022-x; Taghizadeh-Toosi A, 2012, PLANT SOIL, V350, P57, DOI 10.1007/s11104-011-0870-3; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Torii A., 2012, THESIS; Truog E., 1929, IND ENGNG CHEM ANALY, V1, P136, DOI [10.1021/ac50067a011, DOI 10.1021/AC50067A011]; Tucke MR, 1992, SO COOPERATIVE SERIE, V374, P43; Wang YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01173-w; Win KT, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8100216; Win KT, 2018, PLANT PHYSIOL BIOCH, V127, P599, DOI 10.1016/j.plaphy.2018.04.038; Wu WX, 2009, FEMS MICROBIOL ECOL, V67, P93, DOI 10.1111/j.1574-6941.2008.00599.x; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Yang Y, 2015, SUSTAINABILITY-BASEL, V7, P13713, DOI 10.3390/su71013713; Yusif S., 2016, J ADV BIOL BIOTECHNO, V8, P1, DOI DOI 10.9734/JABB/2016/27300; Zhao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070569; Zhao SX, 2018, APPL SOIL ECOL, V123, P484, DOI 10.1016/j.apsoil.2017.09.007; Zheng H, 2013, BIORESOURCE TECHNOL, V130, P463, DOI 10.1016/j.biortech.2012.12.044	62	23	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220236	10.1371/journal.pone.0220236	http://dx.doi.org/10.1371/journal.pone.0220236			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365570	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600029
J	Parejo, M; Gutierrez, JS; Navedo, JG; Soriano-Redondo, A; Abad-Gomez, JM; Villegas, A; Corbacho, C; Sanchez-Guzman, JM; Masero, JA				Parejo, Manuel; Gutierrez, Jorge S.; Navedo, Juan G.; Soriano-Redondo, Andrea; Abad-Gomez, Jose M.; Villegas, Auxiliadora; Corbacho, Casimiro; Sanchez-Guzman, Juan M.; Masero, Jose A.			Day and night use of habitats by northern pintails during winter in a primary rice-growing region of Iberia	PLOS ONE			English	Article							DABBLING DUCKS; PREDATION RISK; FIELDS; WATERBIRDS; CONSERVATION; MANAGEMENT; BIRDS; SELECTION; WETLAND; AREAS	Loss of natural wetlands is a global phenomenon that has severe consequences for waterbird populations and their associated ecosystem services. Although agroecosystems can reduce the impact of natural habitat loss, drivers of use of such artificial habitats by waterbirds remain poorly understood. Using the cosmopolitan northern pintail Anas acuta as a model species, we monitored home-range and fine-scale resource selection across the agricultural landscape. Individuals were tracked using GPS-GSM transmitters, and a suite of environmental and landscape features were measured throughout the winter seasons. Spatial patterns of habitat use were analysed using generalized linear mixed effect models by integrating field-observations with GPS telemetry. All birds used rice fields as foraging grounds at night and commuted to an adjacent reservoir to roost during daylight. Home-ranges and maximum foraging distances of nocturnally foraging birds increased with decreasing availability of flooded fields, and were positively correlated with moonlight levels. Birds selected flooded rice paddies (water depth range: 9-21 cm) with standing stubble and substrate with pebbles smaller than 0.5 cm in diameter. Density of rice seeds, rice paddy size, and other environmental and landscape features did not emerge as significant predictors. Our findings indicate that nocturnal foraging of northern pintails within rice fields is driven primarily by straw manipulation, water level and substrate pebble size. Thus, the presence of standing stubble in flooded paddies with soft bottoms should be prioritized to improve foraging areas for dabbling ducks. These management procedures in themselves would not increase economic costs or affect rice production and could be applied for dabbling-duck conservation throughout the world.	[Parejo, Manuel; Gutierrez, Jorge S.; Navedo, Juan G.; Soriano-Redondo, Andrea; Abad-Gomez, Jose M.; Villegas, Auxiliadora; Corbacho, Casimiro; Sanchez-Guzman, Juan M.; Masero, Jose A.] Univ Extremadura, Dept Anat Cell Biol & Zool, Conservat Biol Res Grp, Fac Sci, Badajoz, Spain; [Gutierrez, Jorge S.] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Estudos Ambiente Mar CESAM, Lisbon, Portugal; [Navedo, Juan G.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Soriano-Redondo, Andrea] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England	Universidad de Extremadura; Universidade de Lisboa; Universidad Austral de Chile; University of Exeter	Parejo, M (corresponding author), Univ Extremadura, Dept Anat Cell Biol & Zool, Conservat Biol Res Grp, Fac Sci, Badajoz, Spain.	mparejonieto@unex.es	Soriano-Redondo, Andrea/AAH-4511-2019; AMADO, CASIMIRO CORBACHO/A-6681-2017; Auxiliadora, Villegas/E-5468-2012; Masero, Jose A./A-9478-2008; Gutiérrez, Jorge S./AAM-6821-2020; Parejo, Manuel/R-2518-2019	Soriano-Redondo, Andrea/0000-0003-0728-730X; AMADO, CASIMIRO CORBACHO/0000-0003-4200-7975; Auxiliadora, Villegas/0000-0001-7906-5613; Masero, Jose A./0000-0001-5318-4833; Gutiérrez, Jorge S./0000-0001-8459-3162; Parejo, Manuel/0000-0001-9054-9758; Abad-Gomez/0000-0002-3757-8856	Junta de Extremadura [PRI09C128]; Government of Extremadura [GR18169]; European Regional Development Fund [ERDF] [GR18169]	Junta de Extremadura; Government of Extremadura; European Regional Development Fund [ERDF](European Commission)	JAM received the project PRI09C128 (Junta de Extremadura), http://ayudaspri.gobex.es.JMSG received the project GR18169 (Government of Extremadura and the European Regional Development Fund [ERDF]), http://cicytex.juntaex.es.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank 'Direccion General de Medio Ambiente de Extremadura' for permissions, and thank volunteers involved in catching activities. Funds were provided by the projects PRI09C128 (Junta de Extremadura), and GR18169 (Junta de Extremadura and European Regional Development Fund [ERDF]).	Amano T, 2008, BIOL CONSERV, V141, P1704, DOI 10.1016/j.biocon.2008.04.012; Amano T, 2018, NATURE, V553, P199, DOI 10.1038/nature25139; Arzel C, 2007, WILDLIFE BIOL, V13, P328, DOI 10.2981/0909-6396(2007)13[328:AMOSEB]2.0.CO;2; Austin VI, 2016, EMU, V116, P423, DOI 10.1071/MU15106; Bengtsson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100764; Beyer, 2018, GEOSPATIAL MODELING; Bird JA, 2000, J APPL ECOL, V37, P728, DOI 10.1046/j.1365-2664.2000.00539.x; Bouten W, 2013, J ORNITHOL, V154, P571, DOI 10.1007/s10336-012-0908-1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Busscher WJ, 2011, ENCY AGROPHYSICS, P357, DOI [10.1007/978-90-481-3585-1_66, DOI 10.1007/978-90-481-3585-1_66]; Callicutt JT, 2011, J FISH WILDL MANAG, V2, P29, DOI 10.3996/102010-JFWM-038; Casazza ML, 2012, WILDLIFE BIOL, V18, P1, DOI 10.2981/09-099; Cizkova H, 2013, AQUAT SCI, V75, P3, DOI 10.1007/s00027-011-0233-4; Czech HA, 2002, WATERBIRDS, V25, P56; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; Davis J. Brian, 2014, Wildfowl, P17; De la Cruz SEW, 2014, BIOL CONSERV, V169, P68, DOI 10.1016/j.biocon.2013.10.021; Duerr AE, 2015, FUNCT ECOL, V29, P779, DOI 10.1111/1365-2435.12381; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Dzialak M. R., 2012, Ecosphere, V3, part30; Dzialak Matthew R., 2015, Ecological Processes, V4, P5; Dzialak MR, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00325.1; Dzialak MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026273; Eadie JM, 2008, WILDLIFE VALUES N AM, P83; Elphick CS, 2010, WATERBIRDS, V33, P231, DOI 10.1675/063.033.s117; Elphick CS, 2015, J ORNITHOL, V156, pS239, DOI 10.1007/s10336-015-1194-5; Elphick CS, 2010, WATERBIRDS, V33, P1, DOI 10.1675/063.033.s101; Elphick CS, 2010, WATERBIRDS, V33, P181, DOI 10.1675/063.033.s114; Elphick CS, 2003, AGR ECOSYST ENVIRON, V94, P17, DOI 10.1016/S0167-8809(02)00022-1; Elphick CS, 1998, J APPL ECOL, V35, P95, DOI 10.1046/j.1365-2664.1998.00274.x; Elphick CS, 2000, CONSERV BIOL, V14, P181, DOI 10.1046/j.1523-1739.2000.98314.x; FAO-STAT, 2014, WORLD RIC STAT; Fasola M, 1996, COLON WATERBIRD, V19, P122, DOI 10.2307/1521955; Flack A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500931; Fleskes J.P., 2005, WATERFOWL DISTRIBUTI; Fogliatto S, 2010, CROP PROT, V29, P1232, DOI 10.1016/j.cropro.2010.07.007; Fox AD, 2017, BIOL REV, V92, P854, DOI 10.1111/brv.12258; Fox T., 2005, DUCKS GEESE SWANS, P595; Fusi A, 2014, SCI TOTAL ENVIRON, V494, P119, DOI 10.1016/j.scitotenv.2014.06.126; Gaston KJ, 2019, AM NAT, V193, P481, DOI 10.1086/702250; Ghermandi A, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009071; Gibbs JP, 2000, CONSERV BIOL, V14, P314, DOI 10.1046/j.1523-1739.2000.98608.x; Gill JA, 2001, J APPL ECOL, V38, P846, DOI 10.1046/j.1365-2664.2001.00643.x; Gill JA, 2007, IBIS, V149, P9, DOI 10.1111/j.1474-919X.2007.00642.x; Golet GH, 2018, ECOL APPL, V28, P409, DOI 10.1002/eap.1658; Green AJ, 2014, BIOL REV, V89, P105, DOI 10.1111/brv.12045; Guillemain M, 2002, WILDLIFE BIOL, V8, P81, DOI 10.2981/wlb.2002.012; Guillemain M, 2002, OIKOS, V98, P547, DOI 10.1034/j.1600-0706.2002.980321.x; Guillemain M, 2002, BIOL CONSERV, V103, P183, DOI 10.1016/S0006-3207(01)00120-3; Guillemain M., 1999, Wildfowl, V50, P123; Guillemain M, 2017, WILDLIFE SOC B, V41, P170, DOI 10.1002/wsb.736; Gurd DB, 2006, ZOOLOGY, V109, P120, DOI 10.1016/j.zool.2005.10.002; Haefele SM, 2014, GEODERMA, V235, P250, DOI 10.1016/j.geoderma.2014.07.019; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Hemmat A, 2003, SOIL TILL RES, V70, P65, DOI 10.1016/S0167-1987(02)00119-8; Johnson WP, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00683-090202; Kirol CP, 2015, ECOL APPL, V25, P968, DOI 10.1890/13-1152.1; Kleyheeg E, 2017, MOV ECOL, V5, DOI 10.1186/s40462-016-0092-7; Kloskowski J, 2009, AQUAT CONSERV, V19, P815, DOI 10.1002/aqc.1027; Korner P, 2016, ANIM BEHAV, V115, P69, DOI 10.1016/j.anbehav.2016.02.026; Larsen JK, 2000, LANDSCAPE ECOL, V15, P755, DOI 10.1023/A:1008127702944; Legagneux P, 2009, J ORNITHOL, V150, P183, DOI 10.1007/s10336-008-0333-7; Lourenco PM, 2009, IBIS, V151, P196, DOI 10.1111/j.1474-919X.2008.00881.x; Maclean J., 2013, RICE ALMANAC; Manly B., 2002, RESOURCE SELECTION A, DOI [10.2307/5247, DOI 10.2307/5247]; MAPAMA Ministerio de Agricultura y Pesca Alimentacion y Medio Ambience, 2017, SUP PROD AN CULT; McDonald TL, 2006, J WILDLIFE MANAGE, V70, P375, DOI 10.2193/0022-541X(2006)70[375:DMIWSE]2.0.CO;2; Milsom TP, 2000, J APPL ECOL, V37, P706, DOI 10.1046/j.1365-2664.2000.00529.x; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Navedo JG, 2015, SCI TOTAL ENVIRON, V511, P288, DOI 10.1016/j.scitotenv.2014.12.068; Navedo JG, 2012, BIRD CONSERV INT, V22, P316, DOI 10.1017/S0959270911000311; Parejo M, 2015, IBIS, V157, P536, DOI 10.1111/ibi.12256; Pernollet CA, 2017, J WILDLIFE MANAGE, V81, P96, DOI 10.1002/jwmg.21167; Pernollet CA, 2015, AGR ECOSYST ENVIRON, V214, P118, DOI 10.1016/j.agee.2015.08.018; Pernollet CA, 2015, BIOL CONSERV, V186, P214, DOI 10.1016/j.biocon.2015.03.019; Ricca MA, 2018, ECOL APPL, V28, P878, DOI 10.1002/eap.1690; Salazar RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148269; Sanchez-Guzman JM, 2007, BIODIVERS CONSERV, V16, P3333, DOI 10.1007/s10531-006-9018-9; Santiago-Quesada F, 2014, AGR ECOSYST ENVIRON, V188, P97, DOI 10.1016/j.agee.2014.02.019; Sauter A, 2012, J ORNITHOL, V153, P713, DOI 10.1007/s10336-011-0788-9; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sesser KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204800; Sesser KA, 2016, BIOL CONSERV, V197, P69, DOI 10.1016/j.biocon.2016.02.021; Sofaer HR, 2016, ECOL APPL, V26, P1677, DOI 10.1890/15-0750.1; Strum KM, 2013, AGR ECOSYST ENVIRON, V179, P116, DOI 10.1016/j.agee.2013.08.003; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tajiri H, 2013, ORNITHOL SCI, V12, P127, DOI 10.2326/osj.12.127; Tamisier A., 1999, CAMARGUE CANARDS FOU; Whittingham MJ, 2006, J APPL ECOL, V43, P640, DOI 10.1111/j.1365-2664.2006.01186.x; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x; Xia SX, 2017, BIOL CONSERV, V210, P72, DOI 10.1016/j.biocon.2016.07.025	91	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220400	10.1371/journal.pone.0220400	http://dx.doi.org/10.1371/journal.pone.0220400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344107	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900098
J	El Mammeri, N; Hierrezuelo, J; Tolchard, J; Camara-Almiron, J; Caro-Astorga, J; Alvarez-Mena, A; Dutour, A; Berbon, M; Shenoy, J; Morvan, E; Grelard, A; Kauffmann, B; Lecomte, S; de Vicente, A; Habenstein, B; Romero, D; Loquet, A				El Mammeri, Nadia; Hierrezuelo, Jesus; Tolchard, James; Camara-Almiron, Jesus; Caro-Astorga, Joaquin; Alvarez-Mena, Ana; Dutour, Antoine; Berbon, Melanie; Shenoy, Jayakrishna; Morvan, Estelle; Grelard, Axelle; Kauffmann, Brice; Lecomte, Sophie; de Vicente, Antonio; Habenstein, Birgit; Romero, Diego; Loquet, Antoine			Molecular architecture of bacterial amyloids in Bacillus biofilms	FASEB JOURNAL			English	Article						functional amyloids; extracellular matrix; solid-state NMR	SECONDARY STRUCTURE; FIBRIL FORMATION; CHEMICAL-SHIFTS; ALPHA-SYNUCLEIN; PROTEIN; POLYMORPHISM; AGGREGATION; INSIGHTS; FIBERS; ANGLE	The formation of biofilms provides structural and adaptive bacterial response to the environment. In Bacillus species, the biofilm extracellular matrix is composed of exopolysaccharides, hydrophobins, and several functional amyloid proteins. We report, using multiscale approaches such as solid-state NMR (SSNMR), electron microscopy, X-ray diffraction, dynamic light scattering, attenuated total reflection Fourier transform infrared (FTIR), and immune-gold labeling, the molecular architecture of B. subtilis and pathogenic B. cereus functional amyloids. SSNMR data reveal that the major amyloid component TasA in its fibrillar amyloid form contain beta-sheet and a-helical secondary structure, suggesting a nontypical amyloid architecture in B. subtilis. Proteinase K digestion experiments indicate the amyloid moiety is similar to 100 as long, and subsequent SSNMR and FTIR signatures for B. subtilis and B. cereus TasA filaments highlight a conserved amyloid fold, albeit with substantial differences in structural polymorphism and secondary structure composition. Structural analysis and coassembly data on the accessory protein TapA in B. subtilis and its counterpart camelysin in B. cereus reveal a catalyzing effect between the functional amyloid proteins and a common structural architecture, suggesting a coassembly in the context of biofilm formation. Our findings highlight nontypical amyloid behavior of these bacterial functional amyloids, underlining structural variations between biofilms even in closely related bacterial species.	[El Mammeri, Nadia; Tolchard, James; Dutour, Antoine; Berbon, Melanie; Shenoy, Jayakrishna; Grelard, Axelle; Lecomte, Sophie; Habenstein, Birgit; Loquet, Antoine] Univ Bordeaux, Inst Chim & Biol Membranes & Nanoobjets CBMN, UMR 5248, Pessac, France; [Morvan, Estelle; Kauffmann, Brice] Univ Bordeaux, Ctr Natl Rech CNRS, IECB, UMS 3033,US 001, Pessac, France; [Hierrezuelo, Jesus; Camara-Almiron, Jesus; Caro-Astorga, Joaquin; Alvarez-Mena, Ana; de Vicente, Antonio; Romero, Diego] Univ Malaga, Dept Microbiol, Malaga, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universidad de Malaga	Romero, D (corresponding author), Univ Malaga, Dept Microbiol, Malaga, Spain.; Loquet, A (corresponding author), Univ Bordeaux, CNRS, CBMN, IECB, F-33607 Pessac, France.	diego_romero@uma.es; a.loquet@iecb.u-bordeaux.fr	Kauffmann, Brice/L-6029-2015; León, Jesús Hierrezuelo/F-7156-2016; Almirón, Jesús Cámara/AAM-6664-2021; de Vicente, Antonio/G-4405-2011; Romero, Diego/D-3849-2013; Loquet, Antoine/A-1465-2010; Habenstein, Birgit/E-4425-2013	Kauffmann, Brice/0000-0002-2932-3255; León, Jesús Hierrezuelo/0000-0002-0056-0927; Almirón, Jesús Cámara/0000-0002-6107-4260; de Vicente, Antonio/0000-0003-2716-9861; Romero, Diego/0000-0002-2052-6515; Loquet, Antoine/0000-0001-7176-7813; Habenstein, Birgit/0000-0003-3723-9552; El Mammeri, Nadia/0000-0002-9979-3359; Alvarez, Ana/0000-0002-5357-8944; Morvan, Estelle/0000-0003-4071-7885; , Jayakrishna Shenoy/0000-0002-0360-645X; GRELARD, Axelle/0000-0002-6708-2253; Caro-Astorga, Joaquin/0000-0003-4650-6376; Tolchard, James/0000-0002-5779-4935	European Research Council [ERC-2014-StG BacBio GA 637971]; European Research Council (European Resuscitation Council (ERC)-2015-StG Weakinteract) [GA 639020]; Agence Nationale de la Recherche [ANR-14-CE09-0020-01]; Contrat de Plan Etat-Region (CPER) CAMPUSB; Ministerio de Economia y Competitividad Spanish Government [AGL2016-78662-R]; CNRS [IR-RMN FR3050]; Ministerio de Economia y Competitividad (Madrid, Spain) [BES-2013-064134, BES-2017-081275]	European Research Council(European Research Council (ERC)European Commission); European Research Council (European Resuscitation Council (ERC)-2015-StG Weakinteract)(European Research Council (ERC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Contrat de Plan Etat-Region (CPER) CAMPUSB; Ministerio de Economia y Competitividad Spanish Government(Spanish Government); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministerio de Economia y Competitividad (Madrid, Spain)(Spanish Government)	The authors thank Juan Felix (Bionand, Malaga, Spain) and Adolfo Mart ' inez [The Society for Cardiovascular Angiography and Interventions-International Management Assistants (SCAI-IMA)] for electron microscopy guidance, and Casimiro C ' ardenas (Universidad de Malaga) for mass spectrometry analysis. This work has benefited from the facilities and expertise of the Biophysical and Structural Chemistry Platform at Institut Europeen de Chimie et Biologie (IECB), Centre National de la Recherche (CNRS) Unite Mixte de Service (UMS) 3033, INSERM US001. This research was supported by the European Research Council (ERC-2014-StG BacBio GA 637971 to D.R. and the European Resuscitation Council (ERC)-2015-StG Weakinteract GA 639020 to A.L.), the Agence Nationale de la Recherche (ANR-14-CE09-0020-01 to A.L.), the Contrat de Plan Etat-Region (CPER) CAMPUSB, the Ministerio de Economia y Competitividad Spanish Government Grant (AGL2016-78662-R to D.R.), and the CNRS (IR-RMN FR3050). J.C.-A. and A.A.-M. were recipients of fixed-price incentive contracts (BES-2013-064134 and BES-2017-081275) from the Ministerio de Economia y Competitividad (Madrid, Spain). The authors declare no conflicts of interest.	Abbasi R, 2019, CHEMBIOCHEM, V20, P355, DOI 10.1002/cbic.201800634; Ahimou F, 2000, ENZYME MICROB TECH, V27, P749, DOI 10.1016/S0141-0229(00)00295-7; Bauer T, 2017, J BIOMOL NMR, V67, P51, DOI 10.1007/s10858-016-0083-4; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Candela T, 2019, MOL MICROBIOL, V111, P1416, DOI 10.1111/mmi.14184; Caro-Astorga J, 2015, FRONT MICROBIOL, V5; Chai L, 2013, J BIOL CHEM, V288, P17559, DOI 10.1074/jbc.M113.453605; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; Deshmukh M, 2018, J MOL BIOL, V430, P3631, DOI 10.1016/j.jmb.2018.07.007; Diehl A, 2018, P NATL ACAD SCI USA, V115, P3237, DOI 10.1073/pnas.1718102115; Dragos A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030060; Dragos A, 2017, TRENDS MICROBIOL, V25, P257, DOI 10.1016/j.tim.2016.12.010; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Erskine E, 2018, MOL MICROBIOL, V110, P897, DOI 10.1111/mmi.13985; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Friedland RP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006654; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hyberts SG, 2012, TOP CURR CHEM, V316, P125, DOI 10.1007/128_2011_187; Linden AH, 2011, J BIOMOL NMR, V51, P283, DOI 10.1007/s10858-011-9535-z; Linser R, 2017, SOLID STATE NUCL MAG, V87, P45, DOI 10.1016/j.ssnmr.2017.08.003; Loquet A, 2018, J MOL BIOL, V430, P3629, DOI 10.1016/j.jmb.2018.07.024; Loquet A, 2018, METHODS, V138, P26, DOI 10.1016/j.ymeth.2018.03.014; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Luca S, 2001, J BIOMOL NMR, V20, P325, DOI 10.1023/A:1011278317489; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Meier BH, 2017, TRENDS BIOCHEM SCI, V42, P777, DOI 10.1016/j.tibs.2017.08.001; Otzen D, 2010, PRION, V4, P256, DOI 10.4161/pri.4.4.13676; Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/bse0560207, 10.1042/BSE0560207]; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Romero D, 2014, INT MICROBIOL, V17, P65, DOI 10.2436/20.1501.01.208; Romero D, 2014, J BACTERIOL, V196, P1505, DOI 10.1128/JB.01363-13; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rouse SL, 2018, J MOL BIOL, V430, P3685, DOI 10.1016/j.jmb.2018.05.004; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Stefani M, 2010, CURR PROTEIN PEPT SC, V11, P343, DOI 10.2174/138920310791330631; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Taylor JD, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00033; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; van der Wel PCA, 2017, SOLID STATE NUCL MAG, V88, P1, DOI 10.1016/j.ssnmr.2017.10.001; Van Gerven N, 2015, TRENDS MICROBIOL, V23, P693, DOI 10.1016/j.tim.2015.07.010; Van Gervent N, 2018, J MOL BIOL, V430, P3657, DOI 10.1016/j.jmb.2018.07.010; Vetri V, 2015, FEBS LETT, V589, P2448, DOI 10.1016/j.febslet.2015.07.006; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhou YZ, 2012, METHODS MOL BIOL, V849, P303, DOI 10.1007/978-1-61779-551-0_21	57	27	27	4	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12146	12163		10.1096/fj.201900831R	http://dx.doi.org/10.1096/fj.201900831R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370706				2022-12-26	WOS:000507461600043
J	Lu, R; Zhang, YG; Xia, YL; Sun, J				Lu, Rong; Zhang, Yong-Guo; Xia, Yinglin; Sun, Jun			Imbalance of autophagy and apoptosis in intestinal epithelium lacking the vitamin D receptor	FASEB JOURNAL			English	Article						Beclin-1; colonoids; enteroids; inflammation; VDR	ACTIVATION; CROSSTALK; CELLS; INFLAMMATION; BARRIER; INJURY; ANALOG; GENE; AVRA	Apoptosis and autophagy are dynamic processes that determine the fate of cells. Vitamin D receptor (VDR) deficiency in the intestine leads to abnormal Paneth cells and impaired autophagy function. Here, we will elucidate the mechanisms of the intestinal epithelial VDR regulation of autophagy and apoptosis. We used in vivo VDRlox and VDR Delta IEC mice and ex vivo organoids generated from small intestine and colon tissues. We found that VDR deficiency induced more apoptotic cells and significantly increased cell death in the small intestine and colon of VDR Delta IEC mice. The proapoptotic protein B-cell lymphoma 2 (BCL-2) associated X protein (Bax) was enhanced, whereas autophagy related 16 like 1 (ATG16L1) and Beclin-1 were decreased in the intestines of VDR(Delta IEC)mice. Apoptosis induced by Bax reduced autophagy by decreasing Beclin-1. Physical interactions between Beclin-1 and Bcl-2 were increased in the VDR-deficient epithelia from mice. The growth of VDR Delta IEC organoids was significantly slower with fewer Paneth cells than that of VDR+/+ organoids. The expression levels of Beclin-1 and lysozyme were decreased in VDR Delta IEC organoids. Bacterial endotoxin levels were high in the serum from VDR Delta IEC mice and made mice susceptible to colitis. In the organoids and colitis IL-10(-/-) mice, vitamin D-3 treatment increased VDR and ATG16L1 protein expression levels, which activated autophagic responses. In summary, intestinal epithelial VDR regulates autophagy and apoptosis through ATG16L1 and Beclin-1. Our studies provide fundamental insights into the tissue-specific function of VDR in modulating the balance between autophagy and apoptosis.	[Lu, Rong; Zhang, Yong-Guo; Xia, Yinglin; Sun, Jun] Univ Illinois, Dept Med, Chicago, IL USA; [Sun, Jun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Sun, Jun] Univ Illinois, Canc Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sun, J (corresponding author), Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, 840 S Wood St,Room 704 CSB,MC716, Chicago, IL 60612 USA.	junsun7@uic.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK105118, R01DK114126]; U.S. Department of Defense [BC160450P1, W81XWH-17-1-0039]; University of Illinois Cancer Center; American Gastroenterological Association (AGA) Young Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114126, R01DK105118] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Defense(United States Department of Defense); University of Illinois Cancer Center; American Gastroenterological Association (AGA) Young Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01 DK105118 and R01DK114126; U.S. Department of Defense Grant BC160450P1, Funding Opportunity W81XWH-17-1-0039; and the University of Illinois Cancer Center (to J.S.). R.L. is a recipient of the American Gastroenterological Association (AGA) Young Investigator Award, and orally presented some of these data at the Digestive Disease Week 2017. The authors declare no conflicts of interest.	Angel B, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0038-9; Bakke Danika, 2018, Nucl Receptor Res, V5, DOI 10.11131/2018/101377; Bakke D, 2018, INFLAMM BOWEL DIS, V24, P1149, DOI 10.1093/ibd/izy092; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; DeMasters G, 2006, MOL CANCER THER, V5, P2786, DOI 10.1158/1535-7163.MCT-06-0316; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Eun CS, 2014, INFECT IMMUN, V82, P2239, DOI 10.1128/IAI.01513-13; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Glenn DJ, 2016, J STEROID BIOCHEM, V164, P292, DOI 10.1016/j.jsbmb.2015.09.034; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20; Lu R, 2017, ALCOHOL CLIN EXP RES, V41, P727, DOI 10.1111/acer.13351; Lu R, 2012, AM J PHYSIOL-GASTR L, V303, pG1113, DOI 10.1152/ajpgi.00453.2011; Luderer HF, 2013, ENDOCRINOLOGY, V154, P16, DOI 10.1210/en.2012-1579; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Naydenov NG, 2012, CELL CYCLE, V11, P4613, DOI 10.4161/cc.22885; Parrish AB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008672; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Rubinstein AD, 2012, J CELL SCI, V125, P5259, DOI 10.1242/jcs.115865; Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Sumagin R, 2016, MUCOSAL IMMUNOL, V9, P1151, DOI 10.1038/mi.2015.135; Sun J, 2010, CURR OPIN GASTROEN, V26, P591, DOI 10.1097/MOG.0b013e32833d4b9f; Sun J, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.31; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wu SP, 2015, GUT, V64, P1082, DOI 10.1136/gutjnl-2014-307436; Wu SP, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-22; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Wu SP, 2010, AM J PHYSIOL-GASTR L, V298, pG784, DOI 10.1152/ajpgi.00526.2009; Xiao YJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12271; Xu DC, 2015, AUTOPHAGY, V11, P617, DOI 10.1080/15548627.2015.1023982; Yao TB, 2015, ANTIOXID REDOX SIGN, V22, P633, DOI 10.1089/ars.2014.5887; Yu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069620; Zhang Y. G., 2016, METHODS MOL BIOL; Zhang YG, 2019, INFLAMM BOWEL DIS, V25, P97, DOI 10.1093/ibd/izy292; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep10642; Zhang YG, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23118; Zhang Y, 2014, PHYSIOL REP, V2, DOI [10.14814/phy2.12008, 10.14814/phy2.12147]; Zhang YC, 2021, ASIA PAC J MANAG, V38, P371, DOI 10.1007/s10490-018-9639-z; Zhu XR, 2015, J CLIN INVEST, V125, P1098, DOI 10.1172/JCI76344; Zhu YS, 2010, PROTEIN CELL, V1, P468, DOI 10.1007/s13238-010-0048-4	52	34	34	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11845	11856		10.1096/fj.201900727R	http://dx.doi.org/10.1096/fj.201900727R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361973	Green Published, Bronze			2022-12-26	WOS:000507461600021
J	Beachboard, DC; Park, M; Vijayan, M; Snider, DL; Fernando, DJ; Williams, GD; Stanley, S; McFadden, MJ; Horner, SM				Beachboard, Dia C.; Park, Moonhee; Vijayan, Madhuvanthi; Snider, Daltry L.; Fernando, Dillon J.; Williams, Graham D.; Stanley, Sydney; McFadden, Michael J.; Horner, Stacy M.			The small GTPase RAB1B promotes antiviral innate immunity by interacting with TNF receptor?associated factor 3 (TRAF3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; innate immunity; RNA virus; flavivirus; antiviral agent; MAVS; RAB1B; TRAF3	INTERFERON REGULATORY FACTOR-3; RIG-I; ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASE; BETA PROMOTER; ACTIVATION; RESPONSES; TBK1; RECOGNITION; AUTOPHAGY	Innate immune detection of viral nucleic acids during viral infection activates a signaling cascade that induces type I and type III IFNs as well as other cytokines, to generate an antiviral response. This signaling is initiated by pattern recognition receptors, such as the RNA helicase retinoic acid-inducible gene I (RIG-I), that sense viral RNA. These sensors then interact with the adaptor protein mitochondrial antiviral signaling protein (MAVS), which recruits additional signaling proteins, including TNF receptor?associated factor 3 (TRAF3) and TANK-binding kinase 1 (TBK1), to form a signaling complex that activates IFN regulatory factor 3 (IRF3) for transcriptional induction of type I IFNs. Here, using several immunological and biochemical approaches in multiple human cell types, we show that the GTPase-trafficking protein RAB1B up-regulates RIG-I pathway signaling and thereby promotes IFN-? induction and the antiviral response. We observed that RAB1B overexpression increases RIG-I?mediated signaling to IFN-? and that RAB1B deletion reduces signaling of this pathway. Additionally, loss of RAB1B dampened the antiviral response, indicated by enhanced Zika virus infection of cells depleted of RAB1B. Importantly, we identified the mechanism of RAB1B action in the antiviral response, finding that it forms a protein complex with TRAF3 to facilitate the interaction of TRAF3 with mitochondrial antiviral signaling protein. We conclude that RAB1B regulates TRAF3 and promotes the formation of innate immune signaling complexes in response to nucleic acid sensing during RNA virus infection.	[Beachboard, Dia C.; Park, Moonhee; Vijayan, Madhuvanthi; Snider, Daltry L.; Fernando, Dillon J.; Williams, Graham D.; Stanley, Sydney; McFadden, Michael J.; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 213 Res Dr,Box 3053 DUMC, Durham, NC 27710 USA; [Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 213 Res Dr,Box 3053 DUMC, Durham, NC 27710 USA.	stacy.horner@duke.edu	Vijayan, Madhuvanthi/U-3524-2019	Horner, Stacy/0000-0002-9351-7409; Stanley, Sydney/0000-0001-6386-2415; Williams, Graham/0000-0003-3387-4356; McFadden, Michael/0000-0003-0303-6968	NIAID, National Institutes of Health [K22 AI100935]; NCI, National Institutes of Health [T32-CA009111]; American Cancer Society [131321-PF-17-188-01-MPC]; Burroughs Wellcome Fund [1016810]; Duke Bridge Award; NATIONAL CANCER INSTITUTE [T32CA009111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI144380] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Duke Bridge Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant K22 AI100935 (to S. M. H.) and NCI, National Institutes of Health Grant T32-CA009111 (to D. C. B.). This work was also supported by American Cancer Society Postdoctoral Fellowship 131321-PF-17-188-01-MPC (to D.C.B.), Burroughs Wellcome Fund Grant 1016810 (to S. M. H), and a Duke Bridge Award (to S. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cantell K, 1981, Methods Enzymol, V78, P29; Chiang C, 2017, TRENDS IMMUNOL, V38, P39, DOI 10.1016/j.it.2016.10.008; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fang R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006720; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fredericksen B, 2002, VIRAL IMMUNOL, V15, P29, DOI 10.1089/088282402317340215; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Galvez T, 2012, CELL, V151, P234, DOI 10.1016/j.cell.2012.09.013; Gillingham AK, 2014, DEV CELL, V31, P358, DOI 10.1016/j.devcel.2014.10.007; Horner SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117963; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459; McFadden MJ, 2017, CURR OPIN VIROL, V22, P36, DOI 10.1016/j.coviro.2016.11.012; Miao YX, 2017, CELL HOST MICROBE, V22, P330, DOI 10.1016/j.chom.2017.08.002; Miao YX, 2016, IMMUNITY, V45, P94, DOI 10.1016/j.immuni.2016.06.023; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Pourcelot M, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0292-z; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rustagi A, 2013, METHODS, V59, P225, DOI 10.1016/j.ymeth.2012.05.011; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Simicek M, 2013, NAT CELL BIOL, V15, P1220, DOI 10.1038/ncb2847; Sparrer KMJ, 2017, NAT MICROBIOL, V2, P1543, DOI 10.1038/s41564-017-0017-2; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takahama M, 2017, CELL REP, V20, P2944, DOI 10.1016/j.celrep.2017.08.085; van Zuylen WJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002747; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674	54	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14231	14240		10.1074/jbc.RA119.007917	http://dx.doi.org/10.1074/jbc.RA119.007917			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31375559	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000499248200007
J	Haridy, Y; Witzmann, F; Asbach, P; Reisz, RR				Haridy, Yara; Witzmann, Florian; Asbach, Patrick; Reisz, Robert R.			Permian metabolic bone disease revealed by microCT: Paget's disease-like pathology in vertebrae of an early amniote	PLOS ONE			English	Article							OSTEITIS DEFORMANS; VARANOPID SYNAPSIDA; RICHARDS SPUR; UPDATE; SPINE; EUPELYCOSAURIA	Bone remodeling is an essential physiological process in growth and healing. In modern systems deviations from normal bone physiology in the form of pathologies aid in the understanding of normal bone metabolism. Here we use external morphology and X-ray microtomography to diagnose and describe a metabolic bone disease in an amniote from the early Permian. The specimen consists of two fused tail vertebrae of a small varanopid from early Permian (289 million years old) cave deposits near Richards Spur, Oklahoma, USA. Inspection of the outer morphology reveals that the fusion encompasses the vertebral centra, zygopophyses and haemal arches, with the fusion zones distinctly swollen on the left side of the specimen. With visualization of its internal structure by microCT, this specimen is diagnosed as a complex metabolic bone disease. The radiological imaging suggests a pathologically high bone turnover rate, as shown by abnormal bone formation in some areas and increased bone resorption in others. This supports that the varanopid suffered from a metabolic bone disease similar to Paget's disease of bone as seen in humans today, which is linked to both genetic and viral factors. This finding extends the occurrence of Paget-like disease to the early Permian, and-provided a viral component was present-would also be by far the oldest evidence of viral infection in the fossil record.	[Haridy, Yara; Witzmann, Florian] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany; [Asbach, Patrick] Charite Univ Med Berlin, Inst Radiol, Berlin, Germany; [Reisz, Robert R.] Jilin Univ, Int Ctr Future Sci, Dinosaur Evolut Res Ctr, Changchun, Jilin, Peoples R China; [Reisz, Robert R.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jilin University; University of Toronto; University Toronto Mississauga	Haridy, Y (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany.	yara.haridy@mfn.belin	haridy, yara/AAT-3129-2021	haridy, yara/0000-0002-6908-5749; Asbach, Patrick/0000-0002-6885-3283	NSERC Discovery Grant; Deutsche Forschungsgemeinschaft (DFG); Open Access Fund of the Leibniz Association	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Fund of the Leibniz Association	This project was supported by funding from NSERC Discovery Grant to R.R.R., and the Deutsche Forschungsgemeinschaft (DFG) to FW. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2014, FIBROUS DYSPLASIA RE, V5; Anderson JS, 2004, J VERTEBR PALEONTOL, V24, P173, DOI 10.1671/1940-13; Antinoff N, 1997, OSTEOMYELITIS REPTIL, V4; Benton MJ, 2015, PALAEONTOLOGY, V58, P1003, DOI 10.1111/pala.12191; Berman DS, 1982, RESTUDY MYCTEROSAURU; Boriani S, 1997, SPINE, V22, P1036, DOI 10.1097/00007632-199705010-00020; Brickley M., 2010, BIOARCHAEOLOGY METAB; Brink KS, 2019, SCI NAT-HEIDELBERG, V106, DOI 10.1007/s00114-018-1598-1; Brocklehurst N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156810; Campione NE, 2011, ACTA PALAEONTOL POL, V56, P739, DOI 10.4202/app.2010.0071; Cundy T, 2008, TRENDS ENDOCRIN MET, V19, P246, DOI 10.1016/j.tem.2008.06.001; Cundy T, 2018, METABOLISM, V80, P5, DOI 10.1016/j.metabol.2017.06.010; Dell'Atti C, 2007, SKELETAL RADIOL, V36, P609, DOI 10.1007/s00256-006-0270-6; DiCaprio MR, 2005, J BONE JOINT SURG AM, V87A, P1848, DOI 10.2106/JBJS.D.02942; Evans DC, 2009, PALAEONTOLOGY, V52, P219, DOI 10.1111/j.1475-4983.2008.00837.x; Ford DP, 2019, PAP PALAEONTOL, V5, P197, DOI 10.1002/spp2.1236; FRYE FL, 1974, VET MED SM ANIM CLIN, V69, P186; Frye FL, 2000, P ASS REPTILIAN AMPH, V19; Galiova M, 2010, ANAL BIOANAL CHEM, V398, P1095, DOI 10.1007/s00216-010-3976-1; Gennari L, 2018, EXPERT OPIN ORPHAN D, V6, P485, DOI 10.1080/21678707.2018.1500691; Haridy Y, 2019, JAMA ONCOL, V5, P425, DOI 10.1001/jamaoncol.2018.6766; HOLDSWORTH F, 1970, J BONE JOINT SURG AM, VA 52, P1534, DOI 10.2106/00004623-197052080-00002; HUGHES HC, 1971, VET PATHOL, V8, P414, DOI 10.1177/0300985871008005-00603; KASTERT J, 1952, Beitr Klin Tuberk Spezif Tuberkuloseforsch, V106, P455, DOI 10.1007/BF02144554; Khan MA, 2002, ANN INTERN MED, V136, P896, DOI 10.7326/0003-4819-136-12-200206180-00011; Kiel J.L., 1983, American Association of Zoo Veterinarians Annual Proceedings, V1983, P201; Kurihara N, 2011, CELL METAB, V13, P23, DOI 10.1016/j.cmet.2010.12.002; LANDER P, 1991, SPINE, V16, P46, DOI 10.1097/00007632-199101000-00009; MacDougall M. J., 2017, THESIS; Maddin HC, 2006, J VERTEBR PALEONTOL, V26, P957, DOI 10.1671/0272-4634(2006)26[957:AEPVVS]2.0.CO;2; McKean D, 2016, BJR CASE REP, V2, DOI 10.1259/bjrcr.20150405; Menendez-Bueyes LR, 2017, REUMATOL CLIN, V13, P66, DOI [10.1016/j.reuma.2016.02.008, 10.1016/j.reumae.2016.02.009]; PAAJANEN H, 1989, SKELETAL RADIOL, V18, P523, DOI 10.1007/BF00351753; Pelletier V, 2014, VERTEBR PALEOBIOL PA, P53, DOI 10.1007/978-94-007-6841-3_4; Prescher A, 1998, EUR J RADIOL, V27, P181, DOI 10.1016/S0720-048X(97)00165-4; Preziosi R, 2007, VET J, V174, P669, DOI 10.1016/j.tvjl.2006.11.012; Reisz R.R., 1997, OKLA GEOL NOTES, V57, P160; Reisz RR, 2007, J VERTEBR PALEONTOL, V27, P734, DOI 10.1671/0272-4634(2007)27[734:HSFTPO]2.0.CO;2; Roches E, 2002, INT J OSTEOARCHAEOL, V12, P229, DOI 10.1002/oa.617; Rothschild BM, 2006, B NEW MEXICO MUSEUM, V33; Rothschild BM, 1998, J ZOO WILDLIFE MED, V7; Singer FR, 2011, CELL METAB, V13, P5, DOI 10.1016/j.cmet.2010.12.014; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Walters B, 2012, COMPLETE DINOSAUR; White G, 2013, TRAUMA, V27, P254, DOI DOI 10.1016/J.MP0RTH.2013.07.001; Witzmann F, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1080719; Witzmann F, 2011, CURR BIOL, V21, pR647, DOI 10.1016/j.cub.2011.08.006; Yamada K, 1999, J VET MED SCI, V61, P1055, DOI 10.1292/jvms.61.1055; ZLATKIN MB, 1986, RADIOLOGY, V160, P155, DOI 10.1148/radiology.160.1.2940618	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0219662	10.1371/journal.pone.0219662	http://dx.doi.org/10.1371/journal.pone.0219662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390345	Green Submitted, Green Published, gold			2022-12-26	WOS:000484999400007
J	Montroni, D; Zhang, XL; Leonard, J; Kaya, M; Amemiya, C; Falini, G; Rolandi, M				Montroni, Devis; Zhang, Xiaolin; Leonard, Janet; Kaya, Murat; Amemiya, Chris; Falini, Giuseppe; Rolandi, Marco			Structural characterization of the buccal mass of Ariolimax californicus (Gastropoda; Stylommatophora)	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; RADULA TEETH; BETA-CHITIN; BIOMINERALIZATION; PLEUROBRANCHAEA; PLASTICITY; MORPHOLOGY; MOVEMENTS; APPARATUS; PATTERNS	Biological materials such as chiton tooth, squid beak, and byssal threads of bivalves have inspired the development of new technologies. To this end, we have characterized the acellular components in the buccal mass of the terrestrial slug Ariolimax californicus (banana slug). These components are the radula, the jaw, and the odontophore. In the radula, calcium-rich denticles are tightly interlocked one to the other on top of a nanofibrous chitin membrane. The jaw has a nanostructured morphology made of chitin to achieve compression resistance and is directly linked to the foregut cuticle, which has a protective nanofibrous structure. Finally, in the odontophore, we observed a structurally elastic microstructure that interfaces soft tissues with a highly stressed radula membrane. Based on those observations, we discuss the interaction between these components and highlight how the materials in these task-specific components have evolved. This structure-properties-function study of the A. californicus' buccal mass may aid in the design and fabrication of novel bioinspired materials.	[Montroni, Devis; Zhang, Xiaolin; Rolandi, Marco] Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA; [Montroni, Devis; Falini, Giuseppe] Univ Bologna, Dept Chem Giacomo Ciamician, Alma Mater Studiorum, Bologna, Italy; [Leonard, Janet] Univ Calif Santa Cruz, Inst Marine Sci, Joseph M Long Marine Lab, Santa Cruz, CA 95064 USA; [Kaya, Murat] Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, Aksaray, Turkey; [Amemiya, Chris] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Santa Cruz; University of Bologna; University of California System; University of California Santa Cruz; Aksaray University; University of California System; University of California Merced	Rolandi, M (corresponding author), Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA.	mrolandi@ucsc.edu	Kaya, Murat/AAA-7668-2020; Montroni, Devis/AAC-1893-2019	Montroni, Devis/0000-0003-1731-4578	Office of Naval Research Award [N000141410724]; University of California Santa Cruz; National Science Foundation [ECCS-1542152]	Office of Naval Research Award(Office of Naval Research); University of California Santa Cruz(University of California System); National Science Foundation(National Science Foundation (NSF))	This work is supported by the Office of Naval Research Award (N000141410724), and start-up funding at the University of California Santa Cruz. Part of this work was performed at the Stanford Nano Shared Facilities (SNSF), supported by the National Science Foundation under award ECCS-1542152.	Aldersey-Williams H, 2004, NAT MATER, V3, P277, DOI 10.1038/nmat1119; Alvim J, 2014, J MOLLUS STUD, V80, P604, DOI 10.1093/mollus/eyu063; Amini S, 2015, NAT MATER, V14, P943, DOI [10.1038/NMAT4309, 10.1038/nmat4309]; Binney WG, 1874, ACAD NAT SCI, V26, P33; Binney WG, 1876, P ACAD NAT SCI PHILA, V28, P183; Binney WG, 1875, JAW LINGUAL MEMBRANE, V27, P140; CARRIKER MR, 1974, MAR BIOL, V25, P63, DOI 10.1007/BF00395108; Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7; EVANS LA, 1992, CALCIFIED TISSUE INT, V51, P78, DOI 10.1007/BF00296222; Fabritius HO, 2012, Z KRIST-CRYST MATER, V227, P766, DOI 10.1524/zkri.2012.1532; Falini G, 2013, J STRUCT BIOL, V183, P226, DOI 10.1016/j.jsb.2013.05.001; Gao XZ, 2013, INT J BIO-INSPIR COM, V5, P336, DOI 10.1504/IJBIC.2013.058911; Gervais JA, 1998, AM MIDL NAT, V140, P103, DOI 10.1674/0003-0031(1998)140[0103:TPFSDB]2.0.CO;2; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; GRAHAM A, 1973, J ZOOL, V169, P317; Gu ZZ, 2003, ANGEW CHEM INT EDIT, V42, P894, DOI 10.1002/anie.200390235; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1309, DOI 10.1152/jn.1996.75.4.1309; Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20176; Kawamura T, 2001, FISHERIES SCI, V67, P596, DOI 10.1046/j.1444-2906.2001.00295.x; Kinoshita S., 2002, FORMA, V17, P103; Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI [10.1146/annurev-matsci-070909-104427, 10.1146/annurev-matsci-070909-10442]; Leonard JL, 2002, INVERTEBR REPROD DEV, V41, P83, DOI 10.1080/07924259.2002.9652738; MACKENSTEDT U, 1987, ZOOMORPHOLOGY, V107, P209, DOI 10.1007/BF00312262; Mackenstedt U, 2001, BIOL TERRESTRIAL MOL; MCCLELLAN AD, 1982, J EXP BIOL, V98, P195; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Montroni D, 2019, CARBOHYD POLYM, V207, P26, DOI 10.1016/j.carbpol.2018.11.069; Montroni D, 2018, ACS BIOMATER SCI ENG, V4, P57, DOI 10.1021/acsbiomaterials.7b00743; Montroni D, 2017, RSC ADV, V7, P36605, DOI 10.1039/c7ra06664c; Onelli OD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01496-8; Onitsuka T, 2004, J SHELLFISH RES, V23, P1079; Padilla DK, 1998, VELIGER, V41, P201; Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152; PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109; Reid DG, 1999, J MOLLUS STUD, V65, P355, DOI 10.1093/mollus/65.3.355; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; ROLLO CD, 1983, RES POPUL ECOL, V25, P20, DOI 10.1007/BF02528782; RUDALL KM, 1973, BIOL REV, V48, P597, DOI 10.1111/j.1469-185X.1973.tb01570.x; Runham N. W., 1997, Scientia Marina, V61, P67; Saunders M, 2009, J STRUCT BIOL, V167, P55, DOI 10.1016/j.jsb.2009.03.003; Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343; Senseman D. M, 1976, THESIS; SENSEMAN DM, 1977, J CHEM ECOL, V3, P707, DOI 10.1007/BF00988069; Sone ED, 2007, J STRUCT BIOL, V158, P428, DOI 10.1016/j.jsb.2007.01.001; VANDERWAL P, 1989, J ULTRA MOL STRUCT R, V102, P147, DOI 10.1016/0889-1605(89)90052-9; Vortsepneva E, 2013, ZOOMORPHOLOGY, V132, P359, DOI 10.1007/s00435-013-0199-y; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Weaver JC, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70016-X; WOLTER K, 1992, J MOLLUS STUD, V58, P245, DOI 10.1093/mollus/58.3.245	49	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0212249	10.1371/journal.pone.0212249	http://dx.doi.org/10.1371/journal.pone.0212249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390363	Green Published, gold, Green Submitted			2022-12-26	WOS:000484999400001
J	Berg, M; Linnebjerg, JF; Taylor, G; Ismar-Rebitz, SMH; Bell, M; Gaskin, CP; Akesson, S; Rayner, MJ				Berg, Martin; Linnebjerg, Jannie F.; Taylor, Graeme; Ismar-Rebitz, Stefanie M. H.; Bell, Mike; Gaskin, Chris P.; Akesson, Susanne; Rayner, Matt J.			Year-round distribution, activity patterns and habitat use of a poorly studied pelagic seabird, the fluttering shearwater Puffinus gavia	PLOS ONE			English	Article							WANDERING ALBATROSSES; SEXUAL-DIMORPHISM; RISSA-TRIDACTYLA; SARDINOPS-SAGAX; MIGRATION; ECOLOGY; DISPERSAL; AUSTRALIA; REVEALS; CLIMATE	We present the first study to examine the year-round distribution, activity patterns, and habitat use of one of New Zealand's most common seabirds, the fluttering shearwater (Puffinus gavia). Seven adults from Burgess Island, in the Hauraki Gulf, and one individual from Long Island, in the Marlborough Sounds, were successfully tracked with combined light-saltwater immersion loggers for one to three years. Our tracking data confirms that fluttering shearwaters employ different overwintering dispersal strategies, where three out of eight individuals, for at least one of the three years when they were being tracked, crossed the Tasman Sea to forage over coastal waters along eastern Tasmania and southeastern Australia. Resident birds stayed confined to waters of northern and central New Zealand year-round. Although birds frequently foraged over pelagic shelf waters, the majority of tracking locations were found over shallow waters close to the coast. All birds foraged predominantly in daylight and frequently visited the colony at night throughout the year. We found no significant inter-seasonal differences in the activity patterns, or between migratory and resident individuals. Although further studies of inter-colony variation in different age groups will be necessary, this study presents novel insights into year-round distribution, activity patterns and habitat use of the fluttering shearwater, which provide valuable baseline information for conservation as well as for further ecological studies.	[Berg, Martin; Linnebjerg, Jannie F.; Akesson, Susanne] Lund Univ, Ctr Anim Movement Res, Dept Biol, Lund, Sweden; [Linnebjerg, Jannie F.] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Taylor, Graeme] New Zealand Dept Conservat, Wellington, New Zealand; [Ismar-Rebitz, Stefanie M. H.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Expt Ecol Benthos Ecol, Kiel, Germany; [Ismar-Rebitz, Stefanie M. H.; Rayner, Matt J.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Bell, Mike] Wildlife Management Int Ltd, Wellington, New Zealand; [Gaskin, Chris P.] Northern New Zealand Seabird Trust, Warkworth, New Zealand; [Rayner, Matt J.] Auckland Museum, Auckland, New Zealand	Lund University; Aarhus University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Auckland	Berg, M; Akesson, S (corresponding author), Lund Univ, Ctr Anim Movement Res, Dept Biol, Lund, Sweden.	martin.berg20@gmail.com; Susanne.Akesson@biol.lu.se	Linnebjerg, Jannie/AAI-4571-2020	Linnebjerg, Jannie Fries/0000-0003-4043-0606	Auckland Zoo Research Grant; Lund University Student Research Grant; ERASMUS+ Grant; Carlsberg Foundation; Linnaeus grant from the Swedish Research Council [349-2007-8690]; Lund University	Auckland Zoo Research Grant; Lund University Student Research Grant; ERASMUS+ Grant; Carlsberg Foundation(Carlsberg Foundation); Linnaeus grant from the Swedish Research Council; Lund University	This research was made possible by the Auckland Zoo Research Grant and by the Lund University Student Research Grant. Martin Berg was further supported by the ERASMUS+ Grant. Jannie F. Linnebjerg was funded by the Carlsberg Foundation. Jannie F. Linnebjerg and Susanne Akesson are supported by a Linnaeus grant to the Centre for Animal Movement Research (CAnMove) at Lund University from the Swedish Research Council (349-2007-8690) and Lund University. The funder provided support in the form of salaries for authors [JFL, GT, SMHI, MBELL, CPG, SA, MJR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section in the manuscript.; We thank Ngati Rehua for supporting this study on Pokohinu and Jim Foye at Maritime New Zealand for permission to use their facilities for accommodation. We are grateful for the hard work and dedication of many field assistants, particularly Jonas Kotlarz, Jesper Wadstain, Kajsa Svensson, Leon Berard and Jemma Welch. We also thank James Ross and Piers Barney for logistic support and transport to the island in variable weather conditions. Thanks to Northern New Zealand Seabird Trust and Auckland Museum for support with field equipment. We are also grateful to two anonymous reviewers for helpful comments on the submitted version of this paper. This is a report from the Centre for Animal Movement Research (CAnMove) at Lund University.	[Anonymous], 2021, LANG ENV STAT COMP; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Berg M, 2018, EMU, V118, P173, DOI 10.1080/01584197.2017.1366831; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; BRADFORD JM, 1982, DEEP-SEA RES, V29, P1501, DOI 10.1016/0198-0149(82)90039-5; Brummelen V, 2013, HEAVENLY MATH FORGOT; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Catry P, 2013, ECOLOGY, V94, P1230, DOI 10.1890/12-2177.1; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chastel O, 1995, AUK, V112, P964, DOI 10.2307/4089027; Cornell Lab of Ornithology, 2016, EBIRD BAS DAT VERS E; Crossland J, 1981, FISH EGGS LARVAE HAU; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Daunt F, 2014, ECOLOGY, V95, P2077, DOI 10.1890/13-1797.1; Dias MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049376; FLETCHER WJ, 1992, AUST J MAR FRESH RES, V43, P1437; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gaskin CP., 2013, SEABIRDS HAURAKI GUL; Goldsworthy SD, 2013, ECOL MODEL, V255, P38, DOI 10.1016/j.ecolmodel.2013.01.006; Gonzalez-Solis J, 2000, OIKOS, V90, P390, DOI 10.1034/j.1600-0706.2000.900220.x; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Gutowsky SE, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0023-4; Hauraki Gulf Forum, 2014, STAT OUR GULF 2014; Hoedt FE, 1995, MAR FRESHWATER RES, V46, P1085, DOI 10.1071/MF9951085; Hope RM, 2013, RMISC RMISC RYAN MIS; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; McKnight A, 2011, MAR ECOL PROG SER, V442, P241, DOI 10.3354/meps09373; Miskelly C, 2012, RENA OIL SPILL NZ SE; Mitchell GW, 2012, J ANIM ECOL, V81, P1024, DOI 10.1111/j.1365-2656.2012.01978.x; Neira FJ, 1999, AUST J ZOOL, V47, P37, DOI 10.1071/ZO98068; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Onley D., 2007, ALBATROSSES PETRELS; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinet P, 2011, MAR ECOL PROG SER, V423, P291, DOI 10.3354/meps08971; Ramos R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23447; Rayner MJ, 2016, MAR ECOL PROG SER, V549, P217, DOI 10.3354/meps11707; Rayner MJ, 2008, MAR ECOL PROG SER, V370, P271, DOI 10.3354/meps07660; Rayner MJ, 2011, J AVIAN BIOL, V42, P266, DOI 10.1111/j.1600-048X.2010.05238.x; Rayner MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1330; Reid TA, 2002, BIRDS AUSTR MONOGRAP, V4; Robertson C.J.R., 1984, International Council for Bird Preservation Technical Publication, P573; Sarkar D, 2008, USE R, P1; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Taylor GA, 2000, THREATENED SPECIES O, V17; Ward EJ, 2015, ECOL APPL, V25, P2198, DOI 10.1890/15-0051.1.sm; Ward T, 2002, FISH RES, V56, P37, DOI 10.1016/S0165-7836(01)00314-9; Waugh SM, 2003, TUHINGA, V24, P159; Weimerskirch H, 2006, J AVIAN BIOL, V37, P23, DOI 10.1111/j.2006.0908-8857.03675.x; Weimerskirch H, 2016, SCIENCE, V353, P74, DOI 10.1126/science.aaf4374; Whiteway T, 2009, DATABASE AUSTR BATHY; Wickham H., 2016, DPLYR GRAMMAR DATA M; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zeldis JR, 2015, NEW ZEAL J MAR FRESH, V49, P69, DOI 10.1080/00288330.2014.955806	59	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219986	10.1371/journal.pone.0219986	http://dx.doi.org/10.1371/journal.pone.0219986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386672	Green Published, Green Accepted, gold			2022-12-26	WOS:000484997100013
J	Adams, WM; Adams, JD; Karras, EM; Rysanek, E				Adams, William M.; Adams, J. D.; Karras, Eleni M.; Rysanek, Erin			Validity of temperature, duration, and vessel seal on 24-hour urinary hydration markers	PLOS ONE			English	Article							BIOMARKERS; VOLUME	The purpose of this study was to examine the effect of storage temperature, duration, and storage vessel seal on 24 h urinary hydration markers. Twenty-one males (n = 8) and females (n = 13) (mean +/- SD; age, 24 +/- 5 y; body mass, 68.9 +/- 24.2 kg; height, 160.2 +/- 32.1 cm) without a history of renal disease or currently taking any medications or supplements known to affect the accuracy of urinary hydration markers were enrolled in this study. Participants provided a 24 h urine sample in a clean container with each urine sample being separate into four separate containers, two in each of the following temperatures: 7 degrees C and 22 degrees C. One specimen container at each temperature was either sealed using the manufacturers cap (single sealed) or the manufacturers cap plus laboratory wrapping film (double sealed). Each sample was analyzed after 1, 2, 3, 7 and 10 days. Urine samples were assessed for urine osmolality (U-OSMO), urine specific gravity (U-SG) and urine color (U-COL). U-OSMO was stable at 7 degrees C for two days (mean difference [95% CI]; +1 mmol.kg(-1) [0+3], p>0.05) and three days (+1 mmol.kg(-1) [0, +3], p>0.05) for single sealed and double sealed containers, respectively. U-SG measures were stable for singled sealed and double sealed for up to ten days when stored at 22 degrees C. U-COL measures were maintained for up to three days in all storage methods (p>0.05). In conclusion, if immediate analysis is unavailable, such as in the case of field based or longitudinal research, it is recommended that 24 h urine samples are stored in a refrigerated environment and hydration markers (U-OSMO and U-COL) be assessed within 48 h.	[Adams, William M.; Karras, Eleni M.; Rysanek, Erin] Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC 27412 USA; [Adams, J. D.] Mayo Clin, Div Endocrinol Diabet & Metab, Rochester, MN USA	University of North Carolina; University of North Carolina Greensboro; Mayo Clinic	Adams, WM (corresponding author), Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC 27412 USA.	emadams@uncg.edu	; Adams, William/K-3312-2014	Adams, J.D./0000-0002-0738-5826; Adams, William/0000-0001-7372-8455	Safrit Measurement in Research Fund; Department if Kinesiology at the University of North Carolina at Greensboro	Safrit Measurement in Research Fund; Department if Kinesiology at the University of North Carolina at Greensboro	This study was funded by the Safrit Measurement in Research Fund and was awarded by the Department if Kinesiology at the University of North Carolina at Greensboro.	Adams Heather M, 2015, Asian J Sports Med, V6, pe24041, DOI 10.5812/asjsm.24041; Adams JD, 2017, INT J SPORT NUTR EXE, V27, P18, DOI 10.1123/ijsnem.2016-0098; Armstrong LE, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121928; Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Bezuidenhout K, 2016, ANN CLIN BIOCHEM, V53, P452, DOI 10.1177/0004563215602028; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Borghi L, 1999, NEPHRON, V81, P31, DOI 10.1159/000046296; Cheuvront SN, 2010, AM J CLIN NUTR, V92, P565, DOI 10.3945/ajcn.2010.29490; Clark WF, 2011, CLIN J AM SOC NEPHRO, V6, P2634, DOI 10.2215/CJN.01990211; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Ellis LA, 2016, INT J SPORT NUTR EXE, V26, P356, DOI 10.1123/ijsnem.2015-0244; Gunter EW, 1997, CHEMOSPHERE, V34, P1945, DOI 10.1016/S0045-6535(97)00056-8; Halim, 2009, URINALYSIS APPROVED; Hunt A., 2011, J HLTH SAF ENV, V27, P139; Padrao P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111272; Perrier E, 2013, EUR J CLIN NUTR, V67, P939, DOI 10.1038/ejcn.2013.93; Perrier E, 2013, BRIT J NUTR, V109, P1678, DOI 10.1017/S0007114512003601; Perrier ET, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/231063; Slawson M, 1980, RN, V43, P40	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220724	10.1371/journal.pone.0220724	http://dx.doi.org/10.1371/journal.pone.0220724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381592	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600030
J	Sonda, TB; Horumpende, PG; Kumburu, HH; van Zwetselaar, M; Mshana, SE; Alifrangis, M; Lund, O; Aarestrup, FM; Chilongola, JO; Mmbaga, BT; Kibiki, GS				Sonda, Tolbert B.; Horumpende, Pius G.; Kumburu, Happiness H.; van Zwetselaar, Marco; Mshana, Stephen E.; Alifrangis, Michael; Lund, Ole; Aarestrup, Frank M.; Chilongola, Jaffu O.; Mmbaga, Blandina T.; Kibiki, Gibson S.			Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; INFECTIONS; CEPHALOSPORINS; MANAGEMENT; CHILDREN; STRAINS	Excessive use of antibiotics, especially watch group antibiotics such as ceftriaxone leads to emergence and spread of antimicrobial resistance (AMR). In low and middle-income countries (LMICs), antibiotics are overused but data on consumption is scarcely available. We aimed at determining the extent and predictors of ceftriaxone use in a tertiary care university teaching hospital in Kilimanjaro, Tanzania. A hospital-based cross-sectional study was conducted from August 2013 through August 2015. Patients admitted in the medical, surgical wards and their respective intensive care units, receiving antimicrobials and other medications for various ailments were enrolled. Socio-demographic and clinical data were recorded in a structured questionnaire from patients' files and logistic regression was performed to determine the predictors for ceftriaxone use. Out of the 630 patients included in this study, 322 (51.1%) patients were on ceftriaxone during their time of hospitalization. Twenty-two patients out of 320 (6.9%) had been on ceftriaxone treatment without evidence of infection. Ceftriaxone use for surgical prophylaxis was 44 (40.7%), of which 32 (72.7%) and 9 (20.5%) received ceftriaxone prophylaxis before and after surgery, respectively. Three (6.8%) received ceftriaxone prophylaxis during surgery. Predicting factors for that the health facility administered ceftriaxone were identified as history of any medication use before referral to hospital [OR = 3.4, 95% CI (1.0-11.4), p = 0.047], bacterial infection [OR = 18.0, 95% CI (1.4-225.7, p = 0.025)], surgical ward [OR = 2.9, 95% CI (0.9-9.4), p = 0.078] and medical wards [OR = 5.0, 95% CI (0.9-28.3), p = 0.070]. Overall, a high ceftriaxone use at KCMC hospital was observed. Antimicrobial stewardship programs are highly needed to monitor and regulate hospital antimicrobial consumption, which in turn could help in halting the rising crisis of antimicrobial resistance.	[Sonda, Tolbert B.; Horumpende, Pius G.; Kumburu, Happiness H.; van Zwetselaar, Marco; Chilongola, Jaffu O.; Mmbaga, Blandina T.] Kilimanjaro Clin Res Inst, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Horumpende, Pius G.; Chilongola, Jaffu O.; Mmbaga, Blandina T.] Kilimanjaro Christian Med Univ Coll, Dept Biochem & Mol Biol, Moshi, Tanzania; [Horumpende, Pius G.] Lugalo Gen Mil Hosp, Mil Coll Med Sci, Dar Es Salaam, Tanzania; [Mshana, Stephen E.] Catholic Univ Hlth & Allied Sci, Mwanza, Tanzania; [Alifrangis, Michael] Copenhagen Univ Hosp, Ctr Med Parasitol, Copenhagen, Denmark; [Lund, Ole] Tech Univ Denmark, Ctr Biol Sequence Anal, Copenhagen, Denmark; [Aarestrup, Frank M.] Tech Univ Denmark, Ctr Genom Epidemiol, Copenhagen, Denmark; [Kibiki, Gibson S.] East Africa Hlth Res Commiss, Bujumbura, Burundi	Kilimanjaro Christian Medical Centre; University of Copenhagen; Technical University of Denmark; Technical University of Denmark	Horumpende, PG (corresponding author), Kilimanjaro Clin Res Inst, Kilimanjaro Christian Med Ctr, Moshi, Tanzania.; Horumpende, PG (corresponding author), Kilimanjaro Christian Med Univ Coll, Dept Biochem & Mol Biol, Moshi, Tanzania.; Horumpende, PG (corresponding author), Lugalo Gen Mil Hosp, Mil Coll Med Sci, Dar Es Salaam, Tanzania.	p.horumpende@kcri.ac.tz	Lund, Ole/F-4437-2014; Mmbaga, Blandina Theophil/AAR-8707-2021; Mshana, Stephen/AAE-1900-2022; Chilongola, Jaffu/K-9552-2017; van Zwetselaar, Marco/AAJ-6241-2020; Horumpende, Pius/AAS-2712-2020	Lund, Ole/0000-0003-1108-0491; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Chilongola, Jaffu/0000-0003-2997-6747; van Zwetselaar, Marco/0000-0002-5953-0060; Horumpende, Pius/0000-0003-1241-6997; Aarestrup, Frank/0000-0002-7116-2723; Alifrangis, Michael/0000-0002-3835-3333	DANIDA through Danida Fellowship Centre [12-007DTU]	DANIDA through Danida Fellowship Centre	This study was supported by DANIDA through Danida Fellowship Centre award number DFC No. 12-007DTU.	Ampaire L, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.432; Argaw Nitsuh Alemayehu, 2017, BMC Res Notes, V10, P160, DOI 10.1186/s13104-017-2475-2; Arwyn-Jones J., 2019, SURGERY, V37, P9, DOI [10.1016/j.mpsur.2018.11.006, DOI 10.1016/J.MPSUR.2018.11.006]; Ayele AA, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.383; Ayinalem GA, 2017, INT J BASIC CLIN PHA; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Chiotos K, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-015-0510-9; Christopher A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-27; Dasaraju PV, 1996, MED MICROBIOLOGY; Egbuchulam N, 2018, J HOSP ADM, V7, P36, DOI [10.5430/jha.v7n2p36, DOI 10.5430/JHA.V7N2P36]; ELTAHAWY ATAE, 1988, CHEMIOTERAPIA, V7, P75; Garraffo A, 2014, MED MALADIES INFECT, V44, P63, DOI 10.1016/j.medmal.2013.12.002; Halawi Ezaedin, 2018, BMC Res Notes, V11, P538, DOI 10.1186/s13104-018-3643-8; Hurst AL, 2017, J PEDIAT INF DIS SOC, V6, P57, DOI 10.1093/jpids/piv082; Iddi Z., 2013, THESIS; JACOBSON KL, 1995, CLIN INFECT DIS, V21, P1107, DOI 10.1093/clinids/21.5.1107; Jroundi I, 2013, ANTIBIOTICS-BASEL, V2, P450, DOI 10.3390/antibiotics2040450; Kemigisha E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205316; Kiguba R, 2016, J ANTIMICROB CHEMOTH, V71, P1697, DOI 10.1093/jac/dkw025; Kumburu HH, 2017, TROP MED INT HEALTH, V22, P454, DOI 10.1111/tmi.12836; Lee Hyuck, 2009, Korean Journal of Internal Medicine, V24, P374, DOI 10.3904/kjim.2009.24.4.374; Lin HA, 2016, J MICROBIOL IMMUNOL, V49, P237, DOI 10.1016/j.jmii.2014.12.010; Lo D, 2015, DRAFT GLOBAL AMR ACT; Mascellino MT, 2017, DRUG DES DEV THER, V11, P2209, DOI 10.2147/DDDT.S136240; Masinde A, 2009, Tanzan J Health Res, V11, P154; Moremi N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2082-1; Muller A, 2004, J ANTIMICROB CHEMOTH, V54, P173, DOI 10.1093/jac/dkh282; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Newman RE, 2012, PEDIATRICS, V129, pE597, DOI 10.1542/peds.2011-1533; Nimmich Elizabeth B, 2017, Hosp Pharm, V52, P691, DOI 10.1177/0018578717720506; Ntirenganya C, 2015, AM J TROP MED HYG, V92, P865, DOI 10.4269/ajtmh.14-0607; Nyongole O, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.226.6253; Pereira LMP, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-59; Shimels Tariku, 2015, J Pharm Policy Pract, V8, P26, DOI 10.1186/s40545-015-0047-1; Sileshi A, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0057-x; Thriemer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055495; Velickovic-Radovanovic R, 2015, J CLIN PHARM THER, P31, DOI [10.5633/amm.2015.0205, DOI 10.5633/AMM.2015.0205]	37	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220261	10.1371/journal.pone.0220261	http://dx.doi.org/10.1371/journal.pone.0220261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381579	Green Published, gold, Green Submitted			2022-12-26	WOS:000484993600013
J	Zhou, C; Jiao, Y; Browder, J				Zhou, Can; Jiao, Yan; Browder, Joan			How much do we know about seabird bycatch in pelagic longline fisheries? A simulation study on the potential bias caused by the usually unobserved portion of seabird bycatch	PLOS ONE			English	Article							MORTALITY; MODEL	Not much is known about the fleet level total seabird bycatch from pelagic longlines of United States vessels in the western North Atlantic or other fleets of the Atlantic or other oceans. Onboard observers generally only record seabird bycatch during line hauling. Seabirds are predominantly caught during the line setting stage, and, due to predation or mechanical action, those caught prior to the haul can drop off the hook and be lost to the onboard observer. We developed a model to gauge the size of this bycatch loss problem and provide a first approximation of its impact on estimates of total fleet bycatch. We started with a traditional loss-free bycatch model, which assumes that birds recorded were the only birds captured, and integrated into it two crucial components of the bycatch process: capture origin (set or haul) and bycatch loss of set-captures. We extracted count data on seabird bycatch loss and bycatch mortality from the literature on other longline fisheries and used these data to simulate potential total seabird bycatch in the western North Atlantic. Simulations revealed the shortcomings of both the traditional bycatch model and the current haul-only observer protocol, each of which contributed to biologically significant underestimation of total bycatch and estimation uncertainty. Based on our results, we recommend a loss-corrected modeling approach to provide a more accurate estimate of seabird mortalities in pelagic longline fisheries. Where possible, fishery-specific seabird bycatch loss rates need to be ascertained via specific set and haul observing protocols. But, even where fishery-specific estimates for a region are not available, the methodology developed here is applicable to other pelagic longline fisheries to approximate fleet-level loss-corrected bycatch.	[Zhou, Can; Jiao, Yan] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Browder, Joan] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA	Virginia Polytechnic Institute & State University; National Oceanic Atmospheric Admin (NOAA) - USA	Zhou, C (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	eidotog@gmail.com	Zhou, Can/AAZ-9771-2020	Zhou, Can/0000-0003-4533-5333; Jiao, Yan/0000-0002-8804-5005	National Oceanic and Atmospheric Administration National Marine Fisheries Service, Southeast Fisheries Science Center [WC133F15SE1858]; National Oceanic and Atmospheric Administration Fisheries' National Seabird Program; National Seabird Program	National Oceanic and Atmospheric Administration National Marine Fisheries Service, Southeast Fisheries Science Center; National Oceanic and Atmospheric Administration Fisheries' National Seabird Program; National Seabird Program	This work received funding from the National Oceanic and Atmospheric Administration National Marine Fisheries Service, Southeast Fisheries Science Center, grant number WC133F15SE1858 (https://www.sefsc.noaa.gov/) to YJ, and funding from National Oceanic and Atmospheric Administration Fisheries' National Seabird Program (https://www.st.nmfs.noaa.gov/national-seabird-program/) to JB and to the Southeast Fisheries Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The second grant from the National Seabird Program was an internal one, and it doesn't have a grant number.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Babcock E. A, 2003, MUCH OBSERVER COVERA; Beerkircher L.R., 2002, MAR FISH REV, V64, P40, DOI DOI 10.1037/0003-066x.59.1.29; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Brothers N, 2016, ACAP 7 M SEAB BYC WO; Brothers N.P., 1999, INCIDENTAL CATCH SEA; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; Burnham K P, 2003, MODEL SELECT MULTIMO; Camphuysen C.J., 1995, CONSUMPTION DISCARDS; Croxall JP, 1998, POPULATION CHANGES A; Debski I., 2016, OBSERVER COVERAGE MO; Diaz G.A., 2009, COLLECTIVE VOLUME SC, V64, P2415; Gales R, 1998, BIOL CONSERV, V86, P37, DOI 10.1016/S0006-3207(98)00011-1; Gilman E, 2003, OCEAN COAST MANAGE, V46, P985, DOI 10.1016/j.ocecoaman.2003.12.001; Gilman EL, 2009, MINIMIZING BYCATCH S; Gilman E, 2007, FISHERIES SCI, V73, P208, DOI 10.1111/j.1444-2906.2007.01321.x; Gilman E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155477; Hata D, 2006, UNPUB; Huin Nicolas, 1996, Marine Ornithology, V24, P19; Kadane JB, 2006, BAYESIAN ANAL, V1, P363, DOI 10.1214/06-BA113; Lawson T., 2006, SCI ASPECTS OBSERVER; Lee David S., 1999, Journal of the Elisha Mitchell Scientific Society, V115, P294; Li Y, 2015, ESTIMATED SEABIRD BY; Li Y, 2014, ESTIMATED SEABIRD BY; Li Y, 2016, ICES J MAR SCI, V73, P2687, DOI 10.1093/icesjms/fsw088; Li Y, 2013, ECOL MODEL, V260, P36, DOI 10.1016/j.ecolmodel.2013.03.021; Lord D, 2008, ACCIDENT ANAL PREV, V40, P1123, DOI 10.1016/j.aap.2007.12.003; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M., 2002, J R STAT SOC B, V64, P620, DOI [10.1111/1467-9868.00353., DOI 10.1111/1467-9868.00353]; R Development Core Team, 2016, R LANG ENV STAT COMP; Rodriguez A, FUTURE DIRECTIONS CO; Shmueli G, 2005, J ROY STAT SOC C-APP, V54, P127, DOI 10.1111/j.1467-9876.2005.00474.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tennyson A., 1990, Forest & Bird (Wellington), V21, P23; Vega R, 2009, FISH RES, V98, P22, DOI 10.1016/j.fishres.2009.03.010; Vucetich JA, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P35, DOI 10.1007/978-0-387-85952-1_3; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Winter A, 2011, WATERBIRDS, V34, P289, DOI 10.1675/063.034.0304; Zhou C., 2017, ESTIMATED SEABIRD BY; Zhou Can, 2019, Ecological Modelling, V407, DOI 10.1016/j.ecolmodel.2019.108726; Zhou C, 2019, AQUAT CONSERV, V29, P1324, DOI 10.1002/aqc.3066; Zuur Alain F., 2009, P1	42	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220797	10.1371/journal.pone.0220797	http://dx.doi.org/10.1371/journal.pone.0220797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381613	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600036
J	Appel, JM; Fullerton, K; Hennessy, E; Korn, AR; Tovar, A; Allender, S; Hovmand, PS; Kasman, M; Swinburn, BA; Hammond, RA; Economos, CD				Appel, Julia M.; Fullerton, Karen; Hennessy, Erin; Korn, Ariella R.; Tovar, Alison; Allender, Steven; Hovmand, Peter S.; Kasman, Matt; Swinburn, Boyd A.; Hammond, Ross A.; Economos, Christina D.			Design and methods of Shape Up Under 5: Integration of systems science and community-engaged research to prevent early childhood obesity	PLOS ONE			English	Article							INTERVENTIONS; DISPARITIES; DIFFUSION; NUTRITION; CHILDREN; WHOLE	Shape Up Under 5 (SUU5) was a two-year early childhood obesity prevention pilot study in Somerville, Massachusetts (2015-2017) designed to test a novel conceptual framework called Stakeholder-driven Community Diffusion. For whole-of-community interventions, this framework posits that diffusion of stakeholders' knowledge about and engagement with childhood obesity prevention efforts through their social networks will improve the implementation of health-promoting policy and practice changes intended to reduce obesity risk. SUU5 used systems science methods (agent-based modeling, group model building, social network analysis) to design, facilitate, and evaluate the work of 16 multisector stakeholders ('the Committee'). In this paper, we describe the design and methods of SUU5 using the conceptual framework: the approach to data collection, and methods and rationale for study inputs, activities and evaluation, which together may further our understanding of the hypothesized processes within Stakeholder-driven Community Diffusion. We also present a generalizable conceptual framework for addressing childhood obesity and similar complex public health issues through whole-of-community interventions.	[Appel, Julia M.; Fullerton, Karen; Hennessy, Erin; Korn, Ariella R.; Economos, Christina D.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Tovar, Alison] Univ Rhode Isl, Dept Nutr & Food Sci, South Kingston, RI USA; [Allender, Steven; Swinburn, Boyd A.] Deakin Univ, Global Obes Ctr GLOBE, Ctr Populat Hlth Res, Geelong, Vic, Australia; [Hovmand, Peter S.] Washington Univ, George Warren Brown Sch Social Work, Social Syst Design Lab, St Louis, MO 63130 USA; [Kasman, Matt; Hammond, Ross A.] Brookings Inst, Ctr Social Dynam & Policy, Washington, DC 20036 USA; [Swinburn, Boyd A.] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand	Tufts University; University of Rhode Island; Deakin University; Washington University (WUSTL); Brookings Institution; University of Auckland	Economos, CD (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	christina.economos@tufts.edu		Allender, Steven/0000-0002-4842-3294	National Institutes of Health (NIH) from the National Heart, Lung and Blood Institute (NHLBI) [1R01HL115485]; Office for Behavioral and Social Sciences Research (OBSSR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Heart, Lung and Blood Institute (NHLBI); Office for Behavioral and Social Sciences Research (OBSSR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	COMPACT and Shape Up Under 5 were funded by National Institutes of Health (NIH, https://www.nih.gov/), grant #1R01HL115485 from the National Heart, Lung and Blood Institute (NHLBI, https://www.nhlbi.nih.gov/) and the Office for Behavioral and Social Sciences Research (OBSSR, https://obssr.od.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski T, 2018, CHILD OBES, V14, P1, DOI 10.1089/chi.2017.0303; Benjamin SE, 2007, J NUTR EDUC BEHAV, V39, P142, DOI 10.1016/j.jneb.2006.08.027; Boelsen-Robinson T, 2015, OBES REV, V16, P806, DOI 10.1111/obr.12297; Bosse T, 2013, AUTON AGENT MULTI-AG, V27, P52, DOI 10.1007/s10458-012-9201-1; Cowan R, 2004, J ECON DYN CONTROL, V28, P1557, DOI 10.1016/j.jedc.2003.04.002; Dearing JW, 2008, J PUBLIC HEALTH MAN, V14, P99, DOI 10.1097/01.PHH.0000311886.98627.b7; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Economos CD, 2017, OBESITY, V25, P1155, DOI 10.1002/oby.21893; Friedkin NE, 1999, ADV GROUP, V16, P1; Gillman MW, 2008, OBESITY, V16, P1651, DOI 10.1038/oby.2008.260; Gillman MW, 2016, JAMA PEDIATR, V170, P9, DOI 10.1001/jamapediatrics.2015.2786; Hammond RA, 2009, PREV CHRONIC DIS, V6; Henderson KE, 2011, J AM DIET ASSOC, V111, P1306, DOI 10.1016/j.jada.2011.06.011; Hovmand PS, 2011, INT C SYST DYN 2011; Huang TT, 2009, PREV CHRONIC DIS, V6; Institute of Medicine, 2012, 9780309221542 I MED; Ip EH, 2013, HEALTH EDUC BEHAV, V40, p123S, DOI 10.1177/1090198113493911; Korn AR, 2018, CHILD OBES, V14, P537, DOI 10.1089/chi.2018.0032; Korn AR, 2018, BMC PUBLIC HEALTH, V18, DOI [10.1186/s12889-018-5588-1, 10.1186/S12889-018-5588-1]; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Mezirow J., 1997, TRANSFORMATIVE DIMEN, V74, P3, DOI DOI 10.1002/ACE.7401; Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Shoham David A, 2015, Curr Epidemiol Rep, V2, P71; Skinner AC, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-1916, 10.1542/peds.2017-3459, 10.1542/peds.2018-0725]; Taveras EM, 2017, OBESITY, V25, P1159, DOI 10.1002/oby.21866; Taveras EM, 2015, CHILD OBES, V11, P11, DOI 10.1089/chi.2014.0031; Taveras EM, 2013, JAMA PEDIATR, V167, P731, DOI 10.1001/jamapediatrics.2013.85; Thompson AL, 2013, SOC SCI MED, V97, P288, DOI 10.1016/j.socscimed.2012.12.007; Wolfenden L, 2014, PREV MED, V62, P193, DOI 10.1016/j.ypmed.2014.01.031	30	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220169	10.1371/journal.pone.0220169	http://dx.doi.org/10.1371/journal.pone.0220169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369570	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900032
J	Ramalho, SHR; Cipriano, G; Vieira, PJC; Nakano, EY; Winkelmann, ER; Callegaro, CC; Chiappa, GR				Rodolpho Ramalho, Sergio Henrique; Cipriano Junior, Gerson; Cardoso Vieira, Paulo Jose; Nakano, Eduardo Yoshio; Winkelmann, Eliane R.; Callegaro, Carine C.; Chiappa, Gaspar Rogerio			Inspiratory muscle strength and six-minute walking distance in heart failure: Prognostic utility in a 10 years follow up cohort study	PLOS ONE			English	Article							REFERENCE VALUES; EXERCISE; MORTALITY; WEAKNESS; TESTS	Background Maximal inspiratory pressure (PImax) and 6-minutes walk distance test (6MWD) may be more available and feasible alternatives for prognostic assessment than cardiopulmonary testing. We hypothesized that the PImax and 6MWD combination could improve their individual accuracy as risk predictors. We aimed to evaluate PImax ability as a mortality predictor in HF and whether the combination to 6MWD could improve risk stratification. Methods Prospective cohort from HF Clinics of three University Hospitals. PImax, 6MWD and pVO(2) were obtained at baseline. The end point was all cause mortality. Results Consecutive 256 individuals (50% woman, 57.4 +/- 10.4years) with low ejection fraction (LVEF) (31.8 +/- 8.6%) were followed up to 10years. During a median follow-up of 34.7 (IQR 37) months, 110 participants died. Mean +/- SD values were: pVO(2) 14.9 +/- 5.1mL/kg/min, PImax 5.5 +/- 1.3kPa and 6MWD 372 +/- 118m. In multivariate Cox regression, pVO(2), PImax, 6MWD and LVEF were independent mortality predictors. The pVO(2) showed gold standard accuracy, followed by PImax (AUC = 0.84) and 6MWD (AUC = 0.74). Kaplan-Meier mean survival time (MST +/- SE) for lower (<= 5.0kPa) and higher (>6.0kPa) PImax tertiles, were 37.9 +/- 2.8months and 105.0 +/- 5.2months respectively, and addition of 6MWD did not restratified risk. For intermediate PImax tertile, MST was 81.5 +/- 5.5months, but adding 6MWD, MST was lower (53.3 +/- 7.6months) if distance was <= 350m and higher (103.1 +/- 5.7months) for longer distances. Conclusion PImax is an independent mortality predictor in HF, more accurate than 6MWD and LVEF. Addition of 6MWD empowers risk stratification only for intermediate PImax tertile. Although less accurate than pVO(2), this simpler approach could be a feasible alternative as a prognostic assessment.	[Rodolpho Ramalho, Sergio Henrique; Cipriano Junior, Gerson; Chiappa, Gaspar Rogerio] Univ Brasilia, Hlth Sci & Technol Program, Brasilia, DF, Brazil; [Cipriano Junior, Gerson] Univ Brasilia, Rehabil Sci Program, Brasilia, DF, Brazil; [Cardoso Vieira, Paulo Jose] Hosp Cristo Redentor, Intens Care Unit, Porto Alegre, RS, Brazil; [Nakano, Eduardo Yoshio] Univ Brasilia, Dept Stat, Brasilia, DF, Brazil; [Winkelmann, Eliane R.] Univ Reg Noroeste Estado Rio Grande do Sul UNIJUI, Ijui, Brazil; [Callegaro, Carine C.] Univ Fed Santa Maria, Dept Physiotherapy, Santa Maria, RS, Brazil; [Chiappa, Gaspar Rogerio] Fac Integradas Uniao Educ Planalto Cent, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUI; Universidade Federal de Santa Maria (UFSM)	Ramalho, SHR (corresponding author), Univ Brasilia, Hlth Sci & Technol Program, Brasilia, DF, Brazil.	shrramalho@gmail.com	Nakano, Eduardo Y/G-1660-2011; Ramalho, Sergio/AAE-2098-2019; Cipriano Jr., Gerson/K-6317-2014; Londoner, Kenneth L/AAD-2222-2019	Nakano, Eduardo Y/0000-0002-9071-8512; Ramalho, Sergio/0000-0001-8444-2655; Cipriano Jr., Gerson/0000-0001-6323-7003; Londoner, Kenneth L/0000-0001-9085-3813; Technologies, BioSig/0000-0001-8277-164X; Callegaro, Carine/0000-0001-9482-5457; Winkelmann, Eliane Roseli/0000-0002-4922-6516	Brazilian Government agencies for this research: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [407527/2013-3]; Coordenacao de Aperfeic oamento de Pessoal de Nivel Superior (CAPES) [53001010088P8]	Brazilian Government agencies for this research: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeic oamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	GRC was supported by Brazilian Government agencies for this research: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 407527/2013-3 and Coordenacao de Aperfeic oamento de Pessoal de Nivel Superior (CAPES; 53001010088P8). The authors declare no potential conflicts of interest with respect to the research, authorship or publication of this article.	Adsett J, 2011, EUR J CARDIOV PREV R, V18, P601, DOI 10.1177/1741826710389403; Arena Ross, 2012, Congest Heart Fail, V18, P302, DOI 10.1111/j.1751-7133.2012.00296.x; Billebeau G, 2017, EUR J PREV CARDIOL, V24, P1127, DOI 10.1177/2047487317705488; Cacciatore F, 2012, EUR J PREV CARDIOL, V19, P1401, DOI 10.1177/1741826711422991; Cahalin LP, 2013, EXPERT REV CARDIOVAS, V11, P161, DOI [10.1586/ERC.12.191, 10.1586/erc.12.191]; Chase PJ, 2013, JACC-HEART FAIL, V1, P427, DOI 10.1016/j.jchf.2013.05.008; Coats AJS, 1996, J MOL CELL CARDIOL, V28, P2255, DOI 10.1006/jmcc.1996.0218; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; Frankenstein L, 2008, EUR J CARDIOV PREV R, V15, P156, DOI 10.1097/HJR.0b013e3282f0d6ea; Frankenstein L, 2009, EUR J CARDIOV PREV R, V16, P424, DOI 10.1097/HJR.0b013e3283030a7e; Gilstrap LG, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008789; Goldberg LR, 2007, CIRCULATION, V116, P360, DOI 10.1161/CIRCULATIONAHA.107.713735; Guazzi M, 2012, EUR HEART J, V33, P2917, DOI 10.1093/eurheartj/ehs221; Iliou MC, 2017, EUR J PREV CARDIOL, V24, P1274, DOI 10.1177/2047487317712601; Kelley RC, 2017, HEART FAIL REV, V22, P191, DOI 10.1007/s10741-016-9549-4; Keteyian SJ, 2016, J AM COLL CARDIOL, V67, P780, DOI 10.1016/j.jacc.2015.11.050; Komajda M, 2017, EUR J HEART FAIL, V19, P1495, DOI 10.1002/ejhf.876; Meyer FJ, 2001, CIRCULATION, V103, P2153; Meyer T, 2001, INT J SPORTS MED, V22, P593, DOI 10.1055/s-2001-18523; Montemezzo D, 2014, ARCH PHYS MED REHAB, V95, P1398, DOI 10.1016/j.apmr.2014.02.022; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Palau P, 2019, REV ESP CARDIOL, V72, P288, DOI 10.1016/j.rec.2018.01.010; Piepoli MF, 2011, EUR J HEART FAIL, V13, P347, DOI 10.1093/eurjhf/hfr017; Ribeiro Jorge P, 2009, Curr Heart Fail Rep, V6, P95; Rodrigues A, 2017, CHEST, V152, P32, DOI 10.1016/j.chest.2016.11.045; Rostagno C, 2003, EUR J HEART FAIL, V5, P247, DOI 10.1016/S1388-9842(02)00244-1; Savarese G, 2018, EUR J HEART FAIL, V20, P284; Smart NA, 2013, INT J CARDIOL, V167, P1502, DOI 10.1016/j.ijcard.2012.04.029; Tikunov B, 1997, CIRCULATION, V95, P910; van der Palen J, 2004, THORAX, V59, P1063, DOI 10.1136/thx.2004.021915; Verissimo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118218; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220638	10.1371/journal.pone.0220638	http://dx.doi.org/10.1371/journal.pone.0220638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369636	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900073
J	Buytaert, D; Vandekerckhove, K; Panzer, J; Rubbens, L; De Wolf, D; Bacher, K				Buytaert, Dimitri; Vandekerckhove, Kristof; Panzer, Joseph; Rubbens, Lukas; De Wolf, Daniel; Bacher, Klaus			Local DRLs and automated risk estimation in paediatric interventional cardiology	PLOS ONE			English	Article							DIAGNOSTIC REFERENCE LEVELS; CARDIAC-CATHETERIZATION; CORONARY-ANGIOGRAPHY; RADIATION-EXPOSURE; CANCER-RISK; ORGAN; CHILDREN	Introduction Cardiac catheterization procedures result in high radiation doses and often multiple procedures are necessary for congenital heart disease patients. However, diagnostic reference levels (DRL) remain scarce. Our first goal was finding the optimal DRL parameter and determining appropriate DRLs. The second goal was to calculate organ doses (OD), effective doses (ED) and lifetime attributable risks (LAR) per procedure and to provide conversion factors based on dose area product (DAP). Materials and methods DRLs are calculated for each procedure type, as the 75th percentile of the cumulative value per procedure from the corresponding parameter. All irradiation events in the DICOM Structured Reports were automatically processed and simulated using PCXMC, resulting in OD, ED and LAR. Using a Kruskal Wallis H test and subsequent pairwise comparisons, differences in median values of the DRL parameter between procedure types were assessed. Results Linear regression showed a strong correlation and narrow confidence interval between DAP and product of body weight and fluoroscopy time (BWxFT), even when all procedures (diagnostic and interventional) are combined. Only 15% of the pairwise comparisons were statistically significant for DAP normalized to BWxFT (DAP(BWxFT)). The latter pairs contained less frequent procedure types with significant outliers. For DAP normalized to BW (DAP(BW)), 38% of the pairwise comparisons showed statistically significant differences. Conversion factors from DAP(BW) to OD and ED were reported for various weight groups, due to the higher correlation between DAP(BW) and both OD and ED than between DAP and both OD and ED. Conclusions The P75 of DAP(BWxFT) for all procedures combined serves as an appropriate DRL value. This facilitates local DRL determination in smaller paediatric centres, which often have insufficient data to produce appropriate DRLs for different procedure types. Conversion factors are more reliable starting from DAP(BW) instead of DAP and should be used according to the appropriate BW group.	[Buytaert, Dimitri; Bacher, Klaus] Univ Ghent, Dept Human Struct & Repair, Ghent, Belgium; [Vandekerckhove, Kristof; Panzer, Joseph; Rubbens, Lukas; De Wolf, Daniel] Ghent Univ Hosp, Dept Paediat Cardiol, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Buytaert, D (corresponding author), Univ Ghent, Dept Human Struct & Repair, Ghent, Belgium.	Dimitri.Buytaert@UGent.be	Vandekerckhove, Kristof/ABH-3798-2020; de wolf, daniel/F-7481-2013; Panzer, Joseph/HHM-2095-2022; Vandekerckhove, Kristof/M-9012-2019	de wolf, daniel/0000-0002-0846-8914; Panzer, Joseph/0000-0002-8667-8001; Vandekerckhove, Kristof/0000-0002-1481-0878; Buytaert, Dimitri/0000-0003-0592-5873	Flanders Innovation and Entrepreneurship (VLAIO, Flanders, Belgium) [141670]	Flanders Innovation and Entrepreneurship (VLAIO, Flanders, Belgium)	This work is supported by the Agency for Innovation by Science and Technology (IWT, Flanders, Belgium), which is now part of Flanders Innovation and Entrepreneurship (VLAIO, Flanders, Belgium), grant number 141670 to DB; https://www.fwo.be/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi MG, 2006, EUR HEART J, V27, P2703, DOI 10.1093/eurheartj/ehl014; [Anonymous], 2013, UNSCEAR 2013 REP; Bacher K, 2005, CIRCULATION, V111, P83, DOI 10.1161/01.CIR.0000151098.52656.3A; Barnaoui S, 2014, PEDIATR CARDIOL, V35, P1037, DOI 10.1007/s00246-014-0895-5; BPCA, 2012, REC BRIT PAED CARD A; Brambilla M, 2017, PHYS MEDICA, V42, P189, DOI 10.1016/j.ejmp.2017.09.131; Chida K, 2010, AM J ROENTGENOL, V195, P1175, DOI 10.2214/AJR.10.4466; Commission E, 2018, RAD PROTECTION, V185; Corredoira E, 2015, J RADIOL PROT, V35, P179, DOI 10.1088/0952-4746/35/1/179; Eloot L, 2015, J COMPUT ASSIST TOMO, V39, P591, DOI 10.1097/RCT.0000000000000253; Eloot L, 2013, CATHETER CARDIO INTE, V82, pE419, DOI 10.1002/ccd.24879; Fisher DR, 2017, HEALTH PHYS, V113, P102, DOI 10.1097/HP.0000000000000674; Harbron RW, 2016, J RADIOL PROT, V36, pR131, DOI 10.1088/0952-4746/36/4/R131; Johnson JN, 2014, CIRCULATION, V130, P161, DOI 10.1161/CIRCULATIONAHA.113.005425; Nguyen HH, 2016, PEDIATR CARDIOL, V37, P1429, DOI 10.1007/s00246-016-1453-0; NR C, 2006, HLTH RISKS EXP LOW L; Onnasch DGW, 2007, BRIT J RADIOL, V80, P177, DOI 10.1259/bjr/19929794; Peck D, UNDERSTAND COMMUNICA; Strauss KJ, 2015, AM J ROENTGENOL, V204, pW713, DOI 10.2214/AJR.14.13630; Sullivan PM, 2017, PEDIATR CARDIOL, V38, P1583, DOI 10.1007/s00246-017-1700-z; Tapiovaara M, 2008, PCXMC MONTE CARLO PR, V2nd; Taylor S, 2017, EUR RADIOL, V27, P365, DOI 10.1007/s00330-016-4333-3; Triedman JK, 2016, CIRCULATION, V133, P2716, DOI 10.1161/CIRCULATIONAHA.116.023544; Ubeda C, 2017, PHYS MEDICA, V40, P95, DOI 10.1016/j.ejmp.2017.07.015; Ubeda C, 2015, MED PHYS, V42, P615, DOI 10.1118/1.4905116; Valentin Jack, 2007, Annals of the ICRP, V37, P3	26	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220359	10.1371/journal.pone.0220359	http://dx.doi.org/10.1371/journal.pone.0220359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365573	Green Published, Green Submitted, gold			2022-12-26	WOS:000484983600041
J	Cheyne, SM; Capilla, BR; Abdulaziz, K; Supiansyah; Adul; Cahyaningrum, E; Smith, DE				Cheyne, Susan M.; Capilla, Bernat Ripoll; Abdulaziz, K.; Supiansyah; Adul; Cahyaningrum, Eka; Smith, David Ehlers			Home range variation and site fidelity of Bornean southern gibbons [Hylobates albibarbis] from 2010-2018	PLOS ONE			English	Article							PEAT-SWAMP FOREST; NOMASCUS-CONCOLOR-JINGDONGENSIS; CENTRAL KALIMANTAN; BEHAVIORAL ECOLOGY; SABANGAU CATCHMENT; FRUIT AVAILABILITY; SIBERUT-ISLAND; NATIONAL-PARK; HABITAT USE; SIZE	Gibbons are highly territorial and have two key areas within these territories. The core area in which we find all sleeping trees and the trees from which the gibbons duet and the wider home range (HR) which has varying levels of overlap with neighbouring gibbon groups. The core area is strenously defended, with the wider HR being more of a shared area for neighbouring groups. We present ranging and movement data on four wild gibbon groups from January 2010 to July 2018. Global Positioning System (GPS) data were collected every 5 mins on habitauted groups in Sebangau, Central Kalimantan, Indonesia resulting in 35,521 waypoints. Gibbon home-and corerange sizes were calculated using 95%, and 50%, volume contours of kernel density estimates. Home-ranges ranged from 58.74-147.75 ha with a mean of 95.7 +/- SD 37.75 ha, the highest of comparable Hylobates species. Core-range size ranged from 20.7-51.31 ha with a mean size of 31.7 +/- SD 13.76 ha. Gibbons had consistant site fidelity for their home-and core ranges; percentage overlap ranged from 4.3 23.97% with a mean 16.5 +/- SD 8.65% overlap in home-range area. Core ranges did not overlap with the exception of two groups, in which a 0.64 ha (2.69%) overlap occurred. Unsurprisingly forest loss from fire does affect the location of the HR of the impacted group, but does not appear to affect adjacent groups, though more data are needed on this. Understanding the complex use of space of these territorial animals is important in assessing both carrying capacity for wild populations and understading how reintroduced gibbon pairs will establish their core and HR.	[Cheyne, Susan M.] Borneo Nat Fdn, Palangka Raya, Central Kaliman, Indonesia; [Cheyne, Susan M.; Capilla, Bernat Ripoll; Abdulaziz, K.; Supiansyah; Adul; Cahyaningrum, Eka] Oxford Brookes Univ, Fac Social Sci, Oxford, England; [Smith, David Ehlers] Univ KwaZulu Natal, Pietermaritzburg, South Africa	Oxford Brookes University; University of Kwazulu Natal	Cheyne, SM (corresponding author), Borneo Nat Fdn, Palangka Raya, Central Kaliman, Indonesia.; Cheyne, SM (corresponding author), Oxford Brookes Univ, Fac Social Sci, Oxford, England.	s.cheyne@borneonature.org	Smith, David Ehlers/AAA-6016-2020; Cheyne, Susan/C-9856-2013	Smith, David Ehlers/0000-0002-6357-0751; Cheyne, Susan/0000-0002-9180-3356	Arcus Foundation; Rufford Small Grants for Conservation; BBC Wildlife Fund; CIMTROP	Arcus Foundation; Rufford Small Grants for Conservation; BBC Wildlife Fund; CIMTROP	Funding was provided by the Arcus Foundation (https://www.arcusfoundation.org/), the Rufford Small Grants for Conservation (https://www.rufford.org/) and the BBC Wildlife Fund (http://www.bbc.co.uk/wild/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was carried out within the BNF-CIMTROP multi-disciplinary research project in the northern Sebangau forest, Central Kalimantan, Indonesia. We thank Dr Suwido Limindecision to publish, or preparation of the manuscript.and CIMTROP for sponsorship and The Indonesian Ministry of Research and Technology [RISTEK] for research permits. Special thanks to the Indonesian research team: Dewa, Twenty, Santi, Ambut, Yudhi, Ari, Coes and Hendry, who helped us collect data during daily follows and to all BNF students, volunteers and interns who contributed to this work. This research was carried out by Yayasan Borneo Nature Indonesia staff and under the following permits from RISTEK: SMC [26/EXT/SIP/FRP/SM/V/2011; 246/SIP/FRP/SM/VII/2012; 45/EXT/SIP/FRP/SM/VI/2012; 217/SIP/FRP/SM/VI/2013; 217-A/SIP/FRP/SM/I/2014]. BRC: 35/EXT/SIP/FRP/SM/VII/2015. DES: 255/SIP/FRP/SM/VII/2012.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], [No title captured]; Asensio N, 2010, ANIM COGN; Bartlett TQ, 2009, GIBBONS KHAO YAI SEA; BENNETT EL, 1986, FOLIA PRIMATOL, V47, P26, DOI 10.1159/000156261; Bradley BJ, 2004, CURR BIOL, V14, P153; Bryant JV, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0430-1; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campbell C. O., 2015, BEST PRACTICE GUIDEL; Carpenter CR, 1939, SCI MON, V48, P319; CARPENTER C. R., 1940, COMPAR PSYCHOL MONOGR, V16, P1; Carretero-Pinzon X, 2016, BIODIVERS CONSERV, V25, P37, DOI 10.1007/s10531-015-1028-z; Chetry D, 2008, SLEEPING TREE SELECT, P403; Cheyne S. M., 2012, International Zoo Yearbook, V46, P265, DOI 10.1111/j.1748-1090.2011.00149.x; Cheyne SM., 2013, ASIAN PRIMATES, V3, P13; Cheyne SM, 2010, GIBBON J, V6; Cheyne SM, 2008, BIODIVERS CONSERV, V17, P1741, DOI 10.1007/s10531-008-9378-4; Cheyne SM, 2008, AM J PRIMATOL, V70, P386, DOI 10.1002/ajp.20502; Cheyne SM, 2008, PRIMATES, V49, P50, DOI 10.1007/s10329-007-0063-0; Cheyne SM, 2016, ENDANGER SPECIES RES, V30, P133, DOI 10.3354/esr00734; Cheyne SM, 2012, FOLIA PRIMATOL, V83, P299, DOI 10.1159/000342145; Cheyne SM, 2010, DEV PRIMATOL-PROG PR, P121, DOI 10.1007/978-1-4419-1560-3_8; Cheyne Susan M., 2010, Endangered Species Research, V9, P159, DOI 10.3354/esr00216; Cheyne Susan M., 2009, P477, DOI 10.1007/978-0-387-88604-6_23; CHIVERS DJ, 1976, BEHAVIOUR, V57, P116, DOI 10.1163/156853976X00136; Coiner-Collier S, 2016, J HUM EVOL, V98, P103, DOI 10.1016/j.jhevol.2016.07.005; DECKER BS, 1994, INT J PRIMATOL, V15, P703, DOI 10.1007/BF02737428; Digby LJ, 2008, 22 C INT PRIM SOC ED; Ellefson J. O., 1974, GIBBON SIAMANG, V3, P1; Ellefson JO, 1968, PRIMATES STUDIES ADA, P180; Erb WM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25847-1; Fan PF, 2008, AM J PRIMATOL, V70, P871, DOI 10.1002/ajp.20577; Fan PF, 2008, AM J PRIMATOL, V70, P153, DOI 10.1002/ajp.20470; Fan PF, 2010, INT J PRIMATOL, V31, P1, DOI 10.1007/s10764-009-9375-9; Fei HL, 2012, AM J PRIMATOL, V74, P998, DOI 10.1002/ajp.22049; FISCHER JO, 1990, PRIMATES, V31, P481, DOI 10.1007/BF02382532; Geissmann T, 2006, AM J PRIMATOL, V68, P1, DOI 10.1002/ajp.20203; Gittins S.P., 1984, P420; Gittins S.P., 1980, International Journal of Primatology, V1, P381, DOI 10.1007/BF02692281; Hamard M, 2010, AM J PRIMATOL, V72, P607, DOI 10.1002/ajp.20815; HAMILTON WJ, 1982, AM J PRIMATOL, V3, P41, DOI 10.1002/ajp.1350030104; Harrison M., 2010, BIODIVERSITY MUNGKU; Harrison M.E., 2012, PRELIMINARY ASSESSME; Harrison ME, 2016, BIOTROPICA, V48, P188, DOI 10.1111/btp.12265; Harrison ME, 2010, INT J PRIMATOL, V31, P585, DOI 10.1007/s10764-010-9415-5; Harrison ME, 2007, INT S WORKSH TROP PE; Hashimoto C, 1998, INT J PRIMATOL, V19, P1045, DOI 10.1023/A:1020378320913; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Hu Yu, 1990, Acta Ecologica Sinica, V10, P155; Inoue Y, 2016, RAFFLES B ZOOL, V64, P127; Jolly A., 1972, EVOLUTION PRIMATE BE; Kim S, 2010, AM J PRIMATOL, V71, P1; Koda H, 2012, PRIMATES, V53, P327, DOI 10.1007/s10329-012-0313-7; Leighton D, 1984, MONOGAMY TERRITORIAL; Lewis MC, 2017, INT J PRIMATOL, V38, P751, DOI 10.1007/s10764-017-9978-5; Limin S., 2004, WISE USE PEATLANDS, V1, P679; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; Lucas PW, 2012, J R SOC INTERFACE, V9, P34, DOI 10.1098/rsif.2011.0188; Ma C, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22695; MacKinnon J.R., 1984, P291; Marshall Andrew J., 2009, P97; Marshall Andrew J., 2009, P161, DOI 10.1007/978-0-387-88604-6_9; Miettinen J, 2017, ENVIRON MANAGE, V60, P747, DOI 10.1007/s00267-017-0911-7; MITANI JC, 1985, BEHAVIOUR, V92, P59, DOI 10.1163/156853985X00389; MITANI JC, 1989, AM J PRIMATOL, V18, P87, DOI 10.1002/ajp.1350180203; MITANI JC, 1979, BEHAV ECOL SOCIOBIOL, V5, P241, DOI 10.1007/BF00293673; O'Hagan R, 2019, J ACOUST ACOUST; Olupot W, 2000, CONSERV BIOL, V14, P833, DOI 10.1046/j.1523-1739.2000.98585.x; Overdorff DJ, 1996, AM J PHYS ANTHROPOL, V100, P487; Page SE, 1999, PHILOS T R SOC B, V354, P1885, DOI 10.1098/rstb.1999.0529; Page SE, 2002, BIODIVERSITY PEAT SW; PALOMBIT RA, 1993, AM J PRIMATOL, V31, P311, DOI 10.1002/ajp.1350310407; R Core Team, 2021, R LANGUAGE ENV STAT; Rodman P. S., 1977, P383; Savini T, 2008, AM J PHYS ANTHROPOL, V135, P1, DOI 10.1002/ajpa.20578; SEKULIC R, 1982, FOLIA PRIMATOL, V39, P22, DOI 10.1159/000156067; Shepherd P.A., 1997, BIODIVESITY SUSTAINA, P191; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Singh M, 2018, ECOL INDIC, V87, P167, DOI 10.1016/j.ecolind.2017.12.041; Singleton I, 2001, INT J PRIMATOL, V22, P877, DOI 10.1023/A:1012033919441; Smith DAE, 2013, INT J PRIMATOL, V34, P957, DOI 10.1007/s10764-013-9715-7; Smith DAE, 2013, AM J PRIMATOL, V75, P848, DOI 10.1002/ajp.22148; Smith Jaima Hillary, 2018, Folia Primatologica, V88, P507; Svensson MS, 2018, AM J PHYS ANTHROPOL, V166, P563, DOI 10.1002/ajpa.23450; TENAZA RR, 1975, FOLIA PRIMATOL, V24, P60, DOI 10.1159/000155685; Terborgh J, 1983, 5 NEW WORLD PRIMATES; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Vasudev D, 2015, BIOL CONSERV, V181, P124, DOI 10.1016/j.biocon.2014.11.021; Vogel ER, 2009, AM J PHYS ANTHROPOL, V140, P716, DOI 10.1002/ajpa.21119; WHITTEN AJ, 1982, ANIM BEHAV, V30, P182, DOI 10.1016/S0003-3472(82)80253-4; Wich SA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500789; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wrangham R, 2007, BEHAVIOUR, V144, P1599, DOI 10.1163/156853907782512092; WRANGHAM RW, 1993, BEHAV ECOL SOCIOBIOL, V32, P199	94	9	9	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0217784	10.1371/journal.pone.0217784	http://dx.doi.org/10.1371/journal.pone.0217784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365525	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600003
J	Chen, YF; Watson, TR; Criss, SD; Eckel, A; Palazzo, L; Sheehan, DF; Kong, CY				Chen, Yufan; Watson, Tina R.; Criss, Steven D.; Eckel, Andrew; Palazzo, Lauren; Sheehan, Deirdre F.; Kong, Chung Yin			A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea	PLOS ONE			English	Article							SMOKING PREVALENCE; UNITED-STATES; MORTALITY; TRENDS; CT; OUTCOMES; PROGRAM; MODELS; IMPACT; NLST	More than 50% of the world's lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U. S. National Lung Screening Trial has shown that lung cancer screening with computed tomography ( CT) can reduce lung cancer deaths. Using the Lung Cancer Policy Model-Asia ( LCPM-Asia), we estimated the potential mortality reduction achievable through the implementation of CT-based lung cancer screening in China, Japan, Singapore, and South Korea. The LCPM-Asia was calibrated to the smoking prevalence of each of the aforementioned countries based on published national surveys and to lung cancer mortality rates from the World Health Organization. The calibrated LCPM-Asia was then used to simulate lung cancer deaths under screening and no-screening scenarios for the four countries. Using screening eligibility criteria recommended by the U. S. Centers for Medicare & Medicaid Services ( CMS), which are based on age and smoking history, we estimated the lung cancer mortality reduction from screening through year 2040. By 2040, lung cancer screening would result in 91,362 life-years gained and 4.74% mortality reduction in South Korea; 290,325 life-years gained and 4.33% mortality reduction in Japan; 3,014,215 life-years gained and 4.22% mortality reduction in China; and 8,118 life-years gained and 3.76% mortality reduction in Singapore. As for mortality reduction by smoker type, current smokers would have the greatest mortality reduction in each country, ranging from 5.56% in Japan to 6.86% in Singapore. Among the four countries, lung cancer screening under CMS eligibility criteria was most effective in South Korea and least effective in Singapore. Singapore's low smoking prevalence and South Korea's aging population and higher smoking prevalence may partially explain the discrepancy in effectiveness. CT screening was shown to be promising as a means of reducing lung cancer mortality in the four countries.	[Chen, Yufan; Watson, Tina R.; Criss, Steven D.; Eckel, Andrew; Palazzo, Lauren; Sheehan, Deirdre F.; Kong, Chung Yin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Kong, Chung Yin] Harvard Med Sch, Boston, MA 02115 USA; [Sheehan, Deirdre F.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kong, CY (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Kong, CY (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	joey@mgh-ita.org		Eckel, Andrew/0000-0002-5263-756X; Kong, Chung Yin/0000-0001-6431-7830; Criss, Steven/0000-0002-9394-1381	National Institutes of Health [U01CA199284]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work received funding from National Institutes of Health, Grant number: U01CA199284 (https://www.nih.gov/) to CYK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Assunta M, 2004, TOB CONTROL, V13, P51, DOI 10.1136/tc.2004.008359; Au JSK, 2004, LUNG CANCER, V45, P143, DOI 10.1016/j.lungcan.2004.01.012; Caverly TJ, 2018, ANN INTERN MED, V169, P1, DOI [10.7326/M17-2561, 10.7326/m17-2561]; Centers for Medicare & Medicaid Services (CMS), 2015, DEC MEM SCREEN LUNG; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Criss SD, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002506; De Koning H, 2018, J THORAC ONCOL, V13, pS185, DOI 10.1016/j.jtho.2018.08.012; Drope J., 2018, TOBACCO ATLAS; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Funatogawa I, 2013, B WORLD HEALTH ORGAN, V91, P332, DOI 10.2471/BLT.12.108092; Gianna Gayle Herrera Amul TP, 2017, PROGR TOBACCO CONTRO; Greenhalgh EM., 2018, TOBACCO AUSTR FACTS; Han SS, 2017, CANCER CAUSE CONTROL, V28, P947, DOI 10.1007/s10552-017-0907-x; International Agency for Research on Cancer, LUNG CANC EST INC MO; International Early Lung Cancer Action Program, 2013, WHO IS EL LUNG CANC; Jang SH, 2015, J KOREAN MED ASSOC, V58, P291, DOI 10.5124/jkma.2015.58.4.291; Japan Tobacco Inc, JTS ANN JAP SMOK RAT; Jeon J, 2018, ANN INTERN MED, V169, P684, DOI [10.7326/M18-1250, 10.7326/m18-1250]; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; Korea Centers for Disease Control & Prevention, 2018, KOR NAT HLTH NUTR EX; Lam WK, 2004, INT J TUBERC LUNG D, V8, P1045; Lee HP, 2010, SINGAP MED J, V51, P170; Lee JW, 2018, KOREAN J RADIOL, V19, P803, DOI 10.3348/kjr.2018.19.4.803; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Meza R, 2014, CANCER-AM CANCER SOC, V120, P1713, DOI 10.1002/cncr.28623; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nawa T, 2002, CHEST, V122, P15, DOI 10.1378/chest.122.1.15; Nawa T, 2019, JPN J CLIN ONCOL, V49, P130, DOI 10.1093/jjco/hyy185; OKAMOTO Y, 1992, BRIT MED J, V305, P403, DOI 10.1136/bmj.305.6850.403; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Orcutt GH., 1957, REV ECON STAT, V39, P116, DOI 10.2307/1928528; Pinsky PF, 2018, TRANSL LUNG CANCER R, V7, P234, DOI 10.21037/tlcr.2018.05.12; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Rogers T, 2010, TOB CONTROL, V19, pI1, DOI 10.1136/tc.2010.036293; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Sagawa M, 2003, LUNG CANCER-J IASLC, V41, P29, DOI 10.1016/S0169-5002(03)00197-1; Sheehan DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173119; Shin DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192626; Singapore Department of Statistics, 2017, POP TRENDS 2017; Suh M, 2013, CANCER RES TREAT, V45, P86, DOI 10.4143/crt.2013.45.2.86; Tabuchi T, 2016, J EPIDEMIOL, V26, P14, DOI 10.2188/jea.JE20140183; ten Haaf K, 2015, CANCER EPIDEM BIOMAR, V24, P154, DOI 10.1158/1055-9965.EPI-14-0745; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Tramontano AC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010227; UNDP, 2018, HUMAN DEV INDICES IN; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Wang TW, 2018, MMWR-MORBID MORTAL W, V67, P1225, DOI 10.15585/mmwr.mm6744a2; World Health Organization, 2018, GLOBOCAN 2018; Yang GH, 2015, LANCET, V385, P1019, DOI 10.1016/S0140-6736(15)60174-X; Zhao SJ, 2015, THORAC CANCER, V6, P385, DOI 10.1111/1759-7714.12253; Zhao Y, 2006, SCI TOTAL ENVIRON, V366, P500, DOI 10.1016/j.scitotenv.2005.10.010; Zhou QH, 2015, THORAC CANCER, V6, P812, DOI 10.1111/1759-7714.12287; Zhou QH, 2014, THORAC CANCER, V5, P197, DOI 10.1111/1759-7714.12078	55	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220610	10.1371/journal.pone.0220610	http://dx.doi.org/10.1371/journal.pone.0220610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361789	Green Submitted, gold, Green Published			2022-12-26	WOS:000484981300044
J	Peharda, M; Vilibic, I; Black, B; Uvanovic, H; Markulin, K; Mihanovic, H				Peharda, Melita; Vilibic, Ivica; Black, Bryan; Uvanovic, Hana; Markulin, Kresimir; Mihanovic, Hrvoje			A network of bivalve chronologies from semi-enclosed seas	PLOS ONE			English	Article							ARCTICA-ISLANDICA BIVALVIA; ATLANTIC MARINE CLIMATE; SHELL GROWTH; SCLEROCHRONOLOGICAL ARCHIVE; ADRIATIC SEA; FRESH-WATER; TEMPERATURE; VARIABILITY; CIRCULATION; L.	Four chronologies of the bivalve species Glycymeris pilosa have been constructed along a 300 km gradient of the eastern coastal Adriatic Sea, all of which span the common period of 1982-2015. The chronologies are compared to local and remote environmental drivers suspected to influence the biology of the system, including air and seawater temperature, precipitation and freshwater discharge. The Adriatic-Ionian Bimodal Oscillating System (BiOS), a key oceanographic feature quantified by satellite-derived absolute dynamic topography, is also compared to the chronologies. The chronologies at the two southern sites are more strongly influenced by local river discharge, while the two northern chronologies are more strongly influenced by BiOS. These results highlight the broadscale importance of BiOS to the Adriatic system as well as the heterogeneity of nearshore environmental and drivers of growth. These G. pilosa chronologies provide unique multidecadal, continuous, biological time series to better understand the ecology and fine-scale variability of the Adriatic with potential for other shallow, semi-enclosed seas.	[Peharda, Melita; Vilibic, Ivica; Uvanovic, Hana; Markulin, Kresimir; Mihanovic, Hrvoje] Inst Oceanog & Fisheries, Split, Croatia; [Black, Bryan] Univ Arizona, Lab Tree Ring Res, Tucson, AZ USA	Croatian Institute of Oceanography & Fisheries (IZOR); University of Arizona	Peharda, M (corresponding author), Inst Oceanog & Fisheries, Split, Croatia.	melita@izor.hr	Peharda, Melita/G-9426-2017; Uvanović, Hana/GOG-8265-2022; Markulin, Krešimir/AAR-7530-2020; Vilibic, Ivica/AAE-5160-2019	Peharda, Melita/0000-0002-9486-9633; Uvanovic, Hana/0000-0003-1752-1673; Markulin, Kresimir/0000-0002-1503-8496	Croatian Science Foundation [IP-2014-09-5747]	Croatian Science Foundation	Research has been financed by the Croatian Science Foundation (www.hrzz.hr) under the project SCOOL (IP-2014-09-5747 to MPU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose WG, 2006, GLOBAL CHANGE BIOL, V12, P1595, DOI 10.1111/j.1365-2486.2006.01181.x; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1492, DOI 10.1175/1520-0485(1997)027<1492:TASGCP>2.0.CO;2; Ballesta-Artero I, 2018, MAR ENVIRON RES, V133, P67, DOI 10.1016/j.marenvres.2017.12.004; Batistic M, 2014, CLIM RES, V61, P231, DOI 10.3354/cr01248; Black BA, 2016, GLOBAL CHANGE BIOL, V22, P2582, DOI 10.1111/gcb.13256; Black BA, 2014, SCIENCE, V345, P1498, DOI 10.1126/science.1253209; Black BA, 2009, PALAEOGEOGR PALAEOCL, V278, P40, DOI 10.1016/j.palaeo.2009.04.010; Black BA, 2008, CAN J FISH AQUAT SCI, V65, P2572, DOI 10.1139/F08-158; Bonitz FGW, 2018, J MARINE SYST, V179, P72, DOI 10.1016/j.jmarsys.2017.11.005; Briffa KR, 2004, GLOBAL PLANET CHANGE, V40, P11, DOI 10.1016/S0921-8181(03)00095-X; Brocas WM, 2013, PALAEOGEOGR PALAEOCL, V373, P133, DOI 10.1016/j.palaeo.2012.03.030; Buselic I, 2015, J SEA RES, V95, P139, DOI 10.1016/j.seares.2014.07.011; Butler PG, 2017, PALAEOGEOGR PALAEOCL, V465, P295, DOI 10.1016/j.palaeo.2016.11.013; Butler PG, 2013, PALAEOGEOGR PALAEOCL, V373, P141, DOI 10.1016/j.palaeo.2012.01.016; Butler PG, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001715; Butler PG, 2009, EARTH PLANET SC LETT, V279, P230, DOI 10.1016/j.epsl.2008.12.043; Calic M, 2013, ENVIRON MONIT ASSESS, V185, P7543, DOI 10.1007/s10661-013-3118-2; Civitarese G, 2010, BIOGEOSCIENCES, V7, P3987, DOI 10.5194/bg-7-3987-2010; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; Cook ER, 1996, INT TREE RING DATA B; Dautovic J, 2017, SCI TOTAL ENVIRON, V587, P185, DOI 10.1016/j.scitotenv.2017.02.111; DOUGLASS A. E., 1941, JOUR FOREST, V39, P825; Eldevik T, 2014, QUATERNARY SCI REV, V106, P225, DOI 10.1016/j.quascirev.2014.06.028; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Featherstone AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189782; Franco P., 1992, SCI TOTAL ENVIRON S, P35; Fritts H. C., 1976, TREE RINGS CLIMATE; Gacic M, 2014, OCEAN SCI, V10, P513, DOI 10.5194/os-10-513-2014; Gacic M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043216; Gillanders BM, 2002, OCEANOGR MAR BIOL, V40, P233; Goodwin DH, 2001, PALAIOS, V16, P387, DOI 10.2307/3515578; Grbec B., 2006, ACTA ADRIAT, V47, P97; Grilli F, 2013, MAR CHEM, V153, P1, DOI 10.1016/j.marchem.2013.04.005; Helama S, 2010, BOREAS, V39, P734, DOI 10.1111/j.1502-3885.2010.00165.x; Helser TE, 2012, ECOL MODEL, V247, P210, DOI 10.1016/j.ecolmodel.2012.08.024; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Judd EJ, 2018, PALAEOGEOGR PALAEOCL, V490, P70, DOI 10.1016/j.palaeo.2017.09.034; Martin PJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004842; Matic F, 2017, CONT SHELF RES, V132, P11, DOI 10.1016/j.csr.2016.11.006; Morrongiello JR, 2012, NAT CLIM CHANGE, V2, P849, DOI [10.1038/NCLIMATE1616, 10.1038/nclimate1616]; Nemeth A, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00076; Orlic M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003271; Peharda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23773-w; Peharda M, 2019, CHEM GEOL, V526, P23, DOI 10.1016/j.chemgeo.2017.09.029; Peharda M, 2016, MAR ENVIRON RES, V119, P79, DOI 10.1016/j.marenvres.2016.05.022; Piermattei A, 2017, GLOBAL PLANET CHANGE, V155, P213, DOI 10.1016/j.gloplacha.2017.07.010; Purroy A, 2018, MAR ENVIRON RES, V134, P138, DOI 10.1016/j.marenvres.2018.01.011; Raicich F, 1996, J MARINE SYST, V9, P305, DOI 10.1016/S0924-7963(96)00042-5; Reynolds DJ, 2018, PALEOCEANOGR PALEOCL, V33, P1086, DOI 10.1029/2018PA003366; Reynolds DJ, 2017, GLOBAL BIOGEOCHEM CY, V31, P1718, DOI 10.1002/2017GB005708; Reynolds DJ, 2017, PALAEOGEOGR PALAEOCL, V465, P333, DOI 10.1016/j.palaeo.2016.08.006; Reynolds DJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13502; Reynolds DJ, 2013, HOLOCENE, V23, P1711, DOI 10.1177/0959683613505335; Schone BR, 2013, GLOBAL PLANET CHANGE, V111, P199, DOI 10.1016/j.gloplacha.2013.09.013; Schone BR, 2005, PALAIOS, V20, P78, DOI 10.2110/palo.2003.p03-101; Scourse J, 2006, HOLOCENE, V16, P967, DOI 10.1177/0959683606hl987rp; Shirai K, 2018, MAR ENVIRON RES, V133, P49, DOI 10.1016/j.marenvres.2017.10.009; Steinhardt J, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00176; Svendsen L, 2014, GEOPHYS RES LETT, V41, P1295, DOI 10.1002/2013GL059076; Tanabe K, 2017, GLOBAL PLANET CHANGE, V157, P35, DOI 10.1016/j.gloplacha.2017.08.010; Vihtakari M, 2016, PALAEOGEOGR PALAEOCL, V446, P263, DOI 10.1016/j.palaeo.2016.01.008; Vilibic I, 2012, BIOGEOSCIENCES, V9, P2085, DOI 10.5194/bg-9-2085-2012; Vilibic I, 2016, OCEAN MODEL, V101, P17, DOI 10.1016/j.ocemod.2016.03.001; Wanamaker AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1901; Wanamaker AD, 2011, PALAEOGEOGR PALAEOCL, V302, P1, DOI 10.1016/j.palaeo.2010.12.024; WEIDMAN CR, 1994, J GEOPHYS RES-OCEANS, V99, P18305, DOI 10.1029/94JC01882; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilson RJS, 2005, INT J CLIMATOL, V25, P611, DOI 10.1002/joc.1150; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Zang C, 2015, ECOGRAPHY, V38, P431, DOI 10.1111/ecog.01335	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220520	10.1371/journal.pone.0220520	http://dx.doi.org/10.1371/journal.pone.0220520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361771	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300038
J	Su, P; Li, G; Wu, C; Vijay-Shanker, K				Su, Peng; Li, Gang; Wu, Cathy; Vijay-Shanker, K.			Using distant supervision to augment manually annotated data for relation extraction	PLOS ONE			English	Article								Significant progress has been made in applying deep learning on natural language processing tasks recently. However, deep learning models typically require a large amount of annotated training data while often only small labeled datasets are available for many natural language processing tasks in biomedical literature. Building large-size datasets for deep learning is expensive since it involves considerable human effort and usually requires domain expertise in specialized fields. In this work, we consider augmenting manually annotated data with large amounts of data using distant supervision. However, data obtained by distant supervision is often noisy, we first apply some heuristics to remove some of the incorrect annotations. Then using methods inspired from transfer learning, we show that the resulting models outperform models trained on the original manually annotated sets.	[Su, Peng; Li, Gang; Wu, Cathy; Vijay-Shanker, K.] Univ Delaware, Dept Comp & Informat Sci, Newark, DE USA; [Wu, Cathy] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE USA	University of Delaware; University of Delaware	Su, P (corresponding author), Univ Delaware, Dept Comp & Informat Sci, Newark, DE USA.	psu@udel.edu	Su, Peng/AAN-1483-2020	Wu, Cathy/0000-0001-6379-8601; Su, Peng/0000-0003-3592-6762	National Institute of General Medical Sciences [U01GM120953]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM120953] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by the grant U01GM120953 for CW and KVS. The funder is National Institute of General Medical Sciences, and its homepage is: https://www.nigms.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Boutet Emmanuel, 2007, V406, P89; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Cejuela JM, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2021-9; Cejuela JM, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau033; Chiu B, 2016, P 15 WORKSH BIOM NAT, P166; Craven M, 1999, Proc Int Conf Intell Syst Mol Biol, P77; Go A., 2009, CS224N PROJECT REPOR, V1; Hoffmann R, 2011, P 49 ANN M ASS COMPU, P541; Hsieh Y-L, 2017, P 8 INT JOINT C NAT, V2, P240; Hua L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8479587; Kim JD, P BIONLP SHAR TASK 2; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Lamurias A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171929; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee JG, 2017, ADV DIFFER EQU-NY, P1, DOI 10.1186/s13662-017-1084-7; Li G, 2017, BIONLP 2017, P184, DOI DOI 10.18653/V1/W17-2323; McClosky D., 2010, ANY DOMAIN PARSING A; Min B., 2013, P 2013 C N AM CHAPT, P777, DOI [DOI 10.1186/S40537-016-0043-6, 10.1609/aaai.v33i01.33016407]; Mintz M., 2009, P JOINT C 47 ANN M A, V2, P1003, DOI DOI 10.3115/1690219.1690287; Nguyen TH, 2015, P 1 WORKSHOP VECTOR, P39, DOI DOI 10.3115/V1/W15-1506; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Peng Y., 2017, BIONLP 2017, P29, DOI [10.18653/v1/W17-2304, DOI 10.18653/V1/W17-2304]; Peng Yifan, 2015, P BIONLP, P21; Roth B., 2013, PROC WORKSHOP AUTOMA, P73; Surdeanu M, 2010, SIMPLE DISTANT SUPER; Surdeanu M, 2012, P 2012 JOINT C EMP M, V2012, P455; Takamatsu Shingo, 2012, LONG PAPERS, V1, P721; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Van Landeghem  S., 2008, P 3 INT S SEM MIN BI, P77; Wei CH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/918710; Weiss Karl, 2016, Journal of Big Data, V3, DOI 10.1186/s40537-016-0043-6; Yang Zhilin, 2017, ICLR; Zeng Daojian, 2015, P 2015 C EMP METH NA, P1753, DOI 10.18653/v1/D15-1203; Zhao ZH, 2016, INT J DATA MIN BIOIN, V15, P145, DOI 10.1504/IJDMB.2016.076534; Zheng W, 2015, J BIOMED INFORM, V57, P134, DOI 10.1016/j.jbi.2015.07.013	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0216913	10.1371/journal.pone.0216913	http://dx.doi.org/10.1371/journal.pone.0216913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361753	gold, Green Published, Green Submitted			2022-12-26	WOS:000484981300007
J	Keshari, S; Sipayung, AD; Hsieh, CC; Su, LJ; Chiang, YR; Chang, HC; Yang, WC; Chuang, TH; Chen, CL; Huang, CM				Keshari, Sunita; Sipayung, Apriska Dewi; Hsieh, Ching-Chuan; Su, Li-Jen; Chiang, Yun-Ru; Chang, Huan-Cheng; Yang, Wu-Chang; Chuang, Tsung-Hsien; Chen, Chien-Lung; Huang, Chun-Ming			IL-6/p-BTK/p-ERK signaling mediates calcium phosphate-induced pruritus	FASEB JOURNAL			English	Article						Bruton's tyrosine kinase; CaP; CKD	BRUTONS TYROSINE KINASE; POSITIVE FEEDBACK LOOP; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; MOUSE MODEL; HEMODIALYSIS-PATIENTS; SCRATCHING BEHAVIOR; BTK FUNCTION; ITCH; INTERLEUKIN-6	Uremic pruritus with elevated levels of calcium phosphate (CaP) in skin is a common symptom in patients with chronic kidney disease (CKD). In this study, we demonstrate that intradermal injection of CaP into mice triggered scratching by up-regulating the IL-6 in skin and phosphorylation of ERKs in dorsal root ganglion (DRG) in a dose-dependent manner. IL-6 is essential because the CaP-induced up-regulation of phosphorylated (p)-ERK in DRG was considerably reduced in the IL-6 knockout mice. Microarray analysis in conjunction with real-time PCR revealed a higher mRNA expression of Bruton's tyrosine kinase (BTK) gene in DRG after CaP injection. The inhibition of BTK by ibrutinib noticeably diminish the CaP-induced up-regulation of IL-6 and p-ERK in mice. A high amount of IL-6 was detected in itchy skin and blood of patients with CKD. The expressions of p-BTK and p-ERK in DRG primary cells reached maximum levels at 1 and 10 min, respectively, after treatment of recombinant IL-6 and were significantly reduced by treatment of IL-6 along with ibrutinib. The mechanism by which the CaP-induced pruritus mediated by the IL-6/p-BTK/p-ERK signaling was revealed.	[Keshari, Sunita; Sipayung, Apriska Dewi; Huang, Chun-Ming] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Su, Li-Jen; Chiang, Yun-Ru; Chen, Chien-Lung; Huang, Chun-Ming] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Hsieh, Ching-Chuan] Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Chiayi, Taiwan; [Chang, Huan-Cheng; Yang, Wu-Chang; Chen, Chien-Lung] Landseed Hosp, Div Nephrol, Taoyuan, Taiwan; [Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Taiwan; [Huang, Chun-Ming] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92103 USA	National Central University; National Central University; Chang Gung Memorial Hospital; National Health Research Institutes - Taiwan; University of California System; University of California San Diego	Huang, CM (corresponding author), Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan.; Chen, CL (corresponding author), Landseed Hosp, Div Nephrol, Taoyuan, Taiwan.	chencl4922@gmail.com; chunming@ncu.edu.tw	Keshari, Sunita/AAK-9842-2021; Chiang, Yun/GRJ-5251-2022; , Chun-Ming/AAM-1856-2020; Chuang, Tsung-Hsien/F-9679-2010; Sipayung, Apriska Dewi/CAJ-3741-2022	, Chun-Ming/0000-0002-3352-5394; 	Landseed Hospital-NCU joint grants [106/107]; National Health Research Institutes (NHRI) [NHRIEX106-10607SI]; Ministry of Science and Technology (MOST) [107-2314-B-008 -001, 107-2622-B-008-002-CC1, 106/107-2622-B-008-001-CC1]	Landseed Hospital-NCU joint grants; National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	The authors thank Wei-Hsin Sun [National Central University (NCU)], and postdoctoral scholar, Wei-Shin Chen (Academic Sinica, Taipei, Taiwan) for teaching isolation of DRG from mice and DRG primary cell culture. This work was supported by 106/107-Landseed Hospital-NCU joint grants, National Health Research Institutes (NHRI) Grant NHRIEX106-10607SI, and Ministry of Science and Technology (MOST) Grants 107-2314-B-008 -001, 107-2622-B-008-002-CC1, and 106/107-2622-B-008-001-CC1. The authors declare no conflicts of interest.	Akiyama T, 2015, ACTA DERM-VENEREOL, V95, P147, DOI 10.2340/00015555-1879; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Block G, 2003, SEMIN DIALYSIS, V16, P140, DOI 10.1046/j.1525-139X.2003.160301.x; Brancaccio D, 2002, NEPHROL DIAL TRANSPL, V17, P201, DOI 10.1093/ndt/17.2.201; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chalmers SA, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-017-1500-0; Chalmers SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26164; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; Che Q, 2014, INT J CANCER, V135, P282, DOI 10.1002/ijc.28679; Chen Y, 2009, OSTEOARTHR CARTILAGE, V17, P244, DOI 10.1016/j.joca.2008.06.015; Cordova KB, 2009, SEMIN DIALYSIS, V22, P45, DOI 10.1111/j.1525-139X.2008.00534.x; CUI SL, 1993, LAB ANIM, V27, P116, DOI 10.1258/002367793780810397; Eddington H, 2009, CLIN KIDNEY J, V2, P267, DOI 10.1093/ndtplus/sfp044; Hoenich NA, 2007, BLOOD PURIFICAT, V25, P62, DOI 10.1159/000096400; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Kimura K, 1999, KIDNEY INT, V56, pS238, DOI 10.1046/j.1523-1755.1999.07163.x; Konda D, 2015, ASIAN J PSYCHIATR, V17, P24, DOI 10.1016/j.ajp.2015.07.010; Kong W, 2018, CLIN RHEUMATOL, V37, P43, DOI 10.1007/s10067-017-3717-3; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Li SR, 2017, SCI CHINA LIFE SCI, V60, P617, DOI 10.1007/s11427-016-9058-6; Linnskog R, 2016, ONCOTARGET, V7, P37790, DOI 10.18632/oncotarget.9332; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1072; Lopez-Herrera G, 2014, J LEUKOCYTE BIOL, V95, P243, DOI 10.1189/jlb.0513307; Ma TKW, 2017, NEPHROL DIAL TRANSPL, V32, P129, DOI 10.1093/ndt/gfw336; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33; Momose A, 2004, NEPHROL DIAL TRANSPL, V19, P2061, DOI 10.1093/ndt/gfh287; Morton CA, 1996, NEPHROL DIAL TRANSPL, V11, P2031, DOI 10.1093/oxfordjournals.ndt.a027092; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Oliveira FA, 2004, PHARMACOL BIOCHEM BE, V78, P719, DOI 10.1016/j.pbb.2004.05.013; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Pecoits R, 2003, NEPHROL DIAL TRANSPL, V18, P1042, DOI 10.1093/ndt/gfg111; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684; Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461; Ren L, 2016, J BIOL CHEM, V291, P3043, DOI 10.1074/jbc.M115.687251; SMITH CIE, 1994, J IMMUNOL, V152, P557; Sun J, 2016, CLIN J AM SOC NEPHRO, V11, P1163, DOI 10.2215/CJN.10441015; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; TakahashiTezuka M, 1997, ONCOGENE, V14, P2273, DOI 10.1038/sj.onc.1201071; Thomsen JS, 2001, ACTA DERM-VENEREOL, V81, P250, DOI 10.1080/00015550152572868; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Yamaura K, 2011, J TOXICOL SCI, V36, P669; Yosipovitch G, 2003, LANCET, V361, P690, DOI 10.1016/S0140-6736(03)12570-6; Zakrzewska-Pniewska B, 2001, NEUROPHYSIOL CLIN, V31, P181, DOI 10.1016/S0987-7053(01)00257-X; Zhang L, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-25; Zhang WR, 2012, HYPERTENSION, V59, P136, DOI 10.1161/HYPERTENSIONAHA.111.173328	59	10	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12036	12046		10.1096/fj.201900016RR	http://dx.doi.org/10.1096/fj.201900016RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365830	Green Published			2022-12-26	WOS:000507461600034
J	Liu, LR; Zou, JN; Guan, YJ; Zhang, YH; Zhang, W; Zhou, XX; Xiong, CX; Tolbert, E; Zhao, TC; Bayliss, G; Zhuang, SG				Liu, Lirong; Zou, Jianan; Guan, Yingjie; Zhang, Yunhe; Zhang, Wei; Zhou, Xiaoxu; Xiong, Chongxiang; Tolbert, Evelyn; Zhao, Ting C.; Bayliss, George; Zhuang, Shougang			Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						transforming growth factor; Snail; Notch1; Smad3; ERSD	CELL-CYCLE ARREST; INTERSTITIAL FIBROSIS; THERAPEUTIC TARGET; TGF-BETA; EPIGENETIC REGULATION; PTEN EXPRESSION; EMERGING ROLES; KLOTHO; METHYLATION; GROWTH	Disruptor of telomeric silencing-1 like (DOT1L) protein specifically catalyzes the methylation of histone H3 on Lys79 (H3K79) and is implicated in tumors. But its role in tissue fibrosis remains unclear. Here we demonstrated that injury to the kidney increased DOT1L expression and H3K79 dimethylation in renal tubular epithelial cells and myofibroblasts in a murine model of unilateral ureteral obstruction. Administration of EPZ5676, a highly selective inhibitor of DOT1L, attenuated renal fibrosis. Treatment with EPZ5676 or DOT1L small interfering RNA also inhibited TGF-beta 1 and serum-induced activation of renal interstitial fibroblasts and epithelial-mesenchymal transition (EMT) in vitro. Moreover, blocking DOT1L abrogated injury-induced epithelial G(2)/M arrest; reduced expression of Snail, Twist, and Notch1; and inactivated several profibrotic signaling molecules in the injured kidney, including Smad3, epidermal growth factor receptor, platelet-derived growth factor receptor, signal transducer and activator of transcription 3, protein kinase B, and NF-kappa B. Conversely, DOT1L inhibition increased expression of phosphatase and tensin homolog, a protein associated with dephosphorylation of tyrosine kinase receptors, and prevented decline in levels of Klotho and Smad7, 2 renoprotective factors. Thus, our data indicate that targeting DOT1L attenuates renal fibrosis through inhibition of renal fibroblasts and EMT by suppressing activation of multiple profibrotic signaling pathways while retaining expression of renoprotective factors.	[Liu, Lirong; Zou, Jianan; Guan, Yingjie; Zhang, Yunhe; Zhang, Wei; Zhou, Xiaoxu; Xiong, Chongxiang; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Alpert Med Sch, Providence, RI 02903 USA; [Liu, Lirong] Guizhou Med Univ, Affiliated Hosp, Dept Clin Hematol, Guiyang, Peoples R China; [Zhao, Ting C.] Boston Univ, Med Sch, Roger Williams Med Ctr, Dept Surg, Providence, RI USA; [Zhuang, Shougang] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Nephrol, Shanghai 200120, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Guizhou Medical University; Boston University; Roger Williams Medical Center; Tongji University	Zhuang, SG (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Nephrol, Shanghai 200120, Peoples R China.	szhuang@lifespan.org		Zhang, Yunhe/0000-0003-3684-7580	National Nature Science Foundation of China [81670623, 81830021]; Ministry of Science and Technology of China [2018YFA0108802]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [2R01DK08506505A1]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Nature Science Foundation of China (81670623 and 81830021 to S.Z.), the Ministry of Science and Technology of China (2018YFA0108802 to S.Z.), and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grant 2R01DK08506505A1 to S.Z.). The authors declare no conflicts of interest.	Abouantoun TJ, 2011, J NEURO-ONCOL, V101, P215, DOI 10.1007/s11060-010-0259-9; Annala M, 2014, EMBO MOL MED, V6, P1121, DOI 10.15252/emmm.201404210; Azuma M, 2012, FASEB J, V26, P4264, DOI 10.1096/fj.12-211631; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bienaime F, 2016, J AM SOC NEPHROL, V27, P3690, DOI 10.1681/ASN.2015091014; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Cho MH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8821; Doi S, 2017, CONTRIB NEPHROL, V189, P178, DOI 10.1159/000450776; Haddadi N, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0803-3; Hein K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005892; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Hu MC, 2013, CONTRIB NEPHROL, V180, P47, DOI 10.1159/000346778; Hu MC, 2012, NAT REV NEPHROL, V8, P423, DOI 10.1038/nrneph.2012.92; Imamura M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94979; Irifuku T, 2016, KIDNEY INT, V89, P147, DOI 10.1038/ki.2015.291; Ishii Y, 2017, PATHOL INT, V67, P235, DOI 10.1111/pin.12530; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Lee JY, 2016, CELL MOL LIFE SCI, V73, P4643, DOI 10.1007/s00018-016-2313-z; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060972; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu XY, 2014, CELL SIGNAL, V26, P2276, DOI 10.1016/j.cellsig.2014.05.018; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; McLean CM, 2014, LEUKEMIA, V28, P2131, DOI 10.1038/leu.2014.169; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Morera L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0223-4; Neyra JA, 2016, VITAM HORM, V101, P257, DOI 10.1016/bs.vh.2016.02.007; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Rau RE, 2016, BLOOD, V128, P971, DOI 10.1182/blood-2015-11-684225; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Sato Y, 2017, INFLAMM REGEN, V37, DOI 10.1186/s41232-017-0048-3; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Song H, 2011, BIOCHEM BIOPH RES CO, V404, P68, DOI 10.1016/j.bbrc.2010.11.064; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; Tamada S, 2006, J PHARMACOL SCI, V100, P17, DOI 10.1254/jphs.FMJ05003X4; Tang JH, 2013, AM J PATHOL, V183, P160, DOI 10.1016/j.ajpath.2013.04.005; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang X, 2016, CURR OPIN GENET DEV, V36, P68, DOI 10.1016/j.gde.2016.03.015; Wanner N, 2017, CELL TISSUE RES, V369, P75, DOI 10.1007/s00441-017-2588-x; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wood K, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010011; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457; Zhuang SG, 2014, KIDNEY INT SUPPL, V4, P70, DOI 10.1038/kisup.2014.13; Zoccali C, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.52	52	13	13	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11941	11958		10.1096/fj.201801861R	http://dx.doi.org/10.1096/fj.201801861R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373855	Green Published			2022-12-26	WOS:000507461600028
J	Wang, J; Guillaume, J; Janssens, J; Remesh, SG; Ying, G; Bitra, A; Van Calenbergh, S; Zajonc, DM				Wang, Jing; Guillaume, Joren; Janssens, Jonas; Remesh, Soumya G.; Ying, Ge; Bitra, Aruna; Van Calenbergh, Serge; Zajonc, Dirk M.			A molecular switch in mouse CD1d modulates natural killer T cell activation by ?-galactosylsphingamides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolipid; antigen presentation; major histocompatibility complex (MHC); T-cell receptor (TCR); cellular immune response; glycoprotein structure; X-ray crystallography; ?-galactosylceramide (?-GalCer); immune signaling; natural killer T cell activation	NKT CELLS; ANTIGEN PRESENTATION; GLYCOLIPIDS; BINDING; RECOGNITION; LIGAND	Type I natural killer T (NKT) cells are a population of innate like T lymphocytes that rapidly respond to ?-GalCer presented by CD1d via the production of both pro- and anti-inflammatory cytokines. While developing novel ?-GalCer analogs that were meant to be utilized as potential adjuvants because of their production of pro-inflammatory cytokines (Th1 skewers), we generated ?-galactosylsphingamides (?GSA). Surprisingly, ?GSAs are not potent antigens in vivo despite their strong T-cell receptor (TCR)?binding affinities. Here, using surface plasmon resonance (SPR), antigen presentation assays, and X-ray crystallography (yielding crystal structures of 19 different binary (CD1d-glycolipid) or ternary (CD1d-glycolipid-TCR) complexes at resolutions between 1.67 and 2.85 ?), we characterized the biochemical and structural details of ?GSA recognition by murine NKT cells. We identified a molecular switch within murine (m)CD1d that modulates NKT cell activation by ?GSAs. We found that the molecular switch involves a hydrogen bond interaction between Tyr-73 of mCD1d and the amide group oxygen of ?GSAs. We further established that the length of the acyl chain controls the positioning of the amide group with respect to the molecular switch and works synergistically with Tyr-73 to control NKT cell activity. In conclusion, our findings reveal important mechanistic insights into the presentation and recognition of glycolipids with polar moieties in an otherwise apolar milieu. These observations may inform the development ?GSAs as specific NKT cell antagonists to modulate immune responses.	[Wang, Jing; Remesh, Soumya G.; Ying, Ge; Bitra, Aruna; Zajonc, Dirk M.] La Jolla Inst Immunol LJI, Div Immune Regulat, La Jolla, CA 92037 USA; [Guillaume, Joren; Janssens, Jonas; Van Calenbergh, Serge] Univ Ghent, Fac Pharmaceut Sci, Lab Med Chem FFW, B-9000 Ghent, Belgium; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Ghent University; Ghent University	Zajonc, DM (corresponding author), Pfizer, Canc Immunol Discovery, San Diego, CA 92121 USA.	Dirk.Zajonc@pfizer.com		Zajonc, Dirk/0000-0001-7215-1981; Bitra, Aruna/0000-0003-1675-3544	U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; U.S. Dept. of Energy, Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Dept. of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The Stanford Synchrotron Radiation Light Structural Molecular Biology Program is supported by the U.S. Dept. of Energy, Office of Biological and Environmental Research, and by the NIGMS (including P41GM103393), National Institutes of Health.	Aspeslagh S, 2013, J IMMUNOL, V191, P2916, DOI 10.4049/jimmunol.1203134; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Birkholz A, 2015, J BIOL CHEM, V290, P17206, DOI 10.1074/jbc.M115.654814; Brossay L, 1998, J IMMUNOL, V160, P3681; Carreno LJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.14; Coelho-Dos-Reis Jordana Grazziela, 2018, F1000Res, V7, DOI 10.12688/f1000research.13794.1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Girardi E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001189; Godfrey DI, 2011, NAT IMMUNOL, V12, P1135, DOI 10.1038/ni.2162; Guillaume J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04461-7; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, J CLIN IMMUNOL, V25, P522, DOI 10.1007/s10875-005-8064-5; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kishi J, 2019, BIOORG MED CHEM LETT, V29, P970, DOI 10.1016/j.bmcl.2019.02.018; Lawton AP, 2005, J IMMUNOL, V174, P3179, DOI 10.4049/jimmunol.174.6.3179; Li XM, 2017, EXPERT REV VACCINES, V16, P73, DOI 10.1080/14760584.2017.1256208; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Niu YH, 2008, HELV CHIM ACTA, V91, P746, DOI 10.1002/hlca.200890076; Padte NN, 2011, CLIN IMMUNOL, V140, P142, DOI 10.1016/j.clim.2010.11.009; Schiefner A, 2009, J MOL BIOL, V394, P71, DOI 10.1016/j.jmb.2009.08.061; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Silk JD, 2008, J IMMUNOL, V180, P6452, DOI 10.4049/jimmunol.180.10.6452; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224	45	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14345	14356		10.1074/jbc.RA119.009963	http://dx.doi.org/10.1074/jbc.RA119.009963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31391251	Green Published, hybrid			2022-12-26	WOS:000499248200016
J	Wei, JS; Ran, G; Wang, X; Jiang, N; Liang, JQ; Lin, XH; Ling, C; Zhao, B				Wei, Jinsong; Ran, Gai; Wang, Xin; Jiang, Ning; Liang, Jianqing; Lin, Xinhua; Ling, Chen; Zhao, Bing			Gene manipulation in liver ductal organoids by optimized recombinant adeno-associated virus vectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; hepatocyte; differentiation; signaling; gene therapy; adeno-associated virus (AAV) vector; cholangiocyte-to-hepatocyte differentiation; functional screening; gene manipulation; liver ductal organoid	STEM-CELLS; TRANSDUCTION; EXPRESSION; MUTATIONS; PANCREAS; THERAPY; CULTURE; TOPHAT; GROWTH; SAFETY	Understanding the mechanism of how liver ductal cells (cholangiocytes) differentiate into hepatocytes would permit liver-regenerative medicine. Emerging liver ductal organoids provide an ex vivo system to investigate cholangiocyte-to-hepatocyte differentiation. However, as current gene manipulation methods require organoid dissociation into single cells and have only low efficiency, it is difficult to dissect specific gene functions in these organoids. Here we developed the adeno-associated virus (AAV) vector AAV-DJ as a powerful tool to transduce mouse and human liver ductal organoids. Via AAV-DJ-mediated up- or down-regulation of target genes, we successfully manipulated cholangiocyte-to-hepatocyte differentiation. We induced differentiation by overexpressing the hepatocyte-specifying regulator hepatocyte nuclear factor 4 alpha (HNF4 alpha) and blocked differentiation by stimulating Notch signaling or interfering with Smad signaling. Further screening for transcriptional factors critical for cholangiocyte-to-hepatocyte differentiation identified HOP homeobox (HOPX), T-box 15 (TBX15), and transcription factor CP2-like 1 (TFCP2L1) as master regulators. We conclude that this highly efficient and convenient gene manipulation system we developed could facilitate investigation into genes involved in cell lineage transitions and enable application of engineered organoids in regenerative medicine.	[Wei, Jinsong; Ran, Gai; Wang, Xin; Jiang, Ning; Liang, Jianqing; Lin, Xinhua; Ling, Chen; Zhao, Bing] Fudan Univ, Zhongshan Hosp, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Lin, Xinhua] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Dev Biol, Cincinnati, OH 45229 USA; [Ling, Chen] Univ Florida, Coll Med, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32610 USA	Fudan University; Cincinnati Children's Hospital Medical Center; State University System of Florida; University of Florida	Lin, XH; Ling, C; Zhao, B (corresponding author), Fudan Univ, Zhongshan Hosp, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.; Lin, XH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Dev Biol, Cincinnati, OH 45229 USA.; Ling, C (corresponding author), Univ Florida, Coll Med, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32610 USA.	xlin@fudan.edu.cn; lingchenchina@fudan.edu.cn; bingzhao@fudan.edu.cn		Wei, Jinsong/0000-0003-2343-9705; Zhao, Bing/0000-0001-9891-3569	National Key Research and Development Program of China [2018YFA0109400]; National Natural Science Foundation of China [31771614]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China Grant 2018YFA0109400 and the National Natural Science Foundation of China Grant 31771614. The authors declare that they have no conflicts of interest with the contents of this article.	Agbandje-McKenna M, 2011, METHODS MOL BIOL, V807, P47, DOI 10.1007/978-1-61779-370-7_3; Allende ML, 2018, J LIPID RES, V59, P550, DOI 10.1194/jlr.M081323; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Broutier L, 2017, NAT MED, V23, P1424, DOI 10.1038/nm.4438; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; Choi TY, 2017, HEPATOLOGY, V66, P1616, DOI 10.1002/hep.29309; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022; Friedman CE, 2018, CELL STEM CELL, V23, P586, DOI 10.1016/j.stem.2018.09.009; Fujii M, 2015, NAT PROTOC, V10, P1474, DOI 10.1038/nprot.2015.088; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Itoh T, 2016, HEPATOLOGY, V64, P663, DOI 10.1002/hep.28661; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Lee KY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9054; Ling C, 2010, HUM GENE THER, V21, P1741, DOI 10.1089/hum.2010.075; Liu Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0036-z; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Michalopoulos GK, 2018, CELL STEM CELL, V23, P11, DOI 10.1016/j.stem.2018.06.006; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nuciforo S, 2018, CELL REP, V24, P1363, DOI 10.1016/j.celrep.2018.07.001; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Schwank G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076871; Sen D, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0103-1; Sun HW, 2018, J CELL PHYSIOL, V233, P6944, DOI 10.1002/jcp.26483; Thorne CA, 2018, DEV CELL, V44, P624, DOI 10.1016/j.devcel.2018.01.024; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang XH, 2019, J BIOL CHEM, V294, P6007, DOI 10.1074/jbc.RA118.006341; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Zhong L, 2008, VIROLOGY, V381, P194, DOI 10.1016/j.virol.2008.08.027; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zhong L, 2007, MOL THER, V15, P1323, DOI 10.1038/sj.mt.6300170	41	13	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14096	14104		10.1074/jbc.RA119.008616	http://dx.doi.org/10.1074/jbc.RA119.008616			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366731	Green Published, hybrid			2022-12-26	WOS:000490729800022
J	Hsueh, YS; Chang, HH; Shan, YS; Sun, HS; Fletcher, JA; Li, CF; Chen, LT				Hsueh, Yuan-Shuo; Chang, Hui Hua; Shan, Yan-Shen; Sun, H. Sunny; Fletcher, Jonathan Alfred; Li, Chien-Feng; Chen, Li-Tzong			Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors	ONCOGENE			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; MOLECULAR-BASIS; CELLS; PROLIFERATION; DEGRADATION; EXPRESSION; RECEPTOR; GROWTH; MECHANISMS	Gastrointestinal stromal tumors (GISTs) are frequently driven by auto-activated, mutant KIT and have durable response to KIT tyrosine kinase inhibitor. However, acquired resistance is an increasing clinical issue in GIST patients receiving frontline imatinib therapy. Our previous studies showed the colocalization of KIT with DAPI-stained nuclei in GIST cells without knowing the role of nuclear KIT in GIST tumorigenesis. In this article, we first identified the binding of nuclear KIT to the promoter of NFKB inhibitor beta (NFKBIB) by chromatin immunoprecipitation (ChIP) sequencing and ChIP assays, which was accompanied with enhanced NFKBIB protein expression in GIST cells. Clinically, high NCCN risk GISTs had significantly higher mean expression levels of nuclear phospho-KIT and NFKBIB as compared with those of intermediate or low/very low-risk GISTs. Conversely, downregulation of NFKBIB by siRNA led to RELA nuclear translocation that could bind to the KIT promoter region and subsequently reduced KIT transcription/expression and the viability of GIST cells. These findings were further confirmed by either RELA overexpression or NFKB/RELA inducer, valproic acid, treatment to result in reduced KIT expression and relative cell viability of imatinib-resistant GIST cells. Combining valproic acid with imatinib showed significantly better growth inhibitory effects on imatinib-resistant GIST48 and GIST430 cells in vitro, and in the GIST430 animal xenograft model. Taken together, these results demonstrate the existence of a nuclear KIT-driven NFKBIB-RELA-KIT autoregulatory loop in GIST tumorigenesis, which are potential targets for developing combination therapy to overcome imatinib-resistant of KIT-expressing GISTs.	[Hsueh, Yuan-Shuo; Li, Chien-Feng; Chen, Li-Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hsueh, Yuan-Shuo] Natl Cheng Kung Univ, Int Ctr Wound Repair & Regenerat, Tainan, Taiwan; [Chang, Hui Hua; Chen, Li-Tzong] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan; [Chang, Hui Hua] Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan; [Chang, Hui Hua] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Pharm, Tainan, Taiwan; [Chang, Hui Hua] Natl Cheng Kung Univ Hosp, Dept Pharm, Dou Liou Branch, Touliu, Yunlin, Taiwan; [Shan, Yan-Shen] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan; [Shan, Yan-Shen] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan, Taiwan; [Sun, H. Sunny] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan; [Sun, H. Sunny] Natl Cheng Kung Univ, Bioinformat Ctr, Tainan, Taiwan; [Fletcher, Jonathan Alfred] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Fletcher, Jonathan Alfred] Harvard Med Sch, Boston, MA 02115 USA; [Li, Chien-Feng] Chi Mei Fdn Med Ctr, Dept Pathol, Tainan, Taiwan; [Li, Chien-Feng] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Chen, Li-Tzong] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Li, CF; Chen, LT (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.; Chen, LT (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan.; Li, CF (corresponding author), Chi Mei Fdn Med Ctr, Dept Pathol, Tainan, Taiwan.; Li, CF (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.; Chen, LT (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan.; Chen, LT (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	angelo.p@yahoo.com.tw; leochen@nhri.org.tw		Li, Chien-Feng/0000-0002-9527-7576; Sun, Sunny/0000-0002-3661-4448; Hsueh, Yuan-Shuo/0000-0002-2584-9380	NHRI [05A1-CAPP19-014, 06A1-CAPP19-014]; Ministry of Science and Technology in Executive Yuan, Taiwan [MOST 104-2321-B-400-019-MY3]	NHRI(National Health Research Institutes - Taiwan); Ministry of Science and Technology in Executive Yuan, Taiwan	We appreciate the funding support provided by NHRI (05A1-CAPP19-014, 06A1-CAPP19-014) and the Ministry of Science and Technology (MOST 104-2321-B-400-019-MY3) in Executive Yuan, Taiwan.	Pavon MA, 2016, HEAD NECK-J SCI SPEC, V38, pE1392, DOI 10.1002/hed.24232; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Chen F, 2006, J BIOL CHEM, V281, P37142, DOI 10.1074/jbc.M603631200; Chen PS, 2017, PHARMACOGENOMICS J, V17, P155, DOI 10.1038/tpj.2015.96; Chen YW, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00219; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Dong Y, 2015, CANCER LETT, V361, P137, DOI 10.1016/j.canlet.2015.02.044; Du YP, 2016, TUMOR BIOL, V37, P1261, DOI 10.1007/s13277-015-3921-1; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Floris G, 2011, MOL CANCER THER, V10, P1897, DOI 10.1158/1535-7163.MCT-11-0148; Foster R, 2004, J MOL GRAPH MODEL, V23, P139, DOI 10.1016/j.jmgm.2004.04.003; Hayashi Y, 2015, GASTROENTEROLOGY, V149, P420, DOI 10.1053/j.gastro.2015.04.006; Hsueh YS, 2014, ONCOTARGET, V5, P11723, DOI 10.18632/oncotarget.2607; Hsueh YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065762; Hsueh YS, 2013, AUTOPHAGY, V9, P220, DOI 10.4161/auto.22802; Isaksson HS, 2014, ONCOTARGET, V5, P4040, DOI 10.18632/oncotarget.1938; Jones J, 2009, J CELL MOL MED, V13, P2342, DOI 10.1111/j.1582-4934.2008.00603.x; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Le Gall M, 2015, MOL CANCER THER, V14, P2595, DOI 10.1158/1535-7163.MCT-15-0321; Lee CC, 2010, ONCOGENE, V29, P3110, DOI 10.1038/onc.2010.55; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Liberati S, 2014, CELLS-BASEL, V3, P660, DOI 10.3390/cells3020660; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Ma LJ, 2014, TUMOR BIOL, V35, P1703, DOI 10.1007/s13277-013-1235-8; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mol CD, 2004, CURR OPIN DRUG DISC, V7, P639; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Nishida T, 2000, HISTOL HISTOPATHOL, V15, P1293, DOI 10.14670/HH-15.1293; Rezaeian AH, 2017, NAT CELL BIOL, V19, P38, DOI 10.1038/ncb3445; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Sarfstein Rive, 2010, Cancers (Basel), V2, P233, DOI 10.3390/cancers2020233; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Sleijfer S, 2007, ONCOLOGIST, V12, P719, DOI 10.1634/theoncologist.12-6-719; Sugito K, 2013, PEDIATR BLOOD CANCER, V60, P383, DOI 10.1002/pbc.24282; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Wang CY, 2016, MOL NEUROBIOL, V53, P6774, DOI 10.1007/s12035-015-9600-9; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251	46	7	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2019	38	38					6550	6565		10.1038/s41388-019-0900-9	http://dx.doi.org/10.1038/s41388-019-0900-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IY7XR	31363162	Green Published, hybrid			2022-12-26	WOS:000486609000006
J	Wang, C; Arrington, J; Ratliff, AC; Chen, JJ; Horton, HE; Nie, YH; Yue, F; Hrycyna, CA; Tao, WA; Kuang, SH				Wang, Chao; Arrington, Justine; Ratliff, Anna C.; Chen, Jingjuan; Horton, Hannah E.; Nie, Yaohui; Yue, Feng; Hrycyna, Christine A.; Tao, W. Andy; Kuang, Shihuan			Methyltransferase-like 21c methylates and stabilizes the heat shock protein Hspa8 in type I myofibers in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; myogenesis; development; autophagy; skeletal muscle; chaperone-mediated autophagy (CMA); methyltransferase-like 21c (Mettl21c); myocyte enhancer factor 2 (Mef2); protein methylation; skeletal muscle; posttranslational modification; heat shock protein family A (Hsp70) member 8 (HSPA8); Hsc70	MEF2 TRANSCRIPTION FACTOR; LYSINE METHYLATION; QUALITY-CONTROL; AUTOPHAGY; DEGRADATION; ACTIVATION; ROLES; DIFFERENTIATION; METTL21C; PATHWAY	Protein methyltransferases mediate posttranslational modifications of both histone and nonhistone proteins. Whereas histone methylation is well-known to regulate gene expression, the biological significance of nonhistone methylation is poorly understood. Methyltransferase-like 21c (Mettl21c) is a newly classified nonhistone lysine methyltransferase whose in vivo function has remained elusive. Using a Mettl21c(LacZ) knockin mouse model, we show here that Mettl21c expression is absent during myogenesis and restricted to mature type I (slow) myofibers in the muscle. Using co-immunoprecipitation, MS, and methylation assays, we demonstrate that Mettl21c trimethylates heat shock protein 8 (Hspa8) at Lys-561 to enhance its stability. As such, Mettl21c knockout reduced Hspa8 trimethylation and protein levels in slow muscles, and Mettl21c overexpression in myoblasts increased Hspa8 trimethylation and protein levels. We further show that Mettl21c-mediated stabilization of Hspa8 enhances its function in chaperone-mediated autophagy, leading to degradation of client proteins such as the transcription factors myocyte enhancer factor 2A (Mef2A) and Mef2D. In contrast, Mettl21c knockout increased Mef2 protein levels in slow muscles. These results identify Hspa8 as a Mettl21c substrate and reveal that nonhistone methylation has a physiological function in protein stabilization.	[Wang, Chao; Chen, Jingjuan; Nie, Yaohui; Yue, Feng; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Arrington, Justine; Ratliff, Anna C.; Hrycyna, Christine A.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Horton, Hannah E.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Hrycyna, Christine A.; Tao, W. Andy; Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wang, C; Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.; Kuang, SH (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	wangc129@gmail.com; skuang@purdue.edu	Wang, Chao/V-8994-2019	Wang, Chao/0000-0002-4051-364X; Arrington, Justine/0000-0003-1511-8805; Kuang, Shihuan/0000-0001-9180-3180	National Institutes of Health [R01AR071649]; National Institute of Food and Agriculture [NC-1184]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health Grant R01AR071649 and the National Institute of Food and Agriculture Grant NC-1184. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Huang J, 2014, J BONE MINER RES, V29, P1531, DOI 10.1002/jbmr.2200; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Page N, 2011, ANN RHEUM DIS, V70, P837, DOI 10.1136/ard.2010.139832; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Tahrir FG, 2017, J CELL PHYSIOL, V232, P797, DOI 10.1002/jcp.25476; Wang C, 2019, FASEB J, V33, P9672, DOI 10.1096/fj.201900582R; Wang C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2279; Wang C, 2017, DEVELOPMENT, V144, P235, DOI 10.1242/dev.138099; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Wiederstein JL, 2018, CELL REP, V23, P1342, DOI 10.1016/j.celrep.2018.03.136; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2002, J CLIN INVEST, V109, P1327, DOI 10.1172/JCI200215417; Wust S, 2018, CELL METAB, V27, P1026, DOI 10.1016/j.cmet.2018.02.022; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhang HQ, 2015, STRUCTURE, V23, P472, DOI 10.1016/j.str.2015.01.003; Zhang L, 2014, AUTOPHAGY, V10, P1015, DOI 10.4161/auto.28477	40	11	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13718	13728		10.1074/jbc.RA119.008430	http://dx.doi.org/10.1074/jbc.RA119.008430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346037	Green Published, hybrid			2022-12-26	WOS:000486418600017
J	Sodergren, A; Karp, K; Bengtsson, C; Moller, B; Rantapaa-Dahlqvist, S; Wallberg-Jonsson, S				Sodergren, Anna; Karp, Kjell; Bengtsson, Christine; Moller, Bozena; Rantapaa-Dahlqvist, Solbritt; Wallberg-Jonsson, Solveig			Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; RISK-FACTORS; ATHEROSCLEROSIS; INFLAMMATION; METAANALYSIS; VALIDATION; MORTALITY; EVENTS; EXTENT	Objectives Patients with rheumatoid arthritis (RA) have an increased mortality and morbidity due to cardiovascular disease (CVD). In this prospective 5-year follow up of patients with RA, we analysed several biomarkers, known to be associated with atherosclerosis and/or inflammation in the general population. The aim of this study was to find out whether the RA-disease per se affect these biomarkers and if those could be associated with the progression of atherosclerosis, as measured by intima media thickness (IMT) among patients with early RA. Methods Patients from northern Sweden diagnosed with early RA, are consecutively recruited into an ongoing prospective study on CVD comorbidity. A subgroup of patients, aged <= 60 years (n = 71) was included for ultrasound measurements of IMT at inclusion (T0) and after 5 years (T5) together with age-sex-matched controls (n = 40). The patients were clinically assessed. Blood was analysed for lipids, ESR and CRP and several biomarkers known to be associated with atherosclerosis in the general population. Results At T0, the patients with RA had significantly lower levels of MIF and significantly higher levels of interleukin (IL)-18 and MIC-1 compared with controls. At T5, the patients with RA had significantly higher levels of pentraxin3, MIC-1, TNF-R2, ICAM-1, VCAM-1 and endostatin compared with controls. At T0 the levels of MPO correlated with DAS28, sCD40L with CRP and IL-18 with systolic blood pressure and Reynolds risk score. Using PLSR on a CVD-panel analysed with multiplex immunoassay, the patients with RA could be correctly classified into those who had a worsening in their IMT over the five years or not. Here, MMP3 was identified as influential. Conclusions This study indicates that the RA disease itself could affect several of the biomarkers in this study, and possibly also the processes involved in the development of atherosclerosis.	[Sodergren, Anna; Bengtsson, Christine; Rantapaa-Dahlqvist, Solbritt; Wallberg-Jonsson, Solveig] Univ Umea, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden; [Sodergren, Anna] Umea Univ, WCMM, Umea, Sweden; [Karp, Kjell] Univ Umea, Dept Surg & Perioperat Sci, Umea, Sweden; [Bengtsson, Christine] Kristianstad Hosp, Dept Rheumatol, Kristianstad, Sweden; [Moller, Bozena] Sunderby Hosp, Dept Rheumatol, Lulea, Sweden	Umea University; Umea University; Umea University; Sunderby Hospital	Sodergren, A (corresponding author), Univ Umea, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden.; Sodergren, A (corresponding author), Umea Univ, WCMM, Umea, Sweden.	anna.sodergren@umu.se			Swedish Research Council [K 2007-52X-20307-01-3]; Swedish Rheumatism Association; Swedish Rheumatism Association in the Vasterbotten County; Visare Norr, Norrlandstingens regionforbund (Northern County Councils); Swedish Heart-Lung Foundation; King Gustaf V's 80-Year Fund, Sweden; Swedish Society for Medical Research (SSMF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Swedish Rheumatism Association in the Vasterbotten County; Visare Norr, Norrlandstingens regionforbund (Northern County Councils); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V's 80-Year Fund, Sweden; Swedish Society for Medical Research (SSMF)	This work was supported by grants from the Swedish Research Council (grant number K 2007-52X-20307-01-3); the Swedish Rheumatism Association; the Swedish Rheumatism Association in the Vasterbotten County; Visare Norr, Norrlandstingens regionforbund (Northern County Councils); the Swedish Heart-Lung Foundation; the King Gustaf V's 80-Year Fund, Sweden; and the Swedish Society for Medical Research (SSMF).	Ambrosino P, 2015, THROMB HAEMOSTASIS, V113, P916, DOI 10.1160/TH14-11-0921; Arlestig L, 2012, J RHEUMATOL, V39, P939, DOI 10.3899/jrheum.111336; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Brown DA, 2007, ARTHRITIS RHEUM, V56, P753, DOI 10.1002/art.22410; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; Dessein PH, 2005, J RHEUMATOL, V32, P435; Evans MR, 2011, ARTHRITIS RHEUM-US, V63, P1211, DOI 10.1002/art.30265; Galil SMA, 2016, INT J RHEUM DIS, V19, P377, DOI 10.1111/1756-185X.12434; Giles JT, 2011, ARTHRITIS RHEUM-US, V63, P3216, DOI 10.1002/art.30542; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Klingenberg R, 2015, EUR HEART J, V36, P3423, DOI 10.1093/eurheartj/ehv489; Kozera L, 2011, RHEUMATOLOGY, V50, P1944, DOI 10.1093/rheumatology/ker232; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mamehara Akira, 2010, Kobe J Med Sci, V56, pE98; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Pamuk GE, 2008, PLATELETS, V19, P146, DOI 10.1080/09537100701210057; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Sellam J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2833; Sodergren A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/673018; Sodergren A, 2015, J RHEUMATOL, V42, P935, DOI 10.3899/jrheum.140694; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Tyrrell PN, 2010, ARTERIOSCL THROM VAS, V30, P1014, DOI 10.1161/ATVBAHA.109.198424; van Sijl AM, 2011, SEMIN ARTHRITIS RHEU, V40, P389, DOI 10.1016/j.semarthrit.2010.06.006; Volin MV, 2011, J INTERF CYTOK RES, V31, P745, DOI 10.1089/jir.2011.0050; Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220531	10.1371/journal.pone.0220531	http://dx.doi.org/10.1371/journal.pone.0220531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381601	Green Submitted, gold, Green Published			2022-12-26	WOS:000484993600022
J	Nadal-Serrano, JM; de la Pedrosa, EGG; Lopez-Vallejo, M; Gonzalez, ADF; Lopez-Barrio, C				Nadal-Serrano, Jose M.; de la Pedrosa, Elia Gomez G.; Lopez-Vallejo, Marisa; Fernandez Gonzalez, Alvaro de Guzman; Lopez-Barrio, Carlos			Simple method to generate calibrated synthetic smoke-like atmospheres at microscopic scale	PLOS ONE			English	Article							FRACTAL AGGREGATE; SOOT; SCATTERING; PARTICLES; VESSEL; MODEL	Artificial smokes focusing on macroscopic or fluid properties of smoke have been available for a long time. This paper presents a simple method to generate fully customizable smoke-like atmospheres at microscopic scale (i.e. considering their constituent particles as discrete elements) using a different approach. Synthetic, reproducible media can be generated combining monodisperse microspheres with known geometrical and optical properties conveniently parameterized. The method is presented as a proof-of-concept, highlighting the design decisions along with their implications. Practical issues such as aerosol nebulization, particle carrier selection or the features of the medium chamber where the smoke-like atmosphere is to be tested are analyzed. A comparison between methanol and ethanol as carriers for polystyrene microsphere nebulization is also made. The method could be the seed for the obtention of standard reference media for calibration or standardized characterization of not only smoke detectors and exhaust smoke sensors but also other instruments relying on optical properties of dispersive media (dust in PV panels, public lighting, etc.).	[Nadal-Serrano, Jose M.; Lopez-Vallejo, Marisa; Fernandez Gonzalez, Alvaro de Guzman; Lopez-Barrio, Carlos] Univ Politecn Madrid, ETSI Telecomunicac, Madrid, Spain; [de la Pedrosa, Elia Gomez G.] Hosp Univ Ramon y Cajal, Madrid, Spain	Universidad Politecnica de Madrid; Hospital Universitario Ramon y Cajal	Nadal-Serrano, JM (corresponding author), Univ Politecn Madrid, ETSI Telecomunicac, Madrid, Spain.	jmnadal@ieee.org	Lopez-Vallejo, Marisa/K-9456-2014; Barrio, Carlos A. López/I-1311-2015	Lopez-Vallejo, Marisa/0000-0002-3833-524X; Barrio, Carlos A. López/0000-0002-2423-5272				BANKSTON CP, 1981, COMBUST FLAME, V41, P273, DOI 10.1016/0010-2180(81)90062-6; Baumgardner D, 2012, ATMOS MEAS TECH, V5, P1869, DOI 10.5194/amt-5-1869-2012; Black JD, 2017, SOOT GENERATING DEVI; Brandrup J., 1975, POLYM HDB, V2nd ed.; Bryan JL, SMOKE DETERMINANT HU; CHRISTOFORIDIS AJ, 1971, CHEST, V59, P629, DOI 10.1378/chest.59.6.629; Davies NW, 2018, ACCURACY AEROSOL PHO; Deng XY, 2004, APPL OPTICS, V43, P2925, DOI 10.1364/AO.43.002925; Di Sarli V, 2014, J LOSS PREVENT PROC, V27, P8, DOI 10.1016/j.jlp.2013.10.015; DOBBINS RA, 1994, ATMOS ENVIRON, V28, P889, DOI 10.1016/1352-2310(94)90247-X; Doner N, 2017, J QUANT SPECTROSC RA, V187, P10, DOI 10.1016/j.jqsrt.2016.09.005; Frank SR, 2004, RESP INFECT TREATMEN; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Hull P, 2004, APPL OPTICS, V43, P3433, DOI 10.1364/AO.43.003433; Ishii K, 1998, APPL OPTICS, V37, P5014, DOI 10.1364/AO.37.005014; Jiang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07114; Kashef A, 2004, 5 INT C TUNN FIR LON, P185; Kobes M, 2010, FIRE SAFETY J, V45, P1, DOI 10.1016/j.firesaf.2009.08.005; Kou L., 1996, BLACK CARBON ATMOSPH; Labs B, 2013, MICR AGGR; Labs B, 2013, DRYING RES MICR; Ma XY, 2003, PHYS MED BIOL, V48, P4165, DOI 10.1088/0031-9155/48/24/013; MERCER TT, 1968, AM IND HYG ASSOC J, V29, P66, DOI 10.1080/00028896809342983; Middleton N, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9061053; Moallemi A, 2019, J AEROSOL SCI, V135, P46, DOI 10.1016/j.jaerosci.2019.05.004; Mulholland GW, 1995, SFPE HDB FIRE PROTEC; Nadal-Serrano JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187219; Nadal-Serrano JM, 2015, FIRE SAFETY J, V71, P299, DOI 10.1016/j.firesaf.2014.11.029; NIST, 2013, SRM 2975 DIES PART M; OCallaghan C, 1997, THORAX, V52, pS31, DOI 10.1136/thx.52.2008.S31; PHIPPS PR, 1990, CHEST, V97, P1327, DOI 10.1378/chest.97.6.1327; Prahl S., 2012, MIE SCATTERING; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Seinfeld J.H., 2016, ENVIRONMENT, DOI [10.1080/00139157.1999.10544295, DOI 10.1080/00139157.1999.10544295]; SPANNER G, 1994, J AEROSOL SCI, V25, P265, DOI 10.1016/0021-8502(94)90078-7; Tan S, 2019, RELIAB ENG SYST SAFE, V188, P233, DOI 10.1016/j.ress.2019.03.012; Tumolva L, 2010, AEROSOL SCI TECH, V44, P202, DOI 10.1080/02786820903518907; Webb AK, 2006, FDS MODELLING HOT SM; Weinert D. W., 2002, FIR SAF SCI P 7 INT, P209; Wu WW, 2017, J LOSS PREVENT PROC, V49, P299, DOI 10.1016/j.jlp.2017.07.012	40	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220700	10.1371/journal.pone.0220700	http://dx.doi.org/10.1371/journal.pone.0220700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374105	gold, Green Published, Green Submitted			2022-12-26	WOS:000484991500027
J	Absi, M; Eid, BG; Ashton, N; Hart, G; Gurney, AM				Absi, Mais; Eid, Basma G.; Ashton, Nick; Hart, George; Gurney, Alison M.			Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE; RHO-KINASES; RAT; INHIBITION; HYPERTENSION; STATINS; CELLS; ECHOCARDIOGRAPHY; SENSITIZATION	Simvastatin reduces pulmonary arterial pressure and right ventricular hypertrophy in animal models of pulmonary arterial hypertension (PAH) and is thought to restore endothelial dysfunction. In vivo effects of drugs are complicated by several factors and little is known of the direct effects of statins on pulmonary arteries. This study investigated the direct effects of simvastatin on pulmonary arteries isolated from rats with or without monocrotaline-induced PAH. Simvastatin suppressed contractions evoked by the thromboxane A2 receptor agonist U46619 (30 nM), the alpha(1)-adrenergic agonist phenylephrine (5 mu M) and KCl (50 mM) by similar to 50% in healthy and diseased arteries, but did not reduce contraction evoked by sarco/endoplasmic reticulum ATPase blockers. It relaxed hypertensive arteries in the absence of stimulation. Removing the endothelium or inhibiting eNOS did not prevent the inhibition by simvastatin. Inhibiting RhoA/rho kinase (ROCK) with Y27632 (10 mu M) suppressed contractions to U46619 and phenylephrine by similar to 80% and prevented their inhibition by simvastatin. Y27632 reduced KCl-induced contraction by similar to 30%, but did not prevent simvastatin inhibition. Simvastatin suppressed Ca2+ entry into smooth muscle cells, as detected by Mn2+ quench of fura-2 fluorescence. The calcium antagonist, nifedipine (1 mu M), almost abolished K+-induced contraction with less effect against U46619 and phenylephrine. We conclude that simvastatin relaxes pulmonary arteries by acting on smooth muscle to interfere with signalling through G-protein coupled receptors and voltage-dependent Ca2+ entry. Its actions likely include inhibition of ROCK-dependent Ca2+ sensitisation and voltage-gated Ca2+ channels. These are likely to contribute to the beneficial effects of simvastatin in animal models of PAH.	[Absi, Mais; Eid, Basma G.; Ashton, Nick; Hart, George; Gurney, Alison M.] Univ Manchester, Fac Biol Med & Hlth, Core Technol Facil Level, Manchester, Lancs, England; [Absi, Mais] Kings Coll London, Cardiovasc Sci, London, England; [Eid, Basma G.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia	University of Manchester; University of London; King's College London; King Abdulaziz University	Gurney, AM (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Core Technol Facil Level, Manchester, Lancs, England.	Alison.gurney@manchester.ac.uk		Ashton, Nicholas/0000-0002-3579-8804; Ashton, Nick/0000-0003-3366-1617	British Heart Foundation [PG/14/22/30714]; European Respiratory Society; King Abdulaziz University; Saudi Ministry of Higher Education	British Heart Foundation(British Heart Foundation); European Respiratory Society; King Abdulaziz University; Saudi Ministry of Higher Education	This work was supported by: British Heart Foundation, PG/14/22/30714 to AG and GH (www.bhf.org.uk); European Respiratory Society travel grant to MA (www.ersnet.org), King Abdulaziz University (www.kau.edu.sa) and Saudi Ministry of Higher Education (www.moe.gov.sa) scholarship to BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Aoki C, 2012, INT J CARDIOL, V156, P55, DOI 10.1016/j.ijcard.2010.10.029; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bergdahl A, 2003, PHARMACOL TOXICOL, V93, P128, DOI 10.1034/j.1600-0773.2003.930304.x; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; CLAPP LH, 1991, EXP PHYSIOL, V76, P677, DOI 10.1113/expphysiol.1991.sp003535; CLAPP LH, 1991, PFLUG ARCH EUR J PHY, V418, P462, DOI 10.1007/BF00497774; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Dhaliwal JS, 2007, AM J PHYSIOL-LUNG C, V293, pL1306, DOI 10.1152/ajplung.00189.2007; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Girgis RE, 2003, AM J PHYSIOL-HEART C, V285, pH938, DOI 10.1152/ajpheart.01097.2002; Ito KM, 2000, AM J PHYSIOL-HEART C, V279, pH1786, DOI 10.1152/ajpheart.2000.279.4.H1786; Jernigan NL, 2014, MICROCIRCULATION, V21, P259, DOI 10.1111/micc.12096; Kang S, 2014, TOXICOL SCI, V138, P446, DOI 10.1093/toxsci/kfu011; Khalil RA, 2010, C SERIES INTEGRATED, DOI [10.4199/c00012ed1v01y201005isp007, DOI 10.4199/C00012ED1V01Y201005ISP007]; Knipe RS, 2015, PHARMACOL REV, V67, P103, DOI 10.1124/pr.114.009381; Koskenvuo JW, 2010, INT J CARDIOVAS IMAG, V26, P509, DOI 10.1007/s10554-010-9596-1; Laufs U, 1997, J BIOL CHEM, V272, P31725, DOI 10.1074/jbc.272.50.31725; Li XL, 2012, J CARDIOVASC PHARM, V60, P219, DOI 10.1097/FJC.0b013e31825cce63; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; Mraiche F, 2005, BRIT J PHARMACOL, V144, P715, DOI 10.1038/sj.bjp.0706114; Muck W, 2000, CLIN PHARMACOKINET, V39, P99; Nagaoka T, 2004, AM J PHYSIOL-LUNG C, V287, pL665, DOI 10.1152/ajplung.00050.2003; Nakagami H, 2003, ANN MED, V35, P398, DOI 10.1080/07853890310001294; Ng LC, 2001, CIRC RES, V89, P923, DOI 10.1161/hh2201.100315; NG LL, 1994, CIRC RES, V74, P173, DOI 10.1161/01.RES.74.2.173; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; OKA M, 1993, AM J PHYSIOL, V264, pL587, DOI 10.1152/ajplung.1993.264.6.L587; Omori H, 2002, BRIT J CLIN PHARMACO, V54, P395, DOI 10.1046/j.1365-2125.2002.01677.x; Robertson TP, 2000, BRIT J PHARMACOL, V131, P5, DOI 10.1038/sj.bjp.0703537; Rossoni LV, 2011, CLIN SCI, V121, P449, DOI 10.1042/CS20110259; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Steeds RP, 1997, BRIT J PHARMACOL, V122, P99, DOI 10.1038/sj.bjp.0701356; Taraseviciene-Stewart L, 2006, AM J PHYSIOL-LUNG C, V291, pL668, DOI 10.1152/ajplung.00491.2005; Temple IP, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003432; Tennakoon M, 2019, MOL PHARMACOL, V95, P361, DOI 10.1124/mol.118.114710; Tesfamariam B, 1999, J CARDIOVASC PHARM, V34, P95, DOI 10.1097/00005344-199907000-00016; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, pL401, DOI 10.1152/ajplung.00114.2010; Vaquero M, 2007, J MOL CELL CARDIOL, V42, P931, DOI 10.1016/j.yjmcc.2007.03.807; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; WANSTALL JC, 1995, BRIT J PHARMACOL, V114, P109, DOI 10.1111/j.1476-5381.1995.tb14913.x; Yada T, 1999, BRIT J PHARMACOL, V126, P1205, DOI 10.1038/sj.bjp.0702397; Yi SL, 2006, FREE RADICAL BIO MED, V41, P942, DOI 10.1016/j.freeradbiomed.2006.05.035; Zhao L, 2009, EUR RESPIR J, V34, P948, DOI 10.1183/09031936.00143508	48	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220473	10.1371/journal.pone.0220473	http://dx.doi.org/10.1371/journal.pone.0220473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369604	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900053
J	Antol, A; Rojek, W; Singh, S; Piekarski, D; Czarnoleski, M				Antol, Andrzej; Rojek, Wiktoria; Singh, Sanjeev; Piekarski, Damian; Czarnoleski, Marcin			Hypoxia causes woodlice (Porcellio scaber) to select lower temperatures and impairs their thermal performance and heat tolerance	PLOS ONE			English	Article							OXYGEN LIMITATION; TERRESTRIAL ISOPODS; CLIMATE-CHANGE; CRUSTACEA; PHYSIOLOGY; ARTHROPOD; LIMITS; METABOLISM; ADAPTATION; LOCOMOTION	Environmental temperatures and oxygen availability are important for the balance between oxygen supply and demand. Terrestrial organisms are generally perceived to be less limited by access to oxygen than their aquatic counterparts. Nevertheless, even terrestrial environments can be deficient in oxygen, especially for organisms occurring in soil, litter, wood, rotten fruit or at high elevations. While isopods are the best adapted to a terrestrial lifestyle among crustaceans, many species, including woodlice, occupy environmental gradients of temperature and oxygen. To investigate whether mismatches between oxygen supply and demand can result in a loss of performance in a terrestrial organism, we studied the effects of atmospheric oxygen concentration on the thermal performance of the common rough woodlouse (Porcellio scaber). We compared the thermal preference, thermal sensitivity of running speed, and tolerance to extreme temperatures of woodlice exposed to one of two oxygen concentrations (21% - normoxia, 7% - hypoxia). Under hypoxia, P. scaber preferred microhabitats with temperatures that were on average 3 degrees C lower than those preferred under normoxia. The running speed tended to reach its maximum at a lower temperature under hypoxia than under normoxia (25.13 degrees C vs 28.87 degrees C, respectively, although p was equal to 0.09), and normoxic woodlice ran approximately 1.5-fold faster than hypoxic woodlice at the point of maximum speed. Heat tolerance was significantly lower under hypoxia (38.9 degrees C) than under normoxia (40.7 degrees C), but there was no difference in cold tolerance (5.81 degrees C under normoxia and 5.44 degrees C under hypoxia). Overall, our results indicate that environmental gradients of temperature and oxygen may shape the physiological performance of terrestrial ectotherms, likely via their effects on the balance between oxygen supply and demand, which may have fitness consequences for these organisms in nature.	[Antol, Andrzej; Rojek, Wiktoria; Singh, Sanjeev; Piekarski, Damian; Czarnoleski, Marcin] Jagiellonian Univ, Inst Environm Sci, Ul Gronostajowa, Krakow, Poland	Jagiellonian University	Antol, A (corresponding author), Jagiellonian Univ, Inst Environm Sci, Ul Gronostajowa, Krakow, Poland.	andrzejantol@gmail.com	Czarnoleski, Marcin/H-2893-2015; Antoł, Andrzej/W-6110-2019	Czarnoleski, Marcin/0000-0003-2645-0360; Antoł, Andrzej/0000-0002-9730-7417; Rojek, Wiktoria/0000-0003-1300-5372	National Science Center in Poland [ETIUDA 2018/28/T/NZ8/00217]; NSC research grant [OPUS 2016/21/B/NZ8/00303]; Jagiellonian University [DS/WBiNoZ/INoS/757/2018, DS/MND/WBiNoZ/INoS/3/2016]	National Science Center in Poland(National Science Centre, Poland); NSC research grant; Jagiellonian University	AA was supported by a doctoral stipend provided by the National Science Center in Poland (ETIUDA 2018/28/T/NZ8/00217). MC and the conceptual part of the study were supported by an NSC research grant (OPUS 2016/21/B/NZ8/00303). Additional funds were provided by Jagiellonian University (DS/WBiNoZ/INoS/757/2018 and DS/MND/WBiNoZ/INoS/3/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Antol A, 2018, J ETHOL, V36, P199, DOI 10.1007/s10164-018-0540-5; Atkinson D, 2006, EVOL DEV, V8, P202, DOI 10.1111/j.1525-142X.2006.00090.x; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Beron P., 2008, HIGH ALTITUDE ISOPOD; Boardman L, 2015, J EXP BIOL, V218, P1677, DOI 10.1242/jeb.120261; Broly P, 2013, EVOL ECOL, V27, P461, DOI 10.1007/s10682-012-9625-8; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Cadena V, 2009, J EXP BIOL, V212, P137, DOI 10.1242/jeb.023531; Carbines GD., 1992, INT J COMP PSYCHOL, V5, P138; Castaneda LE, 2005, J INSECT PHYSIOL, V51, P1346, DOI 10.1016/j.jinsphys.2005.08.005; Castaneda LE, 2004, EVOL ECOL RES, V6, P579; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; Csonka D, 2013, ARTHROPOD STRUCT DEV, V42, P229, DOI 10.1016/j.asd.2013.01.002; Currie RJ, 1998, ENVIRON BIOL FISH, V51, P187, DOI 10.1023/A:1007447417546; Czarnoleski M, 2005, EVOL ECOL RES, V7, P821; Czarnoleski M, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00024.1; Dailey TM, 2009, COMP BIOCHEM PHYS A, V153, P162, DOI 10.1016/j.cbpa.2009.02.005; DuBois PM, 2017, J THERM BIOL, V68, P170, DOI 10.1016/j.jtherbio.2017.02.008; Fox J, 2018, J STAT SOFTW, V87, P1, DOI 10.18637/jss.v087.i09; Gudowska A, 2018, J INSECT PHYSIOL, V107, P7, DOI 10.1016/j.jinsphys.2018.02.004; Gudowska A, 2017, J THERM BIOL, V68, P89, DOI 10.1016/j.jtherbio.2016.11.009; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HICKS JW, 1985, AM J PHYSIOL, V248, pR595, DOI 10.1152/ajpregu.1985.248.5.R595; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hoefnagel KN, 2015, J THERM BIOL, V54, P56, DOI 10.1016/j.jtherbio.2014.12.003; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; Horvathova T, 2017, J EXP BIOL, V220, P1563, DOI 10.1242/jeb.156661; Jumbam KR, 2008, J INSECT PHYSIOL, V54, P1008, DOI 10.1016/j.jinsphys.2008.03.011; Klok CJ, 2004, J EXP BIOL, V207, P2361, DOI 10.1242/jeb.01023; Kozlowski J, 2004, INTEGR COMP BIOL, V44, P480, DOI 10.1093/icb/44.6.480; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; Lighton JRB, 2007, J THERM BIOL, V32, P134, DOI 10.1016/j.jtherbio.2007.01.009; Lins LSF, 2017, ORG DIVERS EVOL, V17, P813, DOI 10.1007/s13127-017-0346-2; Neven LG, 2014, J THERM BIOL, V42, P9, DOI 10.1016/j.jtherbio.2014.02.017; PAIM U, 1964, CAN J ZOOLOG, V42, P59, DOI 10.1139/z64-006; Peacock AJ, 1998, BRIT MED J, V317, P1063; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; POLLARD SD, 1995, ETHOL ECOL EVOL, V7, P271, DOI 10.1080/08927014.1995.9522957; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; R Core Team, 2018, R LANG ENV STAT COMP; Schmalfuss H., 2003, STUTTGARTER BEITR A, V654, P341; Schmidt C, 2001, ACTA ZOOL-STOCKHOLM, V82, P315, DOI 10.1046/j.1463-6395.2001.00092.x; Schuler MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020905; SCHURMANN H, 1992, J FISH BIOL, V41, P927, DOI 10.1111/j.1095-8649.1992.tb02720.x; SCHURMANN H, 1991, J EXP BIOL, V157, P75; Sepulveda R, 2014, J ARACHNOL, V42, P299, DOI 10.1636/B13-87.1; Stevens MM, 2010, J EXP BIOL, V213, P2209, DOI 10.1242/jeb.040170; SUNDERLAND KD, 1980, J ANIM ECOL, V49, P987, DOI 10.2307/4240; Verberk WCEP, 2013, INTEGR COMP BIOL, V53, P609, DOI 10.1093/icb/ict015; Verberk WCEP, 2018, FUNCT ECOL, V32, P926, DOI 10.1111/1365-2435.13050; Verberk WCEP, 2016, COMP BIOCHEM PHYS A, V192, P64, DOI 10.1016/j.cbpa.2015.10.020; Verberk WCEP, 2015, J EXP BIOL, V218, P2083, DOI 10.1242/jeb.119560; Verberk WCEP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0473; Verberk WCEP, 2013, FUNCT ECOL, V27, P1275, DOI 10.1111/1365-2435.12152; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Walczynska A, 2015, J THERM BIOL, V54, P78, DOI 10.1016/j.jtherbio.2014.11.002; Wang YJ, 2010, MAR BIOL, V157, P747, DOI 10.1007/s00227-009-1358-z; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wood SC, 1996, COMP BIOCHEM PHYS B, V113, P37, DOI 10.1016/0305-0491(95)02045-4; Wright JC, 2006, COMP BIOCHEM PHYS A, V145, P235, DOI 10.1016/j.cbpa.2006.06.020	63	10	10	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220647	10.1371/journal.pone.0220647	http://dx.doi.org/10.1371/journal.pone.0220647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369635	gold, Green Published, Green Submitted			2022-12-26	WOS:000484987900075
J	Choi, B; Crisp, MD; Cook, LG; Meusemann, K; Edwards, RD; Toon, A; Kulheim, C				Choi, Bokyung; Crisp, Michael D.; Cook, Lyn G.; Meusemann, Karen; Edwards, Robert D.; Toon, Alicia; Kulheim, Carsten			Identifying genetic markers for a range of phylogenetic utility-From species to family level	PLOS ONE			English	Article							MODEL SELECTION; NUCLEAR LOCI; DNA; MYRTACEAE; TREE; ENRICHMENT; ALGORITHM; EVOLUTION; SEQUENCES; EUCALYPTS	Resolving the phylogenetic relationships of closely related species using a small set of loci is challenging as sufficient information may not be captured from a limited sample of the genome. Relying on few loci can also be problematic when conflict between gene-trees arises from incomplete lineage sorting and/or ongoing hybridization, problems especially likely in recently diverged lineages. Here, we developed a method using limited genomic resources that allows identification of many low copy candidate loci from across the nuclear and chloroplast genomes, design probes for target capture and sequence the captured loci. To validate our method we present data from Eucalyptus and Melaleuca, two large and phylogenetically problematic genera within the Myrtaceae family. With one annotated genome, one transcriptome and two whole-genome shotgun sequences of one Eucalyptus and four Melaleuca species, respectively, we identified 212 loci representing 263 kbp for targeted sequence capture and sequencing. Of these, 209 were successfully tested from 47 samples across five related genera of Myrtaceae. The average percentage of reads mapped back to the reference was 57.6% with coverage of more than 20 reads per position across 83.5% of the data. The methods developed here should be applicable across a large range of taxa across all kingdoms. The core methods are very flexible, providing a platform for various genomic resource availabilities and are useful from shallow to deep phylogenies.	[Choi, Bokyung; Crisp, Michael D.; Kulheim, Carsten] Australian Natl Univ, Res Sch Biol, Div Ecol & Evolut, Canberra, ACT, Australia; [Cook, Lyn G.; Edwards, Robert D.; Toon, Alicia] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Meusemann, Karen] Univ Freiburg, Inst Biol, Evolutionary Biol & Ecol, Freiburg, Germany; [Meusemann, Karen] CSIRO, Australian Natl Inset Collect, Natl Res Collect Australia, Canberra, ACT, Australia; [Edwards, Robert D.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kulheim, Carsten] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Australian National University; University of Queensland; University of Freiburg; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan Technological University	Kulheim, C (corresponding author), Australian Natl Univ, Res Sch Biol, Div Ecol & Evolut, Canberra, ACT, Australia.; Kulheim, C (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	ckulheim@mtu.edu	Cook, Lyn/G-7336-2012; Kulheim, Carsten/AAR-2734-2021	Cook, Lyn/0000-0002-3172-4920; Edwards, Robert/0000-0002-4993-2453; Kulheim, Carsten/0000-0002-0798-3324	Australian Research Council [DP130101141]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council (https://www.arc.gov.au/) grant to LGC and MDC (DP130101141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Akhani H, 2013, BOT J LINN SOC, V171, P519, DOI 10.1111/boj.12015; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Biffin E, 2007, MOL PHYLOGENET EVOL, V43, P124, DOI 10.1016/j.ympev.2006.08.013; Boekhorst J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-356; Bragg JG, 2016, MOL ECOL RESOUR, V16, P1059, DOI 10.1111/1755-0998.12449; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; Cook LG, 2008, MOL PHYLOGENET EVOL, V47, P506, DOI 10.1016/j.ympev.2008.02.012; Craven LA, 2014, TAXON, V63, P663, DOI 10.12705/633.38; Crisp MD, 2012, NATURE COMM, V2, P193; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Edwards RD, 2010, TAXON, V59, P744, DOI 10.1002/tax.593007; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Hsieh JF, 2018, PHYTOPATHOLOGY, V108, P495, DOI 10.1094/PHYTO-09-17-0307-R; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; Kadlec M, 2017, PEERJ, V5, DOI 10.7717/peerj.3569; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klopfstein S, 2017, SYST BIOL, V66, P769, DOI 10.1093/sysbio/syx051; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lemmon AR, 2012, SYST BIOL, V61, P745, DOI 10.1093/sysbio/sys051; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lucas EJ, 2007, TAXON, V56, P1105, DOI 10.2307/25065906; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Myburg AA, 2013, NATURE; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Paiva JAP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-137; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Penalba JV, 2014, MOL ECOL RESOUR, V14, P1000, DOI 10.1111/1755-0998.12249; Portik DM, 2016, MOL ECOL RESOUR, V16, P1069, DOI 10.1111/1755-0998.12541; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Schmickl R, 2016, MOL ECOL RESOUR, V16, P1124, DOI 10.1111/1755-0998.12487; Schuster TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195034; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Smith DR, 2015, GENOME BIOL EVOL, V7, P1227, DOI 10.1093/gbe/evv069; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tekaia F, 2016, GENOMICS INSIGHTS, V9, DOI [10.4137/gei.s37925, DOI 10.4137/GEI.S37925]; Thornhill AH, 2019, AUST SYST BOT, V32, P29, DOI 10.1071/SB18015; Thornhill AH, 2015, MOL PHYLOGENET EVOL, V93, P29, DOI 10.1016/j.ympev.2015.07.007; Thornhill AH, 2012, AUST SYST BOT, V25, P171, DOI 10.1071/SB11019; Tonnabel J, 2014, MOL PHYLOGENET EVOL, V70, P37, DOI 10.1016/j.ympev.2013.07.027; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Weitemier K, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400042; Wilson PG, 2001, AM J BOT, V88, P2013, DOI 10.2307/3558428; Xiang QP, 2015, MOL PHYLOGENET EVOL, V82, P1, DOI 10.1016/j.ympev.2014.10.008; Zhu WD, 2013, BOT J LINN SOC, V171, P377, DOI 10.1111/j.1095-8339.2012.01318.x	66	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218995	10.1371/journal.pone.0218995	http://dx.doi.org/10.1371/journal.pone.0218995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369563	Green Published, gold			2022-12-26	WOS:000484987900012
J	Navarro-Torres, A; Alastruey-Benede, J; Ibanez-Marin, P; Vinals-Yufera, V				Navarro-Torres, Agustin; Alastruey-Benede, Jesus; Ibanez-Marin, Pablo; Vinals-Yufera, Victor			Memory hierarchy characterization of SPEC CPU2006 and SPEC CPU2017 on the Intel Xeon Skylake-SP	PLOS ONE			English	Article								SPEC CPU is one of the most common benchmark suites used in computer architecture research. CPU2017 has recently been released to replace CPU2006. In this paper we present a detailed evaluation of the memory hierarchy performance for both the CPU2006 and single-threaded CPU2017 benchmarks. The experiments were executed on an Intel Xeon Skylake-SP, which is the first Intel processor to implement a mostly non-inclusive last-level cache (LLC). We present a classification of the benchmarks according to their memory pressure and analyze the performance impact of different LLC sizes. We also test all the hardware prefetchers showing they improve performance in most of the benchmarks. After comprehensive experimentation, we can highlight the following conclusions: i) almost half of SPEC CPU benchmarks have very low miss ratios in the second and third level caches, even with small LLC sizes and without hardware prefetching, ii) overall, the SPEC CPU2017 benchmarks demand even less memory hierarchy resources than the SPEC CPU2006 ones, iii) hardware prefetching is very effective in reducing LLC misses for most benchmarks, even with the smallest LLC size, and iv) from the memory hierarchy standpoint the methodologies commonly used to select benchmarks or simulation points do not guarantee representative workloads.	[Navarro-Torres, Agustin; Alastruey-Benede, Jesus; Ibanez-Marin, Pablo; Vinals-Yufera, Victor] Univ Zaragoza, Dept Informat & Ingn Sistemas, Aragon Inst Engn Res I3A, Zaragoza, Spain	University of Zaragoza	Alastruey-Benede, J (corresponding author), Univ Zaragoza, Dept Informat & Ingn Sistemas, Aragon Inst Engn Res I3A, Zaragoza, Spain.	jalastru@unizar.es	Ibáñez, Pablo/F-4214-2016; Alastruey-Benedé, Jesús/AAA-1773-2019	Ibáñez, Pablo/0000-0002-5916-7898; Alastruey-Benedé, Jesús/0000-0003-4164-5078; Navarro Torrres, Agustin/0000-0002-3556-2244	Agencia Estatal de Investigacion [TIN2016-76635-C2-1-R]; European Regional Development Fund (ERDF); Aragon Goverment [gaZ: T58_17R]; European Social Fund (ESF)	Agencia Estatal de Investigacion; European Regional Development Fund (ERDF)(European Commission); Aragon Goverment; European Social Fund (ESF)(European Social Fund (ESF))	All authors acknowledge support in part from grants (1) TIN2016-76635-C2-1-R from Agencia Estatal de Investigacion (AEI, http://www.ciencia.gob.es/portal/site/MICINN/aei) and European Regional Development Fund (ERDF, https://ec.europa.eu/regional_policy/en/funding/erdf/), and (2) gaZ: T58_17R research group from Aragon Goverment (http://www.aragon.es/) and European Social Fund (ESF, http://ec.europa.eu/esf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests:	Cook Jeanine, 2011, Performance Evaluation Review, V38, P75, DOI 10.1145/1964218.1964231; Corporation SPE, SPEC CPU BENCHM SUIT; De Melo A. C, 2010, LIN K, V18; Falk H, 2016, TACLEBENCH BENCHMARK, V55; Ferdman M, 2012, ACM SIGPLAN NOTICES, V47, P37, DOI 10.1145/2248487.2150982; Hennessy J. L., 2017, COMPUTER ARCHITECTUR, V6th; Jain A, 2016, CONF PROC INT SYMP C, P78, DOI 10.1109/ISCA.2016.17; Jaleel A., 2010, MEMORY CHARACTERIZAT; Kanter D., 2017, MICROPROCESSOR REPOR, P6; Korn W., 2007, Computer Architecture News, V35, P97, DOI 10.1145/1241601.1241620; Kumar T, ISAST T COMPUT SOFTW, V2, P36; Limaye A, 2018, INT SYM PERFORM ANAL, P149, DOI 10.1109/ISPASS.2018.00028; McCurdy C., 2005, SIGARCH COMPUT ARCHI, V33, P39, DOI [10.1145/1127577.1127586, DOI 10.1145/1127577.1127586]; Panda R, 2018, INT S HIGH PERF COMP, P271, DOI 10.1109/HPCA.2018.00032; Perelman E., 2003, Performance Evaluation Review, V31, P318, DOI 10.1145/885651.781076; Wenisch TF, 2006, IEEE MICRO, V26, P18, DOI 10.1109/MM.2006.79	16	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220135	10.1371/journal.pone.0220135	http://dx.doi.org/10.1371/journal.pone.0220135			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369592	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900029
J	Ye, XM; Hu, DN; Guo, YP; Sun, RX				Ye, Xuemin; Hu, Dongnan; Guo, Yangping; Sun, Rongxi			Complete chloroplast genome of Castanopsis sclerophylla (Lindl.) Schott: Genome structure and comparative and phylogenetic analysis	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; PLASTID GENOME; FAGACEAE; SEQUENCE; BIAS	Castanopsis sclerophylla (Lindl.) Schott is an important species of evergreen broad-leaved tree in subtropical areas and has high ecological and economic value. However, there are few studies on its chloroplast genome. In this study, the complete chloroplast genome sequence of C. sclerophylla was determined using the Illumina HiSeq 2500 platform. The complete chloroplast genome of C. sclerophylla is 160,497 bp long, including a pair of inverted repeat (IR) regions (25,675 bp) separated by a large single-copy (LSC) region of 90,255 bp and a small single-copy (SSC) region of 18,892 bp. The overall GC content of the chloroplast genome is 36.82%. A total of 131 genes were found; of these, 111 genes are unique and annotated, including 79 protein-coding genes, 27 transfer RNA genes (tRNAs), and four ribosomal RNA genes (rRNAs). Twenty-one genes were found to be duplicated in the IR regions. Comparative analysis indicated that IR contraction might be the reason for the smaller chloroplast genome of C. sclerophylla compared to three congeneric species. Sequence analysis indicated that the LSC and SSC regions are more divergent than IR regions within Castanopsis; furthermore, greater divergence was found in noncoding regions than in coding regions. The maximum likelihood phylogenetic analysis showed that four species of the genus Castanopsis form a monophyletic clade and that C. sclerophylla is closely related to Castanopsis hainanensis with strong bootstrap values. These results not only provide a basic understanding of Castanopsis chloroplast genomes, but also illuminate Castanopsis species evolution within the Fagaceae family. Furthermore, these findings will be valuable for future studies of genetic diversity and enhance our understanding of the phylogenetic evolution of Castanopsis.	[Ye, Xuemin; Hu, Dongnan; Guo, Yangping; Sun, Rongxi] Jiangxi Agr Univ, Coll Forestry, Jiangxi Prov Key Lab Silviculture, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Sun, RX (corresponding author), Jiangxi Agr Univ, Coll Forestry, Jiangxi Prov Key Lab Silviculture, Nanchang, Jiangxi, Peoples R China.	rongxisun@163.com			Doctoral Scientific Research Foundation of Jiangxi Agricultural University [9232306460]	Doctoral Scientific Research Foundation of Jiangxi Agricultural University	This research was funded by the Doctoral Scientific Research Foundation of Jiangxi Agricultural University (9232306460).	Alexandros S, 2017, SYST BIOL, V57, P758; Ane C, 2005, MOL BIOL EVOL, V22, P914, DOI 10.1093/molbev/msi076; Asaf S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00304; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; Chen JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00447; Chen XD, 2018, CONSERV GENET RESOUR, V10, P825, DOI 10.1007/s12686-017-0940-9; Cheng L, 2017, 2017 IEEE 7TH ANNUAL COMPUTING AND COMMUNICATION WORKSHOP AND CONFERENCE IEEE CCWC-2017; Conden PJ, 2002, THESIS; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Dong WP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01148; Dong WP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08348; Gupta SK, 2004, J BIOMOL STRUCT DYN, V21, P527, DOI 10.1080/07391102.2004.10506946; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang XQ, 2012, APPL MECH MATER, V140, P360, DOI 10.4028/www.scientific.net/AMM.140.360; Huang YL, 2012, PHYTOCHEM LETT, V5, P158, DOI 10.1016/j.phytol.2011.11.014; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li B, 2017, SCI REPORTS, V7, P1, DOI DOI 10.1038/srep43082; Li B, 2016, CONSERV GENET RESOUR, V8, P447, DOI 10.1007/s12686-016-0593-0; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Manos PS, 2001, INT J PLANT SCI, V162, P1361, DOI 10.1086/322949; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Oh SH, 2008, TAXON, V57, P434, DOI 10.2307/25066014; Park I, 2017, MOLECULES, V22, DOI 10.3390/molecules22060982; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Raman G, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120115; Ren T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041050; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; Shen XF, 2017, MOLECULES, V22, DOI 10.3390/molecules22081330; Shetty SM, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.09.0089; Shi YS, 2011, AM J BOT, V98, pE19, DOI 10.3732/ajb.1000400; Simeone MC, 2016, PEERJ, V4, DOI 10.7717/peerj.1897; Tang XL, 2017, ANN FOREST SCI, V74, DOI 10.1007/s13595-016-0603-0; Tu ZC, 2008, FOOD RES DEV, V1, P33; Vitelli M, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-016-1086-8; Wang R, 2012, ECOL EVOL, V2, P2250, DOI 10.1002/ece3.344; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xuan L, 2018, INT J MOL SCI, V19, P2443; Yang YC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00082; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110656; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Ye Lin-Jiang, 2014, Plant Diversity and Resources, V36, P443, DOI 10.7677/ynzwyj201413191; Ye XM, 2019, MITOCHONDRIAL DNA B, V4, DOI 10.1080/23802359.2019.1605850; Yue Hua-feng, 2010, Forest Research, V23, P453; [张欣 ZHANG Xin], 2007, [生态学报, Acta Ecologica Sinica], V27, P424, DOI 10.1016/S1872-2032(07)60014-6	54	3	3	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0212325	10.1371/journal.pone.0212325	http://dx.doi.org/10.1371/journal.pone.0212325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361757	Green Submitted, Green Published, gold			2022-12-26	WOS:000484981300002
J	Kim, CM; Seo, JW; Kim, DM; Yun, NR; Park, JW; Chung, JK; Song, HJ				Kim, Choon Mee; Seo, Ji Won; Kim, Dong Min; Yun, Na Ra; Park, Jung Wook; Chung, Jae Keun; Song, Hyun Jae			Detection of Borrelia miyamotoi in Ixodes nipponensis in Korea	PLOS ONE			English	Article							LYME-DISEASE; SCAPULARIS; FEVER; IDENTIFICATION; HUMANS; TICKS	Background This study investigated Borrelia species prevalence in ticks from vegetation, through a molecular method, in Gwangju Metropolitan City, South Korea. Methodology/Principal findings A total of 484 ticks were collected through flagging and dragging in a suburban area of Gwangju Metropolitan City, South Korea, in 2014. These ticks were morphologically identified and subjected to nested PCR, targeting Borrelia-specific CTP synthase (pyrG), outer surface protein A (ospA) and flagellin (flaB) genes. Molecular biological species identification of Borrelia-positive ticks was conducted via 16S rRNA PCR assays. Of the 484 ticks collected, 417 (86.2%) were identified as Haemaphysalis longicornis, 42 (8.7%) as H. flava, and 25 (5.2%) as Ixodes nipponensis. All the ixodid ticks containing Borrelia species bacteria were confirmed to be I. nipponensis adults, by both morphological and molecular methods. Of the 25 I. nipponensis ticks collected, four (16%) were positive for Borrelia species, three of which were B. afzelii and one B. miyamotoi. Conclusions/Significance Our study has shown the harboring of B. miyamotoi by I. nipponensis in South Korea. Morphological and molecular genetic analyses revealed that, in South Korea, I. nipponensis could potentially transmit B. miyamotoi to humans.	[Kim, Choon Mee] Chosun Univ, Coll Med, Premed Sci, Gwangju, South Korea; [Seo, Ji Won] Gwangju Sci Acad Gifted, Gwangju, South Korea; [Kim, Dong Min; Yun, Na Ra] Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea; [Park, Jung Wook; Chung, Jae Keun] Hlth & Environm Res Inst Gwangju City, Div Infect Dis Invest, Gwangju, South Korea; [Song, Hyun Jae] Gwangju Hlth Univ, Clin Pathol, Gwangju, South Korea	Chosun University; Chosun University	Kim, DM (corresponding author), Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea.	drongkim@chosun.ac.kr		Kim, Dong-Min/0000-0001-6373-0922; park, jungwook/0000-0003-2906-9709	Chosun University	Chosun University	This research was supported by research funds from Chosun University, 2017 awarded to DM Kim. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Choi YJ, 2007, MICROBIOL IMMUNOL, V51, P1201, DOI 10.1111/j.1348-0421.2007.tb04015.x; Crowder CD, 2014, EMERG INFECT DIS, V20, P1678, DOI 10.3201/eid2010.131583; Eisen RJ, 2016, J MED ENTOMOL, V53, P349, DOI 10.1093/jme/tjv237; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Fukunaga M, 1996, INT J SYST BACTERIOL, V46, P898, DOI 10.1099/00207713-46-4-898; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hao Q, 2011, J CLIN MICROBIOL, V49, P647, DOI 10.1128/JCM.00725-10; Im JH, 2019, VECTOR-BORNE ZOONOT, V19, P225, DOI 10.1089/vbz.2018.2298; Krause PJ, 2015, CLIN MICROBIOL INFEC, V21, P631, DOI 10.1016/j.cmi.2015.02.006; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Noh Y, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01298-14; Nunes M, 2015, VECTOR-BORNE ZOONOT, V15, P515, DOI 10.1089/vbz.2014.1765; PARK KH, 1993, J CLIN MICROBIOL, V31, P1831, DOI 10.1128/JCM.31.7.1831-1837.1993; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Rar V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2186-5; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Sapi E, 2013, INT J MED SCI, V10, P362, DOI 10.7150/ijms.5698; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Shin SH, 2013, EXP APPL ACAROL, V61, P337, DOI 10.1007/s10493-013-9699-1; Song BG, 2017, GEOGRAPHICAL DISTRIB; Takano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104532; Tian ZC, 2011, EXP APPL ACAROL, V54, P165, DOI 10.1007/s10493-010-9423-3; WHO, 2014, GLOB BRIEF VECT BORN; YAMAGUTI N, 1971, Brigham Young University Science Bulletin Biological Series, V15, P1; Yun SM, 2014, EMERG INFECT DIS, V20, P1358, DOI 10.3201/eid2008.131857	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220465	10.1371/journal.pone.0220465	http://dx.doi.org/10.1371/journal.pone.0220465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356600	Green Published, gold, Green Submitted			2022-12-26	WOS:000484047000032
J	Dlask, M; Kukal, J; Poplova, M; Sovka, P; Cifra, M				Dlask, Martin; Kukal, Jaromir; Poplova, Michaels; Sovka, Pavel; Cifra, Michel			Short-time fractal analysis of biological autoluminescence	PLOS ONE			English	Article							WEAK PHOTON-EMISSION; BIOPHOTON EMISSION; ANOMALOUS SUBDIFFUSION; PHOTOCOUNT STATISTICS; CELL COMMUNICATION; SQUEEZED STATE; COHERENCE; LUMINESCENCE; PERSPECTIVE; ULTRAWEAK	Biological systems manifest continuous weak autoluminescence, which is present even in the absence of external stimuli. Since this autoluminescence arises from internal metabolic and physiological processes, several works suggested that it could carry information in the time series of the detected photon counts. However, there is little experimental work which would show any difference of this signal from random Poisson noise and some works were prone to artifacts due to lacking or improper reference signals. Here we apply rigorous statistical methods and advanced reference signals to test the hypothesis whether time series of autoluminescence from germinating mung beans display any intrinsic correlations. Utilizing the fractional Brownian bridge that employs short samples of time series in the method kernel, we suggest that the detected autoluminescence signal from mung beans is not totally random, but it seems to involve a process with a negative memory. Our results contribute to the development of the rigorous methodology of signal analysis of photonic biosignals.	[Dlask, Martin; Kukal, Jaromir] Czech Tech Univ, Fac Nucl Sci & Phys Engn, Trojanova 12, Prague, Czech Republic; [Poplova, Michaels; Cifra, Michel] Czech Acad Sci, Inst Photon & Elect, Chaberska 57, Prague 8, Czech Republic; [Sovka, Pavel] Czech Tech Univ, Fac Elect Engn, Dept Circuit Theory, Tech 2, Prague 6, Czech Republic	Czech Technical University Prague; Czech Academy of Sciences; Institute of Photonics & Electronics of the Czech Academy of Sciences; Czech Technical University Prague	Cifra, M (corresponding author), Czech Acad Sci, Inst Photon & Elect, Chaberska 57, Prague 8, Czech Republic.	cifra@ufe.cz	Cifra, Michal/D-4416-2013	Cifra, Michal/0000-0002-8853-9523	Czech Technical University [SGS17/196/OHK4/3T/14]; OP VVV MEYS [CZ.02.1.01/0.0/0.0/16_019/0000765]; internal CTU grant [SGS17/183/OHK3/3T/13]; Czech Science Foundation [18-23597S]	Czech Technical University; OP VVV MEYS; internal CTU grant; Czech Science Foundation(Grant Agency of the Czech Republic)	Authors were supported by the following grants: No. SGS17/196/OHK4/3T/14 of the Czech Technical University, CZ.02.1.01/0.0/0.0/16_019/0000765 "Research Center for Informatics" of the OP VVV MEYS, internal CTU grant SGS17/183/OHK3/3T/13 "Special Applications of Signal Processing." MC and MP acknowledge Czech Science Foundation project no. 18-23597S.	ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; AON MA, 1994, FEBS LETT, V344, P1, DOI 10.1016/0014-5793(94)00321-1; Aon MA, 2000, CELL BIOL INT, V24, P581, DOI 10.1006/cbir.2000.0572; Bajpai RP, 2005, PHYS LETT A, V337, P265, DOI 10.1016/j.physleta.2005.01.079; Bajpai RP, 2004, PHYS LETT A, V322, P131, DOI 10.1016/j.physleta.2003.12.050; Benichou O, 2010, NAT CHEM, V2, P472, DOI [10.1038/nchem.622, 10.1038/NCHEM.622]; Bohdalova M, 2010, ACTA POLYTECH HUNG, V7, P14; Budagovsky AV, 2005, QUANTUM ELECTRON+, V35, P369, DOI 10.1070/QE2005v035n04ABEH02837; Burgos RCR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01229-x; Burgos RCR, 2016, J PHOTOCH PHOTOBIO B, V163, P237, DOI 10.1016/j.jphotobiol.2016.08.030; Captur G, 2017, NAT REV CARDIOL, V14, P56, DOI 10.1038/nrcardio.2016.161; Casella G, 2001, CENGAGE LEARNING; Cifra M, 2015, J LUMIN, V164, P38, DOI 10.1016/j.jlumin.2015.03.020; Cifra M, 2014, J PHOTOCH PHOTOBIO B, V139, P2, DOI 10.1016/j.jphotobiol.2014.02.009; COLLINSON MM, 1995, SCIENCE, V268, P1883, DOI 10.1126/science.268.5219.1883; Delignieres D, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/485623; Dietrich CR, 1997, SIAM J SCI COMPUT, V18, P1088, DOI 10.1137/S1064827592240555; Dlask M, 2018, SIGNAL IMAGE AND VID; Dlask M, 2018, 2018 INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND INFORMATION SECURITY (ICSPIS), P1; Dlask M, 2015, 33RD INTERNATIONAL CONFERENCE MATHEMATICAL METHODS IN ECONOMICS (MME 2015), P115; Dubovikov PM, 2004, PHYSICA A, V339, P591, DOI 10.1016/j.physa.2004.03.025; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Erramilli A, 1994, FRACTALS, V2, P409, DOI 10.1142/S0218348X94000545; FOORD R, 1969, APPL OPTICS, V8, P1975, DOI 10.1364/AO.8.001975; Gallep CD, 2014, LUMINESCENCE, V29, P963, DOI 10.1002/bio.2658; Gallep CM, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28671; Gallep CM, 2013, PROTOPLASMA, V250, P793, DOI 10.1007/s00709-012-0447-x; Guo JL, 2017, OPEN LIFE SCI, V12, P393, DOI 10.1515/biol-2017-0046; Hurst HE., 1956, P I CIVIL ENG, V5, P519, DOI DOI 10.1680/IICEP.1956.11503; Iranifam M, 2010, LUMINESCENCE, V25, P409, DOI 10.1002/bio.1203; JOHNSON FA, 1966, PHYS REV LETT, V16, P589, DOI 10.1103/PhysRevLett.16.589; Julian M, 2015, PHYSIOL MEAS, V36, P2231, DOI 10.1088/0967-3334/36/11/2231; Kobayashi M, 2000, APPL OPTICS, V39, P183, DOI 10.1364/AO.39.000183; Kobayashi M, 2016, J PHOTOCH PHOTOBIO B, V159, P186, DOI 10.1016/j.jphotobiol.2016.03.037; KOPELMAN R, 1988, SCIENCE, V241, P1620, DOI 10.1126/science.241.4873.1620; Kristoufek L, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062802; Kucera O, 2015, CURR TOP MED CHEM, V15, P513, DOI 10.2174/1568026615666150225103105; Kucera O, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-87; Laager F, 2015, FRONT PHYS-LAUSANNE, V3, DOI 10.3389/fphy.2015.00055; Li CF, 2003, GEOPHYS J INT, V153, P201, DOI 10.1046/j.1365-246X.2003.01893.x; Li DH, 2018, J INTERNET TECHNOL, V19, P2088, DOI 10.3966/160792642018121907012; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; Nerudova M, 2015, SPIE P, DOI 10.1117/12.2069897; OLIVER CJ, 1968, J PHYS D APPL PHYS, V1, P1459, DOI 10.1088/0022-3727/1/11/310; Ondrusova B, 2016, MEASUREMENT OPTIMIZA; Ou-Yang H, 2014, J PHOTOCH PHOTOBIO B, V139, P63, DOI 10.1016/j.jphotobiol.2013.10.003; Poplova M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188622; POPP FA, 1984, CELL BIOPHYS, V6, P33, DOI 10.1007/BF02788579; Pospisil P, 2014, J PHOTOCH PHOTOBIO B, V139, P11, DOI 10.1016/j.jphotobiol.2014.02.008; Prasad A, 2014, J PHOTOCH PHOTOBIO B, V139, P47, DOI 10.1016/j.jphotobiol.2014.03.004; Prasad A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.085004; PRASAD J, 1987, J PHYS CHEM-US, V91, P265, DOI 10.1021/j100286a007; QUICKENDEN TI, 1991, J PHOTOCH PHOTOBIO B, V8, P169, DOI 10.1016/1011-1344(91)80055-M; Rac M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08882; Rafieiolhosseini N, 2016, J PHOTOCH PHOTOBIO B, V162, P50, DOI 10.1016/j.jphotobiol.2016.06.001; Ratto TV, 2003, LANGMUIR, V19, P1788, DOI 10.1021/la0261803; Saeidfirozeh H, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-34485-6, 10]; Saxton MJ, 2012, BIOPHYS J, V103, P2411, DOI 10.1016/j.bpj.2012.10.038; Scholkmann F, 2013, AM J TRANSL RES, V5, P586; Scholkmann F, 2011, J PHYS CONF SER, V329, DOI 10.1088/1742-6596/329/1/012020; Seber G. A. F., 2003, NONLINEAR REGRESSION; TILBURY RN, 1992, J BIOLUM CHEMILUM, V7, P245, DOI 10.1002/bio.1170070404; van Wijk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084579; Van Wijk EPA, 2010, J PHOTOCH PHOTOBIO B, V99, P133, DOI 10.1016/j.jphotobiol.2010.03.008; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V84, P46, DOI 10.1016/j.jphotobiol.2006.01.010; Vogel R, 1999, LUMINESCENCE, V14, P99, DOI 10.1002/(SICI)1522-7243(199903/04)14:2<99::AID-BIO519>3.0.CO;2-7; Vogel R, 1998, BIOELECTROCH BIOENER, V46, P59, DOI 10.1016/S0302-4598(98)00123-8; Walls D., 2008, QUANTUM OPT, DOI DOI 10.1007/978-3-540-28574-8; Wang J, 2009, LUMINESCENCE, V24, P209, DOI 10.1002/bio.1096; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Yang MN, 2015, BIOMED OPT EXPRESS, V6, P1331, DOI 10.1364/BOE.6.001331; Zhao X. H., 2017, METALS, V7, P1; Zhao XL, 2017, J PHOTOCH PHOTOBIO B, V166, P232, DOI 10.1016/j.jphotobiol.2016.12.009; Zhao X, 2016, J PHOTOCH PHOTOBIO B, V162, P529, DOI 10.1016/j.jphotobiol.2016.07.030	75	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0214427	10.1371/journal.pone.0214427	http://dx.doi.org/10.1371/journal.pone.0214427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348777	gold, Green Published, Green Submitted			2022-12-26	WOS:000484979500002
J	Dong, JS; Zhu, DX; Tang, XJ; Lu, D; Qiu, XM; Li, BJ; Lin, D; Li, L; Liu, JW; Zhou, QH				Dong, Jingsi; Zhu, Daxing; Tang, Xiaojun; Lu, Dan; Qiu, Xiaoming; Li, Bingjie; Lin, Dan; Li, Lu; Liu, Jiewei; Zhou, Qinghua			Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer	PLOS ONE			English	Article							TREATED PATIENTS; VENOUS-BLOOD; NIVOLUMAB; DOCETAXEL; CARCINOMA; NSCLC; STATISTICS; VALIDATION; SURVIVAL; OUTCOMES	Background Lung cancer is the leading cause of death caused by malignant tumors. PD-L1(programmed cell death protein-1) has shown tremendous achievement in treating NSCLC. We sought to find the relationship between CTCs in the pulmonary vein and postoperative PFS, besides we detected PD-L1 in CTCs. Method We enrolled 112 NSCLC patients. CTC tests were performed at four time points (preoperative, pulmonary vein, intraoperative and postoperative) on every NSCLC patient who received surgery. The RNA of PD-L1 was tested by FISH. The levels of the PD-L1 mRNA and protein in tissue samples were detected. Results The CTCs in the PV were the highest (P< 0.001), and CTCs in the PPA were the lowest (P< 0.001). The PFS in the group with PV CTCs >= 16/5 ml was shorter than that in the group with PV CTCs< 16/5 ml (11.1 months vs 21.2 months, respectively; P< 0.001). The PFS in the group with PPA CTCs >= 3/5 ml was shorter than that in the group with CTCs< 3/5 ml (14.8 months vs 20.7 months, respectively; P< 0.001). The CTCs in stage I were lower than those in stage II-IV (P = 0.025). No linear relationship was found between the CTCs and tumor size (P> 0.05) or LN metastasis (P> 0.05). In total, fifty-two (50.5%) patients had positive PD-L1 expression in CTC. In PD-L1-positive CTC patients, the value of PD-L1 tissue expression was higher than that in PD-L1-negative CTC patients (P = 0.0153). Conclusion CTCs in the pulmonary vein can be an effective prognosis indicator of NSCLC patients.	[Dong, Jingsi; Zhu, Daxing; Tang, Xiaojun; Qiu, Xiaoming; Li, Bingjie; Lin, Dan; Li, Lu; Liu, Jiewei; Zhou, Qinghua] Sichuan Univ, West China Hosp, Dept Lung Canc Ctr, Chengdu, Sichuan, Peoples R China; [Lu, Dan] Sichuan Univ, West China Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zhou, QH (corresponding author), Sichuan Univ, West China Hosp, Dept Lung Canc Ctr, Chengdu, Sichuan, Peoples R China.	Zhouqh135@163.com	qiu, xiaoming/AAK-3631-2020		Department of Science and Technology of Sichuan Province [2018SZ0152]; Health and Family Planning Commission of Sichuan Province [18PJ432]	Department of Science and Technology of Sichuan Province; Health and Family Planning Commission of Sichuan Province	This work was supported by the Department of Science and Technology of Sichuan Province, 2018SZ0152 to JD and the Health and Family Planning Commission of Sichuan Province (CN), 18PJ432 to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Alix-Panabieres C, 2016, MOL ONCOL, V10, P443, DOI 10.1016/j.molonc.2016.01.004; Bagley SJ, 2017, LUNG CANCER, V106, P1, DOI 10.1016/j.lungcan.2017.01.013; Benej M, 2017, BRATISL MED J, V118, P299, DOI 10.4149/BLL_2017_073; Blanchon F, 2006, LANCET ONCOL, V7, P829, DOI 10.1016/S1470-2045(06)70868-3; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Borghaei H, 2016, J THORAC ONCOL, V11, pS237, DOI 10.1016/j.jtho.2016.08.106; Chansky K, 2017, J THORAC ONCOL, V12, P1109, DOI 10.1016/j.jtho.2017.04.011; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2013, NEW ENGL J MED, V369, P93, DOI 10.1056/NEJMc1306040; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gubens MA, 2017, J NATL COMPR CANC NE, V15, P692, DOI 10.6004/jnccn.2017.0075; Haanen JBAG, 2015, PROG TUMOR RES, V42, P55, DOI 10.1159/000437178; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Heymann JJ, 2017, CANCER CYTOPATHOL, V125, P896, DOI 10.1002/cncy.21937; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Ilie M, 2018, ANN ONCOL, V29, P193, DOI 10.1093/annonc/mdx636; Jiang YQ, 2010, CLIN CHEM, V56, P1492, DOI 10.1373/clinchem.2010.143297; Kallergi G, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758834017750121; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Lee L, 2016, J CLIN PHARMACOL, V56, DOI 10.1002/jcph.591; Leprieur EG, 2017, EUR J CANCER, V78, P16, DOI 10.1016/j.ejca.2016.12.041; Marchetti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103883; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Muinelo-Romay L, 2014, CANCERS, V6, P153, DOI 10.3390/cancers6010153; Okumura Y, 2009, ANN THORAC SURG, V87, P1669, DOI 10.1016/j.athoracsur.2009.03.073; Pachmann K, 2008, J CLIN ONCOL, V26, P1208, DOI 10.1200/JCO.2007.13.6523; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Reddy RM, 2016, J THORAC CARDIOV SUR, V151, P852, DOI 10.1016/j.jtcvs.2015.09.126; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Wang X, 2017, J CANCER, V8, P3099, DOI 10.7150/jca.18032; Wu SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123976; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	43	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220306	10.1371/journal.pone.0220306	http://dx.doi.org/10.1371/journal.pone.0220306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WC	31348821	Green Published, Green Submitted, gold			2022-12-26	WOS:000484979500028
J	Fahrni, ML; Azmy, MT; Usir, E; Abd Aziz, N; Hassan, Y				Fahrni, Mathumalar Loganathan; Azmy, Mohd Taufiq; Usir, Ezlina; Abd Aziz, Noorizan; Hassan, Yahaya			Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre, prospective study	PLOS ONE			English	Article							SCREENING TOOL; STOPP/START CRITERIA; MEDICATION USE; BEERS CRITERIA; ALERT DOCTORS; POLYPHARMACY; IMPACT; RISK; PEOPLE; PRESCRIPTIONS	Objectives To provide baseline information on inappropriate prescribing (IP), and to evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions) criteria, were associated with preventable adverse drug events (ADEs) and/or hospitalization. Methods We prospectively studied older patients (n = 301) admitted to three urban, public-funded hospitals. We scrutinized their medical records and used STOPP-START (Screening Tool to Alert Prescribers to Right Treatment) criteria to determine PIM and potential prescribing omissions (PPO) respectively-together these constitute IP. Prescriptions with PIM(s) were subjected to a pharmacist medication review, aimed at detecting cases of ADE(s). The vetted cases were further assessed by an expert consensus panel to ascertain: i) causality between the ADE and hospitalization, using, the World Health Organization Uppsala Monitoring Centre criteria, and, ii) whether the ADEs were avoidable (using Hallas criteria). Finally, percentages of PIM-associated ADEs that were both preventable and linked to hospitalization were calculated. Results IP prevalence was 58.5% (n = 176). A majority (49.5%, n = 150) had moderate to severe degree of comorbidities (Charlson Comorbidity Index score >= 3). Median age was 72 years. Median number of medications was 6 and 30.9% (n = 93) had >= 8 medications. PIM prevalence was 34.9% (117 PIMs, n = 105) and PPO 37.9% (191 PPOs, n = 114). Most PIMs and PPOs involved overuse of aspirin and underuse of both antiplatelets and statins respectively. With every increase in the number of medications prescribed, the likelihood of PIM occurrence increased by 20%, i.e. 1.2 fold (OR 1.20, 95% CI: 1.1-1.3). Among the 105 patients with PIMs, 33 ADEs (n = 33); 31 ADEs (n = 31) considered "causal" or "contributory" to hospitalization; 27 ADEs (n = 27) deemed "avoidable" or "potentially avoidable"; and 25 PIM-associated ADEs, preventable, and that induced hospitalization (n = 25), were identified: these equated to prevalence of 31.4%, 29.5%, 25.7%, and 23.8% respectively. The most common ADEs were masked hypoglycemia and gastrointestinal bleed. With every additional PIM prescribed, the odds for ADE occurrence increased by 12 folds (OR 11.8, 95% CI 5.20-25.3). Conclusion The majority of the older patients who were admitted to secondary care for acute illnesses were potentially exposed to IP. Approximately a quarter of the patients were prescribed with PIMs, which were plausibly linked with preventable ADEs that directly caused or contributed to hospitalization.	[Fahrni, Mathumalar Loganathan; Azmy, Mohd Taufiq; Usir, Ezlina] Univ Teknol MARA UiTM, Fac Pharm, Dept Clin Pharm & Pharm Practice, Selangor Branch, Puncak Alam Campus, Selangor Darul Ehsan, Malaysia; [Fahrni, Mathumalar Loganathan] Univ Teknol MARA UiTM, Communities Res Pharmaceut & Life Sci, Collaborat Drug Discovery Res CDDR Grp, Selangor Darul Ehsan, Malaysia; [Abd Aziz, Noorizan; Hassan, Yahaya] Management & Sci Univ, Shah Alam, Selangor, Malaysia	Management Science University	Fahrni, ML (corresponding author), Univ Teknol MARA UiTM, Fac Pharm, Dept Clin Pharm & Pharm Practice, Selangor Branch, Puncak Alam Campus, Selangor Darul Ehsan, Malaysia.; Fahrni, ML (corresponding author), Univ Teknol MARA UiTM, Communities Res Pharmaceut & Life Sci, Collaborat Drug Discovery Res CDDR Grp, Selangor Darul Ehsan, Malaysia.	mathumalar@gmail.com	Fahrni, Mathumalar Loganathan/F-6421-2015; Usir, EZLINA/AAU-3392-2020; Fahrni, Mathumalar/GRO-4323-2022	Fahrni, Mathumalar Loganathan/0000-0002-9042-4290; Usir, EZLINA/0000-0001-6510-2049; 	UiTM Cawangan Selangor Grant [(DUCS) 600-UiTMSEL (PI. 5/4) (059/2018) EU]	UiTM Cawangan Selangor Grant	This project was funded by the UiTM Cawangan Selangor Grant (DUCS) 600-UiTMSEL (PI. 5/4) (059/2018) EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida TA, 2018, RES SOCIAL ADM PHARM; Anathhanam S, 2012, THER ADV DRUG SAF, V3, P165, DOI 10.1177/2042098612443848; [Anonymous], US WHO UMC SYST STAN; Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Boparai MK, 2011, MT SINAI J MED, V78, P613, DOI 10.1002/msj.20278; Bradley MC, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-72; Cadogan CA, 2016, DRUG SAFETY, V39, P109, DOI 10.1007/s40264-015-0378-5; Chang CB, 2012, PHARMACOEPIDEM DR S, V21, P1269, DOI 10.1002/pds.3274; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen LL, 2012, INT J CLIN PHARM-NET, V34, P596, DOI 10.1007/s11096-012-9651-1; Coupland CA, NIHR HEALTH TECHNOLO; Dalleur O, 2012, DRUG AGING, V29, P829, DOI 10.1007/s40266-012-0016-1; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2007, J CLIN PHARM THER, V32, P113, DOI 10.1111/j.1365-2710.2007.00793.x; Gallagher P, 2008, AGE AGEING, V37, P673, DOI 10.1093/ageing/afn197; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Garcia-Gollarte F, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.02.009; Gates PJ, 2019, DRUG SAFETY, V42, P13, DOI 10.1007/s40264-018-0715-6; Ghadimi H, 2011, PHARMACOEPIDEM DR S, V20, P482, DOI 10.1002/pds.2106; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Hamilton Hilary J, 2009, BMC Geriatr, V9, P5, DOI 10.1186/1471-2318-9-5; Henschel Frank, 2015, Drugs Real World Outcomes, V2, P249; Hiance-Delahaye A, 2018, INT PSYCHOGERIATR, V30, P715, DOI 10.1017/S1041610217002290; Hill-Taylor B, 2013, J CLIN PHARM THER, V38, P360, DOI 10.1111/jcpt.12059; Hughes CM, 2016, INT J PHARMACEUT, V512, P360, DOI 10.1016/j.ijpharm.2016.02.035; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; Karani MV, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00250; Katzung B.G., 2010, BASIC CLIN PHARM; Kaufmann CP, 2014, EUR J CLIN PHARMACOL, V70, P1, DOI 10.1007/s00228-013-1575-8; Kim DS, 2010, HEALTHC INFORM RES, V16, P231, DOI 10.4258/hir.2010.16.4.231; Kuijpers MAJ, 2008, BRIT J CLIN PHARMACO, V65, P130, DOI 10.1111/j.1365-2125.2007.02961.x; Lam MPS, 2012, EXPERT REV CLIN PHAR, V5, P187, DOI [10.1586/ecp.12.6, 10.1586/ECP.12.6]; Lao CK, 2013, INT J CLIN PHARM-NET, V35, P805, DOI 10.1007/s11096-013-9811-y; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Lindquist M, 2001, J RHEUMATOL, V28, P1180; Liu CL, 2012, ARCH GERONTOL GERIAT, V55, P148, DOI 10.1016/j.archger.2011.07.001; Loganathan M, 2011, AGE AGEING, V40, P150, DOI 10.1093/ageing/afq161; Lonnbro J, 2017, EUR J CLIN PHARMACOL, V73, P499, DOI 10.1007/s00228-016-2188-9; Meyboom R., 1992, PHARMACOEPIDEM DR S, V1, P87; Miller GE, 2017, HEALTH SERV RES, V52, P1534, DOI 10.1111/1475-6773.12562; Morin L, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.06.011; Vishwas H, 2012, GERIATR GERONTOL INT, V12, P506, DOI 10.1111/j.1447-0594.2011.00806.x; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Noelker LS, 2014, GERONTOLOGIST, V54, P13, DOI 10.1093/geront/gnt086; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Parfitt K, 2009, MARTINDALE COMPLETE; PETTY DR, 2001, PHARM J, V267, P863; Projovic I, 2016, EUR J CLIN PHARMACOL, V72, P93, DOI 10.1007/s00228-015-1957-1; Ryan C, 2009, ANN PHARMACOTHER, V43, P1239, DOI 10.1345/aph.1M157; Silva RDS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210312; Sheikh A, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010422; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Stausberg J, 2010, DTSCH ARZTEBL INT, V107, P23, DOI 10.3238/arztebl.2010.0023; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Stevens GA, 2011, LANCET, V378, P31; Thevelin S, 2019, DRUGS AGING, V29, P1; Thevelin S, 2018, BRIT J CLIN PHARMACO, V84, P2600, DOI 10.1111/bcp.13716; Wauters M, 2016, BRIT J CLIN PHARMACO, V82, P1382, DOI 10.1111/bcp.13055; Weng MC, 2013, QJM-INT J MED, V106, P1009, DOI 10.1093/qjmed/hct141; Winit-Watjana W, 2008, ARCH GERONTOL GERIAT, V47, P35, DOI 10.1016/j.archger.2007.06.006; World Health Organization, 2002, IMP PHARM SAF MON ME, P52	63	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0219898	10.1371/journal.pone.0219898	http://dx.doi.org/10.1371/journal.pone.0219898			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WC	31348784	Green Published, Green Submitted, gold			2022-12-26	WOS:000484979500013
J	Nicot, S; Verchere, J; Belondrade, M; Mayran, C; Betemps, D; Bougard, D; Baron, T				Nicot, Simon; Verchere, Jeremy; Belondrade, Maxime; Mayran, Charly; Betemps, Dominique; Bougard, Daisy; Baron, Thierry			Seeded propagation of alpha-synuclein aggregation in mouse brain using protein misfolding cyclic amplification	FASEB JOURNAL			English	Article						prion; seeding; PMCA; alpha-syn	MICE; PATHOLOGY; DISEASE; TRANSMISSION; PRIONS; SYSTEM	alpha-Synuclein (alpha-syn) protein aggregation is associated with several neurodegenerative disorders collectively referred to as synucleinopathies, including Parkinson's disease. We used protein misfolding cyclic amplification (PMCA) to study alpha-syn aggregation in brain homogenates of wild-type or transgenic mice expressing normal (D line) or A53T mutant (M83 line) human alpha-syn. We found that sonication-incubation cycles of M83 mouse brain gradually produce large quantities of SDS-resistant alpha-syn aggregates, involving both human and mouse proteins. These PMCA products, containing partially proteinase K-resistant alpha-syn species, are competent to accelerate the onset of neurologic symptoms after intracerebral inoculation to young M83 mice and to seed aggregate formation of alpha-syn following PMCA, including in D and wild-type mouse brain substrates. PMCA seeding activity in the M83 diseased brain correlates positively with regions mostly targeted by the alpha-syn pathology in this model. Our data indicate that similar to prions, PMCA can reproduce some characteristics of alpha-syn aggregation and seeded propagation in vitro in a complex milieu. This opens new opportunities for the molecular study of synucleinopathies.	[Nicot, Simon; Belondrade, Maxime; Mayran, Charly; Bougard, Daisy] Univ Montpellier, INSERM, Etab Francais Sang, Pathogenesis & Control Chron Infect, Montpellier, France; [Verchere, Jeremy; Betemps, Dominique; Baron, Thierry] Univ Lyon, French Agcy Food Environm & Occupat Hlth & Safety, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Baron, T (corresponding author), ANSES, Lab Lyon, 31 Ave Tony Garnier, F-69364 Lyon 7, France.	thierry.baron@anses.fr		BOUGARD, Daisy/0000-0002-8779-9251; MAYRAN, Charly/0000-0003-0262-5138				Ayers JI, 2018, J VIROL, V92, DOI 10.1128/JVI.00586-18; Ayers JI, 2017, J VIROL, V91, DOI 10.1128/JVI.02095-16; Becker K, 2018, MOL NEUROBIOL, V55, P8728, DOI 10.1007/s12035-018-1007-y; Bencsik A, 2014, J NEUROPATH EXP NEUR, V73, P1144, DOI 10.1097/NEN.0000000000000137; Betemps D, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-29; Betemps D, 2015, JOVE-J VIS EXP, DOI 10.3791/52752; Bougard D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1257; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Breid S, 2016, J VIROL, V90, P9182, DOI 10.1128/JVI.01399-16; Candelise N, 2019, ANN NEUROL, V85, P691, DOI 10.1002/ana.25446; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Dhillon JKS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0733-3; Fairfoul G, 2016, ANN CLIN TRANSL NEUR, V3, P812, DOI 10.1002/acn3.338; Fenyi A, 2019, NEUROBIOL DIS, V129, P38, DOI 10.1016/j.nbd.2019.05.002; Ferreira ND, 2019, CURR OPIN PHARMACOL, V44, P1, DOI 10.1016/j.coph.2018.10.001; Flagmeier P, 2016, P NATL ACAD SCI USA, V113, P10328, DOI 10.1073/pnas.1604645113; Froula JM, 2019, J BIOL CHEM, V294, P10392, DOI 10.1074/jbc.RA119.007743; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Herva ME, 2014, J BIOL CHEM, V289, P11897, DOI 10.1074/jbc.M113.542340; Jung BC, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.1; Kang LJ, 2011, J AM CHEM SOC, V133, P13465, DOI 10.1021/ja203979j; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lohmann S., 2019, ACTA NEUROPATHOL; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mokretar K, 2018, BRAIN, V141, P2419, DOI 10.1093/brain/awy157; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Paciotti S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00415; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Roostaee A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-5; Rutherford NJ, 2017, HUM MOL GENET, V26, P4906, DOI 10.1093/hmg/ddx371; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sacino AN, 2014, ACTA NEUROPATHOL, V127, P645, DOI 10.1007/s00401-014-1268-0; Sargent D, 2017, J NEUROCHEM, V143, P126, DOI 10.1111/jnc.14139; Shahnawaz M, 2017, JAMA NEUROL, V74, P163, DOI 10.1001/jamaneurol.2016.4547; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Steiner JA, 2018, CELL TISSUE RES, V373, P161, DOI 10.1007/s00441-018-2814-1; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Ugalde CL, 2019, J BIOL CHEM, V294, P9016, DOI 10.1074/jbc.REV119.007500; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Woerman AL, 2018, ACTA NEUROPATHOL, V135, P49, DOI 10.1007/s00401-017-1762-2	48	9	10	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12073	12086		10.1096/fj.201900354R	http://dx.doi.org/10.1096/fj.201900354R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370680	Green Published			2022-12-26	WOS:000507461600037
J	Caslini, C; Hong, S; Ban, YJ; Chen, XS; Ince, TA				Caslini, Corrado; Hong, Sunhwa; Ban, Yuguang J.; Chen, Xi S.; Ince, Tan A.			HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells	ONCOGENE			English	Article							DEACETYLASE INHIBITORS; EXPRESSION; MATURATION; REPRESSION; PROMOTER; IDENTITY; ROLES; TIP60	Chromatin regulation through histone modifications plays an essential role in coordinated expression of multiple genes. Alterations in chromatin induced by histone modifiers and readers regulate critical transcriptional programs involved in both normal development and tumor differentiation. Recently, we identified that histone deacetylases HDAC1 and HDAC7 are necessary to maintain cancer stem cells (CSCs) in both breast and ovarian tumors. Here, we sought to investigate the CSC-specific function of HDAC1 and HDAC7 mechanistically by using a stem-like breast cancer (BrCa) cell model BPLER and matched nonstem tumor cell (nsTC)-like HMLER, along with conventional BrCa cell lines with different CSC enrichment levels. We found that HDAC1 and HDAC3 inhibition or knockdown results in HDAC7 downregulation, which is associated with a decrease in histone 3 lysine 27 acetylation (H3K27ac) at transcription start sites (TSS) and super-enhancers (SEs) prominently in stem-like BrCa cells. Importantly, these changes in chromatin landscape also correlate with the repression of many SE-associated oncogenes, including c-MYC, CD44, CDKN1B, SLUG, VDR, SMAD3, VEGFA, and XBP1. In stem-like BrCa cells, HDAC7 binds near TSS and to SEs of these oncogenes where it appears to contribute to both H3K27ac and transcriptional regulation. These results suggest that HDAC7 inactivation, directly or through inhibition of HDAC1 and HDAC3, can result in the inhibition of the CSC phenotype by downregulating multiple SE-associated oncogenes. The CSC selective nature of this mechanism and the prospect of inhibiting multiple oncogenes simultaneously makes development of HDAC7 specific inhibitors a compelling objective.	[Caslini, Corrado; Hong, Sunhwa; Ban, Yuguang J.; Chen, Xi S.; Ince, Tan A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Biomed Res Bldg, Miami, FL 33136 USA; [Ban, Yuguang J.; Chen, Xi S.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Caslini, C; Ince, TA (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Biomed Res Bldg, Miami, FL 33136 USA.; Ince, TA (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.; Ince, TA (corresponding author), Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA.	ccaslini@med.miami.edu; TInce@med.miami.edu	Caslini, Corrado/W-6123-2019	Caslini, Corrado/0000-0001-8326-8368; Ban, Yuguang/0000-0002-2874-0647; Ince, Tan/0000-0003-0315-6425	Breast Cancer Research Foundation (NY); Florida Breast Cancer Foundation (FL); Sylvester Comprehensive Cancer Center	Breast Cancer Research Foundation (NY); Florida Breast Cancer Foundation (FL); Sylvester Comprehensive Cancer Center	We gratefully acknowledge the Sylvester Comprehensive Cancer Center, Onco-Genomics Shared Resource for ChIP, and RNA sequencing services. This work was funded by grants to TAI from Breast Cancer Research Foundation (NY), Florida Breast Cancer Foundation (FL), and Sylvester Comprehensive Cancer Center.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Ahn MY, 2017, J ORAL PATHOL MED, V46, P276, DOI 10.1111/jop.12560; Ai W, 2007, NUCLEIC ACIDS RES, V35, P6137, DOI 10.1093/nar/gkm656; Aude-Garcia C, 2010, BIOCHEM J, V430, P237, DOI 10.1042/BJ20100131; Barneda-Zahonero B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.594; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gao S, 2018, CLIN TRANSL ONCOL, V20, P703, DOI 10.1007/s12094-017-1770-7; Glaser KB, 2003, MOL CANCER THER, V2, P151; Greer CB, 2015, CELL REP, V13, P1444, DOI 10.1016/j.celrep.2015.10.013; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hull EE, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8797206; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Kaletsch A, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0531-y; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kim YJ, 2013, ONCOGENE, V32, P2828, DOI 10.1038/onc.2013.32; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lei YB, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0736-2; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Ma C, 2011, J BIOL CHEM, V286, P4819, DOI 10.1074/jbc.M110.146860; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Rickels R, 2018, TRENDS CELL BIOL, V28, P608, DOI 10.1016/j.tcb.2018.04.003; Sanchez GJ, 2018, NUCLEIC ACIDS RES, V46, P1756, DOI 10.1093/nar/gkx1225; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Singh J, 2002, ONCOGENE, V21, P1812, DOI 10.1038/sj.onc.1205252; Toh Y, 2003, ONCOL REP, V10, P333; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Witt AE, 2017, ONCOGENE, V36, P1707, DOI 10.1038/onc.2016.337; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yano M, 2018, ONCOL LETT, V15, P3524, DOI 10.3892/ol.2018.7726; Yu Y, 2017, CLIN TRANSL ONCOL, V19, P1045, DOI 10.1007/s12094-017-1639-9; Zhu CH, 2011, J MOL MED, V89, P279, DOI 10.1007/s00109-010-0701-7	45	46	46	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2019	38	39					6599	6614		10.1038/s41388-019-0897-0	http://dx.doi.org/10.1038/s41388-019-0897-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JA5AQ	31375747	hybrid			2022-12-26	WOS:000487856000003
J	Marcum, RD; Radhakrishnan, I				Marcum, Ryan Dale; Radhakrishnan, Ishwar			Inositol phosphates and core subunits of the Sin3L/Rpd3L histone deacetylase (HDAC) complex up-regulate deacetylase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription regulation; chromatin modification; histone deacetylase (HDAC); protein-protein interaction; allosteric regulation; inositol phosphate; signaling; gene expression; epigenetics; cofactor-mediated protein-protein interaction; convergent evolution	COREPRESSOR COMPLEX; SIN3A COREPRESSOR; CLASS-I; PROTEIN; REPRESSOR; SAP30L; ROLES	The constitutively nuclear histone deacetylases (HDACs) 1, 2, and 3 erase acetyl marks on acetyllysine residues, alter the landscape of histone modifications, and modulate chromatin structure and dynamics and thereby crucially regulate gene transcription in higher eukaryotes. Nuclear HDACs exist as at least six giant multiprotein complexes whose nonenzymatic subunits confer genome targeting specificity for these enzymes. The deacetylase activity of HDACs has been shown previously to be enhanced by inositol phosphates, which also bridge the catalytic domain in protein-protein interactions with SANT (Swi3, Ada2, N-Cor, and TFIIIB) domains in all HDAC complexes except those that contain the Sin3 transcriptional corepressors. Here, using purified recombinant proteins, coimmunoprecipitation and HDAC assays, and pulldown and NMR experiments, we show that HDAC1/2 deacetylase activity in one of the most ancient and evolutionarily conserved Sin3L/Rpd3L complexes is inducibly up-regulated by inositol phosphates but involves interactions with a zinc finger motif in the Sin3-associated protein 30 (SAP30) subunit that is structurally unrelated to SANT domains, indicating convergent evolution at the functional level. This implies that this mode of regulation has evolved independently multiple times and provides an evolutionary advantage. We also found that constitutive association with another core subunit, Rb-binding protein 4 chromatin-binding factor (RBBP4), further enhances deacetylase activity, implying both inducible and constitutive regulatory mechanisms within the same HDAC complex. Our results indicate that inositol phosphates stimulate HDAC activity and that the SAP30 zinc finger motif performs roles similar to that of the unrelated SANT domain in promoting the SAP30-HDAC1 interaction and enhancing HDAC activity.	[Marcum, Ryan Dale; Radhakrishnan, Ishwar] Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr, Evanston, IL 60208 USA	Northwestern University	Radhakrishnan, I (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr, Evanston, IL 60208 USA.	i-radhakrishnan@northwestern.edu	Radhakrishnan, Ishwar/AHA-7392-2022	Radhakrishnan, Ishwar/0000-0002-0195-9710; Marcum, Ryan/0000-0002-4595-8023	American Heart Association [14GRNT20170003, 17GRNT33680167, 16PRE27260041]; NIGMS, National Institutes of Health [T32 GM008382]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008382] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grants 14GRNT20170003 and 17GRNT33680167 (to I. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by predoctoral fellowships from the NIGMS, National Institutes of Health (T32 GM008382) and the American Heart Association (16PRE27260041).	Adams GE, 2018, BIOCHEM J, V475, P3921, DOI 10.1042/BCJ20170314; Arrar M, 2013, PROTEIN SCI, V22, P83, DOI 10.1002/pro.2190; Banks CAS, 2018, MOL CELL PROTEOMICS, V17, P1432, DOI 10.1074/mcp.TIR118.000661; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barker CJ, 2004, BIOCHEM J, V380, P465, DOI 10.1042/BJ20031872; Bowman CJ, 2014, NAT CELL BIOL, V16, P1202, DOI 10.1038/ncb3062; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chaubal A, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0188-y; Clark MD, 2015, P NATL ACAD SCI USA, V112, pE3669, DOI 10.1073/pnas.1504021112; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; He Y, 2009, NUCLEIC ACIDS RES, V37, P2142, DOI 10.1093/nar/gkp051; Jamaladdin S, 2014, P NATL ACAD SCI USA, V111, P9840, DOI 10.1073/pnas.1321330111; Laitaoja M, 2016, PROTEIN SCI, V25, P572, DOI 10.1002/pro.2849; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Portolano N, 2014, JOVE-J VIS EXP, DOI 10.3791/51897; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Salerno WJ, 2004, NUCLEIC ACIDS RES, V32, pW566, DOI 10.1093/nar/gkh434; Schultz BE, 2004, BIOCHEMISTRY-US, V43, P11083, DOI 10.1021/bi0494471; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Viiri KM, 2006, NUCLEIC ACIDS RES, V34, P3288, DOI 10.1093/nar/gkl401; Viiri KM, 2009, MOL CELL BIOL, V29, P342, DOI 10.1128/MCB.01213-08; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watson PJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11262; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Worley J, 2013, CELL REP, V3, P1476, DOI 10.1016/j.celrep.2013.03.043; Xie T, 2011, J BIOL CHEM, V286, P27814, DOI 10.1074/jbc.M111.252494; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	37	10	10	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13928	13938		10.1074/jbc.RA119.009780	http://dx.doi.org/10.1074/jbc.RA119.009780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31358618	hybrid, Green Published			2022-12-26	WOS:000490729800008
J	Uematsu, A; Kido, K; Takahashi, H; Takahashi, C; Yanagihara, Y; Saeki, N; Yoshida, S; Maekawa, M; Honda, M; Kai, T; Shimizu, K; Higashiyama, S; Imai, Y; Tokunaga, F; Sawasaki, T				Uematsu, Atsushi; Kido, Kohki; Takahashi, Hirotaka; Takahashi, Chikako; Yanagihara, Yuta; Saeki, Noritaka; Yoshida, Shuhei; Maekawa, Masashi; Honda, Mamoru; Kai, Tsutomu; Shimizu, Kouhei; Higashiyama, Shigeki; Imai, Yuuki; Tokunaga, Fuminori; Sawasaki, Tatsuya			The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; inflammation; NF-kappa B (NF-KB); autoimmunity; cellular immune response; CYLD; mind bomb homologue 2 (MIB2); mind bomb E3 ubiquitin protein ligase 2; multiple familial trichoepithelioma (MFT); protein array; NF-kappa B pathway	NF-KAPPA-B; MULTIPLE FAMILIAL TRICHOEPITHELIOMA; BROOKE-SPIEGLER-SYNDROME; TUMOR-SUPPRESSOR CYLD; MISSENSE MUTATION; LINEAR UBIQUITIN; CHINESE FAMILY; CELL-DEATH; GENE; CYLINDROMATOSIS	The tumor suppressor CYLD is a deubiquitinating enzyme that suppresses polyubiquitin-dependent signaling pathways, including the proinflammatory and cell growth-promoting NF-kappa B pathway. Missense mutations in the CYLD gene are present in individuals with syndromes such as multiple familial trichoepithelioma (MFT), but the pathogenic roles of these mutations remain unclear. Recent studies have shown that CYLD interacts with a RING finger domain protein, mind bomb homologue 2 (MIB2), in the regulation of NOTCH signaling. However, whether MIB2 is an E3 ubiquitin ligase that acts on CYLD is unknown. Here, using the cell-free-based AlphaScreen and pulldown assays to detect protein-protein interactions, along with immunofluorescence assays and murine Mib2 knockout cells and animals, we demonstrate that MIB2 promotes proteasomal degradation of CYLD and enhances NF-kappa B signaling. Of note, arthritic inflammation was suppressed in Mib2-deficient mice. We further observed that the ankyrin repeat in MIB2 interacts with the third CAP domain in CYLD and that MIB2 catalyzes Lys-48-linked polyubiquitination of CYLD at Lys-338 and Lys-530. MIB2-dependent CYLD degradation activated NF-kappa B signaling via tumor necrosis factor alpha (TNF alpha) stimulation and the linear ubiquitination assembly complex (LUBAC). Mib2-knockout mice had reduced serum interleukin-6 (IL-6) and exhibited suppressed inflammatory responses in the K/BxN serum-transfer arthritis model. Interestingly, MIB2 significantly enhanced the degradation of a CYLDP904L variant identified in an individual with MFT, although the molecular pathogenesis of the disease was not clarified here. Together, these results suggest that MIB2 enhances NF-kappa B signaling in inflammation by promoting the ubiquitin-dependent degradation of CYLD.	[Uematsu, Atsushi; Kido, Kohki; Takahashi, Hirotaka; Takahashi, Chikako; Shimizu, Kouhei; Sawasaki, Tatsuya] Proteosci Ctr PROS, Div Cell Free Sci, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan; [Yanagihara, Yuta; Saeki, Noritaka; Yoshida, Shuhei; Imai, Yuuki] PROS, Div Integrat Pathophysiol, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan; [Maekawa, Masashi] PROS, Div Cell Growth & Tumor Regulat, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan; [Maekawa, Masashi; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan; [Honda, Mamoru; Kai, Tsutomu] Shimadzu Technores Inc, Pharmaceut & Life Sci Div, Nakagyo Ku, Kyoto 6048436, Japan; [Tokunaga, Fuminori] Osaka City Univ, Grad Sch Med, Dept Pathobiochem, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan; [Shimizu, Kouhei] Tohoku Univ, Grad Sch Dent, Ctr Adv Stem Cell & Regenerat Res, Sendai, Miyagi 9808575, Japan	Ehime University; Osaka Metropolitan University; Tohoku University	Sawasaki, T (corresponding author), Proteosci Ctr PROS, Div Cell Free Sci, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	sawasaki@ehime-u.ac.jp	Imai, Yuuki/ABC-4687-2020; Saeki, Noritaka/AAK-8797-2021	Tokunaga, Fuminori/0000-0003-3626-9119; Sawasaki, Tatsuya/0000-0002-7952-0556; Maekawa, Masashi/0000-0002-9574-1906; Saeki, Noritaka/0000-0002-2520-8292; Shimizu, Kouhei/0000-0001-9523-4296	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)), Japan Agency for Medical Research and Development (AMED) Grants [JP17am0101077, 18am0101077, 19am0101077]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [JP25117719, JP16H06579]; Japan Society for the Promotion of Science (JSPS) [JP15J03774]; JSPS KAKENHI Grants [JP15J03774, JP16K18570, JP16H04729, 19H03218]; Takeda Science Foundation	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)), Japan Agency for Medical Research and Development (AMED) Grants; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI Grants; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was mainly supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)), Japan Agency for Medical Research and Development (AMED) Grants JP17am0101077, 18am0101077, and 19am0101077 (to T. S.); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) Grants-in-Aid for Scientific Research on Innovative Areas JP25117719 and JP16H06579 (to T. S.); and Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for JSPS Research Fellow JP15J03774 (to A. U.). This work was also partially supported by JSPS KAKENHI Grants JP15J03774 (to A. U.), JP16K18570 (to H. T.), JP16H04729 (to T. S.), and 19H03218 (to T. S.), and by the Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Almeida S, 2008, J INVEST DERMATOL, V128, P587, DOI 10.1038/sj.jid.5701045; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bowen S, 2005, J INVEST DERMATOL, V124, P919, DOI 10.1111/j.0022-202X.2005.23688.x; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ditzel HJ, 2004, TRENDS MOL MED, V10, P40, DOI 10.1016/j.molmed.2003.11.004; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Dupe V, 1997, DEVELOPMENT, V124, P399; Espana A, 2007, ARCH DERMATOL, V143, P1209, DOI 10.1001/archderm.143.9.1209; Feltham R, 2018, CELL REP, V23, P470, DOI 10.1016/j.celrep.2018.03.054; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu GF, 2003, J INVEST DERMATOL, V121, P732, DOI 10.1046/j.1523-1747.2003.12514.x; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Hyun TS, 2004, MOL CELL BIOL, V24, P4329, DOI 10.1128/MCB.24.10.4329-4340.2004; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kazakov DV, 2009, AM J SURG PATHOL, V33, P705, DOI 10.1097/PAS.0b013e3181966762; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Lv HL, 2008, J DERMATOL SCI, V50, P143, DOI 10.1016/j.jdermsci.2007.11.012; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rajan N, 2014, ONCOTARGET, V5, P12126, DOI 10.18632/oncotarget.2573; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schlicher L, 2016, EMBO REP, V17, P1485, DOI 10.15252/embr.201642592; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Shimizu K, 2014, FEBS LETT, V588, P3030, DOI 10.1016/j.febslet.2014.05.060; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sima R, 2010, DIAGN MOL PATHOL, V19, P83, DOI 10.1097/PDM.0b013e3181ba2d96; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stempin CC, 2011, J BIOL CHEM, V286, P37147, DOI 10.1074/jbc.M111.263384; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Takahashi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156718; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Takeuchi T, 2005, AM J PATHOL, V166, P1817, DOI 10.1016/S0002-9440(10)62491-1; Tokunaga F, 2013, J BIOCHEM, V154, P313, DOI 10.1093/jb/mvt079; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang FX, 2010, ARCH DERMATOL RES, V302, P67, DOI 10.1007/s00403-009-1003-1; Wu XM, 2014, ONCOTARGET, V5, P4211, DOI 10.18632/oncotarget.1971; Yano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156716; Ye JS, 2014, J VIROL, V88, P12765, DOI 10.1128/JVI.02037-14; Yoshida Y, 2015, P NATL ACAD SCI USA, V112, P4630, DOI 10.1073/pnas.1422313112; Young AL, 2006, CLIN GENET, V70, P246, DOI 10.1111/j.1399-0004.2006.00667.x; Zheng GY, 2004, HUM MUTAT, V23, P400, DOI 10.1002/humu.9231; Zinngrebe J, 2014, EMBO REP, V15, P28, DOI 10.1002/embr.201338025; Zuo YG, 2007, BRIT J DERMATOL, V157, P818, DOI 10.1111/j.1365-2133.2007.08081.x	68	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14135	14148		10.1074/jbc.RA119.010119	http://dx.doi.org/10.1074/jbc.RA119.010119			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366726	hybrid, Green Published			2022-12-26	WOS:000490729800025
J	Kim, D; Jung, IH; Kim, DH; Park, SW				Kim, Do Hee; Jung, In Hye; Kim, Dong Hee; Park, Seung Woo			Knockout of longevity gene Sirt1 in zebrafish leads to oxidative injury, chronic inflammation, and reduced life span	PLOS ONE			English	Article							STRESS; PATHWAY	Sirt1, a member of the sirtuin gene family, encodes the most conserved mammalian NAD(+)-dependent deacetylase enzyme responsible for removing acetyl groups from many proteins. The Sirt1 gene is known as a longevity gene whose knockout in mice leads to decreased lifespan relative to the wild type. This study aimed to explore phenotypic changes in zebrafish Sirt1-knockouts and to investigate the function of the Sirt1 gene. Targeted knockout of Sirt1 in zebrafish (Danio rerio) was achieved using the CRISPR-Cas9 genome editing system. We created a 4-bp insertion-homozygote Sirt1-knockout zebrafish. Although there was no evident difference in appearance in the early stages of development, a significant increase in reactive oxygen species and in the extent of apoptosis in Sirt1-knockout zebrafish was observed. Sirt1 knockout caused inflammatory genes, including IL-1b, IL-6 and TNF-alpha to be highly expressed. Additionally, the lack of Sirt1 caused chronic inflammation and intestinal atrophy, thereby increasing pro-apoptotic events, which ultimately reduced the lifespan of transgenic zebrafish. Overall, our data demonstrate that lack of Sirt1 caused a significantly increased generation of reactive oxygen species that resulted in chronic inflammation and regeneration. Continuous repetition of these events played an important role in accelerating aging, thereby decreasing lifespan. Our findings using the knockout zebrafish model confirmed the association of the Sirt1 gene to aging processes and lifespan. Furthermore, the Sirt1-knockout mutant zebrafish developed in our study will surely be a valuable model to explore the mechanism of chronic inflammation.	[Kim, Do Hee; Kim, Dong Hee] Yonsei Univ, Postgrad Sch Nano Sci & Technol, Seoul, South Korea; [Jung, In Hye; Park, Seung Woo] Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Inst Gastroenterol, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Park, SW (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Inst Gastroenterol, Seoul, South Korea.	swoopark@yuhs.ac		Park, Seung Woo/0000-0001-8230-964X	Technology Innovation Program - Ministry of Trade, Industry & Energy (MOTIE, Korea) [10063396]; Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education [2015R1D1A1A09060230]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1324]	Technology Innovation Program - Ministry of Trade, Industry & Energy (MOTIE, Korea); Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education; Korea Health Technology R&D Project through the Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by the Technology Innovation Program (10063396 to SWP, Zebrafish-based services in efficacy, Toxicity, and druggability) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea), Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education(2015R1D1A1A09060230 to SWP), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute(KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI14C1324 to SWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Chan SH, 2017, REDOX BIOL, V13, P301, DOI 10.1016/j.redox.2017.05.027; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Haegens A, 2008, EUR RESPIR J, V31, P252, DOI 10.1183/09031936.00029307; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Halasi M, 2013, BIOCHEM J, V454, P201, DOI 10.1042/BJ20130282; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jung IH, 2015, NEOPLASIA, V17, P586, DOI 10.1016/j.neo.2015.07.005; Jung IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027941; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Li Kai, 2011, N Am J Med Sci (Boston), V4, P104; Liu Tie Fu, 2013, Genes Cancer, V4, P135, DOI 10.1177/1947601913476948; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zou Y, 2003, FASEB J, V17, P320, DOI 10.1096/fj.03-0849fje	24	21	21	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220581	10.1371/journal.pone.0220581	http://dx.doi.org/10.1371/journal.pone.0220581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386694	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100025
J	At Thobari, J; Satria, CD; Ridora, Y; Watts, E; Handley, A; Samad, S; Bachtiar, NS; Bines, JE; Soenarto, Y; Buttery, JP				At Thobari, Jarir; Satria, Cahya Dewi; Ridora, Yohanes; Watts, Emma; Handley, Amanda; Samad, Samad; Bachtiar, Novilia S.; Bines, Julie E.; Soenarto, Yati; Buttery, Jim P.			Antimicrobial use in an Indonesian community cohort 0-18 months of age	PLOS ONE			English	Article							ANTIBIOTIC USE; OPHTHALMIA NEONATORUM; CHILDREN; CHLORAMPHENICOL; FORMULATIONS; ASSOCIATION; INFECTIONS; PREVENTION; EFFICACY; INFANTS	Background Antimicrobial resistance has become a global health emergency and is contributed to by inappropriate antibiotic use in community clinical settings. The aim of this study was to evaluate the antimicrobial use pattern in infants from birth until 18 months of age in Indonesia. Methods A post-hoc analysis was conducted in 1621 participants from the RV3BB Phase IIb trial conducted in Indonesia from January 2013 through July 2016. Any health events were documented in the trial as adverse events. Concomitant medication surveillance recorded all medications, including antibiotics during the 18 months of follow-up. Information included the frequency, duration of usage, formulation, classes, and their indications, including prophylactic antibiotic and perinatal use. Results Of 1621 participants, 551 (33.99%) received at least one antibiotic for treatment of infections during the 18 months observation period. Additionally, during the perinatal period, prophylactic antibiotics were used in 1244 (76.74%) participants and antibiotics consumed in 235 mothers of participants (14.50%). A total of 956 antibiotic consumptions were recorded for 18 months follow up, 67 (7.01%) as part of antimicrobial combinations. The average duration of antibiotic course was 4.92 days. Penicillin and sulfonamides were the most common antibiotic classes consumed (38.81% and 24.48%, respectively). Conclusions Despite the low community consumption rate, the overuse of antibiotic in URTIs and nonbloody diarrhea in our setting represents a major opportunity for antimicrobial stewardship, particularly in early life.	[At Thobari, Jarir; Satria, Cahya Dewi; Ridora, Yohanes; Soenarto, Yati] Univ Gadjah Mada, Pediat Res Off, Dept Pediat, Fac Med Publ Hlth & Nursing, Yogyakarta, Special Region, Indonesia; [At Thobari, Jarir] Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nursing, Yogyakarta, Special Region, Indonesia; [Watts, Emma; Handley, Amanda; Bines, Julie E.; Buttery, Jim P.] Murdoch Childrens Res Inst, RV3 Rotavirus Vaccine Program, Parkville, Vic, Australia; [Handley, Amanda] Med Dev Global Hlth, Melbourne, Vic, Australia; [Samad, Samad; Bines, Julie E.] Soeradji Tirtonegoro Gen Hosp, Klaten, Central Java, Indonesia; [Bachtiar, Novilia S.] PT Bio Farma, Bandung, West Java, Indonesia; [Bines, Julie E.; Buttery, Jim P.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Bines, Julie E.] Royal Childrens Hosp Melbourne, Dept Gastroenterol & Clin Nutr, Parkville, Vic, Australia; [Buttery, Jim P.] Monash Univ, Dept Paediat, Clayton, Vic, Australia; [Buttery, Jim P.] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia; [Buttery, Jim P.] Monash Childrens Hosp, Dept Infect & Immun, Clayton, Vic, Australia	Gadjah Mada University; Gadjah Mada University; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; Monash University; Monash University	At Thobari, J (corresponding author), Univ Gadjah Mada, Pediat Res Off, Dept Pediat, Fac Med Publ Hlth & Nursing, Yogyakarta, Special Region, Indonesia.; At Thobari, J (corresponding author), Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nursing, Yogyakarta, Special Region, Indonesia.	j.atthobari@ugm.ac.id	At Thobari, Jarir/GOP-2379-2022	At Thobari, Jarir/0000-0002-7035-4846; Ridora, Yohanes/0000-0002-7104-9595; Bines, Julie/0000-0002-5452-6601	PT Biofarma; Murdoch Children's Research Institute	PT Biofarma; Murdoch Children's Research Institute	The vaccine company PT Bio Farma provided support for this study in the form of a salary for the author NSB. The specific role of this author is articulated in the 'author contributions' section. Additionally, PT Biofarma was one of the funders of the RV3-BB Phase IIb trial. Another funding source of the RV3-BB Phase IIb trial was Murdoch Children's Research Institute. The funders had roles in the study design, decision to publish, and preparation of the manuscript.	Ahmed AM, 2010, ANN PHARMACOTHER, V44, P1986, DOI 10.1345/aph.1P423; Allegaert Karel, 2013, World J Clin Pediatr, V2, P1, DOI 10.5409/wjcp.v2.i1.1; Altiner A, 2007, J ANTIMICROB CHEMOTH, V60, P638, DOI 10.1093/jac/dkm254; [Anonymous], 2014, WHO GLOB REP SURV AN; [Anonymous], 2011, WHO EV TECHN UPD POC; Bailey LC, 2014, JAMA PEDIATR, V168, P1063, DOI 10.1001/jamapediatrics.2014.1539; Batchelor HK, 2015, BRIT J CLIN PHARMACO, V79, P405, DOI 10.1111/bcp.12268; Biezen R, 2017, NPJ PRIM CARE RESP M, V27, P1, DOI [10.1038/s41533-016-0007-5, DOI 10.1038/S41533-016-0007-5]; Bines JE, 2018, NEW ENGL J MED, V378, P719, DOI 10.1056/NEJMoa1706804; Bramantyo T, 2015, ASIA-PAC J OPHTHALMO, V4, P180, DOI 10.1097/APO.0000000000000070; Cabral C, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-63; Clift C, 2017, VACCINE, V35, P6591, DOI 10.1016/j.vaccine.2017.09.053; Darling EK, 2010, J MIDWIFERY WOM HEAL, V55, P319, DOI 10.1016/j.jmwh.2009.09.003; De Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154662; de Tejada BM, 2014, INT J ENV RES PUB HE, V11, P7993, DOI 10.3390/ijerph110807993; Fuchs A, 2018, PAEDIATR INT CHILD H, V38, pS3, DOI 10.1080/20469047.2017.1408738; Grimwood K, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0006-x; Holstiege J, 2013, EUR J PEDIATR, V172, P787, DOI 10.1007/s00431-013-1958-y; Joseph F, 2015, ETHIOP J HEALTH SCI, V25, P73, DOI 10.4314/ejhs.v25i1.10; Kastelan S, 2018, MED SCI MONITOR, V24, P8042, DOI 10.12659/MSM.910705; Klugman KP, 2018, P NATL ACAD SCI USA, V115, P12896, DOI 10.1073/pnas.1721095115; Kuperman AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0636-0; Laporte JR, 1998, BRIT J CLIN PHARMACO, V46, P181, DOI 10.1046/j.1365-2125.1998.00773.x; Laxminarayan R, 2012, BMJ-BRIT MED J, V344, P25; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lee ACC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001741; Lee CF, 2018, J ANTIMICROB CHEMOTH, V73, P844, DOI 10.1093/jac/dkx492; Levy Y, 2004, CLIN PEDIATR, V43, P99, DOI 10.1177/000992280404300114; Lindell A, 2011, AM FAM PHYSICIAN, V83, P747; Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16; Maindoka FS, 2017, PHARMACON, V6, P240; Matejcek A, 2013, CAN FAM PHYSICIAN, V59, P1187; Mensah KB, 2017, J PHARM POLICY PRACT, V10, P4; MoH Republic of Indonesia, 2010, ESS NEWB CAR TECHN G; Hoa NQ, 2011, T ROY SOC TROP MED H, V105, P628, DOI 10.1016/j.trstmh.2011.07.015; Pandey Anuja A, 2010, Indian J Community Med, V35, P70, DOI 10.4103/0970-0218.62564; Pudjiadi Antonius H, 2009, PEDOMAN PELAYANAN ME; Pujiarto PS, 2010, B WORLD HEALTH ORGAN, V87, P570; Puspitasari HP, 2011, TROP MED INT HEALTH, V16, P840, DOI 10.1111/j.1365-3156.2011.02782.x; Rahmawati F, 2006, MAJ FARM INDONES, V17, P177; Ramasethu J, 2017, SEMIN FETAL NEONAT M, V22, P278, DOI 10.1016/j.siny.2017.07.001; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Rogawski ET, 2017, B WORLD HEALTH ORGAN, V95, P49, DOI 10.2471/BLT.16.176123; Salazar ML, 2012, CLIN PEDIATR, V51, P632, DOI 10.1177/0009922812439243; Schaller UC, 2001, B WORLD HEALTH ORGAN, V79, P262; Schrag SJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2013; Stam J, 2012, ACTA PAEDIATR, V101, P929, DOI 10.1111/j.1651-2227.2012.02728.x; Turnbull SL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008615; van Riet-Nales DA, 2013, ARCH DIS CHILD, V98, P725, DOI 10.1136/archdischild-2012-303303; WHO, 2017, WHO REC NEWB HLTH; Wong DM, 2006, AM FAM PHYSICIAN, V74, P956; World Health Organization, 2014, CHART BOOKL IMCI INT; Youngster I, 2017, J PEDIATR-US, V182, P239, DOI 10.1016/j.jpeds.2016.11.027; Zuppa AA, 2011, J MATERN-FETAL NEO M, V24, P769, DOI 10.3109/14767058.2010.531326	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219097	10.1371/journal.pone.0219097	http://dx.doi.org/10.1371/journal.pone.0219097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381611	Green Published, gold			2022-12-26	WOS:000484993600003
J	Hackett, RA; Steptoe, A; Cadar, D; Fancourt, D				Hackett, Ruth A.; Steptoe, Andrew; Cadar, Dorina; Fancourt, Daisy			Social engagement before and after dementia diagnosis in the English Longitudinal Study of Ageing	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; RISK; METAANALYSIS; DEPRESSION; SYMPTOMS; DECLINE; LIFE	Background Social engagement protects against dementia onset. Less is known about patterns of social engagement around the time of dementia diagnosis. We investigated face-to-face and telephone contact at three times (pre-diagnosis, at report of diagnosis, 2 years post-diagnosis) in individuals who developed dementia and a comparison group. Methods Social engagement was assessed at waves 2-7 of the English Longitudinal Study of Ageing in 4171 individuals aged 50 and older. Dementia was ascertained by either self-reported physician diagnosis or through an informant evaluation of a participant's functional and cognitive performance compared with a few years earlier. Generalized estimating equations were used to examine differences by group, time, and group-by-time interactions. Results The dementia group reported less face-to-face (p < 0.001) and telephone contact (p < 0.001) than the dementia-free group pre-diagnosis. The dementia group experienced greater reductions in social engagement leading up to dementia diagnosis and in the 2 years following diagnosis (p's < 0.001). Conclusion Given that social engagement reduces dementia risk and supports the lived experience of people with dementia, it is important to find ways of promoting social interaction in older adults.	[Hackett, Ruth A.; Steptoe, Andrew; Cadar, Dorina; Fancourt, Daisy] UCL, Dept Behav Sci & Hlth, London, England	University of London; University College London	Hackett, RA (corresponding author), UCL, Dept Behav Sci & Hlth, London, England.	ruth.hackett.09@ucl.ac.uk	Cadar, Dorina/D-4510-2017	Cadar, Dorina/0000-0003-1398-5841; Hackett, Ruth/0000-0002-5428-2950	National Institute on Aging [RO1AG7644]; consortium of U.K. government departments; ESRC [ES/S013830/1] Funding Source: UKRI	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); consortium of U.K. government departments; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	ELSA is funded by the National Institute on Aging (Grant RO1AG7644) and by a consortium of U.K. government departments coordinated by the Economic and Social Research Council (ESRC). Declarations of interest: None. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Banks J., 2003, SOCIOECONOMIC POSITI, P71; Bathgate D, 2001, ACTA NEUROL SCAND, V103, P367, DOI 10.1034/j.1600-0404.2001.2000236.x; Bora E, 2017, J GERIATR PSYCH NEUR, V30, P206, DOI 10.1177/0891988717710337; Bora E, 2015, J NEUROL NEUROSUR PS, V86, P714, DOI 10.1136/jnnp-2014-309445; Boss L, 2015, INT PSYCHOGERIATR, V27, P541, DOI 10.1017/S1041610214002749; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Caddell L.S., 2011, DEMENTIA, V10, P379, DOI [DOI 10.1177/1471301211408255, 10.1177/1471301211408255]; Corner L, 2004, J AGING STUD, V18, P143, DOI 10.1016/j.jaging.2004.01.007; Department of Health, 2009, LIVING WELL DEMENTIA; Fancourt D, CULTURAL ENGAGEMENT; Forbes D., 2011, ONLINE J RURAL NURS, V11, P27, DOI DOI 10.14574/OJRNHC.V11I2.18; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gelfo F, 2018, NEUROSCIENCE, V370, P218, DOI 10.1016/j.neuroscience.2017.07.065; Hackett RA, J AM GERIATR SOC; Hsiao Y-H, 2018, J BIOMED SCI, P25, DOI [10.1186/s12929-018-0410-z, DOI 10.1186/S12929-018-0410-Z]; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Khondoker M, 2017, J ALZHEIMERS DIS, V58, P99, DOI [10.3233/JAD-161160, 10.3233/jad-161160]; Kim HK, 2016, PROG NEURO-PSYCHOPH, V67, P51, DOI 10.1016/j.pnpbp.2016.01.008; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; McKeith I, 2005, LANCET NEUROL, V4, P735, DOI 10.1016/S1474-4422(05)70219-2; McMunn A, 2003, 6 HLTH HLTH WEALTH L, P207; Meek KP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010158; Min J, 2016, AGE AGEING, V45, P838, DOI 10.1093/ageing/afw125; Peres K, 2008, J AM GERIATR SOC, V56, P37, DOI 10.1111/j.1532-5415.2007.01499.x; Port CL, 2001, GERONTOLOGIST, V41, P589, DOI 10.1093/geront/41.5.589; Prince M., 2014, DEMENTIA UK UPDATE; Quinn TJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010079.pub2; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rafnsson S. B, 2017, J GERONTOL B-PSYCHOL, DOI [10.1093/geronb/gbx087, DOI 10.1093/GERONB/GBX087]; Reeves A, 2016, SOCIOL REV, V64, P550, DOI 10.1111/1467-954X.12406; Steeman E, 2006, J ADV NURS, V54, P722, DOI 10.1111/j.1365-2648.2006.03874.x; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Ward R, 2012, DEMENTIA-LONDON, V11, P287, DOI 10.1177/1471301211421064	35	44	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220195	10.1371/journal.pone.0220195	http://dx.doi.org/10.1371/journal.pone.0220195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369590	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900036
J	Kimura, T; Ueno, T; Doi, S; Nakashima, A; Doi, T; Ashitani, A; Kawano, R; Yamane, K; Masaki, T				Kimura, Tomoe; Ueno, Toshinori; Doi, Shigehiro; Nakashima, Ayumu; Doi, Toshiki; Ashitani, Aki; Kawano, Reo; Yamane, Kiminori; Masaki, Takao			High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate >= 60 mL/min/1.73 m(2): A cross-sectional study	PLOS ONE			English	Article							LOW-GRADE ALBUMINURIA; C-REACTIVE PROTEIN; ALL-CAUSE; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; RISK; HYPERFILTRATION; CORONARY; MICROALBUMINURIA; MORTALITY	Background Low-grade albuminuria has been considered a predictor of cardiovascular mortality. We investigated the relationship between high-normal albuminuria and subclinical atherosclerosis in non-diabetic men with estimated glomerular filtration rate (eGFR) >= 60 mL/min/1.73 m(2). Methods In this cross-sectional study, 1,756 men with eGFR >= 60 mL/min/1.73 m(2) and urine albumin-to-creatinine ratio (UACR) <30 mg/g, who attended general health checkups between April 2012 and March 2015, underwent blood sampling, urinalysis, and carotid ultrasonography. We excluded the subjects who were diabetic and/or received an anti-hypertensive drug. Carotid intima-media thickness (IMT) and the number of focal atheromatous plaques were used as indicators of subclinical atherosclerosis. Multiple linear regression analysis was performed to identify clinical factors associated with carotid IMT. Poisson regression analysis was used to assess the determinants of the carotid plaque number. Results Median UACR was 4.8 mg/g (interquartile range, 3.6-6.9 mg/g). Compared with subjects with low-normal UACR (<10.0 mg/g), subjects with high-normal UACR (10.0-29.8 mg/g) had greater IMT and higher carotid plaque number. High-normal UACR was independently associated with thickened IMT in the model adjusted for conventional cardiovascular disease risk factors. Moreover, participants with high-normal UACR were also more likely to be associated with increased plaque count (prevalence ratio: 1.06; 95% confidence interval: 1.01-1.14) after adjustment for conventional cardiovascular disease risk factors. Conclusions Our results indicate that high-normal albuminuria is associated with both carotid IMT and plaque formation in the non-diabetic male population with eGFR >= 60 mL/min/1.73 m(2).	[Kimura, Tomoe; Ueno, Toshinori; Doi, Shigehiro; Nakashima, Ayumu; Doi, Toshiki; Ashitani, Aki; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan; [Kawano, Reo] Hiroshima Univ Hosp, Ctr Integrated Med Res, Hiroshima, Japan; [Yamane, Kiminori] Nippon Telegraph & Tel West Corp, Chugoku Hlth Adm Ctr, Hiroshima, Japan	Hiroshima University; Hiroshima University	Ueno, T; Masaki, T (corresponding author), Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.	tueno-ygc@umin.ac.jp; masakit@hiroshima-u.ac.jp	Doi, Shigehiro/AAQ-2655-2020; Nakashima, Ayumu/CAF-0274-2022; Nakashima, Ayumu/N-9158-2017; Kawano, Reo/M-2661-2018	Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494; Kawano, Reo/0000-0001-8699-3768; DOI, TOSHIKI/0000-0001-8870-5790	Nippon Telegraph and Telephone West Corporation	Nippon Telegraph and Telephone West Corporation	Nippon Telegraph and Telephone West Corporation provided support in the form of salaries for author [KY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American Diabetes Association, 2016, DIABETES CARE, V39, pS13, DOI [10.2337/dc16-S005, DOI 10.2337/DC16-S005, DOI 10.2337/DC16-ER09]; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Cosson E, 2006, DIABETES CARE, V29, P107, DOI 10.2337/diacare.29.1.107; Elias-Smale SE, 2007, ATHEROSCLEROSIS, V195, pE195, DOI 10.1016/j.atherosclerosis.2007.07.006; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; LOEB JN, 1972, ARTHRITIS RHEUM-US, V15, P189, DOI 10.1002/art.1780150209; Lorenz MW, 2007, STROKE, V38, P1774, DOI 10.1161/STROKEAHA.106.476135; Ma H, 2013, ATHEROSCLEROSIS, V228, P237, DOI 10.1016/j.atherosclerosis.2013.02.007; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melsom T, 2016, CLIN J AM SOC NEPHRO, V11, P2186, DOI 10.2215/CJN.04940516; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; Naresh CN, 2013, AM J KIDNEY DIS, V62, P1095, DOI 10.1053/j.ajkd.2013.06.016; Naya T, 2007, ANGIOLOGY, V58, P677, DOI 10.1177/0003319707303589; Ogna A, 2016, EUR J NUTR, V55, P1089, DOI 10.1007/s00394-015-0923-0; Okamura T, 2007, ATHEROSCLEROSIS, V190, P216, DOI 10.1016/j.atherosclerosis.2006.01.024; Palatini P, 2012, AM J HYPERTENS, V25, P1011, DOI 10.1038/ajh.2012.73; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Rabelink TJ, 2015, NAT REV NEPHROL, V11, P667, DOI 10.1038/nrneph.2015.162; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; Stan RV, 2007, J AM SOC NEPHROL, V18, P2432, DOI 10.1681/ASN.2007060687; Stehouwer CDA, 2004, KIDNEY INT, V66, pS42, DOI 10.1111/j.1523-1755.2004.09211.x; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tanaka F, 2016, J HYPERTENS, V34, P506, DOI 10.1097/HJH.0000000000000809; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Tonneijck L, 2017, J AM SOC NEPHROL, V28, P1023, DOI 10.1681/ASN.2016060666; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Wasserman BA, 2008, STROKE, V39, P329, DOI 10.1161/STROKEAHA.107.498634; Yang GK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068908, 10.1371/journal.pone.0078355]; Zhang X, 2017, TRANSL RES, V183, P14, DOI 10.1016/j.trsl.2016.12.004	40	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218290	10.1371/journal.pone.0218290	http://dx.doi.org/10.1371/journal.pone.0218290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369578	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900008
J	Pantano, E; Marchi, S; Biagini, M; Di Fede, M; Dei, VN; Paccani, SR; Pizza, M; Cartocci, E				Pantano, Elisa; Marchi, Sara; Biagini, Massimiliano; Di Fede, Martina; Dei, Vincenzo Nardi; Paccani, Silvia Rossi; Pizza, Mariagrazia; Cartocci, Elena			NHBA is processed by kallikrein from human saliva	PLOS ONE			English	Article							HEPARIN-BINDING PROTEIN; NEISSERIA-MENINGITIDIS; SEROGROUP-B; ANTIGEN NHBA; CARRIAGE; VACCINE; PEPTIDASES	Neisserial Heparin Binding Antigen (NHBA) is a surface-exposed lipoprotein of Neisseria meningitidis and a component of the Bexsero vaccine. NHBA is characterized by the presence of a highly conserved Arg-rich region involved in binding to heparin and heparan sulphate proteoglycans present on the surface of host epithelial cells, suggesting a possible role of NHBA during N. meningitidis colonization. NHBA has been shown to be cleaved by the meningococcal protease NalP and by human lactoferrin (hLF), a host protease presents in different body fluids (saliva, breast milk and serum). Cleavage occurs upstream or downstream the Arg-rich region. Since the human nasopharynx is the only known reservoir of infection, we further investigated the susceptibility of NHBA to human proteases present in the saliva to assess whether proteolytic cleavage could happen during the initial steps of colonization. Here we show that human saliva proteolytically cleaves NHBA, and identified human kallikrein 1 (hK1), a serine protease, as responsible for this cleavage. Kallikrein-related peptidases (KLKs) have a distinct domain structure and exist as a family of 15 genes which are differentially expressed in many tissues and in the central nervous system. They are present in plasma, lymph, urine, saliva, pancreatic juices, and other body fluids where they catalyze the proteolysis of several human proteins. Here we report the characterization of NHBA cleavage by the tissue kallikrein, expressed in saliva and the identification of the cleavage site on NHBA both, as recombinant protein or as native protein, when expressed on live bacteria. Overall, these findings provide new insights on NHBA as target of host proteases, highlights the potential role of NHBA in the Neisseria meningitidis nasopharyngeal colonization, and of kallikrein as a defensive agent against meningococcal infection.	[Pantano, Elisa; Marchi, Sara; Biagini, Massimiliano; Di Fede, Martina; Paccani, Silvia Rossi; Pizza, Mariagrazia; Cartocci, Elena] GSK, Siena, Italy; [Dei, Vincenzo Nardi] GSK, Wavre, Belgium	GlaxoSmithKline; GlaxoSmithKline	Cartocci, E (corresponding author), GSK, Siena, Italy.	elena.cartocci@gsk.com			GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was sponsored by GlaxoSmithKline Biologicals SA in the form of salaries for authors [S. M., M. B., V. N. D., S. R. P., M. P., E. C.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. No additional external funding received for this study.	Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; Beaufort N, 2010, BIOL CHEM, V391, P581, DOI 10.1515/BC.2010.055; BROOME CV, 1986, J ANTIMICROB CHEMOTH, V18, P25, DOI 10.1093/jac/18.Supplement_A.25; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Casellato A, 2014, CELL MICROBIOL, V16, P925, DOI 10.1111/cmi.12250; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Di Fede M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194662; Elena DelTordello, 2014, P NATL ACAD SCI USA, V111, P427, DOI [10.1073/pnas.1321556111, DOI 10.1073/PNAS.1321556111]; Esposito V, 2011, J BIOL CHEM, V286, P41767, DOI 10.1074/jbc.M111.289314; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Lalmanach G, 2010, BIOCHIMIE, V92, P1568, DOI 10.1016/j.biochi.2010.03.011; Li HX, 2008, PROTEIN SCI, V17, P664, DOI 10.1110/ps.073333208; Maritan M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201922; Mathieu C, 2012, VIRULENCE, V3, P164, DOI DOI 10.4161/VIRU.18639; Pathak M, 2013, THROMB HAEMOSTASIS, V110, P423, DOI 10.1160/TH12-11-0840; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Schoen C, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00114; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; STEPHENS DS, 1983, J INFECT DIS, V148, P369, DOI 10.1093/infdis/148.3.369; Stephens DS, 1999, LANCET, V353, P941, DOI 10.1016/S0140-6736(98)00279-7; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Vacca I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162878; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0203234	10.1371/journal.pone.0203234	http://dx.doi.org/10.1371/journal.pone.0203234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369555	Green Submitted, gold, Green Published			2022-12-26	WOS:000484987900001
J	Shtar, G; Rokach, L; Shapira, B				Shtar, Guy; Rokach, Lior; Shapira, Bracha			Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS	Drug-drug interactions are preventable causes of medical injuries and often result in doctor and emergency room visits. Computational techniques can be used to predict potential drug-drug interactions. We approach the drug-drug interaction prediction problem as a link prediction problem and present two novel methods for drug-drug interaction prediction based on artificial neural networks and factor propagation over graph nodes: adjacency matrix factorization (AMF) and adjacency matrix factorization with propagation (AMFP). We conduct a retrospective analysis by training our models on a previous release of the DrugBank database with 1,141 drugs and 45,296 drug-drug interactions and evaluate the results on a later version of DrugBank with 1,440 drugs and 248,146 drug-drug interactions. Additionally, we perform a holdout analysis using DrugBank. We report an area under the receiver operating characteristic curve score of 0.807 and 0.990 for the retrospective and holdout analyses respectively. Finally, we create an ensemble-based classifier using AMF, AMFP, and existing link prediction methods and obtain an area under the receiver operating characteristic curve of 0.814 and 0.991 for the retrospective and the holdout analyses. We demonstrate that AMF and AMFP provide state of the art results compared to existing methods and that the ensemble-based classifier improves the performance by combining various predictors. Additionally, we compare our methods with multi-source data-based predictors using cross-validation. In the multi-source data comparison, our methods outperform various ensembles created using 29 different predictors based on several data sources. These results suggest that AMF, AMFP, and the proposed ensemble-based classifier can provide important information during drug development and regarding drug prescription given only partial or noisy data. Additionally, the results indicate that the interaction network (known DDIs) is the most useful data source for identifying potential DDIs and that our methods take advantage of it better than the other methods investigated. The methods we present can also be used to solve other link prediction problems. Drug embeddings (compressed representations) created when training our models using the interaction network have been made public.	[Shtar, Guy; Rokach, Lior; Shapira, Bracha] Ben Gurion Univ Negev, Dept Software & Informat Syst Engn, Beer Sheva, Israel	Ben Gurion University	Shtar, G (corresponding author), Ben Gurion Univ Negev, Dept Software & Informat Syst Engn, Beer Sheva, Israel.	Shtar@post.bgu.ac.il	Rokach, Lior/F-8247-2010					Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Corrigan OP, 2002, SOC SCI MED, V55, P497, DOI 10.1016/S0277-9536(01)00183-6; Cukierski W, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1237, DOI 10.1109/IJCNN.2011.6033365; Diederik P.K., 2015, INT C LEARNING REPRE; Fan JC, 2018, NEURAL NETWORKS, V98, P34, DOI 10.1016/j.neunet.2017.10.007; Fire M, 2013, ACM T INTEL SYST TEC, V5, DOI 10.1145/2542182.2542192; Glorot X., 2010, P 13 INT C ARTIFICIA, V9, P249, DOI DOI 10.1.1/207.2059; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Hagberg A., 2008, P 7 PYTH SCI C SCIPY; He XN, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P173, DOI 10.1145/3038912.3052569; Huang Z, 2005, ACM-IEEE J CONF DIG, P141, DOI 10.1145/1065385.1065415; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Lim S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190926; Park K, 2015, PLOS ONE, V10, P1; Qato DM, 2016, JAMA INTERN MED, V176, P473, DOI 10.1001/jamainternmed.2015.8581; Raschetti R, 1999, EUR J CLIN PHARMACOL, V54, P959, DOI 10.1007/s002280050582; Ryu JY, 2018, P NATL ACAD SCI USA, V115, pE4304, DOI 10.1073/pnas.1803294115; Shi JY, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2379-8; Sun X, 2014, IEEE SIGNAL PROC LET, V21, P1389, DOI 10.1109/LSP.2014.2337313; Sun Y, 2018, COMPLEXITY, DOI 10.1155/2018/8645793; Vilar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058321; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Wu H, 2018, KNOWL-BASED SYST, V145, P46, DOI 10.1016/j.knosys.2018.01.003; Yang Y, 2015, KNOWL INF SYST, V45, P751, DOI 10.1007/s10115-014-0789-0; Zhang PW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13501; Zhang W, 2019, INFORM SCIENCES, V497, P189, DOI 10.1016/j.ins.2019.05.017; Zhang W, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1415-9	31	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219796	10.1371/journal.pone.0219796	http://dx.doi.org/10.1371/journal.pone.0219796			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369568	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900018
J	Fu, GH; Huang, XY; Qin, B; Wu, YQ; Wang, Y; Zhao, S; Zhou, JF; Fang, WH				Fu, Guihong; Huang, Xuanyun; Qin, Bo; Wu, Yanqing; Wang, Yuan; Zhao, Shu; Zhou, Junfang; Fang, Wenhong			Effects of emodin on ABC transporter gene expression in grass carp (Ctenopharyngodon idellus) exposed to diazinon	PLOS ONE			English	Article							P-GLYCOPROTEIN; DRUG TRANSPORTERS; COMMON CARP; IN-VITRO; ANTHRAQUINONES; TOXICITY; PROTEINS; EMBRYOS	This study aimed to investigate the function of ATP-binding cassette (ABC) transporter genes in grass carp treated with emodin combined with diazinon (DZN) exposure. The transcription levels of five ABC transporter genes in different tissues of grass carp and at different time points were measured by real-time quantitative PCR (qRT-PCR). The analysis of different tissues showed higher ABCB1 expression in the skin (26-fold) and gill (2-fold) than in the liver. In addition, ABCB11 expression was higher in the skin (109-fold) and gill (57-fold) than in the liver, ABCC1 was more highly expressed in the gill (50-fold) than in the liver, and ABCG2 was expressed at higher levels in the skin (659-fold, p < 0.01), gill (628-fold, p < 0.01) and liver (659-fold, p < 0.01) than in brain tissue. The analysis of different time points revealed that the ABCB1, ABCB11, ABCC1, ABCC2 and ABCG2 genes were highly expressed at 24 h in the liver in the experimental group. However, analysis of the intestinal tissue of the experimental group showed that the expression of ABCB1 and ABCB11 peaked at 6 h, the expression of ABCC1 and ABCC2 peaked at 5 d, and the expression of ABCG2 peaked at 3 d. Furthermore, the emodin concentrations in the liver and intestine reached their peak levels (50.18 and 117.24 mu g.ml(-1), respectively) after 48 and 1 h of treatment with emodin combined with DZN, respectively. The peak DZN concentrations in the liver (1.42 ng.ml(-1)) and intestine (0.2 ng.ml(-1)) were detected 3 and 6 h after emodin treatment combined with DZN, respectively. In conclusion, this study shows that the transcript levels of ABC transporters respond to the presence of emodin, which indicates their potential involvement in and contribution with the metabolic process in grass carp.	[Fu, Guihong; Huang, Xuanyun; Qin, Bo; Wu, Yanqing; Wang, Yuan; Zhao, Shu; Zhou, Junfang; Fang, Wenhong] Minist Agr & Rural Affairs, Key Lab East China Sea Fishery Resources Exploita, Shanghai, Peoples R China; [Fu, Guihong; Huang, Xuanyun; Qin, Bo; Wu, Yanqing; Wang, Yuan; Zhao, Shu; Zhou, Junfang] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Fang, WH (corresponding author), Minist Agr & Rural Affairs, Key Lab East China Sea Fishery Resources Exploita, Shanghai, Peoples R China.	fwenhong@163.com			National Natural Science Foundation of China [31402345]; Special Scientific Research Funds for Central Nonprofit Institutes, Chinese Academy of Fishery Sciences [2015M1640]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Scientific Research Funds for Central Nonprofit Institutes, Chinese Academy of Fishery Sciences	This work was financed by the National Natural Science Foundation of China (Grant No. 31402345) and Special Scientific Research Funds for Central Nonprofit Institutes, Chinese Academy of Fishery Sciences (Grant No. 2015M1640).	Al-Ghanim KA, 2014, PAK J ZOOL, V46, P161; Aydin R, 2005, PESTIC BIOCHEM PHYS, V82, P220, DOI 10.1016/j.pestbp.2005.03.001; Bennett HS, 2005, CONF P INDIUM PHOSPH, P1; Bradbury SP, 2010, ENVIRON TOXICOL CHEM, V5, P567; Burkepile DE, 2000, B ENVIRON CONTAM TOX, V64, P114, DOI 10.1007/s001289910018; CHAN KM, 1992, BIOCHIM BIOPHYS ACTA, V1171, P65, DOI 10.1016/0167-4781(92)90140-U; Choi RJ, 2013, EUR J PHARM SCI, V48, P272, DOI 10.1016/j.ejps.2012.10.027; Cycon M, 2009, CHEMOSPHERE, V76, P494, DOI 10.1016/j.chemosphere.2009.03.023; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Eisler R., 1986, BIOL REP, V85, P25; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; FAO, 2012, FAO YB FISH AQ STAT; Galloway T, 2003, ECOTOXICOLOGY, V12, P345, DOI 10.1023/A:1022579416322; Grosell M, 2011, FISH PHYSIOL, piii, DOI [10.1152/physiol.00032.2011, DOI 10.1152/PHYSIOL.00032.2011]; Hu K, 2014, ENVIRON TOXICOL PHAR, V37, P529, DOI 10.1016/j.etap.2013.12.017; Huang Q, 2007, MED RES REV, V27, P609, DOI 10.1002/med.20094; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Ito K, 2005, PHARM RES-DORDR, V22, P1559, DOI 10.1007/s11095-005-6810-2; Jeong CB, 2017, COMP BIOCHEM PHYS D, V21, P17, DOI 10.1016/j.cbd.2016.10.003; Jeong CB, 2017, AQUAT TOXICOL, V185, P29, DOI 10.1016/j.aquatox.2017.01.013; Kleinow K, 2008, TOXICOKINETICS FISHE; Kobayashi I, 2008, BLOOD, V111, P1131, DOI 10.1182/blood-2007-08-104299; Lawrence Ezemonye, 2015, J ENV CHEM ECOTOXICO, V7, P20, DOI [10.5897/JECE2014.0337, DOI 10.5897/JECE2014.0337]; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li X, 2014, TOXICOL APPL PHARM, V275, P163, DOI 10.1016/j.taap.2013.12.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loncar J, 2010, COMP BIOCHEM PHYS C, V151, P209, DOI 10.1016/j.cbpc.2009.10.009; Loo TW, 1999, BIOCHEM CELL BIOL, V77, P11, DOI 10.1139/bcb-77-1-11; Luckenbach T, 2014, COMP BIOCHEM PHYS C, V165, P28, DOI 10.1016/j.cbpc.2014.05.002; Marshall W.S., 2005, PHYSL FISHES, P177; Montuori P, 2016, SCI TOTAL ENVIRON, V571, P1001, DOI 10.1016/j.scitotenv.2016.07.089; Oostendorp RL, 2009, CANCER TREAT REV, V35, P137, DOI 10.1016/j.ctrv.2008.09.004; Schlenk Daniel, 2008, P153, DOI 10.1201/9780203647295.ch4; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Tan SW, 2014, ECOTOX ENVIRON SAFE, V108, P258, DOI 10.1016/j.ecoenv.2014.07.011; Tutundjian R, 2002, COMP BIOCHEM PHYS B, V132, P463, DOI 10.1016/S1096-4959(02)00058-1; Velki M, 2017, CHEMOSPHERE, V180, P65, DOI 10.1016/j.chemosphere.2017.04.017; Zaja R, 2016, COMP BIOCHEM PHYS C, V190, P15, DOI 10.1016/j.cbpc.2016.07.005	40	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219866	10.1371/journal.pone.0219866	http://dx.doi.org/10.1371/journal.pone.0219866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365567	Green Published, Green Submitted, gold			2022-12-26	WOS:000484983600021
J	Malekbala, MR; Soltani, S; Rashid, SA; Abdullah, LC; Choong, TSY				Malekbala, Mohamad Rasool; Soltani, Soroush; Rashid, Suraya Abdul; Abdullah, Luqman Chuah; Choong, Thomas Shean Yaw			Study the effect of various wash-coated metal oxides over synthesized carbon nanofibers coated monolith substrates	PLOS ONE			English	Article							CHEMICAL-VAPOR-DEPOSITION; CATALYTIC DECOMPOSITION; NANOTUBES; GROWTH; HYDROGEN; METHANE; ENERGY	In this research work, carbon nanofibers (CNFs) were synthesized on honeycomb monolith substrates using injection chemical vapor deposition (ICVD) technique. The effect of various wash-coated materials and catalyst promoter on the growth rate of CNFs on monolith substrates were examined. The characteristics of the synthesized CNFs-coated monolith composites were examined using Raman spectroscopy, Brunauer-Emmett-Teller (BET), thermogravimetric analysis (TGA), field emission scanning electron microscopy (FE-SEM), and Transmission electron microscopy (TEM) techniques. According to the textural characterization study, the specific surface area and pore volume of CNFs-coated monolith composites were significantly improved as compared to bare monolith which might be attributed to the growth of highly pure and aligned CNFs over monolith substrate. Besides that, the synthesized CNFs-coated monolith possessed extremely well thermal stability up to the temperature of 550 degrees C which was corresponded to the strong attachment of highly graphitized CNFs over monolith substrates.	[Malekbala, Mohamad Rasool; Soltani, Soroush; Abdullah, Luqman Chuah; Choong, Thomas Shean Yaw] Univ Putra Malaysia, SPERC, Dept Chem & Environm Engn, Serdang, Malaysia; [Rashid, Suraya Abdul] Univ Putra Malaysia, Inst Adv Technol, Mat Proc & Technol Lab, Serdang, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Choong, TSY (corresponding author), Univ Putra Malaysia, SPERC, Dept Chem & Environm Engn, Serdang, Malaysia.	csthomas@upm.edu.my	Abdullah, Luqman Chuah/L-8915-2016; Soltani, Soroush/AAZ-5723-2021	Abdullah, Luqman Chuah/0000-0003-4785-9296; Abdul Rashid, Suraya/0000-0003-4808-3653	Geran Putra [UPM/GP-IPB/2016/9515200]; Universiti Putra Malaysia (UPM) through Geran Putra [UPM/GP-IPB/2016/9515200]	Geran Putra; Universiti Putra Malaysia (UPM) through Geran Putra	This work was supported by Geran Putra UPM/GP-IPB/2016/9515200.; The authors extend their appreciation to Universiti Putra Malaysia (UPM) for funding this research work through Geran Putra UPM/GP-IPB/2016/9515200.	Allaedini G, 2016, INT J NANO DIMENS, V7, P186, DOI 10.7508/ijnd.2016.03.002; Dickey EC, 2001, APPL PHYS LETT, V79, P4022, DOI 10.1063/1.1419238; Gong BB, 2008, CATAL LETT, V122, P287, DOI 10.1007/s10562-007-9374-4; Guevara JC, 2010, INT J HYDROGEN ENERG, V35, P3509, DOI 10.1016/j.ijhydene.2010.01.068; Shang HY, 2007, FUEL PROCESS TECHNOL, V88, P117, DOI 10.1016/j.fuproc.2004.08.010; Hosseini S, 2016, J TAIWAN INST CHEM E, V59, P440, DOI 10.1016/j.jtice.2015.07.015; Ionescu MI, 2009, ECS TRANSACTIONS, V25, P737, DOI 10.1149/1.3207662; Jarrah N, 2003, CATAL TODAY, V79, P29, DOI 10.1016/S0920-5861(03)00039-7; Jiang KL, 2007, J NANOSCI NANOTECHNO, V7, P1494, DOI 10.1166/jnn.2007.332; Kapteijn F, 1999, CATTECH, V3, P24; Kitiyanan B, 2000, CHEM PHYS LETT, V317, P497, DOI 10.1016/S0009-2614(99)01379-2; Li GH, 2006, APPL CATAL A-GEN, V301, P16, DOI 10.1016/j.apcata.2005.11.013; Mayne M, 2001, CHEM PHYS LETT, V338, P101, DOI 10.1016/S0009-2614(01)00278-0; Melechko AV, 2005, J APPL PHYS, V97, DOI 10.1063/1.1857591; Muhulet A, 2018, MATER TODAY ENERGY, V9, P154, DOI 10.1016/j.mtener.2018.05.002; Myung Y, 2019, ACS SUSTAIN CHEM ENG, V7, P3772, DOI 10.1021/acssuschemeng.8b04202; Restivo J, 2013, CHEM ENG J, V230, P115, DOI 10.1016/j.cej.2013.06.064; Schutt F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01324-7; Sharma M, 2019, CHEM ENG J, V358, P540, DOI 10.1016/j.cej.2018.10.031; Singh C, 2003, CARBON, V41, P359, DOI 10.1016/S0008-6223(02)00314-7; Soltani S, 2017, CHEM ENG TECHNOL, V40, P1931, DOI 10.1002/ceat.201700138; Soltani S, 2017, J TAIWAN INST CHEM E, V70, P219, DOI 10.1016/j.jtice.2016.10.054; Su XH, 2010, J NANOPART RES, V12, P1813, DOI 10.1007/s11051-009-9739-2; Tripathi KM, 2016, NANOCOMPOSITES, V2, P125, DOI 10.1080/20550324.2016.1227546; Venegoni D, 2002, CARBON, V40, P1799, DOI 10.1016/S0008-6223(02)00057-X; Venugopal A, 2007, INT J HYDROGEN ENERG, V32, P1782, DOI 10.1016/j.ijhydene.2007.01.007; Wang YL, 2012, NEW CARBON MATER, V27, P153, DOI 10.1016/S1872-5805(12)60009-2; Wei BQ, 2002, NANO LETT, V2, P1105, DOI [10.1021/nl025719e, 10.1021/n1025719e]	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219936	10.1371/journal.pone.0219936	http://dx.doi.org/10.1371/journal.pone.0219936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365558	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000484983600023
J	Sigdel, TK; Yang, JYC; Bestard, O; Schroeder, A; Hsieh, SC; Liberto, JM; Demm, I; Geraedts, ACM; Sarwal, MM				Sigdel, Tara K.; Yang, Joshua Y. C.; Bestard, Oriol; Schroeder, Andrew; Hsieh, Szu-Chuan; Liberto, Juliane M.; Demm, Izabella; Geraedts, Anna C. M.; Sarwal, Minnie M.			A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring	PLOS ONE			English	Article							RENAL-ALLOGRAFT REJECTION; HUMORAL REJECTION; MESSENGER-RNA; EXPRESSION; RECIPIENTS; DIAGNOSIS; MARKERS; CXCL10; POSTTRANSPLANT; PREDICTION	A Common Rejection Module (CRM) consisting of 11 genes expressed in allograft biopsies was previously reported to serve as a biomarker for acute rejection (AR), correlate with the extent of graft injury, and predict future allograft damage. We investigated the use of this gene panel on the urine cell pellet of kidney transplant patients. Urinary cell sediments collected from patients with biopsy-confirmed acute rejection, borderline AR (bAR), BK virus nephropathy (BKVN), and stable kidney grafts with normal protocol biopsies (STA) were analyzed for expression of these 11 genes using quantitative polymerase chain reaction (qPCR). We assessed these 11 CRM genes for their abundance, autocorrelation, and individual expression levels. Expression of 10/11 genes were elevated in AR when compared to STA. Psmb9 and Cxcl10could classify AR versus STA as accurately as the 11-gene model (sensitivity = 93.6%, specificity = 97.6%). A uCRM score, based on the geometric mean of the expression levels, could distinguish AR from STA with high accuracy (AUC = 0.9886) and correlated specifically with histologic measures of tubulitis and interstitial inflammation rather than tubular atrophy, glomerulosclerosis, intimal proliferation, tubular vacuolization or acute glomerulitis. This urine gene expression-based score may enable the non-invasive and quantitative monitoring of AR.	[Sigdel, Tara K.; Yang, Joshua Y. C.; Bestard, Oriol; Schroeder, Andrew; Hsieh, Szu-Chuan; Liberto, Juliane M.; Demm, Izabella; Geraedts, Anna C. M.; Sarwal, Minnie M.] Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA; [Bestard, Oriol] UB, Bellvitge Univ Hosp, Kidney Transplant Unit, Barcelona, Spain	University of California System; University of California San Francisco; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Sarwal, MM (corresponding author), Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA.	minnie.sarwal@ucsf.edu	Sigdel, Tara/AAV-5886-2020; Liberto, Juliane M/ABA-9675-2020; Yang, Joshua Young Cynming/P-6447-2018	Sigdel, Tara/0000-0001-8448-0328; Liberto, Juliane M/0000-0003-1927-5058; Yang, Joshua Young Cynming/0000-0003-2410-7817; Sarwal, Minnie/0000-0003-1212-3959; Geraedts, Anna/0000-0002-6476-6027	NIH (NIAID); NIH (NIDDK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI113362] Funding Source: NIH RePORTER	NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MMS and TKS have research support from the NIH (NIAID and NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JH, 2005, CLIN TRANSPLANT, V19, P785, DOI 10.1111/j.1399-0012.2005.00422.x; Crespo M, 2001, TRANSPLANTATION, V71, P652, DOI 10.1097/00007890-200103150-00013; Davis ID, 1998, PEDIATR NEPHROL, V12, P96, DOI 10.1007/s004670050412; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Faddoul G, 2018, TRANSPLANTATION, V102, P673, DOI 10.1097/TP.0000000000002026; Hartono C, 2010, CURR OPIN ORGAN TRAN, V15, P35, DOI 10.1097/MOT.0b013e3283342728; Hauser IA, 2005, J AM SOC NEPHROL, V16, P1849, DOI 10.1681/ASN.2004100836; Hricik DE, 2013, AM J TRANSPLANT, V13, P2634, DOI 10.1111/ajt.12426; Hu HZ, 2009, TRANSPLANTATION, V87, P1814, DOI 10.1097/TP.0b013e3181a66b3e; Jackson JA, 2011, AM J TRANSPLANT, V11, P2228, DOI 10.1111/j.1600-6143.2011.03680.x; Keslar KS, 2013, AJT; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Kotsch K, 2010, TRANSPLANTATION, V90, P958, DOI 10.1097/TP.0b013e3181f546e8; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Lazzeri E, 2005, TRANSPLANTATION, V79, P1215, DOI 10.1097/01.TP.0000160759.85080.2E; Lodhi SA, 2011, AM J TRANSPLANT, V11, P2264, DOI 10.1111/j.1600-6143.2011.03713.x; Loupy A, 2014, J AM SOC NEPHROL, V25, P2267, DOI 10.1681/ASN.2013111149; Matz M, 2006, KIDNEY INT, V69, P1683, DOI 10.1038/sj.ki.5000343; Menon MC, 2017, JASN; Montojo Jason, 2014, F1000Res, V3, P153, DOI 10.12688/f1000research.4572.1; Moreso F, 2001, AM J TRANSPLANT, V1, P82, DOI 10.1034/j.1600-6143.2001.010115.x; Naesens M, 2017, JASN; Naesens M, 2011, KIDNEY INT, V80, P1364, DOI 10.1038/ki.2011.245; Pape L, 2004, TRANSPLANTATION, V77, P1191, DOI 10.1097/01.TP.0000120099.92220.7A; PROVOOST AP, 1984, J PEDIATR SURG, V19, P63, DOI 10.1016/S0022-3468(84)80018-4; Racusen LC, 2004, TRANSPL P, V36, P753, DOI 10.1016/j.transproceed.2004.03.031; Roedder S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001759; Sacreas A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205107; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Sarwal MM, 2012, AM J TRANSPLANT, V12, P2719, DOI 10.1111/j.1600-6143.2012.04145.x; Schaub S, 2009, AM J TRANSPLANT, V9, P1347, DOI 10.1111/j.1600-6143.2009.02645.x; Segerer S, 2001, AM J KIDNEY DIS, V37, P518; Sigdel TK, 2016, KIDNEY INT, V89, P1244, DOI 10.1016/j.kint.2015.12.049; Sigdel TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138133; Sigdel TK, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00057; Sigdel TK, 2013, TRANSPLANTATION, V96, P97, DOI 10.1097/TP.0b013e318295ee5a; Sigdel TK, 2012, J AM SOC NEPHROL, V23, P750, DOI 10.1681/ASN.2011060596; Sigdel TK, 2011, EXPERT REV PROTEOMIC, V8, P705, DOI [10.1586/EPR.11.66, 10.1586/epr.11.66]; Simon T, 2003, AM J TRANSPLANT, V3, P1121, DOI 10.1034/j.1600-6143.2003.00187.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Suthanthiran M, 2013, NEW ENGL J MED, V369, P20, DOI 10.1056/NEJMoa1215555; Tatapudi RR, 2004, KIDNEY INT, V65, P2390, DOI 10.1111/j.1523-1755.2004.00663.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yang JYC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020241; Yang JYC, 2017, NAT REV GENET, V18, P309, DOI 10.1038/nrg.2017.12; Yannaraki M, 2006, TRANSPLANT INT, V19, P759, DOI 10.1111/j.1432-2277.2006.00351.x	47	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220052	10.1371/journal.pone.0220052	http://dx.doi.org/10.1371/journal.pone.0220052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365568	Green Submitted, Green Published, gold			2022-12-26	WOS:000484983600027
J	Xia, L; Gildersleeve, JC				Xia, Li; Gildersleeve, Jeffrey C.			Anti-glycan IgM repertoires in newborn human cord blood	PLOS ONE			English	Article							MOLECULAR RECOGNITION PROPERTIES; NATURAL ANTIBODIES; AUTOANTIBODY REPERTOIRES; IMMUNOGLOBULINS IGG; SCHISTOSOMA-MANSONI; SERUM ANTIBODIES; CANCER VACCINES; MICROARRAY; INNATE; CELLS	Natural antibodies are an innate-like subset of serum antibodies involved in host defense, tumor surveillance, homeostasis, and autoimmunity. Defining the natural antibody repertoire is critical for identifying biomarkers, developing vaccines, controlling and preventing autoimmunity, and understanding the development and organization of the immune system. While natural antibodies to protein antigens have been studied in depth, little is known about natural antibodies to carbohydrate antigens. To address this, we profiled IgM from umbilical cord blood and matched maternal sera on a glycan microarray. Since standard methods to detect maternal contamination in cord serum did not have sufficient sensitivity for our study, we developed a highly sensitive microarray-based assay. Using this method, we found that over 50% of the cord samples had unacceptable levels of maternal contamination. For the cord samples with high purity, anti-glycan IgM antibodies were prevalent and recognized a broad range of non-human and human glycans. Using principal component analysis and hierarchical clustering, cord IgM repertoires showed a high degree of similarity with each other but were distinct from maternal IgM repertoires. Our results demonstrate that many anti-glycan antibodies in human serum are natural antibodies and provide new insights into the development of anti-glycan antibody repertoires.	[Xia, Li; Gildersleeve, Jeffrey C.] NCI, Chem Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gildersleeve, JC (corresponding author), NCI, Chem Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA.	gildersj@mail.nih.gov		Gildersleeve, Jeffrey/0000-0002-3744-6423	Intramural Research Program of the National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC011055] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, NIH, to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Consortium for Functional Glycomics (GM62116; The Scripps Research Institute), X. Huang (Michigan State University), T. Tolbert (University of Kansas), Lai-Xi Wang (University of Maryland), J. Barchi (National Cancer Institute), T. Lowary (University of Alberta), and Omicron Biochemicals Inc. for generously contributing glycans for the array. This work was supported by the Intramural Research Program of the National Cancer Institute, NIH. We thank Dorothy Ackerman Butler and Life Science Editors for editing assistance. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BOERSMA ER, 1981, ARCH DIS CHILD, V56, P31, DOI 10.1136/adc.56.1.31; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Brandlein S, 2003, CANCER RES, V63, P7995; BRANDRIS.MW, 1969, NATURE, V221, P960, DOI 10.1038/221960a0; Broecker F, 2016, CELL CHEM BIOL, V23, P1014, DOI 10.1016/j.chembiol.2016.07.009; Burford B, 2013, BRIT J CANCER, V108, P2045, DOI 10.1038/bjc.2013.214; Campbell CT, 2014, P NATL ACAD SCI USA, V111, pE1749, DOI 10.1073/pnas.1314722111; Campbell CT, 2013, CLIN CANCER RES, V19, P1290, DOI 10.1158/1078-0432.CCR-12-2478; Campbell Christopher T, 2010, Curr Protoc Chem Biol, V2, P37, DOI 10.1002/9780470559277.ch090228; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; COHEN IR, 1968, J CLIN INVEST, V47, P1053, DOI 10.1172/JCI105795; Cohen IR, 2013, TRENDS IMMUNOL, V34, P620, DOI 10.1016/j.it.2013.05.003; Durbin SV, 2018, ACS OMEGA, V3, P16882, DOI 10.1021/acsomega.8b02238; FARAH FS, 1973, IMMUNOLOGY, V25, P217; Giannini EG, 2014, CANCER-AM CANCER SOC, V120, P2150, DOI 10.1002/cncr.28706; Gildersleeve JC, 2016, GLYCOBIOLOGY, V26, P443, DOI 10.1093/glycob/cwv171; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Gronwall C, 2014, J CLIN IMMUNOL, V34, pS12, DOI 10.1007/s10875-014-0025-4; Gronwall C, 2016, J AUTOIMMUN, V73, P30, DOI 10.1016/j.jaut.2016.05.014; Hamanova M, 2015, IMMUNOL LETT, V164, P40, DOI 10.1016/j.imlet.2015.02.001; Haro MA, 2019, CANCER RES, V79, P159, DOI 10.1158/0008-5472.CAN-18-0981; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; HIDE DW, 1991, CLIN EXP ALLERGY, V21, P739, DOI 10.1111/j.1365-2222.1991.tb03204.x; Jacob F, 2014, BRIT J CANCER, V111, P1634, DOI 10.1038/bjc.2014.455; Jeyakanthan M, 2016, AM J TRANSPLANT, V16, P1548, DOI 10.1111/ajt.13625; Khasbiullina NR, 2015, BIOCHEMISTRY-MOSCOW+, V80, P820, DOI 10.1134/S0006297915070032; Li Q, 2010, INT J CANCER, V126, P459, DOI 10.1002/ijc.24716; Lubkowski J, 2017, FEBS J, V284, P429, DOI 10.1111/febs.13989; Lutz HU, 2012, ADV EXP MED BIOL, V750, pVII; Madi A, 2015, J IMMUNOL, V194, P5272, DOI 10.4049/jimmunol.1402771; Madi A, 2012, ADV EXP MED BIOL, V750, P198, DOI 10.1007/978-1-4614-3461-0_15; Madi A, 2009, P NATL ACAD SCI USA, V106, P14484, DOI 10.1073/pnas.0901528106; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Manimala JC, 2006, ANGEW CHEM INT EDIT, V45, P3607, DOI 10.1002/anie.200600591; Mannoor K, 2013, AUTOIMMUNITY, V46, P138, DOI 10.3109/08916934.2012.748753; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; Mickum ML, 2016, INFECT IMMUN, V84, P1371, DOI 10.1128/IAI.01349-15; Muthana SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19509; Muthana SM, 2014, CANCER BIOMARK, V14, P29, DOI 10.3233/CBM-130383; New JS, 2016, IMMUNOL REV, V270, P32, DOI 10.1111/imr.12397; Ownby DR, 1996, PEDIATR ALLERGY IMMU, V7, P125, DOI 10.1111/j.1399-3038.1996.tb00119.x; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; Ozdemir SA, 2016, J MATERN-FETAL NEO M, V29, P972, DOI 10.3109/14767058.2015.1027680; Panda S, 2015, J IMMUNOL, V194, P13, DOI 10.4049/jimmunol.1400844; Pochechueva T, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0305-8; Rapaka RR, 2010, J EXP MED, V207, P2907, DOI 10.1084/jem.20100034; Rathore Abhishek Singh, 2015, Enzyme Res, V2015, P791907, DOI 10.1155/2015/791907; Scheepers C, 2017, AIDS, V31, P2199, DOI 10.1097/QAD.0000000000001643; Schneider C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010524; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Tsang KS, 2002, CYTOTHERAPY, V4, P375, DOI 10.1080/146532402760271163; TSENG RYM, 1989, ACTA PAEDIATR SCAND, V78, P127, DOI 10.1111/j.1651-2227.1989.tb10900.x; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; van Diepen A, 2015, INT J PARASITOL, V45, P465, DOI 10.1016/j.ijpara.2015.02.008; Vollmers HP, 2007, J AUTOIMMUN, V29, P295, DOI 10.1016/j.jaut.2007.07.013; Xia L, 2016, CELL CHEM BIOL, V23, P1515, DOI 10.1016/j.chembiol.2016.10.012; Xia Li, 2015, Methods Mol Biol, V1331, P27, DOI 10.1007/978-1-4939-2874-3_3; Zhang YL, 2010, MOL BIOSYST, V6, P1583, DOI 10.1039/c002259d; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0218575	10.1371/journal.pone.0218575	http://dx.doi.org/10.1371/journal.pone.0218575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365539	gold, Green Published, Green Submitted			2022-12-26	WOS:000484983600004
J	Linscott, ML; Chung, WCJ				Linscott, Megan L.; Chung, Wilson C. J.			TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; FGF8; DNA; MOUSE; METHYLATION; MIDBRAIN; HYDROXYMETHYLATION; NEURODEVELOPMENT; IDENTIFICATION	Fibroblast growth factor 8 (FGF8) is a potent morphogen that regulates the ontogenesis of gonadotropin-releasing hormone (GnRH) neurons, which control the hypothalamus-pituitarygonadal (HPG) axis, and therefore reproductive success. Indeed, FGF8 and FGFR1 deficiency severely compromises vertebrate reproduction in mice and humans and is associated with Kallmann Syndrome (KS), a congenital disease characterized by hypogonadotropic hypogonadism associated with anosmia. Our laboratory demonstrated that FGF8 signaling through FGFR1, both of which are KS-related genes, is necessary for proper GnRH neuron development in mice and humans. Here, we investigated the possibility that non-genetic factors, such as the epigenome, may contribute to KS onset. For this purpose, we developed an embryonic explant model, utilizing the mouse olfactory placode (OP), the birthplace of GnRH neurons. We show that TET1, which converts 5-methylcytosine residues (5mC) to 5-hydroxymethylated cytosines (5hmC), controls transcription of Fgf8 during GnRH neuron ontogenesis. Through MeDIP and ChIP RT-qPCR we found that TET1 bound to specific CpG islands on the Fgf8 promoter. We found that the temporal expression of Fgf8 correlates with not only TET1 binding, but also with 5hmC enrichment. siRNA knockdown of Tet1 reduced Fgf8 and Fgfr1 mRNA expression. During this time period, Fgf8 also switched histone status, most likely via recruitment of EZH2, a major component of the polycomb repressor complex-2 (PRC2) at E13.5. Together, these studies underscore the significance of epigenetics and chromatin modifications to temporally regulated genes involved in KS.	[Linscott, Megan L.; Chung, Wilson C. J.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Chung, Wilson C. J.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Linscott, ML (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	mlinscot@kent.edu		Chung, Wilson/0000-0003-0550-7567	National Institute of Child Health and Human Development, NIH [R00 HD058044]	National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research was funded by the National Institute of Child Health and Human Development, NIH R00 HD058044 to WCJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre P, 2006, DEVELOPMENT, V133, P2905, DOI 10.1242/dev.02460; Beermann F, 2006, GENESIS, V44, P1, DOI 10.1002/gene.20177; Bonasio R, 2014, ELIFE, V3, DOI 10.7554/eLife.02637; Cartron Pierre-Francois, 2013, Genes Cancer, V4, P235, DOI 10.1177/1947601913489020; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; Chung WCJ, 2010, J NEUROENDOCRINOL, V22, P944, DOI 10.1111/j.1365-2826.2010.02024.x; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Chung WCJ, 2013, PFLUG ARCH EUR J PHY, V465, P573, DOI 10.1007/s00424-013-1258-4; Chung WCJ, 2010, FRONT HORM RES, V39, P37, DOI 10.1159/000312692; Creuzet S, 2004, P NATL ACAD SCI USA, V101, P4843, DOI 10.1073/pnas.0400869101; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gatto S, 2017, NUCLEIC ACIDS RES, V45, P5739, DOI 10.1093/nar/gkx163; Gill JC, 2006, BIOL REPROD, V74, P463, DOI 10.1095/biolreprod.105.046904; Gu TP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1464-7; Guo QX, 2007, DEVELOPMENT, V134, P2251, DOI 10.1242/dev.004929; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Inoue F, 2006, DEV GROWTH DIFFER, V48, P447, DOI 10.1111/j.1440-169x.2006.00882.x; Juan D, 2016, CELL REP, V14, P1246, DOI 10.1016/j.celrep.2016.01.008; Kaneko S, 2014, GENE DEV, V28, P1983, DOI 10.1101/gad.247940.114; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kong LC, 2016, NUCLEIC ACIDS RES, V44, P8682, DOI 10.1093/nar/gkw529; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Kurian JR, 2016, ENDOCRINOLOGY, V157, P3588, DOI 10.1210/en.2016-1087; Lee SM, 2015, EPIGENOMICS-UK, V7, P527, DOI [10.2217/EPI.15.38, 10.2217/epi.15.38]; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lim MS, 2015, INT J STEM CELLS, V8, P228, DOI 10.15283/ijsc.2015.8.2.228; Linscott ML, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00034; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald JL, 2005, DEV BIOL, V288, P461, DOI 10.1016/j.ydbio.2005.09.048; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; McCabe MJ, 2011, J CLIN ENDOCR METAB, V96, pE1709, DOI 10.1210/jc.2011-0454; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mendonca A, 2014, BBA-GENE REGUL MECH, V1839, P1323, DOI 10.1016/j.bbagrm.2014.09.014; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Ngo TTM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10813; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Santiago M, 2014, GENOMICS, V104, P334, DOI 10.1016/j.ygeno.2014.08.018; Schor IE, 2010, EPIGENETICS-US, V5, P1, DOI 10.4161/epi.5.3.11316; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Stevenson Erica L, 2013, Front Endocrinol (Lausanne), V4, P89, DOI 10.3389/fendo.2013.00089; Stewart CE, 2016, BRAIN RES, V1646, P287, DOI 10.1016/j.brainres.2016.06.015; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Sui XY, 2012, CURR GENOMICS, V13, P603, DOI 10.2174/138920212803759730; Sun WJ, 2014, GENOMICS, V104, P347, DOI 10.1016/j.ygeno.2014.08.021; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Sunmonu NA, 2011, DEVELOPMENT, V138, P725, DOI 10.1242/dev.055665; Suzuki-Hirano A, 2009, SEMIN CELL DEV BIOL, V20, P719, DOI 10.1016/j.semcdb.2009.04.002; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Teif VB, 2014, GENOME RES, V24, P1285, DOI 10.1101/gr.164418.113; Theil T, 2008, DEV DYNAM, V237, P3417, DOI 10.1002/dvdy.21765; Toyoda R, 2010, DEVELOPMENT, V137, P3439, DOI 10.1242/dev.055392; Tsai PS, 2011, FRONT NEUROENDOCRIN, V32, P95, DOI 10.1016/j.yfrne.2010.11.002; Verma N, 2018, NAT GENET, V50, P83, DOI 10.1038/s41588-017-0002-y; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Xin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07645; Xu JS, 2000, DEVELOPMENT, V127, P1833; Yosefzon Y, 2017, P NATL ACAD SCI USA, V114, P10131, DOI 10.1073/pnas.1704393114; Zemke M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0210-9; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhou Y, 2015, STEM CELL REV REP, V11, P87, DOI 10.1007/s12015-014-9542-z	72	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220530	10.1371/journal.pone.0220530	http://dx.doi.org/10.1371/journal.pone.0220530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361780	Green Published, Green Submitted, gold			2022-12-26	WOS:000484981300040
J	Orozco-Diaz, R; Sanchez-Alvarez, A; Hernandez-Hernandez, JM; Tapia-Ramirez, J				Orozco-Diaz, Raul; Sanchez-Alvarez, Angelica; Manuel Hernandez-Hernandez, Jose; Tapia-Ramirez, Jose			The interaction between RE1-silencing transcription factor (REST) and heat shock protein 90 as new therapeutic target against Huntington's disease	PLOS ONE			English	Article							GENE; EXPRESSION; BINDING; REPRESSOR; NUCLEAR; STRESS; TRAFFICKING; REST/NRSF; NEURONS; MODEL	The wild type huntingtin protein (Htt), supports the production of brain-derived neurotrophic factor (BDNF), a survival factor for striatal neurons, through cytoplasmic sequestering of RE-1silencing transcription factor (REST). In Huntington's Disease an inherited degenerative disease, caused by a CAG expansion in the 5'coding region of the gene, the mutant huntingtin protein (mHtt), causes that REST enters pathologically into the nucleus of cells, resulting in the repression of neuronal genes including BDNF, resulting in the progressive neuronal death. It has been reported that Htt associates with Hsp90 and this interaction is involved in regulation of huntingtin aggregation. Discovering mechanisms to reduce the cellular levels of mutant huntingtin and REST provide promising strategies for treating Huntington disease. Here, we use the yeast two-hybrid system to show that N-terminus or REST interacts with the heat shock protein 90 (Hsp90) and identifies REST as an Hsp90 Client Protein. To assess the effects of Hsp90 we used antisense oligonucleotide, and evaluated the levels mHtt and REST levels. Our results show that direct knockdown of endogenous Hsp90 significantly reduces the levels of REST and mutant Huntingtin, decreased the percentage of cells with mHtt in nucleus and rescued cells from mHtt-induced cellular cytotoxicity. Additionally Hsp90-specific inhibitors geldanamicyn and PUH71 dramatically reduced mHtt and REST levels, thereby providing neuroprotective activity. Our data show that Hsp90 is necessary to maintain the levels of REST and mHtt, which suggests that the interactions between Hsp90-REST and Hsp90-Huntingtin could be potential therapeutic targets in Huntington's disease.	[Orozco-Diaz, Raul; Sanchez-Alvarez, Angelica; Tapia-Ramirez, Jose] IPN, Ctr Invest & Estudios Avanzados, Dept Genet & Mol Biol, Mexico City, DF, Mexico; [Manuel Hernandez-Hernandez, Jose] IPN, Ctr Invest & Estudios Avanzados, Dept Cell Biol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Tapia-Ramirez, J (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Dept Genet & Mol Biol, Mexico City, DF, Mexico.	jtapia@cinvestav.mx		Tapia, Jose/0000-0002-4641-7181	SEP-CONACyT [48249-M]; CONACyT [203531, 203599]	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by a grant from SEP-CONACyT to JT (no. 48249-M). APSA was recipient of a CONACyT fellowship (no. 203531). ROD was recipient of a CONACyT fellowship (no. 203599).	Ashton NJ, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.113; Baldelli P, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0010-15.2015; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Banez-Coronel M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002481; Beebe K, 2013, ONCOTARGET, V4, P1065, DOI 10.18632/oncotarget.1099; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Calderone A, 2003, J NEUROSCI, V23, P2112; Chen GL, 2017, J CELL MOL MED, V21, P2974, DOI 10.1111/jcmm.13209; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Datta M, 2011, J BIOL CHEM, V286, P33759, DOI 10.1074/jbc.M111.265173; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Farley MM, 2018, ANNU REV PATHOL-MECH, V13, P93, DOI 10.1146/annurev-pathol-012414-040354; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Hunter RG, 2013, EPIGENOMICS-UK, V5, P177, DOI [10.2217/EPI.13.8, 10.2217/epi.13.8]; Kamal Adeela, 2004, Discov Med, V4, P277; Kaneko N, 2014, J NEUROSCI, V34, P6030, DOI 10.1523/JNEUROSCI.4045-13.2014; Kawamura M, 2019, NEUROSCI LETT, V699, P59, DOI 10.1016/j.neulet.2019.01.042; Lee N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39049; Li SH, 2000, HUM MOL GENET, V9, P2859, DOI 10.1093/hmg/9.19.2859; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mampay M, 2019, FRONT NEUROENDOCRIN, V53, DOI 10.1016/j.yfrne.2019.04.001; McClelland S, 2014, ELIFE, V3, DOI 10.7554/eLife.01267; Nasca C, 2013, P NATL ACAD SCI USA, V110, P4804, DOI 10.1073/pnas.1216100110; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Patterson KP, 2017, J NEUROSCI, V37, P3799, DOI 10.1523/JNEUROSCI.3748-16.2017; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ravache M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014311; Satoh J, 2013, BIOINFORM BIOL INSIG, V7, P357, DOI 10.4137/BBI.S13279; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shimojo M, 2008, J BIOL CHEM, V283, P34880, DOI 10.1074/jbc.M804183200; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Soldati C, 2013, J NEUROCHEM, V124, P418, DOI 10.1111/jnc.12090; Thompson LM, 2003, NAT GENET, V35, P13, DOI 10.1038/ng0903-13; Voss AK, 2000, DEVELOPMENT, V127, P1; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Zaidi NF, 2006, J NEUROCHEM, V98, P1290, DOI 10.1111/j.1471-4159.2006.03972.x; Zhong JH, 2003, GENOME RES, V13, P2691, DOI 10.1101/gr.1134603; Zou M, 2017, ONCOGENE, V36, P2160, DOI 10.1038/onc.2016.375; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220393	10.1371/journal.pone.0220393	http://dx.doi.org/10.1371/journal.pone.0220393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361762	Green Published, Green Submitted, gold			2022-12-26	WOS:000484981300028
J	Platzer, A; Nussbaumer, T; Karonitsch, T; Smolen, JS; Aletaha, D				Platzer, Alexander; Nussbaumer, Thomas; Karonitsch, Thomas; Smolen, Josef S.; Aletaha, Daniel			Analysis of gene expression in rheumatoid arthritis and related conditions offers insights into sex-bias, gene biotypes and co-expression patterns	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; SYNOVIAL TISSUE; KEY REGULATOR; INFLAMMATION; CELLS; ASSOCIATION; PATHWAY; GENOME; INTERLEUKIN-17A; PATHOGENESIS	The era of next-generation sequencing has mounted the foundation of many gene expression studies. In rheumatoid arthritis research, this has led to the discovery of important candidate genes which offered novel insights into mechanisms and their possible roles in the cure of the disease. In the last years, data generation has outstripped data analysis and while many studies focused on specific aspects of the disease, a global picture of the disease is not yet accomplished. Here, we analyzed and compared a collection of gene expression information from healthy individuals and from patients suffering under different arthritis conditions from published studies containing the following clinical conditions: early and established rheumatoid arthritis, osteoarthritis and arthralgia. We show comprehensive overviews of this data collection and give new insights specifically on gene expression in the early stage, into sex-dependent gene expression, and we describe general differences in expression of different biotypes of genes. Many genes that are related to cytoskeleton changes (actin filament related genes) are differently expressed in early rheumatoid arthritis in comparison to healthy subjects; interestingly, eight of these genes reverse their expression ratio significantly between men and women compared early rheumatoid arthritis and healthy subjects. There are some slighter changes between men and woman between the conditions early and established rheumatoid arthritis. Another aspect are miRNAs and other gene biotypes which are not only promising candidates for diagnoses but also change their expression grossly in average at rheumatoid arthritis and arthralgia compared to the healthy condition. With a selection of intersecting genes, we were able to generate simple classification models to distinguish between healthy and rheumatoid arthritis as well as between early rheumatoid arthritis to other arthritides based on gene expression.	[Platzer, Alexander; Karonitsch, Thomas; Smolen, Josef S.; Aletaha, Daniel] Med Univ Vienna, Dept Med 3, Div Rheumatol, Vienna, Austria; [Nussbaumer, Thomas] Tech Univ Munich, UNIKA T, Chair & Inst Environm Med, Augsburg, Germany; [Nussbaumer, Thomas] Helmholtz Zentrum Munchen, Augsburg, Germany; [Nussbaumer, Thomas] Helmholtz Ctr Munich, Inst Network Biol INET, Neuherberg, Germany	Medical University of Vienna; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Platzer, A (corresponding author), Med Univ Vienna, Dept Med 3, Div Rheumatol, Vienna, Austria.	alexander.platzer@meduniwien.ac.at		Karonitsch, Thomas/0000-0001-8310-6211; Platzer, Alexander/0000-0002-2318-8806				Adler D, 2005, VIOPLOT VIOLIN PLOT; Aidinis V, 2005, PLOS GENET, V1, P455, DOI 10.1371/journal.pgen.0010048; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Angelotti F, 2017, CLIN EXP RHEUMATOL, V35, P368; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Batliwalla FM, 2005, GENES IMMUN, V6, P388, DOI 10.1038/sj.gene.6364209; Besmond C, 2018, LIVER INT, V38, P358, DOI 10.1111/liv.13547; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Castaneda-Delgado Julio E, 2017, Front Immunol, V8, P285, DOI 10.3389/fimmu.2017.00285; Catrina AI, 2016, IMMUNOL REV, V269, P162, DOI 10.1111/imr.12379; Corvaisier M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001395; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Cutolo Maurizio, 2002, Autoimmunity Reviews, V1, P284, DOI 10.1016/S1568-9972(02)00064-2; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Engler A, 2007, BIOCHEM BIOPH RES CO, V359, P884, DOI 10.1016/j.bbrc.2007.05.178; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Flytlie HA, 2010, CYTOKINE, V49, P24, DOI 10.1016/j.cyto.2009.10.005; Forslind K, 2007, ANN RHEUM DIS, V66, P46, DOI 10.1136/ard.2006.056937; Frank E, 2016, DATA MINING PRACTICA, P4; Frank E, 1998, GENERATING ACCURATE; Freund Y., 1999, ALTERNATING DECISION; Furer V, 2010, CLIN IMMUNOL, V136, P1, DOI 10.1016/j.clim.2010.02.005; Galligan CL, 2007, GENES IMMUN, V8, P480, DOI 10.1038/sj.gene.6364400; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Guo YX, 2017, J IMMUNOL, V198, P4490, DOI 10.4049/jimmunol.1601988; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Jin M, 2006, BRAIN RES, V1075, P117, DOI 10.1016/j.brainres.2005.12.099; John G.H., 1995, UAI 95 P 11 C UNC AR; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasperkovitz PV, 2005, ARTHRITIS RHEUM-US, V52, P430, DOI 10.1002/art.20811; Kassambara A., 2016, FACTOEXTRA EXTRACT V, V1; Kenji K, 1992, P 9 INT WORKSH MACH, P249, DOI DOI 10.1016/B978-1-55860-247-2.50037-1; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Kraan MC, 2001, ARTHRITIS RES, V3, P65, DOI 10.1186/ar141; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee AYS, 2014, IMMUNOL CELL BIOL, V92, P354, DOI 10.1038/icb.2013.97; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li GQ, 2013, MOL IMMUNOL, V53, P227, DOI 10.1016/j.molimm.2012.08.018; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu MZ, 2004, ARTHRITIS RHEUM-US, V50, P3112, DOI 10.1002/art.20567; Liu T, 2015, GENE, V571, P97, DOI 10.1016/j.gene.2015.06.058; Lleo A, 2008, AUTOIMMUN REV, V7, P626, DOI 10.1016/j.autrev.2008.06.009; Malhotra Samir, 2004, MedGenMed, V6, P6; Parra-Torres NM, 2014, PROTEOME SCI, V12, DOI 10.1186/s12953-014-0055-0; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nicklin J, 2010, ARTHRIT CARE RES, V62, P1559, DOI 10.1002/acr.20282; Niu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113659; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; Onuora S., 2014, BLOOD, V8; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Platt  J., 1998, FAST TRAINING SUPPOR; Pollard LC, 2006, RHEUMATOLOGY, V45, P885, DOI 10.1093/rheumatology/kel021; Proost P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1997; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan Ross, 2014, C4 5 PROGRAMS MACHIN; Radstake TRDJ, 2005, ANN RHEUM DIS, V64, P359, DOI 10.1136/ard.2003.017566; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez Pedro C, 2012, Results Immunol, V2, P204, DOI 10.1016/j.rinim.2012.11.001; Ruyssen-Witrand A, 2014, JOINT BONE SPINE, V81, P228, DOI 10.1016/j.jbspin.2013.10.002; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; SHA F, 2005, P 22 INT C MACH LEAR; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sireci SG, 2003, J EDUC MEAS, V40, P277, DOI 10.1111/j.1745-3984.2003.tb01108.x; Slowikowski K, 2016, GGREPEL REPULSIVE TE, V5; Smolen JS, 2016, LANCET, V388, P1984; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Subhash S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1250-z; Sugiyama T, 2002, FEBS LETT, V517, P121, DOI 10.1016/S0014-5793(02)02588-7; Tasaki S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05044-4; Tavasolian F, 2018, J CELL BIOCHEM, V119, P478, DOI 10.1002/jcb.26205; Team RC, 2015, R LANG ENV STAT COMP; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P66, DOI DOI 10.1080/13506280444000102; Vasilopoulos Y, 2007, ANN RHEUM DIS, V66, P23, DOI 10.1136/ard.2007.079822; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Walsh AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183928; Walsh AM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0948-6; Weyand CM, 1998, ARTHRITIS RHEUM, V41, P817, DOI 10.1002/1529-0131(199805)41:5<817::AID-ART7>3.0.CO;2-S; Wickham H., 2015, R PACKAGE VERSION 04; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; World Health Organization, CHRON RHEUM COND; Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15145; Yoshida S, 2012, SCAND J RHEUMATOL, V41, P170, DOI 10.3109/03009742.2011.623137; Yoshizawa T, 2008, J IMMUNOL, V181, P3252, DOI 10.4049/jimmunol.181.5.3252; ZACHARSKI LR, 1992, CLIN IMMUNOL IMMUNOP, V63, P155, DOI 10.1016/0090-1229(92)90008-C; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	109	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219698	10.1371/journal.pone.0219698	http://dx.doi.org/10.1371/journal.pone.0219698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344123	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900025
J	Wiedenhoeft, AC; Simeone, J; Smith, A; Parker-Forney, M; Soares, R; Fishman, A				Wiedenhoeft, Alex C.; Simeone, John; Smith, Amy; Parker-Forney, Meaghan; Soares, Richard; Fishman, Akiva			Fraud and misrepresentation in retail forest products exceeds US forensic wood science capacity	PLOS ONE			English	Article							TIMBER TRADE; IDENTIFICATION	Fraud and misrepresentation in forest products supply chains is often associated with illegal logging, but the extent of fraud in the U.S. forest products market, and the availability of forensic expertise to detect it, is unknown. We used forensic wood anatomy to test 183 specimens from 73 consumer products acquired from major U.S. retailers, surveyed U.S. experts regarding their forensic wood anatomy capacity, and conducted a proficiency-testing program of those experts. 62% of tested products (45 of 73) had one or more type of fraudulent or misrepresented claim. Survey respondents reported a total capacity of 830 wood specimens per year, and participants' identification accuracy ranged from 6% to 92%. Given the extent of fraud and misrepresentation, U.S. wood forensic wood anatomy capacity does not scale with the need for such expertise. We call for increased training in forensic wood anatomy and its broader application in forest products supply chains to eliminate fraud and combat illegal logging.	[Wiedenhoeft, Alex C.; Soares, Richard] Ctr Wood Anat Res, Forest Prod Lab, Madison, WI 53726 USA; [Wiedenhoeft, Alex C.; Soares, Richard] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Wiedenhoeft, Alex C.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Wiedenhoeft, Alex C.] Univ Estadual Paulista Botucatu, Ciencias Biol Bot, Sao Paulo, Brazil; [Simeone, John] Simeone Consulting LLC, Anchorage, AK USA; [Simeone, John; Smith, Amy; Fishman, Akiva] World Wildlife Fund, 1250 24th St,NW, Washington, DC 20037 USA; [Parker-Forney, Meaghan] World Resources Inst, Washington, DC 20006 USA	United States Department of Agriculture (USDA); United States Forest Service; University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidade Estadual Paulista; World Wildlife Fund	Wiedenhoeft, AC (corresponding author), Ctr Wood Anat Res, Forest Prod Lab, Madison, WI 53726 USA.; Wiedenhoeft, AC (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.; Wiedenhoeft, AC (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.; Wiedenhoeft, AC (corresponding author), Univ Estadual Paulista Botucatu, Ciencias Biol Bot, Sao Paulo, Brazil.	acwieden@wisc.edu	Wiedenhoeft, Alex C./AAE-6626-2020	Wiedenhoeft, Alex C./0000-0002-7053-8565; Simeone, John/0000-0003-1015-9384	World Resources Institute; World Wildlife Fund; US Forest Service; WWF	World Resources Institute; World Wildlife Fund; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service); WWF	Funding and other support for this study was provided to the authors by the World Resources Institute (MPF), World Wildlife Fund (AS, AF, JS, ACW) and the US Forest Service (ACW, RS, JS). Funders (WWF and US Forest Service) contracted one of the authors, JS, who is the sole employee at Simeone Consulting, LLC, to help execute the study, including involvement in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2015, FURNITURE TODAY; Bailey M, 2016, CURR OPIN ENV SUST, V18, P25, DOI 10.1016/j.cosust.2015.06.004; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Carvalho DC, 2011, MITOCHONDR DNA, V22, P97, DOI 10.3109/19401736.2011.588219; Dormontt EE, 2015, BIOL CONSERV, V191, P790, DOI 10.1016/j.biocon.2015.06.038; Evans PD, 2017, IAWA J, V38, P266, DOI 10.1163/22941932-20170171; Finch K, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1600158; Forest Legality Initiative, RISK INF TOOL; Gasson P, 2011, IAWA J, V32, P137, DOI 10.1163/22941932-90000049; Global Trade Atlas, 2018, IHS MARK; Hassold S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157881; Jiao LC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20381-6; Lowe AJ, 2016, BIOSCIENCE, V66, P990, DOI 10.1093/biosci/biw129; Nellemann C., 2012, RAPID RESPONSE ASSES; NRF, 2015, TOP 100 RET 2015; Ostapkowicz J, 2017, J ARCHAEOL SCI-REP, V16, P341, DOI 10.1016/j.jasrep.2017.08.018; Paula PL, 2014, MACH VISION APPL, V25, P1019, DOI 10.1007/s00138-014-0592-7; Phillips AW, 2017, ACAD MED, V92, P222, DOI [10.1097/ACM.0000000000001410, 10.1097/ACM.0000000000001334]; Ravindran P, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0292-9; Rutherford C., 2015, CITES TIMBER GUIDE C; Siew KF, 2017, PROC SPIE, V10443, DOI 10.1117/12.2280616; Siple MC, 2017, CONSERV LETT, V10, P788, DOI 10.1111/conl.12384; Snel FA, 2018, WOOD SCI TECHNOL, V52, P1411, DOI 10.1007/s00226-018-1027-9; UNODC Timber Manual, 2016, BEST PRACT GUID FOR; Walker Linda, 2015, COUNTRY PROFILES 201; Willette DA, 2017, CONSERV BIOL, V31, P1076, DOI 10.1111/cobi.12888; Yu M, 2017, PLANTA, V246, P1165, DOI 10.1007/s00425-017-2758-9	27	18	21	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219917	10.1371/journal.pone.0219917	http://dx.doi.org/10.1371/journal.pone.0219917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344141	gold, Green Published			2022-12-26	WOS:000484977900040
J	Chau, DDL; Yung, KWY; Chan, WWL; An, Y; Hao, Y; Chan, HYE; Ngo, JCK; Lau, KF				Chau, Dennis Dik-Long; Yung, Kristen Wing-Yu; Chan, William Wai-Lun; An, Ying; Hao, Yan; Chan, Ho-Yin Edwin; Ngo, Jacky Chi-Ki; Lau, Kwok-Fai			Attenuation of amyloid-beta generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35	FASEB JOURNAL			English	Article						Alzheimer's disease; GULP1; amyloid precursor protein	PRECURSOR PROTEIN; A-BETA; ALZHEIMERS-DISEASE; PKC-ZETA; INTRACELLULAR DOMAIN; NEURITE OUTGROWTH; INSULIN; FE65; APP; ACTIVATION	Amyloid-beta (A beta) is derived from the proteolytic processing of amyloid precursor protein (APP), and the deposition of extracellular A beta to form amyloid plaques is a pathologic hallmark of Alzheimer's disease (AD). Although reducing A beta generation and accumulation has been proposed as a means of treating the disease, adverse side effects and unsatisfactory efficacy have been reported in several clinical trials that sought to lower A beta levels. Engulfment adaptor phosphotyrosine-binding (PTB) domain containing 1 (GULP1) is a molecular adaptor that has been shown to interact with APP to alter A beta production. Therefore, the modulation of the GULP1-APP interaction maybe an alternative approach to reducing A beta. However, the mechanisms that regulate GULP1-APP binding remain elusive. As GULP1 is a phosphoprotein, and because phosphorylation is a common mechanism that regulates protein interaction, we anticipated that GULP1 phosphorylation would influence GULP1-APP interaction and thereby A beta production. We show here that the phosphorylation of GULP1 threonine 35 (T35) reduces GULP1-APP interaction and suppresses the stimulatory effect of GULP1 on APP processing. The residue is phosphorylated by an isoform of atypical PKC (PKC zeta). Overexpression of PKC zeta reduces both GULP1-APP interaction and GULP1-mediated A beta generation. Moreover, the activation of PKC zeta via insulin suppresses APP processing. In contrast, GULP1-mediated APP processing is enhanced in PKC zeta knockout cells. Similarly, PKC iota, another member of atypical PKC, also decreases GULP1-mediated APP processing. Intriguingly, our X-ray crystal structure of GULP1 PTB-APP intracellular domain (AICD) peptide reveals that GULP1 T35 is not located at the GULP1-AICD binding interface; rather, it immediately precedes the beta 1-alpha 2 loop that forms a portion of the binding groove for the APP helix alpha C. Phosphorylating the residue may induce an allosteric effect on the conformation of the binding groove. Our results indicate that GULP1 T35 phosphorylation is a mechanism for the regulation of GULP1-APP interaction and thereby APP processing. Moreover, the activation of atypical PKC, such as by insulin, may confer a beneficial effect on AD by lowering GULP1-mediated A beta production.	[Chau, Dennis Dik-Long; Yung, Kristen Wing-Yu; Chan, William Wai-Lun; An, Ying; Hao, Yan; Chan, Ho-Yin Edwin; Ngo, Jacky Chi-Ki; Lau, Kwok-Fai] Chinese Univ Hong Kong, Sch Life Sci, Fac Sci, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ngo, JCK; Lau, KF (corresponding author), Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	jackyngo@cuhk.edu.hk; kflau@cuhk.edu.hk	An, Ying/GQP-4457-2022; Chan, Edwin/A-9478-2011; Ngo, Jacky Chi Ki/O-8093-2017	Chan, Edwin/0000-0003-4307-474X; Ngo, Jacky Chi Ki/0000-0002-6004-7041; Lau, Kwok-Fai/0000-0002-0193-1152; Yung, Kristen Wing Yu/0000-0001-7389-3012	Health and Medical Research Fund of Hong Kong; Research Grants Council Hong Kong; Chinese University of Hong Kong (CUHK) Direct Grant Scheme; United College Endowment Fund; TUYF Charitable Trust	Health and Medical Research Fund of Hong Kong; Research Grants Council Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong (CUHK) Direct Grant Scheme; United College Endowment Fund; TUYF Charitable Trust	The authors thank Tommaso Russo (University of Naples Federico II, Naples, Italy) for pRc-CMV-APP695, and Kodi Ravichandran (University of Virginia, Charlottesville, Virginia, USA) for pEBB GULP1. This work was supported by funds from the Health and Medical Research Fund of Hong Kong, the Research Grants Council Hong Kong, The Chinese University of Hong Kong (CUHK) Direct Grant Scheme, United College Endowment Fund and the TUYF Charitable Trust. The authors declare no conflicts of interest.	Aboitiz F, 2002, BRAIN RES BULL, V57, P481, DOI 10.1016/S0361-9230(01)00681-5; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Asadbegi M, 2016, BRAIN RES BULL, V121, P178, DOI 10.1016/j.brainresbull.2016.02.005; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926; Besancon R, 1998, Hum Mutat, V11, P481, DOI 10.1002/(SICI)1098-1004(1998)11:6<481::AID-HUMU13>3.0.CO;2-N; Beyer AS, 2012, NEUROBIOL AGING, V33, P732, DOI 10.1016/j.neurobiolaging.2010.06.006; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bredeston LM, 2002, BIOCHEM J, V361, P355, DOI 10.1042/0264-6021:3610355; Bukhari H, 2017, PROG NEUROBIOL, V156, P189, DOI 10.1016/j.pneurobio.2017.05.005; Buoso E, 2010, PHARMACOL RES, V62, P308, DOI 10.1016/j.phrs.2010.05.002; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Chow WNV, 2015, BIOCHEM J, V470, P303, DOI 10.1042/BJ20141485; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; Devi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032792; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Drummond ML, 2016, J MOL BIOL, V428, P1455, DOI 10.1016/j.jmb.2016.03.003; Dunning CJR, 2016, J NEUROCHEM, V137, P518, DOI 10.1111/jnc.13571; Edreira MM, 2009, J BIOL CHEM, V284, P27480, DOI 10.1074/jbc.M109.011312; Frankland PW, 2013, NATURE, V493, P312, DOI 10.1038/nature11850; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Glanzman David L, 2013, F1000 Biol Rep, V5, P4, DOI 10.3410/B5-4; Goldberg M, 1996, BIOCHEM PHARMACOL, V51, P1089, DOI 10.1016/0006-2952(96)00046-9; Greer YE, 2013, J BIOL CHEM, V288, P9438, DOI 10.1074/jbc.M112.448282; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Gunaratne A, 2013, MOL CELL BIOL, V33, P874, DOI 10.1128/MCB.00837-12; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hao Y, 2011, BIOCHEM J, V437, P576, DOI 10.1042/BJ4370576; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kelly MT, 2007, J NEUROSCI, V27, P3439, DOI 10.1523/JNEUROSCI.5612-06.2007; Khodosevich K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-18; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Kiss RS, 2006, J BIOL CHEM, V281, P12081, DOI 10.1074/jbc.M600621200; Koo EH, 1997, MOL MED, V3, P204, DOI 10.1007/BF03401673; Lau KF, 2002, MOL CELL NEUROSCI, V20, P13, DOI 10.1006/mcne.2002.1108; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Law BM, 2018, J ALZHEIMERS DIS, V61, P673, DOI 10.3233/JAD-170393; Le Good JA, 2004, BIOCHEM J, V378, P83, DOI 10.1042/BJ20031194; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12334-2; Li W, 2018, J BIOL CHEM, V293, P7674, DOI 10.1074/jbc.RA117.000505; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; Martins-Silva C, 2006, BRAIN RES, V1119, P1, DOI 10.1016/j.brainres.2006.08.064; Matt L, 2013, EMBO J, V32, P1348, DOI 10.1038/emboj.2013.81; Mayanglambam A, 2011, BIOCHEM PHARMACOL, V82, P505, DOI 10.1016/j.bcp.2011.05.022; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Moore P, 1998, NEUROSCI LETT, V254, P29, DOI 10.1016/S0304-3940(98)00653-3; Nekhoroshkova E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004647; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Ren SQ, 2013, EMBO J, V32, P1365, DOI 10.1038/emboj.2013.60; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Sajan MP, 2012, METABOLISM, V61, P459, DOI 10.1016/j.metabol.2011.12.008; Saluja I, 2009, NEUROBIOL DIS, V36, P162, DOI 10.1016/j.nbd.2009.07.006; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Shineman DW, 2009, BIOCHEMISTRY-US, V48, P3787, DOI 10.1021/bi802070j; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Taru H, 2009, J ALZHEIMERS DIS, V18, P253, DOI 10.3233/JAD-2009-1148; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375; Wagner MJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008987; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wang X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00294; Wang X, 2014, NEUROENDOCRINOL LETT, V35, P224; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Wu HY, 2009, ANAL CHEM, V81, P7778, DOI 10.1021/ac9013435; Xie J, 2000, MOL BRAIN RES, V82, P107, DOI 10.1016/S0169-328X(00)00187-X; XU HX, 1995, J BIOL CHEM, V270, P23243, DOI 10.1074/jbc.270.40.23243; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zambrano N, 2004, J BIOL CHEM, V279, P16161, DOI 10.1074/jbc.M311027200; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	95	7	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12019	12035		10.1096/fj.201802825RR	http://dx.doi.org/10.1096/fj.201802825RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373844	Green Published, Bronze			2022-12-26	WOS:000507461600033
J	Yan, HY; Ren, SW; Lin, Q; Yu, Y; Chen, CY; Hua, XH; Jin, HL; Lu, YY; Zhang, HX; Xie, QP; Huang, CS; Huang, HS				Yan, Huiying; Ren, Shuwei; Lin, Qi; Yu, Yuan; Chen, Caiyi; Hua, Xiaohui; Jin, Honglei; Lu, Yongyong; Zhang, Huxiang; Xie, Qipeng; Huang, Chuanshu; Huang, Haishan			Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth	FASEB JOURNAL			English	Article						proliferation; tumor growth; cell cycle; 3&amp; PRIME; -UTR	DEPENDENT KINASE 6; DOWN-REGULATION; CDK4/6 INHIBITOR; IN-VITRO; EXPRESSION; MICRORNA; PROGRESSION; RECEPTOR	BC cell growth-associated effectors is of great significance. Cyclin-dependent kinase (CDK)6 is a member of the CDK family of cell cycle-related proteins and plays an important role in cancer cell growth. This is borne out by the fact that a CDK6 inhibitor had been approved to treat several types of cancers. Nevertheless, underlying molecular mechanisms concerning how to regulate CDK6 expression in BC remains unclear. In the present study, it was observed that miR-934 was much higher in human BCs and human BC cell lines as well. The results also revealed that miR-934 inhibition dramatically decreased human BC cell monolayer growth in vitro and xenograft tumor growth in vivo; the outcomes were accompanied by CDK6 protein down-regulation and G(0)-G(1) cell cycle arrest. Moreover, overexpression of CDK6 reversed the inhibition of BC cell growth induced by miR-934. Further studies showed that miR-934 binds to a 3'-UTR of ubiquitin-conjugating enzyme 2N (ube2n) mRNA, down-regulated UBE2N protein expression; this, in turn, attenuated CDK6 protein degradation and led to CDK6 protein accumulation as well as the promotion of BC tumor growth. Collectively, this study not only establishes a novel regulatory axis of miR-934/UBE2N of CDK6 but also provides data suggesting that miR-934 and UBE2N may be potentially promising targets for therapeutic strategies against BC.	[Yan, Huiying; Ren, Shuwei; Yu, Yuan; Chen, Caiyi; Hua, Xiaohui; Jin, Honglei; Xie, Qipeng; Huang, Haishan] Wenzhou Med Univ, Zhejiang Prov Key Lab Technol & Applicat Model Or, Key Lab Lab Med, Sch Lab Med & Life Sci,Minist Educ, Wenzhou, Zhejiang, Peoples R China; [Lin, Qi; Lu, Yongyong; Zhang, Huxiang] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Huang, Chuanshu] NYU, Sch Med, Dept Environm Med, 341 East 25th St, New York, NY 10010 USA	Wenzhou Medical University; Wenzhou Medical University; New York University	Huang, CS (corresponding author), NYU, Sch Med, Dept Environm Med, 341 East 25th St, New York, NY 10010 USA.; Huang, HS (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Chashan Campus, Wenzhou 325035, Zhejiang, Peoples R China.	chuanshu.huang@nyulangone.org; haishan_333@163.com	xie, qipeng/ABG-5941-2021	Huang, Chuanshu/0000-0003-4133-5096; Huang, Haishan/0000-0002-7658-2188	Natural Science Foundation of China [NSFC81702530, NSFC81872587]; Wenzhou Science and Technology Bureau [Y20170028]; Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology Bureau; Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A)	The authors thank Dr. Xiaoqun Zheng (Wenzhou Medical University) for providing an experimental resource in the manuscript revision. The authors also thank all of the participants, specimen donors, and research groups who developed The Cancer Genome Atlas (TCGA) bladder cancer dataset resource for their contributions. These results partially based upon data generated by the TCGA Research Network (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga).This work was partially supported by the Natural Science Foundation of China (NSFC81702530 and NSFC81872587); the Wenzhou Science and Technology Bureau (Y20170028); and the Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A). The authors declare no conflicts of interest.	Acunzo Mario, 2015, Adv Biol Regul, V57, P1, DOI 10.1016/j.jbior.2014.09.013; Castilla MA, 2014, ENDOCR-RELAT CANCER, V21, P587, DOI 10.1530/ERC-13-0485; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bellail AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5234; Chen L, 2019, EXP THER MED, V17, P1476, DOI 10.3892/etm.2018.7084; Choo JRE, 2018, EXPERT OPIN DRUG MET, V14, P1123, DOI 10.1080/17425255.2018.1541347; Chowdhari S, 2014, J CELL PHYSIOL, V229, P1630, DOI 10.1002/jcp.24608; Corona SP, 2018, DRUG DES DEV THER, V12, P321, DOI 10.2147/DDDT.S137783; Deng M, 2017, CANCER LETT, V403, P175, DOI 10.1016/j.canlet.2017.06.006; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Hou Y, 2019, ONCOL LETT, V17, P73, DOI 10.3892/ol.2018.9594; Huang HS, 2015, CLIN CANCER RES, V21, P3783, DOI 10.1158/1078-0432.CCR-14-2829; Huang HS, 2014, ONCOTARGET, V5, P493, DOI 10.18632/oncotarget.1643; Iwata H, 2018, BREAST CANCER-TOKYO, V25, P402, DOI 10.1007/s12282-017-0827-3; Jiang SH, 2017, NATURE, V544, P460, DOI 10.1038/nature22032; Jin HL, 2018, MOL THER-NUCL ACIDS, V11, P312, DOI 10.1016/j.omtn.2018.03.003; Jin HL, 2016, ONCOTARGET, V7, P56540, DOI 10.18632/oncotarget.10645; Ju LX, 2017, J CANCER, V8, P1311, DOI 10.7150/jca.17817; Li XY, 2018, 2018 INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND BIG DATA (ICAIBD), P1; Li X, 2018, EXPERT OPIN THER PAT, V28, P919, DOI 10.1080/13543776.2018.1549229; Liang Z, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0664-1; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Liu MH, 2018, ONCOL REP, V39, P901, DOI 10.3892/or.2018.6221; Lopez-Tarruella S, 2017, FUTURE ONCOL, V13, P2137, DOI 10.2217/fon-2017-0183; Luo H., 2017, ENERGY TECHNOL-GER, V5, P1, DOI DOI 10.1177/; Lynce F, 2018, PHARMACOL THERAPEUT, V191, P65, DOI 10.1016/j.pharmthera.2018.06.008; Martin-Sanchez D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0043-2; Munoz-Rodriguez JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124340; Parylo S, 2019, J ONCOL PHARM PRACT, V25, P110, DOI 10.1177/1078155218770904; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Saad MA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0452-8; Sang HY, 2016, MED SCI MONITOR, V22, P4066, DOI 10.12659/MSM.897254; Sarosiek Tomasz, 2018, Pol Merkur Lekarski, V44, P5; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Si WG, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-018-0587-8; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Stone SL, 2019, INT REV CEL MOL BIO, V343, P65, DOI 10.1016/bs.ircmb.2018.05.012; Timmermann S, 1997, CELL GROWTH DIFFER, V8, P361; Wang G, 2012, ONCOL LETT, V4, P43, DOI 10.3892/ol.2012.695; Yang R, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0569-4; Yin L, 2018, EUR J MED CHEM, V144, P1, DOI 10.1016/j.ejmech.2017.12.003; Yu XC, 2013, GENE, V532, P87, DOI 10.1016/j.gene.2013.09.048; Yuan DZ, 2017, ONCOTARGET, V8, P67663, DOI 10.18632/oncotarget.18801; Zeng XR, 2016, MOL CANCER THER, V15, P512, DOI 10.1158/1535-7163.MCT-15-0606; Zhang E, 2017, ONCOTARGET, V8, P114072, DOI 10.18632/oncotarget.23120; Zhang J, 2016, EUR REV MED PHARMACO, V20, P4494; Zhu JL, 2017, MOL THER-NUCL ACIDS, V7, P299, DOI 10.1016/j.omtn.2017.04.012	48	17	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12112	12123		10.1096/fj.201900499RR	http://dx.doi.org/10.1096/fj.201900499RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373842				2022-12-26	WOS:000507461600040
J	Ghimire, K; Chiba, T; Minhas, N; Meijles, DN; Lu, B; O'Connell, P; Rogers, NM				Ghimire, Kedar; Chiba, Takuto; Minhas, Nikita; Meijles, Daniel N.; Lu, Bo; O'Connell, Philip; Rogers, Natasha M.			Deficiency in SIRP-alpha cytoplasmic recruitment confers protection from acute kidney injury	FASEB JOURNAL			English	Article						thrombospondin-1; CD47; AKI; ischemia-reperfusion injury	HUMAN T-CELL; PROTEIN-ALPHA; DOWN-REGULATION; SIGNAL; CD47; ACTIVATION; THROMBOSPONDIN-1; SHPS-1; PROLIFERATION; ASSOCIATION	Acute kidney injury (AKI) remains an important source of progressive chronic kidney injury. Loss of renal blood flow with subsequent restoration, termed ischemia reperfusion (IR), is a common cause of AKI. The cell surface receptor signal regulatory protein alpha (SIRP-alpha) is expressed on macrophages and limits inflammation and phagocytosis. SIRP-alpha has recently been found to have wider cell-based expression and play a role in renal IR. We have explored this in a genetic model of deficient SIRP-alpha signaling. Mice lacking SIRP-alpha cytoplasmic signaling (SIRP-alpha(mut)) and wild-type (WT) littermate controls underwent renal ischemia and reperfusion. Chimeric mice transplanted with WT or SIRP-alpha(mut) bone marrow were similarly challenged following engraftment. Molecular and immunohistochemical analysis of renal function, tissue damage, and key molecular targets was performed. SIRP-alpha(mut) mice were protected from renal IR compared with WT animals, demonstrating improved serum creatinine, less histologic damage, reduced proinflammatory cytokine production, and diminished production of reactive oxygen species (ROS). Resistance to renal IR in SIRP-alpha(mut) occurred alongside down-regulation of CD47 and thrombospondin-1, which are known to exert SIRP-alpha crosstalk and also promote IR. In chimeric mice, lack of SIRP-alpha signaling conferred protection to IR regardless of the genotype of circulating cells. Renal tubular epithelial cells from SIRP-alpha(mut) mice produced fewer ROS and proinflammatory cytokines in vitro. These results identify parenchymal SIRP-alpha as an independent driver of IR-mediated AKI and a potential therapeutic target.-Ghimire, K., Chiba, T., Minhas, N., Meijles, D. N., Lu, B., O'Connell, P., Rogers, N. M. Deficiency in SIRP-alpha cytoplasmic recruitment confers protection from acute kidney injury.	[Ghimire, Kedar; Minhas, Nikita; O'Connell, Philip; Rogers, Natasha M.] Ctr Transplant & Renal Res, Westmead Inst Med Res, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia; [Ghimire, Kedar; Chiba, Takuto; Lu, Bo; Rogers, Natasha M.] Univ Pittsburgh, Sch Med, Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA USA; [Meijles, Daniel N.] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [O'Connell, Philip; Rogers, Natasha M.] Univ Sydney, Westmead Clin Sch, Dept Med, Sydney, NSW, Australia; [Rogers, Natasha M.] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA	University of Sydney; Westmead Institute for Medical Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Georges University London; University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rogers, NM (corresponding author), Ctr Transplant & Renal Res, Westmead Inst Med Res, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia.	natasha.rogers@health.nsw.gov.au	Rogers, Natasha/ABC-2546-2020; O'Connell, Philip John/AFK-9353-2022; Meijles, Daniel/J-6457-2014	O'Connell, Philip John/0000-0002-2036-283X; Meijles, Daniel/0000-0002-5557-3549; Ghimire, Kedar/0000-0002-4672-5256	American Heart Association Postdoctoral Fellowship [17POST33670685]; National Health and Medical Research Council (NHMRC) [GNT1138372]; NHMRC Career Development Fellowship [GNT1158597]; NHMRC Practitioner Fellowship; Westmead Charitable Trust Clinical Researcher Award; Royal Australasian College of Physicians Jacquot Research Establishment Award	American Heart Association Postdoctoral Fellowship(American Heart Association); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Westmead Charitable Trust Clinical Researcher Award; Royal Australasian College of Physicians Jacquot Research Establishment Award	This study was supported by American Heart Association Postdoctoral Fellowship 17POST33670685 (to T.C.), National Health and Medical Research Council (NHMRC) Project Grant GNT1138372 (to N.M.R.), NHMRC Career Development Fellowship GNT1158597 (to N.M.R.), the NHMRC Practitioner Fellowship (to P.O'C.), a Westmead Charitable Trust Clinical Researcher Award (to N.M.R.), and a Royal Australasian College of Physicians Jacquot Research Establishment Award (to N.M.R.). The authors declare no conflicts of interest.	Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Brown JR, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4278579; Csanyi G, 2012, ARTERIOSCL THROM VAS, V32, P2966, DOI 10.1161/ATVBAHA.112.300031; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; Haller H, 2016, CURR OPIN NEPHROL HY, V25, P42, DOI 10.1097/MNH.0000000000000186; Hsu RK, 2016, SEMIN NEPHROL, V36, P283, DOI 10.1016/j.semnephrol.2016.05.005; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Isenberg JS, 2008, SURGERY, V144, P752, DOI 10.1016/j.surg.2008.07.009; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kurihara H, 2010, AM J PHYSIOL-RENAL, V299, pF517, DOI 10.1152/ajprenal.00571.2009; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Londino JD, 2015, J BIOL CHEM, V290, P31113, DOI 10.1074/jbc.M115.682914; Maile LA, 2012, DIABETOLOGIA, V55, P835, DOI 10.1007/s00125-011-2416-x; Novelli EM, 2012, AM J HEMATOL, V87, P326, DOI 10.1002/ajh.22274; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Rogers NM, 2017, CARDIOVASC RES, V113, P15, DOI 10.1093/cvr/cvw218; Rogers NM, 2016, KIDNEY INT, V90, P334, DOI 10.1016/j.kint.2016.03.034; Rogers NM, 2012, J AM SOC NEPHROL, V23, P1538, DOI 10.1681/ASN.2012020137; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Sinclair NRS, 1999, SCAND J IMMUNOL, V50, P10; Stefanidakis M, 2008, BLOOD, V112, P1280, DOI 10.1182/blood-2008-01-134429; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Tien SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10420; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; van Beek EM, 2009, FASEB J, V23, P4081, DOI 10.1096/fj.09-131557; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Verma R, 2016, MOL CELL BIOL, V36, P596, DOI 10.1128/MCB.00956-15; Wang L, 2012, J NEUROCHEM, V122, P834, DOI 10.1111/j.1471-4159.2012.07818.x; Win S, 2016, HEPATOLOGY, V63, P1987, DOI 10.1002/hep.28486; Yao MY, 2014, J AM SOC NEPHROL, V25, P1171, DOI 10.1681/ASN.2013040433	40	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11528	11540		10.1096/fj.201900583R	http://dx.doi.org/10.1096/fj.201900583R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31370677	Bronze			2022-12-26	WOS:000489166300076
J	Johnsen, SAL; Bollmann, J; Gebuehr, C; Herrle, JO				Johnsen, Simen Alexander Linge; Bollmann, Jorg; Gebuehr, Christina; Herrle, Jens O.			Relationship between coccolith length and thickness in the coccolithophore species Emiliania huxleyi and Gephyrocapsa oceanica	PLOS ONE			English	Article							SEAWATER CARBONATE CHEMISTRY; CALCIUM-CARBONATE; CO2 CONCENTRATION; CALCIFICATION; MORPHOLOGY; PRYMNESIOPHYCEAE; TEMPERATURE; SEA; CALIBRATION; SATURATION	Coccolith mass is an important parameter for estimating coccolithophore contribution to carbonate sedimentation, organic carbon ballasting and coccolithophore calcification. Single coccolith mass is often estimated based on the k(s) model, which assumes that length and thickness increase proportionally. To evaluate this assumption, this study compared coccolith length, thickness, and mass of seven Emiliania huxleyi strains and one Gephyrocapsa oceanica strain grown in 25, 34, and 44 salinity artificial seawater. While coccolith length increased with salinity in four E. huxleyi strains, thickness did not increase significantly with salinity in three of these strains. Only G. oceanica showed a consistent increase in length with salinity that was accompanied by an increase in thickness. Coccolith length and thickness was also not correlated in 14 of 24 individual experiments, and in the experiments in which there was a positive relationship r(2) was low (<0.4). Because thickness did not increase with length in E. huxleyi, the increase in mass was less than expected from the ks model, and thus, mass can not be accurately estimated from coccolith length alone.	[Johnsen, Simen Alexander Linge; Bollmann, Jorg] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada; [Gebuehr, Christina; Herrle, Jens O.] Goethe Univ Frankfurt, Inst Geosci, Frankfurt, Germany; [Gebuehr, Christina] Biodivers & Climate Res Ctr BIK F, Frankfurt, Germany	University of Toronto; Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Johnsen, SAL (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON, Canada.	simen.johnsen@mail.utoronto.ca	Herrle, Jens O/B-9088-2008		NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by NSERC through J. B.'s NSERC Discovery Grant [http://www.nserccrsng.gc.ca]. NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Batvik H, 1997, EUR J PHYCOL, V32, P155, DOI 10.1017/S0967026297001212; Baumann KH, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P367; Beaufort L, 2005, MICROPALEONTOLOGY, V51, P289, DOI 10.2113/gsmicropal.51.4.289; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beaufort L, 1999, DEEP-SEA RES PT II, V46, P2147, DOI 10.1016/S0967-0645(99)00058-2; Bell, 1999, MEASUREMENT GOOD PRA, V11, P1; Berger WH, 1985, CO2 INCREASE CLIMATE; Bollmann J, 1997, MAR MICROPALEONTOL, V29, P319, DOI 10.1016/S0377-8398(96)00028-X; Bollmann J, 2014, BIOGEOSCIENCES, V11, P1899, DOI 10.5194/bg-11-1899-2014; Bollmann J., 2013, BIOGEOSCIENCES DISCU, V10, P11155, DOI [DOI 10.5194/BGD-10-11155-2013, 10.5194/bgd-10-11155-2013]; Bollmann J., 2013, BIOGEOSCIENCES DISCU, V10, pC6961; Bollmann J, 2007, EARTH PLANET SC LETT, V255, P273, DOI 10.1016/j.epsl.2006.12.029; Bollmann J, 2010, PROTIST, V161, P78, DOI 10.1016/j.protis.2009.08.002; Bollmann J, 2009, EARTH PLANET SC LETT, V284, P320, DOI 10.1016/j.epsl.2009.05.003; Buitenhuis E, 1996, MAR ECOL PROG SER, V143, P271, DOI 10.3354/meps143271; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Charalampopoulou A, 2016, BIOGEOSCIENCES, V13, P5917, DOI 10.5194/bg-13-5917-2016; CRAIG DB, 1961, AM MINERAL, V46, P757; DERICHE R, 1987, INT J COMPUT VISION, V1, P167, DOI 10.1007/BF00123164; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Fabry V. L., 2010, GUIDE BEST PRACTICES, P201, DOI DOI 10.2777/66906; Fielding SR, 2009, LIMNOL OCEANOGR, V54, P1475, DOI 10.4319/lo.2009.54.5.1475; Fiorini S, 2011, J PHYCOL, V47, P1281, DOI 10.1111/j.1529-8817.2011.01080.x; Fox J., 2019, R COMPANION APPL REG, V.; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gibbs SJ, 2013, NAT GEOSCI, V6, P218, DOI 10.1038/ngeo1719; Gonzalez-Lemos S, 2018, BIOGEOSCIENCES, V15, P1079, DOI 10.5194/bg-15-1079-2018; Green JC, 1998, PHYCOLOGIA, V37, P121, DOI 10.2216/i0031-8884-37-2-121.1; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hagino K, 2011, J PHYCOL, V47, P1164, DOI 10.1111/j.1529-8817.2011.01053.x; Hansen E. W., 1988, Proceedings of the SPIE - The International Society for Optical Engineering, V891, P190, DOI 10.1117/12.944306; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Johnsen SAL, 2018, J MICROSC-OXFORD, V269, P321, DOI 10.1111/jmi.12641; Jones BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061868; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Langer Gerald, 2011, Journal of Nannoplankton Research, V32, P29; Langer Gerald, 2009, Journal of Nannoplankton Research, V30, P77; Leon P, 2018, ESTUAR COAST SHELF S, V202, P302, DOI 10.1016/j.ecss.2018.01.011; Lochte A.A., 2014, THESIS; McClelland HLO, 2016, SCI REP-UK, V6, DOI 10.1038/srep34263; Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; O'Dea SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6363; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oviedo AM, 2017, ESTUAR COAST SHELF S, V186, P58, DOI 10.1016/j.ecss.2015.12.007; Paasche E, 1996, PHYCOLOGIA, V35, P394, DOI 10.2216/i0031-8884-35-5-394.1; Paasche E, 1998, EUR J PHYCOL, V33, P33, DOI 10.1017/S0967026297001480; Pena EA, 2006, J AM STAT ASSOC, V101, P341, DOI 10.1198/016214505000000637; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rosas-Navarro A, 2016, BIOGEOSCIENCES, V13, P2913, DOI 10.5194/bg-13-2913-2016; Rost B, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P99; Saruwatari K, 2016, BIOGEOSCIENCES, V13, P2743, DOI 10.5194/bg-13-2743-2016; Schroeder DC, 2005, J PHYCOL, V41, P874, DOI 10.1111/j.1529-8817.2005.04188.x; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Sucheras-Marx B, 2014, GLOBAL PLANET CHANGE, V123, P97, DOI 10.1016/j.gloplacha.2014.10.015; SWANN MM, 1950, J EXP BIOL, V27, P226; von Dassow P, 2018, BIOGEOSCIENCES, V15, P1515, DOI 10.5194/bg-15-1515-2018; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; WATABE N, 1966, LIMNOL OCEANOGR, V11, P567, DOI 10.4319/lo.1966.11.4.0567; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; Young JR, 2014, BIOGEOSCIENCES, V11, P4771, DOI 10.5194/bg-11-4771-2014; Young J. R, 2003, GUIDE EXTANT COCCOLI; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Young JR, 2000, DEEP-SEA RES PT II, V47, P1679, DOI 10.1016/S0967-0645(00)00003-5; Zeebe RE, 2012, ANNU REV EARTH PL SC, V40, P141, DOI 10.1146/annurev-earth-042711-105521; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0	70	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220725	10.1371/journal.pone.0220725	http://dx.doi.org/10.1371/journal.pone.0220725			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381588	Green Submitted, Green Published, gold			2022-12-26	WOS:000484993600031
J	Kazemian, N; Pakpour, S; Milani, AS; Klironomos, J				Kazemian, Negin; Pakpour, Sepideh; Milani, Abbas S.; Klironomos, John			Environmental factors influencing fungal growth on gypsum boards and their structural biodeterioration: A university campus case study	PLOS ONE			English	Article							BUILDING-MATERIALS; MOLD GROWTH; HEALTH; CONTAMINATION; MOISTURE; AEROSOLIZATION; ASSOCIATIONS; MYCOTOXINS; FILTRATION; PARTICLES	The new era in the design of modern healthy buildings necessitates multidisciplinary research efforts that link principles of engineering and material sciences with those of building biology, in order to better comprehend and apply underlying interactions among design criteria. As part of this effort, there have been an array of studies in relation to the effects of building characteristics on indoor microbiota and their propensity to cause health issues. Despite the abundance of scientific inquiries, limited studies have been dedicated to concomitantly link these effects to the deterioration of 'structural integrity' in the building materials. This study focuses on the observed biodeteriorative capabilities of indoor fungi upon the ubiquitous gypsum board material as a function of building age and room functionality within a university campus. We observed that the fungal growth significantly affected the physical (weight loss) and mechanical (tensile strength) properties of moisture-exposed gypsum board samples; in some cases, tensile strength and weight decreased by more than 80%. Such intertwined associations between the biodeterioration of building material properties due to viable indoor fungi, and as a function of building characteristics, would suggest a critical need towards multi-criteria design and optimization of next-generation healthy buildings. Next to structural integrity measures, with a better understanding of what factors and environmental conditions trigger fungal growth in built environment materials, we can also optimize the design of indoor living spaces, cleaning strategies, as well as emergency management measures during probable events such as flooding or water damage.	[Kazemian, Negin; Klironomos, John] Univ British Columbia, Dept Biol, Kelowna, BC, Canada; [Kazemian, Negin; Pakpour, Sepideh; Milani, Abbas S.] Univ British Columbia, Sch Engn, Kelowna, BC, Canada; [Pakpour, Sepideh] Broad Inst, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA; [Milani, Abbas S.] Okanagan Node, Composites Res Network, Kelowna, BC, Canada	University of British Columbia; University of British Columbia; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Klironomos, J (corresponding author), Univ British Columbia, Dept Biol, Kelowna, BC, Canada.; Pakpour, S; Milani, AS (corresponding author), Univ British Columbia, Sch Engn, Kelowna, BC, Canada.; Pakpour, S (corresponding author), Broad Inst, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA.; Milani, AS (corresponding author), Okanagan Node, Composites Res Network, Kelowna, BC, Canada.	sepideh.pakpour@ubc.ca; abbas.milani@ubc.ca; john.klironomos@ubc.ca	Kazemian, Negin/ABF-4238-2021	Kazemian, Negin/0000-0001-6974-5201	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work received support from Natural Sciences and Engineering Research Council of Canada; Discover Grants (A.S.M & J.K). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the University of British Columbia Okanagan campus for providing the necessary facilities for dust sample collection and the support received from different research laboratories. The financial support from the Natural Sciences and Engineering Research Council of Canada is greatly acknowledged.	Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0112-7; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Adan OCG, 2011, FUNDAMENTALS OF MOLD GROWTH IN INDOOR ENVIRONMENTS AND STRATEGIES FOR HEALTHY LIVING, P1, DOI 10.3921/978-90-8686-722-6; Andersen B, 2017, INDOOR AIR, V27, P6, DOI 10.1111/ina.12298; Andersen B, 2002, MYCOLOGIA, V94, P392, DOI 10.2307/3761773; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; [Anonymous], 2018, INSTALL HANG DRYWALL; [Anonymous], 2018, IMAGEJ; [Anonymous], 2018, COST REMOVE DRYWALL; Baxi SN, 2016, J ALLER CL IMM-PRACT, V4, P396, DOI 10.1016/j.jaip.2016.01.008; Betancourt DA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-283; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Cabral JPS, 2010, SCI TOTAL ENVIRON, V408, P4285, DOI 10.1016/j.scitotenv.2010.07.005; Canada Housing and Mortgage Association, REL MOIST CONT MECH; Chen Z, 2010, J MATER SCI, V45, P4444, DOI 10.1007/s10853-010-4527-z; Chew GL, 2003, ALLERGY, V58, P13, DOI 10.1034/j.1398-9995.2003.00013.x; Crawford B, 2017, MATERIALS, V10, DOI 10.3390/ma10111252; Dacarro C, 2003, J APPL MICROBIOL, V95, P904, DOI 10.1046/j.1365-2672.2003.02044.x; Dannemiller KC, 2016, INDOOR AIR, V26, P179, DOI 10.1111/ina.12205; Dedesko S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0137-y; Drews K, 2008, MOULD GROWS; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Flannigan B, 2001, MICROORGANISMS IN HO; Flannigan B, 2011, MICROORGANISMS IN HOME AND INDOOR WORK ENVIRONMENTS: DIVERSITY, HEALTH IMPACTS, INVESTIGATION AND CONTROL, 2ND EDITION; Foarde K, 2004, J EXPO ANAL ENV EPID, V14, pS41, DOI 10.1038/sj.jea.7500357; Frankel M, 2014, INDOOR AIR, V24, P16, DOI 10.1111/ina.12055; Fromme H, 2016, INT J HYG ENVIR HEAL, V219, P143, DOI 10.1016/j.ijheh.2015.11.004; Gadd G. M., 2004, Mycologist, V18, P60, DOI 10.1017/S0269915X04002022; Genuis SJ, 2007, EUR J INTERN MED, V18, P516, DOI 10.1016/j.ejim.2007.05.005; Ghazi Wakili K, 2015, FIRE MATER, V39, P85, DOI 10.1002/fam.2234; GRANT C, 1989, INT BIODETERIOR, V25, P259, DOI 10.1016/0265-3036(89)90002-X; Guggemos AA, 2005, J INFRASTRUCT SYST, V11, P93, DOI 10.1061/(ASCE)1076-0342(2005)11:2(93); Haugland R., 2002, METHOD IDENTIFYING Q, Patent No. [6,387,652, 6387652]; Hicks JB, 2005, J OCCUP ENVIRON HYG, V2, P481, DOI 10.1080/15459620500252860; Hope J, 2013, SCI WORLD J, DOI 10.1155/2013/767482; Hyvarinen A, 2002, INT BIODETER BIODEGR, V49, P27, DOI 10.1016/S0964-8305(01)00103-2; Iino H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7828; Jamriska M, 2000, INDOOR AIR, V10, P19, DOI 10.1034/j.1600-0668.2000.010001019.x; Karunasena E, 2001, MYCOPATHOLOGIA, V150, P91, DOI 10.1023/A:1010920611811; Karunasena E, 2010, MYCOPATHOLOGIA, V170, P377, DOI 10.1007/s11046-010-9330-5; Kemp PC, 2002, INDOOR BUILT ENVIRON, V11, P214, DOI 10.1159/000066011; Khan AAH, 2012, SAUDI J BIOL SCI, V19, P405, DOI 10.1016/j.sjbs.2012.06.002; Kolarkar P, 2014, FIRE MATER, V38, P13, DOI 10.1002/fam.2155; Krause M, 2006, J OCCUP ENVIRON HYG, V3, P435, DOI 10.1080/15459620600798663; Mankowski M, 2000, WOOD FIBER SCI, V32, P340; McMullin DR, 2013, MYCOTOXIN RES, V29, P47, DOI 10.1007/s12550-012-0144-9; Mihinova D, 2012, BRATISL MED J, V113, P314, DOI 10.4149/BLL_2012_073; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; Mudarri DH, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/2386596; Muilenberg ML., 1995, THE OUTDOOR AEROSOL; Nielsen KF, 2004, INT BIODETER BIODEGR, V54, P325, DOI 10.1016/j.ibiod.2004.05.002; Nielsen KF, 1998, INT BIODETER BIODEGR, V42, P9, DOI 10.1016/S0964-8305(98)00038-9; Pasanen P, 1997, ENVIRON INT, V23, P425, DOI 10.1016/S0160-4120(97)00027-5; Pekhtasheva E, 2012, CHEM TECHNOL, V6; Phelka AD, 2012, CRIT REV TOXICOL, V42, P1, DOI 10.3109/10408444.2011.613067; Portnoy JM, 2004, J ALLERGY CLIN IMMUN, V113, P189, DOI 10.1016/j.jaci.2003.11.021; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ratnaseelan AM, 2018, CLIN THER, V40, P903, DOI 10.1016/j.clinthera.2018.05.004; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Rogers CA, 2003, IMMUNOL ALLERGY CLIN, V23, P501, DOI 10.1016/S0889-8561(03)00061-4; Sanchez-Silva M, 2008, J MATER CIVIL ENG, V20, P352, DOI 10.1061/(ASCE)0899-1561(2008)20:5(352); Sharpe R, 2014, CLIN EXP ALLERGY, V44, P631, DOI 10.1111/cea.12281; Sivasubramani SK, 2004, INDOOR AIR, V14, P405, DOI 10.1111/j.1600-0668.2004.00262.x; Tischer C, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.OA3319; Vacher S, 2010, BUILD ENVIRON, V45, P916, DOI 10.1016/j.buildenv.2009.09.011; Verdier T, 2014, BUILD ENVIRON, V80, P136, DOI 10.1016/j.buildenv.2014.05.030; Viitanen H, 2010, J BUILD PHYS, V33, P201, DOI 10.1177/1744259109343511; Wani KA, 2014, INDOOR BUILT ENVIRON, V23, P724, DOI 10.1177/1420326X13480374; Webb JS, 2000, APPL ENVIRON MICROB, V66, P3194, DOI 10.1128/AEM.66.8.3194-3200.2000; Yan L, 2015, FOREST PROD J, V65, P272, DOI 10.13073/FPJ-D-14-00085; Zhao D, 2015, INT J ENV RES PUB HE, V12, P8448, DOI 10.3390/ijerph120708448	72	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220556	10.1371/journal.pone.0220556	http://dx.doi.org/10.1371/journal.pone.0220556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374095	Green Submitted, Green Published, gold			2022-12-26	WOS:000484991500018
J	Bricout, H; Torcel-Pagnon, L; Lecomte, C; Almas, MF; Matthews, I; Lu, XY; Wheelock, A; Sevdalis, N				Bricout, Helene; Torcel-Pagnon, Laurence; Lecomte, Coralie; Almas, Mariana F.; Matthews, Ian; Lu, Xiaoyan; Wheelock, Ana; Sevdalis, Nick			Determinants of shingles vaccine acceptance in the United Kingdom	PLOS ONE			English	Article							HERPES-ZOSTER VACCINATION; POSTHERPETIC NEURALGIA; INFLUENZA VACCINATION; PUBLIC AWARENESS; BARRIERS; PREDICTORS; DECISION; COVERAGE; ENGLAND; PROGRAM	Background The United Kingdom (UK) was the first European country to introduce a national immunisation program for shingles (2013-2014). That year, vaccination coverage ranged from 50 to 64% across the UK, but uptake has declined ever since. This study explored determinants of the acceptance of the shingles vaccine in the UK. Methods Vaccinated and unvaccinated individuals, who were eligible for the last catch-up cohort of the 2014-2015 shingles vaccination campaign, were identified using the Clinical Practice Research Datalink (the National Health Service data research service) and invited to participate by their general practitioner (GP). An anonymised self-administered questionnaire was developed using the Health Belief Model as a theoretical framework, to collect data on demographic and socio-economic characteristics, health status, knowledge, influences, experiences and attitudes to shingles and the shingles vaccine. Multivariable logistic regression was used to identify the factors associated with vaccination. Physicians' views concerning perceived barriers to vaccination were also assessed. Results Of the 2,530 questionnaires distributed, 536 were returned (21.2%) from 69 general practices throughout the UK. The majority of responders were female (58%), lived in care homes (56%) and had completed secondary or higher education (88%). There were no differences between vaccinated and unvaccinated responders. Being offered the shingles vaccine by a GP/nurse (odds ratio (OR) = 2.3), and self-efficacy (OR = 1.2) were associated with being vaccinated (p<0.05). In contrast, previous shingles history (OR = 0.4), perceived barriers to vaccination (OR = 0.7) and perceived control of the disease (OR = 0.7) were associated with not being vaccinated against shingles (p<0.05). Less than half (44.0%) of GPs were aware of the local communication campaigns regarding shingles and the shingles vaccine. Conclusions Socio-psychological factors largely influence shingles vaccination acceptance in this study. The results add to existing evidence that healthcare providers (HCPs) have a pivotal role against vaccine hesitancy. Campaigns focusing on GPs and accessible information offered to eligible members of the public can further enhance shingles vaccine uptake.	[Bricout, Helene; Torcel-Pagnon, Laurence] Sanofi Pasteur, Lyon, France; [Lecomte, Coralie] IQVIA, Ouen, France; [Almas, Mariana F.] IQVIA, Slough, Berks, England; [Matthews, Ian] MSD Ltd, Maidenhead, Berks, England; [Lu, Xiaoyan] MSD Vaccins, Lyon, France; [Wheelock, Ana] Imperial Coll London, Natl Inst Hlth Res, Dept Surg & Canc, Imperial Patient Safety Translat Res Ctr, London, England; [Sevdalis, Nick] Kings Coll London, Ctr Implementat Sci, London, England	Sanofi-Aventis; Sanofi France; IQVIA; IQVIA; Merck & Company; Imperial College London; University of London; King's College London	Lu, XY (corresponding author), MSD Vaccins, Lyon, France.	xiaoyan.lu@msd.com	Sevdalis, Nick/AAJ-6280-2020; Wheelock, Ana/AAE-9248-2019	Sevdalis, Nick/0000-0001-7560-8924; Wheelock, Ana/0000-0003-0855-7252; Lu, Xiaoyan/0000-0002-5592-7239; Helene, BRICOUT/0000-0002-5439-8064; Matthews, Ian/0000-0001-6175-6512	Sanofi Pasteur MSD; MSD	Sanofi Pasteur MSD; MSD	This work was funded initially by Sanofi Pasteur MSD and lately by MSD from January 2017. Bricout H, Torcel-Pagnon L, Wheelock A and Sevdalis N contributed to the conception/design of the study. Matthews I, Lu X, Lecomte C and Almas MF drafted the initial manuscript. Bricout H and Torcel-Pagnon L were employee of Sanofi Pasteur MSD. Matthews I and Lu X are employed by MDS. Wheelock A and Sevdalis N have received consultancy fees from of Sanofi Pasteur MSD and MDS. Lecomte C and Almas M are employed by IQVIA which received funds from Sanofi Pasteur MSD and MSD to conduct the study. The funder provided support in the form of salaries for authors Bricout H, Torcel-Pagnon L, Matthews I, and Lu X, but did not have any additional role in the study design, data collection of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amirthalingam G, 2018, LANCET PUBLIC HEALTH, V3, pE82, DOI 10.1016/S2468-2667(17)30234-7; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Eid Deeb D, 2015, Consult Pharm, V30, P459, DOI 10.4140/TCP.n.2015.459; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Health Protection Scotland, SHINGL HERP ZOST VAC; Hurley LP, 2010, ANN INTERN MED, V152, P555, DOI 10.7326/0003-4819-152-9-201005040-00005; Javed Saba, 2012, Dermatol Online J, V18, P2; Kohlhammer Y, 2007, PUBLIC HEALTH, V121, P742, DOI 10.1016/j.puhe.2007.02.011; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lehmann BA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-547; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Matthews I, 2018, VACCINE, V36, P7105, DOI 10.1016/j.vaccine.2018.08.037; Mick G, 2013, J CLIN GERONTOL GERI, V4, P102, DOI DOI 10.1016/j.jcgg.2013.03.001; Nexoe J, 1999, SCAND J PRIM HEALTH, V17, P105, DOI 10.1080/028134399750002737; Nunnally J., 1978, PSYCHOMETRIC THEORY; Opstelten W, 2009, VACCINE, V27, P192, DOI 10.1016/j.vaccine.2008.10.047; Paek E, 2010, GERONTOLOGY, V56, P20, DOI 10.1159/000240046; Preston CC, 2000, ACTA PSYCHOL, V104, P1, DOI 10.1016/S0001-6918(99)00050-5; Public Health Agency, ANN IMM VACC PREV DI; Public Health England, HERP ZOST SHINGL IMM; Public Health England, 2014, HERP ZOST SHINGL IMM; Public Health Wales, SHINGL IMM UPT DAT; Robinson A, 2001, QUAL HEALTH CARE, V10, pI34; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Rubin D. B., 2004, MULTIPLE IMPUTATION; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Sheldon H., INCREASING RESPONSE; Shim E, 2012, J R SOC INTERFACE, V9, P2234, DOI 10.1098/rsif.2012.0115; Shiraki K, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx007; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Teeter BS, 2014, VACCINE, V32, P5749, DOI 10.1016/j.vaccine.2014.08.040; Valente N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011539; Walker JL, 2018, VACCINE, V36, P2371, DOI 10.1016/j.vaccine.2018.02.021; Ward C, 2017, VACCINE, V35, P2372, DOI 10.1016/j.vaccine.2017.03.042; Wheelock A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014668; Wheelock A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113503; World Health Organization (WHO), REP SAGE WORK GROUP; Yang TU, 2015, HUM VACC IMMUNOTHER, V11, P719, DOI 10.1080/21645515.2015.1008885; Zhang DM, 2017, AM J PREV MED, V52, pE17, DOI 10.1016/j.amepre.2016.08.029	42	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220230	10.1371/journal.pone.0220230	http://dx.doi.org/10.1371/journal.pone.0220230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369608	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900037
J	Dolan, M; Mastri, M; Tracz, A; Christensen, JG; Chatta, G; Ebos, JML				Dolan, Melissa; Mastri, Michalis; Tracz, Amanda; Christensen, James G.; Chatta, Gurkamal; Ebos, John M. L.			Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance	PLOS ONE			English	Article							TARGETED THERAPY; TUMOR-GROWTH; ANGIOGENESIS; INHIBITOR; VEGF; RECEPTORS; SUNITINIB; EPHRIN-B2; CANCER; MET	Tyrosine kinase inhibitors (TKIs) that primarily target angiogenesis are approved to treat several cancers in the metastatic setting; however, resistance is common. Sequential treatment or 'switching' from one TKI to another following failure can be effective, but predicting which drugs will have cross-over sensitivity remains a challenge. Here we examined sitravatinib (MGCD516), a spectrum-selective TKI able to block MET, TAM (TYRO3, AXL, MerTK) and multiple receptor families (including PDGFRs, VEGFRs, and Ephs). Transcriptomic analysis of several mouse and human cell lines revealed diverse molecular changes after resistance to two TKIs (sunitinib and axitinib) with multiple sitravatinib targets found to be upregulated. Sitravatinib treatment in vitro resulted in enhanced anti-proliferative effects in resistant cells and was improved compared to TKIs with similar target profiles. In vivo, primary tumor growth inhibition after sitravatinib treatment in mice was enhanced in resistant tumors and metastasis suppression improved when tumors were surgically removed. Together, these results suggest that the diverse and often inconsistent compensatory signaling mechanisms found to contribute to TKI resistance may paradoxically improve the tumor-inhibiting effects of broad-spectrum TKIs such as sitravatinib that are able to block multiple signaling pathways. Sitravatinib in the second-line setting following antiangiogenic TKI treatment may have enhanced inhibitory effects in local and disseminated disease, and improve outcomes in patients with refractory disease.	[Dolan, Melissa; Ebos, John M. L.] Roswell Pk Comprehens Canc Ctr, Dept Expt Therapeut, Buffalo, NY 14203 USA; [Mastri, Michalis; Tracz, Amanda; Ebos, John M. L.] Roswell Pk Comprehens Canc Ctr, Dept Canc Genet & Genom, Buffalo, NY 14203 USA; [Chatta, Gurkamal; Ebos, John M. L.] Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY 14203 USA; [Christensen, James G.] Mirati Therapeut, San Diego, CA USA		Ebos, JML (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Expt Therapeut, Buffalo, NY 14203 USA.; Ebos, JML (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Canc Genet & Genom, Buffalo, NY 14203 USA.; Ebos, JML (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY 14203 USA.	John.Ebos@RoswellPark.org		Dolan, Melissa/0000-0002-8425-7780; Ebos, John/0000-0002-7175-9044	Roswell Park Cancer Institute (RPCI) Support Grant from the National Cancer Institute (NCI) [P30CA016056]; Roswell Park Alliance Foundation (RPAF); American Cancer Society (ACS) [RSG-18-064-01 - TBG]; Department of Defense (DoD) through the Peer Reviewed Cancer Research Program [W81XWH-14-1-0210]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Roswell Park Cancer Institute (RPCI) Support Grant from the National Cancer Institute (NCI); Roswell Park Alliance Foundation (RPAF); American Cancer Society (ACS)(American Cancer Society); Department of Defense (DoD) through the Peer Reviewed Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work used shared resources supported by Roswell Park Cancer Institute (RPCI) Support Grant from the National Cancer Institute (NCI) (P30CA016056) and was supported by the Roswell Park Alliance Foundation (RPAF); the American Cancer Society (ACS) via a Research Scholar Grant (RSG-18-064-01 - TBG); and, the Department of Defense (DoD) through the Peer Reviewed Cancer Research Program (Award No. W81XWH-14-1-0210), all to JMLE. Mirati Therapeutics also provided support in the form of salaries (AT) via a sponsored research agreement to JMLE, with roles articulated in the 'Author Contribution' sections. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marrawi MY, 2013, TARGET ONCOL, V8, P203, DOI 10.1007/s11523-012-0252-7; Azad NS, 2008, J CLIN ONCOL, V26, P3709, DOI 10.1200/JCO.2007.10.8332; Benzekry S, 2016, CANCER RES, V76, P535, DOI 10.1158/0008-5472.CAN-15-1389; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Chowdhury S, 2017, P AN M AM SOC CLIN, V35, P4506, DOI DOI 10.1200/JC0.2017.35.15_; Cook RS, 2013, J CLIN INVEST, V123, P3231, DOI 10.1172/JCI67655; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du WT, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124184; Ebos J, 2016, CURR DRUG TARGETS; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; Ebos JML, 2014, EMBO MOL MED, V6, P1561, DOI 10.15252/emmm.201403989; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Gacche RN, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.14; Gacche RN, 2018, DRUG RESIST UPDATE, V36, P47, DOI 10.1016/j.drup.2018.01.002; Gao YA, 2018, TOXINS, V10, DOI 10.3390/toxins10010013; Germain S, 2010, NAT MED, V16, P752, DOI 10.1038/nm0710-752; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Guerin E, 2013, CANCER RES, V73, P2743, DOI 10.1158/0008-5472.CAN-12-4183; Jimenez-Valerio G, 2016, CURR DRUG TARGETS, V17, P1728, DOI 10.2174/1389450117666160301101425; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Kasikara C, 2017, MOL CANCER RES, V15, P753, DOI 10.1158/1541-7786.MCR-16-0350; Ko B, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.09; Kuczynski EA, 2013, NAT REV CLIN ONCOL, V10, P571, DOI 10.1038/nrclinonc.2013.158; Lai YC, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0530-2; Leal TA, 2017, J THORAC ONCOL, V12, pS1567, DOI 10.1016/j.jtho.2017.09.046; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Ma Shaolin, 2018, F1000Res, V7, P326, DOI 10.12688/f1000research.11771.1; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mastri M, 2018, CELL REP, V25, P3706, DOI 10.1016/j.celrep.2018.12.017; Mastri M, 2018, MOL CANCER THER, V17, P1602, DOI 10.1158/1535-7163.MCT-17-1066; Mastri M, 2016, CURR DRUG TARGETS, V17, P1747, DOI 10.2174/1389450117666151209123544; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; Msaouel P, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.6_suppl.TPS708; Pant S, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4568; Paolino M, 2016, CANCERS, V8, DOI 10.3390/cancers8100097; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Patwardhan PP, 2016, ONCOTARGET, V7, P4093, DOI 10.18632/oncotarget.6547; Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714; Rini BI, 2010, J CLIN ONCOL, V28, pE284, DOI 10.1200/JCO.2009.27.1759; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schmidinger Manuela, 2013, EJC Suppl, V11, P172, DOI 10.1016/j.ejcsup.2013.07.016; Shojaei F, 2012, CANCER LETT, V320, P48, DOI 10.1016/j.canlet.2012.01.026; Spina A, 2015, BIOMEDICINES, V3, P71, DOI 10.3390/biomedicines3010071; Tracz A, 2014, JOVE-J VIS EXP, DOI 10.3791/51485; Uhl C, 2018, ANGIOGENESIS, V21, P873, DOI 10.1007/s10456-018-9633-6; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Zembruski NCL, 2012, ANAL BIOCHEM, V429, P79, DOI 10.1016/j.ab.2012.07.005; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343	54	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220101	10.1371/journal.pone.0220101	http://dx.doi.org/10.1371/journal.pone.0220101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369645	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900023
J	Kumthip, K; Khamrin, P; Ushijima, H; Maneekarn, N				Kumthip, Kattareeya; Khamrin, Pattara; Ushijima, Hiroshi; Maneekarn, Niwat			Enteric and non-enteric adenoviruses associated with acute gastroenteritis in pediatric patients in Thailand, 2011 to 2017	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CHILDREN; VIRUSES; INFECTION; INFANTS	Human adenovirus (HAdV) is known to be a common cause of diarrhea in children worldwide. Infection with adenovirus is responsible for 2-10% of diarrheic cases. To increase a better understanding of the prevalence and epidemiology of HAdV infection, a large scale and long-term study was needed. We implemented a multi-year molecular detection and characterization study of HAdV in association with acute gastroenteritis in Chiang Mai, Thailand from 2011 to 2017. Out of 2,312 patients, HAdV was detected in 165 cases (7.2%). The positive rate for HAdV infection was highest in children of 1 and 2 years of age compared to other age groups. HAdV subgroup C (40.6%) was the most prevalent, followed by subgroups F (28.5%), B (20.6%), A and D (4.8% each), and E (0.6%). Of these, HAdV-F41 (22.4%), HAdV-C2 (18.2%), HAdV-B3 (15.2%), and HAdV-C1 (13.3%) were the most common genotypes detected. HAdV infection occurred throughout the year with a higher detection rate between May and July. In conclusion, our study demonstrated the infection rate, seasonal distribution and genotype diversity of HAdV infection in children with diarrhea in Chiang Mai, Thailand over a period of 7 year. Not only enteric adenovirus (F40 and F41) but also non-enteric adenovirus (B3, C1, C2) may play an important role in gastroenteritis in this area. The information will be beneficial for the prevention and control of HAdV outbreaks in the future.	[Kumthip, Kattareeya; Khamrin, Pattara; Maneekarn, Niwat] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand; [Kumthip, Kattareeya; Khamrin, Pattara; Maneekarn, Niwat] Chiang Mai Univ, Ctr Excellence Emerging & Re Emerging Diarrhea Vi, Chiang Mai, Thailand; [Ushijima, Hiroshi] Univ Tokyo, Sch Int Hlth, Grad Sch Med, Dept Dev Med Sci, Tokyo, Japan; [Ushijima, Hiroshi] Nihon Univ, Dept Pathol & Microbiol, Div Microbiol, Sch Med, Tokyo, Japan	Chiang Mai University; Chiang Mai University; University of Tokyo; Nihon University	Maneekarn, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand.; Maneekarn, N (corresponding author), Chiang Mai Univ, Ctr Excellence Emerging & Re Emerging Diarrhea Vi, Chiang Mai, Thailand.	niwat.m@cmu.ac.th			Thailand Research Fund [KKMRG6180145]	Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by the grant from the Thailand Research Fund (KKMRG6180145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2017, J MED VIROL, V89, P606, DOI 10.1002/jmv.24672; Chaimongkol N, 2012, CLIN LAB, V58, P117; Desselberger Ulrich, 2014, VirusDisease, V25, P147, DOI 10.1007/s13337-014-0223-y; Dey SK, 2013, EPIDEMIOL INFECT, V141, P958, DOI 10.1017/S0950268812001586; Dey SK, 2009, INFECT GENET EVOL, V9, P518, DOI 10.1016/j.meegid.2009.02.001; Echavarria M., 2009, Principles and practice of clinical virology, P463, DOI 10.1002/9780470741405.ch19; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; Huh JW, 2009, J CLIN VIROL, V44, P152, DOI 10.1016/j.jcv.2008.11.016; Kim JS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1602054; Kittigul L, 2009, J MED VIROL, V81, P345, DOI 10.1002/jmv.21380; Lazic G, 2015, FOOD ENV VIROL; Lee JI, 2012, MICROBIOL IMMUNOL, V56, P523, DOI 10.1111/j.1348-0421.2012.00469.x; Liu LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088791; Moyo SJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0666-1; Nakanishi K, 2009, J CLIN VIROL, V46, P94, DOI 10.1016/j.jcv.2009.06.014; Pereira E, 2007, J MED MICROBIOL, V56, P313, DOI 10.1099/jmm.0.46685-0; Qiu FZ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3340-1; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Scott MK, 2016, EMERG INFECT DIS, V22, P1044, DOI 10.3201/eid2206.151898; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; UHNOO I, 1984, J CLIN MICROBIOL, V20, P365, DOI 10.1128/JCM.20.3.365-372.1984; Verma H, 2009, J MED VIROL, V81, P60, DOI 10.1002/jmv.21331; Yan Hainian, 2004, Kansenshogaku Zasshi, V78, P699	24	30	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220263	10.1371/journal.pone.0220263	http://dx.doi.org/10.1371/journal.pone.0220263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369615	Green Submitted, gold, Green Published			2022-12-26	WOS:000484987900039
J	Huang, M; Tao, Z; Lei, T; Chen, JN; Cao, FB; Yin, XH; Zou, YB				Huang, Min; Tao, Zui; Lei, Tao; Chen, Jiana; Cao, Fangbo; Yin, Xiaohong; Zou, Yingbin			Contrasting change in biomass translocation with environment in two rice hybrids	PLOS ONE			English	Article							DRY-MATTER; YIELD STABILITY; GRAIN-YIELD; DETERMINANTS; SOIL	Translocation of biomass produced during pre-heading to grains is a determinant of grain yield, but also plays an important role in adaptation to unfavorable environments during post-heading in rice. In this study, field experiments were conducted to determine the critical factors that regulate biomass translocation in rice. Biomass translocation and production characteristics of two rice hybrids (Guiliangyou 2 and Y-liangyou 1) were compared between two site-year environments (Naning-2014 and Yongan-2018). Results showed that biomass translocation parameters (biomass translocation amount and rate and contribution of biomass translocation to filled grain weight) and ratio of biomass production during pre-heading to post-heading (BPpre/BPpost ratio) decreased in Guiliangyou 2 but increased in Y-liangyou 1 with the environment change from Nanning-2014 to Yongan-2018. The decreased BPpre/BPpost in Guiliangyou 2 was attributable to increased biomass production during post-heading (BPpost), while the increased BPpre/BPpost ratio in Y-liangyou 1 was due to increased biomass production during pre-heading (BPpre). Higher cumulative incident solar radiation and larger diurnal temperature variation were responsible for the increased BPpost in Guiliangyou 2 and the increased BPpre in Y-liangyou 1 grown in Yongan in 2018 compared to in Nanning in 2014. The results of this study indicate that changes in biomass translocation and production with environment (climate) in rice are dependent on genotype and that the BPpre/BPpost ratio is an important factor regulating biomass translocation in rice.	[Huang, Min; Tao, Zui; Lei, Tao; Chen, Jiana; Cao, Fangbo; Yin, Xiaohong; Zou, Yingbin] Hunan Agr Univ, Coll Agron, Crop & Environm Res Ctr, Changsha, Hunan, Peoples R China; [Yin, Xiaohong] Guangxi Acad Agr Sci, Rice Res Inst, Guangxi Key Lab Rice Genet & Breeding, Nanning, Peoples R China	Hunan Agricultural University; Guangxi Academy of Agricultural Sciences	Huang, M (corresponding author), Hunan Agr Univ, Coll Agron, Crop & Environm Res Ctr, Changsha, Hunan, Peoples R China.	mhuang@hunau.edu.cn		Huang, Min/0000-0002-6944-8538	National Natural Science Foundation of China [31771722]; Earmarked Fund of China Agriculture Research System [CARS-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund of China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (31771722) and the Earmarked Fund of China Agriculture Research System (CARS-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calderini DF, 1998, FIELD CROP RES, V57, P335, DOI 10.1016/S0378-4290(98)00080-X; Huang M, 2016, NJAS-WAGEN J LIFE SC, V78, P123, DOI 10.1016/j.njas.2016.05.004; Huang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158601; Huang M, 2016, FIELD CROP RES, V193, P87, DOI 10.1016/j.fcr.2016.03.009; Huang M, 2012, FIELD CROP RES, V129, P28, DOI 10.1016/j.fcr.2012.01.013; Jiang P, 2016, RICE, V9, DOI 10.1186/s12284-016-0085-6; Laza RC, 2003, PLANT PROD SCI, V6, P28, DOI 10.1626/pps.6.28; Miah MNH, 1996, JPN J CROP SCI, V65, P672, DOI 10.1626/jcs.65.672; Muthayya S, 2014, ANN NY ACAD SCI, V1324, P7, DOI 10.1111/nyas.12540; Normile D, 2008, SCIENCE, V321, P330, DOI 10.1126/science.321.5887.330; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Qiu J, 2010, NATURE, V465, P142, DOI 10.1038/465142a; Rakshit S, 2014, CROP SCI, V54, P1571, DOI 10.2135/cropsci2012.12.0697; Shi WJ, 2013, NEW PHYTOL, V197, P825, DOI 10.1111/nph.12088; WENG JH, 1982, JPN J CROP SCI, V51, P500, DOI 10.1626/jcs.51.500; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang W, 2008, AGRON J, V100, P1390, DOI 10.2134/agronj2007.0356; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]; Yin XH, 2018, AGR ENV LETT, V3, DOI 10.2134/ael2017.11.0038; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang Z, 2014, EUR J AGRON, V59, P49, DOI 10.1016/j.eja.2014.05.008	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220651	10.1371/journal.pone.0220651	http://dx.doi.org/10.1371/journal.pone.0220651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365589	Green Submitted, Green Published, gold			2022-12-26	WOS:000484983600063
J	Shin, JY; Son, J; Kim, WS; Gwak, J; Ju, BG				Shin, Jee Yoon; Son, Jeongin; Kim, Won Sun; Gwak, Jungsug; Ju, Bong-Gun			Jmjd6a regulates GSK3 beta RNA splicing in Xenopus laevis eye development	PLOS ONE			English	Article							PROTEIN 6 JMJD6; BETA-CATENIN; ARGININE METHYLATION; ECTOPIC EYES; EXPRESSION; RECEPTOR; 2-OXOGLUTARATE; DOMAIN; GENE; PHOSPHORYLATION	It has been suggested that Jmjd6 plays an important role in gene regulation through its demethylation or hydroxylation activity on histone and transcription factors. In addition, Jmjd6 has been shown to regulate RNA splicing by interaction with splicing factors. In this study, we demonstrated that Jmjd6a is expressed in developing Xenopus laevis eye during optic vesicle formation and retinal layer differentiation stages. Knockdown of Jmjd6a by an antisense morpholino resulted in eye malformation including a deformed retinal layer and no lens formation. We further found down-regulation of gene expression related to eye development such as Rx1, Otx2, and Pax6 in Jmjd6a morpholino injected embryos. Jmjd6 interacts with splicing factor U2AF25 and GSK3 beta RNA in the anterior region of Xenopus embryos. Knockdown of Jmjd6a led to deletion of GSK3 beta RNA exon 1 and 2, which resulted in generation of N'-terminal truncated GSK3 beta protein. This event further caused decreased phosphorylation of beta-catenin and subsequently increased beta-catenin stability. Therefore, our result may suggest that Jmjd6a plays an important role in Xenopus eye development through regulation of GSK3 beta RNA splicing and canonical Wnt/beta-catenin signaling.	[Shin, Jee Yoon; Son, Jeongin; Kim, Won Sun; Gwak, Jungsug; Ju, Bong-Gun] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Son, Jeongin] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Sogang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gwak, J; Ju, BG (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	gwakjs@sogang.ac.kr; bgju@sogang.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NSF) - Ministry of Education, Science and Technology, the Republic of Korea [2009-0093822, 2013R1A1A1009085]	Basic Science Research Program through the National Research Foundation of Korea (NSF) - Ministry of Education, Science and Technology, the Republic of Korea	This work was supported by Basic Science Research Program (to BG Ju, grant #2009-0093822 and J Gwak, grant #2013R1A1A1009085) through the National Research Foundation of Korea (NSF) funded by the Ministry of Education, Science and Technology, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Hernan G, 2013, IMMUNOREACTIVITY DEV; Aprelikova O, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0205-6; Barman-Aksozen J, 2013, BLOOD CELL MOL DIS, V51, P151, DOI 10.1016/j.bcmd.2013.05.008; Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Chow RL, 1999, DEVELOPMENT, V126, P4213; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; Eom TY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-14; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Farago M, 2005, KINASE INACTIVE GLYC, P5792; Ferkey DM, 2002, J BIOL CHEM, V277, P16147, DOI 10.1074/jbc.M112363200; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Fujimura N, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00138; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Gao WW, 2018, MOL CELL, V70, P340, DOI 10.1016/j.molcel.2018.03.006; Hagglund AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081158; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Heavner W, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008391; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kwok J, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00032; Lawrence P, 2014, VIROLOGY, V452, P1, DOI 10.1016/j.virol.2013.12.040; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Liu XJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0744-2; Liu Y, 2019, ONCOGENE, V38, P980, DOI 10.1038/s41388-018-0466-y; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Meyers JR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-30; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; Muranishi Y, 2012, DEV GROWTH DIFFER, V54, P341, DOI 10.1111/j.1440-169X.2012.01337.x; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Phukan S, 2010, BRIT J PHARMACOL, V160, P1, DOI 10.1111/j.1476-5381.2010.00661.x; Sinn R, 2013, MECH DEVELOP, V130, P347, DOI 10.1016/j.mod.2013.05.001; Sive S, 2000, EARLY DEV XENOPUS LA, V125-41, P99; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Tikhanovich I, 2015, J BIOL CHEM, V290, P22236, DOI 10.1074/jbc.M115.653543; Vangimalla SS, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020041; Viczian AS, 2006, DEV DYNAM, V235, P1133, DOI 10.1002/dvdy.20708; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wu TF, 2015, J BIOL CHEM, V290, P20556, DOI 10.1074/jbc.M114.607713; Yi J, 2017, NUCLEIC ACIDS RES, V45, P3503, DOI 10.1093/nar/gkw1144; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang X, 2015, PROCEEDINGS OF THE 2015 7TH IEEE INTERNATIONAL CONFERENCE ON CYBERNETICS AND INTELLIGENT SYSTEMS (CIS) AND ROBOTICS, AUTOMATION AND MECHATRONICS (RAM), P1, DOI 10.1109/ICCIS.2015.7274538	58	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0219800	10.1371/journal.pone.0219800	http://dx.doi.org/10.1371/journal.pone.0219800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361752	gold, Green Submitted, Green Published			2022-12-26	WOS:000484981300016
J	Nawa, N; Hirata, K; Kawatani, K; Nambara, T; Omori, S; Banno, K; Kokubu, C; Takeda, J; Nishimura, K; Ohtaka, M; Nakanishi, M; Okuzaki, D; Taniguchi, H; Arahori, H; Wada, K; Kitabatake, Y; Ozono, K				Nawa, Nobutoshi; Hirata, Katsuya; Kawatani, Keiji; Nambara, Toshihiko; Omori, Sayaka; Banno, Kimihiko; Kokubu, Chikara; Takeda, Junji; Nishimura, Ken; Ohtaka, Manami; Nakanishi, Mahito; Okuzaki, Daisuke; Taniguchi, Hidetoshi; Arahori, Hitomi; Wada, Kazuko; Kitabatake, Yasuji; Ozono, Keiichi			Elimination of protein aggregates prevents premature senescence in human trisomy 21 fibroblasts	PLOS ONE			English	Article							CHROMOSOME MIS-SEGREGATION; COPY-NUMBER ALTERATIONS; GENE-EXPRESSION; CELL-PROLIFERATION; OXIDATIVE STRESS; ANEUPLOIDY; DEFECTS; GROWTH; YEAST; CONSEQUENCES	Chromosome abnormalities induces profound alterations in gene expression, leading to various disease phenotypes. Recent studies on yeast and mammalian cells have demonstrated that aneuploidy exerts detrimental effects on organismal growth and development, regardless of the karyotype, suggesting that aneuploidy-associated stress plays an important role in disease pathogenesis. However, whether and how this effect alters cellular homeostasis and long-term features of human disease are not fully understood. Here, we aimed to investigate cellular stress responses in human trisomy syndromes, using fibroblasts and induced pluripotent stem cells (iPSCs). Dermal fibroblasts derived from patients with trisomy 21, 18 and 13 showed a severe impairment of cell proliferation and enhanced premature senescence. These phenomena were accompanied by perturbation of protein homeostasis, leading to the accumulation of protein aggregates. We found that treatment with sodium 4-phenylbutyrate (4-PBA), a chemical chaperone, decreased the protein aggregates in trisomy fibroblasts. Notably, 4-PBA treatment successfully prevented the progression of premature senescence in secondary fibroblasts derived from trisomy 21 iPSCs. Our study reveals aneuploidy-associated stress as a potential therapeutic target for human trisomies, including Down syndrome.	[Nawa, Nobutoshi; Hirata, Katsuya; Kawatani, Keiji; Nambara, Toshihiko; Omori, Sayaka; Banno, Kimihiko; Taniguchi, Hidetoshi; Arahori, Hitomi; Wada, Kazuko; Kitabatake, Yasuji; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan; [Hirata, Katsuya; Arahori, Hitomi] Osaka Womens & Childrens Hosp, Dept Neonatal Med, Izumi Ku, Osaka, Japan; [Banno, Kimihiko] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Kokubu, Chikara; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Genome Biol, Suita, Osaka, Japan; [Nishimura, Ken] Univ Tsukuba, Lab Gene Regulat, Fac Med, Tsukuba, Ibaraki, Japan; [Ohtaka, Manami; Nakanishi, Mahito] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Suita, Osaka, Japan	Osaka University; Indiana University System; Indiana University Bloomington; Osaka University; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University	Kitabatake, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan.	ykitaba@ped.med.osaka-u.ac.jp	Hirata, Katsuya/AAM-7603-2020; Hirata, Katsuya/AFS-4860-2022; Okuzaki, Daisuke/AAN-5641-2020; Nawa, Nobutoshi/AAT-5292-2020; Nishimura, KEN/HGC-6147-2022	Hirata, Katsuya/0000-0003-3148-9892; Okuzaki, Daisuke/0000-0002-4552-783X; Nawa, Nobutoshi/0000-0001-6785-7867; Kitabatake, Yasuji/0000-0002-2907-9512; Banno, Kimihiko/0000-0002-1458-0881	Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED) [JP18bm0804009]; JSPS KAKENHI [JP16K10090]; Mitsui Life Social Welfare Foundation; Shionogi Co., Ltd.	Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsui Life Social Welfare Foundation; Shionogi Co., Ltd.	This work was supported by the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED) (JP18bm0804009 to Y.K.) and JSPS KAKENHI (JP16K10090 to Y.K.). This work was also supported by the grants from Mitsui Life Social Welfare Foundation, and Shionogi & Co., Ltd. Additionally, Tokiwa-Bio, Inc. provided support in the form of salary for author MN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; Banno K, 2016, CELL REP, V15, P1228, DOI 10.1016/j.celrep.2016.04.031; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Bonney ME, 2015, GENE DEV, V29, P898, DOI 10.1101/gad.261743.115; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Contestabile A, 2009, CELL PROLIFERAT, V42, P171, DOI 10.1111/j.1365-2184.2009.00587.x; Cortez L, 2014, PRION, V8, P197, DOI 10.4161/pri.28938; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gimeno A, 2014, BBA-MOL BASIS DIS, V1842, P116, DOI 10.1016/j.bbadis.2013.10.014; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Haydar TF, 2012, TRENDS NEUROSCI, V35, P81, DOI 10.1016/j.tins.2011.11.001; Helguera P, 2013, CELL METAB, V17, P132, DOI 10.1016/j.cmet.2012.12.005; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hu Z, 2014, GENE DEV, V28, P396, DOI 10.1101/gad.233221.113; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lana-Elola E, 2011, DIS MODEL MECH, V4, P586, DOI 10.1242/dmm.008078; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lott IT, 2012, BBA-MOL BASIS DIS, V1822, P657, DOI 10.1016/j.bbadis.2011.12.010; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Meena JK, 2015, EMBO J, V34, P1371, DOI 10.15252/embj.201490070; Nawa N, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.44; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Okuzaki D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19456; Omori S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00714-7; Oromendia AB, 2014, DIS MODEL MECH, V7, P15, DOI 10.1242/dmm.013391; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pasyukova EG, 2017, MECH AGEING DEV, V166, P6, DOI 10.1016/j.mad.2017.08.008; Rasmussen SA, 2003, PEDIATRICS, V111, P777, DOI 10.1542/peds.111.4.777; Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Rodriguez-Sureda V, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/509241; Santaguida S, 2017, DEV CELL, V41, P638, DOI 10.1016/j.devcel.2017.05.022; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Shamsi TN, 2017, INT J BIOL MACROMOL, V105, P993, DOI 10.1016/j.ijbiomac.2017.07.116; Sheltzer JM, 2017, CANCER CELL, V31, P240, DOI 10.1016/j.ccell.2016.12.004; Sheltzer JM, 2012, P NATL ACAD SCI USA, V109, P12644, DOI 10.1073/pnas.1209227109; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Stenberg P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000465; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Thorburn RR, 2013, MOL BIOL CELL, V24, P1274, DOI 10.1091/mbc.E12-07-0520; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Toussaint Olivier, 2002, TheScientificWorldJOURNAL, V2, P230; Vallejos CA, 2017, NAT METHODS, V14, P565, DOI [10.1038/NMETH.4292, 10.1038/nmeth.4292]; Weids AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24554; Wiley JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009135; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wright JM, 2004, PHYSIOL GENOMICS, V16, P204, DOI 10.1152/physiolgenomics.00160.2003; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Zhang ZG, 2017, NUCLEIC ACIDS RES, V45, P2986, DOI 10.1093/nar/gkx106	63	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0219592	10.1371/journal.pone.0219592	http://dx.doi.org/10.1371/journal.pone.0219592			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356639	Green Published, gold			2022-12-26	WOS:000484047000007
J	Nayar, K; McKinney, W; Hogan, AL; Martin, GE; La Valle, C; Sharp, K; Berry-Kravis, E; Norton, ES; Gordon, PC; Losh, M				Nayar, Kritika; McKinney, Walker; Hogan, Abigail L.; Martin, Gary E.; La Valle, Chelsea; Sharp, Kevin; Berry-Kravis, Elizabeth; Norton, Elizabeth S.; Gordon, Peter C.; Losh, Molly			Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutation	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; WORKING-MEMORY CAPACITY; BROAD AUTISM PHENOTYPE; TREMOR/ATAXIA-SYNDROME; EYE-MOVEMENTS; CURVILINEAR ASSOCIATION; EXECUTIVE FUNCTIONS; PRAGMATIC LANGUAGE; SPEED PROCESSES; CGG EXPANSIONS	The FMR1 premutation (PM) is relatively common in the general population. Evidence suggests that PM carriers may exhibit subtle differences in specific cognitive and language abilities. This study examined potential mechanisms underlying such differences through the study of gaze and language coordination during a language processing task (rapid automatized naming; RAN) among female carriers of the FMR1 PM. RAN taps a complex set of underlying neuropsychological mechanisms, with breakdowns implicating processing disruptions in fundamental skills that support higher order language and executive functions, making RAN (and analysis of gaze/language coordination during RAN) a potentially powerful paradigm for revealing the phenotypic expression of the FMR1 PM. Forty-eight PM carriers and 56 controls completed RAN on an eye tracker, where they serially named arrays of numbers, letters, colors, and objects. Findings revealed a pattern of inefficient language processing in the PM group, including a greater number of eye fixations (namely, visual regressions) and reduced eye-voice span (i.e., the eyes' lead over the voice) relative to controls. Differences were driven by performance in the latter half of the RAN arrays, when working memory and processing load are the greatest, implicating executive skills. RAN deficits were associated with broader social-communicative difficulties among PM carriers, and with FMR1-related molecular genetic variation (higher CGG repeat length, lower activation ratio, and increased levels of the fragile X mental retardation protein; FMRP). Findings contribute to an understanding of the neurocognitive profile of PM carriers and indicate specific gene-behavior associations that implicate the role of the FMR1 gene in language-related processes.	[Nayar, Kritika; McKinney, Walker; Hogan, Abigail L.; La Valle, Chelsea; Norton, Elizabeth S.; Losh, Molly] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [McKinney, Walker] Univ Kansas, Clin Child Psychol Program, Lawrence, KS 66045 USA; [Hogan, Abigail L.] Univ South Carolina, Psychol, Columbia, SC 29208 USA; [Martin, Gary E.] St Johns Univ, Commun Sci & Disorders, Queens, NY USA; [La Valle, Chelsea] Boston Univ, Psychol, Boston, MA 02215 USA; [Sharp, Kevin; Berry-Kravis, Elizabeth] Rush Univ, Pediat, Med Ctr, Chicago, IL 60612 USA; [Gordon, Peter C.] Univ North Carolina Chapel Hill, Psychol & Neurosci, Chapel Hill, NC USA	Northwestern University; University of Kansas; University of South Carolina System; University of South Carolina Columbia; Saint John's University; Boston University; Rush University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Losh, M (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	m-losh@northwestern.edu			National Institutes of Health [R01DC010191, R01MH091131, P30 HD03110]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by grants from the National Institutes of Health (R01DC010191, R01MH091131, to ML; and P30 HD03110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeduto L, 1997, MENT RETARD DEV D R, V3, P313, DOI 10.1002/(SICI)1098-2779(1997)3:4<313::AID-MRDD6>3.0.CO;2-O; Abbeduto L, 2007, MENT RETARD DEV D R, V13, P36, DOI 10.1002/mrdd.20142; Amtmann D, 2007, READ WRIT, V20, P785, DOI 10.1007/s11145-006-9041-y; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bailey DB, 2008, AM J MED GENET A, V146A, P2060, DOI 10.1002/ajmg.a.32439; Banerjee A, 2018, BRAIN RES, V1693, P24, DOI 10.1016/j.brainres.2018.04.008; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2005, ANN NEUROL, V57, P144, DOI 10.1002/ana.20360; Bishop DVM, 2004, AM J MED GENET B, V128B, P54, DOI 10.1002/ajmg.b.30039; Booth RW, 2013, MEM COGNITION, V41, P82, DOI 10.3758/s13421-012-0244-y; Bourgeois JA, 2009, J CLIN PSYCHIAT, V70, P852, DOI 10.4088/JCP.08m04476; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; Ciaccio C, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0355-y; Coffee B, 2009, AM J HUM GENET, V85, P503, DOI 10.1016/j.ajhg.2009.09.007; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Cornish K, 2005, BRAIN COGNITION, V57, P53, DOI 10.1016/j.bandc.2004.08.020; Cornish KM, 2015, NEUROLOGY, V84, P1631, DOI 10.1212/WNL.0000000000001496; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DENCKLA M B, 1974, Cortex, V10, P186; Elbaz A, 1998, J INTELL DISABIL RES, V42, P81, DOI 10.1046/j.1365-2788.1998.00064.x; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Filley CM, 2015, NEUROLOGY, V84, P2146, DOI 10.1212/WNL.0000000000001612; Garner C, 1999, J INTELL DISABIL RES, V43, P466, DOI 10.1046/j.1365-2788.1999.00207.x; Georgiou G., 2013, PRESCHOOL PRIMARY ED, V1, P67, DOI DOI 10.12681/PPEJ.46; Gordon PC, 2016, J EXP PSYCHOL HUMAN, V42, P742, DOI 10.1037/xhp0000171; Grigsby J, 2008, NEUROPSYCHOLOGY, V22, P48, DOI 10.1037/0894-4105.22.1.48; Grigsby J, 2016, CLIN NEUROPSYCHOL, V30, P815, DOI 10.1080/13854046.2016.1184652; Grigsby J, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-28; Hagerman PJ, 2008, J MED GENET, V45, P498, DOI 10.1136/jmg.2008.059055; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hagerman PJ, 2004, MENT RETARD DEV D R, V10, P25, DOI 10.1002/mrdd.20005; Hagerman RJ, 2003, AM J HUM GENET, V73, P266; Hall SS, 2008, AM J MENT RETARD, V113, P44, DOI 10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2; Hessl D, 2005, AM J MED GENET B, V139B, P115, DOI 10.1002/ajmg.b.30241; Hessl D, 2011, BIOL PSYCHIAT, V70, P859, DOI 10.1016/j.biopsych.2011.05.033; Hogan-Brown AL, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-33; Hooper SR, 2008, NEUROPSYCHOLOGY, V22, P36, DOI 10.1037/0894-4105.22.1.36; Hunter JE, 2009, GENET MED, V11, P79, DOI 10.1097/GIM.0b013e31818de6ee; Jiraanont Poonnada, 2017, eNeurologicalSci, V7, P49, DOI 10.1016/j.ensci.2017.04.003; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; Kim KC, 2016, BIOMOL THER, V24, P207, DOI 10.4062/biomolther.2016.061; Kim SY, 2014, BEHAV BRAIN RES, V261, P240, DOI 10.1016/j.bbr.2013.12.044; Klusek J., 2017, J NEURODEVELOPMENTAL, V9, P1, DOI DOI 10.1186/S11689-017-9211-Z; Klusek J, 2015, INTERNATIONAL CONFER; Klusek J, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00344; Klusek J, 2014, J SPEECH LANG HEAR R, V57, P1692, DOI 10.1044/2014_JSLHR-L-13-0064; Koga K, 2015, J NEUROSCI, V35, P2033, DOI 10.1523/JNEUROSCI.2644-14.2015; Kogan CS, 2010, BRAIN COGNITION, V73, P236, DOI 10.1016/j.bandc.2010.05.008; Kraan CM, 2018, GENET MED, V20, P1627, DOI 10.1038/gim.2018.52; Kuperman V, 2016, SCI STUD READ, V20, P173, DOI 10.1080/10888438.2015.1128435; LaFauci G, 2013, J MOL DIAGN, V15, P508, DOI 10.1016/j.jmoldx.2013.02.006; LANDA R, 1992, PSYCHOL MED, V22, P245, DOI 10.1017/S0033291700032918; Laubrock J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01432; Leehey MA, 2008, NEUROLOGY, V70, P1397, DOI 10.1212/01.wnl.0000281692.98200.f5; Lewis P, 2006, J INTELL DISABIL RES, V50, P532, DOI 10.1111/j.1365-2788.2006.00803.x; Loesch D, 2012, ADV EXP MED BIOL, V769, P78; Loesch DZ, 2003, AM J MED GENET A, V122A, P13, DOI 10.1002/ajmg.a.20214; Losh M, 2008, AM J MED GENET B, V147B, P424, DOI 10.1002/ajmg.b.30612; Losh M, 2007, J CHILD PSYCHOL PSYC, V48, P105, DOI 10.1111/j.1469-7610.2006.01594.x; Losh Molly, 2012, Perspect Lang Learn Educ, V19, P48; Losh M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00266; Losh M, 2012, AM J MED GENET B, V159B, P660, DOI 10.1002/ajmg.b.32070; Losh M, 2010, J NEURODEV DISORD, V2, P109, DOI 10.1007/s11689-010-9045-4; Maenner MJ, 2013, AM J MED GENET B, V162B, P466, DOI 10.1002/ajmg.b.32176; Mailick MR, 2014, AM J MED GENET B, V165, P705, DOI 10.1002/ajmg.b.32277; Mankowski JB, 2007, 40 ANN GATL C RES TH; Martin GE, 2013, INT J LANG COMM DIS, V48, P432, DOI 10.1111/1460-6984.12019; MAZZOCCO MMM, 1993, J DEV BEHAV PEDIATR, V14, P328; Misra M, 2004, SCI STUD READ, V8, P241, DOI 10.1207/s1532799xssr0803_4; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Movaghar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02682-4; Murphy MM, 2008, J LEARN DISABIL-US, V41, P29, DOI 10.1177/0022219407311038; Nayar K, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0233-5; Norton ES, 2014, NEUROPSYCHOLOGIA, V61, P235, DOI 10.1016/j.neuropsychologia.2014.06.015; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; Owens KM, 2018, AM J MED GENET A, V176, P1304, DOI 10.1002/ajmg.a.38692; Pan J, 2013, DEVELOPMENTAL SCI, V16, P967, DOI 10.1111/desc.12075; Peprah E, 2010, J HUM GENET, V55, P66, DOI 10.1038/jhg.2009.121; Perea M, 2003, BEHAV BRAIN SCI, V26, P497, DOI 10.1017/S0140525X03420104; Pesso R, 2000, PRENATAL DIAG, V20, P611, DOI 10.1002/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M; Qin M, 2011, NEUROBIOL DIS, V42, P85, DOI 10.1016/j.nbd.2011.01.008; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2010, PSYCHON B REV, V17, P834, DOI 10.3758/PBR.17.6.834; Rice ML, 2005, APPL PSYCHOLINGUIST, V26, P7, DOI 10.1017/S0142716405050034; Roberts JE, 2009, AM J MED GENET B, V150B, P130, DOI 10.1002/ajmg.b.30786; Roth RM., 2005, BRIEF A BEHAV RATING; Schneider A, 2016, CLIN NEUROPSYCHOL, V30, P929, DOI 10.1080/13854046.2016.1189536; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Seritan A, 2013, CURR PSYCHIATRY REV, V9, P78, DOI 10.2174/157340013805289635; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shelton AL, 2017, NEUROLOGY, V88, P2080, DOI 10.1212/WNL.0000000000003979; Shelton AL, 2017, HUM BRAIN MAPP, V38, P1056, DOI 10.1002/hbm.23438; Shelton AL, 2016, CEREBELLUM, V15, P565, DOI 10.1007/s12311-016-0782-0; Shelton AL, 2015, BEHAV BRAIN RES, V282, P194, DOI 10.1016/j.bbr.2015.01.011; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Sterling AM, 2013, BRAIN COGNITION, V82, P84, DOI 10.1016/j.bandc.2013.02.009; Tassone F, 2007, AM J MED GENET B, V144B, P566, DOI 10.1002/ajmg.b.30482; Team RC, 2016, R LANG ENV STAT COMP; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang JY, 2017, NEUROBIOL AGING, V55, P11, DOI 10.1016/j.neurobiolaging.2017.03.018; Wang JY, 2012, ARCH NEUROL-CHICAGO, V69, P482, DOI 10.1001/archneurol.2011.2023; Wang LW, 2010, NEUROTHERAPEUTICS, V7, P264, DOI 10.1016/j.nurt.2010.05.005; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER ADULT INTEL; Wheeler AC, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-30; Wilding J, 2002, NEUROPSYCHOLOGIA, V40, P1343, DOI 10.1016/S0028-3932(01)00212-3; Wolf M, 2000, J LEARN DISABIL-US, V33, P387, DOI 10.1177/002221940003300409; Wolf M, 2000, J LEARN DISABIL-US, V33, P322, DOI 10.1177/002221940003300404; Yang JC, 2013, ANN NEUROL, V74, P275, DOI 10.1002/ana.23933; Yuan J, 2008, J ACOUST SOC AM, V124, P2078, DOI 10.1121/1.2968700	116	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0219924	10.1371/journal.pone.0219924	http://dx.doi.org/10.1371/journal.pone.0219924			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WC	31348790	Green Published, gold, Green Submitted			2022-12-26	WOS:000484979500014
J	Oldham, S; Fulcher, B; Parkes, L; Arnatkeviciute, A; Suo, C; Fornito, A				Oldham, Stuart; Fulcher, Ben; Parkes, Linden; Arnatkeviciute, Aurina; Suo, Chao; Fornito, Alex			y Consistency and differences between centrality measures across distinct classes of networks	PLOS ONE			English	Article							HUBS; INDEXES	The roles of different nodes within a network are often understood through centrality analysis, which aims to quantify the capacity of a node to influence, or be influenced by, other nodes via its connection topology. Many different centrality measures have been proposed, but the degree to which they offer unique information, and whether it is advantageous to use multiple centrality measures to define node roles, is unclear. Here we calculate correlations between 17 different centrality measures across 212 diverse real-world networks, examine how these correlations relate to variations in network density and global topology, and investigate whether nodes can be clustered into distinct classes according to their centrality profiles. We find that centrality measures are generally positively correlated to each other, the strength of these correlations varies across networks, and network modularity plays a key role in driving these cross-network variations. Data-driven clustering of nodes based on centrality profiles can distinguish different roles, including topological cores of highly central nodes and peripheries of less central nodes. Our findings illustrate how network topology shapes the pattern of correlations between centrality measures and demonstrate how a comparative approach to network centrality can inform the interpretation of nodal roles in complex networks.	[Oldham, Stuart; Fulcher, Ben; Parkes, Linden; Arnatkeviciute, Aurina; Suo, Chao; Fornito, Alex] Monash Univ, Sch Psychol Sci & Monash Biomed Imaging, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Fulcher, Ben] Univ Sydney, Sch Phys, Sydney, NSW, Australia	Monash University; University of Sydney	Oldham, S (corresponding author), Monash Univ, Sch Psychol Sci & Monash Biomed Imaging, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia.	stuart.oldham@monash.edu	Fulcher, Ben/H-8733-2019	Fulcher, Ben/0000-0002-3003-4055; Arnatkeviciute, Aurina/0000-0003-4098-7084	National Health and Medical Research Council [1089718, 1146292, 1050504, 1104580, 1066779]; Australian Research Council [FT130100589]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	BF was supported by a National Health and Medical Research Council (https://www.nhmrc. gov. au/) Early Career Fellowship (ID: 1089718); AF was supported by the Australian Research Council http://www.arc.gov.au/(ID: FT130100589) and National Health and Medical Research Council https://www.nhmrc.gov.au/(IDs: 1146292, 1050504, 1104580 and 1066779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Andreotti J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115503; [Anonymous], 2004, LETTERS, V92, P1, DOI [10.1103/PhysRevLett.92.069901, DOI 10.1103/PHYSREVLETT.92.069901, DOI 10.1103/PHYSREVLETT.92.118701]; Ashtiani M, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0598-2; Avena-Koenigsberger A, 2018, NAT REV NEUROSCI, V19, P17, DOI 10.1038/nrn.2017.149; Batool K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090283; Bell DC, 1999, SOC NETWORKS, V21, P1, DOI 10.1016/S0378-8733(98)00010-0; Benzi M, 2013, J COMPLEX NETW, V1, P124, DOI 10.1093/comnet/cnt007; BLOCH F, 2016, CENTRALITY MEASURES, DOI DOI 10.1038/NATURE03288; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; BOLLOBAS B, 1984, T AM MATH SOC, V286, P257, DOI 10.2307/1999405; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Brandes U, 2005, LECT NOTES COMPUT SC, V3404, P533; Clauset E.T.A., 2016, COLORADO INDEX COMPL; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; DELRIO G, 2009, BMC SYST BIOL, V3, DOI DOI 10.1016/J.ECOCOM.2007.02.018; Estrada E, 2006, EUR PHYS J B, V52, P563, DOI 10.1140/epjb/e2006-00330-7; Estrada E, 2006, EUROPHYS LETT, V73, P649, DOI 10.1209/epl/i2005-10441-3; ESTRADA E, 2005, PHYS REV E, V71, P29, DOI DOI 10.1103/PHYSREVE.71.056103; Estrada E., 2005, PHYS REV E, V71, P29, DOI DOI 10.1103/PHYSREVE.83.046127; Estrada E, 2007, ECOL COMPLEX, V4, P48, DOI 10.1016/j.ecocom.2007.02.018; Estrada E, 2009, PHYSICA A, V388, P764, DOI 10.1016/j.physa.2008.11.011; Fornito A, 2016, FUNDAMENTALS BRAIN N; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Frantz TL, 2009, COMPUT MATH ORGAN TH, V15, P303, DOI 10.1007/s10588-009-9063-5; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fulcher BD, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0048; Ghasemi A., 2018, ARXIV180210582V2, P1, DOI DOI 10.1016/J.SOCNET.2004.11.009; Gili T, 2013, J NEUROSCI, V33, P4024, DOI 10.1523/JNEUROSCI.3480-12.2013; Goni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058070; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hancer E, 2017, SWARM EVOL COMPUT, V32, P49, DOI 10.1016/j.swevo.2016.06.004; Hwang W., 2008, P 14 ACM SIGKDD INT, P336, DOI DOI 10.1145/1401890; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jalili M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143111; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; KATZ L, 1953, PSYCHOMETRIKA, V18, P39, DOI DOI 10.1016/J.NEURON.2013.07.035; Kim PJ, 2007, EUR PHYS J B, V55, P109, DOI 10.1140/epjb/e2007-00033-7; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Koschutzki D., 2004, P GERM C BIOINF GCB, P199, DOI DOI 10.1080/13645579.2014.888238; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LI C, 2015, EUR PHYS J B, V88, DOI DOI 10.1140/EPJB/E2007-00033-7; Lozares C, 2015, INT J SOC RES METHOD, V18, P209, DOI 10.1080/13645579.2014.888238; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; NEWMAN MEJ, 2010, NETWORKS INTRO, DOI DOI 10.1098/RSTA.2015.0202; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Qi X., 2013, SOCIAL NETWORKING, V2, P19, DOI DOI 10.4236/SN.2013.21003; Qi XQ, 2012, INFORM SCIENCES, V194, P240, DOI 10.1016/j.ins.2011.12.027; RONQUI JRF, 2015, J STAT MECH-THEORY E, DOI DOI 10.1088/1742-5468/2015/05/P05030; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Schoch D, 2016, EUR J APPL MATH, V27, P971, DOI 10.1017/S0956792516000401; Schoch D, 2018, SOC NETWORKS, V54, P50, DOI 10.1016/j.socnet.2017.12.003; Schoch D, 2017, SOC NETWORKS, V50, P46, DOI 10.1016/j.socnet.2017.03.010; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Tabachnick B.G., 2014, USING MULTIVARIATE S, VSixth; Valente Thomas W, 2008, Connect (Tor), V28, P16; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Wang XD, 2018, HUM BRAIN MAPP, V39, P1647, DOI 10.1002/hbm.23941; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan EJ, 2009, J AM SOC INF SCI TEC, V60, P2107, DOI 10.1002/asi.21128	74	99	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2019	14	7							e0220061	10.1371/journal.pone.0220061	http://dx.doi.org/10.1371/journal.pone.0220061			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4WC	31348798	Green Published, gold, Green Submitted			2022-12-26	WOS:000484979500019
J	DeGolia, AH; Hiroyasu, EHT; Anderson, SE				DeGolia, Alexander H.; Hiroyasu, Elizabeth H. T.; Anderson, Sarah E.			Economic losses or environmental gains? Framing effects on public support for environmental management	PLOS ONE			English	Article							WORLDS ECOSYSTEM SERVICES; CLIMATE-CHANGE; ECOLOGICAL PARADIGM; POLICY; ATTITUDES; FRAMES; CONSERVATION; MATTERS; SPREAD; VALUES	Environmental managers face major challenges related to project implementation and communicating the significance of those projects to the public. Effective communication can mitigate public opposition or increase support for specific projects and increase public and political support for environmental management more generally. In this study, we evaluate which types of benefits or losses environmental managers should communicate and how to frame those attributes to achieve greater public support. To do so, we field a survey experiment that presents the benefits of an invasive species management project, utilizing a two (economic, ecological) by two (gain, loss) factorial design as well as a control message. Ecological messages lead to significantly more support for invasive species management than economic messages, and loss frames are more effective than gain frames. We also find that treatment responses differ across several covariates including political ideology and environmentalism. These results indicate that the public is more concerned with managing invasive species for intrinsic environmental worth than economic benefit and that preventing further environmental degradation is more motivating than promoting additional environmental gains.	[DeGolia, Alexander H.; Hiroyasu, Elizabeth H. T.; Anderson, Sarah E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [DeGolia, Alexander H.] Catena Fdn, Carbondale, CO 81623 USA	University of California System; University of California Santa Barbara	DeGolia, AH (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.; DeGolia, AH (corresponding author), Catena Fdn, Carbondale, CO 81623 USA.	alex@catenafoundation.com		Anderson, Sarah/0000-0002-7522-2340	William H. Kuni Fellowship at the Bren School of Environmental Science and Management, University of California Santa Barbara; H. William Kuni Fellowship for Interdisciplinary Collaboration at the Bren School of Environmental Science Management	William H. Kuni Fellowship at the Bren School of Environmental Science and Management, University of California Santa Barbara; H. William Kuni Fellowship for Interdisciplinary Collaboration at the Bren School of Environmental Science Management	AD and EH received funding to support this work through the William H. Kuni Fellowship at the Bren School of Environmental Science and Management, University of California Santa Barbara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the H. William Kuni Fellowship for Interdisciplinary Collaboration at the Bren School of Environmental Science & Management. The authors would like to thank Bruce Kendall for his thoughtful review and members of the Environmental Politics Workshop at UCSB for their feedback.	Amburgey JW, 2012, ENVIRON BEHAV, V44, P235, DOI 10.1177/0013916511402064; [Anonymous], POLICY STUDIES REV, DOI DOI 10.1111/J.1541-1338.1999.TB00879.X; Ansolabehere S, 2012, DAEDALUS-US, V141, P61, DOI 10.1162/DAED_a_00146; Bain PG, 2012, NAT CLIM CHANGE, V2, P600, DOI 10.1038/NCLIMATE1532; Bertolino S, 2003, BIOL CONSERV, V109, P351, DOI 10.1016/S0006-3207(02)00161-1; Bertolotti M, 2014, EUR J SOC PSYCHOL, V44, P474, DOI 10.1002/ejsp.2033; Bolsen T, 2011, INT J PRESS/POLIT, V16, P143, DOI 10.1177/1940161210392782; Bradshaw CJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12986; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Cantrill J. G., 1993, J APPL COMMUNICATION, V21, P66, DOI DOI 10.1080/00909889309365356; Cheng T, 2011, SOC MARK Q, V17, P48, DOI 10.1080/15245004.2011.570859; Clifford S, 2013, J POLIT, V75, P659, DOI 10.1017/S0022381613000492; Clout M., 2002, P INT C ER ISL INV, P155, DOI [10.1016/0006-3207(96)00021-3, DOI 10.1016/0006-3207(96)00021-3]; Cobb MD, 2005, SCI COMMUN, V27, P221, DOI 10.1177/1075547005281473; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 1998, ECOL ECON, V25, P3, DOI 10.1016/S0921-8009(98)00020-2; Costello CJ, 2010, P NATL ACAD SCI USA, V107, P8108, DOI 10.1073/pnas.0911488107; Crowley SL, 2017, FRONT ECOL ENVIRON, V15, P133, DOI 10.1002/fee.1471; Daniels D.P., 2012, HDB US ENV POL, P461; DAVIS JJ, 1995, JOURNALISM MASS COMM, V72, P285, DOI 10.1177/107769909507200203; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; Doherty TS, 2016, P NATL ACAD SCI USA, V113; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Dunlap Riley E., 2001, ENVIRON POLIT, V10, P23, DOI DOI 10.1080/714000580; Eden S., 1996, PUBL UNDERSTAND SCI, V5, P183, DOI DOI 10.1088/0963-6625/5/3/001; FAZIO RH, 1978, J PERS, V46, P228, DOI 10.1111/j.1467-6494.1978.tb00177.x; FAZIO RH, 1978, J EXP SOC PSYCHOL, V14, P398, DOI 10.1016/0022-1031(78)90035-5; Feinberg M, 2013, PSYCHOL SCI, V24, P56, DOI 10.1177/0956797612449177; Feygina I, 2010, PERS SOC PSYCHOL B, V36, P326, DOI 10.1177/0146167209351435; Fitzgerald G., 2007, PUBLIC ATTITUDES INV; GONZALES MH, 1988, J APPL SOC PSYCHOL, V18, P1049, DOI 10.1111/j.1559-1816.1988.tb01192.x; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Guber DL, 2002, GRASSROOTS GREEN REV; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hardisty DJ, 2009, J EXP PSYCHOL GEN, V138, P329, DOI 10.1037/a0016433; Hiroyasu EHT, 2019, HUM DIMENS WILDL, V24, P401, DOI 10.1080/10871209.2019.1622055; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Keller R. P., 2009, BIOECONOMICS INVASIV; Keller RP, 2008, CONSERV BIOL, V22, P80, DOI 10.1111/j.1523-1739.2007.00811.x; Krosnick J.A., 1992, QUESTIONS QUESTIONS, P177, DOI DOI 10.7758/9781610445269.16; Lakoff G, 2010, ENVIRON COMMUN, V4, P70, DOI 10.1080/17524030903529749; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Loroz PS, 2007, PSYCHOL MARKET, V24, P1001, DOI 10.1002/mar.20193; Markowitz EM, 2012, NAT CLIM CHANGE, V2, P243, DOI [10.1038/NCLIMATE1378, 10.1038/nclimate1378]; Marshall GR, 2016, LAND USE POLICY, V56, P100, DOI 10.1016/j.landusepol.2016.04.028; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; McNeely J.A., 2001, GLOBAL STRATEGY INVA, P1; MEYEROWITZ BE, 1987, J PERS SOC PSYCHOL, V52, P500, DOI 10.1037/0022-3514.52.3.500; Moser WK, 2009, J FOREST, V107, P320; Nelson TE, 1997, POLIT BEHAV, V19, P221, DOI 10.1023/A:1024834831093; Nelson TE, 1999, J POLIT, V61, P1040, DOI 10.2307/2647553; Nisbet M.C., 2012, TALKING GREEN EXPLOR, P9; Novemsky N, 2005, J MARKETING RES, V42, P119, DOI 10.1509/jmkr.42.2.119.62292; O'Faircheallaigh C, 2010, ENVIRON IMPACT ASSES, V30, P19, DOI 10.1016/j.eiar.2009.05.001; Page BenjaminI., 1992, RATIONAL PUBLIC 50 Y; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Peterson TD, 2006, ENERGY POLICY; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Popkin S., 1994, REASONING VOTER COMM, V2nd ed.; QUATTRONE GA, 1984, J PERS SOC PSYCHOL, V46, P237, DOI 10.1037/0022-3514.46.2.237; R Development Core Team, 2016, R LANG ENV STAT COMP, DOI [10.1038/sj.hdy.6800737, DOI 10.1038/SJ.HDY.6800737]; Saatchi S, 2015, GLOBAL ECOL BIOGEOGR, V24, P606, DOI 10.1111/geb.12256; Sacchi S, 2014, J ENV PSYCHOL; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schuttler E, 2011, J NAT CONSERV, V19, P175, DOI 10.1016/j.jnc.2010.12.001; Schwartz SH, 2010, POLIT PSYCHOL, V31, P421, DOI 10.1111/j.1467-9221.2010.00764.x; Selge S, 2011, BIOL CONSERV, V144, P3089, DOI 10.1016/j.biocon.2011.09.014; Selin H, 2007, REV POLICY RES; Sharp RL, 2011, BIOL CONSERV, V144, P2097, DOI 10.1016/j.biocon.2011.04.032; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.2307/3868440; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Speth JG, 2006, PUNCTUATED EQUILIBRI; Stern P.C., 1999, HUM ECOL REV, V6, P81; Tanentzap AJ, 2012, FOREST ECOL MANAG, V264, P159, DOI 10.1016/j.foreco.2011.10.005; Vezirgiannidou SE, 2013, ENVIRON POLIT, V22, P593, DOI 10.1080/09644016.2013.806632; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1; White K, 2011, J MARKETING RES, V48, P472, DOI 10.1509/jmkr.48.3.472; Wilson C., 2005, J SOCIAL SCI, V1, P47, DOI [10.22004/ag.econ.51417, DOI 10.22004/AG.ECON.51417, DOI 10.3844/jssp.2005.47.51]	79	14	14	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220320	10.1371/journal.pone.0220320	http://dx.doi.org/10.1371/journal.pone.0220320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344095	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900083
J	Chen, LY; Becker, TM; Koch, U; Stauber, T				Chen, Lingye; Becker, Thorsten M.; Koch, Ursula; Stauber, Tobias			The LRRC8/VRAC anion channel facilitates myogenic differentiation of murine myoblasts by promoting membrane hyperpolarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; cell differentiation; chloride channel; myogenesis; skeletal muscle; hyperpolarization; membrane potential; volume-regulated anion channel (VRAC)	SKELETAL MYOGENESIS; ESSENTIAL COMPONENT; CALCIUM REGULATION; CA2+ SIGNALS; K+ CURRENT; FUSION; KIR2.1; IDENTIFICATION; HETEROMERS; EXPRESSION	Skeletal muscle myoblast differentiation involves elaborate signaling networks, including the activity of various ion channels and transporters. Several K+ and Ca2+ channels have been shown to affect myogenesis, but little is known about roles of Cl-? channels in the associated processes. Here, we report that the leucine-rich repeat containing family 8 (LRRC8)/volume-regulated anion channel (VRAC) promotes mouse myoblast differentiation. All LRRC8 subunits of heteromeric VRAC were expressed during myotube formation of murine C2C12 myoblasts. Pharmacological VRAC inhibitors, siRNA-mediated knockdown of the essential VRAC subunit LRRC8A, or VRAC activity-suppressing overexpression of LRRC8A effectively reduced the expression of the myogenic transcription factor myogenin and suppressed myoblast fusion while not affecting myoblast proliferation. We found that inhibiting VRAC impairs plasma membrane hyperpolarization early during differentiation. At later times (more than 6 h after inducing differentiation), VRAC inhibition no longer suppressed myoblast differentiation, suggesting that VRAC acts upstream of K+ channel activation. Consequently, VRAC inhibition prevented the increase of intracellular steady-state Ca2+ levels that normally occurs during myogenesis. Our results may explain the mechanism for the thinning of skeletal muscle bundles observed in LRRC8A-deficient mice and highlight the importance of the LRRC8/VRAC anion channel in cell differentiation.	[Chen, Lingye; Stauber, Tobias] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Becker, Thorsten M.; Koch, Ursula] Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany	Free University of Berlin; Free University of Berlin	Stauber, T (corresponding author), Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany.	tobias.stauber@fu-berlin.de	Stauber, Tobias/E-4005-2010	Stauber, Tobias/0000-0003-0727-6109; Chen, Lingye/0000-0002-9877-2118; Koch, Ursula/0000-0002-7550-1622	Oversea Study Program of Guangzhou Elite Project [JY201624]; German Federal Ministry of Education and Research BMBF [031A314]	Oversea Study Program of Guangzhou Elite Project; German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the Oversea Study Program of Guangzhou Elite Project JY201624 Fellowship (to L. C.). The research group is supported by the German Federal Ministry of Education and Research BMBF Grant 031A314 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Afzali AM, 2016, AM J PHYSIOL-CELL PH, V311, pC583, DOI 10.1152/ajpcell.00363.2015; Antigny F, 2014, CELL CALCIUM, V56, P513, DOI 10.1016/j.ceca.2014.10.014; Antigny F, 2013, J CELL SCI, V126, P2525, DOI 10.1242/jcs.122911; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bijlenga P, 1998, J PHYSIOL-LONDON, V512, P317, DOI 10.1111/j.1469-7793.1998.317be.x; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Carton I, 2002, AM J PHYSIOL-CELL PH, V283, pC115, DOI 10.1152/ajpcell.00038.2001; Chen LY, 2019, BIOL CHEM, V400, P1481, DOI 10.1515/hsz-2019-0189; DallAsta V, 1997, EXP CELL RES, V231, P260, DOI 10.1006/excr.1996.3469; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Friard J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00328; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Iannotti FA, 2014, P NATL ACAD SCI USA, V111, pE2472, DOI 10.1073/pnas.1406728111; Iannotti FA, 2013, MOL BIOL CELL, V24, P274, DOI 10.1091/mbc.E11-12-1044; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02664-0; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; Konig B, 2019, ELIFE, V8, DOI 10.7554/eLife.45421; Konig B, 2019, BIOPHYS J, V116, P1185, DOI 10.1016/j.bpj.2019.02.014; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Leem YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158707; Liu JH, 1998, J PHYSIOL-LONDON, V510, P467, DOI 10.1111/j.1469-7793.1998.467bk.x; Liu JH, 2003, DEVELOPMENT, V130, P3437, DOI 10.1242/dev.00562; Liu TB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112663; Mandai S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46369; Mongin AA, 2016, PFLUG ARCH EUR J PHY, V468, P421, DOI 10.1007/s00424-015-1765-6; Nakanishi K, 2015, FASEB J, V29, P2137, DOI 10.1096/fj.14-261529; Neveux I, 2010, AM J PHYSIOL-CELL PH, V298, pC1006, DOI 10.1152/ajpcell.00359.2009; Okada Y, 2019, PHARMACOL REV, V71, P49, DOI 10.1124/pr.118.015917; Pedersen SF, 2016, PFLUG ARCH EUR J PHY, V468, P371, DOI 10.1007/s00424-015-1781-6; Pietrangelo T, 2006, J PHYSIOL-LONDON, V572, P721, DOI 10.1113/jphysiol.2005.102194; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; PRZYBYLSKI RJ, 1989, IN VITRO CELL DEV B, V25, P830; PRZYBYLSKI RJ, 1994, CELL CALCIUM, V15, P132, DOI 10.1016/0143-4160(94)90052-3; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sacco S, 2015, HUM MOL GENET, V24, P471, DOI 10.1093/hmg/ddu462; Sato-Numata K, 2016, PFLUG ARCH EUR J PHY, V468, P795, DOI 10.1007/s00424-015-1786-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stauber T, 2015, BIOL CHEM, V396, P975, DOI 10.1515/hsz-2015-0127; Strange K, 2019, J GEN PHYSIOL, V151, P100, DOI 10.1085/jgp.201812138; Stuhlmann T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04353-y; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737; Voets T, 1997, AM J PHYSIOL-CELL PH, V272, pC667, DOI 10.1152/ajpcell.1997.272.2.C667; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Woo JS, 2010, EXP MOL MED, V42, P614, DOI 10.3858/emm.2010.42.9.061; Yang JH, 2019, NEURON, V102, P813, DOI 10.1016/j.neuron.2019.03.029; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784; Zhang YH, 2017, NAT CELL BIOL, V19, P504, DOI 10.1038/ncb3514	57	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14279	14288		10.1074/jbc.RA119.008840	http://dx.doi.org/10.1074/jbc.RA119.008840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31387946	hybrid, Green Published			2022-12-26	WOS:000499248200011
J	Jones-Jamtgaard, KN; Wozniak, AL; Koga, H; Ralston, R; Weinman, SA				Jones-Jamtgaard, Kellyann N.; Wozniak, Ann L.; Koga, Hiroshi; Ralston, Robert; Weinman, Steven A.			Hepatitis C virus infection increases autophagosome stability by suppressing lysosomal fusion through an Arl8b-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatitis C virus (HCV); autophagy; intracellular trafficking; lysosome; GTPase; Arl8b	UNFOLDED PROTEIN RESPONSE; INDUCTION; RAB7; REPLICATION; MATURATION; RILP; RECRUITMENT; KNOCKDOWN; TRANSPORT; IMMUNITY	Autophagy is a conserved cellular process involving intracellular membrane trafficking and degradation. Pathogens, including hepatitis C virus (HCV), often exploit this process to promote their own survival. The aim of this study was to determine the mechanism by which HCV increases steady-state autophagosome numbers while simultaneously inhibiting flux through the autophagic pathway. Using the lysosomal inhibitor bafilomycin A1, we showed that HCV-induced alterations in autophagy result from a blockage of autophagosome degradation rather than an increase in autophagosome generation. In HCV-infected cells, lysosome function was normal, but a tandem RFP?GFP?LC3 failed to reach the lysosome even under conditions that activate autophagy. Autophagosomes and lysosomes isolated from HCV-infected cells were able to fuse with each other normally in vitro, suggesting that the cellular fusion defect resulted from trafficking rather than an inability of vesicles to fuse. Arl8b is an Arf-like GTPase that specifically localizes to lysosomes and plays a role in autophagic flux through its effect on lysosomal positioning. At basal levels, Arl8b was primarily found in a perinuclear localization and co-localized with LC3-positive autophagosomes. HCV infection increased the level of Arl8b 3-fold and redistributed Arl8b to a more diffuse, peripheral pattern that failed to co-localize with LC3. Knockdown of Arl8b in HCV-infected cells restored autophagosome?lysosome fusion and autophagic flux to levels seen in control cells. Thus, HCV suppresses autophagic flux and increases the steady-state levels of autophagosomes by increasing the expression of Arl8b, which repositions lysosomes and prevents their fusion with autophagosomes.	[Jones-Jamtgaard, Kellyann N.; Wozniak, Ann L.; Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Microbiol Immunol & Mol Genet, Kansas City, KS 66160 USA; [Weinman, Steven A.] Univ Kansas, Med Ctr, Internal Med & Liver Ctr, Kansas City, KS 66160 USA; [Ralston, Robert] Univ Kansas, Med Ctr, Dept Pharmacol & Toxicol, Kansas City, KS 66160 USA; [Koga, Hiroshi] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Koga, Hiroshi] Albert Einstein Coll Med, Mar Bessin Liver Res Ctr, Bronx, NY 10461 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Weinman, SA (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Immunol & Mol Genet, Kansas City, KS 66160 USA.; Weinman, SA (corresponding author), Univ Kansas, Med Ctr, Internal Med & Liver Ctr, Kansas City, KS 66160 USA.	sweinman@kumc.edu	Ralston, Robert O/A-6924-2009	Wozniak, Ann/0000-0002-8401-6661	NIGMS, National Institutes of Health COBRE Grant [P30 GM103326, P30 GM122731]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326, P30GM118247, P30GM122731] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health COBRE Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. MinKyung Yi for providing materials and Dr. Ana Maria Cuervo for technical expertise on the in vitro fusion assay and comments on the manuscript. We acknowledge the Flow Cytometry Core Laboratory, which is sponsored in part by NIGMS, National Institutes of Health COBRE Grant P30 GM103326, and the Confocal Core, which is sponsored by NIGMS, National Institutes of Health COBRE Grant P30 GM122731.	Adams A, 2018, BIOCHEM BIOPH RES CO, V503, P2619, DOI 10.1016/j.bbrc.2018.08.013; Aggarwal N, 2014, PROTEOM CLIN APPL, V8, P427, DOI 10.1002/prca.201300105; Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Bagshaw RD, 2006, BIOCHEM BIOPH RES CO, V344, P1186, DOI 10.1016/j.bbrc.2006.03.221; Bejarano E, 2018, AGING CELL, V17, DOI 10.1111/acel.12777; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; Creasy BM, 2007, CYTOM PART A, V71A, P114, DOI 10.1002/cyto.a.20365; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Fahmy AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40351; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Huang H, 2013, AUTOPHAGY, V9, P175, DOI 10.4161/auto.22791; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kaniuk NA, 2011, CELL MICROBIOL, V13, P1812, DOI 10.1111/j.1462-5822.2011.01663.x; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kim HJ, 2010, SEMIN IMMUNOPATHOL, V32, P323, DOI 10.1007/s00281-010-0226-8; Kim JH, 2017, J VIROL, V91, DOI 10.1128/JVI.01206-16; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Quan M, 2014, J VIRAL HEPATITIS, V21, P405, DOI 10.1111/jvh.12155; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Scherer J, 2014, J CELL BIOL, V205, P163, DOI 10.1083/jcb.201307116; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Shinohara Y, 2013, BIOCHEM BIOPH RES CO, V432, P326, DOI 10.1016/j.bbrc.2013.01.103; Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15; Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085; Taguwa S, 2011, J VIROL, V85, P13185, DOI 10.1128/JVI.06099-11; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Vescovo T, 2012, GASTROENTEROLOGY, V142, P644, DOI 10.1053/j.gastro.2011.11.033; Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954; Wang LY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004764; Wozniak AL, 2016, P NATL ACAD SCI USA, V113, P12484, DOI 10.1073/pnas.1607277113; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	43	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14257	14266		10.1074/jbc.RA119.008229	http://dx.doi.org/10.1074/jbc.RA119.008229			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31383738	Green Published, hybrid			2022-12-26	WOS:000499248200009
J	Singh, A; Tomberg, J; Nicholas, RA; Davies, C				Singh, Avinash; Tomberg, Joshua; Nicholas, Robert A.; Davies, Christopher			Recognition of the beta-lactam carboxylate triggers acylation of Neisseria gonorrhoeae penicillin-binding protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic action; bacteria; crystal structure; peptidoglycan; protein structure; acylation mechanism; cephalosporin resistance; conformational chages; Neisseria gonorrhoeae; penicillin-binding protein	EXPANDED-SPECTRUM CEPHALOSPORINS; HIGH-LEVEL RESISTANCE; CRYSTAL-STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; STRUCTURAL BASIS; REDUCED SUSCEPTIBILITY; PEPTIDASE REVEALS; DD-PEPTIDASE; STRAINS; CEFTRIAXONE	Resistance of Neisseria gonorrhoeae to extended-spectrum cephalosporins (ESCs) has become a major threat to human health. The primary mechanism by which N. gonorrhoeae becomes resistant to ESCs is by acquiring a mosaic penA allele, encoding penicillin-binding protein 2 (PBP2) variants containing up to 62 mutations compared with WT, of which a subset contribute to resistance. To interpret molecular mechanisms underpinning cephalosporin resistance, it is necessary to know how PBP2 is acylated by ESCs. Here, we report the crystal structures of the transpeptidase domain of WT PBP2 in complex with cefixime and ceftriaxone, along with structures of PBP2 in the apo form and with a phosphate ion bound in the active site at resolutions of 1-7-1.9 angstrom. These structures reveal that acylation of PBP2 by ESCs is accompanied by rotation of the Thr-498 side chain in the KTG motif to contact the cephalosporin carboxylate, twisting of the beta 3 strand to form the oxyanion hole, and rolling of the beta 3-beta 4 loop toward the active site. Recognition of the cephalosporin carboxylate appears to be the key trigger for formation of an acylation-competent state of PBP2. The structures also begin to explain the impact of mutations implicated in ESC resistance. In particular, a G545S mutation may hinder twisting of beta 3 because its side chain hydroxyl forms a hydrogen bond with Thr-498. Overall, our data suggest that acylation is initiated by conformational changes elicited or trapped by binding of ESCs and that these movements are restricted by mutations associated with resistance against ESCs.	[Singh, Avinash; Davies, Christopher] Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA; [Tomberg, Joshua; Nicholas, Robert A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Nicholas, Robert A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Davies, C (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	davies@musc.edu		Nicholas, Robert/0000-0003-2507-8974; Davies, Christopher/0000-0002-6687-4064	National Institutes of Health [GM066861, U19 AI113170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI113170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM066861 (to C. D.) and U19 AI113170 (to R. A. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2012, MMWR-MORBID MORTAL W, V61, P590; BOYD DB, 1979, J MED CHEM, V22, P778, DOI 10.1021/jm00193a006; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Contreras-Martel C, 2009, J MOL BIOL, V387, P899, DOI 10.1016/j.jmb.2009.02.024; Dave K, 2014, ACS MED CHEM LETT, V5, P154, DOI 10.1021/ml400408c; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; Dubee V, 2012, ANTIMICROB AGENTS CH, V56, P4189, DOI 10.1128/AAC.00665-12; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyre DW, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.27.1800323; Fedarovich A, 2014, BIOCHEMISTRY-US, V53, P7596, DOI 10.1021/bi5011317; Fedarovich A, 2012, J MOL BIOL, V418, P316, DOI 10.1016/j.jmb.2012.02.021; Gill MJ, 1998, ANTIMICROB AGENTS CH, V42, P2799, DOI 10.1128/AAC.42.11.2799; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Han S, 2011, J AM CHEM SOC, V133, P20536, DOI 10.1021/ja208835z; Han S, 2010, P NATL ACAD SCI USA, V107, P22002, DOI 10.1073/pnas.1013092107; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; Josephine HR, 2004, J AM CHEM SOC, V126, P8122, DOI 10.1021/ja048850s; King AM, 2016, ACS CHEM BIOL, V11, P864, DOI 10.1021/acschembio.5b00944; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SG, 2010, J ANTIMICROB CHEMOTH, V65, P669, DOI 10.1093/jac/dkp505; Levy N, 2019, J MED CHEM, V62, P4742, DOI 10.1021/acs.jmedchem.9b00338; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lovering AL, 2012, J BIOL CHEM, V287, P32096, DOI 10.1074/jbc.M112.355644; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon TM, 2018, J BIOL CHEM, V293, P18574, DOI 10.1074/jbc.RA118.006052; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Olesky M, 2002, ANTIMICROB AGENTS CH, V46, P2811, DOI 10.1128/AAC.46.9.2811-2820.2002; Osaka Kazuyoshi, 2008, Journal of Infection and Chemotherapy, V14, P195, DOI 10.1007/s10156-008-0610-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pernot L, 2004, J BIOL CHEM, V279, P16463, DOI 10.1074/jbc.M313492200; Powell AJ, 2009, J BIOL CHEM, V284, P1202, DOI 10.1074/jbc.M805761200; Ren JS, 2016, FEBS LETT, V590, P288, DOI 10.1002/1873-3468.12054; Ropp PA, 2002, ANTIMICROB AGENTS CH, V46, P769, DOI 10.1128/AAC.46.3.769-777.2002; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Sauvage E, 2005, J BIOL CHEM, V280, P31249, DOI 10.1074/jbc.M503271200; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Silvaggi NR, 2003, BIOCHEMISTRY-US, V42, P1199, DOI 10.1021/bi0268955; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0; Tomberg J, 2017, BIOCHEMISTRY-US, V56, P1140, DOI 10.1021/acs.biochem.6b01030; Tomberg J, 2013, ANTIMICROB AGENTS CH, V57, P3029, DOI 10.1128/AAC.00093-13; Tomberg J, 2010, BIOCHEMISTRY-US, V49, P8062, DOI 10.1021/bi101167x; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Whiley DM, 2007, ANTIMICROB AGENTS CH, V51, P3111, DOI 10.1128/AAC.00306-07; Whiley DM, 2018, LANCET INFECT DIS, V18, P717, DOI 10.1016/S1473-3099(18)30340-2; Yamada M, 2007, ANTIMICROB AGENTS CH, V51, P3902, DOI 10.1128/AAC.00743-07; Zervosen A, 2012, MOLECULES, V17, P12478, DOI 10.3390/molecules171112478; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	54	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14020	14032		10.1074/jbc.RA119.009942	http://dx.doi.org/10.1074/jbc.RA119.009942			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31362987	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000490729800016
J	Singh, S; Kumar, M; Kumar, S; Sen, S; Upadhyay, P; Bhattacharjee, S; Naveen, M; Tomar, VS; Roy, S; Dutt, A; Kundu, TK				Singh, Siddharth; Kumar, Manoj; Kumar, Sanjeev; Sen, Shrinka; Upadhyay, Pawan; Bhattacharjee, Sayan; Naveen, M.; Tomar, Vivek Singh; Roy, Siddhartha; Dutt, Amit; Kundu, Tapas K.			The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carcinogenesis; tumor suppressor gene; tumor cell biology; gene expression; DNA-binding protein; gain-of-function mutant; P152Lp53; p53 tetramerization; transcriptional regulator	SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; P53 CORE DOMAIN; MUTANT P53; DNA-BINDING; WILD-TYPE; LUNG-CANCER; MUTATIONS; MIGRATION; INVASION	TP53 is the most frequently mutated tumor suppressor gene in many cancers, yet biochemical characterization of several of its reported mutations with probable biological significance have not been accomplished enough. Specifically, missense mutations in TP53 can contribute to tumorigenesis through gain-of-function of biochemical and biological properties that stimulate tumor growth. Here, we identified a relatively rare mutation leading to a proline to leucine substitution (P152L) in TP53 at the very end of its DNA-binding domain (DBD) in a sample from an Indian oral cancer patient. Although the P152Lp53 DBD alone bound to DNA, the full-length protein completely lacked binding ability at its cognate DNA motifs. Interestingly, P152Lp53 could efficiently tetramerize, and the mutation had only a limited impact on the structure and stability of full-length p53. Significantly, when we expressed this variant in a TP53-null cell line, it induced cell motility, proliferation, and invasion compared with a vector-only control. Also, enhanced tumorigenic potential was observed when P152Lp53-expressing cells were xenografted into nude mice. Investigating the effects of P152Lp53 expression on cellular pathways, we found that it is associated with up-regulation of several pathways, including cell-cell and cell-extracellular matrix signaling, epidermal growth factor receptor signaling, and Rho-GTPase signaling, commonly active in tumorigenesis and metastasis. Taken together, our findings provide a detailed account of the biochemical and cellular alterations associated with the cancer-associated P152Lp53 variant and establish it as a gain-of-function TP53 variant.	[Singh, Siddharth; Kumar, Manoj; Sen, Shrinka; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bengaluru 560064, India; [Kumar, Sanjeev; Naveen, M.] BioCOS Life Sci Pvt Ltd, Bengaluru, India; [Upadhyay, Pawan; Dutt, Amit] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Integrated Canc Genom Lab, Navi Mumbai, India; [Bhattacharjee, Sayan] Indian Inst Chem Biol, Dept Struct Biol & Bioinformat, Kolkata 700032, India; [Tomar, Vivek Singh] Indian Inst Sci, Dept Microbiol & Cell Biol, Bengaluru 560012, India; [Roy, Siddhartha] Bose Inst, Dept Biophys, Kolkata 700054, India; [Kumar, Manoj] Banasthali Vidyapith, Dept Biosci & Biotechnol, Jaipur 304022, Rajasthan, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Bose Institute; Banasthali Vidyapith	Kundu, TK (corresponding author), JNCASR, Jakkur PO, Bengaluru 560064, India.	tapas@jncasr.ac.in	Upadhyay, Pawan/AAM-6668-2020; Dutt, Amit/I-1911-2013; BHATTACHARJEE, SAYAN/AAD-7587-2019; upadhyay, pawan/ABF-5339-2021	Upadhyay, Pawan/0000-0003-4945-5375; Dutt, Amit/0000-0002-1119-4774; Kundu, Tapas/0000-0001-7790-214X; KUMAR, MANOJ/0000-0002-6838-2995	Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Department of Biotechnology (DBT), Government of India, Virtual National Oral Cancer Institute (VNOCI) Grant [BT/PRI7576/MED/30/1690/2016]; Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Department of Biotechnology (DBT), Government of India, Life Science Education and Training at JNCASR Grant [DBT/INF/22/SP27679/2018]; Department of Science and Technology (DST), Government of India, Sir JC Bose National Fellowship Grant [SR/S2/JCB-28/2010]; Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)	Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Department of Biotechnology (DBT), Government of India, Virtual National Oral Cancer Institute (VNOCI) Grant; Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Department of Biotechnology (DBT), Government of India, Life Science Education and Training at JNCASR Grant; Department of Science and Technology (DST), Government of India, Sir JC Bose National Fellowship Grant; Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)(Department of Science & Technology (India))	This work was supported by Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Department of Biotechnology (DBT), Government of India, Virtual National Oral Cancer Institute (VNOCI) Grant (BT/PRI7576/MED/30/1690/2016) and Life Science Education and Training at JNCASR Grant (DBT/INF/22/SP27679/2018), Department of Science and Technology (DST), Government of India, Sir JC Bose National Fellowship Grant SR/S2/JCB-28/2010 (to T. K. K.), and an Integrated Ph.D. program scholarship of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abarzua P, 1996, ONCOGENE, V13, P2477; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Ahn J, 2009, CELL CYCLE, V8, P1603, DOI 10.4161/cc.8.10.8548; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Brachmann RK, 2004, CELL CYCLE, V3, P1030; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CASSON AG, 1991, CANCER RES, V51, P4495; DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hartley SW, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0670-5; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hsieh LL, 2001, CARCINOGENESIS, V22, P1497, DOI 10.1093/carcin/22.9.1497; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kaypee S, 2018, ISCIENCE, V4, P260, DOI 10.1016/j.isci.2018.06.002; Kumar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09353-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lazarus P, 1996, CARCINOGENESIS, V17, P733, DOI 10.1093/carcin/17.4.733; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mandal AK, 2003, J BIOL CHEM, V278, P36077, DOI 10.1074/jbc.M211207200; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; Merabet A, 2010, BIOCHEM J, V427, P225, DOI 10.1042/BJ20091888; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen LH, 2016, ONCOL REP, V36, P877, DOI 10.3892/or.2016.4869; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; STENGER JE, 1992, MOL CARCINOGEN, V5, P102, DOI 10.1002/mc.2940050204; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WAGNER J, 1994, JNCI-J NATL CANCER I, V86, P1707, DOI 10.1093/jnci/86.22.1707; Wasserman JD, 2015, J CLIN ONCOL, V33, P602, DOI 10.1200/JCO.2013.52.6863; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Xie TX, 2013, LARYNGOSCOPE, V123, P1416, DOI 10.1002/lary.23846; Yoshikawa K, 2010, BIOMED RES-TOKYO, V31, P401, DOI 10.2220/biomedres.31.401; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; Zhou FF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4388	54	2	3	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14081	14095		10.1074/jbc.RA118.007265	http://dx.doi.org/10.1074/jbc.RA118.007265			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366730	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000490729800021
J	Moodley, J; Scott, SE; Mwaka, AD; Constant, D; Githaiga, JN; Stewart, TS; Payne, A; Cairncross, L; Somdyala, NIM; Walter, FM				Moodley, J.; Scott, S. E.; Mwaka, A. D.; Constant, D.; Githaiga, J. N.; Stewart, T. S.; Payne, A.; Cairncross, L.; Somdyala, N. I. M.; Walter, F. M.			Development and validation of the African Women Awareness of CANcer (AWACAN) tool for breast and cervical cancer	PLOS ONE			English	Article							DELAYED PRESENTATION; PATIENT DELAY; DIAGNOSIS; KNOWLEDGE; SURVIVAL; SYMPTOMS; QUALITY; STAGE	Background Measuring factors influencing time to presentation is important in developing and evaluating interventions to promote timely cancer diagnosis, yet there is a lack of validated, culturally relevant measurement tools. This study aimed to develop and validate the African Women Awareness of CANcer (AWACAN) tool to measure awareness of breast and cervical cancer in Sub-Saharan Africa (SSA). Methods Development of the AWACAN tool followed 4 steps: 1) Item generation based on existing measures and relevant literature. 2) Refinement of items via assessment of content and face validity using cancer experts' ratings and think aloud interviews with community participants in Uganda and South Africa. 3) Administration of the tool to community participants, university staff and cancer experts for assessment of validity using test-retest reliability (using Intra-Class Correlation (ICC) and adjusted Kappa coefficients), construct validity (comparing expert and community participant responses using t-tests) and internal reliability (using the Kuder-Richarson (KR-20) coefficient). 4) Translation of the final AWACAN tool into isiXhosa and Acholi. Results ICC scores indicated good test-retest reliability (>= 0.7) for all breast cancer knowledge domains and cervical cancer risk factor and lay belief domains. Experts had higher knowledge of breast cancer risk factors (p < 0.001), and cervical cancer risk factors (p = 0.003) and symptoms (p = 0.001) than community participants, but similar knowledge of breast cancer symptoms (p = 0.066). Internal reliability for breast cancer risk factors, lay beliefs and symptom and cervical cancer symptom subscales was good with KR-20 values > 0.7, and lower (0.6) for the cervical cancer risk subscale. Conclusion The final AWACAN tool includes items on socio-demographic details; breast and cervical cancer symptom awareness, risk factor awareness, lay beliefs, anticipated help-seeking behaviour; and barriers to seeking care. The tools showed evidence of content, face, construct and internal validity and test-retrest reliability and are available for use in SSA in three languages.	[Moodley, J.; Constant, D.; Githaiga, J. N.] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Moodley, J.; Payne, A.] Univ Cape Town, Fac Hlth Sci, Canc Res Initiat, Cape Town, South Africa; [Moodley, J.] Univ Cape Town, Fac Hlth Sci, SAMRC Gynaecol Canc Res Ctr, Cape Town, South Africa; [Scott, S. E.] Kings Coll London, Fac Dent Oral & Craniofacial Sci, Ctr Oral Clin & Translat Sci, London, England; [Mwaka, A. D.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda; [Stewart, T. S.] Plymouth Hosp NHS Trust, Derriford Hosp, Dept Obstet & Gynaecol, Plymouth, Devon, England; [Cairncross, L.] Univ Cape Town, Dept Surg, Div Gen Surg, Surg Endocrine Oncol Unit, Cape Town, South Africa; [Somdyala, N. I. M.] South African Med Res Council, Burden Dis Res Unit, Eastern Cape Canc Registry, Tygerberg, South Africa; [Walter, F. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	University of Cape Town; University of Cape Town; University of Cape Town; University of London; King's College London; Makerere University; Derriford Hospital; University of Plymouth; University of Cape Town; South African Medical Research Council; University of Cambridge	Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa.; Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, Canc Res Initiat, Cape Town, South Africa.; Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, SAMRC Gynaecol Canc Res Ctr, Cape Town, South Africa.	Jennifer.moodley@uct.ac.za	Walter, Fiona/F-3054-2014; Walter, Fiona/GYR-1347-2022; Scott, Suzanne/A-4697-2009	Walter, Fiona/0000-0002-7191-6476; Scott, Suzanne/0000-0001-5536-9612; Moodley, Jennifer/0000-0002-9398-5202; Githaiga, Jennifer/0000-0002-4511-9393; Constant, Deborah/0000-0002-7176-9963; Payne, Alexandra/0000-0001-6770-1846; Somdyala, Nontuthuzelo Iris Muriel/0000-0001-6564-8754	Cancer Association of South Africa (CANSA); University of Cape Town; South African Medical Research Council; South African National Department of Health; GlaxoSmithKline (GSK) Africa Non-Communicable Disease Open Lab [023]; United Kingdom Medical Research Council (Newton Fund); Cancer Research UK [C8640/A23385]; MRC [MC_PC_16098] Funding Source: UKRI	Cancer Association of South Africa (CANSA); University of Cape Town; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African National Department of Health; GlaxoSmithKline (GSK) Africa Non-Communicable Disease Open Lab; United Kingdom Medical Research Council (Newton Fund); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research reported in this article was jointly supported by the Cancer Association of South Africa (CANSA), the University of Cape Town and the South African Medical Research Council with funds received from the South African National Department of Health, GlaxoSmithKline (GSK) Africa Non-Communicable Disease Open Lab (via a supporting grant Project Number: 023), the United Kingdom Medical Research Council (via the Newton Fund). GSK provided in-kind scientific and statistical support as part of capacity strengthening. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the participants for sharing their experiences and participating in the validation processes; the providers and managers of the primary health care clinics and our students for support in the data collection process and the University of Cape Town human resources department for facilitating access to non-medical staff. This research is linked to the CanTest Collaborative, which is funded by Cancer Research UK [C8640/A23385], of which FionaMWalter is Director.	Amone C., 2015, AFRICAN IDENTITIES, V13, P129; [Anonymous], 2009, BREAST MOD CANC AW M; Anthoine Emmanuelle, 2014, Health Qual Life Outcomes, V12, P176, DOI 10.1186/s12955-014-0176-2; Arndt V, 2002, BRIT J CANCER, V86, P1034, DOI 10.1038/sj.bjc.6600209; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; D'Alonzo KT, 2011, REV LAT-AM ENFERM, V19, P1255, DOI 10.1590/S0104-11692011000500025; Demment MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134618; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; El-Shinawi M, 2013, BREAST, V22, P1210, DOI 10.1016/j.breast.2013.08.010; Ericsson KA, PROTOCOL ANAL VERBAL; Fox MC, 2011, PSYCHOL BULL, V137, P316, DOI 10.1037/a0021663; Fregene A, 2005, CANCER-AM CANCER SOC, V103, P1540, DOI 10.1002/cncr.20978; Frenk J, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-42; Ginsburg OM, 2013, J CANCER POLICY, V1, pE35, DOI 10.1016/j.jcpo.2013.07.002; Gyenwali D, 2013, ASIAN PAC J CANCER P, V14, P4373, DOI 10.7314/APJCP.2013.14.7.4373; Jones CEL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004076; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuder GF, 1937, PSYCHOMETRIKA, V2, P151, DOI 10.1007/BF02288391; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JW, 2002, RES NURS HEALTH, V25, P295, DOI 10.1002/nur.10041; Linn R.L., 2000, MEASUREMENT ASSESSME; Lynn MR, 1986, NURS RES; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Moodley J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4219-7; Moodley J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009905; Mwaka AD, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0167-4; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Norsa'adah B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-141; Ramathuba DU, 2015, CURATIONIS, V38, P1, DOI DOI 10.4102/curationis.v38i1.1551; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Robb K, 2009, BRIT J CANC, V101; Sainsbury R, 1999, LANCET, V353, P1132; Sankaranarayanan R, 2010, ANN ONCOL, V21, P1935, DOI 10.1093/annonc/mdq049; Simon AE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001758; Simon AE, 2012, J FAM PLAN REPROD H, V38, P167, DOI 10.1136/jfprhc-2011-100118; Simon AE, 2010, CANCER EPIDEM BIOMAR, V19, P2272, DOI 10.1158/1055-9965.EPI-10-0219; Statistics South Africa, 2012, STAT S AFR CONS 2011; Streiner D. L., 2015, HLTH MEASUREMENT SCA, V5<feminine, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001, 10.1093/MED/9780199685219.001.0001]; Stubbings S, 2009, BRIT J CANC, V101; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; UCL Health Behaviour Research Centre, 2007, CERV CANC AW MEAS CA; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465; Wachira J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2058-x	48	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220545	10.1371/journal.pone.0220545	http://dx.doi.org/10.1371/journal.pone.0220545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386684	Green Published, gold, Green Submitted			2022-12-26	WOS:000484997100024
J	Nostedt, JJ; Churchill, T; Ghosh, S; Thiesen, A; Hopkins, J; Lees, MC; Adam, B; Freed, DH; Shapiro, AMJ; Bigam, DL				Nostedt, Jordan J.; Churchill, Tom; Ghosh, Sunita; Thiesen, Aducio; Hopkins, Jessica; Lees, Mackenzie C.; Adam, Benjamin; Freed, Darren H.; Shapiro, A. M. James; Bigam, David L.			Avoiding initial hypothermia does not improve liver graft quality in a porcine donation after circulatory death (DCD) model of normothermic perfusion	PLOS ONE			English	Article							MACHINE PERFUSION; CARDIAC DEATH; COLD-STORAGE; TRANSPLANTATION; PRESERVATION; REPERFUSION; DONORS; INJURY; ISCHEMIA	Background Normothermic machine perfusion (NMP) of liver grafts donated after circulatory death (DCD) has shown promise in large animal and clinical trials. Following procurement, initial flush with a cold preservation solution is the standard of care. There is concern that initial cooling followed by warming may exacerbate liver injury, and the optimal initial flush temperature has yet to be identified. We hypothesize that avoidance of the initial cold flush will yield better quality liver grafts. Methods Twenty-four anaesthetized pigs were withdrawn from mechanical ventilation and allowed to arrest. After 60-minutes of warm ischemia to simulate a DCD procurement, livers were flushed with histidine-tryptophan-ketoglutarate (HTK) at 4 degrees C, 25 degrees C or 35 degrees C (n = 4 per group). For comparison, an adenosine-lidocaine crystalloid solution (AD), shown to have benefit at warm temperatures in heart perfusions, was also used (n = 4 per group). During 12-hours of NMP, adenosine triphosphate (ATP), lactate, transaminase levels, and histological injury were determined. Bile production and hemodynamics were monitored continuously. Results ATP levels recovered substantially following 1-hour of NMP reaching pre-ischemic levels by the end of NMP with no difference between groups. There was no difference in peak aspartate aminotransferase (AST) or in lactate dehydrogenase (LDH). Portal vein resistance was lowest in the 4 degrees C group reaching significance after 2 hours (0.13 CI -0.01,0.277, p = 0.025). Lactate levels recovered promptly with no difference between groups. Comparison to AD groups showed no statistical difference in the abovementioned parameters. On electron microscopy the HTK4 degrees C group had the least edema with mean cell thickness of 2.92 mu m (p = 0.41) while also having the least sinusoidal dilatation with a mean diameter of 5.36 mu m (p = 0.04). For AD, the 25 degrees C group had the lowest mean cell thickness at 3.14 mu m (p = 0.09). Conclusions Avoidance of the initial cold flush failed to demonstrate added benefit over standard 4 degrees C HTK in this DCD model of liver perfusion.	[Nostedt, Jordan J.; Hopkins, Jessica; Lees, Mackenzie C.; Shapiro, A. M. James; Bigam, David L.] Univ Alberta, Dept Surg, Div Gen Surg, Edmonton, AB, Canada; [Churchill, Tom] Univ Alberta, Dept Surg, Div Surg Res, Edmonton, AB, Canada; [Ghosh, Sunita] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada; [Thiesen, Aducio; Adam, Benjamin] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Freed, Darren H.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Freed, Darren H.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Freed, Darren H.] Univ Alberta, Dept Surg, Div Cardiac Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Nostedt, JJ; Bigam, DL (corresponding author), Univ Alberta, Dept Surg, Div Gen Surg, Edmonton, AB, Canada.	nostedt@ualberta.ca; david.bigam@albertahealthservices.ca		Freed, Darren/0000-0002-6239-1444; Nostedt, Jordan/0000-0002-3984-5700; Adam, Benjamin/0000-0003-1908-1739	University of Alberta Clinician Investigator Program	University of Alberta Clinician Investigator Program	JN was funded by the University of Alberta Clinician Investigator Program. The funder provided support in the form of salaries for JN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Berendsen TA, 2011, TRANSPL P, V43, P1484, DOI 10.1016/j.transproceed.2010.12.066; Bhogal RH, 2018, SEMIN LIVER DIS, V38, P252, DOI 10.1055/s-0038-1661371; Boehnert MU, 2013, AM J TRANSPLANT, V13, P1441, DOI 10.1111/ajt.12224; Bral M, 2017, AM J TRANSPLANT, V17, P1071, DOI 10.1111/ajt.14049; Brockmann J, 2009, ANN SURG, V250, P1, DOI 10.1097/SLA.0b013e3181a63c10; Bruinsma BG, 2017, TRANSPLANTATION, V101, P1637, DOI 10.1097/TP.0000000000001699; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Carini R, 1999, EXP CELL RES, V248, P280, DOI 10.1006/excr.1999.4408; CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001; Coffey JC, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13068; Foley DP, 2005, ANN SURG, V242, P724, DOI 10.1097/01.sla.0000186178.07110.92; Hashimoto K, 2010, AM J TRANSPLANT, V10, P2665, DOI 10.1111/j.1600-6143.2010.03337.x; Janssen H, 2003, TRANSPLANT INT, V16, P515, DOI 10.1007/s00147-003-0583-5; Kim WR, 2018, AM J TRANSPLANT, V18, P172, DOI 10.1111/ajt.14559; Liu Q, 2016, AM J TRANSPLANT, V16, P794, DOI 10.1111/ajt.13546; Liu Q, 2014, LIVER TRANSPLANT, V20, P987, DOI 10.1002/lt.23906; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu TF, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e24; Mergental H, 2018, LIVER TRANSPLANT, V24, P1453, DOI 10.1002/lt.25291; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; Nassar A, 2016, ARTIF ORGANS, V40, P999, DOI 10.1111/aor.12699; Passonneau JV, 1993, ENZYMATID ANAL PRACT; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Perera MTPR, 2014, BRIT J SURG, V101, P775, DOI 10.1002/bjs.9478; Radi ZA, 2011, AM J PATHOL, V179, P240, DOI 10.1016/j.ajpath.2011.03.029; Ravikumar R, 2016, AM J TRANSPLANT, V16, P1779, DOI 10.1111/ajt.13708; Reddy S, 2005, LIVER TRANSPLANT, V11, P35, DOI 10.1002/lt.20287; Reinders ME, 1996, TRANSPLANT INT, V9, P446, DOI 10.1111/j.1432-2277.1996.tb00987.x; Schon MR, 2001, ANN SURG, V233, P114, DOI 10.1097/00000658-200101000-00017; Selzner M, 2016, LIVER TRANSPLANT, V22, P1501, DOI 10.1002/lt.24499; van Golen RF, 2012, FREE RADICAL BIO MED, V52, P1382, DOI 10.1016/j.freeradbiomed.2012.01.013; Watson CJE, 2019, AM J TRANSPLANT, V19, P1745, DOI 10.1111/ajt.15241; Watson Christopher J E, 2018, Curr Transplant Rep, V5, P72, DOI 10.1007/s40472-018-0178-9; Watson CJE, 2017, TRANSPLANTATION, V101, P1084, DOI 10.1097/TP.0000000000001661; White CW, 2016, AM J TRANSPLANT, V16, P773, DOI 10.1111/ajt.13574; Xu HZ, 2012, J SURG RES, V173, pE83, DOI 10.1016/j.jss.2011.09.057	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220786	10.1371/journal.pone.0220786	http://dx.doi.org/10.1371/journal.pone.0220786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386697	Green Published, gold, Green Submitted			2022-12-26	WOS:000484997100037
J	Guillen, S; Prieto, L; de Ory, SJ; Gonzalez-Tome, MI; Rojo, P; Navarro, ML; Mellado, MJ; Escosa, L; Sainz, T; Francisco, L; Munoz-Fernandez, MA; Ramos, JT; Hortelano, MG; Blazquez, D; Epalza, C; Saavedra, J; Santos, M; Munoz, MA; Santiago, B; Carrasco, I; Roa, MA; Beceiro, J; Penin, M; Martinez, J; Badillo, K; Apilanez, M; Pocheville, I; Garrote, E; Colino, E; Sirvent, JG; Garzon, M; Roman, V; Munoz, MJ; Angulo, R; Neth, O; Falcon, L; Terol, P; Santos, JL; Moreno, D; Lendinez, F; Peromingo, E; Montero, M; Grande, A; Romero, FJ; Perez, C; Martinez, M; Lillo, M; Losada, B; Herranz, M; Bustillo, M; Guerrero, C; Collado, P; Couceiro, JA; Vila, L; Calvino, C; Piqueras, AI; Breton, R; Oltra, M; Lopez, E; Segarra, I; Gavilan, C; Montesinos, E; Dapena, M; Alvarez, C; Jimenez, B; Andres, AG; Marugan, V; Ochoa, C; Alfayate, S; Menasalvas, AI; del Prado, YR; Soler-Palacin, P; Frick, MA; Mur, A; Lopez, N; Mendez, M; Mayol, L; Vallmanya, T; Calavia, O; Garcia, L; Pineda, V; Rius, N; Duenas, J; Fortuny, C; Noguera-Julian, A				Guillen, Sara; Prieto, Luis; Jimenez de Ory, Santiago; Isabel Gonzalez-Tome, Maria; Rojo, Pablo; Luisa Navarro, Maria; Jose Mellado, Maria; Escosa, Luis; Sainz, Talia; Francisco, Laura; Angeles Munoz-Fernandez, Maria; Tomas Ramos, Jose; Garcia Hortelano, Milagros; Blazquez, Daniel; Epalza, Cristina; Saavedra, Jesus; Santos, Mar; Angeles Munoz, Ma; Santiago, Begona; Carrasco, Itziar; Angel Roa, Miguel; Beceiro, Jose; Penin, Maria; Martinez, Jorge; Badillo, Katie; Apilanez, Miren; Pocheville, Itziar; Garrote, Elisa; Colino, Elena; Gomez Sirvent, Jorge; Garzon, Monica; Roman, Vicente; Jose Munoz, Maria; Angulo, Raquel; Neth, Olaf; Falcon, Lola; Terol, Pedro; Luis Santos, Juan; Moreno, David; Lendinez, Francisco; Peromingo, Estrella; Montero, Maria; Grande, Ana; Jose Romero, Francisco; Perez, Carlos; Martinez, Maria; Lillo, Miguel; Losada, Begona; Herranz, Mercedes; Bustillo, Matilde; Guerrero, Carmelo; Collado, Pilar; Antonio Couceiro, Jose; Vila, Leticia; Calvino, Consuelo; Isabel Piqueras, Ana; Breton, Rafael; Oltra, Manuel; Lopez, Eva; Segarra, Inmaculada; Gavilan, Cesar; Montesinos, Elena; Dapena, Marta; Alvarez, Cristina; Jimenez, Beatriz; Gloria Andres, Ana; Marugan, Victor; Ochoa, Carlos; Alfayate, Santiago; Isabel Menasalvas, Ana; Ruiz del Prado, Yolanda; Soler-Palacin, Pere; Antoinette Frick, Maria; Mur, Antonio; Lopez, Nuria; Mendez, Maria; Mayol, Lluis; Vallmanya, Teresa; Calavia, Olga; Garcia, Lourdes; Pineda, Valenti; Rius, Neus; Duenas, Joaquin; Fortuny, Claudia; Noguera-Julian, Antoni		CoRISpe Cohorte Nacl VIH Pediat RE	Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; T-CELL-ACTIVATION; IMMUNE RECONSTITUTION; 1-INFECTED CHILDREN; HIV-1-INFECTED CHILDREN; THYMIC OUTPUT; AGE; RECOVERY; NORMALIZATION; INDIVIDUALS	Background Combination antiretroviral therapy (cART) is associated with marked immune reconstitution. Although a long term viral suppression is achievable, not all children however, attain complete immunological recovery due to persistent immune activation. We use CD4/CD8 ratio like a marker of immune reconstitution. Methods Perinatal HIV-infected children who underwent a first-line cART, achieved viral suppression in the first year and maintained it for more than 5 years, with no viral rebound were included. Logistic models were applied to estimate the prognostic factors, clinical characteristics at cART start, of a lower CD4/CD8 ratio at the last visit. Results 146 HIV-infected children were included: 77% Caucasian, 45% male and 28% CDC C. Median age at cART initiation was 2.3 years (IQR: 0.5-6.2). 42 (30%) children received mono-dual therapy previously to cART. Time of undetectable viral load was 9.5 years (IQR: 7.8, 12.5). 33% of the children not achieved CD4/CD8 ratio >1. Univariate analysis showed an association between CD4/CD8 <1 with lower CD4 nadir and baseline CD4; older age at diagnosis and at cART initiation; and a previous exposure to mono-dual therapy. Multivariate analysis also revealed relationship between CD4/CD8 <1 and lower CD4 nadir (OR: 1.002, CI 95% 1.000-1.004) as well as previous exposure to mono-dual therapy (OR: 0.16, CI 95% 0.003-0.720). Conclusions CD4/CD8 > 1 was not achieved in 33% of the children. Lower CD4 nadir and previous exposure to suboptimal therapy, before initiating cART, are factors showing independently association with a worse immune recovery (CD4/CD8 < 1).	[Guillen, Sara] Hosp Univ Getafe, Dept Pediat, Madrid, Spain; [Prieto, Luis; Isabel Gonzalez-Tome, Maria; Rojo, Pablo] Hosp Univ 12 Octubre Madrid, Dept Pediat, Madrid, Spain; [Jimenez de Ory, Santiago; Angeles Munoz-Fernandez, Maria] Hosp Univ Gregorio Maranon, Dept Immunol, Madrid, Spain; [Luisa Navarro, Maria] Hosp Univ Gregorio Maranon, Dept Pediat, Madrid, Spain; [Jose Mellado, Maria; Escosa, Luis; Sainz, Talia] Hosp Univ La Paz, Dept Pediat, Madrid, Spain; [Francisco, Laura; Tomas Ramos, Jose] Hosp Clin Univ San Carlos, Dept Pediat, Madrid, Spain; [Jose Mellado, Maria; Escosa, Luis; Sainz, Talia; Garcia Hortelano, Milagros] Hosp La Paz, Madrid, Spain; [Isabel Gonzalez-Tome, Maria; Rojo, Pablo; Blazquez, Daniel; Epalza, Cristina] Hosp Doce Octubre, Madrid, Spain; [Tomas Ramos, Jose] Hosp Clin San Carlos, Madrid, Spain; [Guillen, Sara; Prieto, Luis] Hosp Getafe, Getafe, Spain; [Jimenez de Ory, Santiago; Luisa Navarro, Maria; Saavedra, Jesus; Santos, Mar; Angeles Munoz, Ma; Santiago, Begona; Carrasco, Itziar] Hosp Gregorio Maranon, Madrid, Spain; [Angel Roa, Miguel] Hosp Mostoles, Madrid, Spain; [Beceiro, Jose; Penin, Maria] Hosp Principe Asturias, Alcala De Henares, Spain; [Martinez, Jorge] Hosp Nino Jesus, Madrid, Spain; [Badillo, Katie] Hosp Torrejon, Torrejon de Ardoz, Spain; [Apilanez, Miren] Hosp Donostia, San Sebastian, Spain; [Pocheville, Itziar] Hosp Cruces, Bilbao, Spain; [Garrote, Elisa] Hosp Basurto, Bilbao, Spain; [Colino, Elena] Hosp Insular Materno Infantil, Las Palmas Gran Canaria, Spain; [Gomez Sirvent, Jorge] Hosp Virgen de laCandelaria, Santa Cruz De Tenerife, Spain; [Garzon, Monica; Roman, Vicente] Hosp Lanzarote, Arrecife, Spain; [Jose Munoz, Maria; Angulo, Raquel] Hosp Poniente, El Ejido, Spain; [Neth, Olaf; Falcon, Lola] Hosp Virgen de Rocio, Seville, Spain; [Terol, Pedro] Hosp Virgen de la Macarena, Seville, Spain; [Luis Santos, Juan] Hosp Virgen de las Nieves, Granada, Spain; [Moreno, David] Hosp Carlos Haya, Malaga, Spain; [Lendinez, Francisco] Hosp Torrecardenas, Almeria, Spain; [Peromingo, Estrella; Montero, Maria] Hosp Puerta Mar, Cadiz, Spain; [Grande, Ana] Complejo Hosp Univ Infanta Cristina, Badajoz, Spain; [Jose Romero, Francisco] Complejo Hosp Caceres, Caceres, Spain; [Perez, Carlos] Hosp Cabuenes, Gijon, Spain; [Martinez, Maria] Hosp Univ Cent Asturias, Oviedo, Spain; [Lillo, Miguel] Hosp Albacete, Albacete, Spain; [Losada, Begona] Hosp Virgen de la Salud, Toledo, Spain; [Herranz, Mercedes] Hosp Virgen del Camino, Pamplona, Spain; [Bustillo, Matilde; Guerrero, Carmelo] Hosp Miguel Servet, Zaragoza, Spain; [Collado, Pilar] Hosp Clin Lozano Blesa, Zaragoza, Spain; [Antonio Couceiro, Jose] Complejo Hosp Pontevedra, Pontevedra, Spain; [Vila, Leticia] Complejo Hosp Univ La Coruna, La Coruna, Spain; [Calvino, Consuelo] Hosp Univ Lucus Augusti Lugo, Lugo, Spain; [Isabel Piqueras, Ana; Breton, Rafael; Oltra, Manuel; Lopez, Eva; Segarra, Inmaculada] Hosp La Fe, Valencia, Spain; [Gavilan, Cesar] Hosp San Juan Alicante, Alicante, Spain; [Montesinos, Elena] Hosp Gen Valencia, Valencia, Spain; [Dapena, Marta] Hosp Castellon, Castellon de La Plana, Spain; [Alvarez, Cristina; Jimenez, Beatriz] Hosp Marques Valdecilla, Santander, Spain; [Gloria Andres, Ana] Hosp Leon, Leon, Spain; [Marugan, Victor; Ochoa, Carlos] Hosp Zamora, Zamora, Spain; [Alfayate, Santiago; Isabel Menasalvas, Ana] Hosp Virgen Arrixaca, Murcia, Spain; [Ruiz del Prado, Yolanda] Complejo Hosp San Millan San Pedro, Logrono, Spain; [Soler-Palacin, Pere; Antoinette Frick, Maria] Hosp Univ Vall dHebron, Barcelona, Spain; [Mur, Antonio; Lopez, Nuria] Hosp Univ Mar, Barcelona, Spain; [Mendez, Maria] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Mayol, Lluis] Hosp Univ Josep Trueta, Girona, Spain; [Vallmanya, Teresa] Hosp Arnau Vilanova, Lleida, Spain; [Calavia, Olga] Hosp Univ Joan XXIII, Tarragona, Spain; [Garcia, Lourdes] Consorci Sanitari Maresme, Mataro, Spain; [Garcia, Lourdes] Hosp Gen Granollers, Granollers, Spain; [Pineda, Valenti] Corp Sanitaria Parc Tauli, Sabadell, Spain; [Rius, Neus] Hosp Univ St Joan, Reus, Spain; [Duenas, Joaquin] Hosp Son Espases, Mallorca, Spain; [Fortuny, Claudia; Noguera-Julian, Antoni] Hosp St Joan de Deu, Esplugues, Spain	Hospital Universitario de Getafe; Hospital Universitario 12 de Octubre; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Hospital Clinico San Carlos; Hospital Universitario de Getafe; General University Gregorio Maranon Hospital; Prince of Asturias University Hospital; University Hospital Donostia; Hospital Universitario Cruces; Basurto Hospital; Hospital Universitario Virgen de las Nieves; Hospital Carlos Haya; Hospital Torrecardenas; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital de Cabuenes; Central University Hospital Asturias; Complejo Hospitalario de Toledo; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital; Complexo Hospitalario Universitario de Pontevedra; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitari i Politecnic La Fe; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Leon; Hospital de Leon; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Universitari Vall d'Hebron; Hospital Germans Trias i Pujol; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University Hospital Arnau de Vilanova; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitari Son Espases	Guillen, S (corresponding author), Hosp Univ Getafe, Dept Pediat, Madrid, Spain.; Guillen, S (corresponding author), Hosp Getafe, Getafe, Spain.	sguillenmartin@hotmail.com	Escosa-Garcia, Luis/AFZ-2323-2022; Moreno, David/J-2969-2012; Soler-Palacin, Pere/N-2373-2014; Villanueva, Rita Guadalupe Angulo/I-8399-2017; Carrasco, Itziar/O-1724-2018; Prieto, Luis Enrique/HFZ-7903-2022; García, Lourdes/GZK-6681-2022	Moreno, David/0000-0002-7017-4095; Soler-Palacin, Pere/0000-0002-0346-5570; Villanueva, Rita Guadalupe Angulo/0000-0003-2694-3501; ROJO, PABLO/0000-0002-0197-5462; DUENAS MORALES, JOAQUIN/0000-0001-6500-0042; Munoz-Fernandez/0000-0002-0813-4500; Guillen, Sara/0000-0001-8204-1858; Mellado Pena, Maria Jose/0000-0003-2251-9666				Caby F, 2017, AIDS, V31, P1685, DOI [10.1097/QAD.0000000000001533, 10.1097/qad.0000000000001533]; Caby F, 2016, CLIN INFECT DIS, V62, P1297, DOI 10.1093/cid/ciw076; Cohen S, 2015, JAIDS-J ACQ IMM DEF, V68, P178, DOI 10.1097/QAI.0000000000000431; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, 2008, AIDS, V22, P1463, DOI 10.1097/QAD.0b013e3282f88d02; Collins IJ, 2013, 7 IAS C HIV PATH TRE; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; De Biasi S, 2016, AIDS, V30, P2599, DOI 10.1097/QAD.0000000000001247; De Rossi A, 2002, J INFECT DIS, V186, P312, DOI 10.1086/341657; Diaz L, 2012, JAIDS-J ACQ IMM DEF, V60, P447, DOI 10.1097/QAI.0b013e318259254f; Gibb DM, 2000, LANCET, V355, P1331, DOI 10.1016/S0140-6736(00)02117-6; Hainaut M, 2003, PEDIATR INFECT DIS J, V22, P62, DOI 10.1097/00006454-200301000-00016; Krogstad P, 2015, AIDS, V29, P683, DOI 10.1097/QAD.0000000000000598; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Newell ML, 2006, J INFECT DIS, V193, P954, DOI 10.1086/500842; Patel K, 2008, CLIN INFECT DIS, V46, P1751, DOI 10.1086/587900; Petoumenos K, 2017, ANTIVIR THER, V22, P659, DOI 10.3851/IMP3155; Phongsamart W, 2014, INT J INFECT DIS, V22, P19, DOI 10.1016/j.ijid.2013.12.011; Puthanakit T, 2009, PEDIATR INFECT DIS J, V28, P488, DOI 10.1097/INF.0b013e318194eea6; Rainwater-Lovett K, 2014, JAIDS-J ACQ IMM DEF, V67, P455, DOI 10.1097/QAI.0000000000000342; Resino S, 2006, CLIN INFECT DIS, V42, P862, DOI 10.1086/500412; Resino S, 2006, PEDIATR INFECT DIS J, V25, P365, DOI 10.1097/01.inf.0000207419.50016.5e; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Sandgaard KS, 2014, AIDS, V28, P209, DOI 10.1097/QAD.0000000000000063; Sauter R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005094; Serrano-Villar S, 2017, J ANTIMICROB CHEMOTH, V72, P235, DOI 10.1093/jac/dkw375; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Soh CH, 2003, LANCET, V362, P2045, DOI 10.1016/S0140-6736(03)15098-2; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Van Dyke RB, 2011, JAIDS-J ACQ IMM DEF, V57, P165, DOI 10.1097/QAI.0b013e318215c7b1; van Rossum AMC, 2001, AIDS, V15, P2267, DOI 10.1097/00002030-200111230-00008; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007	33	3	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220552	10.1371/journal.pone.0220552	http://dx.doi.org/10.1371/journal.pone.0220552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381604	Green Published, gold			2022-12-26	WOS:000484993600024
J	Margulis, AV; Hernandez-Diaz, S; McElrath, T; Rothman, KJ; Plana, E; Almqvist, C; D'Onofrio, BM; Oberg, AS				Margulis, Andrea, V; Hernandez-Diaz, Sonia; McElrath, Thomas; Rothman, Kenneth J.; Plana, Estel; Almqvist, Catarina; D'Onofrio, Brian M.; Oberg, Anna Sara			Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth	PLOS ONE			English	Article							INTRAUTERINE GROWTH; FETAL-GROWTH; MATERNAL USE; EPILEPSY; DELIVERY; OUTCOMES; RISK; MALFORMATIONS; ASSOCIATION; POPULATION	Background The associations of individual antiepileptic drugs (AEDs) with pregnancy duration and size at birth, and potential dose relations, are not well characterized. Methods This cohort study used nationwide Swedish register data (1996-2013). Adjusting for smoking, epilepsy and other AED indications, we used linear and quantile regression to explore associations with pregnancy duration, and birth weight, length, and head circumference (the last three operationalized as z-scores). We used logistic regression for preterm delivery, small for gestational age, and microcephaly. Lamotrigine was the reference drug. Results 6,720 infants were exposed to AEDs in utero; AED exposure increased over the study period. Relative to lamotrigine-exposed infants, carbamazepine-exposed infants were born, on average, 1.3 days earlier (mean [95% confidence interval]: -1.3 [-2.3 to 0.3]); were 0.1 standard deviations (SDs) lighter (-0.1 [-0.2 to 0.0]); and had a head circumference that was 0.2 SDs smaller (-0.2 [-0.3 to 0.1]). Pregabalin-exposed infants were born, on average, 1.1 days earlier (-1.1 [-3.0 to 0.8]); were 0.1 SDs lighter (-0.1 [-0.3 to 0.0]); and had the same head circumference as lamotrigine-exposed infants. Levetiracetam-exposed infants were born, on average, 0.5 days earlier (-0.5 [-2.6 to 1.6]); were 0.1 SDs lighter (-0.1 [-0.3 to 0.0]); and had a head circumference 0.1 SDs smaller (-0.1 [-0.3 to 0.1]). Valproic acid-exposed infants had, on average, the same duration of gestation and birth weight z-score as lamotrigine-exposed infants, but had a head circumference 0.2 SDs smaller (-0.2 [-0.2 to 0.1]). Associations between carbamazepine exposure and pregnancy duration and between valproic acid exposure and pregnancy duration and birth weight z-score were more negative at the left than at the right tails of the outcome distributions. Effect-measure modification and dose-response relations were noted for some of the associations. Conclusions Relative to lamotrigine, valproic acid and carbamazepine were associated with smaller head circumference.	[Margulis, Andrea, V; Plana, Estel] RTI Hlth Solut, Barcelona, Spain; [Hernandez-Diaz, Sonia; Oberg, Anna Sara] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [McElrath, Thomas] Harvard Med Sch, Brigham & Womens Hosp, Div Maternal Fetal Med, Boston, MA 02115 USA; [Rothman, Kenneth J.] RTI Hlth Solut, Waltham, MA USA; [Almqvist, Catarina; D'Onofrio, Brian M.; Oberg, Anna Sara] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [D'Onofrio, Brian M.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Research Triangle Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Research Triangle Institute; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Indiana University System; Indiana University Bloomington	Margulis, AV (corresponding author), RTI Hlth Solut, Barcelona, Spain.	amargulis@rti.org	Oberg, Anna Sara/AAH-1078-2021; Margulis, Andrea/G-2833-2013	Oberg, Anna Sara/0000-0001-6638-1895; Plana, Estel/0000-0001-8675-7503; Margulis, Andrea/0000-0001-7388-6082	Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]	Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM)	ASO, CA and BMD received funds from the Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For AVM, KJR, and EP: this project was internally funded. TM received no specific funding for this work.	Abrahamsson K., 2018, SWEDISH REGISTER ED; Almgren M, 2009, SEIZURE-EUR J EPILEP, V18, P672, DOI 10.1016/j.seizure.2009.09.002; Artama M, 2013, DRUG SAFETY, V36, P359, DOI 10.1007/s40264-013-0052-8; Battino D, 1999, EPILEPSY RES, V36, P53, DOI 10.1016/S0920-1211(99)00020-0; Bromley RL, 2017, JAMA-J AM MED ASSOC, V318, P1700, DOI 10.1001/jama.2017.14485; Bromley RL, 2017, SEIZURE-EUR J EPILEP, V44, P225, DOI 10.1016/j.seizure.2016.10.006; Bruckner TA, 2017, EPIDEMIOLOGY, V28, P580, DOI 10.1097/EDE.0000000000000661; de Jong Josta, 2016, Drugs Real World Outcomes, V3, P131; Elkjaer LS, 2018, JAMA NEUROL, V75, P663, DOI 10.1001/jamaneurol.2017.5035; EMA, 2008, ANN 2 SCI CONCL GROU; EMA, 2016, PUBL SUMM OP ORPH DE; EMA, 2018, NEW MEAS AV VALPR EX; EMA, 2017, LAM SUMM PROD CHAR; European Commission, 2019, PUBL HLTH UN REG MED; Foch C, 2018, INT J PEDIATR OTORHI, V113, P192, DOI 10.1016/j.ijporl.2018.07.035; Gerard EE, 2015, J PEDIATR GENET, V4, P94, DOI 10.1055/s-0035-1556741; Hagenfeldt K., 1998, ROUTINE ULTRASOUND E; Hao L, 2007, QUANTILE REGRESSION; Hernandez-Diaz S, 2017, ANN NEUROL, V82, P457, DOI 10.1002/ana.25031; Hernandez-Diaz S, 2014, OBSTET GYNECOL, V123, P21, DOI 10.1097/AOG.0000000000000018; HIILESMAA VK, 1981, LANCET, V2, P165; Hvas CL, 2000, BRIT J OBSTET GYNAEC, V107, P896, DOI 10.1111/j.1471-0528.2000.tb11089.x; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Kallen B., 2003, SWEDISH MED BIRTH RE; Kilic D, 2014, EPILEPSIA, V55, P1714, DOI 10.1111/epi.12758; Kolstad E, 2016, EPILEPSIA, V57, P1849, DOI 10.1111/epi.13573; Koren G, 2018, PEDIATR DRUGS, V20, P331, DOI 10.1007/s40272-018-0294-0; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Margulis AV, 2017, PHARMACOEPIDEM DR S, V26, P408; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McInerney KA, 2018, BJOG; Mostacci B, 2018, J NEUROL NEUROSUR PS, V89, pE1, DOI 10.1136/jnnp-2017-316143corr1; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Pariente G, 2017, CNS DRUGS, V31, P451, DOI 10.1007/s40263-017-0439-7; Pariente G, 2017, CNS DRUGS, V31, P439, DOI 10.1007/s40263-017-0433-0; Patorno E, 2017, NEUROLOGY, V88, P2020, DOI [10.1212/wnl.0000000000003959, 10.1212/WNL.0000000000003959]; Pennell PB, 2012, EPILEPSY BEHAV, V24, P449, DOI 10.1016/j.yebeh.2012.05.010; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Petersen MR, 2006, AM J EPIDEMIOL, V163, P1158, DOI 10.1093/aje/kwj162; Raguideau F, 2016, EXPOSITION ACIDE VAL; Raguideau F, 2017, EXPOSITION IN UTERO; Shorvon SD, 2009, EPILEPSIA, V50, P93, DOI 10.1111/j.1528-1167.2009.02042.x; Tomson T, 2018, LANCET NEUROL, V17, P530, DOI 10.1016/S1474-4422(18)30107-8; Vajda FJE, 2018, ACTA NEUROL SCAND, V138, P115, DOI 10.1111/ane.12965; Vajda FJ, 2013, NEUROLOGY, V81, P999, DOI 10.1212/WNL.0b013e3182a43e81; Veiby G, 2014, J NEUROL, V261, P579, DOI 10.1007/s00415-013-7239-x; Veiby G, 2009, EPILEPSIA, V50, P2130, DOI 10.1111/j.1528-1167.2009.02147.x; Veroniki AA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017248; Veroniki AA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0845-1; Viale L, 2015, LANCET, V386, P1845, DOI 10.1016/S0140-6736(15)00045-8; Wen XR, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1190-7; Weston J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010224.pub2; WHO Collaborating Center for Drug Statistics Methodology, 2009, DEF DAIL DOS DEF GEN; Wide K, 2000, EPILEPSIA, V41, P854, DOI 10.1111/j.1528-1157.2000.tb00253.x; Winterfeld U, 2016, NEUROLOGY, V86, P2251, DOI 10.1212/WNL.0000000000002767	56	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0214180	10.1371/journal.pone.0214180	http://dx.doi.org/10.1371/journal.pone.0214180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381574	Green Submitted, gold, Green Published			2022-12-26	WOS:000484993600002
J	Esmaeili, S; Hemami, MR; Goheen, JR				Esmaeili, Saeideh; Hemami, Mahmoud-Reza; Goheen, Jacob R.			Human dimensions of wildlife conservation in Iran: Assessment of human-wildlife conflict in restoring a wide-ranging endangered species	PLOS ONE			English	Article							MANAGEMENT; PERFORMANCE; EXTINCTION; INTERESTS; DIVERSITY; ATTITUDES	Human-wildlife conflicts restrict conservation efforts, especially for wide-ranging animals whose home ranges overlap with human activities. We conducted a study to understand conflicts with, and factors influencing the perceived value of an expanding population of onagers (Equus hemionus onager) in local communities in southern Iran. We asked about locals' perceptions of six potential management strategies intended to lessen human-onager conflict. We found that human-onager conflict was restricted to 45% of respondents within the Bahram-e-Goor Protected Area, all of whom were involved in farming or herding activities. Locals within the protected area were more knowledgeable about onagers and valued onagers more than those living outside the protected area. The perceived value of onagers increased with level of education, total annual income, and perceptions of onager population trends; the perceived value of onagers decreased with the magnitude of conflict between onagers and locals. To tolerate or avoid conflicts with onagers, locals were supportive of monetary compensation and changing from a traditional lifestyle to industrialized farming (for farmers) or livestock production (for herders) with the help of government; locals did not support selling land to the government. Our study is among the first in human-wildlife conflict and local attitudes towards an endangered species and its recovery in Iran. We conclude that current levels of human-onager conflict are relatively low and perceived value of onagers is still relatively high. Therefore, wildlife authorities should consider the development of mitigation strategies with local communities before conflicts intensify.	[Esmaeili, Saeideh; Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Hemami, Mahmoud-Reza] Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran	University of Wyoming; Isfahan University of Technology	Esmaeili, S (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	saeideh.esmaeili@uwyo.edu	Hemami, Mahmoud-Reza/AAH-2553-2022; Hemami, Mahmoud-Reza/AFM-0224-2022	Esmaeili, Saeideh/0000-0002-8678-7048	Cleveland Metroparks Zoo; Eva Mayr-Stihl Stiftung	Cleveland Metroparks Zoo; Eva Mayr-Stihl Stiftung	This work was funded by: 1-Cleveland Metroparks Zoo, https://www.clevelandmetroparks.com/zoo to MRH, SE; and 2Eva Mayr-Stihl Stiftung: http://www.eva-mayr-stihlstiftung.de/en to MRH, SE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; [Anonymous], 2009, IRAN 2006 CENSUS; Beck, 1998, YALE SCH FORESTRY EN, V103, P58; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Bulte EH, 2005, J WILDLIFE MANAGE, V69, P14, DOI 10.2193/0022-541X(2005)069&lt;0014:WCWDMB&gt;2.0.CO;2; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Decker DJ, 1997, WILDLIFE SOC B, V25, P788; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Farhadinia MS, 2017, BIOL CONSERV, V213, P210, DOI 10.1016/j.biocon.2017.07.011; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Ghoshtasb H, 2012, J NAT ENV IRANINAN J, V65, P247; Gliem J. A., 2003, MIDW RES PRACT C AD, P82, DOI [DOI 10.1109/PROC.1975.9792, 10.1016/j.encep.2016.05.011]; Goldberg EJ, 2018, ABBASID CAROLINGIAN, P73; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Gusset M, 2008, BIODIVERS CONSERV, V17, P83, DOI 10.1007/s10531-007-9232-0; Harrell FE, 2018, PACKAGE RMS CRAN; Hemami MR, 2013, ORYX, V47, P266, DOI 10.1017/S0030605311001827; Hemami P, 2015, IUCN RED LIST THREAT; Hobbs NT, 2012, ECOL APPL, V22, P1640, DOI 10.1890/11-1309.1; Hosseini-Zavarei F, 2013, J ZOOL, V290, P127, DOI 10.1111/jzo.12022; Kaczensky P., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.EN]; Kaczensky P., 2006, MONGOLIA DISCUSSION; Kansky R, 2014, BIOL CONSERV, V179, P93, DOI 10.1016/j.biocon.2014.09.008; Kolahi M, 2013, ENVIRON MANAGE, V52, P514, DOI 10.1007/s00267-013-0061-5; Lele S, 2010, CURR OPIN ENV SUST, V2, P94, DOI 10.1016/j.cosust.2010.03.006; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Manfredo MJ, 2008, WHO CARES WILDLIFE E; Marshall K, 2007, BIODIVERS CONSERV, V16, P3129, DOI 10.1007/s10531-007-9167-5; Martin-Lopez B, 2009, BIOL CONSERV, V142, P1370, DOI 10.1016/j.biocon.2009.01.030; Mohammadi A, 2016, HUM-WILDL INTERACT, V10, P103; Nyhus PJ, 2005, CONSERV BIOL SER, V9, P107; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Santos J.R.A., 1999, J EXT, V37, P1; Schwerdtner K, 2007, BIOL CONSERV, V134, P354, DOI 10.1016/j.biocon.2006.08.010; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Tatin L, 2003, ORYX, V37, P488; Teel TL, 2010, CONSERV BIOL, V24, P128, DOI 10.1111/j.1523-1739.2009.01374.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wingard J, 2014, GUIDELINES ADDRESSIN; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Yackulic CB, 2011, P NATL ACAD SCI USA, V108, P4024, DOI 10.1073/pnas.1015097108; Yasmi Y, 2006, ENVIRON SCI POLICY, V9, P538, DOI 10.1016/j.envsci.2006.04.003; Zeileis A, 2016, PACKAGE BETAREG CRAN	52	8	8	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220702	10.1371/journal.pone.0220702	http://dx.doi.org/10.1371/journal.pone.0220702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374100	Green Published, gold			2022-12-26	WOS:000484991500028
J	Huth, S; Sindt, S; Selhuber-Unkel, C				Huth, Steven; Sindt, Sandra; Selhuber-Unkel, Christine			Automated analysis of soft hydrogel microindentation: Impact of various indentation parameters on the measurement of Young's modulus	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; SUBSTRATE STIFFNESS; MATRIX; ELASTICITY; ROUGHNESS; MIGRATION; FRICTION; GRADIENT; CONTACT	Measurements of Young's moduli are mostly evaluated using strong assumptions, such as sample homogeneity and isotropy. At the same time, descriptions of measurement parameters often lack detailed specifications. Many of these assumptions are, for soft hydrogels especially, not completely valid and the complexity of hydrogel microindentation demands more sophisticated experimental procedures in order to describe their elastic properties more accurately. We created an algorithm that automates indentation data analysis as a basis for the evaluation of large data sets with consideration of the influence of indentation depth on the measured Young's modulus. The algorithm automatically determines the Young's modulus in indentation regions where it becomes independent of the indentation depth and furthermore minimizes the error from fitting an elastic model to the data. This approach is independent of the chosen elastic fitting model and indentation device. With this, we are able to evaluate large amounts of indentation curves recorded on many different sample positions and can therefore apply statistical methods to overcome deviations due to sample inhomogeneities. To prove the applicability of our algorithm, we carried out a systematic analysis of how the indentation speed, indenter size and sample thickness affect the determination of Young's modulus from atomic force microscope (AFM) indentation curves on polyacrylamide (PAAm) samples. We chose the Hertz model as the elastic fitting model for this proof of principle of our algorithm and found that all of these parameters influence the measured Young's moduli to a certain extent. Hence, it is essential to clearly state the experimental parameters used in microindentation experiments to ensure reproducibility and comparability of data.	[Huth, Steven; Sindt, Sandra; Selhuber-Unkel, Christine] Univ Kiel, Inst Mat Sci, Biocompatible Nanomat, Kiel, Germany	University of Kiel	Selhuber-Unkel, C (corresponding author), Univ Kiel, Inst Mat Sci, Biocompatible Nanomat, Kiel, Germany.	cse@tf.uni-kiel.de	Selhuber-Unkel, Christine/D-9715-2016	Selhuber-Unkel, Christine/0000-0002-5051-4822	ERC [336104, 768740, RTG 2154]; German Research Foundation	ERC(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG))	C. S. and S. H. acknowledge support through the ERC (Starting grant no. 336104, Proof of Concept Grant no. 768740). S. S. is a doctoral researcher in the Research Training Group RTG 2154 "Materials for Brain," which is funded by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w; Barthel E, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/16/163001; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647; Burmistrova A, 2011, COLLOID POLYM SCI, V289, P613, DOI 10.1007/s00396-011-2383-2; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Chaudhri MM, 1996, PHILOS MAG A, V74, P1213, DOI 10.1080/01418619608239721; COHEN Y, 1992, J POLYM SCI POL PHYS, V30, P1055, DOI 10.1002/polb.1992.090300913; Crick SL, 2007, BIOMECH MODEL MECHAN, V6, P199, DOI 10.1007/S10237-006-0046-x; Darnell M, 2017, NAT MATER, V16, P1178, DOI 10.1038/nmat4991; Denisin AK, 2016, ACS APPL MATER INTER, V8, P21893, DOI 10.1021/acsami.5b09344; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179; FIELD JS, 1995, J MATER RES, V10, P101, DOI 10.1557/JMR.1995.0101; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Galluzzi M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05902-1; Gavara N, 2016, SCI REP-UK, V6, DOI 10.1038/srep21267; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]; Gross W, 2017, SOFT MATTER, V13, P1048, DOI 10.1039/c6sm02470j; Gutekunst SB, 2019, ACS BIOMATER SCI ENG, V5, P1784, DOI 10.1021/acsbiomaterials.8b01009; Guz N, 2014, BIOPHYS J, V107, P564, DOI 10.1016/j.bpj.2014.06.033; Hadden WJ, 2017, P NATL ACAD SCI USA, V114, P5647, DOI 10.1073/pnas.1618239114; Hagel V, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-36; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Krieg M, 2019, NAT REV PHYS, V1, P41, DOI 10.1038/s42254-018-0001-7; Kronenberg NM, 2017, NAT CELL BIOL, V19, P864, DOI 10.1038/ncb3561; Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038; Platzman I, 2013, RSC ADV, V3, P13293, DOI [10.1039/C3RA41579A, 10.1039/c3ra41579a]; Pratt JR, 2010, J APPL PHYS, V107, DOI 10.1063/1.3284957; Rico F, 2008, NANOSCI TECHNOL, P89, DOI 10.1007/978-3-540-74083-4_4; RUCHEL R, 1975, ANAL BIOCHEM, V68, P415, DOI 10.1016/0003-2697(75)90637-5; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stiernstedt J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2006407; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; van Zwol PJ, 2008, LANGMUIR, V24, P7528, DOI 10.1021/la800664f; Wang JHC, 2007, ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS, P227, DOI 10.1007/978-3-540-45456-4_14; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Xu LN, 2008, J CENT SOUTH UNIV T, V15, P443, DOI 10.1007/s11771-008-0396-x; Yashima S, 2014, SOFT MATTER, V10, P3192, DOI 10.1039/c3sm52883a	46	20	20	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220281	10.1371/journal.pone.0220281	http://dx.doi.org/10.1371/journal.pone.0220281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374079	Green Published, Green Submitted, gold			2022-12-26	WOS:000484991500007
J	Multini, LC; de Souza, ALD; Marrelli, MT; Wilke, ABB				Multini, Laura Cristina; da Silva de Souza, Ana Leticia; Marrelli, Mauro Toledo; Bruno Wilke, Andre Barretto			Population structuring of the invasive mosquito Aedes albopictus (Diptera: Culicidae) on a microgeographic scale	PLOS ONE			English	Article							ASIAN TIGER MOSQUITO; SAO-PAULO; GENETIC DIVERSITY; GLOBAL RISK; R-PACKAGE; VIRUS; SOFTWARE; AEGYPTI; VECTOR; BRAZIL	Aedes albopictus is an invasive mosquito species that has spread globally and can transmit several arboviruses, including dengue, chikungunya and yellow fever. The species was first reported in Brazil in 1986 and since then has been found in 24 of the 27 Brazilian states, often in peri-urban environments close to highly urbanized areas. To date, population genetics of this important mosquito in areas in the city of Sao Paulo has not been investigated. In this study, we used 12 microsatellite loci to investigate the microgeographic population genetics of Ae. albopictus, which is present throughout the city of Sao Paulo. All the analyses revealed structuring of the populations studied, divided into two groups with restricted gene flow between them and without evidence of isolation by distance. We propose two hypotheses to explain the results: (i) low dispersal capability-limited gene flow between populations is due to the low dispersal capability inherent to Ae. albopictus; and (ii) multiple introductions-the structure identified here results from multiple introductions, which led to different dispersal patterns within the city and more genetic heterogeneity. The ability of Ae. albopictus to invade new areas and expand may explain why these mosquito populations appear to be well established and thriving in the city of Sao Paulo.	[Multini, Laura Cristina; Marrelli, Mauro Toledo] Univ Sao Paulo, Fac Publ Hlth, Dept Epidemiol, Sao Paulo, SP, Brazil; [da Silva de Souza, Ana Leticia; Marrelli, Mauro Toledo] Univ Sao Paulo, Sao Paulo Inst Trop Med, Sao Paulo, SP, Brazil; [Bruno Wilke, Andre Barretto] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Miami	Multini, LC (corresponding author), Univ Sao Paulo, Fac Publ Hlth, Dept Epidemiol, Sao Paulo, SP, Brazil.	lauramultini@usp.br	Wilke, Andre B B/J-9973-2014; Marrelli, Mauro/AHB-7335-2022	Wilke, Andre B B/0000-0002-6629-7666; Multini, Laura Cristina/0000-0002-1322-9889	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/15313-4]; FAPESP fellowship [2015/23386-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant 2013/15313-4. LCM is the recipient of a FAPESP fellowship (grant 2015/23386-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5; Amraoui F, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.39.30361; [Anonymous], 2002, CULICIDOLOGIA MED; Ayllon T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195014; Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Wilke ABB, 2017, J MED ENTOMOL, V54, P1582, DOI 10.1093/jme/tjx149; Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150; Buhaug H, 2013, GLOBAL ENVIRON CHANG, V23, P1, DOI 10.1016/j.gloenvcha.2012.10.016; Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Ceretti W, 2015, J AM MOSQUITO CONTR, V31, P172, DOI 10.2987/14-6457R; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Conn JE, 2006, AM J TROP MED HYG, V74, P798, DOI 10.4269/ajtmh.2006.74.798; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009; Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866; GOMES AD, 1985, REV SAUDE PUBL, V19, P190, DOI 10.1590/S0034-89101985000200009; Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35; Hill MP, 2014, AUSTRAL ECOL, V39, P469, DOI 10.1111/aec.12105; Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamgang Basile, 2018, Wellcome Open Res, V3, P79, DOI 10.12688/wellcomeopenres.14659.1; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290; Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091; Kotsakiozi P, 2017, ECOL EVOL, V7, P10143, DOI 10.1002/ece3.3514; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851; Lourenco AF, 2017, ESTUDOS, V44, P72; Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624; Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332; Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5; Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x; Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014; Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167; Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328; NASCI RS, 1981, MOSQ NEWS, V41, P808; Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691; Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x; Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2017, LANG ENV STAT COMP, P1; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rissler LJ, 2016, P NATL ACAD SCI USA, V113, P8079, DOI 10.1073/pnas.1601073113; Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmidt TL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006009; SERUFO JC, 1993, MEM I OSWALDO CRUZ, V88, P503, DOI 10.1590/S0074-02761993000300025; Sherpa S, 2018, INFECT GENET EVOL, V58, P145, DOI 10.1016/j.meegid.2017.12.018; Martins WFS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005917; Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058; United Nations Department of Economic and Social Affairs Population Division. United Nations, 2015, WORLD URB PROSP 2014; Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; WHO, 2018, YELL FEV BRAZ; Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003; Wilke ABB, 2018, INFECT GENET EVOL, V65, P333, DOI 10.1016/j.meegid.2018.08.017; Zielke DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099093	76	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220773	10.1371/journal.pone.0220773	http://dx.doi.org/10.1371/journal.pone.0220773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374109	Green Published, gold, Green Submitted			2022-12-26	WOS:000484991500032
J	Mahmood, T; Younas, A; Akrim, F; Andleeb, S; Hamid, A; Nadeem, MS				Mahmood, Tariq; Younas, Ayesha; Akrim, Faraz; Andleeb, Shaista; Hamid, Abdul; Nadeem, Muhammad Sajid			Range contraction of snow leopard (Panthera uncia)	PLOS ONE			English	Article								Snow Leopard (Panthera uncia) is native to mountain ranges of Central and South Asia, where it occurs from 3,000-4500 m elevation. The species is enlisted as "Endangered" by IUCN and its populations are reportedly declining. In the current study, we compared the past and current distribution ranges of the species using spatial analysis. We used Quantum Geographical Information System (QGIS) software to reconstruct and quantify its past distribution range and compare with its current one. Snow leopard was found more widely distributed in the past having a distribution range of approximately 10.47 million km(2) against the current 3.20 million km(2). Range contraction of the species approximates 69%. A total of 719 terrestrial protected areas of Asia (out of total 7209) had this species in the past whereas at current, only 311 protected areas support this species. The results emphasize escalating conservation efforts to save its remaining distribution range.	[Mahmood, Tariq; Younas, Ayesha; Akrim, Faraz; Andleeb, Shaista; Hamid, Abdul] Pir Mehr Ali Shah Arid Agr Univ, Dept Wildlife Management, Rawalpindi, Pakistan; [Akrim, Faraz] Univ Kotli, Dept Zool, Kotli, Azad Jammu & Ka, Pakistan; [Nadeem, Muhammad Sajid] Pir Mehr Ali Shah Arid Agr Univ, Dept Zool, Rawalpindi, Pakistan	Arid Agriculture University; Arid Agriculture University	Akrim, F (corresponding author), Pir Mehr Ali Shah Arid Agr Univ, Dept Wildlife Management, Rawalpindi, Pakistan.; Akrim, F (corresponding author), Univ Kotli, Dept Zool, Kotli, Azad Jammu & Ka, Pakistan.	farazakrim@hotmail.com	Akrim, Faraz/C-5032-2013	Akrim, Faraz/0000-0001-9313-0637; Nadeem, Muhammad/0000-0002-2839-6989				Anwar MB, 2014, EUROPEAN J WILDLIFE, V57, P1077; CBD, 2008, PROT AR TOD WORLD TH, P96; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Dewas M, 2012, MAMMAL REV, V42, P144, DOI 10.1111/j.1365-2907.2011.00196.x; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Fox J L, 1994, P 7 INT SNOW LEOP S, P315; Fox JL, 1989, REV STATUS ECOLOGY S, P40; Ghoshal A, 2017, ORYX, V53, P1, DOI [10.1017/S0030605317001107, DOI 10.1017/S0030605317001107]; IUCN U-Wa, 2015, PROT PLAN WORLD DAT; Jackson R, 2008, IUCN RED LIST THREAT, V2008, DOI [DOI 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.EN, 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.en]; Jackson R, 1992, SNOW LEOPARD UNPUB; Jackson RM, 1996, THESIS, P233; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Kachel S, 2014, THESIS, P98; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Li J, 2016, CHALLENGES SNOW LEOP; Licht DS, 2010, BIOSCIENCE, V60, P147, DOI 10.1525/bio.2010.60.2.9; Mallon DP, 2014, SNOW LEOPARD SURVIVA, P135; Manij U, 2010, THESIS, P90; McCarthy T., 2017, PANTHERA UNCIA IUCN; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Riordan P, 2010, SNOW LEOPARD CHINA, P14; Sanderson E., 2006, SETTING PRIORITIES C; Sechrest W.W., 2003, THESIS; Soberon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019359; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Sukumar R., 2003, LIVING ELEPHANTS EVO; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; Taubmann J, 2016, ORYX, V50, P220, DOI 10.1017/S0030605315000502; Theile S, 2003, FADING FOOTPRINTS KI; Thinley P, 2014, ESTIMATING SNOW LEOP, P45; Thinley P., 2016, NATL SNOW LEOPARD SU; Thinley P. Dendup T. Rajaratnam R. Vernes K. Tempa K. Chophel T. & Norbu L., 2015, COUNTING TIGERS BHUT; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108	36	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218460	10.1371/journal.pone.0218460	http://dx.doi.org/10.1371/journal.pone.0218460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369579	Green Published, Green Submitted, gold			2022-12-26	WOS:000484987900010
J	Casali, Y; Heinimann, HR				Casali, Ylenia; Heinimann, Hans R.			A topological characterization of flooding impacts on the Zurich road network	PLOS ONE			English	Article								Infrastructure systems are the structural backbone of cities, facilitating the flow of essential services. Because those systems can be disrupted by natural hazards, risk management has been the prevailing approach for assessing the consequences and expected level of damage. Although this may be a valuable metric, the practice of risk assessment does not represent how hazards affect a network of assets on a larger scale. In contrast, network topology metrics are useful because they evaluate the performance of network infrastructures by looking at the system as a whole. As described here, we began this study to improve our understanding of how flooding events affect the topological properties of road networks, in this case, the urban road infrastructure of Zurich, Switzerland. Using maps of flooding risk, we developed a procedure to extract the damaged networks and analyze the centrality metrics for peak water levels on the surface of the city. Our approach modelled roads as edges and junctions between roads as nodes. The betweenness centrality metric characterizes the importance of nodes or edges for any type of exchange within a network, whereas the closeness centrality metric measures the accessibility of a specific node to all the other nodes. This investigation produced three main findings. First, descriptive analyses showed that the characteristics and patterns of nodes and edges changed under the flooding events. Second, the distribution function of centrality metrics became heavier in the tails as the flood magnitude increased. Third, the associated strain shifted critical nodes to areas in which those nodes would not be important under normal conditions. These findings are essential for identifying crucial locations and devising plans to address risks. Future projects could expand our approach by including traffic flow to move the analysis closer to real-world flows, and by studying the accessibility under emergency conditions at local levels.	[Casali, Ylenia; Heinimann, Hans R.] Swiss Fed Inst Technol, Future Resilient Syst, SEC, Singapore, Singapore; [Casali, Ylenia; Heinimann, Hans R.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Casali, Y (corresponding author), Swiss Fed Inst Technol, Future Resilient Syst, SEC, Singapore, Singapore.; Casali, Y (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland.	ylenia.casali@frs.eth.ch		Casali, Ylenia/0000-0003-1747-5056	Future Resilient Systems research programme at the Singapore-ETH Centre (SEC); National Research Foundation (NRF) Singapore [FI 370074011]; NRF's Campus for Research Excellence and Technological Enterprise (CREATE) programme	Future Resilient Systems research programme at the Singapore-ETH Centre (SEC); National Research Foundation (NRF) Singapore(National Research Foundation, Singapore); NRF's Campus for Research Excellence and Technological Enterprise (CREATE) programme	This work is supported by the Future Resilient Systems research programme at the Singapore-ETH Centre (SEC), which was established collaboratively between ETH Zurich and the National Research Foundation (NRF) Singapore (FI 370074011 to YC), under the auspices of the NRF's Campus for Research Excellence and Technological Enterprise (CREATE) programme, Website: http://www.sec.ethz.ch/research/frs.html.	[Anonymous], OBJ SWISSTLM3D 1 5 2; [Anonymous], 2017, STAT JB STADT ZURICH; [Anonymous], 2017, HOCHW SIHL; Barrat A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/05/P05003; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Barthelemy M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02153; Bavelas A., 1950, J ACOUST SOC AM, V22, P725, DOI [10.1121/1.1906679, DOI 10.1121/1.1906679]; BEAUCHAMP MA, 1965, BEHAV SCI, V10, P161, DOI 10.1002/bs.3830100205; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Crucitti P, 2006, CHAOS, V16, DOI 10.1063/1.2150162; Crucitti P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036125; de Moel H, 2009, NAT HAZARD EARTH SYS, V9, P289, DOI 10.5194/nhess-9-289-2009; Erath A, 2008, NETW SPAT ECON, V9, P379; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Kermanshah A, 2017, NAT HAZARDS, V86, P151, DOI 10.1007/s11069-016-2678-1; Kirkin AF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03217-9; Lammer S, 2006, PHYSICA A, V363, P89, DOI 10.1016/j.physa.2006.01.051; Ma D, 2019, ENVIRON PLAN B-URBAN, V46, P1297, DOI 10.1177/2399808318792268; Marshall M, 2019, THEORY RES EDUC, V17, P165, DOI 10.1177/1477878519862544; Pregnolato M, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160023; Strano E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00296; Wolhuter KM, 2015, GEOMETRIC DESIGN OF ROADS HANDBOOK, P1, DOI 10.1201/b18344	22	9	9	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220338	10.1371/journal.pone.0220338	http://dx.doi.org/10.1371/journal.pone.0220338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365555	gold, Green Submitted, Green Published			2022-12-26	WOS:000484983600040
J	Wolff, D; Frese, C; Schoilew, K; Dalpke, A; Wolff, B; Boutin, S				Wolff, Diana; Frese, Cornelia; Schoilew, Kyrill; Dalpke, Alexander; Wolff, Bjoern; Boutin, Sebastien			Amplicon-based microbiome study highlights the loss of diversity and the establishment of a set of species in patients with dentin caries	PLOS ONE			English	Article							REAL-TIME PCR; MOLECULAR ANALYSIS; BACTERIAL PROFILES; SODIUM-FLUORIDE; ORAL MICROFLORA; HEALTH; ADULTS	Objectives To elicit patterns in pathogenic biofilm composition we characterized the oral microbiome present in patients with dentin caries in comparison to healthy subjects. Methods 16S amplicon sequencing was used to analyse a total of 56 patients; 19 samples of carious dentin (pooled from at least three teeth) and 37 supragingival samples (pooled from three healthy tooth surfaces). Oral and periodontal status and socio-demographic parameters were recorded. Group assignment, smoking and further socio-demographic parameters were used as explanatory variables in the microbiome composition analysis. Results Overall, a total of 4,110,020 DNA high-quality sequences were yielded. Using a threshold of similarity >97% for assigning operational taxonomic units (OTU), a total of 1,537 OTUs were identified. PERMANOVA showed significant differences in microbiome composition between the groups caries/healthy (p = 0.001), smoking/non-smoking (p = 0.007) and fluoride intake during childhood yes/no (tablets p = 0.003, salt p = 0.023). The healthy microbiome had a significantly higher diversity (alpha diversity, p < 0.001) and a lower dominance (Berger-Parker index, p< 0.001). It was dominated by Fusobacteria. A linear discriminant analysis effect size (LEfSe) yielded a set of 39 OTUs being more abundant in carious dentin samples, including Atopobium spp. (14.9 log2FoldChange), Lactobacillus casei (11.6), Acinetobacter spp. (10.8), Lactobacillus gasseri (10.6), Parascardovia denticolens (10.5), Olsenella profusa (10.4), and others. Also Propionibacterium acidifaciens (7.2) and Streptococcus mutans (5.2) were overabundant in caries lesions. Conclusions The healthy microbiome was highly diverse. The advanced caries microbiome was dominated by a set of carious associated bacteria where S. mutans played only a minor role. Smoking and fluoride intake during childhood influenced the microbiome composition significantly. Clinical significance The presented investigation adds knowledge to the still not fully comprehended patterns of oral microbiomes in caries compared with oral health. By analysing the genetics of biofilm samples from oral health and severe tooth decay we found distinct discriminating species which could be targets for future therapeutic approaches.	[Wolff, Diana] Univ Tubingen, Ctr Dent Oral Med & Maxillofacial Surg, Dept Conservat Dent, Tubingen, Germany; [Frese, Cornelia; Schoilew, Kyrill; Wolff, Bjoern] Heidelberg Univ, Sch Dent Med, Dept Conservat Dent, Heidelberg, Germany; [Dalpke, Alexander] Tech Univ Dresden, Med Microbiol & Hyg, Dresden, Germany; [Boutin, Sebastien] Univ Hosp Heidelberg, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Ruprecht Karls University Heidelberg	Wolff, D (corresponding author), Univ Tubingen, Ctr Dent Oral Med & Maxillofacial Surg, Dept Conservat Dent, Tubingen, Germany.	diana.wolff@med.uni-tuebingen.de	Wolff, Diana/L-2329-2013; Wolff, Diana/AAA-7730-2019; Boutin, Sébastien/AAX-5334-2021; Wolff, Diana/AAB-3241-2020	Wolff, Diana/0000-0003-3353-9355; Boutin, Sébastien/0000-0002-0499-2460; 				Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Al-Hebshi NN, 2019, J ORAL MICROBIOL, V11, DOI 10.1080/20002297.2018.1557986; Anderson AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32544-6; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x; Belstrom D, 2014, CARIES RES, V48, P368, DOI 10.1159/000357502; Benn AML, 2018, AUST DENT J, V63, P14, DOI 10.1111/adj.12565; Burne R A, 2018, Adv Dent Res, V29, P66, DOI 10.1177/0022034517735293; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Eriksson L, 2018, J DENT RES, V97, P275, DOI 10.1177/0022034517731758; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Hurley E, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-018-0693-1; Jiang Q, 2019, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00442; Johansson I, 2016, J DENT RES, V95, P80, DOI 10.1177/0022034515609554; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Koopman JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137318; Langfeldt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087449; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Martin FE, 2002, J CLIN MICROBIOL, V40, P1698, DOI 10.1128/JCM.40.5.1698-1704.2002; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Obata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103712; Philip N, 2018, BRIT DENT J, V224, DOI 10.1038/sj.bdj.2018.81; R Development Core Team, 2014, R LANG ENV STAT COMP; Reilly C, 2016, ORAL DIS, V22, P155, DOI 10.1111/odi.12407; Reilly C, 2014, J APPL MICROBIOL, V117, P1798, DOI 10.1111/jam.12655; Richards VP, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00106-17, 10.1128/iai.00106-17]; Rosier BT, 2018, J DENT RES, V97, P371, DOI 10.1177/0022034517742139; Rupf S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32361-x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siqueira JF, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.21077; Tanzer J M, 2001, J Dent Educ, V65, P1028; Thurnheer T, 2018, ARCH ORAL BIOL, V89, P77, DOI 10.1016/j.archoralbio.2018.02.010; Utter DR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00564; Wolff D, 2013, CARIES RES, V47, P69, DOI 10.1159/000344022; Xiao CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01145; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zheng JX, 2019, J ENDODONT, V45, P302, DOI 10.1016/j.joen.2018.11.017; Zhou JY, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02412-16	42	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219714	10.1371/journal.pone.0219714	http://dx.doi.org/10.1371/journal.pone.0219714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365560	Green Submitted, gold, Green Published			2022-12-26	WOS:000484983600016
J	Tanue, EA; Nsagha, DS; Njamen, TN; Assob, NJC				Tanue, Elvis Asangbeng; Nsagha, Dickson Shey; Njamen, Theophile Nana; Assob, Nguedia Jules Clement			Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon	PLOS ONE			English	Article							CO-INFECTED PATIENTS; COLLABORATIVE ACTIVITIES; CONTROL PROGRAM; REGION; TB	Background Tuberculosis (TB) and HIV co-infection challenges treatment and worsens the outcome of TB treatment. This study aimed to assess the outcome of TB treatment and factors facilitating treatment success among people living with HIV/AIDS in Fako Division of the South West Region of Cameroon. Methods A hospital-based retrospective cohort study was conducted by manually reviewing medical records of HIV/TB co-infected patients from January 2010 to September 2017. A structured data collection form was used to review the medical records of HIV patients co-infected with TB aged 10 years and older. Patients with incomplete files were dropped from the study. Treatment success was defined as the sum of patients who were declared cured and those who had completed treatment, as per the World Health Organization's recommendations. Data were analyzed using Statistical Package for Social Sciences version 21. Bivariate and multivariate logistic regression model was carried out to identify factors facilitating successful TB treatment outcome. Significance was obtained through adjusted odds ratio with its 95% confidence interval and a p< 0.05. Results A total of 2,986 files were reviewed but 2,928 (98.1%) were retained. Out of the 2,928 medical files of adult TB patients reviewed, 1,041 (35.6%, [95% CI 33.8%-37.3%]) were HIV/TB co-infected. The 1,041 co-infected patients had a mean age of 37.07 (SD of 10.02) years and 56.3% were females. The treatment outcome of TB patients were 795(76.4%) cured, 23 (2.2%) treatment completed, 99(9.5%) were lost to follow-up, 16 (1.5%) failed, 72(6.9%) died and 36(3.5%) transferred out. A successful treatment outcome was achieved in 818 (78.6%,[95% CI: 76.0%-81.0%]) patients. Being a female [COR 1.61, 95% CI: 1.19-2.17, p = 0.002], receiving TB treatment in 2014 [COR 2.00, 95% CI: 1.11-3.60, p = 0.021] and 2015 [COR 2.50, 95% CI: 1.39-4.50, p = 0.002], having relapsed TB infection [COR 0.46, 95% CI: 0.23-0.93, p = 0.031], receiving ART [COR 1.95, 95% CI: 1.28-2.97, p = 0.002] and Cotrimoxazole [COR 2.03, 95% CI: 1.12-3.66, p = 0.019] were factors significantly associated with successful treatment. After adjusting for confounders, successful treatment outcome were associated with being a female [AOR 1.6; 95% CI: 1.21-2.22, p = 0.001], diagnosis of TB in 2014 [AOR 1.90; 95% CI: 1.04-3.45, p = 0.036] and 2015 [AOR 2.43; 95% CI: 1.33-4.43, p = 0.004]. Conclusion There is a high TB treatment success rate among HIV/TB co-infected patients in our setting, although below the target set by the WHO. Specific interventions aimed at enhancing patient outcomes are recommended.	[Tanue, Elvis Asangbeng; Nsagha, Dickson Shey] Univ Buea, Fac Hlth Sci, Dept Publ Hlth & Hyg, Buea, Cameroon; [Njamen, Theophile Nana] Univ Buea, Fac Hlth Sci, Dept Obstet & Gynecol, Buea, Cameroon; [Assob, Nguedia Jules Clement] Univ Buea, Fac Hlth Sci, Dept Med Lab Sci, Buea, Cameroon		Nsagha, DS (corresponding author), Univ Buea, Fac Hlth Sci, Dept Publ Hlth & Hyg, Buea, Cameroon.	nsaghads@hotmail.com		Assob, Jules Clement Nguedia/0000-0001-9793-1298				Agbor AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115211; Ambadekar NN, 2015, PUBLIC HEALTH, V129, P783, DOI 10.1016/j.puhe.2015.03.006; [Anonymous], 2015, HARRISONS PRINCIPLES; Ansa GA, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-13; Atekem KA, 2018, INT J MYCOBACT, V7, P137, DOI 10.4103/ijmy.ijmy_20_18; Balcha TT, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27048; Belayneh M, 2015, BRAZ J INFECT DIS, V19, P47, DOI 10.1016/j.bjid.2014.09.002; Biruk Yimam B, 2016, ADV PUBLIC HLTH; do Prado TN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-415; Fiseha T., 2015, J BIOENG BIOMED SCI, P1; Giri PA, 2013, N AM J MED SCI, V5, P37, DOI [10.4103/1947-2714.114169, 10.4103/1947-2714.106193, 10.4103/1947-2714.107537]; Huyen TTT, 2016, PUBLIC HEALTH ACTION, V6, P8, DOI 10.5588/pha.16.0011; Ismail I, 2013, PREV MED, V57, pS27, DOI 10.1016/j.ypmed.2012.12.023; Jacobson KB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127024; Kapata N, 2012, TROP MED INT HEALTH, V17, P760, DOI 10.1111/j.1365-3156.2012.02981.x; Kefale AT, 2017, INT J GEN MED, V10, P161, DOI 10.2147/IJGM.S135305; Luetkemeyer A., HIV SITE KNOWLEDGE B; Mekonnen Daniel, 2015, BMC Res Notes, V8, P666, DOI 10.1186/s13104-015-1664-0; Mitku AA, 2016, AFR HEALTH SCI, V16, P588, DOI 10.4314/ahs.v16i2.29; Ofoegbu OS, 2015, S AFR FAM PRACT, V57, P50, DOI 10.1080/20786190.2014.995913; Shastri S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-838; Tripathi S. B., 2015, National Journal of Community Medicine, V6, P462; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2018, GLOB TUB REP 2018	24	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0218800	10.1371/journal.pone.0218800	http://dx.doi.org/10.1371/journal.pone.0218800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361755	Green Published, Green Submitted, gold			2022-12-26	WOS:000484981300008
J	Imrie, L; Le Bihan, T; O'Toole, A; Hickner, PV; Dunn, WA; Weise, B; Rund, SSC				Imrie, Lisa; Le Bihan, Thierry; O'Toole, Aine; Hickner, Paul V.; Dunn, W. Augustine; Weise, Benjamin; Rund, Samuel S. C.			Genome annotation improvements from cross-phyla proteogenomics and time-of-day differences in malaria mosquito proteins using untargeted quantitative proteomics	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; STEPHENSI; TRANSCRIPTOME; RHYTHMS	The malaria mosquito, Anopheles stephensi, and other mosquitoes modulate their biology to match the time-of-day. In the present work, we used a non-hypothesis driven approach (untargeted proteomics) to identify proteins in mosquito tissue, and then quantified the relative abundance of the identified proteins from An. stephensi bodies. Using these quantified protein levels, we then analyzed the data for proteins that were only detectable at certain times-of-the day, highlighting the need to consider time-of-day in experimental design. Further, we extended our time-of-day analysis to look for proteins which cycle in a rhythmic 24-hour ("circadian") manner, identifying 31 rhythmic proteins. Finally, to maximize the utility of our data, we performed a proteogenomic analysis to improve the genome annotation of An. stephensi. We compare peptides that were detected using mass spectrometry but are 'missing' from the An. stephensi predicted proteome, to reference proteomes from 38 other primarily human disease vector species. We found 239 such peptide matches and reveal that genome annotation can be improved using proteogenomic analysis from taxonomically diverse reference proteomes. Examination of 'missing' peptides revealed reading frame errors, errors in gene-calling, overlapping gene models, and suspected gaps in the genome assembly.	[Imrie, Lisa; Le Bihan, Thierry] Univ Edinburgh, Sch Biol Sci, SynthSys Synthet & Syst Biol, Edinburgh, Midlothian, Scotland; [Le Bihan, Thierry; Weise, Benjamin; Rund, Samuel S. C.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Le Bihan, Thierry] Rapid Novor, Kitchener, ON, Canada; [O'Toole, Aine] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Hickner, Paul V.; Rund, Samuel S. C.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Dunn, W. Augustine] Boston Childrens Hosp, Boston, MA USA	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Notre Dame; Harvard University; Boston Children's Hospital	Rund, SSC (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland.; Rund, SSC (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	srund@nd.edu	Rund, Samuel SC/AAH-5724-2019; Le Bihan, Thierry/AAN-2534-2020	Rund, Samuel SC/0000-0002-1701-7787; Imrie, Lisa/0000-0003-1115-1720; Le Bihan, Thierry/0000-0003-0498-8063	Royal Society Newton International Fellowship [NF140517]; Wellcome Trust [095831, 202769/Z/16/Z, 095831/Z/11/Z]	Royal Society Newton International Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission)	Samuel S. C. Rund was funded by a Royal Society Newton International Fellowship (NF140517) and a strategic award from the Wellcome Trust (No. 095831) for the Centre for Immunity, Infection and Evolution. Aine O'Toole was funded by the Wellcome Trust (202769/Z/16/Z; PhD programme in Hosts, Pathogens and Global 348 422 Health). The LC-MS QExactive equipment was purchased by a Wellcome Trust Institutional Strategic Support Fund and a strategic award from the Wellcome Trust for the Centre for Immunity, Infection and Evolution (095831/Z/11/Z). Rapid Novor provided support in the form of a salary for author TLB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining funders also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Balmert NJ, 2014, J INSECT PHYSIOL, V64, P30, DOI 10.1016/j.jinsphys.2014.02.013; Champion MM, 2016, ENTOMOL FOCUS, V4, P37, DOI 10.1007/978-3-319-24244-6_2; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Souza GA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002527; Dinglasan RR, 2009, INSECT BIOCHEM MOLEC, V39, P125, DOI 10.1016/j.ibmb.2008.10.010; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Fontaine A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-614; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Guillaume E, 2009, J PROTEOMICS, V72, P771, DOI 10.1016/j.jprot.2009.03.004; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Jiang XF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0459-2; Kalume DE, 2005, PROTEOMICS, V5, P3765, DOI 10.1002/pmic.200401210; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Kriventseva EV, 2008, NUCLEIC ACIDS RES, V36, pD271, DOI 10.1093/nar/gkm845; Kumar A, 2009, EUKARYOT CELL, V8, P1321, DOI 10.1128/EC.00143-09; Kurz S, 2015, J PROTEOMICS, V126, P172, DOI 10.1016/j.jprot.2015.05.030; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Le Bihan T, 2011, J PROTEOMICS, V74, P2060, DOI 10.1016/j.jprot.2011.05.028; Leming MT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1128; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Mideo N, 2013, TRENDS PARASITOL, V29, P10, DOI 10.1016/j.pt.2012.10.006; Millet C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9664; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Pike A, 2014, INSECT BIOCHEM MOLEC, V52, P82, DOI 10.1016/j.ibmb.2014.06.005; Prasad TSK, 2017, GENOME RES, V27, P133, DOI 10.1101/gr.201368.115; Reece SE, 2017, J BIOL RHYTHM, V32, P516, DOI 10.1177/0748730417718904; ROWLAND M, 1989, PHYSIOL ENTOMOL, V14, P77, DOI 10.1111/j.1365-3032.1989.tb00939.x; Ruggles KV, 2016, MOL CELL PROTEOMICS, V15, P1060, DOI 10.1074/mcp.M115.056226; Rund SSC, 2016, INSECTS, V7, DOI 10.3390/insects7020014; Rund SSC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02494; Rund SSC, 2011, P NATL ACAD SCI USA, V108, pE421, DOI 10.1073/pnas.1100584108; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sikulu MT, 2015, J PROTEOMICS, V126, P234, DOI 10.1016/j.jprot.2015.06.008; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405	44	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220225	10.1371/journal.pone.0220225	http://dx.doi.org/10.1371/journal.pone.0220225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356616	Green Published, gold, Green Submitted			2022-12-26	WOS:000484047000021
J	Dhital, R; Silwal, RC; Simkhada, P; van Teijlingen, E; Jimba, M				Dhital, Rolina; Silwal, Ram Chandra; Simkhada, Padam; van Teijlingen, Edwin; Jimba, Masamine			Assessing knowledge and behavioural changes on maternal and newborn health among mothers following post-earthquake health promotion in Nepal	PLOS ONE			English	Article								Introduction Disasters can disrupt the existing health system affecting the whole population, but especially vulnerable people such as pregnant women, new mothers and their babies. Despite the global progress in maternal, newborn and child health (MNCH) programmes over the years, emergency responses after a disaster are often poor. Post-disaster health promotion could play an important role in improving MNCH outcomes. However, evidence remains limited on the effect of post disaster health promotion activities in low-income countries such as Nepal. Methods This is an uncontrolled before and after study conducted in Dhading district which was severely affected by the 2015 earthquake in Nepal. The study participants were mothers who had a child in the previous 12 months. The intervention was implemented between 2016 and 2018 and included community-engagement health promotion activities where the local stakeholders and resources were mobilized. The outcome variables included: knowledge of danger signs of pregnancy, childbirth and in newborns; and behaviours including ever attending antenatal care (ANC), a minimum of four ANC sessions and having an institutional delivery. Data were analysed using chi-squared tests, independent sample t-tests and multiple logistic regression models. Results In total 364 mothers were recruited in the pre-intervention group and 377 in the post-intervention group. The post-intervention group was more likely to have knowledge of at least three danger signs in pregnancy (AOR [Adjusted Odds Ratio] = 2.96, P<0.001), at least three danger signs in childbirth (AOR = 3.8, P<0.001), and at least five danger signs in newborns (AOR = 1.56, P<0.001) compared to the pre-intervention group. The mothers in the post-intervention group were also more likely to ever attend ANC (AOR = 7.18, P<0.001), attend a minimum of four ANC sessions (AOR = 5.09, P<0.001), and have institutional deliveries (AOR = 2.56, P<0.001). Religious minority groups were less likely to have knowledge of all danger signs compared to the majority Hindu group. Mothers from poorer households were also less likely to attend four ANC sessions. Mothers with higher education were more likely to have knowledge of all the danger signs. Mothers whose husbands had achieved higher education were also more likely to have knowledge of danger signs and have institutional deliveries. Conclusion Health promotion intervention helped the disaster-affected mothers in improving the knowledge and behaviours related to MNCH. However, the vulnerable population would need more support to gain benefit from such intervention.	[Dhital, Rolina; Silwal, Ram Chandra; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo, Japan; [Silwal, Ram Chandra] CPC, GPO, Green Tara Nepal, Kathmandu, Nepal; [Simkhada, Padam] Publ Hlth Inst, Fac Educ Hlth & Commun, Mt Pleasant, England; [van Teijlingen, Edwin] Bournemouth Univ, Fac Hlth & Social Sci, Bournemouth, Dorset, England	University of Tokyo; Bournemouth University	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo, Japan.	mjimba@m.u-tokyo.ac.jp	Jimba, Masamine/AAF-5630-2020; dhital, rolina/AGW-9575-2022; van Teijlingen, Edwin R/A-3727-2010	van Teijlingen, Edwin R/0000-0001-5523-8583	Green Tara Trust; Liverpool John Moores University; Karuna Trust; Karuna Germany; University of Tokyo	Green Tara Trust; Liverpool John Moores University; Karuna Trust; Karuna Germany; University of Tokyo	This study is part of a post disaster health promotion project in Nepal supported by The Green Tara Trust, Liverpool John Moores University, Karuna Trust, Karuna Germany and the University of Tokyo. The funding sources had no role in the study design, implementation of the intervention, data collection and analysis and interpretation of data; in the writing of the report or in the decision to submit the article for publication.; The authors would like to thank to the Green Tara Trust, Liverpool John Moores University, Karuna Trust, Karuna Germany and the University of Tokyo for funding this project. Our special thank goes to Collette Fanning (Padmadharini), Susanne Traud-Dubois (Amoghamati) and Salita Gurung for their significant contribution. We would like to extend our thanks to the Health Promoters of Green Tara Nepal, health post staff and the Female Community Health Volunteers. We are also grateful to all mothers in the rural communities and the research assistants for their kind support in this study.	Amenu G, 2016, SCI CAIRO, V2016; Ampt F, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0561-9; Brunson J, 2017, MATERN CHILD HLTH J, V21, P2267, DOI 10.1007/s10995-017-2350-8; Calvello EJ, 2015, B WORLD HEALTH ORGAN, V93, P417, DOI 10.2471/BLT.14.146571; CARE, 2016, SEX REPR HLTH EM; Central Bureau of Statistics Government of Nepal, 2012, NAT POP HOUS CENS 20; CHOINIERE R, 2000, CMAJ, V162, pS1; Davis J, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0184-2; Department of Health Services MOHP, 2013, COMM BAS NEWB CAR PR; Eccles M, 2003, QUAL SAF HEALTH CARE, V12, P47, DOI 10.1136/qhc.12.1.47; Family Health Division National Health Training Centre and National Health Education Information and Communication Centre, 2009, BIRTH PREP PACK REF; Foster AM, 2017, REPROD HEALTH MATTER, V25, P18, DOI 10.1080/09688080.2017.1403277; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Gerdin M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001632; Goel V, 1998, Cancer Prev Control, V2, P211; Government of Nepal, 2015, NEP EARTHQ 2015 POST; Green Tara Nepal, 2018, FIN REP POSTD HLTH P; Hahn RA, 2015, INT J HEALTH SERV, V45, P657, DOI 10.1177/0020731415585986; Heymann D., 2002, OXFORD TXB PUBLIC HL, V1, P171; Jackson SF, 2017, HEALTH PROMOT INT, V32, P1057, DOI 10.1093/heapro/daw029; McPherson RA, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-31; Mehata S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5079234; Ministry of Health New ERA and ICF, 2017, NEP DEM HLTH SURV 20; Ministry of Health-Nepal New Era ICF, 2012, NEP DEM HLTH SURV 20; Mwilike B, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-017-1628-6; Nepal Family Health Program, 2007, BAS SURV COMM BAS MA; O'Donovan J, ONGOING TRAINING COM; Padela AI, 2013, J RELIG HEALTH, V52, P1333, DOI 10.1007/s10943-012-9620-y; Salem A, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1664-x; UNFPA, 2015, NEP EARTHQ WOM GIRLS; UNIDSR, 2017, CONS MARG MIN GROUPS; United Nations, 2010, MIN RIGHTS INT STAND; Vaughan K, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0070-y; Wang H, 2005, ENCY STAT SCI, P1; WHO UNICEF, 2018, PROGR REP REACH EV N; Woldie M, COMMUNITY HLTH VOLUN; World Health Organization, HLTH PROMOTION; Yargawa J, 2015, J EPIDEMIOL COMMUN H, V69, P604, DOI 10.1136/jech-2014-204784; Zeid S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4346	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220191	10.1371/journal.pone.0220191	http://dx.doi.org/10.1371/journal.pone.0220191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344147	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000484977900064
J	Donker, T; Smieszek, T; Henderson, KL; Walker, TM; Hope, R; Johnson, AP; Woodford, N; Crook, DW; Peto, TEA; Walker, AS; Robotham, JV				Donker, Tjibbe; Smieszek, Timo; Henderson, Katherine L.; Walker, Timothy M.; Hope, Russell; Johnson, Alan P.; Woodford, Neil; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah; Robotham, Julie V.			Using hospital network-based surveillance for antimicrobial resistance as a more robust alternative to self-reporting	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS MRSA; SPREAD	Hospital performance is often measured using self-reported statistics, such as the incidence of hospital-transmitted micro-organisms or those exhibiting antimicrobial resistance (AMR), encouraging hospitals with high levels to improve their performance. However, hospitals that increase screening efforts will appear to have a higher incidence and perform poorly, undermining comparison between hospitals and disincentivising testing, thus hampering infection control. We propose a surveillance system in which hospitals test patients previously discharged from other hospitals and report observed cases. Using English National Health Service (NHS) Hospital Episode Statistics data, we analysed patient movements across England and assessed the number of hospitals required to participate in such a reporting scheme to deliver robust estimates of incidence. With over 1.2 million admissions to English hospitals previously discharged from other hospitals annually, even when only a fraction of hospitals (41/155) participate (each screening at least 1000 of these admissions), the proposed surveillance system can estimate incidence across all hospitals. By reporting on other hospitals, the reporting of incidence is separated from the task of improving own performance. Therefore the incentives for increasing performance can be aligned to increase (rather than decrease) screening efforts, thus delivering both more comparable figures on the AMR problems across hospitals and improving infection control efforts.	[Donker, Tjibbe; Johnson, Alan P.; Woodford, Neil; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah; Robotham, Julie V.] Univ Oxford, Hlth Protect Res Unit Healthcare Associated Infec, NIHR, Oxford, England; [Donker, Tjibbe; Walker, Timothy M.; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah] Univ Oxford, Nuffield Dept Med, Oxford, England; [Donker, Tjibbe; Smieszek, Timo; Henderson, Katherine L.; Hope, Russell; Johnson, Alan P.; Woodford, Neil; Crook, Derrick W.; Robotham, Julie V.] Publ Hlth England, Natl Infect Serv, London, England; [Smieszek, Timo] Imperial Coll London, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England; [Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah] NIHR Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford; Public Health England; Imperial College London; University of Oxford	Donker, T (corresponding author), Univ Oxford, Hlth Protect Res Unit Healthcare Associated Infec, NIHR, Oxford, England.; Donker, T (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Donker, T (corresponding author), Publ Hlth England, Natl Infect Serv, London, England.	tjibbe.donker@ndm.ox.ac.uk	Walker, Timothy/AAD-5991-2019; Hope, Russell/CAF-3297-2022; Walker, Sarah/HDM-8717-2022	Hope, Russell/0000-0003-2838-6833; Henderson, Katherine/0000-0003-2918-3341; Robotham, Julie/0000-0003-2515-4084; Crook, Derrick/0000-0002-0590-2850; Walker, Timothy/0000-0003-0421-9264	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford; NIHR Oxford Biomedical Research Centre; PHE [HPRU-2012-10041]	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); PHE	The research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with PHE [grant number HPRU-2012-10041]. ASW, TEAP and DWC are supported by the NIHR Oxford Biomedical Research Centre. TEAP and DWC are NIHR Senior Investigators. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calfee DP, 2003, INFECT CONT HOSP EP, V24, P422, DOI 10.1086/502225; Ciccolini M, 2014, J ANTIMICROB CHEMOTH, P1, DOI [10.1093/JAC/DKT329, DOI 10.1093/JAC/DKT329]; Donker T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035002; Donker T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000715; Fernandez-Gracia J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02245-7; Freeman Tim, 2002, Health Serv Manage Res, V15, P126, DOI 10.1258/0951484021912897; Health Quality Ontario, 2013, QUAL IMPR PRIM QUAL, P1; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Huang S, 2010, INFECT CONT HOSP EP, V31, P1160, DOI 10.1086/656747; Iwashyna TJ, 2009, MED CARE, V47, P787, DOI 10.1097/MLR.0b013e318197b1f5; Johnson AP, 2012, J ANTIMICROB CHEMOTH, V67, P802, DOI 10.1093/jac/dkr561; Karkada UH, 2011, INTENS CARE MED, V37, P1633, DOI 10.1007/s00134-011-2341-y; Lee BY, 2011, AM J PUBLIC HEALTH, V101, P707, DOI 10.2105/AJPH.2010.202754; Maynard A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c88; Nekkab N, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005666; Ray MJ, 2016, SPREAD CARBAPENEM RE, P1; Shrestha M, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0155-7; Simmering JE, 2015, INFECT CONT HOSP EP, P1, DOI [10.1017/ICE.2015.308, DOI 10.1017/ICE.2015.308]; Stadtfeld C, 2016, SOC NETWORKS, V44, P363, DOI 10.1016/j.socnet.2015.04.010; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219994	10.1371/journal.pone.0219994	http://dx.doi.org/10.1371/journal.pone.0219994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344075	Green Submitted, gold, Green Published			2022-12-26	WOS:000484977900046
J	Noar, RD; Thomas, E; Xie, DY; Carter, ME; Ma, DM; Daub, ME				Noar, Roslyn D.; Thomas, Elizabeth; Xie, De-Yu; Carter, Morgan E.; Ma, Dongming; Daub, Margaret E.			A polyketide synthase gene cluster associated with the sexual reproductive cycle of the banana pathogen, Pseudocercospora fijiensis	PLOS ONE			English	Article							LEAF STREAK DISEASE; BLACK SIGATOKA-DISEASE; MYCOSPHAERELLA-FIJIENSIS; FATTY-ACID; CAUSAL AGENT; SECONDARY METABOLISM; ASCOCHYTA-RABIEI; BIOSYNTHESIS; PLANT; GENOME	Disease spread of Pseudocercospora fijiensis, causal agent of the black Sigatoka disease of banana, depends on ascospores produced through the sexual reproductive cycle. We used phylogenetic analysis to identify P. fijiensis homologs (PKS8-4 and Hybrid8-3) to the PKS4 polyketide synthases (PKS) from Neurospora crassa and Sordaria macrospora involved in sexual reproduction. These sequences also formed a clade with lovastatin, compactin, and betaenone-producing PKS sequences. Transcriptome analysis showed that both the P. fijiensis Hybrid8-3 and PKS8-4 genes have higher expression in infected leaf tissue compared to in culture. Domain analysis showed that PKS8-4 is more similar than Hybrid8-3 to PKS4. pPKS8-4:GFP transcriptional fusion transformants showed expression of GFP in flask-shaped structures in mycelial cultures as well as in crosses between compatible and incompatible mating types. Confocal microscopy confirmed expression in spermagonia in leaf substomatal cavities, consistent with a role in sexual reproduction. A disruption mutant of pks8-4 retained normal pathogenicity on banana, and no differences were observed in growth, conidial production, and spermagonia production. GC-MS profiling of the mutant and wild type did not identify differences in polyketide metabolites, but did identify changes in saturated fatty acid methyl esters and alkene and alkane derivatives. To our knowledge, this is the first report of a polyketide synthase pathway associated with spermagonia.	[Noar, Roslyn D.] North Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Thomas, Elizabeth; Xie, De-Yu; Carter, Morgan E.; Ma, Dongming; Daub, Margaret E.] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Noar, Roslyn D.] North Carolina State Univ, NSF Ctr Integrated Pest Management, Raleigh, NC 27695 USA; [Carter, Morgan E.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Sch Integrat Plant Sci, Ithaca, NY USA; [Ma, Dongming] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Science Foundation (NSF); University of North Carolina; North Carolina State University; Cornell University; Guangzhou University of Chinese Medicine	Daub, ME (corresponding author), North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	margaret_daub@ncsu.edu		Carter, Morgan/0000-0001-5639-2013; XIE, DE-YU/0000-0002-3054-1188	NC State College of Agriculture and Life Sciences; National Science Foundation; National Institutes of Health	NC State College of Agriculture and Life Sciences; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a gift from Dole Food Company to MED, by funds from the NC State College of Agriculture and Life Sciences to MED, and by graduate fellowships from the National Science Foundation and National Institutes of Health to RDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakonya AE, 2018, PLANT PATHOL, V67, P759, DOI 10.1111/ppa.12824; Isaza REA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005876; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; BENNETT RS, 2003, PLANT HLTH INSTRUCTO, DOI DOI 10.1094/PHI-I-2003-0905-01; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brauers G, 2000, J NAT PROD, V63, P739, DOI 10.1021/np9905259; BROBST SW, 1994, CAN J CHEM, V72, P200, DOI 10.1139/v94-031; BROWN DW, 1994, APPL ENVIRON MICROB, V60, P979, DOI 10.1128/AEM.60.3.979-983.1994; Campbell CD, 2010, BIOPOLYMERS, V93, P755, DOI 10.1002/bip.21428; Carreras CW, 1997, TOP CURR CHEM, V188, P85; Chang TC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005904; Chen YP, 2008, J AGR FOOD CHEM, V56, P5639, DOI 10.1021/jf800595k; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Conde-Ferraez L, 2007, MOL PLANT PATHOL, V8, P111, DOI [10.1111/j.1364-3703.2006.00376.x, 10.1111/J.1364-3703.2006.00376.X]; Cox RJ, 2018, MYCOTA COMPREHENSIVE, V15; Crawford JM, 2008, BIOORG CHEM, V36, P16, DOI 10.1016/j.bioorg.2007.11.002; Crawford JM, 2010, NAT REV MICROBIOL, V8, P879, DOI 10.1038/nrmicro2465; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Daub ME, 2013, ANTIOXID REDOX SIGN, V19, P970, DOI 10.1089/ars.2012.5080; Daub ME., 2009, MYCOTA, P201, DOI DOI 10.1007/978-3-540-87407-2_11; Droc G, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat035; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; El-Mongy M. A., 2012, Canadian Journal of Pure & Applied Sciences, V6, P1937; Etebu E, 2003, PHYTOPARASITICA, V31, P69, DOI 10.1007/BF02979768; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Goodwin S.B., 2014, GENOMICS PLANT ASS F, P123; Graziani S, 2004, APPL ENVIRON MICROB, V70, P2984, DOI 10.1128/AEM.70.5.2984-2988.2004; Hoss R, 2000, J PHYTOPATHOL, V148, P387, DOI 10.1046/j.1439-0434.2000.00530.x; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; KAUR S, 1995, PLANT SCI, V109, P23, DOI 10.1016/0168-9452(95)04144-J; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim W, 2015, MOL PLANT MICROBE IN, V28, P482, DOI 10.1094/MPMI-08-14-0234-R; Koch A, 2013, P NATL ACAD SCI USA, V110, P19324, DOI 10.1073/pnas.1306373110; Kodama R, 1999, GENETICS, V151, P585; LONG PG, 1979, T BRIT MYCOL SOC, V72, P299, DOI 10.1016/S0007-1536(79)80046-7; Ma D-M, 2012, AM J PLANT SCI, V3, P1759, DOI DOI 10.4236/AJPS.2012.312215; Ma DM, 2015, MOL PLANT, V8, P1580, DOI 10.1016/j.molp.2015.07.004; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McLoughlin AG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25434-4; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Mendoza-Rodriguez MF, 2018, TROP PLANT PATHOL, V43, P1, DOI 10.1007/s40858-017-0188-7; MEREDITH DS, 1969, T BRIT MYCOL SOC, V52, P459, DOI 10.1016/S0007-1536(69)80130-0; MEREDITH DS, 1973, T BRIT MYCOL SOC, V60, P547, DOI 10.1016/S0007-1536(73)80038-5; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Mizushina Y, 2002, J BIOL CHEM, V277, P630, DOI 10.1074/jbc.M105144200; Noar RD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212229; Noar RD, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3031-5; Noar RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158471; Nowrousian M, 2009, CURR GENET, V55, P185, DOI 10.1007/s00294-009-0236-z; OHAGAN D, 1995, NAT PROD REP, V12, P1, DOI 10.1039/np9951200001; Onyilo F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00291; Onyilo F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00830; Peraza-Echeverria L, 2008, AUSTRALAS PLANT PATH, V37, P460, DOI 10.1071/AP08042; Rodriguez HA, 2016, PLANT DIS, V100, P1170, DOI 10.1094/PDIS-08-15-0950-RE; SAKAI R, 1985, Annals of the Phytopathological Society of Japan, V51, P219, DOI 10.3186/jjphytopath.51.219; Timm ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160083; Sanchez-Rangel D, 2010, TOXIN REV, V29, P73, DOI 10.3109/15569543.2010.515370; Schindler D, 2014, FUNGAL GENET BIOL, V68, P48, DOI 10.1016/j.fgb.2014.04.008; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shi MZ, 2011, PLANTA, V233, P787, DOI 10.1007/s00425-010-1335-2; Song ZS, 2004, CHEMBIOCHEM, V5, P1196, DOI 10.1002/cbic.200400138; Stergiopoulos I, 2014, MOL PLANT PATHOL, V15, P447, DOI 10.1111/mpp.12104; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Stergiopoulos I, 2012, MOL BIOL EVOL, V29, P3371, DOI 10.1093/molbev/mss143; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; STIERLE AA, 1991, EXPERIENTIA, V47, P853, DOI 10.1007/BF01922472; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Sweigard JA, 1997, FUNGAL GENETNEWSLETT, V44; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; TOKOUSBALIDES MC, 1979, PESTIC BIOCHEM PHYS, V11, P64, DOI 10.1016/0048-3575(79)90048-8; Ugai T, 2015, CHEM COMMUN, V51, P1878, DOI 10.1039/c4cc09512j; UPADHYAY RK, 1990, EXPERIENTIA, V46, P982, DOI 10.1007/BF01939396; Utermark J., 2008, NAT PROTOC ONLINE, DOI [10.1038/nprot.2008.83, DOI 10.1038/NPROT.2008.83]; Walsh TA, 2016, NAT BIOTECHNOL, V34, P881, DOI 10.1038/nbt.3585; WANG YL, 1994, APPL ENVIRON MICROB, V60, P3864, DOI 10.1128/AEM.60.10.3864-3866.1994; Watanabe CMH, 2002, CHEM BIOL, V9, P981, DOI 10.1016/S1074-5521(02)00213-2; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024	84	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220319	10.1371/journal.pone.0220319	http://dx.doi.org/10.1371/journal.pone.0220319			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344104	Green Submitted, Green Published, gold			2022-12-26	WOS:000484977900082
J	Mulvenna, N; Hantke, I; Burchell, L; Nicod, S; Bell, D; Turgay, K; Wigneshweraraj, S				Mulvenna, Nancy; Hantke, Ingo; Burchell, Lynn; Nicod, Sophie; Bell, David; Turgay, Kuersad; Wigneshweraraj, Sivaramesh			Xenogeneic modulation of the ClpCP protease of Bacillus subtilis by a phage-encoded adaptor-like protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; bacteria; ATP-dependent protease; chaperone; Bacillus	TYROSINE KINASE; HOST-TAKEOVER; INFECTION; GENE; COMPETENCE; EXPRESSION; SEQUENCE; PRODUCT; GENOME; CELL	yyyyy Like eukaryotic and archaeal viruses, which coopt the host's cellular pathways for their replication, bacteriophages have evolved strategies to alter the metabolism of their bacterial host. SPO1 bacteriophage infection of Bacillus subtilis results in comprehensive remodeling of cellular processes, leading to conversion of the bacterial cell into a factory for phage progeny production. A cluster of 26 genes in the SPO1 genome, called the host takeover module, encodes for potentially cytotoxic proteins that specifically shut down various processes in the bacterial host, including transcription, DNA synthesis, and cell division. However, the properties and bacterial targets of many genes of the SPO1 host takeover module remain elusive. Through a systematic analysis of gene products encoded by the SPO1 host takeover module, here we identified eight gene products that attenuated B. subtilis growth. Of the eight phage gene products that attenuated bacterial growth, a 25-kDa protein called Gp53 was shown to interact with the AAA+ chaperone protein ClpC of the ClpCP protease of B. subtilis. Our results further reveal that Gp53 is a phage-encoded adaptor-like protein that modulates the activity of the ClpCP protease to enable efficient SPO1 phage progeny development. In summary, our findings indicate that the bacterial ClpCP protease is the target of xenogeneic (dys)regulation by a SPO1 phage-derived factor and add Gp53 to the list of antibacterial products that target bacterial protein degradation and therefore may have utility for the development of novel antibacterial agents.	[Mulvenna, Nancy; Burchell, Lynn; Nicod, Sophie; Wigneshweraraj, Sivaramesh] Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Hantke, Ingo; Turgay, Kuersad] Leibniz Univ Hannover, Inst Mikrobiol, Herrenhauser Str 2, D-30419 Hannover, Germany; [Bell, David] Imperial Coll London, iHub, SynbiCITE, London W12 0BZ, England; [Turgay, Kuersad] Max Planck Unit Sci Pathogens, Charitepl 1, D-10117 Berlin, Germany	Imperial College London; Leibniz University Hannover; Imperial College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wigneshweraraj, S (corresponding author), Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	s.r.wig@imperial.ac.uk	; Turgay, Kursad/D-4828-2011	Wigneshweraraj, Sivaramesh/0000-0002-1418-4029; Turgay, Kursad/0000-0002-8959-492X	Wellcome Trust Investigator Award [100958]; Medical Research Council Ph.D. studentship; Deutsche Forschungsgemeinschaft [Tu106/6-2, Tu106/8-1]; Engineering and Physical Sciences Research Council; MRC [MR/P028225/1, MC_PC_17162] Funding Source: UKRI	Wellcome Trust Investigator Award(Wellcome Trust); Medical Research Council Ph.D. studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Investigator Award 100958 (to S. W.) and a Medical Research Council Ph.D. studentship (to N. M.). Work in the laboratory of K. T. was supported by the Deutsche Forschungsgemeinschaft (Tu106/6-2 and Tu106/8-1), and work in the laboratory of D. B. was supported by Engineering and Physical Sciences Research Council funding.	Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Batth TS, 2014, METAB ENG, V26, P48, DOI 10.1016/j.ymben.2014.08.004; BERNARDI A, 1984, NUCLEIC ACIDS RES, V12, P9415, DOI 10.1093/nar/12.24.9415; Culp E, 2017, J ANTIBIOT, V70, P366, DOI 10.1038/ja.2016.138; De Smet J, 2017, NAT REV MICROBIOL, V15, P517, DOI 10.1038/nrmicro.2017.61; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gray DA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08719-8; Hilliard JJ, 1998, J BIOL CHEM, V273, P524, DOI 10.1074/jbc.273.1.524; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2005, EMBO J, V24, P3435, DOI 10.1038/sj.emboj.7600780; Kirstein J, 2007, EMBO J, V26, P2061, DOI 10.1038/sj.emboj.7601655; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Kobiler O, 2004, J STRUCT BIOL, V146, P72, DOI 10.1016/j.jsb.2003.10.021; Kojetin DJ, 2009, J MOL BIOL, V387, P639, DOI 10.1016/j.jmb.2009.01.046; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Malik IT, 2017, NAT PROD REP, V34, P815, DOI 10.1039/c6np00125d; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Moliere N. P, 2012, THESIS; Moliere N, 2009, RES MICROBIOL, V160, P637, DOI 10.1016/j.resmic.2009.08.020; Nguyen HD, 2007, CURR MICROBIOL, V55, P89, DOI 10.1007/s00284-006-0419-5; PERO J, 1979, J VIROL, V31, P156, DOI 10.1128/JVI.31.1.156-171.1979; Roucourt B, 2009, ENVIRON MICROBIOL, V11, P2789, DOI 10.1111/j.1462-2920.2009.02029.x; Sampath A, 2004, J BACTERIOL, V186, P1785, DOI 10.1128/JB.186.6.1785-1792.2004; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; SONENSHE.AL, 1969, VIROLOGY, V39, P265, DOI 10.1016/0042-6822(69)90047-6; Stewart CR, 2013, VIROLOGY, V447, P249, DOI 10.1016/j.virol.2013.09.005; Stewart CR, 2009, VIROLOGY, V392, P271, DOI 10.1016/j.virol.2009.06.046; Stewart CR, 2009, J MOL BIOL, V388, P48, DOI 10.1016/j.jmb.2009.03.009; Stewart CR, 1998, VIROLOGY, V246, P329, DOI 10.1006/viro.1998.9197; Tabib-Salazar A, 2018, P NATL ACAD SCI USA, V115, pE5353, DOI 10.1073/pnas.1800429115; Thomas M, 1999, ONCOGENE, V18, P7690, DOI 10.1038/sj.onc.1202953; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; WEI P, 1993, J BACTERIOL, V175, P7887, DOI 10.1128/JB.175.24.7887-7900.1993; WEI P, 1995, J BACTERIOL, V177, P2933, DOI 10.1128/jb.177.10.2933-2937.1995	37	7	7	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17501	17511		10.1074/jbc.RA119.010007	http://dx.doi.org/10.1074/jbc.RA119.010007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31362989	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000503173500027
J	Rabaglino, MB; Conrad, KP				Belen Rabaglino, Maria; Conrad, Kirk P.			Evidence for shared molecular pathways of dysregulated decidualization in preeclampsia and endometrial disorders revealed by microarray data integration	FASEB JOURNAL			English	Article						implantation failure; recurrent miscarriage; pregnancy; endometriosis; transcriptomics	ADVERSE PREGNANCY; NEONATAL OUTCOMES; CYTOSCAPE PLUGIN; GENE-EXPRESSION; WOMEN; RISK; CELLS; IMPLANTATION; RECEPTOR; FETAL	Microarray data of chorionic villous samples (CVSs) obtained from women of similar to 11.5 gestational weeks who developed preeclampsia with severe features (sPE; PE-CVS) revealed a molecular signature of impaired endometrial maturation (decidualization) before and during early pregnancy. Because endometrial disorders are also associated with aberrant decidualization, we asked whether they share molecular features with sPE. We employed microarray data integration to compare the molecular pathologies of PE-CVS and endometrial disorders, as well as decidua obtained postpartum from women with sPE. Eight public databases were reanalyzed with R software to determine differentially expressed genes (DEGs) in pathologic tissues relative to normal controls. DEGs were then compared to explore overlap. Shared DEGs were examined for enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Principal component and network analyses were subsequently applied to selected DEGs. There was significant overlap of DEGs changing in the same direction for PE-CVS and endometrial disorders, suggesting common molecular pathways. Shared DEGs were enriched for cytokine-cytokine receptor interaction. Genes in this pathway revealed expression patterns forming 2 distinct clusters, one for normal and the other pathologic endometrium. The most affected hub genes were related to decidualization and NK cell function. Few DEGs were shared by PE-CVS, and PE decidua obtained postpartum. sPE may be part of a biologic continuum of "endometrial spectrum disorders."	[Belen Rabaglino, Maria] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ciencias Salud INICSA, Cordoba, Argentina; [Conrad, Kirk P.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Conrad, Kirk P.] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rabaglino, MB (corresponding author), Pabellon Biol Celular, Enfermera Gordillo, Ciudad Univ, RA-5016 Cordoba Capital, Argentina.; Conrad, KP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Gen, 1600 SW Archer Rd,M552,POB 100274, Gainesville, FL 32610 USA.	belenrabaglino@icloud.com; kpconrad@ufl.edu		Rabaglino, Maria/0000-0002-0099-045X	U.S. Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [P01 HD065647]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD065647] Funding Source: NIH RePORTER	U.S. Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge Dr. Matthew Dyson (Feinberg School of Medicine, Northwestern University, Chicago, IL, USA), for providing the microarray data set on endometriosis. This work was partly supported by U.S. Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant P01 HD065647 (to K.P.C.). Portions were published in abstract form (70, 71). The authors declare no conflicts of interest.	Andraweera PH, 2016, J MATERN-FETAL NEO M, V29, P1072, DOI 10.3109/14767058.2015.1034102; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Benirschke KKP, 2000, PATHOLOGY OF THE HUM; Berlac JF, 2017, ACTA OBSTET GYN SCAN, V96, P751, DOI 10.1111/aogs.13111; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brosens IA, 2007, HUM REPROD, V22, P1725, DOI 10.1093/humrep/dem072; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Burke SD, 2010, AM J REPROD IMMUNOL, V63, P472, DOI 10.1111/j.1600-0897.2010.00818.x; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Conrad KP, 2017, PLACENTA, V60, P119, DOI 10.1016/j.placenta.2017.06.005; Craven CM, 1998, PLACENTA, V19, P241, DOI 10.1016/S0143-4004(98)90055-8; Cubro H, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0833-7; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duncan WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023595; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Falconer H, 2013, SEMIN REPROD MED, V31, P178, DOI 10.1055/s-0032-1333484; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Garrido-Gomez T, 2017, P NATL ACAD SCI USA, V114, pE8468, DOI 10.1073/pnas.1706546114; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Glavind MT, 2017, FERTIL STERIL, V107, P160, DOI 10.1016/j.fertnstert.2016.09.020; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gunnarsdottir J, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.01.041; Hadfield RM, 2009, HUM REPROD, V24, P2348, DOI 10.1093/humrep/dep123; Hanna N, 2000, J IMMUNOL, V164, P5721, DOI 10.4049/jimmunol.164.11.5721; Hashii K, 1998, HUM REPROD, V13, P2738, DOI 10.1093/humrep/13.10.2738; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Jacques M, 2016, REPROD BIOMED ONLINE, V32, P626, DOI 10.1016/j.rbmo.2016.03.005; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones RL, 1998, J CLIN ENDOCR METAB, V83, P258, DOI 10.1210/jc.83.1.258; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kodama A, 2010, HUM REPROD, V25, P751, DOI 10.1093/humrep/dep455; Lagani V, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1153-z; Lalani S, 2018, HUM REPROD, V33, P1854, DOI 10.1093/humrep/dey269; LaMarca B, 2016, AM J PHYSIOL-REG I, V311, pR1, DOI 10.1152/ajpregu.00052.2016; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Ledee N, 2011, J PATHOL, V225, P554, DOI 10.1002/path.2948; Li J., 2014, SCI REP, V4; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Monsivais D, 2017, ENDOCRINOLOGY, V158, P979, DOI 10.1210/en.2016-1629; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; PAGE EW, 1972, J OBSTET GYN BR COMM, V79, P883; Pan ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181261; Peng J, 2015, P NATL ACAD SCI USA, V112, pE5098, DOI 10.1073/pnas.1514498112; Perez-Lopez FR, 2018, PREGNANCY HYPERTENS, V14, P213, DOI 10.1016/j.preghy.2018.01.003; Pijnenborg R, 2011, PREGNANCY HYPERTENS, V1, P66, DOI 10.1016/j.preghy.2010.10.010; Rabaglino MB, 2017, REPROD SCI, V24, p91A; Rabaglino MB, 2015, HYPERTENSION, V65, P421, DOI 10.1161/HYPERTENSIONAHA.114.04481; RABAGLINO MB, 2018, REPROD SCI, V25, pA31; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romero R, 2011, BEST PRACT RES CL OB, V25, P313, DOI 10.1016/j.bpobgyn.2011.02.006; Sahu MB, 2019, PREGNANCY HYPERTENS, V15, P64, DOI 10.1016/j.preghy.2018.11.003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sones JL, 2014, AM J PHYSIOL-REG I, V307, pR490, DOI 10.1152/ajpregu.00176.2014; Silva VRS, 2015, ARCH GYNECOL OBSTET, V291, P1029, DOI 10.1007/s00404-014-3503-2; Stephansson O, 2009, HUM REPROD, V24, P2341, DOI 10.1093/humrep/dep186; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Trogstad L, 2009, BJOG-INT J OBSTET GY, V116, P108, DOI 10.1111/j.1471-0528.2008.01978.x; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Wu J, 2012, GCRMA BACKGROUND ADJ, P2200; Yang JCS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8149109; Yin XQ, 2012, J CLIN ENDOCR METAB, V97, pE35, DOI 10.1210/jc.2011-1527; Zullo F, 2017, FERTIL STERIL, V108, P667, DOI 10.1016/j.fertnstert.2017.07.019	71	19	20	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11682	11695		10.1096/fj.201900662R	http://dx.doi.org/10.1096/fj.201900662R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31356122	Green Published			2022-12-26	WOS:000507461600009
J	Abdullah, S; Lynn, ML; McConnell, MT; Klass, MM; Baldo, AP; Schwartz, SD; Tardiff, JC				Abdullah, Salwa; Lynn, Melissa L.; McConnell, Mark T.; Klass, Matthew M.; Baldo, Anthony P.; Schwartz, Steven D.; Tardiff, Jil C.			FRET-based analysis of the cardiac troponin T linker region reveals the structural basis of the hypertrophic cardiomyopathy-causing Delta 160E mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular dynamics; fluorescence resonance energy transfer (FRET); allosteric regulation; cardiomyopathy; mutant; troponin; allostery; cardiac thin filament; heart disease; hypertrophic cardiomyopathy; muscle contraction	RESONANCE ENERGY-TRANSFER; MUSCLE THIN-FILAMENTS; MYOSIN HEAVY-CHAIN; FUNCTIONAL REGIONS; GENE-MUTATIONS; ATOMIC MODEL; TROPOMYOSIN; SKELETAL; PREVALENCE; ACTIN	Mutations in the cardiac thin filament (TF) have highly variable effects on the regulatory function of the cardiac sarcomere. Understanding the molecular-level dysfunction elicited by TF mutations is crucial to elucidate cardiac disease mechanisms. The hypertrophic cardiomyopathy-causing cardiac troponin T (cTnT) mutation Delta 160Glu (Delta 160E) is located in a putative "hinge" adjacent to an unstructured linker connecting domains TNT1 and TNT2. Currently, no high-resolution structure exists for this region, limiting significantly our ability to understand its role in myofilament activation and the molecular mechanism of mutation-induced dysfunction. Previous regulated in vitro motility data have indicated mutation-induced impairment of weak actomyosin interactions. We hypothesized that cTnT-Delta 160E repositions the flexible linker, altering weak actomyosin electrostatic binding and acting as a biophysical trigger for impaired contractility and the observed remodeling. Using time-resolved FRET and an all-atom TF model, here we first defined the WT structure of the cTnT-linker region and then identified Delta 160E mutation-induced positional changes. Our results suggest that the WT linker runs alongside the C terminus of tropomyosin. The Delta 160E-induced structural changes moved the linker closer to the tropomyosin C terminus, an effect that was more pronounced in the presence of myosin subfragment (S1) heads, supporting previous findings. Our in silico model fully supported this result, indicating a mutation-induced decrease in linker flexibility. Our findings provide a framework for understanding basic pathogenic mechanisms that drive severe clinical hypertrophic cardiomyopathy phenotypes and for identifying structural targets for intervention that can be tested in silico and in vitro.	[Abdullah, Salwa; Tardiff, Jil C.] Univ Arizona, Dept Cellular & Mol Med, 1656 East Mabel St,Med Res Bldg 312,MS 245217, Tucson, AZ 85724 USA; [Lynn, Melissa L.; McConnell, Mark T.; Tardiff, Jil C.] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85724 USA; [Klass, Matthew M.; Tardiff, Jil C.] Univ Arizona, Dept Physiol Sci, Tucson, AZ 85724 USA; [Baldo, Anthony P.; Schwartz, Steven D.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85724 USA; [Tardiff, Jil C.] Univ Arizona, Dept Med, Tucson, AZ 85724 USA; [Abdullah, Salwa] Kuwait Univ, Dept Physiol, POB 24923, Kuwait 13110, Kuwait	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; Kuwait University	Tardiff, JC (corresponding author), Univ Arizona, Dept Cellular & Mol Med, 1656 East Mabel St,Med Res Bldg 312,MS 245217, Tucson, AZ 85724 USA.	jtardiff@email.arizona.edu			National Institutes of Health [R01-HL075619]; Gootter Foundation; Kuwait University faculty of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107046, R01HL075619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gootter Foundation; Kuwait University faculty of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01-HL075619 (to J. C. T. and S. D. S.) and Gootter Foundation support (to J. C. T.). We also acknowledge funding from Kuwait University faculty of Medicine (to S. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Ackerman MJ, 2002, J AM COLL CARDIOL, V39, P2042, DOI 10.1016/S0735-1097(02)01900-9; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]; ANAN R, 1994, J CLIN INVEST, V93, P280, DOI 10.1172/JCI116957; Capek P, 2006, METHOD INFORM MED, V45, P169; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Coppini R, 2014, J AM COLL CARDIOL, V64, P2589, DOI 10.1016/j.jacc.2014.09.059; Crocini C, 2016, J MOL CELL CARDIOL, V91, P42, DOI 10.1016/j.yjmcc.2015.12.013; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Fujino N, 2001, CLIN CARDIOL, V24, P397, DOI 10.1002/clc.4960240510; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Haim TE, 2007, J MOL CELL CARDIOL, V42, P1098, DOI 10.1016/j.yjmcc.2007.03.906; Harada K, 2000, J BIOCHEM-TOKYO, V127, P263, DOI 10.1093/oxfordjournals.jbchem.a022603; Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang PM, 2014, P NATL ACAD SCI USA, V111, P14412, DOI 10.1073/pnas.1410775111; Jimenez J, 2011, AM J PHYSIOL-HEART C, V300, pH627, DOI 10.1152/ajpheart.00247.2010; Kast D, 2010, P NATL ACAD SCI USA, V107, P8207, DOI 10.1073/pnas.1001941107; Kimura A, 2016, J HUM GENET, V61, P41, DOI 10.1038/jhg.2015.83; Kimura-Sakiyama C, 2008, J MOL BIOL, V376, P80, DOI 10.1016/j.jmb.2007.10.078; Koga Y, 1996, J Card Fail, V2, pS97, DOI 10.1016/S1071-9164(96)80064-9; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; LIN SH, 1993, BIOPHYS J, V65, P1433, DOI 10.1016/S0006-3495(93)81209-8; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Manning EP, 2012, J MOL BIOL, V421, P54, DOI 10.1016/j.jmb.2012.05.008; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Matsuo N, 2002, J BIOCHEM, V131, P375, DOI 10.1093/oxfordjournals.jbchem.a003112; McConnell M, 2017, BIOCHEMISTRY-US, V56, P3403, DOI 10.1021/acs.biochem.7b00266; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mijailovich SM, 2017, BIOPHYS J, V112, P984, DOI 10.1016/j.bpj.2017.01.021; Miki M, 1998, J BIOCHEM-TOKYO, V123, P1104; Millat G, 2010, EUR J MED GENET, V53, P261, DOI 10.1016/j.ejmg.2010.07.007; Moolman-Smook JC, 1999, AM J HUM GENET, V65, P1308, DOI 10.1086/302623; Moore RK, 2014, ARCH BIOCHEM BIOPHYS, V552, P21, DOI 10.1016/j.abb.2014.01.016; Moore RK, 2013, J MOL CELL CARDIOL, V58, P188, DOI 10.1016/j.yjmcc.2013.02.004; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Orzechowski M, 2014, BIOPHYS J, V107, P694, DOI 10.1016/j.bpj.2014.06.034; Otsuka H, 2012, CIRC J, V76, P453, DOI 10.1253/circj.CJ-11-0876; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Pasquale F, 2012, CIRC-CARDIOVASC GENE, V5, P10, DOI 10.1161/CIRCGENETICS.111.959973; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Sweeney HL, 1998, P NATL ACAD SCI USA, V95, P14406, DOI 10.1073/pnas.95.24.14406; Takeda S, 1997, EUR J BIOCHEM, V246, P611, DOI 10.1111/j.1432-1033.1997.00611.x; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TAO T, 1983, BIOCHEMISTRY-US, V22, P3059, DOI 10.1021/bi00282a006; Torricelli F, 2003, AM J CARDIOL, V92, P1358, DOI 10.1016/j.amjcard.2003.08.031; Ueda K, 2011, BIOPHYS J, V100, P2432, DOI 10.1016/j.bpj.2011.03.021; Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Williams MR, 2016, P NATL ACAD SCI USA, V113, P3257, DOI 10.1073/pnas.1519541113; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3; Yang SX, 2014, BIOPHYS J, V106, P855, DOI 10.1016/j.bpj.2014.01.007	64	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14634	14647		10.1074/jbc.RA118.005098	http://dx.doi.org/10.1074/jbc.RA118.005098			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31387947	Green Published, hybrid			2022-12-26	WOS:000497955000011
J	Magoro, T; Dandekar, A; Jennelle, LT; Bajaj, R; Lipkowitz, G; Angelucci, AR; Bessong, PO; Hahn, YS				Magoro, Tshifhiwa; Dandekar, Aditya; Jennelle, Lucas T.; Bajaj, Rohan; Lipkowitz, Gabriel; Angelucci, Angelina R.; Bessong, Pascal O.; Hahn, Young S.			IL-1 beta/TNF-alpha/IL-6 inflammatory cytokines promote STAT1-dependent induction of CH25H in Zika virus-infected human macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavivirus; infection; inflammation; innate immunity; macrophage; cholesterol 25-hydroxylase	PATTERN-RECOGNITION RECEPTORS; CHOLESTEROL 25-HYDROXYLASE; 25-HYDROXYCHOLESTEROL; INNATE; APOPTOSIS; ACTIVATION; TRANSCRIPTION; MECHANISMS; SREBPS; ATF3	Zika virus (ZIKV)(3) is an enveloped, single-stranded, positive-sense RNA virus of the Flaviviridae family that has emerged as a public health threat because of its global transmission and link to microcephaly. Currently there is no vaccine for this virus. Conversion of cholesterol to 25-hydroxycholesterol by cholesterol 25-hydroxylase (CH25H) has been shown to have broad antiviral properties. However, the molecular basis of induction of CH25H in humans is not known. Elucidation of signaling and transcriptional events for induction of CH25H expression is critical for designing therapeutic antiviral agents. In this study, we show that CH25H is induced by ZIKV infection or Toll-like receptor stimulation. Interestingly, CH25H is induced by pro-inflammatory cytokines, including IL-1 beta, tumor necrosis factor alpha, and IL-6, and this induction depends on the STAT1 transcription factor. Additionally, we observed that cAMP-dependent transcription factor (ATF3) weakly binds to the CH25H promoter, suggesting cooperation with STAT1. However, ZIKV-induced CH25H was independent of type I interferon. These findings provide important information for understanding how the Zika virus induces innate inflammatory responses and promotes the expression of anti-viral CH25H protein.	[Magoro, Tshifhiwa; Bessong, Pascal O.] Univ Venda, Dept Microbiol, HIV AIDS & Global Hlth Res Program, Thohoyandou, Limpopo, South Africa; [Magoro, Tshifhiwa; Dandekar, Aditya; Jennelle, Lucas T.; Bajaj, Rohan; Lipkowitz, Gabriel; Angelucci, Angelina R.; Hahn, Young S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Magoro, Tshifhiwa; Dandekar, Aditya; Jennelle, Lucas T.; Bajaj, Rohan; Lipkowitz, Gabriel; Angelucci, Angelina R.; Hahn, Young S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, 345 Crispell Dr,MR6 Bldg,Rm 3715, Charlottesville, VA 22908 USA	University of Venda; University of Virginia; University of Virginia	Hahn, YS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, 345 Crispell Dr,MR6 Bldg,Rm 3715, Charlottesville, VA 22908 USA.	ysh5e@virginia.edu	; Magoro, Tshifhiwa/X-3466-2018	Angelucci, Angelina/0000-0003-2006-8099; Magoro, Tshifhiwa/0000-0002-9295-1027	Global Infectious Diseases Research Training Programme of the Fogarty International Center/National Institute of Health [D43 TW006578]; Research and Publication Committee of the University of Venda, South Africa; Global Infectious Diseases Institute of University of Virginia, Seed Grant; FOGARTY INTERNATIONAL CENTER [D43TW006578] Funding Source: NIH RePORTER	Global Infectious Diseases Research Training Programme of the Fogarty International Center/National Institute of Health; Research and Publication Committee of the University of Venda, South Africa; Global Infectious Diseases Institute of University of Virginia, Seed Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was partially supported by Global Infectious Diseases Research Training Programme of the Fogarty International Center/National Institute of Health Grant D43 TW006578 and the Research and Publication Committee of the University of Venda, South Africa. This work was also funded by a Global Infectious Diseases Institute of University of Virginia, Seed Grant (to Y. S. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Anggakusuma,, 2015, HEPATOLOGY, V62, P702, DOI 10.1002/hep.27913; Ares MPS, 1997, J LIPID RES, V38, P2049; AyalaTorres S, 1997, EXP CELL RES, V235, P35, DOI 10.1006/excr.1997.3630; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Choi YK, 2008, FREE RADICAL RES, V42, P544, DOI 10.1080/10715760802146062; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Diczfalusy U, 2013, BIOCHIMIE, V95, P455, DOI 10.1016/j.biochi.2012.06.016; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Keyel PA, 2012, J IMMUNOL, V189, P4621, DOI 10.4049/jimmunol.1200828; Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Pfaender S, 2015, APPL ENVIRON MICROB, V81, P1616, DOI 10.1128/AEM.03580-14; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637; Shrivastava-Ranjan P, 2016, MBIO, V7, DOI [10.1128/mBio.01808-16, 10.1128/mbio.01808-16]; Sood V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08584-9; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Wang WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25482; Xiang Y, 2015, J VIROL, V89, P6805, DOI 10.1128/JVI.00587-15; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	46	18	20	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14591	14602		10.1074/jbc.RA119.007555	http://dx.doi.org/10.1074/jbc.RA119.007555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31375561	Green Published, hybrid			2022-12-26	WOS:000497955000008
J	Sommerkamp, JA; Frankenberg-Dinkel, N; Hofmann, E				Sommerkamp, Johannes A.; Frankenberg-Dinkel, Nicole; Hofmann, Eckhard			Crystal structure of the first eukaryotic bilin reductase GtPEBB reveals a flipped binding mode of dihydrobiliverdin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; biosynthesis; crystal structure; photosynthetic pigment; enzyme mechanism; ferredoxin-dependent bilin reductase; phycoerythrobilin; radical enzyme; regiospecificity; tetrapyrrole	PHYCOCYANOBILIN-FERREDOXIN OXIDOREDUCTASE; PHYTOCHROMOBILIN SYNTHASE; RADICAL MECHANISM; BIOSYNTHESIS; INSIGHTS; COMPLEX; HY2	Phycobilins are light-harvesting pigments of cyanobacteria, red algae, and cryptophytes. The biosynthesis of phycoerythrobilin (PEB) is catalyzed by the subsequent action of two ferredoxin-dependent bilin reductases (FDBRs). Although 15,16-dihydrobiliverdin (DHBV):ferredoxin oxidoreductase (PebA) catalyzes the two-electron reduction of biliverdin IX alpha to 15,16-DHBV, PEB:ferredoxin oxidoreductase (PebB) reduces this intermediate further to PEB. Interestingly, marine viruses encode the FDBR PebS combining both activities within one enzyme. Although PebA and PebS share a canonical fold with similar substrate-binding pockets, the structural determinants for the stereo- and regiospecific modification of their tetrapyrrole substrates are incompletely understood, also because of the lack of a PebB structure. Here, we solved the X-ray crystal structures of both substrate-free and -bound PEBB from the cryptophyte Guillardia theta at 1.90 and 1.65 angstrom, respectively. The structures of PEBB exhibit the typical alpha/beta/alpha-sandwich fold. Interestingly, the open-chain tetrapyrrole substrate DHBV is bound in an unexpected flipped orientation within the canonical FDBR active site. Biochemical analyses of the WT enzyme and active site variants identified two central aspartate residues Asp-99 and Asp-219 as essential for catalytic activity. In addition, the conserved Arg-215 plays a critical role in substrate specificity, binding orientation, and active site integrity. Because these critical residues are conserved within certain FDBRs displaying A-ring reduction activity, we propose that they present a conserved mechanism for this reaction. The flipped substrate-binding mode indicates that two-electron reducing FDBRs utilize the same primary site within the binding pocket and that substrate orientation is the determinant for A- or D-ring regiospecificity.	[Sommerkamp, Johannes A.; Hofmann, Eckhard] Ruhr Univ Bochum, Fac Biol & Biotechnol, Prot Crystallog, D-44801 Bochum, Germany; [Frankenberg-Dinkel, Nicole] Tech Univ Kaiserslautern, Dept Biol, Microbiol, D-67663 Kaiserslautern, Germany	Ruhr University Bochum; University of Kaiserslautern	Hofmann, E (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Prot Crystallog, D-44801 Bochum, Germany.	eckhard.hofmann@rub.de	Hofmann, Eckhard/GPF-5024-2022; Frankenberg-Dinkel, Nicole/C-1058-2011	Hofmann, Eckhard/0000-0003-4874-372X; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839	Deutsche Forschungsgemeinschaft [HO2600/3-1, FR1487/10-1]; Deutsche Forschungsgemeinschaft Research Training Group [GRK 2341]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Research Training Group(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft Grants HO2600/3-1 and FR1487/10-1 (to E. H. and N. F.-D.). This work was supported in part by Deutsche Forschungsgemeinschaft Research Training Group GRK 2341 "Microbial Substrate Conversion (MiCon)."	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2018, MOL OP ENV MOE; Aras M, 2020, FEBS J, V287, P284, DOI 10.1111/febs.15003; Busch AWU, 2011, BIOCHEM J, V439, P257, DOI 10.1042/BJ20110814; Busch AWU, 2011, BIOCHEM J, V433, P469, DOI 10.1042/BJ20101642; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; Fukamizo T, 2000, J BIOL CHEM, V275, P25633, DOI 10.1074/jbc.M002574200; GANTT E, 1971, J CELL BIOL, V48, P280, DOI 10.1083/jcb.48.2.280; GLAZER AN, 1977, MOL CELL BIOCHEM, V18, P125, DOI 10.1007/BF00280278; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hagiwara Y, 2016, FEBS LETT, V590, P3425, DOI 10.1002/1873-3468.12387; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kraeutler Bernhard, 2006, V25, P237; Ledermann B, 2018, FEBS J, V285, P339, DOI 10.1111/febs.14341; Ledermann B, 2016, ENVIRON MICROBIOL, V18, P4337, DOI 10.1111/1462-2920.13290; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; McDowell MT, 2001, PLANT PHYSIOL, V126, P1546, DOI 10.1104/pp.126.4.1546; Overkamp KE, 2014, J BIOL CHEM, V289, P26691, DOI 10.1074/jbc.M114.591131; Rockwell NC, 2017, NEW PHYTOL, V214, P1145, DOI 10.1111/nph.14422; Stoebe B, 2002, PROTOPLASMA, V219, P123, DOI 10.1007/s007090200013; Sugishima M, 2010, J MOL BIOL, V402, P879, DOI 10.1016/j.jmb.2010.08.021; Tu SL, 2008, J BIOL CHEM, V283, P27555, DOI 10.1074/jbc.M803761200; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; Unno M, 2015, J AM CHEM SOC, V137, P5452, DOI 10.1021/jacs.5b00645; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012	35	3	3	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					13889	13901		10.1074/jbc.RA119.009306	http://dx.doi.org/10.1074/jbc.RA119.009306			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366727	hybrid, Green Published			2022-12-26	WOS:000490729800005
J	Nishimura, A; Nasuno, R; Yoshikawa, Y; Jung, M; Ida, T; Matsunaga, T; Morita, M; Takagi, H; Motohashi, H; Akaike, T				Nishimura, Akira; Nasuno, Ryo; Yoshikawa, Yuki; Jung, Minkyung; Ida, Tomoaki; Matsunaga, Tetsuro; Morita, Masanobu; Takagi, Hiroshi; Motohashi, Hozumi; Akaike, Takaaki			Mitochondrial cysteinyl-tRNA synthetase is expressed via alternative transcriptional initiation regulated by energy metabolism in yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl-tRNA synthetase; yeast; transcription; energy metabolism; gene regulation; alternative transcription; cysteinyl-tRNA synthetase; Hap complex; mitochondrial bioenergetics; transcriptional start site	GENE ENCODES; COMPLEX	Eukaryotes typically utilize two distinct aminoacyl-tRNA synthetase isoforms, one for cytosolic and one for mitochondrial protein synthesis. However, the genome of budding yeast (Saccharomyces cerevisiae) contains only one cysteinyl-tRNA synthetase gene (YNL247W, also known as CRS1). In this study, we report that CRS1 encodes both cytosolic and mitochondrial isoforms. The 5' complementary DNA end method and GFP reporter gene analyses indicated that yeast CRS1 expression yields two classes of mRNAs through alternative transcription starts: a long mRNA containing a mitochondrial targeting sequence and a short mRNA lacking this targeting sequence. We found that the mitochondrial Crs1 is the product of translation from the first initiation AUG codon on the long mRNA, whereas the cytosolic Crs1 is produced from the second in-frame AUG codon on the short mRNA. Genetic analysis and a ChIP assay revealed that the transcription factor heme activator protein (Hap) complex, which is involved in mitochondrial biogenesis, determines the transcription start sites of the CRS1 gene. We also noted that Hap complex-dependent initiation is regulated according to the needs of mitochondrial energy production. The results of our study indicate energy-dependent initiation of alternative transcription of CRS1 that results in production of two Crs1 isoforms, a finding that suggests Crs1's potential involvement in mitochondrial energy metabolism in yeast.	[Nishimura, Akira; Jung, Minkyung; Ida, Tomoaki; Matsunaga, Tetsuro; Morita, Masanobu; Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Med & Mol Toxicol, Sendai, Miyagi 9808575, Japan; [Nasuno, Ryo; Yoshikawa, Yuki; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Motohashi, Hozumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Sendai, Miyagi 9808575, Japan	Tohoku University; Nara Institute of Science & Technology; Tohoku University	Akaike, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Environm Med & Mol Toxicol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	takaike@tohoku.med.ac.jp	Matsunaga, Tetsuro/AAC-9437-2019; Nasuno, Ryo/AAD-7128-2022; Yoshikawa, Yuki/AAC-1783-2022; Motohashi, Hozumi/AAZ-2628-2020	Nasuno, Ryo/0000-0002-4456-2801; Yoshikawa, Yuki/0000-0001-7406-9834; Matsunaga, Tetsuro/0000-0003-2944-3326; Jung, Minkyung/0000-0002-6489-1696; Nishimura, Akira/0000-0002-0168-9829; Akaike, Takaaki/0000-0002-0623-1710	Ministry of Education, Sciences, Sports, and Technology (MEXT) Japan [18H04794, 18H02621, 15K21759, 18H05277, 17K08619, 17K15408, 26111008]; AMED [JP19gm5010002, JP18fm0208029]	Ministry of Education, Sciences, Sports, and Technology (MEXT) Japan; AMED	This work was supported in part by Grants-in-Aid for Scientific Research (S), (B), and (C) and for Young Scientists (B) 18H04794 and 18H02621 (to H. M.), 15K21759 and 18H05277 (to T. A.), 17K08619 (to T. I.), and 17K15408 (to A. N.) and Grant-in-Aid for Scientific Research on Innovative Areas 26111008 (to T. A.) from the Ministry of Education, Sciences, Sports, and Technology (MEXT) Japan and by AMED under Grants JP19gm5010002 (to H. M.) and JP18fm0208029 (to T. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Akaike T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01311-y; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brindefalk B, 2007, MOL BIOL EVOL, V24, P743, DOI 10.1093/molbev/msl202; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; CHATTON B, 1988, J BIOL CHEM, V263, P52; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Fujii S, 2019, BRIT J PHARMACOL, V176, P607, DOI 10.1111/bph.14356; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Garg SG, 2016, TRENDS CELL BIOL, V26, P894, DOI 10.1016/j.tcb.2016.07.001; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Huot JL, 2014, BIOCHIMIE, V100, P95, DOI 10.1016/j.biochi.2014.01.004; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Imamura Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130397; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MARTIN NC, 1994, BIOCHIMIE, V76, P1161, DOI 10.1016/0300-9084(94)90045-0; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Sasaki T, 2013, GENES CELLS, V18, P459, DOI 10.1111/gtc.12049; Smith DR, 2015, P NATL ACAD SCI USA, V112, P10177, DOI 10.1073/pnas.1422049112; Solomon Kevin V, 2016, Metab Eng Commun, V3, P68, DOI 10.1016/j.meteno.2016.03.004; Soontorngun N, 2017, CURR GENET, V63, P1, DOI 10.1007/s00294-016-0609-z; Supekova L, 2010, P NATL ACAD SCI USA, V107, P5047, DOI 10.1073/pnas.1000735107; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Teixeira MC, 2018, NUCLEIC ACIDS RES, V46, pD348, DOI 10.1093/nar/gkx842; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; Wang YC, 2014, YEAST, V31, P127, DOI 10.1002/yea.3002; Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3; Yoboue Edgar D, 2012, Int J Cell Biol, V2012, P403870, DOI 10.1155/2012/403870; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004	42	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13781	13788		10.1074/jbc.RA119.009203	http://dx.doi.org/10.1074/jbc.RA119.009203			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31350340	hybrid, Green Published			2022-12-26	WOS:000486418600022
J	Nien, CW; Lee, CY; Wu, PH; Chen, HC; Chi, JCY; Sun, CC; Huang, JY; Lin, HY; Yang, SF				Nien, Chan-Wei; Lee, Chia-Yi; Wu, Pei-Hsuan; Chen, Hung-Chi; Chi, Jessie Chao-Yun; Sun, Chi-Chin; Huang, Jing-Yang; Lin, Hung-Yu; Yang, Shun-Fa			The development of optic neuropathy after chronic rhinosinusitis: A population-based cohort study	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; ASSOCIATION; DIAGNOSIS; NEURITIS; AGE	Background To evaluate the risk of developing optic neuropathy (ON) in patient with both non-surgery and surgery-indicated chronic rhinosinusitis (CRS) via the national health insurance research database in Taiwan. Methodology/Principal findings 44,176 Patients with a diagnostic code of CRS was selected, which included 6,678 received functional endoscopic sinus surgery (FESS) regarded as the surgery-indicated CRS. Each individual in the study group was matched to two non-CRS patients by age and gender. The outcome was set as the occurrence of ON according to the diagnostic codes occurred after the index date. Poisson regression was used to calculate the adjusted relative risk (aRR) and conditional Cox proportional model was used to estimate the adjusted hazard ratio (aHR). There were 131 and 144 events of ON occurred in the study group and the control group respectively during the follow-up period. The whole study group, whether received FESS or not, demonstrated both significant aRR and aHR compared to the control group after adjusting demographic data, prominent ocular diseases, and systemic co-morbidities. In addition, both the aRR and aHR were higher in CRS patient received FESS than those with CRS but without FESS management. Conclusion The existence of CRS, especially the surgery-indicated CRS is a significant risk factor for the following ON using multivariable analysis.	[Nien, Chan-Wei; Chi, Jessie Chao-Yun; Lin, Hung-Yu; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Nien, Chan-Wei; Lee, Chia-Yi; Lin, Hung-Yu] Show Chwan Mem Hosp, Dept Ophthalmol, Changhua, Taiwan; [Lee, Chia-Yi] Chung Hwa Univ Med Technol, Coll Med & Life Sci, Dept Optometry, Tainan, Taiwan; [Wu, Pei-Hsuan] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Chen, Hung-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chen, Hung-Chi] Chang Gung Univ, Dept Med, Coll Med, Taoyuan, Taiwan; [Chen, Hung-Chi] Chang Gung Mem Hosp, Ctr Tissue Engn, Linkou, Taiwan; [Chi, Jessie Chao-Yun] Taichung Hosp, Dept Otorhinolaryngol Head & Neck Surg, Minist Hlth & Welf, Taichung, Taiwan; [Sun, Chi-Chin] Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan; [Sun, Chi-Chin] Chang Gung Univ, Dept Chinese Med, Taoyuan, Taiwan; [Huang, Jing-Yang; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Hung-Yu] Chung Shan Med Univ, Dept Optometry, Taichung, Taiwan; [Lin, Hung-Yu] Chung Chou Univ Sci & Technol, Dept Exercise & Hlth Promot, Changhua, Taiwan	Chung Shan Medical University; Show Chwan Memorial Hospital; Chung Hua University; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Yang, SF (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Chen, Hung-Chi/0000-0002-1117-7878	Chung Shan Medical University Hospital [CSH-2018-E-001-Y2]	Chung Shan Medical University Hospital	This study was supported by a grant (CSH-2018-E-001-Y2) from Chung Shan Medical University Hospital to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo-Lima WT, 2007, AM J RHINOL, V21, P719, DOI 10.2500/ajr.2007.21.3102; Barac A, 2015, EUR ARCH OTO-RHINO-L, V272, P3727, DOI 10.1007/s00405-015-3511-2; Biousse V, 2016, LANCET NEUROL, V15, P1355, DOI 10.1016/S1474-4422(16)30237-X; Brooks SG, 2018, INT FORUM ALLERGY RH, V8, P668, DOI 10.1002/alr.22109; Cazzavillan A, 2010, Int J Immunopathol Pharmacol, V23, P74; Chang YS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184477; Cheng HC, 2015, OPHTHALMOLOGY, V122, P2553, DOI 10.1016/j.ophtha.2015.08.022; Constantin Farah, 2017, Rom J Ophthalmol, V61, P133; Costello Fiona, 2014, Continuum (Minneap Minn), V20, P816, DOI 10.1212/01.CON.0000453316.60013.52; Del Noce C, 2017, CASE REP OPHTHALM, V8, P421, DOI 10.1159/000476057; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Gulati SP, 2008, INDIAN J OTOLARYNGOL, V60, P152, DOI 10.1007/s12070-008-0037-6; Gurrola J, 2017, J ALLERGY CLIN IMMUN, V140, P1499, DOI 10.1016/j.jaci.2017.10.006; Jin YP, 1998, J NEUROL SCI, V159, P107, DOI 10.1016/S0022-510X(98)00141-5; Koh YN, 2017, INT MED CASE REP J, V10, P263, DOI 10.2147/IMCRJ.S124524; Kuo CL, 2017, JAMA OTOLARYNGOL, V143, P757, DOI 10.1001/jamaoto.2017.0130; Neo WL, 2018, AM J OTOLARYNG, V39, P791, DOI 10.1016/j.amjoto.2018.08.008; Olcott CM, 2016, INT FORUM ALLERGY RH, V6, P841, DOI 10.1002/alr.21745; Park DY, 2016, J CRANIOFAC SURG, V27, pE248, DOI 10.1097/SCS.0000000000002440; Petzold A, 2014, AUTOIMMUN REV, V13, P539, DOI 10.1016/j.autrev.2014.01.009; Pfeiffer Margaret L, 2018, Am J Ophthalmol Case Rep, V10, P84, DOI 10.1016/j.ajoc.2018.01.041; Poletti SC, 2017, RHINOLOGY, V55, P70, DOI [10.4193/Rhino16.194, 10.4193/Rhin16.194]; Ramakrishnan VR, 2017, AM J RHINOL ALLERGY, V31, P283, DOI 10.2500/ajra.2017.31.4457; Ramakrishnan VR, 2011, CURR ALLERGY ASTHM R, V11, P220, DOI 10.1007/s11882-011-0182-y; Ramm L, 2017, CURR EYE RES, V42, P1313, DOI 10.1080/02713683.2017.1307415; Renner M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00254; Saliba J, 2016, LARYNGOSCOPE, V126, pE174, DOI 10.1002/lary.25952; Sedaghat AR, 2017, AM FAM PHYSICIAN, V96, P500; Shin IH, 2018, RETINA-J RET VIT DIS, V38, P253, DOI 10.1097/IAE.0000000000001535; Siedek V, 2009, INT J PEDIATR OTORHI, V73, P741, DOI 10.1016/j.ijporl.2009.01.019; Soelberg K, 2017, MULT SCLER J, V23, P1893, DOI 10.1177/1352458517734070; Stunkel L, 2018, ASIA-PAC J OPHTHALMO, V7, P218, DOI 10.22608/APO.2018127; Tan BK, 2009, OTOLARYNG CLIN N AM, V42, P227, DOI 10.1016/j.otc.2009.01.012; Tong J, 2015, NEURO-OPHTHALMOLOGY, V39, P236, DOI 10.3109/01658107.2015.1056380; Welch KC, 2009, LARYNGOSCOPE, V119, P2258, DOI 10.1002/lary.20618; Wong W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196007; Woung LC, 2007, NEUROEPIDEMIOLOGY, V29, P250, DOI 10.1159/000112858; Xiong Mengfei, 2018, Eur J Case Rep Intern Med, V5, P000905, DOI 10.12890/2018_000905	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220286	10.1371/journal.pone.0220286	http://dx.doi.org/10.1371/journal.pone.0220286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390351	Green Published, Green Submitted, gold			2022-12-26	WOS:000484999400014
J	Liu, CL; Sun, QW; Xing, QG; Wang, SF; Tang, DL; Zhu, DH; Xing, X				Liu, Chunli; Sun, Qiwei; Xing, Qianguo; Wang, Sufen; Tang, Danling; Zhu, Donghe; Xing, Xiang			Variability in phytoplankton biomass and effects of sea surface temperature based on satellite data from the Yellow Sea, China	PLOS ONE			English	Article							CHLOROPHYLL-A; SPATIOTEMPORAL VARIABILITY; INTERANNUAL VARIABILITY; SEASONAL VARIABILITY; OCEAN COLOR; LONG-TERM; CLIMATE; PACIFIC; RECONSTRUCTION; TRENDS	A time series of satellite data on Chlorophyll-a concentration (Chl-a) that used ocean color was studied to determine mechanisms of phytoplankton variation in recent decade in the Yellow Sea, China during 2003-2015. The variability patterns on seasonal and inter-annual oscillation periods were confirmed using the Empirical Orthogonal Function (EOF), and Morlet wavelet transform analyses, respectively. The first EOF mode for Chl-a was dominated by obvious spring and fall blooms in a spatial pattern that was related to the strong mixing of the water masses from the Yellow Sea Cold Warm Mass (YSCWM) and the Yellow Sea Warm Current (YSWC) in winter. The second EOF mode for Chl-a showed an opposite spatial pattern between the northern and southern regions. The temporal coefficient showed differences in the timing of blooms. On an inter-annual scale, Chl-a indicated variation at periods of 2-4 years during 2003-2015. Chl-a showed a significantly negative correlation with the sea surface temperature (r = -0.21, p<0.01), with time lags of 4 months (Chl-a ahead). Chl-a was coupled with El Nino Southern Oscillation (ENSO) events, with a positive correlation (r = 0.46, p<0.01) at a lag of 3-5 months (ENSO ahead). The present study demonstrated that the variation in phytoplankton biomass was controlled primarily by water mass seasonally, and it was influenced by ENSO events on an inter-annual scale.	[Liu, Chunli; Xing, Xiang] Shandong Univ Weihai, Marine Coll, Weihai, Peoples R China; [Sun, Qiwei] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China; [Sun, Qiwei] Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing, Peoples R China; [Xing, Qianguo] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Wang, Sufen; Tang, Danling] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangdong Key Lab Remote Sensing, Guangzhou, Guangdong, Peoples R China; [Zhu, Donghe] Zhejiang Univ, Ocean Coll, Zhoushan, Peoples R China	Shandong University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Zhejiang University	Liu, CL; Xing, X (corresponding author), Shandong Univ Weihai, Marine Coll, Weihai, Peoples R China.	chunliliu@sdu.edu.cn; xingxiang@sdu.edu.cn	Xing, Qianguo/AAR-7174-2021	Sun, Qiwei/0000-0002-7128-224X	National Natural Science Foundation of China-Shandong joint fund [U1806203]; National Science Foundation of China [41206166]; Fundamental Research Funds for the Central Universities [2019ZRJC005]; Postdoctoral Science Foundation of China [2017M622180]; Fundamental of Guangdong Key Laboratory of Ocean Remote Sensing (South China Sea Institute of Oceanology Chinese Academy of Sciences) [2017B030301005-LORS1803]	National Natural Science Foundation of China-Shandong joint fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental of Guangdong Key Laboratory of Ocean Remote Sensing (South China Sea Institute of Oceanology Chinese Academy of Sciences)	This study was supported by the National Natural Science Foundation of China-Shandong joint fund (U1806203), the National Science Foundation of China (41206166), the Fundamental Research Funds for the Central Universities (2019ZRJC005), the Postdoctoral Science Foundation of China (2017M622180), the Fundamental of Guangdong Key Laboratory of Ocean Remote Sensing (South China Sea Institute of Oceanology Chinese Academy of Sciences) (2017B030301005-LORS1803).	Alvera-Azcarate A, 2015, ESTUAR COAST SHELF S, V159, P28, DOI 10.1016/j.ecss.2015.03.026; Beckers JM, 2006, OCEAN SCI, V2, P183, DOI 10.5194/os-2-183-2006; Beckers JM, 2003, J ATMOS OCEAN TECH, V20, P1839, DOI 10.1175/1520-0426(2003)020<1839:ECADFF>2.0.CO;2; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Chu P, 2005, ADV ATMOS SCI, V22, P1, DOI 10.1007/BF02930865; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gao S, 2013, ACTA OCEANOL SIN, V32, P48, DOI 10.1007/s13131-013-0266-8; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Gregg WW, 2005, GEOPHYS GEOPHYS RES, V32, P259; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; He RY, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042658; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Hou XY, 2016, J MARINE SYST, V158, P59, DOI 10.1016/j.jmarsys.2016.01.008; Huynh HNT, 2016, J OCEANOGR, V72, P707, DOI 10.1007/s10872-016-0365-1; Li YZ, 2014, REMOTE SENS ENVIRON, V144, P98, DOI 10.1016/j.rse.2014.01.019; Lie H-J, 2009, J GEOPHYS RES, V114, P362; Liu DY, 2013, PROG OCEANOGR, V116, P154, DOI 10.1016/j.pocean.2013.07.003; Liu ML, 2014, CONT SHELF RES, V75, P15, DOI 10.1016/j.csr.2013.12.010; Matsumoto K, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006845; Messie M, 2006, DEEP-SEA RES PT I, V53, P1581, DOI 10.1016/j.dsr.2006.06.007; Miles TN, 2010, CONT SHELF RES, V30, P1951, DOI 10.1016/j.csr.2010.08.016; Moradi M, 2015, MAR POLLUT BULL, V98, P14, DOI 10.1016/j.marpolbul.2015.07.018; NORTH GR, 1982, MON WEATHER REV, V110, P699, DOI 10.1175/1520-0493(1982)110<0699:SEITEO>2.0.CO;2; Olita A, 2011, OCEAN DYNAM, V61, P89, DOI 10.1007/s10236-010-0344-9; Park JY, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007056; Qiu FW, 2011, CHIN J OCEANOL LIMN, V29, P18, DOI 10.1007/s00343-011-9931-y; Racault MF, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00133; Rousseaux CS, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008083; Shi W, 2012, PROG OCEANOGR, V104, P30, DOI 10.1016/j.pocean.2012.05.001; Shiozaki T, 2013, ADV SPACE RES, V52, P668, DOI 10.1016/j.asr.2013.05.005; Siswanto E, 2011, J OCEANOGR, V67, P627, DOI 10.1007/s10872-011-0062-z; Thomas AC, 2012, DEEP-SEA RES PT II, V77-80, P99, DOI 10.1016/j.dsr2.2012.04.008; Townsend DW, 2010, CONT SHELF RES, V30, P820, DOI 10.1016/j.csr.2010.01.019; Tseng CM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038252; Volpe G, 2012, REMOTE SENS ENVIRON, V117, P223, DOI 10.1016/j.rse.2011.09.020; Wei QS, 2016, J SEA RES, V112, P1, DOI 10.1016/j.seares.2016.02.004; Wilson C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002724; Xie SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015884; Xu M, 2016, MAR POLLUT BULL, V105, P58, DOI 10.1016/j.marpolbul.2016.02.067; Yamaguchi H, 2012, PROG OCEANOGR, V105, P22, DOI 10.1016/j.pocean.2012.04.004; Yu F, 2010, CHIN J OCEANOL LIMN, V28, P677, DOI 10.1007/s00343-010-0006-2; Zhang SW, 2008, CONT SHELF RES, V28, P442, DOI 10.1016/j.csr.2007.10.002; Zhao H, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003536	46	10	10	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220058	10.1371/journal.pone.0220058	http://dx.doi.org/10.1371/journal.pone.0220058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386653	Green Submitted, gold, Green Published			2022-12-26	WOS:000484997100015
J	Bennasrallah, C; Kacem, M; Dhouib, W; Zemni, I; Ben Fredj, M; Abroug, H; Djobbi, A; Green, A; Said, SG; Maalel, I; Stambouli, S; Zhir, W; Youssef, HBH; Belguith, AS				Bennasrallah, Cyrine; Kacem, Meriem; Dhouib, Wafa; Zemni, Imen; Ben Fredj, Manel; Abroug, Hela; Djobbi, Amira; Green, Assia; Said, Samia Grira; Maalel, Issam; Stambouli, Sarra; Zhir, Wafa; Youssef, Hichem Bel Haj; Belguith, Asma Sriha			BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; METAANALYSIS; PROTECTION; RISK	We aimed to describe incidence, trends of tuberculosis (TB) over 18 years and to evaluate the impact of the BCG vaccine after four decades of immunization program according to three protocols. We performed a cohort study including declared cases in Monastir from January 1, 2000 to December 31, 2017. We reported 997 cases of TB. The predominant site was pulmonarylocalization (n = 486). The age standardized incidence of pulmonary and lymph node TB per 100,000 inh were 5.71 and 2.57 respectively. Trends were negative for pulmonary TB (PTB) (b = -0.82; r = -0.67; p< 10(-3)) and positive for lymph node localization (b = 1.31; r = 0.63; p< 10(-3)). We had not notified cases of HIV associated with TB. Crude incidence rate (CIR) of PTB per 100,000 inh was 8.17 in Non-Vaccinated Cohort (NVC) and 2.85 in Vaccinated Cohort (VC) (p < 0.0001). Relative risk reduction (RRR) of BCG vaccination was 65.1% (95% CI: 57.5; 71.4) for pulmonary localization and 65% (95% CI: 55; 73) for other localizations. We have not established a significant RRR of BCG vaccination on lymph node TB. Protocol 3 (at birth) had the highest effectiveness with a RRR of 96.7% (95% CI: 86.6%; 99.2%) and 86% (95% CI: 71%; 91%) in patients with PTB and other localizations TB respectively. In Cox regression model the HR was 0.061 (95% CI 0.015-0.247) for PTB and 0.395 (95% CI 0.185-0.844) for other localizations TB in patients receiving protocol 3 compared to NVC. For lymph-node TB, HR was 1.390 (95% CI 1.043-1.851) for protocol 1 and 1.849 (95% CI 1.232-2.774) for protocol 2 compared to NVC. Depending on the three protocols, the BCG vaccine had a positive impact on PTB and other TB localizations that must be kept and improved. However, protocols 1 and 2 had a reverse effect on lymph node TB.	[Bennasrallah, Cyrine; Kacem, Meriem; Dhouib, Wafa; Zemni, Imen; Ben Fredj, Manel; Abroug, Hela; Belguith, Asma Sriha] Univ Monastir, Dept Epidemiol & Prevent Med, Monastir, Tunisia; [Djobbi, Amira; Green, Assia; Said, Samia Grira; Maalel, Issam; Youssef, Hichem Bel Haj] Reg Direct Primary Hlth Monastir, Monastir, Tunisia; [Stambouli, Sarra; Zhir, Wafa] Univ Monastir, Dept Family Med, Monastir, Tunisia	Universite de Monastir; Universite de Monastir	Belguith, AS (corresponding author), Univ Monastir, Dept Epidemiol & Prevent Med, Monastir, Tunisia.	belguith_asma@yahoo.fr	Abroug, Hela/AAD-6764-2019	Abroug, Hela/0000-0002-9666-4914				Abebe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-504; [Anonymous], 2015, GLOBAL TUBERCULOSIS; Baily G V, 1980, Indian J Med Res, V72 Suppl, P1; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; De Cock K, 1994, Afr Health, V16, P8; Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8; Fader T, 2010, INT J INFECT DIS, V14, pE102, DOI 10.1016/j.ijid.2009.03.023; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Gaifer ZA, 2017, INT J MYCOBACT, V6, P356, DOI 10.4103/ijmy.ijmy_123_17; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Kacem M, 2018, REV SYSTEMATIQUE LIT, P696; Khattab MA, 2015, ADV INFECT DIS, V5, P148, DOI [DOI 10.4236/aid.2015.54018, DOI 10.1038/ni1443]; Kouni Chahed M, 2010, SANTE, V20, P87, DOI [10.1684/san.2010.0191, DOI 10.1684/SAN.2010.0191]; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Meddeb N, 2005, OSTEOPOROSIS INT, V16, P180, DOI 10.1007/s00198-004-1658-6; Meira L, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.PA2653; Moliva JI, 2015, VACCINE, V33, P5035, DOI 10.1016/j.vaccine.2015.08.033; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Newman Thomas B., GOLDMAN CECIL MED, V9, P32, DOI [10.1186/1741-7015-9-32, DOI 10.1186/1741-7015-9-32]; Reuter H, 2009, TUBERCULOSIS COMPREH, P377; Rowinska-Zakrzewska Ewa, 2013, Pneumonol Alergol Pol, V81, P121; Smaoui S, 2015, INT J MYCOBACT, V4, P196, DOI 10.1016/j.ijmyco.2015.04.004; Snow KJ, 2018, EPIDEMIOL INFECT, V146, P946, DOI 10.1017/S0950268818000821; Tatar D, 2016, IRAN J PUBLIC HEALTH, V45, P305; Tinsa Faten, 2009, Tunis Med, V87, P693; Tiwari V, 2016, INT J ADV INTEGR MED, V1, P95, DOI [10.5005/jp-journals-10050-10033, DOI 10.5005/JP-JOURNALS-10050-10033]; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; World Health Organization, 2013, GLOBALTUBERCULOSISRE; World Health Organization, WHO GLOBAL TUBERCULO; Zhang Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011732; 2014, FRAMEWORK TOWARDS TU, P1	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219991	10.1371/journal.pone.0219991	http://dx.doi.org/10.1371/journal.pone.0219991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381577	Green Published, Green Submitted, gold			2022-12-26	WOS:000484993600008
J	Cho, YK; Lee, J; Kang, YM; Yoo, JH; Park, JY; Jung, CH; Lee, WJ				Cho, Yun Kyung; Lee, Jiwoo; Kang, Yu Mi; Yoo, Jee Hee; Park, Joong-Yeol; Jung, Chang Hee; Lee, Woo Je			Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITORS; DOUBLE-BLIND; ADD-ON; SGLT2 INHIBITORS; METFORMIN; 24-WEEK; WEIGHT	We aimed to investigate the clinical factors affecting the therapeutic effectiveness of the sodium-glucose cotransporter-2 inhibitor empagliflozin in patients with type 2 diabetes mellitus (T2DM). We reviewed the medical records of 374 T2DM patients aged between 20 and 75 years who were prescribed empagliflozin 10 mg or 25 mg as add-on therapy for more than 90 consecutive days. Changes in hemoglobin A1c (HbA1c) from baseline levels and the reduction in body weights of the study participants were assessed. We found that younger patients (. 50 years), patients with the highest levels of HbA1c (> 9%) at baseline, patients with an estimated glomerular filtration rate (eGFR) of > 90 mL/min/1.73 m(2), and patients with a shorter duration of T2DM (< 10 years) were more likely to exhibit a better glycemic response. Multivariate linear regression analysis revealed that a shorter duration of T2DM, higher baseline levels of HbA1c, and higher eGFR were positively associated with HbA1c reduction. Higher BMI and lower HbA1c levels were predictors of a more significant reduction in body weight among patients taking empagliflozin. The glucose-lowering effect of empagliflozin was more evident in T2DM patients with higher baseline HbA1c levels, better renal function, and shorter duration of T2DM.	[Cho, Yun Kyung; Lee, Jiwoo; Park, Joong-Yeol; Jung, Chang Hee; Lee, Woo Je] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea; [Cho, Yun Kyung] Kangwon Natl Univ, Dept Internal Med, Sch Med, Chunchon, South Korea; [Kang, Yu Mi] Univ Ulsan, Int Healthcare Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea; [Yoo, Jee Hee] Sungkyunkwan Univ, Samsung Med Ctr, Dept Internal Med, Sch Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; Kangwon National University; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WJ (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea.	lwjatlas@amc.seoul.kr	Jung, Chang Hee/AAU-7897-2020; Kang, Yu Mi/AAW-2935-2020	LEE, WOO JE/0000-0002-9605-9693				Abdul-Ghani MA, 2013, DIABETES, V62, P3324, DOI 10.2337/db13-0604; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; DeFronzo RA, 2015, DIABETES CARE, V38, P384, DOI 10.2337/dc14-2364; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Haring HU, 2014, DIABETES CARE, V37, P1650, DOI 10.2337/dc13-2105; Haring HU, 2013, DIABETES CARE, V36, P3396, DOI 10.2337/dc12-2673; Iemitsu Kotaro, 2016, J Clin Med Res, V8, P373, DOI 10.14740/jocmr2492w; Kalra S, 2014, DIABETES THER, V5, P355, DOI 10.1007/s13300-014-0089-4; Ko SH, 2017, DIABETES METAB J, V41, P337, DOI 10.4093/dmj.2017.41.5.337; Kohan DE, 2014, KIDNEY INT, V85, P962, DOI 10.1038/ki.2013.356; Korean Diabetes Association, DIAB FACT SHEET; Korean Society for the Study of Obesity, 2017 OB FACT SHEET; Kovacs CS, 2014, DIABETES OBES METAB, V16, P147, DOI 10.1111/dom.12188; Lee JY, 2017, DIABETES METAB, V43, P191, DOI 10.1016/j.diabet.2016.11.005; Lee PC, 2018, OBES REV, V19, P1630, DOI 10.1111/obr.12755; Li J, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007201; Roden M, 2013, LANCET DIABETES ENDO, V1, P208, DOI 10.1016/S2213-8587(13)70084-6; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Yagi S, 2018, ADV THER, V35, P124, DOI 10.1007/s12325-017-0639-z; Zanoli L, 2015, ScientificWorldJournal, V2015, P317507, DOI 10.1155/2015/317507; Zhang L, 2010, DIABETES OBES METAB, V12, P510, DOI 10.1111/j.1463-1326.2010.01216.x	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220667	10.1371/journal.pone.0220667	http://dx.doi.org/10.1371/journal.pone.0220667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369642	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900078
J	Sanghera, DK; Hopkins, R; Malone-Perez, MW; Bejar, C; Tan, CC; Mussa, H; Whitby, P; Fowler, B; Rao, CV; Fung, KA; Lightfoot, S; Frazer, JK				Sanghera, Dharambir K.; Hopkins, Ruth; Malone-Perez, Megan W.; Bejar, Cynthia; Tan, Chengcheng; Mussa, Huda; Whitby, Paul; Fowler, Ben; Rao, Chinthapally, V; Fung, KarMing A.; Lightfoot, Stan; Frazer, J. Kimble			Targeted sequencing of candidate genes of dyslipidemia in Punjabi Sikhs: Population-specific rare variants in GCKR promote ectopic fat deposition	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; DIABETES SUSCEPTIBILITY; ABDOMINAL OBESITY; HDL CHOLESTEROL; HEART-DISEASE; IN-VIVO	Dyslipidemia is a well-established risk factor for cardiovascular diseases. Although, advances in genome-wide technologies have enabled the discovery of hundreds of genes associated with blood lipid phenotypes, most of the heritability remains unexplained. Here we performed targeted resequencing of 13 bona fide candidate genes of dyslipidemia to identify the underlying biological functions. We sequenced 940 Sikh subjects with extreme serum levels of hypertriglyceridemia (HTG) and 2,355 subjects were used for replication studies; all 3,295 participants were part of the Asian Indians Diabetic Heart Study. Gene-centric analysis revealed burden of variants for increasing HTG risk in GCKR (p = 2.1x10(-5)), LPL (p = 1.6x10(-3)) and MLXIPL (p = 1.6x10(-2)) genes. Of these, three missense and damaging variants within GCKR were further examined for functional consequences in vivo using a transgenic zebrafish model. All three mutations were South Asian population-specific and were largely absent in other multiethnic populations of Exome Aggregation Consortium. We built different transgenic models of human GCKR with and without mutations and analyzed the effects of dietary changes in vivo. Despite the short-term of feeding, profound phenotypic changes were apparent in hepatocyte histology and fat deposition associated with increased expression of GCKR in response to a high fat diet (HFD). Liver histology of the GCKR(mut) showed severe fatty metamorphosis which correlated with similar to 7 fold increase in the	[Sanghera, Dharambir K.; Hopkins, Ruth; Bejar, Cynthia; Tan, Chengcheng] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Genet,Coll Med, Oklahoma City, OK 73190 USA; [Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73104 USA; [Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73104 USA; [Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA; [Malone-Perez, Megan W.; Frazer, J. Kimble] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Pediat Hematol Oncol,Coll Med, Oklahoma City, OK 73190 USA; [Mussa, Huda; Whitby, Paul] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Infect Dis,Coll Med, Oklahoma City, OK 73190 USA; [Fowler, Ben] Oklahoma Med Res Fdn, Imaging Core Facil, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Rao, Chinthapally, V] Univ Oklahoma, Hlth Sci Ctr, Ctr Canc Prevent & Drug Dev, Stephenson Canc Ctr, Oklahoma City, OK USA; [Fung, KarMing A.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Lightfoot, Stan] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Sanghera, DK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Sect Genet,Coll Med, Oklahoma City, OK 73190 USA.; Sanghera, DK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73104 USA.; Sanghera, DK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73104 USA.; Sanghera, DK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA.	Dharambir-sanghera@ouhsc.edu		Frazer, John Kimble/0000-0003-2936-2817; Sanghera, Dharambir/0000-0001-7203-8655	National Institutes of Health [R01DK082766, NOT-HG-11-009]; Presbyterian Health Foundation; National Heart, Lung, and Blood Institute of the National Institutes of Health [HHSN268201100037C]; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103639]; National Cancer Institute of the National Institutes of Health [P30CA225520]; Hyundai Hope On Wheels; Oklahoma Center for the Advancement of Science and Technology [HRP-067]; National Institute of General Medical Sciences INBRE pilot project award [P20 GM103447]; E.L. & Thelma Gaylord Endowed Chair of the Children's Hospital Foundation; NATIONAL CANCER INSTITUTE [P30CA225520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447, P20GM103639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Presbyterian Health Foundation; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hyundai Hope On Wheels; Oklahoma Center for the Advancement of Science and Technology; National Institute of General Medical Sciences INBRE pilot project award; E.L. & Thelma Gaylord Endowed Chair of the Children's Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.K.S: The Sikh Diabetes Study/Asian Indian Diabetic Heart Study was supported by National Institutes of Health grants-R01DK082766 (NIDDK) (https://www.niddk.nih.gov/), NOT-HG-11-009 (NHGRI) (https://www.genome.gov/), and grants from the Presbyterian Health Foundation (http://phfokc.com/).Sequencing services were provided through the RS&G Service by the Northwest Genomics Center at the University of Washington, Department of Genome Sciences, under U.S. Federal Government contract number HHSN268201100037C from the National Heart, Lung, and Blood Institute of the National Institutes of Health (https://www.nhlbi.nih.gov/).Cancer Core Lab: Funding for the use of Histology and Immunohistochemistry Core was provided by an Institutional Development Award (IDeA) grant number P20 GM103639 from the National Institute of General Medical Sciences of the National Institutes of Health (https://www.nigms.nih.gov/Research/DRCB/IDeA/pages/INBRE.aspx), and Tissue Pathology Shared Resources by National Cancer Institute Grant P30CA225520 of the National Institutes of Health (https://www.cancer.gov/).The ZebraFish laboratory of J.K.F. was funded by grants from Hyundai Hope On Wheels (https://hyundaihopeonwheels.org/), the Oklahoma Center for the Advancement of Science and Technology (HRP-067) (https://www.ok.gov/ocast/), a National Institute of General Medical Sciences (P20 GM103447) INBRE pilot project award (https://www.nigms.nih.gov/Research/DRCB/IDeA/pages/INBRE.aspx), and the E.L. & Thelma Gaylord Endowed Chair of the Children's Hospital Foundation (https://chfkids.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2001, J DIABETES COMPLICAT, V15, P320, DOI 10.1016/S1056-8727(01)00161-1; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; BANERJI MA, 1995, DIABETES, V44, P141, DOI 10.2337/diabetes.44.2.141; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Baroukh N, 2004, ARTERIOSCL THROM VAS, V24, P1297, DOI 10.1161/01.ATV.0000130463.68272.1d; Been LF, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-18; Braun TR, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000213; Brouwers MCGJ, 2015, TRENDS MOL MED, V21, P583, DOI 10.1016/j.molmed.2015.08.004; Brunham LR, 2010, CURR DIABETES REP, V10, P55, DOI 10.1007/s11892-009-0090-x; Cheng TMK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000135; Chowdhury B, 1996, METABOLISM, V45, P634, DOI 10.1016/S0026-0495(96)90036-0; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Havel RJ, 2010, ARTERIOSCL THROM VAS, V30, P9, DOI 10.1161/ATVBAHA.108.178756; Hayward BE, 1998, GENOMICS, V49, P137, DOI 10.1006/geno.1997.5195; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; KAHN HS, 1993, J CLIN EPIDEMIOL, V46, P491, DOI 10.1016/0895-4356(93)90027-X; Karter AJ, 1996, DIABETES, V45, P1547, DOI 10.2337/diabetes.45.11.1547; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Lee W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008311; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Lloyd DJ, 2013, NATURE, V504, P437, DOI 10.1038/nature12724; Mahajan A, 2018, NAT GENET, V50, P559, DOI 10.1038/s41588-018-0084-1; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; MCKEIGUE PM, 1992, DIABETOLOGIA, V35, P785; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Raimondo A, 2015, CURR OPIN LIPIDOL, V26, P88, DOI 10.1097/MOL.0000000000000155; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reddivari L, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1278-8; RISSANEN AM, 1977, BRIT HEART J, V39, P875, DOI 10.1136/hrt.39.8.875; ROBERTSON FW, 1981, GENET RES, V37, P1, DOI 10.1017/S0016672300019972; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sanghera DK, 2006, HUM BIOL, V78, P43, DOI 10.1353/hub.2006.0027; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Sanghera DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021188; Sanghera DK, 2016, MED UPDATE 2016 1; Santoro N, 2012, HEPATOLOGY, V55, P781, DOI 10.1002/hep.24806; Sapkota BR, 2016, J STEROID BIOCHEM, V158, P149, DOI 10.1016/j.jsbmb.2015.12.014; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2014, CIRC-CARDIOVASC GENE, V7, P287, DOI 10.1161/CIRCGENETICS.113.000412; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Schierer A, 2012, PHARMACOGENET GENOM, V22, P95, DOI 10.1097/FPC.0b013e32834dc9ef; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schlegel A, 2012, CELL MOL LIFE SCI, V69, P3953, DOI 10.1007/s00018-012-1037-y; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; SING CF, 1978, AM J HUM GENET, V30, P491; Snieder H, 1999, ARTERIOSCL THROM VAS, V19, P2826, DOI 10.1161/01.ATV.19.12.2826; SPRECHER DL, 1994, CIRCULATION, V90, P1177, DOI 10.1161/01.CIR.90.3.1177; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; YANG WS, 1995, P NATL ACAD SCI USA, V92, P4462, DOI 10.1073/pnas.92.10.4462; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963; ZIMMET PZ, 1992, DIABETES CARE, V15, P232, DOI 10.2337/diacare.15.2.232	69	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0211661	10.1371/journal.pone.0211661	http://dx.doi.org/10.1371/journal.pone.0211661			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369557	gold, Green Submitted, Green Published			2022-12-26	WOS:000484987900002
J	Batista, EPA; Mapua, SA; Ngowo, H; Matowo, NS; Melo, EF; Paixao, KS; Eiras, AE; Okumu, FO				Batista, Elis P. A.; Mapua, Salum A.; Ngowo, Halfan; Matowo, Nancy S.; Melo, Elizangela F.; Paixao, Kelly S.; Eiras, Alvaro E.; Okumu, Fredros O.			Videographic analysis of flight behaviours of host-seeking Anopheles arabiensis towards BG-Malaria trap	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITOS; GAMBIAE-SENSU-STRICTO; CARBON-DIOXIDE; DIPTERA; ODOR; CULICIDAE; CATCHES; 1-OCTEN-3-OL; ORIENTATION; ACTIVATION	The BG-Malaria trap (BGM) is an adaptation of the well-known BG-Sentinel trap (BGS) with greater trapping efficiencies for anopheline and culicine mosquitoes. Its continued optimization requires greater understanding of mosquito flight behaviors near it. We used three high-resolution infrared cameras (68 frames/second) to track flight behaviors of laboratory-reared Anopheles arabiensis females in vicinity of the BGM in comparison with BGS. Additional comparisons were done for BGM at 20, 40 and 80cm heights, and for BGMs baited with Ifakara blend plus CO2, CO2 alone, or no bait. More mosquitoes were observed near BGM than BGS. Both BGMs installed 20cm above the floor and baited with CO2 received more visits by host-seeking mosquitoes than the other BGMs evaluated in their respective experiments. Trap designs, height and attractants all influence mosquito activity in vicinity of the traps which can be readily visualized using infrared cameras to accelerate trap development and testing. The greater activity of host-seeking mosquitoes near BGM than BGS supports the proven superiority of BGM traps in field and semi-field settings.	[Batista, Elis P. A.; Melo, Elizangela F.; Paixao, Kelly S.; Eiras, Alvaro E.] Univ Fed Minas Gerais, Biol Sci Inst, Dept Parasitol, Lab Innovat Technol Vector Control, Belo Horizonte, MG, Brazil; [Batista, Elis P. A.; Mapua, Salum A.; Ngowo, Halfan; Matowo, Nancy S.; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania; [Mapua, Salum A.] Univ Keele, Sch Life Sci, Keele, Staffs, England; [Mapua, Salum A.] Univ Salford, Sch Environm & Life Sci, Manchester, Lancs, England; [Ngowo, Halfan; Okumu, Fredros O.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Matowo, Nancy S.] Univ Basel, Basel, Switzerland; [Matowo, Nancy S.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Okumu, Fredros O.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Parktown, South Africa	Universidade Federal de Minas Gerais; Ifakara Health Institute; Keele University; University of Manchester; University of Salford; University of Glasgow; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; University of Witwatersrand	Batista, EPA (corresponding author), Univ Fed Minas Gerais, Biol Sci Inst, Dept Parasitol, Lab Innovat Technol Vector Control, Belo Horizonte, MG, Brazil.; Batista, EPA (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania.	ebatista@ihi.or.tz	Eiras, Alvaro/Z-6023-2019; Ngowo, Halfan/AFS-8039-2022; Batista, Elis P A/O-7790-2018; Mapua, Salum Abdallah/HGB-8797-2022	Eiras, Alvaro/0000-0002-3045-0673; Ngowo, Halfan/0000-0003-2789-0261; Batista, Elis P A/0000-0002-5545-6633; Mapua, Salum Abdallah/0000-0002-3309-4328; Matowo, Nancy/0000-0002-2302-3796	Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine grant [WT102350/Z/13]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.133584/2016-01]; Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine [212633/Z/18/Z]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e Inovacao (CNPq/MCTI) [310205/2014-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [PPM-00502-15]	Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine grant(Wellcome Trust); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e Inovacao (CNPq/MCTI); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was funded by Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine grant awarded to FOO (Grant Number: WT102350/Z/13). EPAB was funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Grant 88881.133584/2016-01). SAM was funded by Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine (Grant Number: 212633/Z/18/Z). AEE was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e Inovacao (CNPq/MCTI) (Grant 310205/2014-0) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (Grant PPM-00502-15).	Batista EPA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205358; Batista EPA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186696; Cooper RD, 2004, J AM MOSQUITO CONTR, V20, P239; Cooperband MF, 2006, MED VET ENTOMOL, V20, P11, DOI 10.1111/j.1365-2915.2006.00613.x; Cribellier A, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180246; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x; Dekker T, 1998, ENTOMOL EXP APPL, V87, P295, DOI 10.1023/A:1003278228021; EIRAS A, 2001, FEROMONIOS INSETOS B, P206; EIRAS A, 1996, P IFS WORKSH CHEM EC; Gama RA, 2013, MEM I OSWALDO CRUZ, V108, P763, DOI 10.1590/0074-0276108062013013; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Govella NJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1513-1; Grant AJ, 1996, CIBA F SYMP, V200, P233; Hawkes F, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1609-z; HEALY TP, 1995, MED VET ENTOMOL, V9, P331, DOI 10.1111/j.1365-2915.1995.tb00143.x; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Hiwat H, 2011, J MED ENTOMOL, V48, P1039, DOI 10.1603/ME10245; Jawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019676; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kline DL, 1999, J AM MOSQUITO CONTR, V15, P276; Kline DL, 2002, J VECTOR ECOL, V27, P1; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Laarman JJ, 1955, HOST SEEKING BEHAV M; Lacey ES, 2011, MED VET ENTOMOL, V25, P94, DOI 10.1111/j.1365-2915.2010.00921.x; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Maia MF, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-124; Maliti DV, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1025-4; Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137; Mboera LE., 1997, REV MED VET ENTOMOL, V85, P355; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Lima JBP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005245; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; REEVES WC, 1953, AM J TROP MED HYG, V2, P325, DOI 10.4269/ajtmh.1953.2.325; Rodrigues MS, 2014, J AM MOSQUITO CONTR, V30, P184, DOI 10.2987/14-6423R.1; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Siria DJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2823-7; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x; Takken W, 1997, J INSECT BEHAV, V10, P395, DOI 10.1007/BF02765606; Tangena JAA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138735; Team RC, 2015, R LANG ENV STAT COMP; van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046; WHO, 2015, GLOB TECHN STRAT MAL; Wilton DP, 1975, MOSQUITO NEWS	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220563	10.1371/journal.pone.0220563	http://dx.doi.org/10.1371/journal.pone.0220563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365584	Green Published, Green Accepted, gold			2022-12-26	WOS:000484983600055
J	Hirschenhauser, K; Frigerio, D; Leithinger, V; Schenkenfelder, I; Neubock-Hubinger, B				Hirschenhauser, Katharina; Frigerio, Didone; Leithinger, Victoria; Schenkenfelder, Ines; Neuboeck-Hubinger, Brigitte			Primary pupils, science and a model bird species: Evidence for the efficacy of extracurricular science education	PLOS ONE			English	Article							ATTITUDE; TECHNOLOGY; KNOWLEDGE; TEACHERS; MOTIVATION; PCK	Beyond subject matter learning, primary science teaching aims at encouraging positive attitudes toward, and lasting interest in, science. This study tested whether the learning and science commitment of 8- to 10-year old pupils was affected by extracurricular learning opportunities involving repeated interactions with free-living northern bald ibis (Geronticus eremita; an endangered bird species) and professional researchers. To examine the project's efficacy, pupils' learning progress was monitored by repeated measures of knowledge (i) about northern bald ibises in specific, and (ii) of bird diversity in general. In addition, the children's attitudes toward science were monitored and their dynamic mental models of northern bald ibis' morphology and size were assessed from drawings. A total of 55 pupils from two schools were tested for eight months (before, during and after the experience). Control groups went through regular (curricular) science lessons with similar content and time investment. The extracurricular experience produced a clear learning progress with large effect sizes, which was particularly evident on a long timescale. In addition to subject matter knowledge, the project group pupils could name more bird species and expressed their views about the importance of scientific research for society in a higher proportion than control groups. Differences between schools suggest that project participation also changed the teacher's own interest in northern bald ibises, which affected learning in the control group taught by the same teacher. Beyond the pupils' language and reading skills, learning progress was also visible by scoring ibis-typical features in drawings; their mental models of relative size were not changed due to project participation, however. The results are discussed in reference to inducing and maintaining pupils' attitude and interest in a topic. The study adds empirical evidence for the potentials of advancing primary science education e.g. by fostering the collaboration of schools with scientists.	[Hirschenhauser, Katharina; Leithinger, Victoria; Schenkenfelder, Ines; Neuboeck-Hubinger, Brigitte] Univ Coll Educ Upper Austria, Linz, Austria; [Frigerio, Didone] Univ Vienna, Core Facil Konrad Lorenz Res Stn Behav & Cognit, Grunau Im Almtal, Austria; [Frigerio, Didone] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna; University of Vienna	Hirschenhauser, K (corresponding author), Univ Coll Educ Upper Austria, Linz, Austria.	katharina.hirschenhauser@ph-ooe.at		Hirschenhauser, Katharina/0000-0001-8710-9022; Frigerio, Didone/0000-0001-5866-0413	Programme Sparkling Science, Project [SPA-05/26]	Programme Sparkling Science, Project	DF was funded by the Programme Sparkling Science, Project SPA-05/26. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams I, 2012, J RES SCI TEACH, V49, P1035, DOI 10.1002/tea.21036; Ainley M, 2011, CONTEMP EDUC PSYCHOL, V36, P4, DOI 10.1016/j.cedpsych.2010.08.001; Anderson R.D., 2002, J SCI TEACH EDUC, V13, P1, DOI DOI 10.1023/A:1015171124982; Bartoszeck A.B., 2017, EUR J ED RES, V6, P29; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Brooks M, 2009, INT J SCI EDUC, V31, P319, DOI 10.1080/09500690802595771; Caravita S., 1994, LEARN INSTR, V4, P89, DOI DOI 10.1016/0959-4752(94)90020-5; Decristan J, 2015, J EDUC RES, V108, P358, DOI 10.1080/00220671.2014.899957; Dewey J., 1913, INTEREST EFFORT ED; Frigerio D, MONITORING PUBLIC AW; Frigerio D, 2018, ETHOLOGY, V124, P365, DOI 10.1111/eth.12746; Frigerio Didone, 2013, Oeko-L, V35, P3; Gee NR, 2010, ANTHROZOOS, V23, P173, DOI 10.2752/175303710X12682332910051; Hidi S, 2000, REV EDUC RES, V70, P151, DOI 10.2307/1170660; Kelly S, 1995, PEOPLE POWER IN CATCHMENT CARE, P42; Kline MA., 2015, BEHAV BRAIN SCI, V38, P1, DOI [10.1017/S0140525X14000090, DOI 10.1017/S0140525X14000090]; Krapp A, 1992, ROLE INTEREST LEARNI, DOI DOI 10.1002/TEA.3660250602; Krapp A, 2011, INT J SCI EDUC, V33, P27, DOI 10.1080/09500693.2010.518645; Lederman NG, 2002, J RES SCI TEACH, V39, P497, DOI 10.1002/tea.10034; Loretto MC, 2010, BIOL LETTERS, V6, P14, DOI 10.1098/rsbl.2009.0510; Maio GR, 2018, PSYCHOL ATTITUDES AT, P370, DOI [10.1080/00220671.2014.899957, DOI 10.1080/00220671.2014.899957]; Miczajka VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143229; Minner DD, 2010, J RES SCI TEACH, V47, P474, DOI 10.1002/tea.20347; MITCHELL M, 1993, J EDUC PSYCHOL, V85, P424, DOI 10.1037/0022-0663.85.3.424; Motz BA, 2018, J LEARN ANAL, V5, P47, DOI 10.18608/jla.2018.52.4; Motz BA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181775; Mueller MP, 2017, ANIMALS SCI ED; Nadelson LS, 2018, INT J EDUC PSYCHOL, V7, P151, DOI 10.17583/ijep.2018.3349; Neubock-Hubinger B, 2016, GDSU J, V5, P59; OECD, 2007, PISA 2006 SCI COMP T, V2; Osborne J, 2003, INT J SCI EDUC, V25, P1049, DOI 10.1080/0950069032000032199; Park S, 2008, RES SCI EDUC, V38, P261, DOI 10.1007/s11165-007-9049-6; Patrick P, 2011, J SCI EDUC TECHNOL, V20, P630, DOI 10.1007/s10956-011-9290-7; Potvin P, 2014, STUD SCI EDUC, V50, P85, DOI 10.1080/03057267.2014.881626; Puehringer-Sturmayr V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191441; Rennie, 1996, RES SCI TECHNOLOGICA, V14, P43, DOI [10.1080/0263514960140104, DOI 10.1080/0263514960140104]; Rohaan EJ, 2010, INT J TECHNOL DES ED, V20, P15, DOI 10.1007/s10798-008-9055-7; Salmi H, 2015, JCOM-J SCI COMMUN, V14; Scheuch M, 2018, J BIOL EDUC, V52, P79, DOI 10.1080/00219266.2017.1405530; Schutz P. A., 2007, EMOTION ED; SHYMANSKY JA, 1983, J RES SCI TEACH, V20, P387, DOI 10.1002/tea.3660200504; Swirski H, 2018, INT J SCI EDUC, V40, P1136, DOI 10.1080/09500693.2018.1470348; Thornton A, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X14000636; Tintner A, 2002, ZOO BIOL, V21, P467, DOI 10.1002/zoo.10050; Tunicliffe S.D., 2007, VISUAL COMMUNICATION, V6, P99, DOI DOI 10.1177/1470357207071467; Tunnicliffe S. D., 2011, CEPS J, V1, P63; Wilde M, 2012, INT J SCI EDUC, V34, P2797, DOI 10.1080/09500693.2012.654829; WILLSON VL, 1983, J RES SCI TEACH, V20, P839, DOI 10.1002/tea.3660200906; Zhang DH, 2017, INT J SCI EDUC, V39, P1381, DOI 10.1080/09500693.2017.1332797; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011	50	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220635	10.1371/journal.pone.0220635	http://dx.doi.org/10.1371/journal.pone.0220635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365595	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600061
J	Spencer, L; McKenna, L; Fary, R; Jacques, A; Briffa, K				Spencer, Linda; McKenna, Leanda; Fary, Robyn; Jacques, Angela; Briffa, Kathy			Upper back pain in postmenopausal women and associated physical characteristics	PLOS ONE			English	Article							VERTEBRAL FRACTURES; OLDER WOMEN; BREAST SIZE; MUSCLE ENDURANCE; FLEXED POSTURE; RISK-FACTORS; KYPHOSIS; AGE; PREVALENCE; EXERCISE	The physical characteristics of postmenopausal women that are associated with upper back pain are not well-understood. The aim of this cross-sectional study was to identify the physical characteristics associated with presence and severity of upper back pain in healthy post-menopausal women. Self-reported upper back pain presence (within the previous month) and severity (numerical rating scale) were examined against the physical characteristics: height; weight; body mass index; breast size; breast ptosis; upper back extensor muscle endurance (isometric chest raise test); head, shoulder and upper back posture (photogrammetry); thoracic extension mobility (photogrammetry); bone mineral density (dual-energy x-ray absorptiometry (DXA)); body composition (DXA); and thoracic kyphosis, thoracic osteo-arthritis and thoracic vertebral fracture (all radiography). A multivariable logistic regression model, adjusted for age, was built using physical characteristics with a significant univariate association with upper back pain. Censored Tobit regression, adjusted for age, was used to examine each physical characteristic against upper back pain severity. Postmenopausal women (n = 119) with a mean (SD) age of 61.4 (7.0) years participated in the study. After adjusting for age, the physical characteristics independently associated with upper back pain were: height (OR: 0.50, 95% CI: 0.31-0.79); and upper back extensor muscle endurance (OR: 0.46, 95% CI: 0.28-0.75). This model explained 31% of the variance in upper back pain (p< 0.001). After adjusting for age, being taller and having better upper back extensor muscle endurance were associated with lower odds for upper back pain. After adjusting for age, differences in upper back pain severity were explained by upper back extensor muscle endurance (p = < 0.001) and lean mass (p = 0.01). Conclusion: As a modifiable physical characteristic of postmenopausal women with upper back pain, upper back extensor muscle endurance is worth considering clinically.	[Spencer, Linda; McKenna, Leanda; Fary, Robyn; Jacques, Angela; Briffa, Kathy] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia	Curtin University	Spencer, L (corresponding author), Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia.	Linda.spencer@curtin.edu.au	McKenna, Leanda/GMW-7930-2022	McKenna, Leanda/0000-0003-3007-8231; SPENCER, LINDA/0000-0001-8744-3346; Jacques, Angela/0000-0002-0461-681X	Australian Government Research Training Program Scholarship; Curtin University Research Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Curtin University Research Scholarship	The primary researcher (LS) undertook this work as part of completion of a PhD and was supported by an Australian Government Research Training Program Scholarship and Curtin University Research Scholarship, https://www.education.gov.au/research-training-program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameona, 2017, BREAST FORM FITT GUI; Australian Bureau of Statistics, 2013, POP PROJ AUSTR 2012; Berlei, 2018, AUSTR BRA SIZ; Boonstra AM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01466; Briggs AM, 2007, PHYS THER, V87, P595, DOI 10.2522/ptj.20060119; Briggs AM, 2009, J OCCUP HEALTH, V51, P177, DOI 10.1539/joh.K8007; Brown WJ, 2002, INT J BEHAV MED, V9, P53, DOI 10.1207/S15327558IJBM0901_04; Coltman C, 2015, SPORTS MED, V2, P5; Coltman CE, 2018, CLOTH TEXT RES J, V36, P78, DOI 10.1177/0887302X17743814; Coltman CE, 2018, CLIN BIOMECH, V53, P46, DOI 10.1016/j.clinbiomech.2018.02.002; den Tonkelaar I, 2004, MATURITAS, V48, P51, DOI 10.1016/j.maturitas.2003.10.002; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Drzal-Grabiec J, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-108; Edmondston SJ, 2012, J MANIP PHYSIOL THER, V35, P203, DOI 10.1016/j.jmpt.2012.01.008; Ensrud KE, 1997, J AM GERIATR SOC, V45, P682, DOI 10.1111/j.1532-5415.1997.tb01470.x; ETTINGER B, 1994, OSTEOPOROSIS INT, V4, P55, DOI 10.1007/BF02352262; Falla D, 2007, PHYS THER, V87, P408, DOI 10.2522/ptj.20060009; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fejer R, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-24; Findikcioglu K, 2007, AESTHET PLAST SURG, V31, P23, DOI 10.1007/s00266-006-0178-5; Gibson SJ, 2001, CLIN GERIATR MED, V17, P433, DOI 10.1016/S0749-0690(05)70079-3; Granito Renata Neves, 2014, Rev. bras. ortop., V49, P286, DOI 10.1016/j.rboe.2014.04.002; Greenbaum AR, 2003, BRIT J PLAST SURG, V56, P230, DOI 10.1016/S0007-1226(03)00122-X; Greendale GA, 2009, J AM GERIATR SOC, V57, P1569, DOI 10.1111/j.1532-5415.2009.02391.x; Griffith JF, 2015, QUANT IMAGING MED SU, V5, P592, DOI 10.3978/j.issn.2223-4292.2015.08.01; Hammann-Kloss JS, 2014, EUR J RADIOL, V83, P1092, DOI 10.1016/j.ejrad.2014.03.028; Harrison D E, 2001, Spine (Phila Pa 1976), V26, pE227, DOI 10.1097/00007632-200106010-00002; Hinman Martha R, 2004, Spine J, V4, P413, DOI 10.1016/j.spinee.2004.01.002; Huang C, 1996, J BONE MINER RES, V11, P1026; Ito T, 1996, ARCH PHYS MED REHAB, V77, P75, DOI 10.1016/S0003-9993(96)90224-5; ITOI E, 1994, MAYO CLIN PROC, V69, P1054, DOI 10.1016/S0025-6196(12)61372-X; Jang HJ, 2019, J GERIATR PHYS THER, V42, pE17, DOI 10.1519/JPT.0000000000000146; Jang HJ, 2015, J PHYS THER SCI, V27, P1161, DOI 10.1589/jpts.27.1161; Kado DM, 2013, J BONE MINER RES, V28, P179, DOI 10.1002/jbmr.1728; Katzman WB, 2007, ARCH PHYS MED REHAB, V88, P192, DOI 10.1016/j.apmr.2006.10.033; Machida Y, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000289; Mannion AF, 1997, J ANAT, V190, P505, DOI 10.1046/j.1469-7580.1997.19040505.x; MCALISTER WH, 1975, RADIOL CLIN N AM, V13, P113; McGhee D, 2010, J SCI MED SPORT S1, V13, pe87, DOI [10.1016/j.jsams.2010.10.646, DOI 10.1016/J.JSAMS.2010.10.646]; McGhee DE, 2018, CLIN BIOMECH, V51, P99, DOI 10.1016/j.clinbiomech.2017.12.009; McGhee DE, 2013, APPL ERGON, V44, P112, DOI 10.1016/j.apergo.2012.05.006; McIntosh G, 1998, J REHABIL OUTCOMES M, V2, P20; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; O'Sullivan PB, 2006, MANUAL THER, V11, P264, DOI 10.1016/j.math.2005.04.004; Parsons S, 2007, FAM PRACT, V24, P308, DOI 10.1093/fampra/cmm027; Raine S, 1997, ARCH PHYS MED REHAB, V78, P1215, DOI 10.1016/S0003-9993(97)90335-X; Raine S, 1994, Aust J Physiother, V40, P25, DOI 10.1016/S0004-9514(14)60451-7; Risius D, 2014, EUR J AGEING, V11, P233, DOI 10.1007/s10433-014-0310-3; RYAN PJ, 1994, BONE, V15, P27, DOI 10.1016/8756-3282(94)90887-7; Schinkel-Ivy A, 2016, J BACK MUSCULOSKELET, V29, P741, DOI 10.3233/BMR-160680; Shahidi B, 2015, J PAIN, V16, P1288, DOI 10.1016/j.jpain.2015.09.002; Shepherd JA, 2017, BONE, V104, P101, DOI 10.1016/j.bone.2017.06.010; Sinaki M, 1996, MAYO CLIN PROC, V71, P951, DOI 10.4065/71.10.951; Sinaki M, 2002, BONE, V30, P836, DOI 10.1016/S8756-3282(02)00739-1; Smith A, 2017, J ORTHOP SPORT PHYS, V47, P752, DOI 10.2519/jospt.2017.7464; Smith RL, 2004, MAYO CLIN PROC, V79, P353, DOI 10.4065/79.3.353; Spencer L, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-20; Wood K, 2008, CHIROPR OSTEOPAT, V16, P1340; Zheng R, 2006, WOODHEAD TEXT SER, P28	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220452	10.1371/journal.pone.0220452	http://dx.doi.org/10.1371/journal.pone.0220452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4XR	31365548	Green Published, Green Submitted, gold			2022-12-26	WOS:000484983600045
J	Sun, JK; He, L; Li, T				Sun, Jingkuan; He, Lei; Li, Tian			Response of seedling growth and physiology of Sorghum bicolor (L.) Moench to saline-alkali stress	PLOS ONE			English	Article							ANTIOXIDANT ENZYME-ACTIVITIES; OXIDATIVE-STRESS; ION ACCUMULATION; WATER RELATIONS; SALT TOLERANCE; HALOPHYTE; PHOTOSYNTHESIS; GERMINATION; PARAMETERS; EMERGENCE	Soil salinization is a serious problem that affects the seedling growth in many regions. A greenhouse experiment was carried to investigate the adaptation ability of seedlings (Sorghum bicolor (L.) Moench.) in coastal saline alkaline environment. Seedlings of sorghum were treated by different salt and alkali stress (NaCl: Na2SO4: NaHCO3 were 2: 1: 0, 2: 1: 1, 2: 1: 2). The treatments consisted of three levels of salinity (100, 200 and 300 mmol/L) and pH values were 7.08, 8.78 and 9.04. The results showed that the seedlings of sorghum have good adaptability to salt stress under low pH (pH <= 7.08). The plant height, the maximum leave areas of seedlings all dropped and root length first ascended and then descended with the increasing of salt and alkali stress. The contents of Chlorophyll b degraded significantly under salt and alkali stress. Salt and alkali stress stimulated the accumulation of organic solutes (proline and protein) and inorganic ions (Na+, Cl-, SO42-). Our results showed that salt and alkali stress have significant effect on growth indexes except root length and the interaction effect has significantly on physiology.	[Sun, Jingkuan; He, Lei; Li, Tian] Binzhou Univ, Shandong Key Lab Ecoenvironm Sci Yellow River Del, Binzhou, Peoples R China	Binzhou University	Sun, JK (corresponding author), Binzhou Univ, Shandong Key Lab Ecoenvironm Sci Yellow River Del, Binzhou, Peoples R China.	sunjingkuan@126.com			National Natural Science Foundation of China [41871089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Jingkuan Sun were supported by the National Natural Science Foundation of China (No. 41871089).	Agarwal S, 2004, BIOL PLANTARUM, V48, P555, DOI 10.1023/B:BIOP.0000047152.07878.e7; Ashraf M, 2004, FLORA, V199, P361, DOI 10.1078/0367-2530-00165; Bernstein N, 2010, FREE RADICAL BIO MED, V49, P1161, DOI 10.1016/j.freeradbiomed.2010.06.032; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Candan N, 2003, PLANT PHYSIOL BIOCH, V41, P35, DOI 10.1016/S0981-9428(02)00006-2; Chelli-Chaabouni A, 2010, ENVIRON EXP BOT, V69, P302, DOI 10.1016/j.envexpbot.2010.05.010; de Lacerda CF, 2005, ENVIRON EXP BOT, V54, P69, DOI 10.1016/j.envexpbot.2004.06.004; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Gunes A, 2007, J PLANT PHYSIOL, V164, P728, DOI 10.1016/j.jplph.2005.12.009; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hu GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125305; Imada S, 2009, J ARID ENVIRON, V73, P245, DOI 10.1016/j.jaridenv.2008.10.006; Khan MA, 1999, J PLANT NUTR, V22, P191, DOI 10.1080/01904169909365617; Khan MA, 2000, ANN BOT-LONDON, V85, P225, DOI 10.1006/anbo.1999.1022; KINGSBURY RW, 1984, PLANT PHYSIOL, V74, P417, DOI 10.1104/pp.74.2.417; Koyro HW, 2006, ENVIRON EXP BOT, V56, P136, DOI 10.1016/j.envexpbot.2005.02.001; Lee G, 2008, ENVIRON EXP BOT, V63, P19, DOI 10.1016/j.envexpbot.2007.10.009; Li QY, 2008, COLLOID SURFACE B, V65, P220, DOI 10.1016/j.colsurfb.2008.04.007; Li R, 2010, ENVIRON EXP BOT, V68, P66, DOI 10.1016/j.envexpbot.2009.10.004; Liu J, 2010, PHOTOSYNTHETICA, V48, P278, DOI 10.1007/s11099-010-0034-3; Ma HC, 1997, FOREST ECOL MANAG, V93, P55, DOI 10.1016/S0378-1127(96)03943-6; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Parida AK, 2004, AQUAT BOT, V80, P77, DOI 10.1016/j.aquabot.2004.07.005; Pushpalatha G., 2013, Indian Journal of Plant Physiology, V18, P360, DOI 10.1007/s40502-014-0061-3; Ramoliya PJ, 2003, FOREST ECOL MANAG, V176, P185, DOI 10.1016/S0378-1127(02)00271-2; RENGEL Z, 1992, PLANT CELL ENVIRON, V15, P625, DOI 10.1111/j.1365-3040.1992.tb01004.x; Shalata A, 2001, PHYSIOL PLANTARUM, V112, P487, DOI 10.1034/j.1399-3054.2001.1120405.x; Shams M, 2016, HORTIC ENVIRON BIOTE, V57, P225, DOI 10.1007/s13580-016-0021-0; Shi DC, 2005, ENVIRON EXP BOT, V54, P8, DOI 10.1016/j.envexpbot.2004.05.003; Song J, 2008, AQUAT BOT, V88, P331, DOI 10.1016/j.aquabot.2007.11.004; Tiwari JK, 2010, ACTA PHYSIOL PLANT, V32, P103, DOI 10.1007/s11738-009-0385-1; Tuna AL, 2008, ENVIRON EXP BOT, V62, P1, DOI 10.1016/j.envexpbot.2007.06.007; Vasilakoglou I, 2011, FIELD CROP RES, V120, P38, DOI 10.1016/j.fcr.2010.08.011; Wang XP, 2011, SCI HORTIC-AMSTERDAM, V130, P248, DOI 10.1016/j.scienta.2011.07.006; Wei Y, 2006, ANN APPL BIOL, V149, P263, DOI 10.1111/j.1744-7348.2006.00092.x; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	38	26	28	12	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220340	10.1371/journal.pone.0220340	http://dx.doi.org/10.1371/journal.pone.0220340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361760	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300024
J	Zhang, Y; Legland, D; El Hage, F; Devaux, MF; Guillon, F; Reymond, M; Mechin, V				Zhang, Yu; Legland, David; El Hage, Fadi; Devaux, Marie-Francoise; Guillon, Fabienne; Reymond, Matthieu; Mechin, Valerie			Changes in cell walls lignification, feruloylation and p-coumaroylation throughout maize internode development	PLOS ONE			English	Article							FERULATE CROSS-LINKS; CHEMICAL-COMPOSITION; STEM CHARACTERISTICS; LIGNIN COMPOSITION; FERMENTATION CHARACTERISTICS; DEGRADABILITY; L.; IDENTIFICATION; TRANSFERASE; TISSUES	Plant cell walls development is an integrated process during which several components are deposited successively. In the cell walls in grass, the accessibility of structural polysaccharides is limited by the cell walls structure and composition mainly as a result of phenolic compounds. Here, we studied the patterns of cell walls establishment in the internode supporting the ear in three distinct maize genotypes. The developmental patterns observed in the internode cell walls in terms of its composition are reported with an emphasis on lignification, p-coumaroylation and feruloylation. We combined biochemical and histological approaches and revealed that internode cell walls development in maize before flowering is characterized by the rapid deposition of secondary cell walls components and robust lignification in both the pith and the rind. After flowering and until silage maturity, the slow deposition of secondary walls components occurs in the cortical region, and the deposited lignins are rich in beta-O-4 bonds and are highly p-coumaroylated. We conclude the paper by proposing a revised spatiotemporal model based on that proposed by Terashima et al. (1993) for cell walls development in grass.	[Zhang, Yu; El Hage, Fadi; Reymond, Matthieu; Mechin, Valerie] Univ Paris Saclay, CNRS, AgroParisTech, UMR 1318,Inst Jean Pierre Bourgin,INRA, Versailles, France; [Zhang, Yu] Nanjing Agr Univ, Weed Res Lab, Nanjing, Jiangsu, Peoples R China; [Legland, David; Devaux, Marie-Francoise; Guillon, Fabienne] INRA, Biopolymeres Interact & Assemblages, UR1268, Nantes, France; [El Hage, Fadi] Univ Paris Saclay, Univ Paris Sud, Ecole Doctorale 567 Sci Vegetal, Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Nanjing Agricultural University; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Mechin, V (corresponding author), Univ Paris Saclay, CNRS, AgroParisTech, UMR 1318,Inst Jean Pierre Bourgin,INRA, Versailles, France.	valerie.mechin@inra.fr	Legland, David/AAI-2455-2020	Legland, David/0000-0001-7456-4632; MECHIN, valerie/0000-0003-3743-7225	French Government [ANR-10-LABX-0040-SPS, ANR-11-BTBR-0006, ANR-11-IDEX-0003-02]; CEPIA INRA Division; ecole doctorale Sciences du Vegetal; French Research National Agency (ANR) [ANR-08-BLAN-0307-01]; INRA CEPIA; INRA BV	French Government; CEPIA INRA Division; ecole doctorale Sciences du Vegetal; French Research National Agency (ANR)(French National Research Agency (ANR)); INRA CEPIA; INRA BV	This study was funded by French Government Grants (LabEx Saclay Plant SciencesSPS, ref. ANR-10-LABX-0040-SPS to VM, and ANR-11-BTBR-0006 BIOMASS FOR THE FUTURE to VM), managed by the French National Research Agency under an "Investments for the Future" program (ref. ANR-11-IDEX-0003-02 to VM). This work was also funded by CEPIA INRA Division grants (AIC HistoChem and Integrale to VM). The study was also funded by the ecole doctorale Sciences du Vegetal in the form of salary to FEH. This work was also supported by the French Research National Agency (ANR) in the context of the MAGIC program (ANR-08-BLAN-0307-01 to VM). YZ was supported by grants from INRA CEPIA and INRA BV.	Barros-Rios J, 2012, PHYTOCHEMISTRY, V83, P43, DOI 10.1016/j.phytochem.2012.07.026; Baucher M, 1999, PLANT MOL BIOL, V39, P437, DOI 10.1023/A:1006182925584; BernardVailhe MA, 1996, J AGR FOOD CHEM, V44, P1164, DOI 10.1021/jf950481j; Boon EJMC, 2012, NJAS-WAGEN J LIFE SC, V59, P13, DOI 10.1016/j.njas.2011.05.001; Boon EJMC, 2008, NJAS-WAGEN J LIFE SC, V56, P101, DOI 10.1016/S1573-5214(08)80019-X; Boon EJMC, 2005, NJAS-WAGEN J LIFE SC, V53, P87, DOI 10.1016/S1573-5214(05)80012-0; Bunzel M, 2005, MOL NUTR FOOD RES, V49, P551, DOI 10.1002/mnfr.200500030; Casler MD, 2002, THEOR APPL GENET, V104, P127, DOI 10.1007/s001220200015; Culhaoglu T, 2011, J CHROMATOGR B, V879, P3017, DOI 10.1016/j.jchromb.2011.08.039; Demont-Caulet N, 2010, PHYTOCHEMISTRY, V71, P1673, DOI 10.1016/j.phytochem.2010.06.011; Dence CW, 1992, METHODS LIGNIN CHEM, P33, DOI DOI 10.1007/978-3-642-74065-7_3; Devaux M. F., 2014, MICROSCOPY ADV SCI R, V2, P681; Devaux MF, 2008, POSTHARVEST BIOL TEC, V47, P199, DOI 10.1016/j.postharvbio.2007.06.017; Devaux MF, 2009, MACROVISION ANAL GRA, P93; EFFLAND MJ, 1977, TAPPI, V60, P143; El Hage F, 2018, J AGR FOOD CHEM, V66, P4800, DOI 10.1021/acs.jafc.7b05755; Engels FM, 1998, ANN BOT-LONDON, V82, P561, DOI 10.1006/anbo.1998.0705; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Grabber JH, 1996, PHYTOCHEMISTRY, V43, P1189, DOI 10.1016/S0031-9422(96)00431-1; Grabber JH, 1998, J AGR FOOD CHEM, V46, P2609, DOI 10.1021/jf9800099; Grabber JH, 2002, J AGR FOOD CHEM, V50, P6008, DOI 10.1021/jf0205312; GRABBER JH, 1991, CROP SCI, V31, P1058, DOI 10.2135/cropsci1991.0011183X003100040043x; Grabber JH, 2009, J SCI FOOD AGR, V89, P122, DOI 10.1002/jsfa.3418; Hatfield R, 2005, CROP SCI, V45, P832, DOI 10.2135/cropsci2004.0238; Hatfield RD, 1999, J SCI FOOD AGR, V79, P891, DOI 10.1002/(SICI)1097-0010(19990501)79:6&lt;891::AID-JSFA304&gt;3.0.CO;2-#; Hatfield RD, 1999, J SCI FOOD AGR, V79, P403, DOI 10.1002/(SICI)1097-0010(19990301)79:3&lt;403::AID-JSFA263&gt;3.0.CO;2-0; HATFIELD RD, 1993, J CELL BIOCHEM, P28; Hatfield RD, 2008, J SCI FOOD AGR, V88, P2529, DOI 10.1002/jsfa.3376; Hatfield RD, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02056; Hatfield RD, 2009, J AGR FOOD CHEM, V57, P4243, DOI 10.1021/jf900360z; Hatfield RD, 2009, PLANTA, V229, P1253, DOI 10.1007/s00425-009-0900-z; ISHII T, 1990, CARBOHYD RES, V196, P175, DOI 10.1016/0008-6215(90)84117-D; Jung HG, 2006, CROP SCI, V46, P1793, DOI 10.2135/cropsci2005.02-0085; JUNG HG, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P315; Jung HJG, 1999, J SCI FOOD AGR, V79, P922, DOI 10.1002/(SICI)1097-0010(19990501)79:6&lt;922::AID-JSFA307&gt;3.0.CO;2-9; Jung HJG, 2003, PHYTOCHEMISTRY, V63, P543, DOI 10.1016/S0031-9422(03)00221-8; JUNG HJG, 1994, J SCI FOOD AGR, V66, P313, DOI 10.1002/jsfa.2740660308; Jung HJG, 2000, J SCI FOOD AGR, V80, P419, DOI 10.1002/1097-0010(200002)80:3&lt;419::AID-JSFA544&gt;3.0.CO;2-I; Lam TBT, 2003, PHYTOCHEMISTRY, V64, P603, DOI 10.1016/S0031-9422(03)00301-7; LAPIERRE C, 1986, HOLZFORSCHUNG, V40, P47, DOI 10.1515/hfsg.1986.40.1.47; LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323; LOPEZ S, 1993, ACTA BOT NEERL, V42, P165; Lu FC, 1999, J AGR FOOD CHEM, V47, P1988, DOI 10.1021/jf981140j; Marita JM, 2014, PLANT J, V78, P850, DOI 10.1111/tpj.12510; Mechin V, 2005, J AGR FOOD CHEM, V53, P5872, DOI 10.1021/jf050722f; Mechin V, 2000, J SCI FOOD AGR, V80, P574, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;574::AID-JSFA575&gt;3.0.CO;2-R; Mechin V, 2007, PHYTOCHEMISTRY, V68, P571, DOI 10.1016/j.phytochem.2006.11.024; Morrison TA, 1998, CROP SCI, V38, P455, DOI 10.2135/cropsci1998.0011183X003800020031x; Pedersen JF, 2005, CROP SCI, V45, P812, DOI 10.2135/cropsci2004.0155; Quideau S, 1997, J CHEM SOC PERK T 1, P2351, DOI 10.1039/a701808h; RALPH J, 1994, J CHEM SOC PERK T 1, P3485, DOI 10.1039/p19940003485; RALPH J, 1995, CARBOHYD RES, V275, P167, DOI 10.1016/0008-6215(95)00237-N; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Sarath G, 2008, APPL BIOCHEM BIOTECH, V150, P1, DOI 10.1007/s12010-008-8168-5; Sarath G, 2007, BIORESOURCE TECHNOL, V98, P2985, DOI 10.1016/j.biortech.2006.10.020; SCOBBIE L, 1993, J SCI FOOD AGR, V61, P217, DOI 10.1002/jsfa.2740610213; Sibout R, 2016, PLANT PHYSIOL, V170, P1358, DOI 10.1104/pp.15.01877; TERASHIMA N, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P247; WALLACE G, 1994, INT REV CYTOL, V151, P229, DOI 10.1016/S0074-7696(08)62634-0; Withers S, 2012, J BIOL CHEM, V287, P8347, DOI 10.1074/jbc.M111.284497; Zhang Y, 2013, J AGR FOOD CHEM, V61, P3186, DOI 10.1021/jf400912s; Zhang Y, 2011, J AGR FOOD CHEM, V59, P10129, DOI 10.1021/jf2028279	62	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0219923	10.1371/journal.pone.0219923	http://dx.doi.org/10.1371/journal.pone.0219923			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361770	Green Published, Green Submitted, gold			2022-12-26	WOS:000484981300018
J	Arteaga-Marrero, N; Villa, E; Gonzalez-Fernandez, J; Martin, Y; Ruiz-Alzola, J				Arteaga-Marrero, Natalia; Villa, Enrique; Gonzalez-Fernandez, Javier; Martin, Yolanda; Ruiz-Alzola, Juan			Polyvinyl alcohol cryogel phantoms of biological tissues for wideband operation at microwave frequencies	PLOS ONE			English	Article							DEPENDENT DIELECTRIC-PROPERTIES; PERMITTIVITY; MODEL	The aim of this work is to provide a methodology to model the dielectric properties of human tissues based on phantoms prepared with an aqueous solution, in a semi-solid form, by using off-the-shelf components. Polyvinyl alcohol cryogel (PVA-C) has been employed as a novel gelling agent in the fabrication of phantoms for microwave applications in a wide frequency range, from 500 MHz to 20 GHz. Agar-based and deionized water phantoms have also been manufactured for comparison purposes. Mathematical models dependent on frequency and sucrose concentration are proposed to obtain the complex permittivity of the desired mimicked tissues. These models have been validated in the referred bandwidth showing a good agreement to experimental data for different sucrose concentrations. The PVA-C model provides a great performance as compared to agar, increasing the shelf-life of the phantoms and improving their consistency for contact-required devices. In addition, the feasibility of fabricating a multilayer phantom has been demonstrated with a two-layer phantom that exhibits a clear interface between each layer and its properties. Thus, the use of PVA-C extends the option for producing complex multilayer and multimodal phantoms.	[Arteaga-Marrero, Natalia; Villa, Enrique; Martin, Yolanda; Ruiz-Alzola, Juan] IAC, IACTec Med Technol Grp, San Cristobal la Laguna, Santa Cruz De T, Spain; [Gonzalez-Fernandez, Javier] ITC, Dept Ingn Biomed, San Cristobal la Laguna, Santa Cruz De T, Spain; [Ruiz-Alzola, Juan] Univ Palmas Gran Canaria, IUIBS, Dept Senales & Comunicac, Las Palmas Gran Canaria, Las Palmas, Spain	Instituto de Astrofisica de Canarias; Universidad de Las Palmas de Gran Canaria	Arteaga-Marrero, N (corresponding author), IAC, IACTec Med Technol Grp, San Cristobal la Laguna, Santa Cruz De T, Spain.	narteaga@iac.es	Villa, Enrique/H-9796-2015; Arteaga Marrero, Natalia/AAC-6524-2022	Villa, Enrique/0000-0003-1028-6957; Arteaga Marrero, Natalia/0000-0002-1645-0810; Ruiz-Alzola, Juan/0000-0002-3545-2328	IACTec Technological Training program (TF INNOVA 2016-2021); European Union [MAC/1.1.b/098]	IACTec Technological Training program (TF INNOVA 2016-2021); European Union(European Commission)	This work was supported by the IACTec Technological Training program (TF INNOVA 2016-2021) and European Union Interreg-Mac funding program under grant MAC/1.1.b/098 (MACbioIDi project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHEY TW, 1982, IEEE T MICROW THEORY, V30, P82, DOI 10.1109/TMTT.1982.1131021; Beck BL, 2004, CONCEPT MAGN RESON B, V20B, P30, DOI 10.1002/cmr.b.20002; Bindu G, 2006, J MATER SCI, V41, P7419, DOI 10.1007/s10853-006-0793-1; Castello-Palacios S, 2017, IEEE ENG MED BIO, P3032, DOI 10.1109/EMBC.2017.8037496; Castello-Palacios S, 2017, INT SYM MED INFORM, P27, DOI 10.1109/ISMICT.2017.7891760; Chew KM, ADV MAT RES, V646; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Dabbagh A, 2014, ULTRASONIC IMAGING, V36, P291, DOI 10.1177/0161734614526372; Di Meo S, 2018, EUR MICROW CONF, P320; Di Meo S, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/aafeec; Duan Q, 2014, MED PHYS, V41, DOI 10.1118/1.4895823; Fromageau J, 2007, IEEE T ULTRASON FERR, V54, P498, DOI 10.1109/TUFFC.2007.273; Gabriel C, 2006, PHYS MED BIOL, V51, P6033, DOI 10.1088/0031-9155/51/23/006; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Goharian M, 2007, NUCL INSTRUM METH B, V263, P239, DOI 10.1016/j.nimb.2007.04.111; Hellerbach A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070343; Ianniello C, 2018, MAGN RESON MED, V80, P413, DOI 10.1002/mrm.27005; Iravani A, 2014, J BIOMAT SCI-POLYM E, V25, P181, DOI 10.1080/09205063.2013.848327; Karacolak T, 2013, MICROW OPT TECHN LET, V55, P1160, DOI 10.1002/mop.27515; Keysight Technologies Inc., KEYS N1501A DIEL PRO; Kotsuka Y., 2006, RF MICROWAVE INTERAC, V181; La Gioia A, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8020040; Lazebnik M, 2006, PHYS MED BIOL, V51, P1941, DOI 10.1088/0031-9155/51/7/022; Lazebnik M, 2005, PHYS MED BIOL, V50, P4245, DOI 10.1088/0031-9155/50/18/001; Liu YL, 2013, IEEE INT WORKS GENET, P1, DOI 10.1109/GEFS.2013.6601048; Maccabi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191919; Maher A, 2011, 8 INT MULT SYST SIGN; Melia G., 2013, ELECTROMAGNETIC ABSO; Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543; NYSHADHAM A, 1992, IEEE T MICROW THEORY, V40, P305, DOI 10.1109/22.120103; Ohta Makoto, 2004, Technol Health Care, V12, P225; Oliveira BL, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aaaaff; Pavlov ND, 2015, J PHYS CONF SER, V643, DOI 10.1088/1742-6596/643/1/012047; Porter E, 2010, PROCEEDINGS OF THE FOURTH EUROPEAN CONFERENCE ON ANTENNAS AND PROPAGATION; Romeo S, 2011, MICROW OPT TECHN LET, V53, P1276, DOI 10.1002/mop.26001; RStudio Team, 2015, INT DEV ENV R; Said T, 2009, IEEE MTT S INT MICR, P1445, DOI 10.1109/MWSYM.2009.5165979; Takahashi R, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON CYBORG AND BIONIC SYSTEMS (CBS), P150; Yu CH, 2015, TECHNOL HEALTH CARE, V23, pS301, DOI 10.3233/THC-150966	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219997	10.1371/journal.pone.0219997	http://dx.doi.org/10.1371/journal.pone.0219997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344092	gold, Green Submitted, Green Published			2022-12-26	WOS:000484977900047
J	Molema, C; Veldwijk, J; Wendel-Vos, W; de Wit, A; van de Goor, I; Schuit, J				Molema, Claudia; Veldwijk, Jorien; Wendel-Vos, Wanda; de Wit, Ardine; van de Goor, Ien; Schuit, Jantine			Chronically ill patients' preferences for a financial incentive in a lifestyle intervention. Results of a discrete choice experiment	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ACCEPTABILITY; BEHAVIORS; DISEASE	Background The preferences of diabetes type 2 patients and cardiovascular disease patients for a financial incentive added to a specified combined lifestyle intervention were investigated. Methods A discrete choice experiment questionnaire was filled out by 290 diabetes type 2 patients (response rate 29.9%). Panel-mixed-logit models were used to estimate the preferences for a financial incentive. Potential uptake rates of different financial incentives and relative importance scores of the included attributes were estimated. Included attributes and levels were: form of the incentive (cash money and different types of vouchers), value of the incentive (ranging from 15 to 100 euros), moment the incentive is received (start, halfway, after finishing the intervention) and prerequisite for receiving the incentive (registration, attendance or results at group or individual level). Results Prerequisites for receiving the financial incentive were the most important attribute, according to the respondents. Potential uptake rates for different financial incentives ranged between 37.9% and 58.8%. The latter uptake rate was associated with a financial incentive consisting of cash money with a value of (sic)100 that is handed out after completing the lifestyle program with the prerequisite that the participant attended at least 75% of the scheduled meetings. Conclusions The potential uptake of the different financial incentives varied between 37.9% and 58.8%. The value of the incentive does not significantly influence the potential uptake. However, the potential uptake and associated potential effect of the financial incentive is influenced by the type of financial incentive. The preferred type of incentive is (sic)100 in cash money, awarded after completing the lifestyle program if the participant attended at least 75% of the scheduled meetings.	[Molema, Claudia; van de Goor, Ien] Tilburg Univ, Dept Tranzo, Sci Ctr Care & Welf, Tilburg, Netherlands; [Molema, Claudia; Veldwijk, Jorien; Wendel-Vos, Wanda; de Wit, Ardine; Schuit, Jantine] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Veldwijk, Jorien] Uppsala Univ, Ctr Res Eth & Bioeth, Uppsala, Sweden; [de Wit, Ardine] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schuit, Jantine] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Schuit, Jantine] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Tilburg University; Netherlands National Institute for Public Health & the Environment; Uppsala University; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Molema, C (corresponding author), Tilburg Univ, Dept Tranzo, Sci Ctr Care & Welf, Tilburg, Netherlands.; Molema, C (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	claudia.molema@rivm.nl		Schuit, Jantine/0000-0002-7499-1391	ZonMw [525001006]	ZonMw(Netherlands Organization for Health Research and Development)	This work was funded by ZonMw, number: 525001006 (https://www.zonmw.nl/en/) to IvdG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2014, HEALTH PSYCHOL REV, V8, P286, DOI 10.1080/17437199.2013.848410; Barte J, 2015, BEHAV MED, DOI [10.1080/08964289.2015.1074880, DOI 10.1080/08964289.2015.1074880]; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; BIDDLE SJH, 2001, PSYCHOL PHYS ACTIVIT; Bliemer MCJ, 2009, TRANSP RES BROAD ANN; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Chew LD, 2004, FAM MED, V36, P588; Coast J, 2012, HEALTH ECON, V21, P730, DOI 10.1002/hec.1739; Fransen MP, 2011, J HEALTH COMMUN, V16, P134, DOI 10.1080/10810730.2011.604383; Giles EL, 2015, PREV MED, V73, P145, DOI 10.1016/j.ypmed.2014.12.029; Giles EL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1409-y; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; HLS-EU CONSORTIUM, 2012, COMP REP HLTH LIT 8; Huber J, 1996, J MARKETING RES, V33, P307, DOI 10.2307/3152127; James DVB, 2008, J SPORT SCI, V26, P217, DOI 10.1080/02640410701468863; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Mitchell MS, 2014, PSYCHOL HEALTH, V29, P1032, DOI 10.1080/08870446.2014.904863; Mitchell MS, 2013, AM J PREV MED, V45, P658, DOI 10.1016/j.amepre.2013.06.017; Molema CCM, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0041-1; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Praet SFE, 2009, ACTA DIABETOL, V46, P263, DOI 10.1007/s00592-009-0129-0; Promberger M, 2013, HEALTH PSYCHOL, V32, P950, DOI 10.1037/a0032727; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Ries Nola M, 2012, Healthc Policy, V7, P23; Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3; Shaw JD, 2015, HUM RESOUR MANAG J, V25, P281, DOI 10.1111/1748-8583.12080; Strohacker K, 2014, ANN BEHAV MED, V48, P92, DOI 10.1007/s12160-013-9577-4; Sutherland K., 2008, PAYING PATIENT DOES; Toobert DJ, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-1; van Gils PF, 2011, PATIENT PREFER ADHER, V5, P537, DOI 10.2147/PPA.S16854; Wanders JOP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-870; Watson V, 2017, HEALTH ECON, V26, P810, DOI 10.1002/hec.3354; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219112	10.1371/journal.pone.0219112	http://dx.doi.org/10.1371/journal.pone.0219112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344135	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900009
J	Spitz, N; Mello, FCA; Moreira, AS; Gusatti, CS; Martins, RMB; Gomes, SA; Bello, G; Araujo, NM				Spitz, Natalia; Mello, Francisco C. A.; Moreira, Aline S.; Gusatti, Carolina S.; Martins, Regina M. B.; Gomes, Selma A.; Bello, Gonzalo; Araujo, Natalia M.			Reconstruction of the spatial and temporal dynamics of hepatitis B virus genotype D in the Americas	PLOS ONE			English	Article							GENETIC DIVERSITY; PHYLOGENETIC RELATEDNESS; NATURAL-HISTORY; BLOOD-DONORS; SUBGENOTYPES; GENOMES; ORIGIN; MUTATIONS; STRAINS; AFRICAN	Hepatitis B virus (HBV) genotype D (HBV/D) is globally widespread, and ten subgenotypes (D1 to D10) showing distinct geographic distributions have been described to date. The evolutionary history of HBV/D and its subgenotypes, for which few complete genome sequences are available, in the Americas is not well understood. The main objective of the current study was to determine the full-length genomic sequences of HBV/D isolates from Brazil and frequency, origin and spread of HBV/D subgenotypes in the Americas. Complete HBV/D genomes isolated from 39 Brazilian patients infected with subgenotypes D1 (n = 1), D2 (n = 10), D3 (n = 27), and D4 (n = 1) were sequenced and analyzed together with reference sequences using the Bayesian coalescent and phylogeographic framework. A search for HBV/D sequences available in GenBank revealed 209 complete and 926 partial genomes from American countries (Argentina, Brazil, Canada, Chile, Colombia, Cuba, Haiti, Martinique, Mexico, USA and Venezuela), with the major circulating subgenotypes identified as D1 (26%), D2 (17%), D3 (36%), D4 (21%), and D7 (1%) within the continent. The detailed evolutionary history of HBV/D in the Americas was investigated by using different evolutionary time scales. Spatiotemporal reconstruction analyses using short-term substitution rates suggested times of the most recent common ancestor for the American HBV/D subgenotypes coincident with mass migratory movements to Americas during the 19 th and 20 th centuries. In particular, significant linkages between Argentina and Syria (D1), Brazil and Central/Eastern Europe (D2), USA and India (D2), and Brazil and Southern Europe (D3) were estimated, consistent with historical and epidemiological data.	[Spitz, Natalia; Gomes, Selma A.; Araujo, Natalia M.] Fiocruz MS, Oswaldo Cruz Inst, Lab Mol Virol, Rio De Janeiro, Brazil; [Mello, Francisco C. A.] Fiocruz MS, Oswaldo Cruz Inst, Lab Viral Hepatitis, Rio De Janeiro, Brazil; [Moreira, Aline S.] Fiocruz MS, Oswaldo Cruz Inst, Lab Funct Genom & Bioinformat, Rio De Janeiro, Brazil; [Gusatti, Carolina S.] State Fdn Med Prod & Res, Ctr Sci & Technol Dev, Porto Alegre, RS, Brazil; [Martins, Regina M. B.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Bello, Gonzalo] Fiocruz MS, Oswaldo Cruz Inst, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Goias; Fundacao Oswaldo Cruz	Araujo, NM (corresponding author), Fiocruz MS, Oswaldo Cruz Inst, Lab Mol Virol, Rio De Janeiro, Brazil.	nmaraujo@ioc.fiocruz.br	Araujo, Natalia M/B-6596-2013	Spitz Toledo Dias, Natalia/0000-0003-4776-1758; dos Santos Moreira, Aline/0000-0002-7979-6376	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [428676/20189]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [grant number 428676/20189 to NMA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencastro L. F. de, 2000, TRATO VIVENTES TRAFI; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2018, SYRIAN ARABIC REPUBL; [Anonymous], 2018, LEBANESE REPUBLIC; Araujo NM, 2011, INFECT GENET EVOL, V11, P1199, DOI 10.1016/j.meegid.2011.04.017; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; ArauzRuiz P, 1997, J INFECT DIS, V176, P851, DOI 10.1086/516507; Argentino A, 2012, INMIGRACIO PRIME N S; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Banerjee P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109425; Bertolini DA, 2012, INFECT GENET EVOL, V12, P1295, DOI 10.1016/j.meegid.2012.04.009; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Candotti D, 2006, J VIRAL HEPATITIS, V13, P715, DOI 10.1111/j.1365-2893.2006.00741.x; Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x; Ciccozzi M, 2014, J MED VIROL, V86, P109, DOI 10.1002/jmv.23740; Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024; de Matos MAD, 2013, MEM I OSWALDO CRUZ, V108, P386, DOI 10.1590/S0074-02762013000300019; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Barros LMF, 2014, INFECT GENET EVOL, V24, P68, DOI 10.1016/j.meegid.2014.03.007; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUNTHER S, 1995, J VIROL, V69, P5437; Gusatti CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135816; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Hubschen JM, 2009, J MED VIROL, V81, P435, DOI 10.1002/jmv.21412; Hundie GB, 2016, J VIRAL HEPATITUS, DOI [10.1111/jvh, DOI 10.1111/JVH]; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kostaki EG, 2018, ELIFE, V7, DOI 10.7554/eLife.36709; Kowalec K, 2013, J VIRAL HEPATITIS, V20, P122, DOI 10.1111/j.1365-2893.2012.01632.x; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Krause-Kyora B, 2018, ELIFE, V7, DOI 10.7554/eLife.36666; Kwange SO, 2013, VIRUS GENES, V47, P448, DOI 10.1007/s11262-013-0976-1; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lampe E, 2017, J GEN VIROL, V98, P1389, DOI 10.1099/jgv.0.000789; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Locarnini S, 2013, SEMIN CANCER BIOL, V23, P561, DOI 10.1016/j.semcancer.2013.08.006; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Loureiro CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118959; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; McLaren L., 2016, EUROPEAN IMMIGRATION; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Mello FCA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-236; Michitaka K, 2006, J MED VIROL, V78, P44, DOI 10.1002/jmv.20502; Muhlemann B, 2018, NATURE, V557, P418, DOI 10.1038/s41586-018-0097-z; NAUMANN H, 1993, J GEN VIROL, V74, P1627, DOI 10.1099/0022-1317-74-8-1627; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Osiowy C, 2011, J VIRAL HEPATITIS, V18, pe11, DOI 10.1111/j.1365-2893.2010.01356.x; Paraskevis D, 2015, MOL PHYLOGENET EVOL, V93, P44, DOI 10.1016/j.ympev.2015.07.010; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Paredes RM, 2000, MISCELANEA ESTUD ARA, V49, P15; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Sanchez ZR, 2018, TENCON IEEE REGION, P1870, DOI 10.1109/TENCON.2018.8650415; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Schultz AK, 2012, NUCLEIC ACIDS RES, V40, pW193, DOI 10.1093/nar/gks414; Schwartz Stuart, 1988, SEGREDOS INTERNOS EN; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Spitz N, 2015, MEM I OSWALDO CRUZ, V110, P151, DOI 10.1590/0074-02760140426; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x; Yuen MF, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2018.36, 10.1038/nrdp.2018.35]; Zehender G, 2014, WORLD J GASTROENTERO, V20, P7622, DOI 10.3748/wjg.v20.i24.7622; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198; Zehender G, 2012, INFECT GENET EVOL, V12, P291, DOI [10.1016/j.meegid.2011.11.009, 10.101]; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1; Zong J., 2017, SUBSAHARAN AFRICAN I	78	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220342	10.1371/journal.pone.0220342	http://dx.doi.org/10.1371/journal.pone.0220342			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344111	Green Submitted, Green Published, gold			2022-12-26	WOS:000484977900088
J	Fuqua, JD; Mere, CP; Kronemberger, A; Blomme, J; Bae, D; Turner, KD; Harris, MP; Scudese, E; Edwards, M; Ebert, SM; de Sousa, LGO; Bodine, SC; Yang, L; Adams, CM; Lira, VA				Fuqua, Jordan D.; Mere, Caleb P.; Kronemberger, Ana; Blomme, Jay; Bae, Dam; Turner, Kristen D.; Harris, Matthew P.; Scudese, Estevao; Edwards, Mitchell; Ebert, Scott M.; de Sousa, Luis G. O.; Bodine, Sue C.; Yang, Ling; Adams, Christopher M.; Lira, Vitor A.			ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle	FASEB JOURNAL			English	Article						ULK1; p62; NBR1; proteostasis; autophagy; aggrephagy	MAMMALIAN AUTOPHAGY; PATHWAY; INSULIN; GENE; METABOLISM; DEFECTS; GADD45A; DISEASE; GLUCOSE; BINDING	Basal protein turnover, which largely relies on the degradation of ubiquitinated substrates, is instrumental for maintenance of muscle mass and function. However, the regulation of ubiquitinated protein degradation in healthy, nonatrophying skeletal muscle is still evolving, and potential tissue-specific modulators remain unknown. Using an unbiased expression analysis of 34 putative autophagy genes across mouse tissues, we identified unc-51 like autophagy activating kinase (Ulk)2, a homolog of the yeast autophagy related protein 1, as particularly enriched in skeletal muscle. Subsequent experiments revealed accumulations of insoluble ubiquitinated protein aggregates associated with the adaptors sequestosome 1 (SQSTM1, also known as p62) and next to breast cancer type 1 susceptibility protein gene 1 protein (NBR1) in adult muscles with ULK2 deficiency. ULK2 deficiency also led to impaired muscle force and caused myofiber atrophy and degeneration. These features were not observed in muscles with deficiency of the ULK2 paralog, ULK1. Furthermore, short-term ULK2 deficiency did not impair autophagy initiation, autophagosome to lysosome fusion, or protease activities of the lysosome and proteasome. Altogether, our results indicate that skeletal muscle ULK2 has a unique role in basal selective protein degradation by stimulating the recognition and proteolytic sequestration of insoluble ubiquitinated protein aggregates associated with p62 and NBR1. These findings have potential implications for conditions of poor protein homeostasis in muscles as observed in several myopathies and aging.	[Fuqua, Jordan D.; Mere, Caleb P.; Kronemberger, Ana; Blomme, Jay; Bae, Dam; Turner, Kristen D.; Harris, Matthew P.; Scudese, Estevao; Edwards, Mitchell; Lira, Vitor A.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA USA; [Ebert, Scott M.; Adams, Christopher M.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [de Sousa, Luis G. O.; Bodine, Sue C.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bodine, Sue C.; Yang, Ling; Adams, Christopher M.; Lira, Vitor A.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Yang, Ling] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Yang, Ling; Adams, Christopher M.; Lira, Vitor A.] Univ Iowa, Pappajohn Biomed Inst, Iowa City, IA 52242 USA; [Adams, Christopher M.; Lira, Vitor A.] Univ Iowa, Obes Res & Educ Initiat, Iowa City, IA 52242 USA; [Lira, Vitor A.] Univ Iowa, Francois M Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Scudese, Estevao] Fed Univ State Rio de Janeiro, Nursing & Biosci, Rio De Janeiro, Brazil	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Lira, VA (corresponding author), Univ Iowa, 169 Newton Rd,4324PBDB, Iowa City, IA 52242 USA.	vitor-lira@uiowa.edu	Lira, Vitor/AAN-3403-2021; Oliveira de Sousa, Luis Gustavo/M-6807-2017	Lira, Vitor/0000-0002-3162-3804; Adams, Christopher/0000-0002-5795-7212; Turner, Kristen D./0000-0003-4418-5281; Harris, Matthew/0000-0002-8078-3847; Yang, Ling/0000-0002-3105-3063; Oliveira de Sousa, Luis Gustavo/0000-0003-1013-2595	Carver College of Medicine; Fraternal Order of Eagles Pilot Research Grant; American Heart Association [16SDG30360001]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG060637] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976] Funding Source: NIH RePORTER	Carver College of Medicine; Fraternal Order of Eagles Pilot Research Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors acknowledge use of the University of Iowa Central Microscopy Research Facility, a core resource supported by the University of Iowa Vice President for Research, and the Carver College of Medicine. This study was supported by a Fraternal Order of Eagles Pilot Research Grant and American Heart Association Grant 16SDG30360001 (to V.A.L.). The authors declare no conflicts of interest.	Ayyadevara S, 2016, AGING-US, V8, P3486, DOI 10.18632/aging.101141; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Buford TW, 2010, AGEING RES REV, V9, P369, DOI 10.1016/j.arr.2010.04.004; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gavriilidis C, 2018, NAT CELL BIOL, V20, P198, DOI 10.1038/s41556-017-0024-9; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Kitajima Y, 2014, J CELL SCI, V127, P5204, DOI 10.1242/jcs.150961; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koukourikos Konstantinos, 2014, Acta Inform Med, V22, P406, DOI 10.5455/aim.2014.22.406-410; Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Lystad AH, 2015, METHODS, V75, P112, DOI 10.1016/j.ymeth.2014.12.019; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McMillan EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119382; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Miranda DR, 2017, J GEN PHYSIOL, V149, P55, DOI 10.1085/jgp.201611603; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; Park JM, 2016, AUTOPHAGY, V12, P547, DOI 10.1080/15548627.2016.1140293; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ro SH, 2013, AUTOPHAGY, V9, P2103, DOI 10.4161/auto.26563; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shukla S, 2014, J BIOL CHEM, V289, P22306, DOI 10.1074/jbc.M114.567032; Solomon V, 1998, J BIOL CHEM, V273, P25216, DOI 10.1074/jbc.273.39.25216; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Visser M, 2011, CLIN GERIATR MED, V27, P387, DOI 10.1016/j.cger.2011.03.006; Walrand S, 2011, CLIN GERIATR MED, V27, P365, DOI 10.1016/j.cger.2011.03.005; Weihl CC, 2010, CURR OPIN NEUROL, V23, P482, DOI 10.1097/WCO.0b013e32833d3897; Yan Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08480-2; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhou J, 2017, AGING-US, V9, P583, DOI 10.18632/aging.101181	54	20	21	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11735	11745		10.1096/fj.201900766R	http://dx.doi.org/10.1096/fj.201900766R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361156	Green Published, hybrid			2022-12-26	WOS:000507461600013
J	Gulman, NK; Armon, L; Shalit, T; Urbach, A				Gulman, Nelly Komarovsky; Armon, Leah; Shalit, Tali; Urbach, Achia			Heterochronic regulation of lung development via the Lin28-Let-7 pathway	FASEB JOURNAL			English	Article						heterochronic genes; miRNA; organogenesis	GROWTH-FACTOR-BETA; PROGENITOR CELLS; EMBRYONIC LUNG; LIN28; MORPHOGENESIS; METABOLISM; MECHANISMS; EXPRESSION; GENERATION; EPITHELIUM	The heterochronic gene Lin28 regulates diverse developmental processes. It was shown previously that global Lin28A overexpression during mouse embryogenesis results in perinatal lethality. However, the reason for this early lethality has not been elucidated. Here, we showed that Lin28A overexpression prevents normal lung development via the inhibition of the Let-7 micro RNAs, thus causing the perinatal lethality. We further found that Lin28A overexpression in lung mesenchymal cells, but not epithelial cells, is sufficient to recapitulate the lung phenotype. Moreover, we defined the specific time window wherein Lin28A expression exerts its effect. Deep characterization of the transgenic lungs suggests that the Lin28A-Let-7 pathway delays the transition from one developmental stage to another but does not completely abrogate the differentiation capacity of the lung progenitor cells. Finally, we suggested that the effect of Lin28A-Let-7 on embryonic lung development is mediated at least in part through the TGF-beta 1-signaling pathway. Altogether, these findings define for the first time the Lin28-Let-7 pathway as a critical heterochronic regulator of lung development.	[Gulman, Nelly Komarovsky; Armon, Leah; Urbach, Achia] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Shalit, Tali] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Ilana & Pascal Mantoux Inst Bioinformat, Rehovot, Israel	Bar Ilan University; Weizmann Institute of Science	Urbach, A (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	achia.urbach@biu.ac.il	/GLR-9975-2022	Urbach, Achia/0000-0001-9393-4504	Israel Science Foundation (ISF) [1389/15, 1204/17]	Israel Science Foundation (ISF)(Israel Science Foundation)	The authors thank Dr. Daley (Boston Children's Hospital, Boston, MA, USA) for kindly providing the Lox-stop-Lox-TetOnLin28A mice, Dr. Avi Jacob and Dr. Irit Shoval (Scientific Equipment Center, Bar-Ilan University) for helping with the confocal microscopy analysis, and the staff at the Crown Genomics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine (Weizmann Institute of Science) for performing the RNA sequencing. This work was funded by Israel Science Foundation (ISF) Grants 1389/15 and 1204/17. The authors declare no conflicts of interest.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bragg AD, 2001, MECH DEVELOP, V109, P13, DOI 10.1016/S0925-4773(01)00508-1; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Carmel-Gross I, 2016, STEM CELLS DEV, V25, P367, DOI 10.1089/scd.2015.0322; Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Dixit R, 2013, DEVELOPMENT, V140, P4398, DOI 10.1242/dev.098079; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Jiang S, 2016, CANCER LETT, V375, P108, DOI 10.1016/j.canlet.2016.02.050; Keyte AL, 2014, SEMIN CELL DEV BIOL, V34, P99, DOI 10.1016/j.semcdb.2014.06.015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lu Yun, 2008, Proc Am Thorac Soc, V5, P300, DOI 10.1513/pats.200710-162DR; Ludtke TH, 2016, DEV CELL, V39, P239, DOI 10.1016/j.devcel.2016.08.007; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCulley D, 2015, CURR OPIN GENET DEV, V32, P98, DOI 10.1016/j.gde.2015.01.011; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Orgeig S, 2016, COMPR PHYSIOL, V6, P363, DOI 10.1002/cphy.c150003; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Rawlins EL, 2012, AM J RESP CELL MOL, V46, P269, DOI 10.1165/rcmb.2011-0372PS; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robinton DA, 2019, DEV CELL, V48, P396, DOI 10.1016/j.devcel.2018.12.016; Romer-Seibert JS, 2019, FASEB J, V33, P3291, DOI 10.1096/fj.201801118R; Saito A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082460; Saito A, 2015, AM J PHYSIOL-LUNG C, V309, pL756, DOI 10.1152/ajplung.00238.2015; Sanford EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149425; Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Smith KK, 2003, INT J DEV BIOL, V47, P613; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tu HC, 2015, GENE DEV, V29, P1074, DOI 10.1101/gad.256693.114; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Yang M, 2015, DEVELOPMENT, V142, P1616, DOI 10.1242/dev.120543; Yermalovich AV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08127-4; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	56	6	7	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12008	12018		10.1096/fj.201802702R	http://dx.doi.org/10.1096/fj.201802702R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373834	Bronze, Green Published			2022-12-26	WOS:000507461600032
J	Tripathi, V; Chatterjee, KS; Das, R				Tripathi, Vasvi; Chatterjee, Kiran Sankar; Das, Ranabir			Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host?pathogen interaction; post-translational modification (PTM); viral protein; SUMO-interacting motif (SIM); sumoylation; phosphorylation; nuclear magnetic resonance (NMR); enzyme kinetics; transcription co-activator; viral transcription	SUBSTRATE RECOGNITION; IE86 PROTEIN; SUMOYLATION; CONJUGATION; UBC9; IDENTIFICATION; BINDING; SITE; AUTOREPRESSION; REPLICATION	Many viral factors manipulate the host post-translational modification (PTM) machinery for efficient viral replication. In particular, phosphorylation and SUMOylation can distinctly regulate the activity of the human cytomegalovirus (HCMV) transactivator immediate early 2 (IE2). However, the molecular mechanism of this process is unknown. Using various structural, biochemical, and cell-based approaches, here we uncovered that IE2 exploits a cross-talk between phosphorylation and SUMOylation. A scan for small ubiquitin-like modifier (SUMO)-interacting motifs (SIMs) revealed two SIMs in IE2, and a real-time SUMOylation assay indicated that the N-terminal SIM (IE2-SIM1) enhances IE2 SUMOylation up to 4-fold. Kinetic analysis and structural studies disclosed that IE2 is a SUMO cis-E3 ligase. We also found that two putative casein kinase 2 (CK2) sites adjacent to IE2-SIM1 are phosphorylated in vitro and in cells. The phosphorylation drastically increased IE2-SUMO affinity, IE2 SUMOylation, and cis-E3 activity of IE2. Additional salt bridges between the phosphoserines and SUMO accounted for the increased IE2-SUMO affinity. Phosphorylation also enhanced the SUMO-dependent transactivation activity and auto-repression activity of IE2. Together, our findings highlight a novel mechanism whereby SUMOylation and phosphorylation of the viral cis-E3 ligase and transactivator protein IE2 work in tandem to enable transcriptional regulation of viral gene.	[Tripathi, Vasvi; Chatterjee, Kiran Sankar; Das, Ranabir] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Das, R (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India.	rana@ncbs.res.in		Tripathi, Vasvi/0000-0002-9438-5049	National Center for Biological Sciences; Tata Institute of Fundamental Research	National Center for Biological Sciences; Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	This work was supported by intramural grants from the National Center for Biological Sciences and the Tata Institute of Fundamental Research. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JH, 2001, J VIROL, V75, P3859, DOI 10.1128/JVI.75.8.3859-3872.2001; Arend KC, 2018, J VIROL, V92, DOI 10.1128/JVI.02128-17; Barrasa MI, 2005, J VIROL, V79, P1428, DOI 10.1128/JVI.79.3.1428-1437.2005; Beauclair G, 2015, BIOINFORMATICS, V31, P3483, DOI 10.1093/bioinformatics/btv403; Berndt A, 2009, J VIROL, V83, P12881, DOI 10.1128/JVI.01525-09; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bryant LA, 2000, J VIROL, V74, P7230, DOI 10.1128/JVI.74.16.7230-7237.2000; Colletti KS, 2004, J VIROL, V78, P9203, DOI 10.1128/JVI.78.17.9203-9214.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; HAGEMEIER C, 1992, J VIROL, V66, P4452, DOI 10.1128/JVI.66.7.4452-4456.1992; Harel NY, 1998, J VIROL, V72, P5481, DOI 10.1128/JVI.72.7.5481-5492.1998; Heider JA, 2002, J VIROL, V76, P928, DOI 10.1128/JVI.76.2.928-932.2002; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; JUPP R, 1993, J VIROL, V67, P5595, DOI 10.1128/JVI.67.9.5595-5604.1993; Kim ET, 2010, J VIROL, V84, P8111, DOI 10.1128/JVI.00459-10; KNELLER DG, 1993, J CELL BIOCHEM, P254; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kolesar P, 2012, NUCLEIC ACIDS RES, V40, P7831, DOI 10.1093/nar/gks484; LANG D, 1995, J VIROL, V69, P6030, DOI 10.1128/JVI.69.10.6030-6037.1995; Lee SB, 2011, CELL RES, V21, P1230, DOI 10.1038/cr.2011.53; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; Nogalski MT, 2007, J VIROL, V81, P5305, DOI 10.1128/JVI.02382-06; Petrik DT, 2006, J VIROL, V80, P3872, DOI 10.1128/JVI.80.8.3872-3883.2006; Reeves M, 2006, J VIROL, V80, P9998, DOI 10.1128/JVI.01297-06; Reuter N, 2018, J GEN VIROL, V99, P369, DOI 10.1099/jgv.0.001021; Scherer M, 2013, J GEN VIROL, V94, P1373, DOI 10.1099/vir.0.051078-0; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; STENBERG RM, 1984, J VIROL, V49, P190, DOI 10.1128/JVI.49.1.190-199.1984; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P3168, DOI 10.1021/bi026861x; Tozluoglu M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000913; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11	39	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14546	14561		10.1074/jbc.RA119.009601	http://dx.doi.org/10.1074/jbc.RA119.009601			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31371453	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000497955000005
J	Ribeiro, JCT; Nunes-Freitas, AF; Fidalgo, ECC; Uzeda, MC				Tenius Ribeiro, Juliana C.; Nunes-Freitas, Andre Felippe; Cardoso Fidalgo, Elaine Cristina; Uzeda, Mariella Camardelli			Forest fragmentation and impacts of intensive agriculture: Responses from different tree functional groups	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; NUTRIENT ENRICHMENT; SPECIES RICHNESS; SOIL-CONDITIONS; RAIN-FOREST; LANDSCAPE; EDGE; PHOSPHORUS; COMMUNITY; NITROGEN	Agricultural landscapes are seen as areas of extreme importance for studying and developing strategies which integrate biodiversity conservation and ecosystem services with food production. The main strategies for intensifying agriculture are based on conventional agricultural practices of frequently using inputs for fertilization and correcting soil pH. Some studies show that these practices generate impacts on nearby forest fragments through soil contamination and increasing nutrient content. The objective of this study was to identify the impacts on the functional groups of sciophilous (late successional/shade-tolerant species) and heliophilous (pioneer/sun-loving) species of a tree community of 14 forest fragments near pasture areas and agricultural areas under conventional practices, raising the hypothesis that higher-fertility forest fragments adjacent to intensive agriculture modify the floristic composition of the tree community. Consequently, this study is based on the following questions: i) Do forest fragments within intensive farming environments present differences in floristic composition of species?; ii) Does the soil fertility influence the tree species composition?; iii) Which variables influence species abundance and richness in the forest fragments with different types of use around their environment? The floristic composition of fragments close to agricultural areas are more similar to each other than the composition of fragments close to pasture areas. Furthermore, the General Linear Model (GLM) results show a clear influence of the intensive farming environment on the richness and abundance of the two functional groups in the forest fragments, directly benefiting the abundance of heliophilous species, which are also benefited by the greater declivity and smaller fragment area, while the abundance of sciophytes is negatively correlated with these last two variables. The increase of calcium content is beneficial for the richness of heliophilous species, while the increase in phosphorus content influences a reduction in the richness of sciophyte species, which also strongly respond to the isolation between fragments. The results indicate a dominance trend of pioneer species in fragments with nutritionally enriched soils, providing evidence that the intense adoption of inputs in cultivated areas causes concrete impacts on the diversity of the tree community.	[Tenius Ribeiro, Juliana C.; Nunes-Freitas, Andre Felippe] Univ Fed Rural Rio de Janeiro, Inst Florestas, Dept Ciencias Ambientais, Seropedica, RJ, Brazil; [Cardoso Fidalgo, Elaine Cristina] Empresa Brasileira Pesquisa Agr, Ctr Nacl Pesquisa Solos, Rio De Janeiro, RJ, Brazil; [Uzeda, Mariella Camardelli] Empresa Brasileira Pesquisa Agr, Ctr Nacl Pesquisa Agrobiol, Seropedica, RJ, Brazil; [Nunes-Freitas, Andre Felippe] Univ Fed Rural Rio de Janeiro, Lab Ecol Florestal & Biol Vegetal, Dept Ciencias Ambientais, Inst Florestas, Seropedica, RJ, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Uzeda, MC (corresponding author), Empresa Brasileira Pesquisa Agr, Ctr Nacl Pesquisa Agrobiol, Seropedica, RJ, Brazil.	mariella.uzeda@embrapa.br	Nunes-Freitas, André F/E-6351-2014; Nunes-Freitas, André/AAF-7374-2019	Nunes-Freitas, André F/0000-0002-5149-9070; Nunes-Freitas, André/0000-0002-5149-9070	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Empresa Brasileira de Pesquisa Agropecuaria, EMBRAPA - Agrobiologia; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Empresa Brasileira de Pesquisa Agropecuaria, EMBRAPA - Agrobiologia(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was partly financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. Empresa Brasileira de Pesquisa Agropecuaria, EMBRAPA - Agrobiologia, and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) also provided financial support for the study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Clare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123796; Andrade ER, 2015, FOREST ECOL MANAG, V349, P73, DOI 10.1016/j.foreco.2015.03.049; Baker TR, 2003, PERSPECT PLANT ECOL, V6, P21, DOI 10.1078/1433-8319-00040; Balmford A, 2018, NAT SUSTAIN, V1, P477, DOI 10.1038/s41893-018-0138-5; Becknell JM, 2014, CAN J FOREST RES, V44, P604, DOI 10.1139/cjfr-2013-0331; Benitez-Malvido J, 2003, BIOTROPICA, V35, P530, DOI 10.1111/j.1744-7429.2003.tb00609.x; Benitez-Malvido J, 1998, CONSERV BIOL, V12, P380, DOI 10.1046/j.1523-1739.1998.96295.x; Bentos TV, 2017, FOREST ECOL MANAG, V396, P124, DOI 10.1016/j.foreco.2017.04.018; Boutin C, 1998, ECOL APPL, V8, P544, DOI 10.1890/1051-0761(1998)008[0544:IOAPAE]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carvalho F. A., 2006, ACTA BOT BRAS, V20, P727, DOI DOI 10.1590/S0102-33062006000300022; Chabrerie O, 2013, J VEG SCI, V24, P58, DOI 10.1111/j.1654-1103.2012.01449.x; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; de Toledo JJ, 2011, FOREST ECOL MANAG, V262, P331, DOI 10.1016/j.foreco.2011.03.039; Demchik MC, 2001, FOREST ECOL MANAG, V144, P239, DOI 10.1016/S0378-1127(00)00388-1; Didham RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116474; Do Carmo Adenilza Borges, 2011, Revista Brasileira de Botanica, V34, P31, DOI 10.1590/S0100-84042011000100004; Donagema G.K, 2011, MANUAL METODOS ANALI; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Duncan DH, 2008, LANDSCAPE ECOL, V23, P107, DOI 10.1007/s10980-007-9160-0; Engelbrecht BMJ, 2001, J TROP ECOL, V17, P207, DOI 10.1017/S0266467401001146; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2015, AGR ECOSYST ENVIRON, V200, P219, DOI 10.1016/j.agee.2014.11.018; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; FAO, 2016, STAT WORLDS FOR 2016; Fedoroff E, 2005, AGR ECOSYST ENVIRON, V105, P283, DOI 10.1016/j.agee.2004.02.006; Fidalgo ECC, 2008, EMBRAPA SOLOS SERIE, V105, P32; Finotti R, 2012, ACTA BOT BRAS, V26, P464, DOI 10.1590/S0102-33062012000200022; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Sobrinho VG, 2008, CIENC FLOREST, V18, P493, DOI 10.5902/19805098433; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Jackson HB, 2000, ENCY BIODIVERS, V4, P50; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Joly CA, 2014, NEW PHYTOL, V204, P459, DOI 10.1111/nph.12989; Lambert AM, 2014, AQUAT BOT, V112, P16, DOI 10.1016/j.aquabot.2013.07.004; Laurance SGW, 2010, J VEG SCI, V21, P96, DOI 10.1111/j.1654-1103.2009.01122.x; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Laurance William F., 2009, Oecologia Brasiliensis, V13, P434; Melo FPL, 2007, ECOSCIENCE, V14, P124, DOI 10.2980/1195-6860(2007)14[124:EOLSFT]2.0.CO;2; Maciel M.N.M., 2003, REV ACAD CIENCIAS AG, V1, P69; Magrach A, 2014, CONSERV BIOL, V28, P1342, DOI 10.1111/cobi.12304; Martins KG, 2015, FOREST ECOL MANAG, V349, P4, DOI 10.1016/j.foreco.2015.04.018; Martins SV, 2012, ECOLOGIA FLORESTAS T, P372; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; Mcgarigal K., FRAGSTATS USER GUIDE; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; Moran C, 2014, CONSERV BIOL, V28, P551, DOI 10.1111/cobi.12236; Mueller-Dombois D., 1974, Aims and methods of vegetation ecology.; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Oliveira-Filho A. T., 2001, Edinburgh Journal of Botany, V58, P139; Pedreira B da CCG, 2009, B PESQUISA DESENVOLV; Peixoto Gustavo Luna, 2004, Acta Bot. Bras., V18, P151, DOI 10.1590/S0102-33062004000100013; Perfecto I., 2008, ANN NY ACAD SCI, V200, P173; Perfecto I., 2009, NATURES MATRIX LINKI; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; R Core Team, 2016, R LANG ENV STAT COMP; Rezende CL, 2018, PERSPECT ECOL CONSER, V16, P208, DOI 10.1016/j.pecon.2018.10.002; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Sardans J, 2012, PLANT PHYSIOL, V160, P1741, DOI 10.1104/pp.112.208785; Spasojevic MJ, 2019, PLANT SOIL, V438, P377, DOI 10.1007/s11104-019-04009-w; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; THIMONIER A, 1994, NEW PHYTOL, V126, P533, DOI 10.1111/j.1469-8137.1994.tb04252.x; THIMONIER A, 1992, FOREST ECOL MANAG, V55, P149, DOI 10.1016/0378-1127(92)90098-T; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tittonell P, 2014, CURR OPIN ENV SUST, V8, P53, DOI 10.1016/j.cosust.2014.08.006; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Uzeda MC, 2016, PESQUI AGROPECU BRAS, V51, P1120, DOI 10.1590/s0100-204x2016000900011; Veloso H. M. P., 1991, CLASSIFICACAO VEGETA; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1	81	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0212725	10.1371/journal.pone.0212725	http://dx.doi.org/10.1371/journal.pone.0212725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369550	Green Submitted, Green Published, gold			2022-12-26	WOS:000484987900003
J	Nguyen, QL; Wang, YN; Helbling, N; Simon, MA; Shiva, S				Nguyen, Quyen L.; Wang, Yinna; Helbling, Nicole; Simon, Marc A.; Shiva, Sruti			Alterations in platelet bioenergetics in Group 2 PH-HFpEF patients	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; RIGHT-VENTRICULAR HYPERTROPHY; PRESERVED EJECTION FRACTION; NITRIC-OXIDE; HEART-FAILURE; METABOLIC SYNDROME; GUANYLYL CYCLASE; DYSFUNCTION; RESPONSIVENESS; ACTIVATION	Background Pulmonary hypertension (PH) is characterized by elevated pulmonary artery pressure but classified into subgroups based on disease etiology. It is established that systemic bioenergetic dysfunction contributes to the pathogenesis of pulmonary arterial hypertension classified as World Health Organization (WHO) Group 1. Consistent with this, we previously showed that platelets from Group 1 PH patients demonstrate increased glycolysis and enhanced maximal capacity for oxidative phosphorylation, which is due to increased fatty acid oxidation (FAO). However, it remains unclear whether identical mitochondrial alterations contribute to the pathology of other PH subgroups. The most prevalent subgroup of PH is WHO Group 2, which encompasses pulmonary venous hypertension secondary to left heart disease. Here, we hypothesized that platelets from Group 2 subjects show bioenergetic alteration compared to controls, and that these changes were similar to Group 1 PH patients. Method and results We isolated platelets from subjects with Group 2 PH and controls (n = 20) and measured platelet bioenergetics as well as hemodynamic parameters. We demonstrate that Group 2 PH platelets do not show a change in glycolytic rate but do demonstrate enhanced maximal capacity of respiration due at least partially to increased FAO. Moreover, this enhanced maximal capacity correlates negatively with right ventricular stroke work index and is not changed by administration of inhaled nitrite, a modulator of pulmonary hemodynamics. Conclusions These data demonstrate that Group 2 PH subjects have altered bioenergetic function though this alteration is not identical to that of Group 1 PH. The implications of this alteration for disease pathogenesis will be discussed.	[Nguyen, Quyen L.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Wang, Yinna; Helbling, Nicole; Simon, Marc A.; Shiva, Sruti] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15260 USA; [Simon, Marc A.] Univ Pittsburgh, Div Cardiol, Pittsburgh, PA USA; [Shiva, Sruti] Univ Pittsburgh, Ctr Metab & Mitochondria Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shiva, S (corresponding author), Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15260 USA.; Shiva, S (corresponding author), Univ Pittsburgh, Ctr Metab & Mitochondria Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	sss43@pitt.edu	Simon, Marc/AAH-3404-2020	Shiva, Sruti/0000-0003-3535-2113; Simon, Marc/0000-0003-3080-3675	NIH [1 F32 HL132466-01, PO1HL103455]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL132466, T32HL007563, P01HL103455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the NIH grants 1 F32 HL132466-01 (to QLN), PO1HL103455 (to MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2004, EUR J HEART FAIL, V6, P47, DOI 10.1016/S1388-9842(03)00038-2; Beuve A, 2017, ANTIOXID REDOX SIGN, V26, P137, DOI 10.1089/ars.2015.6591; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Brittain EL, 2013, JACC-HEART FAIL, V1, P300, DOI 10.1016/j.jchf.2013.05.004; Brittain EL, 2013, PULM CIRC, V3, P589, DOI 10.1086/674326; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; Catrysse L, 2017, TRENDS CELL BIOL, V27, P417, DOI 10.1016/j.tcb.2017.01.006; Chirkov YY, 2007, PHARMACOL THERAPEUT, V116, P287, DOI 10.1016/j.pharmthera.2007.06.012; Crosswhite P, 2014, MOL MED, V20, P191, DOI 10.2119/molmed.2013.00165; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dromparis P, 2010, J MOL MED, V88, P1003, DOI 10.1007/s00109-010-0670-x; Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9; Feng ZY, 2016, ONCOTARGET, V7, P15410, DOI 10.18632/oncotarget.7645; Fillmore N, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0005-x; Freund-Michel V, 2014, INT J BIOCHEM CELL B, V55, P93, DOI 10.1016/j.biocel.2014.08.012; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2013, J AM COLL CARDIOL, V62, pD1, DOI 10.1016/j.jacc.2013.10.030; Gkaliagkousi E, 2010, AM J HYPERTENS, V23, P229, DOI 10.1038/ajh.2009.247; Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127; Gorter TM, 2016, EUR J HEART FAIL, V18, P1472, DOI 10.1002/ejhf.630; Graham BB, 2015, AM J PHYSIOL-LUNG C, V309, pL435, DOI 10.1152/ajplung.00169.2015; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guazzi M, 2012, CIRCULATION, V126, P975, DOI 10.1161/CIRCULATIONAHA.111.085761; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Huang C, 2017, J BIOL CHEM, V292, P14362, DOI 10.1074/jbc.M117.787390; Johnson SR, 2006, CHEST, V130, P545, DOI 10.1016/S0012-3692(15)51873-4; Kates AM, 2003, J AM COLL CARDIOL, V41, P293, DOI 10.1016/S0735-1097(02)02714-6; Kong APS, 2006, CURR DIABETES REV, V2, P397, DOI 10.2174/1573399810602040397; Lahera V, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0710-9; Lai YC, 2016, CIRCULATION, V133, P717, DOI 10.1161/CIRCULATIONAHA.115.018935; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Linher-Melville K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-56; Ma YN, 2015, COMPR PHYSIOL, V5, P667, DOI 10.1002/cphy.c140041; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; MEHTA JL, 1994, AM J CARDIOL, V74, P901, DOI 10.1016/0002-9149(94)90583-5; Meyer P, 2010, CIRCULATION, V121, P252, DOI 10.1161/CIRCULATIONAHA.109.887570; Mohammed SF, 2014, CIRCULATION, V130, P2310, DOI 10.1161/CIRCULATIONAHA.113.008461; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Nguyen QL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91415; Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Perrone-Filardi P, 2015, EUR HEART J, V36, P2630, DOI 10.1093/eurheartj/ehv350; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6; Procter NEK, 2015, INT J CARDIOL, V179, P160, DOI 10.1016/j.ijcard.2014.10.137; Rajendran S, 2008, CARDIOVASC DRUG THER, V22, P193, DOI 10.1007/s10557-008-6098-7; Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012; Santilli F, 2012, OBES REV, V13, P27, DOI 10.1111/j.1467-789X.2011.00930.x; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Simon MA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89620; Suslova TE, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00501; Sutendra G, 2013, J MOL MED, V91, P1315, DOI 10.1007/s00109-013-1059-4; Sutendra G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001327; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Vachiery JL, 2013, J AM COLL CARDIOL, V62, pD100, DOI 10.1016/j.jacc.2013.10.033; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Willoughby SR, 2005, ARTERIOSCL THROM VAS, V25, P2661, DOI 10.1161/01.ATV.0000193622.77294.57; Winnica D, 2019, ANTIOXID REDOX SIGN, V31, P673, DOI 10.1089/ars.2018.7627; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Xu WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132007; Zanjani KS, 2012, IRAN J PEDIATR, V22, P145	62	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220490	10.1371/journal.pone.0220490	http://dx.doi.org/10.1371/journal.pone.0220490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365585	Green Submitted, Green Published, gold			2022-12-26	WOS:000484983600049
J	Arakawa, Y; Yokoyama, K; Tasaki, S; Kato, J; Nakashima, K; Takeyama, M; Nakatani, A; Suzuki, M				Arakawa, Yuuichi; Yokoyama, Kazumasa; Tasaki, Shinya; Kato, Junichi; Nakashima, Kosuke; Takeyama, Michiyasu; Nakatani, Atsushi; Suzuki, Motohisa			Transgenic mice overexpressing miR-137 in the brain show schizophrenia-associated behavioral deficits and transcriptome profiles	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; NEGATIVE SYMPTOMS; EXPRESSION; VARIANT; RISK; PATHOPHYSIOLOGY; NEURONS; MIR137; BLOOD	Schizophrenia is a psychiatric disorder characterized by positive and negative symptoms and cognitive deficits. The exact cause of schizophrenia is still unknown, but substantial evidence indicates that it has a genetic component. Genome wide association studies demonstrate variants within miR-137 host gene are a risk factor for schizophrenia. However, the direct relationship between the pathophysiology of schizophrenia and the dosage of miR-137 remains unclear. Therefore, in this study, we generated transgenic mice overexpressing miR-137 (miR-137 Tg mice) with the neuron-specific Thy-1 promoter and examined schizophrenia- related phenotypes in these mice. Overexpression of miR-137 was observed in various brain regions of the miR-137 Tg mice, with down-regulation of putative miR-137 targets. MiR-137 Tg mice showed sensory gating deficits in a prepulse inhibition test, social deficits in a sociability and social novelty test, and cognitive deficits in a novel object recognition test. Interestingly, the predicted-altered pathways of the medial prefrontal cortex of miR-137 Tg mice were partially overlapped with those of the dorsolateral prefrontal cortex in postmortem brain of patients who died in equal to or less than 4 years after initial diagnosis of schizophrenia in published data. These results suggest that overexpression of miR-137 in the whole brain induces the several phenotypes that are relevant to aspects of psychiatric disorders, such as schizophrenia. Based on these findings, miR-137 Tg mice may have the potential to become a useful tool in researching the pathophysiology of psychiatric disorders.	[Arakawa, Yuuichi; Kato, Junichi; Nakashima, Kosuke; Nakatani, Atsushi; Suzuki, Motohisa] Takeda Pharmaceut Co Ltd, Neurosci Drug Discovery Unit, Res, Fujisawa, Kanagawa, Japan; [Yokoyama, Kazumasa; Tasaki, Shinya; Takeyama, Michiyasu] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Integrated Technol Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Suzuki, M (corresponding author), Takeda Pharmaceut Co Ltd, Neurosci Drug Discovery Unit, Res, Fujisawa, Kanagawa, Japan.	motohisa.suzuki@takeda.com		Suzuki, Motohisa/0000-0001-8416-2733	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This work was funded by Takeda Pharmaceutical Company Limited who provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ahmed AO, 2014, CNS DRUGS, V28, P301, DOI 10.1007/s40263-014-0146-6; Arslan A, 2018, PROG NEURO-PSYCHOPH, V80, P155, DOI 10.1016/j.pnpbp.2017.06.018; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brown VJ, 2002, TRENDS NEUROSCI, V25, P340, DOI 10.1016/S0166-2236(02)02164-1; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Davis J, 2016, NEUROSCI BIOBEHAV R, V65, P185, DOI 10.1016/j.neubiorev.2016.03.017; Dong DB, 2018, SCHIZOPHRENIA BULL, V44, P168, DOI 10.1093/schbul/sbx034; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Forrest MP, 2017, CELL STEM CELL, V21, P305, DOI 10.1016/j.stem.2017.07.008; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Green MJ, 2013, MOL PSYCHIATR, V18, P774, DOI 10.1038/mp.2012.84; Guella I, 2013, J PSYCHIATR RES, V47, P1215, DOI 10.1016/j.jpsychires.2013.05.021; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Krystal JH, 2017, BIOL PSYCHIAT, V81, P874, DOI 10.1016/j.biopsych.2017.01.004; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Kurtz MM, 2005, SCHIZOPHR RES, V74, P15, DOI 10.1016/j.schres.2004.07.005; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lett TA, 2013, MOL PSYCHIATR, V18, P443, DOI 10.1038/mp.2013.17; Lieberman JA, 2001, BIOL PSYCHIAT, V50, P884, DOI 10.1016/S0006-3223(01)01303-8; Liu S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15751-5; Losak J, 2016, SCHIZOPHRENIA BULL, V42, P1517, DOI 10.1093/schbul/sbw065; Mahmoudi E, 2017, MOL PSYCHIATR, V22, P44, DOI 10.1038/mp.2016.150; McGlashan TH, 1998, J PSYCHIATR RES, V32, P133, DOI 10.1016/S0022-3956(97)00015-0; Mervis JE, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00044; Narayan S, 2008, BRAIN RES, V1239, P235, DOI 10.1016/j.brainres.2008.08.023; Powell Susan B, 2012, Curr Top Behav Neurosci, V12, P251, DOI 10.1007/7854_2011_195; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Siegert S, 2015, NAT NEUROSCI, V18, P1008, DOI 10.1038/nn.4023; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Swerdlow NR, 2016, CURR TOP BEHAV NEURO, V28, P305, DOI 10.1007/7854_2015_5012; Tanimizu T, 2018, BRAIN RES BULL, V141, P27, DOI 10.1016/j.brainresbull.2017.05.017; Thomas EA, 2006, MOL NEUROBIOL, V34, P109, DOI 10.1385/MN:34:2:109; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Warburton A, 2016, SCHIZOPHRENIA BULL, V42, P1003, DOI 10.1093/schbul/sbv144; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Wilson CA, 2014, EUR NEUROPSYCHOPHARM, V24, P759, DOI 10.1016/j.euroneuro.2013.11.008; Wright C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00147; Wu SS, 2016, EBIOMEDICINE, V12, P133, DOI 10.1016/j.ebiom.2016.09.012; Yang SS, 2015, PROG NEURO-PSYCHOPH, V61, P30, DOI 10.1016/j.pnpbp.2015.03.007; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Young JW, 2009, PHARMACOL THERAPEUT, V122, P150, DOI 10.1016/j.pharmthera.2009.02.004	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220389	10.1371/journal.pone.0220389	http://dx.doi.org/10.1371/journal.pone.0220389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361772	Green Published, gold, Green Submitted			2022-12-26	WOS:000484981300027
J	Fradera-Sola, A; Thomas, A; Gasior, D; Harper, J; Hegarty, M; Armstead, I; Fernandez-Fuentes, N				Fradera-Sola, Albert; Thomas, Ann; Gasior, Dagmara; Harper, John; Hegarty, Matthew; Armstead, Ian; Fernandez-Fuentes, Narcis			Differential gene expression and gene ontologies associated with increasing water-stress in leaf and root transcriptomes of perennial ryegrass (Lolium perenne)	PLOS ONE			English	Article							DROUGHT STRESS; ANALYSIS REVEALS; WHEAT GENOTYPES; BARLEY; IDENTIFICATION; PROFILES; ADJUSTMENT; TOLERANCE; RESPONSES; SEQUENCE	Perennial ryegrass (Lolium perenne) is a forage and amenity grass species widely cultivated in temperate regions worldwide. As such, perennial ryegrass populations are exposed to a range of environmental conditions and stresses on a seasonal basis and from year to year. One source of potential stress is limitation on water availability. The ability of these perennial grasses to be able to withstand and recover after periods of water limitation or drought can be a key component of grassland performance. Thus, we were interested in looking at changes in patterns of gene expression associated with increasing water stress. Clones of a single genotype of perennial ryegrass were grown under non-flowering growth room conditions in vermiculite supplemented with nutrient solution. Leaf and root tissue was sampled at 4 times in quadruplicate relating to estimated water contents of 35%, 15%, 5% and 1%. RNA was extracted and RNAseq used to generate transcriptome profiles at each sampling point. Transcriptomes were assembled using the published reference genome sequence and differential gene expression analysed using 3 different programmes, DESeq2, edgeR and limma (with the voom transformation), individually and in combination, deriving Early, Middle and Late stage comparisons. Identified differentially expressed genes were then associated with enriched GO terms using BLAST2GO. For the leaf, up-regulated differentially expressed genes were strongly associated with GO terms only during the Early stage and the majority of GO terms were associated with only down-regulated genes at the Middle or Late stages. For the roots, few differentially expressed genes were identified at either Early or Middle stages. Only one replicate at 1% estimated water content produced high quality data for the root, however, this indicated a high level of differential expression. Again the majority of enriched GO terms were associated with down-regulated genes. The performance of the different analysis programmes and the annotations associated with identified differentially expressed genes is discussed.	[Fradera-Sola, Albert] Inst Mol Biol, Quantitat Prote, Mainz, Germany; [Thomas, Ann; Gasior, Dagmara; Harper, John; Hegarty, Matthew; Armstead, Ian; Fernandez-Fuentes, Narcis] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	Institute of Molecular Biology (IMB); Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Fernandez-Fuentes, N (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	naf4@aber.ac.uk		Fernandez-Fuentes, Narcis/0000-0002-6421-1080; Fradera-Sola, Albert/0000-0002-4780-9312; Hegarty, Matthew/0000-0001-6547-3800	Biotechnology and Biological Science Research Council (BBSRC) [BB/J004405/1, BB/CSP1730/1]; BBSRC [BBS/E/W/10962A01B, BBS/E/W/0012843D, BBS/E/W/10962A01D] Funding Source: UKRI	Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been funded by the Biotechnology and Biological Science Research Council (BBSRC) through the following institutional awards: BB/J004405/1 (ISPG) and BB/CSP1730/1 (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andrews S, FASTQC QUALITY CONTR; Aper J. GA, 2014, QUANTITATIVE TRAITS, P367; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bedada G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-995; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Byrne SL, 2015, PLANT J, V84, P816, DOI 10.1111/tpj.13037; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Challa GS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205582; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152; Csiszar J, 2012, PLANT PHYSIOL BIOCH, V52, P119, DOI 10.1016/j.plaphy.2011.12.006; Cyriac D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194977; Dalal M, 2018, PLANT PHYSIOL BIOCH, V130, P482, DOI 10.1016/j.plaphy.2018.07.035; Ding XP, 2013, INT J MOL SCI, V14, P5214, DOI 10.3390/ijms14035214; dos Santos AB, 2015, J AGR FOOD CHEM, V63, P4708, DOI 10.1021/jf5061858; Dudhate A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195908; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Foito A, 2009, PLANT BIOTECHNOL J, V7, P719, DOI 10.1111/j.1467-7652.2009.00437.x; Guo R, 2018, AOB PLANTS, V10, DOI 10.1093/aobpla/ply016; Habte E, 2014, PLANT CELL ENVIRON, V37, P1321, DOI 10.1111/pce.12242; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Harper J, 2019, ANN BOT-LONDON, V123, P977, DOI 10.1093/aob/mcy230; He XY, 2015, J EXP BOT, V66, P7405, DOI 10.1093/jxb/erv436; Hittalmani S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3850-z; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; Hu L, 2018, PLANT SCI, V272, P276, DOI 10.1016/j.plantsci.2018.03.036; Jonaviciene K, 2012, BIOL PLANTARUM, V56, P473, DOI 10.1007/s10535-012-0110-6; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kokas F, 2016, DATA BRIEF, V8, P334, DOI 10.1016/j.dib.2016.05.051; KSOURI N, 2016, FRONT PLANT SCI, V7, DOI DOI 10.3389/FPLS.2015.01715; Kulkarni M, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00106; Kwasniewski M, 2016, J EXP BOT, V67, P1079, DOI 10.1093/jxb/erv498; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lees J, 2010, NUCLEIC ACIDS RES, V38, pD296, DOI 10.1093/nar/gkp987; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li JQ, 2016, PEERJ, V4, DOI 10.7717/peerj.2005; Li Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00485; Liu SW, 2010, PHYSIOL PLANTARUM, V139, P375, DOI 10.1111/j.1399-3054.2010.01374.x; Liu W, 2018, SCI HORTIC-AMSTERDAM, V237, P257, DOI 10.1016/j.scienta.2018.04.024; Liu ZG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00436; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meents MJ, 2018, ANN BOT-LONDON, V121, P1107, DOI 10.1093/aob/mcy005; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Monroe JG, 2018, ELIFE, V7, DOI 10.7554/eLife.41038; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Pan L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00519; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez-Urdaneta AB, 2005, CEREAL RES COMMUN, V33, P697, DOI 10.1556/CRC.33.2005.2-3.137; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Seeve CM, 2017, PLANT CELL ENVIRON, V40, P686, DOI 10.1111/pce.12891; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Silva EN, 2010, ENVIRON EXP BOT, V69, P279, DOI 10.1016/j.envexpbot.2010.05.001; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Takahashi H, 2008, EUPHYTICA, V164, P761, DOI 10.1007/s10681-008-9720-7; Talukder SK, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0050; Tardieu F, 2012, J EXP BOT, V63, P25, DOI 10.1093/jxb/err269; van Belle G, 2004, WILEY SERIES PROBABI; Wang JPP, 2007, MOL GENET GENOMICS, V277, P571, DOI 10.1007/s00438-007-0208-2; Williams CR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1457-z; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Hoang XLT, 2017, CURR GENOMICS, V18, P483, DOI [10.2174/1389101918666170227150057, 10.2174/1389202918666170227150057]	74	3	3	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2019	14	7							e0220518	10.1371/journal.pone.0220518	http://dx.doi.org/10.1371/journal.pone.0220518			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4WU	31361773	Green Published, gold			2022-12-26	WOS:000484981300037
J	Kolosova, NP; Ilyicheva, TN; Danilenko, AV; Bulanovich, JA; Svyatchenko, SV; Durymanov, AG; Goncharova, NI; Gudymo, AS; Shvalov, AN; Susloparov, IM; Marchenko, VY; Tregubchak, TV; Gavrilova, EV; Maksyutov, RA; Ryzhikov, AB				Kolosova, Natalia P.; Ilyicheva, Tatyana N.; Danilenko, Alexey V.; Bulanovich, Julia A.; Svyatchenko, Svetlana V.; Durymanov, Alexander G.; Goncharova, Natalia I.; Gudymo, Andrei S.; Shvalov, Alexander N.; Susloparov, Ivan M.; Marchenko, Vasiliy Y.; Tregubchak, Tatyana V.; Gavrilova, Elena V.; Maksyutov, Rinat A.; Ryzhikov, Alexander B.			Severe cases of seasonal influenza in Russia in 2017-2018	PLOS ONE			English	Article							UNITED-STATES; VIRUSES; ASIA	The 2017-2018 influenza epidemic season in Russia was characterized by a relatively low morbidity and mortality. We evaluated herd immunity prior to the 2017-2018 influenza season in hemagglutination inhibition assay, and performed characterization of influenza viruses isolated from severe or fatal influenza cases and from influenza cases in people vaccinated in the fall of 2017. During the 2017-2018 epidemic season, 87 influenza A and B viruses were isolated and viruses of the 75 influenza cases, including selected viral isolates and viruses analyzed directly from the original clinical material, were genetically characterized. The analyzed A(H1N1)pdm09 viruses belonged to clade 6B.1, B/Yamagata-like viruses belonged to clade 3, and B/Victoria-like viruses belonged to clade 1A and they were antigenically similar to the corresponding vaccine strains. A(H3N2) viruses belonged to clade 3C.2a and were difficult to characterize antigenically and the analysis indicated antigenic differences from the corresponding egg-grown vaccine strain. The next generation sequencing revealed the presence of D222/G/N polymorphism in the hemagglutinin gene in 32% of the analyzed A(H1N1)pdm09 lethal cases. This study demonstrated the importance of monitoring D222G/N polymorphism, including detection of minor viral variants with the mutations, in the hemagglutinin gene of A(H1N1)pdm09 for epidemiological surveillance. One strain of influenza virus A(H1N1)pdm09 was resistant to oseltamivir and had the H275Y amino acid substitution in the NA protein. All other isolates were susceptible to NA inhibitors. Prior to the 2017-2018 epidemic season, 67.4 million people were vaccinated, which accounted for 46.6% of the country's population. Just before the epidemic season 33-47% and 24-30% of blood sera samples collected within the territory of Russia showed the presence of protective antibody titers against vaccine strains of influenza A and influenza B/Victoria-like, respectively. Mass vaccination of the population had evidently reduced the severity of the flu epidemic during the 2017-2018 influenza epidemic season in Russia.	[Kolosova, Natalia P.; Ilyicheva, Tatyana N.; Danilenko, Alexey V.; Bulanovich, Julia A.; Svyatchenko, Svetlana V.; Durymanov, Alexander G.; Goncharova, Natalia I.; Gudymo, Andrei S.; Shvalov, Alexander N.; Susloparov, Ivan M.; Marchenko, Vasiliy Y.; Tregubchak, Tatyana V.; Gavrilova, Elena V.; Maksyutov, Rinat A.; Ryzhikov, Alexander B.] State Res Ctr Virol & Biotechnol Vector, Novosibirsk, Russia; [Ilyicheva, Tatyana N.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia	State Research Center of Virology & Biotechnology VECTOR; Novosibirsk State University	Kolosova, NP (corresponding author), State Res Ctr Virol & Biotechnol Vector, Novosibirsk, Russia.	nataliak.mail@gmail.com	Kolosova, Natalia/AAH-6399-2020	Kolosova, Natalia/0000-0001-8865-8592; Gudymo, Andrei/0000-0001-6952-6412; Tregubchak, Tatyana/0000-0001-9608-2044; Gavrilova, Elena/0000-0002-7118-5749; Susloparov, Ivan/0000-0002-9718-7339	FBRI SRC VB VECTOR, Rospotrebnadzor [1/16, 2/18]	FBRI SRC VB VECTOR, Rospotrebnadzor	This work was supported by State Assignments no. 1/16 and 2/18 (FBRI SRC VB VECTOR, Rospotrebnadzor), http://www.vector.nsc.ru/.The funders supported obtaining a number of reagents, funded sequencing and HI tests, data analysis and covered publication fees.	Adlhoch C, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.13.18-00146; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P369; [Anonymous], 2011, WHO SURVEILLANCE NET; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Asha K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020192; Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Barr IG, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0079-z; Black S, 2011, PEDIATR INFECT DIS J, V30, P1081, DOI 10.1097/INF.0b013e3182367662; Blanton L, 2017, MMWR-MORBID MORTAL W, V66, P668, DOI 10.15585/mmwr.mm6625a3; Blumberg EA, 2018, AM J TRANSPLANT, V18, P2829, DOI 10.1111/ajt.15140; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Deng YM, 2015, J CLIN VIROL, V68, P43, DOI 10.1016/j.jcv.2015.04.019; European Centre for Disease Prevention and Control, 2018, INF VIR CHAR SUMM EU; Garten R, 2018, MMWR-MORBID MORTAL W, V67, P634, DOI 10.15585/mmwr.mm6722a4; Geneva: World Health Organization, 2019, DAT FLUNET; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt A., 2009, FLUOROMETRIC NEURAMI; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Ilyicheva T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165332; Ilyicheva T, 2013, INFECT GENET EVOL, V20, P177, DOI 10.1016/j.meegid.2013.08.025; Ilyicheva T, 2011, INFECT GENET EVOL, V11, P2107, DOI 10.1016/j.meegid.2011.05.002; Ilyicheva T, 2016, J MED VIROL, V88, P35, DOI 10.1002/jmv.24301; Ilyicheva TN, 2018, ARCH VIROL, V163, P2675, DOI 10.1007/s00705-018-3904-9; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Lackenby A, 2018, ANTIVIR RES, V157, P38, DOI 10.1016/j.antiviral.2018.07.001; Marchenko VY, 2017, ARCH VIROL, V162, P1381, DOI 10.1007/s00705-017-3246-z; McCauley JW, 2012, VIRUS TAXONOMY, P749, DOI DOI 10.1016/B978-0-12-384684-6.00061-6; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; ROBERTSON JS, 1991, J GEN VIROL, V72, P2671, DOI 10.1099/0022-1317-72-11-2671; Selkova EP, 2018, RMJ MED REV, V11, P49; Selleri M, 2013, CLIN MICROBIOL INFEC, V19, P668, DOI 10.1111/j.1469-0691.2012.03984.x; St George K, 2012, INFLUENZA VIRUS METH, DOI [10.1007/978-1-61779-621-01, DOI 10.1007/978-1-61779-621-01]; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; WHO (World Health Organization), 2018, INFLUENZA; Yang JR, 2018, J CLIN VIROL, V99-100, P15, DOI 10.1016/j.jcv.2017.12.012; Yang L., 2019, BIOSAFETY HLTH, V1, P41, DOI 10.1016/j.bsheal.2019.02.007; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	38	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220401	10.1371/journal.pone.0220401	http://dx.doi.org/10.1371/journal.pone.0220401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356626	Green Submitted, gold, Green Published			2022-12-26	WOS:000484047000030
J	Gonzalez, J; Henschke, CI; Yankelevitz, DF; Seijo, LM; Reeves, AP; Yip, R; Xie, YT; Chung, M; Sanchez-Salcedo, P; Alcaide, AB; Campo, A; Berto, J; Ocon, MD; Pueyo, J; Bastarrika, G; de-Torres, JP; Zulueta, JJ				Gonzalez, Jessica; Henschke, Claudia I.; Yankelevitz, David F.; Seijo, Luis M.; Reeves, Anthony P.; Yip, Rowena; Xie, Yiting; Chung, Michael; Sanchez-Salcedo, Pablo; Alcaide, Ana B.; Campo, Aranzazu; Berto, Juan; del Mar Ocon, Maria; Pueyo, Jesus; Bastarrika, Gorka; de-Torres, Juan P.; Zulueta, Javier J.			Emphysema phenotypes and lung cancer risk	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; COMPUTED-TOMOGRAPHY; CT; MATRIX-METALLOPROTEINASE-9; DIAGNOSIS; VOLUME; DEATH; COPD	Background To assess the relationship between lung cancer and emphysema subtypes. Objective Airflow obstruction and emphysema predispose to lung cancer. Little is known, however, about the lung cancer risk associated with different emphysema phenotypes. We assessed the risk of lung cancer based on the presence, type and severity of emphysema, using visual assessment. Methods Seventy-two consecutive lung cancer cases were selected from a prospective cohort of 3,477 participants enrolled in the Clinica Universidad de Navarra's lung cancer screening program. Each case was matched to three control subjects using age, sex, smoking history and body mass index as key variables. Visual assessment of emphysema and spirometry were performed. Logistic regression and interaction model analysis were used in order to investigate associations between lung cancer and emphysema subtypes. Results Airflow obstruction and visual emphysema were significantly associated with lung cancer (OR = 2.8, 95%CI: 1.6 to 5.2; OR = 5.9, 95%CI: 2.9 to 12.2; respectively). Emphysema severity and centrilobular subtype were associated with greater risk when adjusted for confounders (OR = 12.6, 95%CI: 1.6 to 99.9; OR = 34.3, 95%CI: 25.5 to 99.3, respectively). The risk of lung cancer decreases with the added presence of paraseptal emphysema (OR = 4.0, 95%CI: 3.6 to 34.9), losing this increased risk of lung cancer when it occurs alone (OR = 0.7, 95%CI: 0.5 to 2.6). Conclusions Visual scoring of emphysema predicts lung cancer risk. The centrilobular phenotype is associated with the greatest risk.	[Gonzalez, Jessica; Seijo, Luis M.; Alcaide, Ana B.; Campo, Aranzazu; Berto, Juan; del Mar Ocon, Maria; de-Torres, Juan P.; Zulueta, Javier J.] Clin Univ Navarra, Pulm Serv, Pamplona, Spain; [Henschke, Claudia I.; Yankelevitz, David F.; Yip, Rowena; Chung, Michael] Mt Sinai Sch Med, Dept Radiol, New York, NY USA; [Reeves, Anthony P.; Xie, Yiting] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA; [Reeves, Anthony P.] D4Vision Inc, Ithaca, NY USA; [Sanchez-Salcedo, Pablo] Complejo Hosp Navarra, Pulm Serv, Pamplona, Spain; [Pueyo, Jesus; Bastarrika, Gorka] Clin Univ Navarra, Radiol Dept, Pamplona, Spain; [de-Torres, Juan P.; Zulueta, Javier J.] Navarras Hlth Res Inst IDISNA, Pamplona, Spain; [Zulueta, Javier J.] ISCIII, CIBERONC, Madrid, Spain; [Zulueta, Javier J.] VisionGate Inc, Phoenix, AZ USA	University of Navarra; Icahn School of Medicine at Mount Sinai; Cornell University; Servicio Navarro de Salud - Osasunbidea; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III	Zulueta, JJ (corresponding author), Clin Univ Navarra, Pulm Serv, Pamplona, Spain.; Zulueta, JJ (corresponding author), Navarras Hlth Res Inst IDISNA, Pamplona, Spain.; Zulueta, JJ (corresponding author), ISCIII, CIBERONC, Madrid, Spain.; Zulueta, JJ (corresponding author), VisionGate Inc, Phoenix, AZ USA.	jzulueta@unav.es	Zulueta, Javier J/H-5127-2011; Zulueta, Javier J/GXZ-5810-2022; Campo, Arantza/F-9487-2017	Zulueta, Javier J/0000-0003-3182-3555; Alcaide Ocana, Ana Belen/0000-0003-0733-3564; de Torres, Juan Pablo/0000-0003-1231-4894; Gonzalez Gutierrez, Jessica/0000-0002-6847-5315; Sanchez-Salcedo, Pablo/0000-0001-5690-4947; Berto, Juan/0000-0001-5673-2954; Campo, Arantza/0000-0001-9700-4355	Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, the Spanish Ministry of Economy and Competitiveness [RD12/0036/0062, RD12/0036/0040]; European Regional Development Fund "Una manera de hacer Europa"; Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Government of Spain [PI04/2404, PI07/0792, PI10/01652, PI11/01626]	Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, the Spanish Ministry of Economy and Competitiveness; European Regional Development Fund "Una manera de hacer Europa"; Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Government of Spain	This work was supported in part by a grant [RD12/0036/0062 and RD12/0036/0040] from Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, the Spanish Ministry of Economy and Competitiveness and European Regional Development Fund "Una manera de hacer Europa." It was also supported by grants PI04/2404, PI07/0792, PI10/01652, and PI11/01626 from the Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Government of Spain. The funder provided support in the form of salaries for authors [JJZ, JPd-T, DY, CH, AR]. The specific roles of these authors are articulated in the author contributions section. Funding agencies were not involved in study design, data collection nor analysis, decision to publish, or preparation of the manuscript.	Bourboulia D, 2013, ONCOTARGET, V4, P166; BYERS TE, 1984, JNCI-J NATL CANCER I, V72, P1271; Carr LL, 2018, CHEST; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Copley SJ, 2002, RADIOLOGY, V223, P812, DOI 10.1148/radiol.2233010760; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Gagnat AA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01162-2016; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Henschke CI, 2015, LUNG CANCER, V88, P42, DOI 10.1016/j.lungcan.2015.01.014; Kishi K, 2002, EUR RESPIR J, V19, P1093, DOI 10.1183/09031936.02.00264202; Kukkonen MK, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-36; Li Y, 2011, CANCER PREV RES, V4, P43, DOI 10.1158/1940-6207.CAPR-10-0151; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Maldonado F, 2010, CHEST, V138, P1295, DOI 10.1378/chest.09-2567; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Remillard Taylor C, 2014, Mol Cell Ther, V2, P17, DOI 10.1186/2052-8426-2-17; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; SAMET JM, 1986, AM REV RESPIR DIS, V134, P466; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Smith BM, 2012, LUNG CANCER, V77, P58, DOI 10.1016/j.lungcan.2012.02.019; Smith DH, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.06.030; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; Turner MC, 2007, AM J RESP CRIT CARE, V176, P285, DOI 10.1164/rccm.200612-1792OC; Vignola AM, 1998, AM J RESP CRIT CARE, V158, P1945, DOI 10.1164/ajrccm.158.6.9803014; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Wilson DO, 2011, J THORAC ONCOL, V6, P1200, DOI 10.1097/JTO.0b013e318219aa93; Zhang Y, 2014, ONCOL LETT, V7, P499, DOI 10.3892/ol.2013.1718; Zulueta JJ, 2015, ANN AM THORAC SOC, V12, P1120, DOI 10.1513/AnnalsATS.201506-360ED; Zulueta JJ, 2012, CHEST, V141, P1216, DOI 10.1378/chest.11-0101	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219187	10.1371/journal.pone.0219187	http://dx.doi.org/10.1371/journal.pone.0219187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344121	Green Submitted, Green Published, gold			2022-12-26	WOS:000484977900013
J	Rahman, MA; Rahman, MM; Rahman, MM; Jesmin, SS				Rahman, Md. Aminur; Rahman, Md. Mosfequr; Rahman, Md. Mosiur; Jesmin, Syeda S.			The double burden of under- and overnutrition among Bangladeshi women: Socioeconomic and community-level inequalities	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION TRANSITION; MATERNAL UNDERWEIGHT; OBESITY; OVERWEIGHT; WEIGHT; MEDIA; RISK; MALNUTRITION; PATTERNS	Background The prevalence of overweightness in Bangladesh is increasing, while underweightness also continues to persist. A better understanding of the patterns and socioeconomic risk factors of both conditions, particularly among women, is critical in order to promote the development of interventions to improve maternal health in Bangladesh. This study therefore sought to assess the patterns of under-and overweightness between 2004 and 2014 and to examine the predictors of individual and community-level inequalities of under-and overnutrition in Bangladesh. Methods Cross-sectional data of 10, 431, and 16,478 ever-married nonpregnant women aged between 15 and 49 years who did not give birth in the two months preceding the survey were extracted from the 2004 and 2014 Bangladesh Demographic and Health Surveys, respectively. Body mass index was used to measure weight status, and underweightness, at-risk for overweightness, overweightness, and obesity were the main outcome variables. Patterns of nutritional change over time was examined by considering the annual average rate of change. Multilevel multinomial logistic regression and quantile regression were used to identify the inequalities. Results In 2014, the age-adjusted prevalence values of underweightness, at-risk for overweightness, overweightness, and obesity were 19.7%, 14.9%, 18.1% and 4.0%, respectively. A higher average annual rate of reduction of underweightness was found among wealthier, highly educated, and wealthier community-living women, while a rate of increase of overweightness was found among poorer, uneducated, and poor community-living women. Individual and community-level inequalities of malnutrition were observed among these populations. In comparison with women living in low wealth communities, women from wealthier communities were at an increased risk of being at-risk for over-weightness [adjusted odds ratio (AOR): 1.53, 95% confidence interval (CI): 1.23-1.91], overweight (AOR: 1.60, 95% CI: 1.27-2.00), and obese (AOR: 2.12, 95% CI: 1.42-3.18). Conclusions This study suggests the coexistence of a double burden of under-and overnutrition in Bangladesh and that the prevalence of overweightness surpasses that of underweightness. The burdens of under-and overnutrition are strongly associated with women's individual socioeconomic positions and the nature of the community in which they live.	[Rahman, Md. Aminur; Rahman, Md. Mosfequr; Rahman, Md. Mosiur] Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh; [Rahman, Md. Mosiur] Tokyo Med & Dent Univ, Div Publ Hlth, Dept Global Hlth Entrepreneurship, Tokyo, Japan; [Jesmin, Syeda S.] Univ North Texas, Sociol & Psychol Dept, Dallas, TX USA	University of Rajshahi; Tokyo Medical & Dental University (TMDU); University of North Texas System; University of North Texas Denton	Rahman, MM (corresponding author), Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh.	mosfeque@ru.ac.bd	Rahman, Md. Mosfequr/D-9107-2017	Rahman, Md. Mosfequr/0000-0002-2402-5814				Agbeko MP, 2013, OPEN OBESITY J, V5; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2017, DHS PROGRAM WHAT WE; Assaf S., 2015, DHS METHODOLOGICAL R, V16; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Aviram A, 2011, INT J GYNECOL OBSTET, V115, pS6, DOI 10.1016/S0020-7292(11)60004-0; Baker P, 2014, OBES REV, V15, P564, DOI 10.1111/obr.12174; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Birmeta K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-256; Bishwajit G., 2017, OBESITY SCI PRACTICE; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177395; Bosy-Westphal A, 2006, INT J OBESITY, V30, P475, DOI 10.1038/sj.ijo.0803144; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Corsi DJ, 2011, J NUTR, V141, P631, DOI 10.3945/jn.110.131599; Delisle HF, 2008, ANN NY ACAD SCI, V1136, P172, DOI 10.1196/annals.1425.026; Doku DT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2033-6; Fernald LC, 2009, PERCEPTION BODY WEIG; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Hanandita W, 2015, SSM-POPUL HLTH, V1, P16, DOI 10.1016/j.ssmph.2015.10.002; He Y, 2016, AM J PUBLIC HEALTH, V106, P2103, DOI 10.2105/AJPH.2016.303499; Hindin TJ, 2004, J AM DIET ASSOC, V104, P192, DOI 10.1016/j.jada.2003.11.006; Hong SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194454; Hoque ME, 2015, NUTR REV, V73, P438, DOI 10.1093/nutrit/nuv003; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Inoue S, 2012, J EPIDEMIOL, V22, P50, DOI 10.2188/jea.JE20110054; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Jones-Smith JC, 2011, AM J EPIDEMIOL, V173, P667, DOI 10.1093/aje/kwq428; Kamal SMM, 2015, J HEALTH POPUL NUTR, V33, P92; Kandala NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101103; Kennedy G., 2006, FAO Food and Nutrition Paper, P1; Khan SH, 2013, OBES REV, V14, P126, DOI 10.1111/obr.12100; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; KOENKER R., 2005, ECONOMETRIC SOC MONO, V38, DOI [10.1017/CBO9780511754098, DOI 10.1017/CBO9780511754098]; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Miles A, 2001, HEALTH EDUC RES, V16, P357, DOI 10.1093/her/16.3.357; Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Molini V, 2007, EVIDENCE VIETNAM 199; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; Naugle DA, 2014, J HEALTH COMMUN, V19, P190, DOI 10.1080/10810730.2014.918217; Papachatzi E, 2013, J Neonatal Perinatal Med, V6, P203, DOI 10.3233/NPM-1370313; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; Pullum TW, 2008, ASSESSMENT QUALITY D; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Razak F, 2005, INT J OBESITY, V29, P656, DOI 10.1038/sj.ijo.0802937; Razak F, 2013, LANCET, V381, P626, DOI 10.1016/S0140-6736(13)60344-X; Rguibi Mohamed, 2006, Body Image, V3, P395, DOI 10.1016/j.bodyim.2006.07.007; Rutstein S.O., 2004, DHS COMP REPORTS; Shafique S, 2007, INT J EPIDEMIOL, V36, P449, DOI 10.1093/ije/dyl306; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Subramanian SV, 2009, AM J CLIN NUTR, V90, P369, DOI 10.3945/ajcn.2009.27487; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Tsawe M, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0162-2; Turi KN, 2013, INT J ENV RES PUB HE, V10, P4967, DOI 10.3390/ijerph10104967; UNICEF, TECHN NOT CALC AV AN; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; WHO, 2003, WHO TECH REP SER, V916, P1; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Zahangir MS, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.2; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	68	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0219968	10.1371/journal.pone.0219968	http://dx.doi.org/10.1371/journal.pone.0219968			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4VN	31344076	Green Published, gold, Green Submitted			2022-12-26	WOS:000484977900044
J	Sannolo, M; Carretero, MA				Sannolo, Marco; Carretero, Miguel Angel			Dehydration constrains thermoregulation and space use in lizards	PLOS ONE			English	Article							PREFERRED BODY-TEMPERATURE; EVAPORATIVE WATER-LOSS; CLIMATE-CHANGE; POPULATION; BEHAVIOR; IMPACTS; GROWTH; MORPHOLOGY; PHYSIOLOGY; DIVERSITY	Climate change is negatively affecting many species. The increase in mean air temperature is often associated with shifts in distribution, changes in phenology, and local extinctions. Other factors that only partially correlate with air temperature, like water shortage, may also contribute to the negative consequences of climate change. Although the effect of temperature on lizards' ecophysiology is highly studied, many lizards are also at risks of increased water loss and dehydration, which are predicted to increase under climate change. Here we aimed for the first time to explore if lacertid lizards exposed to dehydration thermoregulate less precisely than hydrated lizards and if dehydrated lizards are less active, change the daily pattern of thermoregulation and balance water balance against thermoregulation. We exposed four lizard species with differences in the thermal preference to thermal gradients with or without a source of water. We measured preferred body temperatures, daily pattern of thermoregulation, and the use of space. Dehydration negatively affected thermoregulation in all investigated species. Dehydrated lizards reduced their preferred body temperature and showed a species-specific pattern of hourly change in thermal preference. Furthermore, they more frequently used the colder parts of the gradients and spent more time hidden. Lizards experiencing dehydration may suffer a reduction in survival and fitness because of poor thermoregulation. Similarly, they may spend more time hidden, waiting for more favourable weather conditions. Such inactivity may carry ecological costs especially in those regions that undergo either short or prolonged periods of droughts.	[Sannolo, Marco; Carretero, Miguel Angel] Univ Porto, InBIO, CIBIO, Res Ctr Biodivers & Genet Resources, Campus Vairao,Rua Padre Armando Quintas, Vairao, Vila Do Conde, Portugal; [Sannolo, Marco] Univ Porto, Fac Ciencias, Dept Biol, Porto, Portugal	Universidade do Porto; Universidade do Porto	Sannolo, M (corresponding author), Univ Porto, InBIO, CIBIO, Res Ctr Biodivers & Genet Resources, Campus Vairao,Rua Padre Armando Quintas, Vairao, Vila Do Conde, Portugal.; Sannolo, M (corresponding author), Univ Porto, Fac Ciencias, Dept Biol, Porto, Portugal.	marco.sannolo@gmail.com	Sannolo, Marco/AAA-7909-2020; Carretero, Miguel A/A-1472-2013	Sannolo, Marco/0000-0001-6760-1159; Carretero, Miguel A/0000-0002-2335-7198	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/103549/2014, NORTE-01-0145FEDER-000007, PTDC/BIA-CBI/28014/2017, 28014 02/SAICT/2017]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research is funded by Fundacao para a Ciencia e a Tecnologia (FCT), grant SFRH/BD/103549/2014 to MS, grant NORTE-01-0145FEDER-000007 to MAC, grant PTDC/BIA-CBI/28014/2017 to MAC, and grant 28014 02/SAICT/2017 to MAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Raquel Ponti for the precious help in the field, Memeo for the invaluable company during the drafting of the manuscript and Frederico Barroso and Ofir Levy for revising it before submission. Barry Sinervo and an anonymous reviewer provided valuable comments on a earlier draft of the manuscript. Permits for lizards capturing and handling were provided by the Instituto da Conservacao da Natureza e das Florestas (ICNF Portugal, no. 576/2017/CAPT). Experiments followed the ethical guidelines of the University of Porto.	Adamopoulou C, 2005, ISR J ZOOL, V51, P39, DOI 10.1560/HWWQ-R26Y-WTHB-K00V; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; AVERY HW, 1993, PHYSIOL ZOOL, V66, P902, DOI 10.1086/physzool.66.6.30163746; AVERY R A, 1990, Amphibia-Reptilia, V11, P111, DOI 10.1163/156853890X00519; Barroso FM, 2016, J THERM BIOL, V62, P90, DOI 10.1016/j.jtherbio.2016.10.004; Benjamini Y, 2001, ANN STAT, V29, P1165; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Carretero MA, 2005, HERPETOL J, V15, P51; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowles Raymond Bridgman, 1944, BULL AMER MUS NAT HIST, V83, P261; CROWLEY SR, 1987, COPEIA, P25, DOI 10.2307/1446033; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DEWITT CB, 1979, AM ZOOL, V19, P195; Dupoue A, 2017, OECOLOGIA, V185, P561, DOI 10.1007/s00442-017-3973-6; FOA A, 1992, HERPETOL J, V2, P86; Garcia-Munoz E, 2013, ACTA HERPETOL, V8, P123; Gomes V, 2016, ACTA OECOL, V70, P87, DOI 10.1016/j.actao.2015.12.005; HERTZ PE, 1992, OECOLOGIA, V90, P127, DOI 10.1007/BF00317818; Huey R.B., 1982, Biology of Reptilia, V12, P25; Huey R. B., 2017, FUNCTIONAL ECOLOGY, V32, P334; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; Huey RB, 2010, SCIENCE, V328, P832, DOI 10.1126/science.1190374; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HUEY RB, 1977, ECOLOGY, V58, P1066, DOI 10.2307/1936926; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Kaliontzopoulou A, 2012, ZOOL J LINN SOC-LOND, V164, P173, DOI 10.1111/j.1096-3642.2011.00760.x; Kaliontzopoulou A, 2011, BIOL J LINN SOC, V103, P779, DOI 10.1111/j.1095-8312.2011.01703.x; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Komsta L., 2015, MOMENTS MOMENTS CUMU; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lorenzon P, 1999, OECOLOGIA, V118, P423, DOI 10.1007/s004420050744; MAUTZ WJ, 1980, COMP BIOCHEM PHYS A, V67, P429, DOI 10.1016/S0300-9629(80)80019-3; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Meyer L., 2014, CLIMATE CHANGE 2014; Minnich J.E., 1982, Biology of Reptilia, V12, P325; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Osojnik N, 2013, HERPETOLOGICA, V69, P445; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pinheiro J., 2017, NLME LINEAR NONLINEA; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; R Core Team, 2021, R LANGUAGE ENV STAT; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rusch TW, 2017, FUNCT ECOL, V31, P1519, DOI 10.1111/1365-2435.12869; Rutherford PL, 2003, ECOSCIENCE, V10, P24, DOI 10.1080/11956860.2003.11682746; Ryan MJ, 2016, FUNCT ECOL, V30, P964, DOI 10.1111/1365-2435.12595; Sacchi R, 2016, TECH ECOL CONSERVAT, P59; Sannolo M, 2014, J ZOOL, V293, P71, DOI 10.1111/jzo.12121; Sannolo M, 2018, ZOOLOGY, V126, P58, DOI 10.1016/j.zool.2017.12.003; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Selong JH, 2001, T AM FISH SOC, V130, P1026, DOI 10.1577/1548-8659(2001)130<1026:EOTOGA>2.0.CO;2; Sequeira F, 2008, ATLAS ANFIBIOS REPTE, P92; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; TORCHIANO M, 2017, EFFSIZE EFFICIENT EF, V7, P1; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Wang Y, 2016, OECOLOGIA, V182, P961, DOI 10.1007/s00442-016-3727-x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiens JJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2001104	64	31	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220384	10.1371/journal.pone.0220384	http://dx.doi.org/10.1371/journal.pone.0220384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344149	gold, Green Published, Green Submitted			2022-12-26	WOS:000484977900096
J	Tarazanova, M; Huppertz, T; Starrenburg, M; Todt, T; van Hijum, S; Kok, J; Bachmann, H				Tarazanova, Mariya; Huppertz, Thom; Starrenburg, Marjo; Todt, Tilman; van Hijum, Sacha; Kok, Jan; Bachmann, Herwig			Transcriptional response of Lactococcus lactis during bacterial emulsification	PLOS ONE			English	Article							CELL-SURFACE PROPERTIES; GRAM-POSITIVE BACTERIA; ACID BACTERIA; WATER EMULSIONS; MICROBIAL-CELLS; ADHESION; FOOD; CODY; PARTICLES; PROTEINS	Microbial surface properties are important for interactions with the environment in which cells reside. Surface properties of lactic acid bacteria significantly vary and some strains can form strong emulsions when mixed with a hydrocarbon. Lactococcus lactis NCDO712 forms oil-in-water emulsions upon mixing of a cell suspension with petroleum. In the emulsion the bacteria locate at the oil-water interphase which is consistent with Pickering stabilization. Cells of strain NCDO712 mixed with sunflower seed oil did not stabilize the oil droplets. This study shows that the addition of either ethanol or ammonium sulfate led to cell aggregation, which subsequently allowed stabilizing oil-in-water emulsions. From this, we conclude that bacterial cell aggregation is important for emulsion droplet stabilization. To determine how bacterial emulsification influences the microbial transcriptome RNAseq analysis was performed on lactococci taken from the oil-water interphase. In comparison to cells in suspension 72 genes were significantly differentially expressed with a more than 4-fold difference. The majority of these genes encode proteins involved in transport processes and the metabolism of amino acids, carbohydrates and ions. Especially the proportion of genes belonging to the CodY regulon was high. Our results also point out that in a complex environment such as food fermentations a heterogeneous response of microbes might be caused by microbe-matrix interactions. In addition, microdroplet technologies are increasingly used in research. The understanding of interactions between bacterial cells and oil-water interphases is of importance for conducting and interpreting such experiments.	[Tarazanova, Mariya; Huppertz, Thom; Starrenburg, Marjo; van Hijum, Sacha; Kok, Jan; Bachmann, Herwig] TI Food & Nutr, Wageningen, Netherlands; [Tarazanova, Mariya; Huppertz, Thom; Starrenburg, Marjo; van Hijum, Sacha; Bachmann, Herwig] NIZO, Ede, Netherlands; [Tarazanova, Mariya; Starrenburg, Marjo; Kok, Jan] Univ Groningen, Mol Genet, Groningen, Netherlands; [Todt, Tilman; van Hijum, Sacha] Radboud Univ Nijmegen, Med Ctr CMBI, Geert Grootepl, Nijmegen, Netherlands; [Todt, Tilman] Univ Appl Sci, PGL, HAN, Nijmegen, Netherlands; [Huppertz, Thom] FrieslandCampina, Amersfoort, Netherlands	Top Institute Food & Nutrition; NIZO Food Research; University of Groningen; Radboud University Nijmegen	Bachmann, H (corresponding author), TI Food & Nutr, Wageningen, Netherlands.; Bachmann, H (corresponding author), NIZO, Ede, Netherlands.	Herwig.Bachmann@nizo.com	Bachmann, Herwig/ABE-6301-2021	Bachmann, Herwig/0000-0002-8224-0993	Top Institute Food & Nutrition (TIFN, Wageningen, The Netherlands) [FF001]	Top Institute Food & Nutrition (TIFN, Wageningen, The Netherlands)	This study was funded by the Top Institute Food & Nutrition (TIFN, Program FF001, Wageningen, The Netherlands). MS, TH, SvH and HB are also employed by NIZO Food Research. TIFN provided support in the form of salaries for authors MT, MS, TH, SvH, JK and HB. The specific roles of these authors are articulated in the ' author contributions' section. Neither NIZO food research nor TIFN had an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; ATLAS RM, 1991, J CHEM TECHNOL BIOT, V52, P149; Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4; Bachmann H, 2013, P NATL ACAD SCI USA, V110, P14302, DOI 10.1073/pnas.1308523110; Bayoudh S, 2009, COLLOID SURFACE B, V73, P1, DOI 10.1016/j.colsurfb.2009.04.030; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boonaert CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000; Burgain J, 2014, ADV COLLOID INTERFAC, V213, P21, DOI 10.1016/j.cis.2014.09.005; Burgain J, 2015, COLLOID SURFACE B, V134, P332, DOI 10.1016/j.colsurfb.2015.06.068; Chambellon E, 2003, APPL ENVIRON MICROB, V69, P3061, DOI 10.1128/AEM.69.6.3061-3068.2003; Chapot-Chartier MP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S9; Das N, 2011, BIOTECHNOL RES INT, V2011, P1, DOI [10.4061/2011/941810, DOI 10.4061/2011/941810]; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; den Hengst CD, 2006, J BACTERIOL, V188, P3280, DOI 10.1128/JB.188.9.3280-3289.2006; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; den Hengst CD, 2005, J BACTERIOL, V187, P512, DOI 10.1128/JB.187.2.512-521.2005; Dickinson E, 2010, CURR OPIN COLLOID IN, V15, P40, DOI 10.1016/j.cocis.2009.11.001; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dorobantu LS, 2004, APPL ENVIRON MICROB, V70, P6333, DOI 10.1128/AEM.70.10.6333-6336.2004; Ercan O, 2015, APPL ENVIRON MICROB, V81, P2554, DOI 10.1128/AEM.03748-14; Feehily C, 2013, J APPL MICROBIOL, V114, P11, DOI 10.1111/j.1365-2672.2012.05434.x; Firoozmand H, 2016, FOOD RES INT, V81, P66, DOI 10.1016/j.foodres.2015.10.018; Firoozmand H, 2014, FOOD HYDROCOLLOID, V42, P204, DOI 10.1016/j.foodhyd.2014.04.040; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; Heeres AS, 2014, TRENDS BIOTECHNOL, V32, P221, DOI 10.1016/j.tibtech.2014.02.002; Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6; Jeanson S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01284; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; Kaczorek E, 2011, BIODEGRADATION, V22, P359, DOI 10.1007/s10532-010-9406-4; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Larsen N, 2007, INT J FOOD MICROBIOL, V114, P113, DOI 10.1016/j.ijfoodmicro.2006.10.033; Le-Tien C, 2004, BIOTECHNOL APPL BIOC, V39, P347, DOI 10.1042/BA20030158; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; LIN L, 1995, COLLOID SURFACE B, V5, P127, DOI 10.1016/0927-7765(95)01189-P; Ly MH, 2008, FOOD HYDROCOLLOID, V22, P742, DOI 10.1016/j.foodhyd.2007.03.001; Ly MH, 2006, COLLOID SURFACE B, V52, P149, DOI 10.1016/j.colsurfb.2006.04.015; Ly MH, 2006, INT J FOOD MICROBIOL, V112, P26, DOI 10.1016/j.ijfoodmicro.2006.05.022; Ly-Chatain MH, 2010, FOOD RES INT, V43, P1594, DOI 10.1016/j.foodres.2010.04.019; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Millsap KW, 1996, J MICROBIOL METH, V27, P239, DOI 10.1016/S0167-7012(96)00937-2; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Neu T R, 1990, J Biomater Appl, V5, P107, DOI 10.1177/088532829000500203; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e; Pelletier C, 1997, APPL ENVIRON MICROB, V63, P1725, DOI 10.1128/AEM.63.5.1725-1731.1997; Poortinga AT, 2002, SURF SCI REP, V47, P3, DOI 10.1016/S0167-5729(02)00032-8; Price CE, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-018-1331-x; Rayner M, 2014, COLLOID SURFACE A, V458, P48, DOI 10.1016/j.colsurfa.2014.03.053; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; ROSENBERG M, 1984, FEMS MICROBIOL LETT, V22, P289; Rutter PR, MICROBIAL ADHESION A, DOI [10.1016/j.colsurfb.2009.04.030, DOI 10.1016/J.COLSURFB.2009.04.030]; STARRENBURG MJC, 1991, APPL ENVIRON MICROB, V57, P3535, DOI 10.1128/AEM.57.12.3535-3540.1991; Tadros T. F., 2013, EMULSION FORMATION S, DOI [10.1002/9783527647941, DOI 10.1002/9783527647941.CH1]; Tarazanova M, 2018, MICROB BIOTECHNOL, V11, P770, DOI 10.1111/1751-7915.13278; Tarazanova M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01691; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van der Mei HC, 2001, J COLLOID INTERF SCI, V241, P327, DOI 10.1006/jcis.2001.7768; VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893, DOI 10.1128/AEM.53.8.1893-1897.1987; VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898, DOI 10.1128/AEM.53.8.1898-1901.1987; Vestergaard M, 2017, MBIO, V8, P1, DOI DOI 10.1128/MBI0.00526-17; Wongkongkatep P, 2012, LANGMUIR, V28, P5729, DOI 10.1021/la300660x; Xiao J, 2016, TRENDS FOOD SCI TECH, V55, P48, DOI 10.1016/j.tifs.2016.05.010; Yvon M, 2011, INT DAIRY J, V21, P335, DOI 10.1016/j.idairyj.2010.11.010	67	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220048	10.1371/journal.pone.0220048	http://dx.doi.org/10.1371/journal.pone.0220048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344087	Green Submitted, Green Published, gold			2022-12-26	WOS:000484977900050
J	Psonis, JJ; Chahales, P; Henderson, NS; Rigel, NW; Hoffman, PS; Thanassi, DG				Psonis, John J.; Chahales, Peter; Henderson, Nadine S.; Rigel, Nathan W.; Hoffman, Paul S.; Thanassi, David G.			The small molecule nitazoxanide selectively disrupts BAM-mediated folding of the outer membrane usher protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						outer membrane; bacteria; protein folding; small molecule; protein secretion; Bam complex; fimbriae; nitazoxanide; pili; usher protein; bacterial outer membrane; virulence factor	UROPATHOGENIC ESCHERICHIA-COLI; PILUS BIOGENESIS; STRUCTURAL BASIS; CHAPERONE FUNCTION; YAET COMPLEX; N-TERMINUS; INFECTIONS; DOMAIN; SURA; RECONSTITUTION	Bacterial pathogens assemble adhesive surface structures termed pili or fimbriae to initiate and sustain infection of host tissues. Uropathogenic Escherichia coli, the primary causative agent of urinary tract infections, expresses type 1 and P pili required for colonization of the bladder and kidney, respectively. These pili are assembled by the conserved chaperone?usher (CU) pathway, in which a periplasmic chaperone works together with an outer membrane (OM) usher protein to build and secrete the pilus fiber. Previously, we found that the small molecule and antiparasitic drug nitazoxanide (NTZ) inhibits CU pathway?mediated pilus biogenesis in E. coli by specifically interfering with proper maturation of the usher protein in the OM. The usher is folded and inserted into the OM by the ?-barrel assembly machine (BAM) complex, which in E. coli comprises five proteins, BamA?E. Here, we show that sensitivity of the usher to NTZ is modulated by BAM expression levels and requires the BamB and BamE lipoproteins. Furthermore, a genetic screen for NTZ-resistant bacterial mutants isolated a mutation in the essential BamD lipoprotein. These findings suggest that NTZ selectively interferes with an usher-specific arm of the BAM complex, revealing new details of the usher folding pathway and BAM complex function. Evaluation of a set of NTZ derivatives identified compounds with increased potency and disclosed that NTZ's nitrothiazole ring is critical for usher inhibition. In summary, our findings indicate highly specific effects of NTZ on the usher folding pathway and have uncovered NTZ analogs that specifically decrease usher levels in the OM.	[Psonis, John J.; Chahales, Peter; Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Psonis, John J.; Chahales, Peter; Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Rigel, Nathan W.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA; [Hoffman, Paul S.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hofstra University; University of Virginia	Thanassi, DG (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	david.thanassi@stonybrook.edu			NIGMS, National Institutes of Health (NIH) [R01GM062987]; NIAID, NIH [R21AI121639]; NIH [S10OD020155]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121639, T32AI007539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062987] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health (NIH), Grant R01GM062987 and NIAID, NIH, Grant R21AI121639 (to D. G. T.). This work was also supported by NIH Grant S10OD020155 (to M. Seeliger, Stony Brook University). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; [Anonymous], EXPT GENE FUSIONS; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Arnold T, 2010, J BIOL CHEM, V285, P18003, DOI 10.1074/jbc.M110.112516; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Ballard TE, 2011, CHEMMEDCHEM, V6, P362, DOI 10.1002/cmdc.201000475; Bergal HT, 2016, STRUCTURE, V24, P243, DOI 10.1016/j.str.2015.10.030; Cabello RR, 1997, T ROY SOC TROP MED H, V91, P701, DOI 10.1016/S0035-9203(97)90531-9; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chahales P, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.UTI-0018-2013; Chahales P, 2016, ANTIMICROB AGENTS CH, V60, P2028, DOI 10.1128/AAC.02221-15; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Du MG, 2018, NATURE, V562, P444, DOI 10.1038/s41586-018-0587-z; Dubreuil L, 1996, ANTIMICROB AGENTS CH, V40, P2266, DOI 10.1128/AAC.40.10.2266; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Geibel S, 2014, BBA-MOL CELL RES, V1843, P1559, DOI 10.1016/j.bbamcr.2013.09.023; Gilles HM, 2002, TRENDS PARASITOL, V18, P95, DOI 10.1016/S1471-4922(01)02205-X; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hart EM, 2019, MBIO, V10, DOI 10.1128/mBio.00662-19; Henderson NS, 2011, MOL MICROBIOL, V79, P954, DOI 10.1111/j.1365-2958.2010.07505.x; Hoffman PS, 2007, ANTIMICROB AGENTS CH, V51, P868, DOI 10.1128/AAC.01159-06; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Konovalova A, 2017, ANNU REV MICROBIOL, V71, P539, DOI 10.1146/annurev-micro-090816-093754; Konovalova A, 2014, P NATL ACAD SCI USA, V111, pE4350, DOI 10.1073/pnas.1417138111; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lee J, 2018, P NATL ACAD SCI USA, V115, P2359, DOI 10.1073/pnas.1711727115; Lo AWH, 2014, J ANTIMICROB CHEMOTH, V69, P1017, DOI 10.1093/jac/dkt467; Mahoney TF, 2016, J BACTERIOL, V198, P1984, DOI 10.1128/JB.00263-16; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; McCabe AL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00373-17; Ng TW, 2004, J BACTERIOL, V186, P5321, DOI 10.1128/JB.186.16.5321-5331.2004; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; NORGREN M, 1987, MOL MICROBIOL, V1, P169, DOI 10.1111/j.1365-2958.1987.tb00509.x; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Paharik AE, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0504-3; Palomino C, 2011, J BACTERIOL, V193, P5222, DOI 10.1128/JB.05585-11; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMra1108296, 10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Piatek R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-131; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Psonis John J, 2019, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0033-2018; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Reisch Christopher R, 2017, Curr Protoc Mol Biol, V117, DOI 10.1002/cpmb.29; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Ricci Dante P, 2019, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0035-2018; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Rigel NW, 2012, J BACTERIOL, V194, P1002, DOI 10.1128/JB.06426-11; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Shamir ER, 2010, ANTIMICROB AGENTS CH, V54, P1526, DOI 10.1128/AAC.01279-09; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Stubenrauch C, 2016, MOL MICROBIOL, V102, P753, DOI 10.1111/mmi.13527; Stubenrauch C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.64, 10.1038/nmicrobiol.2016.64]; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; Svensson A, 2001, CHEMBIOCHEM, V2, P915, DOI 10.1002/1439-7633(20011203)2:12<915::AID-CBIC915>3.3.CO;2-D; Tata M, 2019, MBIO, V10, DOI 10.1128/mBio.00660-19; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Warner LR, 2017, STRUCTURE, V25, P94, DOI 10.1016/j.str.2016.11.013; Watts KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003359; Werneburg Glenn T, 2018, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0007-2017; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zav'yalov V, 2010, FEMS MICROBIOL REV, V34, P317, DOI 10.1111/j.1574-6976.2009.00201.x	77	9	9	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14357	14369		10.1074/jbc.RA119.009616	http://dx.doi.org/10.1074/jbc.RA119.009616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31391254	Green Published, hybrid			2022-12-26	WOS:000499248200017
J	Truzzi, DR; Coelho, FR; Paviani, V; Alves, SV; Netto, LES; Augusto, O				Truzzi, Daniela R.; Coelho, Fernando R.; Paviani, Veronica; Alves, Simone V.; Netto, Luis E. S.; Augusto, Ohara			The bicarbonate/carbon dioxide pair increases hydrogen peroxide-mediated hyperoxidation of human peroxiredoxin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peroxiredoxin; hydrogen peroxide; carbon dioxide; bicarbonate; thiol; redox signaling; antioxidant defense; hyperoxidation; inactivation; peroxymonocarbonate; thiol oxidation	CYSTEINE-SULFINIC ACID; OXIDATIVE STRESS; MAMMALIAN THIOREDOXIN; MASS-SPECTROMETRY; RATE-CONSTANTS; INACTIVATION; MECHANISM; KINETICS; PEROXYMONOCARBONATE; PHOSPHORYLATION	2-Cys peroxiredoxins (Prxs) rapidly reduce H2O2, thereby acting as antioxidants and also as sensors and transmitters of H2O2 signals in cells. Interestingly, eukaryotic 2-Cys Prxs lose their peroxidase activity at high H2O2 levels. Under these conditions, H2O2 oxidizes the sulfenic acid derivative of the Prx peroxidatic Cys (CPSOH) to the sulfinate (CPSO2-) and sulfonated (CPSO3-) forms, redirecting the CPSOH intermediate from the catalytic cycle to the hyperoxidation/inactivation pathway. The susceptibility of 2-Cys Prxs to hyperoxidation varies greatly and depends on structural features that affect the life-time of the CPSOH intermediate. Among the human Prxs, Prx1 has an intermediate susceptibility to H2O2 and was selected here to investigate the effect of a physiological concentration of HCO3-/CO2 (25 mM) on its hyperoxidation. Immunoblotting and kinetic and MS/MS experiments revealed that HCO3-/CO2 increases Prx1 hyperoxidation and inactivation both in the presence of excess H2O2 and during enzymatic (NADPH/thioredoxin reductase/thioredoxin) and chemical (DTT) turnover. We hypothesized that the stimulating effect of HCO3-/CO2 was due to HCO4-, a peroxide present in equilibrated solutions of H2O2 and HCO3-/CO2. Indeed, additional experiments and calculations uncovered that HCO4- oxidizes CPSOH to CPSO2- with a second-order rate constant 2 orders of magnitude higher than that of H2O2 ((1.5 +/- 0.1) x 10(5) and (2.9 +/- 0.2) x 10(3) M-1.s(-1), respectively) and that HCO4- is 250 times more efficient than H2O2 at inactivating 1% Prx1 per turnover. The fact that the biologically ubiquitous HCO3-/CO2 pair stimulates Prx1 hyperoxidation and inactivation bears relevance to Prx1 functions beyond its antioxidant activity.	[Truzzi, Daniela R.; Coelho, Fernando R.; Paviani, Veronica; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, Av Lineu Prestes 748, BR-05508000 Sao Paulo, Brazil; [Alves, Simone V.; Netto, Luis E. S.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508090 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Av Lineu Prestes 748, BR-05508000 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Augusto, Ohara/D-3839-2012; Netto, Luis/A-3783-2008; Truzzi, Daniela R/B-2540-2014	Augusto, Ohara/0000-0002-7220-4286; Netto, Luis/0000-0002-4250-9177; Truzzi, Daniela R/0000-0003-4421-9621; Paviani Sampaio, Veronica/0000-0003-0718-2436	Sao Paulo Research Foundation (FAPESP) [2013/07937-8]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) [573530/2008-4]; Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant [2011.1.9352.1.8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant	This work was supported by Sao Paulo Research Foundation (FAPESP) Grant 2013/07937-8, Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) Grant 573530/2008-4, and Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant 2011.1.9352.1.8. The authors are members of NAP Redoxoma (PRPUSP), and the CEPID Redoxoma (FAPESP). The authors declare that they have no conflicts of interest with the contents of this article.	Arai H, 2005, P NATL ACAD SCI USA, V102, P10472, DOI 10.1073/pnas.0504685102; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Augusto O, 2019, FREE RADICAL BIO MED, V135, P210, DOI 10.1016/j.freeradbiomed.2019.02.026; Bakhmutova-Albert EV, 2010, INORG CHEM, V49, P11287, DOI 10.1021/ic1007389; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bolduc JA, 2018, J BIOL CHEM, V293, P11901, DOI 10.1074/jbc.RA117.001690; Brown JD, 2013, CELL REP, V5, P1425, DOI 10.1016/j.celrep.2013.10.036; Carvalho LAC, 2017, J BIOL CHEM, V292, P8705, DOI 10.1074/jbc.M116.767657; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Dagnell M, 2019, J BIOL CHEM, V294, P12330, DOI 10.1074/jbc.RA119.009001; Dalla Rizza J, 2019, PROTEIN SCI, V28, P191, DOI 10.1002/pro.3520; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; de Oliveira MA, 2005, ACTA CRYSTALLOGR F, V61, P387, DOI 10.1107/S174430910500758X; Dost B, 2012, J COMPUT BIOL, V19, P337, DOI 10.1089/cmb.2009.0267; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Hanzen S, 2016, CELL, V166, P140, DOI 10.1016/j.cell.2016.05.006; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kil IS, 2012, MOL CELL, V46, P584, DOI 10.1016/j.molcel.2012.05.030; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Nelson KJ, 2013, METHOD ENZYMOL, V527, P21, DOI 10.1016/B978-0-12-405882-8.00002-7; Netto LES, 2016, MOL CELLS, V39, P65, DOI 10.14348/molcells.2016.2349; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Peixoto AS, 2018, J BIOL CHEM, V293, P1450, DOI 10.1074/jbc.M117.807016; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Portillo-Ledesma S, 2018, BIOCHEMISTRY-US, V57, P3416, DOI 10.1021/acs.biochem.8b00188; Reyes AM, 2011, FREE RADICAL BIO MED, V51, P464, DOI 10.1016/j.freeradbiomed.2011.04.023; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Richardson DE, 2000, J AM CHEM SOC, V122, P1729, DOI 10.1021/ja9927467; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Tairum CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33133; Toledo JC, 2011, FREE RADICAL BIO MED, V50, P1032, DOI 10.1016/j.freeradbiomed.2011.02.020; Trindade DF, 2006, CHEM RES TOXICOL, V19, P1475, DOI 10.1021/tx060146x; Truzzi D. R., 2018, HYDROGEN PEROXIDE ME, P83; Veal EA, 2018, ANTIOXID REDOX SIGN, V28, P574, DOI 10.1089/ars.2017.7214; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200; Zhou HY, 2011, J AM CHEM SOC, V133, P15803, DOI 10.1021/ja2077137	54	20	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2019	294	38					14055	14067		10.1074/jbc.RA119.008825	http://dx.doi.org/10.1074/jbc.RA119.008825			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JE5JX	31366734	hybrid, Green Published			2022-12-26	WOS:000490729800019
J	He, YF; Johnson, DT; Yang, JS; Wu, HQ; You, S; Yoon, J; Lee, DH; Kim, WK; Aldahl, J; Le, V; Hooker, E; Yu, EJ; Geradts, J; Cardiff, RD; Sun, ZJ				He, Yongfeng; Johnson, Daniel T.; Yang, Julie S.; Wu, Huiqing; You, Sungyong; Yoon, Junhee; Lee, Dong-Hoon; Kim, Won Kyung; Aldahl, Joseph; Le, Vien; Hooker, Erika; Yu, Eun-Jeong; Geradts, Joseph; Cardiff, Robert D.; Sun, Zijie			Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; RB DEFICIENCY; CHIP-SEQ; CANCER; P53; GENE; DATABASE; EXPRESSION; STEM; RESISTANCE	Recent genome analysis of human prostate cancers demonstrated that both AR gene amplification and TP53 mutation are among the most frequently observed alterations in advanced prostate cancer. However, the biological role of these dual genetic alterations in prostate tumorigenesis is largely unknown. In addition, there are no biologically relevant models that can be used to assess the molecular mechanisms for these genetic abnormalities. Here, we report a novel mouse model, in which elevated transgenic AR expression and Trp53 deletion occur simultaneously in mouse prostatic epithelium to mimic human prostate cancer cells. These compound mice developed an earlier onset of high-grade prostatic intraepithelial neoplasia and accelerated prostate tumors in comparison with mice harboring only the AR transgene. Histological analysis showed prostatic sarcomatoid and basaloid carcinomas with massive squamous differentiation in the above compound mice. RNA-sequencing analyses identified a robust enrichment of the signature genes for human prostatic basal cell carcinomas in the above prostate tumors. Master regulator analysis revealed SOX2 as a transcriptional regulator in prostatic basal cell tumors. Elevated expression of SOX2 and its downstream target genes were detected in prostatic tumors of the compound mice. Chromatin immunoprecipitation analyses implicate a coregulatory role of AR and SOX2 in the expression of prostatic basal cell signature genes. Our data demonstrate a critical role of SOX2 in prostate tumorigenesis and provide mechanistic insight into prostate tumor aggressiveness and progression mediated by aberrant AR and p53 signaling pathways.	[He, Yongfeng; Yang, Julie S.; Lee, Dong-Hoon; Kim, Won Kyung; Aldahl, Joseph; Le, Vien; Hooker, Erika; Yu, Eun-Jeong; Sun, Zijie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [He, Yongfeng; Johnson, Daniel T.; Hooker, Erika; Yu, Eun-Jeong; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Wu, Huiqing] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA 91010 USA; [You, Sungyong; Yoon, Junhee] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Surg, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA; [Geradts, Joseph] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Cardiff, Robert D.] Univ Calif Davis, Ctr Comparat Med, 4115 Primate Res Dr, Davis, CA 95616 USA	City of Hope; Beckman Research Institute of City of Hope; Stanford University; City of Hope; Beckman Research Institute of City of Hope; Cedars Sinai Medical Center; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Davis	Sun, ZJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.; Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	zjsun@coh.org	He, Yongfeng/AAR-8257-2020; You, Sungyong/AAJ-7372-2020; le, vien/GWV-7308-2022	You, Sungyong/0000-0003-3513-1783; Hooker, Erika/0000-0002-4515-4041; Johnson, Daniel/0000-0003-4669-037X	Public Health Service grants [R01CA070297, R01CA166894, R21CA190021, R01DK104941]; NATIONAL CANCER INSTITUTE [R01CA070297, R21CA190021, R01CA166894] Funding Source: NIH RePORTER	Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grants, R01CA070297, R01CA166894, R21CA190021, and R01DK104941.	Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chamarthy Murthy R., 2011, Yale Journal of Biology and Medicine, V84, P391; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen L, 2011, BIOINFORMATICS, V27, P1447, DOI 10.1093/bioinformatics/btr156; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Esposito S, 2015, ONCOTARGET, V6, P17121, DOI 10.18632/oncotarget.2736; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Frohwitter G, 2016, ONCOL LETT, V12, P107, DOI 10.3892/ol.2016.4588; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Johnson DT, 2013, J BIOL CHEM, V288, P3727, DOI 10.1074/jbc.M112.417568; Kleihues P, 1997, AM J PATHOL, V150, P1; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Koivisto P, 1997, CANCER RES, V57, P314; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Lee SH, 2016, ONCOGENE, V35, P702, DOI 10.1038/onc.2015.117; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; Mollaoglu G, 2018, IMMUNITY, V49, P764, DOI 10.1016/j.immuni.2018.09.020; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stoyanova T, 2013, P NATL ACAD SCI USA, V110, P20111, DOI 10.1073/pnas.1320565110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda DY, 2018, CELL, V174, P422, DOI 10.1016/j.cell.2018.05.037; VOELLER HJ, 1994, J UROLOGY, V151, P492; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wyce A, 2010, MOL ENDOCRINOL, V24, P1665, DOI 10.1210/me.2010-0138; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; You SY, 2016, CANCER RES, V76, P4948, DOI 10.1158/0008-5472.CAN-16-0902; You S, 2014, P NATL ACAD SCI USA, V111, P550, DOI 10.1073/pnas.1311239111; Zhao SG, 2017, JAMA ONCOL, V3, P1663, DOI 10.1001/jamaoncol.2017.0751; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	49	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2019	38	38					6507	6520		10.1038/s41388-019-0901-8	http://dx.doi.org/10.1038/s41388-019-0901-8			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IY7XR	31358900	Green Accepted, Green Submitted			2022-12-26	WOS:000486609000003
J	Kim, YE; Won, M; Lee, SG; Park, C; Song, CH; Kim, KK				Kim, Yong-Eun; Won, Minho; Lee, Sung-Gwon; Park, Chungoo; Song, Chang-Hwa; Kim, Kee K.			RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition	ONCOGENE			English	Article							JUNCTION PROTEIN ZO-1; RNA-BINDING PROTEINS; TIGHT JUNCTIONS; CELLS; ISOFORMS; GROWTH; MOTIF	Morphological and functional changes in cells during the epithelial-mesenchymal transition (EMT) process are known to be regulated by alternative splicing. However, only a few splicing factors involved in EMT have been reported and their underlying mechanisms remain largely unknown. Here, we showed that an isoform of tight junction protein 1 (TJP1) lacking exon 20 (TJP1-alpha-) is predominantly expressed in tumor tissues and in A549 cells during transforming growth factor-beta (TGF-beta-induced EMT. RBM47 promoted the inclusion of exon 20 of TJP1, the alternative exon encoding the a-domain, by which RBM47 recognizes to (U)GCAUG in the downstream intronic region of exon 20. We also found that the first RNA recognition motif (RRM) domain of RBM47 is critical in the regulation of alternative splicing and its recognition to pre-mRNA of TJP1. Furthermore, we demonstrated that the TJP1-alpha- isoform enhances the assembly of actin stress fibers, thereby promoting cellular migration in a wound healing assay. Our results suggest the regulatory mechanism for the alternative splicing of TJP1 pre-mRNA by RBM47 during EMT, providing a basis for studies related to the modulation of EMT via alternative splicing.	[Kim, Yong-Eun; Kim, Kee K.] Chungnam Natl Univ, Dept Biochem, Daejeon 34134, South Korea; [Kim, Yong-Eun; Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Dept Med Sci,Dept Microbiol, Daejeon 35015, South Korea; [Won, Minho] Chungnam Natl Univ, Sch Med, Dept Pharmacol, Daejeon 35015, South Korea; [Lee, Sung-Gwon; Park, Chungoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju 61186, South Korea	Chungnam National University; Chungnam National University; Chungnam National University; Chonnam National University	Kim, KK (corresponding author), Chungnam Natl Univ, Dept Biochem, Daejeon 34134, South Korea.	songch@cnu.ac.kr; kimkk@cnu.ac.kr	Song, Chang-Hwa/AAD-7917-2022	Song, Chang-Hwa/0000-0002-9490-0573; Lee, Sung-Gwon/0000-0002-0928-9950; Won, Minho/0000-0002-5873-5216	National Research Foundation of Korea within the Basic Science Research Program through the Ministry of Education [NRF-2018R1A1A1A05018628]; National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2016R1A2B2008178]	National Research Foundation of Korea within the Basic Science Research Program through the Ministry of Education(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea within the Basic Science Research Program through the Ministry of Education under Grant NRF-2018R1A1A1A05018628. This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF-2016R1A2B2008178).	Aparicio LA, 2013, CELL MOL LIFE SCI, V70, P4463, DOI 10.1007/s00018-013-1379-0; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; BALDA MS, 1993, AM J PHYSIOL, V264, pC918, DOI 10.1152/ajpcell.1993.264.4.C918; BIEDLER JL, 1973, CANCER RES, V33, P2643; Braeutigam C, 2014, ONCOGENE, V33, P1082, DOI 10.1038/onc.2013.50; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Ciana A, 2010, CELL BIOL INT, V34, P669, DOI 10.1042/CBI20090067; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Fan Q, 2015, ONCOL REP, V34, P1787, DOI 10.3892/or.2015.4143; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fong N, 2014, GENE DEV, V28, P2663, DOI 10.1101/gad.252106.114; Fossat N, 2014, EMBO REP, V15, P903, DOI 10.15252/embr.201438450; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Inada M, 2016, INT J MOL MED, V37, P1521, DOI 10.3892/ijmm.2016.2568; Kadener S, 2002, P NATL ACAD SCI USA, V99, P8185, DOI 10.1073/pnas.122246099; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kim YE, 2016, MOL CELLS, V39, P625, DOI 10.14348/molcells.2016.0150; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Pradella D, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0579-2; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rokavec M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04234-2; Sakurai T, 2016, ONCOGENE, V35, P5000, DOI 10.1038/onc.2016.35; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vanharanta S, 2014, ELIFE, V3, DOI 10.7554/eLife.02734; Wan LD, 2019, GUT, V68, P118, DOI 10.1136/gutjnl-2017-314983; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Yang YQ, 2016, MOL CELL BIOL, V36, P1704, DOI 10.1128/MCB.00019-16; Zhang JY, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040041; Zhang K, 2013, INT J MOL MED, V32, P464, DOI 10.3892/ijmm.2013.1396; Zhao Q, 2017, CELL MOL NEUROBIOL, V37, P643, DOI 10.1007/s10571-016-0401-0	42	20	20	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2019	38	38					6521	6536		10.1038/s41388-019-0892-5	http://dx.doi.org/10.1038/s41388-019-0892-5			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IY7XR	31358901				2022-12-26	WOS:000486609000004
J	Khan, Z; Terrien, E; Delhommel, F; Lefebvre-Omar, C; Bohl, D; Vitry, S; Bernard, C; Ramirez, J; Chaffotte, A; Ricquier, K; Vincentelli, R; Buc, H; Prehaud, C; Wolff, N; Lafon, M				Khan, Zakir; Terrien, Elouan; Delhommel, Florent; Lefebvre-Omar, Cynthia; Bohl, Delphine; Vitry, Sandrine; Bernard, Clara; Ramirez, Juan; Chaffotte, Alain; Ricquier, Kevin; Vincentelli, Renaud; Buc, Henri; Prehaud, Christophe; Wolff, Nicolas; Lafon, Monique			Structure-based optimization of a PDZ-binding motif within a viral peptide stimulates neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine; threonine protein kinase; PDZ domain; neurite outgrowth; protein-protein interaction; viral protein; interfering peptide; neurodegenerative diseases; nuclear magnetic resonance; structure-function analysis; therapeutic drug candidate	SINGLE-DOMAIN ANTIBODIES; CELL-SURVIVAL; PTEN DELETION; EXCITOTOXICITY; GLYCOPROTEIN; SPECIFICITY; INHIBITION; SELECTION; TARGETS; STROKE	Protection of neuronal homeostasis is a major goal in the management of neurodegenerative diseases. Microtubule-associated Ser/Thr kinase 2 (MAST2) inhibits neurite outgrowth, and its inhibition therefore represents a potential therapeutic strategy. We previously reported that a viral protein (G-protein from rabies virus) capable of interfering with protein-protein interactions between the PDZ domain of MAST2 and the C-terminal moieties of its cellular partners counteracts MAST2-mediated suppression of neurite outgrowth. Here, we designed peptides derived from the native viral protein to increase the affinity of these peptides for the MAST2-PDZ domain. Our strategy involved modifying the length and flexibility of the noninteracting sequence linking the two subsites anchoring the peptide to the PDZ domain. Three peptides, Neurovita1 (NV1), NV2, and NV3, were selected, and we found that they all had increased affinities for the MAST2-PDZ domain, with K-d values decreasing from 1300 to 60 nm, while target selectivity was maintained. A parallel biological assay evaluating neurite extension and branching in cell cultures revealed that the NV peptides gradually improved neural activity, with the efficacies of these peptides for stimulating neurite outgrowth mirroring their affinities for MAST2-PDZ. We also show that NVs can be delivered into the cytoplasm of neurons as a gene or peptide. In summary, our findings indicate that virus-derived peptides targeted to MAST2-PDZ stimulate neurite outgrowth in several neuron types, opening up promising avenues for potentially using NVs in the management of neurodegenerative diseases.	[Khan, Zakir; Vitry, Sandrine; Bernard, Clara; Prehaud, Christophe; Lafon, Monique] CNRS, UMR 3569, Inst Pasteur, Unite Neuroimmunol Virale, F-75015 Paris, France; [Terrien, Elouan; Delhommel, Florent; Ramirez, Juan; Chaffotte, Alain; Ricquier, Kevin; Wolff, Nicolas] CNRS, UMR 3528, Inst Pasteur, Unite RMN Biomol, F-75015 Paris, France; [Lefebvre-Omar, Cynthia; Bohl, Delphine] Sorbonne Univ, CNRS, UMR 7225, Inst Cerveau & Moelle Epiniere ICM,INSERM,U1127, F-75013 Paris, France; [Vincentelli, Renaud] Aix Marseille Univ, CNRS, UMR 7257, AFMB, F-13009 Marseille, France; [Buc, Henri] Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris 15, France; [Khan, Zakir] Cedars Sinai Med Ctr, Dept Biomed Sci, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Wolff, Nicolas] CNRS, UMR 3571, Inst Pasteur, Unite Recepteurs Canaux, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Cedars Sinai Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lafon, M (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris 15, France.	monique.lafon@pasteur.fr	Delhommel, Florent/HCH-2439-2022	Delhommel, Florent/0000-0001-7021-087X; Vitry, Sandrine/0000-0003-4693-7694; Bohl, Delphine/0000-0001-8262-5642	ANR (Agence Nationale de la Recherche) [BSV8-0008-01 MAST-2-PTEN]; AFM (Association Francaise Contre les Myopathies) "Characterization of Pathological Defects in Motor Neurons Derived from Patients, Amyotrophic Lateral Sclerosis (ALS)"; Grand Prix de l'Academie des Sciences/Fondation Generale de Sante; Institut Carnot-Pasteur Maladies Infectieuses "Unraveling the Neuroprotective Functions and Optimization of New Neuroprotective Compound"; Investissements d'Avenir [ANR-10-IAIHU-06, ANR-11-INBS-0011]; Ministere de l'Enseignement Superieur et de la Recherche; Revive [ANR-10-LABX-73]	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); AFM (Association Francaise Contre les Myopathies) "Characterization of Pathological Defects in Motor Neurons Derived from Patients, Amyotrophic Lateral Sclerosis (ALS)"; Grand Prix de l'Academie des Sciences/Fondation Generale de Sante; Institut Carnot-Pasteur Maladies Infectieuses "Unraveling the Neuroprotective Functions and Optimization of New Neuroprotective Compound"; Investissements d'Avenir(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Revive	This work was supported by ANR (Agence Nationale de la Recherche) Grant BSV8-0008-01 MAST-2-PTEN; AFM (Association Francaise Contre les Myopathies) "Characterization of Pathological Defects in Motor Neurons Derived from Patients, Amyotrophic Lateral Sclerosis (ALS)"; Grand Prix de l'Academie des Sciences/Fondation Generale de Sante; and Incentive Grant from Institut Carnot-Pasteur Maladies Infectieuses "Unraveling the Neuroprotective Functions and Optimization of New Neuroprotective Compound"; and the research leading to the results on IPSC was recipient of funding from the programs Investissements d'Avenir ANR-10-IAIHU-06 and ANR-11-INBS-0011-NeurATRIS: " Translational Research Infrastructure for Biotherapies in Neurosciences." Z. K., M. L., C. P., E. T., S. V., and N. W. are co-inventors of the two following patents: PCT/EP2012/072073, WO2013068430, European Patent 11 306 454.7; C. P. and M. L. are co-inventors of Institut Pasteur Patent PCT/EP2015/070669, EP14306388.1.; Recipients of Ph.D. fellowships from the Ministere de l'Enseignement Superieur et de la Recherche.; Supported by Ph.D. Fellowship ANR-10-LABX-73 from Revive.	Bach A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12157; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chopy D, 2011, J NEUROVIROL, V17, P353, DOI 10.1007/s13365-011-0041-6; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; da Costa A, 2019, JOVE-J VIS EXP, DOI 10.3791/59220; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Delhommel F, 2015, BIOCHEM J, V469, P159, DOI 10.1042/BJ20141198; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Fujii N, 2003, J AM CHEM SOC, V125, P12074, DOI 10.1021/ja035540l; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Karlsson OA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34269; Khan Z, 2014, CURR MED CHEM, V21, P2632, DOI 10.2174/0929867321666140303145312; Knafo S, 2017, TRENDS NEUROSCI, V40, P83, DOI 10.1016/j.tins.2016.11.008; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lafon M, 2011, ADV VIRUS RES, V79, P33, DOI 10.1016/B978-0-12-387040-7.00003-2; Li TF, 2017, IMMUNOL LETT, V188, P89, DOI 10.1016/j.imlet.2017.07.001; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mo SF, 2016, BRAIN RES, V1648, P250, DOI 10.1016/j.brainres.2016.07.012; Nissen KB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117668; Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003; Prehaud C, 2010, Patent, Patent No. [WO/2010/116258, 2010116258]; Prehaud C., 2015, [U. S. Patent, September 9 2015], Patent No. [WO/2016/038122, 2016038122]; Prehaud C, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000510; Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seo W, 2017, MICROBES INFECT, V19, P476, DOI 10.1016/j.micinf.2017.05.006; SHOLL DA, 1953, J ANAT, V87, P387; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Terrien E., 2012, THESIS; Terrien E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002941; Terrien E, 2009, BIOMOL NMR ASSIGN, V3, P45, DOI 10.1007/s12104-008-9138-0; Thomas M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005766; Toli D, 2015, NEUROBIOL DIS, V82, P269, DOI 10.1016/j.nbd.2015.06.011; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Vincentelli R, 2015, NAT METHODS, V12, P787, DOI [10.1038/nmeth.3438, 10.1038/NMETH.3438]; Vitry S, 2009, MOL CELL NEUROSCI, V41, P8, DOI 10.1016/j.mcn.2009.01.001; Wu QJ, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0357-8; Wyatt LA, 2014, J COMP NEUROL, V522, P2741, DOI 10.1002/cne.23580; Yeyeodu S, 2011, CELL MOL NEUROBIOL, V31, P145, DOI 10.1007/s10571-010-9563-3; Zhang XC, 2012, BIOCHEM J, V444, P457, DOI 10.1042/BJ20120098; Zhang YJ, 2012, BRAIN, V135, P2736, DOI 10.1093/brain/aws196; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	59	8	8	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13755	13768		10.1074/jbc.RA119.008238	http://dx.doi.org/10.1074/jbc.RA119.008238			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31346033	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000486418600020
J	Kaufmann, P; Muenzner, M; Kastorf, M; Santos, K; Hartmann, T; Dienelt, A; Rehfeld, L; Bergmann, A				Kaufmann, Paul; Muenzner, Matthias; Kaestorf, Mandy; Santos, Karine; Hartmann, Tobias; Dienelt, Anke; Rehfeld, Linda; Bergmann, Andreas			A novel and highly efficient purification procedure for native human dipeptidyl peptidase 3 from human blood cell lysate	PLOS ONE			English	Article							AMINOPEPTIDASE-III; RAT-BRAIN; ASSAY	Dipeptidyl amino-peptidase 3 (DPP3) is an aminopeptidase involved in peptide degradation, including hormone peptides as angiotensin II and enkephalins. DPP3 plasma activity increases in septic patients and correlates with mortality risk. However, the exact physiological role of DPP3 remains unclear and animal studies are necessary to reveal the function of DPP3 in vivo. To this demand, we developed a two-step purification procedure for isolation of native human DPP3 from blood cell lysate (BCL) that is suitable for in vivo applications. With the use of monoclonal antibodies coupled to beads in combination with an ion-exchange chromatography, we recovered 68% of human DPP3 activity from BCL with a purity of >= 95%. Purified human DPP3 was assayed for activity and protein concentration using recently published DPP3-activity- and immunoassays. Additionally, protein stability and storage in relevant buffers were tested. Our results provide a promising strategy for fast and efficient isolation of human DPP3. The purified human DPP3 represents the native state of DPP3, suitable for future in vivo applications to investigate the physiological role of DPP3 and its involvement in pathophysiological conditions.	[Kaufmann, Paul] Sphingotec GmbH, Hennigsdorf, Germany; [Muenzner, Matthias; Kaestorf, Mandy; Santos, Karine; Hartmann, Tobias; Dienelt, Anke; Rehfeld, Linda; Bergmann, Andreas] Sphingotec Therapeut GmbH, Hennigsdorf, Germany		Kaufmann, P (corresponding author), Sphingotec GmbH, Hennigsdorf, Germany.	kaufmann@sphingotec.de		Bergmann, Andreas/0000-0002-4466-1682				ABRAMIC M, 1988, BIOL CHEM H-S, V369, P29, DOI 10.1515/bchm3.1988.369.1.29; Abramic M, 2000, BIOL CHEM, V381, P1233, DOI 10.1515/BC.2000.151; ALBA F, 1995, PEPTIDES, V16, P325, DOI 10.1016/0196-9781(94)00186-3; Baral PK, 2008, J BIOL CHEM, V283, P22316, DOI 10.1074/jbc.M803522200; Barsun M, 2007, BIOL CHEM, V388, P343, DOI 10.1515/BC.2007.039; Cicin-Sain L, 2008, NEUROPEPTIDES, V42, P435, DOI 10.1016/j.npep.2008.04.007; Dostal DE, 1997, J MOL CELL CARDIOL, V29, P2893, DOI 10.1006/jmcc.1997.0524; ELLIS S, 1967, J BIOL CHEM, V242, P4623; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; He M, 2010, CLIN CANCER RES, V16, P249, DOI 10.1158/1078-0432.CCR-09-1602; JONES THD, 1982, ANAL BIOCHEM, V119, P418, DOI 10.1016/0003-2697(82)90607-8; Kimple ME, 2013, CURR PROTOC PROTEIN, V73, DOI [10.1002/0471140864.ps0909s73, DOI 10.1002/0471140864.PS0909S73]; LEE CM, 1982, J BIOL CHEM, V257, P2043; LYNN KR, 1991, INT J BIOCHEM, V23, P47, DOI 10.1016/0020-711X(91)90007-A; Mazzocco C, 2006, FEBS J, V273, P1056, DOI 10.1111/j.1742-4658.2006.05132.x; Mazzocco C, 2001, EUR J BIOCHEM, V268, P4940, DOI 10.1046/j.1432-1327.2001.02425.x; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pang XL, 2016, HYPERTENSION, V68, P630, DOI 10.1161/HYPERTENSIONAHA.116.07357; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Prajapati SC, 2011, FEBS J, V278, P3256, DOI 10.1111/j.1742-4658.2011.08275.x; Rehfeld L, 2019, J APPL LAB MED, V3, P943, DOI 10.1373/jalm.2018.027995; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; Sentandreu MA, 2001, FOOD CHEM, V75, P159, DOI 10.1016/S0308-8146(01)00145-5; SHIMAMORI Y, 1986, CHEM PHARM BULL, V34, P3333; Shukla AA, 2010, FEBS J, V277, P1861, DOI 10.1111/j.1742-4658.2010.07603.x; Simaga S, 2003, GYNECOL ONCOL, V91, P194, DOI 10.1016/S0090-8258(03)00462-1; Simaga S, 1998, EUR J CANCER, V34, P399, DOI 10.1016/S0959-8049(97)00401-2; SMYTH M, 1994, J NEUROCHEM, V63, P1439; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220866	10.1371/journal.pone.0220866	http://dx.doi.org/10.1371/journal.pone.0220866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390378	Green Published, Green Submitted, gold			2022-12-26	WOS:000484999400035
J	Beaulieu, A; zur Linden, A; Phillips, J; Arroyo, LG; Koenig, J; Monteith, G				Beaulieu, Alexandra; zur Linden, Alex; Phillips, John; Arroyo, Luis G.; Koenig, Judith; Monteith, Gabrielle			Various 3D printed materials mimic bone ultrasonographically: 3D printed models of the equine cervical articular process joints as a simulator for ultrasound guided intra-articular injections	PLOS ONE			English	Article							QUANTITATIVE ULTRASOUND; OSTEOARTHRITIS; EDUCATION; HORSE	Introduction In the equine racehorse industry, reduced athletic performance due to joint injury and lameness has been extensively reviewed. Intra-articular injections of glucocorticoids are routinely used to relieve pain and inflammation associated with osteoarthritis. Intra-articular injections of pharmaceutical agents require practice for precise needle placement and to minimize complications. Training on simulators or models is a viable alternative for developing these technical skills. The purpose of this study was to compare the qualitative ultrasonographic characteristics of three-dimensional (3D) printed models of equine cervical articular process joints to that of a dissected equine cervical spine (gold standard). Methods A randomized complete block design study was conducted in which a total of thirteen cervical articular process joint models were printed using several materials, printers, and printing technologies. Ultrasound video clips with the models immersed in water were recorded. Two board certified veterinary radiologists and three veterinary radiology residents reviewed the videos and responded to a survey assessing and comparing the ultrasonographic characteristics of the 3D printed models to those of the gold standard. Results Six 3D printed models had ultrasonographic characteristics similar to the gold standard. These six models were (material, printer, printing technology): nylon PA 12, EOS Formiga P100, selective laser sintering (P = 0.99); Onyx nylon with chopped carbon fiber, Markforged Onyx Two, fused deposition modeling (P = 0.48); polycarbonate, Ultimaker 3, fused deposition modeling (P = 0.28); gypsum, ProJet CJP 660 Pro, ColorJet Printing (P = 0.28); polylactic acid, Prusa I3, fused deposition modeling (P = 0.23); and high temperature V1 resin, Form 2, stereolithography (P = 0.22). Conclusion When assessed in water, it is possible to replicate the qualitative ultrasonographic characteristics of bone using three dimensional printed models made by combining different materials, printing technologies, and printers. However, not all models share similar qualitative ultrasonographic characteristics with bone. We suggest that the aforementioned six models be used as proxy for simulating bones or joints for use with ultrasound. In order to replicate the resistance and acoustic window provided by soft tissues, further work testing the ability of these models to withstand embedding in material such as ballistic gelatin is required.	[Beaulieu, Alexandra; zur Linden, Alex; Arroyo, Luis G.; Koenig, Judith; Monteith, Gabrielle] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON, Canada; [Phillips, John] Univ Guelph, Coll Arts, Digital Hapt Lab, Guelph, ON, Canada; [Phillips, John] Sheridan Coll, Ctr Adv Mfg & Design Technol, Brampton, ON, Canada	University of Guelph; University of Guelph	zur Linden, A (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON, Canada.	azurlind@uoguelph.ca		Beaulieu, Alexandra/0000-0002-9333-8275; zur Linden, Alex/0000-0002-5663-0197	Equine Guelph [EG2017 04]; SONAMI	Equine Guelph; SONAMI	Funding was provided to AZL by Equine Guelph, www.equineguelph.ca (EG2017 04) and SONAMI, https://www.ncinnovation.ca/sonami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Elq AH, 2010, J FAM COMMUNITY MED, V17, P35, DOI 10.4103/1319-1683.68787; Ayhan E, 2014, WORLD J ORTHOP, V5, P351, DOI 10.5312/wjo.v5.i3.351; Barkmann R, 2000, OSTEOPOROSIS INT, V11, P745, DOI 10.1007/s001980070053; Brandt KD, 2009, MED CLIN N AM, V93, P1, DOI 10.1016/j.mcna.2008.08.009; Bushberg JT, 2012, ESSENTIAL PHYS MED I, P501; Chae MP, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00025; CLARKE AJ, 1994, PHYS MED BIOL, V39, P1677, DOI 10.1088/0031-9155/39/10/011; Culjat MO, 2010, ULTRASOUND MED BIOL, V36, P861, DOI 10.1016/j.ultrasmedbio.2010.02.012; David F, 2007, EQUINE VET J, V39, P79, DOI 10.2746/042516407X153093; De Lasalle J, 2016, VET RADIOL ULTRASOUN, V57, P489, DOI 10.1111/vru.12370; deSouza MV, 2016, BRAZ ARCH BIOL TECHN, V59; Favier V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189486; Fox V, 2013, J VET MED EDUC, V40, P152, DOI 10.3138/jvme.0912-083R1; Goodrich LR, 2006, VET J, V171, P51, DOI 10.1016/j.tvjl.2004.07.008; Herdrich MRA, 2017, AM J VET RES, V78, P1077, DOI 10.2460/ajvr.78.9.1077; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; JEFFCOTT LB, 1982, EQUINE VET J, V14, P185, DOI 10.1111/j.2042-3306.1982.tb02389.x; Johnson JP, 2017, VET COMP ORTHOPAED, V30, P165, DOI [10.3415/VCOT-16-09-0139, 10.3415/vcot-16-09-0139]; Kidd JA, 2001, EQUINE VET EDUC, V13, P160, DOI 10.1111/j.2042-3292.2001.tb00082.x; Kleider N., 2013, Proceedings of the 59th Annual Convention of the American Association of Equine Practitioners, Nashville, Tennessee, USA, 7-11 December 2013, P220; Kremkau FW, 2016, SONOGRAPHY PRINCIPLE, P183; Mattoon JS, 2004, VET RADIOL ULTRASOUN, V45, P238, DOI 10.1111/j.1740-8261.2004.04042.x; McIlwraith CW, 2012, BONE JOINT RES, V1, P297, DOI 10.1302/2046-3758.111.2000132; McMenamin PG, 2014, ANAT SCI EDUC, V7, P479, DOI 10.1002/ase.1475; Mitsouras D, 2015, RADIOGRAPHICS, V35, P1966, DOI 10.1148/rg.2015140320; Motola I, 2013, MED TEACH, V35, pE1511, DOI 10.3109/0142159X.2013.818632; Mowry SE, 2015, OTOL NEUROTOL, V36, P1562, DOI 10.1097/MAO.0000000000000848; Nielsen JV, 2003, EQUINE VET J, V35, P637; RADIN EL, 1991, SEMIN ARTHRITIS RHEU, V21, P12, DOI 10.1016/0049-0172(91)90036-Y; Sorensen JL, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-016-0838-3; Takahashi K, 2017, ANN OTO RHINOL LARYN, V126, P530, DOI 10.1177/0003489417705395; Tatarinov A, 1999, MECH COMPOS MATER, V35, P147, DOI 10.1007/BF02257245; Whitcomb MB, 2016, VET RADIOL ULTRASOUN, V57, P199, DOI 10.1111/vru.12323; Ziv A, 2003, ACAD MED, V78, P783, DOI 10.1097/00001888-200308000-00006	34	7	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220332	10.1371/journal.pone.0220332	http://dx.doi.org/10.1371/journal.pone.0220332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386687	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100018
J	DiBartolomeis, M; Kegley, S; Mineau, P; Radford, R; Klein, K				DiBartolomeis, Michael; Kegley, Susan; Mineau, Pierre; Radford, Rosemarie; Klein, Kendra			An assessment of acute insecticide toxicity loading (AITL) of chemical pesticides used on agricultural land in the United States	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDES; SEED TREATMENTS; TREATED SEEDS; SOYBEAN APHID; HONEY-BEES; EXPOSURE; CONTAMINATION; POLLINATORS; MANAGEMENT	We present a method for calculating the Acute Insecticide Toxicity Loading (AITL) on US agricultural lands and surrounding areas and an assessment of the changes in AITL from 1992 through 2014. The AITL method accounts for the total mass of insecticides used in the US, acute toxicity to insects using honey bee contact and oral LD50 as reference values for arthropod toxicity, and the environmental persistence of the pesticides. This screening analysis shows that the types of synthetic insecticides applied to agricultural lands have fundamentally shifted over the last two decades from predominantly organophosphorus and N-methyl carbamate pesticides to a mix dominated by neonicotinoids and pyrethroids. The neonicotinoids are generally applied to US agricultural land at lower application rates per acre; however, they are considerably more toxic to insects and generally persist longer in the environment. We found a 48- and 4-fold increase in AITL from 1992 to 2014 for oral and contact toxicity, respectively. Neonicotinoids are primarily responsible for this increase, representing between 61 to nearly 99 percent of the total toxicity loading in 2014. The crops most responsible for the increase in AITL are corn and soybeans, with particularly large increases in relative soybean contributions to AITL between 2010 and 2014. Oral exposures are of potentially greater concern because of the relatively higher toxicity (low LD(50)s) and greater likelihood of exposure from residues in pollen, nectar, guttation water, and other environmental media. Using AITL to assess oral toxicity by class of pesticide, the neonicotinoids accounted for nearly 92 percent of total AITL from 1992 to 2014. Chlorpyrifos, the fifth most widely used insecticide during this time contributed just 1.4 percent of total AITL based on oral LD(50)s. Although we use some simplifying assumptions, our screening analysis demonstrates an increase in pesticide toxicity loading over the past 26 years, which potentially threatens the health of honey bees and other pollinators and may contribute to declines in beneficial insect populations as well as insectivorous birds and other insect consumers.	[DiBartolomeis, Michael; Kegley, Susan] Toxicol Res Int, Haiku, HI 96708 USA; [Radford, Rosemarie] Pesticide Res Inst Inc, Santa Rosa, CA USA; [Mineau, Pierre] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [Klein, Kendra] Friends Earth US, Berkeley, CA USA	Carleton University	DiBartolomeis, M (corresponding author), Toxicol Res Int, Haiku, HI 96708 USA.	mjd@toxicologistint.com			Friends of the Earth U.S. (FOE)	Friends of the Earth U.S. (FOE)	This study was funded by Friends of the Earth U.S. (FOE). MD, SK, RR, and PM received research fees as contractors to FOE. KK is a staff scientist at FOE. SK and RR are paid employees of the Pesticide Research Institute (PRI). The specific roles of these authors are articulated in the "author contributions." The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alkassab AT, 2017, J PLANT DIS PROTECT, V124, P1, DOI 10.1007/s41348-016-0041-0; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Baker N. T., 2017, ESTIMATED ANN AGR PE; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; CDPR, 2015, 2015 STAT REP PEST C; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; David A, 2016, ENVIRON INT, V88, P169, DOI 10.1016/j.envint.2015.12.011; Dorsey J, 2006, 2006P00028 OFF INSP; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Douglas MR, 2015, J APPL ECOL, V52, P250, DOI 10.1111/1365-2664.12372; Gaspar AP, 2014, AGRON J, V106, P1955, DOI 10.2134/agronj14.0277; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2018, PEERJ, V6, DOI 10.7717/peerj.5255; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gustafson D, 2011, FUNDAMENTAL CONCEPTS; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Heard MS, 2017, SCI TOTAL ENVIRON, V578, P357, DOI 10.1016/j.scitotenv.2016.10.180; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Hopwood J., 2016, NEONICOTINOIDS CAN K; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2012, PESTICIDES HONEY BEE; Kaplan M, 2016, FOOD TECHNOL BIOTECH, V54, P497, DOI [10.17113/ftb.54.04.16.4635, 10.17113/ft b.54.04.16.4635]; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kurwadkar S, 2016, ENVIRON TOXICOL CHEM, V35, P1718, DOI 10.1002/etc.3335; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Le Conte Y, 2008, REV SCI TECH OIE, V27, P485, DOI 10.20506/rst.27.2.1819; Lee-Mader E., 2013, BIRDS BEES EFFECTS N; Lewis KA, 2016, HUM ECOL RISK ASSESS, V22, P1050, DOI 10.1080/10807039.2015.1133242; Li Y, 2018, ENVIRON SCI POLLUT R, V25, P31318, DOI 10.1007/s11356-018-3121-9; Long EY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11629; Lopez JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40853; Lundgren JG, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500558; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Millot F, 2017, ENVIRON SCI POLLUT R, V24, P5469, DOI 10.1007/s11356-016-8272-y; Mineau P., 2018, NEONICOTINOID INSECT; Moffat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24764; Mogren CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29608; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; Mullin CA, 2015, PESTIC BIOCHEM PHYS, V120, P27, DOI 10.1016/j.pestbp.2014.12.026; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; NPIC, 2011, IMIDACLOPRID TECHNIC; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Raimets R, 2018, PEST MANAG SCI, V74, P541, DOI 10.1002/ps.4756; Samson-Robert O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108443; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Stewart SD, 2014, ENVIRON SCI TECHNOL, V48, P9762, DOI 10.1021/es501657w; Stone W.W., 2015, US GEOLOGICAL SURVEY, V907; Stone Wesley W, 2013, US GEOLOGICAL SURVEY, V752; Turnbull LA, 2010, NATURE, V466, P36, DOI 10.1038/466036a; U.S. EPA, 2015, GUID CALC REPR HALF; United States Environmental Protection Agency, SUMM FED INS FUNG RO; University of Hertfordshire, 2017, PEST PROP DAT BAS PP; US EPA, EPA PUBL C, V7501C; US EPA, 2016, PROC REQ EXP EFF TES; US EPA, 2010, FED REGISTER, V75, P5584; USDA, 2014, 2012 CENS AGR US SUM; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wood TJ, 2017, ENVIRON SCI POLLUT R, V24, P17285, DOI 10.1007/s11356-017-9240-x; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zhu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178421; Zhu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176837	70	73	74	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220029	10.1371/journal.pone.0220029	http://dx.doi.org/10.1371/journal.pone.0220029			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386666	Green Published, Green Submitted, gold			2022-12-26	WOS:000484997100014
J	van den Berg, EH; Corsetti, JP; Bakker, SJL; Dullaart, RPF				van den Berg, Eline H.; Corsetti, James P.; Bakker, Stephan J. L.; Dullaart, Robin P. F.			Plasma ApoE elevations are associated with NAFLD: The PREVEND Study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-E POLYMORPHISM; FATTY LIVER-DISEASE; CATALYTIC ACTIVITY CONCENTRATIONS; E GENOTYPES; HEPATIC STEATOSIS; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK; STEATOHEPATITIS	Non-alcoholic fatty liver disease (NAFLD) is featured by increased plasma very low density lipoproteins (VLDL). The extent to which plasma apolipoprotein E (ApoE) levels are elevated in NAFLD is unclear. We determined whether plasma ApoE is elevated in subjects with suspected NAFLD. Plasma ApoE and genotypes were determined in 6,762 participants of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) cohort. A Fatty Liver Index (FLI) >= 60 was used as a proxy of NAFLD. A total of 1,834 participants had a FLI >= 60, which coincided with increased triglycerides, non-HDL cholesterol, ApoB and ApoE (all P< 0.001). In multivariable linear regression analysis, plasma ApoE levels were positively associated with an elevated FLI when taking account of ApoE genotypes and other clinical and laboratory covariates (fully adjusted model: beta = 0.201, P< 0.001). Stratified analysis for ApoE genotypes (ApoE epsilon 3 epsilon 3 homozygotes, ApoE epsilon 2 carriers, and ApoE epsilon 3 epsilon 4 and epsilon 4 epsilon 4 carriers combined), also showed positive associations of plasma ApoE levels with an elevated FLI in each group (all P< 0.001). In conclusion, it is suggested that NAFLD is characterized by increased plasma ApoE levels, even when taking account of the various ApoE geno-types. Increased plasma ApoE may contribute to altered VLDL metabolism and to increased atherosclerosis susceptibility in NAFLD.	[van den Berg, Eline H.; Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [van den Berg, Eline H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Corsetti, James P.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA; [Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Rochester; University of Groningen	van den Berg, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.; van den Berg, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	e.h.van.den.berg@umcg.nl		van den Berg, Eline H./0000-0003-2703-2320	Dutch Kidney Foundation [E.033]; Dade Behring; Ausam; Roche; Abbott; Dutch Heart Foundation [2001-005]	Dutch Kidney Foundation; Dade Behring; Ausam; Roche(Roche Holding); Abbott(Abbott Laboratories); Dutch Heart Foundation(Netherlands Heart Foundation)	The Dutch Kidney Foundation supported the infrastructure of the PREVEND program from 1997 to 2003 (Grant E.033). The University Medical Center Groningen supported the infrastructure from 2003 to 2006. Dade Behring, Ausam, Roche, and Abbott financed laboratory equipment and reagents by which various laboratory determinations could be performed. The Dutch Heart Foundation supported studies on lipid metabolism (Grant 2001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; ALLAN CM, 1995, GENOMICS, V28, P291, DOI 10.1006/geno.1995.1144; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Batal R, 2000, J LIPID RES, V41, P706; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Blaauwwiekel EE, 1998, DIABETIC MED, V15, P1031, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1031::AID-DIA705>3.0.CO;2-6; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Borggreve SE, 2005, J CLIN ENDOCR METAB, V90, P4198, DOI 10.1210/jc.2005-0182; Bril F, 2016, J CLIN ENDOCR METAB, V101, P644, DOI 10.1210/jc.2015-3111; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cali AMG, 2007, DIABETES CARE, V30, P3093, DOI 10.2337/dc07-1088; Cohn JS, 1996, ARTERIOSCL THROM VAS, V16, P149, DOI 10.1161/01.ATV.16.1.149; Corsetti JP, 2016, J CLIN LIPIDOL, V10, P842, DOI 10.1016/j.jacl.2016.03.003; Corsetti JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039110; Corsetti JP, 2012, METABOLISM, V61, P996, DOI 10.1016/j.metabol.2011.11.010; Curtiss LK, 2000, CURR OPIN LIPIDOL, V11, P243, DOI 10.1097/00041433-200006000-00004; Davignon J, 1999, CLIN CHIM ACTA, V286, P115, DOI 10.1016/S0009-8981(99)00097-2; De Feo E, 2012, MOL BIOL REP, V39, P7381, DOI 10.1007/s11033-012-1570-7; DEMANT T, 1991, J CLIN INVEST, V88, P1490, DOI 10.1172/JCI115459; Demirag MD, 2007, DIGEST DIS SCI, V52, P3399, DOI 10.1007/s10620-007-9740-5; Dullaart RPF, 2013, ATHEROSCLEROSIS, V230, P6, DOI 10.1016/j.atherosclerosis.2013.06.019; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaidukov L, 2005, BIOCHEMISTRY-US, V44, P11843, DOI 10.1021/bi050862i; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gruppen EG, 2018, AM J CLIN NUTR, V108, P1283, DOI 10.1093/ajcn/nqy217; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jiang ZG, 2016, LIVER INT, V36, P1213, DOI 10.1111/liv.13076; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kappelle PJWH, 2011, J INTERN MED, V269, P232, DOI 10.1111/j.1365-2796.2010.02323.x; Karavia EA, 2011, FEBS J, V278, P3119, DOI 10.1111/j.1742-4658.2011.08238.x; Kunutsor SK, 2017, CLIN CHIM ACTA, V466, P54, DOI 10.1016/j.cca.2017.01.008; Lee Dong-Min, 2002, Taehan Kan Hakhoe Chi, V8, P355; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Luc G, 1997, ATHEROSCLEROSIS, V131, P257, DOI 10.1016/S0021-9150(97)00053-1; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Mooijaart SP, 2006, PLOS MED, V3, P874, DOI 10.1371/journal.pmed.0030176; MYKLEBOST O, 1988, HUM GENET, V78, P244, DOI 10.1007/BF00291670; Nass KJ, 2017, METABOLISM, V72, P37, DOI 10.1016/j.metabol.2017.04.004; Nayyar G, 2012, ATHEROSCLEROSIS, V224, P326, DOI 10.1016/j.atherosclerosis.2012.05.040; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; PLUMP AS, 1995, ANNU REV NUTR, V15, P495, DOI 10.1146/annurev.nu.15.070195.002431; Puoti C, 2017, EUR J INTERN MED, V46, P1, DOI 10.1016/j.ejim.2017.06.024; RALL SC, 1982, J BIOL CHEM, V257, P4171; Rasmussen KL, 2016, ATHEROSCLEROSIS, V246, P63, DOI 10.1016/j.atherosclerosis.2015.12.038; Riches FM, 1998, J LIPID RES, V39, P1752; Sazci A, 2008, DIGEST DIS SCI, V53, P3218, DOI 10.1007/s10620-008-0271-5; Schierwagen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12931; Schumann G, 2002, CLIN CHEM LAB MED, V40, P734, DOI 10.1515/CCLM.2002.126; Schumann G, 2002, CLIN CHEM LAB MED, V40, P725, DOI 10.1515/CCLM.2002.125; Schumann G, 2002, CLIN CHEM LAB MED, V40, P718, DOI 10.1515/CCLM.2002.124; SMIT M, 1988, HUM GENET, V80, P287, DOI 10.1007/BF01790099; Soderlund S, 2010, METABOLISM, V59, P1502, DOI 10.1016/j.metabol.2010.01.015; Stachowska E, 2013, J PHYSIOL PHARMACOL, V64, P711; van den Berg EH, 2019, J LIPID RES, V60, P168, DOI 10.1194/jlr.P088997; van den Berg EH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171502; Welty FK, 2000, ARTERIOSCL THROM VAS, V20, P1807, DOI 10.1161/01.ATV.20.7.1807; Yang MH, 2005, HEPATO-GASTROENTEROL, V52, P1832	69	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220659	10.1371/journal.pone.0220659	http://dx.doi.org/10.1371/journal.pone.0220659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386691	gold, Green Published, Green Submitted			2022-12-26	WOS:000484997100030
J	Selakovic, I; Dubljanin-Raspopovic, E; Markovic-Denic, L; Marusic, V; Cirkovic, A; Kadija, M; Tomanovic-Vujadinovic, S; Tulic, G				Selakovic, Ivan; Dubljanin-Raspopovic, Emilija; Markovic-Denic, Lijiljana; Marusic, Vuk; Cirkovic, Andja; Kadija, Marko; Tomanovic-Vujadinovic, Sanja; Tulic, Goran			Can early assessment of hand grip strength in older hip fracture patients predict functional outcome?	PLOS ONE			English	Article							BODY-COMPOSITION; LEAN MASS; SARCOPENIA; WOMEN; BONE; CONSENSUS; DENSITY; EUROQOL; REPAIR; HEALTH	Decreased muscle strength is not only a risk factor for hip fracture in older patients, but plays a role in recovery of physical function. Our aim was to assess the role of grip strength measured early after hip fracture, and classified according to the EWGSOP2 criteria in predicting short- and long-term functional recovery. One hundred ninety-one patients with acute hip fracture consecutively admitted to an orthopaedic hospital have been selected. A multidimensional geriatric assessment evaluating sociodemographic variables, cognitive status, functional status and quality of life prior to fracture, as well as perioperative variables were performed. Follow-ups at 3 and 6 months after surgery were carried out to evaluate functional recovery. Multivariate regression models were used to assess the predictive role of handgrip strength. The mean age of the participants was 80.3 +/- 6.8 years. Thirty-five percent of our patients with clinically relevant hand grip strength weakness were significantly older, more often female, had a lower BMI, and were of worse physical health. They also had a lower cognitive level, lower Barthel index, and lower EQ5D scores before fracture. Multivariate regression analysis adjusted for age and gender revealed that hand grip weakness was an independent predictor of worse functional outcome at 3 and 6 months after hip fracture for both genders and in all age populations. Our study supports the prognostic role of hand grip strength assessed at hospital admission in patients with hip fracture. Thus, clinicians should be encouraged to include hand grip assessment in their evaluation of hip fracture patients in the acute setting in order to optimize treatment of high-risk individuals.	[Selakovic, Ivan; Dubljanin-Raspopovic, Emilija; Tomanovic-Vujadinovic, Sanja] Clin Ctr Serbia, Clin Phys Med & Rehabil, Belgrade, Serbia; [Dubljanin-Raspopovic, Emilija; Markovic-Denic, Lijiljana; Marusic, Vuk; Cirkovic, Andja; Kadija, Marko; Tomanovic-Vujadinovic, Sanja; Tulic, Goran] Univ Belgrade, Fac Med, Belgrade, Serbia; [Markovic-Denic, Lijiljana; Marusic, Vuk] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Cirkovic, Andja] Univ Belgrade, Fac Med, Dept Med Stat & Informat, Belgrade, Serbia; [Kadija, Marko; Tulic, Goran] Clin Ctr Serbia, Inst Orthopaed Surg & Traumatol, Belgrade, Serbia	Clinical Centre of Serbia; University of Belgrade; University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Selakovic, I (corresponding author), Clin Ctr Serbia, Clin Phys Med & Rehabil, Belgrade, Serbia.	ivan.selakovic@gmail.com	Raspopovic, Emilija Dubljanin/AAT-4827-2020	Tulic, Goran/0000-0002-4988-341X; Cirkovic, Andja/0000-0002-7542-5690	Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja (Ministry of Education, Science and Technological Development of the Republic of Serbia) [175046]	Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja (Ministry of Education, Science and Technological Development of the Republic of Serbia)	This work has been done as a part of project of Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja (Ministry of Education, Science and Technological Development of the Republic of Serbia) Project number is 175046, and it lasts from 2011 to 2020. The funder had no role in study design, data collection and analysis,	Alley DE, 2014, J GERONTOL A-BIOL, V69, P559, DOI 10.1093/gerona/glu011; ALVAREZ MN, P L; AVAILABLE F, DG; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; BEATON DE, 1995, J HAND SURG-AM, V20A, P293, DOI 10.1016/S0363-5023(05)80029-2; Beloosesky Y, 2010, DISABIL REHABIL, V32, P367, DOI 10.3109/09638280903168499; Benichou O, 2016, CALCIFIED TISSUE INT, V98, P531, DOI 10.1007/s00223-016-0107-9; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; CRUZJENTOFT AJ, A J, DOI DOI 10.1093/AGEING/AFY169; D'Adamo CR, 2014, AGE AGEING, V43, P275, DOI 10.1093/ageing/aft198; Di Monaco M, 2017, J GERIATR PHYS THER, V40, P80, DOI 10.1519/JPT.0000000000000075; Di Monaco M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000542; Di Monaco M, 2014, ARCH PHYS MED REHAB, V95, P1719, DOI 10.1016/j.apmr.2014.04.003; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Fess EE., 1992, CLIN ASSESSMENT RECO, P41; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Fox KM, 2000, OSTEOPOROSIS INT, V11, P31, DOI 10.1007/s001980050003; He H, 2016, OSTEOPOROSIS INT, V27, P473, DOI 10.1007/s00198-015-3241-8; Hirschfeld HP, 2017, OSTEOPOROSIS INT, V28, P2781, DOI 10.1007/s00198-017-4151-8; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kristensen MT, 2011, EUR J PHYS REHAB MED, V47, P257; Landi F, 2017, OSTEOPOROSIS INT, V28, P1569, DOI 10.1007/s00198-017-3929-z; Lee SY, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.08.021; MAHONEY F I, 1965, Md State Med J, V14, P61; Menendez-Colino R, 2018, INJURY, V49, P656, DOI 10.1016/j.injury.2018.01.003; O, EURO, DOI DOI 10.1093/AGEING/AFQ034; O, 2016, EURO, V1, P556; O, 2019, EURO, V1, P48, DOI DOI 10.1371/JOURNAL.PONE.0184780; O, EURO; Oliveira A, 2015, CLIN RHEUMATOL, V34, P1673, DOI 10.1007/s10067-015-2943-9; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Richards LG, 1997, ARCH PHYS MED REHAB, V78, P1154, DOI 10.1016/S0003-9993(97)90143-X; Savino E, 2013, AM J MED, V126, P1068, DOI 10.1016/j.amjmed.2013.04.017; STEIHAUG OM, 2017, PLOS ONE, V13, P12, DOI DOI 10.1371/J0URNAL.P0NE.0184780; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; TARANTINO U, 2015, J BONE JOINT SURG AM, V4, P97, DOI DOI 10.1007/S00198-017-4151-8; Wehren LE, 2005, J GERONTOL A-BIOL, V60, P80, DOI 10.1093/gerona/60.1.80	41	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0213223	10.1371/journal.pone.0213223	http://dx.doi.org/10.1371/journal.pone.0213223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369561	Green Published, gold, Green Submitted			2022-12-26	WOS:000484987900004
J	Schumann, C; Winkler, A; Bruggenwirth, M; Kopcke, K; Knoche, M				Schumann, Christine; Winkler, Andreas; Brueggenwirth, Martin; Koepcke, Kevin; Knoche, Moritz			Crack initiation and propagation in sweet cherry skin: A simple chain reaction causes the crack to 'run'	PLOS ONE			English	Article							CELL-WALLS; WATER TRANSPORT; FRUIT SURFACE; MONOCLONAL-ANTIBODIES; MECHANICAL-PROPERTIES; FRACTURE PROPERTIES; CUTICLE; CALCIUM; PECTIN; STRAIN	Rain cracking severely affects the commercial production of many fleshy-fruit species, including of sweet cherries. The objectives were to investigate how the gaping macroscopic cracks (macrocracks) of a rain-cracked fruit can develop from microscopic cracks in the cuticle (microcracks). Incubating fruit in deionized water is well known to cause significant macrocracking. We found that after a lag phase of 2 h, the numbers and lengths of macrocracks increased. Macrocrack number approached an asymptote at 12 h, whereas macrocrack length continued to increase. The rate of macrocrack propagation (extension at the crack tip) was initially 10.8 mm h(-1) but then decreased to a near-constant 0.5 mm h(-1). Light microscopy revealed three characteristic zones along a developing macrocrack. In zone I (ahead of the crack), the cuticle was intact, the epidermal cells were unbroken and their cell walls were thin. In zone II, the cuticle was fractured, the first epidermal cells died and their cell walls began to thicken (swell). In zone III, most epidermal cells had died, their cell walls were swollen and cell: cell separation began along the middle lamellae. The thickness of the anticlinal epidermal cell walls and the percentage of intact living cells along a crack were closely and negatively related. Cracks were stained by calcofluor white, but there was no binding of monoclonal antibodies (mAbs) specific for hemicelluloses (LM11, LM21, LM25). Strong binding was obtained with the anti-homogalacturonan mAb (LM19), indicating the presence of unesterified homogalacturonans on the crack surface. We conclude that macrocrack propagation is related to cell death and to cell wall swelling. Cell wall swelling weakens the cell: cell adhesion between neighbouring epidermal cells, which separate along their middle lamellae. The skin macrocrack propagates like a 'run' in a fine, knitted fabric.	[Schumann, Christine; Winkler, Andreas; Brueggenwirth, Martin; Koepcke, Kevin; Knoche, Moritz] Leibniz Univ Hannover, Inst Hort Prod Syst, Hannover, Germany	Leibniz University Hannover	Knoche, M (corresponding author), Leibniz Univ Hannover, Inst Hort Prod Syst, Hannover, Germany.	moritz.knoche@obst.uni-hannover.de	Winkler, Andreas/AAG-3226-2020; Knoche, Moritz/AAI-3104-2021	Knoche, Moritz/0000-0003-0357-8935; Winkler, Andreas/0000-0002-8766-8892	DFG [KN 402]; Gisela Foundation; Leibniz Universitat Hannover	DFG(German Research Foundation (DFG)); Gisela Foundation; Leibniz Universitat Hannover	This study was funded in part by a grant from the DFG (KN 402) to M.K. and from the Gisela Foundation to A.W. The publication of this article was funded by the Open Access fund of Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkio M, 2012, ANN BOT-LONDON, V110, P101, DOI 10.1093/aob/mcs087; Avci U, 2012, BIOMASS CONVERSION M, V908; Beyer M, 2002, HORTSCIENCE, V37, P637, DOI 10.21273/HORTSCI.37.4.637; Bruggenwirth M, 2017, PLANTA, V245, P765, DOI 10.1007/s00425-016-2639-7; Bruggenwirth M, 2016, J AM SOC HORTIC SCI, V141, P485, DOI 10.21273/JASHS03810-16; Bruggenwirth M, 2016, TREES-STRUCT FUNCT, V30, P1821, DOI 10.1007/s00468-016-1415-4; Bruggenwirth M, 2016, J AM SOC HORTIC SCI, V141, P162, DOI 10.21273/JASHS.141.2.162; Brueggenwirth M, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu019; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; CONSIDINE JA, 1972, AUST J AGR RES, V23, P17, DOI 10.1071/AR9720017; GLENN GM, 1989, J AM SOC HORTIC SCI, V114, P781; Gong SY, 2007, J MATER ENG PERFORM, V16, P607, DOI 10.1007/s11665-007-9065-8; Grimm E, 2015, J AM SOC HORTIC SCI, V140, P472, DOI 10.21273/JASHS.140.5.472; Grimm E, 2012, J AM SOC HORTIC SCI, V137, P383, DOI 10.21273/JASHS.137.6.383; Herrmann K., 2001, INHALTSSTOFFE OBST G; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; JARVIS MC, 1992, PLANTA, V187, P218, DOI 10.1007/BF00201941; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Knoche M, 2006, J AM SOC HORTIC SCI, V131, P192, DOI 10.21273/JASHS.131.2.192; Knoche M, 2017, CRIT REV PLANT SCI, V36, P190, DOI 10.1080/07352689.2017.1369333; Knoche M, 2017, CHERRIES: BOTANY, PRODUCTION AND USES, P140, DOI 10.1079/9781780648378.0140; Knoche M, 2014, J AM SOC HORTIC SCI, V139, P3, DOI 10.21273/JASHS.139.1.3; Lai XT, 2016, PLANTA, V244, P1145, DOI 10.1007/s00425-016-2572-9; Lang G, 1998, ACTA HORTIC, P649, DOI 10.17660/ActaHortic.1998.468.81; Lee KJD, 2011, MOL PLANT, V4, P212, DOI 10.1093/mp/ssq075; LIN GM, 1993, J MATER SCI, V28, P5240, DOI 10.1007/BF00570071; LINERS F, 1989, PLANT PHYSIOL, V91, P1419, DOI 10.1104/pp.91.4.1419; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MECHOLSKY JJ, 1995, DENT MATER, V11, P113, DOI 10.1016/0109-5641(95)80045-X; Niklas KJ., 1992, PLANT BIOMECHANICS E, DOI DOI 10.1007/BF01875445; Opara L. U., 1996, Horticultural Reviews, V19, P217, DOI 10.1002/9780470650622.ch4; Ordaz-Ortiz JJ, 2009, MOL PLANT, V2, P910, DOI 10.1093/mp/ssp049; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Peschel S, 2005, J AM SOC HORTIC SCI, V130, P487, DOI 10.21273/JASHS.130.4.487; Redgwell RJ, 1997, PLANTA, V203, P162, DOI 10.1007/s004250050178; Schumann C, 2014, J AM SOC HORTIC SCI, V139, P349, DOI 10.21273/JASHS.139.4.349; Vashishth D, 2000, J BIOMECH, V33, P1169, DOI 10.1016/S0021-9290(00)00010-5; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; VINCENT JFV, 1990, ADV BOT RES, V17, P235, DOI 10.1016/S0065-2296(08)60135-4; von Wetzhausen C., 1819, SYSTEMATISCHE CLASSI, P65; Weichert H, 2004, J AM SOC HORTIC SCI, V129, P781, DOI 10.21273/JASHS.129.6.0781; Weichert H, 2006, J AGR FOOD CHEM, V54, P3951, DOI 10.1021/jf053220a; Willats WGT, 2004, PLANTA, V218, P673, DOI 10.1007/s00425-003-1147-8; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Winkler A, 2019, SCI HORTIC-AMSTERDAM, V245, P107, DOI 10.1016/j.scienta.2018.10.012; Winkler A, 2016, J AM SOC HORTIC SCI, V141, P653, DOI 10.21273/JASHS03937-16; Winkler A, 2015, J AM SOC HORTIC SCI, V140, P280, DOI 10.21273/JASHS.140.3.280	49	21	21	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0219794	10.1371/journal.pone.0219794	http://dx.doi.org/10.1371/journal.pone.0219794			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365556	Green Published, gold			2022-12-26	WOS:000484983600019
J	Yao, Y; Carretero-Paulet, L; Van de Peer, Y				Yao, Yao; Carretero-Paulet, Lorenzo; Van de Peer, Yves			Using digital organisms to study the evolutionary consequences of whole genome duplication and polyploidy	PLOS ONE			English	Article							HOPEFUL MONSTERS; MODULARITY; COST; LIFE; ADAPTATION; INSIGHTS; REVEALS; DRIVE	The potential role of whole genome duplication (WGD) in evolution is controversial. Whereas some view WGD mainly as detrimental and an evolutionary 'dead end', there is growing evidence that the long-term establishment of polyploidy might be linked to environmental change, stressful conditions, or periods of extinction. However, despite much research, the mechanistic underpinnings of why and how polyploids might be able to out'-compete non-polyploids at times of environmental upheaval remain indefinable. Here, we improved our recently developed bio-inspired framework, combining an artificial genome with an agent-based system, to form a population of so-called Digital Organisms (DOs), to examine the impact of WGD on evolution under different environmental scenarios mimicking extinction events of varying strength and frequency. We found that, under stable environments, DOs with non-duplicated genomes formed the majority, if not all, of the population, whereas the numbers of DOs with duplicated genomes increased under dramatically challenging environments. After tracking the evolutionary trajectories of individual genomes in terms of sequence and encoded gene regulatory networks (GRNs), we propose that duplicated GRNs might provide polyploids with better chances to acquire the drastic changes necessary to adapt to challenging conditions, thus endowing DOs with increased adaptive potential under extinction events. In contrast, under stable environments, random mutations might easily render the GRN less well adapted to such environments, a phenomenon that is exacerbated in duplicated, more complex GRNs. We believe that our results provide some additional insights into how genome duplication and polyploidy might help organisms to compete for novel niches and survive ecological turmoil, and confirm the usefulness of our computational simulation in studying the role of WGD in evolution and adaptation, helping to overcome some of the traditional limitations of evolution experiments with model organisms.	[Yao, Yao; Carretero-Paulet, Lorenzo; Van de Peer, Yves] VIB, Ctr Plant Syst Biol, Ghent, Belgium; [Yao, Yao; Carretero-Paulet, Lorenzo; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Van de Peer, Yves] Univ Pretoria, Ctr Microbial Ecol & Genom, Dept Biochem Genet & Microbiol, Pretoria, South Africa	Flanders Institute for Biotechnology (VIB); Ghent University; University of Pretoria	Van de Peer, Y (corresponding author), VIB, Ctr Plant Syst Biol, Ghent, Belgium.; Van de Peer, Y (corresponding author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium.; Van de Peer, Y (corresponding author), Univ Pretoria, Ctr Microbial Ecol & Genom, Dept Biochem Genet & Microbiol, Pretoria, South Africa.	yves.vandepeer@psb.vib-ugent.be	Carretero-Paulet, Lorenzo/Z-2744-2019; Van de Peer, Yves/AAE-7666-2019	Carretero-Paulet, Lorenzo/0000-0001-6697-827X; Van de Peer, Yves/0000-0003-4327-3730	European Union [322739 DOUBLEUP]	European Union(European Commission)	D Y.V.d.P. acknowledges funding from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Advanced Grant Agreement 322739 DOUBLEUP. The authors would also like to thank Arthur Zwaenepoel and Eshchar Mizrachi for helpful discussions. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Y.V.d.P. acknowledges funding from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Advanced Grant Agreement 322739 DOUBLEUP. The authors would also like to thank Arthur Zwaenepoel and Eshchar Mizrachi for helpful discussions, Steven Maere for help with Fig 8, and two anonymous reviewers for constructive comments that greatly helped improving the paper. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	Albertin Warren, 2012, Proc Biol Sci, V279, P2497, DOI 10.1098/rspb.2012.0434; Altenberg L., 1995, GENOME GROWTH EVOLUT; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arrigo N, 2012, CURR OPIN PLANT BIOL, V15, P140, DOI 10.1016/j.pbi.2012.03.010; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bolker JA, 2000, AM ZOOL, V40, P770, DOI 10.1668/0003-1569(2000)040[0770:MIDAWI]2.0.CO;2; Cai LM, 2019, NEW PHYTOL, V221, P565, DOI 10.1111/nph.15357; CALABRETTA R, 1998, COM ADAP SY, P275; Carbone I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-111; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Cuypers TD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003547; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Diallo AM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00821; Espinosa-Soto C, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006172; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Fusco D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-77; Godfree RC, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170934; Gorochowski TE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9751; Grozinger CM, 2014, APIDOLOGIE, V45, P327, DOI 10.1007/s13592-013-0253-2; Hallinan J, 2004, BIOSYSTEMS, V74, P51, DOI 10.1016/j.biosystems.2004.02.004; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lohaus R, 2016, CURR OPIN PLANT BIOL, V30, P62, DOI 10.1016/j.pbi.2016.01.006; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Meyers LA, 2006, EVOLUTION, V60, P1198, DOI 10.1111/j.0014-3820.2006.tb01198.x; MOORE MJ, 1995, P I MECH ENG A-J POW, V209, P251, DOI 10.1243/PIME_PROC_1995_209_002_01; Oberlander KC, 2016, AM J BOT, V103, P1336, DOI 10.3732/ajb.1500474; Ohno S., 1970, P1; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Pandit MK, 2011, J ECOL, V99, P1108, DOI 10.1111/j.1365-2745.2011.01838.x; Reil T, 1999, LECT NOTES ARTIF INT, V1674, P457; Rowland MA, 2017, BIOPHYS J, V112, P1539, DOI 10.1016/j.bpj.2017.02.044; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Sessa EB, 2019, NEW PHYTOL, V221, P5, DOI 10.1111/nph.15513; Soltis DE, 2014, AM J BOT, V101, P1057, DOI 10.3732/ajb.1400178; Soltis PS, 2016, CURR OPIN PLANT BIOL, V30, P159, DOI 10.1016/j.pbi.2016.03.015; Soltis PS, 2015, CURR OPIN GENET DEV, V35, P119, DOI 10.1016/j.gde.2015.11.003; Soltis PS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0351; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; ten Tusscher KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002208; Theissen G, 2006, THEOR BIOSCI, V124, P349, DOI 10.1016/j.thbio.2005.11.002; Theissen G, 2009, THEOR BIOSCI, V128, P43, DOI 10.1007/s12064-009-0058-z; Van De Peer Y, 2017, NAT REV GENET, V18, P411, DOI 10.1038/nrg.2017.26; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vanneste K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0353; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Welch JJ, 2003, EVOLUTION, V57, P1723, DOI 10.1554/02-673; Wendel JF, 2015, AM J BOT, V102, P1753, DOI 10.3732/ajb.1500320; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Yao Y, 2017, CYB CYBCONF 2017 3 I; Yao Y, 2016, ADAPTIVE SELF ORGANI, P68; Yao Y, 2016, PEERJ, V4, DOI 10.7717/peerj.2812; Yao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090695	62	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2019	14	7							e0220257	10.1371/journal.pone.0220257	http://dx.doi.org/10.1371/journal.pone.0220257			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4XR	31365541	Green Published, gold, Green Submitted			2022-12-26	WOS:000484983600033
J	Pai, YW; Lin, CH; Lin, SY; Lee, IT; Chang, MH				Pai, Yen-Wei; Lin, Ching-Heng; Lin, Shih-Yi; Lee, I-Te; Chang, Ming-Hong			Reconfirmation of newly discovered risk factors of diabetic peripheral neuropathy in patients with type 2 diabetes: A case-control study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; VARIABILITY; COMPLICATIONS; ALBUMINURIA; MARKER	Aims The aim of the present study was to investigate the major determinants of diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes (T2D), considering the traditional and newly discovered risk factors, including hypoglycaemia and glycemic variability. Methods This retrospective case-control study was conducted in a tertiary care hospital in Taiwan. A total of 2,837 patients with T2D were recruited, medical history and biochemical data were obtained, and patients were screened for DPN using the Michigan Neuropathy Screening Instrument (MNSI). DPN was defined as an MNSI exam score > 2. A stepwise selection of variables was used based on the Akaike Information Criterion (AIC) and the Schwarz Criterion (SC). Multivariate analysis was performed using the identified variables obtained from the stepwise selection. Results Among the recruited patients, 604 (21.3%) were found to have DPN. 275 patients with DPN were selected because of longer follow up period before enrollment and complete data of glycemic parameters, and paired with 351 patients with T2D without DPN and matched for age, gender, and diabetes duration. The results of the stepwise selection showed that the presence of moderately and severely increased albuminuria yielded the lowest values of AIC and SC, which indicate the best predictive performance. Multivariate analysis demonstrated that moderately and severely increased albuminuria and greater long-term glycemic variability significantly increased the risk of DPN, with a corresponding odds ratio of 1.85 and 1.61 (95% confidence intervals of 1.25-2.73and1.02-2.55, respectively), after adjusted for hypoglycaemia and types of diabetes treatment. Conclusions Albuminuria is a potent predictor of DPN, and greater long-term glycemic variabilityis clearly associated with DPN in adults with T2D. These findings indicate that, in addition to achieve average blood glucose control, screening for albuminuria and reducing blood glucose fluctuations might be useful for improving diabetic microvascular complications.	[Pai, Yen-Wei; Chang, Ming-Hong] Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Shih-Yi] Taichung Vet Gen Hosp, Ctr Geriatr & Gerontol, Taichung, Taiwan; [Lin, Shih-Yi; Lee, I-Te] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei, Taiwan; [Lee, I-Te] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan; [Lee, I-Te] Chung Shan Med Univ, Sch Med, Dept Med, Taichung, Taiwan; [Chang, Ming-Hong] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University	Chang, MH (corresponding author), Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan.; Lee, IT (corresponding author), Natl Yang Ming Univ, Dept Med, Sch Med, Taipei, Taiwan.; Lee, IT (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan.; Lee, IT (corresponding author), Chung Shan Med Univ, Sch Med, Dept Med, Taichung, Taiwan.; Chang, MH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan.	itlee@vghtc.gov.tw; cmh50@ms10.hinet.net		Chang, Ming-Hong/0000-0002-7699-334X	Medical Research Project of Taichung Veterans General Hospital [TCVGH 1073404C]	Medical Research Project of Taichung Veterans General Hospital	This study was supported by the Medical Research Project of Taichung Veterans General Hospital (TCVGH 1073404C), but nothing from commercial or not-for-profit sectors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS105, DOI 10.2337/dc18-S010; [Anonymous], 2017, DIABETES CARE, V40, pS48, DOI 10.2337/dc17-S009; Callaghan BC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007543.pub2; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; de Zeeuw D, 2004, KIDNEY INT, V66, pS2, DOI 10.1111/j.1523-1755.2004.09201.x; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jaiswal M, 2013, DIABETES CARE, V36, P3903, DOI 10.2337/dc13-1213; Jensen VFH, 2014, J NEUROENDOCRINOL, V26, P482, DOI 10.1111/jne.12170; Lee CL, 2017, DIABETES METAB; Monnier L, 2017, DIABETES METAB; Nalysnyk L, 2010, DIABETES OBES METAB, V12, P288, DOI 10.1111/j.1463-1326.2009.01160.x; Nematollahi LR, 2009, METABOLISM, V58, P443, DOI 10.1016/j.metabol.2008.10.018; Pai YW, 2018, DIABETES METAB, V44, P129, DOI 10.1016/j.diabet.2018.01.015; Pai YW, 2017, DIABETES METAB; POTTER CG, 1988, J NEUROL SCI, V88, P293, DOI 10.1016/0022-510X(88)90226-2; Roustit M, 2016, J CLIN ENDOCR METAB, V101, P3401, DOI 10.1210/jc.2016-2030; Su JB, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0693-0; Thoenes M, 2007, FUTUR CARDIOL, V3, P519, DOI 10.2217/14796678.3.5.519; Vrieze SI, 2012, PSYCHOL METHODS, V17, P228, DOI 10.1037/a0027127; Yang CP, 2017, NEUROLOGY, V88, P944, DOI 10.1212/WNL.0000000000003682	22	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0220175	10.1371/journal.pone.0220175	http://dx.doi.org/10.1371/journal.pone.0220175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356602	Green Published, gold, Green Submitted			2022-12-26	WOS:000484047000019
J	Wolters, FJ; Yang, Q; Biggs, ML; Jakobsdottir, J; Li, S; Evans, DS; Bis, JC; Harris, TB; Vasan, RS; Zilhao, NR; Ghanbari, M; Ikram, MA; Launer, L; Psaty, BM; Tranah, GJ; Kulminski, AM; Gudnason, V; Seshadri, S				Wolters, Frank J.; Yang, Qiong; Biggs, Mary L.; Jakobsdottir, Johanna; Li, Shuo; Evans, Daniel S.; Bis, Joshua C.; Harris, Tamara B.; Vasan, Ramachandran S.; Zilhao, Nuno R.; Ghanbari, Mohsen; Ikram, M. Arfan; Launer, Lenore; Psaty, Bruce M.; Tranah, Gregory J.; Kulminski, Alexander M.; Gudnason, Vilmundur; Seshadri, Sudha		E2-CHARGE Investigators	The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; GENOME-WIDE ASSOCIATION; ALZHEIMER-DISEASE; HUMAN LONGEVITY; OLDEST-OLD; AGE; METAANALYSIS; MORTALITY; RISK; SUSCEPTIBILITY	Background Apolipoprotein E is a glycoprotein best known as a mediator and regulator of lipid transport and uptake. The APOE-epsilon 4 allele has long been associated with increased risks of Alzheimer's disease and mortality, but the effect of the less prevalent APOE-epsilon 2 allele on diseases in the elderly and survival remains elusive. Methods We aggregated data of 38,537 individuals of European ancestry (mean age 65.5 years; 55.6% women) from six population-based cohort studies (Rotterdam Study, AGES-Reykjavik Study, Cardiovascular Health Study, Health-ABC Study, and the family-based Framingham Heart Study and Long Life Family Study) to determine the association of APOE, and in particular APOE-epsilon 2, with survival in the population. Results During a mean follow-up of 11.7 years, 17,021 individuals died. Compared with homozygous APOE-epsilon 3 carriers, APOE-epsilon 2 carriers were at lower risk of death (hazard ratio, 95% confidence interval: 0.94,0.90-0.99; P = 1.1*10(-2)), whereas APOE-epsilon 4 carriers were at increased risk of death (HR 1.17,1.12-1.21; P = 2.8*10(-16)). APOE was associated with mortality risk in a dose-dependent manner, with risk estimates lowest for homozygous APOE-epsilon 2 (HR 0.89,0.74-1.08), and highest for homozygous APOE-epsilon 4 (HR 1.52,1.371.70). After censoring for dementia, effect estimates remained similar for APOE-epsilon 2 (HR 0.95,0.90-1.01), but attenuated for APOE-epsilon 4 (HR 1.07,1.01-1.12). 000Results were broadly similar across cohorts, and did not differ by age or sex. APOE genotype was associated with baseline lipid fractions (e.g. mean difference(95% CI) in LDL(mg/dL) for epsilon 2 versus epsilon 33: -17.1(-18.1-16.0), and epsilon 4 versus epsilon 33: +5.7(4.8;6.5)), but the association between APOE and mortality was unaltered after adjustment for baseline LDL or cardiovascular disease. Given the European ancestry of the study population, results may not apply to other ethnicities. Conclusion Compared with APOE-epsilon 3, APOE-epsilon 2 is associated with prolonged survival, whereas mortality risk is increased for APOE-epsilon 4 carriers. Further collaborative efforts are needed to unravel the role of APOE and in particular APOE-epsilon 2 in health and disease.	[Wolters, Frank J.; Ghanbari, Mohsen; Ikram, M. Arfan] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Yang, Qiong; Li, Shuo] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Biggs, Mary L.; Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Biggs, Mary L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Jakobsdottir, Johanna; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykavik, Iceland; [Evans, Daniel S.; Tranah, Gregory J.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Harris, Tamara B.; Launer, Lenore] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Zilhao, Nuno R.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Kulminski, Alexander M.] Duke Univ, Biodemog Aging Res Unit, Social Sci Res Inst, Durham, NC USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Erasmus University Rotterdam; Erasmus MC; Boston University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Iceland; California Pacific Medical Center; California Pacific Medical Center Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Boston University; Boston University; Icelandic Heart Association; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; Duke University; Boston University	Wolters, FJ (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.; Seshadri, S (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	f.j.wolters@erasmusmc.nl; suseshad@bu.edu	Wolters, Frank J./A-6107-2011; Gudnason, Vilmundur/AAE-7126-2019; Ghanbari, Mohsen/AAH-1340-2020; Wolters, Frank J./AAQ-8535-2020; Ikram, M. Arfan/AAM-5225-2021	Wolters, Frank J./0000-0003-2226-4050; Gudnason, Vilmundur/0000-0001-5696-0084; Ghanbari, Mohsen/0000-0002-9476-7143; Wolters, Frank J./0000-0003-2226-4050; Jakobsdottir, Johanna/0000-0002-8019-9683; Seshadri, Sudha/0000-0001-6135-2622; Li, Shuo/0000-0003-2331-2448; Zilhao, Nuno/0000-0002-4648-4288	National Heart, Lung, and Blood Institute (NHLBI) [HL105756, AG033193, U19AG023122]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG052409, R01AG033193, P01AG043352, R01AG054076, R01AG047310, U19AG023122, R01AG061853, R01AG049607, U01AG023712, R01AG033040] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Infrastructure for the CHARGE Consortium members in this grant is supported in part by the National Heart, Lung, and Blood Institute (NHLBI, http://www.nhlbi.nih.gov) grant HL105756 (Psaty) and AG033193 (Seshadri). This work was also supported by a grant from the Consortium to Study the Genetics of Longevity (U19AG023122; PI Cummings; subproject title 'APOE2 Genotype in Longevity and Healthy Aging', PI: Seshadri). Detailed funding information for all studies that contributed to this work are provided in the online Appendix funding section (S5 Supporting information). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2014, J CANCER RES CLIN, V140, P1075, DOI 10.1007/s00432-014-1634-2; Broer L, 2015, J GERONTOL A-BIOL, V70, P110, DOI 10.1093/gerona/glu166; Corder EH, 1996, ARCH NEUROL-CHICAGO, V53, P418, DOI 10.1001/archneur.1996.00550050048022; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corrada MM, 2013, ALZHEIMERS DEMENT, V9, P12, DOI 10.1016/j.jalz.2011.12.004; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; Deelen J, 2014, HUM MOL GENET, V23, P4420, DOI 10.1093/hmg/ddu139; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fazekas F, 2006, J NEUROL SCI, V245, P35, DOI 10.1016/j.jns.2005.08.018; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Ifere GO, 2013, INT J ONCOL, V43, P1002, DOI 10.3892/ijo.2013.2057; Khan TA, 2013, INT J EPIDEMIOL, V42, P475, DOI 10.1093/ije/dyt034; Kulminski AM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004141; Li FQ, 2010, J PHARMACOL EXP THER, V334, P106, DOI 10.1124/jpet.110.167882; Lindahl-Jacobsen R, 2013, J GERONTOL A-BIOL, V68, P389, DOI 10.1093/gerona/gls192; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; LOUHIJA J, 1994, ARTERIOSCLER THROMB, V14, P1084, DOI 10.1161/01.ATV.14.7.1084; Mahley RW, 1996, ANN NY ACAD SCI, V777, P139, DOI 10.1111/j.1749-6632.1996.tb34412.x; Matsunaga A, 2014, CLIN EXP NEPHROL, V18, P220, DOI 10.1007/s10157-013-0918-1; Mostafavi H, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002458; Mulder SD, 2014, GLIA, V62, P493, DOI 10.1002/glia.22619; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Newman AB, 2010, J GERONTOL A-BIOL, V65, P478, DOI 10.1093/gerona/glq028; Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930; Rannikmae K, 2013, J NEUROL NEUROSUR PS, V84, P901, DOI 10.1136/jnnp-2012-303898; Rea IM, 2001, MECH AGEING DEV, V122, P1367, DOI 10.1016/S0047-6374(01)00278-0; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schilling S, 2013, NEUROLOGY, V81, P292, DOI 10.1212/WNL.0b013e31829bfda4; Schupf N, 2013, NEUROBIOL AGING, V34, P1287, DOI 10.1016/j.neurobiolaging.2012.08.019; Sebastiani P, 2009, AM J EPIDEMIOL, V170, P1555, DOI 10.1093/aje/kwp309; Tai LM, 2016, ACTA NEUROPATHOL, V131, P709, DOI 10.1007/s00401-016-1547-z; Wilson PW, 1994, JAMA, V272; Yao XL, 2016, AM J RESP CELL MOL, V55, P159, DOI 10.1165/rcmb.2016-0060TR; Yu CE, 2013, HUM MOL GENET, V22, P5036, DOI 10.1093/hmg/ddt354; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	44	31	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0219668	10.1371/journal.pone.0219668	http://dx.doi.org/10.1371/journal.pone.0219668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IV1OL	31356640	Green Published, gold, Green Submitted			2022-12-26	WOS:000484047000008
J	Yasir, M; Dutta, D; Willcox, MDP				Yasir, Muhammad; Dutta, Debarun; Willcox, Mark D. P.			Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability	PLOS ONE			English	Article							LIPOTEICHOIC ACIDS; CATIONIC PEPTIDES; CONTACT-LENS; MECHANISM; TRYPTOPHAN; MELIMINE; TIME; BACTERIOCINS; SELECTIVITY; DEFENSINS	Mel4 is a novel cationic peptide with potent activity against Gram-positive bacteria. The current study examined the anti-staphylococcal mechanism of action of Mel4 and its precursor peptide melimine. The interaction of peptides with lipoteichoic acid (LTA) and with the cytoplasmic membrane using DiSC(3)-5, Sytox green, Syto-9 and PI dyes were studied. Release of ATP and DNA/RNA from cells exposed to the peptides were determined. Bacteriolysis and autolysin-activated cell death were determined by measuring decreases in OD620nm and killing of Micrococcus lysodeikticus cells by cell-free media. Both peptides bound to LTA and rapidly dissipated the membrane potential (within 30 seconds) without affecting bacterial viability. Disturbance of the membrane potential was followed by the release of ATP (50% of total cellular ATP) by melimine and by Mel4 (20%) after 2 minutes exposure (p<0.001). Mel4 resulted in staphylococcal cells taking up PI with 3.9% cells predominantly stained after 150 min exposure, whereas melimine showed 34% staining. Unlike melimine, Mel4 did not release DNA/RNA. Cell-free media from Mel4 treated cells hydrolysed peptidoglycan and produced greater zones of inhibition against M. lysodeikticus lawn than melimine treated samples. These findings suggest that pore formation is unlikely to be involved in Mel4-mediated membrane destabilization for staphylococci, since there was no significant Mel4-induced PI staining and DNA/RNA leakage. It is likely that the S. aureus killing mechanism of Mel4 involves the release of autolysins followed by cell death. Whereas, membrane interaction is the primary bactericidal activity of melimine, which includes membrane depolarization, pore formation, release of cellular contents leading to cell death.	[Yasir, Muhammad; Dutta, Debarun; Willcox, Mark D. P.] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Dutta, Debarun] Aston Univ Birmingham, Ophthalm Res Grp, Sch Hlth & Life Sci, Birmingham, W Midlands, England	University of New South Wales Sydney; Aston University	Yasir, M (corresponding author), Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	yasirjri85@gmail.com	Yasir, Muhammad/HHC-1474-2022	YASIR, MUHAMMAD/0000-0003-4589-4311; Dutta, Debarun/0000-0002-2204-5272	Australian Research Council [DP160101664]	Australian Research Council(Australian Research Council)	Prof Mark Willcox received the funding to accomplish this project. Australian Research Council was the funding body who granted fund under project number DP160101664 to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEE T, 1995, FEMS MICROBIOL LETT, V129, P1, DOI 10.1016/0378-1097(95)00137-T; Altman H, 2006, J ANTIMICROB CHEMOTH, V58, P198, DOI 10.1093/jac/dkl181; Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; Baranska-Rybak W, 2011, CHEMOTHERAPY RES PRA, P6; Behrendt R, 2016, J PEPT SCI, V22, P4, DOI 10.1002/psc.2836; Berry T, 2018, LANGMUIR; Bi X, 2013, J APPL MICROBIOL, V115, P663, DOI 10.1111/jam.12262; BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; BLONDELLE SE, 1991, BIOCHEMISTRY-US, V30, P4671, DOI 10.1021/bi00233a006; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Bucki R, 2006, ANTIMICROB AGENTS CH, V50, P2932, DOI 10.1128/AAC.00134-06; Carson CF, 2002, ANTIMICROB AGENTS CH, V46, P1914, DOI 10.1128/AAC.46.6.1914-1920.2002; Casciaro B, 2018, PEPTIDE SCI, V110, DOI 10.1002/bip.23074; Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Dutta D, 2017, CONTACT LENS ANTERIO, V40, P175, DOI 10.1016/j.clae.2017.01.002; Dutta D, 2016, BIOFOULING, V32, P429, DOI 10.1080/08927014.2015.1129533; Dutta D, 2013, INVEST OPHTH VIS SCI, V54, P175, DOI 10.1167/iovs.12-10989; FISCHER W, 1981, J BACTERIOL, V146, P467, DOI 10.1128/JB.146.2.467-475.1981; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gongora-Benitez M, 2013, ACS COMB SCI, V15, P217, DOI 10.1021/co300153c; Guillamet CV, 2016, CURR OPIN INFECT DIS, V29, P116, DOI 10.1097/QCO.0000000000000244; Hume EBH, 2005, IMMUNOL CELL BIOL, V83, P294, DOI 10.1111/j.1440-1711.2005.01326.x; Jalbert I, 2000, CORNEA, V19, P116, DOI 10.1097/00003226-200001000-00023; Kleinschmidt JH, 2003, CELL MOL LIFE SCI, V60, P1547, DOI 10.1007/s00018-003-3170-0; Lee JK, 2013, BBA-BIOMEMBRANES, V1828, P443, DOI 10.1016/j.bbamem.2012.09.005; Leitch EC, 1999, J MED MICROBIOL, V48, P867, DOI 10.1099/00222615-48-9-867; Li LR, 2012, INT J ANTIMICROB AG, V40, P337, DOI 10.1016/j.ijantimicag.2012.05.026; Li ZJ, 2009, MOL IMMUNOL, V46, P3232, DOI 10.1016/j.molimm.2009.08.006; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Malanovic N, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030059; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mishra AK, 2018, MOLECULES, V23, DOI 10.3390/molecules23040815; MYLOTTE JM, 1987, REV INFECT DIS, V9, P891; Nan YH, 2009, PEPTIDES, V30, P832, DOI 10.1016/j.peptides.2009.01.015; Netz DJA, 2002, APPL ENVIRON MICROB, V68, P5274, DOI 10.1128/AEM.68.11.5274-5280.2002; Okuda K, 2013, ANTIMICROB AGENTS CH, V57, P5572, DOI 10.1128/AAC.00888-13; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P4398, DOI 10.1128/AAC.00372-13; Pag U, 2008, J ANTIMICROB CHEMOTH, V61, P341, DOI 10.1093/jac/dkm479; Rasul R, 2010, INT J ANTIMICROB AG, V35, P566, DOI 10.1016/j.ijantimicag.2010.02.005; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Saint Jean KD, 2018, PROBIOTICS ANTIMICRO, V10, P408, DOI 10.1007/s12602-017-9345-z; Schneewind O, 2014, J BACTERIOL, V196, P1133, DOI 10.1128/JB.01155-13; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Suh SJ, 2016, J MICROBIOL METH, V125, P81, DOI 10.1016/j.mimet.2016.04.009; te Winkel JD, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00029; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; van Hal SJ, 2013, CLIN INFECT DIS, V56, P1779, DOI 10.1093/cid/cit178; Veldhuizen EJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095939; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wang Y, 2017, P NATL ACAD SCI USA, V114, pE5094, DOI 10.1073/pnas.1703427114; WHO AR, 2014, GLOB REP SURV ANT RE; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x; Wilmes M, 2014, ANTIBIOTICS-BASEL, V3, P617, DOI 10.3390/antibiotics3040617; Yang X, 2017, MICROBIOL RES, V195, P18, DOI 10.1016/j.micres.2016.11.002; Yasir M, 2018, MATERIALS, V11, DOI 10.3390/ma11122468; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114605	69	44	45	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2019	14	7							e0215703	10.1371/journal.pone.0215703	http://dx.doi.org/10.1371/journal.pone.0215703			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV1OL	31356627	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000484047000004
J	Li, CC; Huang, MS; Liu, J; Ji, SP; Zhao, RQ; Zhao, D; Sun, RL				Li, Changchao; Huang, Miansong; Liu, Jian; Ji, Shuping; Zhao, Ruiqi; Zhao, Di; Sun, Ruilian			Isotope-based water-use efficiency of major greening plants in a sponge city in northern China	PLOS ONE			English	Article							CARBON; DISCRIMINATION; C3; RATIOS; LEAF; C4; INDICATORS; DELTA-C-13; NITROGEN; GROWTH	To tackle urban water issues, the Chinese government has promoted the construction of sponge cities in recent years. Thirty cities have been designated as experimental sites to serve as models for future sponge city construction, as more than 80% of the built-up urban areas in China must reach the standards of sponge cities by 2030. Greening plants play an important role in sponge cities, and water-use efficiency (WUE) is a vital index to determine whether plants could adapt to and grow healthily in environments with water deficits. In this study, WUE of greening plants was quantified by measuring the stable carbon isotope fractionation. Suitable plants for the green spaces in Guyuan sponge city, in northern China, were selected based on their WUE, and the main factors affecting WUE were studied in four habitats within the city. Plant species identity had the greatest effect on WUE, while habitat and plant life form had lower effect, illustrating that WUE is a relatively stable and reliable index for the classification of plant species. We can improve the WUE and ecological function of green spaces in sponge cities by using isotope technology to select suitable plant species with high WUE. To our knowledge, this study is the first to select plant species for sponge city by using this method, providing a quick and scientific method for the selection of greening plants for future sponge cities.	[Li, Changchao; Liu, Jian; Ji, Shuping; Zhao, Ruiqi; Zhao, Di; Sun, Ruilian] Shandong Univ, Inst Environm Res, Qingdao, Shandong, Peoples R China; [Huang, Miansong] Ningxia Capital Sponge City Construct & Dev Co Lt, Guyuan, Peoples R China; [Huang, Miansong] Beijing Capital Co Ltd, Beijing, Peoples R China	Shandong University	Huang, MS (corresponding author), Ningxia Capital Sponge City Construct & Dev Co Lt, Guyuan, Peoples R China.; Huang, MS (corresponding author), Beijing Capital Co Ltd, Beijing, Peoples R China.	hms@capitalwater.cn	Li, Changchao/AGY-8921-2022; Liu, Jian/T-1760-2017; Liu, Jian/AAG-9184-2019	Li, Changchao/0000-0002-3943-6413; Liu, Jian/0000-0003-1920-2641; Liu, Jian/0000-0003-1920-2641	Research Program for Key Technologies of Sponge City Construction and Management in Guyuan City [SCHM-2018]; China Major Science and Technology Program for Water Pollution Control and Treatment [2017ZX07101003]; National Natural Science Foundation of China [41601333]	Research Program for Key Technologies of Sponge City Construction and Management in Guyuan City; China Major Science and Technology Program for Water Pollution Control and Treatment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Research Program for Key Technologies of Sponge City Construction and Management in Guyuan City (No. SCHM-2018) to Miansong Huang, the China Major Science and Technology Program for Water Pollution Control and Treatment (No. 2017ZX07101003) to Jian Liu, and the National Natural Science Foundation of China (No. 41601333) to Ruilian Sun. Miansong Huang is employed by a commercial company Beijing Capital Co., Ltd, and the funder provided support in the form of salaries for Miansong Huang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the "author contributions" section.	Abbate PE, 2004, CROP SCI, V44, P474, DOI 10.2135/cropsci2004.0474; Barbier S, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009041; Barbosa ICR, 2010, GLOBAL CHANGE BIOL, V16, P1171, DOI 10.1111/j.1365-2486.2009.02018.x; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; [曹生奎 CAO Sheng-Kui], 2009, [生态学报, Acta Ecologica Sinica], V29, P3882; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; [崔广柏 Cui Guangbo], 2016, [水资源保护, Water Resources Protection], V32, P1; Damesin C, 2003, PLANT CELL ENVIRON, V26, P207, DOI 10.1046/j.1365-3040.2003.00951.x; Danjie W., 2016, CHINA SOFT SCI, V1, P79; EHLERINGER JR, 1987, OECOLOGIA, V72, P109, DOI 10.1007/BF00385053; Eleki K, 2005, CROP SCI, V45, P879, DOI 10.2135/cropsci2004.0170; EVANS JR, 1983, PLANT PHYSIOL, V72, P297, DOI 10.1104/pp.72.2.297; Farquhar G.D., 1989, STABLE ISOTOPES ECOL, V68, P21, DOI [10.1007/978-1-4612-3498-2_2, DOI 10.1007/978-1-4612-3498-2_2]; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Forster BP, 1994, ASPECTS APPL BIOL; [高琦 Gao Qi], 2018, [南开大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Nankaiensis], V51, P1; Guo X, 2017, BARLEY CEREAL SCI, V34, P50, DOI [10.14069/j.cnki.32-1769/s.2017.05.011, DOI 10.14069/J.CNKI.32-1769/S.2017.05.011]; Han S-C., 2010, NINGXIA ENG TECHNOLO, V9, P68; Hu J, 2010, NEW PHYTOL, V185, P1000, DOI 10.1111/j.1469-8137.2009.03154.x; Huang JianHui, 2005, Acta Phytoecologica Sinica, V29, P530; HUBICK KT, 1986, AUST J PLANT PHYSIOL, V13, P803, DOI 10.1071/PP9860803; KORNER C, 1988, OECOLOGIA, V74, P623, DOI 10.1007/BF00380063; Lajtha K, 1994, FRESHWATER BIOL, V54, P434, DOI [10.1111/j.1365-2427.2008.02114.x, DOI 10.1111/J.1365-2427.2008.02114.X]; Leffler AJ, 2001, TREE PHYSIOL, V21, P1149, DOI 10.1093/treephys/21.15.1149; Lockhart E, 2016, FUNCT PLANT BIOL, V43, P1149, DOI 10.1071/FP16022; Lu R., 2000, ANAL METHODS SOILS A; Luo Y, 2009, J DESERT RES; MARSHALL JD, 1994, ECOLOGY, V75, P1887, DOI 10.2307/1941593; MARTINELLI LA, 1991, NATURE, V353, P57, DOI 10.1038/353057a0; McCarthy HR, 2011, ECOL APPL, V21, P3115, DOI 10.1890/11-0048.1; Moghaddam A, 2013, EUR J AGRON, V50, P82, DOI 10.1016/j.eja.2013.05.010; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; [潘晓 Pan Xiao], 2018, [草业科学, Pratacultural Science], V35, P2622; Pauleit S, 2019, URBAN FOR URBAN GREE, V40, P1, DOI 10.1016/j.ufug.2019.04.007; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Ponton S, 2006, GLOBAL CHANGE BIOL, V12, P294, DOI 10.1111/j.1365-2486.2005.01103.x; Pronger J, 2019, SCI TOTAL ENVIRON, V665, P698, DOI 10.1016/j.scitotenv.2019.02.014; Ren J, 2017, TIANJIN AGR SCI, V23, P97, DOI [10.3969/j.issn.1006-6500.2017.03.023, DOI 10.3969/J.ISSN.1006-6500.2017.03.023]; Ross JD, 1993, PHYTOCHEMISTRY, DOI [10.1016/s0031-9422(00)90556-9, DOI 10.1016/S0031-9422(00)90556-9, 10.1016/S0031-9422(00)90556-9]; [桑建人 SANG Jianren], 2006, [中国沙漠, Journal of Desert Research], V26, P122; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Scartazza A, 2004, OECOLOGIA, V140, P340, DOI 10.1007/s00442-004-1588-1; SCHMIDT G, 1993, ISOTOPENPRAXIS, V29, P9, DOI 10.1080/10256019308046129; Shi YH, 2018, INT J BIOMETEOROL, V62, P141, DOI 10.1007/s00484-017-1434-x; Sun BN, 2003, P NATL ACAD SCI USA, V100, P7141, DOI 10.1073/pnas.1232419100; Sun ZJ, 1996, PLANT CELL ENVIRON, V19, P887, DOI 10.1111/j.1365-3040.1996.tb00425.x; Tanner CC, 1996, ECOL ENG, V7, P59, DOI 10.1016/0925-8574(95)00066-6; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; WRIGHT GC, 1994, CROP SCI, V34, P92, DOI 10.2135/cropsci1994.0011183X003400010016x; Yang Y., 2015, S ARCHIT, V167, P59, DOI DOI 10.3969/J.ISSN.1000-0232.2015.03.059	52	6	6	8	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2019	14	7							e0220083	10.1371/journal.pone.0220083	http://dx.doi.org/10.1371/journal.pone.0220083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4VN	31344093	Green Published, Green Submitted, gold			2022-12-26	WOS:000484977900054
